Citrus Sinensis ID: 038098

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580
Protein Sequence
GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR
Secondary Structure (PSIPRED)
cccccccccccccccccccEEEcccccccccccHHHHccccccEEEccccccccccccccccccccccEEccccccccccHHccccccccccccccccccccccccccccccccccccccccHHHcccccccEEccccccccccccHHHHccccccEEccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccEEEEEccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccccccccHHHcccccccEEEccccccEccccccccEEEEcEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHcccHHHccHHHcccccEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHcccHHcEEEcccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHccHHcHHHHHEEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEcccccHHHHHHcHHHHEccccccccEEEEcccccccccHHcEEEEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHccccEEEEcHHHcccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
GNNLNGSIPIAVGKLQKLQLLslednqlegsipdDLCRLAALFEldsggnkldgfvpacfgnltnlrnlylgsnkltsipstlWNLKDILYLDLSSNFLLIGNLKVLVQVDLsmnnfsdvipttigglkDLQYLFLEYNrlqgsipdsigdlinlkslnlsnnnlsgtipisLEKLLDLKDINVSFNklegeipnkgpfrnfstesfegnellcgmpnlqvppcrtrihhtsrknDLLIGIVLPLSTIFMMAVILFILRYrkrgkplpndanmprisnqrRFTYLEIFQAtngfsennligrggfgSVYKARIQDGMEVAVKVFDLqygrafksfdIECDMIKRIRHRNIIKIISSCSSDDFKALVLEymphgslekclyssnYILDIFQRLNIMIDVASALEYLhfgysvpiihcdlkpsnvllddnmvahlsdfgmakpllkedqslTQTQTLATIgymapeygregqvstngdvYSFGIMLMETftrkkptdeiffgdmTLKHWVNDLLPISVMEIVDAnllsqkdehfttkgQCVSFIFNLAmkctvespeqrINAKEIVTRLLKIRDSLLKNVKR
Flexible Loop (DISEMBL)
GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNklegeipnkgpfRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRkrgkplpndanmprisnQRRFTYLEIFQATngfsennliGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCtvespeqrinakeIVTRLLKirdsllknvkr
Low Complexity Region (SEG)
GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDlinlkslnlsnnnlsGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMikrirhrniikiisscssDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR
Disordered region (IsUnstruct)
*******IPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKR*************SNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD********
Disordered Region (DISOPRED)
GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPN********************IGIVLPLSTIFMMAVILFILR********************RRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED***TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK****
Disordered Region (DISEMBL)
GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR
Disordered Region (DISPRO)
****NGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC*******SRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGK*******MPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS*******
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	580	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.982	0.564	0.407	1e-118
C0LGT6	1031	LRR receptor-like serine/	no	no	0.974	0.548	0.370	1e-104
Q9SD62	1025	Putative receptor-like pr	no	no	0.989	0.56	0.384	3e-99
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.963	0.570	0.359	7e-91
Q9FL28	1173	LRR receptor-like serine/	no	no	0.968	0.479	0.332	7e-80
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.974	0.452	0.325	1e-78
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.970	0.449	0.337	3e-75
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.9	0.432	0.324	5e-75
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.9	0.432	0.322	1e-74
Q9LJF3	1164	Receptor-like protein kin	no	no	0.955	0.475	0.318	2e-73

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  424 bits (1090), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 250/614 (40%), Positives = 365/614 (59%), Gaps = 44/614 (7%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N L+G +P ++GKL  L+ LSL  N+L G IP  +  +  L  LD   N  +G VP   G
Sbjct: 395  NMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLG 454

Query: 62   NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
            N ++L  L++G NKL  +IP  +  ++ +L LD+S N L+      IG L+ L  + L  
Sbjct: 455  NCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGD 514

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N  S  +P T+G    ++ LFLE N   G IPD  G L+ +K ++LSNN+LSG+IP    
Sbjct: 515  NKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFA 573

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRTRI----- 228
                L+ +N+SFN LEG++P KG F N +T S  GN  LCG +   Q+ PC ++      
Sbjct: 574  SFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVK 633

Query: 229  HHTSRKNDLLIGIVLPLSTI---FMMAVILFILRYRKRGKPLPNDANMPRISN----QRR 281
             H+SR   ++IG+ + ++ +   FM +V L  LR RK+ K    + N P  S       +
Sbjct: 634  KHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK----ETNNPTPSTLEVLHEK 689

Query: 282  FTYLEIFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECD 340
             +Y ++  ATNGFS +N++G G FG+VYKA +  +   VAVKV ++Q   A KSF  EC+
Sbjct: 690  ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749

Query: 341  MIKRIRHRNIIKIISSCSS-----DDFKALVLEYMPHGSLEKCLYSS--------NYILD 387
             +K IRHRN++K++++CSS     ++F+AL+ E+MP+GSL+  L+          +  L 
Sbjct: 750  SLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLT 809

Query: 388  IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
            + +RLNI IDVAS L+YLH     PI HCDLKPSNVLLDD++ AH+SDFG+A+ LLK D+
Sbjct: 810  LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869

Query: 448  -----SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM 502
                  L+      TIGY APEYG  GQ S NGDVYSFGI+L+E FT K+PT+E+F G+ 
Sbjct: 870  ESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNF 929

Query: 503  TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
            TL  +    LP  +++IVD ++L           +C++ +F + ++C  ESP  R+    
Sbjct: 930  TLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSI 989

Query: 563  IVTRLLKIRDSLLK 576
            +V  L+ IR+   K
Sbjct: 990  VVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  379 bits (972), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 237/639 (37%), Positives = 342/639 (53%), Gaps = 74/639 (11%)

Query: 1    GNNL-NGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            G NL +G+IP  +G L  LQ LSLE N L G +P    +L  L  +D   N + G +P+ 
Sbjct: 377  GQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSY 436

Query: 60   FGNLTNLRNLYLGSNKL-------------------------TSIPSTLWNLKDILYLDL 94
            FGN+T L+ L+L SN                            +IP  +  +  + Y+DL
Sbjct: 437  FGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDL 496

Query: 95   SSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDS 148
            S+NFL       +G L++LV +  S N  S  +P  IGG   +++LF++ N   G+IPD 
Sbjct: 497  SNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD- 555

Query: 149  IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFE 208
            I  L++LK+++ SNNNLSG IP  L  L  L+++N+S NK EG +P  G FRN +  S  
Sbjct: 556  ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVF 615

Query: 209  GNELLCG-MPNLQVPPCRTRIHHTSRK-----NDLLIGIVLPLSTIFMMAVILFILRYRK 262
            GN  +CG +  +Q+ PC  +     RK       ++ GI + ++++ ++ ++  +  + K
Sbjct: 616  GNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMK 675

Query: 263  RGKPLPNDANMPRISN-----QRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARI-QDG 316
            R K        P  S        + +Y E+  AT+ FS  NLIG G FG+V+K  +  + 
Sbjct: 676  RKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPEN 735

Query: 317  MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS-----DDFKALVLEYMP 371
              VAVKV +L    A KSF  EC+  K IRHRN++K+I+ CSS     +DF+ALV E+MP
Sbjct: 736  KLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMP 795

Query: 372  HGSLEKCLY--------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
             GSL+  L           +  L   ++LNI IDVASALEYLH     P+ HCD+KPSN+
Sbjct: 796  KGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNI 855

Query: 424  LLDDNMVAHLSDFGMAKPLLKEDQ-----SLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
            LLDD++ AH+SDFG+A+ L K D+       +      TIGY APEYG  GQ S  GDVY
Sbjct: 856  LLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVY 915

Query: 479  SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
            SFGI+L+E F+ KKPTDE F GD  L  +   +L         +   S    +   +G  
Sbjct: 916  SFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL---------SGCTSSGGSNAIDEG-- 964

Query: 539  VSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
            +  +  + +KC+ E P  R+   E V  L+ IR     +
Sbjct: 965  LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  362 bits (930), Expect = 3e-99,   Method: Compositional matrix adjust.
 Identities = 236/614 (38%), Positives = 353/614 (57%), Gaps = 40/614 (6%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N L G +P ++G+L +L+ + L  N L G IP  L  ++ L  L    N  +G +P+  G
Sbjct: 411  NLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLG 470

Query: 62   NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
            + + L +L LG+NKL  SIP  L  L  ++ L++S N L+      IG LK L+ +D+S 
Sbjct: 471  SCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSY 530

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N  S  IP T+     L++L L+ N   G IPD I  L  L+ L+LS NNLSGTIP  + 
Sbjct: 531  NKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMA 589

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRT---RIHH 230
                L+++N+S N  +G +P +G FRN S  S  GN  LCG +P+LQ+ PC     R H 
Sbjct: 590  NFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHS 649

Query: 231  TSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDAN------MPRISNQRRFTY 284
            + RK   +    +  + + +   ++++  Y+ R K +  + N       P  S   + +Y
Sbjct: 650  SVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISY 709

Query: 285  LEIFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIK 343
             E+++ T GFS +NLIG G FG+V+K  +      VA+KV +L    A KSF  EC+ + 
Sbjct: 710  DELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALG 769

Query: 344  RIRHRNIIKIISSCSS-----DDFKALVLEYMPHGSLEKCLY--------SSNYILDIFQ 390
             IRHRN++K+++ CSS     +DF+ALV E+MP+G+L+  L+        + +  L +F 
Sbjct: 770  GIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFA 829

Query: 391  RLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
            RLNI IDVASAL YLH     PI HCD+KPSN+LLD ++ AH+SDFG+A+ LLK D+   
Sbjct: 830  RLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTF 889

Query: 451  QTQ-----TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
              Q        TIGY APEYG  G  S  GDVYSFGI+L+E FT K+PT+++F   +TL 
Sbjct: 890  HIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLH 949

Query: 506  HWVNDLLPI-SVMEIVDANLL-SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
             +    L     ++I D  +L     +HF    +C++ +F + + C+ ESP  RI+  E 
Sbjct: 950  SFTKSALQKRQALDITDETILRGAYAQHFNMV-ECLTLVFRVGVSCSEESPVNRISMAEA 1008

Query: 564  VTRLLKIRDSLLKN 577
            +++L+ IR+S  ++
Sbjct: 1009 ISKLVSIRESFFRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  335 bits (858), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 223/620 (35%), Positives = 335/620 (54%), Gaps = 61/620 (9%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           N+L G IP+ +G + +L LL +  N L GSIPD    L+ L  L   GN L G VP   G
Sbjct: 355 NHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLG 414

Query: 62  NLTNLRNLYLGSNKLT-SIP----STLWNLKDILYLDLSSNFLL------IGNLKVLVQV 110
              NL  L L  N LT +IP    S L NLK  LYL+LSSN L       +  + +++ V
Sbjct: 415 KCINLEILDLSHNNLTGTIPVEVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSV 472

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
           DLS N  S  IP  +G    L++L L  N    ++P S+G L  LK L++S N L+G IP
Sbjct: 473 DLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIP 532

Query: 171 ISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRTRIH 229
            S ++   LK +N SFN L G + +KG F   + ESF G+ LLCG +  +Q   C+ +  
Sbjct: 533 PSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHK 590

Query: 230 H-TSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLP---------------NDANM 273
           + +     LL  I  P+  +F   ++    +  + GK L                ND   
Sbjct: 591 YPSVLLPVLLSLIATPVLCVFGYPLV----QRSRFGKNLTVYAKEEVEDEEKQNQNDPKY 646

Query: 274 PRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK 333
           PRIS      Y ++  AT GF+ ++LIG G FG VYK  +++  +VAVKV D +    F 
Sbjct: 647 PRIS------YQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFS 700

Query: 334 -SFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---LDIF 389
            SF  EC ++KR RHRN+I+II++CS   F ALVL  MP+GSLE+ LY   Y    LD+ 
Sbjct: 701 GSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLI 760

Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
           Q +NI  DVA  + YLH    V ++HCDLKPSN+LLDD M A ++DFG+++ +   ++++
Sbjct: 761 QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETV 820

Query: 450 TQTQTLA----------TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFF 499
           +   +++          ++GY+APEYG   + ST+GDVYSFG++L+E  + ++PTD +  
Sbjct: 821 STDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVN 880

Query: 500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG-----QCVSFIFNLAMKCTVESP 554
              +L  ++    P S+  I++  L   K +    K      + +  +  L + CT  +P
Sbjct: 881 EGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNP 940

Query: 555 EQRINAKEIVTRLLKIRDSL 574
             R +  ++   + ++++ L
Sbjct: 941 STRPDMLDVAHEMGRLKEYL 960

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  298 bits (764), Expect = 7e-80,   Method: Compositional matrix adjust.
 Identities = 209/629 (33%), Positives = 347/629 (55%), Gaps = 67/629 (10%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP  +  ++ L +L L +N+  G IP    +L +L  L   GNK +G +PA   
Sbjct: 537  NDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLK 596

Query: 62   NLTNLRNLYLGSNKLT-SIPSTLW-NLKDI-LYLDLSSNFLL------IGNLKVLVQVDL 112
            +L+ L    +  N LT +IP  L  +LK++ LYL+ S+N L       +G L+++ ++DL
Sbjct: 597  SLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDL 656

Query: 113  SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPD------------------------- 147
            S N FS  IP ++   K++  L    N L G IPD                         
Sbjct: 657  SNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQ 716

Query: 148  SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESF 207
            S G++ +L SL+LS+NNL+G IP SL  L  LK + ++ N L+G +P  G F+N +    
Sbjct: 717  SFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDL 776

Query: 208  EGNELLCGMPNLQVPPC--RTRIHHTSRKND---LLIGIVLPLSTIFMMAVILFILRYRK 262
             GN  LCG     + PC  + +  H S++     +++G    L  + ++ +IL   + ++
Sbjct: 777  MGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKE 835

Query: 263  RGKPLPNDANMPRISNQ---RRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEV 319
            +     +++++P + +    +RF   E+ QAT+ F+  N+IG     +VYK +++DG  +
Sbjct: 836  KKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVI 895

Query: 320  AVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIIS-SCSSDDFKALVLEYMPHGSLE 376
            AVKV +L+     + K F  E   + +++HRN++KI+  +  S   KALVL +M +G+LE
Sbjct: 896  AVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLE 955

Query: 377  KCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD 435
              ++ S   I  + +++++ + +AS ++YLH GY  PI+HCDLKP+N+LLD + VAH+SD
Sbjct: 956  DTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSD 1015

Query: 436  FGMAKPL-LKEDQSLTQTQTL--ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK 492
            FG A+ L  +ED S T + +    TIGY+APE+    +V+T  DV+SFGI++ME  T+++
Sbjct: 1016 FGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQR 1075

Query: 493  PT--DEIFFGDMTLKHWVND--------LLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
            PT  ++    DMTL+  V          ++ +  ME+ D+ ++S K E      + +   
Sbjct: 1076 PTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDS-IVSLKQE------EAIEDF 1128

Query: 543  FNLAMKCTVESPEQRINAKEIVTRLLKIR 571
              L + CT   PE R +  EI+T L+K+R
Sbjct: 1129 LKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  294 bits (752), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 213/654 (32%), Positives = 326/654 (49%), Gaps = 89/654 (13%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N L G IP  +GK+++L LL +  N L G+IP  L     L  +D   N L G +P   G
Sbjct: 609  NQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLG 668

Query: 62   NLTNLRNLYLGSNK-LTSIPSTLWNLKDILYLDLSSNFL--------------------- 99
             L+ L  L L SN+ + S+P+ L+N   +L L L  N L                     
Sbjct: 669  KLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDK 728

Query: 100  ---------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ-YLFLEYNRLQGSIPDSI 149
                      +G L  L ++ LS N+ +  IP  IG L+DLQ  L L YN   G IP +I
Sbjct: 729  NQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTI 788

Query: 150  GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEG 209
            G L  L++L+LS+N L+G +P S+  +  L  +NVSFN L G++  K  F  +  +SF G
Sbjct: 789  GTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLG 846

Query: 210  NELLCGMPNLQVPPCRT--RIHHTSRKNDLLIGIVLPLSTIFMMAVILFILR------YR 261
            N  LCG P  +    R+  +    S ++ ++I  +  L+ I +M +++ +        ++
Sbjct: 847  NTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFK 906

Query: 262  KRG-----------------KPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGG 304
            K G                 KPL  +      +++    + +I +AT+  SE  +IG GG
Sbjct: 907  KVGHGSTAYTSSSSSSQATHKPLFRNG-----ASKSDIRWEDIMEATHNLSEEFMIGSGG 961

Query: 305  FGSVYKARIQDGMEVAVKVF----DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS- 359
             G VYKA +++G  VAVK      DL    + KSF  E   + RIRHR+++K++  CSS 
Sbjct: 962  SGKVYKAELENGETVAVKKILWKDDLM---SNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018

Query: 360  -DDFKALVLEYMPHGSLEKCLYSSNYIL-------DIFQRLNIMIDVASALEYLHFGYSV 411
             +    L+ EYM +GS+   L+    +L       D   RL I + +A  +EYLH     
Sbjct: 1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078

Query: 412  PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL--ATIGYMAPEYGREG 469
            PI+H D+K SNVLLD NM AHL DFG+AK L +   + T + T    + GY+APEY    
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSL 1138

Query: 470  QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM---EIVDANLLS 526
            + +   DVYS GI+LME  T K PTD +F  +M +  WV   L ++     +++D  L  
Sbjct: 1139 KATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL-- 1196

Query: 527  QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
            +    F     C   +  +A++CT  SP++R ++++    LL + ++     K+
Sbjct: 1197 KPLLPFEEDAACQ--VLEIALQCTKTSPQERPSSRQACDSLLHVYNNRTAGYKK 1248

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  283 bits (724), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 205/608 (33%), Positives = 318/608 (52%), Gaps = 45/608 (7%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L+G IP+ +G  +KL  + L +N L G IP  L +L  L EL    NK  G +P    
Sbjct: 634  NSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIF 693

Query: 62   NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSM 114
            +LTN+  L+L  N L  SIP  + NL+ +  L+L  N L       IG L  L ++ LS 
Sbjct: 694  SLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSR 753

Query: 115  NNFSDVIPTTIGGLKDLQ-YLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL 173
            N  +  IP  IG L+DLQ  L L YN   G IP +I  L  L+SL+LS+N L G +P  +
Sbjct: 754  NALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQI 813

Query: 174  EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHT-S 232
              +  L  +N+S+N LEG++  K  F  +  ++F GN  LCG P        ++   + S
Sbjct: 814  GDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLS 871

Query: 233  RKNDLLIGIVLPLSTIFMMAVILFILRYRK--------RG-----KPLPNDANMPRISN- 278
             K  ++I  +  L+ I +M V++ IL +++        RG         + +  P  SN 
Sbjct: 872  PKTVVIISAISSLAAIALM-VLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNG 930

Query: 279  --QRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVF----DLQYGRAF 332
              +    + +I +AT+  +E  +IG GG G VYKA +++G  +AVK      DL    + 
Sbjct: 931  GAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLM---SN 987

Query: 333  KSFDIECDMIKRIRHRNIIKIISSCSS--DDFKALVLEYMPHGSLEKCLYSSN-----YI 385
            KSF+ E   +  IRHR+++K++  CSS  D    L+ EYM +GS+   L+++       +
Sbjct: 988  KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047

Query: 386  LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
            L    RL I + +A  +EYLH+    PI+H D+K SNVLLD N+ AHL DFG+AK L   
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107

Query: 446  DQSLTQTQTL--ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT 503
              + T++ T+   + GY+APEY    + +   DVYS GI+LME  T K PT+ +F  +  
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETD 1167

Query: 504  LKHWVNDLLPISVMEIVDANLL-SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
            +  WV  +L           L+ S+       + +    +  +A++CT   P++R ++++
Sbjct: 1168 MVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQ 1227

Query: 563  IVTRLLKI 570
                LL +
Sbjct: 1228 ASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  282 bits (721), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 201/620 (32%), Positives = 291/620 (46%), Gaps = 98/620 (15%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP ++    KL  +SL +NQL G IP  L RL+ L  L  G N + G +PA  G
Sbjct: 509  NDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELG 568

Query: 62   NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDL-------------------SSNFLLI 101
            N  +L  L L +N L  SIP  L+     + + L                   + N L  
Sbjct: 569  NCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEF 628

Query: 102  GNLK-------------------------------VLVQVDLSMNNFSDVIPTTIGGLKD 130
            G ++                                ++ +DLS N     IP  +G +  
Sbjct: 629  GGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYY 688

Query: 131  LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
            L  L L +N L G IP  +G L N+  L+LS N  +GTIP SL  L  L +I++S N L 
Sbjct: 689  LSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLS 748

Query: 191  GEIPNKGPFRNFSTESFEGNELLCGMPNLQVP-PC------------RTRIHHTSRKNDL 237
            G IP   PF  F    F  N  LCG P   +P PC            ++     S    +
Sbjct: 749  GMIPESAPFDTFPDYRFANNS-LCGYP---LPIPCSSGPKSDANQHQKSHRRQASLAGSV 804

Query: 238  LIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQ------------------ 279
             +G++  L  IF + ++    + R+R K    +A M   S+                   
Sbjct: 805  AMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALSI 864

Query: 280  ---------RRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR 330
                     R+ T+ ++ +ATNGF  ++L+G GGFG VYKA+++DG  VA+K      G+
Sbjct: 865  NLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQ 924

Query: 331  AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---LD 387
              + F  E + I +I+HRN++ ++  C   + + LV EYM +GSLE  L+    I   L+
Sbjct: 925  GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLN 984

Query: 388  IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
               R  I I  A  L +LH      IIH D+K SNVLLD+N+ A +SDFGMA+ +   D 
Sbjct: 985  WPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDT 1044

Query: 448  SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW 507
             L+ +    T GY+ PEY +  + ST GDVYS+G++L+E  T K+PTD   FGD  L  W
Sbjct: 1045 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGW 1104

Query: 508  VNDLLPISVMEIVDANLLSQ 527
            V       + ++ D  LL +
Sbjct: 1105 VKLHAKGKITDVFDRELLKE 1124

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  281 bits (718), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 200/620 (32%), Positives = 291/620 (46%), Gaps = 98/620 (15%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP ++    KL  +SL +NQL G IP  L RL+ L  L  G N + G +PA  G
Sbjct: 509  NDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELG 568

Query: 62   NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDL-------------------SSNFLLI 101
            N  +L  L L +N L  SIP  L+     + + L                   + N L  
Sbjct: 569  NCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEF 628

Query: 102  GNLK-------------------------------VLVQVDLSMNNFSDVIPTTIGGLKD 130
            G ++                                ++ +DLS N     IP  +G +  
Sbjct: 629  GGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYY 688

Query: 131  LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
            L  L L +N L G IP  +G L N+  L+LS N  +GTIP SL  L  L +I++S N L 
Sbjct: 689  LSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLS 748

Query: 191  GEIPNKGPFRNFSTESFEGNELLCGMPNLQVP-PC------------RTRIHHTSRKNDL 237
            G IP   PF  F    F  N  LCG P   +P PC            ++     S    +
Sbjct: 749  GMIPESAPFDTFPDYRFANNS-LCGYP---LPLPCSSGPKSDANQHQKSHRRQASLAGSV 804

Query: 238  LIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQ------------------ 279
             +G++  L  IF + ++    + R+R K    +A M   S+                   
Sbjct: 805  AMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALSI 864

Query: 280  ---------RRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR 330
                     R+ T+ ++ +ATNGF  ++L+G GGFG VYKA+++DG  VA+K      G+
Sbjct: 865  NLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQ 924

Query: 331  AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLY---SSNYILD 387
              + F  E + I +I+HRN++ ++  C   + + LV EYM +GSLE  L+    +   L+
Sbjct: 925  GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLN 984

Query: 388  IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
               R  I I  A  L +LH      IIH D+K SNVLLD+N+ A +SDFGMA+ +   D 
Sbjct: 985  WPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDT 1044

Query: 448  SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW 507
             L+ +    T GY+ PEY +  + ST GDVYS+G++L+E  T K+PTD   FGD  L  W
Sbjct: 1045 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGW 1104

Query: 508  VNDLLPISVMEIVDANLLSQ 527
            V       + ++ D  LL +
Sbjct: 1105 VKLHAKGKITDVFDRELLKE 1124

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  277 bits (708), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 201/632 (31%), Positives = 294/632 (46%), Gaps = 78/632 (12%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA--- 58
            N L G IP+ +GKL+KL +L L +N L G+IP +L     L  LD   N L G +P    
Sbjct: 509  NLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELA 568

Query: 59   --------------------------CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYL 92
                                      C G    +    + + +L   P      K  +Y 
Sbjct: 569  SQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYS 628

Query: 93   DLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL 152
             ++    +  +   ++ +DLS N  S  IP   G +  LQ L L +N L G+IPDS G L
Sbjct: 629  GMT--MYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGL 686

Query: 153  INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL 212
              +  L+LS+N+L G +P SL  L  L D++VS N L G IP  G    F    +  N  
Sbjct: 687  KAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSG 746

Query: 213  LCGMPNLQVPPCR-----TRIHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKRG--- 264
            LCG+P   +PPC      TR H   +K  +  G+   +   FM  V+L +  YR R    
Sbjct: 747  LCGVP---LPPCSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQK 803

Query: 265  ---------KPLPNDANMPRISNQ----------------RRFTYLEIFQATNGFSENNL 299
                     + LP   +     +                 R+ T+  + +ATNGFS +++
Sbjct: 804  KEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSM 863

Query: 300  IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
            IG GGFG VYKA++ DG  VA+K      G+  + F  E + I +I+HRN++ ++  C  
Sbjct: 864  IGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 923

Query: 360  DDFKALVLEYMPHGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
             + + LV EYM +GSLE  L+         LD   R  I I  A  L +LH      IIH
Sbjct: 924  GEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIH 983

Query: 416  CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
             D+K SNVLLD + VA +SDFGMA+ +   D  L+ +    T GY+ PEY +  + +  G
Sbjct: 984  RDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKG 1043

Query: 476  DVYSFGIMLMETFTRKKPTDEIFFG-DMTLKHWVNDLL-PISVMEIVDANLLSQKDEHFT 533
            DVYS+G++L+E  + KKP D   FG D  L  W   L       EI+D  L++ K     
Sbjct: 1044 DVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVE 1103

Query: 534  TKGQCVSFIFNLAMKCTVESPEQRINAKEIVT 565
                 +     +A +C  + P +R    +++T
Sbjct: 1104 -----LLHYLKIASQCLDDRPFKRPTMIQVMT 1130

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	580
359483198	1087	PREDICTED: probable LRR receptor-like se	0.979	0.522	0.568	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.974	0.470	0.562	1e-173
224139658	1019	predicted protein [Populus trichocarpa]	0.996	0.567	0.535	1e-171
255572272	1089	serine-threonine protein kinase, plant-t	0.994	0.529	0.514	1e-169
255585401	843	serine-threonine protein kinase, plant-t	0.989	0.680	0.554	1e-168
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.979	0.4	0.546	1e-168
224116832	1061	predicted protein [Populus trichocarpa]	0.982	0.537	0.512	1e-168
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.984	0.464	0.539	1e-167
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.984	0.500	0.530	1e-165
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.982	0.392	0.536	1e-165

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/580 (56%), Positives = 424/580 (73%), Gaps = 12/580 (2%)

Query: 3    NLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGN 62
            +L G+IP ++G+LQKLQ L L  N+L+GSIP+D+C+L  L EL    N+L G +PAC G 
Sbjct: 504  DLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGE 563

Query: 63   LTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMN 115
            LT LR+LYLGSNKL S IPSTLW+L  IL LD+SSNFL+      +GNLKVLV++DLS N
Sbjct: 564  LTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRN 623

Query: 116  NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
              S  IP+ IGGL+DL  L L +NR +G I  S  +L +L+ ++LS+N L G IP SLE 
Sbjct: 624  QLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEG 683

Query: 176  LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKN 235
            L+ LK ++VSFN L GEIP +GPF NFS ESF  N+ LCG P L++PPCRT    ++  +
Sbjct: 684  LVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTIS 743

Query: 236  DLLIGIVLP--LSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNG 293
             LL+  +LP  LST+  +A+I    R RKR   LP  +     +  RR +Y EIFQATNG
Sbjct: 744  WLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNG 803

Query: 294  FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
            FS  NL+GRG  GSVY+  + DG   A+KVF+LQ   AFKSFD EC+++  IRHRN+IKI
Sbjct: 804  FSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKI 863

Query: 354  ISSCSSD--DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +SSCS+   DFKALVLEY+P+GSLE+ LYS NY LDI QRLNIMIDVA A+EYLH G S 
Sbjct: 864  VSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCST 923

Query: 412  PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            P++HCDLKPSN+LLD++   H+ DFG+AK LL+E++S+ +TQTLATIGYMAP+Y   G V
Sbjct: 924  PVVHCDLKPSNILLDEDFGGHVGDFGIAK-LLREEESIRETQTLATIGYMAPKYVSNGIV 982

Query: 472  STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
            +T+GDVYS+GI+LMETFTR++PTDEIF  +M++K+WV D L  S+ E+VDANLL  +DE 
Sbjct: 983  TTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQ 1042

Query: 532  FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
            F  K QC+S I  LAM C  +SPE+RI  K++VT L KI+
Sbjct: 1043 FMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  613 bits (1582), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 330/587 (56%), Positives = 421/587 (71%), Gaps = 22/587 (3%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP   G+LQKLQ+LS+  N++ GSIP  LC L  L  LD   NKL G +P+C G
Sbjct: 618  NDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSG 677

Query: 62   NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSM 114
            NLT LRN+YL SN L S IPS+L NL+ +L L+LSSNFL       +GN+K LV +DLS 
Sbjct: 678  NLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSK 737

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N FS  IP+TI  L++L  L+L +N+LQG IP + GDL++L+SL+LS NNLSGTIP SLE
Sbjct: 738  NQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLE 797

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRK 234
             L  L+ +NVSFNKL+GEIPN GPF NF+ ESF  N  LCG P  QV  C       SRK
Sbjct: 798  HLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACE----KDSRK 853

Query: 235  N--DLLIGIVLPLSTIF--MMAVILFILRYRKRGK---PLPNDANMPRISNQRRFTYLEI 287
            N   LL+  ++PLS     ++ V+LF+   R++ K   P+  D ++PR+   R   + E+
Sbjct: 854  NTKSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRM--HRMIPHQEL 911

Query: 288  FQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH 347
              ATN F E+NLIG+G  G VYK  + DG+ VAVKVF+L+   AFKSF++EC++++ IRH
Sbjct: 912  LYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRH 971

Query: 348  RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
            RN+ KIISSCS+ DFKALVLEYMP+GSLEK LYS NY LD  QRL IMIDVAS LEYLH 
Sbjct: 972  RNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHH 1031

Query: 408  GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             YS P++HCDLKPSNVLLDD+MVAH+SDFG+AK LL   + + +T+TL T+GYMAPEYG 
Sbjct: 1032 YYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAK-LLMGSEFMKRTKTLGTVGYMAPEYGS 1090

Query: 468  EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
            EG VST GD+YS+GI+LMETF RKKPTDE+F  ++TLK WV      ++ME++DANLL++
Sbjct: 1091 EGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTE 1149

Query: 528  KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
            +DE F  K  C S I  LA+ CTVE PE+RIN K++V RL K+ + +
Sbjct: 1150 EDESFALKRACFSSIMTLALDCTVEPPEKRINTKDVVVRLKKLLNQI 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  607 bits (1565), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 315/588 (53%), Positives = 410/588 (69%), Gaps = 10/588 (1%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP  VG L+K+Q+L L  N L GSIP D+C    L ++    N L G +P+C G
Sbjct: 430  NSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIG 489

Query: 62   NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
            NLT+LRNLYL  N L+S IP  LW+LKD+L L+L SNFL       +G ++  + + LS 
Sbjct: 490  NLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSS 549

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N  S  IP+TIG L++L    L  N  QGSIP++ G L++L+ L+LS NNLSG IP SLE
Sbjct: 550  NQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLE 609

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRK 234
             L  L+  +VSFN L+GEIP  GPF NF+  SF  N+ LCG   LQVPPC       S+ 
Sbjct: 610  ALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKT 669

Query: 235  NDLLIGIVLPL--STIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATN 292
               L+   LP   S + ++A I  ++  R+R +  P    +P  + QRR +YLE+  ATN
Sbjct: 670  KSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATN 729

Query: 293  GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
             F E+NL+G G FGSVY+ R++DG+ VAVK+F+LQ  RAF+SFD EC++++ IRHRN++K
Sbjct: 730  EFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVK 789

Query: 353  IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
            II SCS+ DFKALVLEYMP GSLEK LYS NY LDI QR+NIMIDVASALEYLH GY  P
Sbjct: 790  IICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSP 849

Query: 413  IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
            ++HCDLKPSNVLLD++MVAH+ DFG+AK LL E++S  QT+TLATIGYMAPEYG +G VS
Sbjct: 850  VVHCDLKPSNVLLDEDMVAHVCDFGIAK-LLGENESFAQTRTLATIGYMAPEYGLDGLVS 908

Query: 473  TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
            T  DVYSFGIMLME  TRK+PTDE+F G+M+LK  V + LP SV++IVD+N+L++ D + 
Sbjct: 909  TKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYS 968

Query: 533  TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
              K  CV+ I  LA++C  ESP +R+   EI+ RL  I+   L++ +R
Sbjct: 969  VKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRDSER 1016

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  602 bits (1552), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 304/591 (51%), Positives = 415/591 (70%), Gaps = 14/591 (2%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP  +G L+ LQ L L  N L+GSIP +LC L  L+ L+  GNKL G +P CF 
Sbjct: 499  NDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFS 558

Query: 62   NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
            NLT+LRNL+L SN+  S I STLW LKDIL ++L+SN+L       I NL+ +  +++S 
Sbjct: 559  NLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISK 618

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N  S  IP +IGGL+DL  L+L  N+LQG IP S+GD+ +L+ L+LS+NNLSG IP SL+
Sbjct: 619  NQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLD 678

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCR---TRIHHT 231
             LL LK  NVSFN L+GEIP  G F NFS +SF GNE LCG   LQV PC+   +R   T
Sbjct: 679  NLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATET 738

Query: 232  SRKNDLLIGIVLP--LSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQ 289
               + +++  VLP  +  +F++A ++ + RY +R      + +   ++  RR +Y E+  
Sbjct: 739  P-GSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQL 797

Query: 290  ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN 349
            ATNGF E+N +G G FGSVYK  + DG  +A KVF+LQ  RAFKSFD EC++++ +RHRN
Sbjct: 798  ATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRN 857

Query: 350  IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            ++KII+SCS  +FKALVLE+MP+ SLEK LYS +Y L+  QRLNIM+DVAS LEYLH GY
Sbjct: 858  LVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGY 917

Query: 410  SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
            ++P+ HCD+KPSNVLL+++MVA L+DFG++K LL E+ S+ QT TLATIGYMAPEYG EG
Sbjct: 918  TIPMAHCDIKPSNVLLNEDMVAFLADFGISK-LLGEEGSVMQTMTLATIGYMAPEYGSEG 976

Query: 470  QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
             VS  GDVYS+G++LMETFT+KKPTD++F   ++LK WV   L   V +++DANLL  ++
Sbjct: 977  IVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEE 1036

Query: 530  EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
            +H   K  C+  I  LA++C+ + P  RI+ K +VT L KI+   L+++++
Sbjct: 1037 DHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQ 1087

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  598 bits (1543), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 327/590 (55%), Positives = 415/590 (70%), Gaps = 16/590 (2%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           N L GSIP+ +G LQKLQ L L  N L GSIP D+C L+ L EL    N L G +PACFG
Sbjct: 256 NELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFLSNNSLFGPLPACFG 315

Query: 62  NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
           +L +LR L+L SN  TS IP +LW+LKD+L L+LSSN L       IGNLKVL QVD S 
Sbjct: 316 DLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLSIGNLKVLTQVDFSY 375

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
           N+ S +IP  IG L++L  L L +NR +G IP+  G+LI+L+SL+LS+NNLSG IP SLE
Sbjct: 376 NSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNNLSGKIPKSLE 435

Query: 175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRK 234
           +L  LK +NVSFN L+GE+PNKG F NFS  SF GN  LCG   L + PC+   H  S+ 
Sbjct: 436 QLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPCKNNTHGGSKT 495

Query: 235 N-DLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNG 293
           +  LL+  VLP ++I  +A IL  LR +K    L N  ++  +   RR ++ E+ QAT+G
Sbjct: 496 STKLLLIYVLP-ASILTIAFILVFLRCQKVKLELENVMDIITVGTWRRISFQELEQATDG 554

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           F  +NL+G GG+GSVYK R++DG  VA+KVF+L    AFK FD EC+++  IRHRN++KI
Sbjct: 555 FCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSIRHRNLVKI 614

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           IS CS+ DFKA+VLEYMP+GSLEK LYS NY L+I QRL +MIDVASALEYLH G+S PI
Sbjct: 615 ISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVASALEYLHHGFSAPI 674

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           +HCDLKPSNVLLD +MV H++DFGMAK LL E   +TQT+TLATIGYMAPEYG +G VS 
Sbjct: 675 VHCDLKPSNVLLDQDMVGHVADFGMAK-LLGEGDLITQTKTLATIGYMAPEYGSKGIVSI 733

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGD--MTLKHWVND-LLPISVMEIVDANLLSQKDE 530
           +GDVYSFGI+LMETFTR KPTD++ FG+  ++LK ++ D LL  +V EI DAN L   DE
Sbjct: 734 SGDVYSFGILLMETFTRMKPTDDM-FGERVLSLKQYIEDALLHNAVSEIADANFL--IDE 790

Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
              +   CVS I  LA+ C+VE P  RI+  +++  L  I+  LL +  R
Sbjct: 791 KNLSTKDCVSSILGLALDCSVELPHGRIDMSQVLAALRSIKAQLLASSAR 840

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  597 bits (1540), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 320/586 (54%), Positives = 412/586 (70%), Gaps = 18/586 (3%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IPI+ G LQKLQ  ++  N++ GSIP  LC L  L  LD   NKL G +P CFG
Sbjct: 619  NDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFG 678

Query: 62   NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSM 114
            NLT LRN+ L SN L S IPS+LW L+D+L L+LSSNFL       +GN+K L+ +DLS 
Sbjct: 679  NLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSK 738

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N FS  IP+TI  L++L  L+L +N+LQG +P + G L++L+ L+LS NN SGTIP SLE
Sbjct: 739  NQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLE 798

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRK 234
             L  LK +NVSFNKL+GEIPN+GPF NF+ ESF  N  LCG P  QV  C       ++ 
Sbjct: 799  ALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKDARRNTKS 858

Query: 235  NDLLIGIVLPLSTIF--MMAVILFILRYRKRGK---PLPNDANMPRISNQRRFTYLEIFQ 289
              LL+  ++PLS     M+ V+LF L  R++ +   P+  D  +PR+   R  ++ E+  
Sbjct: 859  --LLLKCIVPLSVSLSTMILVVLFTLWKRRQTESESPVQVDLLLPRM--HRLISHQELLY 914

Query: 290  ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN 349
            AT+ F E NLIG+G  G VYK  + DG+ VAVKVF+L+   AFKSF++EC++++ IRHRN
Sbjct: 915  ATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRN 974

Query: 350  IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            + KIISSCS+ DFKALVLEYMP+ SLEK LYS NY LD  QRL IMIDVAS LEYLH  Y
Sbjct: 975  LAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDY 1034

Query: 410  SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
            S P++HCDLKPSNVLLDD+MVAH+SDFG+AK LL   + + +T+TL TIGYMAPEYG EG
Sbjct: 1035 SNPVVHCDLKPSNVLLDDDMVAHISDFGIAK-LLMGSEFMKRTKTLGTIGYMAPEYGSEG 1093

Query: 470  QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
             VST  D YS+GI+LME F RKKPTDE+F  ++TLK WV      ++ME++DANLL+++D
Sbjct: 1094 IVSTKCDTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVESSAN-NIMEVIDANLLTEED 1152

Query: 530  EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
            E F  K  C S I  LA+ CT+E PE+RIN K++V RL KI + ++
Sbjct: 1153 ESFALKQACFSSIMTLALDCTIEPPEKRINMKDVVARLKKILNQIV 1198

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  597 bits (1539), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 305/595 (51%), Positives = 415/595 (69%), Gaps = 25/595 (4%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N L G+IP  +G+L+ LQ  SL  N+L+G IP+++C L  L  L    N   G +PAC  
Sbjct: 470  NELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLS 529

Query: 62   NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMN 115
            N+T+LR LYLGSN+ TSIP+T W+LKD+L ++LS N L       IGNLKV+  +D S N
Sbjct: 530  NITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSN 589

Query: 116  NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
              S  IPT+I  L++L +  L  NR+QG IP S GDL++L+ L+LS N+LSG IP SLEK
Sbjct: 590  QLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEK 649

Query: 176  LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHH--TSR 233
            L+ LK  NVSFN+L+GEI + GPF NFS  SF  NE LCG   +QVPPC++   H  + R
Sbjct: 650  LVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKR 709

Query: 234  KNDLLIGIVLPLSTIFMMAVILFILRYRKRGK--------PLPNDANMPRISNQRRFTYL 285
              + +I  ++P     ++ + L ++ +R+  K        PLP        +  R+ +Y 
Sbjct: 710  PREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPP-------ATWRKISYH 762

Query: 286  EIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI 345
            E+++AT GF+E NL+G G  GSVYK  + DG+ +AVKVF LQ       FD EC++++ +
Sbjct: 763  ELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRML 822

Query: 346  RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
            RHRN++KIISSC + DFKAL+LE++PHGSLEK LYS NY LDI QRLNIMIDVASALEYL
Sbjct: 823  RHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYL 882

Query: 406  HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
            H G + P++HCDLKPSNVL++++MVAH+SDFG+++ LL E  ++TQT TLATIGYMAPEY
Sbjct: 883  HHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISR-LLGEGDAVTQTLTLATIGYMAPEY 941

Query: 466  GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL 525
            G EG VS  GDVYS+GI LMETFTRKKPTD++F G+M+LK+WV   LP ++ E++DANLL
Sbjct: 942  GLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLL 1001

Query: 526  SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
             + +EHF  K  C++ I NLA++C+ + P +RI  ++++  L KI+    K+V+R
Sbjct: 1002 IE-EEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDVER 1055

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 316/586 (53%), Positives = 412/586 (70%), Gaps = 15/586 (2%)

Query: 1    GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             N+L GSIP  +G LQKLQ L +  N+++GSIP+DLC L  L  L    NKL G +P+CF
Sbjct: 646  ANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCF 705

Query: 61   GNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLS 113
            G+L  LR L L SN L  +IP + W+L+D++ L LSSNFL       +GN+K +  +DLS
Sbjct: 706  GDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLS 765

Query: 114  MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL 173
             N  S  IP  +G L++L  L L  N+LQGSIP   GDL++L+S++LS NNL GTIP SL
Sbjct: 766  KNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSL 825

Query: 174  EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC--RTRIHHT 231
            E L+ LK +NVSFNKL+GEIPN GPF NF+ ESF  NE LCG P+ QV  C    R    
Sbjct: 826  EALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSW 885

Query: 232  SRKNDLLIGIVLPL-STIFMMAVILFILRYRKRGK-PLPNDANMPRISNQRRFTYLEIFQ 289
              K+ +L  I+LP+ S + ++A I+  +R R   + P P D+ +P      + +  ++  
Sbjct: 886  KTKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLP--GAHEKISQQQLLY 943

Query: 290  ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN 349
            ATNGF E+NLIG+G  G VYK  + +G+ VA+KVF+L++  A +SFD EC++++ I HRN
Sbjct: 944  ATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRN 1003

Query: 350  IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            +I+II+ CS+ DFKALVLEYMP GSL+K LYS NY LD+FQRLNIMIDVASALEYLH   
Sbjct: 1004 LIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDC 1063

Query: 410  SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
            S  ++HCDLKPSNVLLD+NMVAH++DFG+A+ LL E +S+ QT+TL TIGYMAPEYG +G
Sbjct: 1064 SSLVVHCDLKPSNVLLDNNMVAHVADFGIAR-LLTETESMQQTKTLGTIGYMAPEYGSDG 1122

Query: 470  QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
             VST GDVYS+GI+LME F RKKP DE+F GD+TLK WV   L  SV+E+VDANLL + D
Sbjct: 1123 IVSTKGDVYSYGILLMEVFARKKPMDEMFTGDVTLKTWVES-LSSSVIEVVDANLLRRDD 1181

Query: 530  EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
            E   TK   +S +  LA+ CT +SPE+RIN K++V  L KI+  LL
Sbjct: 1182 EDLATKLSYLSSLMALALACTADSPEERINMKDVVVELKKIKIKLL 1227

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  589 bits (1519), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 311/586 (53%), Positives = 411/586 (70%), Gaps = 15/586 (2%)

Query: 1    GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             N+L GSIP  +G+LQKLQ L +  N++ GSIP+DLC L  L  L    NKL G +P+CF
Sbjct: 558  ANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSNKLSGSIPSCF 617

Query: 61   GNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLS 113
            G+L  L+ L+L SN L  +IP++LW+L+D+L L+LSSNFL       +GN+K +  +DLS
Sbjct: 618  GDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSITTLDLS 677

Query: 114  MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL 173
             N  S  IP+ +G L+ L  L L  NRLQG IP   GDL++L+SL+LS NNLSGTIP SL
Sbjct: 678  KNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSL 737

Query: 174  EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC--RTRIHHT 231
            E L+ LK +NVS NKL+GEIPN GPF NF+ ESF  NE LCG P+ QV  C    R    
Sbjct: 738  EALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSW 797

Query: 232  SRKNDLLIGIVLPLSTIFMMAV--ILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQ 289
              K+ +L  I+LP+ +I  + V  +L+I R      P P D+ +P      + ++ ++  
Sbjct: 798  KTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEKISHQQLLY 855

Query: 290  ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN 349
            ATN F E+NLIG+G  G VYK  + +G+ VA+KVF+L++  A +SFD EC++++ IRHRN
Sbjct: 856  ATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRN 915

Query: 350  IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            +++II+ CS+ DFKALVLEYMP+GSLEK LYS NY LD+ QRLNIMIDVASALEYLH   
Sbjct: 916  LVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDC 975

Query: 410  SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
            S  ++HCDLKP+NVLLDD+MVAH++DFG+ K LL + +S+ QT+TL TIGYMAPE+G +G
Sbjct: 976  SSLVVHCDLKPNNVLLDDDMVAHVADFGITK-LLTKTESMQQTKTLGTIGYMAPEHGSDG 1034

Query: 470  QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
             VST  DVYS+GI+LME F+RKKP DE+F G +TLK WV   L  SV+++VDANLL ++D
Sbjct: 1035 IVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWVES-LSNSVIQVVDANLLRRED 1093

Query: 530  EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
            E   TK  C+S I  LA+ CT  SPE+R+N K+ V  L K +  LL
Sbjct: 1094 EDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  589 bits (1519), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 314/585 (53%), Positives = 409/585 (69%), Gaps = 15/585 (2%)

Query: 2    NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            N+L G IP  +G+L+KLQ L +  N+L GSIP+DLCRL  L  L    N+L G +P+C G
Sbjct: 873  NDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLG 932

Query: 62   NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
             L  LR LYL SN L S IP +LW L+ +L L+LSSNFL       +GN+K +  +DLS 
Sbjct: 933  YLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSK 992

Query: 115  NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            N  S  IP T+G L++L+ L L  NRLQG IP   GDL++LK L+LS NNLSG IP SL+
Sbjct: 993  NQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLK 1052

Query: 175  KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRK 234
             L  LK +NVSFNKL+GEIP+ GPF NF+ ESF  NE LCG P+ QV  C       S +
Sbjct: 1053 ALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWR 1112

Query: 235  NDLLI--GIVLPLSTIFMMAV--ILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQA 290
              L I   I+ P+ +I  + V  +L+I R +    P P D+ +P   +  + ++ ++  A
Sbjct: 1113 TKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP--GSHEKISHQQLLYA 1170

Query: 291  TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI 350
            TN F E+NLIG+G    VYK  + +G+ VAVKVF+L++  AF+SFD EC++++ IRHRN+
Sbjct: 1171 TNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNL 1230

Query: 351  IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
            +KII+ CS+ DFKALVLEYMP GSL+K LYS NY LD+ QRLNIMIDVASALEYLH    
Sbjct: 1231 VKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCP 1290

Query: 411  VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
              ++HCDLKP+N+LLDD+MVAH+ DFG+A+ LL E +S+ QT+TL TIGYMAPEYG +G 
Sbjct: 1291 SLVVHCDLKPNNILLDDDMVAHVGDFGIAR-LLTETESMQQTKTLGTIGYMAPEYGSDGI 1349

Query: 471  VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
            VST GDV+S+GIMLME F RKKP DE+F GD+TLK WV  L   S++E+VDANLL ++DE
Sbjct: 1350 VSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWVESLAD-SMIEVVDANLLRREDE 1408

Query: 531  HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
             F TK  C+S I  LA+ CT +SPE+RI+ K++V  L KI+  LL
Sbjct: 1409 DFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	580
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.582	0.334	0.362	1.3e-95
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.918	0.52	0.363	1.2e-83
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.531	0.300	0.392	4.7e-77
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.953	0.548	0.332	5.9e-73
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.568	0.320	0.368	9.9e-72
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.786	0.451	0.334	8e-62
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.948	0.468	0.314	4e-67
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.836	0.488	0.318	2.5e-66
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.777	0.460	0.354	1.7e-61
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.489	0.226	0.309	4.4e-64

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 503 (182.1 bits), Expect = 1.3e-95, Sum P(2) = 1.3e-95
 Identities = 129/356 (36%), Positives = 187/356 (52%)

Query:     2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             N L+G +P ++GKL  L+ LSL  N+L G IP  +  +  L  LD   N  +G VP   G
Sbjct:   395 NMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLG 454

Query:    62 NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
             N ++L  L++G NKL  +IP  +  ++ +L LD+S N L+      IG L+ L  + L  
Sbjct:   455 NCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGD 514

Query:   115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISLE 174
             N  S  +P T+G    ++ LFLE N   G IPD  G                G+IP    
Sbjct:   515 NKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFA 573

Query:   175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRTRI----- 228
                 L+ +N+SFN LEG++P KG F N +T S  GN  LCG +   Q+ PC ++      
Sbjct:   574 SFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVK 633

Query:   229 HHTSRKNDLLIGI---VLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYL 285
              H+SR   ++IG+   +  L  +FM +V L  LR RK+ K   N           + +Y 
Sbjct:   634 KHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYG 693

Query:   286 EIFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECD 340
             ++  ATNGFS +N++G G FG+VYKA +  +   VAVKV ++Q   A KSF  EC+
Sbjct:   694 DLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
 Identities = 205/564 (36%), Positives = 307/564 (54%)

Query:     2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             NN  GS+P ++G+L+ L +L   +N L GSIP  +  L  L  L  G NK  G++P    
Sbjct:   410 NNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLS 469

Query:    62 NLTNLRNLYLGSNKLTS-IPSTLWNLKDI-LYLDLSSNFLL------IGNLKVLVQVDLS 113
             NLTNL +L L +N L+  IPS L+N++ + + +++S N L       IG+LK LV+    
Sbjct:   470 NLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAE 529

Query:   114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISL 173
              N  S  IP T+G  + L+YL+L+ N L GSIP ++G                G IP SL
Sbjct:   530 SNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSL 589

Query:   174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRTRIHHTS 232
               +  L  +N+SFN   GE+P  G F   S  S +GN  LCG +P+L +P C   + +  
Sbjct:   590 ADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRK 649

Query:   233 RKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATN 292
                 L I + L  +   + ++ L I  +++  K  P+  +M         +Y ++ +AT+
Sbjct:   650 HFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSM---KGHPLVSYSQLVKATD 706

Query:   293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECD-MXXXXXXXXXX 351
             GF+  NL+G G FGSVYK ++     VAVKV  L+  +A KSF  EC+ +          
Sbjct:   707 GFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVK 766

Query:   352 XXXXXXXXD----DFKALVLEYMPHGSLEKCLY------SSNYILDIFQRLNIMIDVASA 401
                     D    DFKA+V ++MP+GSLE  ++      +    L++ +R+ I++DVA A
Sbjct:   767 IVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACA 826

Query:   402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LA 456
             L+YLH     P++HCD+K SNVLLD +MVAH+ DFG+A+ +L +  SL Q  T     + 
Sbjct:   827 LDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR-ILVDGTSLIQQSTSSMGFIG 885

Query:   457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV 516
             TIGY APEYG     ST+GD+YS+GI+++E  T K+PTD  F  D+ L+ +V   L   V
Sbjct:   886 TIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRV 945

Query:   517 MEIVDANLLSQKDE--HFTTKGQC 538
              ++VD  L+   +   + T    C
Sbjct:   946 TDVVDTKLILDSENWLNSTNNSPC 969

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 4.7e-77, Sum P(2) = 4.7e-77
 Identities = 130/331 (39%), Positives = 188/331 (56%)

Query:   269 NDANM-PRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDL 326
             ND +  P  S   + +Y E+++ T GFS +NLIG G FG+V+K  +      VA+KV +L
Sbjct:   693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752

Query:   327 QYGRAFKSFDIECD-MXXXXXXXXXXXXXXXXXXD----DFKALVLEYMPHGSLEKCLY- 380
                 A KSF  EC+ +                  D    DF+ALV E+MP+G+L+  L+ 
Sbjct:   753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812

Query:   381 -------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
                    + +  L +F RLNI IDVASAL YLH     PI HCD+KPSN+LLD ++ AH+
Sbjct:   813 DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHV 872

Query:   434 SDFGMAKPLLKEDQSLTQTQ-----TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF 488
             SDFG+A+ LLK D+     Q        TIGY APEYG  G  S  GDVYSFGI+L+E F
Sbjct:   873 SDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIF 932

Query:   489 TRKKPTDEIFFGDMTLKHWVNDLLPI-SVMEIVDANLL-SQKDEHFTTKGQCVSFIFNLA 546
             T K+PT+++F   +TL  +    L     ++I D  +L     +HF    +C++ +F + 
Sbjct:   933 TGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMV-ECLTLVFRVG 991

Query:   547 MKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
             + C+ ESP  RI+  E +++L+ IR+S  ++
Sbjct:   992 VSCSEESPVNRISMAEAISKLVSIRESFFRD 1022

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
 Identities = 201/605 (33%), Positives = 305/605 (50%)

Query:     2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             N  +G IP  +G L +L  L L +N  EG +P  L   + + +L  G NKL+G +P    
Sbjct:   420 NRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIM 479

Query:    62 NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSM 114
              +  L +L + SN L+ S+P+ +  L++++ L L +N L       +G    +  + L  
Sbjct:   480 QIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQE 539

Query:   115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISLE 174
             N+F   IP  I GL  ++ + L  N L GSI +   +               G +P    
Sbjct:   540 NHFDGTIPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPT--- 595

Query:   175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN--ELLCGMPNLQVPPCRTRIHHTS 232
                            EG   N      F  ++  G+  EL       Q PP  TR  H S
Sbjct:   596 ---------------EGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETR--HPS 638

Query:   233 RKNDLLIGIVLPLSTIFMMAVI-LFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQAT 291
                 + IG+ + ++ + ++ ++ L   + RK  + + N A         + +Y ++  AT
Sbjct:   639 LLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNAT 698

Query:   292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECD-MXXXXXXXX 349
             +GFS +N++G G FG+V+KA +Q +   VAVKV ++Q   A KSF  EC+ +        
Sbjct:   699 DGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNL 758

Query:   350 XXXXXXXXXXD----DFKALVLEYMPHGSLEKCLYSSNY--------ILDIFQRLNIMID 397
                       D    +F+AL+ E+MP+GSL+K L+             L + +RLNI ID
Sbjct:   759 VKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAID 818

Query:   398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQT 452
             VAS L+YLH     PI HCDLKPSN+LLDD++ AH+SDFG+A+ LLK DQ      L+  
Sbjct:   819 VASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSA 878

Query:   453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL 512
                 TIGY APEYG  GQ S +GDVYSFG++++E FT K+PT+E+F G+ TL  +    L
Sbjct:   879 GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAAL 938

Query:   513 PISVMEIVDANLL-SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
             P  V++I D ++L S     F    +C+  I ++ ++C  ESP  R+   E    L+ IR
Sbjct:   939 PERVLDIADKSILHSGLRVGFPVL-ECLKGILDVGLRCCEESPLNRLATSEAAKELISIR 997

Query:   572 DSLLK 576
             +   K
Sbjct:   998 ERFFK 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 508 (183.9 bits), Expect = 9.9e-72, Sum P(2) = 9.9e-72
 Identities = 133/361 (36%), Positives = 185/361 (51%)

Query:   237 LLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISN-QRRFTYLEIFQATNGFS 295
             + IGI   L  I + ++  F+ R +K      N ++   +     + +Y E+  AT+ FS
Sbjct:   654 ICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFS 713

Query:   296 ENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX-- 352
               NLIG G FG+V+K  +  +   VAVKV +L    A KSF  EC+              
Sbjct:   714 STNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLI 773

Query:   353 ---XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNY--------ILDIFQRLNIMIDVASA 401
                       +DF+ALV E+MP GSL+  L   +          L   ++LNI IDVASA
Sbjct:   774 TVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASA 833

Query:   402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS--LTQTQTLA--- 456
             LEYLH     P+ HCD+KPSN+LLDD++ AH+SDFG+A+ L K D+   L Q  +     
Sbjct:   834 LEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRG 893

Query:   457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV 516
             TIGY APEYG  GQ S  GDVYSFGI+L+E F+ KKPTDE F GD  L  +   +L    
Sbjct:   894 TIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL---- 949

Query:   517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK 576
                  +   S    +   +G  +  +  + +KC+ E P  R+   E V  L+ IR     
Sbjct:   950 -----SGCTSSGGSNAIDEG--LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFS 1002

Query:   577 N 577
             +
Sbjct:  1003 S 1003

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 638 (229.6 bits), Expect = 8.0e-62, P = 8.0e-62
 Identities = 163/488 (33%), Positives = 256/488 (52%)

Query:     2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             N L G +P ++GKL +L LLSL  N++ G IP  +  L  L  L    N  +G VP   G
Sbjct:   396 NMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLG 455

Query:    62 NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
               +++ +L +G NKL  +IP  +  +  ++ L +  N L       IG+L+ LV++ L  
Sbjct:   456 KCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLEN 515

Query:   115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISLE 174
             N FS  +P T+G    ++ LFL+ N   G+IP+  G                G+IP    
Sbjct:   516 NKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFA 574

Query:   175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRTR-----I 228
                 L+ +N+S N   G++P+KG F+N +     GN+ LCG + +L++ PC  +      
Sbjct:   575 NFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVET 634

Query:   229 HHTSRKNDLLIGIVLPLSTIFMMAVILFILR-YRKRGKPLPNDANMPRISN--QRRFTYL 285
              H+S    + I + + ++ + ++ +   +L  +RKR K    +  +P        + +Y 
Sbjct:   635 KHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYG 694

Query:   286 EIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMXXX 344
             ++  ATNGFS +N++G G FG+V+KA +  +   VAVKV ++Q   A KSF  EC+    
Sbjct:   695 DLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKD 754

Query:   345 XXXXXXXXXXXXXXXDDF-----KALVLEYMPHGSLEKCLYSSNY--------ILDIFQR 391
                             DF     +AL+ EY+P+GS++  L+             L + +R
Sbjct:   755 TRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLER 814

Query:   392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
             LNI+IDVAS L+YLH     PI HCDLKPSNVLL+D++ AH+SDFG+A+ LLK D+    
Sbjct:   815 LNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFL 874

Query:   452 TQTLATIG 459
              Q L++ G
Sbjct:   875 NQ-LSSAG 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 4.0e-67, P = 4.0e-67
 Identities = 187/595 (31%), Positives = 301/595 (50%)

Query:     1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAAL----FELDSGGNKLDGFV 56
             GN  NGSIP ++  L  L    + DN L G+IP +L  LA+L      L+   N L G +
Sbjct:   584 GNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTI 641

Query:    57 PACFGNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMN 115
             P   G L  ++ + L +N  + SIP +L   K++  LD S N                  
Sbjct:   642 PKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQN------------------ 683

Query:   116 NFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISLE 174
             N S  IP  +  G+  +  L L  N   G IP S G+               G IP SL 
Sbjct:   684 NLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLA 743

Query:   175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC--RTRIHHTS 232
              L  LK + ++ N L+G +P  G F+N +     GN  LCG     + PC  + +  H S
Sbjct:   744 NLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFS 802

Query:   233 RKNDLLIGIVLPLSTIFMMAVILFILRY-RKRGKPLPN--DANMPRISNQ---RRFTYLE 286
             ++  +++ I+   + + ++ +++ IL   +K+ K + N  ++++P + +    +RF   E
Sbjct:   803 KRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKE 862

Query:   287 IFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECD-MXX 343
             + QAT+ F+  N+IG     +VYK +++DG  +AVKV +L+     + K F  E   +  
Sbjct:   863 LEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQ 922

Query:   344 XXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASAL 402
                                KALVL +M +G+LE  ++ S   I  + +++++ + +AS +
Sbjct:   923 LKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGI 982

Query:   403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTL--ATIG 459
             +YLH GY  PI+HCDLKP+N+LLD + VAH+SDFG A+ L  +ED S T + +    TIG
Sbjct:   983 DYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIG 1042

Query:   460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT--DEIFFGDMTLKHWVNDLLPISVM 517
             Y+APE+    +V+T  DV+SFGI++ME  T+++PT  ++    DMTL+  V   +     
Sbjct:  1043 YLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRK 1102

Query:   518 EIVDANLLSQKDEHFTTKGQ-CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
              +V    +   D   + K +  +     L + CT   PE R +  EI+T L+K+R
Sbjct:  1103 GMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 591 (213.1 bits), Expect = 2.5e-66, Sum P(2) = 2.5e-66
 Identities = 165/518 (31%), Positives = 251/518 (48%)

Query:     2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELD-SGGNKLDGFVPACF 60
             N L+G IP + G    L  + + DN+L G +P     L  L  L+ +  N+L G +P   
Sbjct:   397 NQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELP-LTRLELANNNQLQGSIPPSI 455

Query:    61 GNLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLS 113
                 +L  L + +N  +  IP  L +L+D+  +DLS N  L      I  LK L +V++ 
Sbjct:   456 SKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQ 515

Query:   114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISL 173
              N     IP+++    +L  L L  NRL+G IP  +GD               G IP  L
Sbjct:   516 ENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAEL 575

Query:   174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQ-VPPCRTRIHHTS 232
              +L  L   NVS NKL G+IP+ G  ++    SF GN  LC  PNL  + PCR++     
Sbjct:   576 LRL-KLNQFNVSDNKLYGKIPS-GFQQDIFRPSFLGNPNLCA-PNLDPIRPCRSK----- 627

Query:   233 RKNDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATN 292
             R+   ++ I +        A++   ++ +   K  P   N   I  +  FT  +I+    
Sbjct:   628 RETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTEEDIYPQ-- 685

Query:   293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKS---FDIECDMXXXXXXXX 349
               +E+N+IG GG G VY+ +++ G  +AVK    + G+  +S   F  E +         
Sbjct:   686 -LTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGN 744

Query:   350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYI-----LDIFQRLNIMIDVASALEY 404
                       ++F+ LV E+M +GSL   L+S         LD   R +I +  A  L Y
Sbjct:   745 IVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSY 804

Query:   405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI----GY 460
             LH     PI+H D+K +N+LLD  M   ++DFG+AKPL +ED       +++ +    GY
Sbjct:   805 LHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGY 864

Query:   461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIF 498
             +APEYG   +V+   DVYSFG++L+E  T K+P D  F
Sbjct:   865 IAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSF 902

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 1.7e-61, P = 1.7e-61
 Identities = 171/482 (35%), Positives = 244/482 (50%)

Query:     2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             N+L G IP+ +G + +L LL +  N L GSIPD    L+ L  L   GN L G VP   G
Sbjct:   355 NHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLG 414

Query:    62 NLTNLRNLYLGSNKLT-SIP-STLWNLKDI-LYLDLSSNFLL------IGNLKVLVQVDL 112
                NL  L L  N LT +IP   + NL+++ LYL+LSSN L       +  + +++ VDL
Sbjct:   415 KCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDL 474

Query:   113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPIS 172
             S N  S  IP  +G    L++L L  N    ++P S+G                G IP S
Sbjct:   475 SSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPS 534

Query:   173 LEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG-MPNLQVPPCRTRIHHT 231
              ++   LK +N SFN L G + +KG F   + ESF G+ LLCG +  +Q   C+ +  + 
Sbjct:   535 FQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYP 592

Query:   232 SRKNDLLIGIVLPLSTIFMMAVILFILRYRKR-GKPLP----NDANMPRISNQR-----R 281
             S    +L+ ++L L    ++ V  + L  R R GK L      +       NQ      R
Sbjct:   593 S----VLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPR 648

Query:   282 FTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIECD 340
              +Y ++  AT GF+ ++LIG G FG VYK  +++  +VAVKV D +    F  SF  EC 
Sbjct:   649 ISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQ 708

Query:   341 MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMID 397
             +                    F ALVL  MP+GSLE+ LY   Y    LD+ Q +NI  D
Sbjct:   709 ILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSD 768

Query:   398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
             VA  + YLH    V ++HCDLKPSN+LLDD M A ++DFG+++ L++  +    T    +
Sbjct:   769 VAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR-LVQGVEETVSTDDSVS 827

Query:   458 IG 459
              G
Sbjct:   828 FG 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 366 (133.9 bits), Expect = 4.4e-64, Sum P(2) = 4.4e-64
 Identities = 92/297 (30%), Positives = 150/297 (50%)

Query:   286 EIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVF----DLQYGRAFKSFDIECDM 341
             +I +AT+  +E  +IG GG G VYKA +++G  +AVK      DL   ++F   +++   
Sbjct:   940 DIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNR-EVKTLG 998

Query:   342 XXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNY-----ILDIFQRLNIMI 396
                               D    L+ EYM +GS+   L+++       +L    RL I +
Sbjct:   999 TIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIAL 1058

Query:   397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL- 455
              +A  +EYLH+    PI+H D+K SNVLLD N+ AHL DFG+AK L     + T++ T+ 
Sbjct:  1059 GLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMF 1118

Query:   456 -ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI 514
               + GY+APEY    + +   DVYS GI+LME  T K PT+ +F  +  +  WV  +L  
Sbjct:  1119 AGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDT 1178

Query:   515 SVMEIVDANLL-SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                      L+ S+       + +    +  +A++CT   P++R ++++    LL +
Sbjct:  1179 PPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNV 1235

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	580
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-39
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-32
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-26
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  193 bits (493), Expect = 9e-53
 Identities = 158/590 (26%), Positives = 265/590 (44%), Gaps = 55/590 (9%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           N+L G IP ++G  + L+ + L+DN   G +P +  +L  ++ LD   N L G + +   
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNF------LLIGNLKVLVQVDLSMN 115
           ++ +L+ L L  NK        +  K +  LDLS N         +G+L  L+Q+ LS N
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
             S  IP  +   K L  L L +N+L G IP S  ++  L  L+LS N LSG IP +L  
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569

Query: 176 LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQ-VPPCRTRIHHTSRK 234
           +  L  +N+S N L G +P+ G F   +  +  GN  LCG      +PPC+      S  
Sbjct: 570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSW- 628

Query: 235 NDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQAT--- 291
                 I   L    ++A++ F   + +    L     + R+ N+     L+ F +    
Sbjct: 629 ---WFYITCTLGAFLVLALVAFGFVFIRGRNNL----ELKRVENEDGTWELQFFDSKVSK 681

Query: 292 --------NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMI 342
                   +   E N+I RG  G+ YK + I++GM+  VK  +        S   +   +
Sbjct: 682 SITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---M 737

Query: 343 KRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 402
            +++H NI+K+I  C S+    L+ EY+   +L + L +    L   +R  I I +A AL
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKAL 793

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
            +LH   S  ++  +L P  +++D     HL    +   L       T T+   +  Y+A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVA 846

Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWV-----NDLLPISVM 517
           PE      ++   D+Y FG++L+E  T K P D  F    ++  W      +  L + + 
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906

Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             +  ++   ++E        +  + NLA+ CT   P  R  A +++  L
Sbjct: 907 PSIRGDVSVNQNE--------IVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (419), Expect = 1e-47
 Identities = 68/191 (35%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           +G GGFG+VY AR  + G +VA+K+   +      +    E +++K++ H NI+K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
             ++   LV+EY   GSL+  L  +   L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 418 LKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR-EGQVSTNG 475
           LKP N+LLD DN    L+DFG++K L            + T  YMAPE    +G  S   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 476 DVYSFGIMLME 486
           D++S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  165 bits (421), Expect = 3e-47
 Identities = 79/268 (29%), Positives = 118/268 (44%), Gaps = 26/268 (9%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRHRNIIKIIS 355
             +G G FG VY AR  + G  VA+KV   +  +   +    E  ++K+++H NI+++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
               +D   LV+EY   G L   L      L   +    +  + SALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DLKP N+LLD++    L+DFG+A+   + D     T  + T  YMAPE           
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           D++S G++L E  T K P    F GD  L      +             +S         
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISP-------- 225

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEI 563
            +    I     K  V+ PE+R+ A+E 
Sbjct: 226 -EAKDLI----RKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (418), Expect = 8e-47
 Identities = 88/271 (32%), Positives = 125/271 (46%), Gaps = 28/271 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKII 354
           +G G FG+VYKA+    G  VAVK+   +        D     E  +++R+ H NI+++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            +    D   LV+EY   G L     S    L   +   I + +   LEYLH   S  II
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ-VST 473
           H DLKP N+LLD+N V  ++DFG+AK LLK   SLT T    T  YMAPE    G     
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             DV+S G++L E  T K P    F G+            +  ++++   L    +    
Sbjct: 179 KVDVWSLGVILYELLTGKPP----FSGE----------NILDQLQLIRRILGPPLEFDEP 224

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                     +L  KC  + P +R  A+EI+
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 9e-45
 Identities = 76/278 (27%), Positives = 134/278 (48%), Gaps = 31/278 (11%)

Query: 297 NNLIGRGGFGSVYKARIQD-----GMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNI 350
              +G G FG VYK +++       +EVAVK           + F  E  +++++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
           +K++  C+ ++   +V+EYM  G L   L  +   L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
              IH DL   N L+ +N+V  +SDFG+++  L +D    +      I +MAPE  +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 471 VSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
            ++  DV+SFG++L E FT  ++P     +  M+ +          V+E +       + 
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE---------VLEYLKNGYRLPQP 225

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            +      C   +++L ++C  E PE R    E+V  L
Sbjct: 226 PN------CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (395), Expect = 1e-43
 Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 32/279 (11%)

Query: 297 NNLIGRGGFGSVYKARIQDG-----MEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNI 350
              +G G FG VYK  ++       +EVAVK        +  + F  E  +++++ H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           +K++  C+ ++   +V+EYMP G L   L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH DL   N L+ +N+V  +SDFG+++  L +D           I +MAPE  +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 470 QVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
           + ++  DV+SFG++L E FT  ++P     +  M+            V+E +       K
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAE---------VLEYLKKGYRLPK 225

Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             +      C   ++ L ++C  E PE R    E+V  L
Sbjct: 226 PPN------CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (391), Expect = 6e-43
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 28/274 (10%)

Query: 300 IGRGGFGSVYKARI-----QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG VYK  +         +VAVK           + F  E  ++K++ H NI+++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           +  C+  +   +V EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           +H DL   N L+ +N+V  +SDFG+++ + ++D    +      I +MAPE  ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             DV+SFG++L E FT          G+         +    V+E+++      + E+  
Sbjct: 184 KSDVWSFGVLLWEIFT---------LGEQPYP----GMSNEEVLELLEDGYRLPRPEN-- 228

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               C   ++ L ++C    PE R    E+V  L
Sbjct: 229 ----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  148 bits (377), Expect = 5e-41
 Identities = 77/284 (27%), Positives = 129/284 (45%), Gaps = 37/284 (13%)

Query: 298 NLIGRGGFGSVYKARIQDG----MEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNIIK 352
             +G G FG VYK +++       EVAVK          +  F  E  ++K++ H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCL--------YSSNYILDIFQRLNIMIDVASALEY 404
           ++  C+ ++   LVLEYM  G L   L              L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           L    S   +H DL   N L+ +++V  +SDFG+++ +  +D    +T     I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
             ++G  ++  DV+SFG++L E FT    P     +  ++ +          V+E +   
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP-----YPGLSNEE---------VLEYLRKG 223

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               K E+      C   ++ L + C    PE R    E+V RL
Sbjct: 224 YRLPKPEY------CPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 7e-39
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 47/285 (16%)

Query: 298 NLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRA--FKSFDIECDMIKRIRHRNIIKII 354
            L+GRG FGSVY A  +D G  +AVK  +L        ++ + E  ++  ++H NI++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 355 SSCSSDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNI------MIDVASALEYLH 406
            S   ++   L   LEY+  GSL         +L  F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEY 465
              S  I+H D+K +N+L+D + V  L+DFG AK  L + ++   T ++  T  +MAPE 
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IVDANL 524
            R  +     D++S G  ++E  T K P             W     P++ +  I  +  
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP-------------WSELGNPMAALYKIGSSGE 221

Query: 525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
             +  EH + + +   F+     KC    P++R  A E    LL+
Sbjct: 222 PPEIPEHLSEEAK--DFL----RKCLRRDPKKRPTADE----LLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  139 bits (353), Expect = 9e-35
 Identities = 90/227 (39%), Positives = 123/227 (54%), Gaps = 25/227 (11%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           NN  GSIP   G +  L+ L L +N L G IP+D+   ++L  LD GGN L G +P    
Sbjct: 128 NNFTGSIP--RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185

Query: 62  NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
           NLT+L  L L SN+L   IP  L  +K + ++ L  N L       IG L  L  +DL  
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
           NN +  IP+++G LK+LQYLFL  N+L G IP SI  L  L SL+LS+N+LSG IP  + 
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305

Query: 175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQV 221
           +L +L+ +++  N   G+IP                  L  +P LQV
Sbjct: 306 QLQNLEILHLFSNNFTGKIP----------------VALTSLPRLQV 336

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (311), Expect = 6e-32
 Identities = 68/196 (34%), Positives = 97/196 (49%), Gaps = 9/196 (4%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG+GGFG VYKAR  + G EVA+KV  L+     +    E  ++K+ +H NI+K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E+   GSL+  L S+N  L   Q   +  ++   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           K +N+LL  +    L DFG++  L           T+  T  +MAPE           D+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 478 YSFGIMLMETFTRKKP 493
           +S GI  +E    K P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  124 bits (312), Expect = 8e-32
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 50/294 (17%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG V+           D   VAVK   +     A K F+ E +++   +H NI+K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSN-------------YILDIFQRLNIMIDVA 399
               C+  D   +V EYM HG L K L S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 400 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           S + YL   HF      +H DL   N L+  ++V  + DFGM++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPIS 515
            I +M PE     + +T  DV+SFG++L E FT  K+P    ++G          L    
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP----WYG----------LSNEE 232

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
           V+E +    L Q+         C S ++++ + C    P+QRIN K+I  RL K
Sbjct: 233 VIECITQGRLLQRPR------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 81/274 (29%), Positives = 123/274 (44%), Gaps = 31/274 (11%)

Query: 299 LIGRGGFGSVYKARIQDGMEVAVK---VFDLQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
            IG+G FG VYK  ++   EVAVK          +    F  E +++K+  H NI+K+I 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIG 59

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
            C       +V+E +P GSL   L      L + + L + +D A+ +EYL    S   IH
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIH 116

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI--GYMAPEYGREGQVST 473
            DL   N L+ +N V  +SDFGM++   +E    T +  L  I   + APE    G+ ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             DV+S+GI+L ETF+          GD       N        E +++       +   
Sbjct: 175 ESDVWSYGILLWETFS---------LGDTPYPGMSNQ----QTRERIESGYRMPAPQL-- 219

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               C   I+ L ++C    PE R +  EI   L
Sbjct: 220 ----CPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (296), Expect = 5e-29
 Identities = 84/296 (28%), Positives = 123/296 (41%), Gaps = 33/296 (11%)

Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRH-RNIIKII 354
            +G G FG VY AR  D   VA+KV   +     +  + F  E  ++  + H  NI+K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 355 SSCSSDDFKALVLEYMPHGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
                +    LV+EY+  GSLE           L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 413 IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLA----TIGYMAPEY-- 465
           IIH D+KP N+LLD D  V  L DFG+AK L     + +     +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 466 -GREGQVSTNGDVYSFGIMLMETFTRKKP---TDEIFFGDMTLKHWVNDLLPISVMEIVD 521
                  S++ D++S GI L E  T   P            TLK  +    P     +  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +N                    +L  K   + P+ R+++   ++  L     L ++
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 6e-29
 Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 40/275 (14%)

Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
            IG+G FG V     + G +VAVK        A ++F  E  ++  +RH N+++++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 359 SDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
             +   +V EYM  GSL   L S    ++ + Q+L   +DV   +EYL        +H D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   NVL+ +++VA +SDFG+AK     + S  Q      + + APE  RE + ST  DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 478 YSFGIMLMETFTRKKPTDEIFFG-----DMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
           +SFGI+L E ++         FG      + LK  V  +     ME  +           
Sbjct: 183 WSFGILLWEIYS---------FGRVPYPRIPLKDVVPHVEKGYRMEAPEG---------- 223

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                C   ++ +   C    P +R   K++  +L
Sbjct: 224 -----CPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 9e-29
 Identities = 87/285 (30%), Positives = 128/285 (44%), Gaps = 53/285 (18%)

Query: 298 NLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKII 354
           +LIGRG FG VYK   ++ G  VA+K   L+     A KS   E D++K ++H NI+K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFG 408
            S  + D   ++LEY  +GSL +       I+  F           +  V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
               +IH D+K +N+L   + V  L+DFG+A  L   D S      + T  +MAPE    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEM 173

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM-EIVDANLLSQ 527
              ST  D++S G  ++E  T   P    ++          DL P++ +  IV      Q
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP----YY----------DLNPMAALFRIV------Q 213

Query: 528 KDEHFTTKG---QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
            D     +G   +   F+    M+C  + P  R  AK+    LLK
Sbjct: 214 DDHPPLPEGISPELKDFL----MQCFQKDPNLRPTAKQ----LLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (282), Expect = 6e-28
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 25/275 (9%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           F+    +G G FG V++   ++ + VA+K+         + F  E   +KR+RH+++I +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVP 412
            + CS  +   ++ E M  GSL   L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
            IH DL   N+L+ +++V  ++DFG+A+ L+KED  L+  + +    + APE    G  S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIP-YKWTAPEAASHGTFS 182

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
           T  DV+SFGI+L E FT  +    + +  M             V + + A          
Sbjct: 183 TKSDVWSFGILLYEMFTYGQ----VPYPGMNNHE---------VYDQITAGY------RM 223

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               +C   I+ + ++C    PE R + K +   L
Sbjct: 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  118 bits (297), Expect = 9e-28
 Identities = 87/228 (38%), Positives = 116/228 (50%), Gaps = 27/228 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN L G IP ++  L  L+ L+L  NQL G IP +L ++ +L  +  G N L G +P   
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232

Query: 61  GNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSD 119
           G LT+L +L L  N LT  IPS+L NLK++ YL     FL               N  S 
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL-----FLY-------------QNKLSG 274

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL 179
            IP +I  L+ L  L L  N L G IP+ +  L NL+ L+L +NN +G IP++L  L  L
Sbjct: 275 PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334

Query: 180 KDINVSFNKLEGEIP-NKGPFRNF-----STESFEGN--ELLCGMPNL 219
           + + +  NK  GEIP N G   N      ST +  G   E LC   NL
Sbjct: 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL 382

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  116 bits (292), Expect = 4e-27
 Identities = 82/237 (34%), Positives = 125/237 (52%), Gaps = 18/237 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLA-ALFELDSGGNKLDGFVPAC 59
           G N++G I  A+ +L  +Q ++L +NQL G IPDD+   + +L  L+   N   G +P  
Sbjct: 78  GKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR- 136

Query: 60  FGNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDL 112
            G++ NL  L L +N L+  IP+ + +   +  LDL  N L+      + NL  L  + L
Sbjct: 137 -GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           + N     IP  +G +K L++++L YN L G IP  IG L +L  L+L  NNL+G IP S
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255

Query: 173 LEKLLDLKDINVSFNKLEGEIPN------KGPFRNFSTESFEGN--ELLCGMPNLQV 221
           L  L +L+ + +  NKL G IP       K    + S  S  G   EL+  + NL++
Sbjct: 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312

Length = 968

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 9e-27
 Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKIIS 355
           +G+G FG V   R +D G   A+KV   +     K  +    E +++ RI H  I+K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +  +++   LVLEY P G L   L       +   R     ++  ALEYLH   S+ II+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTN 474
            DLKP N+LLD +    L+DFG+AK L  E     +T T   T  Y+APE          
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 475 GDVYSFGIMLMETFTRKKPTDEIFFGD 501
            D +S G++L E  T K P    F+ +
Sbjct: 174 VDWWSLGVLLYEMLTGKPP----FYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (271), Expect = 2e-26
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 11/202 (5%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDL-QYGRAFKSFDI-ECDMIKRIRHRNIIKII 354
             IG+G FG VY  R   DG    +K  DL       +   + E  ++K++ H NIIK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLHFGYSV 411
            S        +V+EY   G L + +         F   Q L+  + +  AL+YLH   S 
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            I+H D+KP N+ L  N +  L DFG++K +L     L +T  + T  Y++PE  +    
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTV-VGTPYYLSPELCQNKPY 180

Query: 472 STNGDVYSFGIMLMETFTRKKP 493
           +   D++S G +L E  T K P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  108 bits (271), Expect = 3e-26
 Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 49/288 (17%)

Query: 300 IGRGGFGSVYKAR------IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG V+ A        +D M VAVK        A K F  E +++  ++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYS---------------SNYILDIFQRLNIMIDV 398
              C   D   +V EYM HG L K L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 399 ASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS 515
             I +M PE     + +T  DV+SFG++L E FT  K            + W   L    
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ-LSNTE 233

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
           V+E +    + ++         C   ++++ + C    P+QR+N KEI
Sbjct: 234 VIECITQGRVLERPR------VCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (265), Expect = 1e-25
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 42/290 (14%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG V+ A        QD M VAVK        A + F  E +++  ++H++I++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSN---YILD-----------IFQRLNIMIDVA 399
              C+      +V EYM HG L + L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           S + YL    S+  +H DL   N L+   +V  + DFGM++ +   D      +T+  I 
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           +M PE     + +T  D++SFG++L E FT  K            + W      +S  E 
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQ----LSNTEA 233

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
           ++     ++ E   T   C   ++ +   C    P+QR+  K+I +RL  
Sbjct: 234 IECITQGRELERPRT---CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 37/293 (12%)

Query: 298 NLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNII 351
             +G G FG V   R        G +VAVK  +       +S F+ E ++++ + H NI+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 352 KIISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           K    C     ++  L++EY+P GSL   L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGRE 468
           S   IH DL   N+L++   +  +SDFG+AK L   +D    +    + I + APE  R 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDE----------IFFGDMTLKHWVNDLLPISVME 518
            + S+  DV+SFG+ L E FT   P+            I  G M +   +  L       
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL------- 239

Query: 519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
                   ++ E       C   +++L   C    P+ R +  +++  + ++R
Sbjct: 240 --------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  104 bits (261), Expect = 4e-25
 Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 47/277 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G+G  G VYK R    G   A+K             D + +  K++     +K + SC 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI---------HVDGDEEFRKQLL--RELKTLRSCE 57

Query: 359 SDD--------FK----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
           S          +K    ++VLEYM  GSL   L     I +      I   +   L+YLH
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH 116

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEY 465
                 IIH D+KPSN+L++      ++DFG++K L   + +L Q  T + T+ YM+PE 
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPER 171

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL 525
            +    S   D++S G+ L+E    K P    F        +  +L+      I D    
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFP----FLPPGQPSFF--ELM----QAICDGPPP 221

Query: 526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
           S   E F+ + +   FI      C  + P++R +A E
Sbjct: 222 SLPAEEFSPEFR--DFI----SACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (270), Expect = 2e-24
 Identities = 70/202 (34%), Positives = 100/202 (49%), Gaps = 8/202 (3%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           NN  G IP+A+  L +LQ+L L  N+  G IP +L +   L  LD   N L G +P    
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377

Query: 62  NLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
           +  NL  L L SN L   IP +L   + +  + L  N            L ++  +D+S 
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
           NN    I +    +  LQ L L  N+  G +PDS G    L++L+LS N  SG +P  L 
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496

Query: 175 KLLDLKDINVSFNKLEGEIPNK 196
            L +L  + +S NKL GEIP++
Sbjct: 497 SLSELMQLKLSENKLSGEIPDE 518

Length = 968

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 85/297 (28%), Positives = 132/297 (44%), Gaps = 57/297 (19%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKII 354
           IG G +G VYKAR  + G  VA+K   ++  +  + F I    E  +++++RH NI+++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 355 SSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
              +S    +  +V EYM H  L   L S        Q    M  +   L+YLH   S  
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------Y 465
           I+H D+K SN+L++++ V  L+DFG+A+P  K   S   T  + T+ Y  PE       Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGATRY 179

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLK 505
           G E  V    D++S G +L E F  K                     PTDE + G   L 
Sbjct: 180 GPE--V----DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233

Query: 506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
            +  +L P    +      L +  +H        S + +L  K     P++RI+A +
Sbjct: 234 WF-ENLKPKKPYK----RRLREFFKHLIDP----SAL-DLLDKLLTLDPKKRISADQ 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  101 bits (254), Expect = 2e-24
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 28/272 (10%)

Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIECDMIKRIRHRNIIKIISSC 357
           L+G+G FG V+K  ++D   VAVK       +  K  F  E  ++K+  H NI+K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           +      +V+E +P G     L      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI--GYMAPEYGREGQVSTNG 475
           L   N L+ +N V  +SDFGM++   +ED  +  +  L  I   + APE    G+ S+  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+S+GI+L ETF+                     + P   M    A    +K    +  
Sbjct: 176 DVWSYGILLWETFSL-------------------GVCPYPGMTNQQAREQVEKGYRMSCP 216

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            +C   ++ +  +C    PE R    E+   L
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 62/188 (32%), Positives = 90/188 (47%), Gaps = 7/188 (3%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G  G VYKA     G EVA+K   L+  +  +    E  ++K  +H NI+    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  +IH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG A  L KE     +   + T  +MAPE  +        D++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200

Query: 479 SFGIMLME 486
           S GIM +E
Sbjct: 201 SLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 1e-23
 Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 14/195 (7%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V+        +VAVK   L+ G  + ++F  E  ++K++RH  ++++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID----VASALEYLHFGYSVPII 414
            ++   +V EYM  GSL   L S         RL  ++D    +A  + YL    S   I
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H DL   N+L+ +N+V  ++DFG+A+ L+++D+   +      I + APE    G+ +  
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 475 GDVYSFGIMLMETFT 489
            DV+SFGI+L E  T
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 33/221 (14%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKI 353
           +IG G F +V  A+  +   E A+K+ D +     +  K   IE +++ R+  H  IIK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 354 ISSCSSDDFKALVLEYMPHGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
             +   ++    VLEY P+G L +    Y S   LD         ++  ALEYLH   S 
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG------------ 459
            IIH DLKP N+LLD +M   ++DFG AK +L  + S    +  AT              
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 460 -------YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
                  Y++PE   E     + D+++ G ++ +  T K P
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 8/192 (4%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V++    +   VAVK   L+ G    K F  E  ++K++RH  +I++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT--LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            ++   +V E M +GSL + L       L + Q +++   VAS + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   NVL+ +N +  ++DFG+A+ ++KED    +      I + APE     + S   DV
Sbjct: 129 LAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 478 YSFGIMLMETFT 489
           +SFGI+L E  T
Sbjct: 188 WSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.3 bits (239), Expect = 5e-22
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG V+ A        QD + VAVK        A K F  E +++  ++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASA 401
              C   D   +V EYM HG L K L +                L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 402 LEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           + YL   HF      +H DL   N L+ +N++  + DFGM++ +   D       T+  I
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME 518
            +M PE     + +T  DV+S G++L E FT         +G        N+     V+E
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT---------YGKQPWYQLSNN----EVIE 233

Query: 519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            +    + Q+         C   +++L + C    P  R+N KEI + L
Sbjct: 234 CITQGRVLQRPR------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 46/291 (15%)

Query: 300 IGRGGFGSVYKARI--QDGME----VAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG VYK  +   +       VA+K   +    +  + F  E +++  ++H NI+ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMID 397
           ++  C+ +    ++ EY+ HG L + L  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ +   D    Q+++L  
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM 517
           + +M PE    G+ +T  D++SFG++L E F+         +G      + N      V+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS---------YGLQPYYGFSNQ----EVI 236

Query: 518 EIV-DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           E++    LL   ++       C + ++ L ++C  E P +R   K+I TRL
Sbjct: 237 EMIRSRQLLPCPED-------CPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 94.3 bits (234), Expect = 9e-22
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 42/271 (15%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNIIKIISSC 357
           IGRG FG V+  R++ D   VAVK          K+ F  E  ++K+  H NI+++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           +      +V+E +  G     L +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI--GYMAPEYGREGQVSTNG 475
           L   N L+ +  V  +SDFGM++   +ED     T  +  I   + APE    G+ S+  
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFGI+L E F                          S+  +  ANL +Q+      +
Sbjct: 178 DVWSFGILLWEAF--------------------------SLGAVPYANLSNQQTREAIEQ 211

Query: 536 G-------QCVSFIFNLAMKCTVESPEQRIN 559
           G        C   ++ L  +C    P QR +
Sbjct: 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 2e-21
 Identities = 78/293 (26%), Positives = 119/293 (40%), Gaps = 54/293 (18%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR-AFKSFDI-ECDMIKRIRHRNIIKIISS 356
           +G G +G VYKAR  + G  VA+K   L        S  + E  ++K ++H NI+K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
             ++    LV EY     L+K L      L      +IM  +   L Y H   S  I+H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGREG 469
           DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y APE       Y    
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHY---- 176

Query: 470 QVSTNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHWVN 509
             ST  D++S G +  E  T K                     PT+E + G   L  +  
Sbjct: 177 --STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234

Query: 510 DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                          L +       +G       +L  K    +P +RI+AKE
Sbjct: 235 ------TFPKFPPKDLEKVLPRLDPEG------IDLLSKMLQYNPAKRISAKE 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 48/292 (16%)

Query: 300 IGRGGFGSVYKARIQ-DGME----VAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +G   FG +YK  +   GM+    VA+K   D+   + +  F  E  ++  + H NI+ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLY----------SSN------YILDIFQRLNIMID 397
           +   + +    ++ EY+  G L + L           SS+        LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 398 VASALEYL--HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++ +   D    Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS 515
             I +M PE    G+ S++ D++SFG++L E F+         FG      + N      
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS---------FGLQPYYGFSNQ----E 234

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           V+E+V      +K +       C   +++L  +C  E P +R   K+I TRL
Sbjct: 235 VIEMV------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 8/196 (4%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRA-FKSFDIECDMIKRIRHRNIIKIISSC 357
           +G G  G V K   +  G  +AVK   L+   A  K    E D++ +     I+    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            ++   ++ +EYM  GSL+K L      +       I + V   L YLH  +   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           +KPSN+L++      L DFG++  L+    SL +T    T  YMAPE  +    S   D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 478 YSFGIMLMETFTRKKP 493
           +S G+ L+E  T + P
Sbjct: 183 WSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 5/193 (2%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           IG G FG V+     +  +VA+K    +   + + F  E  ++ ++ H  ++++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 419
                LV E+M HG L   L +          L + +DV   + YL    S  +IH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYS 479
             N L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 480 FGIMLMETFTRKK 492
           FG+++ E F+  K
Sbjct: 187 FGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 5e-21
 Identities = 64/192 (33%), Positives = 100/192 (52%), Gaps = 13/192 (6%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 360 DDFKA-LVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 478 YSFGIMLMETFT 489
           +SFGI+L E ++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 41/276 (14%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDL----QYGR-AFKSFDIECDMIKRIRHRNIIK 352
           L+G G FGSVY+   + DG   AVK   L    Q G+ A K  + E  ++ +++H NI++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
            + +   +D   + LE +P GSL K L                  +   LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEY-GRE 468
            +H D+K +N+L+D N V  L+DFGMAK      Q +  +   +  G   +MAPE   ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM-EIVDANLLSQ 527
           G      D++S G  ++E  T K P             W + L  ++ + +I  +  L  
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP-------------W-SQLEGVAAVFKIGRSKELPP 222

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
             +H + + +   FI    +KC    P  R  A E+
Sbjct: 223 IPDHLSDEAK--DFI----LKCLQRDPSLRPTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)

Query: 298 NLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGR--AFKSFDIECDMIKRIRHRNIIKII 354
           N IG G FG VY A  +  G  +AVK   +Q       K    E  +++ ++H N++K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 355 SSCSSDDFKALVLEYMPHGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                 +   + +EY   G+LE+   +       + +   + +     L YLH   S  I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQTQTLA-TIGYMAPEYGREGQV 471
           +H D+KP+N+ LD N V  L DFG A  L     ++  + Q+LA T  YMAPE    G+ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 472 STNG---DVYSFGIMLMETFTRKKP 493
             +G   D++S G +++E  T K+P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 14/200 (7%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           I +G +G V+ A+    G   A+KV    D+           E D++ + +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           S        LV+EY+P G L   L +    LD       + ++  ALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ------TQTLATIGYMAPEYGREG 469
            DLKP N+L+D N    L+DFG++K  L   Q           + + T  Y+APE     
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 470 QVSTNGDVYSFGIMLMETFT 489
             S   D +S G +L E   
Sbjct: 177 GHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYG---RAFKSFDI-ECDMIKRIRHRNIIK-- 352
           IG+G FG+V K  R  DG  +  K  ++ YG      K   + E ++++ ++H NI++  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 353 --IISSCSSDDFKALVLEYMPHGSL----EKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
             II   +   +  +V+EY   G L    +KC     YI + F    I+  +  AL   H
Sbjct: 66  DRIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLALYECH 122

Query: 407 FGYSVP---IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
              S P   ++H DLKP+N+ LD N    L DFG+AK +L  D S  +T  + T  YM+P
Sbjct: 123 NR-SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKT-YVGTPYYMSP 179

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           E           D++S G ++ E      P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 298 NLIGRGGFGSVYKARIQDGM-----EVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRN 349
           N +G G FG VY+    D +      + V V  L+ G   +  K F  E  ++    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNY------ILDIFQRLNIMIDVASALE 403
           I+K++  C  ++ + +++E M  G L   L  +        +L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 404 YL---HFGYSVPIIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           YL   HF      IH DL   N L+     D + V  + DFG+A+ + K D    + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
             + +MAPE   +G+ +T  DV+SFG+++ E  T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 35/214 (16%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVK----VF-DLQYG-RAFKSFDIECDMIKRIRHRNI 350
             IG G +G V  A   + G +VA+K    VF DL    R  +    E  +++ +RH NI
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 351 IK---IISSCSSDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
           I    I+   S +DF  +  V E M    L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ-TQTLATIGYMAPE 464
           H   S  +IH DLKPSN+L++ N    + DFG+A+ +  ++      T+ + T  Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 465 -------YGREGQVSTNGDVYSFGIMLMETFTRK 491
                  Y      +   D++S G +  E  TRK
Sbjct: 177 LLLSSSRY------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 22/217 (10%)

Query: 294 FSENN---LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN 349
           + EN    ++G+G +G VY AR +   + +A+K    +  R  +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYS------SNYILDIFQRLNIMIDVASALE 403
           I++ + S S + F  + +E +P GSL   L S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
           YLH      I+H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 463 PEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEI 497
           PE   +G        D++S G  ++E  T K P  E+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 44/281 (15%)

Query: 300 IGRGGFGSVYKA--RIQDG--MEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FGSV K    ++ G  +EVAVK      +  G+  K F  E  ++ ++ H  I++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
           +I  C  +    LV+E  P G L K L       + D+     +   VA  + YL    S
Sbjct: 61  LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLE---S 113

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   NVLL +   A +SDFGM++  L       +  T     + + APE    
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRA-LGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 469 GQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL-LS 526
           G+ S+  DV+S+G+ L E F+   KP     +G+M             V+ ++++   L 
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP-----YGEMK---------GAEVIAMLESGERLP 218

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           + +E       C   I+++ + C    PE R    E+ +  
Sbjct: 219 RPEE-------CPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 68/259 (26%), Positives = 120/259 (46%), Gaps = 26/259 (10%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V+  + +  ++VA+K+  ++ G  +   F  E  ++ ++ H N++++   C+
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKM--IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
                 +V EYM +G L   L      L     L++  DV  A+EYL    S   IH DL
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDL 126

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
              N L+ ++ V  +SDFG+A+ +L +DQ  +   T   + +  PE     + S+  DV+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFG+++ E F+          G M  + + N      V+E V A     + +        
Sbjct: 186 SFGVLMWEVFSE---------GKMPYERFSNS----EVVESVSAGYRLYRPK------LA 226

Query: 539 VSFIFNLAMKCTVESPEQR 557
            + ++ +   C  E PE R
Sbjct: 227 PTEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F     +G G +GSVYKA   + G  VA+KV  +      +    E  ++K+     I+K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN----------IMIDVASAL 402
              S   +    +V+EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--- 459
           EYLH   S   IH D+K  N+LL++   A L+DFG++  L     ++ +  T+  IG   
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTV--IGTPF 164

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEI 497
           +MAPE  +E   +   D++S GI  +E    K P  +I
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 35/204 (17%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G +G VYKAR I  G  VA+KV  L+ G  F+    E  M+K  RH NI+    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN----------IMIDVASALEYLHFG 408
             D   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEY 465
                IH D+K +N+LL ++    L+DFG++  L     ++ + ++   IG   +MAPE 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAPEV 172

Query: 466 G---REGQVSTNGDVYSFGIMLME 486
               R+G      D+++ GI  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 11/196 (5%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G+G FG V+         VA+K   L+ G  + ++F  E  ++K++RH  ++++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 359 SDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGD 476
           L+ +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   D
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 477 VYSFGIMLMETFTRKK 492
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 63/282 (22%), Positives = 103/282 (36%), Gaps = 37/282 (13%)

Query: 299 LIGRGGFGSVYKA--------RIQDGMEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRN 349
            +G G FG V +          I     VAVK     +       F  E  ++  + H N
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFG 408
           +I++     +     +V E  P GSL   L         I    +  + +A+ + YL   
Sbjct: 58  LIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-- 114

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT-IGYMAPEYGR 467
            S   IH DL   N+LL  +    + DFG+ + L + +      + L     + APE  R
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
               S   DV+ FG+ L E FT         +G+         L    +++ +D      
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT---------YGEEPWAG----LSGSQILKKIDKEG--- 217

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
             E       C   I+N+ ++C   +P  R     +   L +
Sbjct: 218 --ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 37/281 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDL-QYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           IG G    VY A  + +  +VA+K  DL +   +      E   + +  H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
              D   LV+ Y+  GSL   + SS     LD      ++ +V   LEYLH   S   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLK--EDQSLTQTQTLATIGYMAPEYGREGQVST 473
            D+K  N+LL ++    ++DFG++  L    +     +   + T  +MAPE   +     
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 474 NG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD--- 529
              D++SFGI  +E  T   P               +   P+ V+      L  Q D   
Sbjct: 186 FKADIWSFGITAIELATGAAP--------------YSKYPPMKVLM-----LTLQNDPPS 226

Query: 530 -EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
            E      +       +   C  + P +R  A+E    LLK
Sbjct: 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE----LLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.3 bits (216), Expect = 4e-19
 Identities = 70/286 (24%), Positives = 136/286 (47%), Gaps = 30/286 (10%)

Query: 292 NGFSENNLIGRGGFGSVYKA--RIQDGMEVAVKVFDLQYGRAFKS---FDIECDMIKRIR 346
           +  ++  +IG G FG V++   ++    EVAV +  L+ G   K    F  E  ++ +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 347 HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
           H NII++    +      ++ EYM +G+L+K L   +     +Q + ++  +A+ ++YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--YMAPE 464
               +  +H DL   N+L++ N+   +SDFG+++ +L++D   T T +   I   + APE
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL 524
                + ++  DV+SFGI++ E  +         FG+    +W  D+    VM+ ++   
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS---------FGER--PYW--DMSNHEVMKAINDGF 227

Query: 525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        C S ++ L ++C  +   +R    +IV  L K+
Sbjct: 228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 54/191 (28%), Positives = 103/191 (53%), Gaps = 13/191 (6%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           IG G FG+V +     G +VAVK  +++     ++F  E  ++ ++ H+N+++++     
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 360 DDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    +V+E M  G+L   L +    ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
              N+L+ ++ VA +SDFG+A+       S+    +   + + APE  +  + S+  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 479 SFGIMLMETFT 489
           S+G++L E F+
Sbjct: 182 SYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 80/302 (26%), Positives = 125/302 (41%), Gaps = 59/302 (19%)

Query: 299 LIGRGGFGSVYKARIQD------GMEVAVKVF-DLQYGRAFKSFDIECDMIKRI-RHRNI 350
            +G G FG V KA             VAVK+  D    +       E +M+K I +H+NI
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCL---------YSSNYILDIFQRL------NIM 395
           I ++  C+ +    +V+EY  HG+L   L          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVN 509
             + +MAPE   +   +   DV+SFG++L E FT         P +E+F           
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----------- 244

Query: 510 DLLPISVMEIVDANLLSQKDEHFTTKGQ-CVSFIFNLAMKCTVESPEQRINAKEIVTRLL 568
            LL               K+ +   K Q C   +++L   C  E P QR   K++V  L 
Sbjct: 245 KLL---------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Query: 569 KI 570
           ++
Sbjct: 290 RM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 17/222 (7%)

Query: 291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVA---VKVFDLQYGRAFKSFDIECDMIKRIR 346
              F     IG+G F  VYKA  + DG  VA   V++F++   +A +    E D++K++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 347 HRNIIKIISSCSSDDFKALVLEYMPHGSLE---KCLYSSNYILDIFQRLNIMIDVASALE 403
           H N+IK ++S   ++   +VLE    G L    K       ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           ++H   S  I+H D+KP+NV +    V  L D G+ +      ++      + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD-MTL 504
           E   E   +   D++S G +L E    + P    F+GD M L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 63/286 (22%), Positives = 120/286 (41%), Gaps = 40/286 (13%)

Query: 300 IGRGGFGSVYK---ARIQDG---MEVAVK-VFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G+G FG VY+     +  G     VA+K V +    R    F  E  ++K     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYS--------SNY-ILDIFQRLNIMIDVASALE 403
           ++   S+     +V+E M  G L+  L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL    +   +H DL   N ++ +++   + DFGM + + + D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IVDA 522
           E  ++G  +T  DV+SFG++L E  T           +   +   N+     V++ ++D 
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQPYQGLSNE----EVLKFVIDG 237

Query: 523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL 568
             L   +        C   +  L   C   +P+ R    EIV+ L 
Sbjct: 238 GHLDLPEN-------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 64/292 (21%), Positives = 122/292 (41%), Gaps = 41/292 (14%)

Query: 293 GFSENNLIGRGGFGSVYKARIQDGME------VAVKVF---DLQYGRAFKSFDIECDMIK 343
              E   +GRG FG V+ A+ +   E      V VK       +       F  E DM +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFR 63

Query: 344 RIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI--------LDIFQRLNIM 395
           ++ H+N+++++  C   +   ++LEY   G L++ L ++           L   Q++ + 
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             +A  +++L    +   +H DL   N L+       +S   ++K +   +    +   L
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NAL 179

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS 515
             + ++APE  +E   ST  DV+SFG+++ E FT      E+ F  ++ +  +N      
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----QGELPFYGLSDEEVLNR----- 230

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                    L            C S ++ L  +C   +P+ R +  E+V+ L
Sbjct: 231 ---------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 27/221 (12%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRA---------FKSFDIECDMIKRIRHR 348
           LIG G FGSVY       G  +AVK  +L    A           +   E  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
           NI++ + S    D   + LEY+P GS+   L +     +   R N +  +   L YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMA 462
            +  IIH D+K +N+L+D+     +SDFG++K L  E  SL+     A      ++ +MA
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFWMA 180

Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT 503
           PE  ++   +   D++S G +++E  T K P     F D T
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-----FPDCT 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 16/211 (7%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIRH 347
           +++  ++G+G +G+VY      G  +AVK  +L         + ++    E D++K ++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDI-FQRLNIMIDVASALEYLH 406
            NI++ + +C  D+  ++ +E++P GS+   L     + +  F +    I     + YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG----YMA 462
              +  ++H D+K +NV+L  N +  L DFG A+ L       T +  L ++     +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           PE   E       D++S G  + E  T K P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 37/216 (17%)

Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F+    IG+G FG VYKA  +     VA+KV DL+        +IE D+ +       I+
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQE------IQ 51

Query: 353 IISSCSS-----------DDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 400
            +S C S              K  +++EY   GS    L      LD      I+ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG- 459
            LEYLH       IH D+K +N+LL +     L+DFG++  L     + T ++    +G 
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFVGT 161

Query: 460 --YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
             +MAPE  ++       D++S GI  +E    + P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 13/197 (6%)

Query: 298 NLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISS 356
           + +G G +G VY+   +   + VAVK    +     + F  E  ++K I+H N+++++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYL---HFGYSVP 412
           C+ +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL   +F     
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----- 125

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     + S
Sbjct: 126 -IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 473 TNGDVYSFGIMLMETFT 489
              DV++FG++L E  T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 299 LIGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRA--FKSFDIECDMIKRIRHRNII 351
            +G+G FGSV   R   +QD  G  VAVK   LQ+  A   + F+ E +++K ++H NI+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 352 KIISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           K    C S   +   LV+EY+P+GSL   L      LD  + L     +   +EYL    
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--- 125

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK--PLLKEDQSLTQTQTLATIGYMAPEYGR 467
           S   +H DL   N+L++      + DFG+ K  P  KE   + +    + I + APE   
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE-SPIFWYAPESLT 184

Query: 468 EGQVSTNGDVYSFGIMLMETFT 489
           E + S   DV+SFG++L E FT
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 20/201 (9%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIEC------DMIKRIRHRNIIK 352
           IG G +G VYKAR    G  VA+K    +    F+S  I         ++K + H NIIK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIK----KIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           ++          LV E+M    L K +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQ 470
           I+H DLKP N+L++   V  L+DFG+A+           T  + T  Y APE   G +  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLG-DKG 175

Query: 471 VSTNGDVYSFGIMLMETFTRK 491
            ST  D++S G +  E  +R+
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 298 NLIGRGGFGSVYKARI-QDG--MEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRNIIK 352
           ++IG G FG V KARI +DG  M+ A+K + +       + F  E +++ ++  H NII 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMID 397
           ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           + +MA E       +TN DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 15/202 (7%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVK-VFDLQYGRAFKSFDI----ECDMIKRIRHRNII 351
             +G G +  VYKAR  + G  VA+K +   +   A    +     E  +++ ++H NII
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            ++          LV E+M    LEK +   + +L      + M+     LEYLH  +  
Sbjct: 66  GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREG 469
            I+H DLKP+N+L+  + V  L+DFG+A+     ++ +T  Q + T  Y APE  +G   
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFGAR- 178

Query: 470 QVSTNGDVYSFGIMLMETFTRK 491
                 D++S G +  E   R 
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 35/273 (12%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG VYKA+  + G+  A K+  ++     + F +E D++   +H NI+ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            ++   +++E+   G+L+  +      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVST 473
           K  N+LL  +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             D++S GI L+E    + P               ++L P+ V+      L   K E  T
Sbjct: 188 KADIWSLGITLIELAQMEPPH--------------HELNPMRVL------LKILKSEPPT 227

Query: 534 ---TKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                    SF   L   C V+ P+ R  A E+
Sbjct: 228 LDQPSKWSSSFNDFLK-SCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 31/282 (10%)

Query: 297 NNLIGRGGFGSVYKA----RIQDGMEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNII 351
              IG G FG VY+        + + VAVK        + +  F  E  ++++  H +I+
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
           K+I   + ++   +V+E  P G L   L  + Y LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
             +H D+   NVL+       L DFG+++  L+++     ++    I +MAPE     + 
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 472 STNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
           ++  DV+ FG+ + E      KP              V +   I  +E           E
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPF-----------QGVKNNDVIGRIE---------NGE 225

Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD 572
                  C   +++L  KC    P +R    E+  +L  I  
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 299 LIGRGGFGSVYKARI--QDG--MEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           ++G G FGSV + ++   DG  ++VAVK    D+      + F  E   +K   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 353 IISSC--SSDDFK----ALVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASA 401
           +I  C  +S   K     ++L +M HG L   L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D           + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTR 490
           A E   +   ++  DV++FG+ + E  TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 59/286 (20%)

Query: 300 IGRGGFGSVY-------------KARIQDGMEVAVKVFDLQ---YGRAFKSFDIECDMIK 343
           +G G FG V+              A   DG  V V V  L+      A   F  E  ++ 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 344 RIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCL-----YS----SNYI--LDIFQRL 392
           R+++ NII+++  C SDD   ++ EYM +G L + L      S    +N I  + I   L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
            + + +AS ++YL    S+  +H DL   N L+ ++    ++DFGM++ L   D    Q 
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL 512
           + +  I +MA E    G+ +T  DV++FG+ L E FT  K                    
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ------------------ 231

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQ---------CVSFIFNLAMKC 549
           P S++   D  ++    E F  +G+         C S +F L M+C
Sbjct: 232 PYSLLS--DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRC 275

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 11/196 (5%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V+        +VAVK   L+ G  + +SF  E  ++K++RH  ++++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            +    +V EYM  GSL   L       L +   +++   VA+ + Y+     +  IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGD 476
           L+ +N+L+ D +V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   D
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 477 VYSFGIMLMETFTRKK 492
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)

Query: 300 IGRGGFGSVYKAR-IQDG----MEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG+VYK   I +G    + VA+KV   +    A K    E  ++  + H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           +  C S     L+ + MP G L   + +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           +H DL   NVL+       ++DFG+AK L  +++          I +MA E       + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 474 NGDVYSFGIMLMETFT-RKKPTDEI 497
             DV+S+G+ + E  T   KP + I
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 16/215 (7%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVK---VFDLQYGRAFKSFDIECDMIKRIRHRN 349
           F     IGRG F  VY+A  + DG+ VA+K   +FDL   +A      E D++K++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI---MIDVASALEYLH 406
           +IK  +S   D+   +VLE    G L + +        +     +    + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYG 466
              S  ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+PE  
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
            E   +   D++S G +L E    + P    F+GD
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP----FYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 48/285 (16%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIRH---RN 349
           LIGRG +G+VY+ + +  G  VA+K+ +L         D+     E  ++ ++R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           I K   S        +++EY   GS+ + L  +  I + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAPEYGRE 468
            V +IH D+K +N+L+ +     L DFG+A  L   +Q+ ++  T     Y MAPE   E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 469 GQV-STNGDVYSFGIMLMETFTRKKP-TDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
           G+   T  D++S GI + E  T   P +D   F  M L              I  +    
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML--------------IPKSKPPR 221

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
            +D  ++   +   F+      C  E P++R++A+E    LLK +
Sbjct: 222 LEDNGYSKLLR--EFV----AACLDEEPKERLSAEE----LLKSK 256

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--------GRAFKSFDIECDMIKR 344
            F    +IG+G FG V   + +D      K+F ++Y          + ++   E  +++ 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTK----KMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 345 IRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDV 398
           + H  ++ +  S   ++   LV++ +  G L        Y L    + +       + ++
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEI 109

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
             ALEYLH   S  IIH D+KP N+LLD+    H++DF +A  +  +  +   T T  T 
Sbjct: 110 VLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           GYMAPE       S   D +S G+   E    K+P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 13/207 (6%)

Query: 293 GFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRN 349
            F     +G+G +GSVYK  R+ D    A+K  DL      +  D   E  ++  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---LNIMIDVASALEYLH 406
           II    +    +   +V+EY P G L K +        +        I I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYG 466
                 I+H DLK +N+LL  N +  + D G++K +LK  +++ +TQ   T  YMAPE  
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISK-VLK--KNMAKTQI-GTPHYMAPEVW 173

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKP 493
           +    S   D++S G +L E  T   P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 298 NLIGRGGFGSVYKARIQ-DG--MEVAVKVF-DLQYGRAFKSFDIECDMIKRI-RHRNIIK 352
           ++IG G FG V +A I+ DG  M  A+K+  +       + F  E +++ ++  H NII 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMID 397
           ++ +C +  +  + +EY P+G+L   L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++    E+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           + +MA E       +T  DV+SFG++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 34/253 (13%)

Query: 331 AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLY--------SS 382
           A + F  E  ++ R+   NI +++  C+ D    +++EYM +G L + L          +
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 383 NYILDIFQR--LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 440
                +     L +   +AS + YL    S+  +H DL   N L+  N    ++DFGM++
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEIF 498
            L   D    Q +    I +MA E    G+ +T  DV++FG+ L E  T  R++P +   
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH-- 236

Query: 499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ---CVSFIFNLAMKCTVESPE 555
              +T    V          I +A    + D       +   C   I+ L ++C     E
Sbjct: 237 ---LT-DQQV----------IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282

Query: 556 QRINAKEIVTRLL 568
            R   +EI   L 
Sbjct: 283 DRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 5/207 (2%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           +G G FG V   + +   +VA+K+   +   +   F  E  ++ ++ H  ++++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 419
                +V EYM +G L   L          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYS 479
             N L+DD     +SDFG+++ +L +D+  +   +   + +  PE     + S+  DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 480 FGIMLMETFTRKKPTDEIFFGDMTLKH 506
           FG+++ E ++  K   E F    T++ 
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNII 351
            +G G F S Y+AR ++ G  +AVK        + +  ++      E  ++ R+ H +II
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLY---------SSNYILDIFQRLNIMIDVASAL 402
           +++ +   D    L +E+M  GS+   L            NY   + +           L
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLKE--DQSLTQTQTLATIG 459
            YLH      IIH D+K +N+L+D       ++DFG A  L  +       Q Q L TI 
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           +MAPE  R  Q   + DV+S G +++E  T K P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 70/251 (27%), Positives = 109/251 (43%), Gaps = 39/251 (15%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVF-----DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           L+G+G FG VY     D G E+AVK         +  +   + + E  ++K ++H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
                  D+  ++ +EYMP GS++  L +   + +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAPE--- 464
           I+H D+K +N+L D      L DFG +K L    Q++  + T       T  +M+PE   
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 465 ---YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTL-----KHWVNDLLPISV 516
              YGR+       DV+S G  ++E  T K P  E  F  M           N  LP  V
Sbjct: 181 GEGYGRK------ADVWSVGCTVVEMLTEKPPWAE--FEAMAAIFKIATQPTNPQLPSHV 232

Query: 517 MEIVDANLLSQ 527
                 N L +
Sbjct: 233 SPDA-RNFLRR 242

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 48/305 (15%)

Query: 286 EIFQATNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVF-DLQYGRAFKSFDIE 338
           EI  +T  F E   +G   FG VYK  +      +    VA+K   D   G   + F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 339 CDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLY---------------SSN 383
             M  R++H NI+ ++   + +   +++  Y  H  L + L                +  
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 384 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 443
             L+    ++I+  +A+ +E+L    S  ++H DL   NVL+ D +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT 503
             D       +L  I +M+PE    G+ S + D++S+G++L E F+         +G   
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQP 226

Query: 504 LKHWVNDLLPISVMEIV-DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
              + N      V+E++ +  +L   D+       C ++++ L ++C  E P +R   K+
Sbjct: 227 YCGYSNQ----DVIEMIRNRQVLPCPDD-------CPAWVYTLMLECWNEFPSRRPRFKD 275

Query: 563 IVTRL 567
           I +RL
Sbjct: 276 IHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.9 bits (199), Expect = 5e-17
 Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 11/196 (5%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRHRNIIKIISSCS 358
           +G+G FG V+        +VA+K   L+ G    ++F  E  ++K++RH  ++ + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            +    +V E+M  GSL   L   +   L + Q +++   +A  + Y+     +  IH D
Sbjct: 72  EEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGD 476
           L+ +N+L+ DN+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   D
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 477 VYSFGIMLMETFTRKK 492
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 27/206 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSF-DI--ECDMIKRIRHRNIIKIIS 355
           IG G FG+VY AR ++    VA+K       ++ + + DI  E   ++++RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY-K 81

Query: 356 SCSSDDFKA-LVLEYMPHGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYLHFGYS 410
            C   +  A LV+EY        CL S++ IL++     Q + I      AL+ L + +S
Sbjct: 82  GCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY---GR 467
              IH D+K  N+LL +     L+DFG A  L+    S      + T  +MAPE      
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSAS-LVSPANSF-----VGTPYWMAPEVILAMD 187

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKP 493
           EGQ     DV+S GI  +E   RK P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 21/201 (10%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGR--AFKSFDIECDMIKRIRHRNIIKIIS 355
           ++G G +G V K R +  G  VA+K F          K+   E  +++++RH NI+ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +        LV EY+    LE  L +S   L      + +  +  A+ Y H   S  IIH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGRE 468
            D+KP N+L+ ++ V  L DFG A+  L+   +   T  +AT  Y APE       YG+ 
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 469 GQVSTNGDVYSFGIMLMETFT 489
                  DV++ G ++ E   
Sbjct: 183 ------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 35/216 (16%)

Query: 298 NLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIK 352
             IG G +G VYKAR +D G  VA+K   L   +  + F I    E  +++++ HRNI+ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70

Query: 353 ----IISSCSSDDFKA------LVLEYMPH---GSLEKCL--YSSNYILDIFQRLNIMID 397
               +     + DFK       LV EYM H   G LE  L  +S ++I    ++L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
               LE L++ +    +H D+K SN+LL++     L+DFG+A+    E+     T  + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVIT 180

Query: 458 IGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRK 491
           + Y  PE   G E +     DV+S G +L E FT+K
Sbjct: 181 LWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 20/214 (9%)

Query: 294 FSENNLIGRGGFGSVYKARIQ----DGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIRH 347
           F+   ++G+G FGSV +A+++       +VAVK+   D+      + F  E   +K   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 348 RNIIKIISSCSSDDFKA------LVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMI 396
            N+IK+I        K       ++L +M HG L   L  S      + L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           D+AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D       +  
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR 490
            + ++A E   +   +T+ DV++FG+ + E  TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 28/210 (13%)

Query: 300 IGRGGFGSV----YKARIQD-GMEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNIIKI 353
           +G G FG V    Y       G  VAVK    + G+   S +  E +++K + H NI+K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 354 ISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
              CS    K   L++EY+P GSL   L      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--------LKEDQSLTQTQTLATIGYMAP 463
             IH DL   NVLLD++ +  + DFG+AK +        ++ED         + + + A 
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD-------SPVFWYAV 179

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           E  +E + S   DV+SFG+ L E  T    
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 29/277 (10%)

Query: 297 NNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNII 351
             +IG G FG V + R++      ++VA+K        +    F  E  ++ +  H NII
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 410
           ++    +      ++ EYM +GSL+K L  ++    + Q + ++  +AS ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
              +H DL   N+L++ N+V  +SDFG+++ L   + + T       I + APE     +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 471 VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
            ++  DV+SFGI++ E  +         +G+       N  +  +V +     L    D 
Sbjct: 185 FTSASDVWSFGIVMWEVMS---------YGERPYWDMSNQDVIKAVED--GYRLPPPMD- 232

Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                  C S ++ L + C  +   +R    +IV+ L
Sbjct: 233 -------CPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 68/301 (22%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVF------DLQYGRAFKSFDIECDMIKRIRH 347
           IG+G FG V++AR       +    VAVK+       D+Q       F  E  ++    H
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-----ADFQREAALMAEFDH 67

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCL--------------------YSSNYI-L 386
            NI+K++  C+      L+ EYM +G L + L                       N + L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 387 DIFQRLNIMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 443
              ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ + 
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDEIFFGDM 502
             D           I +M PE     + +T  DV+++G++L E F+   +P    ++G M
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP----YYG-M 236

Query: 503 TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
             +          +  + D N+LS  D        C   ++NL   C  + P  R +   
Sbjct: 237 AHEE--------VIYYVRDGNVLSCPD-------NCPLELYNLMRLCWSKLPSDRPSFAS 281

Query: 563 I 563
           I
Sbjct: 282 I 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 298 NLIGRGGFGSVYKARI--QDGMEV--AVK----VFDLQYGRAFKSFDIECDMIKRIRHRN 349
            +IG+G FG VY   +   DG ++  AVK    + DL+    F     E  ++K   H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLK---EGIIMKDFSHPN 57

Query: 350 IIKIISSCSSDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
           ++ ++  C   +   LV L YM HG L   + S  +   +   +   + VA  +EYL   
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-- 115

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-KEDQSLTQ-TQTLATIGYMAPEYG 466
            S   +H DL   N +LD++    ++DFG+A+ +  KE  S+   T     + +MA E  
Sbjct: 116 -SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKP 493
           +  + +T  DV+SFG++L E  TR  P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 25/218 (11%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRA----------FKSFDIECDMIKRIRH 347
           LIG+G +G VY A  +  G  +AVK  +L    A           K+   E + +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
            NI++ +   +++++ ++ LEY+P GS+  CL +     +   R      V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAPE 464
             S  I+H DLK  N+L+D + +  +SDFG++K   K D      Q ++   ++ +MAPE
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 465 YGREGQVSTNG--DVYSFGIMLMETFTRKKP--TDEIF 498
                    +   D++S G +++E F  ++P   +E  
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 36/185 (19%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVK------VFD---LQYGRAFKSFDIECDMIKRIRHRN 349
           IG G  G V+KA+  + G  VA+K      +      Q  R  K+       ++  +H  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA-------LQACQHPY 60

Query: 350 IIKII------SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE 403
           ++K++      S         LV+EYMP   L + L      L   Q  + M  +   + 
Sbjct: 61  VVKLLDVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           Y+H   +  I+H DLKP+N+L+  + V  ++DFG+A+   +E+  L   Q +AT  Y AP
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP 169

Query: 464 E--YG 466
           E  YG
Sbjct: 170 ELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 63/265 (23%), Positives = 118/265 (44%), Gaps = 24/265 (9%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           +G G FG V+  + +  ++VA+K  + +   + + F  E  ++ ++ H  ++++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 419
                +V E+M +G L   L      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYS 479
             N L+    V  +SDFGM + +L +D+  + +     + +  PE     + S+  DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 480 FGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCV 539
           FG+++ E FT          G M  +   N      V+E++     S+    +  K   +
Sbjct: 187 FGVLMWEVFTE---------GKMPFEKKSN----YEVVEMI-----SRGFRLYRPKLASM 228

Query: 540 SFIFNLAMKCTVESPEQRINAKEIV 564
           + ++ +   C  E PE R    E++
Sbjct: 229 T-VYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 298 NLIGRGGFGSVYKA----RIQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNI 350
             +G G FG VY+     R  D +E+ V V  L      +    F +E  ++ +  H+NI
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEY 404
           +++I        + ++LE M  G L+  L  +         L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 405 L---HFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           L   HF      IH D+   N LL       VA ++DFGMA+ + +        + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
            +M PE   +G  ++  DV+SFG++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 299 LIGRGGFGSVYKARI--QDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKI 353
           +IG G FG V   R+      E+ V +  L+ G   +  + F  E  ++ +  H NII +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 412
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--YMAPEYGREGQ 470
            +H DL   N+L++ N+V  +SDFG+++ +L++D     T     I   + APE     +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 471 VSTNGDVYSFGIMLMETFT 489
            ++  DV+S+GI++ E  +
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 34/213 (15%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKII 354
           IG+G FG V+KAR  +    VA+K   +      + F I    E  +++ ++H N++ +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 355 SSCSS-----DDFKA---LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
             C +     + +K    LV E+  H  L   L + N    + +   +M  + + L Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGYMAPE 464
                 I+H D+K +N+L+  + +  L+DFG+A+   L K  +    T  + T+ Y  PE
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 465 -------YGREGQVSTNGDVYSFGIMLMETFTR 490
                  YG         D++  G ++ E +TR
Sbjct: 194 LLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVK---VFDLQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           IGRG F  VY+A  + D   VA+K   +F++   +A +    E D++K++ H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 356 SCSSDDFKALVLEYMPHGSLEKCL-YSSNYILDIFQRL--NIMIDVASALEYLHFGYSVP 412
           S   D+   +VLE    G L + + Y       I +R      + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              D++S G +L E    + P    F+GD
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP----FYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.6 bits (199), Expect = 6e-16
 Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 11/156 (7%)

Query: 112 LSMNN--FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           L ++N      IP  I  L+ LQ + L  N ++G+IP S+G + +L+ L+LS N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 170 PISLEKLLDLKDINVSFNKLEGEIPNK--GPFRNFSTESFEGNELLCGMPNLQVPPCRTR 227
           P SL +L  L+ +N++ N L G +P    G   + ++ +F  N  LCG+P L    C   
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPH 540

Query: 228 IHHTSRKNDLLIGIVLPLSTIFMMAVILFILRYRKR 263
           +   ++     IGI   +S  F+  VI  +  +++R
Sbjct: 541 LSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG+G  G+VY A  +  G EVA+K  +LQ     +    E  +++  +H NI+  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 34/230 (14%)

Query: 300 IGRGGFGSVY--------KARIQDGMEVAVKVF-DLQYGRAFKSFDIECDMIKRI-RHRN 349
           +G G FG V         K + ++ + VAVK+  D    +       E +M+K I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS-----NYILDI---------FQRL-NI 394
           II ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              VA  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIF 498
              + +MAPE   +   +   DV+SFG+++ E FT         P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 77.2 bits (190), Expect = 9e-16
 Identities = 63/260 (24%), Positives = 123/260 (47%), Gaps = 28/260 (10%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V+        +VA+K   L+ G  + ++F  E +++K+++H  ++++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            +    ++ EYM +GSL   L +   I L I + +++   +A  + ++        IH D
Sbjct: 72  QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L+ +N+L+ + +   ++DFG+A+ L+++++   +      I + APE    G  +   DV
Sbjct: 128 LRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFGI+L E  T  +    I +  MT    + +L     M   D                
Sbjct: 187 WSFGILLTEIVTYGR----IPYPGMTNPEVIQNLERGYRMPRPDN--------------- 227

Query: 538 CVSFIFNLAMKCTVESPEQR 557
           C   ++ L   C  E PE+R
Sbjct: 228 CPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)

Query: 300 IGRGGFGSVYKA---RIQDG---MEVAVKVFDLQYGRA-FKSFDIECDMIKRIRHRNIIK 352
           +G G FG V KA   R++       VAVK+       +  +    E +++K++ H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMID---------- 397
           +  +CS D    L++EY  +GSL   L  S     +Y+     R +  +D          
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 398 --------VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
                   ++  ++YL     + ++H DL   NVL+ +     +SDFG+++ + +ED  +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
            +++    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 21/212 (9%)

Query: 294 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQ-YGRAFKSFDI-ECDMIKRIRHRNI 350
           F   N IG+G FG V+K  R  D    A+K  DL    R  +   I E  ++ ++    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYS-------SNYILDIFQRLNIMIDVASALE 403
           I+   S        +V+EY  +G L K L          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           +LH   S  I+H D+K  N+ LD      + D G+AK L   D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
           E   +   +   DV++ G++L E  T K P D
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)

Query: 298 NLIGRGGFGSVYKARIQ-DG--MEVAVKVFDLQYGRA--FKSFDIECDMIKRI-RHRNII 351
           ++IG G FG V KARI+ DG  M+ A+K    +Y      + F  E +++ ++  H NII
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMI 396
            ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T    
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
            + +MA E       +TN DV+S+G++L E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 11/222 (4%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           ++GRG FG V+   R  D   V +K   ++        +   EC ++K + H NII+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
           +   D    +V+EY P G+L + +    N +LD    L+  + +  AL ++H   +  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 415 HCDLKPSNVLLDDN-MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           H DLK  N+LLD + MV  + DFG++K L  + ++ T    + T  Y++PE       + 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQ 180

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS 515
             D+++ G +L E  + K+  +      + LK       PIS
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 22/204 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G +G VYKAR +  G   AVK+  L+ G  F     E  M+K  +H NI+    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           S +   + +EY   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGREGQVSTNG 475
           K +N+LL DN    L+DFG+A  +     + T  +  + IG   +MAPE      V  NG
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKI-----TATIAKRKSFIGTPYWMAPEV---AAVEKNG 184

Query: 476 ------DVYSFGIMLMETFTRKKP 493
                 D+++ GI  +E    + P
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 11/199 (5%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           +G+GGFG V   +++  G   A K  D   L+  +  +    E  +++++  R I+ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPII 414
           +  + D   LV+  M  G L+  +Y+         + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           + DLKP NVLLDD+    +SD G+A  L              T GYMAPE  +      +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 475 GDVYSFGIMLMETFTRKKP 493
            D ++ G  L E    + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 11/204 (5%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG VYKA+ ++ G   A KV + +     + + +E +++    H  I+K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            D    +++E+ P G+++  +   +  L       I +     LE L + +S+ IIH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVST 473
           K  NVLL  +    L+DFG++   +K  Q   +   + T  +MAPE       ++     
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             D++S GI L+E    + P  E+
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 39/232 (16%)

Query: 300 IGRGGFGSVYKARIQDGME------------------VAVKVFDLQYGR-AFKSFDIECD 340
           +G G FG V+    + GME                  VAVK+      + A   F  E  
Sbjct: 13  LGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 341 MIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCL---------YSSNYILDIFQR 391
           ++ R++  NII++++ C + D   ++ EYM +G L + L           ++ +   +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 392 LNIM-IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
           L  M   +AS ++YL    S+  +H DL   N L+  N    ++DFGM++ L   D    
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKP----TDE 496
           Q + +  I +M+ E    G+ +T  DV++FG+ L E  T  +++P    +DE
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 8/195 (4%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V+     +  +VAVK   L+ G  + ++F  E +++K ++H  ++++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCD 417
            ++   ++ EYM  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L+ +NVL+ ++++  ++DFG+A+ ++++++   +      I + APE    G  +   DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 478 YSFGIMLMETFTRKK 492
           +SFGI+L E  T  K
Sbjct: 188 WSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G +G VYKAR +  G   A+KV  L+ G  F     E  M+K  +H NI+    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYG---REGQVS 472
           K +N+LL DN    L+DFG++  +     + T  +  + IG   +MAPE     R+G  +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 473 TNGDVYSFGIMLMETFTRKKP 493
              D+++ GI  +E    + P
Sbjct: 188 QLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 66/207 (31%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVF------DLQYGRAFKSFDIECDMIKR 344
               E + +G G  GSV K R+   GM  A+K        DLQ     K    E ++ K 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-----KQILRELEINKS 55

Query: 345 IRHRNIIKIISSC--SSDDFKALVLEYMPHGSLE---KCLYSSNYILDIFQRLNIMIDVA 399
            +   I+K   +    S     + +EY   GSL+   K +      +       I   V 
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
             L YLH   S  IIH D+KPSN+LL       L DFG++  L+    SL  T T  T  
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSF 168

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLME 486
           YMAPE  +    S   DV+S G+ L+E
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 29/222 (13%)

Query: 294 FSENNL-----IGRGGFGSVYKARIQD-GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR 346
           F+  +L     IGRG FG+V K   +  G  +AVK        +  K   ++ D++ R  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 347 H-RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVA--- 399
               I+K   +   +    + +E M   SL+K      Y+ ++ + +    I+  +A   
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKF---YKYVYEVLKSVIPEEILGKIAVAT 116

Query: 400 -SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
             AL YL     + IIH D+KPSN+LLD N    L DFG++  L+    S+ +T+     
Sbjct: 117 VKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCR 171

Query: 459 GYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
            YMAPE      R+G      DV+S GI L E  T K P  +
Sbjct: 172 PYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 70/267 (26%), Positives = 119/267 (44%), Gaps = 28/267 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G  G V  A     G +VAVK  DL+  +  +    E  +++  +H NI+++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL +LH   +  +IH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAPEYGREGQVSTNGDV 477
           K  ++LL  +    LSDFG    + KE   + + ++L    Y MAPE        T  D+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +S GIM++E    + P    +F +           P+  M+ +  NL  +         +
Sbjct: 199 WSLGIMVIEMVDGEPP----YFNEP----------PLQAMKRIRDNLPPKLKNLHKVSPR 244

Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIV 564
             SF+        V  P QR  A E++
Sbjct: 245 LRSFLDR----MLVRDPAQRATAAELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 23/218 (10%)

Query: 300 IGRGGFGSVYKARIQDGME-VAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           +G+GG+G V+ A+ +D  E VA+K      L      +    E D++   +   ++K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPII 414
           +   D++  L +EY+P G   + L ++  +L        M ++  A++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H DLKP N L+D +    L+DFG++K ++    S+     + +  YMAPE  R       
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDFT 178

Query: 475 GDVYSFGIMLMETFTRKKP-----TDEIFFGDMTLKHW 507
            D +S G ML E      P      +E +     LK+W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.5 bits (183), Expect = 8e-15
 Identities = 65/281 (23%), Positives = 129/281 (45%), Gaps = 32/281 (11%)

Query: 299 LIGRGGFGSVYKARI-QDGME---VAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKI 353
           +IG G FG V + R+   G     VA+K     Y  +  + F  E  ++ +  H NII +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
               +      ++ E+M +G+L+  L  ++    + Q + ++  +A+ ++YL     +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAPEYGREGQ 470
           +H DL   N+L++ N+V  +SDFG+++ L  +    T T +L     I + APE     +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 471 VSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
            ++  DV+S+GI++ E  +  ++P     + DM+ +  +N +               ++D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDVINAI---------------EQD 227

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                   C + +  L + C  +    R    +IV+ L K+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 67/234 (28%), Positives = 107/234 (45%), Gaps = 47/234 (20%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNIIK 352
           IG G +G V  A   + G +VA+K    +   AF    +      E  +++  +H NII 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKILRHFKHDNIIA 68

Query: 353 I--ISSCSSDDFKA--LVLEYMPHGSLEKCLYSS--------NYILDIFQRLNIMIDVAS 400
           I  I      DFK   +V++ M    L   ++S          Y L  +Q L        
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFL--YQLLR------- 118

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK--EDQSLTQTQTLATI 458
            L+Y+H   S  +IH DLKPSN+L++++    + DFGMA+ L     +     T+ +AT 
Sbjct: 119 GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 459 GYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            Y APE      + +T  D++S G +  E   R+    ++F G    K++V+ L
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG----KNYVHQL 221

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 37/284 (13%)

Query: 300 IGRGGFGSVYKARI-----QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG V   R        G +VAVK    +  G        E ++++ + H NI+K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 354 ISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
              C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPEYGREGQ 470
             +H DL   NVL++      + DFG+ K +  + +  T    L + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 471 VSTNGDVYSFGIMLMETFT----RKKPTDEIF------FGDMTLKHWVNDLLPISVMEIV 520
                DV+SFG+ L E  T       P            G MT+   V  L         
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL--------- 239

Query: 521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                 ++ +       C   ++ L  KC    P +R   + ++
Sbjct: 240 ------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 30/281 (10%)

Query: 299 LIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIK 352
           L+G G FG+V+K   I +G    + VA+K    + GR  F+        +  + H  I++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           ++  C     + LV +  P GSL   +      LD  + LN  + +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           ++H +L   N+LL  + +  ++DFG+A  L  +D+    ++    I +MA E    G+ +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
              DV+S+G+ + E  +         +G            P + M   +   L +K E  
Sbjct: 190 HQSDVWSYGVTVWEMMS---------YGAE----------PYAGMRPHEVPDLLEKGERL 230

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
                C   ++ + +KC +     R   KE+     ++ RD
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 34/230 (14%)

Query: 300 IGRGGFGSVY--------KARIQDGMEVAVKVF-DLQYGRAFKSFDIECDMIKRI-RHRN 349
           +G G FG V         K +    + VAVK+  D    +       E +M+K I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS-----NYILD---------IFQRL-NI 394
           II ++ +C+ D    +++EY   G+L + L +      +Y  D          F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIF 498
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 294 FSENNL-----IGRGGFGSVYKA------RIQDGMEVAVKVF----DLQYGRAFKSFDIE 338
           F  NNL     +G G FG V +A      +    M+VAVK+           A  S   E
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88

Query: 339 CDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMI 396
             ++  +  H NI+ ++ +C+      ++ EY  +G L   L       L +   L+   
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
            VA  + +L    S   IH DL   NVLL    +  + DFG+A+ ++ +   + +     
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
            + +MAPE       +   DV+S+GI+L E F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 33/284 (11%)

Query: 294 FSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRN 349
           F++   IG+G FG V+K    R Q    VA+K+ DL+      +    E  ++ +     
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           + K   S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++ 
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
              +  D++S GI  +E    + P  E              L P+ V+       L  K+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSE--------------LHPMKVL------FLIPKN 216

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              T +G     +      C  + P  R  AKE++     +R +
Sbjct: 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 70/243 (28%), Positives = 107/243 (44%), Gaps = 63/243 (25%)

Query: 299 LIGRGGFGSVYKARIQDGME----VAVKVF----------DLQYGRAFKSFDIECDMIKR 344
           ++G+GG+G V++ R   G +     A+KV           D  + +A      E ++++ 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA------ERNILEA 56

Query: 345 IRHRNIIKIISSCSSDDFKALVLEYMPHGSL----EK---------CLYSSNYILDIFQR 391
           ++H  I+ +I +  +     L+LEY+  G L    E+         C Y S   L     
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----- 111

Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
                    ALE+LH      II+ DLKP N+LLD      L+DFG+ K  + E  ++T 
Sbjct: 112 ---------ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158

Query: 452 TQTLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFT---------RKKPTDEIFFGD 501
           T    TI YMAPE   R G      D +S G ++ +  T         RKK  D+I  G 
Sbjct: 159 T-FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216

Query: 502 MTL 504
           + L
Sbjct: 217 LNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVF-DLQYGRAFKSFDI-ECDMIKRIRHRNIIKIIS 355
           L+G G +G V K + ++ G  VA+K F + +  +  K   + E  M+K++RH N++ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
                    LV E++ H  L+      N  LD  +    +  +   +E+ H   S  IIH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGRE 468
            D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y APE       YGR 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGRA 181

Query: 469 GQVSTNGDVYSFGIMLMETFT 489
                  D+++ G ++ E  T
Sbjct: 182 ------VDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 35/219 (15%)

Query: 294 FSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI 350
           F++   IG+G FG V+K    R Q    VA+K+ DL+            D I+ I+    
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAE---------DEIEDIQQE-- 52

Query: 351 IKIISSCSSDDFKA------------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
           I ++S C S                 +++EY+  GS    L +  +  D FQ   ++ ++
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEI 110

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T 
Sbjct: 111 LKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTP 165

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEI 497
            +MAPE  ++    +  D++S GI  +E    + P  ++
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 300 IGRGGFGSVYKARI-QDG--MEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKII 354
           +G G FGSV + ++ QD   ++VAVK   +        + F  E   +K   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 355 SSC----SSDDFKA--LVLEYMPHGSLEKCLYSSNY-----ILDIFQRLNIMIDVASALE 403
             C     S+ + +  ++L +M HG L   L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL    S   IH DL   N +L++NM   ++DFG++K +   D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTR 490
           E   +   +T  DV+SFG+ + E  TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 22/227 (9%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISS 356
           IG G FG +Y A+ + D     +K  DL     +  ++   E  ++ +++H NI+   +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 357 CSSDDFKALVLEYMPHGSLEK-------CLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
              +    +V+EY   G L K        L+S + IL  F      + ++  L+++H   
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
              I+H D+K  N+ L  N MVA L DFG+A+  L +   L  T  + T  Y++PE  + 
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYT-CVGTPYYLSPEICQN 176

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS 515
              +   D++S G +L E  T K P +      + LK       PIS
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 72.2 bits (178), Expect = 6e-14
 Identities = 61/218 (27%), Positives = 91/218 (41%), Gaps = 67/218 (30%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDI-----------ECDMIKRIRH 347
           +G G FG V   R +   +  A+K+             I           E  +++ IRH
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--------KIVKLKQVEHVLNEKRILQSIRH 60

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIM----IDVA---- 399
             ++ +  S   D    LV+EY+P G             ++F  L         VA    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYA 107

Query: 400 ----SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
                ALEYLH   S+ I++ DLKP N+LLD +    ++DFG AK +        +T TL
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL 158

Query: 456 -ATIGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
             T  Y+APE      YG+   V    D ++ GI++ E
Sbjct: 159 CGTPEYLAPEIILSKGYGK--AV----DWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 66/275 (24%), Positives = 123/275 (44%), Gaps = 40/275 (14%)

Query: 299 LIGRGGFGSVYKARIQDGME--VAVK---VFDLQYGRAFKSFD-------IECDMIK-RI 345
            +G G FG VYK R ++  +  +A+K   V +  +G+  +  D        E  +IK ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 346 RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF--QRL-NIMIDVASAL 402
           RH NI++   +   +D   +V++ +    L +   S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
            YLH      I+H DL P+N++L ++    ++DFG+AK   ++      T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181

Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE  +        DV++FG +L +  T + P    F+          ++L ++  +IV+A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYS--------TNMLSLA-TKIVEA 228

Query: 523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR 557
                 +  ++        + ++   C     E R
Sbjct: 229 VYEPLPEGMYSED------VTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKV--FD---LQYGRAFKSFDIECDMIKRIRHRNIIK 352
           L+GRG FG VY     D G E+AVK   FD    +  +   + + E  ++K +RH  I++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 353 IISSCSSDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                   + K L +  EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAPE----- 464
             I+H D+K +N+L D      L DFG +K +     S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 465 -YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
            YGR+       DV+S    ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKV--FDL---QYGRAFKSFDIECDMIKRIRHRNIIK 352
           L+G+G FG VY    +  G E+A K   FD    +  +   + + E  ++K ++H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 353 IISSCSSDDFKALV--LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                     K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAPE----- 464
             I+H D+K +N+L D      L DFG +K L     S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 465 -YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
            YGR+       DV+S G  ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 47/240 (19%)

Query: 300 IGRGGFGSVYKARIQDGME-----------------VAVKVFDLQYGR-AFKSFDIECDM 341
           +G G FG V+   + +  +                 VAVK+      + A   F  E  +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 342 IKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---------- 391
           + R++  NII+++  C  +D   ++ EYM +G L + L SS+++ D  +           
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131

Query: 392 ---------LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 442
                    L++ + +AS ++YL    S+  +H DL   N L+ +N+   ++DFGM++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKP----TDE 496
              D    Q + +  I +MA E    G+ +T  DV++FG+ L E     +++P    TDE
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)

Query: 300 IGRGGFGSVYKA--------RIQDGMEVAVKVF-DLQYGRAFKSFDIECDMIKRI-RHRN 349
           +G G FG V +A        R    + VAVK+  D    +       E +++K I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS-----NYILDI---------FQRL-NI 394
           II ++  C+ +    +++EY   G+L + L +      +Y  DI         F+ L + 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     +  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              + +MAPE   +   +   DV+SFGI++ E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 36/231 (15%)

Query: 300 IGRGGFGSVYKARIQDGME---------VAVKVFDLQYG-RAFKSFDIECDMIKRI-RHR 348
           +G G FG V  A    G++         VAVK+       +       E +M+K I +H+
Sbjct: 26  LGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCL---------YSSN------YILDIFQRLN 393
           NII ++ +C+ D    +++EY   G+L + L         Y  N        L     ++
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T 
Sbjct: 145 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIF 498
               + +MAPE   +   +   DV+SFG++L E FT         P +E+F
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 77/295 (26%), Positives = 119/295 (40%), Gaps = 59/295 (20%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F++   IG+G FG VYK       EV A+K+ DL+            D I+ I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 353 IISSCSSDDFKA------------LVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMI 396
           ++S C S                 +++EY+  GS    L+       YI  I +      
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------ 108

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++   L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + 
Sbjct: 109 EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVG 163

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV 516
           T  +MAPE  ++       D++S GI  +E    + P               +DL P+ V
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRV 209

Query: 517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
           +       L  K+   T +GQ           C  + P  R  AKE++      R
Sbjct: 210 L------FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 8/195 (4%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG+G  G+VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 65/274 (23%), Positives = 119/274 (43%), Gaps = 31/274 (11%)

Query: 300 IGRGGFGS--VYKARIQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKIIS 355
           +G+G FG   +Y+ R +D   V  K  +L      +  D   E  ++  ++H NII   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 356 SCSSDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
               D+   + +EY   G+L +K +     + +    L  +  + SA+ Y+H      I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H D+K  N+ L    +  L DFG++K +L  + S+ +T  + T  YM+PE  +  + +  
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181

Query: 475 GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
            D+++ G +L E  T K+  D                    V++IV  N       +   
Sbjct: 182 SDIWALGCVLYELLTLKRTFDA-------------TNPLNLVVKIVQGN-------YTPV 221

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL 568
                S + +L      + PE+R  A E++ + L
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 74/216 (34%), Positives = 107/216 (49%), Gaps = 12/216 (5%)

Query: 1   GNNLNGSIPIAVGKL-QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            NN    IP  +G L   L+ L L DN++E S+P  L  L  L  LD   N L       
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKL- 181

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDLSM 114
             NL+NL NL L  NK++ +P  +  L  +  LDLS+N ++     + NLK L  ++LS 
Sbjct: 182 LSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSN 241

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP-ISL 173
           N   D +P +IG L +L+ L L  N++  S   S+G L NL+ L+LS N+LS  +P I+L
Sbjct: 242 NKLED-LPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIAL 298

Query: 174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEG 209
             LL    +N+       E+       N +  S   
Sbjct: 299 LLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334

Length = 394

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGME-VAVKV--FDLQYGRAFKSFDIECDMIKRIRHRNI 350
           F + N IG G +G VY+AR     E VA+K    D +      S   E  ++  +RH NI
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 351 IKI--ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
           +++  +      D   LV+EY     L   L +        Q   +M+ +   L+YLH  
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YG 466
           +   IIH DLK SN+LL D     ++DFG+A+      + +  T  + T+ Y APE   G
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLG 182

Query: 467 REGQVSTNGDVYSFGIMLMETFTRK 491
                +T  D+++ G +L E    K
Sbjct: 183 CTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 8/212 (3%)

Query: 283 TYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDM 341
           T + I      ++    IG+G  G+V+ A  +  G EVA+K  +LQ     +    E  +
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 342 IKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
           +K +++ NI+  + S    D   +V+EY+  GSL   +  +   +D  Q   +  +   A
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQA 127

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE+LH   +  +IH D+K  NVLL  +    L+DFG    +  E     ++  + T  +M
Sbjct: 128 LEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWM 182

Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           APE           D++S GIM +E    + P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           +G+GGFG V   ++++ G   A K  D   L+     K   +E ++++++    I+ +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPII 414
           +  S     LV+  M  G L+  +Y+     L++ + ++    +   + +LH   S+ I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           + D+KP NVLLDD     LSD G+A   LK+ +++TQ     T GYMAPE  +E   S  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVE-LKDGKTITQRA--GTNGYMAPEILKEEPYSYP 174

Query: 475 GDVYSFGIMLMETFTRKKP 493
            D ++ G  + E    + P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 300 IGRGGFGSVYKARIQDGMEVA-VKVFDLQYGRAFK---SFDIECDMIKRIRHRNIIKIIS 355
           IG G FG V       GM  A V V +L+          F  E    + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYIL------DIFQRLNIMIDVASALEYLHFGY 409
            C       LVLE+ P G L+  L S+  ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
               IH DL   N  L  ++   + D+G+A     ED  +T+      + ++APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 470 Q-------VSTNGDVYSFGIMLMETFT 489
                    +   +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 46/227 (20%)

Query: 290 ATNGFSE---NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI----ECDM 341
           A    SE    N IG G  G+VYK   +  G   A+KV    YG    +       E ++
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEI 125

Query: 342 IKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
           ++ + H N++K       +    ++LE+M  GSLE       +I D     ++   + S 
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSG 180

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT-----QTLA 456
           + YLH      I+H D+KPSN+L++      ++DFG+++        L QT      ++ 
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR-------ILAQTMDPCNSSVG 230

Query: 457 TIGYMAPEYGREGQVSTN----------GDVYSFGIMLMETFTRKKP 493
           TI YM+PE     +++T+          GD++S G+ ++E +  + P
Sbjct: 231 TIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 46/224 (20%)

Query: 300 IGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIECDM----IKRIR----HRNI 350
           +G G FGSVY AR ++  E VA+K       + F S++ EC M    +K +R    H NI
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-EC-MNLREVKSLRKLNEHPNI 60

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-------NIMIDVASALE 403
           +K+      +D    V EYM     E  LY    + D   +        +I+  +   L 
Sbjct: 61  VKLKEVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 404 YLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
           ++H  G+     H DLKP N+L+    V  ++DFG+A+ +         T  ++T  Y A
Sbjct: 114 HIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRA 166

Query: 463 PE-YGREGQVSTNGDVYSFGIMLMETFTRKKP-------TDEIF 498
           PE   R    S+  D+++ G ++ E +T  +P        D+++
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLY 209

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 21/209 (10%)

Query: 299 LIGRGGFGSVYKARIQDGME-VAVKVF---DLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G G FG V+  R +      A+KV    ++   +  +    E  ++K + H  II++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            +     F  +++EY+P G L   L +S    +         ++  ALEYLH   S  I+
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE-YGREGQVS 472
           + DLKP N+LLD      L+DFG AK L        +T TL  T  Y+APE    +G  +
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQSKGH-N 176

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              D ++ GI++ E      P    FF D
Sbjct: 177 KAVDWWALGILIYEMLVGYPP----FFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 71/256 (27%), Positives = 117/256 (45%), Gaps = 43/256 (16%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRHRNIIKIISSC 357
           +G G  G+VYKA  +     +AVKV  L       K    E +++ +     II    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------NIMIDVASALEYLHFGYSV 411
             ++  ++  E+M  GSL           D+++++       I + V   L YL   +S+
Sbjct: 69  FVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL---WSL 114

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            I+H D+KPSN+L++      L DFG++  L+    S+ +T  + T  YMAPE     Q 
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERISGEQY 170

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IVDAN------- 523
             + DV+S GI  ME    + P  +I     +       L+P+ +++ IVD +       
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------LMPLQLLQCIVDEDPPVLPVG 223

Query: 524 LLSQKDEHFTTKGQCV 539
             S+K  HF T  QC+
Sbjct: 224 QFSEKFVHFIT--QCM 237

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI------- 345
           + E   IG G +G+VYKAR +  G  VA+K   +          I    ++ I       
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE----GIPLSTLREIALLKQLE 56

Query: 346 --RHRNIIKIISSCSSDDFK-----ALVLEYMP---HGSLEKCLYSSNYILDIFQRLNIM 395
              H NI++++  C            LV E++       L KC       L      ++M
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLM 113

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             +   +++LH   S  I+H DLKP N+L+  +    ++DFG+A+ +   + +L  T  +
Sbjct: 114 RQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMAL--TSVV 167

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            T+ Y APE   +   +T  D++S G +  E F R+
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 60/188 (31%), Positives = 94/188 (50%), Gaps = 43/188 (22%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVK-VF-------DLQYGRAFKSFDIECDMIKRIR-HRN 349
           +G+G +G V+KA   +    VA+K +F       D Q  R F+    E   ++ +  H N
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR----EIMFLQELGDHPN 68

Query: 350 IIKIISSCSSDDFKA-------LVLEYMP---HGSLEKCLYSSNYILDIFQRLNIMIDVA 399
           I+K++     +  KA       LV EYM    H  +       N + D+ +R  IM  + 
Sbjct: 69  IVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMYQLL 117

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ---TQTLA 456
            AL+Y+H   S  +IH DLKPSN+LL+ +    L+DFG+A+ L + +++      T  +A
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 457 TIGYMAPE 464
           T  Y APE
Sbjct: 175 TRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 5e-13
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG+G  G+VY A  I  G EVA+K  +LQ     +    E  +++  ++ NI+  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   AL++LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 43/221 (19%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY-GRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           IG G +G VYKAR    G  VA+K   L        S  I E  ++K + H NI+K++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA-----LEYLHFGYSV 411
             +++   LV E++ H  L+K        +D      I + +  +     L+ L F +S 
Sbjct: 68  IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAPE--- 464
            ++H DLKP N+L++      L+DFG+A+    P+       T T  + T+ Y APE   
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILL 173

Query: 465 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
               Y      ST  D++S G +  E  TR+     +F GD
Sbjct: 174 GCKYY------STAVDIWSLGCIFAEMVTRRA----LFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 30/274 (10%)

Query: 300 IGRGGFGSV----YKARIQDGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKII 354
           +G G FG V    YK R +  ++VA+KV   +  ++ +   + E +++ ++ +  I+++I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
             C ++    LV+E    G L K L      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT-QTQTLATIGYMAPEYGREGQVST 473
           H DL   NVLL +   A +SDFG++K L  +D     ++     + + APE     + S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             DV+S+GI + E F+         +G    K     +    VM  ++        +   
Sbjct: 178 RSDVWSYGITMWEAFS---------YGQKPYK----KMKGPEVMSFIEQG------KRLD 218

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
              +C   ++ L   C +   E R N  ++  R+
Sbjct: 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 52/288 (18%)

Query: 300 IGRGGFGSVYKARIQD---------GMEVAVKVFDL-QYGRAFKSFDIECDMIKRIRHRN 349
           +G+G F ++YK  ++          G EV+V +  L    R   +F     ++ ++ H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           ++K+   C  D+   +V EY+  G L+  L+     + +  +L++   +ASAL YL    
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 410 SVPIIHCDLKPSNVLL---DDNM----VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
              ++H ++   N+L+     N        LSD G+   +L  ++ + +      I ++A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWIA 172

Query: 463 PEYGREGQVSTN--GDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           PE  R GQ S     D +SFG  L+E  +  ++P   +   +    +     LP+     
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM----- 227

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                    +            + NL  +C    P +R + + I+  L
Sbjct: 228 -----PDCAE------------LANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.8 bits (176), Expect = 6e-13
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 16/188 (8%)

Query: 314 QDGMEVAVKVF--DLQYG-RAFKSFDIECDMIKRIRHRNIIKIISS-CSSDDFKALVLEY 369
             G EVA+K+   D          F  E  +  R+ H NI+ ++ S  +       V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---D 426
           +P  +L + L +++  L   +   +M+ V  AL   H   +  I+H DLKP N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IG---YMAPEYGREGQVSTNGDVYSFG 481
               A + DFG+   L     +   T T  T  +G   Y APE  R   V+ N D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 482 IMLMETFT 489
           ++ +E  T
Sbjct: 177 LIFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 35/224 (15%)

Query: 297 NNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--------------ECDM 341
              +G G +G V KA     G  VA+K   +       + D               E  +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 342 IKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
           +  I+H NI+ ++      DF  LV++ M    L+K +      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK---------PLLKEDQS---L 449
           L  LH  Y    +H DL P+N+ ++   +  ++DFG+A+          L K++      
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 450 TQTQTLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRK 491
             T  + T+ Y APE   G E +     D++S G +  E  T K
Sbjct: 189 EMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL---QYGRAFKSFDIECDMIKRIRHRN 349
           FS+   IG G FG+VY AR +++   VA+K       Q    ++    E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYL 405
            I+       +    LV+EY        CL S++ +L++     Q + I      AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
            + +S  +IH D+K  N+LL +  +  L DFG A  ++        T       +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFVGTPY-----WMAPEV 182

Query: 466 ---GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                EGQ     DV+S GI  +E   RK P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 47/238 (19%)

Query: 298 NLIGRGGFGSVYKA-RIQDGMEVAVK--------VFDLQYGRAFKSFDIECDMIKRIRHR 348
           + IG G +G V  A     G++VA+K         F  +  R  K       +++R +H 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-------ILRRFKHE 63

Query: 349 NIIKI---ISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILD-----IFQRLNIMIDV 398
           NII I   I   S + F    +V E M    L K + + +   D     ++Q L      
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR----- 117

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQTLAT 457
              L+Y+H   S  ++H DLKPSN+LL+ N    + DFG+A+    E D +   T+ +AT
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 458 IGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI 514
             Y APE        +   D++S G +L E  + +     +F G    K +++ L  I
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP----LFPG----KDYLHQLNLI 222

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 65/284 (22%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 300 IGRGGFGSVY----KARIQDGMEVAVKVFDLQYGRAFKS---FDIECDMIKRIRHRNIIK 352
           +G+G FG VY    K  ++D  E  V +  +    + +    F  E  ++K     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMI----DVASALE 403
           ++   S      +++E M  G L+  L S      N  +     L  MI    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T  DV+SFG++L E  T           +   +   N+ +   VME     
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGMSNEQVLRFVME---GG 238

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           LL + D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDL-QYGRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           IG G +G VYKAR    G  VA+K   L        S  I E  ++K + H NI++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
             S++   LV E++    L+K + S     LD     + +  +   + Y H   S  ++H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAPEY---GRE 468
            DLKP N+L+D      L+DFG+A+    P+       T T  + T+ Y APE     R 
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILLGSR- 175

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
            Q ST  D++S G +  E   R+     +F GD
Sbjct: 176 -QYSTPVDIWSIGCIFAEMVNRRP----LFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.0 bits (168), Expect = 1e-12
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL---QYGRAFKSFDIECDMIKRIRHRN 349
           F++   IG G FG+VY AR ++    VA+K       Q    ++    E   ++RI+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYL 405
            I+       +    LV+EY        CL S++ +L++ ++    +++A+    AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG---MAKPLLKEDQSLTQTQTLATIGYMA 462
            + +S  +IH D+K  N+LL +     L+DFG   +A P             + T  +MA
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---------ANSFVGTPYWMA 189

Query: 463 PEY---GREGQVSTNGDVYSFGIMLMETFTRKKP 493
           PE      EGQ     DV+S GI  +E   RK P
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG VYKA+ ++ G+  A KV D +     + + +E D++    H NI+K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEY-----GREGQVS 472
           K  N+L   +    L+DFG++    K  +++ +  + + T  +MAPE       ++    
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEI 497
              DV+S GI L+E    + P  E+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKII 354
           +G G FG VYKAR I+ G  VA+K   +   +    F I    E  ++K+++H N++ +I
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73

Query: 355 ------SSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
                    S     +  +V  YM H  L   L + +  L   Q    M+ +   + YLH
Sbjct: 74  DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ---------TQTLAT 457
                 I+H D+K +N+L+D+  +  ++DFG+A+P      +            T  + T
Sbjct: 133 ---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 458 IGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRK 491
             Y  PE   G E + +T  D++  G +  E FTR+
Sbjct: 190 RWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 47/226 (20%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIR---HRNIIKI 353
           IG G +G+VYKAR    G  VA+K   +Q            E  ++KR+    H NI+++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 354 ISSCSS-----------------DDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIM 395
           +  C++                  D +  + +  P G   E        I D+ ++    
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-------IKDLMRQF--- 117

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
                 L++LH      I+H DLKP N+L+       L+DFG+A+        +  T  +
Sbjct: 118 ---LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVV 168

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
            T+ Y APE   +   +T  D++S G +  E F R+KP   +F G+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGN 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 55/192 (28%), Positives = 103/192 (53%), Gaps = 9/192 (4%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V+ A      +VAVK   ++ G  + ++F  E +++K ++H  ++K+ +  +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCD 417
            +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH D
Sbjct: 72  KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L+ +N+L+  ++V  ++DFG+A+ ++++++   +      I + APE    G  +   DV
Sbjct: 128 LRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 478 YSFGIMLMETFT 489
           +SFGI+LME  T
Sbjct: 187 WSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 33/217 (15%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKV--FDLQYGRAFKSFD-IECD--MIKRIRHRNIIK 352
           L+G+G FG VY     D G E+AVK   FD +     K  + +EC+  ++K + H  I++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 353 IISSCSSDDFK---ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 408
               C  D  +   ++ +E+MP GS++  L S   + + + ++    I     LE + + 
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYL 122

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPE- 464
           +S  I+H D+K +N+L D      L DFG +K L  +   L+ T   +  G   +M+PE 
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPYWMSPEV 180

Query: 465 -----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
                YGR+       D++S G  ++E  T K P  E
Sbjct: 181 ISGEGYGRK------ADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 299 LIGRGGFGSVYKARIQ--DGMEVAVKVFDLQYGRAFK---SFDIECDMIKRIRHRNIIKI 353
           ++G G FG + +  ++     E+ V +  L+ G + K    F  E   + +  H NI+++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVP 412
               +  +   +V EYM +G+L+  L      L   Q + ++  +AS ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL---ATIGYMAPEYGREG 469
            +H  L    VL++ ++V  +S F      L+ED+S     T+   + + + APE  +  
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRR----LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 470 QVSTNGDVYSFGIMLME 486
             S+  DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 32/282 (11%)

Query: 299 LIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIK 352
           ++G G FG+VYK   + +G    + VA+K+ +   G +A   F  E  ++  + H ++++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           ++  C S   + LV + MPHG L   ++     +     LN  + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           ++H DL   NVL+       ++DFG+A+ L  +++          I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 473 TNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
              DV+S+G+ + E  T   KP D                  I   EI D   L +K E 
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDG-----------------IPTREIPD---LLEKGER 229

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
                 C   ++ + +KC +   + R   KE+     ++ RD
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 63/194 (32%), Positives = 91/194 (46%), Gaps = 15/194 (7%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDM------IKRIRHRNIIK 352
           IG+G FG V  A+   DG   AVKV  LQ     K  + +  M      +K ++H  ++ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +  S  + D    VL+Y+  G L   L       +   R     ++ASAL YLH   S+ 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           II+ DLKP N+LLD      L+DFG+ K  +  + S T +    T  Y+APE  R+    
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 473 TNGDVYSFGIMLME 486
              D +  G +L E
Sbjct: 175 RTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI---ECDMIKRIRHRN 349
           F +  ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFG 408
           ++ +  +  + D   LVL  M  G L+  +Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
               I++ DLKP N+LLDD+    +SD G+A   + E Q++     + T+GYMAPE  + 
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVH-VPEGQTI--KGRVGTVGYMAPEVVKN 175

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
            + + + D ++ G +L E    + P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIK 352
           N I  G +G VY+AR  + G  VA+K   L+  +  + F I    E +++ +++H NI+ 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 353 I--ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
           +  +   S+ D   +V+EY+ H  L+  + +        +   +M+ + S + +LH  + 
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGRE 468
             I+H DLK SN+LL++  +  + DFG+A+           TQ + T+ Y APE   G  
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLG-A 181

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
            + ST  D++S G +  E    KKP
Sbjct: 182 KEYSTAIDMWSVGCIFAE-LLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 12/201 (5%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           +G+GGFG V   +++  G   A K  +   L+  + ++   +E  ++ ++  R I+ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +  +     LV+  M  G L   +Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           II+ DLKP NVLLD++    +SD G+A   LK+ QS T+     T G+MAPE  +  +  
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVE-LKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175

Query: 473 TNGDVYSFGIMLMETFTRKKP 493
            + D ++ G+ L E    + P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 66/238 (27%), Positives = 99/238 (41%), Gaps = 42/238 (17%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVK------VFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G GGFG V   +++      A+K      + +        S   E ++++   H  I+K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +  +     +  +++EY   G L   L       D +     +  V  A EYLH   +  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRG 113

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPEYGREGQV 471
           II+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+APE      +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPE-----II 164

Query: 472 STNG-----DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IVDAN 523
              G     D +S GI+L E  T + P    F  D        D  P+ +   I+  N
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDILKGN 210

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 28/213 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHR-----NI 350
           I +G FGSVY A+    G   A+KV    D+       +   E    + I         +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYV 59

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
            K+  S  S D+  LV+EY+  G     + +   + + + +   + +V   +E LH    
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---Q 115

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             IIH D+KP N+L+D      L+DFG+++        L   + + T  Y+APE      
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVG 169

Query: 471 VSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
                D +S G ++ E      P      D +F
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 31/194 (15%)

Query: 293 GFSENNLIGRGGFGSVYKARIQ---DGMEVAVKVF--DLQYGRAFKSFDI-ECDMIKRIR 346
            +     IGRG +G VYKA+ +   DG E A+K F  D +           E  +++ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 347 HRNIIKIISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVASA 401
           H N++ ++        K+  L+ +Y  H   +   +               +++  + + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLKEDQSLT 450
           + YLH   S  ++H DLKP+N+L+     +  V  + D G+A       KPL   D    
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---- 173

Query: 451 QTQTLATIGYMAPE 464
               + TI Y APE
Sbjct: 174 --PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 68/268 (25%), Positives = 124/268 (46%), Gaps = 30/268 (11%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G  G V  AR +  G +VAVK+ DL+  +  +    E  +++  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAPEYGREGQVSTNGDV 477
           K  ++LL  +    LSDFG    + K+   + + ++L    Y MAPE        T  D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IVDANLLSQKDEHFTTKG 536
           +S GIM++E    + P    +F D           P+  M+ + D+     K+ H  +  
Sbjct: 201 WSLGIMVIEMVDGEPP----YFSDS----------PVQAMKRLRDSPPPKLKNAHKIS-- 244

Query: 537 QCVSFIFNLAMKCTVESPEQRINAKEIV 564
                + +   +     P++R  A+E++
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 68/284 (23%), Positives = 120/284 (42%), Gaps = 38/284 (13%)

Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIK 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  ++K     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMI----DVASALE 403
           ++   S      +V+E M HG L+  L S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P+ R    EIV  L
Sbjct: 239 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 11/200 (5%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRHRNIIKIISSC 357
           +G G  GSV K   I  G  +A KV  +    +  K    E  ++   R   I+    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
            +++   + +E+M  GSL++       I ++I  +  I + V   L YL+      I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           D+KPSN+L++      L DFG++  L+    S+  T  + T  YM+PE  + G+ +   D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184

Query: 477 VYSFGIMLMETFTRKKPTDE 496
           V+S GI ++E    K P   
Sbjct: 185 VWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 40/106 (37%), Positives = 55/106 (51%), Gaps = 9/106 (8%)

Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           I + +  ALEYLH   SV  IH D+KPSNVL++ N    L DFG++  L+    S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 454 TLATIGYMAPEY----GREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
                 YMAPE       +       DV+S GI ++E  T + P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 21/176 (11%)

Query: 45  LDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLLIGN 103
           +D  G  + G + +    L  ++ + L +N+L+  IP       DI     S  +L    
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPD------DIFTTSSSLRYL---- 123

Query: 104 LKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN 163
                  +LS NNF+  IP   G + +L+ L L  N L G IP+ IG   +LK L+L  N
Sbjct: 124 -------NLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174

Query: 164 NLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMPN 218
            L G IP SL  L  L+ + ++ N+L G+IP + G  ++        N L   +P 
Sbjct: 175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230

Length = 968

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)

Query: 300 IGRGGFGSVYKARIQDGMEVA-VKVFDLQYGRAFKS---FDIECDMIKRIRHRNIIKIIS 355
           IG G FG V    +  G   A V V +L+   + +    F  E    + ++H N+++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 356 SCSSDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            C+      LV+E+ P G     L  C  +     D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE--G 469
             IH DL   N LL  ++   + D+G++    KED  +T  Q    + ++APE   E  G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 470 QV-----STNGDVYSFGIMLMETF 488
            +     +   +V+S G+ + E F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 288 FQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKR 344
           F   + + +   +G G + +VYK + + +G  VA+KV  LQ   G  F +   E  ++K 
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKG 59

Query: 345 IRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKC-------LYSSNYILDIFQRLNIMID 397
           ++H NI+ +     + +   LV EY+ H  L +        L+  N  L +FQ L     
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR---- 114

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
               L Y+H  Y   I+H DLKP N+L+ D     L+DFG+A+   K   S T +  + T
Sbjct: 115 ---GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVT 166

Query: 458 IGYMAPE-YGREGQVSTNGDVYSFGIMLME 486
           + Y  P+      + ST  D++  G + +E
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 299 LIGRGGFGSVYKARIQDG--------MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI 350
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 351 IKIISSCSSDDFKA-LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           +  +      + K  L+L+Y+  G +   LY  +   +   R     ++  ALE+LH   
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR-E 468
            + I++ D+K  N+LLD      L+DFG++K  L E++  T +    TI YMAPE  R +
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGK 181

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
           G      D +S GI++ E  T   P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G  G V  A     G +VAVK  DL+  +  +    E  +++   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE        T  D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M  +  NL  +  +        
Sbjct: 203 SLGIMVIEMIDGEPP----YFNEP----------PLQAMRRIRDNLPPRVKDSHKVSSVL 248

Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+ +L +   V  P QR  A+E++
Sbjct: 249 RGFL-DLML---VREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 29/221 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKII-- 354
           +IG G +G VYKAR  + G  VA+K+ D+      +    E +++++   H NI      
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71

Query: 355 ----SSCSSDDFKALVLEYMPHGS---LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
               +   +DD   LV+E    GS   L K L      L       I+ +    L YLH 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH- 130

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPE-- 464
                +IH D+K  N+LL  N    L DFG++  L   D +L +  T + T  +MAPE  
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAPEVI 185

Query: 465 ---YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM 502
                 +       DV+S GI  +E    K P       DM
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPP-----LCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 50/220 (22%)

Query: 299 LIGRGGFGSVYKARIQDG--------MEV----AVKVFDLQYGRAFKSFDIECDMIKRIR 346
           ++G+G FG V+  R   G        M+V     +KV D    +      +E D++  + 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK------MERDILAEVN 56

Query: 347 HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN--IMI-------- 396
           H  I+K+  +  ++    L+L+++  G             D+F RL+  +M         
Sbjct: 57  HPFIVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFY 103

Query: 397 --DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
             ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 104 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 158

Query: 455 LATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKP 493
             T+ YMAPE   R G  + + D +SFG+++ E  T   P
Sbjct: 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 300 IGRGGFGSVYKARIQDGME-VAVKVFDL---QYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           IG G FG+VY A      E VAVK       Q    ++    E   +++++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYLHFGYSV 411
               +    LV+EY        CL S++ +L++     Q + I      AL+ L + +S 
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY---GRE 468
            +IH D+K  N+LL +     L+DFG A       +S      + T  +MAPE      E
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDE 194

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
           GQ     DV+S GI  +E   RK P
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 24/201 (11%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRA-FKSFDIECDMIKRIRHRNIIKIISSC 357
           +G+G +GSVYK   +  G+ +A+K   L+   + F    +E D++ +     I+    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 358 SSDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
             +    + +EYM  GSL+K LY    +   +       I   V   L++L   ++  II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGREGQV 471
           H D+KP+NVL++ N    L DFG++  L+    SL +T     IG   YMAPE  + G  
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKTN----IGCQSYMAPERIKSGGP 178

Query: 472 STNG------DVYSFGIMLME 486
           + N       DV+S G+ ++E
Sbjct: 179 NQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)

Query: 298 NLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNI 350
           + +G G +G V  A     G +VA+K       R F+S         E  ++K + H N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 351 IKIIS----SCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDV 398
           I ++     + S +DF+   LV   M    L   +          Q+L+      ++  +
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQI 127

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT 
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATR 179

Query: 459 GYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRK 491
            Y APE    +    Q     D++S G ++ E  T K
Sbjct: 180 WYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 71/296 (23%), Positives = 128/296 (43%), Gaps = 33/296 (11%)

Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVF-DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G    + VA+K   +    +A K    E
Sbjct: 1   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59

Query: 339 CDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             ++  + + ++ +++  C +   + L+ + MP G L   +      +     LN  + +
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  +++          I
Sbjct: 119 AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I               P S  
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---------------PAS-- 218

Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
           EI  +++L +K E       C   ++ + +KC +   + R   +E++    K+ RD
Sbjct: 219 EI--SSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVK----VFD--LQYGRAFKSFDIECDMIKRIRHRNI-- 350
           IG G FG V+     +DG  VA+K    VF   +   R F+    E  M+   +H N+  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63

Query: 351 -IKIISSCSSDDFKAL-VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
            + I+     D F+ + V+  +    L K + S   +     ++  +  +   L+YLH  
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH-- 120

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
            S  I+H D+KP N+L++ N V  + DFG+A+ + + D+S   TQ + T  Y APE    
Sbjct: 121 -SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 469 GQVSTNG-DVYSFGIMLMETFTRK 491
            +  T+  D++S G +  E   R+
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 46/225 (20%)

Query: 287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI-------- 337
           +F+ TN + +   +G G FG V  AR Q  G  VA+K       +  K F          
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTY 57

Query: 338 -ECDMIKRIRHRNII---KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN 393
            E  ++K +RH NII    I  S   D +   V E +  G+    L +S  +   F +  
Sbjct: 58  RELKLLKHLRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY- 112

Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
            +  +   L+Y+H   S  ++H DLKPSN+L+++N    + DFG+A+      Q    T 
Sbjct: 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTG 164

Query: 454 TLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK 491
            ++T  Y APE       Y  E       D++S G +  E    K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 15/195 (7%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDM------IKRIRHRNII 351
           +IG+G FG V  A R  DG   AVKV  LQ     K  +    M      +K ++H  ++
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +  S  + +    VL+Y+  G L   L      L+   R     +VASA+ YLH   S+
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLKP N+LLD      L+DFG+ K  ++ ++  T +    T  Y+APE  R+   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPY 173

Query: 472 STNGDVYSFGIMLME 486
               D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 34/272 (12%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G+G +G V   R   DG +  +K  +L+    R  K+ + E  ++ +++H NI+    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 357 CSSDD-FKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
              +D    +V+ +   G L  K       +L   Q +   + +A AL+YLH  +   I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H DLK  NV L    +  + D G+A+ L  E+Q    +  + T  YM+PE       +  
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 475 GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN--DLLPISVMEIVDANLLSQKDEHF 532
            DV++ G  + E                TLKH  N  D+  + V  I++  L     ++ 
Sbjct: 183 SDVWALGCCVYEM--------------ATLKHAFNAKDMNSL-VYRIIEGKLPPMPKDYS 227

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
              G+ ++ + +       + PE+R + K I+
Sbjct: 228 PELGELIATMLS-------KRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  A ++   E+ AVKV  L+     +  D+EC M  KR+     +H  + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
           ++ S   + D    V+EY+  G L   +  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NVLLD      ++DFGM K  +      T +    T  Y+APE       
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPY 173

Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
               D ++ G++L E    + P      DE+F
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 5e-11
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 35/220 (15%)

Query: 299 LIGRGGFGSV-YKARIQDGMEVAVKVFDLQ------YGRAFKSFD--IECDMIKRIR-HR 348
           ++G G  G+V    R+ DG   AVKV D++        RA       + CD    ++ H 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 349 NIIKIISSCSSDD-------FKALVLEYMPHGSLEKCLYSSNYILDIFQRLN---IMIDV 398
           +  K       D          ALVL+Y   G L + + S       F+      + I V
Sbjct: 99  DFAK------KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK---PLLKEDQSLTQTQTL 455
             A+ ++H   S  +IH D+K +N+LL  N +  L DFG +K     + +D   T     
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT---FC 206

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
            T  Y+APE  R    S   D++S G++L E  T K+P D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 11/193 (5%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY---GRAFKSFDIECD-MIKRIRHRNIIKI 353
           +IG+G FG V  A R  DG   AVKV   +     +  K    E + ++K ++H  ++ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
             S  + +    VL+++  G L   L       +   R     ++ASAL YLH   S+ I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           ++ DLKP N+LLD      L+DFG+ K  +   QS T T    T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 474 NGDVYSFGIMLME 486
             D +  G +L E
Sbjct: 176 TVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 300 IGRGGFGSVYKARIQDGME-VAVKVFDL-QYGRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           IG G +G VYKAR +   E +A+K   L Q      S  I E  ++K ++H NI+++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
             S+    LV EY+    L+K + SS ++  +       +  +   + Y H   S  ++H
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125

Query: 416 CDLKPSNVLLDDNMVA-HLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAPE--YGRE 468
            DLKP N+L+D    A  L+DFG+A+    P+       T T  + T+ Y APE   G  
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPV------RTFTHEVVTLWYRAPEILLGSR 179

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              ST  D++S G +  E   +K     +F GD
Sbjct: 180 -HYSTPVDIWSVGCIFAEMVNQKP----LFPGD 207

Length = 294

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 48/217 (22%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVK----VFD--LQYGRAFKSFDIECDMIKRIRHRNIIK 352
           IGRG +G V  A+  +   +VA+K     FD  +   R  +    E  +++ + H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 353 ---IISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILD------IFQRLNIMIDVASA 401
              I+     + F    +V E M    L + + SS  + D      ++Q L         
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------G 120

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+Y+H   S  ++H DLKPSN+LL+ N    + DFG+A+   ++   +  T+ + T  Y 
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175

Query: 462 APE-------YGREGQVSTNGDVYSFGIMLMETFTRK 491
           APE       Y       T  DV+S G +  E   RK
Sbjct: 176 APELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 26/266 (9%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +++  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M+++  NL  +           
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEP----------PLKAMKMIRDNLPPKLKNLHKVSPSL 246

Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 247 KGFLDRL----LVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 66/232 (28%), Positives = 95/232 (40%), Gaps = 61/232 (26%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKR--IRH----RNII 351
           +IGRG FG V+  R    G   A+KV              + DMIKR  I H    R+I+
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLR------------KSDMIKRNQIAHVRAERDIL 55

Query: 352 KIISS-------CS--SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 402
               S        S   ++   LV+EYMP G L   L   +   +   R  I  ++  AL
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLAL 114

Query: 403 EYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS------------- 448
           + +H  G+    IH D+KP N+L+D +    L+DFG+ K + K                 
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 449 ---------LTQTQTLA--TIG---YMAPEYGREGQVSTNGDVYSFGIMLME 486
                      Q +  A  T+G   Y+APE  R        D +S G++L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)

Query: 300 IGRGGFGSVYKARIQDG--------MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNII 351
           +G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ +R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 352 KIISSCSSDDFKA-LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
             +      D K  L+L+Y+  G L   LY   +  +   R+ I  ++  AL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
           + II+ D+K  N+LLD      L+DFG++K  L E++    +    TI YMAPE  R G 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182

Query: 471 VSTNG--DVYSFGIMLMETFTRKKP 493
              +   D +S G++  E  T   P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)

Query: 299 LIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  AR+ + G   AVKV  L+     +  D+EC M  KRI      H  + 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
           ++     + D    V+E++  G L   +  S    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NVLLD      L+DFGM K  +      T +    T  Y+APE  +E   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQEMLY 173

Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             + D ++ G++L E      P      D++F
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 36/235 (15%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISS- 356
           +IGRGGFG VY  R  D G   A+K  D       K   ++      +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 357 ------CSSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                 C +  F        +L+ M  G L   L       +   R     ++   LE++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H  +   +++ DLKP+N+LLD++    +SD G+A    K+        ++ T GYMAPE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 166

Query: 466 GREGQV-STNGDVYSFGIMLME------TFTRKKPTDEIFFGDMTLKHWVNDLLP 513
            ++G    ++ D +S G ML +       F + K  D+     MTL   VN  LP
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 11/217 (5%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +N    +P ++ +L  L LLS           + L  L  L  LD   N+L   +     
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLP-LPSLDLNLNRLRSNISELL- 113

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILY-LDLSSN-----FLLIGNLKVLVQVDLSMN 115
            LTNL +L L +N +T IP  +  LK  L  LDLS N        + NL  L  +DLS N
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFN 173

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
           + SD +P  +  L +L  L L  N++   +P  I  L  L+ L+LSNN++   +  SL  
Sbjct: 174 DLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230

Query: 176 LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL 212
           L +L  + +S NKLE    + G   N  T     N++
Sbjct: 231 LKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI 267

Length = 394

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 11/205 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI---ECDMIKRIRHRN 349
           F +  ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFG 408
           ++ +  +  + D   LVL  M  G L+  +Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
                ++ DLKP N+LLDD     +SD G+A   +K  +  +    + T+GYMAPE    
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA---VKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
            + + + D +  G ++ E    + P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 7/145 (4%)

Query: 300 IGRGGFGSVYKARIQDGME-VAVKVFDLQY-GRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           IG G +G+V+KA+ ++  E VA+K   L        S  + E  ++K ++H+NI+++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
             SD    LV EY     L+K   S N  +D     + M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKP 441
           DLKP N+L++ N    L+DFG+A+ 
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  A ++   EV A+KV  L+     +  D++C M  KRI     +H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +     + D    V+EY+  G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            +I+ DLK  N+LLD      L+DFGM K  +     +T T    T  Y+APE  +E + 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173

Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             + D ++ G+++ E    + P      D++F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 81/299 (27%), Positives = 123/299 (41%), Gaps = 58/299 (19%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY-GRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           IG G +G VYK R  + G  VA+K   L+       S  I E  ++K ++H NI+ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-------FGY 409
              +    L+ E++    L+K L S              +D      YL+       F +
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAPEY 465
           S  ++H DLKP N+L+D+  V  L+DFG+A+    P+         T  + T+ Y APE 
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR------VYTHEVVTLWYRAPEV 172

Query: 466 GREGQ-VSTNGDVYSFGIMLMETFTRKKP-------TDEIFFGDMTLKHWVNDLLPISVM 517
                  ST  D++S G +  E  T KKP        D++F     L     D+ P    
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPTEDVWP---- 227

Query: 518 EIVDANLLSQKDEHFT----TKGQCVSFIFN-------LAMKCTVESPEQRINAKEIVT 565
                 + S  D   T     KG   S + N       L  K  +  P +RI+AK+ + 
Sbjct: 228 -----GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 32/282 (11%)

Query: 299 LIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIK 352
           ++G G FG+VYK   I DG    + VA+KV       +A K    E  ++  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           ++  C +   + LV + MP+G L   +  +   +     LN  + +A  + YL     V 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           ++H DL   NVL+       ++DFG+A+ L  ++           I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 473 TNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
              DV+S+G+ + E  T   KP D                  I   EI D   L +K E 
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDG-----------------IPAREIPD---LLEKGER 229

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
                 C   ++ + +KC +   E R   +E+V    ++ RD
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 299 LIGRGGFGSVYKARIQDG--------MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI 350
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 351 IKIISSCSSDDFKA-LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI-DVASALEYLHFG 408
           +  +      D K  L+L+Y+  G L   L       +  Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
             + II+ D+K  N+LLD N    L+DFG++K    ED+         TI YMAP+  R 
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180

Query: 469 GQVSTNG--DVYSFGIMLMETFTRKKP 493
           G    +   D +S G+++ E  T   P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 49/121 (40%), Positives = 63/121 (52%), Gaps = 10/121 (8%)

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI-NLKSLNLS 161
           N   +V +DLS  N S  I + I  L  +Q + L  N+L G IPD I     +L+ LNLS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 162 NNNLSGTIP---ISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP 217
           NNN +G+IP   I   + LDL     S N L GEIPN  G F +       GN L+  +P
Sbjct: 127 NNNFTGSIPRGSIPNLETLDL-----SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 218 N 218
           N
Sbjct: 182 N 182

Length = 968

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 59/265 (22%), Positives = 116/265 (43%), Gaps = 32/265 (12%)

Query: 300 IGRGGFGSVYKARIQ---DGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKII 354
           +G G FG+V K   +       VAVK+            ++  E ++++++ +  I+++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
             C ++ +  LV+E    G L K L  + ++ +      ++  V+  ++YL        +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQVS 472
           H DL   NVLL     A +SDFG++K  L  D++  + +T     + + APE     + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
           +  DV+SFG+++ E F+         +G            P   M+  +   + +  E  
Sbjct: 177 SKSDVWSFGVLMWEAFS---------YG----------QKPYKGMKGNEVTQMIESGERM 217

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQR 557
               +C   +++L   C     ++R
Sbjct: 218 ECPQRCPPEMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 22/200 (11%)

Query: 299 LIGR----GGFGSVYKARIQDGMEVAVKVFDL--QYGRAFKSFDIECDMIKRIRHRNIIK 352
           LIG+         + K +  + + VAVK  +L        K    E    ++++H NI+ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVASALEYLHFGY 409
            ++S   D    +V   M +GS E  L    +  +    L    I+ DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ-----TQTLATIGYMAPE 464
           S   IH  +K S++LL  +    LS    +  ++K  +           ++  + +++PE
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 465 YGREGQVSTN--GDVYSFGI 482
             ++     N   D+YS GI
Sbjct: 179 VLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 4e-10
 Identities = 31/81 (38%), Positives = 45/81 (55%), Gaps = 1/81 (1%)

Query: 4   LNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNL 63
           L G IP  + KL+ LQ ++L  N + G+IP  L  + +L  LD   N  +G +P   G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 64  TNLRNLYLGSNKLTS-IPSTL 83
           T+LR L L  N L+  +P+ L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 52/220 (23%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR-------- 344
           F    +IGRG FG V   R +   +V A+K+              + +MIKR        
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS------------KFEMIKRSDSAFFWE 92

Query: 345 ----IRHRN---IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMI 396
               + H N   I+++  +   D +  +V+EYMP G L   +  SNY I + + R     
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA- 149

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           +V  AL+ +H   S+  IH D+KP N+LLD +    L+DFG    +         T  + 
Sbjct: 150 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVG 205

Query: 457 TIGYMAPE----------YGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE          YGRE       D +S G+ L E
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRE------CDWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 28/209 (13%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISS- 356
           +IGRGGFG VY  R  D G   A+K  D       K   ++      +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 357 ------CSSDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                 C S  F      + +L+ M  G L   L S + +    +      ++   LE++
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H  +   +++ DLKP+N+LLD++    +SD G+A    K+        ++ T GYMAPE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 166

Query: 466 GREG-QVSTNGDVYSFGIMLMETFTRKKP 493
            ++G    ++ D +S G ML +      P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 53/222 (23%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVK--------------VFDLQYGRAFKSFDIECDMIK 343
            IG G  G VYK R  + G  +AVK              + DL      KS D  C  I 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV--VLKSHD--CPYIV 77

Query: 344 R-----IRHRNI---IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 395
           +     I   ++   ++++S+C  D     +   +P   L K   +              
Sbjct: 78  KCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDILGKMTVA-------------- 122

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             +  AL YL   + V  IH D+KPSN+LLD +    L DFG++  L+    S  +T++ 
Sbjct: 123 --IVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSA 175

Query: 456 ATIGYMAPEY----GREGQVSTNGDVYSFGIMLMETFTRKKP 493
               YMAPE         +     DV+S GI L+E  T + P
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 17/172 (9%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVF-----DLQYGR-AFKSFDIECDMIKRIRHRNIIK 352
           IG G +G V+K R ++ G  VA+K F     D    + A +    E  M+K+++H N++ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +I          LV EY  H  L + L  +   +       I+     A+ + H      
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHN 120

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            IH D+KP N+L+       L DFG A+ L         T  +AT  Y APE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           +IGRG FG V   R +   +V A+K+   F++        F  E D++       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 413
            +   D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 163

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY----GREG 469
           IH D+KP N+LLD +    L+DFG    + KE      T  + T  Y++PE     G +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 222

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                 D +S G+ L E      P    F+ D
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP----FYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR------IRHRNII 351
           ++G+G FG V  A ++   E  A+K   L+     +  D+EC M++R        H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +  +  + +    V+EY+  G L   + SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPEYGREGQ 470
            II+ DLK  NVLLD +    ++DFGM K  +  +    +  T   T  Y+APE  +  +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQK 172

Query: 471 VSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
            + + D +SFG++L E    + P      DE+F
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           +IGRG FG V   R +   +V A+K+   F++        F  E D++       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN--IMIDVASALEYLHFGYSVP 412
            +   D +  +V+EYMP G L   +  SNY  D+ ++       +V  AL+ +H   S+ 
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALDAIH---SMG 162

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-LTQTQT-LATIGYMAPEY----G 466
           +IH D+KP N+LLD +    L+DFG     +K D++ + +  T + T  Y++PE     G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
            +G      D +S G+ L E      P    F+ D
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTP----FYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)

Query: 299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDM------IKRIRHRNII 351
           +IG+G FG V  AR + +    AVKV  LQ     K  + +  M      +K ++H  ++
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +  S  + D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S+
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            I++ DLKP N+LLD      L+DFG+ K  ++ +   T +    T  Y+APE   +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPY 173

Query: 472 STNGDVYSFGIMLME 486
               D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKII-- 354
           ++G G +G VYK R ++ G   A+KV D+      +   +E +M+K+   HRNI      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 355 ----SSCSSDDFKALVLEYMPHGSLEKCL-------YSSNYILDIFQRLNIMIDVASALE 403
               S    DD   LV+E+   GS+   +          ++I  I +      ++   L 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR------EILRGLA 135

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMA 462
           +LH      +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MA
Sbjct: 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMA 189

Query: 463 PEY-----GREGQVSTNGDVYSFGIMLME 486
           PE        +       D++S GI  +E
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K+   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +T  DV+SFG++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 288 FQATNGFSENNLIGRGGFGSVYK--ARIQDGMEVAVKVFDL--QYGRAFKSFDIECDMIK 343
           F A   +     +G G + +VYK  +RI +G  VA+KV  +  + G  F +   E  ++K
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIR-EASLLK 58

Query: 344 RIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKC-------LYSSNYILDIFQRLNIMI 396
            ++H NI+ +     + +    V EYM H  L +        L+  N  L +FQ L    
Sbjct: 59  GLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR--- 114

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
                L Y+H  +   I+H DLKP N+L+       L+DFG+A+   K   S T +  + 
Sbjct: 115 ----GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVV 165

Query: 457 TIGYMAPE--YGREGQVSTNGDVYSFGIMLMETF 488
           T+ Y  P+   G     S+  D++  G + +E  
Sbjct: 166 TLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISS 356
           L+G G +G VYK R ++ G   A+KV D+  G   +    E +M+K+   HRNI     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 357 C------SSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGY 409
                    DD   LV+E+   GS+   + ++    L       I  ++   L +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEY--- 465
              +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE    
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 466 --GREGQVSTNGDVYSFGIMLME 486
               +       D++S GI  +E
Sbjct: 186 DENPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI---ECDMIKRIRHRN 349
           F    ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFG 408
           ++ +  +  + D   LVL  M  G L+  +Y+  N   D  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-- 119

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
               I++ DLKP N+LLDD     +SD G+A   + E +++     + T+GYMAPE  + 
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVE-IPEGETI--RGRVGTVGYMAPEVVKN 175

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
            + + + D +  G ++ E    K P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.6 bits (147), Expect = 2e-09
 Identities = 69/255 (27%), Positives = 103/255 (40%), Gaps = 49/255 (19%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKV-------FDLQYGRAFKSFDIECDMIKRIRHRNI 350
           LIG+GG G VY A        VA+K          L   R  +   I  D+I    H  I
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI----HPGI 64

Query: 351 IKIISSCSSDDFKALVLEYMPH--GSLEKCLYSSNYILDIFQR-----------LNIMID 397
           + + S CS  D    V   MP+  G   K L  S +  +   +           L+I   
Sbjct: 65  VPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA--KPLLKEDQ-------- 447
           + + +EY+H   S  ++H DLKP N+LL       + D+G A  K L +ED         
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 448 -----SLTQT-QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                S+T   + + T  YMAPE       S + D+Y+ G++L +  T   P        
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 502 MTLKHWVNDLLPISV 516
           ++ +  +    PI V
Sbjct: 239 ISYRDVILS--PIEV 251

Length = 932

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           +G G  G V K + +  G+ +A K+  L+   A ++  I E  ++       I+    + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
            SD   ++ +E+M  GSL++ L  +  I  +I  +++I   V   L YL   +   I+H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHR 128

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           D+KPSN+L++      L DFG++  L+           + T  YM+PE  +    S   D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 477 VYSFGIMLMETFTRKKP 493
           ++S G+ L+E    + P
Sbjct: 185 IWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNII 351
           F + + +G G  G V+K   +  G+ +A K+  L+   A ++  I E  ++       I+
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYS 410
               +  SD   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 124

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             I+H D+KPSN+L++      L DFG++  L+           + T  YM+PE  +   
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 178

Query: 471 VSTNGDVYSFGIMLMETFTRKKP 493
            S   D++S G+ L+E    + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 42/144 (29%)

Query: 21  LSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP 80
           L L++  L G IP+D+ +L  L  ++  GN + G +P   G++T+L  L           
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471

Query: 81  STLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNR 140
                                         DLS N+F+  IP ++G L  L+ L L  N 
Sbjct: 472 ------------------------------DLSYNSFNGSIPESLGQLTSLRILNLNGNS 501

Query: 141 LQGSIPDSIGD-LINLKSLNLSNN 163
           L G +P ++G  L++  S N ++N
Sbjct: 502 LSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V+ A ++      A+K   L+        D+EC M+ KR+      H  + 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +  +  + +    V+EY+  G L   + S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPEYGREGQ 470
            I++ DLK  N+LLD +    ++DFGM K  +  D    +T T   T  Y+APE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQK 172

Query: 471 VSTNGDVYSFGIMLMETFTRKKP 493
            +T+ D +SFG++L E    + P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 8/198 (4%)

Query: 292 NGFSENNLIGRGGFGSVYKARIQDGME-VAVKVF-DLQYGRAFKSFDI-ECDMIKRIRHR 348
           N F    ++G G +G V K R ++  E VA+K F D +     K   + E  M++ ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
           NI+++  +        LV EY+    LE      N +     R  I       ++ +H+ 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
           +   I+H D+KP N+L+  N V  L DFG A+  L E  +   T+ +AT  Y +PE    
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPELLLG 175

Query: 469 GQVSTNGDVYSFGIMLME 486
                  D++S G +L E
Sbjct: 176 APYGKAVDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K+   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 37/189 (19%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI---IS 355
           +G G  G V+ A   D    VAVK   L   ++ K    E  +I+R+ H NI+K+   + 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 356 SCSSDDFKAL-----------VLEYMP---HGSLEKCLYSSNYI-LDIFQRLNIMIDVAS 400
              SD  + +           V EYM       LE+   S  +  L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQ----TQTL 455
            L+Y+H   S  ++H DLKP+NV ++ +++V  + DFG+A+ +   D   +     ++ L
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGL 179

Query: 456 ATIGYMAPE 464
            T  Y +P 
Sbjct: 180 VTKWYRSPR 188

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 9/135 (6%)

Query: 371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 430
           P  +    L + +  L     +     VA+ +E+L    S   +H DL   NVL+ +  +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277

Query: 431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT- 489
             + DFG+A+ ++++   +++  T   + +MAPE       +T  DV+SFGI+L E FT 
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337

Query: 490 -----RKKPTDEIFF 499
                 + P +E F+
Sbjct: 338 GGTPYPELPMNEQFY 352

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K+   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +T  DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 23/184 (12%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKRIR-HRN-------- 349
           I RG FG VY  R ++  ++ AVKV         K+  I  +M+ +++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 350 -IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
            I+ +  S  S +   LV+EY+  G ++  L+   Y  D    +  + +VA AL+YLH  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
               IIH DLKP N+L+ +     L+DFG++K  L  + ++    T  ++     +Y R 
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRT 180

Query: 469 -GQV 471
            GQV
Sbjct: 181 PGQV 184

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 11/205 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI---ECDMIKRIRHRN 349
           F    ++G+GGFG V   +++  G   A K  + +  +  K   +   E  +++++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFG 408
           ++ +  +  + D   LVL  M  G L+  +Y+  N   D  + +    ++   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
               I++ DLKP N+LLDD     +SD G+A  +    +  T    + T+GYMAPE    
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQI---PEGETVRGRVGTVGYMAPEVINN 175

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
            + + + D +  G ++ E    + P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 298 NLIGRGGFGSVYKARIQDGM-----EVAVK-VFD----LQYGRAFKSFDIECDMIKRIRH 347
           +L+  G FG ++   + D       EV VK V D    +Q     +    E  ++  + H
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCLLYGLSH 67

Query: 348 RNIIKIISSCSSDDFKALVLE-YMPHGSLEKCLYSSNYI-------LDIFQRLNIMIDVA 399
           +NI+ I+  C  D     VL  YM  G+L+  L             L   Q +++ I +A
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
             + YLH      +IH D+   N ++D+ +   ++D  +++ L   D           + 
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           +MA E     + S+  DV+SFG++L E  T
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 3/104 (2%)

Query: 386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
           L     L+    VA  +E+L    S   +H DL   NVLL    +  + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              +++  T   + +MAPE   +   +T  DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 300 IGRGGFGSVYKAR--IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIR---HRNIIK 352
           IG G +G V+KAR     G  VA+K   +Q G          E  +++ +    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 353 IISSC--SSDDFKA---LVLEYMPHG---SLEKCL---YSSNYILDIFQRLNIMIDVASA 401
           +   C  S  D +    LV E++       L+K       +  I D+      M  +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM------MFQLLRG 122

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L++LH   S  ++H DLKP N+L+  +    L+DFG+A+  +   Q    T  + T+ Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMAL-TSVVVTLWYR 176

Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTRK 491
           APE   +   +T  D++S G +  E F RK
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 11/153 (7%)

Query: 337 IECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNI 394
           IE  +++ + H ++I++  +  S     +VL   PH S +   Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              +   L YLH   +  IIH D+K  N+ ++D     + D G A+  +     L    T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
           + T    APE     + ++  D++S GI+L E 
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 85/245 (34%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKRIR----------H 347
           L+G+G  G V+  R++   ++ A+KV D       K   I+ + +KR+           H
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLD-------KKEMIKRNKVKRVLTEQEILATLDH 60

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSL--------EKCL-------YSSNYILDIFQRL 392
             +  + +S  ++ +  LV++Y P G L         KCL       Y++          
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA---------- 110

Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED------ 446
               +V  ALEYLH    + I++ DLKP N+LL ++    LSDF ++K    E       
Sbjct: 111 ----EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 447 ---------QSLTQTQTLATIG------------YMAPE----YGREGQVSTNGDVYSFG 481
                     +   ++T +               Y+APE     G    V    D ++ G
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLG 219

Query: 482 IMLME 486
           I+L E
Sbjct: 220 ILLYE 224

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 299 LIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  A ++   E  AVK   L+        D+EC M+ KR+      +  + 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +  +  + +    V+E++  G L   +       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NV+LD +    ++DFGM K  +  D     +    T  Y+APE  +  + 
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKY 173

Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
           + + D +SFG++L E    + P      DE+F
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 26/61 (42%), Positives = 38/61 (62%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN++ G+IP ++G +  L++L L  N   GSIP+ L +L +L  L+  GN L G VPA  
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Query: 61  G 61
           G
Sbjct: 511 G 511

Length = 623

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 52/189 (27%), Positives = 90/189 (47%), Gaps = 9/189 (4%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           +G G  G V K      G+ +A K+  L+   A ++  I E  ++       I+    + 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            SD   ++ +E+M  GSL++ L  +  I +      I I V   L YL   +   I+H D
Sbjct: 69  YSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRD 125

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           +KPSN+L++      L DFG++  L+    S+  +  + T  YM+PE  +    +   D+
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDI 181

Query: 478 YSFGIMLME 486
           +S G+ L+E
Sbjct: 182 WSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 28/234 (11%)

Query: 269 NDANMPRISNQRRFTYLEIFQATN-GFSENNLIGRGGFGSVYKARIQDGME-VAVK--VF 324
           ++ N     ++ +    +I ++ N  +   N+IG G FG VY+A   D  E VA+K  + 
Sbjct: 42  HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101

Query: 325 DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA--------LVLEYMPHGSLE 376
           D QY       + E  ++K + H NII +     ++ FK         +V+E++P    +
Sbjct: 102 DPQYK------NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155

Query: 377 KCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHL 433
              + +  N+ L +F        +  AL Y+H  +   I H DLKP N+L+D N     L
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212

Query: 434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLME 486
            DFG AK LL   +S++    + +  Y APE        +T+ D++S G ++ E
Sbjct: 213 CDFGSAKNLLAGQRSVSY---ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263

Length = 440

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 9/193 (4%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           +G G + +V+K R +     VA+K   L++        I E  ++K ++H NI+ +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            ++    LV EY+    L++ L +   ++ +      M  +   L Y H      I+H D
Sbjct: 73  HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNGD 476
           LKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P+      + ST  D
Sbjct: 129 LKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 477 VYSFGIMLMETFT 489
           ++  G +L E  T
Sbjct: 187 MWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 27/221 (12%)

Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRN 349
           F     +G G FG V  A+ +  G   A+K    +     K       E  ++  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS----NYILDIFQRLNIMIDVASALEYL 405
           I+ ++ S   ++    +LE++  G L   L  +    N +   +       ++  A EYL
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE 464
           H   S  II+ DLKP N+LLD+     ++DFG AK +        +T TL  T  Y+APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE 185

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
             +        D ++ G++L E      P    FF D   +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP----FFDDTPFR 222

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 30/203 (14%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIIS--- 355
           IG+G FG VY+ R +D   + A+KV   +   A K      ++   I  RNI+       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 356 ---------SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI-DVASALEYL 405
                    S  +D    LV +YM  G L   L       +   R    I ++  ALE+L
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEHL 112

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE 464
           H      I++ DLKP N+LLD      L DFG++K  L ++++   T T   T  Y+APE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPE 166

Query: 465 YGREGQVSTNG-DVYSFGIMLME 486
              + +  T   D +S G+++ E
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 11/191 (5%)

Query: 300 IGRGGFGSVYKAR--IQDGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           +G G + +V+K R  + + + VA+K   L++        I E  ++K ++H NI+ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
             +D    LV EY+    L++ +     I+ +    N+ I +   L  L + +   ++H 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR-EGQVSTNG 475
           DLKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P+      + ST  
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186

Query: 476 DVYSFGIMLME 486
           D++  G +  E
Sbjct: 187 DMWGVGCIFFE 197

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 19/199 (9%)

Query: 300 IGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           +G G + +VYK R +   E VA+K   L       S  I E  ++K ++H NI+++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 358 SSDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
            +++   LV EYM    L+K +  +     LD     +    +   + + H      ++H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            DLKP N+L++      L+DFG+A+    P+       T +  + T+ Y AP+     + 
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPV------NTFSNEVVTLWYRAPDVLLGSRT 177

Query: 472 -STNGDVYSFGIMLMETFT 489
            ST+ D++S G ++ E  T
Sbjct: 178 YSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 65/270 (24%), Positives = 105/270 (38%), Gaps = 37/270 (13%)

Query: 307 SVYKARIQDGMEVAVKVFDLQYGRAFKSFDI---ECDMIKRIRHRNIIKI----ISSCSS 359
           S+YK  I +  EV ++ F   +       DI   E   ++RI   NI+KI    I     
Sbjct: 35  SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 419
               +L+LEY   G L + L      L    +L++ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE--GQVSTNGDV 477
             + L+ +N    +   G+ K L     S    + +  + Y + +   +   + +   D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           YS G++L E FT K P     F ++T K            EI D  +             
Sbjct: 206 YSLGVVLWEIFTGKIP-----FENLTTK------------EIYDLIINKNNSLKLPLD-- 246

Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   I  +   CT     +R N KEI+  L
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 7/140 (5%)

Query: 354 ISSCSSDDFKALVLEYMPH----GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            SS  SD +  +            S ++     ++ LD+   L     VA  +++L    
Sbjct: 173 FSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--- 229

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH D+   NVLL D  VA + DFG+A+ ++ +   + +      + +MAPE   + 
Sbjct: 230 SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC 289

Query: 470 QVSTNGDVYSFGIMLMETFT 489
             +   DV+S+GI+L E F+
Sbjct: 290 VYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 49/194 (25%), Positives = 94/194 (48%), Gaps = 11/194 (5%)

Query: 300 IGRGGFGSVYKAR--IQDGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           +G G + +VYK R  + D + VA+K   L++        I E  ++K ++H NI+ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
             ++    LV EY+    L++ L      +++    N+ + +   L  L++ +   ++H 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P+        ST  
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 476 DVYSFGIMLMETFT 489
           D++  G +  E  T
Sbjct: 187 DMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)

Query: 300 IGRGGFGSVY-----KARIQDGMEV--AVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G+G FG+VY     KA  ++ ++V   + V +L      ++ + E  ++ ++ H  I+K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
             +S    D   ++ EY     L+  L    +         +       L  +H+ +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           I+H DLK  N+ L +N++  + DFG+++ LL     L  T T  T  YM+PE  +     
Sbjct: 127 ILHRDLKAKNIFLKNNLL-KIGDFGVSR-LLMGSCDLATTFT-GTPYYMSPEALKHQGYD 183

Query: 473 TNGDVYSFGIMLME 486
           +  D++S G +L E
Sbjct: 184 SKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)

Query: 300 IGRGGFGSVYKAR---IQDGMEVAVK----VFD--LQYGRAFKSFDIECDMIKRIR-HRN 349
           +G+G +G V  AR     +   VA+K    VF   +   RA +    E  +++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 350 IIKIISS--CSSDDFKALVL-EYMPHGSLEKCLYSSNYILD------IFQRLNIMIDVAS 400
           I  +         +F  L L E +    L + + S   + D      I+Q L        
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL-------C 116

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--LKEDQSLTQTQTLATI 458
            L+Y+H   S  ++H DLKP N+L++ +    + DFG+A+       + +   T+ +AT 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 459 GYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 491
            Y APE     Q  T   DV+S G +L E   RK
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 37/207 (17%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G G + +VYK R    G  VA+K   L++  G  F +   E  ++K ++H NI+ +   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDI 71

Query: 357 CSSDDFKALVLEYMPHGSL----EKC---LYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
             +     LV EY+    L    + C   L   N  L +FQ L         L Y H   
Sbjct: 72  IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQRR 123

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP------ 463
              ++H DLKP N+L+ +     L+DFG+A+   K   S T +  + T+ Y  P      
Sbjct: 124 ---VLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLGS 178

Query: 464 -EYGREGQVSTNGDVYSFGIMLMETFT 489
            EY      ST+ D++  G +  E  T
Sbjct: 179 TEY------STSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 14/215 (6%)

Query: 292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRH 347
             F   +L+GRG FG V   R    G   A+KV     L        F+ E D++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
             I ++  +    D   LV+EY P G L   L   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-- 465
            + +  +H D+KP NVL+D      L+DFG A   L  ++ +     + T  Y+APE   
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR-LTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 466 ----GREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
                 +G      D +S G++  E    + P  E
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.3 bits (116), Expect = 1e-07
 Identities = 25/63 (39%), Positives = 34/63 (53%), Gaps = 3/63 (4%)

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
           NLK L   DLS N  + +      GL +L+ L L  N L    P++   L +L+SL+LS 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 163 NNL 165
           NNL
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 53/218 (24%)

Query: 300 IGRGGFGSV---YKARIQDGMEVAVKVFDLQYGRAFKSF------DIECDMIKRIRHRNI 350
           +G G +GSV   Y  R++   +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 351 IKIIS----SCSSDDFKALVLEYMPHGS----LEKC--LYSSNYILDIFQRLNIMIDVAS 400
           I ++     + S ++F  + L     G+    + KC  L   +    I+Q L        
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR------- 129

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   + D  +T        GY
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT--------GY 175

Query: 461 MAPEYGREGQVSTNG-------DVYSFGIMLMETFTRK 491
           +A  + R  ++  N        D++S G ++ E    K
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  A  +   E+ A+K+  L+     +  D+EC M+ KR+     +   + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
           ++ S   + D    V+EY+  G L   +Y    +   F+  + +   A     L F +S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE       
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPY 178

Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             + D ++FG++L E    + P      DE+F
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           L+G+G FG V   R +  G   A+K+   +   A         E  ++K  RH  +  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            S  + D    V+EY+  G L   L       +   R     ++ SAL+YLH G    I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KIV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI----GYMAPEYGREGQ 470
           + DLK  N++LD +    ++DFG+ K      + +T   T+ T      Y+APE   +  
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 471 VSTNGDVYSFGIMLMETFTRKKP 493
                D +  G+++ E    + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 300 IGRGGFGSVYKA---RIQDG-----MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNII 351
           +G+G F  ++K     + D       EV +KV D  +    +SF     M+ ++ H++++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                C   D   +V EY+  GSL+  L  +  +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 412 PIIHCDLKPSNVLL---DDNMVAH-----LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
            + H ++   NVLL   +D    +     LSD G++  +L ++  L +      I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER------IPWVPP 173

Query: 464 EYGREGQ-VSTNGDVYSFGIMLMETFT 489
           E     Q +S   D +SFG  L E F+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 27/203 (13%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSF------DIECDMIKRIRHRNIIK 352
           +G G +GSV  A   + G+ VAVK    +  R F+S         E  ++K ++H N+I 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 353 IIS----SCSSDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
           ++     + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 137

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE   
Sbjct: 138 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 190

Query: 468 EG-QVSTNGDVYSFGIMLMETFT 489
                +   D++S G ++ E  T
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 27/172 (15%)

Query: 338 ECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKC-LYSSNYI-----LDIFQR 391
           E D++K I HR II +I +     +K+ V   MP     KC L++  Y+     L + Q 
Sbjct: 136 EIDILKTISHRAIINLIHAYR---WKSTVCMVMPK---YKCDLFT--YVDRSGPLPLEQA 187

Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
           + I   +  AL YLH      IIH D+K  N+ LD+   A L DFG A    K D     
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241

Query: 452 TQTLATIGYM---APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG 500
            Q     G +   +PE           D++S G++L E   +        FG
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT----LFG 289

Length = 392

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 40/243 (16%)

Query: 267 LPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD 325
           LP    +P  +N R   Y+             L+GR    + + A R  D  E  V  F 
Sbjct: 52  LPEGEEVPESNNPREHMYVL----------TTLVGRNPTTAAFVATRGSDPKEKVVAKFV 101

Query: 326 L---QYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS 382
           +   +   A+   ++ C  +    H  I+K      SDD   L++EY   G L K     
Sbjct: 102 MLNDERQAAYARSELHC--LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK----- 154

Query: 383 NYILDIFQRLN------------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 430
                I QRL             +   +  AL+ +H   S  ++H DLK +N+ L    +
Sbjct: 155 ----QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGI 207

Query: 431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR 490
             L DFG +K           +    T  Y+APE     + S   D++S G++L E  T 
Sbjct: 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267

Query: 491 KKP 493
            +P
Sbjct: 268 HRP 270

Length = 478

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 17/203 (8%)

Query: 300 IGRGGFGSVYKARIQDGMEVA-VKVFDLQYGRAFK---SFDIECDMIKRIRHRNIIKIIS 355
           IG G FG V  + I     VA V V +L+   + K    F  + D  + ++H NI++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYIL---DIFQRLNIMIDVASALEYLHFGYSVP 412
            C       LV EY   G L+  L    +      +     +  ++A+ + ++H      
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY--GREGQ 470
            +H DL   N  L  ++   + D+G+     KED   T+      + ++APE      G 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 471 VSTN-----GDVYSFGIMLMETF 488
           + T       +V++ G+ L E F
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 62/223 (27%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDI-------ECDMIKRIRHRNI 350
            +G G +GSV  A   + G +VA+K    +  R F+S +I       E  ++K ++H N+
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQS-EIFAKRAYRELTLLKHMQHENV 76

Query: 351 IKII----SSCSSDDFKA--LVLEYM---------PHGSLEKCLYSSNYILDIFQRLNIM 395
           I ++    S+ S D+F+   LV+ YM            S +K  Y       ++Q L   
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQML--- 127

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
                 L+Y+H   S  IIH DLKP N+ ++++    + DFG+A+     D  +T     
Sbjct: 128 ----CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT----- 172

Query: 456 ATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFTRK 491
              GY+   + R  +V  N        D++S G ++ E  T K
Sbjct: 173 ---GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 41/217 (18%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  A  +   E+ A+K+  L+     +  D+EC M+ KR+     +   + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYL 405
           ++ S   + D    V+EY+  G L        Y +    +           ++A  L +L
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE 464
           H   S  II+ DLK  NV+LD      ++DFGM K  +   ++   T+T   T  Y+APE
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPE 171

Query: 465 ------YGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
                 YG+      + D ++FG++L E    + P D
Sbjct: 172 IIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 22/239 (9%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDL--QYGRAFKSFDIECDMIKRIRHRNIIKIISS 356
           IG G FG     +  +DG +  +K  ++     +  +    E  ++  ++H NI++   S
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 357 CSSDDFKALVLEYMPHGSLEK-------CLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
              +    +V++Y   G L K        L+  + ILD F      + +  AL+++H   
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHVH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              I+H D+K  N+ L  +    L DFG+A+ +L     L +T  + T  Y++PE     
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELART-CIGTPYYLSPEICENR 176

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD-ANLLSQ 527
             +   D+++ G +L E  T K   +     ++ LK       P+S     D  NL+SQ
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 40/166 (24%)

Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKR-----IR-HRNI- 350
           +IGRG FG V   + +D G   A+K               + +M+++     +R  R+I 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR------------KSEMLEKEQVAHVRAERDIL 55

Query: 351 --------IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVA 399
                   +K+  S   +++  L++EY+P G +   L       D F   +    + +  
Sbjct: 56  AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETI 111

Query: 400 SALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK 444
            A++ +H  GY    IH D+KP N+LLD      LSDFG+   L K
Sbjct: 112 LAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 3/104 (2%)

Query: 386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
           LD    L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              + +      + +MAPE       +   DV+S+GI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDL--QYGRAFKS-FDIECDMIKRIRHRNIIKII 354
           +IGRG FG V   ++++  +V A+K+ +      RA  + F  E D++    ++ I  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSV 411
            +   ++   LV++Y   G L   L    + + +   R  +  M+    ++  LH+    
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---- 467
             +H D+KP N+L+D N    L+DFG    L+ ED ++  +  + T  Y++PE  +    
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 468 -EGQVSTNGDVYSFGIMLMETFTRKKP 493
            +G+     D +S G+ + E    + P
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 37/210 (17%)

Query: 300 IGRGGFGSV-YKARIQDGMEVAVKVF------DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G +G+V      + G +VA+K        +L   RA++    E  ++K ++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 353 IISSCSSD-------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
           ++   + D       DF  LV+ +M    L K +       D  Q L  +  +   L+Y+
Sbjct: 79  LLDVFTPDLSLDRFHDF-YLVMPFM-GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYI 134

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE- 464
           H   +  IIH DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE 
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEV 186

Query: 465 ---YGREGQVSTNGDVYSFGIMLMETFTRK 491
              +    Q     D++S G ++ E  T K
Sbjct: 187 ILNWMHYTQTV---DIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 22/164 (13%)

Query: 330 RAFKSFDIECDMIKRIRHRNIIKIIS----SCSSDDFKA--LVLEYMPHGSLEKCLYSSN 383
           RA++       ++K + H+NII +++      S ++F+   LV+E M   +L + +    
Sbjct: 61  RAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI---Q 112

Query: 384 YILDIFQRLNIMI-DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 442
             LD  +R++ ++  +   +++LH   S  IIH DLKPSN+++  +    + DFG+A+  
Sbjct: 113 MDLD-HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 166

Query: 443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
                S   T  + T  Y APE         N D++S G ++ E
Sbjct: 167 -TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 1/83 (1%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L+G IP  +   +KL  L L  NQL G IP     +  L +LD   N+L G +P   
Sbjct: 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567

Query: 61  GNLTNLRNLYLGSNKL-TSIPST 82
           GN+ +L  + +  N L  S+PST
Sbjct: 568 GNVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  A  +   E+ A+K+  L+     +  D+EC M+ KR+     +   + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGY 409
           ++ S   + D    V+EY+  G L   +Y    +      Q +    +++  L +LH   
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE     
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQ 176

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTD 495
               + D +++G++L E    + P D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 42/213 (19%)

Query: 300 IGRGGFGSVYKARIQDG--MEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           +G G FG V  A  ++     VA+K F+       K  D    E  ++  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 355 SSCSSDDFKALVLEYMPHGSLEK-------------CLYSSNYILDIFQRLNIMIDVASA 401
            S   + +  LVLE++  G                 C Y++  +L IF            
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGY 460
            EYL    S+ I++ DLKP N+LLD +    ++DFG AK +       T+T TL  T  Y
Sbjct: 145 -EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEY 194

Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           +APE           D ++ GI + E      P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 11/202 (5%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           +IGRG +  V   R++    + A+KV   +     +  D    E  + ++  +   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 355 SSCSSDDFKAL-VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
            SC   + +   V+EY+  G L   +     + +   R     +++ AL YLH      I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           I+ DLK  NVLLD      L+D+GM K  L+     T +    T  Y+APE  R      
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGF 175

Query: 474 NGDVYSFGIMLMETFTRKKPTD 495
           + D ++ G+++ E    + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           +IGRG +  V   R++   ++ A+KV      +     D + D ++  +H     +    
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVK----KELVHDDEDIDWVQTEKH-----VFEQA 52

Query: 358 SSDDFKA-------------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
           SS+ F               LV+EY+  G L   +     + +   R     ++  AL +
Sbjct: 53  SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNF 111

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           LH      II+ DLK  NVLLD +    L+D+GM K  L      T +    T  Y+APE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPE 166

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEI 497
             R  +   + D ++ G+++ E    + P D I
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 43/182 (23%)

Query: 330 RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-- 387
           RA    + E   + R+ H NI+KI     S+        YM     +  LYS  Y     
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANT-----YMITQKYDFDLYSFMYDEAFD 259

Query: 388 ------IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 441
                 + Q   IM  +  A+EY+H      +IH D+K  N+ L+ +    L DFG A P
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------------DVYSFGIMLMETF 488
             KE +              A +YG  G V+TN              D++S G++L++  
Sbjct: 317 FEKERE--------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Query: 489 TR 490
           + 
Sbjct: 363 SH 364

Length = 501

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 300 IGRGGFGSVYK-ARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSC 357
           IG+G +G VYK    +DG   AVK+ D       +  + E ++++ +  H N++K     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 358 SSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLH 406
              D        LVLE    GS+ + +     +L   QRL+      I+      L++LH
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY- 465
              +  IIH D+K +N+LL       L DFG++  L      L +  ++ T  +MAPE  
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVI 200

Query: 466 GREGQVSTN----GDVYSFGIMLME 486
             E Q   +     DV+S GI  +E
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 47/228 (20%)

Query: 299 LIGRGGFGSVYKARIQDGM----EVAVKVFDLQ----------YGRAFKSFDIECDM-IK 343
           LIG GGFG VY+ +         +   K+ +L+          Y   +    I     I 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 344 RIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---------NI 394
            I H  I K    C S     +   ++    LEK + ++    +IF+R+         NI
Sbjct: 79  NIDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTK---EIFKRIKCKNKKLIKNI 131

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL---------KE 445
           M D+ + LEY+H      I H D+KP N+++D N   ++ D+G+A   +         KE
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
            + L +     T+ Y   +      V+  GD+ S G  +++    K P
Sbjct: 189 QKDLHR----GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 282 FTYLEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY------GRAFKS 334
           FT L+ +Q          IG G  G V  A     G+ VAVK     +       RA++ 
Sbjct: 17  FTVLKRYQQLKP------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR- 69

Query: 335 FDIECDMIKRIRHRNIIKIIS----SCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDI 388
              E  ++K + H+NII +++      S ++F+   LV+E M   +L + ++     LD 
Sbjct: 70  ---ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDH 122

Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
            +   ++  +   +++LH   S  IIH DLKPSN+++  +    + DFG+A+       +
Sbjct: 123 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTN 176

Query: 449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
              T  + T  Y APE         N D++S G ++ E
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 39/120 (32%), Positives = 53/120 (44%), Gaps = 32/120 (26%)

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-------------KEDQ 447
           ALEYLH   +  I+H DLKP N+L+       L+DFG++K  L             K+ +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 448 SLTQTQTLATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                Q   T  Y+APE      YG+        D ++ GI+L E      P    FFGD
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVP----FFGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 10/199 (5%)

Query: 299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           L+G+G FG V   R +  G   A+K+   +   A         E  +++  RH  +  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            +  + D    V+EY   G L   L       +   R     ++ SALEYLH   S  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           + D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   +      
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 475 GDVYSFGIMLMETFTRKKP 493
            D +  G+++ E    + P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 18/163 (11%)

Query: 338 ECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKC-------LYSSNYILDIFQ 390
           E  ++ +++H NI+    S  +D    +V+EY   G L +        L+  + IL  F 
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106

Query: 391 RLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
                + +   ++++H      ++H D+K  N+ L  N    L DFG A+ LL    +  
Sbjct: 107 -----VQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYA 157

Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
            T  + T  Y+ PE       +   D++S G +L E  T K P
Sbjct: 158 CTY-VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 49/233 (21%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC- 357
           IG G +G VYKAR    G  VA+K       +     D E      +R  ++++++S   
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 358 -----------SSDDFKA---LVLEYMPHGSLEKCLYSSNY-----ILDIFQRLNIMIDV 398
                         + K    LV EY+   S  K    SN       L      + M  +
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYL--DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK----PLLKEDQSLTQTQ 453
              + + H      ++H DLKP N+L+D    +  ++D G+ +    P+         T 
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS------YTH 170

Query: 454 TLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
            + T+ Y APE        ST  D++S G +  E  +RK+P   +F GD  L+
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQ 219

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 2/91 (2%)

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           L+F +   II+ DLK  NVLLD      L+D+GM K  ++     T +    T  Y+APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPE 166

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
             R      + D ++ G+++ E    + P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKIIS 355
           IG+G FG V + R +D   + A+K     +  +         E  ++ ++    I+ +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           S  S +   LVL ++  G L   L       D+ +      ++  ALE LH      +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIY 116

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPEYGREGQVSTN 474
            DLKP N+LLD      L DFG+ K  +K+D    +T T   T  Y+APE       +  
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 475 GDVYSFGIMLMETFTRKKP 493
            D ++ G++L E  T   P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 23/175 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIR-HRNIIK 352
           IG G F  V KA+  + G   A+K       + FKS +      E   ++R+  H NI++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 353 IISSCSSDDFK---ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           +I     D      ALV E M   +L + +      L   +  + M  +  +L+++H   
Sbjct: 63  LIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
              I H D+KP N+L+ D+++  L+DFG  + +         T+ ++T  Y APE
Sbjct: 118 RNGIFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 22/59 (37%), Positives = 31/59 (52%)

Query: 131 LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
           L+ L L  NRL      +   L NLK L+LS NNL+   P +   L  L+ +++S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 8/159 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRN 349
           F    +IGRG FG V   + +D G   A+K+    D+           E D++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           ++K+  S        L++E++P G +   L   + + +   +  I  +   A++ +H   
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
            +  IH D+KP N+LLD      LSDFG+   L K  ++
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 43/223 (19%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI------KRI------- 345
           +GRG FG V  A  +   E+ A+K          K   I  D +      KRI       
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKRIFETANSE 59

Query: 346 RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS---AL 402
           RH  ++ + +   ++D    V+EY   G L   +++     D+F     +   A     L
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGL 114

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ-TQTL-ATIGY 460
           +YLH      I++ DLK  N+LLD      ++DFG    L KE       T T   T  +
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFG----LCKEGMGFGDRTSTFCGTPEF 167

Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
           +APE   E   +   D +  G+++ E    + P      +E+F
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 27/205 (13%)

Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSC 357
           IG+G +G V+K    ++G + AVK+ D  +    +  + E +++K +  H N++K     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 358 SSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLH 406
              D K      LVLE    GS+   +      L   +R+       I+ +    L++LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY- 465
              +   IH D+K +N+LL       L DFG++  L      L +  ++ T  +MAPE  
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVI 196

Query: 466 GREGQVSTN----GDVYSFGIMLME 486
             E Q+ +      DV+S GI  +E
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 29/142 (20%), Positives = 63/142 (44%), Gaps = 15/142 (10%)

Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNII--KIISS 356
           L+  G    VY    +D  +  +K+            + E  +++ +  + +   K+++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPIIH 415
             SD +  L++E++   +L++        +   ++ +I   +A  L  LH     V + H
Sbjct: 62  GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLV-LCH 112

Query: 416 CDLKPSNVLLDDNMVAHLSDFG 437
            DL P N+L+DD  +  + D+ 
Sbjct: 113 GDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIK--- 352
           +IG+G +G V  A     G +VA+K  +  +     +  I  E  +++ +RH +I++   
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 353 IISSCSSDDFKAL--VLEYMPHGSLEKC------LYSSNYILDIFQRLNIMIDVASALEY 404
           I+   S  +FK +  V E M    L +       L   ++   ++Q L        AL+Y
Sbjct: 67  IMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR-------ALKY 118

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP-LLKEDQSLTQTQTLATIGYMAP 463
           +H   +  + H DLKP N+L + +    + DFG+A+        ++  T  +AT  Y AP
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 464 EYGRE--GQVSTNGDVYSFGIMLMETFTRK 491
           E       + +   D++S G +  E  T K
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 8/159 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRN 349
           F    +IGRG FG V   + +D G   A+K+    D+           E D++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           ++K+  S        L++E++P G +   L   + + +   +  I  +   A++ +H   
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
            +  IH D+KP N+LLD      LSDFG+   L K  ++
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 4e-05
 Identities = 24/77 (31%), Positives = 32/77 (41%), Gaps = 17/77 (22%)

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTT 124
           NL++L L +N+LT IP                       L  L  +DLS NN + + P  
Sbjct: 1   NLKSLDLSNNRLTVIPDGA-----------------FKGLPNLKVLDLSGNNLTSISPEA 43

Query: 125 IGGLKDLQYLFLEYNRL 141
             GL  L+ L L  N L
Sbjct: 44  FSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 14/187 (7%)

Query: 292 NGFSENNLIGRGGFGSV-YKARIQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRI 345
             F    +IG+G FG V    +   G   A+K   L     FK   +     E D++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKT--LLKSEMFKKDQLAHVKAERDVLAES 58

Query: 346 RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
               ++ +  S     +  L++E++P G L   L   +   +   R   M +   A+E +
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAV 117

Query: 406 H-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           H  G+    IH D+KP N+L+D      LSDFG++    K+  S    + L         
Sbjct: 118 HKLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 465 YGREGQV 471
             R    
Sbjct: 174 DNRNSVA 180

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIECDMIKRIRHRNIIKI--ISS 356
           +GRG +G VYKA+ +DG +          G     S   E  +++ ++H N+I +  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 357 CSSDDFKALVLEYMPHG-----SLEKCLYSSNYILDIFQRL--NIMIDVASALEYLHFGY 409
             SD    L+ +Y  H         +   ++   + + + +  +++  +   + YLH  +
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 410 SVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLKEDQSLTQTQTLATI 458
              ++H DLKP+N+L+     +     ++D G A       KPL   D        + T 
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD------PVVVTF 179

Query: 459 GYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 491
            Y APE     +  T   D+++ G +  E  T +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 14/146 (9%)

Query: 300 IGRGGFGSVYKARIQDGMEV-AVK------VFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           IG G FG V   R  D   + A+K      V         K+   E D++    +  ++K
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +  S    D    V++Y+P G +   L       +   R  I  ++  A+E +H    + 
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMG 121

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGM 438
            IH D+KP N+L+D +    L+DFG+
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 20/168 (11%)

Query: 330 RAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFKA--LVLEYMPHGSLEKCLYSSN 383
           RA++    E  ++K + H+NII +++  +     ++F+   LV+E M   +L + +    
Sbjct: 62  RAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME- 115

Query: 384 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 443
             LD  +   ++  +   +++LH   S  IIH DLKPSN+++  +    + DFG+A+   
Sbjct: 116 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 167

Query: 444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
               S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 9/199 (4%)

Query: 299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           L+G+G FG V   + +  G   A+K+   +   A         E  +++  RH  +  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            S  + D    V+EY   G L   L       +   R     ++ SAL+YLH   +V  +
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSEKNV--V 118

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           + DLK  N++LD +    ++DFG+ K  +K+    T      T  Y+APE   +      
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 475 GDVYSFGIMLMETFTRKKP 493
            D +  G+++ E    + P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDL--QYGRAFKS-FDIECDMIKRIRHRNIIKII 354
           +IGRG FG V   ++++  +V A+K+ +      RA  + F  E D++     R I  + 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLH-FGYSVP 412
            +   ++   LV++Y   G L   L    + + +   R  +  ++  A++ +H  GY   
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQLGY--- 123

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR----- 467
            +H D+KP NVLLD N    L+DFG    LL  D ++     + T  Y++PE  +     
Sbjct: 124 -VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKP 493
           +G+     D +S G+ + E    + P
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 17/178 (9%)

Query: 317 MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE 376
           + V +KV D  +     +F     ++ ++ H ++  +   C       +V E++ HG L+
Sbjct: 45  LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH---- 432
            CL      + +  ++ +   +ASAL YL       ++H ++   N+LL    +A     
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSP 161

Query: 433 ---LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLME 486
              LSD G++   L  ++ + +      I ++APE    G  +ST  D +SFG  L+E
Sbjct: 162 FIKLSDPGVSFTALSREERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 9e-05
 Identities = 45/176 (25%), Positives = 69/176 (39%), Gaps = 15/176 (8%)

Query: 347 HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
           + N IK+  S ++     L+++Y+  G L   L      L   +   I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMV-AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
                 IIH D+K  NVL D      +L D+G+ K             TL    Y +PE 
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYDGTLD---YFSPEK 177

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP----TDEIFFGDMTLKHWVNDLLPISVM 517
            +      + D ++ G++  E  T K P     DE    +  LK     L  I  +
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233

Length = 267

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 1e-04
 Identities = 21/55 (38%), Positives = 24/55 (43%), Gaps = 1/55 (1%)

Query: 44 ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSN 97
           LD   N+L       F  L NL+ L L  N LTSI       L  +  LDLS N
Sbjct: 4  SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 34/170 (20%)

Query: 330 RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF 389
           RA++    E  ++K + H+NII +++             + P  SLE+  +   YI+   
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNV------------FTPQKSLEE--FQDVYIVMEL 110

Query: 390 QRLNIMIDVASALEYLHFGY-------------SVPIIHCDLKPSNVLLDDNMVAHLSDF 436
              N+   +   L++    Y             S  IIH DLKPSN+++  +    + DF
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170

Query: 437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           G+A+       S   T  + T  Y APE         N D++S G ++ E
Sbjct: 171 GLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 43/219 (19%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR-----IRHRNIIK 352
           +IGRG FG V   +++    + A+K+ +            + +M+KR      R    + 
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILN------------KWEMLKRAETACFREERNVL 55

Query: 353 IISSCS----------SDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNI--MIDVA 399
           +   C            +++  LV++Y   G L   L    + + +   R  I  M+   
Sbjct: 56  VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI 115

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
            ++  LH+      +H D+KP NVLLD N    L+DFG    + + D ++  +  + T  
Sbjct: 116 HSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ-DGTVQSSVAVGTPD 168

Query: 460 YMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKP 493
           Y++PE  +      G+     D +S G+ + E    + P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 44/188 (23%), Positives = 66/188 (35%), Gaps = 45/188 (23%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
           LQ L L +N L       L +   L +L                    L  L LG N+L 
Sbjct: 110 LQELKLNNNGLGDRGLRLLAK--GLKDLPP-----------------ALEKLVLGRNRLE 150

Query: 78  SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV-IPTTIGGLKD---LQY 133
                           L+       +LK L   +L+ N   D  I     GLK    L+ 
Sbjct: 151 GASCE----------ALAKALRANRDLKEL---NLANNGIGDAGIRALAEGLKANCNLEV 197

Query: 134 LFLEYNRL--QGSIPDSIG--DLINLKSLNLSNNNLSGTI-----PISLEKLLDLKDINV 184
           L L  N L  +G+   +     L +L+ LNL +NNL+           L   + L  +++
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257

Query: 185 SFNKLEGE 192
           S N +  +
Sbjct: 258 SCNDITDD 265

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 20/181 (11%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           L+G+G FG V   R +   +  A+K+   +   A         E  +++  RH  +  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            S  + D    V+EY   G L   L       +   R     ++ SAL YLH   S  ++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---SCDVV 117

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL--ATIGYMAPE------YG 466
           + DLK  N++LD +    ++DFG    L KE  S   T      T  Y+APE      YG
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 467 R 467
           R
Sbjct: 174 R 174

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 3e-04
 Identities = 24/61 (39%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 17 KLQLLSLEDNQLEGSIPDDLCR-LAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNK 75
           L+ L L +N+L   IPD   + L  L  LD  GN L    P  F  L +LR+L L  N 
Sbjct: 1  NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 76 L 76
          L
Sbjct: 60 L 60

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 8/149 (5%)

Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRN 349
           F +   +G G FG V  AR  D     A+K     D+           E D++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           ++++  S    D    V++Y+P G +   L       +   R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGM 438
            +  IH D+KP N+L+D +    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 42/178 (23%), Positives = 83/178 (46%), Gaps = 17/178 (9%)

Query: 317 MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE 376
           ++V +KV D  +     +F     M++++ H++I+ +   C  D    +V E++  G L+
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL-------DDNM 429
             ++  + +L    +  +   +ASAL YL       ++H ++   N+LL       +   
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGP 149

Query: 430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLME 486
              LSD G+  P+      L++ + +  I ++APE   + +  S   D +SFG  L E
Sbjct: 150 FIKLSDPGI--PI----TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 8/149 (5%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRN 349
           F +   +G G FG V  A  +      A+K     D+           E D++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           ++K+  S    D    V++Y+P G +   L       ++  R  I  ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGM 438
            +  IH D+KP N+L+D +    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 16/157 (10%)

Query: 338 ECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE-KCLYSSNYILDIFQRLNIMI 396
           E  +++ I H +II++  + + + F  L+L   P    +  C  ++   + I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA-KPLLKEDQSLTQTQTL 455
            V  A++YLH      IIH D+K  N+ ++      L DFG A  P+      +   +  
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV-----DINANKYY 241

Query: 456 ---ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
               TI   APE           D++S GI+L E  T
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 47/214 (21%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIECDMIKRIRHRNIIKI--ISS 356
           +GRG +G VYKA+ +DG +          G     S   E  +++ ++H N+I +  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 357 CSSDDFKALVLEYMPHG-----SLEKCLYSSNYILDIFQRL--NIMIDVASALEYLHFGY 409
             +D    L+ +Y  H         +   ++   + + + +  +++  +   + YLH  +
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 410 SVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLKEDQSLTQTQTLATI 458
              ++H DLKP+N+L+     +     ++D G A       KPL   D        + T 
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD------PVVVTF 179

Query: 459 GYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 491
            Y APE     +  T   D+++ G +  E  T +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 24/223 (10%)

Query: 300 IGRG--GFGSVYKAR-IQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKII 354
           IGRG     SVY AR    G  V V++ DL+       K+   E  +    RH NI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVASALEYLH-FGYS 410
           +  ++  +  ++  +M +GS    L    Y  +        NI+      L YLH  GY 
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQNGY- 122

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ------SLTQTQTLATIGYMAPE 464
              IH ++K S++L+  + +  LS       L++  Q         Q  T + + +++PE
Sbjct: 123 ---IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST-SVLPWLSPE 178

Query: 465 YGREGQVSTN--GDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
             R+     N   D+YS GI   E  T + P  ++    M L+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.002
 Identities = 65/289 (22%), Positives = 119/289 (41%), Gaps = 61/289 (21%)

Query: 300 IGRGGFGSVYKARIQDGMEV----AVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           IG G FG V+  + +   E     A+    L+  R      IE ++++ ++H+NI++ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYID 79

Query: 356 SCSSDDFKAL--VLEYMPHGSL----EKCL-----YSSNYILDIFQRLNIMIDVASALEY 404
              +   + L  ++E+   G L    +KC         + I+DI ++L        AL Y
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133

Query: 405 LHFGYSVP----IIHCDLKPSNVLLDDNM-----------------VAHLSDFGMAKPLL 443
            H     P    ++H DLKP N+ L   +                 +A + DFG++K + 
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193

Query: 444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTN--GDVYSFGIMLMETFTRKKPTDEIFFGD 501
            E  + +    + T  Y +PE       S +   D+++ G ++ E  + K P    F   
Sbjct: 194 IESMAHS---CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP----FHKA 246

Query: 502 MTLKHWVNDL-----LPI----SVMEIVDANLLSQKDEHFTTKGQCVSF 541
                 +++L     LPI      + I+  NLL+   +   +  QC+ +
Sbjct: 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295

Length = 1021

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 35/116 (30%), Positives = 62/116 (53%), Gaps = 10/116 (8%)

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQ-VDLSMNNFSDVIPT 123
           N++ LY  SN+LTSIP+TL +    + L ++    L   L   +Q +DL  N  S  +P 
Sbjct: 221 NIKTLYANSNQLTSIPATLPDTIQEMELSINRITELPERLPSALQSLDLFHNKIS-CLPE 279

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS---GTIPISLEKL 176
            +   ++L+YL +  N ++ ++P  +   I    LN+ +N+L+    T+P  L+ L
Sbjct: 280 NLP--EELRYLSVYDNSIR-TLPAHLPSGIT--HLNVQSNSLTALPETLPPGLKTL 330

Length = 754

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	580
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.75
smart00090	237	RIO RIO-like kinase.	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.68
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.67
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.67
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.6
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.57
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.55
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.55
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
PLN03150	623	hypothetical protein; Provisional	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.38
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.33
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.32
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.3
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.23
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.22
COG4248	637	Uncharacterized protein with protein kinase and he	99.21
PLN03150	623	hypothetical protein; Provisional	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.15
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.13
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.09
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.08
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.93
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.87
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.87
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.79
PRK09902	216	hypothetical protein; Provisional	98.72
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.7
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.64
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.63
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.63

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.1e-71  Score=632.43  Aligned_cols=548  Identities=28%  Similarity=0.448  Sum_probs=404.5

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |++.+.+|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++.....
T Consensus       390 n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p  469 (968)
T PLN00113        390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP  469 (968)
T ss_pred             CEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecC
Confidence            55556666666666666666666666666666666666666666777666666666666666777777777776664333


Q ss_pred             CCcCCCCCceEeCcCCccc------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccc
Q 038098           82 TLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINL  155 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l~------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  155 (580)
                      .....++|+.|+|++|++.      +.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+++.+|..|..+++|
T Consensus       470 ~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  549 (968)
T PLN00113        470 DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVL  549 (968)
T ss_pred             cccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccC
Confidence            3344577888888888772      5678889999999999998889999999999999999999999999999999999


Q ss_pred             ccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCC-CCCCCCCCCccccCCCC
Q 038098          156 KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP-NLQVPPCRTRIHHTSRK  234 (580)
Q Consensus       156 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p-~~~~~~c~~~~~~~~~~  234 (580)
                      +.|+|++|++++.+|..+..+.+|+.|++++|++++.+|....+..+....+.||+..|+.+ ....++|.....  ...
T Consensus       550 ~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~  627 (968)
T PLN00113        550 SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPS  627 (968)
T ss_pred             CEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cce
Confidence            99999999999999999999999999999999999999988777888888899999999854 234566753211  112


Q ss_pred             CcceehhhhhHHHHHHHHHHHHHhhhhcCCCCCCCCC---CCCc---c--ccCCccCHHHHHHHhcCCCcCceeccccCc
Q 038098          235 NDLLIGIVLPLSTIFMMAVILFILRYRKRGKPLPNDA---NMPR---I--SNQRRFTYLEIFQATNGFSENNLIGRGGFG  306 (580)
Q Consensus       235 ~~~ii~~~~~~~~~~~~~vi~~i~~~~~~~~~~~~~~---~~~~---~--~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g  306 (580)
                      ...+++++++++++++++++++++++++++.......   ....   .  ...+.+++.++   ...|...+.||+|+||
T Consensus       628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g  704 (968)
T PLN00113        628 WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKG  704 (968)
T ss_pred             eeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCe
Confidence            2222222222222222222222222222211111100   0000   0  01122333333   3567788899999999


Q ss_pred             eEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCC
Q 038098          307 SVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI  385 (580)
Q Consensus       307 ~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~  385 (580)
                      .||+|.. .+|+.||||.+.....    ....|++++++++||||++++++|.+.+..++||||+++|+|.++++.    
T Consensus       705 ~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----  776 (968)
T PLN00113        705 ASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----  776 (968)
T ss_pred             eEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----
Confidence            9999986 4789999998853322    223568899999999999999999999999999999999999999863    


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCccc
Q 038098          386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY  465 (580)
Q Consensus       386 ~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  465 (580)
                      ++|..+.+++.|||+|++|||+.++.+|+||||||+||+++.++.+++. ||.+.....      .....++..|+|||+
T Consensus       777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~  849 (968)
T PLN00113        777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPET  849 (968)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCccc
Confidence            8999999999999999999997777899999999999999999988875 666543211      122357899999999


Q ss_pred             ccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc-hhhhcchhccCCcccccchhhhhHHHHHH
Q 038098          466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS-VMEIVDANLLSQKDEHFTTKGQCVSFIFN  544 (580)
Q Consensus       466 ~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~  544 (580)
                      +.+..++.++|||||||++|||+||+.||+...........|+....... ....+|+.+...    .........++.+
T Consensus       850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  925 (968)
T PLN00113        850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD----VSVNQNEIVEVMN  925 (968)
T ss_pred             ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC----CCccHHHHHHHHH
Confidence            99999999999999999999999999999766555666777876544332 444445443221    1122345667899


Q ss_pred             HHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          545 LAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       545 l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ++.+||+.||++||+|+||++.|+++.+.
T Consensus       926 l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        926 LALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             HHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            99999999999999999999999988763

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-55  Score=438.02  Aligned_cols=289  Identities=41%  Similarity=0.672  Sum_probs=249.3

Q ss_pred             cCCccCHHHHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeee
Q 038098          278 NQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC  357 (580)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  357 (580)
                      ..+.|++.|+..+|++|...++||+|+||.||+|...+|+.||||++.........+|..|++++++++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999998999999988655432145699999999999999999999999


Q ss_pred             ecCC-ceeeEeeccCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          358 SSDD-FKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       358 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                      .+.+ ..+||||||++|+|.++++.... +++|.+|++||.++|+||+|||+.+.++|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999998776 899999999999999999999998888999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccc-ccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccc-cCCchHHHHHHhhcc
Q 038098          436 FGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIF-FGDMTLKHWVNDLLP  513 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~  513 (580)
                      ||+|+........  .... .||.+|+|||+...+..+.|+|||||||+++||+||+.|.+... .+...+..|+.....
T Consensus       221 FGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999754321111  1111 79999999999999999999999999999999999999988654 345568999877776


Q ss_pred             c-chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          514 I-SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       514 ~-~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      . .+.+++|+.+....   +.. ......+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       299 ~~~~~eiiD~~l~~~~---~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGE---YPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CcchhheeCCCccCCC---CCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            6 48899998876311   110 1456679999999999999999999999999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=393.59  Aligned_cols=257  Identities=33%  Similarity=0.494  Sum_probs=215.1

Q ss_pred             cCceeccccCceEEEEEeCCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCC-ceeeEeeccCC
Q 038098          296 ENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-FKALVLEYMPH  372 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~  372 (580)
                      ..+.+|+|+||+||+|.+.....||||++.....  ...++|.+|+.+|++++|||||+++|+|.++. ..++||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3456999999999999998444499999965432  22568999999999999999999999999887 79999999999


Q ss_pred             CChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEecCCCCCEEeCCCC-cEEEccccCccccCCCCCcc
Q 038098          373 GSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVP-IIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       373 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      |+|.++++. .+..+++..++++|.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999998 4678999999999999999999999   777 99999999999999998 99999999998653321  3


Q ss_pred             cccccccCCCcCCccccc--CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          450 TQTQTLATIGYMAPEYGR--EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      ..+...||+.|||||.+.  ...++.|+||||||+++|||+||+.||.....  ......+           +.      
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v-----------~~------  260 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAV-----------VV------  260 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHH-----------Hh------
Confidence            344478999999999999  56899999999999999999999999976432  1111111           10      


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      ...+...+..++..+..++.+||+.||++||++.+++..|+.+...+..
T Consensus       261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            1122333445888999999999999999999999999999999887764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=373.36  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=209.5

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-ceeeEeeccC
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-FKALVLEYMP  371 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~  371 (580)
                      +..+.||+|..|+||+++++ +++-+|+|++.... ....+++.+|++++++.+||+||+++|+|.... ...++||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            34678999999999999976 78899999995543 344678999999999999999999999999888 4999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|||++++... ..+++...-+++.++++||.|||+  +++|+||||||+|||++..|++||||||.+..+...    ..
T Consensus       162 gGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a  234 (364)
T KOG0581|consen  162 GGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA  234 (364)
T ss_pred             CCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence            99999988765 458999999999999999999993  389999999999999999999999999999877433    45


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ...+||..|||||.+.+..|+.++||||||++++|+++|+.|+......   ..         .+.+.++......+. .
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~---------~~~~Ll~~Iv~~ppP-~  301 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YL---------DIFELLCAIVDEPPP-R  301 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CC---------CHHHHHHHHhcCCCC-C
Confidence            6778999999999999999999999999999999999999998653111   11         122223322222111 1


Q ss_pred             cchhh-hhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          532 FTTKG-QCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       532 ~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .+. .+++++.+++..|+++||.+||+++|+++|
T Consensus       302 --lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 --LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             --CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              223 488999999999999999999999999987

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=393.20  Aligned_cols=255  Identities=29%  Similarity=0.489  Sum_probs=220.3

Q ss_pred             CCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +...+.||+|.||+||.|.+.....||+|.++.. ....++|.+|+++|.+++|++||+++|.|..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3346789999999999999997779999999754 234478889999999999999999999999999999999999999


Q ss_pred             ChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          374 SLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       374 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      +|.+|+.. .+..+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||+|+.. .++......
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASE  362 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeecC
Confidence            99999997 5577899999999999999999999   999999999999999999999999999999944 444454555


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..+.     ..+         +.+.+      ..+.+
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~e---------v~~~l------e~GyR  422 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEE---------VLELL------ERGYR  422 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHH---------HHHHH------hccCc
Confidence            6667889999999999999999999999999999999 888876531     111         11122      23456


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ...|..|+++++++|..||..+|++|||++.+...|+++...
T Consensus       423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            778889999999999999999999999999888888877653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-48  Score=388.83  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=216.9

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..|...+.||+|||+.||+++. .+|+.||+|++...   .....+...+|+++.++++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999986 78999999999753   3456678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+|+.++|.+++. .+.++++.+++.++.||+.|+.|||   +.+|+|||||..|++++++.+|||+|||+|..+..++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999887 6678999999999999999999999   99999999999999999999999999999998754433


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        .....+||+-|+|||++.....+..+||||+||++|-|++|++||+..     +            +.+..+...   
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~------------vkety~~Ik---  231 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----T------------VKETYNKIK---  231 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----h------------HHHHHHHHH---
Confidence              455678999999999999999999999999999999999999999752     1            222222211   


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ...+..|...+.+..+||.++|+.+|++|||+.+|+.|
T Consensus       232 -~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  232 -LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             12344455678889999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=365.91  Aligned_cols=199  Identities=33%  Similarity=0.504  Sum_probs=180.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..+|...+.||+|+||+||+|+++ ++.+||||.+...  ..+..+.+..|+++|+.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888889999999999999965 6899999999655  4455677788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC------CcEEEccccCccc
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN------MVAHLSDFGMAKP  441 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~------~~~kl~Dfg~a~~  441 (580)
                      |||+||+|.+|++..+ .+++.++..++.|||.|+++||   +++||||||||.|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999876 5999999999999999999999   9999999999999999764      4689999999998


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                      +..   .......+|++.|||||+++..+|+.|+|+||+|+|+|+|++|++||+.
T Consensus       165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            742   3345667899999999999999999999999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-48  Score=367.69  Aligned_cols=253  Identities=26%  Similarity=0.355  Sum_probs=207.1

Q ss_pred             hcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccc-------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR-------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      .+.|.+.+.||+|+||.|-+|. .++|+.||||+++.+...       ......+|+++|++++|||||+++++++.++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3557788999999999999997 558999999999654211       22345789999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC---CcEEEccccCc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMA  439 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~a  439 (580)
                      .|+|||||+||+|.+++...+. +.+.....+++|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            9999999999999999876664 778888899999999999999   9999999999999999755   78999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCC---CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      +...   ........+||+.|.|||++.+..   +..++|+||+||++|-+++|.+||.+.. ++..+.+          
T Consensus       327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~-~~~sl~e----------  392 (475)
T KOG0615|consen  327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY-TDPSLKE----------  392 (475)
T ss_pred             hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc-CCccHHH----------
Confidence            9663   333456788999999999997654   3358899999999999999999997632 2221211          


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .+-...+.   .....+.+.+++..+||.+||..||++||++.|+++|
T Consensus       393 --QI~~G~y~---f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 --QILKGRYA---FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             --HHhcCccc---ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence              11111111   1223456788899999999999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-47  Score=395.22  Aligned_cols=257  Identities=30%  Similarity=0.510  Sum_probs=221.1

Q ss_pred             CCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +....+.||+|+||+||+|+..      +...||||.++..... ...+|++|+++++.++|||||+++|.|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3445678999999999999743      3456999999776554 77899999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          366 VLEYMPHGSLEKCLYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                      |+|||..|||.+||....             .+++..+.+.||.|||.||+||.   +..+|||||..+|+|+.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999987432             23889999999999999999999   99999999999999999999999


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhh
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      |+|||+++.....+++.......-+.+|||||.+..+++|++||||||||+|||+++ |+.|+.+...            
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------------  711 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------------  711 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------------
Confidence            999999998887777766666677899999999999999999999999999999999 8899866321            


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                           .++++....   +.-+..++.|+.++++||..||+..|++||+++||-..|+....
T Consensus       712 -----~EVIe~i~~---g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  712 -----QEVIECIRA---GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -----HHHHHHHHc---CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                 122221111   11245678999999999999999999999999999999988754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-48  Score=347.41  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=203.0

Q ss_pred             CCCcCceeccccCceEEEEE-eCCCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEe-eeecCCc-eeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIIS-SCSSDDF-KALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~  367 (580)
                      +|++.+.||+|.||+||++. ..+|..||.|.+...  ..+...+...|+.+|++++|||||++++ .+.++.. +++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46778899999999999997 668999999988643  2345567888999999999999999998 4544444 89999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          368 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       368 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ||+..|+|...+..   .+..+++..+|+++.|++.||.++|....+ .|.||||||.||+++.+|.||++|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999988764   346799999999999999999999943222 28899999999999999999999999999874


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ..  .......+||+.||+||.+.+..|+.||||||+||++|||+.-++||.+.     .+-+.         .+-+...
T Consensus       180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L---------~~KI~qg  243 (375)
T KOG0591|consen  180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSL---------CKKIEQG  243 (375)
T ss_pred             ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHH---------HHHHHcC
Confidence            33  23456789999999999999999999999999999999999999998762     12111         1111111


Q ss_pred             ccCCcccccchh-hhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          524 LLSQKDEHFTTK-GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       524 ~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                         .   ..+.| .-++.++.+|+..|+..||+.||+...++..+
T Consensus       244 ---d---~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  244 ---D---YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ---C---CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence               0   00122 45678899999999999999999855444444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=348.17  Aligned_cols=249  Identities=30%  Similarity=0.399  Sum_probs=206.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|++.++||+|+||.||.++.+ +++.+|+|++++..   ....+...+|..++.+++||+||+++-.|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999855 68999999996552   24567788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +||+.||.|...|++.+ .+++..+.-++..|+.||.|||   +.+|||||+||+|||+|.+|.++|+|||+++.....+
T Consensus       104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999999998665 4899999999999999999999   9999999999999999999999999999998543332


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      .  .....+||+.|||||++.+..++..+|.||+|+++|||++|.+||.+.     +...++.            .....
T Consensus       180 ~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~------------~I~~~  240 (357)
T KOG0598|consen  180 D--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYD------------KILKG  240 (357)
T ss_pred             C--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHH------------HHhcC
Confidence            2  334478999999999999999999999999999999999999999762     2222222            22111


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI----NAKEIVT  565 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~ev~~  565 (580)
                      .   ....+.-.+.+..+++.+.+..||++|.    .+.+|-+
T Consensus       241 k---~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  241 K---LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             c---CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            1   0111222567788999999999999996    4555433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=363.90  Aligned_cols=268  Identities=26%  Similarity=0.412  Sum_probs=218.1

Q ss_pred             HHHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          285 LEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       285 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      .+.+...+...+...||+|.||+||+|+|.  ..||||+++...  ++..+.|+.|+.++++=+|.||+-+.|||..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444445566777899999999999999987  479999997663  3467889999999999999999999999998887


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                       .||+.+|+|.+|+.+++..+..++..+.+.||+|||.||.|||   .++|||||||..||++.+++.|||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             9999999999999999999999999999999999999999999   999999999999999999999999999999743


Q ss_pred             CCCCCcccccccccCCCcCCcccccCC---CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..-..........|...|||||+++..   .|++.+||||||+|+|||+||..||... ..+.             +.-.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq-------------Iifm  604 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ-------------IIFM  604 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh-------------eEEE
Confidence            322222223344578889999998754   5899999999999999999999998731 1110             0000


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      +-+....  .........|+.++.+|+..||..++++||.+.+|+..|+++..+.
T Consensus       605 VGrG~l~--pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  605 VGRGYLM--PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ecccccC--ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            0110000  0112234578889999999999999999999999999999887754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=333.52  Aligned_cols=267  Identities=24%  Similarity=0.317  Sum_probs=207.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +.|+...++|+|+||+||+++.+ +|+.||||++....+  ...+-..+|++++++++|||+|.+++.|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999976 699999999854322  234557789999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      ||+. ++.+-+.....-.+.+.+.+++.|++.|+.|+|   +.+++||||||+|||++.+|.+||||||+|+.+..++. 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9988 555556666666899999999999999999999   99999999999999999999999999999998864333 


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc---cchhhhcchhc
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP---ISVMEIVDANL  524 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~~  524 (580)
                       ..+.++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+.  .+.+.-..+.....   ..-..++...-
T Consensus       157 -~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             -hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcccCHHHHHHhccCC
Confidence             3466789999999999887 68999999999999999999999987652  22222222221111   11122222110


Q ss_pred             ------cCCcc---cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 ------LSQKD---EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ------~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            .....   +-....+..+..+.++++.|+..||++|++-+|++.|
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                  00000   0000123445678999999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-46  Score=376.39  Aligned_cols=269  Identities=25%  Similarity=0.448  Sum_probs=226.9

Q ss_pred             ccCHHHHHHHhcCCC---------cCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcC
Q 038098          281 RFTYLEIFQATNGFS---------ENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR  346 (580)
Q Consensus       281 ~~~~~~~~~~~~~~~---------~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~  346 (580)
                      .++|+|..++...|.         +.++||.|.||+||+|+++-    ...||||.++... .+...+|+.|+.+|.++.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            467777666655543         46889999999999998652    3459999997654 456678999999999999


Q ss_pred             CCCcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          347 HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       347 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ||||+++.|........+||+|||++|+|+.||+.....+++.+...++++||.||.||.   +.++|||||.++|||++
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVN  765 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVN  765 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeec
Confidence            999999999999999999999999999999999999888999999999999999999999   99999999999999999


Q ss_pred             CCCcEEEccccCccccCCCC-CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          427 DNMVAHLSDFGMAKPLLKED-QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      .+...|++|||+++.+.++. .......-.-+.+|.|||.+...++|.+|||||||++|||.++ |..||=++..     
T Consensus       766 snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----  840 (996)
T KOG0196|consen  766 SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----  840 (996)
T ss_pred             cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----
Confidence            99999999999999774433 2222233345678999999999999999999999999999988 8888643211     


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                                  ++++..   ...+.+++.+.+|+..+++||..||++|-.+||.+.+|+.+|.++.+
T Consensus       841 ------------QdVIka---Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  841 ------------QDVIKA---IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ------------HHHHHH---HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                        112211   12345677888999999999999999999999999999999998765

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=354.39  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=213.3

Q ss_pred             HhcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCcee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  364 (580)
                      ..++|..++.||+|+|++|++|+ ..++++||||++.+..   ....+-+..|-++|.+| .||.|++++..|.++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            44678889999999999999997 4579999999996542   23345677899999999 8999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +|+||+++|+|.++|...+ .+++.-++.++.+|+.|++|||   +.|||||||||+|||+|+++.++|+|||-|+.+..
T Consensus       151 FvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999998775 5999999999999999999999   99999999999999999999999999999997754


Q ss_pred             CCCc-----------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc
Q 038098          445 EDQS-----------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       445 ~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ....           ......+||..|.+||++..+..++.+|+|+|||++|+|+.|.+||.+..+    +.-       
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yli-------  295 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLI-------  295 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHH-------
Confidence            3222           112457899999999999999999999999999999999999999976311    000       


Q ss_pred             cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       514 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                        ...+++-        .+..++..++.+.+|+.+.|..||.+|++.++|.+|-
T Consensus       296 --FqkI~~l--------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 --FQKIQAL--------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             --HHHHHHh--------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence              1122211        2344556678899999999999999999999998773

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=346.25  Aligned_cols=259  Identities=31%  Similarity=0.453  Sum_probs=208.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC--ceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--FKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  368 (580)
                      .++...+.||+|+||.||.+... +|+..|||.+........+.+..|+.+|++++|||||+++|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            44667789999999999999865 58999999987654333677899999999999999999999854444  5889999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEccccCccccCC-CC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLK-ED  446 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-~~  446 (580)
                      |+++|+|.+++...+..+++..+..++.||++||+|||   +++|+|+||||+|||++. ++.+||+|||+++.... ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999887767999999999999999999999   999999999999999999 79999999999986643 11


Q ss_pred             CcccccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .........||+.|||||.+..+. ...++||||+||++.||+||++||... ..   ...+        ...+....  
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~---~~~~--------~~~ig~~~--  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE---EAEA--------LLLIGRED--  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc---hHHH--------HHHHhccC--
Confidence            222344577999999999998643 446999999999999999999998752 00   0000        00111100  


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                        .  ....+...+.+..+++.+|+..+|++||||.++++|-....
T Consensus       240 --~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  240 --S--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             --C--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence              0  11334457788999999999999999999999999875433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=354.35  Aligned_cols=267  Identities=23%  Similarity=0.315  Sum_probs=209.6

Q ss_pred             hcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccch-hhhHHHHHHHHhhcC-CCCcceEEeeeecCC-ceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRA-FKSFDIECDMIKRIR-HRNIIKIISSCSSDD-FKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv  366 (580)
                      .++|...+.||.|.||.||+|+ ..+|+.||||.++...... ...-.+|+..|+++. ||||+++.+.+.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            3567788999999999999998 4579999999997653322 233467999999998 999999999998888 99999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ||||+. +|++.+..++..+++..+..|+.||++||+|+|   ++|+.|||+||+|||+..+..+||+|||+|+.+....
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC
Confidence            999976 999999999999999999999999999999999   9999999999999999999999999999999774433


Q ss_pred             CcccccccccCCCcCCcccc-cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc----------
Q 038098          447 QSLTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS----------  515 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  515 (580)
                         ..+.++.|.+|.|||++ +.+.|+.+.|+||+|||++|+.+-++-|.+..+-+. +.. +-+.+...          
T Consensus       165 ---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~K-Ic~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  165 ---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYK-ICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             ---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHH-HHHHhCCCccccchhHHH
Confidence               35677899999999965 567899999999999999999999998865322111 000 00111100          


Q ss_pred             hhhhcchhccCCccccc-chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHF-TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +...+.-.........+ .....++.++.+++.+|+.+||.+|||++|+++|
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111111111111111 1223478899999999999999999999999886

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=356.14  Aligned_cols=250  Identities=27%  Similarity=0.391  Sum_probs=216.1

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ..|.....||+|+.|.||.|. ..+++.||||+++.......+-+.+|+.+|+..+|+|||.+++.|-..+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            447777899999999999997 5578999999998877677788899999999999999999999999889999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +||+|.+.+....  +++.++..|++++++||+|||   ..+|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999886544  899999999999999999999   99999999999999999999999999999987744333  4


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+||+.|||||......|++|+||||||++++||+-|.+||-.   +....+-|.          +     .....+
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrAlyL----------I-----a~ng~P  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRALYL----------I-----ATNGTP  487 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CChHHHHHH----------H-----hhcCCC
Confidence            4567899999999999999999999999999999999999999853   111111111          1     122334


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+..+...+.++.+++.+||+.||++||+++|+++|
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            556677889999999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-44  Score=349.03  Aligned_cols=266  Identities=29%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--CceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  366 (580)
                      +.|+.+++||+|.||.||+|+ ..+|+.||+|.+..+.  ........+||.+|+++.||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            346667899999999999998 5689999999986554  34455667899999999999999999998776  689999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +|||+. ||..++...+-.+++.++..++.|++.||+|||   .++|.|||||.+|||+|.+|.+||+|||+|+++....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999988 999999888888999999999999999999999   9999999999999999999999999999999775443


Q ss_pred             CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCcccc-----------CCchHHHHHHhhccc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFF-----------GDMTLKHWVNDLLPI  514 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~-----------~~~~~~~~~~~~~~~  514 (580)
                       ....+..+-|.+|.|||++.+. .|+.++|+||.|||+.||++|++.|.+..+           |..+-..|....++.
T Consensus       273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence             3346778899999999998875 799999999999999999999999866311           111122222111110


Q ss_pred             chhhhcchhccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ...+.+...  .... .+.....+....+|+..+|..||.+|.|+.+++++
T Consensus       352 --~~~~kp~~~--y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  352 --ATIFKPQQP--YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             --ccccCCCCc--ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence              000000000  0000 01123456778899999999999999999998763

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=383.82  Aligned_cols=259  Identities=28%  Similarity=0.492  Sum_probs=221.1

Q ss_pred             CCcCceeccccCceEEEEEeCC--CC----EEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          294 FSENNLIGRGGFGSVYKARIQD--GM----EVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      -...+.||+|.||.||.|...+  |.    .||||.+... ..+...+|..|..+|+.++|||||+++|.|-+....+++
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            4456789999999999998553  43    3899988654 345678999999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          367 LEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      +|||++|+|..|++..      ...++..+.+.++.|||+|+.||+   ++++|||||.++|+|+++...|||+|||+|+
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            9999999999999988      567899999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .+...+++.......-+..|||||.+..+.+|.|+|||||||++||++| |..||.....                 .++
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------------~~v  913 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------------FEV  913 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------------HHH
Confidence            7766666555444466789999999999999999999999999999999 8888765211                 111


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      .....   .+.+++.+..|++.++++|.+||+.+|++||++..+++.+.++.+...
T Consensus       914 ~~~~~---~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  914 LLDVL---EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             HHHHH---hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            11111   122677888999999999999999999999999999999988876543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.8e-43  Score=317.05  Aligned_cols=264  Identities=27%  Similarity=0.369  Sum_probs=210.0

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .+|...+.+|+|.||.||+|+ ..+|+.||||.++...  +.......+|++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            357778899999999999997 5589999999996542  2334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      ||+. +|...+..+...++..++..++.++++|++|||   .+.|.||||||.|+|++++|.+||+|||+|+.+...+..
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9976 999999999989999999999999999999999   999999999999999999999999999999988665543


Q ss_pred             ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH--hhc--------cc--c
Q 038098          449 LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN--DLL--------PI--S  515 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~--~~~--------~~--~  515 (580)
                      .  +..+.|.+|.|||.+.+. .|+..+||||.|||+.||+-|.+-|.+    +.++.+...  ..+        ++  .
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCccccc
Confidence            2  334789999999998875 689999999999999999999877644    333333211  000        00  0


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.+..+-....... ....-..++.++.+|+.+|+..||.+|++++|+++|
T Consensus       232 lpdY~~~~~~P~~~-~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPP-LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCc-cccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111111111111 111224566778999999999999999999999876

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-43  Score=356.42  Aligned_cols=261  Identities=23%  Similarity=0.410  Sum_probs=206.5

Q ss_pred             hcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecC-C
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD-D  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  361 (580)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++.... ......+..|++++.++ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            35788899999999999999974      235689999986432 23346788999999999 899999999988754 4


Q ss_pred             ceeeEeeccCCCChHHHhhcCC----------------------------------------------------------
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN----------------------------------------------------------  383 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  383 (580)
                      ..++||||+++|+|.+++...+                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999987532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCc
Q 038098          384 ---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY  460 (580)
Q Consensus       384 ---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y  460 (580)
                         .++++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               24788899999999999999999   999999999999999999999999999999865433222222334467889


Q ss_pred             CCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhH
Q 038098          461 MAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCV  539 (580)
Q Consensus       461 ~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  539 (580)
                      +|||.+.+..++.++|||||||++|||++ |..||....... ...   .        ...+.       .....+..++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~---~--------~~~~~-------~~~~~~~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFC---Q--------RLKDG-------TRMRAPENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHH---H--------HHhcC-------CCCCCCCCCC
Confidence            99999998899999999999999999997 999986532110 010   0        00000       0111223456


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          540 SFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       540 ~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      .++.+++.+||+.||++||++.|+++.|+++.++
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            7899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=347.02  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=219.5

Q ss_pred             CCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ...+.++||+|.||+|.......+..||||.++..... ...+|..|+++|.+++||||++++|.|..++..++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            34567889999999999999887899999999766443 45889999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSNYIL-DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +|+|.+|+.....+. +.....+|+.|||+||+||.   +..+|||||.++|+|+|.++++||+|||+++.+...++...
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            999999998876443 66677889999999999999   99999999999999999999999999999998877777766


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh--CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ....+-+.+|||||.+..+++|.+||||+||+++||+++  ...||......  +..+        ...+.++..-   .
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vve--------n~~~~~~~~~---~  762 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVE--------NAGEFFRDQG---R  762 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHH--------hhhhhcCCCC---c
Confidence            777788999999999999999999999999999999865  77787653111  1111        1122222111   1


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ......+.-|+.+++++|.+||+.|-++||+++++..+|.+.
T Consensus       763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            112345678999999999999999999999999999998764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=335.58  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=211.5

Q ss_pred             hcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .+.|...+.||.|..++||+|+ .+.++.||||+++.+... ..+.+.+|+..|+.++||||++++.+|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4678899999999999999997 567899999999876433 35889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||.+||+.+++... ..-+++..+..|.+++++||.|||   ..|.||||||+.|||++++|.|||+|||.+..+...+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999988753 245899999999999999999999   99999999999999999999999999998876655442


Q ss_pred             ccc--ccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          448 SLT--QTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       448 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ...  ....+||++|||||.++.  ..|+.|+||||||++..||.+|..||.....-.+.+...-+ .++...       
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn-~pp~~~-------  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN-DPPTLL-------  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CCCCcc-------
Confidence            211  145689999999998543  46899999999999999999999999764322211111111 111000       


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ......+........+.+++..|+++||++|||++++++|
T Consensus       254 ---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 ---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence               0011223334456689999999999999999999999876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=351.63  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=208.1

Q ss_pred             HHhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecc----cc-chhhhHHHHHHHHhhcC-CCCcceEEeeeecCC
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQ----YG-RAFKSFDIECDMIKRIR-HRNIIKIISSCSSDD  361 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  361 (580)
                      ...++|...+.||+|.||.|+.|.+ .+|+.||+|+++.+    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999975 47899999987654    12 23456778999999999 999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCcc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  440 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a~  440 (580)
                      ..++||||+.||+|.+++.. ...+.+..+..++.|+++|++|||   +.+|+||||||+|||++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 567889999999999999999999   9999999999999999999 999999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCC-C-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQ-V-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ...  .........+||+.|+|||++.+.. | +.++||||+||+||-|++|+.||+...     ......        .
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~--------k  234 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYR--------K  234 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHH--------H
Confidence            663  1222345678999999999998866 6 488999999999999999999998621     111111        0


Q ss_pred             hcchhccCCcccccchhhhh-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQC-VSFIFNLAMKCTVESPEQRINAKEIVT  565 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~Rps~~ev~~  565 (580)
                       +       ....+..+..+ +.++.+|+.+|+..||.+|+++.+|+.
T Consensus       235 -i-------~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 -I-------RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -H-------hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             1       11122333344 788999999999999999999999984

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=349.29  Aligned_cols=244  Identities=26%  Similarity=0.413  Sum_probs=208.0

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChH
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE  376 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  376 (580)
                      ++-||.|+.|.||+|+.+ ++.||||.++       +.-..+|+.|++|+||||+.|.|.|.....+|||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            467999999999999988 7999999764       22345789999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccccc
Q 038098          377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  456 (580)
Q Consensus       377 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  456 (580)
                      ..+...+ ++.......|..+||.||.|||   ...|||||||+-||||..+..|||+|||-++.....   ......+|
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG  273 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG  273 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence            9987655 5777788899999999999999   999999999999999999999999999999866433   23456789


Q ss_pred             CCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhh
Q 038098          457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG  536 (580)
Q Consensus       457 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  536 (580)
                      |..|||||+++....++|+||||||||||||+||..||.....     ...           ++-   ......++..+.
T Consensus       274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----sAI-----------IwG---VGsNsL~LpvPs  334 (904)
T KOG4721|consen  274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----SAI-----------IWG---VGSNSLHLPVPS  334 (904)
T ss_pred             hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----hee-----------EEe---ccCCcccccCcc
Confidence            9999999999999999999999999999999999999864210     000           000   112334566788


Q ss_pred             hhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          537 QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       537 ~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      .|++.+.-|+++||+..|..||++.+++.||.-+..++
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            99999999999999999999999999999997665544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=347.48  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=210.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|-+.+.||+|.||.||||+.+ +.+.||+|.+.+..  .+..+.+.+|++++++++||||+.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777889999999999999854 68899999996543  3456778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+.| +|..++...+ .++++.+..++.++++||.|||   +.+|.|||+||.|||++.+|.+|+||||+|+-+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9977 9999987665 5999999999999999999999   99999999999999999999999999999997643  33


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ...+...||+.|||||...++.|+..+|.||+||++|||++|++||...                 .+.+.+.....+. 
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------------si~~Lv~~I~~d~-  216 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------------SITQLVKSILKDP-  216 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------HHHHHHHHHhcCC-
Confidence            3456778999999999999999999999999999999999999998542                 1222222222111 


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ...+...+..+.+++...+.+||.+|.+..+++.|
T Consensus       217 ---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               12334677889999999999999999999999876

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=353.12  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=213.2

Q ss_pred             CCcCceeccccCceEEEEEeCC--C--CE-EEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          294 FSENNLIGRGGFGSVYKARIQD--G--ME-VAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      -...++||+|+||.||+|.++.  +  .. ||||.....   .......+..|+++|++++|||||+++|.+.....+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3445899999999999998542  2  23 899998753   24566889999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |||+|+||+|.++|...+..++..+++.++.+.|+||+|||   +.+++||||.++|+|++.++.+||+|||+++.-.  
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--  313 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--  313 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc--
Confidence            99999999999999988878999999999999999999999   9999999999999999999999999999987432  


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........-+..|+|||.+..+.+++++|||||||++||+++ |..||.+...  .....++.           .   
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI~-----------~---  377 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKIV-----------K---  377 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHHH-----------h---
Confidence            11111213347789999999999999999999999999999999 8889876321  11222210           1   


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                         .+.+...+...+.++..++.+||..+|++||+|.++.+.++.+.....
T Consensus       378 ---~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  378 ---NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ---cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence               111233344678889999999999999999999999999999887654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-43  Score=350.85  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .-|..++.||.|+.|.|..|++. +|+.+|||++....   ......+.+|+-+|+-+.|||++++++.|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            55788899999999999999864 89999999996552   233466888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|-|.+++-.++ ++++.++.+++.||+.|+.|||   ..+|+|||+||+|+|+|.++++||+|||+|..-.   .
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P  164 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence            9999999999998766 5888889999999999999999   9999999999999999999999999999998542   2


Q ss_pred             cccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      ...-...+|.+.|.|||++++..| +.++||||.|||||.|+||+.||++     ..+..            ++...   
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~------------LLlKV---  224 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRV------------LLLKV---  224 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHH------------HHHHH---
Confidence            223456789999999999999887 7899999999999999999999984     12222            11111   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       ....+..+...+.++.+|+.+|+..||++|.|++||.+|-
T Consensus       225 -~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  225 -QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence             1123455677889999999999999999999999999984

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=315.88  Aligned_cols=236  Identities=27%  Similarity=0.326  Sum_probs=201.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||.|+||.|-.++.+ +|..+|+|+++.+.   -++.+...+|..+++.+.||+++++++.+.+.+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45788899999999999999865 68899999997653   234566778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||++||.|..+++..+ .+++..++-+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.+...  
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            9999999999998766 4999999999999999999999   999999999999999999999999999999976332  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         ....+||+.|+|||.+....++.++|.|||||++|||+.|.+||.....                 ..+.+..+.. 
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------------~~iY~KI~~~-  256 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------------IQIYEKILEG-  256 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------------HHHHHHHHhC-
Confidence               4457899999999999999999999999999999999999999865211                 1111111111 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCC
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQR  557 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  557 (580)
                         ....|.-.+.++.+|+.+.++.|-.+|
T Consensus       257 ---~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 ---KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence               223345567789999999999999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-42  Score=339.74  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ..++|+.+++||+|+||.||.|+-+ +|..+|+|++++.   .....+.++.|-.+|....+|.||+++-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999854 7999999999755   23456778889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||++||++-.+|...+ .+++..+..++.+.+-|++.+|   +.|++||||||+|+|+|..|++||+|||++..+...
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999887766 5899999999999999999999   999999999999999999999999999998643210


Q ss_pred             ----------------------CCc----cc-------------------ccccccCCCcCCcccccCCCCCCchhhHhH
Q 038098          446 ----------------------DQS----LT-------------------QTQTLATIGYMAPEYGREGQVSTNGDVYSF  480 (580)
Q Consensus       446 ----------------------~~~----~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~  480 (580)
                                            +..    ..                   ....+|||.|||||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  000    00                   123469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-
Q 038098          481 GIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-  559 (580)
Q Consensus       481 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-  559 (580)
                      |||+|||+.|.+||.+..    ....|.+         ++....    ...++....++++..+||.+|+. ||++|.. 
T Consensus       375 G~ImyEmLvGyPPF~s~t----p~~T~rk---------I~nwr~----~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSET----PQETYRK---------IVNWRE----TLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHhCCCCCCCCC----HHHHHHH---------HHHHhh----hccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999997632    2222211         111110    01122233456889999999999 9999985 


Q ss_pred             --HHHHHHH
Q 038098          560 --AKEIVTR  566 (580)
Q Consensus       560 --~~ev~~~  566 (580)
                        ++||.+|
T Consensus       437 ~G~~EIK~H  445 (550)
T KOG0605|consen  437 KGAEEIKKH  445 (550)
T ss_pred             ccHHHHhcC
Confidence              6666554

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-41  Score=334.84  Aligned_cols=247  Identities=23%  Similarity=0.289  Sum_probs=200.7

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccch---hhhHHHHHHHHhhcCCCCcceEEeeeec----CCceeeEeec
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA---FKSFDIECDMIKRIRHRNIIKIISSCSS----DDFKALVLEY  369 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  369 (580)
                      ...||+|++|.||+|.+. |+.||||++.......   .+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            367999999999999984 8999999986543222   4677899999999999999999999866    3467899999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++...+ .+++..++.++.|++.|+.|||   + .+++||||||+||+++.++.+||+|||+++.+....  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999987654 6899999999999999999999   6 478899999999999999999999999998653221  


Q ss_pred             ccccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          449 LTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .++...        +..    .
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~--------i~~----~  237 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDL--------IIN----K  237 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------HHh----c
Confidence               23457889999999876  6889999999999999999999999975311     111111        000    0


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      .  .+...+..++.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus       238 ~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 N--NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             C--CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0  0112223567889999999999999999999999999998753

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-42  Score=307.79  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=212.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|++++.||+|-||.||.|+.+ ++-.||+|++.+.   ..+...++.+|+++-+.++||||+++++++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999854 6788999999644   234457888999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          367 LEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      +||..+|++...++..+ ..+++.....++.|+|.|+.|+|   .++|+||||||+|+|++..+.+||+|||.+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998554 46899999999999999999999   9999999999999999999999999999987431  


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                        .......+||..|.+||+..+...+..+|+|++|++.||++.|.+||.... .+.++.....                
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k----------------  236 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK----------------  236 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH----------------
Confidence              334556789999999999999999999999999999999999999997643 2222222111                


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                          .++..+...+.++.++|.+|+..+|.+|.+..|++.|=
T Consensus       237 ----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  237 ----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                12233456677889999999999999999999999873

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-41  Score=339.16  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=203.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCC-----------------CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD-----------------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKI  353 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~  353 (580)
                      ++|...+.||+|+||.||+|.+.+                 +..||+|++..... .....+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468888999999999999997532                 33699999865432 234678899999999999999999


Q ss_pred             EeeeecCCceeeEeeccCCCChHHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 038098          354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSN------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIH  415 (580)
Q Consensus       354 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H  415 (580)
                      ++++...+..++||||+++|+|.+++....                  ..+++..+++++.||+.||+|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999886432                  24688899999999999999999   999999


Q ss_pred             ecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh--CCCC
Q 038098          416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKP  493 (580)
Q Consensus       416 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt--g~~p  493 (580)
                      |||||+||+++.++.+||+|||+++.+.............++..|+|||.+..+.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986644333222333456788999999988899999999999999999987  4566


Q ss_pred             CCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          494 TDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      |....  ......++....        .....   ......+..++..+.+++.+||+.||++||++.||.+.|+
T Consensus       242 ~~~~~--~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELT--DEQVIENAGEFF--------RDQGR---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCC--HHHHHHHHHHHh--------hhccc---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            65421  111111111111        00000   0011122356778999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-41  Score=348.59  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=204.5

Q ss_pred             cCCCcCceeccccCceEEEEEe------CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ++|+..+.||+|+||.||+|.+      .++..||||+++... ......+.+|+.+++.+ +||||+++++++...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688889999999999999963      235689999986432 23346788899999999 899999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC------------------------------------------------------------
Q 038098          364 ALVLEYMPHGSLEKCLYSSN------------------------------------------------------------  383 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  383 (580)
                      ++||||+++|+|.+++...+                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999886432                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          384 --------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       384 --------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                                    ..+++..+++++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                          24788999999999999999999   9999999999999999999999999999998664332222


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+..            ...    
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~------------~~~----  334 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIK------------EGY----  334 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHH------------hCc----
Confidence            2223345678999999999999999999999999999998 88888653211 11111111            110    


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                        +...+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus       335 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 --RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              0111223456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=324.64  Aligned_cols=274  Identities=27%  Similarity=0.325  Sum_probs=211.1

Q ss_pred             HHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEe--ccccchhhhHHHHHHHHhhcCCCCcceEEeeeec---
Q 038098          286 EIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFD--LQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS---  359 (580)
Q Consensus       286 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---  359 (580)
                      +.+.....|...+.||+|+||.|+.|..+ +|+.||||.+.  .+.....++..+|+.+++.++|+||+.+.+.+..   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            34455667777899999999999999854 79999999986  3344556788899999999999999999988754   


Q ss_pred             --CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          360 --DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       360 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                        -...|+|+|+| +.+|...++... .++...+..+++||++||.|+|   +.+|+|||+||+|++++.+..+||+|||
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence              35689999999 459999887654 4899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCccccc-CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---c
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---P  513 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~  513 (580)
                      +|+...........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+...  ...-...-...   +
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPS  248 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCC
Confidence            999775443344557888999999999765 46899999999999999999999998865211  11111111111   1


Q ss_pred             cc-hhhhc----chhcc----CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 IS-VMEIV----DANLL----SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~-~~~~~----d~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +. +..+-    .+.+.    ....+....-+.+.+...+|+.+|+..||.+|+|++|+++|
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11 11111    01111    11111112234667889999999999999999999999886

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.9e-41  Score=346.91  Aligned_cols=258  Identities=24%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ++|+..+.||+|+||.||+|...      ++..||+|++.... ......+..|+++++.+ +|+||+++++++...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46888999999999999998742      24579999986543 23345688899999999 899999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC------------------------------------------------------------
Q 038098          364 ALVLEYMPHGSLEKCLYSSN------------------------------------------------------------  383 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  383 (580)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccc
Q 038098          384 ---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  454 (580)
Q Consensus       384 ---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  454 (580)
                               .++++..+++++.||++||+|||   +.+|+||||||+||++++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     24788899999999999999999   999999999999999999999999999999865333222222233


Q ss_pred             ccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccc
Q 038098          455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT  533 (580)
Q Consensus       455 ~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  533 (580)
                      .++..|+|||.+....++.++|||||||++|||++ |+.||....... ...            .......      ...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~------------~~~~~~~------~~~  335 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY------------KMVKRGY------QMS  335 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH------------HHHHccc------Ccc
Confidence            45678999999988899999999999999999997 999986532111 111            1111000      001


Q ss_pred             hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       534 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      .+...+.++.+++.+||+.||++||++.++++.|+++.
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11234577899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=324.50  Aligned_cols=273  Identities=27%  Similarity=0.340  Sum_probs=204.0

Q ss_pred             CCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhh--cCCCCcceEEeeeecCC----ceeeEe
Q 038098          294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKR--IRHRNIIKIISSCSSDD----FKALVL  367 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~  367 (580)
                      .+..+++|+|+||.||+|++. ++.||||++...   ..+.|.+|-++.+.  ++|+||++++++-...+    ..+||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            445678999999999999987 599999999643   45778888888765  58999999999876555    789999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ||.+.|+|.+|+...-  ++|....+++..+++||+|||++      ++++|+|||||++|||+.+|++..|+|||+|..
T Consensus       288 ~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            9999999999997654  89999999999999999999954      467899999999999999999999999999998


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCC------CCCchhhHhHHHHHHHHHhCCCCCCc--cccCCchHHHHHHhhcc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQ------VSTNGDVYSFGIMLMETFTRKKPTDE--IFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dvws~Gvil~elltg~~p~~~--~~~~~~~~~~~~~~~~~  513 (580)
                      +............+||.+|||||++.+.-      .-.+.||||+|.|+|||+++..-++.  ...-...+..=+...+.
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            86555555556688999999999986542      22468999999999999997755421  11111122211221111


Q ss_pred             c-chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          514 I-SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       514 ~-~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      - ++.+.+-.......-+..-.......-+.+.+..||..||+.|.|+.=|-+.+.++..
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            1 1222221111111100111112456778999999999999999999988888877654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.2e-41  Score=334.48  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=202.8

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .|+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999985 479999999986432   2233467789999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999998876433 46899999999999999999999   9999999999999999999999999999998653221 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||..|+|||.+.+..++.++||||+||++|||++|+.||....... ....             ++......
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~-------------~~~~~~~~  220 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREE-------------VDRRVKED  220 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHH-------------HHHHhhcc
Confidence              1234568999999999999999999999999999999999999997532111 0011             11111000


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                         ....+...+.++.+|+.+||+.||++||+     ++++++|
T Consensus       221 ---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 ---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence               11122345678899999999999999997     8898886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=336.68  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=220.3

Q ss_pred             CCcCceeccccCceEEEEEeCC---CC--EEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          294 FSENNLIGRGGFGSVYKARIQD---GM--EVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ....++||.|-||.||+|.+.+   |+  .||||..+.+ .....+.|..|..+|+.++||||++++|.|.+. ..++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            4456789999999999997542   33  4888988654 345578899999999999999999999999854 579999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |.++-|.|.+|++..+..++......++.||+.||+|||   +..+|||||.++|||+.+...||++|||+++.+..+.+
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999999999999999999999999999999999   99999999999999999999999999999998855444


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      . ..+...-+..|||||.+...+++.+||||.|||.+||++. |..||.+....                    |-....
T Consensus       547 Y-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------------------DVI~~i  605 (974)
T KOG4257|consen  547 Y-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------------------DVIGHI  605 (974)
T ss_pred             h-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--------------------ceEEEe
Confidence            3 3445556788999999999999999999999999999988 99999764222                    222233


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ..+.+.+.++.|++.++.|+.+||..+|.+||++.|+...|.++...
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            45667888999999999999999999999999999999999999873

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.8e-41  Score=329.39  Aligned_cols=255  Identities=21%  Similarity=0.346  Sum_probs=206.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC----CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++.... .....+..|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888899999999999999753    356899999865432 3345788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++......+++.+++.++.||+.|++|||   +.+++||||||+||+++.++.++++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999876432211


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      . .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  .....           +.+.   
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~-----------~~~~---  224 (266)
T cd05064         162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA-----------VEDG---  224 (266)
T ss_pred             h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH-----------HHCC---
Confidence            1 11122335678999999999999999999999999999875 99998653110  01111           1000   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                          .....+..++..+.+++.+||+.+|++||+++++.+.|.++
T Consensus       225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                01122345677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.6e-41  Score=332.04  Aligned_cols=268  Identities=22%  Similarity=0.294  Sum_probs=203.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999865 68999999986442 22345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++ +|.+++...+..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            975 999988777667899999999999999999999   99999999999999999999999999999975432221  


Q ss_pred             cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh--ccc-chhhhcc----
Q 038098          450 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL--LPI-SVMEIVD----  521 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~-~~~~~~d----  521 (580)
                      ......++..|+|||.+.+ ..++.++||||+||++|||+||++||......+ .+.......  .+. ....+.+    
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchhh
Confidence            2234467899999998865 568999999999999999999999986532111 111111100  000 0000000    


Q ss_pred             -hhccCC--cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 -ANLLSQ--KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 -~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ......  ...........+.++.+|+.+|++.||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             000000  000011122456778999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=331.46  Aligned_cols=249  Identities=29%  Similarity=0.440  Sum_probs=208.8

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ..|+..+.||+|.||.||+|.. .+++.||+|+++.+.. ...++++.|+.++++++++||.++++++..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3467778999999999999974 5789999999987643 4467889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      |.||++.+.+.... .+++..+.-++.++..|+.|||   ..+.+|||||+.||++..+|.+|++|||.+-.+.....  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999887654 4588888889999999999999   99999999999999999999999999999986643322  


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....+||+.|||||++....|+.|+||||+|++.+||++|.+|+....              +....-++..    ...
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h--------------PmrvlflIpk----~~P  228 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH--------------PMRVLFLIPK----SAP  228 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC--------------cceEEEeccC----CCC
Confidence            3366789999999999998899999999999999999999999986521              1111111111    111


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.+.  ..++..+.+++..|+++||+.||++.++++|
T Consensus       229 P~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             Cccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1222  2567789999999999999999999999987

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-41  Score=331.23  Aligned_cols=248  Identities=35%  Similarity=0.588  Sum_probs=196.8

Q ss_pred             CceeccccCceEEEEEeC-----CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          297 NNLIGRGGFGSVYKARIQ-----DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+.||.|.||.||+|.+.     .+..|+||++..... +..+.+..|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999876     256799999965433 34688999999999999999999999999888899999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++... ...+++.+++.++.||++||.|||   +.+++|+||+++||++++++.+||+|||++..........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999987 567999999999999999999999   8899999999999999999999999999998763333333


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .......+..|+|||.+....++.++||||||+++|||++ |+.||...     ...++...        +.+.      
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~--------~~~~------  221 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEK--------LKQG------  221 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHH--------HHTT------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc--------cccc------
Confidence            3344557788999999998899999999999999999999 67887542     11111111        1010      


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       .+...+..++..+.+++.+||..+|++||+++++++.|
T Consensus       222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             11223345678899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-41  Score=331.90  Aligned_cols=269  Identities=22%  Similarity=0.249  Sum_probs=203.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|++....  ......+..|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999875 68899999986542  2334667889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |++++.+..+. .....+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            99987776544 34456899999999999999999999   9999999999999999999999999999998653222 1


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH--hhcccc-hhhhc-chhc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN--DLLPIS-VMEIV-DANL  524 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~-~~~~~-d~~~  524 (580)
                      .......|+..|+|||.+.+..++.++||||+||++|||++|++||......+ .......  ...+.. ..... ++..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchh
Confidence            12234568999999999988889999999999999999999999997532111 0100000  000000 00000 0000


Q ss_pred             c----CC----cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 L----SQ----KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~----~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .    ..    ...........+.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0    00    000001112356789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=341.33  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=206.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|...++||+|.||.|++|..+ +++.+|||++++.   ..++.+....|.+++... +||.++.++.+|.+.+++++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            367899999999999999999866 6889999999766   345667788899998877 59999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+.||++..+.  ....+++..+.-+|..|+.||.|||   +++|||||||.+|||+|.+|.+||+|||+++.-.. 
T Consensus       447 vmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-  520 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-  520 (694)
T ss_pred             EEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence            99999999955443  3356999999999999999999999   99999999999999999999999999999986532 


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                       ........+||+.|||||++.+..|+..+|.|||||+||||+.|..||.+.                 +-.++.|..+.
T Consensus       521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-----------------dEee~FdsI~~  582 (694)
T KOG0694|consen  521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-----------------DEEEVFDSIVN  582 (694)
T ss_pred             -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-----------------CHHHHHHHHhc
Confidence             233566789999999999999999999999999999999999999999763                 12344444443


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA  560 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  560 (580)
                      ...    ..|.-++.+..+++++++.++|++|..+
T Consensus       583 d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            322    2345678889999999999999999966

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=310.59  Aligned_cols=252  Identities=22%  Similarity=0.349  Sum_probs=208.0

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +.|++-+.||+|.|+.||+.. ..+|+.+|+|+++..  .....+.+.+|+++.+.++||||+++...+.+.+..++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            557777899999999999986 457999999998644  34467888999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEccccCccccCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~  445 (580)
                      +|+|++|..-+-.+ ..+++..+-..++||++|+.|+|   .++|||||+||+|+++.   ....+|++|||+|..+.  
T Consensus        91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--  164 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--  164 (355)
T ss_pred             cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence            99999997544332 45788889999999999999999   99999999999999995   34469999999999875  


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                       ........+||++|||||.+....++..+|||+.|||+|-|+.|++||.+..     ..+            +......
T Consensus       165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~r------------lye~I~~  226 (355)
T KOG0033|consen  165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHR------------LYEQIKA  226 (355)
T ss_pred             -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHH------------HHHHHhc
Confidence             3345677889999999999999999999999999999999999999986521     111            1111112


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ...+..-..+...+++..+|+++|+..||.+|.|+.|.++|=
T Consensus       227 g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  227 GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            222222335567788899999999999999999999998763

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.2e-41  Score=330.69  Aligned_cols=256  Identities=27%  Similarity=0.500  Sum_probs=207.9

Q ss_pred             cCCCcCceeccccCceEEEEEeCC------CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|+..+.||+|+||.||+|....      ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357888999999999999997542      25799999864432 33456889999999999999999999999989999


Q ss_pred             eEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC
Q 038098          365 LVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  429 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~  429 (580)
                      ++|||+++|+|.+++....               ..+++..++.++.|++.|++|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999987532               35788999999999999999999   99999999999999999999


Q ss_pred             cEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHH
Q 038098          430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWV  508 (580)
Q Consensus       430 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  508 (580)
                      .++|+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |..||......  ....  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~--  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE--  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH--
Confidence            999999999986544333333344557888999999988899999999999999999998 99998653211  1111  


Q ss_pred             HhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          509 NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       509 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                                .+....      ....+..++.++.+|+.+||+.||.+||+++||+++|+++
T Consensus       238 ----------~i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 ----------MIRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ----------HHHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                      111100      1112346778899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.8e-41  Score=335.63  Aligned_cols=259  Identities=23%  Similarity=0.381  Sum_probs=208.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC----EEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM----EVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|++.... ......+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999854 344    38999986442 23456788899999999999999999999764 5679


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+||+++|+|.+++......+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999877767899999999999999999999   999999999999999999999999999999876443


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........++..|+|||.+....++.++|||||||++|||++ |+.||+....  .....            ++... 
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~------------~~~~~-  227 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISS------------ILEKG-  227 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH------------HHhCC-
Confidence            33222223345678999999999999999999999999999998 9999865211  01111            11110 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                           .....+..++.++.+++.+||+.+|++||++.+++.++.++.++.
T Consensus       228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                 111223345677899999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-40  Score=324.29  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|+..+.||+|+||.||+|.++++..+|+|.+... ......+..|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457788999999999999999888889999987533 2234678889999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            99999998866566899999999999999999999   99999999999999999999999999999986533221 112


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....  ........           ...       
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~-----------~~~-------  218 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMIS-----------RGF-------  218 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH-----------CCC-------
Confidence            23345668999999988889999999999999999999 8999865211  11111111           000       


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      +...+...+.++.+++.+||+.+|++||+++|+++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0011223456789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-41  Score=339.00  Aligned_cols=242  Identities=24%  Similarity=0.311  Sum_probs=198.1

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999997542   233456778999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  453 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  453 (580)
                      +|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999887544 6899999999999999999999   9999999999999999999999999999987532221  12234


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccc
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT  533 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  533 (580)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ......        +..    .    ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~--------~~~----~----~~~  213 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFEL--------ILM----E----EIR  213 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHH--------HHc----C----CCC
Confidence            5699999999999998999999999999999999999999864211     111000        000    0    111


Q ss_pred             hhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          534 TKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       534 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      .+...+.++.+++.+||+.||++||     ++.++++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            2234567889999999999999999     79998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=339.66  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=204.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999876 58999999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999987544 5889999999999999999999   99999999999999999999999999999985532   


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..... ...     ......     
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i-~~~-----~~~~~~-----  219 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENL-KYW-----KETLQR-----  219 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHH-Hhc-----cccccC-----
Confidence              2234568999999999998899999999999999999999999987531110 00000 000     000000     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      . .........+.++.+++.+||..+|++||+++++++|
T Consensus       220 ~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 P-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             C-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0 0000012456788999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=320.44  Aligned_cols=273  Identities=26%  Similarity=0.385  Sum_probs=209.4

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHh--hcCCCCcceEEeeeecC----Cc
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIK--RIRHRNIIKIISSCSSD----DF  362 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~----~~  362 (580)
                      +...+....+.||+|.||+||+|+|+ |+.||||++...   +...+.+|.++.+  .++|+||+.+++.-..+    .+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34456777899999999999999998 899999999643   3456666777766  45999999999886443    36


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF-----GYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                      ++||++|.+.|||.|||.+  ..++....++++..+|.||+|||.     +.++.|+|||||+.|||+..++..-|+|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            7999999999999999987  559999999999999999999993     457889999999999999999999999999


Q ss_pred             CccccCCCCC--cccccccccCCCcCCcccccCC------CCCCchhhHhHHHHHHHHHhCC----------CCCCcccc
Q 038098          438 MAKPLLKEDQ--SLTQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTRK----------KPTDEIFF  499 (580)
Q Consensus       438 ~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~elltg~----------~p~~~~~~  499 (580)
                      +|-.......  .......+||.+|||||++...      +.-..+||||||.|+||++...          .||.....
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            9986644322  2234567899999999988543      1235689999999999987643          56655555


Q ss_pred             CCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      .+...++...-..-+.....++         ..-....+...+.++|+.||..+|..|.|+-.|.+.|.++.+.-.+
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ip---------nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek  509 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIP---------NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK  509 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCC---------cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence            5555544433222222111111         1112234667789999999999999999999999999988754333

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-40  Score=334.52  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=205.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|+||.||+++.. +|..||+|++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            67899999999999999999865 688999999875432 3346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++.... .+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||++......   
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          85 MDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            99999999987644 5899999999999999999999   64 6999999999999999999999999999755322   


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc--------------
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI--------------  514 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------  514 (580)
                       ......|+..|+|||.+.+..++.++|||||||++|||+||+.||......  .+..........              
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCcccc
Confidence             123346899999999999889999999999999999999999999642211  111111000000              


Q ss_pred             -----------------chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          515 -----------------SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       515 -----------------~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                                       ...+..+..... ..... ....++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKL-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhC-CCcCC-CCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                             000000000000 00000 0123567899999999999999999999999885

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=334.74  Aligned_cols=245  Identities=25%  Similarity=0.323  Sum_probs=202.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||.||+|... +|+.||+|++....   .+....+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999865 68999999986432   233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999987654 5899999999999999999999   999999999999999999999999999999865322  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.....     ......        +...     
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~--------i~~~-----  213 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEK--------ILAG-----  213 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHhC-----
Confidence               1234689999999999888899999999999999999999999865211     111111        1110     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                         ....+...+..+.+++.+||+.||.+||+     ++|+++|
T Consensus       214 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         214 ---KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               01112234567899999999999999995     8898877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=324.51  Aligned_cols=256  Identities=25%  Similarity=0.435  Sum_probs=208.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|+..+.||+|+||.||+|.+..    ...||+|+++... ......+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998742    3579999986543 23346788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++......+++..++.++.|++.|++|||   +.+|+|+||+|+||++++++.++|+|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999876667999999999999999999999   8999999999999999999999999999998764222


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |..||.....  ........           +.   
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~-----------~~---  224 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVE-----------DG---  224 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHH-----------cC---
Confidence            2222223345678999999998899999999999999999998 9999854211  11111110           00   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                          .....+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus       225 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 ----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                01112234667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-41  Score=311.23  Aligned_cols=266  Identities=24%  Similarity=0.283  Sum_probs=204.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc--hhhhHHHHHHHHhhcCCCCcceEEeeee--cCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR--AFKSFDIECDMIKRIRHRNIIKIISSCS--SDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  366 (580)
                      +.|+.++.|++|.||.||+|+.+ +++.||+|+++.+...  ---...+|+.++.+.+|||||.+-....  +-+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777899999999999999854 7899999999765322  1234578999999999999999987764  34579999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ||||+. +|...+..-+.++...++..++.|+++|++|||   ...|+|||||++|+|+...|.+||+|||+|+.+..+ 
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            999987 999999998889999999999999999999999   889999999999999999999999999999987543 


Q ss_pred             CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc-----
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV-----  520 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  520 (580)
                       -...+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||+++++-|.+..  +.+..+.+-.........++     
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCCCccc
Confidence             2245667889999999988775 68999999999999999999999886532  22211111111111000000     


Q ss_pred             ----chhccCC-----cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 ----DANLLSQ-----KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 ----d~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ...-...     ...++.. ...++.-++|+..++..||.+|.|+.|.++|
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~-~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGA-LSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cchhhccccCCCCchhhhhhccc-cccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                0000000     0001111 1145778899999999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-40  Score=341.26  Aligned_cols=259  Identities=23%  Similarity=0.411  Sum_probs=206.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcC-CCCcceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  362 (580)
                      .++|.+.++||+|+||.||+|...      .+..||||++..... ...+.+..|+++++++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467888999999999999999753      134699999864432 33467889999999996 9999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC-----------------------------------------------------------
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-----------------------------------------------------------  383 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  383 (580)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999876421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC
Q 038098          384 ------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD  427 (580)
Q Consensus       384 ------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~  427 (580)
                                                          ..+++..++.++.||++|++|||   +.+++|+||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                24778888999999999999999   899999999999999999


Q ss_pred             CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHH
Q 038098          428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKH  506 (580)
Q Consensus       428 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~  506 (580)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~~-  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TFY-  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HHH-
Confidence            99999999999986543322222233456788999999988889999999999999999997 999986532111 000 


Q ss_pred             HHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          507 WVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       507 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                                 ..+...      .....+..++.++.+++.+||+.+|++||++.++.+.|+++.
T Consensus       351 -----------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 -----------NKIKSG------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -----------HHHhcC------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                       000000      011223356778999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-41  Score=339.02  Aligned_cols=245  Identities=22%  Similarity=0.288  Sum_probs=202.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+..|+.++++++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999865 68999999996542   233466888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999987654 5889999999999999999999   9999999999999999999999999999998653221 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                          ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....    .. ....        .+...     
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~-~~~~--------~i~~~-----  230 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PF-RIYE--------KILAG-----  230 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HH-HHHH--------HHhcC-----
Confidence                23468999999999998889999999999999999999999986421    11 1111        11110     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                         ....+..++..+.+++.+||+.||++||+     ++|+++|
T Consensus       231 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        231 ---RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               11112234567889999999999999996     7888876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.6e-40  Score=329.88  Aligned_cols=270  Identities=22%  Similarity=0.267  Sum_probs=202.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999865 689999999864432 223467789999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |++ ++|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 5888888776667899999999999999999999   9999999999999999999999999999987542221  


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc--ccc-h---hh--h
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL--PIS-V---ME--I  519 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-~---~~--~  519 (580)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.........+........  ... .   ..  .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            12234568899999998765 45788999999999999999999999763221111111111000  000 0   00  0


Q ss_pred             cchhccCCc-ccccc---hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQK-DEHFT---TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~-~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .++...... .....   .....+..+.+|+.+|++.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000000000 00000   001234568899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=301.48  Aligned_cols=262  Identities=22%  Similarity=0.307  Sum_probs=210.0

Q ss_pred             hcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----Ccee
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DFKA  364 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  364 (580)
                      .++|.+.+.+|+|||+-||.++ ..+++.||+|++.....+..+...+|++..++++|||+++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4679999999999999999998 667899999999766667778899999999999999999999887443     3589


Q ss_pred             eEeeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          365 LVLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      +++.|...|+|.+.+...   +..+++.++++|+.+|++||++||.. ..+++||||||.||++.+.+.+++.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999987653   35799999999999999999999922 23499999999999999999999999999986


Q ss_pred             cCCCCCc-------ccccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh
Q 038098          442 LLKEDQS-------LTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       442 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      ..-.-.+       ........|..|.|||.+.   +...++++|||||||++|+|+.|..||+.....+..+.-     
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-----  253 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-----  253 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence            5322111       1233445889999999874   456799999999999999999999999875432222111     


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                             .+.....     .++....+++.+.+++++|++.||.+||++.+++.++..+
T Consensus       254 -------Av~n~q~-----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 -------AVQNAQI-----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -------eeecccc-----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                   1111111     1122233678899999999999999999999999998765

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-40  Score=327.95  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=209.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+..........+..|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788899999999999999742      345689998865544556678999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEE
Q 038098          366 VLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  433 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl  433 (580)
                      ||||+++++|.+++...+            ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999987432            34899999999999999999999   999999999999999999999999


Q ss_pred             ccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhc
Q 038098          434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       434 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||+| |..||......+  ...      
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~------  233 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE------  233 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------
Confidence            99999986543322222233445778999999988899999999999999999999 888886532110  000      


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                           .+..    ..   ....+..++.++.+++.+||+.+|.+||+++|+.+.|+++.+.
T Consensus       234 -----~i~~----~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 -----CITQ----GR---VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -----HHHc----CC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                 0100    00   0011223556799999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-40  Score=348.94  Aligned_cols=251  Identities=22%  Similarity=0.258  Sum_probs=204.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-C-CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-D-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .|...+.||+|++|.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999754 4 6789999875544444567788999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          371 PHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       371 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ++|+|.+++...   ..++++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887642   346899999999999999999999   99999999999999999999999999999986643322


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....            .......
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~------------~~~~~~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIM------------QQVLYGK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH------------HHHHhCC
Confidence            2223445699999999999999999999999999999999999999865211     1111            1111111


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   ...+..++.++.+++.+||..||++||++++++.+
T Consensus       288 ~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        288 Y---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            0   01123456789999999999999999999999764

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-40  Score=334.53  Aligned_cols=259  Identities=25%  Similarity=0.431  Sum_probs=205.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeec-CCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSS-DDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~~  362 (580)
                      ++|++.+.||+|+||.||+|...      +++.||+|++.... ......+..|+.++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46888999999999999999632      35789999986432 22345677899999999 79999999998764 456


Q ss_pred             eeeEeeccCCCChHHHhhcCC-----------------------------------------------------------
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-----------------------------------------------------------  383 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  383 (580)
                      .++++||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            789999999999999886421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCC
Q 038098          384 -YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA  462 (580)
Q Consensus       384 -~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a  462 (580)
                       ..+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.++|+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             26899999999999999999999   99999999999999999999999999999987643333223334456778999


Q ss_pred             cccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHH
Q 038098          463 PEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF  541 (580)
Q Consensus       463 PE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  541 (580)
                      ||++.+..++.++|||||||++|||++ |..||......+ .+...            +....      ....+...+.+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~------------~~~~~------~~~~~~~~~~~  304 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRR------------LKEGT------RMRAPEYATPE  304 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHH------------HhccC------CCCCCccCCHH
Confidence            999999999999999999999999998 999986532111 11111            10000      01112344577


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          542 IFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       542 l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      +.+++.+||+.+|++||++.|++++|+++..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-41  Score=322.16  Aligned_cols=258  Identities=28%  Similarity=0.389  Sum_probs=203.1

Q ss_pred             HHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--------------chhhhHHHHHHHHhhcCCCCcce
Q 038098          288 FQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--------------RAFKSFDIECDMIKRIRHRNIIK  352 (580)
Q Consensus       288 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~  352 (580)
                      ....++|.+.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345588999999999999999999854 799999999954311              12357889999999999999999


Q ss_pred             EEeeeec--CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc
Q 038098          353 IISSCSS--DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  430 (580)
Q Consensus       353 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~  430 (580)
                      ++++..+  .+..|||+|||..|.+... ......+++.++++++.+++.||+|||   ..+|+||||||+|+|++++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            9999865  5689999999999888652 222223899999999999999999999   999999999999999999999


Q ss_pred             EEEccccCccccCCCC---CcccccccccCCCcCCcccccCCC----CCCchhhHhHHHHHHHHHhCCCCCCccccCCch
Q 038098          431 AHLSDFGMAKPLLKED---QSLTQTQTLATIGYMAPEYGREGQ----VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT  503 (580)
Q Consensus       431 ~kl~Dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~  503 (580)
                      +||+|||.+.......   ........+||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||-+.+    .
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----~  324 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----E  324 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----H
Confidence            9999999998653221   111223468999999999887743    4678899999999999999999986521    1


Q ss_pred             HHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          504 LKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       504 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      +..         ...++...+      .++..++...++.+|+.++|.+||++|.+..+|..|..
T Consensus       325 ~~l---------~~KIvn~pL------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  325 LEL---------FDKIVNDPL------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             HHH---------HHHHhcCcc------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            111         112222111      22233356778999999999999999999999988864

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.8e-40  Score=333.66  Aligned_cols=242  Identities=23%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999864 68999999997542   233456778999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  453 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  453 (580)
                      +|..++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            9998886544 5899999999999999999999   99999999999999999999999999999875322211  2234


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccc
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT  533 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  533 (580)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ....        .+...        ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~--------~~~~~--------~~~  213 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFE--------LILME--------EIR  213 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHH--------HHhcC--------CCC
Confidence            56899999999999999999999999999999999999998642110     0000        00000        011


Q ss_pred             hhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          534 TKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       534 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      .+..++.++.+++.+||+.||++||     ++.++++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            2234567889999999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-40  Score=335.39  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=198.7

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----Ccee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DFKA  364 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  364 (580)
                      +|++.+.||+|+||.||+|... +|+.||||++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999854 68999999986432  23345678899999999999999999987543     2479


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+. ++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68998886544 5899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCC-cccccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc-------
Q 038098          445 EDQ-SLTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI-------  514 (580)
Q Consensus       445 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------  514 (580)
                      ... ........||..|+|||++.+  ..++.++|||||||++|||+||++||.....  .....+.......       
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence            221 122234578999999998865  6789999999999999999999999865311  1111111111100       


Q ss_pred             -----chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 -----SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 -----~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ...+.++.................+.++.+++.+||+.||++||+++|+++|
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                 0001111000000000001112346678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-41  Score=331.77  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=213.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc-eeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF-KALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  367 (580)
                      +.|..++++|+|+||.++..+++ +++.|++|.+....  .........|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888899999999999999865 67899999986543  3334467889999999999999999999999888 99999


Q ss_pred             eccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          368 EYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +|++||++.+.+...+ ..+++..+..++.|++.|+.|||   +..|+|||||+.||+++.++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999987766 67999999999999999999999   9999999999999999999999999999999875544


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        ......+||+.||.||.+.+..|+.|+||||+||++|||++-+++|.+....     ..+.        ++...    
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~--------ki~~~----  221 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELIL--------KINRG----  221 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHH--------HHhhc----
Confidence              2345678999999999999999999999999999999999999999873211     1111        11111    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   -.+.+...+.++..++..|++.+|+.||++.+++.+
T Consensus       222 ~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 L---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             c---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1   123445678889999999999999999999999987

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-40  Score=322.87  Aligned_cols=255  Identities=27%  Similarity=0.465  Sum_probs=211.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ..+|+..+.||.|+||.||+|...+++.+|+|++..........+..|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            35688889999999999999998889999999987665545677889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++.... ..+++..++.++.||+.|+.|||   +.+++|+||+|+||+++.++.+||+|||.+........  
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--  159 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--  159 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence            9999999987643 56899999999999999999999   89999999999999999999999999999986633221  


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+....++.++||||||+++|+|++ |+.||......  .....            +..      
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~------------~~~------  219 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQ------------ITA------  219 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHH------------HHh------
Confidence            1223446778999999988889999999999999999998 89998653110  00010            000      


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ..+...+..++.++.+++.+||+.||++|||++++++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            001122345677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.4e-40  Score=322.17  Aligned_cols=257  Identities=22%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC----EEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM----EVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|...+.||+|+||.||+|.+. +++    .+++|.+..... .....+..|+..++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            45778899999999999999864 454    377777653322 234567778889999999999999998864 45788


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ++||+++|+|.+++......+++..+..++.||+.|++|||   +.+++|+||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999877777999999999999999999999   899999999999999999999999999999865433


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........++..|+|||.+.++.++.++|||||||++|||++ |+.||.....  ....+            ++....
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~------------~~~~~~  228 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPD------------LLEKGE  228 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH------------HHHCCC
Confidence            32222334457788999999988899999999999999999998 9999865311  11111            111110


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                            ....+..++.++.+++.+||..+|++||++.|+++.|..+.+
T Consensus       229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  111122355678899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.1e-40  Score=326.50  Aligned_cols=259  Identities=30%  Similarity=0.470  Sum_probs=209.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .+|...+.||+|+||.||+|...      ++..+++|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            34777889999999999999742      345689999865554555678899999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc
Q 038098          366 VLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  430 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~  430 (580)
                      ||||+++++|.+++....               ..+++..++.++.||+.|++|||   +.+++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999986532               34789999999999999999999   999999999999999999999


Q ss_pred             EEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHH
Q 038098          431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVN  509 (580)
Q Consensus       431 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  509 (580)
                      ++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||+| |+.||......  ...+.  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~--  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIEC--  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--
Confidence            99999999986543332222334456788999999998899999999999999999999 99997652111  01110  


Q ss_pred             hhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          510 DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       510 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                               +... .      ....+..++..+.+++.+||+.+|++||++++|++.|+++...
T Consensus       238 ---------~~~~-~------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 ---------ITQG-R------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---------HhCC-C------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                     0000 0      0011223567789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.9e-40  Score=319.62  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=199.6

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      +.||+|+||.||+|... +++.||+|.+.... .+....+..|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999864 78999999875432 23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  455 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  455 (580)
                      .+++......+++..++.++.|+++||+|||   +.+++||||+|+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999876667899999999999999999999   9999999999999999999999999999987543221111111222


Q ss_pred             cCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccch
Q 038098          456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT  534 (580)
Q Consensus       456 ~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  534 (580)
                      .+..|+|||.+.++.++.++|||||||++|||++ |..||......              .....+....      ....
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~~~~~~~------~~~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTREAIEQGV------RLPC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHHHHHcCC------CCCC
Confidence            3567999999998899999999999999999998 88887542110              0111111100      1112


Q ss_pred             hhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       535 ~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      +..++..+.+++.+|++.+|++||++.++.+.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.4e-40  Score=324.54  Aligned_cols=254  Identities=31%  Similarity=0.497  Sum_probs=205.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      .+|.+.+.||+|+||.||+|...      +++.||+|.+...... ....+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45777889999999999999763      2478999998654333 4578899999999999999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          365 LVLEYMPHGSLEKCLYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      +||||+++++|.+++...+             ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999987542             35788999999999999999999   9999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  510 (580)
                      +|+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.....  ........ 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~~~-  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIECIT-  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH-
Confidence            9999999986533322222233446788999999999999999999999999999999 9999854211  11111100 


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                                 .   ..   ....+..++..+.+++.+||+.||++||++.||++.|+
T Consensus       239 -----------~---~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 -----------Q---GR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -----------c---CC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                       0   00   00112345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.2e-41  Score=337.26  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|... +|+.||+|+++...   ......+..|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999865 68999999997542   234466788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++......+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999877667999999999999999999999   99999999999999999999999999999986643322


Q ss_pred             cccccccccCCCcCCccccc------CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          448 SLTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      . ......||+.|+|||++.      ...++.++|||||||++|||++|+.||.....     .....        .+..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~--------~i~~  223 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYN--------NIMN  223 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHH--------HHHc
Confidence            1 223346899999999886      45678999999999999999999999865211     11111        1111


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..    ....++.....+.++.+|+.+|+. +|++||+++++++|
T Consensus       224 ~~----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         224 FQ----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CC----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            00    000111223456778999999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-40  Score=332.97  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=198.2

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +.||+|+||.||++... +|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999864 68999999997542   234466788999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  453 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  453 (580)
                      +|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9998886543 5899999999999999999999   9999999999999999999999999999987532211  12234


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccc
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT  533 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  533 (580)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     .......            ...    ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~------------~~~----~~~  213 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI------------LME----DIK  213 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHh------------ccC----Ccc
Confidence            5689999999999988999999999999999999999999864211     1111100            000    111


Q ss_pred             hhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          534 TKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       534 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      .+...+.++.+++.+||+.||++||     ++.|+++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2234567789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.4e-40  Score=321.84  Aligned_cols=254  Identities=22%  Similarity=0.384  Sum_probs=207.4

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+..|+.++++++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5688899999999999999998888899999876432 235678899999999999999999999999999999999999


Q ss_pred             CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +|+|.+++... ...+++..++.++.|+++|++|||   +.+++||||+|+||+++.++.++|+|||++........ ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  160 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA  160 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence            99999998754 356899999999999999999999   89999999999999999999999999999986533221 11


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||.+..+.++.++|||||||++|||+| |+.||.....  .....+...            ..     
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~------------~~-----  221 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQR------------GY-----  221 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHHc------------CC-----
Confidence            223345678999999988889999999999999999998 9999864211  111111110            00     


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                       ..+....++.++.+++.+|++.+|++||+++++.+.|+++
T Consensus       222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 -RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             1112234567789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=332.47  Aligned_cols=240  Identities=24%  Similarity=0.293  Sum_probs=195.9

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||+|+||.||+|... +++.||+|++....   ......+..|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 68899999986432   23446677899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  455 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  455 (580)
                      .+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99987644 5899999999999999999999   9999999999999999999999999999997542221  1223456


Q ss_pred             cCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       456 ~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      ||+.|+|||.+.+..++.++||||+||++|||++|+.||....     ........        ..    .    ....+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~--------~~----~----~~~~~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKI--------LQ----E----PLRFP  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHH--------Hc----C----CCCCC
Confidence            8999999999999899999999999999999999999986421     11111111        10    0    11122


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRIN---AKEIVTR  566 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps---~~ev~~~  566 (580)
                      ...+.++.+++.+||+.||++||+   +.|+++|
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            345677899999999999999974   6777665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-40  Score=320.25  Aligned_cols=252  Identities=21%  Similarity=0.363  Sum_probs=204.5

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|...+.||+|+||.||.|.+.++..+|+|.+.... ...+.+..|+.++++++||||+++++++...+..++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3577888999999999999998777789999886432 234678899999999999999999999998889999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++......+++..++.++.||+.|++|||   +.+++|+||+|+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            99999999876657899999999999999999999   99999999999999999999999999999886533221 122


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....++..|+|||...+..++.++|||||||++|||++ |..||.....  ......           +...    .   
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~-----------~~~~----~---  218 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEK-----------VSQG----L---  218 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHH-----------HhcC----C---
Confidence            22345678999999988889999999999999999999 9999864211  011110           1000    0   


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      +...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            01112234577899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=339.45  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999865 68999999996532   233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987654 5899999999999999999999   99999999999999999999999999999875432111


Q ss_pred             cc------------------------------------cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCC
Q 038098          448 SL------------------------------------TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK  491 (580)
Q Consensus       448 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~  491 (580)
                      ..                                    ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011235899999999999889999999999999999999999


Q ss_pred             CCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 038098          492 KPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN---AKEIVTR  566 (580)
Q Consensus       492 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ev~~~  566 (580)
                      .||.....     .....        .+.+.    ............+.++.+++.+|+. +|.+|++   ++|+++|
T Consensus       237 ~Pf~~~~~-----~~~~~--------~i~~~----~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNP-----QETYR--------KIINW----KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCH-----HHHHH--------HHHcC----CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99865311     00000        11110    0000111112346778899999996 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-40  Score=319.73  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=206.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|+..+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688889999999999999998778889999986442 23467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++||||||+||++++++.++|+|||+++....... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999987644 56899999999999999999999   89999999999999999999999999999986642211 1


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .......+..|+|||.+.+..++.++||||||+++|||+| |+.||......  ....            .++...    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~------------~~~~~~----  221 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQ------------QVDQGY----  221 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH------------HHHcCC----
Confidence            1112223457999999988899999999999999999999 99998652110  0000            111100    


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                        ....+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              1112234567799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.8e-40  Score=320.03  Aligned_cols=254  Identities=24%  Similarity=0.402  Sum_probs=206.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|...+.||+|+||.||+|... +++.||+|.+... ......+..|++++++++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777889999999999999865 5889999998643 233567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++.... ..+++..++.++.|+++|++|||   +.+++||||||+||++++++.+||+|||++......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999987543 46899999999999999999999   899999999999999999999999999999865432211 


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||....     ...+...         +....    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~---------~~~~~----  222 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYEL---------LEKGY----  222 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH---------HHCCC----
Confidence            1122234567999999988899999999999999999998 888876421     1111111         11000    


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                        ....+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              1122344677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=338.27  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=205.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999865 78999999996542   234567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC-
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED-  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  446 (580)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998766 46899999999999999999999   8999999999999999999999999999998654332 


Q ss_pred             --------------------------CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC
Q 038098          447 --------------------------QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG  500 (580)
Q Consensus       447 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~  500 (580)
                                                .........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence                                      01122345689999999999999999999999999999999999999865321 


Q ss_pred             CchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 038098          501 DMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-AKEIVTR  566 (580)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~ev~~~  566 (580)
                         ...+ .        .+...    ......+....++.++.+++.+|+. ||++||+ ++|+++|
T Consensus       236 ---~~~~-~--------~i~~~----~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 ---QETY-N--------KIINW----KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ---HHHH-H--------HHhcc----CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence               1111 0        11110    0000111112256788999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.8e-40  Score=338.18  Aligned_cols=253  Identities=21%  Similarity=0.299  Sum_probs=198.9

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .|...+.||+|+||.||+|+.. +++.||+|++....   ......+..|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999854 68899999996542   2334678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 5889999999999999999999   999999999999999999999999999998643210000


Q ss_pred             ---------------------------------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHH
Q 038098          449 ---------------------------------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM  483 (580)
Q Consensus       449 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvi  483 (580)
                                                                   .......||..|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123469999999999988889999999999999


Q ss_pred             HHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhh--ccCCCCCCCCCHH
Q 038098          484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMK--CTVESPEQRINAK  561 (580)
Q Consensus       484 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rps~~  561 (580)
                      +|||+||+.||.......    .         ...+.+..    ...........+.++.+++.+  |+..+|..||+++
T Consensus       238 l~elltG~~Pf~~~~~~~----~---------~~~i~~~~----~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTE----T---------QLKVINWE----NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHH----H---------HHHHHccc----cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            999999999996531110    0         00111100    000111122356778899988  5556666799999


Q ss_pred             HHHHH
Q 038098          562 EIVTR  566 (580)
Q Consensus       562 ev~~~  566 (580)
                      |+++|
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=331.74  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=219.0

Q ss_pred             HHHHHHhcCCCcCceeccccCceEEEEEeCC-CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          285 LEIFQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       285 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      ++.+-...+...-.+||-|.||.||.|.|+. .-.||||.++.+ .....+|..|+.+|..++|||+|+++|.|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3334444556667899999999999999874 456999998654 34568899999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      |||+|||..|+|.+|+++.. ..++....+.+|.||++||+||.   .+.+|||||.++|+|+.++..||++|||+++.+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            99999999999999998765 34666677889999999999999   999999999999999999999999999999988


Q ss_pred             CCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ..+.++ ......-++.|.|||.+....++.|+|||+|||+|||+.| |-.||.+.     ++.+-         .+.+ 
T Consensus       416 tgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqV---------Y~LL-  479 (1157)
T KOG4278|consen  416 TGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQV---------YGLL-  479 (1157)
T ss_pred             cCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHH---------HHHH-
Confidence            654433 2334456788999999999999999999999999999999 77787552     22221         1122 


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                           ..+.+.+.++.|++.+++||+.||+++|++||+++|+-+.++.+.
T Consensus       480 -----EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  480 -----EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -----hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                 234466778899999999999999999999999999999887654

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.6e-40  Score=323.81  Aligned_cols=256  Identities=22%  Similarity=0.414  Sum_probs=203.4

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      +.++|+..+.||+|+||.||+|...      ++..||+|++.... ......+..|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      25679999885432 2234568889999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEE
Q 038098          363 KALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  433 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl  433 (580)
                      .++||||+++|+|.+++...+         ..+++..++.++.|++.|++|||   +.+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         23678899999999999999999   899999999999999999999999


Q ss_pred             ccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhc
Q 038098          434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       434 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.....     .....   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~---  232 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLR---  232 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH---
Confidence            99999975533322222223345778999999998899999999999999999999 6888754211     11111   


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                           .+.....       ...+..++..+.+++.+||+.+|++||++.|++++|+
T Consensus       233 -----~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 -----FVMEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----HHHcCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 0011000       1112345677999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.4e-40  Score=323.87  Aligned_cols=255  Identities=26%  Similarity=0.452  Sum_probs=205.0

Q ss_pred             cCCCcCceeccccCceEEEEEe-----CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|+..+.||+|+||.||+|..     .++..||+|.+.... ......+..|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999974     246789999986432 2334678889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC
Q 038098          366 VLEYMPHGSLEKCLYSSN----------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  429 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~  429 (580)
                      ||||+++++|.+++....                ..+++.+++.++.|++.|++|||   +.+++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                34788999999999999999999   89999999999999999999


Q ss_pred             cEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHH
Q 038098          430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWV  508 (580)
Q Consensus       430 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  508 (580)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  ....   
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~---  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVI---  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHH---
Confidence            999999999986644333222333446778999999988889999999999999999999 8888754211  1111   


Q ss_pred             HhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          509 NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       509 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                               +.++...      ....+..++.++.+++.+||+.||++||++.++.++|++
T Consensus       237 ---------~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 ---------EMVRKRQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---------HHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                     1111110      112234466789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-40  Score=333.65  Aligned_cols=245  Identities=22%  Similarity=0.253  Sum_probs=201.3

Q ss_pred             cCCCcCceeccccCceEEEEEeCC--CCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD--GMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|...+.||+|+||.||+|....  +..||+|++....   ......+..|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999998542  3689999986432   23446678899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            99999999999987654 5899999999999999999999   999999999999999999999999999999865321 


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                          .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....    ... .        ..+.+..   
T Consensus       185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~-~--------~~i~~~~---  244 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLI-Y--------QKILEGI---  244 (340)
T ss_pred             ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHH-H--------HHHhcCC---
Confidence                2234689999999999888899999999999999999999999865211    100 0        0111110   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                           ...+...+..+.+++.+|++.||++|+     +++|+++|
T Consensus       245 -----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 -----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 011233456788999999999999995     89999877

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7e-40  Score=334.84  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=197.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||+||+|... +++.||+|++....   ......+..|+.++.+++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999855 68999999996532   223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987654 5899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCC
Q 038098          448 S---------------------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  494 (580)
Q Consensus       448 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~  494 (580)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999989999999999999999999999999


Q ss_pred             CccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccC--CCCCCCCCHHHHHHH
Q 038098          495 DEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTV--ESPEQRINAKEIVTR  566 (580)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~Rps~~ev~~~  566 (580)
                      .....    ...+ .        .+...    .....++.....+.++.+++.+++.  .++..||+++|+++|
T Consensus       237 ~~~~~----~~~~-~--------~i~~~----~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETP----QETY-K--------KVMNW----KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCH----HHHH-H--------HHHcC----cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            65211    1110 0        01100    0000111111245667788887554  233456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-40  Score=318.35  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=203.2

Q ss_pred             CCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +|+..+.||+|+||.||+|.++++..+|+|++.... .....+..|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            477889999999999999998877889999985432 2335678899999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      ++|.+++......+++..++.++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++....... ....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~  159 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQ  159 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccC
Confidence            9999999876667899999999999999999999   99999999999999999999999999999986532211 1111


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||+.....  .....            +...      ..
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~------------~~~~------~~  219 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVES------------VSAG------YR  219 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHH------------HHcC------Cc
Confidence            2224567999999998899999999999999999999 78888642111  00000            0000      01


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ...+..++.++.+++.+||..+|++||++.|+++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            112234677899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-39  Score=318.12  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=207.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|... +++.||||.+....   ......+..|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888999999999999999854 78999999875422   233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++..   ....+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2345889999999999999999999   99999999999999999999999999999886533


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ...  ......++..|+|||.+.+..++.++||||+|+++|||++|+.||.....   ....+...         +....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~---------~~~~~  224 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQK---------IEQCD  224 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHH---------HhcCC
Confidence            221  12234588899999999888899999999999999999999999854211   11111111         00000


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                         .  ........+..+.+++.+||..+|++||++.+|++.++.++
T Consensus       225 ---~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 ---Y--PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---C--CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               0  00011235577899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-40  Score=330.78  Aligned_cols=242  Identities=26%  Similarity=0.374  Sum_probs=196.8

Q ss_pred             ceeccccCceEEEEEe----CCCCEEEEEEEeccc----cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          298 NLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +.||+|+||.||+++.    .+++.||+|++....    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357899999986432    22345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++|+|.+++...+ .+.+..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999887654 5788889999999999999999   99999999999999999999999999999875422221  


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....        .+...       
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~--------~~~~~-------  215 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTID--------KILKG-------  215 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHH--------HHHcC-------
Confidence            22335689999999999888899999999999999999999999865211     11111        11111       


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                       ....+...+.++.+++.+||+.||++||     +++++++|
T Consensus       216 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         216 -KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             1122334567789999999999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-39  Score=319.27  Aligned_cols=254  Identities=27%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++..........+..|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4688899999999999999986 468899999997655455567888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++... ..+++..+..++.|++.|+.|||   +.+|+|||++|+||+++.++.++|+|||++..+.....  .
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            999999988654 35899999999999999999999   89999999999999999999999999999986532211  1


Q ss_pred             ccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          451 QTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .....++..|+|||.+.   ...++.++|||||||++|||++|+.||......+ ....            ......   
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~~~------------~~~~~~---  226 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFL------------MSKSNF---  226 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hhee------------eecCCC---
Confidence            23345888999999874   3457889999999999999999999985421110 0000            000000   


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ...........+..+.+++.+||+.+|++||+++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0001111223467889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.1e-40  Score=333.66  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=194.8

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +|+..+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3556789999999999999865 689999999865432 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++|+|.+.     ...++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....  .
T Consensus       155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  224 (353)
T PLN00034        155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P  224 (353)
T ss_pred             CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence            99998653     23567788899999999999999   99999999999999999999999999999986532211  1


Q ss_pred             ccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          451 QTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .....||..|+|||.+..     ...+.++|||||||++|||++|+.||.....+     .|....         .....
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~---------~~~~~  290 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLM---------CAICM  290 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHH---------HHHhc
Confidence            234568999999998743     23456899999999999999999998732111     111100         00000


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   .....+..++.++.+|+.+||+.||++||+++|+++|
T Consensus       291 ~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 S---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             c---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   0111223456789999999999999999999999987

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-39  Score=327.97  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=203.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|+..+.||+|+||.||+|... ++..+|+|++..... .....+..|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367899999999999999999866 688999998865432 334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+++|+|.+++...+ .+++..+..++.|++.|+.|||   +. +++|+||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999987644 5889999999999999999999   64 7999999999999999999999999998755322  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--------------
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--------------  513 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------  513 (580)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......  .+.........              
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccCC
Confidence              122346889999999999888999999999999999999999998653211  11100000000              


Q ss_pred             ---------------cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 ---------------ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ---------------~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                                     .......+...... .... .....+.++.+|+.+||+.||++||+++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEP-PPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCC-CccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                           00000000000000 0000 011245678999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.2e-40  Score=335.96  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=202.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457889999999999999999865 68899999996432   22335577899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus       122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999988654  4788889999999999999999   9999999999999999999999999999998653322


Q ss_pred             CcccccccccCCCcCCcccccCC----CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      . .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....     ...        ...+.+.
T Consensus       197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~--------~~~i~~~  262 (370)
T cd05596         197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGT--------YSKIMDH  262 (370)
T ss_pred             c-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHH--------HHHHHcC
Confidence            1 122345699999999988643    478999999999999999999999865211     110        1111111


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~  566 (580)
                      .    ....++.....+.++.+++.+|++.+|.+  ||++.|+++|
T Consensus       263 ~----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 K----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0    00111222245678899999999999998  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=336.01  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=219.1

Q ss_pred             CCcCceeccccCceEEEEEe-CCCC----EEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          294 FSENNLIGRGGFGSVYKARI-QDGM----EVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ....++||.|+||+||+|.| ..|+    +||+|++... ..+...++..|+.+|++++|||+++++|.|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568999999999999975 3443    5899988544 3455688999999999999999999999998766 78999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +||+.|+|.+|++..+..+-....+.|..|||+||.|||   .+++|||||.++|||+.+-..+||.|||+|+.+..++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999999999999999999999999999   99999999999999999999999999999998876666


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      ........-++.|||-|.+....++.++|||||||++||++| |..|+++....              ++.+.+      
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------------eI~dll------  913 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------------EIPDLL------  913 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------------HhhHHH------
Confidence            555555566788999999999999999999999999999999 99998764211              111221      


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      ....++..++.|+.+++-++.+||..|+..||+++++...+.+..+
T Consensus       914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            2234577888999999999999999999999999999998887654

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.4e-40  Score=345.91  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             HHhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC----
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD----  361 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  361 (580)
                      ...++|.+.+.||+|+||+||+|+. .+|+.||||++....  ......+..|+..+..++|+|++++.+.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457899999999999999999985 479999999986542  234456788999999999999999987764332    


Q ss_pred             ----ceeeEeeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEc
Q 038098          362 ----FKALVLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  434 (580)
Q Consensus       362 ----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  434 (580)
                          ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                367999999999999988653   246899999999999999999999   9999999999999999999999999


Q ss_pred             cccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          435 DFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       435 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      |||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...     ....+..     
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~-----  255 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMH-----  255 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHH-----
Confidence            999998664332222334457999999999999999999999999999999999999998652     1111111     


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                             .......   ...+..++.++.+++.+||+.||++||++.+++++
T Consensus       256 -------~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 -------KTLAGRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -------HHhcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                   1111111   11234567789999999999999999999999876

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=314.31  Aligned_cols=248  Identities=22%  Similarity=0.320  Sum_probs=206.9

Q ss_pred             hcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ..+|++.+.||+|.||.|-+|. +..|+.||||.+....   .++.-.+.+|+++|+.++||||+.+++.|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3457777899999999999997 5789999999986543   34455678899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||..+|.|++|+...+ .+++..+..++.||++|+.|+|   +.+|+|||||.+|||+|.++++||+|||++..+....
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999998766 5999999999999999999999   9999999999999999999999999999998774332


Q ss_pred             CcccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                         ..+..+|++-|.+||++.+..| ++.+|-||+||+||-|+.|.-||++..     ....++..         ...-+
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQI---------s~GaY  270 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQI---------SRGAY  270 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHh---------hcccc
Confidence               3456789999999999998877 688999999999999999999998731     11222211         11111


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ..        +.-+.+..-||++|+..+|++|.|+.+|..|-
T Consensus       271 rE--------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 RE--------PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cC--------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            11        12234566899999999999999999998874

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.8e-40  Score=330.34  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=195.8

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHH---hhcCCCCcceEEeeeecCCceeeE
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMI---KRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      |++.+.||+|+||.||+|... +|+.||||+++...   ....+.+..|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999865 68999999997542   22334566666554   566899999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|..++..  ..+++..+..++.||+.|+.|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999988764  35899999999999999999999   9999999999999999999999999999987532221


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....     ......        +...    
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~--------i~~~----  216 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDS--------IVND----  216 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHhC----
Confidence              123345689999999999998999999999999999999999999865211     111111        1100    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                          ....+..++.++.+++.+||+.||++||     ++.++++|
T Consensus       217 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         217 ----EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                0112234567789999999999999999     57777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-40  Score=313.05  Aligned_cols=262  Identities=27%  Similarity=0.348  Sum_probs=197.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-----ceeeE
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-----FKALV  366 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  366 (580)
                      .|...+++|.|+||.||+|... +++.||||..-.+.    +--.+|+++|+.+.|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            3566789999999999999854 57899999875332    22346999999999999999998875422     34689


Q ss_pred             eeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCcccc
Q 038098          367 LEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPL  442 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a~~~  442 (580)
                      ||||+. +|.++++..   +..++.-.+.-++.||.+|++|||   +.+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999977 999988742   456888888889999999999999   9999999999999999965 99999999999987


Q ss_pred             CCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      .....+   ..+..|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+. .+..++...++-.-...-.++-.
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhh
Confidence            544433   455688899999998875 6999999999999999999999988762 22223333333221111111110


Q ss_pred             hhcc------CC--ccccc-chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLL------SQ--KDEHF-TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~------~~--~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....      ..  ..... -.....+++..+|+.+++..+|.+|.++.|++.|
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            0000      00  00010 1234567889999999999999999999999875

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-39  Score=319.87  Aligned_cols=259  Identities=24%  Similarity=0.378  Sum_probs=207.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC----EEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM----EVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|...+.||+|+||+||+|.+. +|+    .||+|++.... ......+..|+.+++.+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56888899999999999999853 454    48999986443 2345678889999999999999999999875 45679


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ++||+++|+|.+++......+++..++.++.||+.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999999999876667999999999999999999999   999999999999999999999999999999866433


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........++..|+|||...+..++.++|||||||++|||++ |..||+....  .....+...            . 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~------------~-  227 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEK------------G-  227 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC------------C-
Confidence            22222223345678999999988899999999999999999998 8899865211  111111111            0 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                           .....+..++.++.+++.+||+.||++||++.|+++.|+++.++.
T Consensus       228 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 -----ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -----CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                 011112345677899999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-39  Score=321.03  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=209.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeCC-----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeec-CCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQD-----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  363 (580)
                      .++|...+.||+|+||.||+|.+.+     +..|++|++.... ......+..|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999998764     6789999886432 2345668889999999999999999998765 5678


Q ss_pred             eeEeeccCCCChHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      ++++||+++|+|.+++....       ..+++.+++.++.|++.|++|||   +.+++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986542       45899999999999999999999   999999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccc
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      |+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||....  ......+....    
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~----  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDG----  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcC----
Confidence            99986643332222223346778999999988889999999999999999999 999986521  11111111110    


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                                    .....+..++.++.+++.+||+.||++||++.|+++.|+.+..+
T Consensus       236 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 --------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             --------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                          01112234567899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9e-40  Score=322.18  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .+|...+.||+|+||.||+|...      ++..+|+|.+..........+..|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35677889999999999999632      356799998865555556788999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          366 VLEYMPHGSLEKCLYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      ||||+++|+|.+++....              ..+++..++.++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              24789999999999999999999   9999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  510 (580)
                      +|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |.+||......  ...     
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~-----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAI-----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHH-----
Confidence            9999999975533222222223345678999999998899999999999999999998 88887542111  000     


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                            ......    .   ....+..++..+.+++.+||+.||++||+++|+.+.|++
T Consensus       235 ------~~~~~~----~---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ------ECITQG----R---ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ------HHHHcC----c---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                  001000    0   111223466779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=337.25  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=198.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|... +|+.||||++....   ......+..|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999854 78999999986432   233466788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999998754 45889999999999999999999   99999999999999999999999999999964321100


Q ss_pred             c---------------------------------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHH
Q 038098          448 S---------------------------------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI  482 (580)
Q Consensus       448 ~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv  482 (580)
                      .                                             .......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001246899999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCC---CC
Q 038098          483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR---IN  559 (580)
Q Consensus       483 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps  559 (580)
                      ++|||+||+.||.....    ... ..        .+...    .....++.....+.++.+++.+|+. +|.+|   ++
T Consensus       237 il~elltG~~Pf~~~~~----~~~-~~--------~i~~~----~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENS----HET-YR--------KIINW----RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCH----HHH-HH--------HHHcc----CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            99999999999865211    000 00        01000    0000111112345678899999997 67665   59


Q ss_pred             HHHHHHH
Q 038098          560 AKEIVTR  566 (580)
Q Consensus       560 ~~ev~~~  566 (580)
                      +.|++.|
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-40  Score=332.25  Aligned_cols=242  Identities=23%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +.||+|+||.||++... +|+.||+|++....   ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999854 78999999997542   223456678999999999999999999999999999999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      +|..++...+ .+++..+..++.||+.||+|||   + .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9998886544 5899999999999999999999   7 7999999999999999999999999999875422221  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||.+.+..++.++|||||||++|||+||+.||.....     .....         .+..   .    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~---------~i~~---~----~~  213 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFE---------LILM---E----EI  213 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHH---------HHhc---C----CC
Confidence            34689999999999988999999999999999999999999864211     11111         0000   0    01


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      ..+...+.++.+++.+||+.||++|+     +++++++|
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            12234567789999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-40  Score=299.29  Aligned_cols=252  Identities=27%  Similarity=0.373  Sum_probs=206.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--------chhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--------RAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      -+.|...+.+|+|..++|.+..++ +|.++|+|++.....        +..+.-..|+.+++++ .||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356777889999999999988754 789999999864321        1234456699999999 699999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ...++|+|.|+.|.|.+++.+.- .+++....+|+.|+.+|++|||   ...|||||+||+|||+|++.++||+|||+|+
T Consensus        96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence            99999999999999999997655 4899999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccCCCcCCccccc------CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      .+.+.   ......+||++|+|||.+.      ...|+..+|+||.|||+|-|+.|.+||-.            +..   
T Consensus       172 ~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------------RkQ---  233 (411)
T KOG0599|consen  172 QLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------------RKQ---  233 (411)
T ss_pred             ccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------------HHH---
Confidence            77432   2445678999999999874      34678899999999999999999999732            110   


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .-.+.....+...-+-+.+.+.+....+|+.+|++.||++|.|++|+++|
T Consensus       234 --mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  234 --MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             --HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence              00111111222222345667788899999999999999999999999987

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=318.26  Aligned_cols=254  Identities=25%  Similarity=0.444  Sum_probs=202.1

Q ss_pred             CCcCceeccccCceEEEEEeC-C---CCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc-----
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-D---GMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF-----  362 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  362 (580)
                      |.+.+.||+|+||.||+|... +   +..||+|++....  ......+..|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567789999999999999854 2   3679999986442  2334678899999999999999999998865544     


Q ss_pred             -eeeEeeccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          363 -KALVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       363 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                       .++++||+++|+|..++...     ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999987543     246899999999999999999999   899999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccc
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      |+++.+.............++..|+|||.+....++.++|||||||++|||++ |..||.....  .....+..      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~------  229 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLR------  229 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH------
Confidence            99986644333222223345678999999988889999999999999999999 8888754211  11111111      


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                           +.       .....+..++.++.+++.+||+.||++||++.|++++|+++
T Consensus       230 -----~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 -----HG-------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----cC-------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 00       01112345677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.3e-40  Score=324.44  Aligned_cols=258  Identities=28%  Similarity=0.454  Sum_probs=207.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  362 (580)
                      .++|+..+.||+|+||.||+|...      +...+|+|.+.... .+....+..|++++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            456888899999999999999854      23679999986432 23445688899999999 89999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC
Q 038098          363 KALVLEYMPHGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD  427 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~  427 (580)
                      .+++|||+++|+|.+++...               ...+++..++.++.|++.|++|||   +.+++||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998642               246899999999999999999999   999999999999999999


Q ss_pred             CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHH
Q 038098          428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKH  506 (580)
Q Consensus       428 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~  506 (580)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.....     .+
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~  242 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----EE  242 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-----HH
Confidence            99999999999986644332222223345678999999988899999999999999999998 8888754211     11


Q ss_pred             HHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          507 WVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       507 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      .         ...+...      .....+..++.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus       243 ~---------~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 L---------FKLLKEG------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H---------HHHHHcC------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            0         0111110      011123345678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.4e-39  Score=321.04  Aligned_cols=267  Identities=24%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC--CCCEEEEEEEecccc--chhhhHHHHHHHHhhc---CCCCcceEEeeee-----c
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRI---RHRNIIKIISSCS-----S  359 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  359 (580)
                      .+|++.+.||+|+||.||+|+..  +|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  468899999865422  2234556677777665   6999999999875     3


Q ss_pred             CCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccC
Q 038098          360 DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  438 (580)
Q Consensus       360 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  438 (580)
                      ....++||||++ ++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 59999887543 45899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---ccc
Q 038098          439 AKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---PIS  515 (580)
Q Consensus       439 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~  515 (580)
                      ++.....   .......||..|+|||.+....++.++|||||||++|||++|++||...... ..+........   +..
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence            9865322   2233456899999999998889999999999999999999999998753211 11111111000   000


Q ss_pred             hhhh--cchhcc-CCccc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 VMEI--VDANLL-SQKDE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ~~~~--~d~~~~-~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....  ...... ..... ........+..+.+++.+|++.||++||++.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000  000000 00000 001112456778899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.9e-40  Score=321.42  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .++|.+.+.||+|++|.||+|.+.      .+..||+|.+..... .....+..|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456888999999999999999865      356789998754432 3345688899999999999999999999988899


Q ss_pred             eeEeeccCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEEEc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLS  434 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~  434 (580)
                      ++||||+++++|.+++...+      ..+++..+++++.||+.|++|||   +.+++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987654      25899999999999999999999   89999999999999998655   59999


Q ss_pred             cccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcc
Q 038098          435 DFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       435 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      |||+++................+..|+|||.+.++.++.++|||||||++|||++ |..||+.....     ...     
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~-----  231 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVM-----  231 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH-----
Confidence            9999986633222222222334568999999998999999999999999999997 99998652111     111     


Q ss_pred             cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       514 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                          +.+...      .....+..++..+.+++.+|++.+|++||++.+|+++|.
T Consensus       232 ----~~~~~~------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 ----EFVTGG------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ----HHHHcC------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                111110      011123345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-39  Score=333.42  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  363 (580)
                      ++|.+.+.||+|+||.||+|++.      .++.||+|++.... ......+..|++++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45777899999999999999853      34679999996542 223456888999999997 99999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC------------------------------------------------------------
Q 038098          364 ALVLEYMPHGSLEKCLYSSN------------------------------------------------------------  383 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  383 (580)
                      ++||||+++|+|.++++..+                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999986432                                                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          384 -------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       384 -------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                                                           ..+++..++.++.||+.|++|||   +.+++||||||+||+++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                 23677888999999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~  505 (580)
                      +++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||......+    
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----  349 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence            999999999999986533222222223456788999999988889999999999999999998 888986531110    


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      .         ..+.+....      +...+..++.++.+++.+||..+|++||+++||++.|+++.
T Consensus       350 ~---------~~~~~~~~~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 Q---------FYNAIKRGY------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H---------HHHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0         001111110      11123345678999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-39  Score=320.04  Aligned_cols=264  Identities=27%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-----CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-----DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  364 (580)
                      ..|++.+.||+|+||.||+|..+     +++.||+|.+..........+..|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999742     578999999876555556788899999999999999999998743  34678


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +|+||+++|+|.+++...+..+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCccc-ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc--------c
Q 038098          445 EDQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI--------S  515 (580)
Q Consensus       445 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~  515 (580)
                      ...... .....++..|+|||.+.+..++.++|||||||++|||++|..|+.....      .+.......        .
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhcccccccccchHH
Confidence            322111 1122244569999999888899999999999999999998877543210      111100000        0


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      +.+.+..      ......+..++.++.+++.+||..+|++|||++|+++.|+++
T Consensus       235 ~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKN------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhc------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111      111222345677899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.4e-39  Score=321.94  Aligned_cols=258  Identities=25%  Similarity=0.433  Sum_probs=204.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC--EEEEEEEecc-ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM--EVAVKVFDLQ-YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++.. .....+.+..|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888899999999999999865 343  4788887632 223446788899999999 799999999999999999999


Q ss_pred             eeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          367 LEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      +||+++|+|.+++....               ..+++..++.++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               34889999999999999999999   8999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  510 (580)
                      ||+|||++.....   .........+..|+|||.+....++.++|||||||++|||++ |..||.....     ..+...
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYEK  230 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence            9999999863311   111111223557999999988889999999999999999998 9999865211     111110


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                               +...      .....+..++.++.+++.+||+.+|.+||+++++++.|+.+.....
T Consensus       231 ---------~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         231 ---------LPQG------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             ---------HhcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                     1000      0111223466789999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-39  Score=320.45  Aligned_cols=267  Identities=25%  Similarity=0.390  Sum_probs=204.4

Q ss_pred             CCcCceeccccCceEEEEEe-----CCCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecC--Cceee
Q 038098          294 FSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKAL  365 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  365 (580)
                      |...+.||+|+||+||.+..     .+++.||+|++..... .....+..|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     3578899999865432 3456788899999999999999999988653  35789


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++...  .+++..++.++.|++.|+.|||   +.+++||||||+||++++++.++|+|||+++.....
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999998754  4899999999999999999999   999999999999999999999999999999866432


Q ss_pred             CCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-ccchhhhcchh
Q 038098          446 DQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-PISVMEIVDAN  523 (580)
Q Consensus       446 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~  523 (580)
                      .... ......++..|+|||.+....++.++||||||+++|||+||+.|+......-.....+..... .....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            2211 112234566799999998889999999999999999999999997643211001111100000 00111111111


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      .      ....+..++.++.+++.+||+.+|++||+++++++.|+++.
T Consensus       241 ~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 M------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             C------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1      11223456788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-39  Score=327.80  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=197.8

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      ++||+|+||.||+|... +++.||+|+++...   ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999865 68899999997542   23345677899999988 799999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|.+++... ..+++..+..++.||+.||+|||   +.+++||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence            9999888654 45899999999999999999999   99999999999999999999999999999874322211  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC---chHHHHHHhhcccchhhhcchhccCCcc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD---MTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ...||..|+|||++.+..++.++||||+||++|||+||+.||+.....+   .....+....       +...       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~-------  220 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-------ILEK-------  220 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-------HHcC-------
Confidence            4568999999999999899999999999999999999999997432111   1111111110       1100       


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRIN------AKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~ev~~~  566 (580)
                       ....+..++.++.+++.+|++.||++||+      ++++++|
T Consensus       221 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         221 -QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             11122345677899999999999999997      6787765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-39  Score=329.31  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=199.8

Q ss_pred             CCCcCceeccccCceEEEEEe----CCCCEEEEEEEeccc----cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          293 GFSENNLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    358899999986432    22345677899999999 589999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999887544 5899999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .... .......||..|+|||.+.+. .++.++|||||||++|||+||+.||....... .........        .  
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~--------~--  224 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRI--------L--  224 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHH--------h--
Confidence            3222 122345689999999998765 47889999999999999999999996432111 111111100        0  


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                        ..    ....+...+..+.+++.+||+.||++||     +++++++|
T Consensus       225 --~~----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 --KC----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --cC----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              00    0112234567789999999999999999     77888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-39  Score=321.40  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=205.7

Q ss_pred             CCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +|++.+.||+|+||.||+|...      ....+|+|.+..... .....+..|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999753      235689998864432 334678889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCC
Q 038098          366 VLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  422 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N  422 (580)
                      |+||+.+|+|.+++....                       ..+++.+++.++.|++.|++|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999876421                       34789999999999999999999   9999999999999


Q ss_pred             EEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCC
Q 038098          423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGD  501 (580)
Q Consensus       423 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~  501 (580)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |..||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999986543332222233345678999999988889999999999999999999 9999864211  


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      ..+.            +.+....      ....+..++.++.+++.+||+.+|++||+++|+++.|+++..
T Consensus       236 ~~~~------------~~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ERLF------------NLLKTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHH------------HHHhCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1111            1111110      111233456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-39  Score=308.00  Aligned_cols=271  Identities=26%  Similarity=0.301  Sum_probs=204.4

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCC-cceEEeeeecCC------c
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRN-IIKIISSCSSDD------F  362 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~  362 (580)
                      .|...++||+|.||+||+|+. .+|+.||+|.+.....  ..-....+|+.++.+++|+| |+++++.+....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            455567899999999999985 4789999999976543  24456788999999999999 999999998776      7


Q ss_pred             eeeEeeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      .++|+||++. +|..++....   ..++...+..++.||++|++|||   +++|+||||||.||+++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence            8899999966 9999998766   35777899999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH--hhcc-cc
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN--DLLP-IS  515 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~-~~  515 (580)
                      +...-+.  ...+..++|..|.|||.+.+. .|+...||||+|||++||+++++-|.+...- .++.....  ..+. ..
T Consensus       168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCccC
Confidence            9553222  235667899999999998886 7899999999999999999999888663221 01111111  0000 00


Q ss_pred             hhhhc---chh-ccCCcc-cc--cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 038098          516 VMEIV---DAN-LLSQKD-EH--FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR--LLKI  570 (580)
Q Consensus       516 ~~~~~---d~~-~~~~~~-~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~--L~~~  570 (580)
                      +..+.   +-. .+.... ..  ............+++.+|++.+|.+|.|++.++.|  +..+
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            11111   100 000000 00  00111222478899999999999999999999988  5444

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-39  Score=323.52  Aligned_cols=260  Identities=26%  Similarity=0.433  Sum_probs=208.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456888899999999999999741        24579999886432 23456788999999999 899999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      +..++||||+++|+|.+++....               ..+++.+++.++.||++|+.|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999987542               34788899999999999999999   9999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...     ..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----CH
Confidence            9999999999999986643332222233346678999999988889999999999999999998 77887542     11


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ..+...         +...      .....+..++..+.+++.+||+.+|++||++.|+++.|+++..-
T Consensus       246 ~~~~~~---------~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         246 EELFKL---------LKEG------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHH---------HHcC------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            111111         1000      01122345678899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-39  Score=324.47  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD  361 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  361 (580)
                      ++|.+.+.||+|+||.||+|...        ++..+|+|.+.... ......+..|+++++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56889999999999999999753        23469999987542 23445688899999999 7999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ..++||||+++|+|.+++...+               ..+++.+++.++.|++.|++|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999987542               24889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~  505 (580)
                      .++.++|+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....     ..
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~~  249 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VE  249 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----HH
Confidence            999999999999976533221111222234568999999988889999999999999999998 888875421     11


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ....         .+...      .....+..++.++.+++.+||..+|++||++.|+++.|+++.....
T Consensus       250 ~~~~---------~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 ELFK---------LLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HHHH---------HHHcC------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            1111         11110      0112234566789999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.2e-40  Score=323.11  Aligned_cols=254  Identities=24%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             CCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +|.+.+.||+|+||.||+|...      +++.||+|++...... ....+..|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3666788999999999999753      2477999998654322 34568889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc
Q 038098          366 VLEYMPHGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  430 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~  430 (580)
                      ++||+.+++|.+++...               +..+++..++.++.|++.|++|||   +.+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               134788899999999999999999   999999999999999999999


Q ss_pred             EEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHH
Q 038098          431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVN  509 (580)
Q Consensus       431 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  509 (580)
                      +||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||....     ..++..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Confidence            99999999886543332222233446788999999988899999999999999999998 777875421     111111


Q ss_pred             hhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          510 DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       510 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                      .        +.+..       ....+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus       238 ~--------i~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 M--------IRNRQ-------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H--------HHcCC-------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1        11110       112234577889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=321.87  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .|+..+.||+|+||.||++... +++.||+|++....   ......+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3777899999999999999864 68999999986432   1223456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+++|+|.+++.... ..+++..+..++.|++.|+.|||   +.+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 46899999999999999999999   8999999999999999999999999999998653221 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......|+..|+|||.+.+..++.++||||+||++|||++|+.||..... ......+.         ..+...    
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~~---------~~~~~~----  220 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVE---------RRVKED----  220 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHHH---------HHhhhc----
Confidence              12234688999999999888999999999999999999999999975211 00111110         001000    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                         ....+...+..+.+++.+||+.||++||     +++++++|
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence               0111234567789999999999999999     88899876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-39  Score=327.44  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 68899999997542   23345677888888877 799999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++...+ .+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            99998876543 5899999999999999999999   99999999999999999999999999999875322211  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC---chHHHHHHhhcccchhhhcchhccCCcc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD---MTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.......   .....+....       +..        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------i~~--------  219 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILE--------  219 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-------Hhc--------
Confidence            4568999999999999999999999999999999999999996422111   1111111110       000        


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRIN------AKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~ev~~~  566 (580)
                      .....+...+.++.+++.+||+.||++||+      +.++++|
T Consensus       220 ~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            011223345677889999999999999998      5677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-39  Score=326.85  Aligned_cols=242  Identities=22%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999997542   22334455677777654 899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999887654 5899999999999999999999   8999999999999999999999999999997543222  2233


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||.+.+..++.++|||||||++|||++|+.||.....     ......        +..    .    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~--------i~~----~----~~  213 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDS--------ILN----D----RP  213 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHc----C----CC
Confidence            45689999999999988999999999999999999999999865211     111111        000    0    01


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAK-EIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ev~~~  566 (580)
                      ..+..++.++.+++.+||+.||++||++. ++.+|
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            11233566788999999999999999875 55443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.5e-40  Score=328.24  Aligned_cols=242  Identities=24%  Similarity=0.318  Sum_probs=195.1

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|+.+ +++.||+|++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999865 68899999986532   23445667788888876 699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence            99999887654 5899999999999999999999   99999999999999999999999999999875422221  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     .......        ...        ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i--------~~~--------~~  213 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAI--------LND--------EV  213 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHH--------hcC--------CC
Confidence            45689999999999988999999999999999999999999865211     1111111        100        01


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINA------KEIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~ev~~~  566 (580)
                      ..+...+.++.+++.+|++.||++||++      +++++|
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            1122356778999999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-39  Score=332.48  Aligned_cols=263  Identities=23%  Similarity=0.234  Sum_probs=199.2

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|...      ...+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            5799999999999999999985 468999999743      234678999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      . ++|..++.... .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...... ...
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~  239 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANK  239 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccc
Confidence            5 68988876543 5899999999999999999999   8999999999999999999999999999997542221 112


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCcccc--CC----chHHHHHHhh------cccc---
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFF--GD----MTLKHWVNDL------LPIS---  515 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~--~~----~~~~~~~~~~------~~~~---  515 (580)
                      .....||+.|+|||++.+..++.++||||+||++|||+||+.||-....  +.    ..+.......      .+..   
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            2345799999999999988999999999999999999999988643211  11    1111111100      0000   


Q ss_pred             -hhhhc---chhccCCcccc--cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 -VMEIV---DANLLSQKDEH--FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 -~~~~~---d~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ..+..   ..........+  .......+.++.+|+.+||+.||++|||++|+++|
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000   00000000001  11122356789999999999999999999999875

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.4e-39  Score=316.77  Aligned_cols=254  Identities=25%  Similarity=0.421  Sum_probs=198.3

Q ss_pred             CCcCceeccccCceEEEEEeCC-CC--EEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC------Cc
Q 038098          294 FSENNLIGRGGFGSVYKARIQD-GM--EVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD------DF  362 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  362 (580)
                      |.+.+.||+|+||.||+|.+.+ ++  .||+|.++...  ......+..|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3456889999999999998654 33  58999886432  23456788899999999999999999987432      24


Q ss_pred             eeeEeeccCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                      .++++||+++|+|.+++...     ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432     245899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccch
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      +++.+.............++..|+|||...+..++.++||||||+++|||++ |+.||.....     ......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~------  226 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDY------  226 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH------
Confidence            9986643322222223346778999999998899999999999999999999 7888864211     111110      


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                         +..      ......+..++..+.+++.+||+.||++||++.+++++|+++
T Consensus       227 ---~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 ---LRQ------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---HHc------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               000      001112234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=309.67  Aligned_cols=252  Identities=27%  Similarity=0.360  Sum_probs=206.4

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .|+..+.||+|.-|+||+++.+ ++..+|+|++++..   .+...+.+.|.+||+.+.||.++.+++.++.++..|+|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            3566789999999999999976 46889999997653   3345677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC--
Q 038098          369 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE--  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  445 (580)
                      ||+||+|....+.+. ..+++..+.-++..++-||+|||   ..|||+|||||+|||+.++|.+.|+||.++......  
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            999999999887654 57999999999999999999999   999999999999999999999999999987532110  


Q ss_pred             ------------------------------C-C---------------------cccccccccCCCcCCcccccCCCCCC
Q 038098          446 ------------------------------D-Q---------------------SLTQTQTLATIGYMAPEYGREGQVST  473 (580)
Q Consensus       446 ------------------------------~-~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~  473 (580)
                                                    . .                     .......+||-.|+|||++.+...+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 0                     00112346888999999999999999


Q ss_pred             chhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCC
Q 038098          474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVES  553 (580)
Q Consensus       474 ~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  553 (580)
                      ++|.|+|||++|||+.|..||.+... +.++.            .++-.      ...+......+..+.+||++.|.+|
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~------------NIv~~------~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNN-KETLR------------NIVGQ------PLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHH------------HHhcC------CCcCCCCCcchhHHHHHHHHHhccC
Confidence            99999999999999999999976321 12222            22211      1133333467788999999999999


Q ss_pred             CCCCCC----HHHHHHH
Q 038098          554 PEQRIN----AKEIVTR  566 (580)
Q Consensus       554 P~~Rps----~~ev~~~  566 (580)
                      |++|..    ++||.+|
T Consensus       376 P~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhhhccccchHHhhcC
Confidence            999998    8888765

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.5e-39  Score=318.93  Aligned_cols=245  Identities=24%  Similarity=0.328  Sum_probs=196.3

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||+|+||+||++... +|+.||+|.+.....   .....+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 689999999864321   2335667899999999999999999999999999999999999999


Q ss_pred             HHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          376 EKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       376 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      ..++..   ....+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            987754   2346899999999999999999999   99999999999999999999999999999976533222  123


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||.+.+..++.++|||||||++|||++|+.||....... ........        +...        ..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~--------~~~~--------~~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQR--------ILND--------SV  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHh--------hccc--------CC
Confidence            3468999999999999999999999999999999999999986521110 01111110        0000        11


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      ..+..++.++.+++.+||+.||++||     +++++++|
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            12234667889999999999999999     77888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.9e-39  Score=321.87  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=205.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ++|...+.||+|+||.||+|...      ++..||+|.++... ....+.+..|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            46888999999999999999741      34579999886442 23346788999999999 799999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      ++||||+.+|+|.+++.... ..+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.++++|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999987644 34899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      .............++..|+|||.+.++.++.++||||+||++|||++ |..||...... .....            .++
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~------------~~~  258 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYK------------LIK  258 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHH------------HHH
Confidence            43322212223345778999999998899999999999999999998 99998653211 11111            111


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ...      ....+...+.++.+++.+|++.+|++||++.|+++.|+++
T Consensus       259 ~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGY------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            110      0011123456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6e-40  Score=337.30  Aligned_cols=253  Identities=22%  Similarity=0.292  Sum_probs=199.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999854 68999999986432   233466788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC-
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED-  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  446 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|..+.... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999987654 5888999999999999999999   9999999999999999999999999999985331100 


Q ss_pred             ----------------------------------------CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHH
Q 038098          447 ----------------------------------------QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME  486 (580)
Q Consensus       447 ----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~e  486 (580)
                                                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0001123469999999999999899999999999999999


Q ss_pred             HHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC---CHHHH
Q 038098          487 TFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI---NAKEI  563 (580)
Q Consensus       487 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s~~ev  563 (580)
                      |++|+.||......     .+...        +...    ...........++.++.+++.+|+ .+|++|+   ++.|+
T Consensus       237 ll~G~~Pf~~~~~~-----~~~~~--------i~~~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         237 MLVGQPPFLADTPA-----ETQLK--------VINW----ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             hhhCCCCCCCCCHH-----HHHHH--------Hhcc----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999753211     11000        0000    000011112245667788998876 5999999   89999


Q ss_pred             HHH
Q 038098          564 VTR  566 (580)
Q Consensus       564 ~~~  566 (580)
                      ++|
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-39  Score=323.32  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=202.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|...+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999865 688899999865432 2334677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++ +|.+++...+..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 898888777767899999999999999999999   99999999999999999999999999999975432221  


Q ss_pred             cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh--cccc-hhhhc-----
Q 038098          450 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL--LPIS-VMEIV-----  520 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~~-----  520 (580)
                      ......++..|+|||.+.+ ..++.++||||+||++|||+||+.||......+ .........  .... ...+.     
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            2223457889999998765 468899999999999999999999986532111 111111000  0000 00000     


Q ss_pred             -chhccC-CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 -DANLLS-QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 -d~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       +..... ............+.++.+++.+|++.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence             000000 0000011123456788999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=339.79  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=208.5

Q ss_pred             cCCCcCceeccccCceEEEEEeCCC-CEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEee-eec------CCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDG-MEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISS-CSS------DDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------~~~  362 (580)
                      .+.++.++|.+|||+.||.|+...+ ..||+|++-.........+.+|+++|++|+ |+|||.+++. ...      .-.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3466778999999999999987654 999999997776677889999999999997 9999999993 321      135


Q ss_pred             eeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      .+|.||||+||.|-++|..+- ..+++.++++|+.|+++|+++|| .+..+|||||||.+|||++.++..||||||.|+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            689999999999999997543 44999999999999999999999 3466799999999999999999999999999974


Q ss_pred             cCCCCCccc-------ccccccCCCcCCcccc---cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh
Q 038098          442 LLKEDQSLT-------QTQTLATIGYMAPEYG---REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       442 ~~~~~~~~~-------~~~~~~~~~y~aPE~~---~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      .........       ......|+.|+|||++   .+..+++|+||||+||+||-|+....||+...             
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------  262 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------  262 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence            432221111       1234589999999976   46678999999999999999999999998631             


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                          -..|++..      ..++....++..+.+||+.||+.||.+||++.+|+.++.++..
T Consensus       263 ----~laIlng~------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  263 ----KLAILNGN------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----ceeEEecc------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                11122211      1223335688999999999999999999999999999988764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-39  Score=327.78  Aligned_cols=247  Identities=21%  Similarity=0.273  Sum_probs=197.9

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCC-CCcceEEeeeecCCceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRH-RNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  367 (580)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....   ......+..|.+++..+.| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999865 57899999996542   2344567789999999976 45888999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999886544 5889999999999999999999   99999999999999999999999999999874322111


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||..|+|||++.+..++.++||||+||++|||+||+.||.....     .....        .+...     
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~--------~i~~~-----  216 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQ--------SIMEH-----  216 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH--------HHHcC-----
Confidence              22345689999999999998999999999999999999999999865211     01000        01100     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                         ....+...+.++.+++.+||..||++|++.     +++.+|
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               111223456778999999999999999976     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-39  Score=333.20  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=200.7

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999865 68899999986431   2234567789999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999988654  4788999999999999999999   999999999999999999999999999999865322


Q ss_pred             CCcccccccccCCCcCCcccccCC----CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      .. .......||+.|+|||.+...    .++.++||||+||++|||++|+.||.....     ...        ...+.+
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~--------~~~i~~  261 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGT--------YSKIMD  261 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHH--------HHHHHh
Confidence            21 122345699999999988653    378899999999999999999999865211     110        111111


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~  566 (580)
                      ...    ....+.....+..+.+++.+|+..+|.+  ||+++|+++|
T Consensus       262 ~~~----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKN----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCc----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            110    0011112235677889999999865544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=321.73  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=201.0

Q ss_pred             cCCCcCceeccccCceEEEEEeCC---------------CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD---------------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIIS  355 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~  355 (580)
                      ++|++.+.||+|+||.||++....               ...||+|.+..... .....+..|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999987532               23489999865422 33457889999999999999999999


Q ss_pred             eeecCCceeeEeeccCCCChHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEE
Q 038098          356 SCSSDDFKALVLEYMPHGSLEKCLYSSN-----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL  424 (580)
Q Consensus       356 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nil  424 (580)
                      ++...+..++||||+++++|.+++....           ..+++..++.++.|++.|++|||   +.+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432           24688999999999999999999   999999999999999


Q ss_pred             eCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh--CCCCCCccccCCc
Q 038098          425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEIFFGDM  502 (580)
Q Consensus       425 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt--g~~p~~~~~~~~~  502 (580)
                      ++.++.+||+|||++................++..|+|||....+.++.++|||||||++|||++  |..||.....  .
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence            99999999999999986543322222233345778999999988899999999999999999998  5566654211  1


Q ss_pred             hHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          503 TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      .......        +..+.....   .....+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       240 ~~~~~~~--------~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTG--------EFFRNQGRQ---IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHH--------Hhhhhcccc---ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111000        000000000   001112235678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-39  Score=327.83  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=202.8

Q ss_pred             cCCCcCceeccccCceEEEEEe------CCCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecC-Cc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSD-DF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  362 (580)
                      ++|++.+.||+|+||.||+|.+      .+++.||||++..... .....+..|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5688999999999999999973      3478899999965432 3345688899999999 689999999988654 46


Q ss_pred             eeeEeeccCCCChHHHhhcCC-----------------------------------------------------------
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-----------------------------------------------------------  383 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  383 (580)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986432                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccccc
Q 038098          384 -------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  456 (580)
Q Consensus       384 -------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  456 (580)
                             ..+++..+..++.||++|++|||   +.+|+||||||+||++++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   23678888999999999999999   99999999999999999999999999999986533322222223345


Q ss_pred             CCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       457 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||....... ...            ..+....      ....+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~------------~~~~~~~------~~~~~  304 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC------------RRLKEGT------RMRAP  304 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHH------------HHHhccC------CCCCC
Confidence            678999999988899999999999999999997 888886521110 000            0000000      11112


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      ...+.++.+++.+||+.+|++||++.|++++|+.+.+
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2345678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-39  Score=335.27  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=197.7

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ......+..|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999864 68899999986542   2334678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC-
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ-  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  447 (580)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999887654 5888999999999999999999   99999999999999999999999999999753321000 


Q ss_pred             --------------------------------------------cccccccccCCCcCCcccccCCCCCCchhhHhHHHH
Q 038098          448 --------------------------------------------SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM  483 (580)
Q Consensus       448 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvi  483 (580)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC---H
Q 038098          484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN---A  560 (580)
Q Consensus       484 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~  560 (580)
                      +|||++|+.||......    ..         ...+...    ............++++.+++.+|+ .+|++|++   +
T Consensus       238 l~elltG~~Pf~~~~~~----~~---------~~~i~~~----~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPL----ET---------QMKVINW----QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHH----HH---------HHHHHcc----CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            99999999999652110    00         0011100    000011112234567788888876 59999997   8


Q ss_pred             HHHHHH
Q 038098          561 KEIVTR  566 (580)
Q Consensus       561 ~ev~~~  566 (580)
                      .|+++|
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.4e-39  Score=311.84  Aligned_cols=247  Identities=28%  Similarity=0.432  Sum_probs=200.2

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChH
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE  376 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  376 (580)
                      ++||+|+||.||+|...+++.||+|++..... .....+..|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999865432 23456888999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccccc
Q 038098          377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  456 (580)
Q Consensus       377 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  456 (580)
                      +++......+++..++.++.|++.|+.|+|   +.+++||||+|+||+++.++.++++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            998876667899999999999999999999   99999999999999999999999999999875422211 11122234


Q ss_pred             CCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       457 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      +..|+|||++.++.++.++||||||+++||+++ |..||......  ....            .+...      .+...+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~------------~~~~~------~~~~~~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QARE------------QVEKG------YRMSCP  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH------------HHHcC------CCCCCC
Confidence            667999999988899999999999999999999 99998643111  0000            00000      011122


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.5e-39  Score=312.98  Aligned_cols=248  Identities=24%  Similarity=0.420  Sum_probs=198.1

Q ss_pred             eeccccCceEEEEEeC---CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCC
Q 038098          299 LIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+..|+.++++++||||+++++++. .+..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999754   355799999865433 23466889999999999999999999886 456799999999999


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc-cccc
Q 038098          375 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQTQ  453 (580)
Q Consensus       375 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~  453 (580)
                      |.+++......+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999876677999999999999999999999   8999999999999999999999999999997553322211 1122


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ..++..|+|||.+....++.++|||||||++||+++ |..||......  .....            +...      ...
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~------------~~~~------~~~  217 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSF------------IEQG------KRL  217 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH------------HHCC------CCC
Confidence            234578999999988889999999999999999996 99998653111  11111            1100      011


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ..+..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            22345678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.9e-39  Score=320.51  Aligned_cols=261  Identities=26%  Similarity=0.409  Sum_probs=205.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCC-----------------CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD-----------------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKI  353 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~  353 (580)
                      .+|++.+.||+|+||.||+|....                 +..||+|.+..... ...+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            568889999999999999987542                 24589999865432 345678899999999999999999


Q ss_pred             EeeeecCCceeeEeeccCCCChHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCE
Q 038098          354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV  423 (580)
Q Consensus       354 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Ni  423 (580)
                      ++++...+..++|+||+++++|.+++....          ..+++..++.++.|++.|++|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence            999999999999999999999999987544          26899999999999999999999   89999999999999


Q ss_pred             EeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh--CCCCCCccccCC
Q 038098          424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEIFFGD  501 (580)
Q Consensus       424 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt--g~~p~~~~~~~~  501 (580)
                      +++.++.++|+|||+++...............++..|+|||.+..+.++.++|||||||++|||++  |..||....  .
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--~  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--D  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--h
Confidence            999999999999999986544333223334456788999999988899999999999999999998  667765421  1


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      .............           .........+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       240 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRD-----------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhcccc-----------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1111111110000           0000011122345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.8e-39  Score=316.80  Aligned_cols=255  Identities=24%  Similarity=0.446  Sum_probs=205.0

Q ss_pred             CCCcCceeccccCceEEEEEeC-CC---CEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DG---MEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .|...+.||+|+||.||+|... ++   ..||+|++.... ......+..|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4777899999999999999865 33   359999986542 334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++......+++.+++.++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999999999876667899999999999999999999   89999999999999999999999999999876543222


Q ss_pred             cccccccc---cCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          448 SLTQTQTL---ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       448 ~~~~~~~~---~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ........   .+..|+|||.+....++.++|||||||++|||++ |..||.....  .....++..             
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~-------------  226 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQ-------------  226 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHc-------------
Confidence            11111111   2457999999998999999999999999999987 9999864211  111111110             


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                           ......+..++..+.+++.+||+.+|++||+++++++.|+++
T Consensus       227 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 -----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 001122245667889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-39  Score=327.78  Aligned_cols=242  Identities=22%  Similarity=0.287  Sum_probs=195.5

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999865 58899999987542   23345567788888866 799999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++...+ .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99998887554 5899999999999999999999   99999999999999999999999999999875422221  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||.+.+..++.++||||+||++|||++|+.||.....     ......        +...        ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~--------i~~~--------~~  213 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFES--------ILHD--------DV  213 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHH--------HHcC--------CC
Confidence            45689999999999888999999999999999999999999975311     111111        1100        01


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRI-------NAKEIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~ev~~~  566 (580)
                      ..+..++.++.+++.+|++.||++||       +++++++|
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11223457789999999999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=329.74  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=211.1

Q ss_pred             cCceeccccCceEEEEEeC--CCC--EEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          296 ENNLIGRGGFGSVYKARIQ--DGM--EVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ..++||+|.||.|++|.|.  +|+  .||||.+..... ....+|.+|+.+|.+++|||++++||.+.+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4578999999999999876  354  489999976543 367899999999999999999999999987 6778999999


Q ss_pred             CCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc-
Q 038098          371 PHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-  448 (580)
Q Consensus       371 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  448 (580)
                      +.|+|.+.++. .+..+-......++.|||.||.||.   .+++||||+.++|+++-....+||+|||+.+.+...... 
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999988 4567888889999999999999999   999999999999999999999999999999987654433 


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......-+..|+|||.+...+++.+||||+|||++|||+| |..||-+..              ...+.+.+|      
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------------g~qIL~~iD------  329 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------------GIQILKNID------  329 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------------HHHHHHhcc------
Confidence            33345556788999999999999999999999999999999 777875521              112334444      


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                      ..+++..+..|+.+|++++++||...|++||++..+.+.+-.
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            234566778899999999999999999999999999855543

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-39  Score=318.12  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+..|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456688999999999999865 5788999998655445567788899999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      ++|..++.....++++..+..++.|+++||.|||   +.+++||||+|+||+++.++.++|+|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999988776667999999999999999999999   9999999999999999999999999999987543221  1223


Q ss_pred             ccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          453 QTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      ...++..|+|||++.     +..++.++|||||||++|||++|++||...... .........                 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~-----------------  223 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS-----------------  223 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhhc-----------------
Confidence            346888999999873     345788999999999999999999998652110 001111000                 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......+..++.++.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111223456778999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.8e-39  Score=313.51  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            46788899999999999999988888999999865432 34578899999999999999999998854 56789999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +++|.+++.... ..+++.+++.++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++..+...... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence            999999987643 45899999999999999999999   899999999999999999999999999999865332211 1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......  ....+            +...      
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~------------~~~~------  219 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ------------VERG------  219 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HHcC------
Confidence            222345678999999988889999999999999999999 88888652110  11111            0000      


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                      ...+.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0111233456789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-39  Score=325.53  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=196.2

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999997542   23345667788888887 699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++...+ .+++..+..++.||+.||.|||   +.+++||||||+||++++++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99999887553 5899999999999999999999   99999999999999999999999999999874322211  122


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||.....     ......        +...        ..
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~--------i~~~--------~~  213 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQS--------ILED--------EV  213 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHH--------HHcC--------CC
Confidence            34689999999999999999999999999999999999999865211     111111        1000        01


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                      ..+..++.++.+++.+||+.||.+||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1123456778999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.8e-39  Score=318.02  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=203.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +.|++.+.||+|+||.||+|... +++.||+|.+..........+..|+++++.++|||++++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45888899999999999999865 58999999987665556677888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|..++......+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++......  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence            999999888766667999999999999999999999   999999999999999999999999999998753221  112


Q ss_pred             ccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          451 QTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.||..... ......+            ..    
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~------------~~----  229 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKI------------AK----  229 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHH------------hc----
Confidence            23345788999999874     34568899999999999999999999854211 0001110            00    


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ........+..++.++.+++.+||+.+|++||+++|++++
T Consensus       230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         230 -SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0001111223455678999999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-39  Score=312.29  Aligned_cols=248  Identities=30%  Similarity=0.526  Sum_probs=205.5

Q ss_pred             ceeccccCceEEEEEeCC----CCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQD----GMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|....    +..||+|++...... ....+..|+++++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998653    788999998755433 367888999999999999999999999999999999999999


Q ss_pred             CChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          373 GSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       373 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ++|.+++...        ...+++..++.++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        467999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |..||.....     .....        .+.+  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~--------~~~~--  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLE--------YLRK--  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH--------HHHc--
Confidence            432233344557889999999988889999999999999999999 6899876311     11111        0111  


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                           ......+..++.++.+++.+||+.+|++||++.|++++|+
T Consensus       223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 1112233455788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8e-39  Score=316.17  Aligned_cols=269  Identities=23%  Similarity=0.394  Sum_probs=205.6

Q ss_pred             CCCcCceeccccCceEEEEEe-----CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--Ccee
Q 038098          293 GFSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKA  364 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  364 (580)
                      -|...+.||+|+||.||.+..     .++..||+|.+.... ......+..|++++++++|||++++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            367789999999999999974     357889999986442 33456788999999999999999999998765  5678


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999776667899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc-chhhhcch
Q 038098          445 EDQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI-SVMEIVDA  522 (580)
Q Consensus       445 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~  522 (580)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||+|++.|+......   ..........+ .....+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHHH
Confidence            32211 112344677899999998888999999999999999999988765331100   00000000000 00000000


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      . .  ...+.+.+..++..+.+++.+||+.+|++||+++++++.++++
T Consensus       239 ~-~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 L-E--EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             H-H--cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0 0  0011222345678899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.9e-39  Score=314.39  Aligned_cols=256  Identities=24%  Similarity=0.459  Sum_probs=206.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC---EEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM---EVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +.|+..+.||+|+||.||+|..+ +++   .+|+|.+.... ......+..|++++++++|+|++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999865 333   69999886542 23356788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.++++|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             Ccc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          447 QSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       447 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ... .......+..|+|||.+....++.++|||||||++|||++ |+.||.....     ..+...         +....
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~---------i~~~~  227 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKA---------INDGF  227 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHH---------HhcCC
Confidence            111 1112223457999999988889999999999999999998 9999854211     111111         10000


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                            ..+....++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  1112234567889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-39  Score=324.73  Aligned_cols=242  Identities=21%  Similarity=0.289  Sum_probs=192.8

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|..+ +|+.||+|+++...   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 68899999997542   23345566778887754 899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            9999988764 35899999999999999999999   9999999999999999999999999999987432111  1233


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||++.+..++.++||||+||++|||++|+.||.....     ......         +..   .    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~---------~~~---~----~~  213 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFES---------IRV---D----TP  213 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH---------HHh---C----CC
Confidence            45689999999999999999999999999999999999999865211     111110         000   0    00


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAK-EIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ev~~~  566 (580)
                      ..+..++.++.+++.+||+.||++||++. ++.+|
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            11223566788999999999999999985 56543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.6e-39  Score=311.51  Aligned_cols=247  Identities=23%  Similarity=0.389  Sum_probs=197.6

Q ss_pred             eeccccCceEEEEEeC---CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          299 LIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      .||+|+||.||+|.++   ++..+|+|+++....  ...+.+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999653   578899999864432  23567888999999999999999999886 45678999999999


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc-ccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQT  452 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  452 (580)
                      +|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987544 5899999999999999999999   9999999999999999999999999999998664332211 112


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ...++..|+|||.+....++.++|||||||++|||++ |+.||......  ...+            .+....      .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~------------~i~~~~------~  216 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ------------MIESGE------R  216 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHCCC------C
Confidence            2234578999999988889999999999999999998 99998653111  1111            111110      1


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ...+..++.++.+++.+||+.||++||++++|++.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            122345678899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.9e-39  Score=312.25  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=203.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|.+.+.||+|+||.||+|...+...||+|.+.... ...+.+..|++++++++||||+++++.+.+ +..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            4688899999999999999988766789999986432 234578899999999999999999998754 56789999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +|+|.+++.... ..+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||.++.+...... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence            999999997643 45799999999999999999999   999999999999999999999999999999865433221 1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||...++.++.++||||||+++|||+| |..||......     ....        .+ ...      
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~--------~~-~~~------  219 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD--------QV-ERG------  219 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHH--------HH-hcC------
Confidence            223346678999999988899999999999999999999 88887653111     0000        00 000      


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ........++..+.+++.+|++.+|++||+++++++.|++.
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            01112234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=311.51  Aligned_cols=254  Identities=27%  Similarity=0.375  Sum_probs=207.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|...+.||.|+||.||+|... +++.+|+|++..........+..|++++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            56888899999999999999864 57889999997665556678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence            999999998876567999999999999999999999   8999999999999999999999999999997653221  12


Q ss_pred             ccccccCCCcCCcccccCC---CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          451 QTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .....++..|+|||.+...   .++.++||||||+++|||+||+.||........ ......            ..   .
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~------------~~---~  221 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISK------------SN---F  221 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh------------cc---C
Confidence            2334678889999998776   889999999999999999999999865321100 000000            00   0


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...........+.++.+++.+||..+|++||++++++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            001111233456779999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-39  Score=330.74  Aligned_cols=258  Identities=23%  Similarity=0.287  Sum_probs=202.6

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      +....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3345578999999999999999999865 68899999986431   2233557789999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999999988654  4788889999999999999999   999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccCCCcCCcccccCC----CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ..... .......||+.|+|||++...    .++.++||||+||++|||++|+.||.....     ....        ..
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~--------~~  258 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY--------SK  258 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHH--------HH
Confidence            33221 122345699999999988653    378999999999999999999999865211     1111        11


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTRL  567 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~L  567 (580)
                      +...    .....+......+..+.+++.+|+..++.+  ||+++|+++|.
T Consensus       259 i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         259 IMNH----KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHcC----CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1110    000111222346677899999999844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-39  Score=316.52  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+..|+.++..++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            56888899999999999999754      24679999986442 233456788999999999999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          365 LVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                      +||||+++|+|.+++....         ..+++..++.++.|++.|+.|||   +.+++|+||||+||++++++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999986532         24788999999999999999999   99999999999999999999999999


Q ss_pred             ccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhccc
Q 038098          436 FGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ||+++...............++..|+|||.+..+.++.++|||||||++||++| |..||.....  .....+..     
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~-----  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVI-----  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHh-----
Confidence            999986544332222233456788999999988889999999999999999998 8888854211  11111110     


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                            +.       .....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ------~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ------DG-------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ------cC-------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                  00       011223345778999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.9e-39  Score=314.15  Aligned_cols=256  Identities=24%  Similarity=0.430  Sum_probs=205.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-C---CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-D---GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .+|.+.+.||+|+||.||+|... +   +..+|+|.++... ......+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999753 2   3379999886442 23356788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++......+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999877667899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             Cccc-ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          447 QSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       447 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .... .....++..|+|||.+.+..++.++||||||+++||+++ |..||.....  ........           +.  
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~-----------~~--  225 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIE-----------EG--  225 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHh-----------CC--
Confidence            2111 112223567999999998899999999999999999887 9999865211  01111111           00  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                           ...+.+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 -----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 01112234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.1e-39  Score=326.10  Aligned_cols=247  Identities=21%  Similarity=0.273  Sum_probs=197.4

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      +|...+.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 57899999987542   22334566688888777 5899999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999999886554 5899999999999999999999   99999999999999999999999999999975422221


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     .....        .+.+.     
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~--------~i~~~-----  216 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ--------SIMEH-----  216 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHH--------HHHhC-----
Confidence              22345689999999999999999999999999999999999999875211     11111        01110     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                         ....+...+.++.+++.+|++.||++|++.     .++.+|
T Consensus       217 ---~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         217 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence               011223456778999999999999999984     666544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.5e-39  Score=319.04  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=204.4

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+..........+..|+.+++.++|+|++++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4688889999999999999985 468999999987665555677889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999988643  4789999999999999999999   99999999999999999999999999999875532221  1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||.....    ...+....        ..      ...
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~~--------~~------~~~  234 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIA--------TN------GTP  234 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHHh--------cC------CCC
Confidence            2234688899999999888899999999999999999999999865321    11111100        00      000


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+...+..+.+++.+||..+|++||++.|++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            111123455678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.8e-39  Score=312.12  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             cCCCcCceeccccCceEEEEEeCC-CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|+..+.||+|+||.||+|...+ ++.||+|.+.....  .+.+..|++++++++||||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            568888999999999999998764 88999999865432  678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...+..+++..+..++.|+++|+.|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            999999999877778999999999999999999999   89999999999999999999999999999986533221  2


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......    ..          ..+..    ....
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~----------~~~~~----~~~~  217 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AI----------FMIPN----KPPP  217 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hh----------hhhcc----CCCC
Confidence            233457889999999988899999999999999999999999986531110    00          00000    0011


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+...+.++.+++.+||+.+|++||++.|++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            122233456778999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.7e-39  Score=313.77  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|.. .+++.+|||.+....   ......+..|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999985 478999999875432   233467888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++++|.+++..   ....+++..++.++.||+.|++|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998764   2346899999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|..||......   ...+....     ...     
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-----~~~-----  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-----EQC-----  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh-----hcC-----
Confidence            221  122345888999999998888999999999999999999999998542111   11111100     000     


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                        ..  .......++.++.+++.+||..+|++|||+.+|++.++++.
T Consensus       224 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 --DY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --CC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              00  00011245678999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.7e-39  Score=320.63  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=203.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCE--EEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGME--VAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|++.+.||+|+||.||+|.++ ++..  +|+|.+.... ......+..|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56888899999999999999864 4544  5777765332 23345788899999999 899999999999999999999


Q ss_pred             eeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          367 LEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      |||+++|+|.+++...+               ..+++.+++.++.||+.|++|||   +.+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999987543               25789999999999999999999   9999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  510 (580)
                      ||+|||++.....   ........++..|+|||.+....++.++|||||||++|||+| |..||.....     .+....
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK  235 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHHHHH
Confidence            9999999863211   111112234667999999988889999999999999999998 9999854211     111110


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                               +...      .....+..++.++.+++.+||+.+|++||++++++.+|+++...-.
T Consensus       236 ---------~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         236 ---------LPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ---------HhcC------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                     0000      0111122356678999999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-39  Score=323.59  Aligned_cols=241  Identities=23%  Similarity=0.328  Sum_probs=192.4

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +++.||+|++....   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999865 57899999997542   23345566788888764 899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|.+++... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            9999988754 35899999999999999999999   99999999999999999999999999999875322111  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||++.+..++.++||||+||++|||++|+.||.....     ......         +..   ..    .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~---------i~~---~~----~  213 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQS---------IRM---DN----P  213 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH---------HHh---CC----C
Confidence            45689999999999988999999999999999999999999865211     111110         000   00    0


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAK-EIVT  565 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ev~~  565 (580)
                      ..+...+.++.+++.+||+.||++||++. ++.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            11123456788999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=318.49  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=206.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|++.+.||.|+||.||+|... +++.||+|++........+.+..|++++++++||||+++++.+......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45788899999999999999865 68999999997665555677889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...+..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~  159 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QK  159 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cc
Confidence            999999998877777999999999999999999999   9999999999999999999999999999987543221  12


Q ss_pred             ccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          451 QTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .....++..|+|||.+.     ...++.++||||||+++|||++|+.||...... .....+            .     
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~------------~-----  221 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKI------------L-----  221 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHH------------h-----
Confidence            23345888999999874     344678999999999999999999998653110 001111            0     


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .........+..++.++.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00011122233456778999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-38  Score=312.48  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=208.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|... +|+.||+|.+...   .......+..|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999876 7999999988532   2233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++..   ....+++..++.++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998864   2356899999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ...  ......++..|+|||.+.+..++.++|||||||++|||++|+.||....   .....+...         +..  
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~---------~~~--  222 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK---------IEK--  222 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh---------hhc--
Confidence            221  1223457889999999988889999999999999999999999985421   111111111         000  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                       .... . ......+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       223 -~~~~-~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 -CDYP-P-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -CCCC-C-CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             0000 0 001245667899999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.2e-39  Score=314.09  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=207.1

Q ss_pred             cCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|...+.||+|+||.||+|.+.+    ...||+|...... ....+.+..|+.++++++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998543    2468999886554 3345678899999999999999999999875 457899


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++......+++..++.++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      . .......++..|+|||.+....++.++||||||+++||+++ |..||......  ....+..                
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~----------------  222 (270)
T cd05056         162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIE----------------  222 (270)
T ss_pred             c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH----------------
Confidence            1 11222334568999999988889999999999999999996 99998653211  1111110                


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                        ...+...+..++..+.+++.+|+..+|++||++.++++.|++++++
T Consensus       223 --~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         223 --NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              0011122345677899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.5e-39  Score=317.94  Aligned_cols=259  Identities=23%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+..|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567899999999999999999643      24579999875432 2233467789999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEE
Q 038098          363 KALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  433 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl  433 (580)
                      .++||||+++|+|.+++....         ...++..+..++.|++.|+.|||   +++|+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986532         34567788999999999999999   999999999999999999999999


Q ss_pred             ccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhc
Q 038098          434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       434 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.....     .++...  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~--  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKF--  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH--
Confidence            99999986543332222223345678999999988899999999999999999999 7888754211     111111  


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                            +.+..       ....+..++..+.+++.+|++.||++||++.++++.|++..
T Consensus       234 ------~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 ------VMDGG-------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ------HHcCC-------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                  11110       01112345678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.6e-39  Score=321.37  Aligned_cols=261  Identities=26%  Similarity=0.428  Sum_probs=206.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD  361 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  361 (580)
                      ++|.+.+.||+|+||.||+|...        ....+|+|.+.... ......+..|+++++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46788899999999999999742        24569999886432 23456788899999999 6999999999999989


Q ss_pred             ceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ..++||||+++|+|.+++....               ..+++.++..++.||+.|+.|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999986532               35889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~  505 (580)
                      .++.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.....     .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~  243 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-----E  243 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----H
Confidence            999999999999986543222211222234567999999988889999999999999999999 8888754211     1


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ...         +.+...      .....+..++.++.+++.+||+.+|++||++.|+++.|+++.....
T Consensus       244 ~~~---------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         244 ELF---------KLLREG------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             HHH---------HHHHcC------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            111         011000      0111234556788999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.5e-39  Score=314.08  Aligned_cols=256  Identities=26%  Similarity=0.365  Sum_probs=203.7

Q ss_pred             HHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          288 FQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       288 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ..+++.+.....||+|+||.||+|... ++..||+|.+..........+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666779999999999999854 6788999998766555667889999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~a~~~~  443 (580)
                      +||+++++|.+++......+  ++..+..++.||+.|++|||   +.+|+||||||+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999998654445  88899999999999999999   999999999999999976 6799999999987653


Q ss_pred             CCCCcccccccccCCCcCCcccccCCC--CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ....  ......++..|+|||.+....  ++.++||||||+++|||++|+.||......  ....|...           
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~--~~~~~~~~-----------  225 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP--QAAMFKVG-----------  225 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh--hhhHhhhh-----------
Confidence            2221  122345788999999886543  789999999999999999999998652111  11111000           


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ...   .....+..++.++.+++.+||+.+|++||++.|++.|
T Consensus       226 --~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 --MFK---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --hhc---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              000   0111223456778999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6e-39  Score=312.94  Aligned_cols=239  Identities=22%  Similarity=0.362  Sum_probs=190.5

Q ss_pred             ceeccccCceEEEEEeCC-------------CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          298 NLIGRGGFGSVYKARIQD-------------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      +.||+|+||.||+|.+.+             ...||+|++..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997532             2258899876554445567888999999999999999999999988999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc-------EEEcccc
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-------AHLSDFG  437 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-------~kl~Dfg  437 (580)
                      +||||+++|+|..++......+++..+++++.||++|++|||   +.+|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998876677999999999999999999999   999999999999999987664       8999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCccccc-CCCCCCchhhHhHHHHHHHHH-hCCCCCCccccCCchHHHHHHhhcccc
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETF-TRKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+  ...         
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~---------  220 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KER---------  220 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHH---------
Confidence            98754221      2345788899999886 466899999999999999998 5888865421100  000         


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                         .....        .........++.+++.+||+.||++||++.+++++|
T Consensus       221 ---~~~~~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         221 ---FYEGQ--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---HHhcC--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence               00000        001112346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-38  Score=310.35  Aligned_cols=249  Identities=26%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|...+.||+|++|.||+|..+ +++.|++|.+...  .......+..|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999865 6899999998643  233456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++... ...+++..++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998775 457899999999999999999999   89999999999999999999999999999886643322 


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......++..|+|||+..+..++.++|||||||++|||++|+.||.....  ......           +..    ...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~-----------~~~----~~~  218 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILK-----------IIR----GVF  218 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-----------HHc----CCC
Confidence             22334578899999999998999999999999999999999999865321  111110           000    000


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ...+..++..+.+++.+||+.+|++||++.+++++
T Consensus       219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               01112456778999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.3e-39  Score=314.30  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 689999999864321   2234456699999999999999999999999999999999999999


Q ss_pred             HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccc
Q 038098          376 EKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  454 (580)
Q Consensus       376 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  454 (580)
                      .+++.... ..+++..+..++.||+.|++|||   +.+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98876543 46899999999999999999999   9999999999999999999999999999987653221   22334


Q ss_pred             ccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccch
Q 038098          455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT  534 (580)
Q Consensus       455 ~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  534 (580)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||..... ..........        .......       ..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-~~~~~~~~~~--------~~~~~~~-------~~  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-KVAKEELKRR--------TLEDEVK-------FE  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHHH--------hhccccc-------cc
Confidence            688999999999888899999999999999999999999864211 1111111111        0100000       01


Q ss_pred             hhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       535 ~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ....+.++.+++.+||+.||++||+++|+++.+
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            123567789999999999999999997765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=311.79  Aligned_cols=252  Identities=26%  Similarity=0.364  Sum_probs=203.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-----chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-----RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|...+.||+|++|.||+|... +++.||+|.+.....     .....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56888999999999999999854 689999999864321     223567889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+||+++++|.+++...+ .+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887544 5889999999999999999999   999999999999999999999999999998755322


Q ss_pred             CCccc-ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....    .....         .....  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~---------~~~~~--  222 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIF---------KIATQ--  222 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHH---------HHhcc--
Confidence            11111 1234577889999999998899999999999999999999999864211    10000         00000  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ......+..++.++.+++.+||..+|.+||++.|++++
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 ----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                00112234466778999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=310.38  Aligned_cols=249  Identities=29%  Similarity=0.473  Sum_probs=205.7

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|...+.||.|+||.||+|... |+.||+|.+..... ..+++..|+.++++++|+||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            56888899999999999999876 78999999975543 45778899999999999999999999998999999999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.++.......   
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            999999987654 36899999999999999999999   99999999999999999999999999999986522111   


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                        ....+..|+|||.+..+.++.++||||||+++|||++ |..||.....  .....            .+...      
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~------------~~~~~------  215 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVP------------HVEKG------  215 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH------------HHhcC------
Confidence              2335667999999988899999999999999999998 9999864211  01111            11000      


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      .....+..++.++.+++.+||..+|++||++.|+++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            01112234567899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.3e-39  Score=311.48  Aligned_cols=252  Identities=22%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|++.+.||+|+||.||+|..++++.||+|.+.... .....+..|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            5688899999999999999998889999999986443 23467889999999999999999999874 456899999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence            999999886543 56899999999999999999999   99999999999999999999999999999976542221 11


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||.+..+.++.++||||||+++|||++ |+.||.....  .......            ...      
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~------------~~~------  219 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNL------------ERG------  219 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH------------HcC------
Confidence            223345678999999988889999999999999999999 9999865321  1111111            000      


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                      .....+...+.++.+++.+|++.+|++||+++++...|+.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0111223356779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.3e-39  Score=329.68  Aligned_cols=266  Identities=25%  Similarity=0.309  Sum_probs=199.0

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-----cee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-----FKA  364 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  364 (580)
                      +|+..+.||+|+||.||+|... +|+.||+|++....  ......+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999864 78999999985432  223467888999999999999999999998766     789


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +|+||+. ++|.+++... ..+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 5888877543 46899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc--------
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS--------  515 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  515 (580)
                      .. ........++..|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ .+.. +.......        
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~-i~~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDL-ITDLLGTPSLEAMRSA  232 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHcCCCCHHHHHHh
Confidence            22 2223344678899999988764 47899999999999999999999997532110 0111 10000000        


Q ss_pred             ---hhhhcchhccCCc--ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 ---VMEIVDANLLSQK--DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ---~~~~~d~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....+........  ..........+.++.+|+.+|++.||++|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               0000000000000  00011122346778999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=321.19  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=212.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  365 (580)
                      ...|...+.||+|.||.||+++.+ +|+.+|+|++.....   .....+.+|+.+|+++. |||||.+.+.+++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999866 599999999976543   24468999999999998 9999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC----CCcEEEccccCccc
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD----NMVAHLSDFGMAKP  441 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~a~~  441 (580)
                      |||++.||.|.+.+...  .+++..+..++.||+.|+.|||   +.||+|||+||+|+|+..    ++.+|++|||+|..
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999998776  3999999999999999999999   999999999999999963    35799999999997


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ...   .......+||+.|+|||.+....++..+||||+||++|.|++|.+||.+.......             ..+..
T Consensus       189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------------~~i~~  252 (382)
T KOG0032|consen  189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------------LAILR  252 (382)
T ss_pred             ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------------HHHHc
Confidence            744   33456778999999999999999999999999999999999999998763211110             01111


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....-....+...+..+.+++.+|+..||.+|++++++++|
T Consensus       253 ----~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  253 ----GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                11122233456678889999999999999999999999997

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8e-39  Score=318.10  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=202.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-----------------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-----------------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKI  353 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  353 (580)
                      ++|++.+.||+|+||.||++...                 ++..||+|++.... ......+..|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                 23468999986543 2334678899999999999999999


Q ss_pred             EeeeecCCceeeEeeccCCCChHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCE
Q 038098          354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV  423 (580)
Q Consensus       354 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Ni  423 (580)
                      ++++...+..++||||+++|+|.+++....          ..+++.+++.++.|++.|++|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987543          24678899999999999999999   99999999999999


Q ss_pred             EeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh--CCCCCCccccCC
Q 038098          424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEIFFGD  501 (580)
Q Consensus       424 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt--g~~p~~~~~~~~  501 (580)
                      +++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence            999999999999999986543322222223345678999998888889999999999999999998  6677754211  


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                         .++...     ..+.......   ......+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       240 ---~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 ---EQVIEN-----TGEFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHH-----HHHHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               111110     0000000000   00111223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-38  Score=318.18  Aligned_cols=267  Identities=21%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+..|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999865 68899999986442 23335677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++ ++|.+++......+++..+..++.||+.||+|||   +.+++|+||||+||++++++.++|+|||++........  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 5999988877677899999999999999999999   99999999999999999999999999999975432221  


Q ss_pred             cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc----chhhhcchhc
Q 038098          450 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI----SVMEIVDANL  524 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~~  524 (580)
                      ......++..|+|||.+.+ ..++.++||||+||++|||+||++||......  ............    ....+.+...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcccc
Confidence            1223457889999998765 35788999999999999999999998653211  111111111110    0111111100


Q ss_pred             cCCcc-cc------cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKD-EH------FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~-~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..... +.      ......++.++.+|+.+|++.||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000 00      01123456788999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.3e-39  Score=317.63  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=204.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .++|+..+.||+|+||.||+|...      ++..||+|++..... .....+..|+.+++++.||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            356888999999999999999853      467899999865432 3346788899999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCC
Q 038098          364 ALVLEYMPHGSLEKCLYSSN---------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  422 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N  422 (580)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||+|||   ..+++||||+|+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999986422                     24788899999999999999999   8999999999999


Q ss_pred             EEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCC
Q 038098          423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGD  501 (580)
Q Consensus       423 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~  501 (580)
                      |++++++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||....   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999876533322222223345677999999988899999999999999999998 888875421   


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                        ..++...        +.+...       ...+..++.++.+++.+||+.+|++||++.|+++.|++
T Consensus       238 --~~~~~~~--------~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 --HEEVIYY--------VRDGNV-------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHHHHHH--------HhcCCC-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              1111111        111100       11123456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.2e-39  Score=323.89  Aligned_cols=237  Identities=28%  Similarity=0.340  Sum_probs=189.1

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHH-HHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECD-MIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999865 68999999996432   122334445544 46788999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            9999988754 35899999999999999999999   9999999999999999999999999999987532221  1233


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....     ..+....        +...    .    .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~--------i~~~----~----~  213 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDN--------ILNK----P----L  213 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHH--------HHcC----C----C
Confidence            4568999999999999899999999999999999999999986521     1111111        1110    0    1


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAK  561 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  561 (580)
                      ..+...+..+.+++.+|++.||++||+++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11233467789999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=309.15  Aligned_cols=248  Identities=30%  Similarity=0.473  Sum_probs=201.2

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChH
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE  376 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  376 (580)
                      ++||+|+||.||+|...+++.||+|.+...... ....+..|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999777999999998654333 4567889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccccc
Q 038098          377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  456 (580)
Q Consensus       377 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  456 (580)
                      +++......+++..++.++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||++.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776667899999999999999999999   99999999999999999999999999999985532221111122234


Q ss_pred             CCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       457 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      +..|+|||.+.++.++.++|||||||++|||+| |..||......  ....            .+...      .....+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~------------~~~~~------~~~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRE------------RIESG------YRMPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHH------------HHhcC------CCCCCC
Confidence            567999999988899999999999999999999 78887542110  1111            11110      011122


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-38  Score=314.80  Aligned_cols=266  Identities=25%  Similarity=0.417  Sum_probs=208.9

Q ss_pred             CCCcCceeccccCceEEEEEeC-----CCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeec--CCcee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-----DGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKA  364 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  364 (580)
                      .|...+.||+|+||.||+|.+.     +++.||+|++...... ....+..|+++++.+.|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4667789999999999999853     3688999998755432 46789999999999999999999999877  55789


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999877667999999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc----chhhh
Q 038098          445 EDQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI----SVMEI  519 (580)
Q Consensus       445 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  519 (580)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+........   .+.......    .+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL---RMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc---cccccccccccHHHHHHH
Confidence            22211 11223455679999999888999999999999999999999999765322110   000000000    01111


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      +..      ..+...+..++.++.+++.+||+.+|++||++.||++.|+++
T Consensus       239 ~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKE------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHc------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111      111222345667899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-39  Score=327.49  Aligned_cols=238  Identities=26%  Similarity=0.356  Sum_probs=193.0

Q ss_pred             ceeccccCceEEEEEe----CCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          298 NLIGRGGFGSVYKARI----QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3588999999975422  233456779999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++... ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            99999988654 35899999999999999999999   9999999999999999999999999999997543221  122


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||.....     .....        .+...        .
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~--------~i~~~--------~  214 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMT--------MILKA--------K  214 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHH--------HHHcC--------C
Confidence            345689999999999888899999999999999999999999865211     11111        01100        1


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKE  562 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  562 (580)
                      ...+...+.++.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1122345677899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-38  Score=317.08  Aligned_cols=260  Identities=24%  Similarity=0.403  Sum_probs=206.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC----EEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM----EVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|+..+.||+|+||.||+|.+. +|+    .||+|.+..... .....+..|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45778899999999999999854 454    478888764432 2234678899999999999999999998754 4679


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ++||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999866433


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |+.||.....  .....+..            .. 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~------------~~-  227 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE------------KG-  227 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH------------CC-
Confidence            22222233446778999999988899999999999999999998 8899865211  11111111            00 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                           .....+..++..+.+++.+||..+|++||+++++++.|+++.....
T Consensus       228 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         228 -----ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence                 0111223455678999999999999999999999999998865543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=314.21  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=209.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC----EEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM----EVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .+|+..+.||+|+||.||+|.++ +|+    .+|+|.+..... .....+..|++++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45788899999999999999854 343    589998765432 344678889999999999999999999987 78899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++......+++..++.++.||+.|++|||   +.+++|+||+|+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999887767999999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........++..|+|||.+....++.++||||||+++||+++ |+.||+....     .++..         .+... 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~---------~~~~~-  227 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPD---------LLEKG-  227 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH---------HHhCC-
Confidence            32222222334568999999988889999999999999999999 9999865311     11111         11100 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                           .....+..++.++.+++.+||..+|.+||++.++++.|+++.+...
T Consensus       228 -----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         228 -----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence                 0112233456678999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-38  Score=345.08  Aligned_cols=260  Identities=25%  Similarity=0.320  Sum_probs=204.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.++||+|+||.||+|... +|+.||+|++.....   ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999865 689999999864322   23467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          368 EYMPHGSLEKCLYSS----------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       368 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                      ||++||+|.+++...          ....++..+++++.||++||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          134567788999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCc----------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC
Q 038098          438 MAKPLLKEDQS----------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD  501 (580)
Q Consensus       438 ~a~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~  501 (580)
                      +++........                .......||+.|+|||.+.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99865211100                01112468999999999999999999999999999999999999986521111


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-NAKEIVTRLLKIRD  572 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ev~~~L~~~~~  572 (580)
                      ....   .        ...++.       ........+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus       239 i~~~---~--------~i~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYR---D--------VILSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh---h--------hccChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0000   0        000000       0011134567788999999999999996 67777777777654

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=327.00  Aligned_cols=244  Identities=27%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             eeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChHH
Q 038098          299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEK  377 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  377 (580)
                      +||+|.||+||.|+.. +...+|||-+.....+....+..|+...++++|.|||+++|++.+++..-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6899999999999865 456799999987777777888999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEccccCccccCCCCCccccccc
Q 038098          378 CLYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQT  454 (580)
Q Consensus       378 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  454 (580)
                      .+..+-.++  .+.++-.+.+||++||.|||   ...|||||||-.|||++ -.|.+||+|||-++.+.  +-+......
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence            999887777  78888889999999999999   89999999999999995 78999999999998763  333344556


Q ss_pred             ccCCCcCCcccccCC--CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          455 LATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       455 ~~~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      -||..|||||++..|  .|+.++|||||||++-||.||++||.+......  +             .+.-..   ...+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--A-------------MFkVGm---yKvHP  798 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--A-------------MFKVGM---YKVHP  798 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--h-------------hhhhcc---eecCC
Confidence            799999999999765  588999999999999999999999976422111  1             111111   22234


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVT  565 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~  565 (580)
                      +.+.+.+.+...++.+|+.+||.+||++++++.
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            567788999999999999999999999999875

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.8e-39  Score=314.64  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=199.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecC------C
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD------D  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~  361 (580)
                      +.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4566888899999999999999865 68899999986543 3346778899999998 699999999998653      4


Q ss_pred             ceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            5789999999999999987643 56899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||.....    ...+..      
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~~------  227 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFL------  227 (272)
T ss_pred             eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHHH------
Confidence            653221  1223456889999999875     34578899999999999999999999864211    111100      


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....     . ........++.++.+++.+||+.+|++||++.|+++|
T Consensus       228 ---~~~~-----~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 ---IPRN-----P-APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---HhcC-----C-CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence               0000     0 0001112355678999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=310.62  Aligned_cols=254  Identities=26%  Similarity=0.439  Sum_probs=206.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|.+.+.||+|+||.||+|..++++.||||.+.... ...+.+..|++++++++|+|++++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            35788899999999999999998878899999986443 23467889999999999999999999999888999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++++|||+++....... .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence            9999999987654 56899999999999999999999   89999999999999999999999999999986543211 1


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||.....  ......           +. ..     
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~-----------~~-~~-----  220 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQ-----------VE-RG-----  220 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-----------HH-cC-----
Confidence            1122335568999999988889999999999999999999 9999854211  001110           00 00     


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                       .....+..++.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0111223346778999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-38  Score=309.69  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             ceeccccCceEEEEEeCC--C--CEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQD--G--MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|++++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3699999876544 556788999999999999999999999988 888999999999


Q ss_pred             CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc-c
Q 038098          373 GSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL-T  450 (580)
Q Consensus       373 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~  450 (580)
                      |+|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++..+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987765 56899999999999999999999   9999999999999999999999999999998764432211 1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.....     .+....         ++.     ..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~---------~~~-----~~  217 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKK---------IDK-----EG  217 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---------HHh-----cC
Confidence            223456788999999988899999999999999999999 9999864211     111110         000     00


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      .....+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-38  Score=316.43  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=204.9

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|+..+.||.|++|.||+|.. .+|+.||+|.+..........+..|+++++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3588889999999999999985 478999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988643  4899999999999999999999   99999999999999999999999999999876533221  1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ... ..           .     ....
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~-~~-----------~-----~~~~  233 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IA-----------T-----NGTP  233 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HH-----------h-----cCCc
Confidence            2234588899999999888899999999999999999999999865321100 000 00           0     0000


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+..++..+.+++.+||..||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            112233456778999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-38  Score=310.15  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=195.8

Q ss_pred             ceeccccCceEEEEEeC----CCCEEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeee-cCCceeeEeeccC
Q 038098          298 NLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCS-SDDFKALVLEYMP  371 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  371 (580)
                      +.||+|+||.||+|.+.    ++..||+|.+... .......+..|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2457999987533 2234567888999999999999999999765 4556789999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc--c
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS--L  449 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~  449 (580)
                      +|+|.+++.......++..+..++.|+++|++|||   +.+++||||||+||++++++.+||+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876666788889999999999999999   899999999999999999999999999999855332211  1


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCC-CCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+ +||....     .......        +..    .  
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~--------~~~----~--  218 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVY--------LLQ----G--  218 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH--------Hhc----C--
Confidence            112334567899999998889999999999999999999954 5554311     1111110        000    0  


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                       .....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             0111123345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.8e-39  Score=329.22  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=198.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||.||+|... +++.||+|++....   ......+..|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999865 68999999996432   234567788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987544 5899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCC
Q 038098          448 S---------------------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  494 (580)
Q Consensus       448 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~  494 (580)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0012346999999999999999999999999999999999999998


Q ss_pred             CccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 038098          495 DEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN---AKEIVTR  566 (580)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ev~~~  566 (580)
                      .....     .....        .+...    .....++.....+.++.+++.+|+ .||.+|++   +.|+++|
T Consensus       237 ~~~~~-----~~~~~--------~i~~~----~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETP-----QETYR--------KVMNW----KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCH-----HHHHH--------HHHcC----CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            65211     11111        11100    000001111124567888998876 49999985   6777766

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-38  Score=309.23  Aligned_cols=252  Identities=24%  Similarity=0.405  Sum_probs=202.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|.+.+.||+|++|.||+|...++..+|+|.+.... .....+..|++++++++|+|++++++++. .+..++||||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999998777789999875432 23467888999999999999999999885 456789999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +|+|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999987643 45899999999999999999999   99999999999999999999999999999976533221 12


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||...+..++.++||||||+++|||+| |+.||......  ....+....                . 
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~----------------~-  220 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERG----------------Y-  220 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC----------------C-
Confidence            223346678999999988899999999999999999999 88898653111  111111100                0 


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                       ....+...+..+.+++.+||..+|++||+++++++.|++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             011123456779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.6e-39  Score=310.44  Aligned_cols=249  Identities=21%  Similarity=0.309  Sum_probs=202.8

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +|+..+.||+|+||.||++... +++.||+|.++.. .....+.+..|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999865 6899999998643 2334567888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++... ...+++..++.++.|++.|+.|||   +.+++|+||+|+||++++++.++++|||.++.......  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988653 356899999999999999999999   99999999999999999999999999999976533221  


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....     ......        +..    ..  
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~--------~~~----~~--  216 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILK--------VCQ----GS--  216 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHH--------Hhc----CC--
Confidence            22335688899999999888899999999999999999999999865211     111110        000    00  


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ....+..++..+.+++.+||+.||++||++.|++..
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             001123345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.8e-39  Score=323.20  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 67899999997542   23345677899999888 699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++...+ .+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99998876543 5899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC-CchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG-DMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||+..... ......+....       +..     .   .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~-----~---~  219 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-------ILE-----K---P  219 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-------HHh-----C---C
Confidence            456899999999999999999999999999999999999999653211 11111111110       000     0   1


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINA------KEIVTR  566 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~ev~~~  566 (580)
                      ...+...+..+.+++.+||+.||++|+++      .++++|
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            11223456778899999999999999984      576655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=321.33  Aligned_cols=255  Identities=22%  Similarity=0.281  Sum_probs=199.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+..|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999865 6899999999642   1223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999876667899999999999999999999   99999999999999999999999999999876533221


Q ss_pred             cccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          448 SLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                       .......||+.|+|||++..     ..++.++||||+||++|||++|+.||....     ..+....        +...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-----~~~~~~~--------i~~~  223 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGK--------IMNH  223 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-----HHHHHHH--------HHcC
Confidence             12223468999999998863     457889999999999999999999986521     1111111        1100


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPE--QRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~Rps~~ev~~~  566 (580)
                      .....   ........+.++.+++.+|+..++.  .||+++++++|
T Consensus       224 ~~~~~---~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         224 KEHFQ---FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCccc---CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00000   0011123567788999998765444  38899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-38  Score=308.76  Aligned_cols=248  Identities=29%  Similarity=0.451  Sum_probs=201.1

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeee-ecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC-SSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  370 (580)
                      .+|...+.||+|+||.||+|... |..||+|.+...  ...+.+..|+.++++++|+|++++++++ ...+..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999876 788999998543  3346788999999999999999999975 4556789999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++.... ..+++..++.++.|++.|++|||   +.+++||||||+||++++++.+||+|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999987654 35899999999999999999999   9999999999999999999999999999987543221   


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                        ....++..|+|||++.+..++.++|||||||++|||++ |+.||...     .........         ...    .
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~---------~~~----~  216 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV---------EKG----Y  216 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH---------hcC----C
Confidence              12234567999999988889999999999999999998 99987542     111111110         000    0


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                        ....+..++..+.+++.+||+.+|++||+++++++.|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0112234577899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-38  Score=314.26  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |+..+.||+|+||+||+|... +++.||+|.+....   ......+..|++++++++|+|++.+.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999864 68999999986442   12234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++...+ ..+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 46999999999999999999999   9999999999999999999999999999997543221  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......|+..|+|||.+.+..++.++|+||+||++|||++|+.||...... .....+..             ..... 
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~-------------~~~~~-  220 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDR-------------RVLET-  220 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-------------hhhcc-
Confidence             123346899999999998889999999999999999999999998652110 00111111             00000 


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                        ........+.++.+++.+|++.||++||+     +.++++|
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              00112345667889999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-38  Score=324.92  Aligned_cols=264  Identities=24%  Similarity=0.265  Sum_probs=198.1

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-----
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-----  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  361 (580)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999864 6899999998643  2233466778999999999999999999886443     


Q ss_pred             -ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          362 -FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       362 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                       ..++||||+++ +|.+.+..   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             46899999976 66665542   4788999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh--hcccc---
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND--LLPIS---  515 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~---  515 (580)
                      .....   .......+|..|+|||.+.+..++.++||||+||++|||++|+.||.....    ...|..-  .....   
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH----IDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCcHH
Confidence            54221   122345689999999999999999999999999999999999999975321    1111110  00000   


Q ss_pred             --------hhhhcchhccCC------------cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          516 --------VMEIVDANLLSQ------------KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       516 --------~~~~~d~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                              ............            ...........+.++.+|+.+||+.||++|||++|+++|-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                    000000000000            0000001112356789999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.5e-39  Score=314.35  Aligned_cols=239  Identities=23%  Similarity=0.358  Sum_probs=188.9

Q ss_pred             eeccccCceEEEEEeCC-------------------------CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceE
Q 038098          299 LIGRGGFGSVYKARIQD-------------------------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI  353 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  353 (580)
                      .||+|+||.||+|.+..                         ...||+|++..........+..|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999997421                         13488998865544445678889999999999999999


Q ss_pred             EeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC----
Q 038098          354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----  429 (580)
Q Consensus       354 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----  429 (580)
                      ++++......++||||+++|+|..++......+++..+..++.||++||+|||   +.+|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998776667899999999999999999999   89999999999999997644    


Q ss_pred             ---cEEEccccCccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHH-hCCCCCCccccCCchH
Q 038098          430 ---VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETF-TRKKPTDEIFFGDMTL  504 (580)
Q Consensus       430 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~ell-tg~~p~~~~~~~~~~~  504 (580)
                         .++++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......  ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS--EK  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--HH
Confidence               4899999988643211      22347788999998865 56899999999999999995 689988653111  11


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ..+.            +...        ..+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       231 ~~~~------------~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFY------------EKKH--------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHH------------Hhcc--------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1111            1000        001112346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-38  Score=316.08  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=204.8

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+..........+..|+.+++.++|+||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5688899999999999999985 479999999997655555567888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++..  ..+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  171 (297)
T cd06656          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (297)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence            99999998864  34789999999999999999999   89999999999999999999999999999876533221  1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||............+                  .....
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~------------------~~~~~  233 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------TNGTP  233 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec------------------cCCCC
Confidence            233458889999999988889999999999999999999999986521111000000                  00001


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+...+..+.+++.+||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111223456678899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.5e-39  Score=321.85  Aligned_cols=247  Identities=21%  Similarity=0.274  Sum_probs=196.6

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  367 (580)
                      +|+..+.||+|+||.||+|... +|+.||+|++....   ......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999865 68999999987542   233456777888888885 577888999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999886544 5899999999999999999999   99999999999999999999999999999875422221


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||..|+|||++.+..++.++||||+||++|||++|+.||.....     .....        .+...     
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~--------~i~~~-----  216 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQ--------SIMEH-----  216 (323)
T ss_pred             --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH--------HHHhC-----
Confidence              22344689999999999988899999999999999999999999875311     11111        11110     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                         ....+...+.++.+++.+|++.+|++|++.     +++.+|
T Consensus       217 ---~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         217 ---NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ---CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence               011223456678899999999999999974     455544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=332.33  Aligned_cols=264  Identities=26%  Similarity=0.310  Sum_probs=193.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecC--------C
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--------D  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~  361 (580)
                      ..+|...+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            356999999999999999999864 68999999885331    2345799999999999999998876332        2


Q ss_pred             ceeeEeeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEcccc
Q 038098          362 FKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFG  437 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg  437 (580)
                      ..++||||+++ ++.+++..   ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46689999975 77776643   3456899999999999999999999   99999999999999999654 79999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc--
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI--  514 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  514 (580)
                      +|+.+....   ......||+.|+|||++.+. .++.++||||+||++|||+||.+||.+.... ..+.......-..  
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence            998653322   22345689999999987654 6899999999999999999999998653111 1111111110000  


Q ss_pred             chhhhcchhccC-------CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVDANLLS-------QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......+....       ........+...+.++.+|+.+||+.||++|||+.|+++|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000000000000       0000011123456789999999999999999999999976

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-38  Score=329.96  Aligned_cols=266  Identities=20%  Similarity=0.193  Sum_probs=200.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ..+|.+.+.||+|+||.||+|... +++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346889999999999999999865 57889999632      23467899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +. ++|.+++......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6999988776667999999999999999999999   9999999999999999999999999999998654332222


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC---C---chHHHHHHhhc------ccc-h
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG---D---MTLKHWVNDLL------PIS-V  516 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~---~---~~~~~~~~~~~------~~~-~  516 (580)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+-.....   .   ..+...+....      +.. .
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            223456999999999999999999999999999999999988764321110   0   11111111100      000 0


Q ss_pred             hhhcch---hccC---Cc--ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDA---NLLS---QK--DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~---~~~~---~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ......   ....   ..  ............++.+|+.+||+.||.+|||+.|+++|
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000000   0000   00  00000011234578899999999999999999999986

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-38  Score=308.57  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=203.9

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.+.... .....+..|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4577889999999999999988778899999886432 234578899999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +++|.+++......+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            99999999876667899999999999999999999   89999999999999999999999999999875532211 112


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....++.+|+|||.+.++.++.++||||||+++|||++ |+.||.....     .......         ....      
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~---------~~~~------  218 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETI---------NAGF------  218 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH---------hCCC------
Confidence            22335678999999988899999999999999999998 9999864211     1111110         0000      


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ....+...+.++.+++.+||+.+|++||++.|++++|
T Consensus       219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0011122457799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-38  Score=312.19  Aligned_cols=253  Identities=26%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|...+.||+|+||.||+|... +++.||+|+++.........+..|+.+++.++||||+++++++...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45777889999999999999854 68999999987665455567788999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...+ .+++.+++.++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999886544 5899999999999999999999   8999999999999999999999999999987653221  12


Q ss_pred             ccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          451 QTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .....|+..|+|||.+.   ...++.++||||+||++|||++|+.||....... .......            ....  
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~------------~~~~--  227 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTK------------SNFQ--  227 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhc------------cCCC--
Confidence            23446889999999874   4568899999999999999999999975421110 0000000            0000  


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .........++..+.+++.+|+..+|++||+++++++|
T Consensus       228 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         228 -PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence             00111112345668899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-38  Score=320.92  Aligned_cols=258  Identities=27%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD  361 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  361 (580)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.+.... ......+..|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            35888999999999999999742        12368999886432 23456788999999999 7999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ..++++||+++|+|.+++....               ..+++.+++.++.|++.|++|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999987532               34788999999999999999999   99999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~  505 (580)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...     ...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PVE  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----CHH
Confidence            999999999999986543322222222334567999999998899999999999999999999 88887542     111


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      .+....         ...      .....+..++.++.+++.+||+.+|++||++.|++++|+++..
T Consensus       244 ~~~~~~---------~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 ELFKLL---------KEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHHH---------HcC------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            111111         000      0111223456789999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-38  Score=312.17  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=199.2

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +|+..++||+|+||.||+|.. .+++.||+|++.... ......+..|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999985 478999999986542 233466888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|..+.     .+++..+..++.|++.|+.|||   +.+|+|+||||+||+++.++.++|+|||++......    .
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~  149 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I  149 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence            999997652     3688899999999999999999   999999999999999999999999999999755322    1


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch--HHHHHHhhcccchhhhcchhccCCc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT--LKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||.........  ...+..        .+.+..     
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~-----  216 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ--------CIVDED-----  216 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH--------HHhccC-----
Confidence            23346889999999999889999999999999999999999998653221111  001110        000000     


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ... ......+.++.+++.+|++.+|++||+++|++++-
T Consensus       217 ~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         217 PPV-LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             CCC-CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            000 01122456789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.3e-38  Score=315.32  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=204.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|+||.||+|... ++..+|+|.+..... .....+..|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 688899998865422 2345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++... ..+++..+..++.|+++||.|||   + .+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            9999999998765 45899999999999999999999   6 589999999999999999999999999987553221  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc-------------
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS-------------  515 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------  515 (580)
                        .....++..|+|||.+.+..++.++|||||||++|||++|+.||....  ......+........             
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCC
Confidence              233468889999999988889999999999999999999999986422  111111111100000             


Q ss_pred             --------hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          516 --------VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       516 --------~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                              ..+..+.... ...+.. ....++.++.+++.+||..+|++||+++|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVN-EPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhc-CCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                    0001111000 000000 0112566799999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=306.29  Aligned_cols=248  Identities=28%  Similarity=0.419  Sum_probs=198.6

Q ss_pred             ceeccccCceEEEEEeCC----CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQD----GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|.+..    +..+|+|.+..... ...+.+..|+++++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            468999999999997532    26899999865433 34567888999999999999999999876 4567999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc-c
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT-Q  451 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~  451 (580)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.+||+|||+++.......... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997655 6899999999999999999999   89999999999999999999999999999986643322111 1


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....  ......+....                  .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~------------------~  215 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESG------------------E  215 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcC------------------C
Confidence            11223567999999988899999999999999999998 999986531  11122221110                  0


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.5e-38  Score=309.03  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=191.8

Q ss_pred             ceeccccCceEEEEEeCC---CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          298 NLIGRGGFGSVYKARIQD---GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +.||+|+||.||+|.+.+   +..+|+|.+..... .....+..|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999997643   45799998865432 33457888999999999999999999999989999999999999


Q ss_pred             ChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          374 SLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       374 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987533    34677888899999999999999   9999999999999999999999999999997543333222


Q ss_pred             cccccccCCCcCCcccccCC-------CCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          450 TQTQTLATIGYMAPEYGREG-------QVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+  ...+.           +.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~-----------~~  224 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT-----------VR  224 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH-----------hh
Confidence            22334577889999987532       35789999999999999997 999986532111  10100           00


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ........  .......+..+.+++.+|| .+|++||+++||++.|+
T Consensus       225 ~~~~~~~~--~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         225 EQQLKLPK--PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cccCCCCC--CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000000  0111234566889999999 58999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-39  Score=313.07  Aligned_cols=253  Identities=32%  Similarity=0.470  Sum_probs=200.0

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchh--hhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAF--KSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      |+..+.||+|+||+||+++.. +++.||+|++........  .....|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999866 567899999976643222  23345999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++. ....+++..+..++.|+++||++||   +.+++|+||||+||+++.++.++|+|||.+...  ......
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             cccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence            9999999998 3345899999999999999999999   899999999999999999999999999999754  122223


Q ss_pred             ccccccCCCcCCccccc-CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|..||.....  ...........    ......       
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~----~~~~~~-------  221 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL----KRPLPS-------  221 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH----HTHHHH-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc----cccccc-------
Confidence            44566889999999998 78899999999999999999999999876410  01111111000    000000       


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ..........++.+++.+||+.||++||++.+++++
T Consensus       222 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 -SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             -HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             -cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000111223789999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-38  Score=329.20  Aligned_cols=266  Identities=22%  Similarity=0.198  Sum_probs=201.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC---CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..+|.+.+.||+|+||.||++...   +++.||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            356999999999999999999743   3578999987532     34567999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |++. ++|.+++. ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++.......
T Consensus       166 e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 58888884 3456899999999999999999999   99999999999999999999999999999986644433


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC--chHHHHHHhhc------ccc----
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD--MTLKHWVNDLL------PIS----  515 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~------~~~----  515 (580)
                      ........||..|+|||++....++.++|||||||++|||++|+.||.+.....  ..+........      +..    
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            333345679999999999998899999999999999999999999986532211  11111111000      000    


Q ss_pred             hhhhcchhccCC-c---ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 VMEIVDANLLSQ-K---DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ~~~~~d~~~~~~-~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +........... .   .+........+.++.+++.+|+..||++||++.|++.|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000 0   00000012345678899999999999999999999987

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-38  Score=309.09  Aligned_cols=248  Identities=29%  Similarity=0.480  Sum_probs=195.8

Q ss_pred             ceeccccCceEEEEEeC-CCC--EEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGM--EVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|..+ ++.  .+|+|.+.... ......+..|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999865 344  46888876432 23446788899999999 799999999999999999999999999


Q ss_pred             CChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          373 GSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       373 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                      |+|.+++...+               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               24789999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccch
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ++....   ..........+..|+|||++....++.++|||||||++|||++ |..||.....     ......      
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~------  223 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK------  223 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHH------
Confidence            986321   1111112234567999999988889999999999999999997 9999854211     111111      


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                         +...      .....+..++.++.+++.+||+.+|.+||++.|+++.|+++.
T Consensus       224 ---~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 ---LPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---HhCC------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence               0000      011122345667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.4e-39  Score=322.41  Aligned_cols=240  Identities=26%  Similarity=0.312  Sum_probs=189.2

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHH-HHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIEC-DMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 57889999986432   12223344444 356788999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|.+++...+ .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999887644 4788888899999999999999   9999999999999999999999999999997542221  1233


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......        +...        ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~--------i~~~--------~~  213 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN--------ILNK--------PL  213 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHH--------HHhC--------Cc
Confidence            45689999999999999999999999999999999999999864211     111111        1100        01


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIV  564 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~  564 (580)
                      ......+..+.+++.+|++.||.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            11234567789999999999999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-38  Score=312.83  Aligned_cols=266  Identities=26%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhc---CCCCcceEEeeeec-----CC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRI---RHRNIIKIISSCSS-----DD  361 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  361 (580)
                      +|+..+.||+|+||.||+|... +|+.||+|.+.....  .....+..|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 689999999865422  2223456677776665   69999999998754     34


Q ss_pred             ceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ..++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999975 8988886543 45899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-cc--chh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-PI--SVM  517 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~  517 (580)
                      ......   ......+|..|+|||.+.+..++.++||||+||++|||++|++||...... ..+........ +.  ...
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence            653221   123346788999999998889999999999999999999999998653111 11111111000 00  000


Q ss_pred             hhcc--hhccCC--cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVD--ANLLSQ--KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d--~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....  ......  ..........++.++.+++.+|++.||++||++.|++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000  000000  000011123456778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.6e-38  Score=308.22  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=202.3

Q ss_pred             CCCcCceeccccCceEEEEEeCCCCEEEEEEEecccc------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +|...+.||+|+||.||+|...+|+.+|+|.+.....      +....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988899999998864321      2235688899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999987544 5889999999999999999999   8999999999999999999999999999987543211


Q ss_pred             C----cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          447 Q----SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       447 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .    ........++..|+|||.+.+..++.++||||+||++|||++|+.||.....    ......         ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~---------~~~~  223 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFY---------IGAH  223 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHHH---------hhhc
Confidence            1    1112234588899999999988899999999999999999999999865211    111000         0000


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .     ......+..++.++.+++.+||+.+|++||++.|++++
T Consensus       224 ~-----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         224 R-----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             c-----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0     00001223456778999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-38  Score=313.44  Aligned_cols=250  Identities=23%  Similarity=0.332  Sum_probs=200.6

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |+..+.||+|+||.||+|... +++.||+|.+.....   .....+..|+.++++++|++++.+++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999865 689999999864421   2234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++...+ ..+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886543 46899999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......|+..|+|||.+.+..++.++||||+||++|||++|+.||....... ....+         ....+.. .   
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~---------~~~~~~~-~---  221 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV---------ERLVKEV-Q---  221 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH---------Hhhhhhh-h---
Confidence             1123468999999999998899999999999999999999999997532110 00000         0000000 0   


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                         ...+..++.++.+++.+||+.||++||+     ++|+++|
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence               0112335667899999999999999999     8899885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-38  Score=320.26  Aligned_cols=255  Identities=19%  Similarity=0.262  Sum_probs=200.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+++.+ +++.||+|++....   ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999865 57889999986421   223345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++......+++..+..++.||+.|+.|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999876667899999999999999999999   99999999999999999999999999999875532221


Q ss_pred             cccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          448 SLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....     .......        +...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~--------i~~~  223 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGK--------IMNH  223 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHH--------HhCC
Confidence             1223356999999999885     3467899999999999999999999986521     1111111        1110


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~  566 (580)
                      ....   ........++.++.+++.+|+..+|.+  |++++|+++|
T Consensus       224 ~~~~---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         224 KERF---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             Cccc---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0000   000112345678899999988665544  7899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.4e-39  Score=321.20  Aligned_cols=237  Identities=27%  Similarity=0.346  Sum_probs=187.9

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHH-HHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECD-MIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      ++||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 68899999986432   122334445544 57889999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++... ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            9999887654 45888899999999999999999   9999999999999999999999999999987532221  1223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....     .......        +...        ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~--------i~~~--------~~  213 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDN--------ILHK--------PL  213 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHH--------HhcC--------CC
Confidence            4568999999999988889999999999999999999999986521     1111111        1110        11


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAK  561 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  561 (580)
                      ..+...+.++.+++.+|++.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            12234456788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.5e-39  Score=321.65  Aligned_cols=238  Identities=26%  Similarity=0.348  Sum_probs=188.8

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHH-HHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECD-MIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999864 68999999996542   223344555554 46778999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|..++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            9999888654 46899999999999999999999   9999999999999999999999999999987432211  1223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||..|+|||.+.+..++.++|||||||++|||++|+.||....     .......        +....        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~--------~~~~~--------~  213 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDN--------ILHKP--------L  213 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHH--------HHcCC--------c
Confidence            4568999999999999999999999999999999999999986521     1111111        11100        0


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKE  562 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  562 (580)
                      ......+..+.+++.+|++.+|++||++++
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            111234567889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.5e-38  Score=308.50  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .|+..+.||.|+||.||+|... +++.||+|++.... ......+..|+.+++++.||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667789999999999999865 58899999987543 344567888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++|+|.+++...  ++++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            999999988653  5889999999999999999999   99999999999999999999999999999976533221  2


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....++..|+|||.+.+..++.++|||||||++|||+||..||.......              ....+...      .
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~~~~~~~------~  217 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------------VLFLIPKN------N  217 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------------HhhhhhcC------C
Confidence            223457888999999988889999999999999999999999986532110              00000000      0


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......++..+.+++.+||+.+|++||++++++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            112234567789999999999999999999999888

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=310.68  Aligned_cols=249  Identities=26%  Similarity=0.345  Sum_probs=203.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... ......+..|+++++.++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35778889999999999999865 68999999986543 34456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||+++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998765  6899999999999999999999   9999999999999999999999999999998764321  1


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......++..|+|||.+.+..++.++|||||||++|||+||+.||......     ....         .+.....    
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~---------~~~~~~~----  215 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLF---------LIPKNNP----  215 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHH---------HhhhcCC----
Confidence            223446788899999999888999999999999999999999998653211     0000         0000000    


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .... ...++.++.+++.+||..+|++||++++++++
T Consensus       216 ~~~~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         216 PSLE-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCCc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0000 01156678999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-38  Score=323.65  Aligned_cols=264  Identities=24%  Similarity=0.283  Sum_probs=198.4

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----  360 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  360 (580)
                      ...++|...+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999854 68899999986432  23345677899999999999999999987543     


Q ss_pred             -CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          361 -DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       361 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                       ...++||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             346899999975 67666643   4788999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH---hhc----
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN---DLL----  512 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~---~~~----  512 (580)
                      +.....   .......+|..|+|||.+.+..++.++|||||||++|||++|+.||.+...    ...|..   ...    
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~  239 (355)
T cd07874         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence            854221   222345689999999999988999999999999999999999999865321    111110   000    


Q ss_pred             ------ccchhhhcchh----------ccCC--cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          513 ------PISVMEIVDAN----------LLSQ--KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       513 ------~~~~~~~~d~~----------~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            .......++..          ....  ...........+.++.+++.+|++.||++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                  00000000000          0000  000001112235678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=303.26  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=213.7

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      |.++++||+|+||.||+|.++ +|..+|+|.+..+  .....+..|+.++++++.|++|+++|.|-....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            456789999999999999865 6999999988654  4567888999999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+..++++.++.+++++.+..+++.-++||+|||   ...-+|||||+.|||++-+|.+|++|||.|..+.+  .-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            9999999999999999999999999999999999   88889999999999999999999999999976532  222345


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||+.|||||++..-.|..++||||+|++..||..|++||...-              +..  .++-  +...+.+.+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH--------------PMR--AIFM--IPT~PPPTF  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH--------------PMR--AIFM--IPTKPPPTF  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc--------------ccc--eeEe--ccCCCCCCC
Confidence            6789999999999999999999999999999999999999986521              110  0000  112334456


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ..++.-+.++-+++++|+-+.|++|.|+-++++|-
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            66778889999999999999999999999998874

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-38  Score=307.90  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc---------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR---------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      +|.+...||+|++|.||+|... +++.||+|.+......         ..+.+..|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 6889999988543211         23567889999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++|+||+++++|.+++... ..+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999998765 45889999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCcc----cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          443 LKEDQSL----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       443 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .......    ......++..|+|||.+.+..++.++||||+||++|||++|+.||.....    ...         +..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~---------~~~  223 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQA---------IFK  223 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHH---------HHH
Confidence            4221111    11223578899999999888899999999999999999999999865211    000         000


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +...       .....+...+..+.+++.+||+.||.+||++.|++++
T Consensus       224 ~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         224 IGEN-------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             Hhcc-------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0000       0111223456778999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-38  Score=320.06  Aligned_cols=255  Identities=19%  Similarity=0.251  Sum_probs=200.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++....   ......+..|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 68899999986431   223455778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999876667899999999999999999999   99999999999999999999999999999986543222


Q ss_pred             cccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          448 SLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                       .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||.....     .....        .+...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~--------~i~~~  223 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYG--------KIMNH  223 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHH--------HHHcC
Confidence             12233569999999998865     5678899999999999999999999864211     11111        11110


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~  566 (580)
                      ......   .......+.++.+++.+|+..++++  |++++++++|
T Consensus       224 ~~~~~~---p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         224 EERFQF---PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCcccC---CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000000   0111235677899999999876654  5688988876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.7e-38  Score=309.89  Aligned_cols=248  Identities=29%  Similarity=0.494  Sum_probs=198.0

Q ss_pred             ceeccccCceEEEEEeCC-------CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          298 NLIGRGGFGSVYKARIQD-------GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+..|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999875432 23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-----cEEEccccC
Q 038098          370 MPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-----VAHLSDFGM  438 (580)
Q Consensus       370 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg~  438 (580)
                      +++++|.+++...      ...+++.+++.++.|++.|++|||   +.+++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998753      234789999999999999999999   89999999999999999887     899999999


Q ss_pred             ccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchh
Q 038098          439 AKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM  517 (580)
Q Consensus       439 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      +................++..|+|||.+.++.++.++|||||||++|||+| |+.||.....  ......          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~----------  225 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH----------  225 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH----------
Confidence            976543322222223345778999999999999999999999999999998 9999864211  111111          


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                        ++.      ......+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus       226 --~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 --VTA------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --Hhc------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              000      0011223345678899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.1e-38  Score=304.11  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=205.2

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||.|+||.||.++. .+++.+++|.+....  ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999974 468999999986442  34456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++... ...+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998765 456899999999999999999999   89999999999999999999999999999986533321 


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.||+...     ......        .+..    ...
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~--------~~~~----~~~  218 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVV--------KIVQ----GNY  218 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHH--------HHHc----CCC
Confidence             2334568899999999988889999999999999999999999986421     111111        1111    000


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                         ......++.++.+++.+||+.+|++||+++|+++++
T Consensus       219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 ---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               111234567789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3e-38  Score=312.45  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=203.1

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeee--
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCS--  358 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--  358 (580)
                      .++.+....++|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34455567789999999999999999999864 68899999875432 2335678899999999 6999999999873  


Q ss_pred             ---cCCceeeEeeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          359 ---SDDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       359 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                         .++..++||||+++++|.+++..   ....+++..+..++.|+++|+.|||   +.+++||||||+||++++++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence               34568999999999999998753   3356889999999999999999999   99999999999999999999999


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHH
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~  507 (580)
                      |+|||+++......  .......|+..|+|||.+..     ..++.++||||+||++|||++|+.||.....    ...+
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~~~~  238 (286)
T cd06638         165 LVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----MRAL  238 (286)
T ss_pred             EccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----hHHH
Confidence            99999998653322  12233468899999998753     4578899999999999999999999865211    1111


Q ss_pred             HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       508 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ..         .. .    ........+..++..+.+++.+||+.||++||++.|++++.
T Consensus       239 ~~---------~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 FK---------IP-R----NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hh---------cc-c----cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00         00 0    00001111223456789999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-38  Score=312.27  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=201.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778899999999999999876 78999999886542 23346788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +++++|..++...  ...+++..+..++.|++.|+.|||   + .+++|+||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999988764  236899999999999999999999   5 589999999999999999999999999997553221


Q ss_pred             CcccccccccCCCcCCcccccCCC------CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQ------VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                          .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||......     .+..     ....+.
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~-----~~~~~~  223 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFA-----QLSAIV  223 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHH-----HHHHHh
Confidence                22335788899999885543      488999999999999999999998642111     0000     011111


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +..       ....+..++.++.+++.+||+.+|++||++++++.+
T Consensus       224 ~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 DGD-------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hcC-------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            110       111223467788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-38  Score=309.95  Aligned_cols=240  Identities=25%  Similarity=0.366  Sum_probs=191.1

Q ss_pred             ceeccccCceEEEEEeCC--------CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          298 NLIGRGGFGSVYKARIQD--------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +.||+|+||.||+|....        ...||+|.+........+.+..|+.+++.+.|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999997542        234888887655445556788899999999999999999999998999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc--------EEEccccCccc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--------AHLSDFGMAKP  441 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--------~kl~Dfg~a~~  441 (580)
                      +++|+|.+++...+..+++..++.++.||+.|++|||   +.+|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999877767899999999999999999999   999999999999999987765        69999999875


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCC-CCCCccccCCchHHHHHHhhcccchhhh
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRK-KPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...      .....++..|+|||.+.+. .++.++|||||||++|||++|. .|+.....     ....         ..
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~~~~---------~~  217 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----QKKL---------QF  217 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----HHHH---------HH
Confidence            422      1224577889999998764 5789999999999999999985 55433110     0000         00


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ...        +...+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       218 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YED--------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHc--------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000        01112233467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.1e-38  Score=311.19  Aligned_cols=268  Identities=26%  Similarity=0.283  Sum_probs=200.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||+|+||.||+|... +|+.||+|++.....  .....+..|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777899999999999999865 689999999864322  2235677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++ ++|.+++......+++..++.++.||++||.|||   +.+++||||+|+||+++.++.++|+|||+++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            97 5888888766667999999999999999999999   99999999999999999999999999999985532211  


Q ss_pred             cccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc------hhhhcch
Q 038098          450 TQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS------VMEIVDA  522 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~  522 (580)
                      ......++..|+|||.+.+.. ++.++|||||||++|||+||+.|+.........+...........      .....+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            123345788999999887644 689999999999999999999886432111111111100000000      0011111


Q ss_pred             hccCCccc---ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDE---HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ........   ........+.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000000   011123456788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.2e-38  Score=310.03  Aligned_cols=267  Identities=25%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||+|++|.||+|... +++.||+|.+....  ......+..|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999865 68999999986432  22346678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ++ ++|.+++....  ..+++..+..++.||++||+|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58988876533  56899999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--cc----hhhh-
Q 038098          448 SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--IS----VMEI-  519 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~----~~~~-  519 (580)
                       .......++..|+|||.+.+. .++.++|||||||++|||+||++||....... ...........  ..    .... 
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence             122334578899999987654 46889999999999999999999987532110 00000000000  00    0000 


Q ss_pred             -cchhccCCccc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 -VDANLLSQKDE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 -~d~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ........... .......++.++.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000000000 001122356788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.5e-38  Score=305.49  Aligned_cols=253  Identities=23%  Similarity=0.405  Sum_probs=204.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|...+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3568889999999999999999877888999987643 2234678889999999999999999999887 7789999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++... ...+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999998764 356889999999999999999999   89999999999999999999999999999976533221 1


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+..+.++.++|||||||++||++| |+.||....  ......+....                 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~-----------------  219 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERG-----------------  219 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCC-----------------
Confidence            2223345677999999988889999999999999999999 898986421  11111111100                 


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                       .........+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       220 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0011123455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.5e-38  Score=316.47  Aligned_cols=267  Identities=20%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             cCceeccc--cCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          296 ENNLIGRG--GFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       296 ~~~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +.++||+|  +|++||++.. .+|+.||+|+++...  ......+..|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  6789999975 478999999986542  233456778999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+......+...
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998653 345899999999999999999999   9999999999999999999999999998755432211110


Q ss_pred             -----cccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch------
Q 038098          450 -----TQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV------  516 (580)
Q Consensus       450 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  516 (580)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....+...      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchh
Confidence                 0122346778999999875  45889999999999999999999999753221111111 000000000      


Q ss_pred             -hhh--------cchhccC-----------CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 -MEI--------VDANLLS-----------QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 -~~~--------~d~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .+.        .+.....           ...........++..+.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence             000        0000000           0000001122346789999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-38  Score=321.41  Aligned_cols=264  Identities=22%  Similarity=0.238  Sum_probs=196.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ...+|.+.+.||+|+||.||+|... +++.||+|+...      .....|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999865 578899997432      233569999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      ++. ++|.+++......+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....   
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            995 5899988877778999999999999999999999   999999999999999999999999999999743221   


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCC-CccccCCc--------hHHHHHHhh--cccc--
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT-DEIFFGDM--------TLKHWVNDL--LPIS--  515 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~-~~~~~~~~--------~~~~~~~~~--~~~~--  515 (580)
                      .......||..|+|||++.+..++.++|||||||++|||+++..|+ +.......        .+.......  .+..  
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            1223456899999999999999999999999999999999966554 32111100        011111100  0000  


Q ss_pred             -------hhhhcchhcc-CCcccccc--hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 -------VMEIVDANLL-SQKDEHFT--TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 -------~~~~~d~~~~-~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                             ....++.... ......+.  .....+.++.+++.+||+.||++|||+.|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                   0000000000 00000000  012345567789999999999999999999876

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-38  Score=310.89  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=199.9

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      |+..+.||+|+||.||+|... +++.||+|.+.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            555678999999999999854 57899999986443 3345678899999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +++|.+++..  ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.++++|||++..+....  ...
T Consensus        86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~  158 (277)
T cd06642          86 GGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR  158 (277)
T ss_pred             CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence            9999998864  35899999999999999999999   8999999999999999999999999999997653321  122


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ....++..|+|||.+.+..++.++|||||||++|||+||+.|+.......  ...+            +....      .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~------------~~~~~------~  218 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFL------------IPKNS------P  218 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhh------------hhcCC------C
Confidence            23457889999999998889999999999999999999999986421110  0000            00000      0


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ......++..+.+++.+||+.+|++||++.|+++|
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            01122356678999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-37  Score=313.06  Aligned_cols=195  Identities=23%  Similarity=0.320  Sum_probs=160.1

Q ss_pred             CceeccccCceEEEEEeC---CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCceeeEeeccC
Q 038098          297 NNLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKALVLEYMP  371 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  371 (580)
                      .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46789999986432  23457789999999999999999998854  456789999986


Q ss_pred             CCChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe----CCCCcEEEccccCc
Q 038098          372 HGSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  439 (580)
Q Consensus       372 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~a  439 (580)
                      + +|.+++...        ...+++..+..++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 888876532        135889999999999999999999   9999999999999999    46679999999999


Q ss_pred             cccCCCCCc-ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCcc
Q 038098          440 KPLLKEDQS-LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEI  497 (580)
Q Consensus       440 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~  497 (580)
                      +.+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            865432211 12234568999999998876 45899999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-38  Score=318.92  Aligned_cols=268  Identities=23%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC---
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD---  360 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  360 (580)
                      .....++|...+.||+|+||.||+|.. .+++.||||++....  ......+.+|++++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            345568899999999999999999985 468899999986432  12345677899999999999999999887533   


Q ss_pred             ---CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          361 ---DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       361 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                         ...++++|++ +++|.+++..  ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence               3468999998 7799887754  35899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--c
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--I  514 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~  514 (580)
                      +++.....     .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+..+......  .
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~  237 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSP  237 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence            99865321     233468999999999876 56899999999999999999999998652111 111111110000  0


Q ss_pred             c-hhhhcch-------hccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 S-VMEIVDA-------NLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~-~~~~~d~-------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      . ...+...       .+....... ........+.+.+|+.+|++.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0 0000000       000000000 00011234567899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-37  Score=304.98  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-----GRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  363 (580)
                      .+|...+.||+|+||.||+|... +++.||+|.+....     .+....+..|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999864 68999999885432     1234567889999999999999999998865  3567


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++++||+++++|.+++.... .+++..++.++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987644 4889999999999999999999   9999999999999999999999999999997653


Q ss_pred             CCCC-cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          444 KEDQ-SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       444 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .... ........++..|+|||.+.+..++.++||||+||++|||++|+.||.....    .... .        .... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~-~--------~~~~-  223 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAI-F--------KIAT-  223 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHH-H--------HHhc-
Confidence            2211 1112234578899999999888899999999999999999999999865211    1110 0        0000 


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ...  ....+......+.+++ +||..+|++||+++||++|
T Consensus       224 ---~~~--~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         224 ---QPT--NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---CCC--CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence               000  1111233456677777 7888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=308.49  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=210.7

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .-|...+.||+|.|++|-.|++ -+|+.||||++++..-  -....+..|++.|+-++|||||++|+.......+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4477788999999999999984 4899999999976532  334677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe-CCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      .=++|+|.+|+-....-+.+.-+.+++.||+.|+.|+|   +..||||||||+||.+ ..-|-||++|||++..+.+.  
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence            99999999999888878999999999999999999999   9999999999999987 46789999999999876433  


Q ss_pred             cccccccccCCCcCCcccccCCCCC-CchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVS-TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       ......+|...|.|||++.+..|. +++||||+|||||-|++|++||......+ +            +..+.|     
T Consensus       173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-T------------LTmImD-----  233 (864)
T KOG4717|consen  173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-T------------LTMIMD-----  233 (864)
T ss_pred             -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-h------------hhhhhc-----
Confidence             234567899999999999998875 67899999999999999999997642211 1            112222     


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         =.+..+...+.+..+||..|+..||.+|.+.+||+.+
T Consensus       234 ---CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 ---CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               1445667788999999999999999999999999764

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.4e-38  Score=304.86  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=203.6

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||+|+||.+|++... +|+.||+|.+....  ......+..|++++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999854 68999999986432  23446788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++.... ..+++.+++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887643 45899999999999999999999   89999999999999999999999999999976533221 


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......++..|+|||...+..++.++|||||||++|||++|+.||....     ....+            +.......
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~------------~~~~~~~~  218 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLV------------LKIIRGSY  218 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHH------------HHHhcCCC
Confidence             1223457888999999988889999999999999999999999986421     11111            11111111


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ...+...+.++.+++.+||+.+|++||++.||++|
T Consensus       219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               11223456779999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-37  Score=308.28  Aligned_cols=267  Identities=25%  Similarity=0.305  Sum_probs=201.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|+||.||+|..+ +|+.||+|++....  ....+.+..|++++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999876 68999999986432  2233567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|..++.. ...+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            9999888876654 345899999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH---hhcccchhhhcchhc
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN---DLLPISVMEIVDANL  524 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~~  524 (580)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+ ....+..   ...+ ...+..+...
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~  232 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIP-RHQQIFSTNQ  232 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh-HHhhhccccc
Confidence             1223457888999998865 457899999999999999999999997532211 1111111   0000 0011111100


Q ss_pred             c------CCccccc---chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 L------SQKDEHF---TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~------~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .      .......   ......+..+.+++.+||+.+|++||++.|++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0      0000000   0112346778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-37  Score=303.38  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec-CCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  368 (580)
                      +|+..+.||+|++|.||++... +++.||+|.+....  ....+.+..|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999865 57899999986442  2344668889999999999999999998764 445789999


Q ss_pred             ccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+++++|.+++... ...+++.+++.++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999998764 346899999999999999999999   99999999999999999999999999999986533221


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||+...     ...+....        .....   
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~--------~~~~~---  219 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRI--------IEGKL---  219 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHH--------HhcCC---
Confidence              2233457889999999999999999999999999999999999986421     11111110        00000   


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ...+...+.++.+++.+|++.+|++||++.+++++
T Consensus       220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                01123456778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=299.48  Aligned_cols=268  Identities=21%  Similarity=0.282  Sum_probs=226.2

Q ss_pred             HHHHHhcCCCcCceeccccCceEEEEEeCC------CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeee
Q 038098          286 EIFQATNGFSENNLIGRGGFGSVYKARIQD------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCS  358 (580)
Q Consensus       286 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~  358 (580)
                      ++.....+++...++.+|.||.||+|.|.+      .+.|.+|.++.... -+...+..|...+....|||+..+.+.+.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            444455668888889999999999997653      34577777654432 34567788999999999999999999874


Q ss_pred             -cCCceeeEeeccCCCChHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc
Q 038098          359 -SDDFKALVLEYMPHGSLEKCLYSSN-------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  430 (580)
Q Consensus       359 -~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~  430 (580)
                       +.+..+++|.++.-|+|..|+...+       +.++..+...++.|++.|++|||   +.+|||.||.++|+++|+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence             4567889999999999999998322       45777888899999999999999   999999999999999999999


Q ss_pred             EEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHH
Q 038098          431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVN  509 (580)
Q Consensus       431 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  509 (580)
                      +||+|=.+++.+.+.++.........+..||+||.+....++.++|||||||++|||+| |+.|+.+....         
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---------  505 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---------  505 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---------
Confidence            99999999999999999888888999999999999999999999999999999999999 89997653111         


Q ss_pred             hhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          510 DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       510 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                           .+      .-+...+.+..+|-+|+++++.+|.-||..+|++||++++++.-|.++..++.+
T Consensus       506 -----Em------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~  561 (563)
T KOG1024|consen  506 -----EM------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR  561 (563)
T ss_pred             -----HH------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence                 11      112233456778889999999999999999999999999999999999988764

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-37  Score=302.79  Aligned_cols=250  Identities=30%  Similarity=0.557  Sum_probs=202.1

Q ss_pred             CCcCceeccccCceEEEEEeCC-----CCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          294 FSENNLIGRGGFGSVYKARIQD-----GMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      +++.+.||+|+||.||++...+     +..||+|++...... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3466889999999999998653     378999998655333 5678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ||+++++|.+++...... +++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998765544 899999999999999999999   9999999999999999999999999999998664432


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .... ....++..|+|||.+.+..++.++||||+|+++|||++ |..||...  ......+...           ..   
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~-----------~~---  220 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLK-----------KG---  220 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHh-----------cC---
Confidence            2211 12337789999999988889999999999999999999 78887541  1111111110           00   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                          .....+..++.++.+++.+|++.+|++|||+.|+++.|
T Consensus       221 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 ----YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                01112233677899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.6e-38  Score=320.22  Aligned_cols=266  Identities=23%  Similarity=0.233  Sum_probs=197.6

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC------
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD------  360 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  360 (580)
                      ..++|...+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999854 68899999986432  23346677899999999999999999987543      


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ...++||||+++ +|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77776643   4788999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--cch--
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--ISV--  516 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~--  516 (580)
                      .....   .......+|..|+|||.+.+..++.++|||||||++|||++|+.||......+ ...........  ...  
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            54221   12234568999999999999999999999999999999999999996532110 01111100000  000  


Q ss_pred             ------hhhcchh----------ccCC--cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 ------MEIVDAN----------LLSQ--KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ------~~~~d~~----------~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            .......          ....  ..............+.+++.+|++.||++|||+.|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  0000000          0000  000000111234578899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-37  Score=304.15  Aligned_cols=257  Identities=25%  Similarity=0.319  Sum_probs=205.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||.|+||+||+|... ++..+|+|++.... ......+..|++.++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 68899999986432 33557788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987642  46899999999999999999999   99999999999999999999999999999986644332


Q ss_pred             cc--cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          448 SL--TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       448 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..  ......++..|+|||.+... .++.++|||||||++|||++|+.||...... ..........         .. .
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~---------~~-~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND---------PP-S  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC---------CC-C
Confidence            21  22334588899999998776 7899999999999999999999998653211 1111111100         00 0


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..    ........+..+.+++.+||..||++||+++++++|
T Consensus       227 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 LE----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cC----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00    000113456788999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-37  Score=306.58  Aligned_cols=267  Identities=22%  Similarity=0.260  Sum_probs=204.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|.+.+.||+|++|.||+|... +|+.||+|++....  ......+..|+.++++++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999864 68999999986543  23356788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      + +++|.+++......+++.+++.++.||++||+|||   +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999998876677999999999999999999999   99999999999999999999999999999986643321 1


Q ss_pred             cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc----hhh---hcc
Q 038098          450 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS----VME---IVD  521 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~---~~d  521 (580)
                      ......++..|+|||.+.+. .++.++||||+|+++|||+||.+||.....  .....+........    ..+   ..+
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcch
Confidence            22344688899999988654 468999999999999999999888754211  11111111111000    000   000


Q ss_pred             --hhccCCc-cc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 --ANLLSQK-DE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 --~~~~~~~-~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ....... .. ......+.+.++.+++.+|++.+|++||+++++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0000000 00 001112446889999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.8e-38  Score=330.51  Aligned_cols=268  Identities=20%  Similarity=0.243  Sum_probs=193.4

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCC------CCcceEEeeeec
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH------RNIIKIISSCSS  359 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~  359 (580)
                      +....++|.+.+.||+|+||.||+|... +++.||||+++... ........|+.+++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999864 68889999986431 223455667777777754      458888888865


Q ss_pred             C-CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCC--------
Q 038098          360 D-DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNM--------  429 (580)
Q Consensus       360 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~--------  429 (580)
                      . +..++|||++ +++|.+++... ..+++..+..++.||+.||+|||   . .+|+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999988 67898888654 35899999999999999999999   7 5999999999999998765        


Q ss_pred             --------cEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC
Q 038098          430 --------VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD  501 (580)
Q Consensus       430 --------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~  501 (580)
                              .+||+|||.+....     .......||..|+|||++.+..++.++|||||||++|||++|+.||+.....+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    49999999886321     12234578999999999999999999999999999999999999997532110


Q ss_pred             chH-----------HHHHHhhcccchhhhcchhccC--Ccc---------cccchhhhhHHHHHHHHhhccCCCCCCCCC
Q 038098          502 MTL-----------KHWVNDLLPISVMEIVDANLLS--QKD---------EHFTTKGQCVSFIFNLAMKCTVESPEQRIN  559 (580)
Q Consensus       502 ~~~-----------~~~~~~~~~~~~~~~~d~~~~~--~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  559 (580)
                       .+           ..|..........+..+.....  ...         ............+.+|+.+||+.||++|||
T Consensus       353 -~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 -HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             -HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence             00           0111100000001111100000  000         000000112456789999999999999999


Q ss_pred             HHHHHHH
Q 038098          560 AKEIVTR  566 (580)
Q Consensus       560 ~~ev~~~  566 (580)
                      ++|+++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999985

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-37  Score=305.15  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=189.2

Q ss_pred             eeccccCceEEEEEeCC---CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCC
Q 038098          299 LIGRGGFGSVYKARIQD---GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      .||+|+||.||+|...+   ...+|+|.+.... ......+.+|++.++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3468888765432 2334567889999999999999999999999999999999999999


Q ss_pred             hHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          375 LEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       375 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      |.+++....    ...++..+..++.||+.|++|||   +.+|+||||||+||++++++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999987654    23467888999999999999999   99999999999999999999999999999875433322222


Q ss_pred             ccccccCCCcCCccccc-------CCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          451 QTQTLATIGYMAPEYGR-------EGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .....++..|+|||.+.       ...++.++|||||||++|||++ |..||......+ .+..            .+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~------------~~~~  225 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQ------------VVRE  225 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHH------------Hhhc
Confidence            23344677899999864       2456889999999999999999 777875421110 0111            0000


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ......  .......++..+.+++..|| .||++||+++||++.|.
T Consensus       226 ~~~~~~--~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 QDIKLP--KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCccCC--CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            000000  01112345677788999999 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.8e-38  Score=306.93  Aligned_cols=254  Identities=24%  Similarity=0.432  Sum_probs=203.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|+....||+|+||.||+|+.+      +.+.|++|.+...... ....+..|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46888899999999999999854      2467999988654333 4567899999999999999999999999989999


Q ss_pred             eEeeccCCCChHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          365 LVLEYMPHGSLEKCLYSSN--------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        25899999999999999999999   899999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccc
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....  ........      
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~------  232 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQ------  232 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHH------
Confidence            9987543221 122233456778999999988889999999999999999999 7788754211  11111110      


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                           ....      ....+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       233 -----~~~~------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 -----AGKL------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----cCCc------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 0000      01112345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=316.95  Aligned_cols=245  Identities=28%  Similarity=0.386  Sum_probs=202.8

Q ss_pred             CCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |+..+-||.|+||.||.|+. .+.+.||||.+.....   +...++..|+.++++++|||++.+-|||-.+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999984 5788999999965433   3456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      |- ||-.|++...+.++.+..+..|..+.+.||+|||   +.+.||||||+.|||+++.|.||++|||.|..+.+     
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            95 5999999888889999999999999999999999   99999999999999999999999999999986533     


Q ss_pred             cccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          450 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       ....+||+.|||||++.   .|+|+-|+||||+|++..||...++|.-.+.    .....+.      +...-.+.+  
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----AMSALYH------IAQNesPtL--  245 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYH------IAQNESPTL--  245 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----HHHHHHH------HHhcCCCCC--
Confidence             34568999999999764   5789999999999999999999999964321    0111111      111111111  


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                             ...+-++.+.+++..|+++-|.+|||.+++++|-
T Consensus       246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                   1234567899999999999999999999999874

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.1e-38  Score=312.06  Aligned_cols=246  Identities=26%  Similarity=0.336  Sum_probs=198.7

Q ss_pred             cCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCC
Q 038098          296 ENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      ....||+|+||.||++... ++..||||.+........+.+..|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            3467999999999999864 688999999876555556678899999999999999999999999999999999999999


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccc
Q 038098          375 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  454 (580)
Q Consensus       375 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  454 (580)
                      |.+++...  .+++..+..++.||+.|++|||   +.+++||||+|+||+++.++.++|+|||++........  .....
T Consensus       106 L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~  178 (292)
T cd06658         106 LTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSL  178 (292)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCcee
Confidence            99987543  4899999999999999999999   89999999999999999999999999999875532221  22334


Q ss_pred             ccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccch
Q 038098          455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT  534 (580)
Q Consensus       455 ~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  534 (580)
                      .++..|+|||...+..++.++||||||+++|||++|+.||.....    ... ...     .......        ....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~-~~~-----~~~~~~~--------~~~~  240 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQA-MRR-----IRDNLPP--------RVKD  240 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH-HHH-----HHhcCCC--------cccc
Confidence            688899999999888899999999999999999999999864211    000 000     0000000        1111


Q ss_pred             hhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       535 ~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+..+.+++.+||..||++||+++|++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            12345678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.3e-38  Score=305.68  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=204.9

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +|+..+.||+|++|.||+|..+ +++.||+|++.... ......+..|++++++++||||+++++++......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999876 68999999986553 234567888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++......+++..+..++.|+++|++|||   + .+++|+||+|+||+++.++.++|+|||.+........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            999999999876567899999999999999999999   8 9999999999999999999999999999875532211  


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.................        ..    ... 
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~----~~~-  221 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--------VN----EPP-  221 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH--------hc----CCC-
Confidence              115688899999999888999999999999999999999999865322111111111111        10    000 


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ... ....++.++.+++.+||..+|++||++.+++.+
T Consensus       222 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            000 011256778999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-38  Score=309.62  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=204.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45777889999999999999865 68899999886543 33456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++... ..+++..+..++.+++.|+.|||   + .+++||||+|+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            9999999988654 35899999999999999999999   5 589999999999999999999999999987542211  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                        .....++..|+|||.+.++.++.++|||||||++|||+||+.||+.....+..      ...+..+.+.+....... 
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~-  229 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQEP-  229 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhhcc-
Confidence              12346889999999998889999999999999999999999999753221100      000001111111111110 


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      .... ....++.++.+++.+|++.||++||++.|++++.
T Consensus       230 ~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 PPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0011 1123567789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.7e-38  Score=308.50  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=203.6

Q ss_pred             cCHHHHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeec
Q 038098          282 FTYLEIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSS  359 (580)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  359 (580)
                      .+..++....+.|+..+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            345566667788999999999999999999864 68899999986543 2345678899999998 69999999999843


Q ss_pred             ------CCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          360 ------DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       360 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                            ....+++|||+++|+|.+++.... ..+++..+..++.||++|++|||   +.+++|+||+|+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999887543 45888899999999999999999   99999999999999999999999


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHH
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~  507 (580)
                      |+|||++........  ......++..|+|||.+.     ...++.++|||||||++|||++|+.||......    .. 
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~-  234 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----RA-  234 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----hh-
Confidence            999999875432211  223346888999999875     346788999999999999999999998642110    00 


Q ss_pred             HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       508 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                              .......      .........++.++.+++.+||+.||++||++.|++++
T Consensus       235 --------~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 --------LFLIPRN------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             --------hhhHhhC------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                    0000000      00001123456789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7e-38  Score=311.15  Aligned_cols=245  Identities=24%  Similarity=0.326  Sum_probs=198.8

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ...||+|+||.||+|... +++.||+|.+..........+..|+.+++.++|||++++++++..++..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            457999999999999864 6899999998765445556788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  455 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  455 (580)
                      .+++..  ..+++..++.++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++........  ......
T Consensus       106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  178 (297)
T cd06659         106 TDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLV  178 (297)
T ss_pred             HHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccccee
Confidence            997754  34899999999999999999999   99999999999999999999999999999875532221  223356


Q ss_pred             cCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       456 ~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      ++..|+|||.+.+..++.++|||||||++|||++|+.||.....  ........            ..    ........
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~------------~~----~~~~~~~~  240 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLR------------DS----PPPKLKNA  240 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh------------cc----CCCCcccc
Confidence            88999999999888899999999999999999999999864211  01111000            00    00011112


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...+..+.+++.+||+.+|++||++++++++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            2345678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-37  Score=302.39  Aligned_cols=248  Identities=28%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-----GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+..|+++++.++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999866 78999999986432     22456788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +||+++++|.+++.... .+++..+..++.||+.|++|||   +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 5889999999999999999999   9999999999999999999999999999987653322


Q ss_pred             CcccccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                         ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||.....    .. ...        .....   
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~-~~~--------~~~~~---  217 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VA-AVF--------KIGRS---  217 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HH-HHH--------HHHhc---
Confidence               223455888999999887766 89999999999999999999999865321    00 000        00000   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ......+..++.++.+++.+||+.+|++||++.+++++
T Consensus       218 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         218 ---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence               00011123456778999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-37  Score=307.15  Aligned_cols=271  Identities=22%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999854 689999999865432 22346778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+. +++.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.+++++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6888777665556788899999999999999999   89999999999999999999999999999975432221


Q ss_pred             cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHH-HHHhhcccc-h-------h
Q 038098          448 SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH-WVNDLLPIS-V-------M  517 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~-~-------~  517 (580)
                        ......++..|+|||.+.+. .++.++|||||||++|||++|+.||+........+.. |..-..+.. .       .
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              12334578899999998754 5788999999999999999999999753221111111 110000000 0       0


Q ss_pred             hhcchhccCCcccccc---hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFT---TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ................   .....+.++.+++.+|+..||++|||++|++.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000000000000000   001124678899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.8e-37  Score=304.73  Aligned_cols=254  Identities=26%  Similarity=0.465  Sum_probs=199.0

Q ss_pred             CCcCceeccccCceEEEEEeC----CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          294 FSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      |.+.+.||+|+||.||+|.+.    +++.||||++....  ....+++..|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999753    36889999986542  234567888999999999999999999875432      


Q ss_pred             ceeeEeeccCCCChHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      ..++++||+.+|+|.+++....     ..+++..++.++.||+.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2468899999999998875322     35789999999999999999999   899999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccc
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      |+++...............++..|++||.+....++.++|||||||++|||++ |++||.....  .....+...     
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~-----  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIK-----  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHc-----
Confidence            99986543322222233445678999999988889999999999999999999 8888764211  111111110     


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                            .       .....+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       231 ------~-------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 ------G-------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------C-------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0       00111234557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-37  Score=301.37  Aligned_cols=237  Identities=23%  Similarity=0.414  Sum_probs=189.4

Q ss_pred             ceeccccCceEEEEEeCC-C----------CEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          298 NLIGRGGFGSVYKARIQD-G----------MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +.||+|+||.||+|...+ +          ..+++|++...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999998763 3          24788877544332 5788899999999999999999999987 778999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-------cEEEccccCc
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-------VAHLSDFGMA  439 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-------~~kl~Dfg~a  439 (580)
                      |||+++|+|.+++......+++..++.++.||+.||+|||   +.+++||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876667899999999999999999999   99999999999999999887       7999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCC--CCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccch
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .....      .....++..|+|||++...  .++.++|||||||++|||++ |..|+.....  .....+..       
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~-------  220 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ-------  220 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh-------
Confidence            86532      1223466789999998776  78999999999999999999 5667654211  11111111       


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                          ...       ...  ......+.+++.+||..+|++||++.|+++.|
T Consensus       221 ----~~~-------~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 ----DQH-------RLP--MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ----cCC-------CCC--CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                000       000  01126788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-37  Score=307.65  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=204.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|...+.||+|+||.||+|... +++.||+|.+........+.+..|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999854 68899999986554455577888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            999999998654  4789999999999999999999   99999999999999999999999999999875533222  2


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....++..|+|||.+....++.++|||||||++||+++|+.||........ ...            ..     .....
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~------------~~-----~~~~~  233 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL------------IA-----TNGTP  233 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee------------hh-----cCCCC
Confidence            2334588899999999888899999999999999999999999865311100 000            00     00011


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+...+..+.+++.+||..+|++||++.+++.|
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112223345678899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-38  Score=340.07  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCcee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKA  364 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  364 (580)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++....  ......+..|+.++++++||||+++++++..  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4468999999999999999999865 57789999986432  2345678889999999999999999998854  45689


Q ss_pred             eEeeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEEecCCCCCEEeCC----------
Q 038098          365 LVLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY----SVPIIHCDLKPSNVLLDD----------  427 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~----~~~i~H~dlk~~Nill~~----------  427 (580)
                      +||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    ..+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998653   246999999999999999999999321    145999999999999964          


Q ss_pred             -------CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccc
Q 038098          428 -------NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIF  498 (580)
Q Consensus       428 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~  498 (580)
                             .+.+||+|||++..+....   ......||+.|+|||++..  ..++.++|||||||++|||+||+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   3358999999998653221   1234568999999998854  458899999999999999999999986421


Q ss_pred             cCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+....         ..    ..  .. .....+.++.+||.+||+.+|.+||++.|++.+
T Consensus       248 ----~~~qli~~l---------k~----~p--~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 ----NFSQLISEL---------KR----GP--DL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             ----cHHHHHHHH---------hc----CC--CC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                111111110         00    00  00 012345678999999999999999999999864

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-37  Score=301.97  Aligned_cols=246  Identities=26%  Similarity=0.465  Sum_probs=198.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|.+.+.||+|+||.||+|.. +++.||+|.+...  .....+..|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588889999999999999975 4788999998643  2346788999999999999999999998754 4799999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +++|.+++.... ..+++..++.++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999987654 45899999999999999999999   999999999999999999999999999998754221     


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......+..|+|||.+.++.++.++|||||||++|||++ |+.||.....     ..+..         .+....     
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~---------~~~~~~-----  214 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKE---------CVEKGY-----  214 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHH---------HHhCCC-----
Confidence            112234567999999988899999999999999999998 9999865311     11111         111110     


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                       ....+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             111123456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-37  Score=303.17  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=199.5

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc----------chhhhHHHHHHHHhhcCCCCcceEEeeeecCC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG----------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD  361 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  361 (580)
                      +|...+.||.|+||.||+|... +|+.||+|.+.....          ...+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999754 689999998753211          11345778999999999999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+++++|.+++... ..+++..+..++.||+.|+.|||   +.+++||||+|+||++++++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999998765 46899999999999999999999   89999999999999999999999999999975


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCC--CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ..............++..|+|||.+....  ++.++||||+|+++||+++|..||....    ....+..         .
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~---------~  224 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFK---------L  224 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHH---------h
Confidence            53222222223345788999999887654  7899999999999999999999985421    1111110         0


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........  ......++.++.+++.+||..+|++||++++|++|
T Consensus       225 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         225 GNKRSAPPIP--PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hccccCCcCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0000000000  01123456789999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-37  Score=308.40  Aligned_cols=260  Identities=23%  Similarity=0.283  Sum_probs=202.7

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      +..++..+.++|...+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455566788999999999999999999864 68899999986432 2345677899999999 899999999998653


Q ss_pred             -----CceeeEeeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          361 -----DFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       361 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                           +..++||||+++|+|.+++..   ....+++..++.++.|++.|+.|||   +.+++||||||+||+++.++.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 357999999999999998763   3356899999999999999999999   89999999999999999999999


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccCC-----CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHH
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-----QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~  507 (580)
                      |+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.||...... ..+..+
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~  245 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKI  245 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHH
Confidence            999999886533221  12234578899999987543     3689999999999999999999998653111 111111


Q ss_pred             HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       508 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...                 .......+......+.+++.+||+.+|++||++.|+++|
T Consensus       246 ~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 PRN-----------------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             hcC-----------------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            000                 000111123345678999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.8e-37  Score=302.66  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=199.7

Q ss_pred             CCCcCceeccccCceEEEEEeCC--CCEEEEEEEeccc----------cchhhhHHHHHHHHhh-cCCCCcceEEeeeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQD--GMEVAVKVFDLQY----------GRAFKSFDIECDMIKR-IRHRNIIKIISSCSS  359 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  359 (580)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+....          ......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999998664  6889999885321          1223456678888765 799999999999999


Q ss_pred             CCceeeEeeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          360 DDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       360 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                      .+..++||||+++++|.+++..   ....+++..++.++.|++.|+.|||   . .+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3456899999999999999999999   5 6799999999999999999999999


Q ss_pred             ccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc
Q 038098          436 FGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ||.+.......   ......++..|+|||.+.++.++.++||||||+++|||++|+.||....     ......      
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~------  223 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLAT------  223 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHH------
Confidence            99998653322   2344568889999999998889999999999999999999999986421     111111      


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                        .+.+......      ....++.++.+++.+||+.||++||++.|+..+++
T Consensus       224 --~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 --KIVEAVYEPL------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --HHhhccCCcC------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              1111100000      01134567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.8e-37  Score=305.07  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=200.6

Q ss_pred             CCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          294 FSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      |...+.||+|++|.||+|.. .+++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44557999999999999985 46889999998655444456688899999999999999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      ++|.+++..  ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||.+........  ...
T Consensus       101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            999999876  45899999999999999999999   99999999999999999999999999998875432211  223


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||....    . ..+.....         ..    .....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~-~~~~~~~~---------~~----~~~~~  235 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----P-LQAMKRIR---------DN----LPPKL  235 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----H-HHHHHHHH---------hc----CCCCC
Confidence            3458889999999988889999999999999999999999985421    1 11111100         00    00011


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....++..+.+++.+||+.+|++||++.+++++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            1122356779999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-38  Score=308.92  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=205.9

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEecc--ccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ..|++.++||+||.+.||++...+.+.||+|.+...  ..+....|..|+..|.+++ |.+||++++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            458889999999999999999888888988876432  3455678999999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |= ..+|..++.......+...+..+..|++.|+.+.|   ..||||.||||.|+|+-. |.+||+|||+|.-+..+..+
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence            86 44999999988766654488889999999999999   999999999999999954 69999999999988888778


Q ss_pred             ccccccccCCCcCCcccccCC-----------CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchh
Q 038098          449 LTQTQTLATIGYMAPEYGREG-----------QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM  517 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ......+||+.|||||.+...           ++++++||||+|||||+|+.|++||.....      .|.+      +.
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK------l~  583 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK------LH  583 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH------HH
Confidence            788888999999999987422           367899999999999999999999865211      1211      23


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+.|+......    +.... ..++.++|+.||..||.+||+..|+++|
T Consensus       584 aI~~P~~~Ief----p~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 AITDPNHEIEF----PDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             hhcCCCccccc----cCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            33343221111    11111 2238899999999999999999999976

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=305.83  Aligned_cols=269  Identities=22%  Similarity=0.281  Sum_probs=199.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+..|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67888999999999999999865 689999999864422 2234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +.+ +|.+++......+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            975 999988876667899999999999999999999   99999999999999999999999999999875422111  


Q ss_pred             cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc--ccc-hhhhcchhcc
Q 038098          450 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL--PIS-VMEIVDANLL  525 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~~d~~~~  525 (580)
                      ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.........+........  ... .....+....
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346788999998865 45789999999999999999999998653211111111111000  000 0000000000


Q ss_pred             -----CCc--ccccchhhhh--HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 -----SQK--DEHFTTKGQC--VSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 -----~~~--~~~~~~~~~~--~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ...  ..........  ..++.+++.+|++.+|++||++.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                 000  0000000111  2677899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-37  Score=300.87  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=201.4

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||+|+||.||+|... +++.+|+|.+....  ......+..|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 68899999986542  23456788899999999999999999999989999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++++ +.++++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997653 45899999999999999999999   8999999999999999854 468999999998653322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+....     ...+..        +....    
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~--------~~~~~----  217 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLK--------IMSGT----  217 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHH--------HHhcC----
Confidence              12234578899999999888899999999999999999999999865211     111110        00000    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....+..++.++.+++.+||+.+|++||++.|++++
T Consensus       218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               011122356778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.1e-37  Score=299.86  Aligned_cols=253  Identities=28%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc--hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR--AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||+|+||.||+|... +++.||+|.+......  ....+..|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999854 6899999998765443  567889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++++|.+++.... .+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987643 4789999999999999999999   9999999999999999999999999999998764433221


Q ss_pred             c--ccccccCCCcCCcccccCCC---CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          450 T--QTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       450 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .  .....++..|+|||.+....   ++.++||||||+++|||++|+.||..... ..........              
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~~~~--------------  221 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGA--------------  221 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHHHhc--------------
Confidence            1  12345788999999987766   88999999999999999999999865321 1011110000              


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ......+....++..+.+++.+||+.+|++||++.|++.+
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              0011111222346778899999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-37  Score=308.25  Aligned_cols=265  Identities=24%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++.....  ...+.+..|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999875 589999998754322  234567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|..+.... ..+++..++.++.||+.|++|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            99999998876543 34899999999999999999999   89999999999999999999999999999886533221 


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH-----hhcccchhhhcch
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN-----DLLPISVMEIVDA  522 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~d~  522 (580)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++|++||.....    ...+..     ........+..+.
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHHhcc
Confidence             2233457889999998865 4578899999999999999999999864211    111111     0000001111100


Q ss_pred             ------hccCCc---ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 ------NLLSQK---DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ------~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            ......   ..........+..+.+++.+||+.+|++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                  000000   00011123457789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.5e-37  Score=300.94  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=186.8

Q ss_pred             eeccccCceEEEEEeCCC---CEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCC
Q 038098          299 LIGRGGFGSVYKARIQDG---MEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      .||+|+||.||+|...++   ..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   345667665432 2345678899999999999999999999999999999999999999


Q ss_pred             hHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          375 LEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       375 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      |.+++....   ...++..+..++.||++||+|||   +.+++|+||||+||+++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987643   34677788899999999999999   899999999999999999999999999998643222221222


Q ss_pred             cccccCCCcCCcccccC-------CCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          452 TQTLATIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||.....     ................++ 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~-  232 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQQVKLFKP-  232 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhcccccCCC-
Confidence            34567889999998743       245789999999999999997 5667654211     111111100000011111 


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                               ......+..+.+++..|| .+|++||++++|++.|
T Consensus       233 ---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         233 ---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             ---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence                     111234567889999999 6799999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.5e-37  Score=308.79  Aligned_cols=263  Identities=21%  Similarity=0.242  Sum_probs=188.0

Q ss_pred             ceeccccCceEEEEEeC---CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeee--cCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS--SDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~  372 (580)
                      ..||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++.  .....++|+||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999865   45789999886432  2346778999999999999999999884  35577899999865


Q ss_pred             CChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe----CCCCcEEEccccCcc
Q 038098          373 GSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAK  440 (580)
Q Consensus       373 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~a~  440 (580)
                       +|.+++...        ...+++..+..++.||+.||.|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             787776422        135889999999999999999999   9999999999999999    567899999999998


Q ss_pred             ccCCCCCc-ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCC--------chHHHHHHh
Q 038098          441 PLLKEDQS-LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD--------MTLKHWVND  510 (580)
Q Consensus       441 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~--------~~~~~~~~~  510 (580)
                      ........ .......+|..|+|||.+.+ ..++.++|||||||++|||+||++||.......        ..+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            66433221 12234568899999998876 457999999999999999999999996532110        011111110


Q ss_pred             hcccc---hhhh------------cchhccCCccc--c-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          511 LLPIS---VMEI------------VDANLLSQKDE--H-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       511 ~~~~~---~~~~------------~d~~~~~~~~~--~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....   ....            ...........  . ..........+.+|+.+|++.||.+|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000   0000            00000000000  0 00011224568899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=317.91  Aligned_cols=241  Identities=25%  Similarity=0.296  Sum_probs=187.3

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc---CCCCcceEEeeeecCCceeeEeeccCC
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI---RHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      ||+|+||+||+|+.. +|+.||+|++....   .........|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 68999999986432   12233445566776655   699999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|.+++... ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.++|+|||++........  ...
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            9999988754 45899999999999999999999   99999999999999999999999999999875322211  223


Q ss_pred             ccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          453 QTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ...||..|+|||.+.+. .++.++||||+||++|||+||+.||....     ..+.....        ..    ...  .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i--------~~----~~~--~  215 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNI--------AF----GKV--R  215 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHH--------Hc----CCC--C
Confidence            45689999999988754 47899999999999999999999986521     11111110        00    000  0


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCC----CHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRI----NAKEIVTR  566 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~ev~~~  566 (580)
                      +. ....+.++.+++.+||+.||.+||    ++.++++|
T Consensus       216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            00 112456788999999999999998    56676654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.8e-37  Score=301.01  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=197.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--Cce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-----GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  363 (580)
                      ++|...+.||+|+||.||.|... +|+.||+|.+....     ......+..|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999864 68999999885321     12345778899999999999999999998663  467


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987553 4788899999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          444 KEDQS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       444 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....    ....         ....  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~---------~~~~--  222 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAI---------FKIA--  222 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHH---------HHHh--
Confidence            22111 112234588899999999888899999999999999999999999864211    0000         0000  


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ....  ....+...+..+.+++.+|+. +|++||+++|++++
T Consensus       223 --~~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         223 --TQPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --cCCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              0000  111233455678899999995 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5e-37  Score=302.17  Aligned_cols=246  Identities=27%  Similarity=0.381  Sum_probs=200.6

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      |+..+.||.|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            667789999999999999854 68899999986432 2344678889999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++..+.....  ..
T Consensus        86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06641          86 GGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence            99999988643  5899999999999999999999   99999999999999999999999999999876533221  12


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ....++..|+|||.+.+..++.++|||||||++|||++|..||.....     ..+...         +...    .  .
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~---------~~~~----~--~  218 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL---------IPKN----N--P  218 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH---------HhcC----C--C
Confidence            234578899999999888899999999999999999999999864211     111110         0000    0  0


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ......++.++.+++.+||+.+|++||+++++++|
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            01123456778899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=303.26  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCC------
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD------  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------  361 (580)
                      .+++|+..+.||+|++|.||+|... +++.+++|++..... ....+..|+++++++ .|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999875 678999999865432 346788999999999 6999999999986544      


Q ss_pred             ceeeEeeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccC
Q 038098          362 FKALVLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  438 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  438 (580)
                      ..++||||+++++|.+++...   +..+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999987653   357899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc
Q 038098          439 AKPLLKEDQSLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       439 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      +.......  .......++..|+|||.+..     ..++.++|||||||++|||++|+.||..... .....+       
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~-------  229 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MRALFK-------  229 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-HHHHHH-------
Confidence            87553221  12234458889999998753     3467899999999999999999999864211 111111       


Q ss_pred             cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           +...     .......+...+.++.+++.+||..||++|||+.|++++
T Consensus       230 -----~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 -----IPRN-----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -----hhcc-----CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                 1000     001112223356788999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.4e-37  Score=305.36  Aligned_cols=267  Identities=24%  Similarity=0.293  Sum_probs=200.7

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc-----hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR-----AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +|...+.||+|++|.||+|... +|+.||+|.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999865 6899999998654322     234567899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+ +|+|.+++......+++..++.++.||++||.|||   +.+++|+||+|+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999766557999999999999999999999   9999999999999999999999999999998664332


Q ss_pred             CcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc---hh---hh
Q 038098          447 QSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS---VM---EI  519 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~  519 (580)
                      .  ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+...........   ..   ..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence            1  1223346778999998754 45789999999999999999998887642211 11111111100000   00   00


Q ss_pred             cchhccC--CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLS--QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+.....  ............+.++.+++.+||+.+|++||+++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000  0000011123346788999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4e-37  Score=304.41  Aligned_cols=253  Identities=28%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++.|+..+.+|+|++|.||+|..+ +++.||+|++..... ....+..|++++++++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566888889999999999999876 689999999975533 45678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876657999999999999999999999   89999999999999999999999999999875532221 


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+.            ..     .
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~------------~~-----~  232 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLIT------------TK-----G  232 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH------------hc-----C
Confidence             122334778899999998888999999999999999999999998642110 0001100            00     0


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .........++.++.+++.+||+.+|.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            00111223356779999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-37  Score=307.08  Aligned_cols=254  Identities=22%  Similarity=0.279  Sum_probs=198.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||++... +++.||+|.+....   ......+..|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999865 57899999986542   223456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++++|.+++...+ .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999987654 5899999999999999999999   89999999999999999999999999999863211000


Q ss_pred             -------------cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          448 -------------SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       448 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                                   ........++..|+|||.+....++.++|||||||++|||++|..||.+..     ...+....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~~~---  228 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQV---  228 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH---
Confidence                         001112357788999999988889999999999999999999999986421     11111110   


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                           ......     .......++.++.+++.+||+.+|++||++.++.+.|
T Consensus       229 -----~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         229 -----ISDDIE-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             -----HhcccC-----CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence                 000000     0001123567789999999999999999854444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=303.09  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=199.7

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcC---CCCcceEEeeeecCCceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR---HRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.... ......+..|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999986 478999999986542 334567888999999997   999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++++|.+++...  .+++..++.++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999988653  6899999999999999999999   9999999999999999999999999999998764433 


Q ss_pred             cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||+....     ..+...         +...   
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~---------~~~~---  217 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML---------IPKS---  217 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc---------cccC---
Confidence             122344688899999988654 468999999999999999999999865311     111100         0000   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ..... .....+.++.+++.+||+.||++||++.|++++
T Consensus       218 -~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 -KPPRL-EDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -CCCCC-CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence             00000 011255678999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.4e-37  Score=296.28  Aligned_cols=250  Identities=30%  Similarity=0.414  Sum_probs=205.6

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      +|+..+.||+|++|.||++... +++.+++|++..........+..|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999875 689999999976544466788999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +++|.+++......+++..+..++.|++.|+.|||   ..+++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999998876567999999999999999999999   89999999999999999999999999999986643321   2


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ....++..|+|||.+....++.++||||||+++|+|++|+.||.....     ......        ...     .....
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~--------~~~-----~~~~~  216 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFK--------IAT-----NGPPG  216 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHH--------HHh-----cCCCC
Confidence            344688899999999888899999999999999999999999865211     000000        000     00001


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ......++..+.+++.+||+.||++||++.|+++|
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11122235678999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.9e-37  Score=298.57  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  367 (580)
                      +|+..+.||.|+||.||+|... +|+.||+|++....  ....+.+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999854 68899999986432  2334668889999999999999999998753  45678999


Q ss_pred             eccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          368 EYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY--SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       368 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      ||+++++|.+++...   ..++++..++.++.||+.|++|||..+  +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998654   457899999999999999999999554  678999999999999999999999999999866


Q ss_pred             CCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .....  ......++..|+|||.+....++.++||||||+++|+|++|+.||....     ...+...         +..
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~---------~~~  224 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK---------IKE  224 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH---------Hhc
Confidence            43221  1233468899999999998889999999999999999999999987532     1111111         000


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..      ....+...+.++.+++.+|++.+|++||++++|+++
T Consensus       225 ~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 GK------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CC------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            00      011223456788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-37  Score=305.47  Aligned_cols=245  Identities=25%  Similarity=0.299  Sum_probs=202.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||.||+|... +++.||+|++....   ......+..|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999865 68999999986432   234567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999998765 46899999999999999999999   899999999999999999999999999999865332  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.....    ...         ...+...     
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---------~~~~~~~-----  213 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQI---------YEKILEG-----  213 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHH---------HHHHhcC-----
Confidence               2334588999999999888889999999999999999999999865221    000         0011100     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                         ....+...+..+.+++.+||..+|++||     +++|+++|
T Consensus       214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence               1112233467789999999999999999     78888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=301.40  Aligned_cols=256  Identities=25%  Similarity=0.299  Sum_probs=201.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeec--CCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  367 (580)
                      ++|...+.||.|++|.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++..  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35778899999999999999864 688999999865432 345678899999999999999999998854  34689999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++++|.+++..   ....+++..+..++.||+.|++|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999987653   3356889999999999999999999   99999999999999999999999999999875432


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCcccc---CCchHHHHHHhhcccchhhhcc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFF---GDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ..    .....++..|+|||.+.+..++.++||||+||++|||++|+.||+....   .......|......        
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  225 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--------  225 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--------
Confidence            21    1234578889999999888999999999999999999999999976421   11112222111100        


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....    ........+.++.+++.+||+.+|++|||+.|++++
T Consensus       226 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         226 PELKD----EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hhhcc----CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00000    001112245678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.2e-37  Score=306.12  Aligned_cols=247  Identities=27%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..|+..+.||+|+||.||+|... +|+.||+|.+....   .+....+..|+++++.++|||++++++++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999865 68999999985432   223456888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+. |++.+++......+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 5888877665667999999999999999999999   999999999999999999999999999998754222  


Q ss_pred             cccccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          448 SLTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                          ....++..|+|||.+.   .+.++.++||||||+++|||+||+.||......    . ...        .+...  
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~-~~~--------~~~~~--  229 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----S-ALY--------HIAQN--  229 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----H-HHH--------HHhcC--
Confidence                2235788899999874   456889999999999999999999998542110    0 000        00000  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                         .. .......++..+.+++.+||+.+|++||++.+++.+.
T Consensus       230 ---~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         230 ---DS-PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             ---CC-CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence               00 0011123566789999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.3e-37  Score=303.07  Aligned_cols=250  Identities=26%  Similarity=0.338  Sum_probs=193.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHH-HhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDM-IKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|+||.||+|... +|+.||+|+++... ......+..|+.. ++..+||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999865 69999999986543 2233455556665 566689999999999999999999999


Q ss_pred             ccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          369 YMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       369 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      |++ |+|.+++..   ....+++..++.++.||+.|++|||   +. +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 588887654   2356899999999999999999999   76 899999999999999999999999999986532


Q ss_pred             CCCcccccccccCCCcCCcccccC----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGRE----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ..   ......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||.........+..            ..
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------~~  221 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ------------VV  221 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH------------HH
Confidence            21   1223457888999998764    44688999999999999999999998642111011111            11


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....     ... ....++.++.+++.+||..+|++||++++++++
T Consensus       222 ~~~~-----~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         222 EEPS-----PQL-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             hcCC-----CCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1000     000 012346778999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=330.23  Aligned_cols=259  Identities=29%  Similarity=0.454  Sum_probs=213.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC----C----CCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----D----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD  361 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  361 (580)
                      ++..+.+.+|+|.||.|++|...    .    ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            34455669999999999999732    1    3469999986543 34567899999999999 5999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ..++|+||+..|+|.+++...+               ..++....+.++.|||.|++||+   +.+++|||+.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999998877               45899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccc-cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQ-TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      ++..+||+|||+|+.....+..... ....-+..|||||.+....++.|||||||||++|||+| |..||.+.. ....+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEEL  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHH
Confidence            9999999999999976554443322 11114667999999999999999999999999999999 888875521 01111


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      .++                  ...+.+...|..|+.+++++|+.||+.+|++||++.++++.++....
T Consensus       532 ~~~------------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  532 LEF------------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHH------------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            111                  12234556778899999999999999999999999999999998544

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.3e-37  Score=303.24  Aligned_cols=267  Identities=25%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||.|++|.||+|+.. +|+.||||.+....  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999865 68999999886442  22335788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +. ++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 58988886543 56899999999999999999999   89999999999999999999999999999875532211 


Q ss_pred             ccccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc-c-h----hhhcc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI-S-V----MEIVD  521 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-~----~~~~d  521 (580)
                       ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||...... ....+........ . .    ....+
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             122334678899999876644 588999999999999999999998653211 1111111110000 0 0    00000


Q ss_pred             h--hccC-CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 A--NLLS-QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~--~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .  .... ............+.++.+++.+||+.||++||+++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0  0000 0000001112345678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.3e-37  Score=299.52  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=201.8

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +|+..+.||+|++|.||+|.. .+++.||+|++.....      .....+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 5789999999864321      134678889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLK  444 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  444 (580)
                      |+||+++++|.+++...+ ++++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++ .++|+|||++..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987544 6899999999999999999999   99999999999999998775 699999999986643


Q ss_pred             CCCc--ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          445 EDQS--LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       445 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ....  .......++..|+|||.+.+..++.++||||+|+++|||++|+.||.......  .......        ... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~--------~~~-  225 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFK--------IAS-  225 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHH--------Hhc-
Confidence            3211  11123457889999999988889999999999999999999999986421111  0111000        000 


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         .  ......+...+.++.+++.+|+..+|++||++.|++++
T Consensus       226 ---~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         226 ---A--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ---c--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence               0  00111223456778999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.6e-37  Score=298.61  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=206.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|++|.||+|... +++.||+|++..... .....+..|++++++++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999866 599999999865543 4457888999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++++|.+++... ..+++..++.++.|+++|++|||   + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999998765 46899999999999999999999   8 99999999999999999999999999999866432221


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                        .....++..|+|||.+.+..++.++||||||+++|||+||+.||......  ...+...        .+.....    
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~--------~~~~~~~----  220 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQ--------AICDGPP----  220 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHH--------HHhcCCC----
Confidence              12345788999999999889999999999999999999999998764320  1111111        1110000    


Q ss_pred             ccccchhhh-hHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQ-CVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ...... ++..+.+++.+||..+|++||++.|++++
T Consensus       221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               011122 56789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-37  Score=302.27  Aligned_cols=248  Identities=24%  Similarity=0.313  Sum_probs=203.1

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +|+..+.||.|+||.||+|... +++.||+|++....   ....+.+..|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999865 68999999996542   2345778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|.+++... .++++..+..++.||++|+.|||   +.+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998765 56899999999999999999999   8999999999999999999999999999988653322  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  .......         ....      
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~---------~~~~------  216 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA---------KQET------  216 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH---------Hhcc------
Confidence             223345788899999998888999999999999999999999998753211  1111111         0000      


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINA--KEIVT  565 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~ev~~  565 (580)
                       .....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0112223456788999999999999999999  77654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.1e-37  Score=305.29  Aligned_cols=268  Identities=26%  Similarity=0.276  Sum_probs=199.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecC--Cceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  365 (580)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.....  .....+.+|++++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999865 689999999864422  2233456799999999999999999998654  56899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+.+ +|.+++......+++..+..++.||+.|++|||   +.+++||||+|+||+++.++.+||+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999965 898888776677999999999999999999999   999999999999999999999999999999866433


Q ss_pred             CCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc----
Q 038098          446 DQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV----  520 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  520 (580)
                      ..  ......++..|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+.... ...........    
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~  237 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLII-QLLGTPNESIWPGFS  237 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HhcCCCChhhchhhh
Confidence            21  1223345778999998865 45789999999999999999999998653211 1111111 11000000000    


Q ss_pred             ch---hcc--C-Ccccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DA---NLL--S-QKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~---~~~--~-~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.   ...  . ..... .......+.++.+++.+|++.||++||++.|++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00   000  0 00000 00112246778899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-36  Score=299.82  Aligned_cols=263  Identities=22%  Similarity=0.266  Sum_probs=196.1

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcC-CCCcceEEeeeecC--CceeeEee
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSD--DFKALVLE  368 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  368 (580)
                      |...+.||+|+||.||+|... +++.||+|++.... .........|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999854 68999999986542 222234456888898885 99999999999877  88999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |++ |++.+++......+++..++.++.|++.||+|||   +.+++||||+|+||+++. +.+||+|||+++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 5888888766667999999999999999999999   899999999999999999 9999999999986533222 


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh---cchhc
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI---VDANL  524 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~~  524 (580)
                        .....++..|+|||.+.. +.++.++||||+||++|||++|..||.....  .....+...........+   .....
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence              123457889999997644 5678999999999999999999999865311  111122221111111100   00000


Q ss_pred             cCCc------cc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQK------DE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~------~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....      .. -.......+.++.+++.+||+.+|++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000      00 000112457889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=286.90  Aligned_cols=269  Identities=23%  Similarity=0.333  Sum_probs=213.5

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecC
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSD  360 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  360 (580)
                      ++.|++..++     +.||+|+|+.|--+. +.+|.+||||++++..+....++.+|++++.+.+ |+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            4677777764     789999999999886 7789999999999888888899999999999995 99999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC---CcEEEcccc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFG  437 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg  437 (580)
                      +..|||||.|.||+|...++.... +++.++.++..+|+.||.+||   .+||.|||+||+|||....   ..+||+||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999999887664 899999999999999999999   9999999999999999644   358999999


Q ss_pred             CccccCCCC-----CcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHH
Q 038098          438 MAKPLLKED-----QSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       438 ~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~  507 (580)
                      +..-+....     .+......+|+..|||||+..     ...|..+.|.||+|||+|-|++|.+||.+.-..   -.-|
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~---dCGW  301 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA---DCGW  301 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC---cCCc
Confidence            876443221     122234556888899999652     235788999999999999999999999764221   1122


Q ss_pred             HHhhcc----cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          508 VNDLLP----ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       508 ~~~~~~----~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      -+...-    +.+.+-+....+..++   ..+...+.+..+++...+..|+.+|.++.+++.|
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFPd---kdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFPD---KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCCh---hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            221111    1123333333333322   3566778899999999999999999999998873

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-37  Score=306.40  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=202.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....   .....+..|+++++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999865 589999999865432   24456888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          368 EYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ||+.+++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998754 356899999999999999999999   9999999999999999999999999999987543211


Q ss_pred             Cc---------------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCcccc
Q 038098          447 QS---------------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFF  499 (580)
Q Consensus       447 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~  499 (580)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011123578899999999888899999999999999999999999865321


Q ss_pred             CCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 038098          500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN----AKEIVTR  566 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~ev~~~  566 (580)
                      .    ..+         ..+.+...      ........+.++.+++.+||..||++||+    ++|+++|
T Consensus       238 ~----~~~---------~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 D----ETF---------SNILKKEV------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             H----HHH---------HHHhcCCc------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            1    111         11111110      11111225678999999999999999999    7777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-36  Score=295.44  Aligned_cols=250  Identities=21%  Similarity=0.233  Sum_probs=196.5

Q ss_pred             HHHHHHhcCCCcCcee--ccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          285 LEIFQATNGFSENNLI--GRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       285 ~~~~~~~~~~~~~~~l--g~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      .+.....++|.+.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +|||++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444555677777776  99999999999854 68899999986442211     122222222 699999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMA  439 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a  439 (580)
                      +..++||||+++|+|.+++.... .+++..+..++.|+++|+.|||   +.+++||||+|+||+++.++ .++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999987654 7999999999999999999999   99999999999999999988 9999999998


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ......      ....++..|+|||.+.+..++.++||||+|+++|||++|+.||............|....        
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  223 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--------  223 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------
Confidence            755322      123578899999999988899999999999999999999999975433322233332211        


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-AKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~ev~~~  566 (580)
                       .        .........+..+.+++.+||+.+|++||+ ++|+++|
T Consensus       224 -~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        224 -Q--------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -c--------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence             0        011112246677899999999999999995 6998864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.2e-37  Score=311.22  Aligned_cols=195  Identities=27%  Similarity=0.377  Sum_probs=170.2

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-C-----CCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-H-----RNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~  364 (580)
                      .+|.+.+.||+|.||.|.+|. .++++.||||+++... .-..+...|+.+|..++ |     -|+|++++++.-.++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            378889999999999999997 5579999999997553 34466778999999996 3     58999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC--CCcEEEccccCccc
Q 038098          365 LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKP  441 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~a~~  441 (580)
                      ||+|.+.. +|.+++...+ ..++...++.++.||+.||.+||   +.+|||+||||+|||+..  ...+||+|||.|+.
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999955 9999998766 46899999999999999999999   999999999999999963  44799999999996


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                      .....     ..++.+..|.|||++.+..|+.+.||||||||++||++|.+-|.+
T Consensus       341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            53222     255677889999999999999999999999999999999887755

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=300.45  Aligned_cols=266  Identities=27%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      |+..+.||.|++|.||+|... +|+.||+|++....  ......+..|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999864 79999999986543  223356788999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      + ++|.+++.... ..+++..++.++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999887654 46899999999999999999999   89999999999999999999999999999975532211  


Q ss_pred             cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-ccc--------hhhh
Q 038098          450 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-PIS--------VMEI  519 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--------~~~~  519 (580)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+........ +..        ..+.
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            11223468889999987654 4688999999999999999999998653211 11111111100 000        0000


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...................+..+.+++.+|++.||++||+++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000000011123455778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-36  Score=294.66  Aligned_cols=252  Identities=28%  Similarity=0.380  Sum_probs=206.5

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecC--CceeeEe
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKALVL  367 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  367 (580)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+..|++++++++|+||+++++++...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3677889999999999999876 789999999865532  4467888999999999999999999999888  8899999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++++|.+++.... .+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999987665 7899999999999999999999   89999999999999999999999999999986644332


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      ........++..|+|||.......+.++||||||+++|+|++|+.||....   ......         .....      
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~---------~~~~~------  218 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAAL---------YKIGS------  218 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHH---------Hhccc------
Confidence            111334568889999999988889999999999999999999999987632   000000         00000      


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......+...+..+.+++.+|++.+|++||++.|++++
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            001112233446789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=313.52  Aligned_cols=250  Identities=23%  Similarity=0.359  Sum_probs=207.9

Q ss_pred             CCcCceeccccCceEEEEEeCC-CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      |.++.-||.|+||.||+|..++ +-..|.|++.....+...++..|+++|+.+.||+||++++.|..++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4456789999999999998764 445678999888888889999999999999999999999999989999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |-.+.++-.-+..+.+.++..+++|++.||.|||   +..|+|||||+.|||++-+|.++++|||.+....  .......
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence            9999999888889999999999999999999999   9999999999999999999999999999986332  2223456


Q ss_pred             ccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          453 QTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      ..+||++|||||+.+     ...|..++||||||++|.||..+.+|......                +.-++.  +...
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----------------MRVllK--iaKS  250 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLLK--IAKS  250 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------------HHHHHH--Hhhc
Confidence            778999999999653     56789999999999999999999999654210                000010  0111


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..+.+..+..-+..+.+++.+|+.++|..||+++++++|
T Consensus       251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            112333455567788999999999999999999999976

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-36  Score=301.62  Aligned_cols=266  Identities=24%  Similarity=0.266  Sum_probs=199.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecC--CceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  366 (580)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.++....  .....+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999876 688999999864422  2234567899999999999999999998776  889999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++ +|.+++......+++..++.++.||+.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 999988776667999999999999999999999   8999999999999999999999999999998664332


Q ss_pred             CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---ccchh-----
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---PISVM-----  517 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~-----  517 (580)
                      .  ......++..|+|||.+.+. .++.++|+||+|+++|||++|++||...... ...........   +....     
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  22334578889999988654 4689999999999999999999998653111 00110000000   00000     


Q ss_pred             -----hhcchhccCCcccccchhhh-hHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 -----EIVDANLLSQKDEHFTTKGQ-CVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 -----~~~d~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ..............  .+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKK--FPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhcc--ccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                 00000000000000  1111 36778999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=302.87  Aligned_cols=268  Identities=25%  Similarity=0.310  Sum_probs=202.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...  ......+..|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999865 68899999886432  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |++++.+..+.. ....+++..+..++.||+.|+.|||   ..+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            999876665544 3455899999999999999999999   89999999999999999999999999999986644332 


Q ss_pred             ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh---cccchhhhcch--
Q 038098          449 LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL---LPISVMEIVDA--  522 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~--  522 (580)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.||......  .........   .+.........  
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCc
Confidence            122335678889999999887 8899999999999999999999998653111  100000000   00000000000  


Q ss_pred             hccC----Ccccc----cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLS----QKDEH----FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~----~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....    .....    ...+..++.++.+++++||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000    00000    00112347889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.9e-36  Score=303.90  Aligned_cols=246  Identities=28%  Similarity=0.356  Sum_probs=197.8

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |...+.||+|+||.||+|... ++..||+|.+....   .+....+..|++++++++|||++++++++..++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            666788999999999999854 68899999986432   23345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +.+ ++.+++.....++++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++.....     
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            974 888887766677999999999999999999999   99999999999999999999999999999875422     


Q ss_pred             cccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          450 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       .....++..|+|||.+.   .+.++.++|||||||++|||++|+.||..... ......+..            ...  
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~------------~~~--  241 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ------------NES--  241 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHh------------ccC--
Confidence             12345788999999873   45789999999999999999999999864210 011111111            000  


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                          ........+..+.+++.+||+.+|++||++.+++++..
T Consensus       242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                00112235567899999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.4e-37  Score=296.76  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=201.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|...+.||+|+||.||+|..+ +|..||+|.+....  ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777899999999999999865 58899999986542  23446778899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~  447 (580)
                      +++++|.+++.... ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++ .++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987644 35899999999999999999999   89999999999999999875 469999999986533221


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......|+..|+|||......++.++||||||+++|||++|+.||....     ..++.....        .....  
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~--------~~~~~--  220 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKIC--------QGYFA--  220 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHh--------cccCC--
Confidence              1223458889999999988889999999999999999999999986421     122222111        11000  


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ......+..+.+++.+||..+|++||++.|++++
T Consensus       221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 1112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=303.47  Aligned_cols=270  Identities=22%  Similarity=0.271  Sum_probs=198.4

Q ss_pred             CCCcCceeccccCceEEEEEeC---CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--Ccee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKA  364 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  364 (580)
                      +|...+.||+|+||.||+|...   +++.||+|.+....   ......+..|+.++++++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   47899999987532   33346678899999999999999999999887  7899


Q ss_pred             eEeeccCCCChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC----CCcEEEccc
Q 038098          365 LVLEYMPHGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD----NMVAHLSDF  436 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~Df  436 (580)
                      +||||+++ ++.+++....    ..+++..++.++.||+.|+.|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6766654322    36899999999999999999999   999999999999999999    999999999


Q ss_pred             cCccccCCCCC-cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCC--------chHHH
Q 038098          437 GMAKPLLKEDQ-SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD--------MTLKH  506 (580)
Q Consensus       437 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~--------~~~~~  506 (580)
                      |+++....... ........++..|+|||.+.+. .++.++|||||||++|||++|++||.......        ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543322 1122344678899999987664 57899999999999999999999997543221        01111


Q ss_pred             HHHhhccc------------chhhhcchhccCCcc-cc----cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          507 WVNDLLPI------------SVMEIVDANLLSQKD-EH----FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       507 ~~~~~~~~------------~~~~~~d~~~~~~~~-~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.......            ......+........ ..    .......+.++.+++.+|++.||++|||+.|+++|
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11100000            000000000000000 00    00011345678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=308.10  Aligned_cols=268  Identities=24%  Similarity=0.279  Sum_probs=198.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----Cce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  363 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467999999999999999999854 78999999986432 23445678899999999999999999886543     357


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++|+||+.+ +|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999965 88887754  35899999999999999999999   9999999999999999999999999999997653


Q ss_pred             CCCCc-ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc----cchh
Q 038098          444 KEDQS-LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP----ISVM  517 (580)
Q Consensus       444 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~  517 (580)
                      ..... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....  .....+......    +...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHH
Confidence            32211 11233468899999998654 5688999999999999999999999865211  111111111111    1111


Q ss_pred             hhcchhcc----CC-ccccc---chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVDANLL----SQ-KDEHF---TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~----~~-~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+.+....    .. .....   ......+.++.+++.+||+.+|++||++.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111000    00 00000   0112346778999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-36  Score=301.95  Aligned_cols=270  Identities=23%  Similarity=0.316  Sum_probs=196.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      .++|...+.||+|+||.||+|... +++.||||.+.....  .....+..|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999865 689999998864322  22345567999999999999999999886554      


Q ss_pred             --ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          362 --FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       362 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                        ..++||||+.+ +|.+++......+++.+++.++.||++|+.|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              34999999965 888888776667899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc--ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh---cc
Q 038098          440 KPLLKEDQS--LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL---LP  513 (580)
Q Consensus       440 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~  513 (580)
                      ..+......  .......++..|+|||.+.+. .++.++||||||+++|||+||+.||.....  ..........   .+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~~~~  244 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCGSIT  244 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence            865432221  112234578889999987654 468899999999999999999999865321  1111111111   00


Q ss_pred             cchh------hhcchhccCCcc-cccc---hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 ISVM------EIVDANLLSQKD-EHFT---TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~~~------~~~d~~~~~~~~-~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....      +..+........ ....   ........+.+++.+||+.||++||+++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0000      000000000000 0000   001124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=277.85  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEecc-ccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeeccC
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ-YGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ..+..||.|..|.||+++.+ +|...|||.+... ..+..+++...++++...+ +|.||+.+|||......++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34567999999999999865 6899999999655 3455678888888887775 8999999999999999999999994


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      - .++..+..-..++++..+=++...+++||.||.+  +++|+|||+||+|||+|+.|++|+||||++..+.+..   ..
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Ah  248 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AH  248 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---cc
Confidence            4 7788888777889998888999999999999996  6799999999999999999999999999998764433   23


Q ss_pred             cccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          452 TQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      +...|-+.|||||.+.-   .+|.-++||||||+.++||.||+.||......-..+            ..+++.    . 
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l------------tkvln~----e-  311 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL------------TKVLNE----E-  311 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH------------HHHHhc----C-
Confidence            44568889999998853   468889999999999999999999997632211111            122221    1 


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+.+......+..+.+++..|+.+|+.+||...++++|
T Consensus       312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            12233334478889999999999999999999999876

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-36  Score=300.92  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=197.4

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChH
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE  376 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  376 (580)
                      ..||+|+||.||+|... +|+.||+|.+..........+..|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999864 78999999986544445567888999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccccc
Q 038098          377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  456 (580)
Q Consensus       377 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  456 (580)
                      +++...  .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++........  ......+
T Consensus       106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~  178 (292)
T cd06657         106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG  178 (292)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence            987543  4799999999999999999999   89999999999999999999999999999875533221  2233458


Q ss_pred             CCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhh
Q 038098          457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG  536 (580)
Q Consensus       457 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  536 (580)
                      +..|+|||.+.+..++.++||||+|+++|||++|..||.....  ........            ....    .......
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~------------~~~~----~~~~~~~  240 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIR------------DNLP----PKLKNLH  240 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH------------hhCC----cccCCcc
Confidence            8899999999888889999999999999999999999864211  00011111            0000    0111122


Q ss_pred             hhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          537 QCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       537 ~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..+..+.+++.+||+.+|.+||++.++++|
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            345678899999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-36  Score=308.14  Aligned_cols=269  Identities=23%  Similarity=0.275  Sum_probs=200.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec----CCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  363 (580)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....  ......+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            467889999999999999999854 69999999986542  2344667789999999999999999988753    3467


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+. |+|.+++.... .+++..+..++.||++||+|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 58999886554 4899999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCCc--ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc------
Q 038098          444 KEDQS--LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI------  514 (580)
Q Consensus       444 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  514 (580)
                      .....  .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......  ............      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence            32221  11223468889999998765 46889999999999999999999999653211  111111111000      


Q ss_pred             ------chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 ------SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ------~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            .+.+..+.................+.++.+++.+||+.+|++||++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  0111111000000000001123457789999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=299.16  Aligned_cols=245  Identities=25%  Similarity=0.338  Sum_probs=202.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      +.|+.-++||+||||.||..+.+ +|+.+|.|.+.+.   ..+.......|-.++.++..+.||.+--+|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777789999999999999755 7999999988543   2234456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          368 EYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ..|+||+|.-+++..+ .-+++..++-+|.+|+.||++||   ..+||+||+||+|||+|+.|+++|+|.|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999998887766 46999999999999999999999   9999999999999999999999999999999874432


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         .....+||.+|||||++.++.|+...|.||+||++|||+.|+.||......    ..          .+-+|.....
T Consensus       342 ---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk----------~eEvdrr~~~  404 (591)
T KOG0986|consen  342 ---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VK----------REEVDRRTLE  404 (591)
T ss_pred             ---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hh----------HHHHHHHHhc
Confidence               334558999999999999999999999999999999999999998652111    11          1122322222


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCC
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN  559 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  559 (580)
                      ..   ...+...+++..+|.+..+.+||++|..
T Consensus       405 ~~---~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  405 DP---EEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ch---hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            11   1233567788899999999999999974

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-36  Score=296.14  Aligned_cols=267  Identities=23%  Similarity=0.294  Sum_probs=199.8

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +|+..+.||.|++|.||+|+.. +|+.||+|++..... .....+..|++++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999975 689999999865432 23456778999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          371 PHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       371 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      ++ +|.+++....  ..+++..+..++.|+++|+.|||   +.+++||||+|+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8988876544  46899999999999999999999   89999999999999999999999999999975532211 


Q ss_pred             ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-c-cc-hhhhcchhc
Q 038098          449 LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-P-IS-VMEIVDANL  524 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~~~~~d~~~  524 (580)
                       ......++..|+|||.+.+. .++.++||||+||++|||++|+.||...... ........... + .. ...+.+...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCch
Confidence             12234568889999987653 5688999999999999999999998753211 11111111000 0 00 000000000


Q ss_pred             cCCc------ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQK------DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....      ..........+..+.+++.+|++.||++||+++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000      00001112346778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=297.68  Aligned_cols=267  Identities=26%  Similarity=0.327  Sum_probs=199.8

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--CceeeEee
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKALVLE  368 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  368 (580)
                      |++.+.||+|++|.||+|... +|+.+|+|++....  ......+..|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999866 58899999997653  33345678899999999999999999999887  88999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++ +|.+++......+++..++.++.||++|++|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899988776567999999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc---cchhhhcc---
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP---ISVMEIVD---  521 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d---  521 (580)
                      .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+.... .............   .......+   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchh
Confidence            12233456788999997764 4578999999999999999999999865321 1111111110000   00000000   


Q ss_pred             -hhccC-Cc-cccc-chhhh-hHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 -ANLLS-QK-DEHF-TTKGQ-CVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 -~~~~~-~~-~~~~-~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ..... .. .... ..... ++.++.+++.+||+.+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             00000 00 0000 00111 36788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.1e-36  Score=296.54  Aligned_cols=244  Identities=24%  Similarity=0.312  Sum_probs=194.2

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 68999999986432   22345567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccccc
Q 038098          376 EKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  454 (580)
Q Consensus       376 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  454 (580)
                      .+++.... ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||.+.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99987654 46899999999999999999999   99999999999999999999999999999876532   1122334


Q ss_pred             ccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccch
Q 038098          455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT  534 (580)
Q Consensus       455 ~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  534 (580)
                      .++..|+|||.+.+..++.++||||+||++|+|++|+.||...... .........             ...   .....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-------------~~~---~~~~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRR-------------TLE---MAVEY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhc-------------ccc---ccccC
Confidence            5788999999998888999999999999999999999998653211 011111000             000   01112


Q ss_pred             hhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          535 KGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       535 ~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      +...+..+.+++.+||+.+|++||     ++.+++.|
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            234567789999999999999999     66667654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.7e-36  Score=305.55  Aligned_cols=270  Identities=25%  Similarity=0.304  Sum_probs=199.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecC--Cce
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD--DFK  363 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  363 (580)
                      ..++|...+.||+|+||.||+|... +|+.+|+|++...  .......+..|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999865 6889999988532  223345677899999999 999999999988643  367


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||++ ++|..++...  .+++..+..++.||+.||+|||   +.+++|+||+|+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999888654  6899999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCCCc---ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh--cc----
Q 038098          444 KEDQS---LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL--LP----  513 (580)
Q Consensus       444 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~----  513 (580)
                      .....   .......++..|+|||.+.. ..++.++||||||+++|||+||+.||......+ .........  ..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            33221   12233468889999998754 457899999999999999999999986532111 000000000  00    


Q ss_pred             -----cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 -----ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 -----~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ......++................++.++.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 00011111000000000011122357789999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.4e-36  Score=300.25  Aligned_cols=272  Identities=25%  Similarity=0.282  Sum_probs=201.5

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC----
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD----  361 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  361 (580)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++...  ......+..|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999875 58999999986542  223356778999999999999999999887654    


Q ss_pred             ------ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          362 ------FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       362 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                            ..++|+||+++ ++.+.+......+++..+..++.||+.||+|||   +.+++|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 787777766567999999999999999999999   89999999999999999999999999


Q ss_pred             ccCccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh---
Q 038098          436 FGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL---  511 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---  511 (580)
                      ||++........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||..... ...+.......   
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence            999986643321 11122346778999998764 3578999999999999999999999865211 11111111100   


Q ss_pred             cccchhhhcchhccCC-------cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQ-------KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+.....+........       ...........+..+.+++.+||+.+|++||++++++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000000000000000       000001122356789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.6e-36  Score=295.42  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=187.8

Q ss_pred             eeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHh---hcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIK---RIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      .||+|+||.||++... +++.+|+|.+.....   .....+..|..+++   ..+|||++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 689999998864321   11223344444333   3479999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++...+ .+++..+..++.|++.|++|||   +.+++|+||||+||++++++.++|+|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999887544 5899999999999999999999   9999999999999999999999999999987543221    2


Q ss_pred             cccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....|+..|+|||.+.+ ..++.++||||+||++|||++|..||........  .. ....        .    ..   .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~-~~~~--------~----~~---~  214 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRM--------T----LT---V  214 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HH-HHHH--------h----hc---C
Confidence            23468999999998864 4578999999999999999999999875322111  11 0000        0    00   0


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      ....+...+.++.+++.+|++.||++||     +++|+++|
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1112334567899999999999999999     69999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.6e-36  Score=306.51  Aligned_cols=262  Identities=24%  Similarity=0.270  Sum_probs=198.8

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----  360 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  360 (580)
                      ...++|+..+.||+|+||.||+|... +|+.||+|++...  .......+..|+.++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            35578999999999999999999854 7899999998543  223345677899999999999999999988543     


Q ss_pred             -CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          361 -DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       361 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                       ...++||||+.+ +|.+.+...   +++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             356999999964 888877543   889999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh--hc---cc
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND--LL---PI  514 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--~~---~~  514 (580)
                      +......   ......++..|+|||.+.+..++.++||||+||++|+|++|+.||.....    ...|..-  ..   +.
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~  238 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----IDQWNKIIEQLGTPSD  238 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcCCCCH
Confidence            8653221   12334578899999999999999999999999999999999999865311    1111110  00   00


Q ss_pred             chhhhcc-----------------------hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVD-----------------------ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d-----------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....++                       .......  ........+..+.+++.+||+.||++||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPD--SESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcc--cccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000                       0000000  000022346678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-36  Score=296.15  Aligned_cols=266  Identities=26%  Similarity=0.289  Sum_probs=202.6

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      |...+.||+|++|.||+|... +|+.+|+|.+.....  .....+..|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999865 689999999865432  24567888999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++ ++.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 898888776667999999999999999999999   9999999999999999999999999999998664432  12


Q ss_pred             ccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---ccchhhhcc---hh
Q 038098          451 QTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---PISVMEIVD---AN  523 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d---~~  523 (580)
                      .....++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+ .+........   +.......+   ..
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2234577889999998776 78999999999999999999999986532110 0111000000   000000000   00


Q ss_pred             ---ccCC-cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 ---LLSQ-KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ---~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         .... ..........++.++.+++.+||+.||.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               0000 000011223467889999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.8e-36  Score=290.64  Aligned_cols=249  Identities=28%  Similarity=0.384  Sum_probs=205.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|...+.||.|+||.||++... +++.||+|++.....  .....+..|++++++++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999865 689999999875533  4556788899999999999999999999988999999999


Q ss_pred             cCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +++++|.+++...   ...+++..+..++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998775   367999999999999999999999   8899999999999999999999999999998653332


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        .......++..|+|||......++.++||||+|+++|+|++|+.||+...     .......        .....   
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~--------~~~~~---  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALK--------ILKGQ---  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHH--------HhcCC---
Confidence              12233468889999999988889999999999999999999999986531     1111111        11100   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+..++..+.+++.+||..+|++||++.|++++
T Consensus       220 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                001122456778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-36  Score=298.64  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=196.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|...+.||+|+||.||+|.+. +++.||||++.... ......+..|+.++.+.. ||||+++++++.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56788899999999999999976 48999999986542 223445666777777775 9999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+. +++.+++......+++..+..++.||+.|++|||   + .+++||||+|+||++++++.++|+|||++..+.....
T Consensus        95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            985 4788877665567999999999999999999999   6 5899999999999999999999999999876533221


Q ss_pred             cccccccccCCCcCCcccccCCC----CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQ----VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                         .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.........+.            .+.+..
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~~~  235 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT------------KILQEE  235 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH------------HHhcCC
Confidence               12234778899999987553    78899999999999999999999864211100011            111111


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ..     .......++.++.+++.+||+.||++||++.+++++-
T Consensus       236 ~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         236 PP-----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            00     1111123567789999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-36  Score=299.50  Aligned_cols=252  Identities=27%  Similarity=0.348  Sum_probs=193.9

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|...+.||+|+||.||++... +++.||+|.+.... ......+..|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3455678999999999999865 68999999986442 234567888999999996 99999999999988899999999


Q ss_pred             cCCCChHHHh---hc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          370 MPHGSLEKCL---YS-SNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       370 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +.. ++.++.   .. ....+++..+..++.|++.|++|||   + .+++||||||+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 655432   22 2356899999999999999999999   5 4899999999999999999999999999976533


Q ss_pred             CCCcccccccccCCCcCCcccccCC---CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ...   .....++..|+|||.+.+.   .++.++||||+||++|||++|+.||....    ....-        ..+...
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~--------~~~~~~  225 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQ--------LTQVVK  225 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHH--------HhhhcC
Confidence            221   1233578899999998766   68999999999999999999999986521    00000        011110


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..   ...........++.++.+|+.+||+.+|++||++++|+++
T Consensus       226 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 GD---PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CC---CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   0000111123467789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.2e-36  Score=297.84  Aligned_cols=268  Identities=24%  Similarity=0.278  Sum_probs=196.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcC-CCCcceEEeeeecCCc-----
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDF-----  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  362 (580)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+.....  .....+..|+.+++++. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999865 689999998865432  23456788999999995 6999999999877665     


Q ss_pred             eeeEeeccCCCChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFG  437 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg  437 (580)
                      .++||||+++ +|.+++....    ..+++..++.++.||+.||.|||   +.+++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 8988876532    35899999999999999999999   999999999999999998 8999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-cc-
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-PI-  514 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-  514 (580)
                      ++..+.....  ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||....... .+........ +. 
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence            9875532211  1223356788999998765 457899999999999999999999986521110 0000000000 00 


Q ss_pred             -c---hhhhcchhccCCcc--cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 -S---VMEIVDANLLSQKD--EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 -~---~~~~~d~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .   .....+........  .........+.++.+++.+||+.||++||+++|++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0   00000000000000  0001112456778999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=290.47  Aligned_cols=248  Identities=30%  Similarity=0.437  Sum_probs=203.7

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|+..+.||+|++|.||+|... +++.||+|.+.....  .....+..|++++++++|+|++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999865 688999999865533  3557788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++++|.+++... ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999988765 46899999999999999999999   999999999999999999999999999999866433221 


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                       .....++..|+|||...+..++.++||||+|+++|+|++|+.||....    .......         ...       .
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~---------~~~-------~  214 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFR---------IVQ-------D  214 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHH---------Hhc-------c
Confidence             233457889999999888888999999999999999999999986421    1111100         000       0


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....+...+..+.+++.+||..+|++||++.|++.+
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            0111223456788999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.1e-36  Score=290.75  Aligned_cols=243  Identities=26%  Similarity=0.342  Sum_probs=196.5

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||.|++|.||+|... +++.||+|++....   ....+.+..|+.++++++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999865 58999999986542   23446788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  455 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  455 (580)
                      .+++.... .+++..+..++.||+.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99987653 4899999999999999999999   8999999999999999999999999999998664322   222345


Q ss_pred             cCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       456 ~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      ++..|+|||.+....++.++|+||+|+++|||++|..||......   ......        .+.+.      ......+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~--------~~~~~------~~~~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYN--------DILKG------NGKLEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHH--------HHhcc------CCCCCCC
Confidence            788999999998888999999999999999999999998653211   111111        11110      0011122


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                      ...+.++.+++.+||+.+|++||+     ++|+++|
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            334678999999999999999999     7777663

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=279.93  Aligned_cols=254  Identities=22%  Similarity=0.246  Sum_probs=203.3

Q ss_pred             HHhcCCCcC-ceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeec----CC
Q 038098          289 QATNGFSEN-NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSS----DD  361 (580)
Q Consensus       289 ~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~  361 (580)
                      ..+++|++. ++||-|-.|.|-...++ +|+.+|+|++..     .....+|++..-.. .|||||.+++.|+.    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            456777765 47899999999988755 799999999742     24456788775554 69999999998754    46


Q ss_pred             ceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEcccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFG  437 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg  437 (580)
                      .+.+|||.|+||.|.+.++.++ ..+++.++-.|+.||+.|+.|||   +..|+||||||+|+|.+   .+..+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence            7889999999999999998776 57999999999999999999999   99999999999999996   46679999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchh
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM  517 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      +|+.-.   ........+-|+.|.|||.+...+|+...|+||+||++|-|++|.+||...-.  ..+        +.+..
T Consensus       210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~ai--------spgMk  276 (400)
T KOG0604|consen  210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAI--------SPGMK  276 (400)
T ss_pred             cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccC--------ChhHH
Confidence            998542   23345566789999999999999999999999999999999999999965321  111        11111


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .-+....+..   ..+.+...+++..++|+.+|..+|++|.|+.|++.|
T Consensus       277 ~rI~~gqy~F---P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  277 RRIRTGQYEF---PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hHhhccCccC---CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            1222222222   224567889999999999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-36  Score=291.01  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=199.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC--Cce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ-----YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  363 (580)
                      .+|...+.||+|+||.||+|... +++.||+|.+...     ..+....+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999854 6899999987532     123446788899999999999999999998654  457


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++++||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999887544 4889999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCC-cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          444 KEDQ-SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       444 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.....    ..            .+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~------------~~~~~  221 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MA------------AIFKI  221 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HH------------HHHHH
Confidence            2111 1112234588899999999888899999999999999999999999864211    00            01100


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....   .....+...+.++.+++.+|++ +|.+||++.+++.|
T Consensus       222 ~~~~---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         222 ATQP---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HcCC---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            0000   0112234566789999999999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-36  Score=304.75  Aligned_cols=272  Identities=24%  Similarity=0.279  Sum_probs=201.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----Cc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  362 (580)
                      .++|...+.||+|+||.||+|... +++.||||.+...  .......+..|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467899999999999999999854 6899999998643  223345677899999999999999999987543     34


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++|+||+. ++|.+++... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999996 6898888654 45999999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh---hcccch--
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND---LLPISV--  516 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~--  516 (580)
                      ....  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ..........   ..+...  
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhh
Confidence            3322  12233457889999998764 4688999999999999999999999865311 0001111000   000000  


Q ss_pred             ------hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 038098          517 ------MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR--LLKI  570 (580)
Q Consensus       517 ------~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~--L~~~  570 (580)
                            ...++................++.++.+++.+||+.+|++||+++|+++|  ++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                  00000000000000011123467889999999999999999999999998  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9e-36  Score=300.01  Aligned_cols=268  Identities=25%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec-CCc
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDF  362 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  362 (580)
                      +...+++|+..+.||+|+||.||+|... +++.||+|++....  ......+..|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999854 78999999875432  2334677889999999999999999998865 567


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++|+||+ +++|.+++...  .+++..+..++.|+++|+.|||   +.+++||||+|+||++++++.++|+|||++...
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            88999998 56898887643  4788889999999999999999   999999999999999999999999999998754


Q ss_pred             CCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH-----------HHHHh
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK-----------HWVND  510 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~-----------~~~~~  510 (580)
                      ...     .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... .....           +|...
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence            221     123457888999998765 5689999999999999999999999865321 00111           11111


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......+.+.................++.++.+++.+|++.+|++||++++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11111011110000000000001112356789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.9e-36  Score=295.65  Aligned_cols=267  Identities=25%  Similarity=0.300  Sum_probs=196.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|++|.||+|..+ +|+.||+|.+....  ......+..|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999865 68999999885432  2234567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEccccCccccCCCC
Q 038098          369 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |++ ++|.+++.... ..+++..+..++.||+.||+|||   +.+++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 58888775443 34688899999999999999999   899999999999999985 5679999999997543221


Q ss_pred             CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc----
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD----  521 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d----  521 (580)
                      .  ......++..|+|||.+.+. .++.++||||+||++|+|+||++||......+ ....... ..........+    
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-ILGTPNEETWPGVTS  233 (294)
T ss_pred             c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChhhcccccc
Confidence            1  12234578899999988664 57899999999999999999999986532111 0111000 00000000000    


Q ss_pred             ---hhc-cCC-ccc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ---ANL-LSQ-KDE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ---~~~-~~~-~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ... ... ... ........+.++.+++.+|++.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000 000 000 001123356778999999999999999999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.6e-36  Score=295.69  Aligned_cols=258  Identities=21%  Similarity=0.273  Sum_probs=185.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccccchh-----------hhHHHHHHHHhhcCCCCcceEEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQYGRAF-----------KSFDIECDMIKRIRHRNIIKIISS  356 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~  356 (580)
                      ++|.+.++||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999998653    45677776433221110           011123344556789999999998


Q ss_pred             eecCC----ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          357 CSSDD----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       357 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                      +....    ..++++|++.. ++.+.+... ...++..+..++.|++.|++|||   +.+|+||||||+|||++.++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            76543    34678887744 666665443 23578889999999999999999   99999999999999999999999


Q ss_pred             EccccCccccCCCCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHH
Q 038098          433 LSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~  507 (580)
                      |+|||+|+.+......     .......||+.|+|||...+..++.++|||||||++|||++|+.||....... ....-
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~~~~  245 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NLIHA  245 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HHHHH
Confidence            9999999866432211     11223469999999999999999999999999999999999999997642211 11110


Q ss_pred             HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       508 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ....   ....+....         .....++.++.+++..|+..+|++||+++++++.+
T Consensus       246 ~~~~---~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCD---FIKRLHEGK---------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHH---HHHHhhhhh---------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0000   000010000         01234567899999999999999999999999876

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.4e-36  Score=291.21  Aligned_cols=247  Identities=26%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|++.+.||+|+||.||++... +++.+|+|.+....  ......+..|++++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999754 68899999986542  23345677899999999999999999999989999999999


Q ss_pred             cCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +++++|.+++...   +..+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   256899999999999999999999   999999999999999999999999999999866433 


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||......  .+...            +...   
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~------------~~~~---  216 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK------------VQRG---  216 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH------------HhcC---
Confidence               122345788999999998888999999999999999999999998653110  11110            0000   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   ....+...+.++.+++.+|++.+|++||++.|++++
T Consensus       217 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 K---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             C---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0   011223456779999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-36  Score=302.71  Aligned_cols=249  Identities=27%  Similarity=0.338  Sum_probs=208.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc--hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR--AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ...|.+...||+|.|+.|..|++. +|..||+|.++.....  ....+.+|+++|..++|||||+++.+.+.+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            466888999999999999999855 7999999999765332  2345788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+.+|.+.+|+...+. ..+..+..++.|+.+|++|||   ++.|+|||||++|||++.+.++||+|||++..+.   .
T Consensus       135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y  207 (596)
T ss_pred             EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---c
Confidence            99999999999988775 444888899999999999999   9999999999999999999999999999999874   3


Q ss_pred             cccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      .......+|++.|.|||+..+.++ ++++|+||+|+++|-|+.|..||++..                 +.+.-++.+..
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-----------------lk~Lr~rvl~g  270 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-----------------LKELRPRVLRG  270 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----------------cccccchheee
Confidence            334556789999999999988765 789999999999999999999998621                 22222222222


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      .    +..+.-.+.+..+++++++..+|.+|++++++.++-
T Consensus       271 k----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  271 K----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             e----ecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            2    222333456678999999999999999999998764

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-35  Score=296.85  Aligned_cols=244  Identities=27%  Similarity=0.336  Sum_probs=194.5

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |...+.||+|+||.||+|+.. +|+.||+|++.....   .....+..|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999864 688999999864322   2345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +. |++.+++.....++++.++..++.||+.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 5888888776677999999999999999999999   89999999999999999999999999999864321     


Q ss_pred             cccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          450 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       .....++..|+|||.+.   .+.++.++|||||||++|||++|..||.....  .....+..           ...   
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~-----------~~~---  236 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIA-----------QND---  236 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH-----------hcC---
Confidence             12345788999999874   45688999999999999999999999865211  00000000           000   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..   .......+..+.+++.+||+.+|.+||++.+++.+
T Consensus       237 ~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 SP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   00112234568899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.1e-36  Score=298.85  Aligned_cols=262  Identities=21%  Similarity=0.243  Sum_probs=191.6

Q ss_pred             eeccccCceEEEEEeCCCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChH
Q 038098          299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE  376 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  376 (580)
                      .+|.|+++.||++.. +++.||||++...  .......+..|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            344444444444444 6899999998654  2345578899999999999999999999999999999999999999999


Q ss_pred             HHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc-----cc
Q 038098          377 KCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LT  450 (580)
Q Consensus       377 ~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~  450 (580)
                      +++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||.+......+..     ..
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            998754 346889999999999999999999   999999999999999999999999999998755332211     11


Q ss_pred             ccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc------------h
Q 038098          451 QTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS------------V  516 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~  516 (580)
                      .....++..|+|||.+..  ..++.++|||||||++|||++|+.||............. ....+..            .
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCccccccCchhhhcCCc
Confidence            223446778999998865  357899999999999999999999997532211111111 0000000            0


Q ss_pred             hh----hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          517 ME----IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       517 ~~----~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ..    ..+....  ...........+.++.+++.+||+.||++||+++++++|-
T Consensus       244 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         244 SQSRSSNEHPNNR--DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             Ccccccccccchh--hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            00    0000000  0011112234567889999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.5e-36  Score=297.91  Aligned_cols=246  Identities=28%  Similarity=0.377  Sum_probs=196.2

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+...   ......++..|+++++.++|+|++++++++...+..++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            566688999999999999865 6788999988642   223345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +. |++.+++.....++++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++......    
T Consensus        97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            96 5888877666667899999999999999999999   899999999999999999999999999998755321    


Q ss_pred             cccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          450 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        ....++..|+|||.+.   .+.++.++|||||||++|||++|+.||..... ......+...            ..  
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~------------~~--  231 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN------------ES--  231 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhc------------CC--
Confidence              2235788999999874   35678899999999999999999999754210 0001111100            00  


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                          ........+..+.+++.+||+.+|++||++.+++++-.
T Consensus       232 ----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             ----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                00112245667899999999999999999999988754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.4e-36  Score=294.04  Aligned_cols=245  Identities=29%  Similarity=0.369  Sum_probs=194.8

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||.|+||.||++... +|+.+|+|++.....   .....+..|++++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 589999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC------cc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ------SL  449 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~  449 (580)
                      .+++...+ .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987655 6899999999999999999999   99999999999999999999999999999875432211      11


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......++..|+|||.......+.++||||||+++|||++|..||.....     ......        ...    ... 
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~--------~~~----~~~-  218 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQN--------ILN----GKI-  218 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------Hhc----CCc-
Confidence            22334578889999999888899999999999999999999999865311     111111        000    000 


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       ........+..+.+++.+||+.+|++||++.++.+.|
T Consensus       219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             0011111367789999999999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-37  Score=306.13  Aligned_cols=244  Identities=26%  Similarity=0.407  Sum_probs=195.4

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEec----cccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc--eeeEeec
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDL----QYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF--KALVLEY  369 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~  369 (580)
                      ..+||+|+|-+||+|... +|.+||--.++.    +..+...+|..|+.+|+.|+||||++++.+|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999864 577776533321    133456889999999999999999999999987655  7799999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +..|+|..|+.+.+. .+......|++||++||.|||+. .++|+|||||-.||+++ ..|.|||+|.|+|+.+..... 
T Consensus       125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-  201 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-  201 (632)
T ss_pred             ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence            999999999887664 78889999999999999999954 68999999999999997 678999999999997744332 


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                         ...+||+.|||||+.. ..|++.+||||||+.++||+|+..||.+......-+..-.....|..+..+-        
T Consensus       202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--------  269 (632)
T KOG0584|consen  202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--------  269 (632)
T ss_pred             ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC--------
Confidence               3368999999999986 7899999999999999999999999976433222222222222222222221        


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                                .+++.++|.+|+.. .++|||+.|++++
T Consensus       270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 ----------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                      35678999999999 9999999999874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=291.34  Aligned_cols=265  Identities=25%  Similarity=0.299  Sum_probs=196.5

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhc---CCCCcceEEeeeecCCc-----
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRI---RHRNIIKIISSCSSDDF-----  362 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  362 (580)
                      |++.+.||+|+||.||+|..+ +++.||+|++.....  .....+..|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 489999999864422  2234556677777666   59999999999987776     


Q ss_pred             eeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      .+++|||+++ +|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8988887644 36899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh-hc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IV  520 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~  520 (580)
                      +.....   .....++..|+|||.+.+..++.++|||||||++|||++|++||..... ......+........... ..
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence            533221   1233478889999999988999999999999999999999999865321 111222221111000000 00


Q ss_pred             c----hhccCC-c-ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 D----ANLLSQ-K-DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d----~~~~~~-~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .    ...... . ..........+..+.+++.+||+.||++||+++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0    000000 0 00011112445778899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=289.33  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=187.1

Q ss_pred             ceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHH-hhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMI-KRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|... +|+.||+|++.....   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999864 689999999864321   1223344454443 445899999999999999999999999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987544 5899999999999999999999   89999999999999999999999999999875422      22


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|..||.....     .......         ...   ......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~---------~~~---~~~~~~  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNI---------LSR---RINWPE  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH---------Hhc---ccCCCC
Confidence            34578889999999888889999999999999999999999864211     1111100         000   000000


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHH---HHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAK---EIVTR  566 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~---ev~~~  566 (580)
                      .....++..+.+++.+||+.+|++||++.   |+++|
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            11224567899999999999999999664   55444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-35  Score=299.40  Aligned_cols=266  Identities=23%  Similarity=0.325  Sum_probs=194.0

Q ss_pred             ceeccc--cCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRG--GFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      ..||+|  +||+||+|... +|+.||+|++....  ....+.+..|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  89999999864 79999999986442  23356788899999999999999999999999999999999999


Q ss_pred             CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc-
Q 038098          373 GSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT-  450 (580)
Q Consensus       373 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  450 (580)
                      +++.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+........... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999887643 35899999999999999999999   99999999999999999999999999986543322111100 


Q ss_pred             ----ccccccCCCcCCcccccCC--CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh---------hcccc
Q 038098          451 ----QTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND---------LLPIS  515 (580)
Q Consensus       451 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~---------~~~~~  515 (580)
                          .....++..|+|||++.+.  .++.++||||+||++|||++|+.||........ .......         ..+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence                1112345679999998763  478999999999999999999999975322111 1110000         00000


Q ss_pred             hhhh-----------cchhcc-----C--CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          516 VMEI-----------VDANLL-----S--QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       516 ~~~~-----------~d~~~~-----~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ....           .+....     .  ....+......++..+.+|+.+||+.||++|||+.|+++|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence            0000           000000     0  00001112345678899999999999999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-35  Score=301.12  Aligned_cols=268  Identities=24%  Similarity=0.290  Sum_probs=196.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      .++|...+.||+|+||.||+|... +|+.||+|++....  ......+..|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999854 68999999986432  222356788999999999999999999886542      


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++|+||+.. +|.++..   ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            45899999964 7776542   35899999999999999999999   89999999999999999999999999999875


Q ss_pred             cCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh--hcccchhh
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND--LLPISVME  518 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  518 (580)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........  .......+
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            4221     123457888999998876 468899999999999999999999997531110 11110000  00000000


Q ss_pred             hcchh--------ccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 038098          519 IVDAN--------LLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR--LLKIR  571 (580)
Q Consensus       519 ~~d~~--------~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~--L~~~~  571 (580)
                      ..+..        ........ .......+.++.+++.+||+.||++||+++|++.|  ++.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            00000        00000000 00112345678899999999999999999999977  55544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-35  Score=289.90  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=187.8

Q ss_pred             eeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHH---HHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          299 LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECD---MIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999854 688999999865321   11122333433   3444579999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++... ..+++..+..++.|+++|+.|||   +.+++||||+|+||+++.++.++|+|||++..+....    .
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            99999988654 46899999999999999999999   8999999999999999999999999999987553221    2


Q ss_pred             cccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........  .....         .    ...   .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~---------~----~~~---~  214 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDR---------M----TLT---M  214 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHH---------H----hhc---c
Confidence            234689999999998754 689999999999999999999999875321111  00000         0    000   0


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      ....+...+.++.+++.+|+..+|++||     ++.+++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1112233467889999999999999999     99999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-36  Score=316.56  Aligned_cols=271  Identities=20%  Similarity=0.214  Sum_probs=190.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeCC--CCEEEEEEEe--------------c---cccchhhhHHHHHHHHhhcCCCCcc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQD--GMEVAVKVFD--------------L---QYGRAFKSFDIECDMIKRIRHRNII  351 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~--------------~---~~~~~~~~~~~e~~~l~~l~h~niv  351 (580)
                      .++|.+.+.||+|+||.||++..+.  +..++.|.+.              .   ........+.+|++++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987542  2222222110              0   1112345678899999999999999


Q ss_pred             eEEeeeecCCceeeEeeccCCCChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC
Q 038098          352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD  427 (580)
Q Consensus       352 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~  427 (580)
                      ++++++...+..++|+|++. ++|.+++....    .......+..++.||+.||+|||   +.+|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            99999999999999999985 47877765432    22345667789999999999999   999999999999999999


Q ss_pred             CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCC-CCccccC-CchHH
Q 038098          428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP-TDEIFFG-DMTLK  505 (580)
Q Consensus       428 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p-~~~~~~~-~~~~~  505 (580)
                      ++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.+ +...... ...+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999986643222 122345699999999999999999999999999999999998854 3321111 11111


Q ss_pred             HHHHhh------cccc---hhhhcchhccCCcccc---cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          506 HWVNDL------LPIS---VMEIVDANLLSQKDEH---FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       506 ~~~~~~------~~~~---~~~~~d~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.....      ++..   ..+.++..........   .......+.++.+++.+|++.||.+||++.|+++|
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111110      0110   1111111100000000   00111244567889999999999999999999876

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-35  Score=300.10  Aligned_cols=273  Identities=25%  Similarity=0.297  Sum_probs=205.4

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-----cee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-----FKA  364 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  364 (580)
                      +|.+.+.||.|++|.||+|+.. +++.||+|++....  ....+.+..|++++++++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999865 58999999986543  344567888999999999999999999987765     789


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||++ ++|.+++.... .+++..++.++.||+.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 48998887654 7999999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCc-ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc---------
Q 038098          445 EDQS-LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP---------  513 (580)
Q Consensus       445 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  513 (580)
                      .... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......  ...........         
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhh
Confidence            3210 122344578899999999887 7899999999999999999999998653211  00000000000         


Q ss_pred             ---cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 038098          514 ---ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR--LLKIRD  572 (580)
Q Consensus       514 ---~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~--L~~~~~  572 (580)
                         ......+..................+..+.+++.+||+.+|++||++++++++  ++.+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence               00001111000000000001122356788999999999999999999999986  554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-35  Score=299.62  Aligned_cols=267  Identities=24%  Similarity=0.313  Sum_probs=198.8

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC--
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--  361 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  361 (580)
                      +....++|+..+.||+|+||.||+|.. .+|+.||||++....  ......+..|++++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            344567899999999999999999974 478999999985432  223456778999999999999999999886543  


Q ss_pred             ----ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          362 ----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       362 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                          ..++||||+ +++|.+++..  ..+++..++.++.||++|++|||   +.+|+||||+|+||+++.++.++++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                358999999 7799888764  35899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH-----------
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK-----------  505 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~-----------  505 (580)
                      ++......     .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ...           
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence            99854221     123357888999998865 458899999999999999999999986531110 011           


Q ss_pred             HHHHhhcccchhhhcchhccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .|............... +....... ......++..+.+++.+|++.||++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         238 EFVQKLQSEDAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHhhcchhHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11111100000000000 00000000 01123456778999999999999999999999854

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-36  Score=323.15  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=190.1

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeec--------
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSS--------  359 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  359 (580)
                      -.++|+..++||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++++|||||+++..|.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3466888899999999999999977 89999999996553 3455778889999999999999999732100        


Q ss_pred             --------------------------------------------------------------------------------
Q 038098          360 --------------------------------------------------------------------------------  359 (580)
Q Consensus       360 --------------------------------------------------------------------------------  359 (580)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 038098          360 -----------------------D--------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG  408 (580)
Q Consensus       360 -----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~  408 (580)
                                             +        ..+||-||||+..++.+++++....-.....++++++|++||+|+|  
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH--  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH--  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH--
Confidence                                   0        1246889999997777777665543357788999999999999999  


Q ss_pred             CCCCeEEecCCCCCEEeCCCCcEEEccccCccccC----------------CCCCcccccccccCCCcCCcccccCC---
Q 038098          409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL----------------KEDQSLTQTQTLATIGYMAPEYGREG---  469 (580)
Q Consensus       409 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~---  469 (580)
                       +.|+|||||||.||++|+++.|||+|||+|+...                ........+..+||.-|+|||.+.+.   
T Consensus       715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence             9999999999999999999999999999998722                00112245677899999999988764   


Q ss_pred             CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhc
Q 038098          470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKC  549 (580)
Q Consensus       470 ~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~c  549 (580)
                      .|+.|+|+||+|||++||+.   ||....+.-..+....+            ..+...  ..+  .....+.=..+|++|
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~------------g~iP~~--~~f--~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK------------GSIPEP--ADF--FDPEHPEEASLIRWL  854 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc------------CCCCCC--ccc--ccccchHHHHHHHHH
Confidence            49999999999999999985   56542221111111111            111111  000  011123345899999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 038098          550 TVESPEQRINAKEIVT  565 (580)
Q Consensus       550 l~~dP~~Rps~~ev~~  565 (580)
                      ++.||.+|||+.|+++
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-35  Score=299.55  Aligned_cols=272  Identities=23%  Similarity=0.288  Sum_probs=201.1

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS  359 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  359 (580)
                      ...++...+++|...+.||+|+||.||+|.. .+|+.||+|++....  ......+..|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            4456777889999999999999999999975 478999999986432  2234567789999999999999999998754


Q ss_pred             C------CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEE
Q 038098          360 D------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  433 (580)
Q Consensus       360 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl  433 (580)
                      .      ...+++++++ +++|.+++...  .+++..+..++.|+++|++|||   +.+++||||||+||++++++.+||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence            3      3467888887 77998877643  4899999999999999999999   999999999999999999999999


Q ss_pred             ccccCccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh-
Q 038098          434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL-  511 (580)
Q Consensus       434 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-  511 (580)
                      +|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+....... 
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~  235 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVG  235 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            99999875422     1223457889999998765 46788999999999999999999998642111 1111111100 


Q ss_pred             -cccchh-hhcch-------hccCCccccc-chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          512 -LPISVM-EIVDA-------NLLSQKDEHF-TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       512 -~~~~~~-~~~d~-------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .+.... .+.+.       .........+ ......+.++.+++.+|++.||++||++.+++.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             000000 00000       0000000000 0011346678999999999999999999999876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=289.77  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=196.5

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      |.+.+.||+|++|.||+|... +++.||+|++..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999975 578999999864422 22234456899999999 999999999999999999999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                       +|+|.+++.... ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             779999887654 56899999999999999999999   89999999999999999999999999999986533221  


Q ss_pred             cccccccCCCcCCccccc-CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc-----------hHHHHHHhhcccchh
Q 038098          450 TQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM-----------TLKHWVNDLLPISVM  517 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~  517 (580)
                       .....++..|+|||.+. ...++.++||||||+++|||++|++||......+.           ....|.....   ..
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  230 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK---LA  230 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh---hh
Confidence             22345788999999875 45578999999999999999999999865311100           0001111000   00


Q ss_pred             hhcchhccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVDANLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...+.......... .......+.++.+++.+||+.+|++||+++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000000 00011225678999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-35  Score=292.86  Aligned_cols=250  Identities=28%  Similarity=0.413  Sum_probs=203.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|...+.||+|+||.||+|... +|+.||+|++....   ......+..|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999865 79999999986532   233467788999999998 99999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++...+ .+++..++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999987654 5999999999999999999999   9999999999999999999999999999988654322


Q ss_pred             Cc------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHH
Q 038098          447 QS------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWV  508 (580)
Q Consensus       447 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~  508 (580)
                      ..                  .......++..|+|||......++.++||||+|+++|++++|+.||.....    ...  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~--  230 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLT--  230 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHH--
Confidence            11                  112234578899999998888899999999999999999999999875321    000  


Q ss_pred             HhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 038098          509 NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA----KEIVTR  566 (580)
Q Consensus       509 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~ev~~~  566 (580)
                             .....+.        ....+...+..+.+++.+||+.+|++||++    +++++|
T Consensus       231 -------~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 -------FQKILKL--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -------HHHHHhc--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                   0011100        111223346678899999999999999999    887764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-36  Score=302.52  Aligned_cols=266  Identities=24%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc---
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF---  362 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  362 (580)
                      ...++|...+.||+|++|.||+|... +++.||+|++....  ......+..|+.++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45678999999999999999999865 68899999986432  2234567789999999999999999988766554   


Q ss_pred             ---eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          363 ---KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       363 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                         .++|+||+ +++|.+++..  ..+++..+..++.|+++|++|||   +.+++||||+|+||++++++.++|+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 6699998865  35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH---------
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN---------  509 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~---------  509 (580)
                      ......     .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.....         
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHH
Confidence            865322     223457888999998765 36789999999999999999999998652110 01111111         


Q ss_pred             --hhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          510 --DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       510 --~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ..........+..................+.++.+++.+|++.+|++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence              000000111110000000000001112346789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.2e-35  Score=294.46  Aligned_cols=271  Identities=23%  Similarity=0.269  Sum_probs=196.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467999999999999999999865 689999999854422  22345678999999999999999998874433      


Q ss_pred             --ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          362 --FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       362 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                        ..++|+||+.+ ++...+......+++..+..++.|+++||+|||   +.+++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46899999965 788777766667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcc---------cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH
Q 038098          440 KPLLKEDQSL---------TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN  509 (580)
Q Consensus       440 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~  509 (580)
                      +.........         ......++..|+|||.+.+. .++.++|||||||++|||++|++||...... ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            7653322111         11233567889999987654 5789999999999999999999998652111 01111110


Q ss_pred             hh--cccc-------hhhhcchhccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          510 DL--LPIS-------VMEIVDANLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       510 ~~--~~~~-------~~~~~d~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..  ....       .....+.......... .........++.+++.+|++.||++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            00  0000       0000000000000000 00112234678899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-35  Score=289.51  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             CCCcCceeccccCceEEEEEe----CCCCEEEEEEEeccc----cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          293 GFSENNLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      .|+..+.||.|+||.||.|..    .+|+.||+|++....    ....+.+..|+.+++++ +|+||+.+++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367788999999999999975    368899999986432    22346678899999999 589999999999998999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++++|.+++.... .+++..+..++.|+++||.|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 5889999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccccCC--CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      .... .......|+..|+|||.+...  .++.++||||||+++|+|++|+.||..... ......+....          
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~----------  224 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRI----------  224 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHh----------
Confidence            3221 122234588899999988653  467899999999999999999999864211 11111111111          


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                        ....    ...+..++..+.+++.+||+.||++||     ++.+++.+
T Consensus       225 --~~~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         225 --LKSE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --hccC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence              0000    011233567789999999999999997     77888775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.7e-35  Score=295.70  Aligned_cols=268  Identities=23%  Similarity=0.262  Sum_probs=196.1

Q ss_pred             cCCCc-CceeccccCceEEEEEeC-CCCEEEEEEEeccccch--------------hhhHHHHHHHHhhcCCCCcceEEe
Q 038098          292 NGFSE-NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRA--------------FKSFDIECDMIKRIRHRNIIKIIS  355 (580)
Q Consensus       292 ~~~~~-~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~  355 (580)
                      ++|.. .+.||+|+||.||+|... +++.||+|.+.......              ...+..|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45653 467999999999999855 68999999985432111              124678999999999999999999


Q ss_pred             eeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       356 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                      ++...+..++||||+. |+|.+++... ..+++.....++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 5999988653 45899999999999999999999   99999999999999999999999999


Q ss_pred             ccCccccCCCCC------------cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCc
Q 038098          436 FGMAKPLLKEDQ------------SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM  502 (580)
Q Consensus       436 fg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~  502 (580)
                      ||++........            ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+ 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-  241 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-  241 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999976541110            1111233467889999988764 46899999999999999999999986532111 


Q ss_pred             hHHHHHHhhcccc----hhhhcc-----hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          503 TLKHWVNDLLPIS----VMEIVD-----ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       503 ~~~~~~~~~~~~~----~~~~~d-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+..... .....    .....+     +................+.++.+++.+|++.+|++||+++|++.+
T Consensus       242 ~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 QLGRIFE-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHH-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1111100 00000    000000     000000000001122346778999999999999999999999875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=278.59  Aligned_cols=249  Identities=24%  Similarity=0.300  Sum_probs=203.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|...++||+|.||.|-.++-+ +|+.+|+|+++++.-   ...+.-..|-++++..+||.+..+--.+...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            366888999999999999999854 799999999976632   3345566799999999999999999899999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+.||.|.-++.+.+ .+++....-+-..|+.||.|||   +.+||+||+|.+|.|+|.+|.+||+|||+++.--.. 
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-  321 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-  321 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence            99999999988776644 5888888889999999999999   999999999999999999999999999999853222 


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       .......+||+.|+|||++....|+.++|.|.+||++|||++|+.||.....+              .+.+.+-..   
T Consensus       322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------------kLFeLIl~e---  383 (516)
T KOG0690|consen  322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------------KLFELILME---  383 (516)
T ss_pred             -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--------------HHHHHHHhh---
Confidence             22445678999999999999999999999999999999999999998652110              111111110   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                          ....+...+++...|+...+.+||.+|.     .++||.+|
T Consensus       384 ----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 ----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                1223455677888999999999999997     45555544

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-35  Score=299.65  Aligned_cols=268  Identities=21%  Similarity=0.272  Sum_probs=196.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecC----------
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD----------  360 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------  360 (580)
                      .+|...+.||.|+||.||+|... +|+.||+|.+........+.+..|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999864 6899999998766555667788999999999999999999776543          


Q ss_pred             ----CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEcc
Q 038098          361 ----DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSD  435 (580)
Q Consensus       361 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~D  435 (580)
                          ...++|+||++ ++|.+++...  .+++..+..++.||++|+.|||   +.+++||||||+||+++ +++.++++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999997 5898887543  4889999999999999999999   89999999999999997 556789999


Q ss_pred             ccCccccCCCCCc-ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc
Q 038098          436 FGMAKPLLKEDQS-LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       436 fg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      ||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ ...........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~  237 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESVPV  237 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence            9999765322111 11123357888999997654 567889999999999999999999996532110 11111111000


Q ss_pred             c------chhhhcchhcc----CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 I------SVMEIVDANLL----SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~------~~~~~~d~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .      ...........    .............+.++.+++.+|++.||++||++.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            0      00000000000    00000001112456778999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=288.93  Aligned_cols=265  Identities=27%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      |+..+.||+|++|.||+|... +++.||+|++....  ......+..|++++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999865 58999999987543  233466778999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      + ++|.+++......+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||.++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876567999999999999999999999   89999999999999999999999999999986543222  1


Q ss_pred             ccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc----chhhhcch---
Q 038098          451 QTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI----SVMEIVDA---  522 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~---  522 (580)
                      .....++..|+|||.+.+. .++.++|||||||++|||++|++||.....  .............    ......+.   
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            2233457789999988766 789999999999999999999999865221  0000001000000    00000000   


Q ss_pred             --hccCCccc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 --NLLSQKDE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 --~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ........ ........+..+.+++.+||..+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence              00000000 001112235679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.5e-35  Score=290.04  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=198.2

Q ss_pred             CCCcCceeccccCceEEEEEe----CCCCEEEEEEEeccc----cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          293 GFSENNLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      +|+..+.||+|++|.||++..    .+++.||||++....    ......+..|++++.++ +||||+++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999974    257889999986431    22345678899999999 599999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++|+|.+++... ..+++..+..++.|+++||.|||   +.+++||||+|+||+++.++.++|+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999988754 35889999999999999999999   8999999999999999999999999999988654


Q ss_pred             CCCCcccccccccCCCcCCcccccCCC--CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ..... ......++..|+|||...+..  .+.++||||||+++|||++|..||..... ......+....        ..
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~--------~~  226 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRI--------LK  226 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHH--------Hc
Confidence            33221 122345788999999987655  78899999999999999999999853211 11111111110        00


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                          .    ....+..++..+.+++.+||+.||++|||++++.+.|+
T Consensus       227 ----~----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         227 ----S----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             ----c----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                0    01122335567899999999999999999877765553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.1e-36  Score=275.80  Aligned_cols=272  Identities=24%  Similarity=0.286  Sum_probs=199.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC---C--CCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeec-CCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ---D--GMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  363 (580)
                      ..|+....||+|.||.||+|.-+   +  ...+|+|.++.+.+  ......-+|+..++.++|||++.+...+-+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46889999999999999999532   2  23799999965532  233556789999999999999999998866 7789


Q ss_pred             eeEeeccCCCChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC----CcEEEcc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN----MVAHLSD  435 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~D  435 (580)
                      ++++||.+. +|.+.++-.+    ..++...+.+|+.||+.|+.|||   +.=|.||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 9998876433    56888999999999999999999   7779999999999999876    8999999


Q ss_pred             ccCccccCCCCCcc-cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccC-------------
Q 038098          436 FGMAKPLLKEDQSL-TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFG-------------  500 (580)
Q Consensus       436 fg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~-------------  500 (580)
                      +|+++.+..+-... .....+-|.+|.|||.+.+. .||.+.||||.|||+.||+|-++-|.+....             
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999886543332 34566789999999998875 6899999999999999999999888653211             


Q ss_pred             -------CchHHHHHHhh-cccchhhhcchh--ccCCc--ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          501 -------DMTLKHWVNDL-LPISVMEIVDAN--LLSQK--DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       501 -------~~~~~~~~~~~-~~~~~~~~~d~~--~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                             ..+...|-.-. .|+.-..+-|-.  .....  ...+.....-++..++|+.+++..||.+|.|+++.+++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence                   11111221100 000000000000  00000  000111111223378999999999999999999998764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.3e-35  Score=286.43  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ-----YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +|.+.+.||+|+||.||++... .+..+++|+++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999865 3455666665421     112234566789999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      |||+++++|.+++..   ....+++..++.++.|+++|+.|||   +.+++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   3356899999999999999999999   999999999999999975 569999999987653


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||....     .......        .... 
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~--------~~~~-  220 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLR--------IVEG-  220 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH--------HHcC-
Confidence            3222  2223457889999999888888999999999999999999999986421     1111110        0000 


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          .  ....+..++.++.+++.+||+.+|++||++.|++++
T Consensus       221 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 ----P--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----C--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                0  111123456788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1e-34  Score=293.40  Aligned_cols=267  Identities=22%  Similarity=0.263  Sum_probs=193.5

Q ss_pred             CCCcCceeccccCceEEEEEeC-C--CCEEEEEEEecccc--chhhhHHHHHHHHhhc-CCCCcceEEeeeec----CCc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-D--GMEVAVKVFDLQYG--RAFKSFDIECDMIKRI-RHRNIIKIISSCSS----DDF  362 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  362 (580)
                      +|...+.||+|+||.||++... +  +..||+|++.....  .....+..|+++++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999865 4  77899999864322  2345678899999999 59999999987532    245


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++++||+. ++|.+++... ..+++..+..++.||+.||+|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788899985 5899888643 45899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCCc--ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHH-----------HH
Q 038098          443 LKEDQS--LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH-----------WV  508 (580)
Q Consensus       443 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~-----------~~  508 (580)
                      ......  .......|+..|+|||.+.+ ..++.++||||+||++|+|++|++||...... ..+..           +.
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            432211  11233468899999998765 46889999999999999999999998653210 00110           10


Q ss_pred             HhhcccchhhhcchhccCCccccc-chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          509 NDLLPISVMEIVDANLLSQKDEHF-TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       509 ~~~~~~~~~~~~d~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .............. ........+ ......+..+.+++.+|++.||++||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000000 000000000 1112346779999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=318.54  Aligned_cols=259  Identities=23%  Similarity=0.304  Sum_probs=211.7

Q ss_pred             HHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC
Q 038098          286 EIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD  361 (580)
Q Consensus       286 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  361 (580)
                      ++....++|.+.++||+|+||.|..++++ +++.||+|++++.   .....+.|..|-++|..-..+-|+.++-+|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445678999999999999999999865 6889999999652   2345677889999999999999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ++|+|||||+||+|-..+.... ++++..+..++..|+-||.-+|   +.|+|||||||+|||+|..|.+||+|||.+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998877 7999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCcccccccccCCCcCCccccc----C-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGR----E-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      +..+ ........+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||.+.     .+..-        .
T Consensus       225 m~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveT--------Y  290 (1317)
T KOG0612|consen  225 MDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVET--------Y  290 (1317)
T ss_pred             cCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHH--------H
Confidence            7544 344566788999999999874    3 67899999999999999999999998652     11111        1


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN---AKEIVTRL  567 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ev~~~L  567 (580)
                      ..|.+..-    ...++....++.+..+||.+.+. +|+.|..   ++|+..|-
T Consensus       291 ~KIm~hk~----~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  291 GKIMNHKE----SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HHHhchhh----hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            22222211    11122224467788899988776 7888887   88887763

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=297.84  Aligned_cols=272  Identities=26%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             CcCceeccccCceEEEEEe-CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecC------CceeeE
Q 038098          295 SENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD------DFKALV  366 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv  366 (580)
                      ...+.||+|+||.||+|++ .+|+.||||.++... ....+...+|++++++++|+|||++++.-++.      ....+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3456899999999999995 479999999996543 34567788999999999999999999875543      356799


Q ss_pred             eeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC--CCC--cEEEccccCcc
Q 038098          367 LEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNM--VAHLSDFGMAK  440 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfg~a~  440 (580)
                      ||||.||||...+.+..  .-+++.+.+.++.+++.||.|||   +.+|+||||||.||++-  ++|  --||+|||.|+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999998654  56999999999999999999999   99999999999999983  334  47999999999


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch-HHHHHHhhc-ccchh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT-LKHWVNDLL-PISVM  517 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~-~~~~~  517 (580)
                      .+..+.   .....+||..|++||+... +.++..+|.|||||++||++||..||......... -..|..-.. +..+.
T Consensus       173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            774332   5677899999999999984 88999999999999999999999999653222211 123332221 22222


Q ss_pred             hhcchhccCC--cccccchh----hhhHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHH
Q 038098          518 EIVDANLLSQ--KDEHFTTK----GQCVSFIFNLAMKCTVESPEQRI--NAKEIVTRLLKIRD  572 (580)
Q Consensus       518 ~~~d~~~~~~--~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rp--s~~ev~~~L~~~~~  572 (580)
                      -..+....+.  ....++.+    ......+-..+..++..+|++|-  .+.+....+..|.+
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1122111111  11111111    22233456677788899999998  77777777766654

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=322.38  Aligned_cols=253  Identities=28%  Similarity=0.374  Sum_probs=204.0

Q ss_pred             hcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      +-+++....||.|.||.||-|. ..+|+..|+|-+....  ....+.+..|..++..++|||+|+++|.-..++..+|-|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456677889999999999997 5579999999876543  345677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |||++|+|.+.+... ...++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus      1314 EyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            999999999987654 45777777789999999999999   99999999999999999999999999999988755432


Q ss_pred             --cccccccccCCCcCCcccccCC---CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          448 --SLTQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       448 --~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                        ........||+.|||||.+.+.   ....+.||||+|||+.||+||+.||.....      .|.-       +--+..
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aI-------My~V~~ 1456 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAI-------MYHVAA 1456 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHH-------HhHHhc
Confidence              2223466899999999998754   356789999999999999999999876321      1211       111111


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..      ....|...+.+-.+++.+|+..||++|-++.|++++
T Consensus      1457 gh------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GH------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cC------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            11      112334477888999999999999999998888765

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=279.35  Aligned_cols=239  Identities=29%  Similarity=0.362  Sum_probs=195.2

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      ||+|+||.||++... +++.+|+|++.....   .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 589999999865432   2456788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  455 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  455 (580)
                      .+++.... .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99987654 5899999999999999999999   8999999999999999999999999999998653322  1223445


Q ss_pred             cCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       456 ~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      ++..|+|||...+...+.++|+||||+++||+++|+.||.....     ......        +..        .....+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~--------~~~--------~~~~~~  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEK--------ILK--------DPLRFP  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------Hhc--------CCCCCC
Confidence            78899999999888889999999999999999999999865311     111111        110        111223


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCH---HHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINA---KEIVT  565 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~---~ev~~  565 (580)
                      ...+..+.+++.+||..||++||++   +++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            3346778999999999999999999   55544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.7e-34  Score=311.52  Aligned_cols=145  Identities=32%  Similarity=0.430  Sum_probs=130.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999866 68999999986432   223467888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ||+.+++|.+++...+ .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999987654 4889999999999999999999   8899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.6e-34  Score=273.53  Aligned_cols=219  Identities=21%  Similarity=0.149  Sum_probs=176.3

Q ss_pred             ccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChHHHhhc
Q 038098          303 GGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYS  381 (580)
Q Consensus       303 G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  381 (580)
                      |.+|.||++... +++.||+|++....     .+..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999864 78999999986432     233455555566799999999999999999999999999999998865


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcC
Q 038098          382 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM  461 (580)
Q Consensus       382 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~  461 (580)
                      .. .+++..+..++.|+++|++|||   +.+++||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            43 5899999999999999999999   999999999999999999999999999988654322     12234567799


Q ss_pred             CcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHH
Q 038098          462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF  541 (580)
Q Consensus       462 aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  541 (580)
                      |||.+....++.++||||+|+++|||++|+.|+......               ...          ......+..++..
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~----------~~~~~~~~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INT----------HTTLNIPEWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccc----------ccccCCcccCCHH
Confidence            999998888999999999999999999999886431100               000          0001122335667


Q ss_pred             HHHHHhhccCCCCCCCCCH
Q 038098          542 IFNLAMKCTVESPEQRINA  560 (580)
Q Consensus       542 l~~l~~~cl~~dP~~Rps~  560 (580)
                      +.+++.+|++.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-36  Score=267.15  Aligned_cols=270  Identities=21%  Similarity=0.300  Sum_probs=200.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEec--cccchhhhHHHHHHHHhhcCCCCcceEEeeeec--------C
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDL--QYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS--------D  360 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  360 (580)
                      +.|....++|+|.||+||+|+.+ +|+.||+|++-.  +...--....+|++++..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            44666788999999999999854 688899987532  222223456789999999999999999987743        2


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ...++||++|+. +|...+......++..++.+++.++..||.|+|   ...|+|||+||.|+|++.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            357999999987 999998887778999999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCC--CcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh----cc
Q 038098          441 PLLKED--QSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL----LP  513 (580)
Q Consensus       441 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~  513 (580)
                      .+....  .....+.++-|..|.+||.+.+ .+++++.|||+.|||+.||+||.+-+.+...  ....+.++..    -+
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSITK  250 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccCCc
Confidence            664332  2334566778999999998776 5789999999999999999999988765322  1111222211    11


Q ss_pred             cchhhhcchhccCC------cccccc------hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          514 ISVMEIVDANLLSQ------KDEHFT------TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       514 ~~~~~~~d~~~~~~------~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      +.+.+...-.++..      +...+.      .+-.-.++..+|+.+++..||.+|+++.+++.|-
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            11111111111100      000000      0111234788999999999999999999998774

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=289.49  Aligned_cols=240  Identities=23%  Similarity=0.261  Sum_probs=193.7

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +++|.....+|.|+|+.|-.+.. .+++..++|++...    ..+...|+.++... .||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45677777899999999988874 47899999999755    23345567666655 69999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe-CCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      .+.|+-+.+.+...+. .. ..+..|+.+|+.|+.|||   ..||||||+||+|||+ ++.++++|+|||.++.....  
T Consensus       397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988776665443 22 677789999999999999   9999999999999999 69999999999999876443  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         ....+-|..|.|||.+....+++++|+||||++||+|++|+.||.....+    .+...            ..... 
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~------------~i~~~-  529 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHT------------RIQMP-  529 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHH------------hhcCC-
Confidence               23345678899999999999999999999999999999999998764322    11111            00000 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         .  .....+....+|+.+||+.||.+||+|.++..|
T Consensus       530 ---~--~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 ---K--FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---c--cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence               1  114567889999999999999999999999765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=275.63  Aligned_cols=242  Identities=22%  Similarity=0.272  Sum_probs=195.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  365 (580)
                      ..+|..+.+||+|+||.|-.|..+ +.+.+|||+++...-   ...+--..|-++|+.. +-|.++++..++..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457888999999999999999755 567899999976532   2233345577777766 57899999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+.||+|--.+++.+. +.+..+.-+|..||-||-+||   ++||++||||..|||+|.+|.+||+|||+++.-...
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999877776653 778888899999999999999   999999999999999999999999999999854333


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      +.  .....+||+.|+|||++....|+..+|.|||||+||||+.|++||++..+.  .+           ...+.+..  
T Consensus       504 ~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--el-----------F~aI~ehn--  566 (683)
T KOG0696|consen  504 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--EL-----------FQAIMEHN--  566 (683)
T ss_pred             Cc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HH-----------HHHHHHcc--
Confidence            22  344678999999999999999999999999999999999999999873221  11           11122221  


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCC
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN  559 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  559 (580)
                            -..+...+.+..++....+.+.|.+|..
T Consensus       567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  2234456777888999999999999963

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=283.74  Aligned_cols=245  Identities=23%  Similarity=0.341  Sum_probs=202.2

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      .++||.|.||+||.|+++ +|+.||||++++..  .+...++.+|+.+++.++||.||.+..-|++.+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999855 79999999996542  344578899999999999999999999999999999999999776


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC---CcEEEccccCccccCCCCCccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      -|.-++......+++..-..+..||+.||.|||   -++|+|.|+||+|||+.+.   .++||||||+|+.+....   -
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            666667776778999888899999999999999   9999999999999999643   369999999999874332   3


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+||+.|+|||.++...|...-|+||.|||+|--++|..||.+..                ++.+.+...-+..   
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----------------dIndQIQNAaFMy---  783 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----------------DINDQIQNAAFMY---  783 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----------------chhHHhhcccccc---
Confidence            345789999999999999999999999999999999999999997621                1211121111111   


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+.+.+.+..+||...++..-++|-+....+.|
T Consensus       784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            112346677888899999999999999999887765

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=277.92  Aligned_cols=256  Identities=28%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEecc--ccc-----hhhhHHHHHHHHhhcCCCCcceEEeeee-cCCc
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQ--YGR-----AFKSFDIECDMIKRIRHRNIIKIISSCS-SDDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~--~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~  362 (580)
                      ++|-.+.+||+|||+.||+|. +...+.||||+-..+  +.+     ..+...+|.++...+.||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            456678899999999999997 556789999986432  211     1234567999999999999999999986 4567


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEccccCc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMA  439 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~a  439 (580)
                      .|-|+|||+|.+|+-|+...+ .+++..+.+|+.||+.||.||. +.+.+|+|-||||.|||+.   .-|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            889999999999999987655 5899999999999999999999 4478999999999999994   5678999999999


Q ss_pred             cccCCCCCccc-----ccccccCCCcCCcccccC----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh
Q 038098          440 KPLLKEDQSLT-----QTQTLATIGYMAPEYGRE----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       440 ~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  510 (580)
                      +.+..+.....     .....||.+|++||.+.-    .+++.|+||||.|||+|.++.|+.||.....    .      
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----Q------  690 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----Q------  690 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----H------
Confidence            98865443321     345679999999997753    3578999999999999999999999975311    1      


Q ss_pred             hcccchhhhcchh-ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038098          511 LLPISVMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVT  565 (580)
Q Consensus       511 ~~~~~~~~~~d~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~  565 (580)
                            .+++... +.....-.++..+.++.+..++|++|+.+.-++|....++..
T Consensus       691 ------QdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 ------QDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ------HHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                  1111111 111112233444567788999999999999999998887754

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=265.76  Aligned_cols=248  Identities=27%  Similarity=0.352  Sum_probs=190.2

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      ...||.|+||+|++-.++ +|+..|||++..... ....++..|.+...+- ++||||+++|.+-.++..++.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            467999999999999765 799999999976544 5567888888875544 799999999999888999999999954 


Q ss_pred             ChHHH---hhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          374 SLEKC---LYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       374 ~L~~~---l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ||+.+   .+. .+..+++...-.|+...+.||.||-+  ...|+|||+||+|||++..|.+|+||||++..+.   .+.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DSI  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---HHH
Confidence            77654   222 22457888888888999999999985  5689999999999999999999999999987653   233


Q ss_pred             cccccccCCCcCCcccccCC--CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc--chhcc
Q 038098          450 TQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV--DANLL  525 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~~~  525 (580)
                      ..+.-+|-..|||||.+...  .+.-+|||||+|++|||+.||+.|+..          |-+-.  +.+..++  |+...
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----------w~svf--eql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----------WDSVF--EQLCQVVIGDPPIL  290 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----------HHHHH--HHHHHHHcCCCCee
Confidence            44555688889999988643  478899999999999999999999865          22210  0111111  11111


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...    ......+..+..++.-|+.+|-+.||...++.++
T Consensus       291 ~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111    1112356778999999999999999999998764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-34  Score=240.35  Aligned_cols=266  Identities=26%  Similarity=0.283  Sum_probs=201.1

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +|...++||+|.||+||+|+. .+++.||+|++....  ...-....+|+-+++.++|.|||++++....+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            355668899999999999984 468899999986543  23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      |+. +|..|..+-..-++.+.+.+++.|+++|+.++|   ++.+.|||+||.|.+++.+|++|++|||+++-+.-+..  
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr--  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence            965 999999988888999999999999999999999   99999999999999999999999999999996633221  


Q ss_pred             cccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHH--hhcccc----hhhhcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVN--DLLPIS----VMEIVD  521 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~--~~~~~~----~~~~~d  521 (580)
                      -....+-|..|.+|..+.+.+ |++..|+||.||++.|+.. |++-|.+..- +.++....+  ..+.++    +...-|
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccCCC
Confidence            234567899999999988765 7888999999999999998 5554544211 112222111  111110    112222


Q ss_pred             hhccCCcccccchhhh----hHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQ----CVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~----~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      -..+..... ...+.+    ....=.+++.+.+.-+|.+|.++++.++|
T Consensus       236 yk~yp~ypa-ttswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  236 YKPYPIYPA-TTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CcccCCccc-cchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            222221111 111222    22334688889999999999999998875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.4e-33  Score=296.28  Aligned_cols=260  Identities=21%  Similarity=0.239  Sum_probs=172.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-C----CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEee------ee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-D----GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISS------CS  358 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  358 (580)
                      ..++|...+.||+|+||.||+|... +    +..||+|++.....  .+....|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999865 4    68999998753221  1111111  1222222233322221      24


Q ss_pred             cCCceeeEeeccCCCChHHHhhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCC
Q 038098          359 SDDFKALVLEYMPHGSLEKCLYSSNYIL-------------------DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  419 (580)
Q Consensus       359 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  419 (580)
                      .....++||||+.+++|.+++.....+.                   ....+..++.||+.||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5667899999999999999987543221                   23345679999999999999   8999999999


Q ss_pred             CCCEEeCC-CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC----------------------CCCCchh
Q 038098          420 PSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG----------------------QVSTNGD  476 (580)
Q Consensus       420 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  476 (580)
                      |+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 6899999999998653322 2223345789999999955322                      2345679


Q ss_pred             hHhHHHHHHHHHhCCCCCCccc--------cCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhh
Q 038098          477 VYSFGIMLMETFTRKKPTDEIF--------FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMK  548 (580)
Q Consensus       477 vws~Gvil~elltg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~  548 (580)
                      |||+||++|||+++..|++...        ..+.....|.....         ..........+...........+|+.+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE---------PRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc---------cccchhhhhhhhhccccchHHHHHHHH
Confidence            9999999999999877654310        01112222322111         100000000011111123346689999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 038098          549 CTVESPEQRINAKEIVTR  566 (580)
Q Consensus       549 cl~~dP~~Rps~~ev~~~  566 (580)
                      |++.||++|||++|+++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999987

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=268.96  Aligned_cols=264  Identities=21%  Similarity=0.248  Sum_probs=198.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-C-C----CcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-H-R----NIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~~  363 (580)
                      +++|.+...+|+|.||.|-..... .+..||||+++.- ....++...|+++++++. + |    -+|.+.+|+.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999998643 5789999998532 234466778999999994 2 2    267788889999999


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---------------
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---------------  427 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---------------  427 (580)
                      |+|+|.+ |.|+.+++...+ .+++..++..++.|+++++++||   +.+++|.||||+|||+.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 669999998866 57999999999999999999999   999999999999999832               


Q ss_pred             -----CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc
Q 038098          428 -----NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM  502 (580)
Q Consensus       428 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~  502 (580)
                           +..++++|||-|+.-....     ...+.|..|.|||++.+-.++.++||||+||||.|+.||..-|...... .
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~-E  316 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL-E  316 (415)
T ss_pred             eccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH-H
Confidence                 3358999999998653332     4456889999999999999999999999999999999999988653211 1


Q ss_pred             hHHHHHHhhcccchhhhcchh---------ccC------C---------ccc---ccchhhhhHHHHHHHHhhccCCCCC
Q 038098          503 TLKHWVNDLLPISVMEIVDAN---------LLS------Q---------KDE---HFTTKGQCVSFIFNLAMKCTVESPE  555 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~d~~---------~~~------~---------~~~---~~~~~~~~~~~l~~l~~~cl~~dP~  555 (580)
                      .+ ........+-....+...         ...      .         ..+   -.........++++|+++|+..||.
T Consensus       317 HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  317 HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            11 111111111111111110         000      0         000   0001122345699999999999999


Q ss_pred             CCCCHHHHHHH
Q 038098          556 QRINAKEIVTR  566 (580)
Q Consensus       556 ~Rps~~ev~~~  566 (580)
                      +|+|+.|++.|
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.5e-33  Score=286.14  Aligned_cols=265  Identities=20%  Similarity=0.263  Sum_probs=184.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEe-----------------CCCCEEEEEEEeccccchh--------------hhHHHH
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI-----------------QDGMEVAVKVFDLQYGRAF--------------KSFDIE  338 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~e  338 (580)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........              +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999963                 2356799999864322211              233457


Q ss_pred             HHHHhhcCCCCc-----ceEEeeeec--------CCceeeEeeccCCCChHHHhhcCC----------------------
Q 038098          339 CDMIKRIRHRNI-----IKIISSCSS--------DDFKALVLEYMPHGSLEKCLYSSN----------------------  383 (580)
Q Consensus       339 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  383 (580)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888876654     677777653        356799999999999999887431                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCC
Q 038098          384 -YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA  462 (580)
Q Consensus       384 -~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a  462 (580)
                       ..+++..+..++.|+++|+.|||   +.+|+||||||+||+++.++.+||+|||++..+.... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence             13467788999999999999999   8999999999999999999999999999997653321 111222335789999


Q ss_pred             cccccCCCC----------------------CCchhhHhHHHHHHHHHhCCC-CCCccccCCchHHHHHHhhcccchhhh
Q 038098          463 PEYGREGQV----------------------STNGDVYSFGIMLMETFTRKK-PTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       463 PE~~~~~~~----------------------~~~~Dvws~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ||.+.....                      ..+.||||+||++|||++|.. |+.........+..+..     .... 
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~-----~~~~-  452 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN-----DLNR-  452 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc-----hHHH-
Confidence            998754321                      234799999999999999885 65432111111111000     0000 


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESP---EQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~ev~~~  566 (580)
                      +..  .......+......+....+|+.+|+..+|   .+|+|++|+++|
T Consensus       453 ~r~--~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        453 WRM--YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             HHh--hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            000  001111223334456778999999999876   689999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-32  Score=263.84  Aligned_cols=239  Identities=31%  Similarity=0.382  Sum_probs=193.6

Q ss_pred             cCceEEEEEeC-CCCEEEEEEEeccccch-hhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChHHHhhc
Q 038098          304 GFGSVYKARIQ-DGMEVAVKVFDLQYGRA-FKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYS  381 (580)
Q Consensus       304 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  381 (580)
                      +||.||+|... +|+.+|+|++....... .+.+..|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999997654433 67889999999999999999999999998999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcC
Q 038098          382 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM  461 (580)
Q Consensus       382 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~  461 (580)
                      ... +++..++.++.+++.++.|||   +.+++|+||+|+||+++.++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            544 899999999999999999999   8899999999999999999999999999998664332   233455788999


Q ss_pred             CcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHH
Q 038098          462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF  541 (580)
Q Consensus       462 aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  541 (580)
                      |||......++.++||||+|+++|+|++|..||.....    ...+..         ....   .... .......++.+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~---------~~~~---~~~~-~~~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFK---------KIGK---PKPP-FPPPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHH---------HHhc---cCCC-CccccccCCHH
Confidence            99999888899999999999999999999999865211    111111         1100   0000 00001115677


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          542 IFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       542 l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.+++.+|+..+|++||++.+++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhhC
Confidence            8999999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=257.59  Aligned_cols=247  Identities=22%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|...++||+|+|+.|-.++++ +.+.+|+|+++++   .++..+..+.|-.+..+- +||.+|.+..|+.++..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            356889999999999999999854 6788999999765   345667788888887776 79999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |.||++||+|--.+++.+ .++++.+.-+...|.-||.|||   ++||++||+|..|||+|..|.+|++|||+++.-..+
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999987776655 4888888899999999999999   999999999999999999999999999999854333


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC--CchHHHHHHhhcccchhhhcchh
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG--DMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      +.  .....+||+.|.|||++++..|+..+|.|++||+++||+.|+.||+.....  +..-.++.-       +-++...
T Consensus       405 gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf-------qvilekq  475 (593)
T KOG0695|consen  405 GD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF-------QVILEKQ  475 (593)
T ss_pred             Cc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH-------HHHhhhc
Confidence            32  345678999999999999999999999999999999999999999864322  222222221       1122221


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI  558 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  558 (580)
                      +        ..+...+.....+++.-+++||.+|.
T Consensus       476 i--------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 I--------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             c--------cccceeehhhHHHHHHhhcCCcHHhc
Confidence            1        12334455667889999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=283.83  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=205.7

Q ss_pred             HhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeee-----cCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCS-----SDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~  362 (580)
                      -++.|.+.+.||.|.+|.||+++. ++|+.+|+|+...... ..+++..|.++++.. .|||++.++|++.     .++.
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            346688899999999999999984 4789999999876543 336678889999888 6999999999984     3678


Q ss_pred             eeeEeeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          363 KALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ++||||||.+||..|.+..- +..+.|..+..|++.++.|+.|||   ...++|||||-.|||++.++.||++|||.+..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            99999999999999987643 467999999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      +..  .-......+||+.|||||++.-     ..|+.++|+||+|++..||.-|.+|+..+-.              .. 
T Consensus       173 lds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------------mr-  235 (953)
T KOG0587|consen  173 LDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------------MR-  235 (953)
T ss_pred             eec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------------hh-
Confidence            532  2234456689999999998853     3577899999999999999999999765311              00 


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ..+.  +...+.+....+..-..++.++|..|+.+|-++||++.++++|
T Consensus       236 -aLF~--IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 -ALFL--IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -hhcc--CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence             0000  1122333445566677889999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=275.88  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=202.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCCC-CEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDG-MEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++..+..||-|+||.|=.++..+. ..+|+|++++.   ..+..+.+..|-.+|...+.|.||++|..|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            3455567799999999999986643 34899988654   2344566778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |-|-||.|+..+..++ .++..++.-++..+++|++|||   .++||+|||||+|.++|.+|-+||.|||+|+.+...  
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--  573 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence            9999999999887655 5899999999999999999999   999999999999999999999999999999977433  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                       ...-..+||+.|.|||++.+.....++|.||+|+++|||+||.+||.+...    +..+ +     .+..-+|      
T Consensus       574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktY-n-----~ILkGid------  636 (732)
T KOG0614|consen  574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTY-N-----LILKGID------  636 (732)
T ss_pred             -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHH-H-----HHHhhhh------
Confidence             334567899999999999999999999999999999999999999976311    1110 0     0111111      


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTRL  567 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~L  567 (580)
                         ....|........+|+++....+|.+|..     +.||.+|-
T Consensus       637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence               12233445666789999999999999985     66776663

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=288.21  Aligned_cols=244  Identities=27%  Similarity=0.411  Sum_probs=189.5

Q ss_pred             CCcCceeccccCc-eEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccC
Q 038098          294 FSENNLIGRGGFG-SVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       294 ~~~~~~lg~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      |...+++|.|+.| .||+|... |+.||||++-.   +..+...+|+..++.- +|||||++++.-.++...|++.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3445678999987 56999987 89999998743   3345678899999988 69999999999999999999999997


Q ss_pred             CCChHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-----CCcEEEccccCccccC
Q 038098          372 HGSLEKCLYSSNY---ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLL  443 (580)
Q Consensus       372 ~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~  443 (580)
                      . +|.+++.....   .......+.++.|+++|++|||   +.+||||||||.||||+.     ...++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 99999987421   1111445789999999999999   999999999999999975     2579999999999886


Q ss_pred             CCCCccc-ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhC-CCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          444 KEDQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       444 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ....+.. .....||.+|+|||++....-+.++||||+||++|+.++| .+||+.....+..+..               
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---------------  727 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---------------  727 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---------------
Confidence            5544332 3456799999999999998889999999999999999995 8998763222111110               


Q ss_pred             hhccCCccc-ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDE-HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .    .... ......++  +..+||.+|++++|..||++.+|+.|
T Consensus       728 ~----~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 G----NYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             C----ccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0    0000 00111112  78899999999999999999999865

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.3e-32  Score=273.33  Aligned_cols=206  Identities=23%  Similarity=0.354  Sum_probs=176.7

Q ss_pred             CCCcCceeccccCceEEEEE-eCCCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      -|..++.||-|+||+|.+++ ..+...||+|.+.+.   .......++.|-+||+.-..+-||+++-.|.+.+.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            36778889999999999997 556778999988644   23455677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |++||++-.+|.+.+ .+.++-++.++..+..|+++.|   +.|+|||||||+|||||.+|.+||+|||+++-+.....+
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999887655 5888999999999999999999   999999999999999999999999999999755321110


Q ss_pred             ----------------------------------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHH
Q 038098          449 ----------------------------------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF  488 (580)
Q Consensus       449 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ell  488 (580)
                                                              ......+||+.|+|||++....++.-+|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                                                    0022446999999999999999999999999999999999


Q ss_pred             hCCCCCCccccCCc
Q 038098          489 TRKKPTDEIFFGDM  502 (580)
Q Consensus       489 tg~~p~~~~~~~~~  502 (580)
                      .|++||.+...++.
T Consensus       866 ~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  866 VGQPPFLADTPGET  879 (1034)
T ss_pred             hCCCCccCCCCCcc
Confidence            99999987655543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-33  Score=252.46  Aligned_cols=266  Identities=24%  Similarity=0.337  Sum_probs=198.0

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----CceeeE
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DFKALV  366 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  366 (580)
                      +..+.||.|+||.||.+... +|+.||+|.+..-  .-...+.+.+|+.++..++|.|++..++...-.     ...|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34578999999999999754 8999999988532  223457888999999999999999988765433     246789


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +|.|.. +|..++-+ ...++.+.+.-+.+||++||.|||   +.+|.||||||.|.|++++..+||||||+|+.- ..+
T Consensus       136 TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve-e~d  209 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTW-DQR  209 (449)
T ss_pred             HHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccccc-chh
Confidence            999855 88886654 456888889999999999999999   999999999999999999999999999999844 334


Q ss_pred             CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch---------
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV---------  516 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  516 (580)
                      .....+..+-|..|.|||++++. .|+.+.||||.|||+.|++..+.-|...  +....-+.+.+......         
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq--~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA--GPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc--ChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            44456677789999999999875 6899999999999999999999887652  22222222222222111         


Q ss_pred             ---hhhcchhccCCccc---ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          517 ---MEIVDANLLSQKDE---HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       517 ---~~~~d~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                         ..++..........   ....+.....+...+..+++..||.+|.+..+.+.++-
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence               11111111111000   11112233456778999999999999999999887753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=234.04  Aligned_cols=198  Identities=27%  Similarity=0.360  Sum_probs=164.0

Q ss_pred             CCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ......||+|++|.|-+-++ ++|+..|+|.+.... .+..++...|+.+..+. .+|.+|.++|.+..+...++.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            34456799999999988875 479999999996543 35567778888886554 7999999999999999999999999


Q ss_pred             CCCChHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          371 PHGSLEKCL---YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       371 ~~g~L~~~l---~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +- ||+.+-   ...+...++...=+||..+.+||.|||+  +..|+|||+||+|||++.+|++||||||++..+.+.- 
T Consensus       128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-  203 (282)
T KOG0984|consen  128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-  203 (282)
T ss_pred             hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence            55 887763   2455678999999999999999999995  5689999999999999999999999999998764322 


Q ss_pred             cccccccccCCCcCCcccccC----CCCCCchhhHhHHHHHHHHHhCCCCCCcc
Q 038098          448 SLTQTQTLATIGYMAPEYGRE----GQVSTNGDVYSFGIMLMETFTRKKPTDEI  497 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dvws~Gvil~elltg~~p~~~~  497 (580)
                        ..+...|-..|||||.+..    ..|+-||||||+|+.+.||.+++.||+..
T Consensus       204 --Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  204 --AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             --HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence              2333457778999998753    36889999999999999999999998763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.6e-31  Score=233.54  Aligned_cols=263  Identities=21%  Similarity=0.290  Sum_probs=195.8

Q ss_pred             HhcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecC--Cceee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSD--DFKAL  365 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l  365 (580)
                      ..++|++.+.+|+|.+++||.|. ..+++.++||+++.-   ..+.+.+|+.++..+. ||||+++++...++  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            34678889999999999999997 557889999999643   3467889999999997 99999999998664  46789


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEccccCccccCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  444 (580)
                      |+||+++.+....-.    .++...+..++.++++||.|+|   +.||.|||+||.|+++| +.-.++|+|+|+|.++.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999988776443    3777788899999999999999   99999999999999998 456799999999998755


Q ss_pred             CCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-----------
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-----------  512 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------  512 (580)
                      ....   .-++.+..|--||.+.. ..+...-|+|||||++..|+..+.||-.-.....++...+.-.-           
T Consensus       186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            4332   23456677889998765 45788899999999999999999997431111112222221111           


Q ss_pred             ----ccchhhhcchhccCCcccccc---hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          513 ----PISVMEIVDANLLSQKDEHFT---TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       513 ----~~~~~~~~d~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          +.....++......... ++.   ...-.++++.+++.+.+..|-++|||++|++.|
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~-~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWS-RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHH-HhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                11111111111111110 011   112245789999999999999999999999876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.1e-29  Score=235.52  Aligned_cols=211  Identities=36%  Similarity=0.553  Sum_probs=183.9

Q ss_pred             eccccCceEEEEEeC-CCCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChHH
Q 038098          300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEK  377 (580)
Q Consensus       300 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  377 (580)
                      ||+|.+|.||++... +++.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999876 4899999998755332 34678899999999999999999999999899999999999999999


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEccccCccccCCCCCccccccccc
Q 038098          378 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLA  456 (580)
Q Consensus       378 ~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  456 (580)
                      ++......+++..++.++.++++++.+||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            98876456899999999999999999999   889999999999999999 89999999999986543321  2233457


Q ss_pred             CCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchh
Q 038098          457 TIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       457 ~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  535 (580)
                      ...|++||..... ..+.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            7889999998877 888999999999999998                                                


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                          ..+.+++.+|++.+|++||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                3366899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=239.44  Aligned_cols=263  Identities=25%  Similarity=0.282  Sum_probs=198.3

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----  360 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  360 (580)
                      ....+|.-...+|.|.- .|..|... .+++||+|.....  .....++..+|...+..++|+|+++++.++.-.     
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34456777788999988 66666543 5899999987433  234557778899999999999999999998543     


Q ss_pred             -CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          361 -DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       361 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                       ...|+|||+|.. +|...+.   ..++..+...+..|++.|++|||   +.+|+||||||+||++..++.+||.|||+|
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence             357899999955 8888776   34788889999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-----cc
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-----PI  514 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~  514 (580)
                      +.-   +.....+..+.|..|.|||.+.+..+.+.+||||.||++.||++|+.-|.    |+..+.+|.....     ..
T Consensus       166 r~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  166 RTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             ccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCH
Confidence            843   33356677889999999999988889999999999999999999998764    4455555532110     00


Q ss_pred             c----hhhh-------cchhccCCccccc---------chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 S----VMEI-------VDANLLSQKDEHF---------TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~----~~~~-------~d~~~~~~~~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .    +...       .+..........+         .....-...+.+++.+||..+|++|-+++++++|
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0    0000       0000000000000         0111224457899999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=261.78  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|.....+|.|.||.||+|+. .+++..|+|+++.......+-.+.|+-+++..+||||+.++|.+...+..+++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            4677889999999999999985 479999999999988888889999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      .+|+|++.- ....++++.++..+.+...+|++|||   +.+-+|||||-.||++++.|.+|++|||.+-.+...  -..
T Consensus        95 gggslQdiy-~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K  168 (829)
T KOG0576|consen   95 GGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK  168 (829)
T ss_pred             CCCccccee-eecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence            999999954 34457999999999999999999999   999999999999999999999999999998755322  123


Q ss_pred             ccccccCCCcCCcccc---cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          451 QTQTLATIGYMAPEYG---REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~---~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .....||+.|||||+.   +.+.|..++|||+.|+..-|+-.-++|.-..              .+...........+. 
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--------------hpmr~l~LmTkS~~q-  233 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--------------HPMRALFLMTKSGFQ-  233 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--------------chHHHHHHhhccCCC-
Confidence            4467899999999965   4578899999999999999998888874221              011111111111111 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .+.......-++.+.++++.|+.++|.+||++..++.|
T Consensus       234 -pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  234 -PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             11223333446778999999999999999999987764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=242.70  Aligned_cols=130  Identities=28%  Similarity=0.377  Sum_probs=109.8

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC--------CCCcceEEeeeec---
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR--------HRNIIKIISSCSS---  359 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~---  359 (580)
                      .+|-+.++||-|.|++||++. .++.+.||+|+.+.. ..-.+....||++|++++        ...||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            568889999999999999997 456788999998644 234466778999999984        3579999998854   


Q ss_pred             -CCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          360 -DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       360 -~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                       +.++|+|+|++ |.+|..++.... +-++...+.+|++||+.||.|||..  .+|+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence             56899999999 668988887665 4589999999999999999999974  499999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-30  Score=251.87  Aligned_cols=196  Identities=24%  Similarity=0.342  Sum_probs=167.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--------cchhhhHHHHHHHHhhcC---CCCcceEEeeeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--------GRAFKSFDIECDMIKRIR---HRNIIKIISSCSS  359 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  359 (580)
                      .+|...+.+|.|+||.|+.|.++ +...|+||.+.++.        ++..-.+-.|+.+|+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45888899999999999999876 46679999886541        112234556999999997   9999999999999


Q ss_pred             CCceeeEeeccC-CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccC
Q 038098          360 DDFKALVLEYMP-HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  438 (580)
Q Consensus       360 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  438 (580)
                      .+..||+||-.. +.+|.+++..+. .+++..+..|+.||+.|+++||   +.+|||||||-+||.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            999999999864 458889887554 5999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCC
Q 038098          439 AKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTD  495 (580)
Q Consensus       439 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~  495 (580)
                      |.+....    .....+||..|.|||.+.+.+| +..-|||++|+++|-++....||.
T Consensus       717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9865332    3456789999999999988876 567899999999999998888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.8e-28  Score=231.77  Aligned_cols=199  Identities=31%  Similarity=0.432  Sum_probs=172.8

Q ss_pred             CCcCceeccccCceEEEEEeCC-CCEEEEEEEeccccc-hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      |...+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+..|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999998764 899999999765444 56788899999999999999999999999899999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +++|.+++......+++..+..++.+++.++.+||   +.+++|+|++|+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            99999998765544899999999999999999999   889999999999999999999999999999876443211 12


Q ss_pred             cccccCCCcCCcccc-cCCCCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          452 TQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            234577889999998 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.7e-28  Score=235.18  Aligned_cols=269  Identities=25%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ...+.|..+++||.|.|++||+|...    ..+.||+|.+...  ....++.+|++++..+ .+.||+++.+++..++..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34567889999999999999999743    4678999998654  3446789999999999 499999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEccccCcccc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPL  442 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~  442 (580)
                      .+|+||++.....++...    ++...+..++..+..||.++|   ..|||||||||+|++.+ ..+.-.|.|||+|...
T Consensus       111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHH
Confidence            999999999888887654    668889999999999999999   99999999999999997 5677899999999721


Q ss_pred             CCCC----------------------------------Cc--------ccccccccCCCcCCcccccC-CCCCCchhhHh
Q 038098          443 LKED----------------------------------QS--------LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYS  479 (580)
Q Consensus       443 ~~~~----------------------------------~~--------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws  479 (580)
                      ....                                  ..        .......||+||.|||++.. +..++++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            1000                                  00        00123469999999998765 56789999999


Q ss_pred             HHHHHHHHHhCCCCCCccccCCchHHHHHH----------------------hhcccchh-----hhcc-hhccCCcc--
Q 038098          480 FGIMLMETFTRKKPTDEIFFGDMTLKHWVN----------------------DLLPISVM-----EIVD-ANLLSQKD--  529 (580)
Q Consensus       480 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~----------------------~~~~~~~~-----~~~d-~~~~~~~~--  529 (580)
                      .|||++-+++++.||-.....-..+.+.+.                      +..+....     +-++ ..+.....  
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            999999999999998553332222222111                      00000000     0000 11111011  


Q ss_pred             cccchh-hhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTK-GQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...... ...+..+++++.+|+..||.+|.|++|.++|
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            011112 2234578999999999999999999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=5.9e-29  Score=242.42  Aligned_cols=267  Identities=23%  Similarity=0.272  Sum_probs=199.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC------CCCcceEEeeeecCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR------HRNIIKIISSCSSDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~  362 (580)
                      ..++|.+....|+|-|++|.+|... -|..||||++..+. ...+.-+.|+++|.+|.      --|+++++..|....+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4567888889999999999999855 48899999997552 23355678999999995      4589999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMA  439 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a  439 (580)
                      +|||+|-+. .+|.+.+...+.  -+...++..++.|+.-||..|-   ..+|+|.||||.|||+++. ..+||||||.|
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            999999984 489999887663  4778899999999999999999   9999999999999999864 56899999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch----------------
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT----------------  503 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~----------------  503 (580)
                      .......    .+.+.-+..|.|||++.+-.|....|+||.||.||||.||+.-|.+.....+.                
T Consensus       585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            8663332    23344566799999999999999999999999999999999888653221110                


Q ss_pred             HHHHHHhhcccc------------------hhhhcch------hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC
Q 038098          504 LKHWVNDLLPIS------------------VMEIVDA------NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN  559 (580)
Q Consensus       504 ~~~~~~~~~~~~------------------~~~~~d~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  559 (580)
                      -.++..+.+...                  +...+.+      .+..... ...........+.+|+.+|+..||++|.|
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~-~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQR-LPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCC-CCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence            011111111111                  0000000      0000000 00112234567899999999999999999


Q ss_pred             HHHHHHH
Q 038098          560 AKEIVTR  566 (580)
Q Consensus       560 ~~ev~~~  566 (580)
                      ..++++|
T Consensus       740 ~nqAL~H  746 (752)
T KOG0670|consen  740 VNQALKH  746 (752)
T ss_pred             HHHHhcC
Confidence            9999876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.1e-27  Score=216.91  Aligned_cols=170  Identities=21%  Similarity=0.190  Sum_probs=131.0

Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      |+|.+++...+..+++.+++.++.||++||.|||   +.+      ||+||+++.++.+++  ||.+......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999877777999999999999999999999   665      999999999999999  9998865321       


Q ss_pred             ccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.||.........+..+.....+.            ... ..
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~-~~  129 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------------DPR-DR  129 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------------Ccc-cc
Confidence            12588999999999999999999999999999999999999865322222222222211110            000 00


Q ss_pred             chhhhhHH--HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          533 TTKGQCVS--FIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       533 ~~~~~~~~--~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ........  ++.+++.+||+.+|++||++.|+++++..+..+
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            11122233  689999999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-28  Score=217.42  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=185.9

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEe-eeecCCceeeE
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIIS-SCSSDDFKALV  366 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~lv  366 (580)
                      ..+.|.+.+.+|+|.||.+-.+.++ +.+.+++|.+.... ...++|.+|...=-.+ .|.||+.-++ .|+..+...++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3466888999999999999999876 57889999886442 3456788876654444 5899988765 46778888999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC--CCCcEEEccccCccccCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||++.|+|.+-+...+  +.+....+++.|+++|+.|+|   +..+||||||.+|||+-  +...+|+||||+++... 
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-  174 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC-
Confidence            99999999998776654  778888899999999999999   99999999999999993  34479999999988542 


Q ss_pred             CCCcccccccccCCCcCCcccccC---C--CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGRE---G--QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                        ...  ....-+..|.|||....   +  ...+.+|||.||+++|.++||+.||....-.+..+..|..=....     
T Consensus       175 --~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk-----  245 (378)
T KOG1345|consen  175 --TTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK-----  245 (378)
T ss_pred             --cee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-----
Confidence              111  11224456899996542   2  357789999999999999999999986544444555543311000     


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .+....       .-...++.+..+.++-+..+|++|=...++.+.
T Consensus       246 -~~~~P~-------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  246 -NPALPK-------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -CccCch-------hhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence             000100       112245667889999999999999555554443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.4e-27  Score=267.28  Aligned_cols=197  Identities=17%  Similarity=0.231  Sum_probs=141.9

Q ss_pred             hcCC-CCcceEEeee-------ecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 038098          344 RIRH-RNIIKIISSC-------SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH  415 (580)
Q Consensus       344 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H  415 (580)
                      .++| +||+++++++       ...+..+.++||+ +++|.+++......+++.+++.++.||++||+|||   +.+|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            3455 6888888877       2234667888987 55999999876667999999999999999999999   999999


Q ss_pred             ecCCCCCEEeCC-------------------CCcEEEccccCccccCCCC--------------CcccccccccCCCcCC
Q 038098          416 CDLKPSNVLLDD-------------------NMVAHLSDFGMAKPLLKED--------------QSLTQTQTLATIGYMA  462 (580)
Q Consensus       416 ~dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~--------------~~~~~~~~~~~~~y~a  462 (580)
                      |||||+|||++.                   ++.+|++|||+++......              .........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   4456666777665321100              0001112457889999


Q ss_pred             cccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHH
Q 038098          463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI  542 (580)
Q Consensus       463 PE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l  542 (580)
                      ||++.+..++.++|||||||++|||++|.+|+....   .....+...        ...+           .........
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~--------~~~~-----------~~~~~~~~~  241 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHR--------VLPP-----------QILLNWPKE  241 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHh--------hcCh-----------hhhhcCHHH
Confidence            999999999999999999999999999988864310   011111100        0000           000112345


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHH
Q 038098          543 FNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       543 ~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+++.+||+++|.+||+|.|+++|
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            688899999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.93  E-value=2e-25  Score=256.97  Aligned_cols=216  Identities=35%  Similarity=0.515  Sum_probs=158.5

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC-CC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS-IP   80 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-lp   80 (580)
                      |++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+++. +|
T Consensus       366 n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  445 (968)
T PLN00113        366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN  445 (968)
T ss_pred             CeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccC
Confidence            33333444444444444444444444444444555555555556666666555555556666666666666666654 33


Q ss_pred             CCCcCCCCCceEeCcCCccc-----ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINL  155 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~-----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  155 (580)
                      ..+..+++|+.|+|++|++.     ....++|+.|++++|++++..|..|..+++|+.|+|++|.+++.+|..+..+++|
T Consensus       446 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  525 (968)
T PLN00113        446 SRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL  525 (968)
T ss_pred             hhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCC
Confidence            44556667777777777662     2245678999999999998889999999999999999999999999999999999


Q ss_pred             ccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          156 KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       156 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      +.|+|++|.+++.+|..+..+++|+.|++++|++++.+|.. ..+..+..+++++|+..+..|
T Consensus       526 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        526 VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             CEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            99999999999999999999999999999999999877754 667888899999999877555

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-26  Score=208.03  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=189.2

Q ss_pred             cCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCC
Q 038098          296 ENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      ...+|.+...|+.|+|+|+ |..+++|++....  .+...+|..|.-.++-+.||||..++|.|..+....++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3456888999999999998 6677788876442  234467888988999999999999999999999999999999999


Q ss_pred             ChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccccc
Q 038098          374 SLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  452 (580)
Q Consensus       374 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  452 (580)
                      +|+..++... ...+..++.+++.+||+|++|||+ .++-|.---+.+..|++|++.+++|+- +-+      ..+....
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarism-ad~------kfsfqe~  344 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISM-ADT------KFSFQEV  344 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheec-ccc------eeeeecc
Confidence            9999998765 356888999999999999999993 223344446889999999999988751 111      1112222


Q ss_pred             ccccCCCcCCcccccCCCC---CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          453 QTLATIGYMAPEYGREGQV---STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       453 ~~~~~~~y~aPE~~~~~~~---~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ...-.+.||+||.+...+-   -.++|+|||++++||+.|...||.....-+             ...++.      ..+
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------------cgmkia------leg  405 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------------CGMKIA------LEG  405 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------------hhhhhh------hcc
Confidence            3345678999999876543   357899999999999999999997632110             011111      112


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      .+...++..+.-+.+|+.-|++.||.+||.+..|+-.|++..
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            234455667778899999999999999999999999998753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.6e-24  Score=214.13  Aligned_cols=166  Identities=20%  Similarity=0.180  Sum_probs=129.6

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC--CCCEEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFDLQ-----YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD  361 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  361 (580)
                      ...++|...+.||+|+||+||+|.+.  +++.||||++...     .......+.+|++++++++|+|++..+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            34578999999999999999999864  5778899987532     112345688999999999999998533222   4


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecC-CCCCEEeCCCCcEEEccccCcc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL-KPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ..++||||++|++|... ..    ..   ...++.|+++||.|||   +.+|+|||| ||+|||++.++.++|+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            57999999999999732 11    11   1467899999999999   999999999 9999999999999999999999


Q ss_pred             ccCCCCCccc------ccccccCCCcCCcccccC
Q 038098          441 PLLKEDQSLT------QTQTLATIGYMAPEYGRE  468 (580)
Q Consensus       441 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~  468 (580)
                      .+........      .....++..|+|||++..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            7755432221      134567888999998854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5.8e-23  Score=205.51  Aligned_cols=262  Identities=22%  Similarity=0.253  Sum_probs=199.0

Q ss_pred             CCCcCceeccccCceEEEEEeCC--CCEEEEEEEeccccchhhhHHHHHHHHhhcCC----CCcceEEeee-ecCCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQD--GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH----RNIIKIISSC-SSDDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  365 (580)
                      +|.+.+.||+|+||.||.+...+  ...+|+|+...........+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999998654  35799998765533333378889999998863    6899999998 57788899


Q ss_pred             EeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-----CcEEEccccCc
Q 038098          366 VLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-----MVAHLSDFGMA  439 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfg~a  439 (580)
                      ||+.+ |.+|.++..... ..++..++++++.|++.+|+++|   +.|++||||||.|+.+...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99998 779999875554 67999999999999999999999   9999999999999999854     46999999999


Q ss_pred             c--ccCCCCCc----cc--ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh
Q 038098          440 K--PLLKEDQS----LT--QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       440 ~--~~~~~~~~----~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      +  .+......    ..  .....||..|+++....+.+.+++.|+||++.++.|+..|..||........ ......  
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~--  251 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEK--  251 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHH--
Confidence            8  33222211    11  2245599999999999999999999999999999999999999865322111 000000  


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                             .........      .....+.++.++...+-..+...+|....+...+++.....
T Consensus       252 -------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 -------DPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -------Hhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                   000000000      11223455667777777789999999999999988776653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-23  Score=193.06  Aligned_cols=264  Identities=17%  Similarity=0.169  Sum_probs=207.0

Q ss_pred             cCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      -.|.+.++||+|.||+++.|+ +-++++||||.-...  ....++..|.+..+.|. .++|..++-+..++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            358899999999999999997 557999999986433  33467788888888884 79999999888888888999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-----CcEEEccccCccccCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-----MVAHLSDFGMAKPLLK  444 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~  444 (580)
                      + |.||.|++.-.+..++..++..+|.|++.-++|+|   ++.+|+|||||+|+||..-     ..+.|+|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 77999999888888999999999999999999999   9999999999999999643     3589999999998866


Q ss_pred             CCCcc-----cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          445 EDQSL-----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       445 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +.+..     ......||.+||+--...+.+.+.+.|.=|+|-++++.+-|..||.+.....  ..+-        ...|
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~k--------YeKI  251 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKEK--------YEKI  251 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHHH--------HHHh
Confidence            54322     2345569999999999999999999999999999999999999998753321  1111        1122


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      -+....   .+-.......+.++..-+.-.=+.+-.+-|..+-+...+..+.+..
T Consensus       252 Ge~Kr~---T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  252 GETKRS---TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             cccccc---CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            222111   1112233456677777777776777778888877777666666553

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-25  Score=220.00  Aligned_cols=210  Identities=22%  Similarity=0.264  Sum_probs=184.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|-|+.+-.++++.++.|++||||.|.|+.+.-..|..=.++++|+|++|.|+.+.-+.|.++.+|.+|-|++|+|+.+|
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            47788888889999999999999999999666677777789999999999999999999999999999999999999999


Q ss_pred             C-CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccc
Q 038098           81 S-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI  153 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  153 (580)
                      . .|.+|++|+.|+|..|+|      +|.++++|+.|.|..|.+......+|-.+.++++|+|+.|+++..-..++.+++
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt  293 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT  293 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence            6 555699999999999998      689999999999999999999899999999999999999999977778999999


Q ss_pred             ccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCC
Q 038098          154 NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGN  210 (580)
Q Consensus       154 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n  210 (580)
                      +|+.|+||+|.|....++.+...++|++|+|++|+|+...+.. ..+..++.+.++.|
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~N  351 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHN  351 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccccc
Confidence            9999999999999888999999999999999999999877643 33344444444443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=184.88  Aligned_cols=265  Identities=19%  Similarity=0.172  Sum_probs=203.9

Q ss_pred             HHhcCCCcCceeccccCceEEEEE-eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC-CCcceEEeeeecCCceeeE
Q 038098          289 QATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH-RNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv  366 (580)
                      ...+.|..++.||.|+||.+|.|. ..+|++||||+-.....  ..++..|..+.+.+++ ..|..+..+..+...-.+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            345789999999999999999997 66899999998754433  3567788999999975 7788888888889999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a~~~~  443 (580)
                      ||.. |.||.+.+.-....++..+++-+|-|++.-++|+|   .++++||||||+|+|+.-   ...+.++|||+|+.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9998 78999998888888999999999999999999999   999999999999999963   3469999999998775


Q ss_pred             CCCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          444 KEDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       444 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      +....     .......||..|.+--...+.+.+.+.|+=|+|.++.+.--|..||.+.......  +-        ...
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~--QK--------yEk  235 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK--QK--------YEK  235 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH--HH--------HHH
Confidence            43321     2234556999999988888888899999999999999999999999875332111  11        111


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      +........   ........+.++.-.+.-|=..--++-|...-+-+..+-+..
T Consensus       236 I~EkK~s~~---ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  236 ISEKKMSTP---IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHhhcCCC---HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            111111110   111234557778888888888888888877666555554443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.90  E-value=3.9e-25  Score=218.79  Aligned_cols=193  Identities=25%  Similarity=0.269  Sum_probs=113.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.-+.|.+|.+|.+|.|+.|+|+...+..|.+|++|+.|+|..|+|.-..--.|.++++|+.|-|..|.|..+-
T Consensus       182 ~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~  261 (873)
T KOG4194|consen  182 SNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLD  261 (873)
T ss_pred             cccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccccc
Confidence            57788877788888888888888888888667777777888888888888876433445666666666666666555554


Q ss_pred             C-CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccc
Q 038098           81 S-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI  153 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  153 (580)
                      + .|..+.++++|+|+.|++      .+-+++.|+.|+||.|.|..+.++.++..++|+.|+|++|+|+...+..|..+.
T Consensus       262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~  341 (873)
T KOG4194|consen  262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS  341 (873)
T ss_pred             CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence            3 233455555555555555      133455555555555555555555555555555555555555544444444444


Q ss_pred             ccccccccccccCCCccccccccCcccEEEccCCcccCCC
Q 038098          154 NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEI  193 (580)
Q Consensus       154 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~  193 (580)
                      .|++|+|++|.++..-...|..+.+|+.|||++|.++..+
T Consensus       342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~I  381 (873)
T KOG4194|consen  342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCI  381 (873)
T ss_pred             HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEE
Confidence            4444444444444433444444444444444444444333

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.6e-21  Score=196.96  Aligned_cols=258  Identities=31%  Similarity=0.392  Sum_probs=197.7

Q ss_pred             CCcCceeccccCceEEEEEeCCCCEEEEEEEeccccc---hhhhHHHHHHHHhhcCCC-CcceEEeeeecCCceeeEeec
Q 038098          294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR---AFKSFDIECDMIKRIRHR-NIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  369 (580)
                      |...+.+|.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999877  78999998655332   367889999999999988 799999999777778999999


Q ss_pred             cCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  446 (580)
                      +.++++.+++....  ..+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997766554  26899999999999999999999   89999999999999999988 79999999998554433


Q ss_pred             Ccc----cccccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccC--CchHHHHHHhhcccchh
Q 038098          447 QSL----TQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG--DMTLKHWVNDLLPISVM  517 (580)
Q Consensus       447 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  517 (580)
                      ...    ......|+..|+|||.+.+   ...+...|+||+|++++++++|..||......  ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    2456679999999999887   57889999999999999999999996553211  01111111110000   


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ..........  .......+.+++.+|+..+|..|.++.+...+
T Consensus       234 -----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -----SLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -----ccccccCccc--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                 0000000000  01223567899999999999999999988765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.1e-23  Score=221.32  Aligned_cols=254  Identities=21%  Similarity=0.214  Sum_probs=187.8

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEe----cc-ccch-hhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFD----LQ-YGRA-FKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ...+++|.|++|.|+.+... ..+..+.|.+.    .. .... ...+..|.-+-..++|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988777533 34444444332    11 1111 122555777778889999988877776666555669


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++ +|..++... ..+....+..++.|+..|++|+|   ..|+.|||+|++|++++.+|.+||+|||.+..+..+..
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999987665 34788889999999999999999   99999999999999999999999999999987655544


Q ss_pred             c--ccccccccCCCcCCcccccCCCCCC-chhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          448 S--LTQTQTLATIGYMAPEYGREGQVST-NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       448 ~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .  .......|+..|+|||.+...+|.+ ..||||.|+++..|.+|+.||......+..+.            +......
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------------~~~~~~~  543 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------------TNNYSDQ  543 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------------hhccccc
Confidence            4  5566778999999999999988865 57999999999999999999876433322210            0000000


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVT  565 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~  565 (580)
                      ..............+.....++.+|++.||.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11111122233456677789999999999999999999976

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=7e-23  Score=216.60  Aligned_cols=248  Identities=21%  Similarity=0.267  Sum_probs=179.8

Q ss_pred             CCCcCceeccccCceEEEEEeCCCCEEEEEEEecccc-chhhhHHH---HHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG-RAFKSFDI---ECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +|...+.+|.+.|=.|.+|+++.|. |+||++-...+ -....+.+   |++ ....+|||++.+.-.-......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5667789999999999999998776 99999865542 23334443   444 556689999999888777888899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC-CCC-
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-KED-  446 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~-~~~-  446 (580)
                      |+.. +|.|.+..+. -+...+...||.|++.|+..+|   ..||+|||||.+|||+++-..+.|+||.--+... +.+ 
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9966 9999887654 3666777789999999999999   9999999999999999999999999997654321 111 


Q ss_pred             ---CcccccccccCCCcCCcccccCC-----------CCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhh
Q 038098          447 ---QSLTQTQTLATIGYMAPEYGREG-----------QVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       447 ---~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  511 (580)
                         ...-......-.+|+|||.+...           ..+++-||||+||+++||++ |++||.-.     ++-.+.+..
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence               12222333445679999965331           25778999999999999999 78887531     111111100


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       .......+            ...  ....+.+++..|++.||++|.++++.++.-
T Consensus       252 -~~~~e~~L------------e~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  252 -ADDPEQLL------------EKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -ccCHHHHH------------HhC--cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence             00000000            000  012477999999999999999999999873

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=5.7e-22  Score=200.51  Aligned_cols=216  Identities=28%  Similarity=0.426  Sum_probs=164.5

Q ss_pred             HhhcCCCCcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EEecCCC
Q 038098          342 IKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI-IHCDLKP  420 (580)
Q Consensus       342 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i-~H~dlk~  420 (580)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......+++.....++++|+.||+|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35678999999999999999999999999999999999988888999999999999999999999   5555 8999999


Q ss_pred             CCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC-------CCCCchhhHhHHHHHHHHHhCCCC
Q 038098          421 SNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-------QVSTNGDVYSFGIMLMETFTRKKP  493 (580)
Q Consensus       421 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dvws~Gvil~elltg~~p  493 (580)
                      +|+++|....+|++|||+.................-..-|.|||.+...       ..+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998866331111111222244569999988763       146789999999999999999999


Q ss_pred             CCccccCCc--hHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          494 TDEIFFGDM--TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       494 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      |+.......  .+..++..    .......        +......+..+++..++.+||..+|++||++++|-..++.+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~----~~~~~~r--------P~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK----GGSNPFR--------PSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCChHHHHHHHHh----cCCCCcC--------cchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            986432221  12222111    0000000        111111144557899999999999999999999988887765


Q ss_pred             H
Q 038098          572 D  572 (580)
Q Consensus       572 ~  572 (580)
                      .
T Consensus       226 ~  226 (484)
T KOG1023|consen  226 K  226 (484)
T ss_pred             c
Confidence            5

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.87  E-value=6.3e-24  Score=211.68  Aligned_cols=205  Identities=32%  Similarity=0.435  Sum_probs=153.2

Q ss_pred             Ccccc-CCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            2 NNLNG-SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         2 N~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      |++.+ -+|..+..|..|+.||||+|+++ ..|..+.+.+++-+|+||+|+|..++...|-+++-|-.|+||+|+|+.+|
T Consensus        88 N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LP  166 (1255)
T KOG0444|consen   88 NNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLP  166 (1255)
T ss_pred             cccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcC
Confidence            55544 57888999999999999999998 89999999999999999999999776678899999999999999999999


Q ss_pred             CCCcCCCCCceEeCcCCcc-------------------------------cccCCCcccEEeCCCCcCCCCCCcccCCcc
Q 038098           81 STLWNLKDILYLDLSSNFL-------------------------------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLK  129 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l-------------------------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  129 (580)
                      +.+..|..|++|+|++|.+                               ++..+.+|..+|||.|.+. ..|..+-.++
T Consensus       167 PQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~  245 (1255)
T KOG0444|consen  167 PQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLR  245 (1255)
T ss_pred             HHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhh
Confidence            9999999999999999987                               1223445666677777775 4466666677


Q ss_pred             ccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCccc--CCCCCCCCCccCccccC
Q 038098          130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE--GEIPNKGPFRNFSTESF  207 (580)
Q Consensus       130 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~--~~~~~~~~~~~l~~~~~  207 (580)
                      +|+.|+||+|.|+ .+........+|++|+||.|+++ .+|..++++++|+.|.+.+|+++  |++...+.+.++.....
T Consensus       246 ~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~a  323 (1255)
T KOG0444|consen  246 NLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHA  323 (1255)
T ss_pred             hhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHh
Confidence            7777777777776 55555555666777777777777 67777777777777777777665  34444444444444433


Q ss_pred             CCC
Q 038098          208 EGN  210 (580)
Q Consensus       208 ~~n  210 (580)
                      ..|
T Consensus       324 anN  326 (1255)
T KOG0444|consen  324 ANN  326 (1255)
T ss_pred             hcc
Confidence            333

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=4.8e-22  Score=183.67  Aligned_cols=171  Identities=13%  Similarity=0.134  Sum_probs=132.9

Q ss_pred             HhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhh---h------HHHHHHHHhhcCCCCcceEEeeeecC
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK---S------FDIECDMIKRIRHRNIIKIISSCSSD  360 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~niv~~~~~~~~~  360 (580)
                      ..++|...+++|.|+||.||.+.. ++..+|+|++.........   .      +.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999766 5778999999655332222   2      67899999999999999998885532


Q ss_pred             --------CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          361 --------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       361 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                              ...++||||++|.+|.++..     ++.    ....+++.++..+|   ..|++|||++|+||+++++| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988632     222    34669999999999   99999999999999999988 99


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHH
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF  488 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ell  488 (580)
                      ++|||.......... .             ..+.....+..++|+||||+.+....
T Consensus       175 liDfg~~~~~~e~~a-~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKA-K-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhh-H-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999998874421111 0             01333445667899999999887543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=3e-21  Score=176.89  Aligned_cols=139  Identities=19%  Similarity=0.186  Sum_probs=108.6

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccc--h-------hh-----------------hHHHHHHHHhhcCCCCc
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR--A-------FK-----------------SFDIECDMIKRIRHRNI  350 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~e~~~l~~l~h~ni  350 (580)
                      ...||+|++|.||+|...+|+.||||+++.....  .       ..                 ....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999999654211  0       11                 22349999999988776


Q ss_pred             ceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEecCCCCCEEeCCCC
Q 038098          351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNM  429 (580)
Q Consensus       351 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~i~H~dlk~~Nill~~~~  429 (580)
                      ........  ...++||||++++++...... ...+++..+..++.|++.++.|+ |   ..+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            44333222  223899999998877654322 24688999999999999999999 7   88999999999999998 47


Q ss_pred             cEEEccccCcccc
Q 038098          430 VAHLSDFGMAKPL  442 (580)
Q Consensus       430 ~~kl~Dfg~a~~~  442 (580)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.85  E-value=3.1e-23  Score=206.77  Aligned_cols=216  Identities=28%  Similarity=0.431  Sum_probs=175.7

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCC-------------------------cC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLD-------------------------GF   55 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-------------------------~~   55 (580)
                      +|+|.+|-..-|-+|+.|-.||||+|++. .+|+.+..|.+|++|+||+|.+.                         .-
T Consensus       135 ~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N  213 (1255)
T KOG0444|consen  135 YNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDN  213 (1255)
T ss_pred             cCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhc
Confidence            36666554456667777777778877777 56667777777777777777651                         12


Q ss_pred             CCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCccc-----ccCCCcccEEeCCCCcCCCCCCcccCCccc
Q 038098           56 VPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKD  130 (580)
Q Consensus        56 ~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~-----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  130 (580)
                      +|..+..+.||..++||.|+|..+|..+.++++|+.|+||+|+|+     .....+|++|+||.|+++ ..|++++.++.
T Consensus       214 ~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~k  292 (1255)
T KOG0444|consen  214 IPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTK  292 (1255)
T ss_pred             CCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHH
Confidence            445566677888888888888888888888889999999999883     445668999999999998 56899999999


Q ss_pred             cceeccccccccc-cCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCC
Q 038098          131 LQYLFLEYNRLQG-SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEG  209 (580)
Q Consensus       131 L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~  209 (580)
                      |+.|.+.+|+++- -+|..++.+.+|+.+..++|++. ..|+.++.+++|+.|.|+.|++-..+...-.++.+..+++..
T Consensus       293 L~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlre  371 (1255)
T KOG0444|consen  293 LTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRE  371 (1255)
T ss_pred             HHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccC
Confidence            9999999998864 47889999999999999999999 899999999999999999999998888888888999999999


Q ss_pred             CccccCCCCC
Q 038098          210 NELLCGMPNL  219 (580)
Q Consensus       210 n~~~c~~p~~  219 (580)
                      ||...-+|.+
T Consensus       372 NpnLVMPPKP  381 (1255)
T KOG0444|consen  372 NPNLVMPPKP  381 (1255)
T ss_pred             CcCccCCCCc
Confidence            9877665543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=1.7e-20  Score=178.65  Aligned_cols=229  Identities=22%  Similarity=0.306  Sum_probs=144.9

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcC----------CCCcceEEeee---
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIR----------HRNIIKIISSC---  357 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~niv~~~~~~---  357 (580)
                      ...+.||.|+++.||.+++. +|+++|||++....   ....+.+.+|.-....+.          |-.++-.++..   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            44678999999999999876 69999999985443   233455555554443322          11111111111   


Q ss_pred             ------ecC---C-----ceeeEeeccCCCChHHHhh---cCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEec
Q 038098          358 ------SSD---D-----FKALVLEYMPHGSLEKCLY---SSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD  417 (580)
Q Consensus       358 ------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~d  417 (580)
                            ...   .     ..+++|+-+. +||.+++.   ...   ..+....++.+..|+++.+++||   ..|++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence                  111   1     2367888874 48887754   222   12445566778899999999999   99999999


Q ss_pred             CCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccC--------CCCCCchhhHhHHHHHHHHHh
Q 038098          418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE--------GQVSTNGDVYSFGIMLMETFT  489 (580)
Q Consensus       418 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dvws~Gvil~ellt  489 (580)
                      |+|+|++++++|.+.|+||+.....   +.....  ...+..|.+||....        -.++.+.|.|++|+++|.|++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRA---GTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEET---TEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeec---Cceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999877643   221111  345577999996533        247889999999999999999


Q ss_pred             CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCC
Q 038098          490 RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR  557 (580)
Q Consensus       490 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  557 (580)
                      |+.||+.........  |                       .+....+.++.+..||..+++.+|++|
T Consensus       246 ~~lPf~~~~~~~~~~--~-----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE--W-----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG--G-----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc--c-----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999997632211000  0                       222333678889999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=3.7e-20  Score=170.51  Aligned_cols=139  Identities=23%  Similarity=0.237  Sum_probs=110.7

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccch--------------------------hhhHHHHHHHHhhcCCCCc
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA--------------------------FKSFDIECDMIKRIRHRNI  350 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni  350 (580)
                      ...||+|++|.||+|...+|+.||||++.......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999997789999999987542110                          1223578899999999987


Q ss_pred             ceEEeeeecCCceeeEeeccCCCChHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCC
Q 038098          351 IKIISSCSSDDFKALVLEYMPHGSLEKC-LYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDN  428 (580)
Q Consensus       351 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~  428 (580)
                      .....+...  ..++||||++++++... +.  ...++...+..++.|++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            554443332  24899999998865433 33  235788899999999999999999   7 8999999999999999 8


Q ss_pred             CcEEEccccCccccC
Q 038098          429 MVAHLSDFGMAKPLL  443 (580)
Q Consensus       429 ~~~kl~Dfg~a~~~~  443 (580)
                      +.++|+|||++..+.
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.84  E-value=6.5e-23  Score=194.57  Aligned_cols=216  Identities=24%  Similarity=0.320  Sum_probs=162.4

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCC-CcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGG-NKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      |.|+.+-|.+|+.|++|++||||+|+|+.+-|++|..+++|.+|-+.+ |+|+.+..+.|++|.+|+.|.+.-|++..++
T Consensus        77 N~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir  156 (498)
T KOG4237|consen   77 NQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIR  156 (498)
T ss_pred             CCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchh
Confidence            888888888999999999999999999989999999999988876666 8898777777777666666666665555433


Q ss_pred             C-CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCc-------------------------------------
Q 038098           81 S-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNN-------------------------------------  116 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~-------------------------------------  116 (580)
                      . .|..+++|..|.|-.|.+      ++..+..++.+.+..|.                                     
T Consensus       157 ~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri  236 (498)
T KOG4237|consen  157 QDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRI  236 (498)
T ss_pred             HHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHh
Confidence            2 333444444444444433      12222222222222221                                     


Q ss_pred             ------------------------CCCC-CCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccc
Q 038098          117 ------------------------FSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI  171 (580)
Q Consensus       117 ------------------------l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~  171 (580)
                                              ...+ +...|..+++|++|+|++|+|+++-+.+|.++..++.|.|..|+|...-..
T Consensus       237 ~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~  316 (498)
T KOG4237|consen  237 NQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSG  316 (498)
T ss_pred             cccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHH
Confidence                                    2222 234588899999999999999988899999999999999999999977788


Q ss_pred             cccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          172 SLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       172 ~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      .|..+..|+.|+|.+|+|++..|.. ..+..++.+.+-+|||.|++-
T Consensus       317 ~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  317 MFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             hhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence            8999999999999999999988765 677788889999999999844

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1e-19  Score=164.36  Aligned_cols=186  Identities=16%  Similarity=0.132  Sum_probs=138.3

Q ss_pred             CcCceeccccCceEEEEEeCCCCEEEEEEEecccc--c--hhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeec
Q 038098          295 SENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG--R--AFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .....|++|+||+||.+.. .+..++.+.+.....  .  ....+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997766 477888777654321  1  1125788999999995 5889999886    346899999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecC-CCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL-KPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +.|.+|.+....        ....++.|++.++.++|   ..||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999999764321        12357889999999999   999999999 799999999999999999999854332210


Q ss_pred             ----cc-------ccccccCCCcCCcccccC-CCCC-CchhhHhHHHHHHHHHhCCCCCCc
Q 038098          449 ----LT-------QTQTLATIGYMAPEYGRE-GQVS-TNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       449 ----~~-------~~~~~~~~~y~aPE~~~~-~~~~-~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                          ..       ......++.|++|+...- ...+ .+.+.++-|.-+|.++|++.+.-.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                00       112336777888874322 1233 567889999999999999988643

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.82  E-value=2e-22  Score=170.02  Aligned_cols=177  Identities=25%  Similarity=0.450  Sum_probs=123.2

Q ss_pred             CCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEe
Q 038098           14 KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLD   93 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~   93 (580)
                      ++.+++.|.||+|+++ .+|..++.|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++..+|.+|+.++.|    
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~l----  104 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPAL----  104 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchh----
Confidence            4445555555555555 44445555555555555555555 44555555555555555555555555555555555    


Q ss_pred             CcCCcccccCCCcccEEeCCCCcCCC-CCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccc
Q 038098           94 LSSNFLLIGNLKVLVQVDLSMNNFSD-VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS  172 (580)
Q Consensus        94 l~~n~l~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~  172 (580)
                                    +.|||+.|++.. ..|..|-.++.|+-|+|++|.+. .+|..++.+++|+.|.+.+|.+- .+|..
T Consensus       105 --------------evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke  168 (264)
T KOG0617|consen  105 --------------EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE  168 (264)
T ss_pred             --------------hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH
Confidence                          555555555543 45778888999999999999998 88999999999999999999999 88999


Q ss_pred             ccccCcccEEEccCCcccCCCCCCCCCccCcc---ccCCCCcc
Q 038098          173 LEKLLDLKDINVSFNKLEGEIPNKGPFRNFST---ESFEGNEL  212 (580)
Q Consensus       173 ~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~---~~~~~n~~  212 (580)
                      ++.+..|++|++++|+++-.+|....+..+..   ..+..|||
T Consensus       169 ig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  169 IGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             HHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCC
Confidence            99999999999999999999988755443322   23445665

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=4.2e-20  Score=175.70  Aligned_cols=197  Identities=20%  Similarity=0.270  Sum_probs=141.2

Q ss_pred             CCCCcceEEeeeec---------------------------CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHH
Q 038098          346 RHRNIIKIISSCSS---------------------------DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV  398 (580)
Q Consensus       346 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  398 (580)
                      +|||||++.++|.+                           +..+|+||..++. +|.+++....  .+...+.-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999876633                           2367899998866 9999998755  4555666799999


Q ss_pred             HHHHHHHhcCCCCCeEEecCCCCCEEeC--CC--CcEEEccccCccccCCC----CCcccccccccCCCcCCcccccCCC
Q 038098          399 ASALEYLHFGYSVPIIHCDLKPSNVLLD--DN--MVAHLSDFGMAKPLLKE----DQSLTQTQTLATIGYMAPEYGREGQ  470 (580)
Q Consensus       399 ~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~--~~~kl~Dfg~a~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~  470 (580)
                      ++|+.|||   +.||.|||+|++|||+.  ++  ..+.|+|||.+---...    ++........|...-||||+.....
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   99999999999999993  33  35899999976311111    1111222345777899999875432


Q ss_pred             ------CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHH
Q 038098          471 ------VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN  544 (580)
Q Consensus       471 ------~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~  544 (580)
                            -..|+|.|+.|-+.||+++...||..  .+++.+..-                -+. ...-...+..++..+.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r----------------~Yq-e~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTR----------------TYQ-ESQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechh----------------hhh-hhhCCCCcccCChHHHH
Confidence                  24689999999999999999999875  233322210                000 00111234567888999


Q ss_pred             HHhhccCCCCCCCCCHHHHHHHH
Q 038098          545 LAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       545 l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ++...++.||++|++..-....|
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHH
Confidence            99999999999999876655554

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.82  E-value=1.1e-22  Score=193.28  Aligned_cols=204  Identities=28%  Similarity=0.449  Sum_probs=131.4

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+++ ..|.+++.+..++.|+.++|+++ .+|+.++.+.+|..|+.+.|.+. ..|+.++.+-.|+.|+..+|+++++|.
T Consensus        78 n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~  154 (565)
T KOG0472|consen   78 NKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPE  154 (565)
T ss_pred             chhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccccCch
Confidence            4444 55667777777777777777776 67777777777777777777776 456666667777777777777777777


Q ss_pred             CCcCCCCCceEeCcCCccc-----ccCCCcccEEeCCCCcCCCCCCc----------------------ccCCcccccee
Q 038098           82 TLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDLSMNNFSDVIPT----------------------TIGGLKDLQYL  134 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l~-----~~~l~~L~~L~l~~N~l~~~~~~----------------------~~~~l~~L~~L  134 (580)
                      +++++.+|..|++.+|++.     .-++..|++||+..|.++ .+|.                      .|+++..|++|
T Consensus       155 ~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~El  233 (565)
T KOG0472|consen  155 DMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKEL  233 (565)
T ss_pred             HHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHH
Confidence            7777777777777776661     112444444444444443 2233                      44455555555


Q ss_pred             ccccccccccCCcccc-cccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcc
Q 038098          135 FLEYNRLQGSIPDSIG-DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       135 ~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~  212 (580)
                      +++.|.|. .+|.... .+.+|..|||.+|+++ ..|+.++.+.+|+.||+|+|.|++.++..+.+ .+..+.+.|||.
T Consensus       234 h~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  234 HVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             HhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            55555554 4444333 5666777777777777 66777777777777777777777777776666 666777777764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.4e-21  Score=194.59  Aligned_cols=225  Identities=25%  Similarity=0.315  Sum_probs=178.5

Q ss_pred             eeccccCceEEEEE----eCCCCEEEEEEEecccc--chhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeeccC
Q 038098          299 LIGRGGFGSVYKAR----IQDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       299 ~lg~G~~g~v~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      .+|+|.||.|+.++    ...|..+|+|+.+....  ........|..++..++ ||.++++.-++..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36999999999874    23477799998865422  12224556788888887 9999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|.|...+..... ++......+...++-|++++|   +.+++|||+|++||+++.+|.+++.|||+++..-....    
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            9999887765543 666666778888899999999   99999999999999999999999999999986533222    


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                        .+||..|||||++.  .....+|.||||++++||+||..||...     ..            ..+..        ..
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-----~~------------~~Il~--------~~  203 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-----TM------------KRILK--------AE  203 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-----HH------------HHHhh--------hc
Confidence              17899999999997  5677899999999999999999998640     00            01111        12


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINA  560 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  560 (580)
                      ...+.+.+..+.+++.+++..+|..|...
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            23456677888899999999999999855

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.4e-18  Score=160.51  Aligned_cols=136  Identities=16%  Similarity=0.228  Sum_probs=106.7

Q ss_pred             CcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhc-----CCCCcceEEeeeecCC---cee-e
Q 038098          295 SENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-----RHRNIIKIISSCSSDD---FKA-L  365 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l  365 (580)
                      ...++||+|+||.||.  +++....+||++........+.+.+|+.+++.+     .||||++++|+++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  443333479998765444567889999999999     5799999999998864   333 7


Q ss_pred             Eeec--cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEEecCCCCCEEeCC----CCcEEEccccC
Q 038098          366 VLEY--MPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDLKPSNVLLDD----NMVAHLSDFGM  438 (580)
Q Consensus       366 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~  438 (580)
                      |+||  +.+|+|.+++...  .+++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+-
T Consensus        83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5579999999664  35555  35677888777 9999   999999999999999974    34799999544


Q ss_pred             c
Q 038098          439 A  439 (580)
Q Consensus       439 a  439 (580)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.4e-18  Score=188.13  Aligned_cols=197  Identities=25%  Similarity=0.299  Sum_probs=158.7

Q ss_pred             HhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC---CCCcceEEeeeecCCceeeE
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR---HRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  366 (580)
                      ..+.|.+.+.+|+|+||.||+|...+|+.||+|+-+....-   +|..-.+++.+|+   -+.|..+..++.-.+.-++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            44668888899999999999999888999999986543221   1222334455555   23445555555566777899


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-------CCCcEEEccccCc
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-------DNMVAHLSDFGMA  439 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-------~~~~~kl~Dfg~a  439 (580)
                      +||.+.|+|.+++.. ...++|.-+..+..|++..+++||   ..+||||||||+|+|+.       ....++|+|||.+
T Consensus       773 ~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            999999999999884 446899999999999999999999   99999999999999994       2446999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCC
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP  493 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p  493 (580)
                      -.+.--.........++|..+-.+|+..+..++...|-|.++-+++-|+.|+.-
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            876543333455667789999999999999999999999999999999999863

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.76  E-value=5.9e-21  Score=181.59  Aligned_cols=179  Identities=31%  Similarity=0.455  Sum_probs=144.8

Q ss_pred             CCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCC
Q 038098            8 IPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLK   87 (580)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~   87 (580)
                      +|++++.+-.|..|+..+|+++ ..|+.+.++.+|..|++.+|++....|..+. ++.|+.|++.+|-++.+|..++.+.
T Consensus       129 l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~  206 (565)
T KOG0472|consen  129 LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPELGGLE  206 (565)
T ss_pred             cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChhhcchh
Confidence            4445555555555555555555 4555555556666666666666643333333 7888888888888899999999999


Q ss_pred             CCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccc
Q 038098           88 DILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN  163 (580)
Q Consensus        88 ~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  163 (580)
                      +|.-|||.+|+|    .|.++..|++|+++.|+|+.++.....++++|..|||.+|+++ ..|+.+.-+.+|.+||+|+|
T Consensus       207 ~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN  285 (565)
T KOG0472|consen  207 SLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNN  285 (565)
T ss_pred             hhHHHHhhhcccccCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCC
Confidence            999999999999    4789999999999999999776667779999999999999999 89999999999999999999


Q ss_pred             ccCCCccccccccCcccEEEccCCcccC
Q 038098          164 NLSGTIPISLEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       164 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~  191 (580)
                      .|+ .+|..++++ .|+.|-+.||++..
T Consensus       286 ~is-~Lp~sLgnl-hL~~L~leGNPlrT  311 (565)
T KOG0472|consen  286 DIS-SLPYSLGNL-HLKFLALEGNPLRT  311 (565)
T ss_pred             ccc-cCCcccccc-eeeehhhcCCchHH
Confidence            999 788899999 99999999999875

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=1.9e-20  Score=158.13  Aligned_cols=166  Identities=32%  Similarity=0.548  Sum_probs=139.4

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC--
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS--   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--   78 (580)
                      +|.++ .+|..+..|.+|+.|++++|+|+ .+|..++.|+.|+.|+++.|++. ++|..|+.++.|+.|+|..|++.+  
T Consensus        42 HNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~  118 (264)
T KOG0617|consen   42 HNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENS  118 (264)
T ss_pred             cCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccccc
Confidence            46666 77889999999999999999999 89999999999999999999999 899999999999999999999986  


Q ss_pred             CCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccc
Q 038098           79 IPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSL  158 (580)
Q Consensus        79 lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  158 (580)
                      +|..|+.++.|+-|+|+.|.                  +. ..|...+.+++|+.|.+.+|.+- .+|..++.++.|+.|
T Consensus       119 lpgnff~m~tlralyl~dnd------------------fe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrel  178 (264)
T KOG0617|consen  119 LPGNFFYMTTLRALYLGDND------------------FE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLREL  178 (264)
T ss_pred             CCcchhHHHHHHHHHhcCCC------------------cc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHH
Confidence            89888877777555555554                  43 67888999999999999999988 889999999999999


Q ss_pred             cccccccCCCccccccccCcc---cEEEccCCccc
Q 038098          159 NLSNNNLSGTIPISLEKLLDL---KDINVSFNKLE  190 (580)
Q Consensus       159 ~l~~N~l~~~~~~~~~~l~~L---~~l~l~~N~l~  190 (580)
                      .+.+|+++ .+|..++.+.-+   +.+.+.+|++-
T Consensus       179 hiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  179 HIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             hcccceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            99999999 666666654322   33455566654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.75  E-value=2e-20  Score=177.76  Aligned_cols=194  Identities=26%  Similarity=0.291  Sum_probs=179.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccC-CcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLED-NQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      +|+|+.|-|++|..|.+|..|-+.+ |+|+.+..+.|++|.+|+.|.+.-|++..+....|..+++|..|.|..|.+..+
T Consensus       100 ~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i  179 (498)
T KOG4237|consen  100 KNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSI  179 (498)
T ss_pred             ccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhh
Confidence            5999999999999999998876555 999988889999999999999999999999999999999999999999999999


Q ss_pred             CC-CCcCCCCCceEeCcCCcc-----------------------------------------------------------
Q 038098           80 PS-TLWNLKDILYLDLSSNFL-----------------------------------------------------------   99 (580)
Q Consensus        80 p~-~~~~l~~L~~L~l~~n~l-----------------------------------------------------------   99 (580)
                      +. .+..+.+++.+++..|.+                                                           
T Consensus       180 ~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d  259 (498)
T KOG4237|consen  180 CKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSED  259 (498)
T ss_pred             ccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcccc
Confidence            97 777899999999998873                                                           


Q ss_pred             ---------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcc
Q 038098          100 ---------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP  170 (580)
Q Consensus       100 ---------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~  170 (580)
                               .|..+++|+.|+|++|+|+.+-+.+|.++..|++|.|..|+|...-...|.++..|++|+|.+|+|+..-|
T Consensus       260 ~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~  339 (498)
T KOG4237|consen  260 FPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP  339 (498)
T ss_pred             CcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence                     15679999999999999999999999999999999999999986667789999999999999999998889


Q ss_pred             ccccccCcccEEEccCCcccCCCC
Q 038098          171 ISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       171 ~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      ..|..+.+|.+|++-.|++.|.+-
T Consensus       340 ~aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  340 GAFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             ccccccceeeeeehccCcccCccc
Confidence            999999999999999999998664

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=8e-18  Score=159.55  Aligned_cols=141  Identities=19%  Similarity=0.168  Sum_probs=110.9

Q ss_pred             CCCcCceeccccCceEEEEE--eCCCCEEEEEEEeccccc------------------------hhhhHHHHHHHHhhcC
Q 038098          293 GFSENNLIGRGGFGSVYKAR--IQDGMEVAVKVFDLQYGR------------------------AFKSFDIECDMIKRIR  346 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  346 (580)
                      .|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  568999999998643210                        0123567999999997


Q ss_pred             CC--CcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEecCCCCCE
Q 038098          347 HR--NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP-IIHCDLKPSNV  423 (580)
Q Consensus       347 h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-i~H~dlk~~Ni  423 (580)
                      +.  .+.+++++    ...++||||+++++|..+.... ...+...+..++.||+.++.+||   ..+ ++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            53  34455543    2348999999998887654322 34566677899999999999999   999 99999999999


Q ss_pred             EeCCCCcEEEccccCcccc
Q 038098          424 LLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       424 ll~~~~~~kl~Dfg~a~~~  442 (580)
                      +++ ++.++|+|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998744

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=4e-19  Score=176.25  Aligned_cols=174  Identities=28%  Similarity=0.387  Sum_probs=130.6

Q ss_pred             ceeeEeeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      ..++.|++++..+|.+|+...+  ...++.....++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999996544  567888999999999999998      57899999999999999999999999999


Q ss_pred             cccCCCC----CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhccc
Q 038098          440 KPLLKED----QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       440 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      .......    .....+...||..||+||.+.+..|+.|+||||+|++++|++. =..+++.    -..+.         
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~---------  470 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLT---------  470 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhh---------
Confidence            8664443    2234556679999999999999999999999999999999998 2333221    11111         


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV  564 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~  564 (580)
                         ++-|..+....  ..+     .++=+.|+.+++.+.|++||++.++.
T Consensus       471 ---d~r~g~ip~~~--~~d-----~p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  471 ---DIRDGIIPPEF--LQD-----YPEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             ---hhhcCCCChHH--hhc-----CcHHHHHHHHhcCCCcccCchHHHHh
Confidence               11111111000  011     12235799999999999999555543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.4e-17  Score=156.69  Aligned_cols=134  Identities=25%  Similarity=0.318  Sum_probs=113.1

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEeccccc--------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR--------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +.||+|++|.||+|.+ +|..|++|+.......        ....+..|++++..+.|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 5788999986533211        124577899999999999988777777677788999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ++|++|.+++....    + .+..++.+++.++.++|   ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886432    2 78899999999999999   99999999999999999 78999999999873

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.7e-17  Score=154.12  Aligned_cols=140  Identities=24%  Similarity=0.193  Sum_probs=110.4

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccc----------------------hhhhHHHHHHHHhhcC
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR----------------------AFKSFDIECDMIKRIR  346 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~  346 (580)
                      .....|...+.||+|+||.||+|...+|+.||||++......                      .......|..++..+.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            333347788999999999999999888999999987543210                      1123567888899988


Q ss_pred             CC--CcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEE
Q 038098          347 HR--NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL  424 (580)
Q Consensus       347 h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nil  424 (580)
                      |+  .+...++.    ...++||||+++++|......       .....++.+++.++.++|   ..+++||||+|+||+
T Consensus        92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil  157 (198)
T cd05144          92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL  157 (198)
T ss_pred             HcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence            77  44455443    345899999999999775321       335678999999999999   899999999999999


Q ss_pred             eCCCCcEEEccccCcccc
Q 038098          425 LDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       425 l~~~~~~kl~Dfg~a~~~  442 (580)
                      +++++.++|+|||++...
T Consensus       158 l~~~~~~~liDfg~~~~~  175 (198)
T cd05144         158 VDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             EcCCCcEEEEECCccccC
Confidence            999999999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.73  E-value=2.6e-19  Score=187.00  Aligned_cols=200  Identities=30%  Similarity=0.477  Sum_probs=153.8

Q ss_pred             CCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCC-
Q 038098            8 IPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNL-   86 (580)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l-   86 (580)
                      +|+.+..+.+|+.|+.++|++. .+|..+..+++|+.|.+..|.++ -+|.....+++|++|+|..|+|.++|..+... 
T Consensus       256 lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~  333 (1081)
T KOG0618|consen  256 LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVL  333 (1081)
T ss_pred             chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhh
Confidence            3455566666666666666664 55656666666666666666666 45555666777777777777777766533321 


Q ss_pred             -------------------------CCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceec
Q 038098           87 -------------------------KDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLF  135 (580)
Q Consensus        87 -------------------------~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  135 (580)
                                               +.|+.|+|.+|.+      .+.+..+|+.|+|+.|++...+...+.+++.|++|+
T Consensus       334 ~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~  413 (1081)
T KOG0618|consen  334 NASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELN  413 (1081)
T ss_pred             hHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHh
Confidence                                     1244555555555      266788999999999999988888999999999999


Q ss_pred             cccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCC-CCCCCCccCccccCCCCcc
Q 038098          136 LEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEI-PNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       136 l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~~~l~~~~~~~n~~  212 (580)
                      ||+|+++ .+|..+..+..|++|...+|++. ..| .+..++.|+.+|++.|+++... +...++++++.++++||.+
T Consensus       414 LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  414 LSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             cccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            9999999 89999999999999999999999 778 8999999999999999999754 5556779999999999996

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=4.1e-17  Score=174.44  Aligned_cols=139  Identities=21%  Similarity=0.284  Sum_probs=113.0

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEecc-cc-------chhhhHHHHHHHHhhcCCCCcceEEeeeecC
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQ-YG-------RAFKSFDIECDMIKRIRHRNIIKIISSCSSD  360 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~-~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  360 (580)
                      .....|...+.||+|+||+||+|.+.+ ..+++|+.... ..       ...+.+..|++++++++|++++....++...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            334556678899999999999998764 34444443211 11       1235678899999999999999888887777


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ...++||||+++++|.+++.         ....++.++++++.|||   +.+++||||||+||++ .++.++|+|||+++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            77899999999999999875         35679999999999999   9999999999999999 67899999999997


Q ss_pred             c
Q 038098          441 P  441 (580)
Q Consensus       441 ~  441 (580)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            4

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=4e-17  Score=152.02  Aligned_cols=130  Identities=22%  Similarity=0.326  Sum_probs=106.2

Q ss_pred             eeccccCceEEEEEeCCCCEEEEEEEecccc--------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQYG--------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .||+|+||.||+|.+. |..|++|+......        .....+..|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4799999999999864 78899998643211        11255678999999999887665555555566678999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      +|++|.+++.....        .++.+++.++.+||   ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988754321        78999999999999   99999999999999999 88999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=9.6e-18  Score=178.04  Aligned_cols=211  Identities=24%  Similarity=0.283  Sum_probs=143.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|..+++|..|+||.||.++++ +.+.+|+|+ +.+..     +.+.  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence            367888999999999999999877 467788854 22211     1110  22233344433                  


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc-
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  448 (580)
                         |+=...+...+ +++...        +.+++|||   +.+|+|||+||+|.+++.-|.+|++|||+++........ 
T Consensus       136 ---gDc~tllk~~g-~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-PLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCC-CCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               22222222222 233222        67899999   999999999999999999999999999998643211111 


Q ss_pred             ------------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          449 ------------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       449 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                                  ......+||+.|.|||++....|+..+|.|++|+|+||.+-|+.||.+... +..+.+.+.+.     
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~-----  274 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDD-----  274 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhh-----
Confidence                        112345799999999999999999999999999999999999999876311 11111111111     


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA  560 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  560 (580)
                             +     .+.+.......++.+++.+.++.+|..|--.
T Consensus       275 -------i-----~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  275 -------I-----EWPEEDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             -------c-----cccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence                   0     0111223456788999999999999999743

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.68  E-value=8.4e-17  Score=174.45  Aligned_cols=158  Identities=25%  Similarity=0.425  Sum_probs=80.5

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLS   95 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~   95 (580)
                      ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+. +|..+.  ++|+.|+|++|+|+.+|..+.  .+|+.|+|+
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRITELPERLP--SALQSLDLF  270 (754)
T ss_pred             cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccCcCChhHh--CCCCEEECc
Confidence            45677777777776 3444443  366777777776663 344332  356666666666666665443  356666666


Q ss_pred             CCcccc--c-CCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccc
Q 038098           96 SNFLLI--G-NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS  172 (580)
Q Consensus        96 ~n~l~~--~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~  172 (580)
                      +|+|..  . -.++|+.|++++|+++++ |..+.  +.|+.|++++|.++ .+|..+.  ++|+.|++++|.+++ +|..
T Consensus       271 ~N~L~~LP~~l~~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~  343 (754)
T PRK15370        271 HNKISCLPENLPEELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPAS  343 (754)
T ss_pred             CCccCccccccCCCCcEEECCCCccccC-cccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChh
Confidence            666521  0 113566666666666543 22221  24555555555555 2333221  344444555554442 3332


Q ss_pred             ccccCcccEEEccCCccc
Q 038098          173 LEKLLDLKDINVSFNKLE  190 (580)
Q Consensus       173 ~~~l~~L~~l~l~~N~l~  190 (580)
                      +.  ++|+.|++++|+|+
T Consensus       344 l~--~sL~~L~Ls~N~L~  359 (754)
T PRK15370        344 LP--PELQVLDVSKNQIT  359 (754)
T ss_pred             hc--CcccEEECCCCCCC
Confidence            22  34444444444444

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.67  E-value=1.8e-16  Score=170.83  Aligned_cols=99  Identities=27%  Similarity=0.268  Sum_probs=44.8

Q ss_pred             cccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccccc-----------
Q 038098          106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE-----------  174 (580)
Q Consensus       106 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-----------  174 (580)
                      +|+.|+|++|+|++++ ...   ++|+.|++++|.|+ .+|...   .+|+.|+|++|+|++ +|....           
T Consensus       343 ~Lq~LdLS~N~Ls~LP-~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N~  413 (788)
T PRK15387        343 GLQELSVSDNQLASLP-TLP---SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLPSELKELMVSGNR  413 (788)
T ss_pred             ccceEecCCCccCCCC-CCC---cccceehhhccccc-cCcccc---cccceEEecCCcccC-CCCcccCCCEEEccCCc
Confidence            5666666666666432 111   23444444444444 233221   234455555555542 222110           


Q ss_pred             ------ccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          175 ------KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       175 ------~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                            ...+|+.|++++|+|+..+.....+..+..+++++|++.
T Consensus       414 LssIP~l~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls  458 (788)
T PRK15387        414 LTSLPMLPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS  458 (788)
T ss_pred             CCCCCcchhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence                  012344445555555443333344555555566666554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.67  E-value=2.3e-16  Score=169.94  Aligned_cols=81  Identities=27%  Similarity=0.278  Sum_probs=62.5

Q ss_pred             cccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEcc
Q 038098          106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS  185 (580)
Q Consensus       106 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~  185 (580)
                      +|+.|++++|+|++++ ..   .++|+.|++++|.|+ .+|..+   .+|+.|+|++|+|+ .+|..+..+++|+.|+++
T Consensus       383 ~L~~LdLs~N~Lt~LP-~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTSLP-VL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccCCC-Cc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            5666777777776532 22   256788888888887 566533   46888999999999 788899999999999999


Q ss_pred             CCcccCCCCC
Q 038098          186 FNKLEGEIPN  195 (580)
Q Consensus       186 ~N~l~~~~~~  195 (580)
                      +|+|++..+.
T Consensus       454 ~N~Ls~~~~~  463 (788)
T PRK15387        454 GNPLSERTLQ  463 (788)
T ss_pred             CCCCCchHHH
Confidence            9999987654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.67  E-value=6.4e-17  Score=175.36  Aligned_cols=191  Identities=25%  Similarity=0.364  Sum_probs=141.1

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+ .+|..+.  ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|.+. .+|..+.  ++|+.|+|++|+|+.+|
T Consensus       208 ~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP  278 (754)
T PRK15370        208 NNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLP  278 (754)
T ss_pred             CCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCccc
Confidence            47777 5666554  58999999999998 5676654  47999999999998 4566553  58999999999999998


Q ss_pred             CCCcCCCCCceEeCcCCcccc--c-CCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFLLI--G-NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKS  157 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~~--~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  157 (580)
                      ..+.  ++|++|+|++|++..  . -.++|+.|++++|.++.+ |..+.  ++|+.|++++|.++ .+|..+.  ++|+.
T Consensus       279 ~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~  350 (754)
T PRK15370        279 ENLP--EELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTAL-PETLP--PGLKTLEAGENALT-SLPASLP--PELQV  350 (754)
T ss_pred             cccC--CCCcEEECCCCccccCcccchhhHHHHHhcCCccccC-Ccccc--ccceeccccCCccc-cCChhhc--CcccE
Confidence            8765  589999999998841  1 123688889999988864 33332  57888888888888 4666553  68888


Q ss_pred             ccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          158 LNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       158 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      |+|++|+|+ .+|..+.  ++|+.|++++|+++..++...  ..+..+++.+|...
T Consensus       351 L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        351 LDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             EECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcc
Confidence            888888888 5665553  578888888888887665432  34556666666553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=1.1e-17  Score=177.87  Aligned_cols=256  Identities=24%  Similarity=0.271  Sum_probs=197.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCC--CCEEEEEEEeccc--cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD--GMEVAVKVFDLQY--GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  366 (580)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++.....+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777889999999998876543  3446666654332  223344445777777776 99999999999999999999


Q ss_pred             eeccCCCChHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCC
Q 038098          367 LEYMPHGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLK  444 (580)
Q Consensus       367 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  444 (580)
                      .||..++++.+-+ .......+...+-.+..|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999887 4444356777778899999999999995  56899999999999999999 999999999998876


Q ss_pred             -CCCccccccccc-CCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          445 -EDQSLTQTQTLA-TIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       445 -~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                       .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|......        
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------  249 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR--------  249 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc--------
Confidence             566666667778 9999999988774 55778999999999999999999998765555444444432100        


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVT  565 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~  565 (580)
                              .....+........++..+++..+|+.|.+.+++..
T Consensus       250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                    011122334555678999999999999999888753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=9.1e-16  Score=136.03  Aligned_cols=135  Identities=21%  Similarity=0.281  Sum_probs=114.2

Q ss_pred             cCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC--CCcceEEeeeecCCceeeEeeccCCC
Q 038098          296 ENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH--RNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      +.+.+|+|.++.||++...+ ..+++|.......  ...+..|+..+..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35789999999999999864 7899999854432  4678889999999976  58999999988888899999999988


Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ++..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        5567778899999999999943335799999999999999999999999999873

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=1e-15  Score=140.95  Aligned_cols=135  Identities=24%  Similarity=0.248  Sum_probs=97.6

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccc--hhhh----------------------HHHHHHHHhhcCCCC--c
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR--AFKS----------------------FDIECDMIKRIRHRN--I  350 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  350 (580)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998643211  1111                      134555566664432  4


Q ss_pred             ceEEeeeecCCceeeEeeccCCCChHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCC
Q 038098          351 IKIISSCSSDDFKALVLEYMPHGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDN  428 (580)
Q Consensus       351 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~  428 (580)
                      .+.+++.    ..++||||++++++.. .+....  .. ..+..++.+++.++.++|   . .+++|+||+|+||+++ +
T Consensus        82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEecC----CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            4444432    3589999999954321 111111  11 567789999999999999   7 9999999999999999 8


Q ss_pred             CcEEEccccCcccc
Q 038098          429 MVAHLSDFGMAKPL  442 (580)
Q Consensus       429 ~~~kl~Dfg~a~~~  442 (580)
                      +.++++|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            99999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=9.1e-15  Score=138.98  Aligned_cols=135  Identities=16%  Similarity=0.234  Sum_probs=105.9

Q ss_pred             Cceec-cccCceEEEEEeCCCCEEEEEEEeccc-------------cchhhhHHHHHHHHhhcCCCCc--ceEEeeeecC
Q 038098          297 NNLIG-RGGFGSVYKARIQDGMEVAVKVFDLQY-------------GRAFKSFDIECDMIKRIRHRNI--IKIISSCSSD  360 (580)
Q Consensus       297 ~~~lg-~G~~g~v~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  360 (580)
                      ...|| .||.|+||.+... +..++||++....             ......+.+|++++.+++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999876 7889999885321             1123567789999999998875  6777765432


Q ss_pred             C-c---eeeEeeccCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          361 D-F---KALVLEYMPH-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       361 ~-~---~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                      . .   .++|||+++| .+|.+++...  .++..    .+.+|+.++.+||   ..||+|+||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2 2   2599999997 6999887643  34443    3678999999999   99999999999999999999999999


Q ss_pred             ccCccc
Q 038098          436 FGMAKP  441 (580)
Q Consensus       436 fg~a~~  441 (580)
                      ||.++.
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999874

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.60  E-value=4.8e-17  Score=163.45  Aligned_cols=205  Identities=23%  Similarity=0.271  Sum_probs=121.9

Q ss_pred             CCcccCCCCCCCEEeccCCcCCC------CCchhhhCCCCCceeeCCCCcCCcCCCccccCCCC---CcEEEcCCCCCCC
Q 038098            8 IPIAVGKLQKLQLLSLEDNQLEG------SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTN---LRNLYLGSNKLTS   78 (580)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~   78 (580)
                      ++..+..+++|++|+++++.+.+      .++..+..+++|+.|+|++|.+....+..+..+.+   |++|++++|+++.
T Consensus        43 i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~  122 (319)
T cd00116          43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD  122 (319)
T ss_pred             HHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccch
Confidence            34455666777777777777652      13345666777777777777776555555544444   7777777777763


Q ss_pred             -----CCCCCcCC-CCCceEeCcCCccc----------ccCCCcccEEeCCCCcCCCC----CCcccCCccccceecccc
Q 038098           79 -----IPSTLWNL-KDILYLDLSSNFLL----------IGNLKVLVQVDLSMNNFSDV----IPTTIGGLKDLQYLFLEY  138 (580)
Q Consensus        79 -----lp~~~~~l-~~L~~L~l~~n~l~----------~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~  138 (580)
                           +...+..+ ++|+.|+|++|.+.          +..+++|+.|++++|.+++.    .+..+..+++|+.|+|++
T Consensus       123 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~  202 (319)
T cd00116         123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN  202 (319)
T ss_pred             HHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence                 22334445 67777777777762          34556677777777777632    123344455777777777


Q ss_pred             cccccc----CCcccccccccccccccccccCCCccccccc-----cCcccEEEccCCcccCCC-----CCCCCCccCcc
Q 038098          139 NRLQGS----IPDSIGDLINLKSLNLSNNNLSGTIPISLEK-----LLDLKDINVSFNKLEGEI-----PNKGPFRNFST  204 (580)
Q Consensus       139 n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~~~-----~~~~~~~~l~~  204 (580)
                      |.+++.    +...+..+++|+.|++++|.+++.....+..     .+.|+.|++++|.++..-     .....++.+..
T Consensus       203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~  282 (319)
T cd00116         203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE  282 (319)
T ss_pred             CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence            776532    2234455667777777777776532222221     257777777777775211     11122355566


Q ss_pred             ccCCCCcc
Q 038098          205 ESFEGNEL  212 (580)
Q Consensus       205 ~~~~~n~~  212 (580)
                      +++++|..
T Consensus       283 l~l~~N~l  290 (319)
T cd00116         283 LDLRGNKF  290 (319)
T ss_pred             EECCCCCC
Confidence            66666654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.57  E-value=1.1e-16  Score=167.66  Aligned_cols=182  Identities=35%  Similarity=0.431  Sum_probs=151.7

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccC-------------------
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGN-------------------   62 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------------------   62 (580)
                      |+| ..+|..+...++|+.|++..|.++ -+|+....++.|++|+|..|+|....+..|.-                   
T Consensus       274 N~l-~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp  351 (1081)
T KOG0618|consen  274 NRL-VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLP  351 (1081)
T ss_pred             hhH-HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccc
Confidence            566 588999999999999999999998 67778888999999999999998543333211                   


Q ss_pred             ------CCCCcEEEcCCCCCCC-CCCCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCcc
Q 038098           63 ------LTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLK  129 (580)
Q Consensus        63 ------l~~L~~L~l~~N~l~~-lp~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  129 (580)
                            ++.|+.|+|.+|.|+. .-+.+.+.++|+.|+|++|++      .+.++..|++|+||+|.++.+ |..+..+.
T Consensus       352 ~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-p~tva~~~  430 (1081)
T KOG0618|consen  352 SYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-PDTVANLG  430 (1081)
T ss_pred             cccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh-hHHHHhhh
Confidence                  3456778888888876 223566789999999999998      367899999999999999855 68899999


Q ss_pred             ccceeccccccccccCCcccccccccccccccccccCCCc-cccccccCcccEEEccCCcc
Q 038098          130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKL  189 (580)
Q Consensus       130 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l  189 (580)
                      .|++|...+|+|. .+| .+..+++|+.+|++.|+++... |....+ ++|++||++||..
T Consensus       431 ~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  431 RLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR  488 (1081)
T ss_pred             hhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence            9999999999999 888 7899999999999999999643 433333 8999999999985

>PLN03210 Resistant to P

Probab=99.55  E-value=4e-14  Score=164.07  Aligned_cols=197  Identities=22%  Similarity=0.258  Sum_probs=94.3

Q ss_pred             CCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCC-CCCCCCCCCcC
Q 038098            7 SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN-KLTSIPSTLWN   85 (580)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~lp~~~~~   85 (580)
                      .+|..| .+.+|+.|+|++|++. .++..+..+++|+.|+|++|.....+| .++.+++|++|+|++| .+..+|..+..
T Consensus       603 ~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~  679 (1153)
T PLN03210        603 CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQY  679 (1153)
T ss_pred             CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhc
Confidence            445444 3456666666666655 445555556666666665544222333 2555556666666554 34455555555


Q ss_pred             CCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcc------------
Q 038098           86 LKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDS------------  148 (580)
Q Consensus        86 l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~------------  148 (580)
                      +++|+.|++++|..     ...++++|+.|++++|......|..   .++|+.|+|++|.++ .+|..            
T Consensus       680 L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~  755 (1153)
T PLN03210        680 LNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILC  755 (1153)
T ss_pred             cCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccccccccccccccccc
Confidence            55555555555432     1113444555555544332222211   123444444444433 22221            


Q ss_pred             ------------------cccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCC
Q 038098          149 ------------------IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN  210 (580)
Q Consensus       149 ------------------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n  210 (580)
                                        +...++|+.|+|++|.....+|..+.++++|+.|++++|+.-..+|....++++..++++++
T Consensus       756 ~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c  835 (1153)
T PLN03210        756 EMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC  835 (1153)
T ss_pred             ccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence                              11123555566666655545566666666666666665543333333323444444444443

syringae 6; Provisional

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.55  E-value=1.9e-16  Score=159.17  Aligned_cols=211  Identities=25%  Similarity=0.242  Sum_probs=145.9

Q ss_pred             Cccc-cCCCcccCCCCCCCEEeccCCcCCCC----CchhhhCCCCCceeeCCCCcCCc------CCCccccCCCCCcEEE
Q 038098            2 NNLN-GSIPIAVGKLQKLQLLSLEDNQLEGS----IPDDLCRLAALFELDSGGNKLDG------FVPACFGNLTNLRNLY   70 (580)
Q Consensus         2 N~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~L~~L~   70 (580)
                      |+++ ...+.-|..+.+|+.|+|+++.++..    ++..+...++|++|++++|.+.+      .++..+..+++|+.|+
T Consensus         8 ~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~   87 (319)
T cd00116           8 ELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD   87 (319)
T ss_pred             CcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEE
Confidence            3444 23344566777899999999988532    45566777889999999988762      2234577788999999


Q ss_pred             cCCCCCCC-CCCCCcCC---CCCceEeCcCCccc----------ccCC-CcccEEeCCCCcCCCC----CCcccCCcccc
Q 038098           71 LGSNKLTS-IPSTLWNL---KDILYLDLSSNFLL----------IGNL-KVLVQVDLSMNNFSDV----IPTTIGGLKDL  131 (580)
Q Consensus        71 l~~N~l~~-lp~~~~~l---~~L~~L~l~~n~l~----------~~~l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L  131 (580)
                      +++|.+.. .+..+..+   ++|++|++++|++.          +..+ ++|+.|++++|.+++.    .+..+..++.|
T Consensus        88 l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L  167 (319)
T cd00116          88 LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDL  167 (319)
T ss_pred             ccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCc
Confidence            99998874 33333333   44999999998873          3455 7889999999998842    23345667789


Q ss_pred             ceecccccccccc----CCcccccccccccccccccccCCCc----cccccccCcccEEEccCCcccCCCCCC--C----
Q 038098          132 QYLFLEYNRLQGS----IPDSIGDLINLKSLNLSNNNLSGTI----PISLEKLLDLKDINVSFNKLEGEIPNK--G----  197 (580)
Q Consensus       132 ~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~l~l~~N~l~~~~~~~--~----  197 (580)
                      +.|+|++|.+++.    ++..+..+++|+.|+|++|.+++..    ...+..+++|+.|++++|+++......  .    
T Consensus       168 ~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~  247 (319)
T cd00116         168 KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLS  247 (319)
T ss_pred             CEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhc
Confidence            9999999988742    3334555678999999999887542    345667788999999999887521110  1    


Q ss_pred             CCccCccccCCCCcc
Q 038098          198 PFRNFSTESFEGNEL  212 (580)
Q Consensus       198 ~~~~l~~~~~~~n~~  212 (580)
                      ....+..+++.+|..
T Consensus       248 ~~~~L~~L~l~~n~i  262 (319)
T cd00116         248 PNISLLTLSLSCNDI  262 (319)
T ss_pred             cCCCceEEEccCCCC
Confidence            135677777777654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=99.53  E-value=5.2e-14  Score=163.17  Aligned_cols=198  Identities=25%  Similarity=0.242  Sum_probs=118.5

Q ss_pred             ccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCC----------
Q 038098            5 NGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN----------   74 (580)
Q Consensus         5 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N----------   74 (580)
                      .+.+| .+..+++|++|+|++|.....+|..+.++++|+.|++++|..-..+|..+ ++++|+.|+|++|          
T Consensus       647 l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~  724 (1153)
T PLN03210        647 LKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDIS  724 (1153)
T ss_pred             cCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccccc
Confidence            34555 47788888888888876555788888888888888888864333445443 5666666666655          


Q ss_pred             -----------CCCCCCCCCcCCCCCceEeCcCCcc-------------cccCCCcccEEeCCCCcCCCCCCcccCCccc
Q 038098           75 -----------KLTSIPSTLWNLKDILYLDLSSNFL-------------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKD  130 (580)
Q Consensus        75 -----------~l~~lp~~~~~l~~L~~L~l~~n~l-------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  130 (580)
                                 .++.+|..+ .+++|++|++.++..             .....++|+.|+|++|.....+|..+.++++
T Consensus       725 ~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~  803 (1153)
T PLN03210        725 TNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHK  803 (1153)
T ss_pred             CCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCC
Confidence                       333333322 233344444333211             0112346777777777766666777777888


Q ss_pred             cceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCC
Q 038098          131 LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEG  209 (580)
Q Consensus       131 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~  209 (580)
                      |+.|+|++|...+.+|..+ .+++|+.|+|++|.....+|..   ..+|+.|++++|.++..+.....++++..+++.+
T Consensus       804 L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~  878 (1153)
T PLN03210        804 LEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNG  878 (1153)
T ss_pred             CCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccChHHHhcCCCCCEEECCC
Confidence            8888887765333566554 4666666666665433344432   2356666666666665554445555555555554

syringae 6; Provisional

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=2.7e-13  Score=140.15  Aligned_cols=140  Identities=20%  Similarity=0.234  Sum_probs=99.4

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccch----------------------------------------hhhHH
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA----------------------------------------FKSFD  336 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  336 (580)
                      .+.||.|++|.||+|+.++|+.||||+.+....+.                                        .-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999985431110                                        01234


Q ss_pred             HHHHHHhhcC----CCCcceEEee-eecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 038098          337 IECDMIKRIR----HRNIIKIISS-CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS-ALEYLHFGYS  410 (580)
Q Consensus       337 ~e~~~l~~l~----h~niv~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~~~  410 (580)
                      .|++.+.+++    |.+-+.+-.. ....+..++||||++|++|.++........   .+..++.+++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence            4555555552    3222332222 223445789999999999988765322222   23456666666 467889   8


Q ss_pred             CCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       411 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .|++|+|++|.||+++.++.++++|||++..+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            99999999999999999999999999998755

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=2.5e-14  Score=154.70  Aligned_cols=118  Identities=32%  Similarity=0.565  Sum_probs=104.9

Q ss_pred             cccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEcc
Q 038098          106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS  185 (580)
Q Consensus       106 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~  185 (580)
                      .++.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccCCCCCCC--CCccCccccCCCCccccCCCCCCCCCCC
Q 038098          186 FNKLEGEIPNKG--PFRNFSTESFEGNELLCGMPNLQVPPCR  225 (580)
Q Consensus       186 ~N~l~~~~~~~~--~~~~l~~~~~~~n~~~c~~p~~~~~~c~  225 (580)
                      +|++++.+|...  ....+..+++.+|+..|+.|.  .++|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            999999888652  223455678899999998763  35664

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=5.8e-16  Score=154.15  Aligned_cols=173  Identities=28%  Similarity=0.455  Sum_probs=127.5

Q ss_pred             CCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeC
Q 038098           15 LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDL   94 (580)
Q Consensus        15 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l   94 (580)
                      |+.-...||+.|++. ++|..++.+..|+.|.|.+|.|. .+|..+.++..|++|||+.|+++.+|..++.|+ |+.|-+
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~  150 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIV  150 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEE
Confidence            444556677777776 67777777777777777777777 667777777777777777777777777776654 677777


Q ss_pred             cCCccc-----ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCc
Q 038098           95 SSNFLL-----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI  169 (580)
Q Consensus        95 ~~n~l~-----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  169 (580)
                      ++|++.     +..+..|.+||.+.|++.. .|+.++++.+|+.|.+..|++. .+|..+.. -.|..||+|+|+++ .+
T Consensus       151 sNNkl~~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~i  226 (722)
T KOG0532|consen  151 SNNKLTSLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YL  226 (722)
T ss_pred             ecCccccCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ec
Confidence            777772     4456677777888888764 4677778888888888888887 66666663 46788888888888 77


Q ss_pred             cccccccCcccEEEccCCcccCCCC
Q 038098          170 PISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       170 ~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      |-.|.+|..|+.|-|.+|+++..+.
T Consensus       227 Pv~fr~m~~Lq~l~LenNPLqSPPA  251 (722)
T KOG0532|consen  227 PVDFRKMRHLQVLQLENNPLQSPPA  251 (722)
T ss_pred             chhhhhhhhheeeeeccCCCCCChH
Confidence            8888888888888888888876443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=8.9e-14  Score=129.98  Aligned_cols=204  Identities=20%  Similarity=0.291  Sum_probs=142.8

Q ss_pred             HHhhcCCCCcceEEeeeecC-----CceeeEeeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 038098          341 MIKRIRHRNIIKIISSCSSD-----DFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVP  412 (580)
Q Consensus       341 ~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~  412 (580)
                      -+-++-|.|||+++.|+.+.     ....+++|||..|++..+|++-+   ..+....-.+|+.||..||.||| .+.++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence            34556799999999998653     35678999999999999987543   45677777889999999999999 56899


Q ss_pred             eEEecCCCCCEEeCCCCcEEEccccCccccCC--CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhC
Q 038098          413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK--EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR  490 (580)
Q Consensus       413 i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg  490 (580)
                      ++|+++.-+-|++..+|-+|+.--.-......  ...........+-++|.|||+-.....+.++|||+||....||..|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999998888743211110000  0001111223367889999998888889999999999999999988


Q ss_pred             CCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          491 KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       491 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                      ..........             ....+.+........+..          =.+++.+|++..|..||+|.+++.|.-
T Consensus       279 Eiq~tnseS~-------------~~~ee~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  279 EIQSTNSESK-------------VEVEENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             eeccCCCcce-------------eehhhhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhhcCce
Confidence            7652221000             001122222222111111          125788999999999999999987753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.2e-13  Score=140.39  Aligned_cols=249  Identities=22%  Similarity=0.214  Sum_probs=184.9

Q ss_pred             CCCcCceecc--ccCceEEEEEe---CCCCEEEEEEEe--ccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCcee
Q 038098          293 GFSENNLIGR--GGFGSVYKARI---QDGMEVAVKVFD--LQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       293 ~~~~~~~lg~--G~~g~v~~~~~---~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  364 (580)
                      .|.....+|.  |.+|.||.+..   .++..+|+|.-+  .........-.+|+.....++ |+|.++....++..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3566678999  99999999975   368889999743  222233344455677767774 999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCc
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMA  439 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a  439 (580)
                      +-+|++. .+|..+.+.....++....+....+..+    |+.++|   ..+++|-|+||.||+...+ ...+++|||+.
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            9999995 6999888877766888888888888888    999999   9999999999999999999 88999999999


Q ss_pred             cccCCCCCcccc---cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          440 KPLLKEDQSLTQ---TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       440 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ..+...+.....   ....|...|++||.. .+.++..+|+|++|.++.+-.++-.+...-     ....|..-.     
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g-----~~~~W~~~r-----  339 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG-----KNSSWSQLR-----  339 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC-----CCCCccccc-----
Confidence            887655422221   222577789999987 457788999999999999999988764321     011121100     


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ...+..      +.......++...+..|++.+|-.|++.+.+..+
T Consensus       340 ----~~~ip~------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  340 ----QGYIPL------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ----cccCch------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                000000      0111223445568999999999999999887653

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.43  E-value=8.9e-14  Score=143.88  Aligned_cols=179  Identities=37%  Similarity=0.528  Sum_probs=101.7

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCC-CCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLA-ALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDI   89 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L   89 (580)
                      .+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++.+|.....+++|
T Consensus       111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L  188 (394)
T COG4886         111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNL  188 (394)
T ss_pred             hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhh
Confidence            3444455666666666665 4444445543 6666666666666 33445666666666666666666666555455666


Q ss_pred             ceEeCcCCccc----c-cCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccc
Q 038098           90 LYLDLSSNFLL----I-GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNN  164 (580)
Q Consensus        90 ~~L~l~~n~l~----~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~  164 (580)
                      +.|++++|++.    . .....|+.|.+++|.+. ..+..+..+..+..|.+++|++. .++..+..++++++|++++|+
T Consensus       189 ~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~  266 (394)
T COG4886         189 NNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ  266 (394)
T ss_pred             hheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence            66666666662    1 12334666666666432 22344555566666666666665 335555566666666666666


Q ss_pred             cCCCccccccccCcccEEEccCCcccCCCCC
Q 038098          165 LSGTIPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       165 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      ++.. +. +..+.+++.|++++|.++..++.
T Consensus       267 i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         267 ISSI-SS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             cccc-cc-ccccCccCEEeccCccccccchh
Confidence            6632 22 55666666666666666555443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=6.1e-12  Score=129.14  Aligned_cols=167  Identities=17%  Similarity=0.213  Sum_probs=129.0

Q ss_pred             eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHH
Q 038098          313 IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL  392 (580)
Q Consensus       313 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  392 (580)
                      ..++.+|.|.+.+...........+-++.++.++||||++++..++.++..|+|+|.+.  .|..++...    ......
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence            44688999998876665556667788899999999999999999999999999999985  566666553    355666


Q ss_pred             HHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCC
Q 038098          393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS  472 (580)
Q Consensus       393 ~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  472 (580)
                      .-+.||+.||.|||+  +.+++|+++.-..|++++.|+.||++|.++......+.  ......---.|..|+.+....  
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence            788999999999985  56899999999999999999999999998864422211  111222223466666543222  


Q ss_pred             CchhhHhHHHHHHHHHhCC
Q 038098          473 TNGDVYSFGIMLMETFTRK  491 (580)
Q Consensus       473 ~~~Dvws~Gvil~elltg~  491 (580)
                      -..|.|.|||++||++.|.
T Consensus       182 ~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cchhhhhHHHHHHHHhCcc
Confidence            2459999999999999993

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.38  E-value=8.9e-14  Score=134.74  Aligned_cols=196  Identities=26%  Similarity=0.255  Sum_probs=147.5

Q ss_pred             CCCCCCEEeccCCcCCCCCc--hhhhCCCCCceeeCCCCcCCcCCC--ccccCCCCCcEEEcCCCCCCCCCCCC--cCCC
Q 038098           14 KLQKLQLLSLEDNQLEGSIP--DDLCRLAALFELDSGGNKLDGFVP--ACFGNLTNLRNLYLGSNKLTSIPSTL--WNLK   87 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~lp~~~--~~l~   87 (580)
                      ++++|+.+.|.+..+. ..+  +....+++++.||||+|-+....+  .....+++|+.|+|+.|++...-++.  ..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            6888999999999987 344  467889999999999999875433  34678999999999999998743322  2578


Q ss_pred             CCceEeCcCCccc-------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCC--cccccccccccc
Q 038098           88 DILYLDLSSNFLL-------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP--DSIGDLINLKSL  158 (580)
Q Consensus        88 ~L~~L~l~~n~l~-------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p--~~~~~l~~L~~L  158 (580)
                      +|+.|.|+.|.++       ...+|+|+.|+|..|...........-+..|+.|||++|++. ..+  ...+.++.|..|
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhh
Confidence            9999999999993       567999999999999644343444556789999999999987 344  456788999999


Q ss_pred             cccccccCCCc-ccc-----ccccCcccEEEccCCcccCCC--CCCCCCccCccccCCCCc
Q 038098          159 NLSNNNLSGTI-PIS-----LEKLLDLKDINVSFNKLEGEI--PNKGPFRNFSTESFEGNE  211 (580)
Q Consensus       159 ~l~~N~l~~~~-~~~-----~~~l~~L~~l~l~~N~l~~~~--~~~~~~~~l~~~~~~~n~  211 (580)
                      +++.+.++..- |+.     ....++|+.|++..|++....  .....++++..+.+.+|+
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~  337 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNY  337 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccc
Confidence            99999998642 333     356789999999999986322  222334444444444443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.38  E-value=2.1e-14  Score=143.18  Aligned_cols=190  Identities=28%  Similarity=0.321  Sum_probs=161.7

Q ss_pred             EEeccCCcCCCCCchhh-hCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCc
Q 038098           20 LLSLEDNQLEGSIPDDL-CRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNF   98 (580)
Q Consensus        20 ~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~   98 (580)
                      +|.|++-++....-+.. ..+..-...||+.|++. .+|..+..+..|+.|.|++|.+..+|..+.++..|++|||+.|+
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~Nq  132 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQ  132 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccch
Confidence            57778777773322322 34555567999999999 78999999999999999999999999999999999999999999


Q ss_pred             cccc----CCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccccc
Q 038098           99 LLIG----NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE  174 (580)
Q Consensus        99 l~~~----~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~  174 (580)
                      +...    ..--|+.|-+++|+++ .+|..++.++.|..||.+.|.+. .+|..+..+.+|+.|.+..|++. .+|..++
T Consensus       133 lS~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~  209 (722)
T KOG0532|consen  133 LSHLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC  209 (722)
T ss_pred             hhcCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh
Confidence            9422    2235899999999998 45777888999999999999999 88889999999999999999999 6777777


Q ss_pred             ccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       175 ~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                      .+ .|..||++.|+++.++-.+..+..+..+.+..||...
T Consensus       210 ~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  210 SL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             CC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCC
Confidence            55 5899999999999999988888999999999998643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=8.4e-12  Score=130.46  Aligned_cols=144  Identities=18%  Similarity=0.176  Sum_probs=91.8

Q ss_pred             cCCCcCceeccccCceEEEEEeCC-CCEEEEEEEeccccc----------------------------------hhh---
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGR----------------------------------AFK---  333 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~---  333 (580)
                      ..|+. +.+|.|++|.||+|++++ |+.||||+......+                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 789999999999999887 999999999643110                                  001   


Q ss_pred             ---hHHHHHHHHhhcC----CCCcceEEeeee-cCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHH-HHH
Q 038098          334 ---SFDIECDMIKRIR----HRNIIKIISSCS-SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA-LEY  404 (580)
Q Consensus       334 ---~~~~e~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~  404 (580)
                         ++..|+..+.+++    +...+.+-..+. -....++||||++|+++.++-.-.....+..   .++...+.. +..
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Q  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQ  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHH
Confidence               2333444444442    333333333222 2445789999999999987522111112211   122222211 223


Q ss_pred             HhcCCCCCeEEecCCCCCEEeCCCC----cEEEccccCcccc
Q 038098          405 LHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPL  442 (580)
Q Consensus       405 Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~a~~~  442 (580)
                      +.   ..|++|+|++|.||+++.++    .+++.|||++..+
T Consensus       276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            34   67999999999999999888    9999999998755

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.36  E-value=1.9e-13  Score=121.36  Aligned_cols=124  Identities=32%  Similarity=0.375  Sum_probs=39.0

Q ss_pred             CCCCCCCEEeccCCcCCCCCchhhh-CCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCc-CCCCCc
Q 038098           13 GKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLW-NLKDIL   90 (580)
Q Consensus        13 ~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~-~l~~L~   90 (580)
                      .+..+++.|+|++|.|+. + +.++ .+.+|+.|+|++|.|+.+  +.+..+++|++|++++|+|++++..+. .+++|+
T Consensus        16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ   91 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred             cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence            344456666777776662 2 2344 456666677777766644  246666666666666666666644332 345555


Q ss_pred             eEeCcCCcccccCCCcccEEeCCCCcCCCCC-CcccCCccccceeccccccccccCCc----cccccccccccc
Q 038098           91 YLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI-PTTIGGLKDLQYLFLEYNRLQGSIPD----SIGDLINLKSLN  159 (580)
Q Consensus        91 ~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~p~----~~~~l~~L~~L~  159 (580)
                      +|+|++|                  +|.... -..+..+++|+.|+|.+|+++. .+.    .+..+++|+.||
T Consensus        92 ~L~L~~N------------------~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   92 ELYLSNN------------------KISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             EEE-TTS---------------------SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred             EEECcCC------------------cCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeC
Confidence            5555555                  444332 1445667778888888888773 232    355677787776

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=4.7e-12  Score=114.55  Aligned_cols=127  Identities=22%  Similarity=0.228  Sum_probs=96.3

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcc-eEEeeeecCCceeeEeeccCCCCh
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNII-KIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+..|+++++.+.+.+++ +++.+..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            356889999999999876 78899998754322 234567899999988665544 4555433  345799999999888


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP-----IIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-----i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      .+.    .     .....++.+++++++.||   ..+     ++|||++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            653    0     111346789999999999   665     59999999999999 6789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.33  E-value=1.6e-12  Score=134.53  Aligned_cols=189  Identities=37%  Similarity=0.476  Sum_probs=159.8

Q ss_pred             EEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCC-CCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCc
Q 038098           20 LLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLT-NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNF   98 (580)
Q Consensus        20 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~   98 (580)
                      .|+++.|.+. ..+..+..++.++.|++.+|.++. ++.....+. +|+.|++++|+++.+|..+..+++|+.|++++|+
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCccccc-CccccccchhhcccccccccchhhhhhhhhccccccccccCCch
Confidence            5888888885 355667777899999999999994 566666674 9999999999999999889999999999999999


Q ss_pred             cc----cc-CCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccc
Q 038098           99 LL----IG-NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL  173 (580)
Q Consensus        99 l~----~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~  173 (580)
                      +.    .. .+++|+.|++++|++..+ |........|+.|.+++|.+. ..+..+..+.++..|.+.+|++. ..+..+
T Consensus       175 l~~l~~~~~~~~~L~~L~ls~N~i~~l-~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~  251 (394)
T COG4886         175 LSDLPKLLSNLSNLNNLDLSGNKISDL-PPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI  251 (394)
T ss_pred             hhhhhhhhhhhhhhhheeccCCccccC-chhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchh
Confidence            93    22 889999999999999865 444445567999999999766 67778899999999999999999 557788


Q ss_pred             cccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       174 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                      ..+++++.|++++|.++.... ...+..+..+++++|...-
T Consensus       252 ~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         252 GNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             ccccccceecccccccccccc-ccccCccCEEeccCccccc
Confidence            899999999999999998777 6778888888888887543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.32  E-value=2e-13  Score=125.92  Aligned_cols=127  Identities=28%  Similarity=0.382  Sum_probs=85.3

Q ss_pred             CCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCccc-----ccCCCcccEEeC
Q 038098           38 RLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDL  112 (580)
Q Consensus        38 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~-----~~~l~~L~~L~l  112 (580)
                      ..+.|++||||+|.|+ .+-+...-+|.++.|++|+|.|..+-+ +..+++|+.||||+|.++     -..+-+++.|.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeeh
Confidence            3445666666666666 334445556666666666666666643 566666666666666662     234566777788


Q ss_pred             CCCcCCCCCCcccCCccccceeccccccccccC-CcccccccccccccccccccCCC
Q 038098          113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLNLSNNNLSGT  168 (580)
Q Consensus       113 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~  168 (580)
                      +.|.|...  +.+..+-+|..||+++|+|.... -..+++++.|+.|.|.+|.+.+.
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            88877654  56677778888888888887321 24578888888888888888843

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.30  E-value=6e-13  Score=118.19  Aligned_cols=60  Identities=28%  Similarity=0.376  Sum_probs=17.3

Q ss_pred             ccEEeCCCCcCCCCCCcccCCccccceeccccccccccC-CcccccccccccccccccccC
Q 038098          107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLNLSNNNLS  166 (580)
Q Consensus       107 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~  166 (580)
                      |+.|++++|.|+.+.+.....+++|+.|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus        66 L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   66 LKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             --EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             hhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            344444444444332211123555666666666554311 123444555555555555554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.30  E-value=3e-13  Score=124.83  Aligned_cols=187  Identities=20%  Similarity=0.224  Sum_probs=130.1

Q ss_pred             cccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCC---cCCC--------------------ccc
Q 038098            4 LNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLD---GFVP--------------------ACF   60 (580)
Q Consensus         4 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~--------------------~~~   60 (580)
                      +...+|-.+..+.+|+.+.+|++.-..+ -+-...=|.|+++...+..++   ...|                    ...
T Consensus       202 ~~~~l~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~  280 (490)
T KOG1259|consen  202 IPNRLSFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSA  280 (490)
T ss_pred             cccccccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEec
Confidence            3344555556677788887777754321 111111234455544443332   1111                    123


Q ss_pred             cCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceecc
Q 038098           61 GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFL  136 (580)
Q Consensus        61 ~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  136 (580)
                      ..+..|++||||+|.|+.+..+..-+++++.|++|+|.|    .++.+++|++||||+|.++.. ...-..+-+.++|.|
T Consensus       281 dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKL  359 (490)
T ss_pred             chHhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhHhh-hhhHhhhcCEeeeeh
Confidence            445678999999999999887777789999999999998    366788999999999988754 333345778899999


Q ss_pred             ccccccccCCcccccccccccccccccccCCCc-cccccccCcccEEEccCCcccCCCC
Q 038098          137 EYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       137 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      ++|.|.+ + ..+..+.+|..||+++|+|.... -..++++|-|+.+.+.+|++.+.+.
T Consensus       360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999873 2 34777888999999999988422 3568888999999999999887664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=5.6e-12  Score=128.37  Aligned_cols=251  Identities=20%  Similarity=0.148  Sum_probs=179.2

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC--CCCEEEEEEEeccccchhhh--HHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFDLQYGRAFKS--FDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      .-..+|..+..||.|.|+.|++...+  ++..|++|-..........+  -..|+.+...+ .|.++++....|..-...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888999999999999998643  57789998764432222221  22355555555 489999988888877888


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCcccc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPL  442 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a~~~  442 (580)
                      ++--||++++++...... ...+++..++++..|++.++.++|   ++..+|+|++|+||++..+ +..++.|||.+..+
T Consensus       342 ~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            899999999988876522 234778888999999999999999   9999999999999999876 88999999998743


Q ss_pred             CCCCCcccccccccCCCcC--CcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          443 LKEDQSLTQTQTLATIGYM--APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .-..    .. .....+++  +|+......+..+.|++|||.-+.|.++|..-...       ..+|..           
T Consensus       418 ~~~~----~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~-----------  474 (524)
T KOG0601|consen  418 AFSS----GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLT-----------  474 (524)
T ss_pred             ceec----cc-ccccccccccchhhccccccccccccccccccccccccCcccCcc-------ccccee-----------
Confidence            1111    11 11223334  56666677889999999999999999998854211       011110           


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                            ...............+..+.+.+...++..||.+.+...+.+-.++
T Consensus       475 ------i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  475 ------IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ------eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                  0011112222333667788999999999999999998887665543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.23  E-value=1.3e-12  Score=126.83  Aligned_cols=184  Identities=26%  Similarity=0.282  Sum_probs=142.6

Q ss_pred             ccCCCCCCCEEeccCCcCCCCC--chhhhCCCCCceeeCCCCcCCcCCCc-cccCCCCCcEEEcCCCCCCC--CCCCCcC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSI--PDDLCRLAALFELDSGGNKLDGFVPA-CFGNLTNLRNLYLGSNKLTS--IPSTLWN   85 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~--lp~~~~~   85 (580)
                      ....|++++.||||.|-+....  -.....||+|+.|+|+.|++...... .-..++.|+.|.|+.|.|+.  +-..+..
T Consensus       141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~  220 (505)
T KOG3207|consen  141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT  220 (505)
T ss_pred             hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence            5678999999999999887443  34557899999999999998744333 23457899999999999985  3333456


Q ss_pred             CCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCC-CcccCCccccceecccccccccc-CCcc-----cccc
Q 038098           86 LKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVI-PTTIGGLKDLQYLFLEYNRLQGS-IPDS-----IGDL  152 (580)
Q Consensus        86 l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~-~p~~-----~~~l  152 (580)
                      .|+|+.|+|..|..      ....+..|+.|||++|++.... -...+.++.|..|+++.|.+.+. .|+.     ...+
T Consensus       221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f  300 (505)
T KOG3207|consen  221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTF  300 (505)
T ss_pred             CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccc
Confidence            79999999999943      2456778999999999997653 24567899999999999999853 3443     4567


Q ss_pred             cccccccccccccCCC-ccccccccCcccEEEccCCcccCCCC
Q 038098          153 INLKSLNLSNNNLSGT-IPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      ++|++|+++.|+|... .-..+..+++|+.|.+..|.++.+..
T Consensus       301 ~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~~  343 (505)
T KOG3207|consen  301 PKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKETD  343 (505)
T ss_pred             ccceeeecccCccccccccchhhccchhhhhhccccccccccc
Confidence            9999999999999732 12345667888999999999886543

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.23  E-value=7.5e-13  Score=125.04  Aligned_cols=176  Identities=22%  Similarity=0.170  Sum_probs=80.9

Q ss_pred             CCCCCCEEeccCCcCCCCCch----hhhCCCCCceeeCCCCcCCcCCCcc-------------ccCCCCCcEEEcCCCCC
Q 038098           14 KLQKLQLLSLEDNQLEGSIPD----DLCRLAALFELDSGGNKLDGFVPAC-------------FGNLTNLRNLYLGSNKL   76 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~l~~N~l   76 (580)
                      ..++|++||||+|.+...-+.    .+.++..|++|.|.+|.+...--..             ...-++|+++...+|++
T Consensus        90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl  169 (382)
T KOG1909|consen   90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL  169 (382)
T ss_pred             cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence            344555555555555433222    2334455555555555554211111             12234555555555555


Q ss_pred             CCCC-----CCCcCCCCCceEeCcCCcc----------cccCCCcccEEeCCCCcCCCCC----CcccCCccccceeccc
Q 038098           77 TSIP-----STLWNLKDILYLDLSSNFL----------LIGNLKVLVQVDLSMNNFSDVI----PTTIGGLKDLQYLFLE  137 (580)
Q Consensus        77 ~~lp-----~~~~~l~~L~~L~l~~n~l----------~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~  137 (580)
                      ..-+     ..+...+.|+.+.++.|.|          .+..+++|+.|||++|-++...    ..+++.+++|+.|+++
T Consensus       170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~  249 (382)
T KOG1909|consen  170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG  249 (382)
T ss_pred             ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence            5422     2233345555555555555          2444555555555555554321    2334455555555555


Q ss_pred             cccccccCCccc-----ccccccccccccccccCCC----ccccccccCcccEEEccCCcc
Q 038098          138 YNRLQGSIPDSI-----GDLINLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKL  189 (580)
Q Consensus       138 ~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l  189 (580)
                      +|.+.......|     ...++|+.|.|.+|.|+..    +...+...+.|+.|++++|.+
T Consensus       250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            555543222111     1234555555555555431    122233345555555555555

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.22  E-value=2.2e-10  Score=103.94  Aligned_cols=135  Identities=20%  Similarity=0.204  Sum_probs=98.2

Q ss_pred             ceeccccCceEEEEEeCC-------CCEEEEEEEeccc------------c----------chhhh----HHHHHHHHhh
Q 038098          298 NLIGRGGFGSVYKARIQD-------GMEVAVKVFDLQY------------G----------RAFKS----FDIECDMIKR  344 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~~  344 (580)
                      ..||.|--+.||.|...+       +..+|||+.....            +          .....    ...|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999997543       4789999874320            0          00112    2378899998


Q ss_pred             cCC--CCcceEEeeeecCCceeeEeeccCCCChHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEecCCC
Q 038098          345 IRH--RNIIKIISSCSSDDFKALVLEYMPHGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVPIIHCDLKP  420 (580)
Q Consensus       345 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~i~H~dlk~  420 (580)
                      +..  -++..++++    ...++||||+.++.+.. .+..  ..++..+...+..+++.++..+ |   ..+++|||+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            853  456666765    34689999997754422 1221  2345556677889999999999 8   88999999999


Q ss_pred             CCEEeCCCCcEEEccccCcccc
Q 038098          421 SNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       421 ~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .||+++ ++.+.|+|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999988744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.21  E-value=9.4e-10  Score=106.97  Aligned_cols=267  Identities=14%  Similarity=0.122  Sum_probs=167.2

Q ss_pred             CcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEee------eec-CCceeeE
Q 038098          295 SENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISS------CSS-DDFKALV  366 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~-~~~~~lv  366 (580)
                      ...+.||+|+-+.+|-.--  -...+.|+..........   ..+.+|... .||-+-.-+.+      ..+ +....++
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3457799999999986421  122445666433222111   223344444 45544331221      111 2235678


Q ss_pred             eeccCCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          367 LEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      |..+.+.-=-..+.+.      -...+|+..++++..+|.+.+.||   ..|.+-||+.++|+|+.+++.+.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            8877664211112211      145799999999999999999999   9999999999999999999999999854322


Q ss_pred             ccCCCCCcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhC-CCCCCccccCC---chHH-HHHHh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGD---MTLK-HWVND  510 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg-~~p~~~~~~~~---~~~~-~~~~~  510 (580)
                       +  ..........+|...|.+||...     +-.-+...|-|.+||++++++.| ++||.+.....   ..++ .....
T Consensus       166 -i--~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 -I--NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             -e--ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence             1  12223344567889999999654     33456789999999999999886 99998753211   1111 22221


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHHh
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVES--PEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      .+....    |...-....+.-....-.++++..|..+|+...  +.-||+++-++..|.++.+++-+
T Consensus       243 ~f~ya~----~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         243 RFAYAS----DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eeeech----hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            111110    111111111121223445678889999999755  56899999999999999988754

>PLN03150 hypothetical protein; Provisional

Probab=99.19  E-value=5.2e-11  Score=129.04  Aligned_cols=106  Identities=38%  Similarity=0.532  Sum_probs=92.1

Q ss_pred             CceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccc
Q 038098           89 ILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN  162 (580)
Q Consensus        89 L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  162 (580)
                      ++.|+|++|.+      .+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            56677777766      256778889999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccccc-CcccEEEccCCcccCCCC
Q 038098          163 NNLSGTIPISLEKL-LDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       163 N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~  194 (580)
                      |++++.+|..+..+ .++..+++.+|+..|-.|
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC
Confidence            99999999988764 467889999998776544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.19  E-value=9.3e-12  Score=133.21  Aligned_cols=250  Identities=23%  Similarity=0.260  Sum_probs=173.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ..+++.+.+-+..|.++.++.+.-. .|...+.|+....   .....+....+-.+.-..++|.+++..-.+.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466777778889999999887633 3434444443211   11122222333333333456777776666666778899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |++|..+++|..-++..+. .+...+......+..+.+|||   ...+.|+|++|.|.+...++..+++|||........
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999998887764 455555567777888999999   887999999999999999999999999843322100


Q ss_pred             -----------------------------CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          446 -----------------------------DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       446 -----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                                                   +.........+|+.|.|||...+......+|.|+.|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                         000112344689999999999999999999999999999999999999876


Q ss_pred             cccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHH
Q 038098          497 IFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAK  561 (580)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  561 (580)
                      ....                 .+++.. ......+...+...+.+..+++.+.+..+|.+|-.+.
T Consensus      1038 ~tpq-----------------~~f~ni-~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ-----------------QIFENI-LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchh-----------------hhhhcc-ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            3221                 111111 1111122334455677788999999999999998776

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=2.6e-10  Score=99.58  Aligned_cols=130  Identities=24%  Similarity=0.361  Sum_probs=101.4

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEE-eccccc-------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVF-DLQYGR-------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ..+++|+-+.+|.+.+. |.++++|.= .+....       ...+-.+|++++++++--.|...+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999876 455667643 222111       124556799999999876776666666777888899999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ++|..|.+.+...        ...++..+-.-+.-||   ..+|+|||+.++||++..+. +.++|||++.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            9999999888765        2456777778888999   99999999999999998765 9999999987

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=2.7e-10  Score=107.93  Aligned_cols=141  Identities=17%  Similarity=0.173  Sum_probs=110.9

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEecccc-chhhhHHHHHHHHhhcCC--CCcceEEeeeecC---CceeeEeeccC
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRH--RNIIKIISSCSSD---DFKALVLEYMP  371 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  371 (580)
                      +.++.|..+.||++...+|+.+++|+...... .....+..|++++..+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887678999998754322 234678899999999976  4467778777654   25689999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-------------------------------------------  408 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------------  408 (580)
                      |.++.+.+..  ..++..+...++.++++++.+||.-                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988775432  3467778888899999999999831                                           


Q ss_pred             ----------CCCCeEEecCCCCCEEeCC--CCcEEEccccCcc
Q 038098          409 ----------YSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAK  440 (580)
Q Consensus       409 ----------~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~a~  440 (580)
                                ....++|+|+.+.||+++.  ++.+.|+||+.+.
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                      0256799999999999998  6678999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.15  E-value=4.7e-10  Score=97.36  Aligned_cols=141  Identities=20%  Similarity=0.212  Sum_probs=104.8

Q ss_pred             cCceeccccCceEEEEEeCCCCEEEEEEE-eccccc-------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          296 ENNLIGRGGFGSVYKARIQDGMEVAVKVF-DLQYGR-------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ...++-+|+-+.|+++.+. |+.+.||-- .+....       ...+..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678999999999999987 788777743 222211       2356677999999987555554444555555567999


Q ss_pred             eccCC-CChHHHhhcCCCCCCHH-HHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEEEccccCcc
Q 038098          368 EYMPH-GSLEKCLYSSNYILDIF-QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAK  440 (580)
Q Consensus       368 e~~~~-g~L~~~l~~~~~~~~~~-~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~a~  440 (580)
                      ||++| .++.+++...-..-..+ ....++.+|-+.+.-||   ..+++||||..+||++.+++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99977 47788876544323333 33678999999999999   99999999999999997554   46899999986

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.13  E-value=1.4e-11  Score=127.69  Aligned_cols=171  Identities=33%  Similarity=0.427  Sum_probs=82.6

Q ss_pred             cCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCce
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILY   91 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~   91 (580)
                      +..+++|+.|+|.+|+|. .+...+..+++|++|+|++|.|+.+  ..+..++.|+.|++++|.|+.++ .+..+++|+.
T Consensus        91 l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~~-~~~~l~~L~~  166 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDIS-GLESLKSLKL  166 (414)
T ss_pred             cccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchhcc-CCccchhhhc
Confidence            444555555555555555 2222244555555555555555544  22444444555555555555542 2333555555


Q ss_pred             EeCcCCccc---c---cCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccc--cccccccccc
Q 038098           92 LDLSSNFLL---I---GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI--NLKSLNLSNN  163 (580)
Q Consensus        92 L~l~~n~l~---~---~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~l~~N  163 (580)
                      +++++|++.   .   ..+..++.+++.+|.+..+  ..+..+..+..+++..|.++..-+  +..+.  .|+.+++++|
T Consensus       167 l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n  242 (414)
T KOG0531|consen  167 LDLSYNRIVDIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGN  242 (414)
T ss_pred             ccCCcchhhhhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccC
Confidence            555555551   1   3444555555555555432  223333444444555555542111  11112  2566666666


Q ss_pred             ccCCCccccccccCcccEEEccCCcccC
Q 038098          164 NLSGTIPISLEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       164 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~  191 (580)
                      .+. ..+..+..+..+..|++.+|.+..
T Consensus       243 ~i~-~~~~~~~~~~~l~~l~~~~n~~~~  269 (414)
T KOG0531|consen  243 RIS-RSPEGLENLKNLPVLDLSSNRISN  269 (414)
T ss_pred             ccc-cccccccccccccccchhhccccc
Confidence            665 333444555556666666665543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.09  E-value=1.3e-11  Score=127.91  Aligned_cols=191  Identities=28%  Similarity=0.342  Sum_probs=134.7

Q ss_pred             CCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEe
Q 038098           14 KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLD   93 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~   93 (580)
                      .+..++.+++..|.|.. .-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+. .+..++.|+.|+
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~-~l~~l~~L~~L~  146 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE-GLSTLTLLKELN  146 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc-chhhccchhhhe
Confidence            46677777788888873 344577788889999999998854 333777888999999999988873 566677788999


Q ss_pred             CcCCccc----ccCCCcccEEeCCCCcCCCCCC-cccCCccccceeccccccccccCCcccccccccccccccccccCCC
Q 038098           94 LSSNFLL----IGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGT  168 (580)
Q Consensus        94 l~~n~l~----~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  168 (580)
                      +++|.|+    +..++.|+.+++++|.+....+ . ...+.+|+.+++.+|.+. .+ ..+..+..+..+++..|.++..
T Consensus       147 l~~N~i~~~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~-~i-~~~~~~~~l~~~~l~~n~i~~~  223 (414)
T KOG0531|consen  147 LSGNLISDISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR-EI-EGLDLLKKLVLLSLLDNKISKL  223 (414)
T ss_pred             eccCcchhccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh-cc-cchHHHHHHHHhhcccccceec
Confidence            9999883    5557788888999998886644 2 467788888899888887 32 3455566777778888888843


Q ss_pred             ccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCC
Q 038098          169 IPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN  210 (580)
Q Consensus       169 ~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n  210 (580)
                      -+.....+..|+.+++++|++.........+..+..++...|
T Consensus       224 ~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n  265 (414)
T KOG0531|consen  224 EGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSN  265 (414)
T ss_pred             cCcccchhHHHHHHhcccCccccccccccccccccccchhhc
Confidence            332211111388899999998865433334444444444433

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.08  E-value=8.1e-12  Score=118.17  Aligned_cols=178  Identities=19%  Similarity=0.169  Sum_probs=131.4

Q ss_pred             hhhCCCCCceeeCCCCcCCcCCCcc----ccCCCCCcEEEcCCCCCCCCC--------------CCCcCCCCCceEeCcC
Q 038098           35 DLCRLAALFELDSGGNKLDGFVPAC----FGNLTNLRNLYLGSNKLTSIP--------------STLWNLKDILYLDLSS   96 (580)
Q Consensus        35 ~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~~lp--------------~~~~~l~~L~~L~l~~   96 (580)
                      ++...++|++||||+|.+....+..    +..+++|++|+|.||.+....              .-..+-++|+.+..++
T Consensus        87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r  166 (382)
T KOG1909|consen   87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR  166 (382)
T ss_pred             HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence            3456678999999999987554443    466789999999999886421              1233457899999999


Q ss_pred             Ccc----------cccCCCcccEEeCCCCcCCCCC----CcccCCccccceeccccccccc----cCCcccccccccccc
Q 038098           97 NFL----------LIGNLKVLVQVDLSMNNFSDVI----PTTIGGLKDLQYLFLEYNRLQG----SIPDSIGDLINLKSL  158 (580)
Q Consensus        97 n~l----------~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L  158 (580)
                      |++          .+...+.|+.+.++.|.|....    ..+|..+++|+.|||.+|-++.    .+...+..+++|+.|
T Consensus       167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El  246 (382)
T KOG1909|consen  167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL  246 (382)
T ss_pred             cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence            998          3667789999999999886422    3457789999999999999874    234567778899999


Q ss_pred             cccccccCCCcccccc-----ccCcccEEEccCCcccCCCC-----CCCCCccCccccCCCCcc
Q 038098          159 NLSNNNLSGTIPISLE-----KLLDLKDINVSFNKLEGEIP-----NKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       159 ~l~~N~l~~~~~~~~~-----~l~~L~~l~l~~N~l~~~~~-----~~~~~~~l~~~~~~~n~~  212 (580)
                      +++++.++..-...+.     ..|+|+.|.+.+|.++..-.     .....+.+..+.+++|..
T Consensus       247 ~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  247 NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            9999999864433322     46889999999999885321     112366777888888876

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.07  E-value=7e-11  Score=86.37  Aligned_cols=61  Identities=39%  Similarity=0.565  Sum_probs=41.1

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCC
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKL   76 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l   76 (580)
                      ++|++|+|++|+|+.+.++.|.++++|++|++++|.|+.+.++.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566677777777655556666677777777777777666666667777777777766654

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=5.3e-09  Score=94.64  Aligned_cols=125  Identities=27%  Similarity=0.319  Sum_probs=82.6

Q ss_pred             eEEEEEeCCCCEEEEEEEecccc-------------c-------------hhhhHHHHHHHHhhcCCC--CcceEEeeee
Q 038098          307 SVYKARIQDGMEVAVKVFDLQYG-------------R-------------AFKSFDIECDMIKRIRHR--NIIKIISSCS  358 (580)
Q Consensus       307 ~v~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~~~~~~~  358 (580)
                      .||.|...+|..+|||+......             .             ......+|.+.|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988899999998743200             0             123456799999999765  466666553 


Q ss_pred             cCCceeeEeeccC--CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          359 SDDFKALVLEYMP--HGSLEKCLYSSNYILDIFQRLNIMIDVASALEY-LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       359 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                         ...+||||++  |..+..+... .  ++......++.+++..+.. +|   ..|++|||+.+.||+++++ .+.|+|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3479999998  6555443222 1  1133445677778775555 68   8999999999999999988 999999


Q ss_pred             ccCcccc
Q 038098          436 FGMAKPL  442 (580)
Q Consensus       436 fg~a~~~  442 (580)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.96  E-value=3.4e-08  Score=98.86  Aligned_cols=168  Identities=18%  Similarity=0.202  Sum_probs=128.0

Q ss_pred             cCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec----CCceeeEeeccCC-CChHH
Q 038098          304 GFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFKALVLEYMPH-GSLEK  377 (580)
Q Consensus       304 ~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~  377 (580)
                      ...+.|++.. .||..|++|+++..........-.-+++++++.|.|+|++.+.+..    +..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4568899974 4899999999965544433334456789999999999999887652    3467899999876 46666


Q ss_pred             Hhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          378 CLYS--------------SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       378 ~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      .-..              .+...++...|.++.|+..||.++|   +.|..-+-+.+.+|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            4321              1235678899999999999999999   9999999999999999999999999888876554


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCC
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP  493 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p  493 (580)
                      .+..                |.+.   --.+-|.=.+|.+++.|.||..-
T Consensus       445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            3321                1111   12356999999999999999754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.93  E-value=1.3e-08  Score=97.77  Aligned_cols=139  Identities=15%  Similarity=0.069  Sum_probs=100.9

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEecccc-----------chhhhHHHHHHHHhhcCCCCc--ceEEeeeec-----
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG-----------RAFKSFDIECDMIKRIRHRNI--IKIISSCSS-----  359 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----  359 (580)
                      +.+-......|++..+. |+.|.||.......           .....+.+|...+.++...+|  ..++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            45555555567777664 78899997743221           111247789999888854333  344555543     


Q ss_pred             CCceeeEeeccCCC-ChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-------CCc
Q 038098          360 DDFKALVLEYMPHG-SLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-------NMV  430 (580)
Q Consensus       360 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-------~~~  430 (580)
                      ....++|+|++++. +|.+++... ..+.+...+..++.+++..+..||   ..||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23468999999886 898887532 234566777889999999999999   999999999999999975       568


Q ss_pred             EEEccccCcc
Q 038098          431 AHLSDFGMAK  440 (580)
Q Consensus       431 ~kl~Dfg~a~  440 (580)
                      +.++||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999886

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=5.2e-10  Score=81.75  Aligned_cols=59  Identities=39%  Similarity=0.562  Sum_probs=31.5

Q ss_pred             cccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccc
Q 038098          106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNN  164 (580)
Q Consensus       106 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~  164 (580)
                      +|+.|++++|+++.+++..|.++++|+.|++++|.++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555555545555555555555555555554444455555555555555554

...

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=1.4e-09  Score=112.62  Aligned_cols=154  Identities=17%  Similarity=0.236  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc-cc------ccccccCCCcCCcccc
Q 038098          394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-LT------QTQTLATIGYMAPEYG  466 (580)
Q Consensus       394 i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~------~~~~~~~~~y~aPE~~  466 (580)
                      =+.+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+.+......... ..      .........|.|||++
T Consensus       104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            34455599999995  788999999999999999999999999987644331110 00      0111244569999999


Q ss_pred             cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHH
Q 038098          467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLA  546 (580)
Q Consensus       467 ~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~  546 (580)
                      .....+.++|+||+||++|.+..|+.+--....+. .......        ...+.       ..+....+.+.++.+=+
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~--------~~~~~-------~~~~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSR--------NLLNA-------GAFGYSNNLPSELRESL  245 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhh--------ccccc-------ccccccccCcHHHHHHH
Confidence            99889999999999999999996555432211111 1111000        00111       11222356778899999


Q ss_pred             hhccCCCCCCCCCHHHHHH
Q 038098          547 MKCTVESPEQRINAKEIVT  565 (580)
Q Consensus       547 ~~cl~~dP~~Rps~~ev~~  565 (580)
                      .+++..++..||++.++..
T Consensus       246 ~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHhcCCcccCcchhhhhc
Confidence            9999999999997776643

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.87  E-value=1.7e-11  Score=125.87  Aligned_cols=178  Identities=29%  Similarity=0.274  Sum_probs=118.4

Q ss_pred             CcccCCCCCCCEEeccCCcCCCCCchhhhCC-CCCceeeCCCCcCCcCCCc-------cccC---CCCCcEEEcCCCCCC
Q 038098            9 PIAVGKLQKLQLLSLEDNQLEGSIPDDLCRL-AALFELDSGGNKLDGFVPA-------CFGN---LTNLRNLYLGSNKLT   77 (580)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~-------~~~~---l~~L~~L~l~~N~l~   77 (580)
                      |-.+..+.+|++|.|.++.|.. .- .+..+ .+|++|. .+|.++. +..       .+.+   +-.|.+.+.+.|+|.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~-~~-GL~~lr~qLe~LI-C~~Sl~A-l~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST-AK-GLQELRHQLEKLI-CHNSLDA-LRHVFASCGGDISNSPVWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh-hh-hhHHHHHhhhhhh-hhccHHH-HHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence            5567788889999999988873 11 11111 1333332 2333321 111       1111   235777788888888


Q ss_pred             CCCCCCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccc
Q 038098           78 SIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI  153 (580)
Q Consensus        78 ~lp~~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  153 (580)
                      .+-.++.=++.|++|||++|++    .+..++.|++|||+.|.+..++--...++. |..|.|++|-++ .+- .+.++.
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~Lk  254 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLK  254 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhccccccchhhhh-heeeeecccHHH-hhh-hHHhhh
Confidence            8777777788888888888888    356788888888888888866544444555 888888888887 332 366778


Q ss_pred             ccccccccccccCCCc-cccccccCcccEEEccCCcccCCC
Q 038098          154 NLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEI  193 (580)
Q Consensus       154 ~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~  193 (580)
                      +|+.||+++|-|.+-- -..+..+..|+.|+|.||++-|-+
T Consensus       255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            8888888888887521 123556678888888888887644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=1.9e-08  Score=93.37  Aligned_cols=133  Identities=24%  Similarity=0.245  Sum_probs=97.6

Q ss_pred             CcCceeccccCceEEEEEeCCCCEEEEEEEecccc----------------------chhhhHHHHHHHHhhcCCC--Cc
Q 038098          295 SENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG----------------------RAFKSFDIECDMIKRIRHR--NI  350 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--ni  350 (580)
                      .+...||-|--+.||.|..+.|.++|||.-.....                      -......+|.++|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45678999999999999999999999997532100                      0123456788999998655  66


Q ss_pred             ceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc
Q 038098          351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  430 (580)
Q Consensus       351 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~  430 (580)
                      .+.+++    +...+|||+++|-.|...-      ++....-.++..|++-+...-   ..||||||+++-||+++++|.
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence            666654    3457999999997665521      123334445556666565555   678999999999999999999


Q ss_pred             EEEccccCcc
Q 038098          431 AHLSDFGMAK  440 (580)
Q Consensus       431 ~kl~Dfg~a~  440 (580)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999996554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.79  E-value=2.4e-09  Score=99.31  Aligned_cols=180  Identities=23%  Similarity=0.183  Sum_probs=95.2

Q ss_pred             CCCCEEeccCCcCCC--CCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC--CCCCCcCCCCCce
Q 038098           16 QKLQLLSLEDNQLEG--SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS--IPSTLWNLKDILY   91 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--lp~~~~~l~~L~~   91 (580)
                      +.++.|||.+|.|+.  .+-.-+.+||.|++|+|+.|.+.+.+...-..+.+|++|.|.+..|.-  ....+..++.++.
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte  150 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE  150 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence            445555555555542  122333455555555555555553222221334455555555554432  2223344555555


Q ss_pred             EeCcCCccc--------ccC-CCcccEEeCCCCcCCCCC--CcccCCccccceeccccccccccC-Cccccccccccccc
Q 038098           92 LDLSSNFLL--------IGN-LKVLVQVDLSMNNFSDVI--PTTIGGLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLN  159 (580)
Q Consensus        92 L~l~~n~l~--------~~~-l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~  159 (580)
                      |++|.|.+.        ... -+.+.+|++..|......  ...-.-+|++..+.+..|.|.... -..+..++.+..|+
T Consensus       151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~Ln  230 (418)
T KOG2982|consen  151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLN  230 (418)
T ss_pred             hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhh
Confidence            555555330        000 012222222222111000  000112467778888888887432 34566778888999


Q ss_pred             ccccccCCC-ccccccccCcccEEEccCCcccCCCCC
Q 038098          160 LSNNNLSGT-IPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       160 l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      |+.|+|... --+.+..+++|..|.+++|++......
T Consensus       231 L~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~  267 (418)
T KOG2982|consen  231 LGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRG  267 (418)
T ss_pred             hcccccccHHHHHHHcCCchhheeeccCCcccccccC
Confidence            999999853 235688899999999999998765543

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=2.7e-07  Score=83.96  Aligned_cols=138  Identities=19%  Similarity=0.109  Sum_probs=103.2

Q ss_pred             eccccCceEEEEEeCCCCEEEEEEEeccc------cchhhhHHHHHHHHhhcCCC--CcceEEeeeec----CCceeeEe
Q 038098          300 IGRGGFGSVYKARIQDGMEVAVKVFDLQY------GRAFKSFDIECDMIKRIRHR--NIIKIISSCSS----DDFKALVL  367 (580)
Q Consensus       300 lg~G~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~----~~~~~lv~  367 (580)
                      -|+||.+.|++.... |+.+-+|+-....      +-....|.+|...+.++..-  .+.+++.+...    .-.-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            477999999998776 5578888764211      22457899999999988532  24555522211    12357999


Q ss_pred             eccCC-CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc--EEEccccCccc
Q 038098          368 EYMPH-GSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKP  441 (580)
Q Consensus       368 e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~a~~  441 (580)
                      |-+++ -+|.+++.... .+.+......++.+++..++-||   ..|+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98763 48988876543 35677888899999999999999   999999999999999986666  99999987763

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.70  E-value=4e-10  Score=116.00  Aligned_cols=99  Identities=34%  Similarity=0.400  Sum_probs=69.6

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeC
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDL   94 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l   94 (580)
                      ..|.+.+.++|.+. .+..++.-++.|+.|||++|+++..  ..+..++.|++|||+.|.|+.+|. ....+. |..|++
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeee
Confidence            35778889999998 7888888899999999999999854  378889999999999999999875 222222 555555


Q ss_pred             cCCccc----ccCCCcccEEeCCCCcCC
Q 038098           95 SSNFLL----IGNLKVLVQVDLSMNNFS  118 (580)
Q Consensus        95 ~~n~l~----~~~l~~L~~L~l~~N~l~  118 (580)
                      ++|.+.    +.++.+|..||++.|-|.
T Consensus       240 rnN~l~tL~gie~LksL~~LDlsyNll~  267 (1096)
T KOG1859|consen  240 RNNALTTLRGIENLKSLYGLDLSYNLLS  267 (1096)
T ss_pred             cccHHHhhhhHHhhhhhhccchhHhhhh
Confidence            555541    334444444444444443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.64  E-value=2.6e-07  Score=86.00  Aligned_cols=106  Identities=25%  Similarity=0.265  Sum_probs=83.9

Q ss_pred             hhhHHHHHHHHhhcCCC--CcceEEeeeecCC----ceeeEeeccCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 038098          332 FKSFDIECDMIKRIRHR--NIIKIISSCSSDD----FKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEY  404 (580)
Q Consensus       332 ~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~  404 (580)
                      .....+|...+.++...  .+.+.+++.+...    ..++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            34677788888887533  3455666665422    347999999884 79998876433 5666778899999999999


Q ss_pred             HhcCCCCCeEEecCCCCCEEeCCCC---cEEEccccCccc
Q 038098          405 LHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKP  441 (580)
Q Consensus       405 Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~a~~  441 (580)
                      ||   ..||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99   99999999999999999887   899999998774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.63  E-value=1.6e-09  Score=89.06  Aligned_cols=112  Identities=24%  Similarity=0.318  Sum_probs=61.1

Q ss_pred             CCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccc
Q 038098           64 TNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQG  143 (580)
Q Consensus        64 ~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~  143 (580)
                      ..|+..+|++|.+..+|..|..                 ..+.++.|+|++|+|+.+ |..+..++.|+.|+++.|.+. 
T Consensus        53 ~el~~i~ls~N~fk~fp~kft~-----------------kf~t~t~lNl~~neisdv-PeE~Aam~aLr~lNl~~N~l~-  113 (177)
T KOG4579|consen   53 YELTKISLSDNGFKKFPKKFTI-----------------KFPTATTLNLANNEISDV-PEELAAMPALRSLNLRFNPLN-  113 (177)
T ss_pred             ceEEEEecccchhhhCCHHHhh-----------------ccchhhhhhcchhhhhhc-hHHHhhhHHhhhcccccCccc-
Confidence            4455556666666655554432                 112234444444444433 444666677777777777776 


Q ss_pred             cCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC
Q 038098          144 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       144 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      ..|..+..+.++..|+..+|.+. .+|-.+-.-......++.++++.+..+.
T Consensus       114 ~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~  164 (177)
T KOG4579|consen  114 AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK  164 (177)
T ss_pred             cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence            66666666777777777777766 3433332222333344566666665543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=2.5e-07  Score=96.51  Aligned_cols=141  Identities=21%  Similarity=0.198  Sum_probs=94.2

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEeccccch----------------------------------------hhhHHH
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA----------------------------------------FKSFDI  337 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  337 (580)
                      +.|+.++-|-||+|++++|+.||||+......+.                                        .-++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6789999999999999999999999985431110                                        012233


Q ss_pred             HHHHHhhcC-----CCCcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 038098          338 ECDMIKRIR-----HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA-LEYLHFGYSV  411 (580)
Q Consensus       338 e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~Lh~~~~~  411 (580)
                      |..-+.+++     .+++.-.-=|++-.....|+|||++|..+.+...-+....+...   ++..++++ +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence            444444442     23332222233445667899999999999887433333355333   33333332 22333   56


Q ss_pred             CeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       412 ~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      |+.|.|..|.||+++.+|.+.+.|||+...+..
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999876643

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.63  E-value=3.2e-09  Score=87.25  Aligned_cols=106  Identities=25%  Similarity=0.302  Sum_probs=86.9

Q ss_pred             CCceEeCcCCcc--------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccc
Q 038098           88 DILYLDLSSNFL--------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN  159 (580)
Q Consensus        88 ~L~~L~l~~n~l--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  159 (580)
                      .+..++|+++.+        .+.....|+.++|++|.+...++..-..++.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus        28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            345566666665        2456677888999999998776655566789999999999999 7888899999999999


Q ss_pred             ccccccCCCccccccccCcccEEEccCCcccCCCCC
Q 038098          160 LSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       160 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      ++.|.+. ..|..+..+.+|-.|+..+|.+-.++-+
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d  141 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD  141 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH
Confidence            9999999 7788888899999999999987765544

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.63  E-value=1e-08  Score=93.92  Aligned_cols=180  Identities=21%  Similarity=0.182  Sum_probs=106.9

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCch----hhhCCCCCceeeCCCCcCCcCCCccc-------------cCCCCCcEEEcCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPD----DLCRLAALFELDSGGNKLDGFVPACF-------------GNLTNLRNLYLGS   73 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~l~~   73 (580)
                      ++..++.|++.+||+|.+....|+    .+++-+.|.+|.|++|.+..+--+-+             .+-|.|++..+..
T Consensus        87 aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgr  166 (388)
T COG5238          87 ALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGR  166 (388)
T ss_pred             HHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEecc
Confidence            455677788888888877655553    44566777788888887653322222             3456777888888


Q ss_pred             CCCCCCCCC-----CcCCCCCceEeCcCCccc-----------ccCCCcccEEeCCCCcCCCCC----CcccCCccccce
Q 038098           74 NKLTSIPST-----LWNLKDILYLDLSSNFLL-----------IGNLKVLVQVDLSMNNFSDVI----PTTIGGLKDLQY  133 (580)
Q Consensus        74 N~l~~lp~~-----~~~l~~L~~L~l~~n~l~-----------~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~  133 (580)
                      |++...|..     +..-..|+.+.+..|.|.           ...+.+|+.|||.+|-++...    ..+++.++.|+.
T Consensus       167 NRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE  246 (388)
T COG5238         167 NRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE  246 (388)
T ss_pred             chhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence            877765432     222346777777777771           334567777777777776432    344566677777


Q ss_pred             eccccccccccCCccc----c--cccccccccccccccCCCcccc-------ccccCcccEEEccCCccc
Q 038098          134 LFLEYNRLQGSIPDSI----G--DLINLKSLNLSNNNLSGTIPIS-------LEKLLDLKDINVSFNKLE  190 (580)
Q Consensus       134 L~l~~n~l~~~~p~~~----~--~l~~L~~L~l~~N~l~~~~~~~-------~~~l~~L~~l~l~~N~l~  190 (580)
                      |.+.+|-++.....++    .  ..++|..|.+.+|.+.+.+-..       -..+|-|..|-+.+|.|+
T Consensus       247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~  316 (388)
T COG5238         247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK  316 (388)
T ss_pred             ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence            7777777764322221    1  1356677777777665432211       113445555555555554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	580
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-32
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-18
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-16
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-15
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-06
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		4e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-06
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		4e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-06
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		6e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		8e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-06
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		8e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-05
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-05
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-05
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		6e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
2r9u_A	174	Crystal Structure Of Lamprey Variable Lymphocyte Re		3e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-04
3g3a_A	178	Structure Of A Lamprey Variable Lymphocyte Receptor		6e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-04
3g39_A	170	Structure Of A Lamprey Variable Lymphocyte Receptor		7e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		8e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 100/297 (33%), Positives = 144/297 (48%), Gaps = 17/297 (5%)
Query: 280 RRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIE 338
           +RF+  E+  A++ FS  N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQRLNIM 395
            +M                     + LV  YM +GS+  CL     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           +  A  L YLH      IIH D+K +N+LLD+   A + DFG+AK +  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG---DMTLKHWVNDLL 512
            TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D        D+ L  WV  LL
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 513 PISVME-IVDANLLSQ-KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               +E +VD +L    KDE        V  +  +A+ CT  SP +R    E+V  L
Sbjct: 265 KEKKLEALVDVDLQGNYKDEE-------VEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 98/297 (32%), Positives = 142/297 (47%), Gaps = 17/297 (5%)
Query: 280 RRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIE 338
           +RF+  E+  A++ F   N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQRLNIM 395
            +M                     + LV  YM +GS+  CL     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           +  A  L YLH      IIH D+K +N+LLD+   A + DFG+AK +  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG---DMTLKHWVNDLL 512
             IG++APEY   G+ S   DV+ +G+ML+E  T ++  D        D+ L  WV  LL
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 513 PISVME-IVDANLLSQ-KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               +E +VD +L    KDE        V  +  +A+ CT  SP +R    E+V  L
Sbjct: 257 KEKKLEALVDVDLQGNYKDEE-------VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 151/303 (49%), Gaps = 17/303 (5%)
Query: 281 RFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECD 340
           R   +++ +ATN F    LIG G FG VYK  ++DG +VA+K    +  +  + F+ E +
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 341 MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMID 397
                               +   L+ +YM +G+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
            A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   + DQ+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT-LKHWVNDLLPISV 516
           +GY+ PEY  +G+++   DVYSFG++L E    +    +    +M  L  W  +      
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 517 ME-IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL---LKIRD 572
           +E IVD NL  +       + + +    + A+KC   S E R +  +++ +L   L++++
Sbjct: 265 LEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 573 SLL 575
           S++
Sbjct: 319 SVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 150/303 (49%), Gaps = 17/303 (5%)
Query: 281 RFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECD 340
           R   +++ +ATN F    LIG G FG VYK  ++DG +VA+K    +  +  + F+ E +
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 341 MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMID 397
                               +   L+ +YM +G+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
            A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   +  Q+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT-LKHWVNDLLPISV 516
           +GY+ PEY  +G+++   DVYSFG++L E    +    +    +M  L  W  +      
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 517 ME-IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL---LKIRD 572
           +E IVD NL  +       + + +    + A+KC   S E R +  +++ +L   L++++
Sbjct: 265 LEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 573 SLL 575
           S++
Sbjct: 319 SVI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 112/237 (47%), Gaps = 21/237 (8%)
Query: 275 RISNQR--RFTYLEIFQATNGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK---- 322
            +S+ R   F++ E+   TN F E       N +G GGFG VYK  + +   VAVK    
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 323 VFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLE---KCL 379
           + D+      + FD E  +                   D   LV  YMP+GSL     CL
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 380 YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA 439
                 L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A
Sbjct: 125 -DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
           +   K  Q++  ++ + T  YMAPE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 282 FTYLEIFQATNGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFDLQYGRA 331
           F++ E+   TN F E       N +G GGFG VYK  + +   VAVK    + D+     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLE---KCLYSSNYILDI 388
            + FD E  +                   D   LV  YMP+GSL     CL      L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
             R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   K  Q+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
           +   + + T  YMAPE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 190 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 282 FTYLEIFQATNGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFDLQYGRA 331
           F++ E+   TN F E       N +G GGFG VYK  + +   VAVK    + D+     
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLE---KCLYSSNYILDI 388
            + FD E  +                   D   LV  YMP+GSL     CL      L  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 126
Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
             R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   K  Q 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
           +   + + T  YMAPE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 282 FTYLEIFQATNGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFDLQYGRA 331
           F++ E+   TN F E       N  G GGFG VYK  + +   VAVK    + D+     
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLE---KCLYSSNYILDI 388
            + FD E  +                   D   LV  Y P+GSL     CL      L  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSW 123
Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
             R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   K  Q 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
           +  ++ + T  Y APE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 8/198 (4%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+V++A    G +VAVK+   Q  +      F  E  +                
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
                 ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DLK  N+L+D      + DFG+++  LK    L       T  +MAPE  R+   +   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 476 DVYSFGIMLMETFTRKKP 493
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 8/198 (4%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+V++A    G +VAVK+   Q  +      F  E  +                
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
                 ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            +LK  N+L+D      + DFG+++  LK    L+      T  +MAPE  R+   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 476 DVYSFGIMLMETFTRKKP 493
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 103/231 (44%), Gaps = 13/231 (5%)
Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           NNL G IP A+ KL +L  L +    + G+IPD L ++  L  LD   N L G +P    
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 62  NLTNLRNLYLGSNKLT-SIPSTLWNLKDILY-LDLSSNFL------LIGNLKVLVQVDLS 113
           +L NL  +    N+++ +IP +  +   +   + +S N L         NL  L  VDLS
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISL 173
            N          G  K+ Q + L  N L   +   +G                GT+P  L
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC 224
            +L  L  +NVSFN L GEIP  G  + F   ++  N+ LCG P   +P C
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 19/141 (13%)
Query: 79  IPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEY 138
           IPS+L NL    YL    NFL IG           +NN    IP  I  L  L YL++ +
Sbjct: 68  IPSSLANLP---YL----NFLYIG----------GINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 139 NRLQGSIPDSIGDXXXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNKLEGEIPNK-G 197
             + G+IPD +                 GT+P S+  L +L  I    N++ G IP+  G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 198 PFRN-FSTESFEGNELLCGMP 217
            F   F++ +   N L   +P
Sbjct: 171 SFSKLFTSMTISRNRLTGKIP 191

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 115/285 (40%), Gaps = 43/285 (15%)
Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
           +G G FG V+ A        +D M VAVK        A K F  E ++            
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYS---------------SNYILDIFQRLNIMIDV 398
                  D   +V EYM HG L K L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           AS + YL    S   +H DL   N L+  N++  + DFGM++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME 518
            +M PE     + +T  DV+SFG++L E FT  K            + W   L    V+E
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ-LSNTEVIE 246
Query: 519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
            +    + ++         C   ++++ + C    P+QR+N KEI
Sbjct: 247 CITQGRVLERPR------VCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVF----DLQYGRAFKSFDIECDMXXXXXXXXXXXXX 354
           +IG GGFG VY+A    G EVAVK      D    +  ++   E  +             
Sbjct: 14  IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                +    LV+E+   G L + L       DI   +N  + +A  + YLH    VPII
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPII 130
Query: 415 HCDLKPSNVLL--------DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYG 466
           H DLK SN+L+          N +  ++DFG+A    +E    T+        +MAPE  
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVI 186
Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKP 493
           R    S   DV+S+G++L E  T + P
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 36/254 (14%)
Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA--- 58
           N L G IP  +G+L+ L +L L +N   G+IP +L    +L  LD   N  +G +PA   
Sbjct: 497 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 556
Query: 59  ---------------------------CFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDIL 90
                                      C G    L    + S +L  + +    N+   +
Sbjct: 557 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 616
Query: 91  YLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIG 150
           Y   +S      N   ++ +D+S N  S  IP  IG +  L  L L +N + GSIPD +G
Sbjct: 617 YGGHTSP--TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 674
Query: 151 DXXXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN 210
           D               G IP ++  L  L +I++S N L G IP  G F  F    F  N
Sbjct: 675 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 734
Query: 211 ELLCGMPNLQVPPC 224
             LCG P   +P C
Sbjct: 735 PGLCGYP---LPRC 745

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 36/254 (14%)
Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA--- 58
           N L G IP  +G+L+ L +L L +N   G+IP +L    +L  LD   N  +G +PA   
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 59  ---------------------------CFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDIL 90
                                      C G    L    + S +L  + +    N+   +
Sbjct: 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619
Query: 91  YLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIG 150
           Y   +S      N   ++ +D+S N  S  IP  IG +  L  L L +N + GSIPD +G
Sbjct: 620 YGGHTSP--TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677
Query: 151 DXXXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN 210
           D               G IP ++  L  L +I++S N L G IP  G F  F    F  N
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 737
Query: 211 ELLCGMPNLQVPPC 224
             LCG P   +P C
Sbjct: 738 PGLCGYP---LPRC 748

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 12/234 (5%)
Query: 269 NDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDL-- 326
            + N  R   QR  +Y    +A+        IG G FG+VYK +     +VAVK+  +  
Sbjct: 14  QEKNKIRPRGQRDSSYYWEIEASEVMLSTR-IGSGSFGTVYKGKWHG--DVAVKILKVVD 70
Query: 327 QYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYIL 386
                F++F  E  +                  D+  A+V ++    SL K L+      
Sbjct: 71  PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKF 129
Query: 387 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
            +FQ ++I    A  ++YLH   +  IIH D+K +N+ L + +   + DFG+A    +  
Sbjct: 130 QMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186
Query: 447 QSLTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEI 497
            S    Q   ++ +MAPE  R       S   DVYS+GI+L E  T + P   I
Sbjct: 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 34/291 (11%)
Query: 295 SENNLIGRGGFGSVYKARIQDG---MEVAVKVFDLQYGRAFKS-FDIECDMXXXXXXXXX 350
           +   +IG G FG VYK  ++      EV V +  L+ G   K   D   +          
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 351 XXXXXXXXXDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
                      +K +++  EYM +G+L+K L   +    + Q + ++  +A+ ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--YMAPEYG 466
            ++  +H DL   N+L++ N+V  +SDFG+++ +L++D   T T +   I   + APE  
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
              + ++  DV+SFGI++ E  T         +G+    +W  +L    VM+ ++     
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT---------YGER--PYW--ELSNHEVMKAINDGF-- 267
Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVT---RLLKIRDSL 574
                  T   C S I+ L M+C  +   +R    +IV+   +L++  DSL
Sbjct: 268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 110/286 (38%), Gaps = 40/286 (13%)
Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
           +G G FG V+ A        QD + VAVK        A K F  E ++            
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASA 401
                  D   +V EYM HG L K L +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           + YL    S   +H DL   N L+ +N++  + DFGM++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD 521
            PE     + +T  DV+S G++L E FT         +G        N+     V+E + 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFT---------YGKQPWYQLSNN----EVIECIT 244
Query: 522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
              + Q+         C   ++ L + C    P  R N K I T L
Sbjct: 245 QGRVLQRPR------TCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 48/291 (16%)
Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
           +G G FG V+ A        QD M VAVK        A + F  E ++            
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 399
                      +V EYM HG L + L S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 400 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV 516
            I +M PE     + +T  DV+SFG++L E FT  K            + W      +S 
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSN 266
Query: 517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            E +D   ++Q  E       C   ++ +   C    P+QR + K++  RL
Sbjct: 267 TEAIDC--ITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 48/291 (16%)
Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
           +G G FG V+ A        QD M VAVK        A + F  E ++            
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 399
                      +V EYM HG L + L S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 400 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV 516
            I +M PE     + +T  DV+SFG++L E FT  K            + W      +S 
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSN 237
Query: 517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            E +D   ++Q  E       C   ++ +   C    P+QR + K++  RL
Sbjct: 238 TEAIDC--ITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 114/291 (39%), Gaps = 48/291 (16%)
Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
           +G G FG V+ A        QD M VAVK        A + F  E ++            
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 399
                      +V EYM HG L + L S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 400 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV 516
            I +M PE     + +T  DV+SFG++L E FT  K            + W      +S 
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSN 243
Query: 517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            E +D   ++Q  E       C   ++ +   C    P+QR + K++  RL
Sbjct: 244 TEAIDC--ITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 139/314 (44%), Gaps = 39/314 (12%)
Query: 273 MPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY 328
           +PR S Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y
Sbjct: 15  VPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 329 G-RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD 387
             +  + F  E  +                       +V EYM +GSL+  L   +    
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 388 IFQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + 
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 189
Query: 447 QSLTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           ++   T+     I + +PE     + ++  DV+S+GI+L E  +         +G+    
Sbjct: 190 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--P 238
Query: 506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEI 563
           +W          E+ + +++   DE +       C + ++ L + C  +    R   ++I
Sbjct: 239 YW----------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 288
Query: 564 VTRLLKIRDSLLKN 577
           V+    I D L++N
Sbjct: 289 VS----ILDKLIRN 298

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXX 356
             ++GRG FG V KA+ +   +VA+K  + +  R  K+F +E  +               
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVE--LRQLSRVNHPNIVKLY 68
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPII 414
               +   LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 69  GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 415 HCDLKPSNVLL-DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           H DLKP N+LL     V  + DFG A      D     T    +  +MAPE       S 
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             DV+S+GI+L E  TR+KP DEI
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXX 356
             ++GRG FG V KA+ +   +VA+K  + +  R  K+F +E  +               
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVE--LRQLSRVNHPNIVKLY 67
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPII 414
               +   LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 68  GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 415 HCDLKPSNVLL-DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           H DLKP N+LL     V  + DFG A      D     T    +  +MAPE       S 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             DV+S+GI+L E  TR+KP DEI
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 133/306 (43%), Gaps = 32/306 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 131 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 186
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 244
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 245 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 297
Query: 575 LKNVKR 580
              V R
Sbjct: 298 AGLVPR 303

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 200
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 258
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 259 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 182
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 240
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 241 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 200
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 258
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 259 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIF 182
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 240
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 241 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            LV E+M HG L   L +   +      L + +DV   + YL       +IH DL   N 
Sbjct: 78  CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLAARNC 134
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+SFG++
Sbjct: 135 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 193
Query: 484 LMETFTRKK 492
           + E F+  K
Sbjct: 194 MWEVFSEGK 202

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 132 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 187
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 245
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 246 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 298

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 182
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 240
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 241 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 243
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 244 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 134 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 189
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 247
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 248 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 300

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 126 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 181
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 239
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 240 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 292

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 133 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 188
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 246
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 247 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 299

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L +    +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 243
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 244 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 125 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 180
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 238
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD +
Sbjct: 239 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 291

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            LV E+M HG L   L +   +      L + +DV   + YL       +IH DL   N 
Sbjct: 81  CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNC 137
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+SFG++
Sbjct: 138 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 196
Query: 484 LMETFTRKK 492
           + E F+  K
Sbjct: 197 MWEVFSEGK 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            LV E+M HG L   L +   +      L + +DV   + YL       +IH DL   N 
Sbjct: 78  CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNC 134
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+SFG++
Sbjct: 135 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 193
Query: 484 LMETFTRKK 492
           + E F+  K
Sbjct: 194 MWEVFSEGK 202

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            LV E+M HG L   L +   +      L + +DV   + YL       +IH DL   N 
Sbjct: 76  CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNC 132
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+SFG++
Sbjct: 133 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191
Query: 484 LMETFTRKK 492
           + E F+  K
Sbjct: 192 MWEVFSEGK 200

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 213
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 271
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD +
Sbjct: 272 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            LV E+M HG L   L +   +      L + +DV   + YL       +IH DL   N 
Sbjct: 98  CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNC 154
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+SFG++
Sbjct: 155 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 213
Query: 484 LMETFTRKK 492
           + E F+  K
Sbjct: 214 MWEVFSEGK 222

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++E++P+GSL + L      +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 243
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 244 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            LV E+M HG L   L +   +      L + +DV   + YL       +IH DL   N 
Sbjct: 79  CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNC 135
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  +SDFGM + +L +DQ  + T T   + + +PE     + S+  DV+SFG++
Sbjct: 136 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194
Query: 484 LMETFTRKK 492
           + E F+  K
Sbjct: 195 MWEVFSEGK 203

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 251
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 252 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 21/231 (9%)
Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVF--DLQ-----YGRAFKSFDIECDMXXXXXXXXX 350
           ++G GG   V+ AR ++D  +VAVKV   DL      Y R  +       +         
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                         +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREG 469
             IIH D+KP+N+++       + DFG+A+ +     S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLLPISV 516
            V    DVYS G +L E  T + P    F GD    +  +H   D +P S 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSA 241

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 21/231 (9%)
Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVF--DLQ-----YGRAFKSFDIECDMXXXXXXXXX 350
           ++G GG   V+ AR ++D  +VAVKV   DL      Y R  +       +         
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                         +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREG 469
             IIH D+KP+N+++       + DFG+A+ +     S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLLPISV 516
            V    DVYS G +L E  T + P    F GD    +  +H   D +P S 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQHVREDPIPPSA 241

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 270
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 271 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 317

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 271
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 272 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 318

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 294 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFDLQYGRAFKSFDIECDMXX 343
           F E +L     +G+G FGSV   R   +QD  G  VAVK          + F+ E ++  
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 344 XXXXXXXXXXXXXXXXDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 459
           +EYL    +   IH +L   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 128 MEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIF 183
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDEIFFGDMTLKHWVNDLLPIS 515
           + APE   E + S   DV+SFG++L E FT     K P  E  F  M        ++   
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 241
Query: 516 VMEIVDAN-LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           ++E++  N  L + D        C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 242 LIELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 250
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 251 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 244
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 245 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +L ++      +T A   + +MA E  + 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 253
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 254 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 247
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 249
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 251
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 252 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 300 IGRGGFGSVYKARIQD---GMEVAVKVFDL---QYGRAFKSFDIECDMXXXXXXXXXXXX 353
           +G GG  +VY A  +D    ++VA+K   +   +     K F+ E               
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                 DD   LV+EY+   +L + +  S+  L +   +N    +   +++ H    + I
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT-QTLATIGYMAPEYGREGQVS 472
           +H D+KP N+L+D N    + DFG+AK L   + SLTQT   L T+ Y +PE  +     
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP 513
              D+YS GI+L E    + P +      + +KH + D +P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSVP 230

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVF-------DLQYGRAFKSFDIECDM 341
           A N       IG+GGFG V+K R ++D   VA+K         + +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE--V 74
Query: 342 XXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 402 LEYLHFGYSVPIIHCDLKPSNVL---LDDN--MVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG+++  +     L     L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----LG 188
Query: 457 TIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI 514
              +MAPE     E   +   D YSF ++L    T + P DE  +G +            
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                   N++ ++    T    C   + N+   C    P++R +   IV  L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LA 456
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ +     S+TQT   + 
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLL 512
           T  Y++PE  R   V    DVYS G +L E  T + P    F GD    +  +H   D +
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPI 237
Query: 513 PISV 516
           P S 
Sbjct: 238 PPSA 241

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LA 456
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ +     S+TQT   + 
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLL 512
           T  Y++PE  R   V    DVYS G +L E  T + P    F GD    +  +H   D +
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPI 237
Query: 513 PISV 516
           P S 
Sbjct: 238 PPSA 241

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 21/231 (9%)
Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVF--DLQ-----YGRAFKSFDIECDMXXXXXXXXX 350
           ++G GG   V+ AR ++D  +VAVKV   DL      Y R  +       +         
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                         +V+EY+   +L   +++      +  +  I + +A A + L+F + 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSHQ 134
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREG 469
             IIH D+KP+N+L+       + DFG+A+ +     S+ QT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLLPISV 516
            V    DVYS G +L E  T + P    F GD    +  +H   D +P S 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSA 241

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LA 456
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ +     S+TQT   + 
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLL 512
           T  Y++PE  R   V    DVYS G +L E  T + P    F GD    +  +H   D +
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPI 254
Query: 513 PISV 516
           P S 
Sbjct: 255 PPSA 258

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+A+ L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 283 TYLEIFQATNGFSEN---------NLIGRGGFGSVYKARI----QDGMEVAVKVFDLQYG 329
           TY E  +A   F+            +IG G  G V   R+    Q  + VA+K     Y 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 330 -RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDI 388
            R  + F  E  +                       +V EYM +GSL+  L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 389 FQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE-D 446
            Q + ++  V + + YL   GY    +H DL   NVL+D N+V  +SDFG+++ L  + D
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
            + T T     I + APE       S+  DV+SFG+++ E   
Sbjct: 207 AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/126 (38%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 365 LVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H DL   NV
Sbjct: 77  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNV 133
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV+SFGI+
Sbjct: 134 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 484 LMETFT 489
           L E ++
Sbjct: 189 LWEIYS 194

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 136/310 (43%), Gaps = 39/310 (12%)
Query: 277 SNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RA 331
           S Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  + 
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR 391
            + F  E  +                       +V EYM +GSL+  L   +    + Q 
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 120
Query: 392 LNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
           + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++  
Sbjct: 121 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 451 QTQTLAT-IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN 509
            T+     I + +PE     + ++  DV+S+GI+L E  +         +G+    +W  
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW-- 223
Query: 510 DLLPISVMEIVDANLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                   E+ + +++   DE +       C + ++ L + C  +    R   ++IV+  
Sbjct: 224 --------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS-- 273
Query: 568 LKIRDSLLKN 577
             I D L++N
Sbjct: 274 --ILDKLIRN 281

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/126 (38%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 365 LVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H DL   NV
Sbjct: 92  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNV 148
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV+SFGI+
Sbjct: 149 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203
Query: 484 LMETFT 489
           L E ++
Sbjct: 204 LWEIYS 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 283 TYLEIFQATNGFSEN---------NLIGRGGFGSVYKARI----QDGMEVAVKVFDLQYG 329
           TY E  +A   F+            +IG G  G V   R+    Q  + VA+K     Y 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 330 -RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDI 388
            R  + F  E  +                       +V EYM +GSL+  L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 389 FQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE-D 446
            Q + ++  V + + YL   GY    +H DL   NVL+D N+V  +SDFG+++ L  + D
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
            + T T     I + APE       S+  DV+SFG+++ E   
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/126 (38%), Positives = 65/126 (51%), Gaps = 9/126 (7%)
Query: 365 LVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H DL   NV
Sbjct: 83  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNV 139
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ VA +SDFG+ K     + S TQ      + + APE  RE   ST  DV+SFGI+
Sbjct: 140 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGIL 194
Query: 484 LMETFT 489
           L E ++
Sbjct: 195 LWEIYS 200

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 40/293 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVF-------DLQYGRAFKSFDIECDM 341
           A N       IG+GGFG V+K R ++D   VA+K         + +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE--V 74
Query: 342 XXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 402 LEYLHFGYSVPIIHCDLKPSNVL---LDDN--MVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG ++  +     L     L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-----LG 188
Query: 457 TIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI 514
              +MAPE     E   +   D YSF ++L    T + P DE  +G +            
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                   N++ ++    T    C   + N+   C    P++R +   IV  L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/126 (38%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 365 LVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H DL   NV
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNV 320
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV+SFGI+
Sbjct: 321 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 484 LMETFT 489
           L E ++
Sbjct: 376 LWEIYS 381

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 253
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 254 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 257
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 258 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 311
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 297 NNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQ----YGRAFKSFDIECDMXXXXXXXXX 350
           N +IGRG FG VY   +   DG ++   V  L      G   +       M         
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    +    +VL YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  + 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 250
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                    C   ++ + +KC     E R +  E+V+R+  I  + +
Sbjct: 251 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L ++    + DFG+A    +   S    Q   +I +MAPE  R       S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L ++    + DFG+A    +   S    Q   +I +MAPE  R       S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI 228

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/318 (22%), Positives = 125/318 (39%), Gaps = 46/318 (14%)
Query: 272 NMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVF- 324
            MP I+  ++    EI  +   F E   +G   FG VYK  +      +    VA+K   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 325 DLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNY 384
           D   G   + F  E  +                  D   +++  Y  HG L + L   + 
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 385 ILDIFQR---------------LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 429
             D+                  ++++  +A+ +EYL    S  ++H DL   NVL+ D +
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182
Query: 430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              +SD G+ + +   D       +L  I +MAPE    G+ S + D++S+G++L E F+
Sbjct: 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
Query: 490 RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKC 549
                    +G          L P       D   + +  +       C ++++ L ++C
Sbjct: 243 ---------YG----------LQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIEC 283
Query: 550 TVESPEQRINAKEIVTRL 567
             E P +R   K+I +RL
Sbjct: 284 WNEFPSRRPRFKDIHSRL 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 42  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +
Sbjct: 161 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 255
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 256 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 94  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNI 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+ + L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNI 240

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 40/293 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVF-------DLQYGRAFKSFDIECDM 341
           A N       IG+GGFG V+K R ++D   VA+K         + +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE--V 74
Query: 342 XXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +   +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 402 LEYLHFGYSVPIIHCDLKPSNVL---LDDN--MVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           +EY+    + PI+H DL+  N+    LD+N  + A ++DF +++  +     L     L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-----LG 188
Query: 457 TIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI 514
              +MAPE     E   +   D YSF ++L    T + P DE  +G +            
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                   N++ ++    T    C   + N+   C    P++R +   IV  L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L ++    + DFG+A    +   S    Q   +I +MAPE  R       S  
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNI 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKS-FDIECDMXXXXXXXXXXXXXXXX 357
           IGRG FG V+  R++ D   VAVK          K+ F  E  +                
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                  +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   N L+ +  V  +SDFGM++       + +       + + APE    G+ S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFGI+L ETF                          S+      NL +Q+   F  KG 
Sbjct: 299 WSFGILLWETF--------------------------SLGASPYPNLSNQQTREFVEKGG 332
Query: 538 -------CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
                  C   +F L  +C    P QR +   I   L  IR
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 131 RAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 189 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 227
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 228 PECPESLHDLMCQCWRKEPEER 249

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 192 SDVYAFGIVLYELMTGQLPYSNI 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKS-FDIECDMXXXXXXXXXXXXXXXX 357
           IGRG FG V+  R++ D   VAVK          K+ F  E  +                
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                  +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   N L+ +  V  +SDFGM++       + +       + + APE    G+ S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFGI+L ETF                          S+      NL +Q+   F  KG 
Sbjct: 299 WSFGILLWETF--------------------------SLGASPYPNLSNQQTREFVEKGG 332
Query: 538 -------CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
                  C   +F L  +C    P QR +   I   L  IR
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +                
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                 A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 101 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTN 474
           LK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE  R   +   S  
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 475 GDVYSFGIMLMETFTRKKPTDEI 497
            DVY+FGI+L E  T + P   I
Sbjct: 217 SDVYAFGIVLYELMTGQLPYSNI 239

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V EYM +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAP 463
           L     +  +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +P
Sbjct: 163 LS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E     + ++  DV+S+GI+L E  +         +G+    +W          E+ + +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQD 258
Query: 524 LLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           ++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V+EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 134 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 192 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 230
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 231 PECPESLHDLMCQCWRKEPEER 252

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V+EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +V EY+ +G L   L S    L+  Q L +  DV   + +L    S   IH DL   N L
Sbjct: 80  IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCL 136
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +D ++   +SDFGM + +L +DQ ++   T   + + APE     + S+  DV++FGI++
Sbjct: 137 VDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E F+          G M    + N  +   V+++   + L +   H  +       I+ 
Sbjct: 196 WEVFS---------LGKMPYDLYTNSEV---VLKVSQGHRLYRP--HLASDT-----IYQ 236
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E PE+R   +++++ +  +R+
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 30/197 (15%)
Query: 365 LVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL+ +N+
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANI 394
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDVYSFGI 482
           L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV+SFGI
Sbjct: 395 LVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452
Query: 483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTKGQCVS 540
           +L E  T+ +                   +P   M  V+  +L Q +  +      +C  
Sbjct: 453 LLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCPPECPE 491
Query: 541 FIFNLAMKCTVESPEQR 557
            + +L  +C  + PE+R
Sbjct: 492 SLHDLMCQCWRKEPEER 508

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 107/270 (39%), Gaps = 34/270 (12%)
Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVF----DLQYGRAFKSFDIECDMXXXXXXXXXXXXX 354
           +G G +GSVYKA   + G  VA+K      DLQ      S   +CD              
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                     +V+EY   GS+   +   N  L   +   I+      LEYLHF      I
Sbjct: 97  TDLW------IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---I 147
Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H D+K  N+LL+    A L+DFG+A  L   D    +   + T  +MAPE  +E   +  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 475 GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
            D++S GI  +E    K P                D+ P+  + ++  N        F  
Sbjct: 206 ADIWSLGITAIEMAEGKPP--------------YADIHPMRAIFMIPTN----PPPTFRK 247
Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                    +   +C V+SPEQR  A +++
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATATQLL 277

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 96  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 152
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 153 VNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 212 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 252
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 253 IMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 307 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT--TK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 365 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 403
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 404 PECPESLHDLMCQCWRKEPEER 425

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/310 (22%), Positives = 135/310 (43%), Gaps = 39/310 (12%)
Query: 277 SNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RA 331
           S Q    + +   ATN  S + ++G G FG V   R++      + VA+K   + Y  + 
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR 391
            + F  E  +                       +V E M +GSL+  L   +    + Q 
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 120
Query: 392 LNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
           + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++  
Sbjct: 121 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 451 QTQTLAT-IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN 509
            T+     I + +PE     + ++  DV+S+GI+L E  +         +G+    +W  
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW-- 223
Query: 510 DLLPISVMEIVDANLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                   E+ + +++   DE +       C + ++ L + C  +    R   ++IV+  
Sbjct: 224 --------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS-- 273
Query: 568 LKIRDSLLKN 577
             I D L++N
Sbjct: 274 --ILDKLIRN 281

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 138 RAANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 196 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 234
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 235 PECPESLHDLMCQCWRKEPEER 256

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 307 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT--TK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 365 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 403
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 404 PECPESLHDLMCQCWRKEPEER 425

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 131
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 132 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 190 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 228
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 229 PECPESLHDLMCQCWRKDPEER 250

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 129
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 130 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 188 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 226
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 227 PECPESLHDLMCQCWRKDPEER 248

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 138 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 196 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 234
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 235 PECPESLHDLMCQCWRKEPEER 256

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 96  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 152
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 153 VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 212 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 252
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 253 IMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H DL
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 307 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT--TK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 365 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 403
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 404 PECPESLHDLMCQCWRKEPEER 425

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 81  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 137
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 138 VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 196
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 197 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 237
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 238 IMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 80  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 136
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 137 VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 195
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 196 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 236
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 237 IMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 87  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 144 VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 202
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 203 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 243
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 244 IMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V E M +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMA 462
           L   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           PE     + ++  DV+S+GI+L E  +         +G+    +W          E+ + 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQ 257
Query: 523 NLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V+EYM  G L   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 81  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 137
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 138 VNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 196
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 197 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 237
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 238 IMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL   N L
Sbjct: 76  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 132
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           ++D  V  +SDFG+++ +L +D+  +   +   + +  PE     + S+  D+++FG+++
Sbjct: 133 VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E ++  K   E F    T +H    L       +   +L S+K             ++ 
Sbjct: 192 WEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK-------------VYT 232
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKIRD 572
           +   C  E  ++R   K +++ +L + D
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 33/294 (11%)
Query: 284 YLEIFQATNGFSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGRAFKSF-DIEC 339
           Y +       F++   IG+G FG V+K    R Q    VA+K+ DL+           E 
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEI 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 399
            +                  D    +++EY+  GS    L      LD  Q   I+ ++ 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREIL 134
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
             L+YLH   S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  
Sbjct: 135 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPF 189
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           +MAPE  ++    +  D++S GI  +E    + P  E              L P+ V+  
Sbjct: 190 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--------------LHPMKVL-- 233
Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
                L  K+   T +G     +      C  + P  R  AKE++     +R++
Sbjct: 234 ----FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 283

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 136/313 (43%), Gaps = 47/313 (15%)
Query: 283 TYLEIFQATNGFSEN---------NLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG 329
           TY +  QA + F++           +IG G FG V   R++      + VA+K   + Y 
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 330 -RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDI 388
            +  + F  E  +                       +V EYM +GSL+  L  ++    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 389 FQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
            Q + ++  +++ ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + +
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 448 SLTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH 506
           +   T+     I + APE     + ++  DV+S+GI++ E  +         +G+    +
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS---------YGERP--Y 228
Query: 507 WVNDLLPISVMEIVDANLLSQKDEHFT--TKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
           W          E+ + +++   +E +   +   C + ++ L + C  +    R    EIV
Sbjct: 229 W----------EMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIV 278
Query: 565 TRLLKIRDSLLKN 577
             L    D L++N
Sbjct: 279 NML----DKLIRN 287

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 33/284 (11%)
Query: 294 FSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGRAFKSF-DIECDMXXXXXXXX 349
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  +        
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++ 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
              +  D++S GI  +E    + P  E              L P+ V+       L  K+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSE--------------LHPMKVL------FLIPKN 219
Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              T +G     +      C  + P  R  AKE++     +R++
Sbjct: 220 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 263

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 125/299 (41%), Gaps = 39/299 (13%)
Query: 276 ISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARI--QDG--MEVAVKVF--DLQYG 329
           IS++ +    ++      F+   ++G+G FGSV +A++  +DG  ++VAVK+   D+   
Sbjct: 7   ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 330 RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKA------LVLEYMPHGSLEKCLYSSN 383
              + F  E                        K       ++L +M HG L   L +S 
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 384 -----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 438
                + L +   +  M+D+A  +EYL    S   IH DL   N +L ++M   ++DFG+
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 439 AKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIF 498
           ++ +   D       +   + ++A E   +   + + DV++FG+ + E  TR +      
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---- 239
Query: 499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR 557
           +  +      N L        +  N L Q  E       C+  +++L  +C    P+QR
Sbjct: 240 YAGIENAEIYNYL--------IGGNRLKQPPE-------CMEEVYDLMYQCWSADPKQR 283

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
             +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 AAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 33/284 (11%)
Query: 294 FSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGRAFKSF-DIECDMXXXXXXXX 349
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  +        
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 136
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++ 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
              +  D++S GI  +E    + P  E              L P+ V+       L  K+
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSE--------------LHPMKVL------FLIPKN 234
Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              T +G     +      C  + P  R  AKE++     +R++
Sbjct: 235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 33/284 (11%)
Query: 294 FSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGRAFKSF-DIECDMXXXXXXXX 349
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  +        
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++ 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
              +  D++S GI  +E    + P  E              L P+ V+       L  K+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSE--------------LHPMKVL------FLIPKN 219
Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              T +G     +      C  + P  R  AKE++     +R++
Sbjct: 220 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 263

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 110/262 (41%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+ +  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 308 RAANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT--TK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 366 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 404
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 405 PECPESLHDLMCQCWRKDPEER 426

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVA---VKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXX 355
           IGRG F  VY+A  + DG+ VA   V++FDL   +A      E D+              
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 356 XXXXDDFKALVLEYMPHGSLE---KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
               D+   +VLE    G L    K       ++         + + SALE++H   S  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+PE   E   +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              D++S G +L E    + P    F+GD
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP----FYGD 239

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 44/290 (15%)
Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVF-DLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           +G   FG VYK  +      +    VA+K   D   G   + F  E  +           
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---------------LNIMID 397
                  D   +++  Y  HG L + L   +   D+                  ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A+ +EYL    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM 517
           I +MAPE    G+ S + D++S+G++L E F+         +G          L P    
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YG----------LQPYCGY 234
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
              D   + +  +       C ++++ L ++C  E P +R   K+I +RL
Sbjct: 235 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL     +  +H DL   N+L
Sbjct: 111 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNIL 167
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAPEYGREGQVSTNGDVYSFG 481
           ++ N+V  +SDFG+++ L  +    T T  L     I + APE  +  + ++  DV+S+G
Sbjct: 168 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 227
Query: 482 IMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVS 540
           I++ E  +  ++P     + DMT +  +N +               ++D        C S
Sbjct: 228 IVMWEVMSYGERP-----YWDMTNQDVINAI---------------EQDYRLPPPMDCPS 267
Query: 541 FIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
            +  L + C  +    R    +IV  L    D +++N
Sbjct: 268 ALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 300

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 110/262 (41%), Gaps = 32/262 (12%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G+G FG V+         VA+K   L+ G       ++                     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 360 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  G L   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDV 477
           + +N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + APE    G+ +   DV
Sbjct: 141 RAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF--TTK 535
           +SFGI+L E  T+ +                   +P   M  V+  +L Q +  +     
Sbjct: 199 WSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRMPCP 237
Query: 536 GQCVSFIFNLAMKCTVESPEQR 557
            +C   + +L  +C  + PE+R
Sbjct: 238 PECPESLHDLMCQCWRKDPEER 259

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 130/296 (43%), Gaps = 37/296 (12%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG-RAFKSFDIECDMXXX 344
           ATN  S + ++G G FG V   R++      + VA+K   + Y  +  + F  E  +   
Sbjct: 44  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                               +V E M +GSL+  L   +    + Q + ++  +AS ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAP 463
           L     +  +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+     I + +P
Sbjct: 163 LS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E     + ++  DV+S+GI+L E  +         +G+    +W          E+ + +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS---------YGER--PYW----------EMSNQD 258
Query: 524 LLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           ++   DE +       C + ++ L + C  +    R   ++IV+    I D L++N
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 19/218 (8%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQ-------YGRAFKSFDIE 338
           I +    F   NL+G+G F  VY+A  I  G+EVA+K+ D +         R      I 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
           C +                   ++  LVLE   +G + + L +        +  + M  +
Sbjct: 66  CQLKHPSILELYNYFED----SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLAT 457
            + + YLH   S  I+H DL  SN+LL  NM   ++DFG+A  L +  ++  T      T
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGT 175
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
             Y++PE           DV+S G M       + P D
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 145 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 204 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 244
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 245 PEELYQLMRLCWKERPEDR 263

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 195 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 235
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 236 PEELYQLMRLCWKERPEDR 254

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 138 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 197 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 237
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 238 PEELYQLMRLCWKERPEDR 256

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 297 NNLIGRGGFGSVYKA--------RIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXX 348
           + +IG+G FG VY          RIQ  ++   ++ ++Q   AF    +   M       
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL--MRGLNHPN 83
Query: 349 XXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
                      +    ++L YM HG L + + S      +   ++  + VA  +EYL   
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA--TIGYMAPEYG 466
                +H DL   N +LD++    ++DFG+A+ +L  +    Q    A   + + A E  
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKP 493
           +  + +T  DV+SFG++L E  TR  P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 195 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 235
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 236 PEELYQLMRLCWKERPEDR 254

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 297 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFDLQYG---RAFKSFDIECDMXXXXXXXXXX 351
             +IG G FG V   R++     +VAV +  L+ G   +  + F  E  +          
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 352 XXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYS 410
                        +V+E+M +G+L+  L   +    + Q + ++  +A+ + YL   GY 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY- 166
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI--GYMAPEYGRE 468
              +H DL   N+L++ N+V  +SDFG+++ ++++D     T T   I   + APE  + 
Sbjct: 167 ---VHRDLAARNILVNSNLVCKVSDFGLSR-VIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 469 GQVSTNGDVYSFGIMLMETFT 489
            + ++  DV+S+GI++ E  +
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 137 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 196 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 236
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 237 PEELYQLMRLCWKERPEDR 255

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 201 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 241
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 242 PEELYQLMRLCWKERPEDR 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 144 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 203 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 243
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 244 PEELYQLMRLCWKERPEDR 262

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 282 FTYLEIFQATNGFSEN---------NLIGRGGFGSVYKARIQ--DGMEVAVKVFDLQYG- 329
           FT+ +  QA   F++           +IG G FG V   R++     E+ V +  L+ G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 330 --RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD 387
             +  + F  E  +                       ++ EYM +GSL+  L  ++    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 388 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
           + Q + ++  + S ++YL     +  +H DL   N+L++ N+V  +SDFGM++ L  + +
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 448 SLTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           +   T+     I + APE     + ++  DV+S+GI++ E  +
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E   S + D+++ G ++ +
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQ 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 131 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 190 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 230
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 231 PEELYQLMRLCWKERPEDR 249

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 201 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 241
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 242 PEELYQLMRLCWKERPEDR 260

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 297 NNLIGRGGFGSVYKARIQ-DG--MEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
            ++IG G FG V KARI+ DG  M+ A+K    +Y       D   ++            
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 354 XXXXXXDDFKA---LVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIM 395
                  + +    L +EY PHG+L   L  S  +               L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
            DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T   
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
             + +MA E       +TN DV+S+G++L E  +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 195 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 235
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 236 PEELYQLMRLCWKERPEDR 254

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 141 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 200 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 240
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 241 PEELYQLMRLCWKERPEDR 259

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+ A      +VAVK        + ++F  E ++                  
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 418
           +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+  ++V  ++DFG+A+ ++++++   +      I + APE    G  +   DV+
Sbjct: 138 RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+LME  T  +                   +P   M   +     ++         C
Sbjct: 197 SFGILLMEIVTYGR-------------------IPYPGMSNPEVIRALERGYRMPRPENC 237
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++N+ M+C    PE+R
Sbjct: 238 PEELYNIMMRCWKNRPEER 256

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 297 NNLIGRGGFGSVYKARIQ-DG--MEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
            ++IG G FG V KARI+ DG  M+ A+K    +Y       D   ++            
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 354 XXXXXXDDFKA---LVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIM 395
                  + +    L +EY PHG+L   L  S  +               L   Q L+  
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
            DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T   
Sbjct: 139 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 192
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
             + +MA E       +TN DV+S+G++L E  +
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 146 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 205 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 245
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 246 PEELYQLMRLCWKERPEDR 264

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P G L   L      LD  + L     +   +EYL    S   +H DL   N+L
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 143
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++      ++DFG+AK L L +D  + +    + I + APE   +   S   DV+SFG++
Sbjct: 144 VESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 203
Query: 484 LMETFT 489
           L E FT
Sbjct: 204 LYELFT 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 289 QATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYG---RAFKSFDIEC----D 340
           Q    +     +G GGFG V +   QD G +VA+K    +     R     +I+     +
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 341 MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR--LNIMIDV 398
                              +D   L +EY   G L K L        + +     ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           +SAL YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ +
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 184
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
            T+ Y+APE   + + +   D +SFG +  E  T  +P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 289 QATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYG---RAFKSFDIEC----D 340
           Q    +     +G GGFG V +   QD G +VA+K    +     R     +I+     +
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 341 MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR--LNIMIDV 398
                              +D   L +EY   G L K L        + +     ++ D+
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           +SAL YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ +
Sbjct: 132 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 185
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
            T+ Y+APE   + + +   D +SFG +  E  T  +P
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 294 FSENNLIGRGGFGSVYKA---RIQDGMEVAVKVFDLQYGRAFKSF-DIECDMXXXXXXXX 349
           F++   IG+G FG V+K    R Q    VA+K+ DL+           E  +        
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                          +++EY+  GS    L +  +  D FQ   ++ ++   L+YLH   
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 137
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAPE  ++ 
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
              +  D++S GI  +E    + P               +D+ P+ V+       L  K+
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPN--------------SDMHPMRVL------FLIPKN 235
Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              T  G            C  + P  R  AKE++     +++S
Sbjct: 236 NPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNS 279

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 70/126 (55%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL     +  +H DL   N+L
Sbjct: 92  IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNIL 148
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++ N+V  +SDFGM++ L  + ++   T+     I + APE     + ++  DV+S+GI+
Sbjct: 149 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 208
Query: 484 LMETFT 489
           + E  +
Sbjct: 209 MWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 70/126 (55%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL     +  +H DL   N+L
Sbjct: 86  IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNIL 142
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++ N+V  +SDFGM++ L  + ++   T+     I + APE     + ++  DV+S+GI+
Sbjct: 143 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 202
Query: 484 LMETFT 489
           + E  +
Sbjct: 203 MWEVMS 208

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 89/194 (45%), Gaps = 7/194 (3%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VA+K   L+ G       +E                     
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 360 DDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           ++   +V EYM  GSL   L       L +   +++   VA+ + Y+     +  IH DL
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ + ++  ++DFG+A+ L+++++   +      I + APE    G+ +   DV+
Sbjct: 132 RSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 479 SFGIMLMETFTRKK 492
           SFGI+L E  T+ +
Sbjct: 191 SFGILLTELVTKGR 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 127
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 188 SACKSSDLWALGCIIYQ 204

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 124
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 185 SACKSSDLWALGCIIYQ 201

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFD-----LQYGRAFK-SFDI 337
           L I    N FS + +IGRGGFG VY  R  D G   A+K  D     ++ G     +  I
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 338 ECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 397
              +                   D  + +L+ M  G L   L       +   R     +
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 300
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +   LE++H  +   +++ DLKP+N+LLD++    +SD G+A    K+        ++ T
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGT 353
Query: 458 IGYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDEIFFGDMTL 504
            GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFD-----LQYGRAFK-SFDI 337
           L I    N FS + +IGRGGFG VY  R  D G   A+K  D     ++ G     +  I
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 338 ECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 397
              +                   D  + +L+ M  G L   L       +   R     +
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 300
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +   LE++H  +   +++ DLKP+N+LLD++    +SD G+A    K+        ++ T
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGT 353
Query: 458 IGYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDEIFFGDMTL 504
            GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 126
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 187 SACKSSDLWALGCIIYQ 203

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 125
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 186 SACKSSDLWALGCIIYQ 202

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+        +VAVK    Q   +  +F  E ++                  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   DV+
Sbjct: 132 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+L E  T  +    I +  MT    + +L               ++         C
Sbjct: 191 SFGILLTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNC 231
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++ L   C  E PE R
Sbjct: 232 PEELYQLMRLCWKERPEDR 250

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 26/259 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXX 359
           +G G FG V+ A      +VAVK        + ++F  E ++                  
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 418
           +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           + +N+L+  ++V  ++DFG+A+ ++++++   +      I + APE    G  +   DV+
Sbjct: 311 RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           SFGI+LME  T  +                   +P   M   +     ++         C
Sbjct: 370 SFGILLMEIVTYGR-------------------IPYPGMSNPEVIRALERGYRMPRPENC 410
Query: 539 VSFIFNLAMKCTVESPEQR 557
              ++N+ M+C    PE+R
Sbjct: 411 PEELYNIMMRCWKNRPEER 429

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFD-----LQYGRAFK-SFDI 337
           L I    N FS + +IGRGGFG VY  R  D G   A+K  D     ++ G     +  I
Sbjct: 181 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 240
Query: 338 ECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 397
              +                   D  + +L+ M  G L   L       +   R     +
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 299
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +   LE++H  +   +++ DLKP+N+LLD++    +SD G+A    K+        ++ T
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 352
Query: 458 IGYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDEIFFGDMTL 504
            GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFD-----LQYGRAFK-SFDI 337
           L I    N FS + +IGRGGFG VY  R  D G   A+K  D     ++ G     +  I
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 338 ECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 397
              +                   D  + +L+ M  G L   L       +   R     +
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 300
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +   LE++H  +   +++ DLKP+N+LLD++    +SD G+A    K+        ++ T
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGT 353
Query: 458 IGYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDEIFFGDMTL 504
            GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           LIGRG +G+VYK  + D   VAVKVF     + F +   E ++                 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNIYRVPLMEHDNIARFIVG 75
Query: 359 XDDFKA-------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF---- 407
            +   A       LV+EY P+GSL K  Y S +  D      +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 408 --GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA---------KPLLKEDQSLTQTQTLA 456
              Y   I H DL   NVL+ ++    +SDFG++         +P  +++ ++++   + 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE---VG 190
Query: 457 TIGYMAPEYGREGQVSTNG--------DVYSFGIMLMETFTR 490
           TI YMAPE   EG V+           D+Y+ G++  E F R
Sbjct: 191 TIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 125/287 (43%), Gaps = 34/287 (11%)
Query: 299 LIGRGGFGSVYKARIQDGME----VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXXX 353
           +IG G FG V + R++   +    VA+K     Y  R  + F  E  +            
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                      ++ E+M +G+L+  L  ++    + Q + ++  +AS + YL     +  
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAPEYGREGQ 470
           +H DL   N+L++ N+V  +SDFG+++ L +     T+T +L     I + APE     +
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 471 VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
            ++  D +S+GI++ E  +         FG+    +W      +S  ++++A    ++D 
Sbjct: 200 FTSASDAWSYGIVMWEVMS---------FGERP--YW-----DMSNQDVINA---IEQDY 240
Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
                  C + +  L + C  +    R    ++V+ L    D +++N
Sbjct: 241 RLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL----DKMIRN 283

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G  G+VY A  +  G EVA++  +LQ     +    E  +                 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     +++ + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 122 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 211 SACKSSDLWALGCIIYQ 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 223

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIEC----DMXXXXXXX 348
            +++  +IG G FG VY+A++ D  E+ V +  +  G+AFK+ +++     D        
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQIMRKLDHCNIVRLR 79
Query: 349 XXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLH 406
                      + +  LVL+Y+P        + S     L +      M  +  +L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 407 -FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y APE
Sbjct: 140 SFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
             +G     S+  DV+S G +L E
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 297 NNLIGRGGFGSVYKARIQ-DG--MEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
            ++IG G FG V KARI+ DG  M+ A+K    +Y       D   ++            
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 354 XXXXXXDDFKA---LVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIM 395
                  + +    L +EY PHG+L   L  S  +               L   Q L+  
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
            DVA  ++YL        IH +L   N+L+ +N VA ++DFG+++    ++  + +T   
Sbjct: 146 ADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 199
Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
             + +MA E       +TN DV+S+G++L E  +
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 211 SACKSSDLWALGCIIYQ 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIEC----DMXXXXXXX 348
            +++  +IG G FG VY+A++ D  E+ V +  +  G+AFK+ +++     D        
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQIMRKLDHCNIVRLR 79
Query: 349 XXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLH 406
                      + +  LVL+Y+P        + S     L +      M  +  +L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 407 -FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y APE
Sbjct: 140 SFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAPE 192
Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
             +G     S+  DV+S G +L E
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 152
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 213 SACKSSDLWALGCIIYQ 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 226

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQ 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 8/197 (4%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMXXXXXXXX 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D+        
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 470 QVSTNGDVYSFGIMLME 486
               + D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 145 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           T  Y++PE   E     + D+++ G ++ +
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 231

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIEC----DMXXXXXXX 348
            +++  +IG G FG VY+A++ D  E+ V +  +  G+AFK+ +++     D        
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQIMRKLDHCNIVRLR 79
Query: 349 XXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLH 406
                      + +  LVL+Y+P        + S     L +      M  +  +L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 407 -FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y APE
Sbjct: 140 SFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
             +G     S+  DV+S G +L E
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL     +  +H  L   N+L
Sbjct: 85  IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRALAARNIL 141
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAPEYGREGQVSTNGDVYSFG 481
           ++ N+V  +SDFG+++ L  +    T T  L     I + APE  +  + ++  DV+S+G
Sbjct: 142 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 201
Query: 482 IMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVS 540
           I++ E  +  ++P     + DMT +  +N +               ++D        C S
Sbjct: 202 IVMWEVMSYGERP-----YWDMTNQDVINAI---------------EQDYRLPPPMDCPS 241
Query: 541 FIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
            +  L + C  +    R    +IV  L    D +++N
Sbjct: 242 ALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 274

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P G L   L      LD  + L     +   +EYL    S   +H DL   N+L
Sbjct: 90  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 146
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++      ++DFG+AK L L +D  + +    + I + APE   +   S   DV+SFG++
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 206
Query: 484 LMETFT 489
           L E FT
Sbjct: 207 LYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P G L   L      LD  + L     +   +EYL    S   +H DL   N+L
Sbjct: 91  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 147
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++      ++DFG+AK L L +D  + +    + I + APE   +   S   DV+SFG++
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 207
Query: 484 LMETFT 489
           L E FT
Sbjct: 208 LYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P G L   L      LD  + L     +   +EYL    S   +H DL   N+L
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 159
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++      ++DFG+AK L L +D  + +    + I + APE   +   S   DV+SFG++
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219
Query: 484 LMETFT 489
           L E FT
Sbjct: 220 LYELFT 225

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 10/135 (7%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP----------II 414
           ++ EY  +G L   L   + +L+      I    AS  + LHF   V            I
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI 186
Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H D+   NVLL +  VA + DFG+A+ ++ +   + +      + +MAPE   +   +  
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246
Query: 475 GDVYSFGIMLMETFT 489
            DV+S+GI+L E F+
Sbjct: 247 SDVWSYGILLWEIFS 261

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G  G+VY A  +  G EVA++  +LQ     +    E  +                 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G  G+VY A  +  G EVA++  +LQ     +    E  +                 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 33/220 (15%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DG--------------MEVAVKVFD-------LQYGRA 331
           F E  LIG GGFG V+KA+ + DG               E  VK          + Y   
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKA----LVLEYMPHGSLEKCLYSSN-YIL 386
           +  FD + +                      K     + +E+   G+LE+ +       L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 387 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           D    L +   +   ++Y+H   S  +IH DLKPSN+ L D     + DFG+   L  + 
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           +   +T++  T+ YM+PE           D+Y+ G++L E
Sbjct: 191 K---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 111/283 (39%), Gaps = 49/283 (17%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFD-------IECDMXXXX 345
           F++ + IG+G FG VYK       EV A+K+ DL+                 +CD     
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 346 XXXXXXXXXXXXXXDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASA 401
                              +++EY+  GS    L+       YI  I +      ++   
Sbjct: 81  RYFGSYLKSTKLW------IIMEYLGGGSALDLLKPGPLEETYIATILR------EILKG 128
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +M
Sbjct: 129 LDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWM 183
Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD 521
           APE  ++       D++S GI  +E    + P               +DL P+ V+    
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVL---- 225
Query: 522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
              L  K+   T +GQ           C  + P  R  AKE++
Sbjct: 226 --FLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G  G+VY A  +  G EVA++  +LQ     +    E  +                 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL+ +N+
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANI 140
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ D +   ++DFG+A+ L+++ +   +      I + APE    G  +   DV+SFGI+
Sbjct: 141 LVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T  +    I +  MT    + +L               ++         C   ++
Sbjct: 200 LTEIVTHGR----IPYPGMTNPEVIQNL---------------ERGYRMVRPDNCPEELY 240
Query: 544 NLAMKCTVESPEQR 557
            L   C  E PE R
Sbjct: 241 QLMRLCWKERPEDR 254

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 297 NNLIGRGGFGSVYKARIQDGME----VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXX 351
             +IG G FG V + R++   +    VA+K     Y  R  + F  E  +          
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 352 XXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                        ++ E+M +G+L+  L  ++    + Q + ++  +AS + YL     +
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAPEYGRE 468
             +H DL   N+L++ N+V  +SDFG+++ L +     T T +L     I + APE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + ++  D +S+GI++ E  +         FG+    +W      +S  ++++A    ++
Sbjct: 196 RKFTSASDAWSYGIVMWEVMS---------FGERP--YW-----DMSNQDVINA---IEQ 236
Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           D        C + +  L + C  +    R    ++V+ L    D +++N
Sbjct: 237 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL----DKMIRN 281

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG VYKA+ ++ G   A KV + +     + + +E ++                 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVST 473
           K  NVL+       L+DFG++   LK  Q   +   + T  +MAPE       ++     
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             D++S GI L+E    + P  E+
Sbjct: 194 KADIWSLGITLIEMAQIEPPHHEL 217

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXXX 354
           +IGRG FG V   R +   +V A+K+   F++        F  E D+             
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 194
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY----GREG 469
           IH D+KP N+LLD +    L+DFG    + KE      T  + T  Y++PE     G +G
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 253
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                 D +S G+ L E      P    F+ D
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTP----FYAD 281

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
           + ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 186
Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
             T+ YMAPE       + + D +SFG+++ E  T   P
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
           + ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 133 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 187
Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
             T+ YMAPE       + + D +SFG+++ E  T   P
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXXX 354
           +IGRG FG V   R +   +V A+K+   F++        F  E D+             
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 189
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY----GREG 469
           IH D+KP N+LLD +    L+DFG    + KE      T  + T  Y++PE     G +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 248
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                 D +S G+ L E      P    F+ D
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTP----FYAD 276

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIECDMXX 343
           L++      + + + +G G F +VYKAR ++  + VA+K   L +    K       +  
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 344 XXXXXXXXXXXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
                           D F      +LV ++M    LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              LEYLH  +   I+H DLKP+N+LLD+N V  L+DFG+AK     +++      + T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTR 176
Query: 459 GYMAPEYGREGQVSTNG-DVYSFGIMLMETFTR 490
            Y APE     ++   G D+++ G +L E   R
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG VYKA+ ++ G   A KV + +     + + +E ++                 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVST 473
           K  NVL+       L+DFG++   LK  Q   +   + T  +MAPE       ++     
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             D++S GI L+E    + P  E+
Sbjct: 202 KADIWSLGITLIEMAQIEPPHHEL 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K    + +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   ST  DV+S+G++L E F+
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
           + ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 186
Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
             T+ YMAPE       + + D +SFG+++ E  T
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 29/224 (12%)
Query: 286 EIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKV----FDLQYGRAFKSFDIECDM 341
            IF+ ++      ++G+G FG   K   ++  EV V      FD +  R F     E  +
Sbjct: 5   RIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKV 60
Query: 342 XXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 401
                             D     + EY+  G+L   + S +      QR++   D+AS 
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG-- 459
           + YLH   S+ IIH DL   N L+ +N    ++DFG+A+ ++ E    TQ + L ++   
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSLKKP 174
Query: 460 -------------YMAPEYGREGQVSTNGDVYSFGIMLMETFTR 490
                        +MAPE           DV+SFGI+L E   R
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXXX 354
           +IGRG FG V   R +   +V A+K+   F++        F  E D+             
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 194
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY----GREG 469
           IH D+KP N+LLD +    L+DFG    + KE      T  + T  Y++PE     G +G
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 253
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                 D +S G+ L E      P    F+ D
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTP----FYAD 281

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G  G+VY A  +  G EVA++  +LQ     +    E  +                 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 479 SFGIMLMETFTRKKP 493
           S GIM +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL---QYGRAFKSFDIECDMXXXXXXXX 349
           FS+   IG G FG+VY AR +++   VA+K       Q    ++    E           
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYL 405
                     +    LV+EY        CL S++ +L++ ++    +++A+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
            + +S  +IH D+K  N+LL +  +  L DFG A  +   +        + T  +MAPE 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 221
Query: 466 ---GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                EGQ     DV+S GI  +E   RK P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL---QYGRAFKSFDIECDMXXXXXXXX 349
           FS+   IG G FG+VY AR +++   VA+K       Q    ++    E           
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYL 405
                     +    LV+EY        CL S++ +L++ ++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
            + +S  +IH D+K  N+LL +  +  L DFG A  +   +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 466 ---GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                EGQ     DV+S GI  +E   RK P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
           L     VA  +E+L F      +H DL   NVL+    V  + DFG+A+ ++ +   + +
Sbjct: 175 LCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
                 + +MAPE   EG  +   DV+S+GI+L E F+
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG V+     +  +VAVK   L+ G  + ++F  E ++                 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCD 417
            ++   ++ EYM  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L+ +NVL+ ++++  ++DFG+A+ ++++++   +      I + APE    G  +   DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 478 YSFGIMLMETFTRKK 492
           +SFGI+L E  T  K
Sbjct: 195 WSFGILLYEIVTYGK 209

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP----------II 414
           ++ EY  +G L   L   + +L+      I     S  + LHF   V            I
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCI 186
Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H D+   NVLL +  VA + DFG+A+ ++ +   + +      + +MAPE   +   +  
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246
Query: 475 GDVYSFGIMLMETFT 489
            DV+S+GI+L E F+
Sbjct: 247 SDVWSYGILLWEIFS 261

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P+ R    EIV  L
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
           + ++A  L++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 136 LAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSF 190
Query: 455 LATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKP 493
             T+ YMAPE   R+G  S + D +S+G+++ E  T   P
Sbjct: 191 CGTVEYMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 33/294 (11%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYGRAFKSFDIECD- 340
           IF+ T    +  ++G G FG+V+K   I +G    + V +KV + + GR  +SF    D 
Sbjct: 27  IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDH 83
Query: 341 -MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 399
            +                       LV +Y+P GSL   +      L     LN  + +A
Sbjct: 84  MLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 143
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
             + YL       ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I 
Sbjct: 144 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 200
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           +MA E    G+ +   DV+S+G+ + E  T         FG            P + + +
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMT---------FGAE----------PYAGLRL 241
Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
            +   L +K E       C   ++ + +KC +     R   KE+     ++ RD
Sbjct: 242 AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 295

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 33/294 (11%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYGRAFKSFDIECD- 340
           IF+ T    +  ++G G FG+V+K   I +G    + V +KV + + GR  +SF    D 
Sbjct: 9   IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDH 65
Query: 341 -MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 399
            +                       LV +Y+P GSL   +      L     LN  + +A
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
             + YL       ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I 
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           +MA E    G+ +   DV+S+G+ + E  T         FG            P + + +
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMT---------FGAE----------PYAGLRL 223
Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
            +   L +K E       C   ++ + +KC +     R   KE+     ++ RD
Sbjct: 224 AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 246
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P+ R    EIV  L
Sbjct: 247 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 6/127 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P GSL    Y   + + + Q L     +   + YLH  +    IH DL   NVL
Sbjct: 112 LVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVL 166
Query: 425 LDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           LD++ +  + DFG+AK + +  +    +    + + + APE  +E +     DV+SFG+ 
Sbjct: 167 LDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 484 LMETFTR 490
           L E  T 
Sbjct: 227 LYELLTH 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S   +H DL   NVL
Sbjct: 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 158
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++      + DFG+ K +  + +  T +    + + + APE   + +     DV+SFG+ 
Sbjct: 159 VESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218
Query: 484 LMETFT 489
           L E  T
Sbjct: 219 LHELLT 224

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGRAFK-SFDIECDMXXXXXXXXXXX 352
           +G G FG VY+ ++         ++VAVK     Y    +  F +E  +           
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYLH 406
                     + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 407 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
             +    IH D+   N LL       VA + DFGMA+ + +          +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E   EG  ++  D +SFG++L E F+          G M      N      V+E V + 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG 276
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                         C   ++ +  +C    PE R N   I+ R+
Sbjct: 277 ------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S   +H DL   NVL
Sbjct: 90  LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 146
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           ++      + DFG+ K +  + +  T +    + + + APE   + +     DV+SFG+ 
Sbjct: 147 VESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 206
Query: 484 LMETFT 489
           L E  T
Sbjct: 207 LHELLT 212

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P  R    EIV  L
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P+ R    EIV  L
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 99  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 155
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 156 RDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYS 215
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 216 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 257
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 258 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/337 (19%), Positives = 135/337 (40%), Gaps = 44/337 (13%)
Query: 253 VILFILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQ------ATNGFSENNLIGRGGFG 306
           VI+  + +RKR      +  +    N   F+  +++       A    + +  +G+G FG
Sbjct: 2   VIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFG 61
Query: 307 SVY----KARIQDGMEVAVKVFDLQYGRAFKS---FDIECDMXXXXXXXXXXXXXXXXXX 359
            VY    K  ++D  E  V +  +    + +    F  E  +                  
Sbjct: 62  MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 121
Query: 360 DDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYS 410
                +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +
Sbjct: 122 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---A 178
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
              +H DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G 
Sbjct: 179 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 238
Query: 471 VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
            +T  DV+SFG++L E  T  +   +    +  L+             +++  LL + D 
Sbjct: 239 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD- 285
Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                  C   +F L   C   +P+ R +  EI++ +
Sbjct: 286 ------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 248
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P+ R    EIV  L
Sbjct: 249 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 289 QATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXX 348
           Q    ++   +IG G FG V++A++ +  EVA+K   LQ  R FK+ +++          
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FKNRELQIMRIVKHPNV 94
Query: 349 XXXXXXXXXXXDD----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI------MIDV 398
                      D     F  LVLEY+P    E    +S +   + Q + +      M  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
             +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK L+  + +++    + +
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICS 204
Query: 458 IGYMAPE--YGREGQVSTNGDVYSFGIMLME 486
             Y APE  +G     +TN D++S G ++ E
Sbjct: 205 RYYRAPELIFG-ATNYTTNIDIWSTGCVMAE 234

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 111 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 160
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 161 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 220
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 221 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 261
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 262 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXXX 354
           +IGRG FG V   R +   +V A+K+   F++        F  E D+             
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                D +  +V+EYMP G L   +  SNY +          +V  AL+ +H   S+ +I
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 196
Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEY----GREG 469
           H D+KP N+LLD +    L+DFG    +  ++  +    T + T  Y++PE     G +G
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                 D +S G+ L E      P    F+ D
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTP----FYAD 282

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 86
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 147 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 199
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 200 ELIFGATDYTSSI-DVWSAGCVLAE 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 97
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 158 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 210
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 211 ELIFGATDYTSSI-DVWSAGCVLAE 234

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 6/127 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P GSL    Y   + + + Q L     +   + YLH   S   IH +L   NVL
Sbjct: 95  LVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVL 149
Query: 425 LDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           LD++ +  + DFG+AK + +  +    +    + + + APE  +E +     DV+SFG+ 
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 484 LMETFTR 490
           L E  T 
Sbjct: 210 LYELLTH 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 79
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P        + S     L +      M  +  +L Y+
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 140 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 192
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 193 ELIFGATDYTSSI-DVWSAGCVLAE 216

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 78
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P        + S     L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 90
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 151 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 203
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 204 ELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVK---------------------VFDLQYGRA 331
           F E  LIG GGFG V+KA+ + DG    +K                     V  + Y   
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 332 FKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQ 390
           +  FD + +                        + +E+   G+LE+ +       LD   
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLF---------IQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 391 RLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
            L +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +   
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177
Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           + ++  T+ YM+PE           D+Y+ G++L E
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 92  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 148
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 149 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 208
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 209 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 250
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 251 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 78
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 126 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 175
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 235
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 236 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 276
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 277 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 119 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 168
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 229 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 269
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 270 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 120 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 169
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 230 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 270
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 271 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 90
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 151 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 203
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 204 ELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 119 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 168
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 229 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 269
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 270 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 112
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 173 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 225
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 226 ELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 120 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 169
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 230 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 270
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 271 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 136 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 185
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 245
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 246 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 286
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 287 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 134 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 183
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 244 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 284
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 285 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 99  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 155
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 156 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 215
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 216 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 257
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 258 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 134 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 183
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 244 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 284
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 285 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 82
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 143 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 195
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 196 ELIFGATDYTSSI-DVWSAGCVLAE 219

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 95  VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 151
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 152 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 211
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 212 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 253
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 254 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 83  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 138
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+ E       + + T  YM+PE  +    S   D++S G+
Sbjct: 139 ILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGL 194
Query: 483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
            L+E    + P                   P+++ E++D  ++++      +    + F 
Sbjct: 195 SLVEMAVGRYPRP-----------------PMAIFELLDY-IVNEPPPKLPSAVFSLEFQ 236
Query: 543 FNLAMKCTVESPEQRINAKEIVTR 566
            +   KC +++P +R + K+++  
Sbjct: 237 -DFVNKCLIKNPAERADLKQLMVH 259

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 78
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P        + S     L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 98  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 154
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 155 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 214
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 215 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 256
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 257 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 91
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 152 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 204
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 205 ELIFGATDYTSSI-DVWSAGCVLAE 228

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 105/260 (40%), Gaps = 38/260 (14%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG V+ A      +VAVK   ++ G  + ++F  E ++                 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCD 417
            +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH D
Sbjct: 248 KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 303
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L+ +N+L+  ++V  ++DFG+A+   K             I + APE    G  +   DV
Sbjct: 304 LRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFTIKSDV 352
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFGI+LME  T  +                   +P   M   +     ++         
Sbjct: 353 WSFGILLMEIVTYGR-------------------IPYPGMSNPEVIRALERGYRMPRPEN 393
Query: 538 CVSFIFNLAMKCTVESPEQR 557
           C   ++N+ M+C    PE+R
Sbjct: 394 CPEELYNIMMRCWKNRPEER 413

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 137 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 186
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 246
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 247 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 287
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 288 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 96  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 152
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 153 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 212
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 213 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 254
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 255 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 83
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 144 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 196
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 197 ELIFGATDYTSSI-DVWSAGCVLAE 220

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 146 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 195
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 196 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 255
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 256 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 296
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 297 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 98  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 154
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 155 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 214
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 215 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 256
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 257 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 160 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 209
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 270 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 310
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 105 VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 161
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 263
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 264 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 106
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 167 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 219
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 220 ELIFGATDYTSSI-DVWSAGCVLAE 243

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 6/126 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P GSL    Y   + + + Q L     +   + YLH  +    IH  L   NVL
Sbjct: 89  LVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           LD++ +  + DFG+AK + +  +    +    + + + APE  +E +     DV+SFG+ 
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 203
Query: 484 LMETFT 489
           L E  T
Sbjct: 204 LYELLT 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 161
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 263
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +F L   C   +P+ R +  EI++ +
Sbjct: 264 -NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 112
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 173 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 225
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 226 ELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNV 222
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 283 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 317
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 318 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXXX 348
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D        
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRLR 117
Query: 349 XXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
                      + +  LVL+Y+P     + +    +   L +      M  +  +L Y+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 407 -FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y APE
Sbjct: 178 SFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 230
Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
             +G     S+  DV+S G +L E
Sbjct: 231 LIFGATDYTSSI-DVWSAGCVLAE 253

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
           D K+ + E  P  S      SS  +LD+   L++  D+A   +YL   +    IH D+  
Sbjct: 120 DLKSFLRETRPRPSQP----SSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAA 169
Query: 421 SNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
            N LL       VA + DFGMA+ + +          +  + +M PE   EG  ++  D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +SFG++L E F+          G M      N      V+E V +               
Sbjct: 230 WSFGVLLWEIFS---------LGYMPYPSKSNQ----EVLEFVTSG------GRMDPPKN 270
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           C   ++ +  +C    PE R N   I+ R+
Sbjct: 271 CPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 6/126 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P GSL    Y   + + + Q L     +   + YLH  +    IH  L   NVL
Sbjct: 90  LVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVL 144
Query: 425 LDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           LD++ +  + DFG+AK + +  +    +    + + + APE  +E +     DV+SFG+ 
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 204
Query: 484 LMETFT 489
           L E  T
Sbjct: 205 LYELLT 210

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 114
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                       + +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 175 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 227
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 228 ELIFGATDYTSSI-DVWSAGCVLAE 251

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 301 GRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKS-FDIEC--DMXXXXXXXXXXXXXXXX 357
            RG FG V+KA++ +   VAVK+F +Q  +++++ +++     M                
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF-------GYS 410
             D    L+  +   GSL   L ++  ++   +  +I   +A  L YLH        G+ 
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGR 467
             I H D+K  NVLL +N+ A ++DFG+A   LK +   +   T   +G   YMAPE   
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLA---LKFEAGKSAGDTHGQVGTRRYMAPEV-L 205
Query: 468 EGQVSTNG------DVYSFGIMLMETFTRKKPTD 495
           EG ++         D+Y+ G++L E  +R    D
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 64/127 (50%), Gaps = 6/127 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+EY+P GSL    Y   + + + Q L     +   + YLH  +    IH +L   NVL
Sbjct: 95  LVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVL 149
Query: 425 LDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           LD++ +  + DFG+AK + +  +    +    + + + APE  +E +     DV+SFG+ 
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 484 LMETFTR 490
           L E  T 
Sbjct: 210 LYELLTH 216

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 124 GLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNV 173
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 174 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 233
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 234 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 268
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 269 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 132 GLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNV 181
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 242 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 276
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 125 GLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNV 174
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 175 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 234
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 235 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 269
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXXX 348
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D        
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRLR 158
Query: 349 XXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
                      + +  LVL+Y+P     + +    +   L +      M  +  +L Y+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 407 -FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y APE
Sbjct: 219 SFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 271
Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
             +G     S+  DV+S G +L E
Sbjct: 272 LIFGATDYTSSI-DVWSAGCVLAE 294

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 41/208 (19%)
Query: 369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN 428
           Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NVL+ ++
Sbjct: 137 YNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTED 186
Query: 429 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF 488
            V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++L E F
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246
Query: 489 TRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
           T         P +E+F                          L ++         C + +
Sbjct: 247 TLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSNCTNEL 281
Query: 543 FNLAMKCTVESPEQRINAKEIVTRLLKI 570
           + +   C    P QR   K++V  L +I
Sbjct: 282 YMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   + P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 132 GLEFSFNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYL---ASKKCIHRDLAARNV 181
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 242 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 276
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 132 GLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNV 181
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 242 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 276
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 277 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
            L   Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NV
Sbjct: 121 GLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNV 170
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ ++ V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++
Sbjct: 171 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 230
Query: 484 LMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           L E FT         P +E+F                          L ++         
Sbjct: 231 LWEIFTLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSN 265
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           C + ++ +   C    P QR   K++V  L +I
Sbjct: 266 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G FG V++ + + G EVAVK+F  +  R+ F+  +I   +                 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SV 411
              +  L L  +Y  HGSL    Y + Y + +   + + +  AS L +LH          
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEY- 465
            I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAPE  
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 466 -----GREGQVSTNGDVYSFGIMLMETFTR 490
                 +  +     D+Y+ G++  E   R
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 24/204 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L     A +SDFG++K L   E+    QT     + + APE     + S+  DV+SFG++
Sbjct: 144 LVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 203
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           + E F+         +G            P   M+  +   + +K E       C   ++
Sbjct: 204 MWEAFS---------YGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCPREMY 244
Query: 544 NLAMKCTVESPEQRINAKEIVTRL 567
           +L   C     E R     +  RL
Sbjct: 245 DLMNLCWTYDVENRPGFAAVELRL 268

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 41/208 (19%)
Query: 369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN 428
           Y P  + E+ L S + +   +Q       VA  +EYL    S   IH DL   NVL+ ++
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTED 171
Query: 429 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF 488
            V  ++DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++L E F
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 489 TRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
           T         P +E+F                          L ++         C + +
Sbjct: 232 TLGGSPYPGVPVEELF-------------------------KLLKEGHRMDKPSNCTNEL 266
Query: 543 FNLAMKCTVESPEQRINAKEIVTRLLKI 570
           + +   C    P QR   K++V  L +I
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G FG V++ + + G EVAVK+F  +  R+ F+  +I   +                 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SV 411
              +  L L  +Y  HGSL    Y + Y + +   + + +  AS L +LH          
Sbjct: 96  NGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 153
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEY- 465
            I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAPE  
Sbjct: 154 AIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 466 -----GREGQVSTNGDVYSFGIMLMETFTR 490
                 +  +     D+Y+ G++  E   R
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 120 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 175 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 488 FT 489
           F+
Sbjct: 235 FS 236

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G FG V++ + + G EVAVK+F  +  R+ F+  +I   +                 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SV 411
              +  L L  +Y  HGSL    Y + Y + +   + + +  AS L +LH          
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEY- 465
            I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAPE  
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 466 -----GREGQVSTNGDVYSFGIMLMETFTR 490
                 +  +     D+Y+ G++  E   R
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 26/205 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 82  LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 137
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQVSTNGDVYSFGI 482
           L     A +SDFG++K  L+ D++  + QT     + + APE     + S+  DV+SFG+
Sbjct: 138 LVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 196
Query: 483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
           ++ E F+         +G            P   M+  +   + +K E       C   +
Sbjct: 197 LMWEAFS---------YGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCPREM 237
Query: 543 FNLAMKCTVESPEQRINAKEIVTRL 567
           ++L   C     E R     +  RL
Sbjct: 238 YDLMNLCWTYDVENRPGFAAVELRL 262

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 139
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQVSTNGDVYSFGI 482
           L     A +SDFG++K  L+ D++  + QT     + + APE     + S+  DV+SFG+
Sbjct: 140 LVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 198
Query: 483 MLMETFTR-KKP 493
           ++ E F+  +KP
Sbjct: 199 LMWEAFSYGQKP 210

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 120 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 175 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 488 FT 489
           F+
Sbjct: 235 FS 236

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 24/204 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 446 LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 501
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L     A +SDFG++K L   E+    QT     + + APE     + S+  DV+SFG++
Sbjct: 502 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 561
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           + E F+         +G            P   M+  +   + +K E       C   ++
Sbjct: 562 MWEAFS---------YGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCPREMY 602
Query: 544 NLAMKCTVESPEQRINAKEIVTRL 567
           +L   C     E R     +  RL
Sbjct: 603 DLMNLCWTYDVENRPGFAAVELRL 626

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G FG V++ + + G EVAVK+F  +  R+ F+  +I   +                 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SV 411
              +  L L  +Y  HGSL    Y + Y + +   + + +  AS L +LH          
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 128
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEY- 465
            I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAPE  
Sbjct: 129 AIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 466 -----GREGQVSTNGDVYSFGIMLMETFTR 490
                 +  +     D+Y+ G++  E   R
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G FG V++ + + G EVAVK+F  +  R+ F+  +I   +                 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SV 411
              +  L L  +Y  HGSL    Y + Y + +   + + +  AS L +LH          
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 133
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEY- 465
            I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAPE  
Sbjct: 134 AIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 466 -----GREGQVSTNGDVYSFGIMLMETFTR 490
                 +  +     D+Y+ G++  E   R
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 26/205 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 447 LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 502
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQVSTNGDVYSFGI 482
           L     A +SDFG++K  L+ D++  + QT     + + APE     + S+  DV+SFG+
Sbjct: 503 LVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 561
Query: 483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
           ++ E F+         +G            P   M+  +   + +K E       C   +
Sbjct: 562 LMWEAFS---------YGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCPREM 602
Query: 543 FNLAMKCTVESPEQRINAKEIVTRL 567
           ++L   C     E R     +  RL
Sbjct: 603 YDLMNLCWTYDVENRPGFAAVELRL 627

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 24/204 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L     A +SDFG++K L   E+    QT     + + APE     + S+  DV+SFG++
Sbjct: 144 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 203
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           + E F+         +G            P   M+  +   + +K E       C   ++
Sbjct: 204 MWEAFS---------YGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCPREMY 244
Query: 544 NLAMKCTVESPEQRINAKEIVTRL 567
           +L   C     E R     +  RL
Sbjct: 245 DLMNLCWTYDVENRPGFAAVELRL 268

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 5/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +V EYMP+G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 105 IVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 161
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N V  ++DFG+++ L+  D           I + APE       S   DV++FG++
Sbjct: 162 LVGENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVL 220
Query: 484 LMETFT 489
           L E  T
Sbjct: 221 LWEIAT 226

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 131 EFVPYKEAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 185
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 186 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245
Query: 488 FT 489
           F+
Sbjct: 246 FS 247

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G FG V++ + + G EVAVK+F  +  R+ F+  +I   +                 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SV 411
              +  L L  +Y  HGSL    Y + Y + +   + + +  AS L +LH          
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 130
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEY- 465
            I H DLK  N+L+  N    ++D G+A   ++ D +     +     + T  YMAPE  
Sbjct: 131 AIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 466 -----GREGQVSTNGDVYSFGIMLMETFTR 490
                 +  +     D+Y+ G++  E   R
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 129 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 184 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 488 FT 489
           F+
Sbjct: 244 FS 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 129 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 184 KNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 488 FT 489
           F+
Sbjct: 244 FS 245

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 149
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQVSTNGDVYSFGI 482
           L     A +SDFG++K  L+ D++  + QT     + + APE     + S+  DV+SFG+
Sbjct: 150 LVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 208
Query: 483 MLMETFT 489
           ++ E F+
Sbjct: 209 LMWEAFS 215

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 306 GSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMXXXXXXXXXXXX--XXXXXXDD 361
           G ++K R Q G ++ VKV  ++    R  + F+ EC                        
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 362 FKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
              L+  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH    +   H  L  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LNS 141
Query: 421 SNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN---GDV 477
            +V++D++M A +S       +     S      +    ++APE  ++    TN    D+
Sbjct: 142 RSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMT 503
           +SF ++L E  TR     E+ F D++
Sbjct: 195 WSFAVLLWELVTR-----EVPFADLS 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 24/204 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 102 LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 157
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L     A +SDFG++K L   E+    QT     + + APE     + S+  DV+SFG++
Sbjct: 158 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 217
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           + E F+         +G            P   M+  +   + +K E       C   ++
Sbjct: 218 MWEAFS---------YGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCPREMY 258
Query: 544 NLAMKCTVESPEQRINAKEIVTRL 567
           +L   C     E R     +  RL
Sbjct: 259 DLMNLCWTYDVENRPGFAAVELRL 282

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H +L   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 250
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P  R    EIV  L
Sbjct: 251 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG V+     +  +VAVK   L+ G  + ++F  E ++                 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCD 417
            ++   ++ E+M  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L+ +NVL+ ++++  ++DFG+A+ ++++++   +      I + APE    G  +   +V
Sbjct: 135 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 478 YSFGIMLMETFTRKK 492
           +SFGI+L E  T  K
Sbjct: 194 WSFGILLYEIVTYGK 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/212 (21%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 90  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 146
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N ++ ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 147 RDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYS 206
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 207 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 248
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +  L   C   +P+ R +  EI++ +
Sbjct: 249 -NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 120 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 175 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 488 FT 489
           F+
Sbjct: 235 FS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 120 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 175 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 488 FT 489
           F+
Sbjct: 235 FS 236

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 5/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 104 LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 159
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L     A +SDFG++K L   E+    QT     + + APE     + S+  DV+SFG++
Sbjct: 160 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 219
Query: 484 LMETFT 489
           + E F+
Sbjct: 220 MWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 5/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L  + ++ D    + ++  V+  ++YL        +H DL   NVL
Sbjct: 104 LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVL 159
Query: 425 LDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L     A +SDFG++K L   E+    QT     + + APE     + S+  DV+SFG++
Sbjct: 160 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 219
Query: 484 LMETFT 489
           + E F+
Sbjct: 220 MWEAFS 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 129 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 488 FT 489
           F+
Sbjct: 244 FS 245

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H +L   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P  R    EIV  L
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 293 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFDLQYGRAFKSFDIEC----DMXXXXXX 347
            +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++     D       
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQIMRKLDHCNIVRL 78
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                         +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 406 H-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 464 E--YGREGQVSTNGDVYSFGIMLME 486
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+    + LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 166 EFVPYKVAPEDLYKD--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 220
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280
Query: 488 FT 489
           F+
Sbjct: 281 FS 282

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 66/141 (46%), Gaps = 13/141 (9%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           ++++Y+  G L   L  S    +   +     +V  ALEYLH   S  II+ DLKP N+L
Sbjct: 83  MIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIYRDLKPENIL 138
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           LD N    ++DFG AK +      L       T  Y+APE       + + D +SFGI++
Sbjct: 139 LDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 485 METFTRKKPTDEIFFGDMTLK 505
            E      P    F+   T+K
Sbjct: 194 YEMLAGYTP----FYDSNTMK 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           E++P+ + E  LY     L +   +     VA  +E+L    S   IH DL   N+LL +
Sbjct: 130 EFVPYKTPED-LYKD--FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
             V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E 
Sbjct: 184 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 488 FT 489
           F+
Sbjct: 244 FS 245

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 121/297 (40%), Gaps = 32/297 (10%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVF-DLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG+G +G V+  + + G +VAVKVF   +    F+  +I   +                 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-YSV---- 411
              +  L L  +Y  +GSL   L S+   LD    L +     S L +LH   +S     
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE--DQSLTQTQTLATIGYMAPEYGREG 469
            I H DLK  N+L+  N    ++D G+A   + +  +  +     + T  YM PE   E 
Sbjct: 162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221
Query: 470 ------QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWV--NDLLPI-----SV 516
                 Q     D+YSFG++L E   R         G +  ++ +  +DL+P       +
Sbjct: 222 LNRNHFQSYIMADMYSFGLILWEVARR------CVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
            EIV    L     +  +  +C+  +  L  +C   +P  R+ A  +   L K+ +S
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXXX 352
           +G+G FG VY+   +D ++      VAVK  +     R    F  E  +           
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 403
                       +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++  +    + DFGM + + +        + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           E  ++G  +T+ D++SFG++L E  +  +   +    +  LK             ++D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
            L Q D        C   + +L   C   +P+ R    EIV  L
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 62/123 (50%), Gaps = 11/123 (8%)
Query: 368 EYMPHGSLEKCLYSSNYILDI-FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD 426
           E++P+  L K   +  +++   FQ       VA  +E+L    S   IH DL   N+LL 
Sbjct: 129 EFVPYKDLYKDFLTLEHLIXYSFQ-------VAKGMEFL---ASRKXIHRDLAARNILLS 178
Query: 427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
           +  V  + DFG+A+ + K+   + +      + +MAPE   +   +   DV+SFG++L E
Sbjct: 179 EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 238
Query: 487 TFT 489
            F+
Sbjct: 239 IFS 241

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 300 IGRGGFGSVYKARIQ-DGMEVAVK----VFDL--QYGRAFKSFDIECDMXXXXXXXXXXX 352
           IG G +G V  AR +  G +VA+K     FD+     R  +   I               
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 353 XXXXXXXDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                   +FK++  VL+ M    L + ++SS   L +      +  +   L+Y+H   S
Sbjct: 122 LRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---S 176
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE--DQSLTQTQTLATIGYMAPEYGRE 468
             +IH DLKPSN+L+++N    + DFGMA+ L     +     T+ +AT  Y APE    
Sbjct: 177 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS 236
Query: 469 GQVSTNG-DVYSFGIMLMETFTRKK 492
               T   D++S G +  E   R++
Sbjct: 237 LHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 49/227 (21%)
Query: 365 LVLEYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGY 409
           +++EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--- 174
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAPE   + 
Sbjct: 175 SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 470 QVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
             +   DV+SFG+++ E FT         P +E+F                         
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------------------- 269
Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
            L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +      
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 97  MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARN 151
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 212 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 253
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 254 IYNVMVQCWAHKPEDR 269

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +      
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +      
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 87  MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARN 141
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 202 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 243
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +      
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 33/220 (15%)
Query: 300 IGRGGFGSVYKARIQDGME------VAVKVFDLQYGRAFKS-FDIECDMXXXXXXXXXXX 352
           IG G FG V++AR    +       VAVK+   +     ++ F  E  +           
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNY-----------------------ILDIF 389
                       L+ EYM +G L + L S +                         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
           ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
                   I +M PE     + +T  DV+++G++L E F+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 155 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 212 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 258
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 259 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +      
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
           L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +
Sbjct: 149 LELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 205
Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 206 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 158 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 215 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 261
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 262 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
           L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +
Sbjct: 157 LELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 214 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 91  MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---SKRFIHRDLAARN 145
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 146 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 205
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 206 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 247
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 248 IYNVMVQCWAHKPEDR 263

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +++E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 87  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 143
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 144 LVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 202
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 203 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 243
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 300 IGRGGFGSVYKARIQ-DGMEVAVK----VFDL--QYGRAFKSFDIECDMXXXXXXXXXXX 352
           IG G +G V  AR +  G +VA+K     FD+     R  +   I               
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 353 XXXXXXXDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                   +FK++  VL+ M    L + ++SS   L +      +  +   L+Y+H   S
Sbjct: 123 LRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---S 177
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE--DQSLTQTQTLATIGYMAPEYGRE 468
             +IH DLKPSN+L+++N    + DFGMA+ L     +     T+ +AT  Y APE    
Sbjct: 178 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS 237
Query: 469 GQVSTNG-DVYSFGIMLMETFTRKK 492
               T   D++S G +  E   R++
Sbjct: 238 LHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 182
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 166 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 269
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 270 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 153 LARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEIFFGDMTLKHWVNDL 511
           + +MAPE   +   +   DV+SFG+++ E FT         P +E+F             
Sbjct: 210 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------- 256
Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                        L ++         C + ++ +   C    P QR   K++V  L +I
Sbjct: 257 ------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 301 GRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKS----FDIECDMXXXXXXXXXXXXXXX 356
            RG FG V+KA++ +   VAVK+F LQ  ++++S    F     M               
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSEREIFSTP-GMKHENLLQFIAAEKRG 81
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF--------G 408
              +    L+  +   GSL    Y    I+   +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
           +   I H D K  NVLL  ++ A L+DFG+A               + T  YMAPE   E
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LE 198
Query: 469 GQVSTNG------DVYSFGIMLMETFTRKKPTD 495
           G ++         D+Y+ G++L E  +R K  D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 97  MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARN 151
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 212 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 253
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 254 IYNVMVQCWAHKPEDR 269

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
           L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +
Sbjct: 155 LELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
              + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 91  MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARN 145
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 146 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 205
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 206 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 247
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 248 IYNVMVQCWAHKPEDR 263

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 87  MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARN 141
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 202 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 243
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 26/196 (13%)
Query: 365 LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           +V E  P GSL   L  +  +++L    R    + VA  + YL    S   IH DL   N
Sbjct: 87  MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARN 141
Query: 423 VLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           +LL    +  + DFG+ + L + +D  + Q        + APE  +    S   D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 482 IMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSF 541
           + L E FT         +G    + W+  L    ++  +D     ++ E       C   
Sbjct: 202 VTLWEMFT---------YGQ---EPWIG-LNGSQILHKID-----KEGERLPRPEDCPQD 243
Query: 542 IFNLAMKCTVESPEQR 557
           I+N+ ++C    PE R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYG-RAFKSFDIE 338
           L I + T       ++G G FG+VYK   + +G    + VA+K+ +   G +A   F  E
Sbjct: 32  LRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 90
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + LV + MPHG L + ++     +     LN  + +
Sbjct: 91  ALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI 149
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+A+ L  +++          I
Sbjct: 150 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 206
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E     + +   DV+S+G+ + E  T   KP D                  I   
Sbjct: 207 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-----------------IPTR 249
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           EI D   L +K E       C   ++ + +KC +   + R   KE+     ++
Sbjct: 250 EIPD---LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 299

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T+   T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +++E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 147
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 148 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 207 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 115/293 (39%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYG-RAFKSFDIE 338
           L I + T    +  ++G G FG+VYK   I DG    + VA+KV       +A K    E
Sbjct: 11  LRILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDE 69
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + LV + MP+G L   +  +   L     LN  + +
Sbjct: 70  AYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI 128
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL     V ++H DL   NVL+       ++DFG+A+ L  ++           I
Sbjct: 129 AKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 185
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E     + +   DV+S+G+ + E  T   KP D                  I   
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG-----------------IPAR 228
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           EI D   L +K E       C   ++ + +KC +   E R   +E+V+   ++
Sbjct: 229 EIPD---LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T     
Sbjct: 212 LARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   + +
Sbjct: 169 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 90  SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSN 145
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YMAPE  +    S   D++S G+
Sbjct: 146 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGL 201
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 202 SLVELAVGRYP 212

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 26/148 (17%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-----------------------LDIFQRLNIMIDVASA 401
           L++EY  +GSL   L  S  +                       L +   ++    ++  
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           ++YL     + ++H DL   N+L+ +     +SDFG+++ + +ED  + ++Q    + +M
Sbjct: 163 MQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM 219
Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFT 489
           A E   +   +T  DV+SFG++L E  T
Sbjct: 220 AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +++E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 142
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 143 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 202 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 26/148 (17%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-----------------------LDIFQRLNIMIDVASA 401
           L++EY  +GSL   L  S  +                       L +   ++    ++  
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           ++YL     + ++H DL   N+L+ +     +SDFG+++ + +ED  + ++Q    + +M
Sbjct: 163 MQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM 219
Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFT 489
           A E   +   +T  DV+SFG++L E  T
Sbjct: 220 AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 31/280 (11%)
Query: 298 NLIGRGGFGSVYKA-RIQDG----MEVAVKVFDLQYG-RAFKSFDIECDMXXXXXXXXXX 351
            ++G G FG+VYK   + +G    + VA+K+ +   G +A   F  E  +          
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 352 XXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                      + LV + MPHG L + ++     +     LN  + +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            ++H DL   NVL+       ++DFG+A+ L  +++          I +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 472 STNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
           +   DV+S+G+ + E  T   KP D                  I   EI D   L +K E
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDG-----------------IPTREIPD---LLEKGE 236
Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                  C   ++ + +KC +   + R   KE+     ++
Sbjct: 237 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 276

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/212 (21%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 365 LVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +   +H
Sbjct: 92  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 148
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N  + ++    + DFGM + + + D      + L  + +M+PE  ++G  +T  
Sbjct: 149 RDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 208
Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFG++L E  T  +   +    +  L+             +++  LL + D      
Sbjct: 209 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD------ 250
Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             C   +  L   C   +P+ R +  EI++ +
Sbjct: 251 -NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 147
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 148 LVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 207 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 365 LVLEYMPHGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF----GYSVPIIHC 416
           +V+EY   G L     K      Y+ + F  L +M  +  AL+  H     G++V  +H 
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSDGGHTV--LHR 140
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           DLKP+NV LD      L DFG+A+ +L  D S  +T  + T  YM+PE       +   D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKT-FVGTPYYMSPEQMNRMSYNEKSD 198
Query: 477 VYSFGIMLME 486
           ++S G +L E
Sbjct: 199 IWSLGCLLYE 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 12/191 (6%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++                
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 358 XXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
              D     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ PE           
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 476 DVYSFGIMLME 486
           D++S G++  E
Sbjct: 192 DLWSLGVLCYE 202

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +++E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 142
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 143 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 202 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 11/104 (10%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
            + ++  AL+YL    +  IIH D+KP N+LLD++   H++DF +A  L +E    TQ  
Sbjct: 120 FICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQIT 172
Query: 454 TLA-TIGYMAPEY--GREGQ-VSTNGDVYSFGIMLMETFTRKKP 493
           T+A T  YMAPE    R+G   S   D +S G+   E    ++P
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  T
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALT 177
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTXLCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXX------XXX 353
           +G+G +G V++   Q G  VAVK+F     R  KS+  E ++                  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 410
                      L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 411 --VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 463
               I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 464 EYGREG-QVST-----NGDVYSFGIMLMETFTR 490
           E   E  QV         D+++FG++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 99  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 154
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 155 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 210
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 211 SLVEMAVGRYP 221

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 26/148 (17%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-----------------------LDIFQRLNIMIDVASA 401
           L++EY  +GSL   L  S  +                       L +   ++    ++  
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           ++YL     + ++H DL   N+L+ +     +SDFG+++ + +ED  + ++Q    + +M
Sbjct: 163 MQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM 219
Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFT 489
           A E   +   +T  DV+SFG++L E  T
Sbjct: 220 AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  T
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALT 177
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 176
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 178
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXX------XXX 353
           +G+G +G V++   Q G  VAVK+F     R  KS+  E ++                  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 410
                      L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 411 --VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 463
               I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 464 EYGREG-QVST-----NGDVYSFGIMLMETFTR 490
           E   E  QV         D+++FG++L E   R
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXX------XXX 353
           +G+G +G V++   Q G  VAVK+F     R  KS+  E ++                  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 410
                      L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 411 --VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 463
               I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 464 EYGREG-QVST-----NGDVYSFGIMLMETFTR 490
           E   E  QV         D+++FG++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 142
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 143 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 202 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 80  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 135
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI 542
            L+E    + P       +       +   P+++ E++D  ++++      +    + F 
Sbjct: 192 SLVEMAVGRYPIPPPDAKE-------DSRPPMAIFELLDY-IVNEPPPKLPSGVFSLEFQ 243
Query: 543 FNLAMKCTVESPEQRINAKEIVTR 566
            +   KC +++P +R + K+++  
Sbjct: 244 -DFVNKCLIKNPAERADLKQLMVH 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 146
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 147 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 206 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 247 ELMRACWQWNPSDRPSFAEI 266

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEX 182
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 181
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 84/202 (41%), Gaps = 15/202 (7%)
Query: 299 LIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           ++G+G FG V  AR+++ G   AVKV  L+     +  D+EC M                
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 358 X------XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                    D    V+E++  G L   +  S    +   R     ++ SAL +LH     
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DK 143
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NVLLD      L+DFGM K  +     +T      T  Y+APE  +E   
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLY 201
Query: 472 STNGDVYSFGIMLMETFTRKKP 493
               D ++ G++L E      P
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
           I +A+     H   ++ IIH D+KPSN+LLD +    L DFG++  L+    S+ +T+  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 456 ATIGYMAPE-----YGREGQVSTNGDVYSFGIMLMETFTRKKP 493
               YMAPE       R+G      DV+S GI L E  T + P
Sbjct: 187 GCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGRFP 228

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 180
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  T
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALT 177
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 182
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 147
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 148 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 207 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 162
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 219 SLVEMAVGRYP 229

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 147
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 148 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 207 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 13/205 (6%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG VYKA+ ++  +  A KV D +     + + +E D+                 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEY-----GREGQVS 472
           K  N+L   +    L+DFG++    K  +++ +  + + T  +MAPE       ++    
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 473 TNGDVYSFGIMLMETFTRKKPTDEI 497
              DV+S GI L+E    + P  E+
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 155
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 156 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 214
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 215 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 255
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 256 ELMRACWQWNPSDRPSFAEI 275

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++   LE LH      I++ DLKP N+LLDD+    +SD G+A   +   +  T    + 
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVG 347
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T+GYMAPE  +  + + + D ++ G +L E    + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 144
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 145 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 204 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI-DVASALEYLHFGYSVPIIHCDLKPSNV 423
           L+L+Y+  G L   L       +    + I + ++  ALE+LH    + II+ D+K  N+
Sbjct: 136 LILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENI 190
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG--DVYSFG 481
           LLD N    L+DFG++K  +  D++        TI YMAP+  R G    +   D +S G
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249
Query: 482 IMLMETFTRKKP 493
           +++ E  T   P
Sbjct: 250 VLMYELLTGASP 261

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 13/105 (12%)
Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT- 450
           L+I + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + ++++  T 
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 451 ---------QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
                     T  + T  YM+PE       S   D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPS 421
           LV+  M  G +   +Y+ +     FQ    +     + S LE+LH      II+ DLKP 
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNGDVYS 479
           NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE   G E   S   D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFA 374
Query: 480 FGIMLMETFTRKKP 493
            G+ L E    + P
Sbjct: 375 LGVTLYEMIAARGP 388

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++   LE LH      I++ DLKP N+LLDD+    +SD G+A   +   +  T    + 
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVG 347
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T+GYMAPE  +  + + + D ++ G +L E    + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 180
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPS 421
           LV+  M  G +   +Y+ +     FQ    +     + S LE+LH      II+ DLKP 
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNGDVYS 479
           NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE   G E   S   D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFA 374
Query: 480 FGIMLMETFTRKKP 493
            G+ L E    + P
Sbjct: 375 LGVTLYEMIAARGP 388

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 142
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 143 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 202 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 174
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPS 421
           LV+  M  G +   +Y+ +     FQ    +     + S LE+LH      II+ DLKP 
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNGDVYS 479
           NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE   G E   S   D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFA 374
Query: 480 FGIMLMETFTRKKP 493
            G+ L E    + P
Sbjct: 375 LGVTLYEMIAARGP 388

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 203
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 144
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 145 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 204 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 80  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 135
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 192 SLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 80  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 135
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 192 SLVEMAVGRYP 202

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 182
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPS 421
           LV+  M  G +   +Y+ +     FQ    +     + S LE+LH      II+ DLKP 
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNGDVYS 479
           NVLLDD+    +SD G+A   LK  Q+ T+     T G+MAPE   G E   S   D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFA 374
Query: 480 FGIMLMETFTRKKP 493
            G+ L E    + P
Sbjct: 375 LGVTLYEMIAARGP 388

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 142 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 197
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 198 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 253
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 254 SLVEMAVGRYP 264

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 11/204 (5%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG VYKA+ ++  +  A KV D +     + + +E D+                 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVST 473
           K  N+L   +    L+DFG++    +  Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             DV+S GI L+E    + P  E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 147
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 148 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 207 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 142
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 143 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 202 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 11/204 (5%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G G FG VYKA+ ++  +  A KV D +     + + +E D+                 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVST 473
           K  N+L   +    L+DFG++    +  Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 474 NGDVYSFGIMLMETFTRKKPTDEI 497
             DV+S GI L+E    + P  E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 141
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 194
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 80  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 135
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 192 SLVEMAVGRYP 202

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQRTATYITELANALSYC 129
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLXGTLDYLPPEM 182
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 364 ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 422
           ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D+KPSN
Sbjct: 80  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 135
Query: 423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
           +L++      L DFG++  L+           + T  YM+PE  +    S   D++S G+
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 483 MLMETFTRKKP 493
            L+E    + P
Sbjct: 192 SLVEMAVGRYP 202

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           +++E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 84  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 140
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 141 LVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   ++      L +KD        C   ++
Sbjct: 200 LWEIAT---------YG----------MSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 142
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 143 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 202 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     IG G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EYMP G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     IG G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EYMP G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           ++G+G +G VY  R + + + +A+K    +  R  +    E  +                
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMI-DVASALEYLHFGYSVPIIH 415
             + F  + +E +P GSL   L S    + D  Q +      +   L+YLH      I+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 416 CDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ--VS 472
            D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAPE   +G     
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEIIDKGPRGYG 189
Query: 473 TNGDVYSFGIMLMETFTRKKPTDEI 497
              D++S G  ++E  T K P  E+
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 144
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 145 LVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 204 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH DL   N 
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 143
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 144 LVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 202
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 203 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 243
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           ++G+G +G VY  R + + + +A+K    +  R  +    E  +                
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMI-DVASALEYLHFGYSVPIIH 415
             + F  + +E +P GSL   L S    + D  Q +      +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 416 CDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ--VS 472
            D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAPE   +G     
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEIIDKGPRGYG 203
Query: 473 TNGDVYSFGIMLMETFTRKKPTDEI 497
              D++S G  ++E  T K P  E+
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDYLPPEM 178
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M      L++LH      I+H DLKP N+L+       L+DFG+A+        +  T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALT 177
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 104/249 (41%), Gaps = 32/249 (12%)
Query: 257 ILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDG 316
           IL Y +  KP  +     R+  +      EI +         +IGRG FG V   ++++ 
Sbjct: 52  ILEYLEWAKPFTSKVKQMRLHRED----FEILK---------VIGRGAFGEVAVVKLKNA 98
Query: 317 MEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPH 372
            +V A+K+   +++        F  E D+                  D+   LV++Y   
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158
Query: 373 GSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 429
           G L   L    + + +   R  +  M+    ++  LH+      +H D+KP N+L+D N 
Sbjct: 159 GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNG 212
Query: 430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQVSTNGDVYSFGIML 484
              L+DFG    L+ ED ++  +  + T  Y++PE      G +G+     D +S G+ +
Sbjct: 213 HIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 485 METFTRKKP 493
            E    + P
Sbjct: 272 YEMLYGETP 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
            I + +  ALE+LH   SV  IH D+KPSNVL++      + DFG++  L+    S+ +T
Sbjct: 157 KIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKT 211
Query: 453 QTLATIGYMAPEY-----GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW 507
                  YMAPE       ++G  S   D++S GI ++E    + P D        LK  
Sbjct: 212 IDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270
Query: 508 VNDLLP 513
           V +  P
Sbjct: 271 VEEPSP 276

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 13/105 (12%)
Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS--- 448
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + ++++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 449 LTQTQTLAT----IG---YMAPEYGREGQVSTNGDVYSFGIMLME 486
           LT     AT    +G   YM+PE       S   D++S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH +L   N 
Sbjct: 332 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNC 388
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 389 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 447
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 448 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 488
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 489 ELMRACWQWNPSDRPSFAEI 508

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 23/229 (10%)
Query: 271 ANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQY 328
           A MP+    R+FT        + F     +G+G FG+VY AR  Q+   +A+KV F  Q 
Sbjct: 5   AEMPK----RKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 53
Query: 329 GRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYIL 386
            +      +  ++                   D K   L+LE+ P G L K L       
Sbjct: 54  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-F 112
Query: 387 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           D  +    M ++A AL Y H      +IH D+KP N+L+       ++DFG +       
Sbjct: 113 DEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHA 165
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
            SL +     T+ Y+ PE           D++  G++  E      P D
Sbjct: 166 PSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 72/321 (22%), Positives = 127/321 (39%), Gaps = 38/321 (11%)
Query: 257 ILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKA-RIQD 315
           +L+ R+  +PL      P   NQ     L I + T  F +  ++G G FG+VYK   I +
Sbjct: 21  LLQERELVEPLTPSGEAP---NQ---ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPE 73
Query: 316 G--MEVAVKVFDLQYG---RAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYM 370
           G  +++ V + +L+     +A K    E  +                     + L+ + M
Sbjct: 74  GEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLM 132
Query: 371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 430
           P G L   +      +     LN  + +A  + YL       ++H DL   NVL+     
Sbjct: 133 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 189
Query: 431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT- 489
             ++DFG+AK L  E++          I +MA E       +   DV+S+G+ + E  T 
Sbjct: 190 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 249
Query: 490 RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKC 549
             KP D I   +++           S++E         K E       C   ++ + +KC
Sbjct: 250 GSKPYDGIPASEIS-----------SILE---------KGERLPQPPICTIDVYMIMVKC 289
Query: 550 TVESPEQRINAKEIVTRLLKI 570
            +   + R   +E++    K+
Sbjct: 290 WMIDADSRPKFRELIIEFSKM 310

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 365 LVLEYMPHGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF----GYSVPIIHC 416
           +V+EY   G L     K      Y+ + F  L +M  +  AL+  H     G++V  +H 
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSDGGHTV--LHR 140
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           DLKP+NV LD      L DFG+A+ +L  D+   + + + T  YM+PE       +   D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLAR-ILNHDEDFAK-EFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 477 VYSFGIMLME 486
           ++S G +L E
Sbjct: 199 IWSLGCLLYE 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 63/130 (48%), Gaps = 13/130 (10%)
Query: 365 LVLEYMPHGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF----GYSVPIIHC 416
           +V+EY   G L     K      Y+ + F  L +M  +  AL+  H     G++V  +H 
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSDGGHTV--LHR 140
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           DLKP+NV LD      L DFG+A+ +L  D S  +   + T  YM+PE       +   D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKA-FVGTPYYMSPEQMNRMSYNEKSD 198
Query: 477 VYSFGIMLME 486
           ++S G +L E
Sbjct: 199 IWSLGCLLYE 208

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 79/194 (40%), Gaps = 13/194 (6%)
Query: 299 LIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXX----- 353
           +IG+G FG V  AR     EV   V  LQ     K  + +  M                 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 354 -XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
                   D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S+ 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           I++ DLKP N+LLD      L+DFG+ K  ++ +   T +    T  Y+APE   +    
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYD 217
Query: 473 TNGDVYSFGIMLME 486
              D +  G +L E
Sbjct: 218 RTVDWWCLGAVLYE 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 12/216 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKARIQDGMEV-AVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR ++   + A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                     D++S G++  E    K P +   + D
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQD 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 108/268 (40%), Gaps = 30/268 (11%)
Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A     G +VAVK  DL+  +  +    E  +                 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE        T  D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLK--HWVNDLLPISVMEIVDANLLSQKDEHFTTKG 536
           S GIM++E    + P    +F +  L+    + D LP  V           KD H     
Sbjct: 226 SLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDSLPPRV-----------KDLH----- 265
Query: 537 QCVSFIFNLAMKCTVESPEQRINAKEIV 564
           +  S +        V  P QR  A+E++
Sbjct: 266 KVSSVLRGFLDLMLVREPSQRATAQELL 293

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 17/227 (7%)
Query: 274 PRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAF 332
           P ++ +R    L+I      F  + ++G+G FG V+ A  +   +  A+K   L+     
Sbjct: 2   PELNKER--PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVL 57
Query: 333 KSFDIECDMXXXXXXXXX------XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYIL 386
              D+EC M                         +    V+EY+  G L   + S  +  
Sbjct: 58  MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKF 116
Query: 387 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           D+ +      ++   L++LH   S  I++ DLK  N+LLD +    ++DFGM K  +  D
Sbjct: 117 DLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 173
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
                 +   T  Y+APE     + + + D +SFG++L E    + P
Sbjct: 174 AK--TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 62/133 (46%), Gaps = 16/133 (12%)
Query: 367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD 426
           +EY  +G+L   ++S N      +   +   +  AL Y+H   S  IIH DLKP N+ +D
Sbjct: 94  MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFID 150
Query: 427 DNMVAHLSDFGMAK------PLLKED------QSLTQTQTLATIGYMAPEY-GREGQVST 473
           ++    + DFG+AK       +LK D       S   T  + T  Y+A E     G  + 
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210
Query: 474 NGDVYSFGIMLME 486
             D+YS GI+  E
Sbjct: 211 KIDMYSLGIIFFE 223

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       +++FG +        S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEM 180
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 23/203 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E  P+G L   L  +   L +   +   + +  A+ YL    S+  +H D+   N+L
Sbjct: 101 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNIL 157
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       L DFG+++ +  ED        L  I +M+PE     + +T  DV+ F + +
Sbjct: 158 VASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRFTTASDVWMFAVCM 216
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E  +  K   + FF       W+ +   I V+E         K +       C   ++ 
Sbjct: 217 WEILSFGK---QPFF-------WLENKDVIGVLE---------KGDRLPKPDLCPPVLYT 257
Query: 545 LAMKCTVESPEQRINAKEIVTRL 567
           L  +C    P  R    E+V  L
Sbjct: 258 LMTRCWDYDPSDRPRFTELVCSL 280

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 5/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 140
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 141 LVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 484 LMETFT 489
           L E  T
Sbjct: 200 LWEIAT 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 23/203 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E  P+G L   L  +   L +   +   + +  A+ YL    S+  +H D+   N+L
Sbjct: 89  IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNIL 145
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       L DFG+++ +  ED        L  I +M+PE     + +T  DV+ F + +
Sbjct: 146 VASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRFTTASDVWMFAVCM 204
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E  +  K   + FF       W+ +   I V+E         K +       C   ++ 
Sbjct: 205 WEILSFGK---QPFF-------WLENKDVIGVLE---------KGDRLPKPDLCPPVLYT 245
Query: 545 LAMKCTVESPEQRINAKEIVTRL 567
           L  +C    P  R    E+V  L
Sbjct: 246 LMTRCWDYDPSDRPRFTELVCSL 268

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 235
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 236 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR--AFKSFDIECDMXXXXXXXXXXXXX 354
             LIG+G FG VY  R     EVA+++ D++       K+F  E                
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 355 XXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 415 HCDLKPSNVLLDDNMVAHLSDFGM------AKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
           H DLK  NV  D+  V  ++DFG+       +   +ED+   Q   L    ++APE  R+
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQ 208
Query: 469 GQ---------VSTNGDVYSFGIMLMETFTRKKP 493
                       S + DV++ G +  E   R+ P
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEM 177
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 86
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +     +L       T  Y+APE   
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIIL 197
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 236
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 237 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH +L   N 
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNC 349
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 350 LVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 408
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   +++     L +KD        C   ++
Sbjct: 409 LWEIAT---------YG----------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 450 ELMRACWQWNPSDRPSFAEI 469

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 233 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEM 180
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 233
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 234 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEM 180
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 16/193 (8%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++                
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 358 XXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
              D     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMA--KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
            D+KP N+LL  N    ++DFG +   P  + D          T+ Y+ PE         
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRD------TLCGTLDYLPPEMIEGRMHDE 189
Query: 474 NGDVYSFGIMLME 486
             D++S G++  E
Sbjct: 190 KVDLWSLGVLCYE 202

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRDDLCGTLDYLPPEM 180
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       +++FG +        S  +T    T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEM 179
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 234
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 235 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 233
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 234 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEM 179
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     D++S G++  E    K P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 23/203 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E  P+G L   L  +   L +   +   + +  A+ YL    S+  +H D+   N+L
Sbjct: 85  IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNIL 141
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       L DFG+++ +  ED        L  I +M+PE     + +T  DV+ F + +
Sbjct: 142 VASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRFTTASDVWMFAVCM 200
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E  +  K   + FF       W+ +   I V+E         K +       C   ++ 
Sbjct: 201 WEILSFGK---QPFF-------WLENKDVIGVLE---------KGDRLPKPDLCPPVLYT 241
Query: 545 LAMKCTVESPEQRINAKEIVTRL 567
           L  +C    P  R    E+V  L
Sbjct: 242 LMTRCWDYDPSDRPRFTELVCSL 264

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 28/267 (10%)
Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  AR +  G +VAVK+ DL+  +  +    E  +                 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + K+     +   + T  +MAPE       +T  D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME-IVDANLLSQKDEHFTTKGQ 537
           S GIM++E    + P    +F D           P+  M+ + D+     K+ H  +   
Sbjct: 226 SLGIMVIEMVDGEPP----YFSDS----------PVQAMKRLRDSPPPKLKNSHKVS--- 268
Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIV 564
               + +   +  V  P++R  A+E++
Sbjct: 269 --PVLRDFLERMLVRDPQERATAQELL 293

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +     +L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 16/210 (7%)
Query: 290 ATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQYGRAFKSFDIECDMXXXXXX 347
           A   F     +G+G FG+VY AR  Q    +A+KV F  Q  +A     +  ++      
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 348 XXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                        D     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA--KPLLKEDQSLTQTQTLATIGYMAP 463
           H   S  +IH D+KP N+LL       ++DFG +   P  + D          T+ Y+ P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD------TLCGTLDYLPP 176
Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           E           D++S G++  E    K P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     IG G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 23/229 (10%)
Query: 271 ANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FDLQY 328
           A MP+    R+FT        + F     +G+G FG+VY AR  Q+   +A+KV F  Q 
Sbjct: 4   AEMPK----RKFT-------IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 52
Query: 329 GRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKA--LVLEYMPHGSLEKCLYSSNYIL 386
            +      +  ++                   D K   L+LE+ P G L K L       
Sbjct: 53  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-F 111
Query: 387 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           D  +    M ++A AL Y H      +IH D+KP N+L+       ++DFG +       
Sbjct: 112 DEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHA 164
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD 495
            SL +     T+ Y+ PE           D++  G++  E      P D
Sbjct: 165 PSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 25/135 (18%)
Query: 362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPS 421
           F  LV + M  G L   L +    L   +  +IM  +  A+ +LH      I+H DLKP 
Sbjct: 174 FMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPE 229
Query: 422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE------------YGREG 469
           N+LLDDNM   LSDFG +  L   +      +   T GY+APE            YG+E 
Sbjct: 230 NILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE- 285
Query: 470 QVSTNGDVYSFGIML 484
                 D+++ G++L
Sbjct: 286 -----VDLWACGVIL 295

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 289 QATNGFSEN----NLIGRGGFGSVYKARIQDGM--EVAVKVFDLQYGRAFKSFDI----- 337
            +T+GF EN     ++GRG   SV +  I      E AVK+ D+  G +F + ++     
Sbjct: 10  HSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 338 ----ECD-MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSL-----EKCLYSSNYILD 387
               E D +                  + F  LV + M  G L     EK   S      
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 388 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
           I + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D 
Sbjct: 129 IMRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DP 176
Query: 448 SLTQTQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 484
                +   T  Y+APE            YG+E       D++S G+++
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 3/80 (3%)
Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ-TQTLATIGYMAPEYGREGQVST 473
           H D+KP N+L+  +  A+L DFG+A      D+ LTQ   T+ T+ Y APE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 474 NGDVYSFGIMLMETFTRKKP 493
             D+Y+   +L E  T   P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 97/239 (40%), Gaps = 20/239 (8%)
Query: 265 KPLP----NDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEV 319
           +PLP    N+      S Q+     +   A   F     +G+G FG+VY AR  Q    +
Sbjct: 3   QPLPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 320 AVKV-FDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKA--LVLEYMPHGSLE 376
           A+KV F  Q  +A     +  ++                   D     L+LEY P G++ 
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY 122
Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 436
           + L   +   D  +    + ++A+AL Y H   S  +IH D+KP N+LL       ++DF
Sbjct: 123 RELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 178
Query: 437 GMA--KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           G +   P  + D          T+ Y+ PE           D++S G++  E    K P
Sbjct: 179 GWSVHAPSSRRD------DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH DL   N 
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNC 140
Query: 424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L+ +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++
Sbjct: 141 LVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 484 LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
           L E  T         +G          + P   ++      L +KD        C   ++
Sbjct: 200 LWEIAT---------YG----------MSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 544 NLAMKCTVESPEQRINAKEI 563
            L   C   +P  R +  EI
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L      + +     ++  V+  ++YL        +H DL   NVL
Sbjct: 86  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVL 142
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L +   A +SDFG++K L  +D   T ++     + + APE     + S+  DV+S+G+ 
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 484 LMETFT 489
           + E  +
Sbjct: 203 MWEALS 208

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 93
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 238

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M      L++LH      I+H DLKP N+L+       L+DFG+A+        +   
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALA 169
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 12/198 (6%)
Query: 300 IGRGGFGSVYKARIQDG-MEVAVKV-FDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           +G+G FG+VY AR +     VA+KV F  Q  +      +  ++                
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 358 XXDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
              D +   L+LEY P G L K L  S    D  +   IM ++A AL Y H      +IH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCH---GKKVIH 146
Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            D+KP N+LL       ++DFG +        SL +     T+ Y+ PE       +   
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 476 DVYSFGIMLMETFTRKKP 493
           D++  G++  E      P
Sbjct: 203 DLWCIGVLCYELLVGNPP 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 23/218 (10%)
Query: 298 NLIGRGGFGSVYKARIQDG--------MEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXX 349
            ++G+GG+G V++ R   G        M+V  K   ++  +       E ++        
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                          L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              II+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAPEILMRS 196
Query: 470 QVSTNGDVYSFGIMLMETFT---------RKKPTDEIF 498
             +   D +S G ++ +  T         RKK  D+I 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG AK L  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 236
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 237 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K  +IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKEIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG+AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 233 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 235
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 236 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 234
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 235 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 235
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 236 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
           L  M+D+A  +EYL    +   +H DL   N +L D+M   ++DFG++K +   D     
Sbjct: 150 LKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR 490
                 + ++A E   +   ++  DV++FG+ + E  TR
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 239
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 240 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG AK L  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 234
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 235 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 93
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 238

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 67/155 (43%), Gaps = 9/155 (5%)
Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS----TLWNLKDILYLDLSSNFL 99
           +LD   NKL       F  LT LR LYL  NKL ++P+     L NL+ +   D     L
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQAL 100
Query: 100 LIG---NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDXXXXX 156
            IG    L  L ++ L  N    + P     L  L YL L YN LQ S+P  + D     
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 157 XXXXXXXXXXGTIPI-SLEKLLDLKDINVSFNKLE 190
                       +P  + +KL +LK + +  N+L+
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGRE 468
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE   G +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXK 186
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              ST  D++S G +  E  TR+     +F GD
Sbjct: 187 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 214

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 233 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGRE 468
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE   G +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXK 179
Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              ST  D++S G +  E  TR+     +F GD
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 94/229 (41%), Gaps = 52/229 (22%)
Query: 289 QATNGFSEN----NLIGRGGFGSVYKARIQDGM--EVAVKVFDLQYGRAFKSFDI----- 337
            +T+GF EN     ++GRG   SV +  I      E AVK+ D+  G +F + ++     
Sbjct: 10  HSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 338 ----ECD-MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSL-----EKCLYSSNYILD 387
               E D +                  + F  LV + M  G L     EK   S      
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 388 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
           I + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D 
Sbjct: 129 IMRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DP 176
Query: 448 SLTQTQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 484
                    T  Y+APE            YG+E       D++S G+++
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 17/227 (7%)
Query: 274 PRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAF 332
           P ++ +R    L+I      F  + ++G+G FG V+ A  +   +  A+K   L+     
Sbjct: 1   PELNKER--PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVL 56
Query: 333 KSFDIECDMXXXXXXXXX------XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYIL 386
              D+EC M                         +    V+EY+  G L   + S  +  
Sbjct: 57  MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKF 115
Query: 387 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           D+ +      ++   L++LH   S  I++ DLK  N+LLD +    ++DFGM K  +  D
Sbjct: 116 DLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172
Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
                     T  Y+APE     + + + D +SFG++L E    + P
Sbjct: 173 AK--TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 238
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 239 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 282

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 6   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 64
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 65  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 124 AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 229
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 230 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 273

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 121
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 266

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 34  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 92
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 257
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 258 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 301

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 226
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 227 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M      L++LH      I+H DLKP N+L+       L+DFG+A+        +   
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALD 169
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K  +IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKEIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG+AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 115 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 171
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 172 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 230
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 231 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 271
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 272 LMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 213 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 266
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 267 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 323
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 324 SSLTKLQRLFFSNNKV 339

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 10/106 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
            + + +  AL YL   + V  IH D+KPSN+LLD+     L DFG++  L+ +     + 
Sbjct: 128 KMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKD 182
Query: 453 QTLATIGYMAPEY-----GREGQVSTNGDVYSFGIMLMETFTRKKP 493
           ++     YMAPE        +       DV+S GI L+E  T + P
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 87  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 144 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 202
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 203 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 243
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 244 LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 212 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 265
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 266 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 322
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 323 SSLTKLQRLFFSNNKV 338

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRIQQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +VLEY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 87  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 144 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 202
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 203 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 243
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 244 LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 9/195 (4%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXXXXXXXXX 357
           +G G +G VYKA+   G  VA+K   L        S  I E  +                
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
             +    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-GREGQVSTNGD 476
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+      + ST+ D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 477 VYSFGIMLMETFTRK 491
           ++S G +  E  T K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 92  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 148
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 149 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 208 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 248
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 249 LMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 9/195 (4%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXXXXXXXXX 357
           +G G +G VYKA+   G  VA+K   L        S  I E  +                
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 358 XXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
             +    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-GREGQVSTNGD 476
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+      + ST+ D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 477 VYSFGIMLMETFTRK 491
           ++S G +  E  T K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 186
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 214

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 183
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 180
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR----ALFPGD 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 90  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 146
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 147 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 205
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 206 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 246
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 247 LMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 102/254 (40%), Gaps = 28/254 (11%)
Query: 288 FQATNGFSENNLIGRGGFG-SVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXX 346
           FQ+   +     IG G FG ++     +DG +  +K  ++       S + E        
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS---RMSSKEREESRREVAV 76
Query: 347 XXXXXXXXXXXXXDDFKA-----LVLEYMPHGSLEK-------CLYSSNYILDIFQRLNI 394
                        + F+      +V++Y   G L K        L+  + ILD F     
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF----- 131
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
            + +  AL+++H      I+H D+K  N+ L  +    L DFG+A+ +L     L +   
Sbjct: 132 -VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARA-C 185
Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI 514
           + T  Y++PE       +   D+++ G +L E  T K   +     ++ LK       P+
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV 245
Query: 515 SVMEIVD-ANLLSQ 527
           S+    D  +L+SQ
Sbjct: 246 SLHYSYDLRSLVSQ 259

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
            V+EY+  G L   +     + +   R     +++ AL YLH      II+ DLK  NVL
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGIIYRDLKLDNVL 153
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           LD      L+D+GM K  L+     T +    T  Y+APE  R      + D ++ G+++
Sbjct: 154 LDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 211
Query: 485 METFTRKKPTD 495
            E    + P D
Sbjct: 212 FEMMAGRSPFD 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
            V+EY+  G L   +     + +   R     +++ AL YLH      II+ DLK  NVL
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGIIYRDLKLDNVL 142
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           LD      L+D+GM K  L+     T +    T  Y+APE  R      + D ++ G+++
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 200
Query: 485 METFTRKKPTD 495
            E    + P D
Sbjct: 201 FEMMAGRSPFD 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 89  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 145
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 146 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 204
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 205 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 245
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 246 LMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 288 FQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVF-DLQYGRAFKSFDI-ECDMXXX 344
           FQ+   +    L+G G +G V K R +D G  VA+K F +    +  K   + E  +   
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKC-LYSSNYILDIFQRLNIMIDVASALE 403
                               LV E++ H  L+   L+ +     + Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
            + F +S  IIH D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193
Query: 464 E-------YGREGQVSTNGDVYSFGIMLMETF 488
           E       YG+        DV++ G ++ E F
Sbjct: 194 ELLVGDVKYGKA------VDVWAIGCLVTEMF 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           D+   +EYLH+     IIH D+KPSN+L+ ++    ++DFG++      D  L  + T+ 
Sbjct: 145 DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVG 199
Query: 457 TIGYMAPEYGREGQVSTNG---DVYSFGIML 484
           T  +MAPE   E +   +G   DV++ G+ L
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           ++M      L++LH      I+H DLKP N+L+       L+DFG+A+        +   
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALF 169
Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
             + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 235
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ +  KC +   + R   +E++    K+
Sbjct: 236 E---------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 33/296 (11%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RD 572
           E         K E       C   ++ +  KC +   + R   +E++    K+ RD
Sbjct: 233 E---------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
            V+EY+  G L   +     + +   R     +++ AL YLH      II+ DLK  NVL
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGIIYRDLKLDNVL 138
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           LD      L+D+GM K  L+     T +    T  Y+APE  R      + D ++ G+++
Sbjct: 139 LDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 196
Query: 485 METFTRKKPTD 495
            E    + P D
Sbjct: 197 FEMMAGRSPFD 207

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
            V+EY+  G L   +     + +   R     +++ AL YLH      II+ DLK  NVL
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGIIYRDLKLDNVL 185
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           LD      L+D+GM K  L+     T +    T  Y+APE  R      + D ++ G+++
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 243
Query: 485 METFTRKKPTD 495
            E    + P D
Sbjct: 244 FEMMAGRSPFD 254

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    Y LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 84  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 140
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 141 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 200 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 216 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 269
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 270 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 326
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 327 SSLTKLQRLFFANNKV 342

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+++ MP G L   +      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG AK L  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 234
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ +  KC +   + R   +E++    K+
Sbjct: 235 E---------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 242
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ +  KC +   + R   +E++    K+
Sbjct: 243 E---------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 169
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 170
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 169
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG AK L  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 239
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 240 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           + SA+EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGS 169
Query: 458 IGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
             Y APE    +       DV+S G++L     R+ P D+
Sbjct: 170 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 24/207 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           L+++ MP G L   +      +     LN  + +A  + YL       ++H DL   NVL
Sbjct: 100 LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVL 156
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       ++DFG+AK L  E++          I +MA E       +   DV+S+G+ +
Sbjct: 157 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 216
Query: 485 METFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
            E  T   KP D I   +++           S++E         K E       C   ++
Sbjct: 217 WELMTFGSKPYDGIPASEIS-----------SILE---------KGERLPQPPICTIDVY 256
Query: 544 NLAMKCTVESPEQRINAKEIVTRLLKI 570
            + +KC +   + R   +E++    K+
Sbjct: 257 MIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           + SA+EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGS 165
Query: 458 IGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
             Y APE    +       DV+S G++L     R+ P D+
Sbjct: 166 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 76/177 (42%), Gaps = 34/177 (19%)
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED---------QSLTQTQTLATIGYMAP 463
           +IH DLKPSN+L++ N    + DFG+A+ ++ E          Q    T+ +AT  Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 464 EYG-REGQVSTNGDVYSFGIMLMETFTRKK--PTDE------IFFGDMTLKHWVNDLLPI 514
           E      + S   DV+S G +L E F R+   P  +      + FG +   H  NDL  I
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 515 S---------VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                      + +  A  L +       KG       +L  +  V  P +RI AKE
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKG------IDLLQRMLVFDPAKRITAKE 302

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG AK L  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ + +KC +   + R   +E++    K+
Sbjct: 233 E---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           + SA+EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGS 174
Query: 458 IGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
             Y APE    +       DV+S G++L     R+ P D+
Sbjct: 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +  A+EY H      I+H DLKP N+LLDDN+   ++DFG++   +  D +  +T +  +
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNFLKT-SCGS 170
Query: 458 IGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
             Y APE    +       DV+S GI+L      + P D+ F  ++  K
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 22/203 (10%)
Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           L+G G +G VYK R ++ G   A+KV D+  G   +    E +M                
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 358 -------XXDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGY 409
                    DD   LV+E+   GS+   + ++    L       I  ++   L +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEY--- 465
              +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE    
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 466 --GREGQVSTNGDVYSFGIMLME 486
               +       D++S GI  +E
Sbjct: 204 DENPDATYDFKSDLWSLGITAIE 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 18/140 (12%)
Query: 374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
            L KC + SN  +  F     +  +   L+Y+H   S  ++H DLKPSN+LL+      +
Sbjct: 118 KLLKCQHLSNDHICYF-----LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI 169
Query: 434 SDFGMAKPL-LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 491
            DFG+A+      D +   T+ +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 492 KPTDEIFFGDMTLKHWVNDL 511
                IF G    KH+++ L
Sbjct: 230 P----IFPG----KHYLDQL 241

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           + SA+EY H      I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGS 175
Query: 458 IGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
             Y APE    +       DV+S G++L     R+ P D+
Sbjct: 176 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLKEDQSL 449
            ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    ED   
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGS 173
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
             +    T GY+APE   +   S   D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 213 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 266
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 267 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 323
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 324 SSLTKLQRLFFYNNKV 339

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLKEDQSL 449
            ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    ED   
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGS 173
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
             +    T GY+APE   +   S   D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLKEDQSL 449
            ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    ED   
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGS 173
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
             +    T GY+APE   +   S   D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 213 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 266
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 267 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 323
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 324 SSLTKLQRLFFYNNKV 339

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 16/133 (12%)
Query: 367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD 426
           +EY  + +L   ++S N      +   +   +  AL Y+H   S  IIH DLKP N+ +D
Sbjct: 94  MEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFID 150
Query: 427 DNMVAHLSDFGMAK------PLLKED------QSLTQTQTLATIGYMAPEY-GREGQVST 473
           ++    + DFG+AK       +LK D       S   T  + T  Y+A E     G  + 
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210
Query: 474 NGDVYSFGIMLME 486
             D+YS GI+  E
Sbjct: 211 KIDMYSLGIIFFE 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 287 IFQATNGFSEN----NLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIEC 339
           +  A+  FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 399
            +                  + F  LV + +  G L + + +  +    +   +    + 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQ 135
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
             LE + + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAG 192
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIML 484
           T GY++PE  ++   S   D+++ G++L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 76/177 (42%), Gaps = 34/177 (19%)
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED---------QSLTQTQTLATIGYMAP 463
           +IH DLKPSN+L++ N    + DFG+A+ ++ E          Q    T+ +AT  Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 464 EYG-REGQVSTNGDVYSFGIMLMETFTRKK--PTDE------IFFGDMTLKHWVNDLLPI 514
           E      + S   DV+S G +L E F R+   P  +      + FG +   H  NDL  I
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 515 S---------VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                      + +  A  L +       KG       +L  +  V  P +RI AKE
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKG------IDLLQRMLVFDPAKRITAKE 302

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLKEDQSL 449
            ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K    ED   
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGS 173
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
             +    T GY+APE   +   S   D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    + LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 87  IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 144 VSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 202
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 203 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 243
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 244 LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-FKSFDIECDMXXXXXXXXXXXXXXXXX 358
           +G+G +G V++  +  G  VAVK+F  +  ++ F+  +I   +                 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 359 XDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS--V 411
            +    L L   Y  HGSL   L      L+    L + +  A  L +LH   FG     
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQGKP 132
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS----LTQTQTLATIGYMAPEYGR 467
            I H D K  NVL+  N+   ++D G+A  ++    S    +     + T  YMAPE   
Sbjct: 133 AIAHRDFKSRNVLVKSNLQCCIADLGLA--VMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 468 EGQVSTN-------GDVYSFGIMLMETFTR 490
           E Q+ T+        D+++FG++L E   R
Sbjct: 191 E-QIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +   + +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 217 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 271 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 327
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 328 SSLTKLQRLFFYNNKV 343

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 464 EYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           E  +  +      DV+S GI+L      + P D+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 12  VGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +G L  L  LSL  NQL+  G+    L  L  L +LD   N++    P     LT L  L
Sbjct: 212 LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 265
Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTI 125
            LG+N++++I S L  L  +  L+L+ N L     I NLK L  + L  NN SD+ P  +
Sbjct: 266 KLGANQISNI-SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 322
Query: 126 GGLKDLQYLFLEYNRL 141
             L  LQ LF   N++
Sbjct: 323 SSLTKLQRLFFYNNKV 338

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +V+EY+  G L   +     + ++  R  +   + SA++Y H      ++H DLKP NVL
Sbjct: 88  MVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY--GREGQVSTNGDVYSFGI 482
           LD +M A ++DFG++   +  D    +T +  +  Y APE   GR        D++S G+
Sbjct: 144 LDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAPEVISGRL-YAGPEVDIWSCGV 199
Query: 483 MLMETFTRKKPTDE 496
           +L        P D+
Sbjct: 200 ILYALLCGTLPFDD 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+L++      + DFG+A+    E D +   T+
Sbjct: 150 LYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTE 206
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 207 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 257

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 114 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 298 NLIGRGGFGSVYKARIQDG--------MEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXX 349
            ++G+GG+G V++ R   G        M+V  K   ++  +       E ++        
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                          L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              II+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAPEILMRS 196
Query: 470 QVSTNGDVYSFGIMLMETFT---------RKKPTDEIF 498
             +   D +S G ++ +  T         RKK  D+I 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 171
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           + + YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 460 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           Y+APE  +  +      DV+S GI+L      + P D+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   +  + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 462 APEYGREGQVS-TNG----------DVYSFGIMLMETFTRKKPTDEIF 498
            PE  ++   S  NG          DV+S G +L      K P  +I 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 464 EYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           E  +  +      DV+S GI+L      + P D+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 464 EYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           E  +  +      DV+S GI+L      + P D+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 86/225 (38%), Gaps = 18/225 (8%)
Query: 286 EIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXX 344
           E+  AT+       +GRG FG V++    Q G + AVK   L+  RA      E      
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAG 141
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                            +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEY 200
Query: 405 LHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLKEDQS---LTQTQTLATIGY 460
           LH   S  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  +
Sbjct: 201 LH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETH 257
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           MAPE           DV+S   M++       P  + F G + LK
Sbjct: 258 MAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 241

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 32/293 (10%)
Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----DLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 339 CDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             +                     + L+ + MP G L   +      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG AK L  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVM 517
            +MA E       +   DV+S+G+ + E  T   KP D I   +++           S++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 234
Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           E         K E       C   ++ +  KC +   + R   +E++    K+
Sbjct: 235 E---------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 11/126 (8%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
            I + +  ALE+LH   SV  IH D+KPSNVL++      + DFG++  L+ +   + + 
Sbjct: 113 KIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKD 167
Query: 453 QTLATIGYMA-----PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW 507
                  YMA     PE  ++G  S   D++S GI ++E    + P D        LK  
Sbjct: 168 IDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 508 VNDLLP 513
           V +  P
Sbjct: 227 VEEPSP 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 464 EYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           E  +  +      DV+S GI+L      + P D+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 241

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 135 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 191
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 192 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 242

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 136 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 192
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 193 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 243

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 127 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 183
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 184 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YLH    + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 464 EYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 496
           E  +  +      DV+S GI+L      + P D+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 241

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 128 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 235

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 241

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 128 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 235

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 130 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 237

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 86/225 (38%), Gaps = 18/225 (8%)
Query: 286 EIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXX 344
           E+  AT+       +GRG FG V++    Q G + AVK   L+  RA      E      
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAG 122
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                            +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEY 181
Query: 405 LHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLKEDQS---LTQTQTLATIGY 460
           LH   S  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  +
Sbjct: 182 LH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETH 238
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           MAPE           DV+S   M++       P  + F G + LK
Sbjct: 239 MAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 150 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 206
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 257

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 132 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 239

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 130 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 237

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 130 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 237

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 132 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 239

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 150 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 206
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 257

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 138 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 195 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 245

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 130 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 237

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 130 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTE 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 237

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 38/232 (16%)
Query: 300 IGRGGFGSVYKA-RIQDGMEVAVK-VFDL-----QYGRAFKSFDIECDMXXXXXXXXXXX 352
           +G+G +G V+K+   + G  VAVK +FD         R F+   I  ++           
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 353 XXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
                   D   LV +YM    L   + ++  IL+   +  ++  +   ++YLH G    
Sbjct: 77  VLRADNDRDV-YLVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---G 129
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK-------------------EDQSLTQTQ 453
           ++H D+KPSN+LL+      ++DFG+++  +                    +D     T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTL 504
            +AT  Y APE        T G D++S G +L E    K     IF G  T+
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP----IFPGSSTM 237

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 11/200 (5%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVAVK+ D       + +    E  +               
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +  ++ +   R      + SA++Y H  +   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE +  +       
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 187
Query: 476 DVYSFGIMLMETFTRKKPTD 495
           DV+S G++L    +   P D
Sbjct: 188 DVWSLGVILYTLVSGSLPFD 207

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 24/207 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           L+ + MP G L   +      +     LN  + +A  + YL       ++H DL   NVL
Sbjct: 100 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVL 156
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       ++DFG+AK L  E++          I +MA E       +   DV+S+G+ +
Sbjct: 157 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 216
Query: 485 METFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
            E  T   KP D I   +++           S++E         K E       C   ++
Sbjct: 217 WELMTFGSKPYDGIPASEIS-----------SILE---------KGERLPQPPICTIDVY 256
Query: 544 NLAMKCTVESPEQRINAKEIVTRLLKI 570
            + +KC +   + R   +E++    K+
Sbjct: 257 MIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 52/225 (23%)
Query: 293 GFSEN----NLIGRGGFGSVYKARIQDGM--EVAVKVFDLQYGRAFKSFDI--------- 337
           GF EN     ++GRG   SV +  I      E AVK+ D+  G +F + ++         
Sbjct: 1   GFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 59
Query: 338 ECD-MXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQR 391
           E D +                  + F  LV + M  G L     EK   S      I + 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
           L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D     
Sbjct: 120 L---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKL 167
Query: 452 TQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 484
            +   T  Y+APE            YG+E       D++S G+++
Sbjct: 168 REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 183
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 211

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 24/207 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           L+ + MP G L   +      +     LN  + +A  + YL       ++H DL   NVL
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVL 149
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       ++DFG+AK L  E++          I +MA E       +   DV+S+G+ +
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
Query: 485 METFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF 543
            E  T   KP D I   +++           S++E         K E       C   ++
Sbjct: 210 WELMTFGSKPYDGIPASEIS-----------SILE---------KGERLPQPPICTIDVY 249
Query: 544 NLAMKCTVESPEQRINAKEIVTRLLKI 570
            + +KC +   + R   +E++    K+
Sbjct: 250 MIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 60/126 (47%), Gaps = 4/126 (3%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV+E    G L K L      + +     ++  V+  ++YL        +H +L   NVL
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVL 468
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
           L +   A +SDFG++K L  +D   T ++     + + APE     + S+  DV+S+G+ 
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 484 LMETFT 489
           + E  +
Sbjct: 529 MWEALS 534

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 22/206 (10%)
Query: 306 GSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMXXXXXXXXXXXX--XXXXXXDD 361
           G ++K R Q G ++ VKV  ++    R  + F+ EC                        
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 362 FKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP 420
              L+  + P+GSL   L+  +N+++D  Q +   +D A    +LH    +   H  L  
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LNS 141
Query: 421 SNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN---GDV 477
            +V +D++  A +S   +         S           ++APE  ++    TN    D 
Sbjct: 142 RSVXIDEDXTARISXADVK-------FSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADX 194
Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMT 503
           +SF ++L E  TR     E+ F D++
Sbjct: 195 WSFAVLLWELVTR-----EVPFADLS 215

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 178
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           I+  V ++  Y+H      I H D+KPSN+L+D N    LSDFG ++ ++  D+ +  ++
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR 211
Query: 454 TLATIGYMAPEYGREGQVSTNG---DVYSFGIMLMETF 488
              T  +M PE+    + S NG   D++S GI L   F
Sbjct: 212 --GTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMF 246

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 178
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 26/266 (9%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +                 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M+++  NL  +           
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEP----------PLKAMKMIRDNLPPRLKNLHKVSPSL 246
Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 247 KGFLDRL----LVRDPAQRATAAELL 268

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR----ALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR----ALFPGD 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 8/113 (7%)
Query: 46  DSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFL----- 99
           D   +K+   + + F + T+L  L L  N++  I  +  W L  +L L+LS NFL     
Sbjct: 281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340
Query: 100 -LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD 151
            +  NL  L  +DLS N+   +   +  GL +L+ L L+ N+L+ S+PD I D
Sbjct: 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    + LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +  N    L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 524 VSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 583 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 623
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 624 LMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+
Sbjct: 132 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTE 188
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 239

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDI-ECDMXXXXXXXXX 350
           F +   IG G +G VYKAR +  G  VA+K   L        S  I E  +         
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 351 XXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                    ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 471 -VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
             ST  D++S G +  E  TR+     +F GD
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 26/266 (9%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +                 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M+++  NL  +           
Sbjct: 210 SLGIMVIEMVDGEPP----YFNEP----------PLKAMKMIRDNLPPRLKNLHKVSPSL 255
Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 256 KGFLDRL----LVRDPAQRATAAELL 277

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 87
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D+     ++DFG AK +      L       T  Y+APE   
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 198
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 232

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 26/266 (9%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +                 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M+++  NL  +           
Sbjct: 205 SLGIMVIEMVDGEPP----YFNEP----------PLKAMKMIRDNLPPRLKNLHKVSPSL 250
Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 251 KGFLDRL----LVRDPAQRATAAELL 272

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 99/243 (40%), Gaps = 36/243 (14%)
Query: 267 LPNDANMPRISNQRRFTYLE-----IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVA 320
           +P  ++M  +S +R   Y +     I++    +   + +G G +GSV  A   + G+ VA
Sbjct: 15  VPRGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 74
Query: 321 VKVFD------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHG 373
           VK         +   R ++   +   M                  ++F  + L  ++   
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 134
Query: 374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
            L   +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    +
Sbjct: 135 DLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 189
Query: 434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLME 486
            DFG+A+     D  +T        GY+A  + R  ++  N        D++S G ++ E
Sbjct: 190 LDFGLAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 238
Query: 487 TFT 489
             T
Sbjct: 239 LLT 241

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 26/266 (9%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +                 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M+++  NL  +           
Sbjct: 212 SLGIMVIEMVDGEPP----YFNEP----------PLKAMKMIRDNLPPRLKNLHKVSPSL 257
Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 258 KGFLDRL----LVRDPAQRATAAELL 279

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 171
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 172
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 172
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T+   T  Y+APE     +   + D++S G+++
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 95
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 206
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 240

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 38/76 (50%)
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH DL   N+LL    +  + DFG+A+ +  +   + +      + +MAPE       + 
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 474 NGDVYSFGIMLMETFT 489
             DV+S+GI L E F+
Sbjct: 245 ESDVWSYGIFLWELFS 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 38/76 (50%)
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH DL   N+LL    +  + DFG+A+ +  +   + +      + +MAPE       + 
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 474 NGDVYSFGIMLMETFT 489
             DV+S+GI L E F+
Sbjct: 243 ESDVWSYGIFLWELFS 258

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 16/132 (12%)
Query: 368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 427
           EY  + +L   ++S N      +   +   +  AL Y+H   S  IIH +LKP N+ +D+
Sbjct: 95  EYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRNLKPXNIFIDE 151
Query: 428 NMVAHLSDFGMAK------PLLKED------QSLTQTQTLATIGYMAPEY-GREGQVSTN 474
           +    + DFG+AK       +LK D       S   T  + T  Y+A E     G  +  
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEK 211
Query: 475 GDVYSFGIMLME 486
            D YS GI+  E
Sbjct: 212 IDXYSLGIIFFE 223

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 38/76 (50%)
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH DL   N+LL    +  + DFG+A+ +  +   + +      + +MAPE       + 
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 474 NGDVYSFGIMLMETFT 489
             DV+S+GI L E F+
Sbjct: 227 ESDVWSYGIFLWELFS 242

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 462 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           APE     +  ST  D++S G +  E  TR+     +F GD
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 121
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 266

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 38/76 (50%)
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH DL   N+LL    +  + DFG+A+ +  +   + +      + +MAPE       + 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 474 NGDVYSFGIMLMETFT 489
             DV+S+GI L E F+
Sbjct: 250 ESDVWSYGIFLWELFS 265

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 26/266 (9%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +                 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +           P+  M+++  NL  +           
Sbjct: 255 SLGIMVIEMVDGEPP----YFNEP----------PLKAMKMIRDNLPPRLKNLHKVSPSL 300
Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 301 KGFLDRL----LVRDPAQRATAAELL 322

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 38/76 (50%)
Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH DL   N+LL    +  + DFG+A+ +  +   + +      + +MAPE       + 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 474 NGDVYSFGIMLMETFT 489
             DV+S+GI L E F+
Sbjct: 250 ESDVWSYGIFLWELFS 265

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 121
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +     +L       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-----GTPEYLAPEIIL 232
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 266

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 10/134 (7%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +V+EY+  G L   +     + ++  R  +   + SA++Y H      ++H DLKP NVL
Sbjct: 88  MVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY--GREGQVSTNGDVYSFGI 482
           LD +M A ++DFG++  ++ + + L    +  +  Y APE   GR        D++S G+
Sbjct: 144 LDAHMNAKIADFGLSN-MMSDGEFL--RDSCGSPNYAAPEVISGRL-YAGPEVDIWSCGV 199
Query: 483 MLMETFTRKKPTDE 496
           +L        P D+
Sbjct: 200 ILYALLCGTLPFDD 213

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 8/103 (7%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLT 450
           IM  + SA+ ++H    V ++H DLKP N+L    +DN+   + DFG A+    ++Q L 
Sbjct: 111 IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL- 166
Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
                 T+ Y APE   +     + D++S G++L    + + P
Sbjct: 167 -KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 75/177 (42%), Gaps = 34/177 (19%)
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED---------QSLTQTQTLATIGYMAP 463
           +IH DLKPSN+L++ N    + DFG+A+ ++ E          Q     + +AT  Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 464 EYG-REGQVSTNGDVYSFGIMLMETFTRKK--PTDE------IFFGDMTLKHWVNDLLPI 514
           E      + S   DV+S G +L E F R+   P  +      + FG +   H  NDL  I
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 515 S---------VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                      + +  A  L +       KG       +L  +  V  P +RI AKE
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKG------IDLLQRMLVFDPAKRITAKE 302

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 291 TNGFSEN----NLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIECDMXX 343
           +  FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 344 XXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE 403
                           + F  LV + +  G L + + +  +    +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            + + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGY 173
Query: 461 MAPEYGREGQVSTNGDVYSFGIML 484
           ++PE  ++   S   D+++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 101
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 246

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR +  G EVAVK+ D       + +    E  +               
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +   + +   R      + SA++Y H  Y   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE +  +       
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 195
Query: 476 DVYSFGIMLMETFTRKKPTD 495
           DV+S G++L    +   P D
Sbjct: 196 DVWSLGVILYTLVSGSLPFD 215

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +    +
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 191 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 241

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 291 TNGFSEN----NLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIECDMXX 343
           +  FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 344 XXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE 403
                           + F  LV + +  G L + + +  +    +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            + + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGY 173
Query: 461 MAPEYGREGQVSTNGDVYSFGIML 484
           ++PE  ++   S   D+++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 13/119 (10%)
Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQ 453
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +    +
Sbjct: 135 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 454 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
            +AT  Y APE     +  T   D++S G +L E  + +     IF G    KH+++ L
Sbjct: 192 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQL 242

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/200 (21%), Positives = 85/200 (42%), Gaps = 13/200 (6%)
Query: 291 TNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXX 347
           ++ +     +G+G F  V +      G+E A K+ + +    R F+  + E  +      
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 348 XXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                       + F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 119
Query: 408 GYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
            +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++PE
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 176
Query: 465 YGREGQVSTNGDVYSFGIML 484
             ++   S   D+++ G++L
Sbjct: 177 VLKKDPYSKPVDIWACGVIL 196

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 178
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 174
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 180
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 218
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 179
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 174
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 173
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 172
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 173 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 26/266 (9%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXX 358
           IG G  G V  A ++  G  VAVK  DL+  +  +    E  +                 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 359 XDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVY 478
           K  ++LL  +    LSDFG    + KE     +   + T  +MAPE           D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 479 SFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQC 538
           S GIM++E    + P    +F +  LK           M+++  NL  +           
Sbjct: 332 SLGIMVIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSL 377
Query: 539 VSFIFNLAMKCTVESPEQRINAKEIV 564
             F+  L     V  P QR  A E++
Sbjct: 378 KGFLDRL----LVRDPAQRATAAELL 399

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 224
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            IM  +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 188
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 189 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLKEDQSL 449
           ++  +   +EYLH   +  ++H DLKPSN+L  D         + DFG AK L  E+  L
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
                  T  ++APE           D++S G++L    T   P
Sbjct: 178 --XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 56/122 (45%), Gaps = 12/122 (9%)
Query: 40  AALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS--IPSTLWNLKD--ILYLDLS 95
           ++L +LD   N L  F P CF  +  L  L L + +L         W L +  I  L L+
Sbjct: 171 SSLRKLDLSSNPLKEFSPGCFQTIGKLFALLLNNAQLNPHLTEKLCWELSNTSIQNLSLA 230
Query: 96  SNFLL------IGNLKV--LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPD 147
           +N LL         LK   L Q+DLS NN  DV   +   L  L+YL LEYN +Q   P 
Sbjct: 231 NNQLLATSESTFSGLKWTNLTQLDLSYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLSPR 290
Query: 148 SI 149
           S 
Sbjct: 291 SF 292

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 82/214 (38%), Gaps = 21/214 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
               +   D ++ G+++ E      P    FF D
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFAD 241

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 12/200 (6%)
Query: 290 ATNGF---SENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXX 345
           A N F   S+  ++G G FG V+K      G+++A K+   +  +  +    E  +    
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 346 XXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                          +   LV+EY+  G L   +   +Y L     +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 406 HFGYSVPIIHCDLKPSNVLL--DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           H  Y   I+H DLKP N+L    D     + DFG+A+     ++         T  ++AP
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAP 257
Query: 464 EYGREGQVSTNGDVYSFGIM 483
           E      VS   D++S G++
Sbjct: 258 EVVNYDFVSFPTDMWSVGVI 277

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVAVK+ D       + +    E  +               
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE +  +       
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 476 DVYSFGIMLMETFTRKKPTD 495
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVAVK+ D       + +    E  +               
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE +  +       
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 476 DVYSFGIMLMETFTRKKPTD 495
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 77/204 (37%), Gaps = 10/204 (4%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFD---LQYGRAFKSFDIECDMXXXXXXXX 349
           +     +G+GGF   Y+    D  EV A KV     L      +    E  +        
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 88  VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR 146
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   + 
Sbjct: 147 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 470 QVSTNGDVYSFGIMLMETFTRKKP 493
             S   D++S G +L      K P
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 82/212 (38%), Gaps = 16/212 (7%)
Query: 288 FQATNGFSENNLIGRGGFGSVYKARIQDG--MEVAVKVFDLQYGRAFKSFDIECDMXXXX 345
            Q T+G+     IG G + SV K  I     ME AVK+ D       +  +I   +    
Sbjct: 18  IQFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYG 73
Query: 346 XXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
                           +  +V E M  G L   +    +  +  +   ++  +   +EYL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYL 132
Query: 406 HFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           H   +  ++H DLKPSN+L  D         + DFG AK L  E+  L       T  ++
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFV 187
Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           APE           D++S G++L    T   P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSL 449
            +M  + +AL Y H   S  ++H DLKP N+L  D   +    + DFG+A+ L K D+  
Sbjct: 128 ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEH- 182
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
             T    T  YMAPE  +   V+   D++S G+++
Sbjct: 183 -STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVM 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLT 450
           ++  V SA++YLH      I+H DLKP N+L    ++N    ++DFG++K     +Q+  
Sbjct: 111 VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
            +    T GY+APE   +   S   D +S G++
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    + LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 87  IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 143
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 144 VSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 202
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 203 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 243
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 244 LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 14/225 (6%)
Query: 286 EIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXX 344
           E  +  +  +    +GRG FG V++ +  Q G + AVK   L+  R  +   + C     
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VAC---AG 106
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                            +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 405 LHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMA---KPLLKEDQSLTQTQTLATIGY 460
           LH   +  I+H D+K  NVLL  D   A L DFG A   +P       LT      T  +
Sbjct: 166 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           MAPE           D++S   M++       P  + F G + LK
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +V+EY+  G L   +   N  LD  +   +   + S ++Y H      ++H DLKP NVL
Sbjct: 93  MVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVL 148
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY--GREGQVSTNGDVYSFGI 482
           LD +M A ++DFG++  ++ + + L    +  +  Y APE   GR        D++S G+
Sbjct: 149 LDAHMNAKIADFGLSN-MMSDGEFL--RXSCGSPNYAAPEVISGR-LYAGPEVDIWSSGV 204
Query: 483 MLMETFTRKKPTDE 496
           +L        P D+
Sbjct: 205 ILYALLCGTLPFDD 218

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLKEDQSL 449
           ++  +   +EYLH   S  ++H DLKPSN+L  D         + DFG AK L  E+  L
Sbjct: 126 VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
                  T  ++APE  +        D++S GI+L
Sbjct: 183 --MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLKEDQSL 449
           ++  +   +EYLH   S  ++H DLKPSN+L  D         + DFG AK L  E+  L
Sbjct: 126 VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
                  T  ++APE  +        D++S GI+L
Sbjct: 183 --MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 77/204 (37%), Gaps = 10/204 (4%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFD---LQYGRAFKSFDIECDMXXXXXXXX 349
           +     +G+GGF   Y+    D  EV A KV     L      +    E  +        
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR 162
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   + 
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKK 217
Query: 470 QVSTNGDVYSFGIMLMETFTRKKP 493
             S   D++S G +L      K P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 14/225 (6%)
Query: 286 EIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXX 344
           E  +  +  +    +GRG FG V++ +  Q G + AVK   L+  R  +   + C     
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VAC---AG 122
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                            +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 123 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEY 181
Query: 405 LHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMA---KPLLKEDQSLTQTQTLATIGY 460
           LH   +  I+H D+K  NVLL  D   A L DFG A   +P       LT      T  +
Sbjct: 182 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           MAPE           D++S   M++       P  + F G + LK
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIII 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 141
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT 
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATR 193
Query: 459 GYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 489
            Y APE        +   D++S G ++ E  T
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ +      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPP----FFADQPIQ 245

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 141
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT 
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATR 193
Query: 459 GYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 489
            Y APE        +   D++S G ++ E  T
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 77/204 (37%), Gaps = 10/204 (4%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFD---LQYGRAFKSFDIECDMXXXXXXXX 349
           +     +G+GGF   Y+    D  EV A KV     L      +    E  +        
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR 162
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   + 
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAPEVLCKK 217
Query: 470 QVSTNGDVYSFGIMLMETFTRKKP 493
             S   D++S G +L      K P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 9/114 (7%)
Query: 385 ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK 444
           +LD      I+ +V   LEYLH       IH D+K  N+LL ++    ++DFG++   L 
Sbjct: 112 VLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLA 167
Query: 445 EDQSLTQTQT----LATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKP 493
               +T+ +     + T  +MAPE   + +      D++SFGI  +E  T   P
Sbjct: 168 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 77/204 (37%), Gaps = 10/204 (4%)
Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFD---LQYGRAFKSFDIECDMXXXXXXXX 349
           +     +G+GGF   Y+    D  EV A KV     L      +    E  +        
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 350 XXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                     DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR 162
Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   + 
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPEVLCKK 217
Query: 470 QVSTNGDVYSFGIMLMETFTRKKP 493
             S   D++S G +L      K P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 141
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT 
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATR 193
Query: 459 GYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 489
            Y APE        +   D++S G ++ E  T
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 9/114 (7%)
Query: 385 ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK 444
           +LD      I+ +V   LEYLH       IH D+K  N+LL ++    ++DFG++   L 
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLA 172
Query: 445 EDQSLTQTQT----LATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKP 493
               +T+ +     + T  +MAPE   + +      D++SFGI  +E  T   P
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + IG G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 139
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT-------- 185
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVAV++ D       + +    E  +               
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE +  +       
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 476 DVYSFGIMLMETFTRKKPTD 495
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           ++G+G FG V  A  +   E+ A+K+  L+     +  D+EC M                
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 358 XXD------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                    D    V+EY+  G L   +Y    +   F+    +   A     L F +  
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQV-GKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NV+LD      ++DFGM K  + +   +T  +   T  Y+APE       
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD--GVTTREFCGTPDYIAPEIIAYQPY 197
Query: 472 STNGDVYSFGIMLMETFTRKKPTD 495
             + D +++G++L E    + P D
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 60/128 (46%), Gaps = 20/128 (15%)
Query: 364 ALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
           +LVLE +  G L     EK  YS     D  ++      +  A+ YLH      I+H DL
Sbjct: 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAYLH---ENGIVHRDL 174
Query: 419 KPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
           KP N+L      +    ++DFG++K  + E Q L +T    T GY APE  R        
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKT-VCGTPGYCAPEILRGCAYGPEV 231
Query: 476 DVYSFGIM 483
           D++S GI+
Sbjct: 232 DMWSVGII 239

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 14/225 (6%)
Query: 286 EIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMXXX 344
           E  +  +  +    +GRG FG V++ +  Q G + AVK   L+  R  +   + C     
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VAC---AG 120
Query: 345 XXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                            +  + +E +  GSL + L      L   + L  +      LEY
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEY 179
Query: 405 LHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMA---KPLLKEDQSLTQTQTLATIGY 460
           LH   +  I+H D+K  NVLL  D   A L DFG A   +P       LT      T  +
Sbjct: 180 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           MAPE           D++S   M++       P  + F G + LK
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 23/206 (11%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +++E    G L   L    + LD+   +     +++AL YL    S   +H D+   NVL
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523
Query: 425 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           +       L DFG+++  +++      ++    I +MAPE     + ++  DV+ FG+ +
Sbjct: 524 VSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582
Query: 485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFN 544
            E                 L H V    P   ++  D     +  E       C   +++
Sbjct: 583 WE----------------ILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 623
Query: 545 LAMKCTVESPEQRINAKEIVTRLLKI 570
           L  KC    P +R    E+  +L  I
Sbjct: 624 LMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 271 ANMPRISNQRRFTYLE-----IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF 324
           ++M  +S +R   Y +     I++    +   + +G G +GSV  A   + G+ VAVK  
Sbjct: 1   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 60
Query: 325 D------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEK 377
                  +   R ++   +   M                  ++F  + L  ++    L  
Sbjct: 61  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 378 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 437
            +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG
Sbjct: 121 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 175
Query: 438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           +A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 176 LAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVAV++ D       + +    E  +               
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNG 475
           DLK  N+LLD +M   ++DFG +      ++     +   +  Y APE +  +       
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 476 DVYSFGIMLMETFTRKKPTD 495
           DV+S G++L    +   P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT 
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATR 186
Query: 459 GYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 489
            Y APE        +   D++S G ++ E  T
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSL 449
            IM D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK   +  Q+ 
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 185
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
            QT    T  Y+APE     +   + D++S G+++
Sbjct: 186 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSL 449
            IM D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK   +  Q+ 
Sbjct: 113 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 166
Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
            QT    T  Y+APE     +   + D++S G+++
Sbjct: 167 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D+KP N++
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIM 181
Query: 425 LDDNMVAHLS--DFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 482
            +    + +   DFG+A  L  ++       T AT  + APE      V    D+++ G+
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 483 M 483
           +
Sbjct: 239 L 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 271 ANMPRISNQRRFTYLE-----IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF 324
           ++M  +S +R   Y +     I++    +   + +G G +GSV  A   + G+ VAVK  
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 325 D------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEK 377
                  +   R ++   +   M                  ++F  + L  ++    L  
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 378 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 437
            +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG
Sbjct: 122 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           +A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 LAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V +  ++  G E A K+ + +    R  +  + E  +               
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              + F  LV + +  G L + + +  Y    +   +    +   LE +   + + ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 417 DLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKEAYGK 185
Query: 474 NGDVYSFGIML 484
             D+++ G++L
Sbjct: 186 PVDIWACGVIL 196

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 131
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 132 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 177
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 132
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 133 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 178
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 283 TYLEIFQATNGFSENNLIGRGGFGSV---YKARIQDGMEVAVKVFD------LQYGRAFK 333
           T  E+ Q   G      +G G +GSV   Y AR++   +VAVK         +   R ++
Sbjct: 22  TVWEVPQRLQGLRP---VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR 76
Query: 334 SFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN 393
              +   +                  +DF  + L     G+    +  S  + D   +  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF- 135
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           ++  +   L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   + D+ +T   
Sbjct: 136 LVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--- 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFTRK 491
                GY+A  + R  ++  N        D++S G ++ E    K
Sbjct: 187 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 130
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 176
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCG 167
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 145
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 146 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT-------- 191
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 271 ANMPRISNQRRFTYLE-----IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF 324
           ++M  +S +R   Y +     I++    +   + +G G +GSV  A   + G+ VAVK  
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 325 D------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEK 377
                  +   R ++   +   M                  ++F  + L  ++    L  
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 378 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 437
            +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG
Sbjct: 122 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFG 176
Query: 438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           +A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 LAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 131
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 132 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 177
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 298 NLIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
            +IGRG FG V   ++++   + A+K+   +++        F  E D+            
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYS 410
                 ++   LV++Y   G L   L    + + +   R  I  M+    ++  LH+   
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 196
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-- 468
              +H D+KP NVLLD N    L+DFG     + +D ++  +  + T  Y++PE  +   
Sbjct: 197 ---VHRDIKPDNVLLDVNGHIRLADFGSCLK-MNDDGTVQSSVAVGTPDYISPEILQAME 252
Query: 469 ---GQVSTNGDVYSFGIMLMETFTRKKP 493
              G+     D +S G+ + E    + P
Sbjct: 253 DGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 21/97 (21%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   + D+ +T        GY+
Sbjct: 136 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYV 181
Query: 462 APEYGREGQVSTNG-------DVYSFGIMLMETFTRK 491
           A  + R  ++  N        D++S G ++ E    K
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 118 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCG 172
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVAVK+ D       + +    E  +               
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPE-YGREGQVS 472
           DLK  N+LLD +M   ++DFG +      ++     +  A  G   Y APE +  +    
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 473 TNGDVYSFGIMLMETFTRKKPTD 495
              DV+S G++L    +   P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 139
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT-------- 185
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 28/228 (12%)
Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVF-DLQYGRAFKSFDI-ECDMXXXXXXXXXXXXXXX 356
           IG G +G V+K R +D G  VA+K F + +     K   + E  M               
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYLHFGYSVP 412
                   LV EY  H  L +        LD +QR      V S     L+ ++F +   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQV 471
            IH D+KP N+L+  + V  L DFG A+  L    S      +AT  Y +PE    + Q 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 472 STNGDVYSFGIMLME------TFTRKKPTDEIFFGDMTLKHWVNDLLP 513
               DV++ G +  E       +  K   D+++    TL     DL+P
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL----GDLIP 224

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 39/240 (16%)
Query: 273 MPRISN--QRRFTYLE------IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKV 323
           +PR S+  Q R T+        I++    +   + +G G +GSV  A   + G+ VAVK 
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 73
Query: 324 FD------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLE 376
                   +   R ++   +   M                  ++F  + L  ++    L 
Sbjct: 74  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 133
Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 436
             +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DF
Sbjct: 134 NIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 188
Query: 437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           G+A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 189 GLAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 39/240 (16%)
Query: 273 MPRISN--QRRFTYLE------IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKV 323
           +PR S+  Q R T+        I++    +   + +G G +GSV  A   + G+ VAVK 
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 74
Query: 324 FD------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLE 376
                   +   R ++   +   M                  ++F  + L  ++    L 
Sbjct: 75  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 134
Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 436
             +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DF
Sbjct: 135 NIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 189
Query: 437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           G+A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 190 GLAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCG 167
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           +G+G F  V +  +I  G E A K+ + +    R  +  + E  +               
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 417 DLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 474 NGDVYSFGIML 484
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 139
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 185
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCG 167
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 133
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 134 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 179
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G+++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G+++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 298 NLIGRGGFGSVYKARIQDGMEV-AVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
            +IGRG FG V   ++++   + A+K+   +++        F  E D+            
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYS 410
                 ++   LV++Y   G L   L    + + +   R  I  M+    ++  LH+   
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 212
Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-- 468
              +H D+KP NVLLD N    L+DFG     + +D ++  +  + T  Y++PE  +   
Sbjct: 213 ---VHRDIKPDNVLLDVNGHIRLADFGSCLK-MNDDGTVQSSVAVGTPDYISPEILQAME 268
Query: 469 ---GQVSTNGDVYSFGIMLMETFTRKKP 493
              G+     D +S G+ + E    + P
Sbjct: 269 DGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 136
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 182
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 21/97 (21%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   + D+ +T        GY+
Sbjct: 144 LKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYV 189
Query: 462 APEYGREGQVSTNG-------DVYSFGIMLMETFTRK 491
           A  + R  ++  N        D++S G ++ E    K
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 17/133 (12%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV E M  GS+   ++   +  ++   + ++ DVASAL++LH   +  I H DLKP N+L
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGIAHRDLKPENIL 143
Query: 425 LDD-NMVA--HLSDFGMAKPL-LKEDQSLTQTQTLAT----IGYMAPE----YGREGQV- 471
            +  N V+   + DFG+   + L  D S   T  L T      YMAPE    +  E  + 
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 472 STNGDVYSFGIML 484
               D++S G++L
Sbjct: 204 DKRCDLWSLGVIL 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           ++G+G FG V  +  +   E+ AVK+  L+     +  D+EC M                
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 358 XXD------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                    D    V+EY+  G L   +Y    +   F+  + +   A     L F  S 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE       
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             + D ++FG++L E    + P      DE+F
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCG 167
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 146
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 147 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 192
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   + S     D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+ +     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 141
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 187
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 136
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 182
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 136
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E      T  +AT 
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATR 188
Query: 459 GYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 489
            Y APE        +   D++S G ++ E  T
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 300 IGRGGFGSVYKA-RIQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           +G+G F  V +  +I  G E A K+ + +    R  +  + E  +               
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 417 DLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 474 NGDVYSFGIML 484
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 146
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 147 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 192
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCG 167
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 146
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 147 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 192
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 145
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 146 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 191
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 136
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMT-------- 182
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      
Sbjct: 116 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCG 170
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 50/114 (43%), Gaps = 7/114 (6%)
Query: 374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
           SL++   +    L   Q    + D   AL +LH   S  ++H D+KP+N+ L       L
Sbjct: 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKL 198
Query: 434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 487
            DFG+   L        Q        YMAPE   +G   T  DV+S G+ ++E 
Sbjct: 199 GDFGLLVELGTAGAGEVQE---GDPRYMAPEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 11/126 (8%)
Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
            I + +  ALE+LH   SV  IH D+KPSNVL++        DFG++  L+ +   + + 
Sbjct: 140 KIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKD 194
Query: 453 QTLATIGYMAPEY-----GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW 507
                  Y APE       ++G  S   D++S GI  +E    + P D        LK  
Sbjct: 195 IDAGCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
Query: 508 VNDLLP 513
           V +  P
Sbjct: 254 VEEPSP 259

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXXXX 357
           ++G+G FG V  +  +   E+ AVK+  L+     +  D+EC M                
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 358 XXD------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                    D    V+EY+  G L   +Y    +   F+  + +   A     L F  S 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE       
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 472 STNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             + D ++FG++L E    + P      DE+F
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor 2913 Ectodomain Length = 174

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 7/73 (9%)
Query: 50  NKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFL------LIG 102
           N++    P  F +L NL+ LY  SNKLT+IP+ +++ L  +  LDL+ N L         
Sbjct: 43  NQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFD 102
Query: 103 NLKVLVQVDLSMN 115
           NLK L  + L  N
Sbjct: 103 NLKSLTHIYLYNN 115

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 21/220 (9%)
Query: 298 NLIGRGGFGSVYKARI-QDGMEVAVKV---FDLQYGRAFKSFDIECDMXXXXXXXXXXXX 353
            +IGRG F  V   ++ Q G   A+K+   +D+        F  E D+            
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 354 XXXXXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 412
                 +++  LV+EY   G L   L      +        + ++  A++ +H  GY   
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY--- 183
Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------Y 465
            +H D+KP N+LLD      L+DFG     L+ D ++     + T  Y++PE        
Sbjct: 184 -VHRDIKPDNILLDRCGHIRLADFGSCLK-LRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
              G      D ++ G+   E F  + P    F+ D T +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTP----FYADSTAE 277

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 8   IPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLR 67
           + +  G   + +LL L  N+++    D+      L EL+   N +    P  F NL NLR
Sbjct: 24  VAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83
Query: 68  NLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFLLI------GNLKVLVQVDLSMNNFSDV 120
            L L SN+L  IP  ++  L ++  LD+S N ++I       +L  L  +++  N+   +
Sbjct: 84  TLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIP 146
                 GL  L+ L LE   L  SIP
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLT-SIP 168

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 140
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 186
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  +  ++ G+++AVK         +   R ++   +  
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 163
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 164 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 209
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 210 GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 137 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 190
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G  VAVK         +   R ++   +  
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +  +    D  Q L  +  +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQI 130
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 176
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 185
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 185
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 9/89 (10%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
           V  A+ YLH    + I+H DLKP N+L    D+     +SDFG++K   K D     +  
Sbjct: 129 VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTA 182
Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIM 483
             T GY+APE   +   S   D +S G++
Sbjct: 183 CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 29/202 (14%)
Query: 365 LVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV 423
           L+LEY   G +   CL     + ++    +++  +   LE +++ +   I+H DLKP N+
Sbjct: 106 LILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 424 LLDDNMV---AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSF 480
           LL          + DFGM++ +     +    + + T  Y+APE      ++T  D+++ 
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 481 GIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVS 540
           GI+     T   P    F G+   + ++N         I   N +   +E F++  Q  +
Sbjct: 220 GIIAYMLLTHTSP----FVGEDNQETYLN---------ISQVN-VDYSEETFSSVSQLAT 265
Query: 541 -FIFNLAMKCTVESPEQRINAK 561
            FI +L +K    +PE+R  A+
Sbjct: 266 DFIQSLLVK----NPEKRPTAE 283

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SAL+YLH   +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      
Sbjct: 259 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCG 314
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 21/218 (9%)
Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXX 352
           F     +G G FG V   + ++ G   A+K+ D Q  +  K   IE  +           
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNF 100
Query: 353 XXXXXXXDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
                    FK      +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S+ +I+ DLKP N+L+D      ++DFG AK +      L  T        +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEIIL 211
Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
               +   D ++ G+++ E      P    FF D  ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SAL+YLH   +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      
Sbjct: 256 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCG 311
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SAL+YLH   +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      
Sbjct: 116 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCG 171
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SAL+YLH   +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      
Sbjct: 117 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCG 172
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 62/123 (50%), Gaps = 11/123 (8%)
Query: 365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           LV E+   G L + + +  +  D     NIM  + S + YLH      I+H D+KP N+L
Sbjct: 123 LVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENIL 178
Query: 425 LDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFG 481
           L++    +   + DFG++     +D  L     L T  Y+APE  ++ + +   DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLS-SFFSKDYKL--RDRLGTAYYIAPEVLKK-KYNEKCDVWSCG 234
Query: 482 IML 484
           +++
Sbjct: 235 VIM 237

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 6/98 (6%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           ++  +   +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T 
Sbjct: 136 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 189
Query: 454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            + T  Y APE         N D++S G ++ E    K
Sbjct: 190 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           ++ SAL+YLH   +V  ++ DLK  N++LD +    ++DFG+ K  +K+    T      
Sbjct: 118 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCG 173
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           T  Y+APE   +       D +  G+++ E    + P
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 16/179 (8%)
Query: 297 NNLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQYGRAFKSFDIECDMXXXXXXXXXXXXXX 355
           + L+G G +  V  A  +Q+G E AVK+ + Q G +      E +               
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 356 XXXXDDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
               DD +  LV E +  GS+   +    +  +  +   ++ DVA+AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 415 HCDLKPSNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQT------LATIGYMAPE 464
           H DLKP N+L +         + DF +    +K + S T   T        +  YMAPE
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSG-MKLNNSCTPITTPELTTPCGSAEYMAPE 191

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G  VAVK         +   R ++   +  
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 130
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 176
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 185
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G+ VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + D+G+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 39/240 (16%)
Query: 273 MPRISN--QRRFTYLE------IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKV 323
           +PR S+  Q R T+        I++    +   + +G G +GSV  A   + G  VAVK 
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKK 73
Query: 324 FD------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLE 376
                   +   R ++   +   M                  ++F  + L  ++    L 
Sbjct: 74  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 133
Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 436
             +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DF
Sbjct: 134 NIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 188
Query: 437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           G+A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 189 GLAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           LH  +   ++H DL P N+LL DN    + DF +A+   ++     +T  +    Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 465 YGREGQVSTN-GDVYSFGIMLMETFTRK 491
              + +  T   D++S G ++ E F RK
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           LH  +   ++H DL P N+LL DN    + DF +A+   ++     +T  +    Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 465 YGREGQVSTN-GDVYSFGIMLMETFTRK 491
              + +  T   D++S G ++ E F RK
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 287 IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD------LQYGRAFKSFDIEC 339
           I++    +   + +G G +GSV  A   + G  VAVK         +   R ++   +  
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 DMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
            M                  ++F  + L  ++    L   +       D  Q L  +  +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 134
Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T        
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 180
Query: 459 GYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 39/240 (16%)
Query: 273 MPRISN--QRRFTYLE------IFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKV 323
           +PR S+  Q R T+        I++    +   + +G G +GSV  A   + G  VAVK 
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKK 74
Query: 324 FD------LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLE 376
                   +   R ++   +   M                  ++F  + L  ++    L 
Sbjct: 75  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 134
Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 436
             +       D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DF
Sbjct: 135 NIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 189
Query: 437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
           G+A+     D  +T        GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 190 GLAR---HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSLT 450
           I   +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK     +   +
Sbjct: 166 IXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 219
Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 483
            T    T  Y+APE     +   + D +S G++
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVI 252

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 21/103 (20%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           ++  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T   
Sbjct: 140 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--- 190
Query: 454 TLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
                GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 191 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
           +   L++LH   + PIIH DLK  N+ +        + D G+A   LK  ++      + 
Sbjct: 138 ILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--TLK--RASFAKAVIG 192
Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS- 515
           T  + APE   E +   + DVY+FG   +E  T + P  E        +   + + P S 
Sbjct: 193 TPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASF 251
Query: 516 -------VMEIVDANLLSQKDEHFTTK 535
                  V EI++  +   KDE ++ K
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYSIK 278

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In Complex With A Protein Antigen Length = 178

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 30/80 (37%), Positives = 39/80 (48%), Gaps = 1/80 (1%)
Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
           Q+L L DNQ+    P    RL  L  LD   N+L       F  LT L  L L  N+L S
Sbjct: 41  QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS 100
Query: 79  IPSTLW-NLKDILYLDLSSN 97
           IP   + NLK + ++ L +N
Sbjct: 101 IPRGAFDNLKSLTHIWLLNN 120

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKEDQSLT 450
           I+  V S + YLH      I+H DLKP N+LL+    + +  + DFG++     E+Q   
Sbjct: 141 IIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQK-K 194
Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
             + L T  Y+APE  R+ +     DV+S G++L
Sbjct: 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Length = 170

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 30/80 (37%), Positives = 39/80 (48%), Gaps = 1/80 (1%)
Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
           Q+L L DNQ+    P    RL  L  LD   N+L       F  LT L  L L  N+L S
Sbjct: 33  QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS 92
Query: 79  IPSTLW-NLKDILYLDLSSN 97
           IP   + NLK + ++ L +N
Sbjct: 93  IPRGAFDNLKSLTHIWLLNN 112

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 31/236 (13%)
Query: 269 NDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFD-- 325
           ++A+  R +  R+     I++    +   + +G G +GSV  A   + G+ VAVK     
Sbjct: 22  SNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 326 ----LQYGRAFKSFDIECDMXXXXXXXXXXXXXXXXXXDDFKALVL-EYMPHGSLEKCLY 380
               +   R ++   +   M                  ++F  + L  ++    L   + 
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 381 SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 440
                 D  Q L  +  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+
Sbjct: 142 CQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 196
Query: 441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
               E             GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 197 HTDDE-----------MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 80/204 (39%), Gaps = 19/204 (9%)
Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMXXXXXXXXXXXXXXX 356
           IG+G F  V  AR I  G EVA+K+ D       + +    E  +               
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 357 XXXDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              +    L++EY   G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI----GYMAPE-YGREGQV 471
           DLK  N+LLD +M   ++DFG +          T    L T      Y APE +  +   
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 472 STNGDVYSFGIMLMETFTRKKPTD 495
               DV+S G++L    +   P D
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLME 486
            APE         N D++S G ++ E
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 78/201 (38%), Gaps = 21/201 (10%)
Query: 298 NLIGRGGFGSVYKA-RIQDGMEVAVKVFDLQY-----GRAFKSFDIECDMXXXXXXXXXX 351
            +IG+G F  V +    + G + AVK+ D+       G + +    E  +          
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 352 XXXXXXXXDDFKALVLEYMPHGSLEKCL-----YSSNYILDIFQRLNIMIDVASALEYLH 406
                   D    +V E+M    L  C        + ++       + M  +  AL Y H
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 407 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
                 IIH D+KP NVLL   +++    L DFG+A  L   +  L     + T  +MAP
Sbjct: 148 ---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAP 202
Query: 464 EYGREGQVSTNGDVYSFGIML 484
           E  +        DV+  G++L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 21/103 (20%)
Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           ++  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+     D  +T   
Sbjct: 136 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--- 186
Query: 454 TLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 489
                GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 187 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 6   GSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLT 64
           G   +  G   +   L LE N L+ S+P+ +   L +L +L  GGNKL       F  LT
Sbjct: 18  GRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT 76
Query: 65  NLRNLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNF 117
           +L  L L +N+L S+P+ +++ L  +  L L++N L      +   L  L  + L  N  
Sbjct: 77  SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIP 146
             V       L  LQY++L  N    + P
Sbjct: 137 KSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           +++LH   S  IIH DLKPSN+++  +    + DFG+A+       +   T  + T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYR 192
Query: 462 APEYGREGQVSTNGDVYSFGIMLME 486
           APE       + N D++S G ++ E
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGE 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 6/91 (6%)
Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
            +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S      + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYY 191
Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            APE         N D++S G ++ E    K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	580
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-79
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-32
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-68
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-65
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-53
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-51
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-49
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-45
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-48
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-40
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-39
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-36
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-31
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-39
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-36
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-33
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-09
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-32
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-32
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-18
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-28
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-24
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-23
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-09
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-25
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-23
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-24
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-11
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-23
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-21
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-05
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-22
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-20
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-04
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-05
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-18
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  270 bits (693), Expect = 1e-86
 Identities = 92/307 (29%), Positives = 158/307 (51%), Gaps = 17/307 (5%)

Query: 277 SNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFD 336
               R   +++ +ATN F    LIG G FG VYK  ++DG +VA+K    +  +  + F+
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83

Query: 337 IECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLN 393
            E + +   RH +++ +I  C   +   L+ +YM +G+L++ LY S+     +   QRL 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143

Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           I I  A  L YLH      IIH D+K  N+LLD+N V  ++DFG++K   + DQ+   T 
Sbjct: 144 ICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIF-FGDMTLKHWVNDLL 512
              T+GY+ PEY  +G+++   DVYSFG++L E    +    +      + L  W  +  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

Query: 513 PIS-VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL---L 568
               + +IVD NL  +         + +    + A+KC   S E R +  +++ +L   L
Sbjct: 261 NNGQLEQIVDPNLADKIRP------ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

Query: 569 KIRDSLL 575
           ++++S++
Sbjct: 315 RLQESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  265 bits (680), Expect = 2e-84
 Identities = 102/298 (34%), Positives = 152/298 (51%), Gaps = 15/298 (5%)

Query: 278 NQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKS-FD 336
             +RF+  E+  A++ FS  N++GRGGFG VYK R+ DG  VAVK    +  +  +  F 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 337 IECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQRLN 393
            E +MI    HRN++++   C +   + LV  YM +GS+  CL     S   LD  +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 394 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           I +  A  L YLH      IIH D+K +N+LLD+   A + DFG+AK L+    +   T 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTA 194

Query: 454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG---DMTLKHWVND 510
              TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D        D+ L  WV  
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 511 LLPI-SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
           LL    +  +VD +L     +      + V  +  +A+ CT  SP +R    E+V  L
Sbjct: 255 LLKEKKLEALVDVDLQGNYKD------EEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  252 bits (645), Expect = 2e-79
 Identities = 78/231 (33%), Positives = 111/231 (48%), Gaps = 13/231 (5%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           NNL G IP A+ KL +L  L +    + G+IPD L ++  L  LD   N L G +P    
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146

Query: 62  NLTNLRNLYLGSNKLT-SIPSTLWNLKDIL-YLDLSSNFL------LIGNLKVLVQVDLS 113
           +L NL  +    N+++ +IP +  +   +   + +S N L         NL  L  VDLS
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205

Query: 114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL 173
            N          G  K+ Q + L  N L   +   +G   NL  L+L NN + GT+P  L
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264

Query: 174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC 224
            +L  L  +NVSFN L GEIP  G  + F   ++  N+ LCG P   +P C
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  142 bits (360), Expect = 3e-38
 Identities = 50/175 (28%), Positives = 70/175 (40%), Gaps = 23/175 (13%)

Query: 25  DNQLEGSIPDDLCRLAALFELDSGGNKLDG--FVPACFGNLTNLRNLYL-GSNKLT-SIP 80
           +    G + D   +   +  LD  G  L     +P+   NL  L  LY+ G N L   IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 81  STLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNR 140
                               I  L  L  + ++  N S  IP  +  +K L  L   YN 
Sbjct: 95  PA------------------IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136

Query: 141 LQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL-KDINVSFNKLEGEIP 194
           L G++P SI  L NL  +    N +SG IP S      L   + +S N+L G+IP
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  126 bits (318), Expect = 2e-32
 Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 20/154 (12%)

Query: 45  LDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT---SIPSTLWNLKDILYLDLSSNFLLI 101
            D       G +         + NL L    L     IPS+L NL  + +L +       
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI---- 86

Query: 102 GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLS 161
                        NN    IP  I  L  L YL++ +  + G+IPD +  +  L +L+ S
Sbjct: 87  -------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 162 NNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
            N LSGT+P S+  L +L  I    N++ G IP+
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 30/172 (17%), Positives = 41/172 (23%), Gaps = 67/172 (38%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L G   +  G  +  Q + L  N L   +                            
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-------------------------V 240

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV 120
           G   NL  L                                         DL  N     
Sbjct: 241 GLSKNLNGL-----------------------------------------DLRNNRIYGT 259

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           +P  +  LK L  L + +N L G IP   G+L        +NN      P+ 
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  238 bits (609), Expect = 3e-74
 Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 31/313 (9%)

Query: 277 SNQRRFTYLEIFQATNGFSE------NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR 330
           +    F++ E+   TN F E       N +G GGFG VYK  + +   VAVK        
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68

Query: 331 A----FKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNY-- 384
                 + FD E  ++ + +H N+++++   S  D   LV  YMP+GSL   L   +   
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 385 ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK 444
            L    R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   K
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTL 504
             Q++  ++ + T  YMAPE  R G+++   D+YSFG++L+E  T     DE       L
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLL 243

Query: 505 KHWVNDLL--PISVMEIVDANLLSQKDEHFTTKG--QCVSFIFNLAMKCTVESPEQRINA 560
                ++     ++ + +D  +         +           ++A +C  E   +R + 
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-----NDADSTSVEAMY----SVASQCLHEKKNKRPDI 294

Query: 561 KEIVTRLLKIRDS 573
           K++   L ++  S
Sbjct: 295 KKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  222 bits (568), Expect = 5e-68
 Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 24/313 (7%)

Query: 277 SNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFD 336
           S+        ++  +       +  RG FG V+KA++     VAVK+F +Q  ++++  +
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NE 66

Query: 337 IECDMIKRIRHRNIIKIISSCSSDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRL 392
            E   +  ++H NI++ I +            L+  +   GSL   L     ++   +  
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELC 124

Query: 393 NIMIDVASALEYLH-------FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
           +I   +A  L YLH        G+   I H D+K  NVLL +N+ A ++DFG+A      
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 446 DQSLTQTQTLATIGYMAPEYGREG-----QVSTNGDVYSFGIMLMETFTRKKPTDEIFFG 500
             +      + T  YMAPE                D+Y+ G++L E  +R    D     
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 501 DMTLKHWVNDLLPISVMEIVDANLLSQKDEHF---TTKGQCVSFIFNLAMKCTVESPEQR 557
            M          P S+ ++ +  +  +K         K   ++ +     +C     E R
Sbjct: 245 YMLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 558 INAKEIVTRLLKI 570
           ++A  +  R+ ++
Sbjct: 304 LSAGCVGERITQM 316

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  226 bits (579), Expect = 2e-65
 Identities = 70/233 (30%), Positives = 100/233 (42%), Gaps = 16/233 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N+ +G+IP  +G  + L  L L  N   G+IP  + +           N + G      
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578

Query: 61  GNLTNLRNLYLGSNKLT---SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVD 111
            N    +  +   N L         L  L      +++S            N   ++ +D
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           +S N  S  IP  IG +  L  L L +N + GSIPD +GDL  L  L+LS+N L G IP 
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698

Query: 172 SLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPC 224
           ++  L  L +I++S N L G IP  G F  F    F  N  LCG P   +P C
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  192 bits (491), Expect = 3e-53
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 11/206 (5%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
           GN+  G++P   G    L+ L+L  N   G +P D L ++  L  LD   N+  G +P  
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362

Query: 60  FGNLT-NLRNLYLGSNKLT-SIPSTLWN--LKDILYLDLSSNFL------LIGNLKVLVQ 109
             NL+ +L  L L SN  +  I   L       +  L L +N         + N   LV 
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           + LS N  S  IP+++G L  L+ L L  N L+G IP  +  +  L++L L  N+L+G I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482

Query: 170 PISLEKLLDLKDINVSFNKLEGEIPN 195
           P  L    +L  I++S N+L GEIP 
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  187 bits (477), Expect = 3e-51
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 10/204 (4%)

Query: 1   GNNLNGSIPIAVGKL-QKLQLLSLEDNQLEGSIPDDLCR--LAALFELDSGGNKLDGFVP 57
            N  +G +P ++  L   L  L L  N   G I  +LC+     L EL    N   G +P
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411

Query: 58  ACFGNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQV 110
               N + L +L+L  N L+ +IPS+L +L  +  L L  N L       +  +K L  +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
            L  N+ +  IP+ +    +L ++ L  NRL G IP  IG L NL  L LSNN+ SG IP
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531

Query: 171 ISLEKLLDLKDINVSFNKLEGEIP 194
             L     L  ++++ N   G IP
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIP 555

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  180 bits (460), Expect = 5e-49
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 13/205 (6%)

Query: 1   GNNLNGSIPIAV---GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVP 57
            N+++G+  +         +L+ L++  N++ G +   + R   L  LD   N     +P
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217

Query: 58  ACFGNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDL 112
              G+ + L++L +  NKL+      +    ++  L++SSN  +       LK L  + L
Sbjct: 218 F-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSL 276

Query: 113 SMNNFSDVIPTTIGG-LKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           + N F+  IP  + G    L  L L  N   G++P   G    L+SL LS+NN SG +P+
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 172 -SLEKLLDLKDINVSFNKLEGEIPN 195
            +L K+  LK +++SFN+  GE+P 
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPE 361

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  168 bits (429), Expect = 8e-45
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 15/206 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD--LCRLAALFELDSGGNKLDGFVPA 58
            +++NGS+         L  L L  N L G +     L   + L  L+   N LD     
Sbjct: 86  NSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144

Query: 59  -CFGNLTNLRNLYLGSNKLT-SIPSTLW---NLKDILYLDLSSNFLL----IGNLKVLVQ 109
                L +L  L L +N ++ +            ++ +L +S N +     +     L  
Sbjct: 145 SGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEF 204

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           +D+S NNFS  IP  +G    LQ+L +  N+L G    +I     LK LN+S+N   G I
Sbjct: 205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263

Query: 170 PISLEKLLDLKDINVSFNKLEGEIPN 195
           P     L  L+ ++++ NK  GEIP+
Sbjct: 264 PPL--PLKSLQYLSLAENKFTGEIPD 287

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  147 bits (373), Expect = 1e-37
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 17/195 (8%)

Query: 13  GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
            K+  + L S   N    ++   L  L  L  L    + ++G V   F    +L +L L 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108

Query: 73  SNKLT-SIPS--TLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIP 122
            N L+  + +  +L +   + +L++SSN L           L  L  +DLS N+ S    
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 123 TTI---GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL 179
                  G  +L++L +  N++ G +   +   +NL+ L++S+NN S  IP  L     L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225

Query: 180 KDINVSFNKLEGEIP 194
           + +++S NKL G+  
Sbjct: 226 QHLDISGNKLSGDFS 240

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  199 bits (508), Expect = 2e-59
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 27/285 (9%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           IG G FG+V++A    G +VAVK+   Q         F  E  ++KR+RH NI+  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            +LK  N+L+D      + DFG+++  LK    L+      T  +MAPE  R+   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DVYSFG++L E  T ++P     +G++          P  V+  V       K +     
Sbjct: 221 DVYSFGVILWELATLQQP-----WGNLN---------PAQVVAAV-----GFKCKRLEIP 261

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
                 +  +   C    P +R +   I+  L  +  S +    R
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (499), Expect = 2e-58
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 40/286 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVF-------DLQYGRAFKSFDIECDMIKRIRHRNII 351
           IG+GGFG V+K R ++D   VA+K         + +    F+ F  E  ++  + H NI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
           K+     +     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 412 PIIHCDLKPSNVLLD-----DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-- 464
           PI+H DL+  N+ L        + A ++DFG+++         + +  L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL 524
              E   +   D YSF ++L    T + P     F + +          I  + ++    
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYS-------YGKIKFINMI---- 242

Query: 525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
             ++    T    C   + N+   C    P++R +   IV  L ++
Sbjct: 243 -REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (498), Expect = 1e-57
 Identities = 78/327 (23%), Positives = 117/327 (35%), Gaps = 37/327 (11%)

Query: 282 FTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDM 341
               E     +      LIGRG +G+VYK  + D   VAVKVF     + F +       
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE-KNIYR 60

Query: 342 IKRIRHRNIIKIISSCSSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 396
           +  + H NI + I               LV+EY P+GSL K  Y S +  D      +  
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAH 118

Query: 397 DVASALEYLH------FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
            V   L YLH        Y   I H DL   NVL+ ++    +SDFG++  L        
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 451 QTQTLA------TIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFTRKKPTDEI 497
             +  A      TI YMAPE                  D+Y+ G++  E F R   TD  
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLF 236

Query: 498 FFGDMT-----LKHWVNDLLPISVME--IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCT 550
               +       +  V +      M+  +       +  E +      V  +      C 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 551 VESPEQRINAKEIVTRLLKIRDSLLKN 577
            +  E R+ A+    R+ ++     +N
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERN 323

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (489), Expect = 3e-57
 Identities = 65/281 (23%), Positives = 121/281 (43%), Gaps = 36/281 (12%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           +     G ++K R Q G ++ VKV  ++    R  + F+ EC  ++   H N++ ++ +C
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 358 SS--DDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
            S       L+  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH      I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
              L   +V++D++M A +S   +         S      +    ++APE  ++    TN
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 475 G---DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
               D++SF ++L E  TR+ P     F D++          + +   V     + +   
Sbjct: 189 RRSADMWSFAVLLWELVTREVP-----FADLS---------NMEIGMKV-----ALEGLR 229

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD 572
            T        +  L   C  E P +R     IV  L K++D
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  193 bits (492), Expect = 4e-57
 Identities = 75/278 (26%), Positives = 115/278 (41%), Gaps = 31/278 (11%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           +GRG FG V KA      +VA+K  + +     K+F +E   + R+ H NI+K+  +C +
Sbjct: 16  VGRGAFGVVCKA-KWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 360 DDFKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                LV+EY   GSL   L+ +           ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 418 LKPSNVLLDDNM-VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           LKP N+LL     V  + DFG A      D     T    +  +MAPE       S   D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 477 VYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG 536
           V+S+GI+L E  TR+KP     F ++             +M  V                
Sbjct: 186 VFSWGIILWEVITRRKP-----FDEI-------GGPAFRIMWAV------HNGTRPPLIK 227

Query: 537 QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                I +L  +C  + P QR + +EIV  +  +    
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  186 bits (474), Expect = 6e-55
 Identities = 76/283 (26%), Positives = 114/283 (40%), Gaps = 38/283 (13%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVF----DLQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           IG GGFG VY+A    G EVAVK      D    +  ++   E  +   ++H NII +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
            C  +    LV+E+   G L + L      +     +N  + +A  + YLH    VPIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 416 CDLKPSNVLLD--------DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
            DLK SN+L+          N +  ++DFG+A    +E    T+        +MAPE  R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIR 187

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
               S   DV+S+G++L E  T + P     F  +           ++V   V     + 
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP-----FRGID---------GLAVAYGV-----AM 228

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                     C      L   C    P  R +   I+ +L  I
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  185 bits (473), Expect = 1e-54
 Identities = 68/273 (24%), Positives = 126/273 (46%), Gaps = 26/273 (9%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  ++++ RH NI+  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           ++    A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE---YGREGQVSTN 474
           LK +N+ L ++    + DFG+A    +   S    Q   +I +MAPE          S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 475 GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
            DVY+FGI+L E  T + P     + ++  +          ++E+V    LS       +
Sbjct: 206 SDVYAFGIVLYELMTGQLP-----YSNINNRD--------QIIEMVGRGSLSPDLSKVRS 252

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
              C   +  L  +C  +  ++R +   I+  +
Sbjct: 253 N--CPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (472), Expect = 3e-54
 Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 39/287 (13%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIIS 355
            LIG+G FG VY  R     EVA+++ D++       K+F  E    ++ RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           +C S    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAK---PLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
            DLK  NV  D+  V  ++DFG+      L    +          + ++APE  R+    
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 473 TNG---------DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
           T           DV++ G +  E   R+ P     F               +++  +   
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP-----FKTQP---------AEAIIWQMGTG 258

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           +         ++      I ++ + C     E+R    +++  L K+
Sbjct: 259 MKPN-----LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (458), Expect = 3e-52
 Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 38/299 (12%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
             +G+G +G V++   Q G  VAVK+F  +  +++   + E      +RH NI+  I+S 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 358 SSDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 408
            +    +    L+  Y   GSL   L      LD    L I++ +AS L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA--TIGYMAPE-- 464
               I H DLK  N+L+  N    ++D G+A    +    L         T  YMAPE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 465 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTD-----EIFFGDMTLKHWVNDLLPIS 515
                          D+++FG++L E   R          +  F D+            S
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND-------PS 242

Query: 516 VMEIVDANLLSQK----DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
             ++     + Q+       + +    ++ +  L  +C  ++P  R+ A  I   L KI
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSD-PTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  181 bits (460), Expect = 3e-52
 Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 30/299 (10%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
             IG+G +G V+  + + G +VAVKVF      ++   + E      +RH NI+  I++ 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100

Query: 358 SSDDFK----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 408
                      L+ +Y  +GSL   L   +  LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA--TIGYMAPE-- 464
               I H DLK  N+L+  N    ++D G+A   + +   +         T  YM PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 465 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV 520
                    Q     D+YSFG++L E   R      +    +     V        M   
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM--- 275

Query: 521 DANLLSQKDE-----HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
              ++  K       +  +  +C+  +  L  +C   +P  R+ A  +   L K+ +S 
Sbjct: 276 -REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  175 bits (447), Expect = 1e-50
 Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 34/288 (11%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G+G FG   K    + G  + +K          ++F  E  +++ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 418
            D     + EY+  G+L   + S +      QR++   D+AS + YLH   S+ IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 419 KPSNVLLDDNMVAHLSDFGMAK------------PLLKEDQSLTQTQTLATIGYMAPEYG 466
              N L+ +N    ++DFG+A+              LK+     +   +    +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
                    DV+SFGI+L E   R                   D LP ++   ++     
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRTMDFGLNVR--- 237

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                      C    F + ++C    PE+R +  ++   L  +R  L
Sbjct: 238 -GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (431), Expect = 5e-48
 Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 30/298 (10%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
             IG+G FG V++ + + G EVAVK+F  +  R++   + E      +RH NI+  I++ 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 358 SSDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 408
           + D+       LV +Y  HGSL   L  + Y + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--LKEDQSLTQTQTLATIGYMAPE-- 464
               I H DLK  N+L+  N    ++D G+A       +   +     + T  YMAPE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 465 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTD-----EIFFGDMTLKHWVNDLLPIS 515
                 +  +     D+Y+ G++  E   R          ++ + D+      +  +   
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV---PSDPSVEEM 280

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              + +  L       + +  + +  +  +  +C   +   R+ A  I   L ++   
Sbjct: 281 RKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  152 bits (385), Expect = 3e-39
 Identities = 55/239 (23%), Positives = 92/239 (38%), Gaps = 20/239 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
            N ++     A   L  L++L L  N++   +       L  +FE+    NK        
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449

Query: 60  FGNLTNLRNLYLGSNKLTSI---PSTLWNLKDILYLDLSSNFL------LIGNLKVLVQV 110
           F  + +L+ L L    L ++   PS    L+++  LDLS+N +      ++  L+ L  +
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509

Query: 111 DLSMNNFSDV--------IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
           DL  NN + +            + GL  L  L LE N       +   DL  LK ++L  
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569

Query: 163 NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN--KGPFRNFSTESFEGNELLCGMPNL 219
           NNL+          + LK +N+  N +           FRN +      N   C   ++
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  145 bits (368), Expect = 4e-37
 Identities = 56/243 (23%), Positives = 96/243 (39%), Gaps = 22/243 (9%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N ++   P    KL  L++L+L+ N+L             L EL    N +       F
Sbjct: 58  FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 61  GNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFL--------LIGNLKVLVQVD 111
               NL  L L  N L+S    T   L+++  L LS+N +         I     L +++
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN---LKSLNLSNNNLSGT 168
           LS N   +  P     +  L  LFL   +L  S+ + +   +    +++L+LSN+ LS T
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237

Query: 169 IPISLE--KLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNEL-------LCGMPN 218
              +    K  +L  +++S+N L     +             E N +       L G+ N
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297

Query: 219 LQV 221
           ++ 
Sbjct: 298 VRY 300

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  141 bits (358), Expect = 8e-36
 Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 12/207 (5%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L         +  +L  L +  N +    P+   +L  L  L+   N+L       F
Sbjct: 34  HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93

Query: 61  GNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS 113
              TNL  L+L SN +  I  +     K+++ LDLS N L          L+ L ++ LS
Sbjct: 94  AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153

Query: 114 MNNFSDVIPTTIGGLKD--LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
            N    +    +    +  L+ L L  N+++   P     +  L  L L+N  L  ++  
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213

Query: 172 SL---EKLLDLKDINVSFNKLEGEIPN 195
            L        ++++++S ++L      
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNT 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  140 bits (355), Expect = 2e-35
 Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 39/244 (15%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDL--CRLAALFELDSGGNKLDGFVPA 58
            N L+ +      +L+ LQ L L +N+++    ++L     ++L +L+   N++  F P 
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189

Query: 59  CFGNLTNLRNLYLGSNKLT-SIPSTL---WNLKDILYLDLSSNFL------LIGNLKV-- 106
           CF  +  L  L+L + +L  S+   L        I  L LS++ L          LK   
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN--- 163
           L  +DLS NN + V   +   L  L+Y FLEYN +Q     S+  L N++ LNL  +   
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309

Query: 164 ------NLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP 217
                 +L      S + L  L+ +N+  N + G   N                +  G+ 
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN----------------MFTGLI 353

Query: 218 NLQV 221
           NL+ 
Sbjct: 354 NLKY 357

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  127 bits (320), Expect = 6e-31
 Identities = 43/216 (19%), Positives = 68/216 (31%), Gaps = 18/216 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG--SIPDDLCRLAALFELDSGGNKLDGFVPA 58
            N        +   +  LQ L L    L+   S P     L  L  LD   N +      
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

Query: 59  CFGNLTNLRNLYLGSNKLTSI---------PSTLWNLKDILYLDLSSNFL------LIGN 103
               L  L  L L  N L  +            L  L  +  L+L SN        +  +
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 104 LKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSN 162
           L  L  +DL +NN + +  +       L+ L L+ N +        G    NL  L++  
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 163 NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGP 198
           N    T       +  + + + +  +L        P
Sbjct: 619 NPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  126 bits (318), Expect = 1e-30
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 19/205 (9%)

Query: 1   GNNLNGSIPIAVG---KLQKLQLLSLEDNQLEGSIPDDL--CRLAALFELDSGGNKLDGF 55
              L  S+   +        ++ LSL ++QL  +        +   L  LD   N L+  
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 56  VPACFGNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSM 114
               F  L  L   +L  N +  +   +L  L ++ YL+L  +           +  +S+
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------FTKQSISL 314

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            +   +   +   LK L++L +E N + G   +    LINLK L+LSN+  S     +  
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374

Query: 175 ----KLLDLKDINVSFNKLEGEIPN 195
                   L  +N++ NK+     +
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESD 399

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  118 bits (298), Expect = 4e-28
 Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 36/217 (16%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            ++      +L   +PDDL     +  L+   N+L     A F   + L +L +G N ++
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 78  SI-PSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFL 136
            + P     L                 LKVL   +L  N  S +   T     +L  L L
Sbjct: 63  KLEPELCQKLP---------------MLKVL---NLQHNELSQLSDKTFAFCTNLTELHL 104

Query: 137 EYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK 196
             N +Q    +      NL +L+LS+N LS T   +  +L +L+++ +S NK++      
Sbjct: 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS-- 162

Query: 197 GPFRNFSTESFE-----GNEL-------LCGMPNLQV 221
                F+  S +      N++          +  L  
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFG 199

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (276), Expect = 2e-25
 Identities = 31/138 (22%), Positives = 51/138 (36%), Gaps = 8/138 (5%)

Query: 64  TNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNF 117
            +         KLT +P  L    +I  L+L+ N L             L  +D+  N  
Sbjct: 4   VSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           S + P     L  L+ L L++N L      +     NL  L+L +N++         K  
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 178 DLKDINVSFNKLEGEIPN 195
           +L  +++S N L      
Sbjct: 122 NLITLDLSHNGLSSTKLG 139

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  150 bits (382), Expect = 4e-39
 Identities = 44/225 (19%), Positives = 84/225 (37%), Gaps = 25/225 (11%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQL-EGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
              +          +K+Q++ +  N L    +   L ++  L  L+   N+L+G +PA F
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-F 349

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSNFL-------LIGNLKVLVQVDL 112
           G+   L +L L  N++T IP+      + +  L  + N L          ++ V+  +D 
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409

Query: 113 SMNNFSDV-------IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNL 165
           S N    V       +  T     ++  + L  N++     +       L S+NL  N L
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469

Query: 166 SG-------TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
           +            + +    L  I++ FNKL   + +        
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  142 bits (360), Expect = 3e-36
 Identities = 38/206 (18%), Positives = 73/206 (35%), Gaps = 14/206 (6%)

Query: 2   NNLNGSIPIAVGKLQKLQL--LSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            +   +      +     L    +  +  + SI           ++    N +  FV   
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKA 201

Query: 60  FGNLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNF-LLIGNLKVLVQVDLSMNNF 117
              LT LR  Y+G++          W  ++  Y        L   NLK L  V++     
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRL--------QGSIPDSIGDLINLKSLNLSNNNL-SGT 168
              +PT +  L ++Q + +  NR                      ++ + +  NNL +  
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321

Query: 169 IPISLEKLLDLKDINVSFNKLEGEIP 194
           +  SL+K+  L  +   +N+LEG++P
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  140 bits (356), Expect = 1e-35
 Identities = 28/198 (14%), Positives = 57/198 (28%), Gaps = 23/198 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG-------SIPDDLCRLAALFELDSGGNKLD 53
            N ++            L  ++L  N L            ++      L  +D   NKL 
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501

Query: 54  GFVPA-CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDL 112
                     L  L  + L  N  +  P+   N   +    + +              D 
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR------------DA 549

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
             N      P  I     L  L +  N ++  + + I    N+  L++ +N         
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSY 606

Query: 173 LEKLLDLKDINVSFNKLE 190
           +   ++     + ++K +
Sbjct: 607 VCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  132 bits (334), Expect = 7e-33
 Identities = 34/233 (14%), Positives = 78/233 (33%), Gaps = 25/233 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG----SIPDDLCRLAALFELDSGGNKLDGFV 56
           G   +G +P A+G+L +L++L+L  +  +       P  +    +  +            
Sbjct: 90  GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149

Query: 57  PACFG--NLTNLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNFLL-----IGNLKVLV 108
                  + ++L    + S+    SI  +         +   SN +      +  L  L 
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLR 209

Query: 109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGT 168
           Q  +  + F           ++      EY +   +      +L +L  + + N      
Sbjct: 210 QFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 169 IPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQV 221
           +P  L+ L +++ INV+ N+       K  ++  +               +Q+
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD--------APVGEKIQI 309

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (257), Expect = 3e-23
 Identities = 30/226 (13%), Positives = 56/226 (24%), Gaps = 57/226 (25%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +       +++    ++  LSLE     G +PD                          G
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA------------------------IG 102

Query: 62  NLTNLRNLYLGSNKLT-----SIPSTLWNLKDILYLDLSSNFLL---IGNLKVLVQVDLS 113
            LT L  L LGS+          P  +                    +         DL 
Sbjct: 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162

Query: 114 MNNFSDV-----IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG- 167
            +  +       I  +         +    N +   +  ++  L  L+   + N+     
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAE 221

Query: 168 ------------------TIPISLEKLLDLKDINVSFNKLEGEIPN 195
                             T  +  + L DL D+ V       ++P 
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 20/128 (15%), Positives = 41/128 (32%), Gaps = 6/128 (4%)

Query: 74  NKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQY 133
               + P   WN    L +  +   + + +   +  + L     S  +P  IG L +L+ 
Sbjct: 50  QGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEV 109

Query: 134 LFLEYNRLQG----SIPDSIGDLINLKSLNLSNNNLSGTIP--ISLEKLLDLKDINVSFN 187
           L L  +  +       P  I   ++ +       +   T       E   DL    ++ +
Sbjct: 110 LALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169

Query: 188 KLEGEIPN 195
             +  I  
Sbjct: 170 PQQKSIKK 177

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.5 bits (181), Expect = 6e-14
 Identities = 16/117 (13%), Positives = 37/117 (31%), Gaps = 7/117 (5%)

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG--- 167
           +  ++ +      ++     +  L LE     G +PD+IG L  L+ L L ++       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 168 -TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS---TESFEGNELLCGMPNLQ 220
              P  +   +  +         +    +  P  +FS    +    +     +    
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  150 bits (381), Expect = 4e-39
 Identities = 43/230 (18%), Positives = 75/230 (32%), Gaps = 16/230 (6%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA-CF 60
            +  G    +      L+ L L  N +   +  +   L  L  LD   + L        F
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 61  GNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDL 112
            +L NL  L +               L  +  L ++ N         +   L+ L  +DL
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           S      + PT    L  LQ L + +N            L +L+ L+ S N++  +    
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537

Query: 173 LEKLLD-LKDINVSFNKLEGEIPNKGPFRNF----STESFEGNELLCGMP 217
           L+     L  +N++ N       ++  F  +         E   + C  P
Sbjct: 538 LQHFPSSLAFLNLTQNDFACTCEHQ-SFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  132 bits (335), Expect = 4e-33
 Identities = 39/190 (20%), Positives = 71/190 (37%), Gaps = 13/190 (6%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            + L L  N L             L  LD    ++       + +L++L  L L  N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 78  SI-PSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDV-IPTTIGGLK 129
           S+       L  +  L      L       IG+LK L +++++ N      +P     L 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLK----SLNLSNNNLSGTIPISLEKLLDLKDINVS 185
           +L++L L  N++Q      +  L  +     SL+LS N ++   P +  K + L  + + 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLR 208

Query: 186 FNKLEGEIPN 195
            N     +  
Sbjct: 209 NNFDSLNVMK 218

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  123 bits (311), Expect = 6e-30
 Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 17/205 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
              +      A   L  L  L L  N ++         L++L +L +    L        
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 61  GNLTNLRNLYLGSNKLTS--IPSTLWNLKDILYLDLSSNFL------LIGNLK----VLV 108
           G+L  L+ L +  N + S  +P    NL ++ +LDLSSN +       +  L     + +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNLSG 167
            +DLS+N  + + P     ++ L  L L  N    ++    I  L  L+   L       
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 168 TIPI---SLEKLLDLKDINVSFNKL 189
              +       L  L ++ +   +L
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRL 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  106 bits (267), Expect = 2e-24
 Identities = 32/139 (23%), Positives = 48/139 (34%), Gaps = 9/139 (6%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDL 112
           C   + N+            IP  L        LDLS N L         +   L  +DL
Sbjct: 3   CVEVVPNIT-YQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           S      +       L  L  L L  N +Q     +   L +L+ L     NL+      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 173 LEKLLDLKDINVSFNKLEG 191
           +  L  LK++NV+ N ++ 
Sbjct: 120 IGHLKTLKELNVAHNLIQS 138

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.4 bits (243), Expect = 2e-21
 Identities = 48/246 (19%), Positives = 75/246 (30%), Gaps = 31/246 (12%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGF---V 56
            N +N  I     K  +L  L+L +N    ++       LA L        +        
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 57  PACFGNLTNLRNLYLGSNKLTS-------IPSTLWNLKDILYLDLSSNFLL----IGNLK 105
                 L  L NL +   +L         I      L ++    L S  +          
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304

Query: 106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNL 165
               ++L    F       +  LK L +        +G    S  DL +L+ L+LS N L
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGL 359

Query: 166 S--GTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL--------LCG 215
           S  G    S      LK +++SFN +     N           F+ + L           
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 216 MPNLQV 221
           + NL  
Sbjct: 420 LRNLIY 425

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (362), Expect = 8e-39
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 36/292 (12%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR--AFKS-FDIECDMIKRIRHRNIIKII 354
            +G GG  +VY A      ++VA+K   +           F+ E     ++ H+NI+ +I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                DD   LV+EY+   +L      S+  L +   +N    +   +++ H    + I+
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREGQVST 473
           H D+KP N+L+D N    + DFG+AK L   + SLTQT   L T+ Y +PE  +      
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLLPISVMEIVDANLLSQKD 529
             D+YS GI+L E    + P    F G+    + +KH + D +P    ++     + Q  
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQSL 244

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQR-INAKEIVTRLLKIRDSLLKNVKR 580
                         N+ ++ T +    R    +E+   L  +      N   
Sbjct: 245 S-------------NVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV 283

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  142 bits (361), Expect = 8e-38
 Identities = 75/275 (27%), Positives = 118/275 (42%), Gaps = 26/275 (9%)

Query: 300 IGRGGFGSVYKARIQ-DGMEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           IGRG FG V+  R++ D   VAVK   +         F  E  ++K+  H NI+++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   N L+ +  V  +SDFGM++       + +       + + APE    G+ S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 478 YSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG 536
           +SFGI+L ETF+    P     + +++ +            E V+        E      
Sbjct: 299 WSFGILLWETFSLGASP-----YPNLSNQ---------QTREFVEKGGRLPCPEL----- 339

Query: 537 QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
            C   +F L  +C    P QR +   I   L  IR
Sbjct: 340 -CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  141 bits (357), Expect = 9e-38
 Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 18/210 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELD-SGGNKL------- 52
              L   +P  + +   L+ L+L  N L  ++P  +  L  L EL      +L       
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170

Query: 53  -DGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-----IGNLKV 106
                      L NL++L L    + S+P+++ NL+++  L + ++ L      I +L  
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPK 230

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFL-EYNRLQGSIPDSIGDLINLKSLNLSNNNL 165
           L ++DL         P   GG   L+ L L + + L  ++P  I  L  L+ L+L     
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVN 289

Query: 166 SGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
              +P  + +L     I V  +       +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  127 bits (322), Expect = 7e-33
 Identities = 45/206 (21%), Positives = 83/206 (40%), Gaps = 22/206 (10%)

Query: 7   SIPIAVGKLQKLQLLSLEDNQLEGSIPDDL--CRLAALFELDSGGNKLDGFVPACFGNLT 64
                       Q+ +     L+ +  D L          L+     L  F P     L+
Sbjct: 47  HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLS 104

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDLSMNNFSD 119
           +L+++ + +  L  +P T+     +  L L+ N L      I +L  L ++ +       
Sbjct: 105 HLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELT 164

Query: 120 VIPTTIG---------GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
            +P  +          GL +LQ L LE+  ++ S+P SI +L NLKSL + N+ LS  + 
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222

Query: 171 ISLEKLLDLKDINVS-FNKLEGEIPN 195
            ++  L  L+++++     L    P 
Sbjct: 223 PAIHHLPKLEELDLRGCTALR-NYPP 247

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  104 bits (261), Expect = 9e-25
 Identities = 33/198 (16%), Positives = 64/198 (32%), Gaps = 25/198 (12%)

Query: 15  LQKLQLLSLED-NQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
               + L  +    L     D L +    +  D               N  N +      
Sbjct: 11  SSGRENLYFQGSTALR-PYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65

Query: 74  NKLTSIPSTLWNLKDI--LYLDLSSNFLL-----IGNLKVLVQVDLSMNNFSDVIPTTIG 126
             L +    L +      + L+L S  L         L  L  + +      + +P T+ 
Sbjct: 66  RALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLME-LPDTMQ 124

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL---------EKLL 177
               L+ L L  N L+ ++P SI  L  L+ L++        +P  L         + L+
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183

Query: 178 DLKDINVSFNKLEGEIPN 195
           +L+ + + +  +   +P 
Sbjct: 184 NLQSLRLEWTGIR-SLPA 200

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 22/140 (15%), Positives = 43/140 (30%), Gaps = 9/140 (6%)

Query: 61  GNLTNLRNLYL-GSNKLTSIPSTLWNLKDILYLDLS--SNFLLIGNLKVLVQVDLSMNNF 117
            + +   NLY  GS  L      L   +     D +   +     N         +    
Sbjct: 9   HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRAL 68

Query: 118 SDVIPTTIGGLKD--LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
                  +          L L    L    PD    L +L+ + +    L   +P ++++
Sbjct: 69  KA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125

Query: 176 LLDLKDINVSFNKLEGEIPN 195
              L+ + ++ N L   +P 
Sbjct: 126 FAGLETLTLARNPLR-ALPA 144

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 2/84 (2%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLED-NQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
           G     + P   G    L+ L L+D + L  ++P D+ RL  L +LD  G      +P+ 
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTL 83
              L     + +  +    +    
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQHR 320

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (355), Expect = 1e-37
 Identities = 64/287 (22%), Positives = 109/287 (37%), Gaps = 40/287 (13%)

Query: 299 LIGRGGFGSVYKARIQD---GMEVAVKVFDLQYGR--AFKS-FDIECDMIKRIRHRNIIK 352
           L+GRGG G VY+A   D      VA+K+          F++    E     R++  +++ 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           I      D    + +  +    L   L      L   + + I+  + SAL+  H   +  
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREGQV 471
             H D+KP N+L+  +  A+L DFG+A      D+ LTQ    + T+ YMAPE   E   
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGD---MTLKHWVNDLLPISVMEIVDANLLSQK 528
           +   D+Y+   +L E  T   P    + GD   +   H    +   S    V   +    
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAHINQAIPRPST---VRPGIPVAF 265

Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQR-INAKEIVTRLLKIRDSL 574
           D               +  +   ++PE R +   ++         + 
Sbjct: 266 D--------------AVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (352), Expect = 2e-37
 Identities = 65/284 (22%), Positives = 108/284 (38%), Gaps = 43/284 (15%)

Query: 297 NNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL--QYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +  IGRG F +VYK    +  +EVA              + F  E +M+K ++H NI++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 354 ISSCSSDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
             S  S         LV E M  G+L K       ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 410 SVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEY 465
           + PIIH DLK  N+ +        + D G+A            +   A IG   +MAPE 
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAPEM 201

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL 525
             E     + DVY+FG+ ++E  T + P             +        +   V + + 
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYP-------------YSECQNAAQIYRRVTSGVK 247

Query: 526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
               +      +    I      C  ++ ++R + K+    LL 
Sbjct: 248 PASFDKVAIP-EVKEII----EGCIRQNKDERYSIKD----LLN 282

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  139 bits (352), Expect = 3e-37
 Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 38/291 (13%)

Query: 298 NLIGRGGFGSVYKARIQDG----MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIK 352
            +IGRG FG VY   + D     +  AVK  +          F  E  ++K   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 353 IISSCSSDDFKAL-VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 408
           ++  C   +   L VL YM HG L   + +  +   +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIGYMAPEYG 466
                +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA E  
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 467 REGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL 525
           +  + +T  DV+SFG++L E  TR   P     + D+             +   +     
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVN---------TFDITVYLLQGRR 250

Query: 526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK 576
             + E+      C   ++ + +KC     E R +  E+V+R+  I  + + 
Sbjct: 251 LLQPEY------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (356), Expect = 3e-37
 Identities = 81/380 (21%), Positives = 148/380 (38%), Gaps = 51/380 (13%)

Query: 222 PPCRTRIHHTSRKNDLLIGIVLPLST--IFMMAVILFILRYRKRGKPLPNDANMPRISNQ 279
           P      HH  R+  +  GI++P  +  +  +  I  +     +     N       +  
Sbjct: 6   PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVH 65

Query: 280 RRFTYL--EIFQATNGFSE---------NNLIGRGGFGSVYKARIQDG----MEVAVKVF 324
              + L  E+ QA               N +IGRG FG VY   + D     +  AVK  
Sbjct: 66  IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125

Query: 325 DLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL-VLEYMPHGSLEKCLYSS 382
           +          F  E  ++K   H N++ ++  C   +   L VL YM HG L   + + 
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185

Query: 383 NYILDIFQRLNIMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA 439
            +   +   +   + VA  +++L    F      +H DL   N +LD+     ++DFG+A
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 440 KPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDE 496
           + +  ++      +T A   + +MA E  +  + +T  DV+SFG++L E  TR   P   
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--- 296

Query: 497 IFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ 556
             + D+             +   +       + E+      C   ++ + +KC     E 
Sbjct: 297 --YPDVN---------TFDITVYLLQGRRLLQPEY------CPDPLYEVMLKCWHPKAEM 339

Query: 557 RINAKEIVTRLLKIRDSLLK 576
           R +  E+V+R+  I  + + 
Sbjct: 340 RPSFSELVSRISAIFSTFIG 359

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (352), Expect = 5e-37
 Identities = 61/315 (19%), Positives = 107/315 (33%), Gaps = 40/315 (12%)

Query: 262 KRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVA 320
           +R  P   D     ++ + +    E  +  +  +    +GRG FG V++ +  Q G + A
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87

Query: 321 VKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLY 380
           VK   L+          E      +    I+ +  +     +  + +E +  GSL + + 
Sbjct: 88  VKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142

Query: 381 SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMA 439
                L   + L  +      LEYLH   +  I+H D+K  NVLL  +   A L DFG A
Sbjct: 143 QMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

Query: 440 KPLLKEDQSLTQTQTLATIG---YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 496
             L  +    +        G   +MAPE           D++S   M++       P   
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP--- 255

Query: 497 IFFGDMTLKHWVNDLLPISVM-EIV-DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESP 554
                     W        +  +I  +   + +              I     +   + P
Sbjct: 256 ----------W-TQYFRGPLCLKIASEPPPIREIPPSCAPLTA--QAI----QEGLRKEP 298

Query: 555 EQRINAKEIVTRLLK 569
             R +A E    L +
Sbjct: 299 VHRASAME----LRR 309

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  138 bits (350), Expect = 6e-37
 Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 39/290 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR--AFKS-FDIECDMIKRIRHRNIIKII 354
           ++G GG   V+ AR ++D  +VAVKV      R  +F   F  E      + H  I+ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 355 SSCSSDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
            +  ++        +V+EY+   +L + +  +   +   + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH---Q 134

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREG 469
             IIH D+KP+N+++       + DFG+A+ +     S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD----MTLKHWVNDLLPISVMEIVDANLL 525
            V    DVYS G +L E  T + P    F GD    +  +H V +          +   L
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VREDPI-PPSARHEG--L 246

Query: 526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR-INAKEIVTRLLKIRDSL 574
           S   +              + +K   ++PE R   A E+   L+++ +  
Sbjct: 247 SADLD-------------AVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  136 bits (346), Expect = 8e-37
 Identities = 67/282 (23%), Positives = 117/282 (41%), Gaps = 36/282 (12%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           IG G FG V+     +  +VA+K           F     E +++ ++ H  ++++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPII 414
                  LV E+M HG L   L +   +      L + +DV   + YL           I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +PE     + S+ 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 475 GDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
            DV+SFG+++ E F+  K P     + + +            V+E +       K     
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP-----YENRSNS---------EVVEDISTGFRLYKPRL-- 229

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
                 + ++ +   C  E PE R     ++ +L +I +S L
Sbjct: 230 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  137 bits (348), Expect = 1e-36
 Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 46/295 (15%)

Query: 300 IGRGGFGSVYKARIQDG----MEVAVKV--FDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FGSV +  ++      ++VAVK    D    R  + F  E   +K   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 354 ISSCSSDDFKA-----LVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALE 403
           +  C     +      ++L +M +G L        L +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 404 YL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
           YL   +F      +H DL   N +L D+M   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           +A E   +   ++  DV++FG+ + E  TR   P     +  +             + + 
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-----YPGVQ---------NHEMYDY 261

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
           +      ++ E       C+  ++ +   C    P  R     +  +L K+ +SL
Sbjct: 262 LLHGHRLKQPED------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  137 bits (347), Expect = 2e-36
 Identities = 67/297 (22%), Positives = 127/297 (42%), Gaps = 49/297 (16%)

Query: 300 IGRGGFGSVYKARIQDG----MEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
           +G+G FGSV +A+++      ++VAVK+   D+      + F  E   +K   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 354 ISSCSSDDFKA------LVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMIDVASAL 402
           +        K       ++L +M HG L   L +S      + L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 403 EYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVME 518
           ++A E   +   + + DV++FG+ + E  TR + P     +  +             +  
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-----YAGIE---------NAEIYN 250

Query: 519 IVDA-NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
            +   N L Q  E       C+  +++L  +C    P+QR +   +   L  I   L
Sbjct: 251 YLIGGNRLKQPPE-------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (345), Expect = 4e-36
 Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 31/291 (10%)

Query: 300 IGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           +G+G FGSV   R        G  VAVK          + F+ E +++K ++H NI+K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 355 SSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
             C S   +   L++EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQ 470
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + APE   E +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 471 VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
            S   DV+SFG++L E FT  + +       M +         + V  ++          
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHLI---------- 273

Query: 531 HFTTKGQ-------CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                         C   I+ +  +C   +  QR + +++  R+ +IRD +
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (343), Expect = 4e-36
 Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 37/279 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           ++G+G +G VY  R + + + +A+K    +  R  +    E  + K ++H+NI++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLHFGYSVPIIH 415
           S + F  + +E +P GSL   L S    L   ++        +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 416 CDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPE--YGREGQV 471
            D+K  NVL++  + V  +SDFG +K L   +     T+T   T+ YMAPE         
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM-EIVDANLLSQKDE 530
               D++S G  ++E  T K P             +     P + M ++    +  +  E
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP-------------FYELGEPQAAMFKVGMFKVHPEIPE 249

Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
             + + +  +FI    +KC    P++R  A +    LL 
Sbjct: 250 SMSAEAK--AFI----LKCFEPDPDKRACAND----LLV 278

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (355), Expect = 5e-36
 Identities = 66/276 (23%), Positives = 127/276 (46%), Gaps = 30/276 (10%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIECDMIKRIRHRNIIKIISS 356
             +G+G FG V+         VA+K   L+ G     +F  E  ++K++RH  ++++ + 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
            S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H
Sbjct: 331 VSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL+ +N+L+ +N+V  ++DFG+A+ L+++++   +      I + APE    G+ +   
Sbjct: 387 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 476 DVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
           DV+SFGI+L E  T+ + P     +  M  +          V++ V+             
Sbjct: 446 DVWSFGILLTELTTKGRVP-----YPGMVNR---------EVLDQVERGYRMPCPPE--- 488

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
              C   + +L  +C  + PE+R   + +   L   
Sbjct: 489 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  135 bits (342), Expect = 5e-36
 Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 31/291 (10%)

Query: 300 IGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           +G+G FGSV   R        G  VAVK          + F+ E +++K ++H NI+K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 355 SSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
             C S   +   L++EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQ 470
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + APE   E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 471 VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
            S   DV+SFG++L E FT  + +       M +         + V  +++         
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHLIE--------- 243

Query: 531 HFTTKGQ-------CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                         C   I+ +  +C   +  QR + +++  R+ +IRD++
Sbjct: 244 -LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 6e-36
 Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 27/285 (9%)

Query: 300 IGRGGFGSVYKAR-----IQDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNII 351
           +G G FG V   R        G +VAVK   L+             E ++++ + H NI+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 352 KIISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           K    C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGR 467
           S   +H DL   NVL++      + DFG+ K  ++ D+     +      + + APE   
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 468 EGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN-LL 525
           + +     DV+SFG+ L E  T     +  +      +      +    ++  +     L
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262

Query: 526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                       C   ++ L  KC    P  R + + ++     +
Sbjct: 263 PCPPN-------CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (351), Expect = 6e-36
 Identities = 66/276 (23%), Positives = 127/276 (46%), Gaps = 30/276 (10%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFK-SFDIECDMIKRIRHRNIIKIISS 356
             +G+G FG V+         VA+K   L+ G     +F  E  ++K++RH  ++++ + 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
            S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H
Sbjct: 248 VSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL+ +N+L+ +N+V  ++DFG+A+ L+++++   +      I + APE    G+ +   
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 476 DVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
           DV+SFGI+L E  T+ + P     +  M  +          V++ V+             
Sbjct: 363 DVWSFGILLTELTTKGRVP-----YPGMVNR---------EVLDQVERGYRMPCPPE--- 405

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
              C   + +L  +C  + PE+R   + +   L   
Sbjct: 406 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  141 bits (358), Expect = 7e-36
 Identities = 53/287 (18%), Positives = 99/287 (34%), Gaps = 52/287 (18%)

Query: 299 LIGRGGFGSVYKAR--IQDGMEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNIIKIIS 355
            I  GG G +Y A     +G  V +K          ++    E   +  + H +I++I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 356 SCSSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                D        +V+EY+   SL++        L + + +  ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAPEYGREG 469
           + +++ DLKP N++L +  +  L D G           +        T G+ APE  R  
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR-T 251

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
             +   D+Y+ G  L                   +     D   +   +           
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT-----RNGRYVDGLPEDDPVLKTYDSYGR------- 299

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQR-INAKEIVTRLLKIRDSLL 575
                          L  +     P QR   A+E+  +L  +   ++
Sbjct: 300 ---------------LLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  134 bits (340), Expect = 9e-36
 Identities = 65/291 (22%), Positives = 110/291 (37%), Gaps = 42/291 (14%)

Query: 300 IGRGGFGSVYKAR----IQDGMEVAVKVF---DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG V +          + VAVK      L    A   F  E + +  + HRN+I+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 409
           +     +   K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAPEYGRE 468
               IH DL   N+LL    +  + DFG+ + L + D      +       + APE  + 
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 469 GQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN--LL 525
              S   D + FG+ L E FT  ++P     +  +             ++  +D     L
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQ---------ILHKIDKEGERL 244

Query: 526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK 576
            + ++       C   I+N+ ++C    PE R     +   LL+ + + ++
Sbjct: 245 PRPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  138 bits (349), Expect = 2e-35
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 32/278 (11%)

Query: 298 NLIGRGGFGSVYKARIQD-GMEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           + +G G +G VY+   +   + VAVK    D      F     E  ++K I+H N+++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLL 282

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPI 413
             C+ +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH +L   N L+ +N +  ++DFG+++ L+  D           I + APE     + S 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 474 NGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
             DV++FG++L E  T    P     +  + L           V E+++ +   ++ E  
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP-----YPGIDLS---------QVYELLEKDYRMERPEG- 443

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                C   ++ L   C   +P  R +  EI      +
Sbjct: 444 -----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  134 bits (339), Expect = 3e-35
 Identities = 62/288 (21%), Positives = 112/288 (38%), Gaps = 44/288 (15%)

Query: 300 IGRGGFGSVYKARIQDGME-----VAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNII 351
           +G G FG+VYK       E     VA+K   L+     +A K    E  ++  + + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 408
           +++  C +   + L+ + MP G L   +      +     LN  + +A  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
                +H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 469 GQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL-LS 526
              +   DV+S+G+ + E  T   KP     +  +             +  I++    L 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP-----YDGIPASE---------ISSILEKGERLP 239

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI-RDS 573
           Q          C   ++ +  KC +   + R   +E++    K+ RD 
Sbjct: 240 QPPI-------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  132 bits (335), Expect = 3e-35
 Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 36/279 (12%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           +G G FG V   + +   +VAVK+          F     E   + ++ H  ++K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPII 414
           S +    +V EY+ +G L   L S    L+  Q L +  DV   + +L    F      I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H DL   N L+D ++   +SDFGM +  + +DQ ++   T   + + APE     + S+ 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 475 GDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
            DV++FGI++ E F+  K P     +   T            V+  V       +     
Sbjct: 186 SDVWAFGILMWEVFSLGKMP-----YDLYTNS---------EVVLKVSQGHRLYRPHL-- 229

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD 572
                   I+ +   C  E PE+R   +++++ +  +R+
Sbjct: 230 ----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (336), Expect = 3e-35
 Identities = 58/279 (20%), Positives = 118/279 (42%), Gaps = 34/279 (12%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V   + +   +VA+K+  ++ G  +   F  E  ++  + H  ++++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPIIH 415
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    F      +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LH 143

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  PE     + S+  
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 476 DVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
           D+++FG+++ E ++  K P     +   T              E +   L   +      
Sbjct: 203 DIWAFGVLMWEIYSLGKMP-----YERFTNS---------ETAEHIAQGLRLYRPHL--- 245

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
                  ++ +   C  E  ++R   K +++ +L + D 
Sbjct: 246 ---ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  133 bits (336), Expect = 3e-35
 Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 42/292 (14%)

Query: 300 IGRGGFGSVYKARIQDG---MEVAVKVFDLQYGRAFKS---FDIECDMIKRIRHRNIIKI 353
           +G G FGSV +   +     ++VA+KV  L+ G           E  ++ ++ +  I+++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 410
           I  C ++    LV+E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAPEYGREG 469
              +H DL   NVLL +   A +SDFG++K L  +D   T        + + APE     
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 470 QVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN-LLSQ 527
           + S+  DV+S+G+ + E  +  +KP     +  M             VM  ++    +  
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP-----YKKMKGP---------EVMAFIEQGKRMEC 234

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVK 579
             E       C   ++ L   C +   E R +   +  R+     SL   V+
Sbjct: 235 PPE-------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (337), Expect = 3e-35
 Identities = 62/293 (21%), Positives = 122/293 (41%), Gaps = 38/293 (12%)

Query: 296 ENNLIGRGGFGSVYKARIQDG----MEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNI 350
            + +IG+G FG VY     D     ++ A+K    +   +  ++F  E  +++ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 351 IKIISSCSSDD-FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---H 406
           + +I      +    ++L YM HG L + + S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIGYMAPE 464
           F      +H DL   N +LD++    ++DFG+A+ +L  +             + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 465 YGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
             +  + +T  DV+SFG++L E  TR   P     +  +          P  +   +   
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP-----YRHID---------PFDLTHFLAQG 244

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK 576
               + E+      C   ++ +  +C    P  R   + +V  + +I  +LL 
Sbjct: 245 RRLPQPEY------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  139 bits (352), Expect = 6e-35
 Identities = 43/246 (17%), Positives = 81/246 (32%), Gaps = 36/246 (14%)

Query: 1   GNNLNGSIP--IAVGKLQKLQLLSLEDNQLEGSIPD-----DLCRLAALFELDSGGNKLD 53
            N L   IP       +  +  +    N++     +     D  +      +    N++ 
Sbjct: 628 HNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686

Query: 54  GFVPACFGNLTNLRNLYLGSNKLTSIPS--------TLWNLKDILYLDLSSNFL------ 99
            F    F   + +  + L +N +TSIP            N   +  +DL  N L      
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDD 746

Query: 100 -LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYL------FLEYNRLQGSIPDSIGDL 152
                L  L  +D+S N FS   PT       L+          E NR+    P  I   
Sbjct: 747 FRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805

Query: 153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL-EGEIPNKGPFRNFSTESFEGN- 210
            +L  L + +N++   +   L     L  ++++ N     ++ +  P+          + 
Sbjct: 806 PSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862

Query: 211 -ELLCG 215
            + + G
Sbjct: 863 TQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  130 bits (328), Expect = 6e-32
 Identities = 37/218 (16%), Positives = 69/218 (31%), Gaps = 27/218 (12%)

Query: 1   GNNLNG-SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            NNL       ++ K+ KL LL    N++     +       L +L    N+++      
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDF 614

Query: 60  FGNLTNLRNLYLGSNKLTSIPST--LWNLKDILYLDLSSN-----------FLLIGNLKV 106
                 +  L    NKL  IP+     ++  +  +D S N            +       
Sbjct: 615 CAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ-------GSIPDSIGDLINLKSLN 159
              V LS N               +  + L  N +             +  +   L +++
Sbjct: 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID 734

Query: 160 LSNNNLSGTIP--ISLEKLLDLKDINVSFNKLEGEIPN 195
           L  N L+ ++        L  L +++VS+N      P 
Sbjct: 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPT 770

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  125 bits (316), Expect = 2e-30
 Identities = 43/241 (17%), Positives = 82/241 (34%), Gaps = 41/241 (17%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIP--------------------------- 33
           G    G +P A+G+L +L++LS   +    S                             
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391

Query: 34  -DDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG--SNKLTSIPSTLWNLKDIL 90
            D   RL     L    N+     P    +  +L++  +G  +N++T I   +  L  + 
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQ 451

Query: 91  YLDLSSNFLLIGNLKV-LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI 149
            +  +++     N+ V     +       +    +   LKDL  + L        +PD +
Sbjct: 452 IIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511

Query: 150 GDLINLKSLNLSNNNLSG---------TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFR 200
            DL  L+SLN++ N              +    +    ++   + +N LE E P     +
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ 570

Query: 201 N 201
            
Sbjct: 571 K 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  119 bits (300), Expect = 2e-28
 Identities = 34/251 (13%), Positives = 76/251 (30%), Gaps = 38/251 (15%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +       + +    ++  LSL     +G +PD + +L  L  L  G +           
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 62  NLTNLRNLYLGSNKLTSI--PSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMN 115
                       +++        L   + +   DL  + +     +  +K   ++ L   
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 116 NFSDV------IPTTIGGLKDLQYLFLEYNRLQG-------------------SIPDSIG 150
              ++      I   I  L  LQ ++   +                       +   S  
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488

Query: 151 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN 210
           +L +L  + L N      +P  L  L +L+ +N++ N+       K  +   + +     
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD----- 543

Query: 211 ELLCGMPNLQV 221
                 P +Q+
Sbjct: 544 --EDTGPKIQI 552

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 68.4 bits (167), Expect = 4e-12
 Identities = 28/218 (12%), Positives = 60/218 (27%), Gaps = 20/218 (9%)

Query: 7   SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNL 66
           S  +   KL K   + ++  +    I D     A    LD    +          +  N 
Sbjct: 243 SFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN- 301

Query: 67  RNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIG 126
                            WN    L +      + + N   +  + L+       +P  IG
Sbjct: 302 -----------------WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVS 185
            L +L+ L    +    S      + +         + +      + L+    L   ++ 
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404

Query: 186 FNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPP 223
            + +    P   P +  S  S +  ++      +    
Sbjct: 405 QDAIN-RNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  132 bits (335), Expect = 9e-35
 Identities = 59/297 (19%), Positives = 122/297 (41%), Gaps = 42/297 (14%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G+G FG VY+   +          VA+K   +    R    F  E  ++K     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 353 IISSCSSDDFKALVLEYMPHGSL---------EKCLYSSNYILDIFQRLNIMIDVASALE 403
           ++   S      +++E M  G L                     + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
           E  ++G  +T  DV+SFG++L E  T  ++P     +  ++ +          V+  V  
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLSNEQ---------VLRFVME 255

Query: 523 -NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNV 578
             LL + D        C   +F L   C   +P+ R +  EI++ + +  +   + V
Sbjct: 256 GGLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  132 bits (335), Expect = 1e-34
 Identities = 70/291 (24%), Positives = 113/291 (38%), Gaps = 34/291 (11%)

Query: 300 IGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           +G+G FGSV   R        G  VAVK          + F  E  ++K +    I+K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 355 SSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
                   ++  LV+EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREGQ 470
            +H DL   N+L++      ++DFG+AK LL  D+     +      I + APE   +  
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 471 VSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
            S   DV+SFG++L E FT   K           +    +      ++E+++        
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-------- 258

Query: 530 EHFTTKGQ-------CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
                +GQ       C + +  L   C   SP+ R +   +  +L  +   
Sbjct: 259 -----EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  132 bits (334), Expect = 1e-34
 Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 25/286 (8%)

Query: 300 IGRGGFGSVYKARIQD-----GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG V            G  VAVK      G +    +  E D+++ + H +IIK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 354 ISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
              C      +  LV+EY+P GSL   L   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREG 469
             IH DL   NVLLD++ +  + DFG+AK  + E     + +      + + APE  +E 
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS-VMEIVDAN-LLSQ 527
           +     DV+SFG+ L E  T    +       + L       + +  + E+++    L +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
            D+       C + +++L   C       R   + ++  L  + + 
Sbjct: 273 PDK-------CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (341), Expect = 1e-34
 Identities = 62/275 (22%), Positives = 126/275 (45%), Gaps = 28/275 (10%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
             +G G FG V+ A      +VAVK        + ++F  E +++K ++H  ++K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
           + +    ++ E+M  GSL   L S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           DL+ +N+L+  ++V  ++DFG+A+ ++++++   +      I + APE    G  +   D
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 477 VYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           V+SFGI+LME  T  + P     +  M+            V+  ++      + E+    
Sbjct: 368 VWSFGILLMEIVTYGRIP-----YPGMSNP---------EVIRALERGYRMPRPEN---- 409

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
             C   ++N+ M+C    PE+R   + I + L   
Sbjct: 410 --CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  134 bits (338), Expect = 3e-34
 Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 34/280 (12%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIK 352
           F   +++G G  G++    + D  +VAVK    +    F   D E  +++    H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
              +     F+ + +E     +L++ +   ++     + + ++    S L +LH   S+ 
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 413 IIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEY- 465
           I+H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++APE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 466 --GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
               +   +   D++S G +     +         FG                  ++ A 
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH----PFGKSL---------QRQANILLGAC 245

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
            L                I     K     P++R +AK +
Sbjct: 246 SLDCLHPEKHEDVIARELI----EKMIAMDPQKRPSAKHV 281

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (331), Expect = 4e-34
 Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 46/294 (15%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYL- 405
            I        + +++E M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 406 --HFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
             HF      IH D+   N LL       VA + DFGMA+ + +          +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           M PE   EG  ++  D +SFG++L E F+    P     +   + +          V+E 
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-----YPSKSNQE---------VLEF 257

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
           V +       ++      C   ++ +  +C    PE R N   I+ R+      
Sbjct: 258 VTSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (328), Expect = 4e-34
 Identities = 65/287 (22%), Positives = 121/287 (42%), Gaps = 42/287 (14%)

Query: 300 IGRGGFGSVYKARIQDG---MEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           +G G FG+V K   Q       VAVK+   +            E ++++++ +  I+++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 411
             C ++ +  LV+E    G L K L  + + +     + ++  V+  ++YL   +F    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAPEYGREG 469
             +H DL   NVLL     A +SDFG++K  L+ D++  + QT     + + APE     
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 470 QVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL-LSQ 527
           + S+  DV+SFG+++ E F+  +KP     +  M             V  +++    +  
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP-----YRGMKGS---------EVTAMLEKGERMGC 241

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                     C   +++L   C     E R     +  RL      +
Sbjct: 242 PAG-------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (334), Expect = 4e-34
 Identities = 59/281 (20%), Positives = 111/281 (39%), Gaps = 39/281 (13%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRH--RNIIKI 353
             IG GG   V++   +     A+K  +L+    +   S+  E   + +++     II++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                +D +  +V+E   +  L   L      +D ++R +   ++  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--------- 464
           +H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   +  + YM PE         
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 465 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
                + ++S   DV+S G +L      K P  +I      L   ++    I   +I + 
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295

Query: 523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                              +      C    P+QRI+  E+
Sbjct: 296 --------------DLQDVL----KCCLKRDPKQRISIPEL 318

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  130 bits (330), Expect = 4e-34
 Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 39/281 (13%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRN--IIKI 353
             IG GG   V++   +     A+K  +L+    +   S+  E   + +++  +  II++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                +D +  +V+E   +  L   L      +D ++R +   ++  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--------- 464
           +H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 465 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
                + ++S   DV+S G +L      K P  +I      L   ++    I   +I + 
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 267

Query: 523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                              +      C    P+QRI+  E+
Sbjct: 268 --------------DLQDVL----KCCLKRDPKQRISIPEL 290

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (330), Expect = 5e-34
 Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 33/279 (11%)

Query: 300 IGRGGFGSVYKARIQDGME-----VAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKI 353
           +G G FG+V+K       E     V +KV + + G ++F++       I  + H +I+++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           +  C     + LV +Y+P GSL   +      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           +H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA E    G+ + 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 474 NGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL-LSQKDEH 531
             DV+S+G+ + E  T   +P     +  + L           V ++++    L+Q    
Sbjct: 197 QSDVWSYGVTVWELMTFGAEP-----YAGLRLAE---------VPDLLEKGERLAQPQI- 241

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                 C   ++ + +KC +     R   KE+     ++
Sbjct: 242 ------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (336), Expect = 6e-34
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 34/279 (12%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 360 DDFKA-LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 478 YSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG 536
           +SFGI+L E ++  + P     +  + LK          V+  V+        +      
Sbjct: 370 WSFGILLWEIYSFGRVP-----YPRIPLKD---------VVPRVEKGYKMDAPDG----- 410

Query: 537 QCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL 575
            C   ++++   C       R    ++  +L  IR   L
Sbjct: 411 -CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (330), Expect = 7e-34
 Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 39/281 (13%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRH--RNIIKI 353
             IG GG   V++   +     A+K  +L+    +   S+  E   + +++     II++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                +D +  +V+E   +  L   L      +D ++R +   ++  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--------- 464
           +H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 465 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA 522
                + ++S   DV+S G +L      K P  +I      L   ++    I   +I + 
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 248

Query: 523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                              +      C    P+QRI+  E+
Sbjct: 249 --------------DLQDVL----KCCLKRDPKQRISIPEL 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (340), Expect = 1e-33
 Identities = 66/292 (22%), Positives = 120/292 (41%), Gaps = 42/292 (14%)

Query: 300 IGRGGFGSVYKARIQDG---MEVAVKVFDLQYGRAFKS---FDIECDMIKRIRHRNIIKI 353
           +G G FGSV +   +     ++VA+KV  L+ G           E  ++ ++ +  I+++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 410
           I  C ++    LV+E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAPEYGREG 469
              +H +L   NVLL +   A +SDFG++K L  +D   T        + + APE     
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 470 QVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL-LSQ 527
           + S+  DV+S+G+ + E  +  +KP     +  M             VM  ++    +  
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP-----YKKMKGP---------EVMAFIEQGKRMEC 560

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVK 579
             E       C   ++ L   C +   E R +   +  R+     SL   V+
Sbjct: 561 PPE-------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (326), Expect = 1e-33
 Identities = 62/294 (21%), Positives = 108/294 (36%), Gaps = 45/294 (15%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            +G GGF  V     + DG   A+K       +  +    E DM +   H NI+++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 358 SSDDFKA----LVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYS 410
             +        L+L +   G+L   +         L   Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-------TIGYMAP 463
               H DLKP+N+LL D     L D G         +   Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 464 E------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM 517
           E      +    + +   DV+S G +L      + P D +F    ++             
Sbjct: 213 ELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----------- 258

Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
             V   L   +    ++       ++ L        P QR +   ++++L  ++
Sbjct: 259 -AVQNQLSIPQSPRHSSA------LWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 1e-33
 Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 73/310 (23%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNII 351
           +G G FG V+ A        +D M VAVK   L+     A K F  E +++  ++H +I+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 352 KIISSCSSDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNIMI 396
           K    C   D   +V EYM HG L               +     +   L + Q L+I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 397 DVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
            +AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       
Sbjct: 141 QIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP 513
           T+  I +M PE     + +T  DV+SFG++L E FT         +G            P
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------YGKQ----------P 235

Query: 514 ---ISVMEIVDANLLSQKDEHFTTKGQ-------CVSFIFNLAMKCTVESPEQRINAKEI 563
              +S  E++             T+G+       C   ++++ + C    P+QR+N KEI
Sbjct: 236 WFQLSNTEVI----------ECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

Query: 564 VTRLLKIRDS 573
              L  +  +
Sbjct: 286 YKILHALGKA 295

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (328), Expect = 2e-33
 Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 46/294 (15%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG VY+ ++         ++VAVK   ++   +    F +E  +I +  H+NI++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYL- 405
            I        + ++LE M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 406 --HFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
             HF      IH D+   N LL       VA + DFGMA+ + +          +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 461 MAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           M PE   EG  ++  D +SFG++L E F+    P     +   + +          V+E 
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-----YPSKSNQE---------VLEF 298

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
           V +       ++      C   ++ +  +C    PE R N   I+ R+      
Sbjct: 299 VTSGGRMDPPKN------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  128 bits (323), Expect = 4e-33
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 40/283 (14%)

Query: 300 IGRGGFGSVYKARIQDG----MEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIK 352
           IG G  G V   R++      + VA+K   L+ G   R  + F  E  ++ +  H NII+
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 409
           +    +      +V EYM +GSL+  L + +    I Q + ++  V + + YL    +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGRE 468
               +H DL   NVL+D N+V  +SDFG+++ L    D + T T     I + APE    
Sbjct: 173 ----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 469 GQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
              S+  DV+SFG+++ E     ++P     + +MT +          V+  V+      
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP-----YWNMTNR---------DVISSVEEGYRLP 274

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                     C   +  L + C  +   QR    +IV+ L  +
Sbjct: 275 APMG------CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  126 bits (320), Expect = 4e-33
 Identities = 61/286 (21%), Positives = 112/286 (39%), Gaps = 43/286 (15%)

Query: 300 IGRGGFGSVYKARIQDG----MEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIK 352
           IG G FG V++          + VA+K    +        + F  E   +++  H +I+K
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 409
           +I   + +    +++E    G L   L    Y LD+   +     +++AL YL    F  
Sbjct: 81  LIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF-- 137

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
               +H D+   NVL+  N    L DFG+++  +++      ++    I +MAPE     
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 470 QVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA-NLLSQ 527
           + ++  DV+ FG+ + E      KP     F  +             V+  ++    L  
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP-----FQGVKNN---------DVIGRIENGERLPM 238

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
                     C   +++L  KC    P +R    E+  +L  I + 
Sbjct: 239 PPN-------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (320), Expect = 4e-33
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 32/276 (11%)

Query: 300 IGRGGFGSVYKARIQDG-MEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G G +G VY+   +   + VAVK    D      F     E  ++K I+H N+++++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           C+ +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   N L+ +N +  ++DFG+++ L+  D           I + APE     + S   
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193

Query: 476 DVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
           DV++FG++L E  T    P     +  + L           V E+++ +   ++ E    
Sbjct: 194 DVWAFGVLLWEIATYGMSP-----YPGIDLS---------QVYELLEKDYRMERPEG--- 236

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
              C   ++ L   C   +P  R +  EI      +
Sbjct: 237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (320), Expect = 5e-33
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 34/279 (12%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
             IG+G FG V     + G +VAVK   ++     ++F  E  ++ ++RH N+++++   
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 358 SSDDFKA-LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
             +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 476 DVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
           DV+SFGI+L E ++  + P     +  + LK          V+  V+        +    
Sbjct: 196 DVWSFGILLWEIYSFGRVP-----YPRIPLKD---------VVPRVEKGYKMDAPDG--- 238

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              C   ++ +   C       R +  ++  +L  I+  
Sbjct: 239 ---CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (319), Expect = 6e-33
 Identities = 59/283 (20%), Positives = 115/283 (40%), Gaps = 43/283 (15%)

Query: 300 IGRGGFGSVYKARIQDG----MEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG VY+    +     + VAVK    +        + F  E  ++K + H +I+K
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 409
           +I     +    +++E  P+G L   L  +   L +   +   + +  A+ YL   +   
Sbjct: 78  LIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
               +H D+   N+L+       L DFG+++  ++++     + T   I +M+PE     
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 470 QVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN-LLSQ 527
           + +T  DV+ F + + E  +  K+P     F  +  K          V+ +++    L +
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP-----FFWLENKD---------VIGVLEKGDRLPK 235

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
            D        C   ++ L  +C    P  R    E+V  L  +
Sbjct: 236 PDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  127 bits (321), Expect = 6e-33
 Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 29/289 (10%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVK---VFDLQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            IGRG F  VY+A  + DG+ VA+K   +FDL   +A      E D++K++ H N+IK  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLHFGYSV 411
           +S   D+   +VLE    G L + +        +          + + SALE++H   S 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            ++H D+KP+NV +    V  L D G+ +       +   +    T  YM+PE   E   
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-GTPYYMSPERIHENGY 213

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
           +   D++S G +L E    + P    F+GD        +L  +   +I   +      +H
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP----FYGDKM------NLYSL-CKKIEQCDYPPLPSDH 262

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVKR 580
           ++ + +       L   C    PE+R +   +     ++      +++ 
Sbjct: 263 YSEELR------QLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  127 bits (322), Expect = 7e-33
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 56/301 (18%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNII 351
           +G G FG V+ A   +       M VAVK   L+     A + F  E +++  ++H++I+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQHIV 106

Query: 352 KIISSCSSDDFKALVLEYMPHGSL--------------EKCLYSSNYILDIFQRLNIMID 397
           +    C+      +V EYM HG L                    +   L + Q L +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 398 VASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
           VA+ + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T
Sbjct: 167 VAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLP 513
           +  I +M PE     + +T  DV+SFG++L E FT  K+P     +  ++          
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----WYQLSNTE------- 268

Query: 514 ISVMEIVDA-NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD 572
              ++ +     L +          C   ++ +   C    P+QR + K++  RL  +  
Sbjct: 269 --AIDCITQGRELERPRA-------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319

Query: 573 S 573
           +
Sbjct: 320 A 320

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (318), Expect = 7e-33
 Identities = 63/275 (22%), Positives = 125/275 (45%), Gaps = 32/275 (11%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           +G G FG V+        +VAVK          AF +   E +++K+++H+ ++++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
           + +    ++ EYM +GSL   L + +   L I + L++   +A  + ++        IH 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           DL+ +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +   D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 477 VYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           V+SFGI+L E  T  + P     +  MT            V++ ++      + ++    
Sbjct: 193 VWSFGILLTEIVTHGRIP-----YPGMTNP---------EVIQNLERGYRMVRPDN---- 234

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
             C   ++ L   C  E PE R     + + L   
Sbjct: 235 --CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  127 bits (321), Expect = 1e-32
 Identities = 70/284 (24%), Positives = 132/284 (46%), Gaps = 41/284 (14%)

Query: 300 IGRGGFGSVYKARIQDG-----MEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNII 351
           IG G FG VYK  ++       + VA+K   L+ G   +    F  E  ++ +  H NII
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 408
           ++    S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL   ++ 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY- 168

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-TLATIGYMAPEYGR 467
                +H DL   N+L++ N+V  +SDFG+++ L  + ++   T      I + APE   
Sbjct: 169 -----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 468 EGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
             + ++  DV+SFGI++ E  T  ++P     + +++            VM+ ++     
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP-----YWELSNH---------EVMKAINDGFRL 269

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                      C S I+ L M+C  +   +R    +IV+ L K+
Sbjct: 270 PTPMD------CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  127 bits (322), Expect = 1e-32
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 15/194 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            + +    PI    L  L  LSL  NQ+E   P  L  L +L    +  N++    P   
Sbjct: 164 ESKVKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--V 217

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNN 116
            N+T L +L +G+NK+T +   L NL  + +L++ +N +     + +L  L  +++  N 
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQ 276

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            SD+    +  L  L  LFL  N+L     + IG L NL +L LS N+++   P++   L
Sbjct: 277 ISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SL 332

Query: 177 LDLKDINVSFNKLE 190
             +   + +   ++
Sbjct: 333 SKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (307), Expect = 1e-30
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 13/198 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           G N N S    +  +  L  L++ +++++   P  +  L  L+ L    N+++   P   
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--L 195

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
            +LT+L       N++T I   + N+  +  L + +N +     + NL  L  +++  N 
Sbjct: 196 ASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQ 254

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            SD+    +  L  L+ L +  N++  S    + +L  L SL L+NN L       +  L
Sbjct: 255 ISDINA--VKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310

Query: 177 LDLKDINVSFNKLEGEIP 194
            +L  + +S N +    P
Sbjct: 311 TNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (306), Expect = 1e-30
 Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 22/229 (9%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN +    P+    L KL  L +  N++  +    L  L  L EL    + +    P   
Sbjct: 75  GNQITDISPL--SNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--L 128

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
            NLT + +L LG+N   S  S L N+  + YL ++ + +     I NL  L  + L+ N 
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQ 188

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
             D+ P  +  L  L Y     N++    P  + ++  L SL + NN ++   P  L  L
Sbjct: 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANL 242

Query: 177 LDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQ 220
             L  + +  N++   I            +   N++     L  +  L 
Sbjct: 243 SQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDISVLNNLSQLN 290

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  111 bits (279), Expect = 7e-27
 Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 22/230 (9%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
              +N   P A   L +     L+   +   +      L ++ +L   G K+        
Sbjct: 9   PAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--I 62

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNN 116
             LTNL  L L  N++T I   L NL  +  L + +N +     + NL  L ++ L+ +N
Sbjct: 63  EYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDN 121

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            SD+ P  +  L  +  L L  N    S    + ++  L  L ++ + +    PI+   L
Sbjct: 122 ISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIA--NL 176

Query: 177 LDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQV 221
            DL  +++++N++E  I       +    +   N++     +  M  L  
Sbjct: 177 TDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITPVANMTRLNS 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  128 bits (323), Expect = 1e-32
 Identities = 66/283 (23%), Positives = 128/283 (45%), Gaps = 40/283 (14%)

Query: 300 IGRGGFGSVYKARIQ----DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG V   R++      + VA+K   L+ G   +  + F  E  ++ +  H NII+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 409
           +    +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL    +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGRE 468
               +H DL   N+L++ N+V  +SDFG+ + L    + + T       I + +PE    
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 469 GQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
            + ++  DV+S+GI+L E  +  ++P     + +M+ +          V++ VD      
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQ---------DVIKAVDEGYRLP 270

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                     C + ++ L + C  +    R   ++IV+ L K+
Sbjct: 271 PPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (320), Expect = 1e-32
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 43/284 (15%)

Query: 300 IGRGGFGSVYKARIQDGME-----VAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNII 351
           +G G FG+VYK       E     VA+K   L+     +A K    E  ++  + + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 408
           +++  C +   + L+ + MP G L   +      +     LN  + +A  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
                +H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 469 GQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL-LS 526
              +   DV+S+G+ + E  T   KP     +  +             +  I++    L 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP-----YDGIPASE---------ISSILEKGERLP 239

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           Q          C   ++ + +KC +   + R   +E++    K+
Sbjct: 240 QPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  130 bits (329), Expect = 3e-32
 Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 14/209 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLD--GFVP 57
            N       I+      L  LS++ N     +    L  L  L ELD   + ++      
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

Query: 58  ACFGNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSNFL-------LIGNLKVLVQ 109
               NL++L++L L  N+  S+ +  +     +  LDL+   L          NL +L  
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI---PDSIGDLINLKSLNLSNNNLS 166
           ++LS +           GL  LQ+L L+ N          +S+  L  L+ L LS  +LS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

Query: 167 GTIPISLEKLLDLKDINVSFNKLEGEIPN 195
                +   L  +  +++S N+L      
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (322), Expect = 2e-31
 Identities = 51/244 (20%), Positives = 94/244 (38%), Gaps = 24/244 (9%)

Query: 1   GNNLNGSIPIAVG--KLQKLQLLSLEDNQLEGSIPDDLCRLAA--LFELDSGGNKLDGFV 56
           G      I   +    +Q L L + ED   E   P     L    +  ++   +      
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 57  PACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQV 110
              F   + L+ L L +  L+ +PS L  L  +  L LS+N           N   L  +
Sbjct: 271 SNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330

Query: 111 DLSMNNFSDVIPT-TIGGLKDLQYLFLEYNRLQGS--IPDSIGDLINLKSLNLSNNNLSG 167
            +  N     + T  +  L++L+ L L ++ ++ S      + +L +L+SLNLS N    
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390

Query: 168 TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS--TE--------SFEGNELLCGMP 217
               + ++   L+ ++++F +L+     + PF+N                   +L  G+P
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

Query: 218 NLQV 221
            LQ 
Sbjct: 450 ALQH 453

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  125 bits (317), Expect = 1e-30
 Identities = 49/209 (23%), Positives = 75/209 (35%), Gaps = 15/209 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFV-PAC 59
             +L+  +P  +  L  L+ L L  N+ E           +L  L   GN     +   C
Sbjct: 287 ATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345

Query: 60  FGNLTNLRNLYLGSNKLTSIPS---TLWNLKDILYLDLSSNFL------LIGNLKVLVQV 110
             NL NLR L L  + + +       L NL  +  L+LS N               L  +
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405

Query: 111 DLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           DL+          +    L  L+ L L ++ L  S       L  L+ LNL  N+     
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465

Query: 170 PI---SLEKLLDLKDINVSFNKLEGEIPN 195
                SL+ L  L+ + +SF  L     +
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQH 494

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  123 bits (312), Expect = 4e-30
 Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 19/234 (8%)

Query: 1   GNNLNGS--IPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVP- 57
            +++  S    + +  L  LQ L+L  N+      +       L  LD    +L      
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418

Query: 58  ACFGNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSNFL---------LIGNLKVL 107
           + F NL  L+ L L  + L      L+  L  + +L+L  N            +  L  L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478

Query: 108 VQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG 167
             + LS  + S +       LK + ++ L +NRL  S  +++  L  +  LNL++N++S 
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISI 537

Query: 168 TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTES----FEGNELLCGMP 217
            +P  L  L   + IN+  N L+    N   F  +  E+     +  + LC  P
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDCTCSNI-YFLEWYKENMQKLEDTEDTLCENP 590

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  122 bits (309), Expect = 1e-29
 Identities = 43/244 (17%), Positives = 78/244 (31%), Gaps = 26/244 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
              ++    I +   + L+ L L  N +             L  LD   N +        
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 61  GNLTNLRNLYL--GSNKLTSIPSTLWNLKDILYLDLSSNFLLIG--------NLKVLVQV 110
            +L    NL L    N +  I    ++      L+      L+          ++ L   
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233

Query: 111 DLSMNNFSDVIPTTIGGLKD--LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGT 168
                +  D+ P    GL +  ++ + L+ +       ++      L+ L+L+  +LS  
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-E 292

Query: 169 IPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFST-----------ESFEGNELLCGMP 217
           +P  L  L  LK + +S NK E          NF +               G   L  + 
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQIS--ASNFPSLTHLSIKGNTKRLELGTGCLENLE 350

Query: 218 NLQV 221
           NL+ 
Sbjct: 351 NLRE 354

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  118 bits (297), Expect = 4e-28
 Identities = 42/207 (20%), Positives = 70/207 (33%), Gaps = 12/207 (5%)

Query: 21  LSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP 80
            + E+  L   IP  L    +   L+   N L       F  L NL  L L   ++  I 
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 81  S-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQY 133
             T  +   +  L L++N L       +   K L  +       S +    +   K L+ 
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 134 LFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL--LDLKDINVSFNKLEG 191
           L+L  N +             LK L+  NN +       +  L       +N++ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 192 EIPNKGPFRNFSTESFEGNELLCGMPN 218
             P       F + +F G + L  +  
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFK 220

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 38/192 (19%), Positives = 65/192 (33%), Gaps = 25/192 (13%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSI---PDDLCRLAALFELDSGGNKLDGFVP 57
            + L+ S       L  LQ L+L+ N          + L  L  L  L      L     
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493

Query: 58  ACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNF 117
             F +L  + ++ L  N+LTS      +    +YL+L+S                  N+ 
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS------------------NHI 535

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           S ++P+ +  L   + + L  N L  +   S    +       +   L  T     E   
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTC--SNIYFLEW--YKENMQKLEDTEDTLCENPP 591

Query: 178 DLKDINVSFNKL 189
            L+ + +S   L
Sbjct: 592 LLRGVRLSDVTL 603

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  126 bits (319), Expect = 3e-32
 Identities = 45/199 (22%), Positives = 87/199 (43%), Gaps = 9/199 (4%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIIS 355
            IG G FG     +  +DG +  +K  ++     +  +    E  ++  ++H NI++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 356 SCSSDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
           S   +    +V++Y   G L ++       +    Q L+  + +  AL+++H      I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
           H D+K  N+ L  +    L DFG+A+ +L     L +     T  Y++PE       +  
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSPEICENKPYNNK 205

Query: 475 GDVYSFGIMLMETFTRKKP 493
            D+++ G +L E  T K  
Sbjct: 206 SDIWALGCVLYELCTLKHA 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  125 bits (316), Expect = 6e-32
 Identities = 69/309 (22%), Positives = 120/309 (38%), Gaps = 62/309 (20%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           IG G FG V++AR            VAVK+  +         F  E  ++    + NI+K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----------------------EKCLYSSNYILDIF 389
           ++  C+      L+ EYM +G L                        +        L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 390 QRLNIMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED 446
           ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLK 505
                      I +M PE     + +T  DV+++G++L E F+   +P     +  M  +
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-----YYGMAHE 283

Query: 506 HWVNDLLPISVME-IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                     V+  + D N+L+  +        C   ++NL   C  + P  R +   I 
Sbjct: 284 E---------VIYYVRDGNILACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIH 327

Query: 565 TRLLKIRDS 573
             L ++ + 
Sbjct: 328 RILQRMCER 336

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  128 bits (325), Expect = 8e-32
 Identities = 44/232 (18%), Positives = 70/232 (30%), Gaps = 17/232 (7%)

Query: 1   GNNLNGSIPIAV--GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA 58
            N L+ S   +        L+ L L  N     +  +   L  L  LD   + L      
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF 417

Query: 59  -CFGNLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFLL-------IGNLKVLVQ 109
             F +L  L  L +               L  +  L ++ N            N   L  
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           +DLS      +       L  LQ L + +N L          L +L +L+ S N +  + 
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537

Query: 170 PISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTES----FEGNELLCGMP 217
            I       L   N++ N +   I     F  +  E         ++ C  P
Sbjct: 538 GILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATP 588

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  122 bits (308), Expect = 1e-29
 Identities = 44/240 (18%), Positives = 83/240 (34%), Gaps = 19/240 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
              L+  +P  +      + + L  N L+          + L  LD    +++      +
Sbjct: 20  DQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76

Query: 61  GNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS 113
             L +L NL L  N + S  P +   L  +  L      L       IG L  L +++++
Sbjct: 77  HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA 136

Query: 114 MNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK----SLNLSNNNLSGT 168
            N      +P     L +L ++ L YN +Q    + +  L        SL++S N +   
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195

Query: 169 IPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS--TESFEGNELLCGMPNLQVPPCRT 226
           I     + + L ++ +  N     I  K   +N +                NL++     
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIM-KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  119 bits (300), Expect = 2e-28
 Identities = 56/226 (24%), Positives = 81/226 (35%), Gaps = 18/226 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L      +     +LQ L L   ++E         L  L  L   GN +  F P  F
Sbjct: 41  FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100

Query: 61  GNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDL 112
             LT+L NL     KL S+ S  +  L  +  L+++ NF+          NL  LV VDL
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160

Query: 113 SMNNFSDVIPTTIGGLKDL----QYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGT 168
           S N    +    +  L++       L +  N +   I D     I L  L L  N  S  
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSN 219

Query: 169 IP-ISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL 213
           I    L+ L  L    +   + + E   +     F     EG   +
Sbjct: 220 IMKTCLQNLAGLHVHRLILGEFKDERNLE----IFEPSIMEGLCDV 261

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  115 bits (289), Expect = 4e-27
 Identities = 45/222 (20%), Positives = 76/222 (34%), Gaps = 20/222 (9%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
              +      A   L  L  L L  N ++   P     L +L  L +   KL        
Sbjct: 65  RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124

Query: 61  GNLTNLRNLYLGSNKLTSI--PSTLWNLKDILYLDLSSNFL----------LIGNLKVLV 108
           G L  L+ L +  N + S   P+   NL +++++DLS N++          L  N +V +
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184

Query: 109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNLSG 167
            +D+S+N    +      G+K L  L L  N    +I    + +L  L    L       
Sbjct: 185 SLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

Query: 168 TIPIS------LEKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
              +       +E L D+               +   F   +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  104 bits (261), Expect = 1e-23
 Identities = 37/156 (23%), Positives = 58/156 (37%), Gaps = 10/156 (6%)

Query: 54  GFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVL 107
           G +  C   + N+        KL+ +P  +        +DLS N L         N   L
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSEL 58

Query: 108 VQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG 167
             +DLS      +      GL  L  L L  N +Q   P S   L +L++L      L+ 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 168 TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
                + +L+ LK +NV+ N +         F N +
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.3 bits (222), Expect = 8e-19
 Identities = 39/206 (18%), Positives = 64/206 (31%), Gaps = 21/206 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFELD------SGGNKLD 53
             N    I     +  KL  L+L  N    +I     + LA L               L+
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248

Query: 54  GFVPACFGNLTNLR--NLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFL----LIGNLKV 106
            F P+    L ++      L      S        L ++  + L+   +     +     
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
              + +               L  L+ L L  N+   SI      L +L  L+LS N LS
Sbjct: 309 WQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALS 363

Query: 167 GTIPISLE--KLLDLKDINVSFNKLE 190
            +   S        L+ +++SFN   
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI 389

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (311), Expect = 9e-32
 Identities = 56/302 (18%), Positives = 111/302 (36%), Gaps = 69/302 (22%)

Query: 300 IGRGGFGSVYKARIQD--------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNII 351
           +G+G F  ++K   ++          EV +KV D  +    +SF     M+ ++ H++++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 408
                C   D   LV E++  GSL+  L  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 409 YSVPIIHCDLKPSNVLLD--------DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 460
                IH ++   N+LL         +     LSD G++  +L +D           I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPW 183

Query: 461 MAPE---YGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISV 516
           + PE     +   ++   D +SFG  L E  +   KP        +  +           
Sbjct: 184 VPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP-----LSALDSQ---------RK 227

Query: 517 MEIVDANLLSQKDEHFTTKGQ-----CVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
           ++  +                       + + NL   C    P+ R + + I+  L  + 
Sbjct: 228 LQFYE-------------DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

Query: 572 DS 573
             
Sbjct: 275 TP 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (311), Expect = 9e-32
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 28/218 (12%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F E  LIG GGFG V+KA+   DG    +K       +A +    E   + ++ H NI+ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68

Query: 353 IISSCSSDDFKA----------------LVLEYMPHGSLEKCL-YSSNYILDIFQRLNIM 395
                   D+                  + +E+   G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L        +T++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSK 182

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
            T+ YM+PE           D+Y+ G++L E       
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (310), Expect = 1e-31
 Identities = 66/302 (21%), Positives = 127/302 (42%), Gaps = 58/302 (19%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNI 350
           +G   FG VYK  +           VA+K   L+        + F  E  +  R++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 351 IKIISSCSSDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNIM 395
           + ++   + D   +++  Y  HG L                    +    L+    ++++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 396 IDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
             +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D      
Sbjct: 135 AQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDL 511
            +L  I +MAPE    G+ S + D++S+G++L E F+   +P     +   + +      
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----YCGYSNQD----- 238

Query: 512 LPISVMEIVDA-NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
               V+E++    +L   D+       C ++++ L ++C  E P +R   K+I +RL   
Sbjct: 239 ----VVEMIRNRQVLPCPDD-------CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

Query: 571 RD 572
            +
Sbjct: 288 GN 289

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  125 bits (317), Expect = 3e-31
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 23/229 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN +    P+    L  L+ L +  N++  S    L +L  L  L +  N++    P   
Sbjct: 164 GNQVTDLKPL--ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--L 217

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
           G LTNL  L L  N+L  I + L +L ++  LDL++N +     +  L  L ++ L  N 
Sbjct: 218 GILTNLDELSLNGNQLKDIGT-LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQ 276

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            S++ P  + GL  L  L L  N+L+   P  I +L NL  L L  NN+S   P+S   L
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SL 330

Query: 177 LDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQ 220
             L+ +    NK+   + +     N +  S   N++     L  +  + 
Sbjct: 331 TKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLTPLANLTRIT 378

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  116 bits (294), Expect = 3e-28
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 22/229 (9%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L    P+    L KL  + + +NQ+    P  L  L  L  L    N++    P   
Sbjct: 77  NNQLTDITPL--KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 130

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLI---GNLKVLVQVDLSMNNF 117
            NLTNL  L L SN ++ I + L  L  +  L   +    +    NL  L ++D+S N  
Sbjct: 131 KNLTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 189

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           SD+    +  L +L+ L    N++    P  +G L NL  L+L+ N L      +L  L 
Sbjct: 190 SDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLT 243

Query: 178 DLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQV 221
           +L D++++ N++   +         +      N++     L G+  L  
Sbjct: 244 NLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTN 291

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  110 bits (277), Expect = 4e-26
 Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 16/193 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN L       +  L  L  L L +NQ+    P  L  L  L EL  G N++    P   
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 283

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
             LT L NL L  N+L  I   + NLK++ YL L  N +     + +L  L ++    N 
Sbjct: 284 AGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNK 342

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            SDV    +  L ++ +L   +N++    P  + +L  +  L L++   +   P++ +  
Sbjct: 343 VSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKAN 397

Query: 177 LDLKDINVSFNKL 189
           + + +   +    
Sbjct: 398 VSIPNTVKNVTGA 410

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  106 bits (266), Expect = 1e-24
 Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 24/228 (10%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             +N         L +     L    +  ++      L  +  L +    +         
Sbjct: 12  TPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VE 65

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNF 117
            L NL  +   +N+LT I   L NL  ++ + +++N +     + NL  L  + L  N  
Sbjct: 66  YLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 124

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           +D+ P  +  L +L  L L  N +  S   ++  L +L+ L+  N          L  L 
Sbjct: 125 TDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---LKPLANLT 177

Query: 178 DLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQ 220
            L+ +++S NK+  +I       N  +     N++     L  + NL 
Sbjct: 178 TLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDITPLGILTNLD 224

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 97.7 bits (244), Expect = 7e-22
 Identities = 42/193 (21%), Positives = 78/193 (40%), Gaps = 15/193 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N ++   P+    L  L  L L +NQLE   P  +  L  L  L    N +    P   
Sbjct: 274 ANQISNISPL--AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 327

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
            +LT L+ L+  +NK++ + S L NL +I +L    N +     + NL  + Q+ L+   
Sbjct: 328 SSLTKLQRLFFYNNKVSDVSS-LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 386

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS--LE 174
           +++        +     +      L    P +I D  +    +++ N  S T  +S    
Sbjct: 387 WTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFS 444

Query: 175 KLLDLKDINVSFN 187
           + + +     +F+
Sbjct: 445 QPVTIGKGTTTFS 457

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 33/174 (18%), Positives = 53/174 (30%), Gaps = 26/174 (14%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            NN++   P+    L KLQ L   +N++       L  L  +  L +G N++    P   
Sbjct: 318 FNNISDISPV--SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 371

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV 120
            NLT +  L L     T+ P        I     +    LI                   
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI------------------- 412

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
            P TI          + +N       +         ++       SGT+   L+
Sbjct: 413 APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 25/162 (15%), Positives = 55/162 (33%), Gaps = 17/162 (10%)

Query: 68  NLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPT 123
                   +  I  T   L + +   L    +       +L  +  +         +   
Sbjct: 6   ATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG- 63

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDIN 183
            +  L +L  +    N+L    P  + +L  L  + ++NN ++   P++   L +L  + 
Sbjct: 64  -VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLT 118

Query: 184 VSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQ 220
           +  N++   I       N +      N +     L G+ +LQ
Sbjct: 119 LFNNQITD-IDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 159

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  127 bits (320), Expect = 4e-31
 Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 37/283 (13%)

Query: 300 IGRGGFGSVYKARIQDG----MEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKII 354
           IG G FG V++          M VA+K           + F  E   +++  H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 411
              + +    +++E    G L   L    + LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
             +H D+   NVL+  N    L DFG+++  +++      ++    I +MAPE     + 
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 472 STNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE 530
           ++  DV+ FG+ + E      KP     F  +             V+  ++         
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP-----FQGVKNN---------DVIGRIENGERLPMPP 615

Query: 531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
           +      C   +++L  KC    P +R    E+  +L  I + 
Sbjct: 616 N------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (307), Expect = 5e-31
 Identities = 64/311 (20%), Positives = 121/311 (38%), Gaps = 72/311 (23%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVK-VFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG V KA             VAVK + +       +    E +++K++ H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----------------------EKCLYSSNYILDIF 389
           +  +CS D    L++EY  +GSL                           +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
             ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+++ + +ED  +
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN 509
            ++Q    + +MA E   +   +T  DV+SFG++L E  T          G         
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGGN------- 251

Query: 510 DLLP---ISVMEIVDANLLSQKDEHFTTKGQ-------CVSFIFNLAMKCTVESPEQRIN 559
              P   I    + +              G        C   ++ L ++C  + P++R  
Sbjct: 252 ---PYPGIPPERLFN----------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

Query: 560 AKEIVTRLLKI 570
             +I   L K+
Sbjct: 299 FADISKDLEKM 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (304), Expect = 6e-31
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 12/205 (5%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIIS 355
            IG G +G   K R   DG  +  K  D         +    E ++++ ++H NI++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 356 SCSSDDFKAL--VLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLH--FG 408
                    L  V+EY   G L   +               L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
               ++H DLKP+NV LD      L DFG+A+ +L  D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTF-VGTPYYMSPEQMNR 190

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKP 493
              +   D++S G +L E      P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (309), Expect = 8e-31
 Identities = 71/309 (22%), Positives = 116/309 (37%), Gaps = 73/309 (23%)

Query: 300 IGRGGFGSVYKARIQD--------GMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRN 349
           +G G FG V  A             + VAVK + D    +       E +M+K I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNI 394
           II ++ +C+ D    +++EY   G+L                         +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 395 MIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
           T     + +MAPE   +   +   DV+SFG+++ E FT          G           
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LGGS--------- 304

Query: 512 LP---ISVMEIVDANLLSQKDEHFTTKGQ-------CVSFIFNLAMKCTVESPEQRINAK 561
            P   I V E+               +G        C + ++ +   C    P QR   K
Sbjct: 305 -PYPGIPVEELFK----------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 353

Query: 562 EIVTRLLKI 570
           ++V  L +I
Sbjct: 354 QLVEDLDRI 362

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  121 bits (305), Expect = 1e-30
 Identities = 40/223 (17%), Positives = 81/223 (36%), Gaps = 13/223 (5%)

Query: 7   SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNL 66
           +I        + ++  + D+ L+ ++         + ELD  GN L     A     T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 67  RNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-LIGNLKVLVQVDLSMNNFSDVIPTTI 125
             L L SN L      L +L  +  LDL++N++  +     +  +  + NN S V  +  
Sbjct: 61  ELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR- 118

Query: 126 GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG-TIPISLEKLLDLKDINV 184
              +  + ++L  N++        G    ++ L+L  N +              L+ +N+
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 185 SFNKLEGEIPNKGPFRNFSTESFEGNEL------LCGMPNLQV 221
            +N +  ++  +  F    T     N+L            +  
Sbjct: 177 QYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTW 218

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  111 bits (280), Expect = 3e-27
 Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 22/203 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN L+      +    KL+LL+L  N L      DL  L+ L  LD   N +        
Sbjct: 43  GNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QEL 95

Query: 61  GNLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS 113
               ++  L+  +N ++ +  S     K    + L++N +        G    +  +DL 
Sbjct: 96  LVGPSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 114 MNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           +N    V           L++L L+YN +   +   +     LK+L+LS+N L+  +   
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE 209

Query: 173 LEKLLDLKDINVSFNKLEGEIPN 195
            +    +  I++  NKL   I  
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEK 231

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 29/189 (15%), Positives = 57/189 (30%), Gaps = 45/189 (23%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N +     +  G   ++Q L L+ N+++ ++                            
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNF----------------------AELA 165

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV 120
            +   L +L L  N +  +         +  LDLSSN L                     
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKL-------------------AF 205

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS-GTIPISLEKLLDL 179
           +         + ++ L  N+L   I  ++    NL+  +L  N    GT+     K   +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 180 KDINVSFNK 188
           + +     K
Sbjct: 265 QTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 27/167 (16%), Positives = 59/167 (35%), Gaps = 4/167 (2%)

Query: 1   GNNLNG-SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            N ++  +          L+ L+L+ N +   +   +   A L  LD   NKL  F+   
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE 209

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSD 119
           F +   +  + L +NKL  I   L   +++ + DL  N    G L+     +  +   + 
Sbjct: 210 FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
                + G  + +              + +      + + L +++  
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (304), Expect = 2e-30
 Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 61/303 (20%)

Query: 300 IGRGGFGSVYKARIQD--------GMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRN 349
           +G G FG V  A             + VAVK + D    +       E +M+K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNI 394
           II ++ +C+ D    +++EY   G+L                         +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP- 513
              + +MAPE   +   +   DV+SFG+++ E FT          G            P 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LGGS----------PY 260

Query: 514 --ISVMEIVDA----NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
             I V E+       + + +          C + ++ +   C    P QR   K++V  L
Sbjct: 261 PGIPVEELFKLLKEGHRMDKPAN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

Query: 568 LKI 570
            +I
Sbjct: 314 DRI 316

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (302), Expect = 3e-30
 Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 52/299 (17%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRNII 351
           +G G FG V +A           M VAVK +    +    ++   E  ++  +  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------------EKCLYSSNYILDIFQRLNI 394
            ++ +C+      ++ EY  +G L                    +      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM---TLKHWVNDL 511
              + +MAPE       +   DV+S+GI L E F+          G      +       
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGSSPYPGMPVDSK-- 256

Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                 +++         EH        + ++++   C    P +R   K+IV  + K 
Sbjct: 257 ----FYKMIKEGFRMLSPEH------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  119 bits (301), Expect = 3e-30
 Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 47/296 (15%)

Query: 300 IGRGGFGSVYKARIQD------GMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRNII 351
           +GRG FG V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 352 KIISSCSSDDFKALV-LEYMPHGSL---------------EKCLYSSNYILDIFQRLNIM 395
            ++ +C+      +V +E+   G+L                         L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPI 514
             + +MAPE   +   +   DV+SFG++L E F+    P    + G + +          
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPG-VKIDE-------- 258

Query: 515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                +      +  ++          ++   + C    P QR    E+V  L  +
Sbjct: 259 EFCRRLKEGTRMRAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  119 bits (300), Expect = 4e-30
 Identities = 55/274 (20%), Positives = 100/274 (36%), Gaps = 34/274 (12%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRI-RHRN 349
           F   + +G G +G V+K R  +DG   AVK     +           E    +++ +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            +++  +        L  E     SL++   +    L   Q    + D   AL +LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S  ++H D+KP+N+ L       L DFG+   L        Q        YMAPE   +G
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-LQG 230

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
              T  DV+S G+ ++E     +       G    +            ++    L  +  
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL----PHGGEGWQ------------QLRQGYLPPEFT 274

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
              +++ +      ++ +      P+ R  A+ +
Sbjct: 275 AGLSSELR------SVLVMMLEPDPKLRATAEAL 302

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  120 bits (302), Expect = 4e-30
 Identities = 58/298 (19%), Positives = 114/298 (38%), Gaps = 50/298 (16%)

Query: 298 NLIGRGGFGSVYKARIQD------GMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRN 349
             +G G FG V +A           ++VAVK +    +    ++   E  ++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSL-------------EKCLYSSNYILDIFQRLNIMI 396
           I+ ++ +C+      ++ EY  +G L             +     +N        L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 397 DVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
            VA  + +L   +       IH D+   NVLL +  VA + DFG+A+ ++ +   + +  
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLL 512
               + +MAPE   +   +   DV+S+GI+L E F+    P    + G +          
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----YPGILVNSK------ 275

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                ++V       +             I+++   C    P  R   ++I + L + 
Sbjct: 276 ---FYKLVKDGYQMAQPAF------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  119 bits (299), Expect = 2e-29
 Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 67/306 (21%)

Query: 300 IGRGGFGSVYKARIQD--------GMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRN 349
           +G G FG V  A              +VAVK +      +       E +M+K I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNI 394
           II ++ +C+ D    +++EY   G+L                   ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 455 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP- 513
              + +MAPE   +   +   DV+SFG++L E FT          G            P 
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LGGS----------PY 294

Query: 514 --ISVMEIVDANLLSQKDEHFTTKGQ-------CVSFIFNLAMKCTVESPEQRINAKEIV 564
             + V E+               +G        C + ++ +   C    P QR   K++V
Sbjct: 295 PGVPVEELFK----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344

Query: 565 TRLLKI 570
             L +I
Sbjct: 345 EDLDRI 350

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (294), Expect = 3e-29
 Identities = 62/303 (20%), Positives = 107/303 (35%), Gaps = 62/303 (20%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F E  ++G+G FG V KAR   D    A+K           +   E  ++  + H+ +++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVR 66

Query: 353 IISSCSSDDFKA-------------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 399
             ++                     + +EY  +G+L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--------LKEDQSLTQ 451
            AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK +        L        
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 452 TQTLAT-IG---YMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG 500
           +  L + IG   Y+A E       Y  +       D+YS GI+  E           F  
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIY-------PFST 230

Query: 501 DMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA 560
            M        +  +  +  V        D++          I           P +R  A
Sbjct: 231 GM------ERVNILKKLRSVSIEFPPDFDDNKMK--VEKKII----RLLIDHDPNKRPGA 278

Query: 561 KEI 563
           + +
Sbjct: 279 RTL 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  116 bits (293), Expect = 5e-29
 Identities = 73/296 (24%), Positives = 131/296 (44%), Gaps = 51/296 (17%)

Query: 298 NLIGRGGFGSVYKARIQDG---MEVAVKVFDLQYG---RAFKSFDIECDMIKRI-RHRNI 350
           ++IG G FG V KARI+     M+ A+K   ++        + F  E +++ ++  H NI
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 351 IKIISSCSSDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNIM 395
           I ++ +C    +  L +EY PHG+L                    S+   L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
            DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T   
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDEIFFGDMTLKHWVNDLLPI 514
             + +MA E       +TN DV+S+G++L E  +    P     +  MT           
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAE-------- 249

Query: 515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
            + E +      +K  +      C   +++L  +C  E P +R +  +I+  L ++
Sbjct: 250 -LYEKLPQGYRLEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  119 bits (299), Expect = 8e-29
 Identities = 39/215 (18%), Positives = 79/215 (36%), Gaps = 13/215 (6%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
             + ++  + D+ L+ ++         + ELD  GN L     A     T L  L L SN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 75  KLTSIPSTLWNLKDILYLDLSSNFL-LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQY 133
            L      L +L  +  LDL++N++  +     +  +  + NN S V  +     +  + 
Sbjct: 69  VLYETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR---GQGKKN 124

Query: 134 LFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG-TIPISLEKLLDLKDINVSFNKLEGE 192
           ++L  N++        G    ++ L+L  N +              L+ +N+ +N +  +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183

Query: 193 IPNKGPFRNFSTESFEGNEL------LCGMPNLQV 221
           +  +  F    T     N+L            +  
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTW 218

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  108 bits (272), Expect = 2e-25
 Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 22/203 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GN L+      +    KL+LL+L  N L      DL  L+ L  LD   N +        
Sbjct: 43  GNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QEL 95

Query: 61  GNLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS 113
               ++  L+  +N ++ +  S     K    + L++N +        G    +  +DL 
Sbjct: 96  LVGPSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 114 MNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           +N    V           L++L L+YN +   +   +     LK+L+LS+N L+  +   
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE 209

Query: 173 LEKLLDLKDINVSFNKLEGEIPN 195
            +    +  I++  NKL   I  
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEK 231

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  100 bits (251), Expect = 9e-23
 Identities = 33/190 (17%), Positives = 66/190 (34%), Gaps = 26/190 (13%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGF-VPAC 59
            NN++    ++  + Q  + + L +N++      D    + +  LD   N++D       
Sbjct: 108 NNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSD 119
             +   L +L L  N +  +   +     +  LDLSSN L                    
Sbjct: 165 AASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKL-------------------A 204

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS-GTIPISLEKLLD 178
            +         + ++ L  N+L   I  ++    NL+  +L  N    GT+     K   
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 179 LKDINVSFNK 188
           ++ +     K
Sbjct: 264 VQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 98.4 bits (245), Expect = 6e-22
 Identities = 28/176 (15%), Positives = 65/176 (36%), Gaps = 14/176 (7%)

Query: 31  SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI-PSTLWNLKDI 89
           +I +               + L   + +   +  N++ L L  N L+ I  + L     +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 90  LYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI 145
             L+LSSN L     + +L  L  +DL+ N         +     ++ L    N +   +
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RV 114

Query: 146 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRN 201
             S       K++ L+NN ++    +       ++ +++  N+++  +       +
Sbjct: 115 SCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 94.5 bits (235), Expect = 9e-21
 Identities = 32/200 (16%), Positives = 62/200 (31%), Gaps = 13/200 (6%)

Query: 1   GNNLNG-SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            N ++  +          L+ L+L+ N +   +   +   A L  LD   NKL  F+   
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE 209

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQ-----VDLSM 114
           F +   +  + L +NKL  I   L   +++ + DL  N    G L+           ++ 
Sbjct: 210 FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG----TIP 170
                +                     +         LI LK    +  +  G     + 
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329

Query: 171 ISLEKLLDLKDINVSFNKLE 190
              E     ++I+    +  
Sbjct: 330 CERENQARQREIDALKEQYR 349

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 22/203 (10%), Positives = 44/203 (21%), Gaps = 36/203 (17%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
             KL+ L L  N+L   +  +    A +  +    NKL   +        NL +  L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 75  KLTSIPSTLW--NLKDILYLDLSSNFLLIG----NLKVLVQVDLSMNNFSDV-------- 120
                    +    + +  +   +   L G       V            D+        
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

Query: 121 --------------------IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNL 160
                               +          + +     + +  I           +L  
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367

Query: 161 SNNNLSGTIPISLEKLLDLKDIN 183
               L   +        +L    
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTL 390

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 18/163 (11%), Positives = 40/163 (24%), Gaps = 7/163 (4%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            +    +        + + +     Q    I     R  A   L+     LD  V     
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381

Query: 62  NLTNLRNLY---LGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGN----LKVLVQVDLSM 114
               L       +G  +L         L+ +  +      + +         +   D+  
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQ 441

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKS 157
           +  + +        K      L       ++ + +    NL S
Sbjct: 442 HKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (293), Expect = 8e-29
 Identities = 34/303 (11%), Positives = 73/303 (24%), Gaps = 57/303 (18%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +  G    V+  R ++   + A+KVF           +          R+   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 355 SSC----------------------SSDDFKA----LVLEYM-----PHGSLEKCLYSSN 383
                                      DD+      L++           S    +Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 384 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 443
               I     +   +      L    S  ++H    P N+ +  +    L D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 444 KEDQSLTQTQTLATIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           K       +     + Y   E+        +   + +  G+ +   +    P     FG 
Sbjct: 243 KVGTRGPASSV--PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP-----FGL 295

Query: 502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAK 561
           +T              +     +       F +      F+  L  +       +R+   
Sbjct: 296 VTPGI-------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348

Query: 562 EIV 564
           E +
Sbjct: 349 EAM 351

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (291), Expect = 1e-28
 Identities = 58/304 (19%), Positives = 107/304 (35%), Gaps = 57/304 (18%)

Query: 300 IGRGGFGSVYKARIQDG------MEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRNII 351
           +G G FG V  A           ++VAVK + +       ++   E  M+ ++  H NI+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 352 KIISSCSSDDFKALVLEYMPHGSL----------------------EKCLYSSNYILDIF 389
            ++ +C+      L+ EY  +G L                               +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM---TLKH 506
            +      + +MAPE   EG  +   DV+S+GI+L E F+          G      +  
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS---------LGVNPYPGIPV 280

Query: 507 WVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR 566
             N        +++       +  +          I+ +   C      +R +   + + 
Sbjct: 281 DAN------FYKLIQNGFKMDQPFY------ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 567 LLKI 570
           L   
Sbjct: 329 LGCQ 332

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (287), Expect = 2e-28
 Identities = 56/292 (19%), Positives = 102/292 (34%), Gaps = 53/292 (18%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISS 356
            +GRGGFG V++A+   D    A+K   L     A +    E   + ++ H  I++  ++
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 357 CSSDDFKA------------LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASAL 402
               +               + ++     +L+  +    +    +    L+I + +A A+
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--- 459
           E+LH   S  ++H DLKPSN+    + V  + DFG+    + +D+      T        
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYARH 187

Query: 460 --------YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
                   YM+PE       S   D++S G++L E           F   M         
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------FSTQMER------- 233

Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
             +  +  V                      + +       SP +R  A  I
Sbjct: 234 --VRTLTDVRNLKFPPLFTQKY------PCEYVMVQDMLSPSPMERPEAINI 277

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  118 bits (298), Expect = 2e-28
 Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 13/212 (6%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
           +N  G+    V  L  L+ L L  N L   G          +L  LD   N +   + + 
Sbjct: 334 SNKGGNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 391

Query: 60  FGNLTNLRNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFL------LIGNLKVLVQVD 111
           F  L  L +L    + L  +   S   +L++++YLD+S          +   L  L  + 
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451

Query: 112 LSMNNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
           ++ N+F +     I   L++L +L L   +L+   P +   L +L+ LN+++N L     
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511

Query: 171 ISLEKLLDLKDINVSFNKLEGEIPNKGPFRNF 202
              ++L  L+ I +  N  +   P       +
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  110 bits (276), Expect = 1e-25
 Identities = 39/191 (20%), Positives = 70/191 (36%), Gaps = 13/191 (6%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            + L L  N L             L  LD    ++       + +L++L  L L  N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 78  SIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDV-IPTTIGGLK 129
           S+       L  +  L      L       IG+LK L +++++ N      +P     L 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLK----SLNLSNNNLSGTIPISLEKLLDLKDINVS 185
           +L++L L  N++Q      +  L  +     SL+LS N ++  I     K + L  + + 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208

Query: 186 FNKLEGEIPNK 196
            N     +   
Sbjct: 209 NNFDSLNVMKT 219

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  109 bits (274), Expect = 2e-25
 Identities = 47/229 (20%), Positives = 80/229 (34%), Gaps = 18/229 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L      +     +LQ+L L   +++         L+ L  L   GN +       F
Sbjct: 37  FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96

Query: 61  GNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDL 112
             L++L+ L      L S+ +  + +LK +  L+++ N +          NL  L  +DL
Sbjct: 97  SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 113 SMNNFSDVIPTTIGGLKDLQYLF----LEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGT 168
           S N    +  T +  L  +  L     L  N +   I       I L  L L NN  S  
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLN 215

Query: 169 IP-ISLEKLLDLKDINVSFNKLEG----EIPNKGPFRNFSTESFEGNEL 212
           +    ++ L  L+   +   +       E  +K         + E   L
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 99.0 bits (247), Expect = 5e-22
 Identities = 40/198 (20%), Positives = 79/198 (39%), Gaps = 20/198 (10%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
             Q L+L++ +  Q          +L +L  L    NK          +L +L  L L  
Sbjct: 305 GWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSR 356

Query: 74  NKLTSI---PSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTI 125
           N L+       + +    + YLDLS N +         L+ L  +D   +N   +   ++
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 126 -GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDIN 183
              L++L YL + +   + +       L +L+ L ++ N+      P    +L +L  ++
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 184 VSFNKLEGEIPNKGPFRN 201
           +S  +LE ++     F +
Sbjct: 477 LSQCQLE-QLSP-TAFNS 492

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 45/246 (18%), Positives = 87/246 (35%), Gaps = 30/246 (12%)

Query: 1   GNNLNGSIP-IAVGKLQKLQLLSLE------DNQLEGSIPDDLCRLAALFELDSGGNKLD 53
            N  + ++    +  L  L++  L       +  LE      L  L  L   +     LD
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 54  GF---VPACFGNLTNLRNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFLLIGNLKVLV 108
            +   +   F  LTN+ +  L S  +  +   S  +  + +  ++          LK L 
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328

Query: 109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ--GSIPDSIGDLINLKSLNLSNNNLS 166
           ++  + N   +        L  L++L L  N L   G    S     +LK L+LS N + 
Sbjct: 329 RLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 167 GTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFST-----------ESFEGNELLCG 215
            T+  +   L  L+ ++   + L+ ++     F +                   N +  G
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF-NGIFNG 443

Query: 216 MPNLQV 221
           + +L+V
Sbjct: 444 LSSLEV 449

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 89.4 bits (222), Expect = 6e-19
 Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 10/151 (6%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDL 112
           C   + N+            IP  L        LDLS N L         +   L  +DL
Sbjct: 3   CVEVVPNI-TYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           S      +       L  L  L L  N +Q     +   L +L+ L     NL+      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 173 LEKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
           +  L  LK++NV+ N ++        F N +
Sbjct: 120 IGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (288), Expect = 2e-28
 Identities = 71/307 (23%), Positives = 115/307 (37%), Gaps = 50/307 (16%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISS 356
           ++  GGF  VY+A+ +  G E A+K          ++   E   +K++  H NI++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 357 CS-------SDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHF 407
            S       +   + L+L  +  G L + L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA----------T 457
               PIIH DLK  N+LL +     L DFG A  +          Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 458 IGYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP 513
             Y  PE    Y     +    D+++ G +L     R+ P     F D            
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP-----FEDG----------- 256

Query: 514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
            + + IV+        +   T     S I          +PE+R++  E+V +L +I  +
Sbjct: 257 -AKLRIVNGKYSIPPHDTQYT--VFHSLI----RAMLQVNPEERLSIAEVVHQLQEIAAA 309

Query: 574 LLKNVKR 580
              N K 
Sbjct: 310 RNVNPKS 316

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (287), Expect = 3e-28
 Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 34/290 (11%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD-LQYGRAFKSFDIECDMIKRIRHRNIIKI--I 354
           ++G+G   +V++ R  + G   A+KVF+ + + R       E +++K++ H+NI+K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
              ++   K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 413 IIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGR 467
           I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189

Query: 468 EGQVSTNG-------DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV 520
                 +        D++S G+      T   P    F      +     +  I   +  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITGKPS 245

Query: 521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
            A    QK E+       + +  ++ + C++ S   ++    ++  +L+ 
Sbjct: 246 GAISGVQKAENGP-----IDWSGDMPVSCSL-SRGLQVLLTPVLANILEA 289

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (289), Expect = 5e-28
 Identities = 39/317 (12%), Positives = 86/317 (27%), Gaps = 90/317 (28%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYG---------------------------- 329
           ++G+    +  +A   + G    V V                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 330 RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM-PHGSLEKCL------YSS 382
           +    F    D++K  + + +I++          +    Y     +L+          S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 383 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 442
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 443 LKEDQSLTQTQTLATIGYMAPEY----------GREGQVSTNGDVYSFGIMLMETFTRKK 492
                      +    G+  PE                ++   D ++ G+ +   +    
Sbjct: 262 ------GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 493 PTDEIFFGD--MTLKHWV---NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAM 547
           P       D  +    W+      +P  V  +++   L +                    
Sbjct: 316 P----NTDDAALGGSEWIFRSCKNIPQPVRALLEG-FL-RYP------------------ 351

Query: 548 KCTVESPEQRINAKEIV 564
                  E R+   + +
Sbjct: 352 ------KEDRLLPLQAM 362

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (283), Expect = 6e-28
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 10/195 (5%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           ++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
            + S    D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQV 471
           +IH D+K  N+LL  +    L+DFG    +       ++  T+  T  +MAPE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 472 STNGDVYSFGIMLME 486
               D++S GIM +E
Sbjct: 194 GPKVDIWSLGIMAIE 208

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (289), Expect = 8e-28
 Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 40/237 (16%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECD-MIKRIRHRNIIK 352
                ++G G  G+V       G  VAVK   + +        +E   + +   H N+I+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 353 IISSCSSDDFKALVLEYMPHGSLE------KCLYSSNYILDIFQRLNIMIDVASALEYLH 406
              S ++D F  + LE     +L+           +  +   +  ++++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 407 FGYSVPIIHCDLKPSNVLLD-------------DNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
              S+ IIH DLKP N+L+              +N+   +SDFG+ K L     S     
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 454 TLA--TIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFTRKKPTDEIFFGD 501
                T G+ APE   E              D++S G +     ++ K      FGD
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH----PFGD 242

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (283), Expect = 1e-27
 Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
                 IG G  G V  AR    G +VAVK+ DL+  +  +    E  +++  +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +  S    +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGREG 469
           +IH D+K  ++LL  +    LSDFG    +    + + + ++L  +G   +MAPE     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAPEVISRS 216

Query: 470 QVSTNGDVYSFGIMLME 486
             +T  D++S GIM++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  115 bits (289), Expect = 1e-27
 Identities = 46/197 (23%), Positives = 87/197 (44%), Gaps = 11/197 (5%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCR-LAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
           L  L+ L L  N+L+  IP  +   L+ L +LD   NK+   +   F +L NL++L +G 
Sbjct: 79  LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 74  NKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIG 126
           N L  I       L  +  L L    L       + +L  L+ + L   N + +   +  
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 186
            L  L+ L + +     ++  +    +NL SL++++ NL+    +++  L+ L+ +N+S+
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSY 257

Query: 187 NKLEGEIPNKGPFRNFS 203
           N +   I          
Sbjct: 258 NPIS-TIEG-SMLHELL 272

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  110 bits (278), Expect = 4e-26
 Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 11/209 (5%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
            N +             L+ L L +N +  ++       L  L  L    N+L       
Sbjct: 41  KNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGV 99

Query: 60  FGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDL 112
           F  L+NL  L +  NK+  +      +L ++  L++  N L          L  L Q+ L
Sbjct: 100 FTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
              N + +    +  L  L  L L +  +      S   L  LK L +S+     T+  +
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219

Query: 173 LEKLLDLKDINVSFNKLEGEIPNKGPFRN 201
               L+L  ++++   L   +P     R+
Sbjct: 220 CLYGLNLTSLSITHCNLT-AVPY-LAVRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  110 bits (276), Expect = 7e-26
 Identities = 47/224 (20%), Positives = 80/224 (35%), Gaps = 12/224 (5%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
            N +   +      L  L+ L + DN L   I       L +L +L      L       
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171

Query: 60  FGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFLL------IGNLKVLVQVDL 112
             +L  L  L L    + +I   +   L  +  L++S    L            L  + +
Sbjct: 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           +  N + V    +  L  L++L L YN +       + +L+ L+ + L    L+   P +
Sbjct: 232 THCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291

Query: 173 LEKLLDLKDINVSFNKLEGEIPNK--GPFRNFSTESFEGNELLC 214
              L  L+ +NVS N+L   +         N  T   + N L C
Sbjct: 292 FRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  107 bits (270), Expect = 4e-25
 Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 19/220 (8%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            +LL L  N+++    D+      L EL+   N +    P  F NL NLR L L SN+L 
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93

Query: 78  SIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKD 130
            IP      L ++  LD+S N +      +  +L  L  +++  N+   +      GL  
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153

Query: 131 LQYLFLEYNRLQGSIPD-SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
           L+ L LE   L  SIP  ++  L  L  L L + N++     S ++L  LK + +S    
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212

Query: 190 EGEIPNKGPFRNFSTE--SFEGNEL-------LCGMPNLQ 220
              +         +    S     L       +  +  L+
Sbjct: 213 LDTMTP-NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 27/165 (16%), Positives = 56/165 (33%), Gaps = 32/165 (19%)

Query: 67  RNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIG 126
           R +     +  ++P             + +             +DL  N    +      
Sbjct: 14  RAVLCHRKRFVAVPE-----------GIPTE---------TRLLDLGKNRIKTLNQDEFA 53

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 186
               L+ L L  N +    P +  +L NL++L L +N L          L +L  +++S 
Sbjct: 54  SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113

Query: 187 NKLEGEIPNKGPFRNFS---TESFEGNEL-------LCGMPNLQV 221
           NK+   + +   F++     +     N+L         G+ +L+ 
Sbjct: 114 NKIV-ILLD-YMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQ 156

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 1e-27
 Identities = 39/245 (15%), Positives = 77/245 (31%), Gaps = 29/245 (11%)

Query: 270 DANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR------IQDGMEVAVKV 323
              +P I  +  F        +     ++L+G G F  VY+A        ++  +  +KV
Sbjct: 48  QCKLPAIKPKTEFQL-----GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV 102

Query: 324 FDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL----EKCL 379
                   F       + +K       +K  S+    +   LV E   +G+L        
Sbjct: 103 QKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162

Query: 380 YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH------- 432
            +   ++     ++  + +   +E +H      IIH D+KP N +L +  +         
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219

Query: 433 ----LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF 488
               L D G +  +    +    T    T G+   E       +   D +     +    
Sbjct: 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279

Query: 489 TRKKP 493
                
Sbjct: 280 FGTYM 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (285), Expect = 2e-27
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD-LQYGRAFKSFDIECDMIKRIRHRNIIKI--I 354
           ++G+G   +V++ R  + G   A+KVF+ + + R       E +++K++ H+NI+K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
              ++   K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 413 IIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGR 467
           I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189

Query: 468 EGQVSTNG-------DVYSFGIML 484
                 +        D++S G+  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTF 213

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (279), Expect = 2e-27
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +     +G G FG VYKA+  + G   A KV + +     + + +E +++    H  I+K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           ++ +   D    +++E+ P G+++  +   +  L   Q   +   +  AL +LH   S  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGREG 469
           IIH DLK  NVL+       L+DFG++       ++L +  +   IG   +MAPE     
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAPEVVMCE 192

Query: 470 QVSTNG-----DVYSFGIMLME 486
            +         D++S GI L+E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  115 bits (290), Expect = 2e-27
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 19/198 (9%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKII--- 354
           +G GGFG V +      G +VA+K    +   +  + + +E  ++K++ H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 355 ---SSCSSDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGY 409
                 + +D   L +EY   G L K L  + +   L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 410 SVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYG 466
              IIH DLKP N++L      ++  + D G AK L  +   L     + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195

Query: 467 REGQVSTNGDVYSFGIML 484
            + + +   D +SFG + 
Sbjct: 196 EQKKYTVTVDYWSFGTLA 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 4e-27
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 14/197 (7%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F     +G G +GSVYKA   + G  VA+K   ++     +    E  ++++    +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
              S   +    +V+EY   GS+   +   N  L   +   I+      LEYLH    + 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGREG 469
            IH D+K  N+LL+    A L+DFG+A  L     ++ +  T+  IG   +MAPE  +E 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVIQEI 200

Query: 470 QVSTNGDVYSFGIMLME 486
             +   D++S GI  +E
Sbjct: 201 GYNCVADIWSLGITAIE 217

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  111 bits (280), Expect = 9e-27
 Identities = 43/220 (19%), Positives = 84/220 (38%), Gaps = 24/220 (10%)

Query: 15  LQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
           L   ++++ +++ +   +P   L     +  L+    +++      F     ++ LY+G 
Sbjct: 44  LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 74  NKLTSIP-STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIG 126
           N +  +P     N+  +  L L  N L      +  N   L  + +S NN   +   T  
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 186
               LQ L L  NRL   +  S+  + +L   N+S N LS     +L   + +++++ S 
Sbjct: 163 ATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 214

Query: 187 NKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQV 221
           N +   +         +    + N L     L   P L  
Sbjct: 215 NSIN-VVRG-PVNVELTILKLQHNNLTDTAWLLNYPGLVE 252

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  107 bits (269), Expect = 2e-25
 Identities = 45/235 (19%), Positives = 87/235 (37%), Gaps = 26/235 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            + +       +   ++++LL+L D Q+E            + +L  G N +    P  F
Sbjct: 54  NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 113

Query: 61  GNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS 113
            N+  L  L L  N L+S+P     N   +  L +S+N L             L  + LS
Sbjct: 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 173

Query: 114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL 173
            N  + V    +  +  L +  + YN L      ++   I ++ L+ S+N+++  +   +
Sbjct: 174 SNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV 224

Query: 174 EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-------LCGMPNLQV 221
              ++L  + +  N L  +      +          NEL          M  L+ 
Sbjct: 225 --NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  100 bits (251), Expect = 4e-23
 Identities = 34/192 (17%), Positives = 67/192 (34%), Gaps = 12/192 (6%)

Query: 7   SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNL 66
            I   +        + ++    +     +   L     +    + +     A   +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 67  RNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSD 119
             L L   ++  I +        I  L +  N +      +  N+ +L  + L  N+ S 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLD 178
           +          L  L +  N L+  I D       +L++L LS+N L+  + +SL  +  
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPS 187

Query: 179 LKDINVSFNKLE 190
           L   NVS+N L 
Sbjct: 188 LFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 36/166 (21%), Positives = 67/166 (40%), Gaps = 27/166 (16%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N++N  +   V    +L +L L+ N L  +    L     L E+D   N+L+  +   F
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPF 268

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV 120
             +  L  LY+ +N+L ++      +  +  LDLS N L                     
Sbjct: 269 VKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL-------------------LH 309

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
           +         L+ L+L++N +  ++   +     LK+L LS+N+  
Sbjct: 310 VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 19/135 (14%), Positives = 43/135 (31%), Gaps = 12/135 (8%)

Query: 75  KLTSIPSTLWNLKDILYLDLSSNFLLIG--------NLKVLVQVDLSMNNFSDVIPTTIG 126
           +   I S L    D ++ D+  +              L     V    +    +    + 
Sbjct: 9   EYKCIDSNL--QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 186
             + ++ L L   +++     +      ++ L +  N +    P   + +  L  + +  
Sbjct: 67  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126

Query: 187 NKLEGEIPNKGPFRN 201
           N L   +P  G F N
Sbjct: 127 NDLS-SLPR-GIFHN 139

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 9e-27
 Identities = 57/306 (18%), Positives = 112/306 (36%), Gaps = 56/306 (18%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           F + + +G G  G V+K      G+ +A K+  L         +I+  +  +I     ++
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---------EIKPAIRNQIIRE--LQ 83

Query: 353 IISSCSSD---DFKA---------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 400
           ++  C+S     F           + +E+M  GSL++ +      +       + I V  
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIK 142

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIG 459
            L YL   +   I+H D+KPSN+L++      L DFG++  L+      +   +   T  
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRS 195

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           YM+PE  +    S   D++S G+ L+E    + P       ++ L          +    
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAM-----------------------KCTVESPEQ 556
                    ++        ++    L                         KC +++P +
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315

Query: 557 RINAKE 562
           R + K+
Sbjct: 316 RADLKQ 321

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (283), Expect = 2e-26
 Identities = 57/226 (25%), Positives = 84/226 (37%), Gaps = 54/226 (23%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRL--------------AALFELD 46
           GN L  S+P+    L +L + S     L  ++P  LC+L                L EL 
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELS 147

Query: 47  SGGNKLDGFVPACFGNLT-----------------NLRNLYLGSNKLTSIPSTLWNLKDI 89
              N+L    PA    L                   L+ L +  N+L S+P+    L   
Sbjct: 148 VSDNQLASL-PALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPTLPSELY-- 204

Query: 90  LYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGS 144
             L   +N L     L   LK L    +S N  +  +P       +L+ L +  NRL  S
Sbjct: 205 -KLWAYNNRLTSLPALPSGLKEL---IVSGNRLTS-LPVLPS---ELKELMVSGNRLT-S 255

Query: 145 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
           +P        L SL++  N L+  +P SL  L     +N+  N L 
Sbjct: 256 LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  105 bits (264), Expect = 4e-24
 Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 27/199 (13%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            +N   S+P    +L KL      +NQL  S+P     L    EL    N+L   +P   
Sbjct: 149 SDNQLASLPALPSELCKLWAY---NNQLT-SLPMLPSGLQ---ELSVSDNQL-ASLPTLP 200

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMN 115
             L  L   +  +N+LTS+P+    LK    L +S N L     L   LK L    +S N
Sbjct: 201 SELYKL---WAYNNRLTSLPALPSGLK---ELIVSGNRLTSLPVLPSELKEL---MVSGN 251

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
             +  +P    GL     L +  N+L   +P+S+  L +  ++NL  N LS     +L +
Sbjct: 252 RLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 306

Query: 176 LLDLKDINVSFNKLEGEIP 194
           +      +    + +    
Sbjct: 307 ITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  104 bits (260), Expect = 1e-23
 Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 25/183 (13%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
                +L++ ++ L  ++PD L   A +  L    N L   +PA       LR L +  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGN 91

Query: 75  KLTSIPSTLWNLKDILYLDLSSNFL--LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ 132
           +LTS+P     L ++         L  L   L  L    +  N  +  +P    G   LQ
Sbjct: 92  QLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKL---WIFGNQLTS-LPVLPPG---LQ 144

Query: 133 YLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE 192
            L +  N+L  S+P        L  L   NN L+ ++P+    L +L   +VS N+L   
Sbjct: 145 ELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-S 195

Query: 193 IPN 195
           +P 
Sbjct: 196 LPT 198

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 90.7 bits (225), Expect = 3e-19
 Identities = 37/164 (22%), Positives = 65/164 (39%), Gaps = 27/164 (16%)

Query: 37  CRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSS 96
           C       L+ G + L   +P C     ++  L +  N LTS+P+    L+    L++S 
Sbjct: 37  CLNNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLTSLPALPPELR---TLEVSG 90

Query: 97  NFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD 151
           N L     L   L  L      + +   +          L  L++  N+L  S+P     
Sbjct: 91  NQLTSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPP- 141

Query: 152 LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
              L+ L++S+N L+ ++P    +L  L       N+L   +P 
Sbjct: 142 --GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPM 178

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 41/198 (20%), Positives = 65/198 (32%), Gaps = 38/198 (19%)

Query: 1   GNNLNGSIPIAVGKLQKLQL-----------------LSLEDNQLEGSIPDDLCRLAALF 43
            +N   S+P    +L KL                   L +  N+L  S+P     L    
Sbjct: 189 SDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLPSELK--- 244

Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL---- 99
           EL   GN+L   +P      + L +L +  N+LT +P +L +L     ++L  N L    
Sbjct: 245 ELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERT 300

Query: 100 -----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP----DSIG 150
                 I +        +  +      P     L      +L   R     P       G
Sbjct: 301 LQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFG 360

Query: 151 DLINLKSLNLSNNNLSGT 168
              N  + +L  + LS T
Sbjct: 361 QEDNADAFSLFLDRLSET 378

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  108 bits (272), Expect = 2e-26
 Identities = 44/228 (19%), Positives = 87/228 (38%), Gaps = 38/228 (16%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRI-RHRN 349
           F E   IG G FGSV+K     DG   A+K        +    +   E      + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLH 406
           +++  S+ + DD   +  EY   GSL   +  +  I+  F   +  ++++ V   L Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 407 FGYSVPIIHCDLKPSNVLLDDN-------------------MVAHLSDFGMAKPLLKEDQ 447
              S+ ++H D+KPSN+ +                      ++  + D G          
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------- 182

Query: 448 SLTQTQTLA-TIGYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKP 493
            ++  Q       ++A E  +E        D+++  + ++     +  
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  112 bits (281), Expect = 3e-26
 Identities = 41/200 (20%), Positives = 75/200 (37%), Gaps = 12/200 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             +   SIP  +     ++ L L  N++      DL   A L  L    ++++      F
Sbjct: 14  SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70

Query: 61  GNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDL 112
            +L +L +L L  N L+S+ S     L  + YL+L  N         L  NL  L  + +
Sbjct: 71  YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130

Query: 113 SMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
                   I      GL  L  L ++   L+     S+  + ++  L L  +  +  + I
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 172 SLEKLLDLKDINVSFNKLEG 191
             + L  ++ + +    L  
Sbjct: 191 FADILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  102 bits (256), Expect = 4e-23
 Identities = 34/198 (17%), Positives = 73/198 (36%), Gaps = 9/198 (4%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N +       +     LQ+L L+ +++     D    L +L  LD   N L     + F
Sbjct: 35  FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWF 94

Query: 61  GNLTNLRNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFLL-------IGNLKVLVQVD 111
           G L++L+ L L  N   ++   S   NL ++  L + +              L  L +++
Sbjct: 95  GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           +   +  +    ++  ++D+ +L L  +     +      L +++ L L + NL+     
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214

Query: 172 SLEKLLDLKDINVSFNKL 189
            L        +     + 
Sbjct: 215 PLPVDEVSSPMKKLAFRG 232

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 92.5 bits (230), Expect = 6e-20
 Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 14/196 (7%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDD---LCRLAALFELDSGGNKLD--GFVPACFGNLTNLRN 68
            L+ L+ L L +N +      +        +L  L    N L            L NL +
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391

Query: 69  LYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLI---GNLKVLVQVDLSMNNFSDVIPTTI 125
           L +  N    +P +    + + +L+LSS  + +      + L  +D+S NN         
Sbjct: 392 LDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSL--- 448

Query: 126 GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS 185
             L  LQ L++  N+L+ ++PD+      L  + +S N L        ++L  L+ I + 
Sbjct: 449 -FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505

Query: 186 FNKLEGEIPNKGPFRN 201
            N  +   P       
Sbjct: 506 TNPWDCSCPRIDYLSR 521

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 83.2 bits (206), Expect = 5e-17
 Identities = 28/235 (11%), Positives = 73/235 (31%), Gaps = 14/235 (5%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             +L      ++  ++ +  L+L  ++    +      L+++  L+     L  F  +  
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSD 119
                   +   + + + +    +N L  +L   L  + +   +  +    D + +    
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL 179
           V          ++ L +    L   +      L  +K + + N+ +        + L  L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336

Query: 180 KDINVSFNKLEGEIPNKGPFRNFSTE----SFEGNEL---------LCGMPNLQV 221
           + +++S N +  E       +             N L         L  + NL  
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 30/116 (25%), Positives = 48/116 (41%), Gaps = 10/116 (8%)

Query: 92  LDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI 145
            D  S         L   +K L   DLS N  + +    +    +LQ L L+ +R+    
Sbjct: 10  CDGRSRSFTSIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 146 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRN 201
            D+   L +L+ L+LS+N+LS         L  LK +N+  N  +  +     F N
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (274), Expect = 3e-26
 Identities = 36/250 (14%), Positives = 77/250 (30%), Gaps = 60/250 (24%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKS----------------------- 334
           ++G+    +  +A   + G    V V          +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 335 -----FDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM-PHGSLEKCL------YSS 382
                F    D++K  + + +I++          +    Y     +L+          S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 383 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 442
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE----H 252

Query: 443 LKEDQSLTQTQTLATIGYMAPEY-----------GREGQVSTNGDVYSFGIMLMETFTRK 491
           L  D +   +    + G+  PE             R   ++ + D ++ G+++   +   
Sbjct: 253 LVRDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 492 KPTDEIFFGD 501
            P       D
Sbjct: 311 LP----ITKD 316

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (269), Expect = 3e-26
 Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 44/238 (18%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
           L+G+G F  VY+A  I  G+EVA+K+ D   +      +    E  +  +++H +I+++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
           +     ++  LVLE   +G + + L +        +  + M  + + + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE------YGR 467
           H DL  SN+LL  NM   ++DFG+A  L    +      TL  T  Y++PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191

Query: 468 EGQVSTNGDVYSFGIML---------------METFTRKKPTDEIFFGDMTLKHWVND 510
           E       DV+S G M                  T  +      +   D  +  +++ 
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVLADYEMPSFLSI 237

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  110 bits (277), Expect = 9e-26
 Identities = 43/220 (19%), Positives = 84/220 (38%), Gaps = 24/220 (10%)

Query: 15  LQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
           L   ++++ +++ +   +P   L     +  L+    +++      F     ++ LY+G 
Sbjct: 50  LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 74  NKLTSIP-STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIG 126
           N +  +P     N+  +  L L  N L      +  N   L  + +S NN   +   T  
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 186
               LQ L L  NRL   +  S+  + +L   N+S N LS     +L   + +++++ S 
Sbjct: 169 ATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 220

Query: 187 NKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQV 221
           N +   +         +    + N L     L   P L  
Sbjct: 221 NSIN-VVRG-PVNVELTILKLQHNNLTDTAWLLNYPGLVE 258

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  102 bits (255), Expect = 4e-23
 Identities = 47/236 (19%), Positives = 89/236 (37%), Gaps = 28/236 (11%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC 59
            + +   +P A+    ++++LL+L D Q+E            + +L  G N +    P  
Sbjct: 60  NSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118

Query: 60  FGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDL 112
           F N+  L  L L  N L+S+P     N   +  L +S+N L             L  + L
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           S N  + V    +  +  L +  + YN L      ++   I ++ L+ S+N+++    + 
Sbjct: 179 SSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VR 227

Query: 173 LEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-------LCGMPNLQV 221
               ++L  + +  N L  +      +          NEL          M  L+ 
Sbjct: 228 GPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 98.1 bits (244), Expect = 1e-21
 Identities = 35/186 (18%), Positives = 65/186 (34%), Gaps = 17/186 (9%)

Query: 18  LQLLSLEDNQLEGSIPD-----DLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
                  D  ++    D     +   L     +    + +     A   +   +  L L 
Sbjct: 24  QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83

Query: 73  SNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTI 125
             ++  I +        I  L +  N +      +  N+ +L  + L  N+ S +     
Sbjct: 84  DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 143

Query: 126 GGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINV 184
                L  L +  N L+  I D       +L++L LS+N L+  + +SL  +  L   NV
Sbjct: 144 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANV 199

Query: 185 SFNKLE 190
           S+N L 
Sbjct: 200 SYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 90.8 bits (225), Expect = 2e-19
 Identities = 34/200 (17%), Positives = 75/200 (37%), Gaps = 13/200 (6%)

Query: 31  SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP-STLWNLKDI 89
            I  +L      +++       D +       L N + +   ++ +  +P + L + + +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 90  LYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQG 143
             L+L+   +             + ++ +  N    + P     +  L  L LE N L  
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 144 SIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNF 202
           S+P  I  +   L +L++SNNNL      + +    L+++ +S N+L   +       + 
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL-SLIPSL 194

Query: 203 STESFEGNEL--LCGMPNLQ 220
              +   N L  L     ++
Sbjct: 195 FHANVSYNLLSTLAIPIAVE 214

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 87.7 bits (217), Expect = 2e-18
 Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 24/157 (15%)

Query: 10  IAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +      +L +L L+ N L  +    L     L E+D   N+L+  +   F  +  L  L
Sbjct: 226 VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283

Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
           Y+ +N+L ++      +  +  LDLS N LL                    +        
Sbjct: 284 YISNNRLVALNLYGQPIPTLKVLDLSHNHLL-------------------HVERNQPQFD 324

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
            L+ L+L++N +  ++   +     LK+L LS+N+  
Sbjct: 325 RLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 20/142 (14%), Positives = 46/142 (32%), Gaps = 12/142 (8%)

Query: 68  NLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIG--------NLKVLVQVDLSMNNFSD 119
           N+     +   I S L    D ++ D+  +              L     V    +    
Sbjct: 8   NVKPRQPEYKCIDSNL--QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL 179
           +    +   + ++ L L   +++     +      ++ L +  N +    P   + +  L
Sbjct: 66  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125

Query: 180 KDINVSFNKLEGEIPNKGPFRN 201
             + +  N L   +P +G F N
Sbjct: 126 TVLVLERNDLS-SLP-RGIFHN 145

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (269), Expect = 1e-25
 Identities = 56/270 (20%), Positives = 98/270 (36%), Gaps = 44/270 (16%)

Query: 268 PNDANMPRISNQRRFTYLEIFQATNGFSENN-----LIGRGGFGSVYKARIQDGMEVAVK 322
           P  +    +SN     YL  +        N+      + +G F  +     +D    A+K
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60

Query: 323 VFD---LQYGRAFKSFDI--------------ECDMIKRIRHRNIIKIISSCSSDDFKAL 365
            ++   L+  R F   +               E  +I  I++   +      ++ D   +
Sbjct: 61  KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120

Query: 366 VLEYMPHGSLEKCLYSSNYILDIFQRL-------NIMIDVASALEYLHFGYSVPIIHCDL 418
           + EYM + S+ K       +   +           I+  V ++  Y+H      I H D+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDV 178

Query: 419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPE--YGREGQVSTNG 475
           KPSN+L+D N    LSDFG ++     D+ +   +    T  +M PE             
Sbjct: 179 KPSNILMDKNGRVKLSDFGESE--YMVDKKI---KGSRGTYEFMPPEFFSNESSYNGAKV 233

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLK 505
           D++S GI L   F    P    F   ++L 
Sbjct: 234 DIWSLGICLYVMFYNVVP----FSLKISLV 259

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (266), Expect = 1e-25
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 50/228 (21%)

Query: 289 QATNGFSEN----NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI------ 337
            +T+GF EN     ++GRG    V +        E AVK+ D+  G +F + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 338 ---ECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDI 388
              E D+++++  H NII++  +  ++ F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129

Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
            +       +   +  LH    + I+H DLKP N+LLDD+M   L+DFG +   L   + 
Sbjct: 130 MR------ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEK 179

Query: 449 LTQTQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 484
           L   +   T  Y+APE            YG+E       D++S G+++
Sbjct: 180 L--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (270), Expect = 1e-25
 Identities = 59/319 (18%), Positives = 110/319 (34%), Gaps = 47/319 (14%)

Query: 300 IGRG--GFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKII 354
           IG+G     +V  AR    G  V V+  +L+         +  E  + K   H NI+   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           ++  +D+   +V  +M +GS +  +       ++      I+  V  AL+Y+H    +  
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIG---YMAPEYGRE 468
           +H  +K S++L+  +   +LS       ++     Q +       ++    +++PE  ++
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 469 GQVSTNG--DVYSFGI-------------------MLMETFTRKKPT-----DEIFFGDM 502
                +   D+YS GI                   ML+E      P              
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269

Query: 503 TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF-NLAMKCTVESPEQRINAK 561
                      +S          S  D       +  S  F +   +C   +P+ R +A 
Sbjct: 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329

Query: 562 EIVTRLLKIRDSLLKNVKR 580
                LL    S  K +KR
Sbjct: 330 T----LLN--HSFFKQIKR 342

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (265), Expect = 1e-25
 Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 64/293 (21%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-----------RH 347
           +GRG +G V K R +  G  +AVK              +     KR+             
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRA---------TVNSQEQKRLLMDLDISMRTVDC 65

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASA 401
              +    +   +    + +E M   SL+K       ++D  Q +       I + +  A
Sbjct: 66  PFTVTFYGALFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           LE+LH   S  +IH D+KPSNVL++      + DFG++  L      + +        YM
Sbjct: 122 LEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYM 176

Query: 462 APE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM 517
           APE       +   S   D++S GI ++E    + P             W     P   +
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP----------YDSWGT---PFQQL 223

Query: 518 E-IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
           + +V+        + F+   + V F      +C  ++ ++R    E    L++
Sbjct: 224 KQVVEEPSPQLPADKFSA--EFVDFT----SQCLKKNSKERPTYPE----LMQ 266

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 1e-25
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNI 350
           F++   IG+G FG V+K    +    VA+K+ DL+        DI  E  ++ +     +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 82

Query: 351 IKIISSCSSDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
            K   S   D    +++EY+  GS    LE        I        I+ ++   L+YLH
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA------TILREILKGLDYLH 136

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 463
              S   IH D+K +NVLL ++    L+DFG+A  L     +  +  T   +G   +MAP
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAP 188

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
           E  ++    +  D++S GI  +E    + P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  106 bits (267), Expect = 2e-25
 Identities = 68/295 (23%), Positives = 109/295 (36%), Gaps = 64/295 (21%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-----------RH 347
           IGRG +GSV K      G  +AVK              ++    K++             
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRS---------TVDEKEQKQLLMDLDVVMRSSDC 80

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASA 401
             I++   +   +    + +E M   S +K          +   +       I +    A
Sbjct: 81  PYIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKA 137

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           L +L       IIH D+KPSN+LLD +    L DFG++  L     S+ +T+      YM
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYM 192

Query: 462 APE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM 517
           APE               DV+S GI L E  T + P  +         + V D L     
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW--------NSVFDQL----T 240

Query: 518 EIVDAN---LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
           ++V  +   L + ++  F+     ++F+      C  +   +R   KE    LLK
Sbjct: 241 QVVKGDPPQLSNSEEREFSP--SFINFV----NLCLTKDESKRPKYKE----LLK 285

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (263), Expect = 3e-25
 Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 17/189 (8%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC-FGNLTNLRNLYLG 72
               L+ L L  N +  ++  +   L  L  LD   + L        F +L NL  L + 
Sbjct: 76  GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134

Query: 73  SNKLTSIPS-TLWNLKDILYLDLSSN----------FLLIGNLKVLVQVDLSMNNFSDVI 121
                   +     L  +  L ++ N          F  + NL  L   DLS      + 
Sbjct: 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL---DLSQCQLEQLS 191

Query: 122 PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD-LK 180
           PT    L  LQ L + +N            L +L+ L+ S N++  +    L+     L 
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251

Query: 181 DINVSFNKL 189
            +N++ N  
Sbjct: 252 FLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (258), Expect = 2e-24
 Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 13/199 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLD--GFVPA 58
              L  S+P  +        L LE N+L+        +L  L +L    N L   G    
Sbjct: 16  SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQVD 111
                T+L+ L L  N + ++ S    L+ + +LD   + L       +  +L+ L+ +D
Sbjct: 73  SDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIP 170
           +S  +          GL  L+ L +  N  Q +    I  +L NL  L+LS   L    P
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192

Query: 171 ISLEKLLDLKDINVSFNKL 189
            +   L  L+ +N+S N  
Sbjct: 193 TAFNSLSSLQVLNMSHNNF 211

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (258), Expect = 2e-24
 Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 20/230 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLE--GSIPDDLCRLAALFELDSGGNKLDGFVPA 58
            N L         KL +L  LSL  N L   G          +L  LD   N +   + +
Sbjct: 37  SNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSS 95

Query: 59  CFGNLTNLRNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFL------LIGNLKVLVQV 110
            F  L  L +L    + L  +   S   +L++++YLD+S          +   L  L  +
Sbjct: 96  NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155

Query: 111 DLSMNNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGT 168
            ++ N+F +     I   L++L +L L   +L+  +  +    L +L+ LN+S+NN    
Sbjct: 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSL 214

Query: 169 IPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTE----SFEGNELLC 214
                + L  L+ ++ S N +      K   ++F +     +   N+  C
Sbjct: 215 DTFPYKCLNSLQVLDYSLNHIM-TSK-KQELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 28/162 (17%)

Query: 69  LYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLI------GNLKVLVQVDLSMNN--FSDV 120
           +   S  LTS+P+ +        L+L SN L          L  L ++ LS N   F   
Sbjct: 12  IRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL-EKLLDL 179
              +  G   L+YL L +N +  ++  +   L  L+ L+  ++NL      S+   L +L
Sbjct: 70  CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128

Query: 180 KDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQV 221
             +++S                        N +  G+ +L+V
Sbjct: 129 IYLDISHTHTR-VAF---------------NGIFNGLSSLEV 154

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (265), Expect = 3e-25
 Identities = 61/239 (25%), Positives = 96/239 (40%), Gaps = 23/239 (9%)

Query: 258 LRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDG 316
           L ++    P+P       + +               FS+   IG G FG+VY AR +++ 
Sbjct: 20  LYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS 79

Query: 317 MEVAVKVFDLQYGRAFKSFDI---ECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHG 373
             VA+K       ++ + +     E   ++++RH N I+       +    LV+EY   G
Sbjct: 80  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138

Query: 374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
           S    L      L   +   +       L YLH   S  +IH D+K  N+LL +  +  L
Sbjct: 139 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 195

Query: 434 SDFGMAKPLLKEDQSLTQTQTLATIG---YMAPE---YGREGQVSTNGDVYSFGIMLME 486
            DFG A         +    +   +G   +MAPE      EGQ     DV+S GI  +E
Sbjct: 196 GDFGSA-------SIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (264), Expect = 4e-25
 Identities = 51/216 (23%), Positives = 78/216 (36%), Gaps = 27/216 (12%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
            L+KLQ L +  N L   IP +L   ++L EL    N++       F  L N+  + +G 
Sbjct: 100 PLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156

Query: 74  NKLTSI---PSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTT 124
           N L +    P     LK + YL +S   L      L   L  L    L  N    +    
Sbjct: 157 NPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLNEL---HLDHNKIQAIELED 212

Query: 125 IGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINV 184
           +     L  L L +N+++     S+  L  L+ L+L NN LS  +P  L  L  L+ + +
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271

Query: 185 SFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQ 220
             N +                 F             
Sbjct: 272 HTNNI----------TKVGVNDFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 42/180 (23%), Positives = 71/180 (39%), Gaps = 14/180 (7%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
             LL L++N +     DD   L  L+ L    NK+       F  L  L+ LY+  N L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 78  SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVI--PTTIGGLK 129
            IP  L     ++ L +  N +      +   L+ +  +++  N   +    P    GLK
Sbjct: 116 EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
            L YL +   +L   IP  +     L  L+L +N +       L +   L  + +  N++
Sbjct: 174 -LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 42/200 (21%), Positives = 66/200 (33%), Gaps = 35/200 (17%)

Query: 1   GNNLNGSIPIAVGKLQ--KLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA 58
           G N   +     G     KL  L + + +L   IP DL     L EL    NK+      
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELE 211

Query: 59  CFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNF 117
                + L  L LG N++  I + +L  L  +  L L +N L                  
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL------------------ 253

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI-------GDLINLKSLNLSNNNLSGTI- 169
              +P  +  LK LQ ++L  N +   +  +                ++L NN +     
Sbjct: 254 -SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 170 -PISLEKLLDLKDINVSFNK 188
            P +   + D   I     K
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 32/143 (22%), Positives = 54/143 (37%), Gaps = 11/143 (7%)

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFS 118
           +LR +      L ++P  +    D   LDL +N +          L+ L  + L  N  S
Sbjct: 34  HLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 119 DVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD 178
            +       L+ LQ L++  N L   IP ++    +L  L + +N +          L +
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148

Query: 179 LKDINVSFNKLEGEIPNKGPFRN 201
           +  I +  N LE      G F  
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDG 171

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (269), Expect = 4e-25
 Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 12/194 (6%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            +LL+L +NQ++    +    L  L  L    N +       F  L NL  L L  N+LT
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 78  SIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS-MNNFSDVIPTTIGGLK 129
           +IP+     L  +  L L +N +          +  L ++DL  +   S +      GL 
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
           +L+YL L    L+  IP+ +  LI L  L+LS N+LS   P S + L+ L+ + +  +++
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243

Query: 190 EGEIPNKGPFRNFS 203
           +  I  +  F N  
Sbjct: 244 Q-VIE-RNAFDNLQ 255

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  102 bits (257), Expect = 1e-23
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 15/225 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
            N +      +   L+ L++L L  N +  +I       LA L  L+   N+L       
Sbjct: 73  ENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGA 131

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSNFLLI-------GNLKVLVQVD 111
           F  L+ L+ L+L +N + SIPS  +  +  +  LDL     L          L  L  ++
Sbjct: 132 FVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           L+M N  ++    +  L  L  L L  N L    P S   L++L+ L +  + +      
Sbjct: 192 LAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249

Query: 172 SLEKLLDLKDINVSFNKLEGEIPNK--GPFRNFSTESFEGNELLC 214
           + + L  L +IN++ N L   +P+    P  +        N   C
Sbjct: 250 AFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 35/138 (25%), Positives = 54/138 (39%), Gaps = 20/138 (14%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLI------GNLKVLVQVDL 112
           C         +      L  +P  +    +   L+L  N + I       +L+ L  + L
Sbjct: 41  CSNQF---SKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPI 171
           S N+   +      GL +L  L L  NRL  +IP+     L  LK L L NN +  +IP 
Sbjct: 96  SRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153

Query: 172 S----LEKL--LDLKDIN 183
                +  L  LDL ++ 
Sbjct: 154 YAFNRIPSLRRLDLGELK 171

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (265), Expect = 5e-25
 Identities = 69/258 (26%), Positives = 103/258 (39%), Gaps = 55/258 (21%)

Query: 261 RKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSEN----NLIGRGGFGSVYKAR-IQD 315
           +K     P         +      L  + A   F +     ++IGRG    V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 316 GMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-----------HRNIIKIISSCSSDDFKA 364
           G E AVK+ ++       S +   ++ +  R           H +II +I S  S  F  
Sbjct: 119 GHEFAVKIMEVT--AERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176

Query: 365 LVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 419
           LV + M  G L     EK   S      I +       +  A+ +LH   +  I+H DLK
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMR------SLLEAVSFLH---ANNIVHRDLK 227

Query: 420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPE------------YG 466
           P N+LLDDNM   LSDFG +   L+  + L     L  T GY+APE            YG
Sbjct: 228 PENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYG 283

Query: 467 REGQVSTNGDVYSFGIML 484
           +E       D+++ G++L
Sbjct: 284 KE------VDLWACGVIL 295

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  103 bits (260), Expect = 6e-25
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 24/199 (12%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKI 353
             +G+G FG+VY AR  Q    +A+KV     L+          E ++   +RH NI+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                      L+LEY P G++ + L   +   +       + ++A+AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE------YGR 467
           IH D+KP N+LL       ++DFG +        S        T+ Y+ PE      +  
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-LCGTLDYLPPEMIEGRMHDE 186

Query: 468 EGQVSTNGDVYSFGIMLME 486
           +       D++S G++  E
Sbjct: 187 K------VDLWSLGVLCYE 199

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (261), Expect = 6e-25
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 24/197 (12%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G+GGF   ++          A K+     L      +   +E  + + + H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                +DF  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE------YGR 467
           H DLK  N+ L++++   + DFG+A  +  + +       L  T  Y+APE      +  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPEVLSKKGHS- 193

Query: 468 EGQVSTNGDVYSFGIML 484
             +V    DV+S G ++
Sbjct: 194 -FEV----DVWSIGCIM 205

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (263), Expect = 7e-25
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 49/213 (23%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIRHRNIIKI 353
           IG+G F  V +    + G + AVK+ D+    +           E  +   ++H +I+++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 354 ISSCSSDDFKALVLEYMPHGSL---------EKCLYS----SNYILDIFQRLNIMIDVAS 400
           + + SSD    +V E+M    L            +YS    S+Y+  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           AL Y H      IIH D+KP  VLL   +++    L  FG+A  L +          + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIML 484
             +MAPE      YG+        DV+  G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  104 bits (262), Expect = 8e-25
 Identities = 42/198 (21%), Positives = 81/198 (40%), Gaps = 26/198 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G+GGF   ++          A K+     L      +   +E  + + + H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
                +DF  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ--TLATIGYMAPE------YG 466
           H DLK  N+ L++++   + DFG+A   ++ D    +    T     Y+APE      + 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAPEVLSKKGHS 219

Query: 467 REGQVSTNGDVYSFGIML 484
              +V    DV+S G ++
Sbjct: 220 --FEV----DVWSIGCIM 231

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  107 bits (269), Expect = 8e-25
 Identities = 46/209 (22%), Positives = 78/209 (37%), Gaps = 29/209 (13%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L  S+P     L+ L      DN+L  ++P+    L     LD   N+L   +P   
Sbjct: 89  QNAL-ISLPELPASLEYLDAC---DNRLS-TLPELPASLK---HLDVDNNQLT-MLPEL- 138

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMN 115
                L  +   +N+LT +P    +L+    L + +N L     L  +L+ L   D+S  
Sbjct: 139 --PALLEYINADNNQLTMLPELPTSLE---VLSVRNNQLTFLPELPESLEAL---DVS-T 189

Query: 116 NFSDVIPTTIGGLKDLQ----YLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           N  + +P         +    +     NR+   IP++I  L    ++ L +N LS  I  
Sbjct: 190 NLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248

Query: 172 SLEKLLDLKDINVSFNKLEGEIPNKGPFR 200
           SL +     D +            +    
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  102 bits (255), Expect = 4e-23
 Identities = 41/202 (20%), Positives = 79/202 (39%), Gaps = 34/202 (16%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           N     +      + +   L L    L  S+PD+L     +  L+   N L    P    
Sbjct: 47  NEAVSLLKEC--LINQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALISL-PELPA 100

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNN 116
           +L  L       N+L+++P    +LK   +LD+ +N L     L   L+ +   +   N 
Sbjct: 101 SLEYL---DACDNRLSTLPELPASLK---HLDVDNNQLTMLPELPALLEYI---NADNNQ 151

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            +  +P        L+ L +  N+L   +P+      +L++L++S N L  ++P    + 
Sbjct: 152 LTM-LPELPTS---LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRN 202

Query: 177 LDLKD----INVSFNKLEGEIP 194
              ++         N++   IP
Sbjct: 203 HHSEETEIFFRCRENRIT-HIP 223

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  105 bits (265), Expect = 1e-24
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 12/192 (6%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            + L+L +N ++    D    L  L  L  G N +       F  L +L  L L  N LT
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 78  SIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTI-GGLK 129
            IPS     L  +  L L +N +          +  L+++DL      + I      GL 
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
           +L+YL L    ++  +P+ +  L+ L+ L +S N+     P S   L  LK + V  +++
Sbjct: 197 NLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254

Query: 190 EGEIPNKGPFRN 201
              I  +  F  
Sbjct: 255 S-LIE-RNAFDG 264

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (257), Expect = 1e-23
 Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 15/225 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
            NN+          L  L++L L  N +   I       LA+L  L+   N L       
Sbjct: 84  ENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGA 142

Query: 60  FGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFLLI-------GNLKVLVQVD 111
           F  L+ LR L+L +N + SIPS     +  ++ LDL     L          L  L  ++
Sbjct: 143 FEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           L M N  D+    +  L  L+ L +  N      P S   L +LK L + N+ +S     
Sbjct: 203 LGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260

Query: 172 SLEKLLDLKDINVSFNKLEGEIPNK--GPFRNFSTESFEGNELLC 214
           + + L  L ++N++ N L   +P+    P R         N   C
Sbjct: 261 AFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 20/138 (14%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDL 112
           C         +      L+ +P  +    +  YL+L  N +         +L  L  + L
Sbjct: 52  CSNQF---SKVVCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQL 106

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNLSGTIPI 171
             N+   +      GL  L  L L  N L   IP  +   L  L+ L L NN +  +IP 
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPS 164

Query: 172 S----LEKL--LDLKDIN 183
                +  L  LDL ++ 
Sbjct: 165 YAFNRVPSLMRLDLGELK 182

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  103 bits (258), Expect = 2e-24
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 50/209 (23%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           ++G G F  V+  +    G   A+K           S + E  ++K+I+H NI+ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 405
            S     LV++ +  G L             F R+             ++  V SA++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 406 HFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 461
           H      I+H DLKP N+L    ++N    ++DFG++K  ++++  ++   T   T GY+
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS---TACGTPGYV 174

Query: 462 APE------YGREGQVSTNGDVYSFGIML 484
           APE      Y +        D +S G++ 
Sbjct: 175 APEVLAQKPYSKA------VDCWSIGVIT 197

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (257), Expect = 3e-24
 Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 26/220 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKL--DGFVP 57
            N L   +P  +   + LQ L + +N++   +       L  +  ++ G N L   G   
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164

Query: 58  ACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVD 111
             F  +  L  + +    +T+IP  L     +  L L  N +       +  L  L ++ 
Sbjct: 165 GAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 112 LSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI 171
           LS N+ S V   ++     L+ L L  N+L   +P  + D   ++ + L NNN+S  I  
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 280

Query: 172 S-------LEKLLDLKDINVSFNKLE-GEIPNKGPFRNFS 203
           +         K      +++  N ++  EI     FR   
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ-PSTFRCVY 319

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 24/221 (10%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
             LL L++N++      D   L  L  L    NK+    P  F  L  L  LYL  N+L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 78  SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVI--PTTIGGLK 129
            +P  +   K +  L +  N +      +   L  ++ V+L  N             G+K
Sbjct: 114 ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
            L Y+ +    +  +IP  +    +L  L+L  N ++     SL+ L +L  + +SFN +
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228

Query: 190 EGEIPNKGPFRNFS--TE-SFEGNEL------LCGMPNLQV 221
              + N G   N     E     N+L      L     +QV
Sbjct: 229 S-AVDN-GSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 267

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 37/166 (22%), Positives = 60/166 (36%), Gaps = 19/166 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPAC 59
             N+  +IP   G    L  L L+ N++   +    L  L  L +L    N +       
Sbjct: 180 DTNIT-TIP--QGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGS 235

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSD 119
             N  +LR L+L +NKL  +P  L + K I  + L +N +            +  N+F  
Sbjct: 236 LANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI----------SAIGSNDFCP 285

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQ-GSIPDSI-GDLINLKSLNLSNN 163
             P           + L  N +Q   I  S    +    ++ L N 
Sbjct: 286 --PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 33/143 (23%), Positives = 56/143 (39%), Gaps = 11/143 (7%)

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFS 118
           +LR +      L  +P  L    D   LDL +N +         NLK L  + L  N  S
Sbjct: 32  HLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 119 DVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD 178
            + P     L  L+ L+L  N+L+  +P+ +     L+ L +  N ++         L  
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146

Query: 179 LKDINVSFNKLEGEIPNKGPFRN 201
           +  + +  N L+      G F+ 
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQG 169

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 14/84 (16%), Positives = 33/84 (39%), Gaps = 11/84 (13%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD-------LCRLAALFELDSGGNKLD 53
            N L   +P  +   + +Q++ L +N +  +I  +         + A+   +    N + 
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

Query: 54  GFV--PACFGNLTNLRNLYLGSNK 75
            +   P+ F  +     + LG+ K
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGNYK 330

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (257), Expect = 5e-24
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 43/206 (20%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD--LQYGRAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G+G F  V +      G+E A K+ +      R F+  + E  + ++++H NI+++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 357 CSSDDFKALVLEYMPHGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEYLHF 407
              + F  LV + +  G L      +  YS    S+ I  I            ++ Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 145

Query: 408 GYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
             S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY++PE
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPE 200

Query: 465 ------YGREGQVSTNGDVYSFGIML 484
                 Y +        D+++ G++L
Sbjct: 201 VLKKDPYSKP------VDIWACGVIL 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (257), Expect = 6e-24
 Identities = 47/236 (19%), Positives = 89/236 (37%), Gaps = 25/236 (10%)

Query: 262 KRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSEN----NLIGRGGFGSVYKAR-IQDG 316
           K   P  ND +       +++    +        +       +G G FG V++      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 317 MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL- 375
                K  +  Y     +   E  ++ ++ H  +I +  +        L+LE++  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 376 -----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 430
                E    S   +      +N M      L+++H      I+H D+KP N++ +    
Sbjct: 137 DRIAAEDYKMSEAEV------INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKA 187

Query: 431 AHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 484
           + +   DFG+A   L  D+ +    T AT  + APE      V    D+++ G++ 
Sbjct: 188 SSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (251), Expect = 9e-24
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 35/202 (17%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G+G F  V +      G+E A K+ + +    R F+  + E  + ++++H NI+++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 357 CSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
              + F  LV + +  G L      +  YS        Q       +  ++ Y H   S 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESIAYCH---SN 124

Query: 412 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE---- 464
            I+H +LKP N+LL          L+DFG+A   + + ++        T GY++PE    
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPEVLKK 181

Query: 465 --YGREGQVSTNGDVYSFGIML 484
             Y +        D+++ G++L
Sbjct: 182 DPYSKP------VDIWACGVIL 197

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (252), Expect = 9e-24
 Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 18/201 (8%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKIISS 356
           IG G    V  A       +VA+K  +L+  +     ++  E   + +  H NI+   +S
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTS 81

Query: 357 CSSDDFKALVLEYMPHGSL-------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
               D   LV++ +  GS+              + +LD      I+ +V   LEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYG 466
               IH D+K  N+LL ++    ++DFG++  L               +G   +MAPE  
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198

Query: 467 REGQV-STNGDVYSFGIMLME 486
            + +      D++SFGI  +E
Sbjct: 199 EQVRGYDFKADIWSFGITAIE 219

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (253), Expect = 1e-23
 Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 32/204 (15%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-----------RH 347
           +G G  G V+K R  + G  +AVK                 +  KRI             
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR---------SGNKEENKRILMDLDVVLKSHDC 83

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
             I++   +  ++    + +E M     EK        +       + + +  AL YL  
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--- 464
            +   +IH D+KPSN+LLD+     L DFG++  L        + ++     YMAPE   
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERID 197

Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
                +       DV+S GI L+E
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVE 221

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 1e-23
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 44/207 (21%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKIISS 356
           +G+G F  V +   +  G E A  + + +   A     +  E  + + ++H NI+++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 357 CSSDDFKALVLEYMPHGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEYLHF 407
            S +    L+ + +  G L      +  YS    S+ I  I            A+ + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127

Query: 408 GYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 463
              + ++H +LKP N+LL          L+DFG+A  +  E Q+       A T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP 182

Query: 464 E------YGREGQVSTNGDVYSFGIML 484
           E      YG+        D+++ G++L
Sbjct: 183 EVLRKDPYGKP------VDLWACGVIL 203

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  104 bits (261), Expect = 1e-23
 Identities = 49/214 (22%), Positives = 78/214 (36%), Gaps = 23/214 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFV-PAC 59
             NL   +P     L   + L L  N +          L  L  L+ G       +    
Sbjct: 13  FCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68

Query: 60  FGNLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFL--------LIGNLKVLVQV 110
           F NL NLR L LGS+K+  +       L  +  L L    L           NLK L ++
Sbjct: 69  FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128

Query: 111 DLSMNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL--INLKSLNLSNNNLSG 167
           DLS N    + +  + G L  L+ +    N++       +  L    L   +L+ N+L  
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188

Query: 168 TIPISLEKL------LDLKDINVSFNKLEGEIPN 195
            + +   K       + L+ ++VS N    +I  
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 99.5 bits (248), Expect = 5e-22
 Identities = 56/239 (23%), Positives = 85/239 (35%), Gaps = 33/239 (13%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFELDSGGNKLDGFVPAC 59
            N +      +   L++LQLL L       +I  +  R L  L  LD G +K+    P  
Sbjct: 33  FNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92

Query: 60  FGNLTNLRNLYLGSNKLTSI---PSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQ 109
           F  L +L  L L    L+          NLK +  LDLS N +         G L  L  
Sbjct: 93  FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152

Query: 110 VDLSMNNFSDVIPTTIGGL--KDLQYLFLEYNRLQGSIPDSIGDLIN------LKSLNLS 161
           +D S N    V    +  L  K L +  L  N L   +    G  +N      L+ L++S
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212

Query: 162 NN------------NLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFE 208
            N             +S +   SL     +      F+ +  + P++  F   +  S  
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI--KDPDQNTFAGLARSSVR 269

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 95.6 bits (238), Expect = 1e-20
 Identities = 52/232 (22%), Positives = 86/232 (37%), Gaps = 27/232 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N++          L+KLQ L L DN L       +  + ++ ++   GNKL        
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL 401

Query: 61  GNLTNLRNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFL-------LIGNLKVLVQVD 111
                   ++L  N+L ++     L  +  +  L L+ N                L Q+ 
Sbjct: 402 ----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 112 LSMNNFSDVIPTTI-----GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
           L  N       T +      GL  LQ L+L +N L    P     L  L+ L+L++N L+
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

Query: 167 GTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPN 218
                 L     L+ +++S N+L    PN   F + S      N+ +C    
Sbjct: 518 VLSHNDLPAN--LEILDISRNQL--LAPNPDVFVSLSVLDITHNKFICECEL 565

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 94.5 bits (235), Expect = 2e-20
 Identities = 46/220 (20%), Positives = 88/220 (40%), Gaps = 21/220 (9%)

Query: 17  KLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNL--TNLRNLYLGSN 74
            + +     N +  S    L     +     G + +       F  L  +++R+L L   
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276

Query: 75  KLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
            + S+ S     LKD+  L+L+ N +          L  L  ++LS N   ++  +   G
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
           L  + Y+ L+ N +      +   L  L++L+L +N L+     ++  +  + DI +S N
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN 391

Query: 188 KLEGEIPNKGPFRNF------STESFEGNELLCGMPNLQV 221
           KL   +P      N         E+ +    L  +P+LQ+
Sbjct: 392 KLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQI 430

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 92.6 bits (230), Expect = 9e-20
 Identities = 51/255 (20%), Positives = 85/255 (33%), Gaps = 37/255 (14%)

Query: 1   GNNLNG-SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAA--LFELDSGGNKLDGFVP 57
            N +    +  + GKL  L+ +    NQ+      +L  L    L       N L   V 
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191

Query: 58  ACFGNLTN------LRNLYLGSNKLTSIPS-------------TLWNLKDILYLDLSSNF 98
             +G   N      L  L +  N  T   +             +L     I+      + 
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

Query: 99  L------LIGNLKV--LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIG 150
           +          L    +  +DLS      +       LKDL+ L L YN++     ++  
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 151 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS---TESF 207
            L NL+ LNLS N L      +   L  +  I++  N +   I +   F+      T   
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQD-QTFKFLEKLQTLDL 369

Query: 208 EGNEL--LCGMPNLQ 220
             N L  +  +P++ 
Sbjct: 370 RDNALTTIHFIPSIP 384

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 88.3 bits (219), Expect = 2e-18
 Identities = 49/209 (23%), Positives = 75/209 (35%), Gaps = 23/209 (11%)

Query: 31  SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI--PSTLWNLKD 88
            +P  L        L    N +     + F  L  L+ L LGS             NL +
Sbjct: 18  QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 89  ILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVI--PTTIGGLKDLQYLFLEYNR 140
           +  LDL S+ +          L  L ++ L     SD +        LK L  L L  N+
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134

Query: 141 LQG-SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL--LDLKDINVSFNKLEGEIPN-- 195
           ++   +  S G L +LKS++ S+N +       LE L    L   +++ N L   +    
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 196 ---KGPFRNFSTESFE--GNELLCGMPNL 219
                PFRN   E  +  GN     +   
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGN 223

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 32/167 (19%), Positives = 56/167 (33%), Gaps = 33/167 (19%)

Query: 67  RNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIG 126
           R  +     LT +P     L     L LS N                      V  ++  
Sbjct: 7   RIAFYRFCNLTQVPQ---VLNTTERLLLSFN------------------YIRTVTASSFP 45

Query: 127 GLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS 185
            L+ LQ L L       +I  ++  +L NL+ L+L ++ +    P + + L  L ++ + 
Sbjct: 46  FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105

Query: 186 FNKLEGEIPNKGPFRNFST-----------ESFEGNELLCGMPNLQV 221
           F  L   +   G FRN               S   +     + +L+ 
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  100 bits (252), Expect = 2e-23
 Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 52/209 (24%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IG G +    +       ME AVK+ D       +  +I   +++  +H NII +     
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVYD 86

Query: 359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYLH 406
              +  +V E M  G L               ++             ++  +   +EYLH
Sbjct: 87  DGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYLH 133

Query: 407 FGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 461
              +  ++H DLKPSN+L      +     + DFG AK L  E+  L    T   T  ++
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANFV 187

Query: 462 APE------YGREGQVSTNGDVYSFGIML 484
           APE      Y          D++S G++L
Sbjct: 188 APEVLERQGYDAA--C----DIWSLGVLL 210

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (250), Expect = 2e-23
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 43/213 (20%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISS 356
           ++G G    V     +    E AVK+ + Q G        E +M+ + + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEY 404
              +D   LV E M  GS+                +             ++ DVASAL++
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 405 LHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATI-- 458
           LH   +  I H DLKP N+L    +      + DF +   + L  D S   T  L T   
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 459 --GYMAPEYGREGQVSTNG-----DVYSFGIML 484
              YMAPE         +      D++S G++L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 36/204 (17%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G+G FG+VY AR  Q+   +A+KV     L+          E ++   +RH NI+++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFG 408
           +         L+LE+ P G L K L           R +       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE---- 464
               +IH D+KP N+L+       ++DFG +           +T    T+ Y+ PE    
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRT-MCGTLDYLPPEMIEG 186

Query: 465 --YGREGQVSTNGDVYSFGIMLME 486
             +  +       D++  G++  E
Sbjct: 187 KTHDEK------VDLWCAGVLCYE 204

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 34/201 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G+G FG V K +      E AVKV +      +   +   E +++K++ H NI+K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 357 CSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                   +V E    G L     ++  +S +    I +       V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH---KH 140

Query: 412 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE---- 464
            I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+APE    
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197

Query: 465 -YGREGQVSTNGDVYSFGIML 484
            Y  +       DV+S G++L
Sbjct: 198 TYDEK------CDVWSAGVIL 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (250), Expect = 2e-23
 Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 49/245 (20%)

Query: 272 NMPRISNQRRFTYLEIFQATN---GFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQ 327
           +M   S  R    +++    +    F    L+G G +G VYK R ++ G   A+KV D+ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 328 YGRAFKSFDIECDMIKRI-RHRNIIKIISS------CSSDDFKALVLEYMPHGSLEKCLY 380
            G   +    E +M+K+   HRNI     +         DD   LV+E+   GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 381 SSNYILDIFQRLN-----------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 429
                 D+ +              I  ++   L +LH      +IH D+K  NVLL +N 
Sbjct: 115 -----TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166

Query: 430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAPEYGREGQVSTNG-----DVYSFG 481
              L DFG++  L   D+++ +  T   IG   +MAPE     +          D++S G
Sbjct: 167 EVKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

Query: 482 IMLME 486
           I  +E
Sbjct: 222 ITAIE 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (250), Expect = 3e-23
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 47/212 (22%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDI-----ECDMIKRIRHRNI 350
           +G G  G V  A   +   +VA+K+        G A ++        E +++K++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 351 IKIISSCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYL 405
           IKI +   ++D+  +VLE M  G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 406 HFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 461
           H      IIH DLKP NVLL   +++ +  ++DFG +K +L E   +    TL  T  Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183

Query: 462 APE---------YGREGQVSTNGDVYSFGIML 484
           APE         Y R   V    D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.0 bits (245), Expect = 5e-23
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 32/199 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           IGRG +G V  A      +  A K     +      F  E +++K + H NII++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 359 SDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
            +    LV+E    G L      K ++  +    I +      DV SA+ Y H    + +
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127

Query: 414 IHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-----Y 465
            H DLKP N L      +    L DFG+A    K  + +     + T  Y++P+     Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLY 184

Query: 466 GREGQVSTNGDVYSFGIML 484
           G E       D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 98.3 bits (245), Expect = 6e-23
 Identities = 31/204 (15%), Positives = 58/204 (28%), Gaps = 43/204 (21%)

Query: 299 LIGRGGFGSVYKARIQD---GMEVAVKVFDLQYGRA--FKS-FDIECDMIKRIRHRNIIK 352
             G       ++A   D     +VA+   D Q                 + RI    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           ++    +     +V E++  GSL++   +S         +  M  +A+A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
           +      PS V +  +        G                 LA    M     ++    
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPDANPQD---- 183

Query: 473 TNGDVYSFGIMLMETFTRKKPTDE 496
              D+   G  L      + P  E
Sbjct: 184 ---DIRGIGASLYALLVNRWPLPE 204

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  100 bits (252), Expect = 6e-23
 Identities = 42/210 (20%), Positives = 78/210 (37%), Gaps = 32/210 (15%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDL-------------CRLAALFELDS 47
            +NL   +P+    ++         ++ E + P                C      EL+ 
Sbjct: 20  SSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELEL 78

Query: 48  GGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL--LIGNLK 105
               L   +P       +L +L    N LT +P    +LK +L  + +   L  L   L+
Sbjct: 79  NNLGLS-SLPE---LPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLE 134

Query: 106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNL 165
            L    +S N    +    +     L+ + ++ N L+  +PD      +L+ +   NN L
Sbjct: 135 YL---GVSNNQLEKLPE--LQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQL 185

Query: 166 SGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
              +P  L+ L  L  I    N L+ ++P+
Sbjct: 186 E-ELP-ELQNLPFLTAIYADNNSLK-KLPD 212

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 98.1 bits (245), Expect = 6e-22
 Identities = 46/210 (21%), Positives = 82/210 (39%), Gaps = 32/210 (15%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L   +P  +  L  L  +  ++N L+  +PD    L     + +G N L+       
Sbjct: 182 NNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNILE--ELPEL 233

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL--LIGNLKVLVQVDLSMNNFS 118
            NL  L  +Y  +N L ++P    +L+ +   D     L  L  +L  L   +   +  S
Sbjct: 234 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 293

Query: 119 DVIP-------------TTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNL 165
           ++ P             +       L+ L +  N+L   +P        L+ L  S N+L
Sbjct: 294 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL 349

Query: 166 SGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
           +  +P   +    LK ++V +N L  E P+
Sbjct: 350 A-EVPELPQN---LKQLHVEYNPLR-EFPD 374

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 92.0 bits (229), Expect = 5e-20
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 40/213 (18%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           GNN+   +P  +  L  L  +  ++N L+ ++PD    L AL   D+    L    P   
Sbjct: 223 GNNILEELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELP 276

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL--LIGNLKVLVQVDLSMNNFS 118
            +LT L    +  N  + +     NL    YL+ SSN +  L      L ++++S N   
Sbjct: 277 QSLTFL---DVSENIFSGLSELPPNLY---YLNASSNEIRSLCDLPPSLEELNVSNNKLI 330

Query: 119 DVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD 178
           + +P     L   + L   +N L   +P+      NLK L++  N L    P   E + D
Sbjct: 331 E-LPALPPRL---ERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVED 381

Query: 179 ----------------LKDINVSFNKLEGEIPN 195
                           LK ++V  N L  E P+
Sbjct: 382 LRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 44/207 (21%), Positives = 72/207 (34%), Gaps = 39/207 (18%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRL--------------AALFELDS 47
           +N    +P     L  L +     + L   +P +L  L               +L EL+ 
Sbjct: 266 DNYLTDLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNV 324

Query: 48  GGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIG 102
             NKL    PA       L  L    N L  +P    NLK    L +  N L     +  
Sbjct: 325 SNNKLIEL-PAL---PPRLERLIASFNHLAEVPELPQNLK---QLHVEYNPLREFPDIPE 377

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
           +++     DL MN+    +P     LK    L +E N L+   PD      +++ L +++
Sbjct: 378 SVE-----DLRMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPE---SVEDLRMNS 425

Query: 163 NNLSGTIPISLEKLLDLKDINVSFNKL 189
             +      + E    L+D     +  
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 33/167 (19%), Positives = 62/167 (37%), Gaps = 21/167 (12%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +N   S+         L+ L++ +N+L   +P    RL     L +  N L   VP    
Sbjct: 306 SNEIRSLC---DLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL-AEVPEL-- 355

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL--LIGNLKVLVQVDLSMNNFSD 119
              NL+ L++  N L   P    +++D L ++     +  L  NLK L    +  N    
Sbjct: 356 -PQNLKQLHVEYNPLREFPDIPESVED-LRMNSHLAEVPELPQNLKQL---HVETNPLR- 409

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
             P     ++DL+   +   R+      +      L+     +++  
Sbjct: 410 EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 34/170 (20%), Positives = 57/170 (33%), Gaps = 32/170 (18%)

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL------IGNLKV--------- 106
           + T L+     S+ LT +P    N+K       + +          G  +          
Sbjct: 9   SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 107 ----LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
                 +++L+    S  +P        L+ L    N L   +P+    L +L   N + 
Sbjct: 69  LDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 163 NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL 212
             LS  +P  LE L       VS N+LE ++P             + N L
Sbjct: 124 KALSD-LPPLLEYL------GVSNNQLE-KLPELQNSSFLKIIDVDNNSL 165

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 19/108 (17%)

Query: 101 IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI------- 153
             +   L +     +N ++ +P     +K     +  ++  + + P   G+         
Sbjct: 7   NVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65

Query: 154 ------NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
                     L L+N  LS ++P   E    L+ +  S N L  E+P 
Sbjct: 66  RDCLDRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPE 108

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 50/208 (24%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSC 357
           +G G F    K    +     AVK+      R   +   E   +K    H NI+K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 405
                  LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 406 HFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
           H    V ++H DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 463 PE------YGREGQVSTNGDVYSFGIML 484
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (251), Expect = 7e-23
 Identities = 62/245 (25%), Positives = 101/245 (41%), Gaps = 56/245 (22%)

Query: 276 ISNQRRFTYLEIFQATNGFSENNL---------IGRGGFGSVYKAR-IQDGMEVAVKVFD 325
           +S  + F + ++           L         +G G  G V  A   +   +VA+++  
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169

Query: 326 ---LQYGRAFKSFDI-----ECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL-- 375
                 G A ++        E +++K++ H  IIKI +   ++D+  +VLE M  G L  
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD 228

Query: 376 ---EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNM 429
                           F        +  A++YLH      IIH DLKP NVLL   +++ 
Sbjct: 229 KVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC 279

Query: 430 VAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPE---------YGREGQVSTNGDVYS 479
           +  ++DFG +K +L E   +    TL  T  Y+APE         Y R   V    D +S
Sbjct: 280 LIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRA--V----DCWS 329

Query: 480 FGIML 484
            G++L
Sbjct: 330 LGVIL 334

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 15/187 (8%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
              +LQ+L L   +++ +I D     L+ L  L   GN +       F  L++L+ L   
Sbjct: 50  SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108

Query: 73  SNKLTSIPSTLW-NLKDILYLDLSSNFL--LIG-----NLKVLVQVDLSMNNFSDVIPTT 124
              L S+ +    +LK +  L+++ N +          NL  L  +DLS N    +  T 
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168

Query: 125 IGGLKDLQY----LFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLK 180
           +  L  +      L L  N +   I       I LK L L  N L        ++L  L+
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQ 227

Query: 181 DINVSFN 187
            I +  N
Sbjct: 228 KIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 20/185 (10%)

Query: 31  SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDI 89
            IPD+L    +   LD   N L       F +   L+ L L   ++ +I      +L  +
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 90  LYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQG 143
             L L+ N +          L  L ++     N + +    IG LK L+ L + +N +Q 
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ- 137

Query: 144 SIP--DSIGDLINLKSLNLSNNNLSGTIPI----SLEKLLDLK-DINVSFNKLEGEIPNK 196
           S    +   +L NL+ L+LS+N +  +I       L ++  L   +++S N +   I   
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP- 194

Query: 197 GPFRN 201
           G F+ 
Sbjct: 195 GAFKE 199

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 42/165 (25%)

Query: 2   NNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
                S+     G L+ L+ L++  N ++ S                        +P  F
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK----------------------LPEYF 145

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVL-VQVDLSMNNFSD 119
            NLTNL +L L SNK+ SI  T                 ++  + +L + +DLS+N  + 
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTD--------------LRVLHQMPLLNLSLDLSLNPMNF 191

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNN 163
           + P     ++ L+ L L+ N+L+ S+PD I D L +L+ + L  N
Sbjct: 192 IQPGAFKEIR-LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 46/180 (25%), Positives = 67/180 (37%), Gaps = 17/180 (9%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
             +L L +N L       L     L +L+    +L   +    G L  L  L L  N+L 
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQLQ 90

Query: 78  SIPSTLWNLKDILYLDLSSN---------FLLIGNLKVLVQVDLSMNNFSDVIPTTIGGL 128
           S+P     L  +  LD+S N            +G L+ L    L  N    + P  +   
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL---YLKGNELKTLPPGLLTPT 147

Query: 129 KDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
             L+ L L  N L   +P  + + L NL +L L  N+L  TIP        L    +  N
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 11/170 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N L       +    +L  L+L+  +L   +  D   L  L  LD   N+L   +P   
Sbjct: 40  ENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLGTLDLSHNQLQS-LPLLG 96

Query: 61  GNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLS 113
             L  L  L +  N+LTS+P   L  L ++  L L  N L      L+     L ++ L+
Sbjct: 97  QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156

Query: 114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN 163
            NN +++    + GL++L  L L+ N L  +IP        L    L  N
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 14/141 (9%)

Query: 57  PAC-FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQ 109
           P C    + +   +      LT++P  L   KD   L LS N L       +     L Q
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           ++L     +  +    G L  L  L L +N+LQ S+P     L  L  L++S N L+ ++
Sbjct: 60  LNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115

Query: 170 PISL-EKLLDLKDINVSFNKL 189
           P+     L +L+++ +  N+L
Sbjct: 116 PLGALRGLGELQELYLKGNEL 136

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 58/328 (17%)

Query: 261 RKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVA 320
                      N+       ++  LE             +G G +G VYKA+   G  VA
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEK------------VGEGTYGVVYKAKDSQGRIVA 49

Query: 321 VKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLE 376
           +K   L      +        E  ++K + H NI+ +I    S+    LV E+M    L+
Sbjct: 50  LKRIRLDAED--EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK 106

Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 436
           K L  +   L   Q    +  +   + + H      I+H DLKP N+L++ +    L+DF
Sbjct: 107 KVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADF 163

Query: 437 GMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRK--- 491
           G+A+      +S   T  + T+ Y AP+   G + + ST+ D++S G +  E  T K   
Sbjct: 164 GLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLF 220

Query: 492 -----------------KPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTT 534
                             P    +     L  W           + +    S     F  
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ-----VFEKKPWSSIIPGFCQ 275

Query: 535 KGQCVSFIFNLAMKCTVESPEQRINAKE 562
           +G       +L        P +RI+A++
Sbjct: 276 EG------IDLLSNMLCFDPNKRISARD 297

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =   99 bits (249), Expect = 3e-22
 Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 21/194 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS 358
           +G G FG V++      G   A K     +    ++   E   +  +RH  ++ +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 359 SDDFKALVLEYMPHGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
            D+   ++ E+M  G L      E    S +        +  M  V   L ++H      
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENN 275

Query: 413 IIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ 470
            +H DLKP N++        L   DFG+    L   QS+    T  T  + APE      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAPEVAEGKP 332

Query: 471 VSTNGDVYSFGIML 484
           V    D++S G++ 
Sbjct: 333 VGYYTDMWSVGVLS 346

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.4 bits (248), Expect = 3e-22
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 34/201 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKIISS 356
           +G G +G V   R     +E A+K+          +  +  E  ++K + H NI+K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 357 CSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                   LV+E    G L      +  ++      I +       V S + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH---KH 155

Query: 412 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE---- 464
            I+H DLKP N+LL   + + +  + DFG++  + +  + +   + L T  Y+APE    
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAPEVLRK 212

Query: 465 -YGREGQVSTNGDVYSFGIML 484
            Y  +       DV+S G++L
Sbjct: 213 KYDEK------CDVWSIGVIL 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 99.0 bits (247), Expect = 3e-22
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 35/202 (17%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
           +G+G FG V   +    G E AVKV     ++     +S   E  ++K++ H NI+K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 356 SCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
                 +  LV E    G L      +  +S      I ++      V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144

Query: 411 VPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--- 464
             I+H DLKP N+LL     +    + DFG++    +  + +     + T  Y+APE   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAPEVLH 201

Query: 465 --YGREGQVSTNGDVYSFGIML 484
             Y  +       DV+S G++L
Sbjct: 202 GTYDEK------CDVWSTGVIL 217

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 61/214 (28%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIRHRNIIK 352
            +GRG    VY+ +        A+KV         K+ D      E  ++ R+ H NIIK
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 400
           +     +    +LVLE +  G L             F R+            + +  +  
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILE 159

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA- 456
           A+ YLH      I+H DLKP N+L      +    ++DFG++K +++    +    T+  
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCG 212

Query: 457 TIGYMAPE------YGREGQVSTNGDVYSFGIML 484
           T GY APE      YG E  V    D++S GI+ 
Sbjct: 213 TPGYCAPEILRGCAYGPE--V----DMWSVGIIT 240

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.0 bits (247), Expect = 4e-22
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 34/201 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISS 356
           +G+G FG V K +      E AVKV +      +   +   E +++K++ H NI+K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 357 CSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                   +V E    G L     ++  +S +          I+  V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH---KH 140

Query: 412 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE---- 464
            I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+APE    
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197

Query: 465 -YGREGQVSTNGDVYSFGIML 484
            Y  +       DV+S G++L
Sbjct: 198 TYDEK------CDVWSAGVIL 212

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 21/200 (10%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
            S+  ++G G FG V+K      G+++A K+   +  +  +    E  ++ ++ H N+I+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 353 IISSCSSDDFKALVLEYMPHGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
           +  +  S +   LV+EY+  G L      E    +    +        M  +   + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
             Y   I+H DLKP N+L  +     +   DFG+A+   K  + L       T  ++APE
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAPE 258

Query: 465 YGREGQVSTNGDVYSFGIML 484
                 VS   D++S G++ 
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 46/182 (25%), Positives = 65/182 (35%), Gaps = 10/182 (5%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN-KL 76
            Q + L  N++             L  L    N L     A F  L  L  L L  N +L
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 77  TSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
            S+   T   L  +  L L    L      L   L  L  + L  N    +   T   L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 130 DLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK 188
           +L +LFL  NR+  S+P+     L +L  L L  N ++   P +   L  L  + +  N 
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 189 LE 190
           L 
Sbjct: 213 LS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 5/100 (5%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPA 58
            N L  ++P      L  L  L L  N++  S+P+     L +L  L    N++    P 
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSN 97
            F +L  L  LYL +N L+++P+     L+ + YL L+ N
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 25/144 (17%), Positives = 48/144 (33%), Gaps = 25/144 (17%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFS 118
           C+               L ++P             + +            ++ L  N  S
Sbjct: 8   CYNE--PKVTTSCPQQGLQAVPV-----------GIPAA---------SQRIFLHGNRIS 45

Query: 119 DVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLL 177
            V   +    ++L  L+L  N L      +   L  L+ L+LS+N    ++  +    L 
Sbjct: 46  HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105

Query: 178 DLKDINVSFNKLEGEIPNKGPFRN 201
            L  +++    L+ E+   G FR 
Sbjct: 106 RLHTLHLDRCGLQ-ELGP-GLFRG 127

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 17/193 (8%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +N+  ++  A   L  +  LS     +  +I   +  L  L  L+   N++    P    
Sbjct: 29  SNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAP--LK 82

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNF 117
           NLT +  L L  N L ++ S +  L+ I  LDL+S  +     +  L  L  + L +N  
Sbjct: 83  NLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           +++ P  + GL +LQYL +   ++   +   + +L  L +L   +N +S  I   L  L 
Sbjct: 142 TNISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DIS-PLASLP 195

Query: 178 DLKDINVSFNKLE 190
           +L ++++  N++ 
Sbjct: 196 NLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 21/217 (9%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
            L     ++   + +  ++      L  +  L + G  +          L NL  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKD 72

Query: 74  NKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
           N++T +   L NL  I  L+LS N L     I  L+ +  +DL+    +DV P  + GL 
Sbjct: 73  NQITDLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLS 129

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
           +LQ L+L+ N++  +I   +  L NL+ L++ N  +S   P  L  L  L  +    NK+
Sbjct: 130 NLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185

Query: 190 EGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQV 221
             +I       N      + N++     L    NL +
Sbjct: 186 S-DISPLASLPNLIEVHLKNNQISDVSPLANTSNLFI 221

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 15/185 (8%)

Query: 11  AVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLY 70
           A+  LQ ++ L L   Q+    P  L  L+ L  L    N++    P     LTNL+ L 
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLS 157

Query: 71  LGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIG 126
           +G+ +++ + + L NL  +  L    N +     + +L  L++V L  N  SDV P  + 
Sbjct: 158 IGNAQVSDL-TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LA 214

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVS 185
              +L  + L    +       +    NL   N+        I P ++         N++
Sbjct: 215 NTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLT 271

Query: 186 FNKLE 190
           +N   
Sbjct: 272 WNLTS 276

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 47/222 (21%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD----------------LQYGRAFKSFDIECDM 341
            IG+G +G V  A    D    A+KV                       A          
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 342 I----------KRIRHRNIIKIIS--SCSSDDFKALVLEYMPHGSL----EKCLYSSNYI 385
           I          K++ H N++K++      ++D   +V E +  G +         S +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 386 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE 445
              FQ      D+   +EYLH      IIH D+KPSN+L+ ++    ++DFG++    K 
Sbjct: 140 RFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKG 189

Query: 446 DQSLTQTQTLATIGYMAPEYGREGQVSTNG---DVYSFGIML 484
             +L    T+ T  +MAPE   E +   +G   DV++ G+ L
Sbjct: 190 SDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.1 bits (239), Expect = 9e-22
 Identities = 55/242 (22%), Positives = 85/242 (35%), Gaps = 66/242 (27%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIRHRNIIKI 353
           IG+G +G V  A   Q     A+K+ +    R     D+     E  ++K++ H NI ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 354 ISSCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRL---------------- 392
                 + +  LV+E    G L          S+        +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 393 ------------------NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL- 433
                             NIM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 434 -SDFGMAK--PLLKEDQSLTQTQTLATIGYMAPE--------YGREGQVSTNGDVYSFGI 482
             DFG++K    L   +    T    T  ++APE        YG +       D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264

Query: 483 ML 484
           +L
Sbjct: 265 LL 266

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.0 bits (239), Expect = 9e-22
 Identities = 40/199 (20%), Positives = 79/199 (39%), Gaps = 14/199 (7%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
           ++ L L +N++      DL R   L  L    N ++      F +L +L +L L  N L+
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 78  SIPS-TLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNN-FSDVIPTTIGGL 128
           ++ S     L  + +L+L  N         L  +L  L  + +   + F+ +      GL
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173

Query: 129 KDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK 188
             L+ L ++ + LQ   P S+  + N+  L L        + I ++    ++ + +    
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233

Query: 189 LEG----EIPNKGPFRNFS 203
           L+     E+   G   +  
Sbjct: 234 LDTFHFSELST-GETNSLI 251

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 34/196 (17%), Positives = 78/196 (39%), Gaps = 20/196 (10%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCR-LAALFELDSGGNKLDGFVPA-CFGNLTNLRNLYL 71
            L  L+ L L  N L  ++     + L++L  L+  GN          F +LT L+ L +
Sbjct: 98  SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156

Query: 72  GSN-KLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPT 123
           G+    T I       L  +  L++ ++ L       + +++ +  + L M     ++  
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI 216

Query: 124 TIGGLKDLQYLFLEYNRLQG----SIP----DSIGDLINLKSLNLSNNNLSGTIPISLEK 175
            +     ++ L L    L       +     +S+      +++ +++ +L   +   L +
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275

Query: 176 LLDLKDINVSFNKLEG 191
           +  L ++  S N+L+ 
Sbjct: 276 ISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 31/192 (16%), Positives = 62/192 (32%), Gaps = 14/192 (7%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPA 58
           GN        ++   L KLQ+L + +      I       L  L EL+   + L  + P 
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192

Query: 59  CFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNF 117
              ++ N+ +L L   +   +    +     +  L+L    L   +           +  
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF----------SEL 242

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           S     ++      + + +    L   +   +  +  L  L  S N L        ++L 
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301

Query: 178 DLKDINVSFNKL 189
            L+ I +  N  
Sbjct: 302 SLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 16/75 (21%), Positives = 31/75 (41%), Gaps = 1/75 (1%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
           K    + + + D  L   +   L +++ L EL+   N+L       F  LT+L+ ++L +
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310

Query: 74  NKLTSIPSTLWNLKD 88
           N        +  L  
Sbjct: 311 NPWDCSCPRIDYLSR 325

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 97.5 bits (242), Expect = 2e-21
 Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 17/200 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             ++  ++     +L  +  +   ++ ++ S+   +  L  + +L   GNKL    P   
Sbjct: 30  KKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--L 83

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
            NL NL  L+L  NK+  + S+L +LK +  L L  N +     + +L  L  + L  N 
Sbjct: 84  TNLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNK 142

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            +D+    +  L  L  L LE N++   I   +  L  L++L LS N++S      L  L
Sbjct: 143 ITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRA--LAGL 196

Query: 177 LDLKDINVSFNKLEGEIPNK 196
            +L  + +   +   +  N 
Sbjct: 197 KNLDVLELFSQECLNKPINH 216

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 93.6 bits (232), Expect = 3e-20
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 15/181 (8%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
              +    +L+   +  ++      L ++ ++ +  + +          L N+  L+L  
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 74

Query: 74  NKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
           NKLT I   L NLK++ +L L  N +     + +LK L  + L  N  SD+    +  L 
Sbjct: 75  NKLTDI-KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDING--LVHLP 131

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
            L+ L+L  N++  +    +  L  L +L+L +N +S  I   L  L  L+++ +S N +
Sbjct: 132 QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 187

Query: 190 E 190
            
Sbjct: 188 S 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 80.9 bits (199), Expect = 3e-16
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 17/168 (10%)

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNF 117
                    L    +T    T   L  I  +  +++ +     I  L  + ++ L+ N  
Sbjct: 19  AFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKL 77

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           +D+ P  +  LK+L +LFL+ N+++  +  S+ DL  LKSL+L +N +S  I   L  L 
Sbjct: 78  TDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLP 131

Query: 178 DLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL-----LCGMPNLQ 220
            L+ + +  NK+  +I          T S E N++     L G+  LQ
Sbjct: 132 QLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 178

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.8 bits (183), Expect = 3e-14
 Identities = 44/234 (18%), Positives = 79/234 (33%), Gaps = 13/234 (5%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
            L+KL+ LSLE N +   I + L  L  L  L  G NK+          LT L  L L  
Sbjct: 107 DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 162

Query: 74  NKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
           N+++ I   L  L  +  L LS N +     +  LK L  ++L      +        L 
Sbjct: 163 NQISDIVP-LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE--KLLDLKDINVSFN 187
               +      L    P+ I D  + +  N+  +    T  +S    + + +      F+
Sbjct: 222 VPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFH 279

Query: 188 KLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGI 241
               +   +    ++  +       +     +  P   T+  +  +        
Sbjct: 280 GRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNG 333

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 48/229 (20%), Positives = 81/229 (35%), Gaps = 36/229 (15%)

Query: 286 EIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVK--VFDLQYGRAFKSFDIECD--- 340
           E+    + ++    I  G +G+V      +G+ VA+K     +  GR             
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 341 ------MIKRIRHRNIIK---IISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIF 389
                 ++    H NI+    I             LV E M    L + ++    ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQ 134

Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
                M  +   L  LH      ++H DL P N+LL DN    + DF +A+    +    
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK- 190

Query: 450 TQTQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK 491
             T  +    Y APE       +      +   D++S G ++ E F RK
Sbjct: 191 --THYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 46/290 (15%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDL-QYGRAFKSFDI-ECDMIKRIRHRNIIKIISS 356
           IG G +G V+K R    G  VA+K F   +     K   + E  M+K+++H N++ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
                   LV EY  H ++   L      +      +I      A+ + H       IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGREG 469
           D+KP N+L+  + V  L DFG A+ L            +AT  Y +PE       Y    
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY---- 180

Query: 470 QVSTNGDVYSFGIMLMETFTRKKP-------TDEIF-----FGDMTLKHW--VNDL---L 512
                 DV++ G +  E  +   P        D+++      GD+  +H    +      
Sbjct: 181 --GPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
            + + +  D   L  K  + +           L   C    P +R+  ++
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPA------LGLLKGCLHMDPTERLTCEQ 281

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 42/210 (20%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD----LQYGRAFKSFDIECDMIKRIRHRNIIK- 352
           L+G G +G V +    +     AVK+       +      +   E  +++R+RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 353 --IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD----------IFQRLNIMIDVAS 400
             ++ +        +V+EY   G  E  +   + + +           F +L        
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQE--ML--DSVPEKRFPVCQAHGYFCQL------ID 120

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI-- 458
            LEYLH   S  I+H D+KP N+LL       +S  G+A+ L           T  T   
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQG 173

Query: 459 --GYMAPE--YGREGQVSTNGDVYSFGIML 484
              +  PE   G +       D++S G+ L
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 48/212 (22%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFD---IECDMIKRIRHRNIIKII 354
           ++G G F +V  AR +    E A+K+ + ++            E D++ R+ H   +K+ 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 355 SSCSSDDFKALVLEYMPHGSL------EKCL-------YSSNYILDIFQRLNIMIDVASA 401
            +   D+     L Y  +G L                 Y++              ++ SA
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--------------EIVSA 142

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGY 460
           LEYLH      IIH DLKP N+LL+++M   ++DFG AK +L  +    +  +   T  Y
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQY 198

Query: 461 MAPE------YGREGQVSTNGDVYSFGIMLME 486
           ++PE        +        D+++ G ++ +
Sbjct: 199 VSPELLTEKSACKS------SDLWALGCIIYQ 224

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 6e-21
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 42/290 (14%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDL-QYGRAFKSFDI-ECDMIKRIRHRNIIKII 354
            L+G G +G V K R    G  VA+K F      +  K   + E  ++K++RH N++ ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
             C       LV E++ H ++   L      LD       +  + + + + H   S  II
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVS 472
           H D+KP N+L+  + V  L DFG A+ L    +       +AT  Y APE   G + +  
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPELLVG-DVKYG 203

Query: 473 TNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHWVNDLL 512
              DV++ G ++ E F  +                                   +    L
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
           P    EI +   L ++    +          +LA KC    P++R    E
Sbjct: 264 P----EIKEREPLERRYPKLSEVV------IDLAKKCLHIDPDKRPFCAE 303

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.2 bits (237), Expect = 7e-21
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 28/256 (10%)

Query: 263 RGKPLPNDANMPRISNQRRFTYLEIFQAT-NGFSENNLIGRGGFGSVYKARIQDGMEV-A 320
              P     +        ++ +LE      + F +  ++GRGGFG V+  +++   ++ A
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA 214

Query: 321 VKVFDLQYGRAFKSFDIECDMIKR-----IRHRNIIKIISSCSSDDFKALVLEYMPHGSL 375
            K   L   R  K    +  M+++     +  R I+ +  +  +     LV+  M  G +
Sbjct: 215 CKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272

Query: 376 EKCLYSSNYILDIF--QRLNIMI-DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH 432
              +Y+ +     F   R       + S LE+LH      II+ DLKP NVLLDD+    
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVR 329

Query: 433 LSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-- 489
           +SD G+A  L       T+T+  A T G+MAPE     +   + D ++ G+ L E     
Sbjct: 330 ISDLGLAVELKAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

Query: 490 -------RKKPTDEIF 498
                   K    E+ 
Sbjct: 387 GPFRARGEKVENKELK 402

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 95.3 bits (237), Expect = 8e-21
 Identities = 43/213 (20%), Positives = 78/213 (36%), Gaps = 15/213 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
                     +   L+ L +  +++     S        A +       +        C 
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSN--------FLLIGNLKVLVQVD 111
            + ++   L    N  T         LK +  L L  N         L+  N+  L  +D
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409

Query: 112 LSMNNF-SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
           +S+N+  S     T    + +  L L  N L GS+   +     +K L+L NN +  +IP
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIP 466

Query: 171 ISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
             +  L  L+++NV+ N+L+  +P  G F   +
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVP-DGVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 81.5 bits (201), Expect = 2e-16
 Identities = 45/177 (25%), Positives = 67/177 (37%), Gaps = 21/177 (11%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           ++      +          L+   N    S+      L  L  L    N L         
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVAL 397

Query: 62  NLTNLRNLYLGSNKLTSIPS------TLWNLKDILYLDLSSNFL-------LIGNLKVLV 108
              N+ +L      L S+ S        W  + IL L+LSSN L       L   +KVL 
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAW-AESILVLNLSSNMLTGSVFRCLPPKVKVL- 455

Query: 109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNN 164
             DL  N     IP  +  L+ LQ L +  N+L+ S+PD + D L +L+ + L +N 
Sbjct: 456 --DLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 47/222 (21%), Positives = 78/222 (35%), Gaps = 21/222 (9%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGF-VPA 58
            +N   S+   V    Q L+ L +  N+L+ +I      +A+L  LD   N  D   V  
Sbjct: 84  SHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCK 140

Query: 59  CFGNLTNLRNLYLGSNKLTSIP-------STLWNLKDILYLDLSSN---FLLIGNLKVLV 108
            FGNLT L  L L + K   +             L D++   +       L I N  VL 
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200

Query: 109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI--GDLINLKSLNLSNNNLS 166
            V    + FS  +  ++  L  LQ   ++ N        +           LN++  ++ 
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260

Query: 167 GTIPISLEKLLDLKDINVSFNKLEG----EIPNKGPFRNFST 204
            T   S++         V +  +      E  ++  F    T
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET 302

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 32/165 (19%), Positives = 58/165 (35%), Gaps = 22/165 (13%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            + LSL  N +      D+  L+ L  L    N++       F    +L  L +  N+L 
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113

Query: 78  SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV-IPTTIGGLKDLQYLFL 136
           +I                        +  L  +DLS N+F  + +    G L  L +L L
Sbjct: 114 NISC--------------------CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153

Query: 137 EYNRLQGSIPDSIGDL-INLKSLNLSNNNLSGTIPISLEKLLDLK 180
              + +      +  L ++   L+L + ++ G    SL+      
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 31/150 (20%), Positives = 55/150 (36%), Gaps = 30/150 (20%)

Query: 56  VPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMN 115
           VP         + L L  N ++ +                 +   +  L+VL    LS N
Sbjct: 46  VPK--DLPPRTKALSLSQNSISELR--------------MPDISFLSELRVL---RLSHN 86

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE- 174
               +        +DL+YL + +NRLQ +I      + +L+ L+LS N+    +P+  E 
Sbjct: 87  RIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEF 142

Query: 175 -KLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
             L  L  + +S  K       +      +
Sbjct: 143 GNLTKLTFLGLSAAKFR-----QLDLLPVA 167

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 11/84 (13%)

Query: 110 VDLSMNNFSDV---IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
           VD S  N + V   +P         + L L  N +       I  L  L+ L LS+N + 
Sbjct: 36  VDYSNRNLTHVPKDLPPR------TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR 89

Query: 167 GTIPISL-EKLLDLKDINVSFNKL 189
            ++   +     DL+ ++VS N+L
Sbjct: 90  -SLDFHVFLFNQDLEYLDVSHNRL 112

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.8 bits (236), Expect = 8e-21
 Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 45/214 (21%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-------------ECDMIK 343
             +G G +G V   +      E A+KV         +  D              E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 344 RIRHRNIIKIISSCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDV 398
            + H NIIK+        +  LV E+   G L      +  +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
            S + YLH      I+H D+KP N+LL   +  +   + DFG++     +D  L     L
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRL 209

Query: 456 ATIGYMAPE-----YGREGQVSTNGDVYSFGIML 484
            T  Y+APE     Y  +       DV+S G+++
Sbjct: 210 GTAYYIAPEVLKKKYNEK------CDVWSCGVIM 237

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 89.6 bits (223), Expect = 9e-21
 Identities = 35/172 (20%), Positives = 69/172 (40%), Gaps = 11/172 (6%)

Query: 22  SLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS 81
            L+ +Q   +IPD      A      G +       A    + +L  + L +  +T + +
Sbjct: 7   GLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDL-T 60

Query: 82  TLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLE 137
            +    +I  L +++        I  L  L ++ +   + +      + GL  L  L + 
Sbjct: 61  GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120

Query: 138 YNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
           ++    SI   I  L  + S++LS N     I   L+ L +LK +N+ F+ +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 32/197 (16%), Positives = 67/197 (34%), Gaps = 17/197 (8%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +  N +IP +    +      L  +         +    +L  +      +         
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTG--IE 63

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMN 115
              N+++L + +   T+  + +  L ++  L +    +       +  L  L  +D+S +
Sbjct: 64  YAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
              D I T I  L  +  + L YN     I   +  L  LKSLN+  + +       +E 
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IED 179

Query: 176 LLDLKDINVSFNKLEGE 192
              L  +      + G+
Sbjct: 180 FPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 20/124 (16%), Positives = 41/124 (33%), Gaps = 6/124 (4%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             +     PI+   L  L+ L +    +      +L  L +L  LD   +  D  +    
Sbjct: 75  NIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNN 116
             L  + ++ L  N   +    L  L ++  L++  + +     I +   L Q+      
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQT 192

Query: 117 FSDV 120
               
Sbjct: 193 IGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 22/135 (16%), Positives = 44/135 (32%), Gaps = 24/135 (17%)

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI 121
                 N  LG +   +I                        +  L  + L+  N +D+ 
Sbjct: 21  TFKAYLNGLLGQSSTANIT--------------------EAQMNSLTYITLANINVTDLT 60

Query: 122 PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKD 181
              I    +++ L +         P  I  L NL+ L +   +++     +L  L  L  
Sbjct: 61  G--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116

Query: 182 INVSFNKLEGEIPNK 196
           +++S +  +  I  K
Sbjct: 117 LDISHSAHDDSILTK 131

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 42/196 (21%), Positives = 76/196 (38%), Gaps = 26/196 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKIISS 356
           +GRG FG V++            K       +      +  E  ++   RHRNI+ +  S
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 357 CSSDDFKALVLEYMPHGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
             S +   ++ E++    +           +   I+        +  V  AL++LH    
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVS------YVHQVCEALQFLHSHN- 122

Query: 411 VPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
             I H D++P N++      + +   +FG A+  LK   +           Y APE  + 
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYYAPEVHQH 177

Query: 469 GQVSTNGDVYSFGIML 484
             VST  D++S G ++
Sbjct: 178 DVVSTATDMWSLGTLV 193

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 28/201 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNIIK 352
           +G G F  V K R    G+E A K    +  RA +          E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
           +     +     L+LE +  G L     +K   S             +  +   + YLH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLH- 132

Query: 408 GYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
             +  I H DLKP N++L           L DFG+A   +++           T  ++AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAP 187

Query: 464 EYGREGQVSTNGDVYSFGIML 484
           E      +    D++S G++ 
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.5 bits (235), Expect = 2e-20
 Identities = 58/261 (22%), Positives = 109/261 (41%), Gaps = 31/261 (11%)

Query: 263 RGKPLPNDANMPRISNQRRFTYLEIFQAT-NGFSENNLIGRGGFGSVYKARIQDGMEV-A 320
              P  +  +    +   ++ +LE    T N F +  ++G+GGFG V   +++   ++ A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 321 VKVFDLQYGRAFKSFDIECDMIKR-----IRHRNIIKIISSCSSDDFKALVLEYMPHGSL 375
            K   L+  R  K       + ++     +  R ++ +  +  + D   LVL  M  G L
Sbjct: 214 CKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271

Query: 376 EKCLYSSNYILDIFQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH 432
           +  +Y  +     F     +    ++   LE LH      I++ DLKP N+LLDD+    
Sbjct: 272 KFHIY--HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR 326

Query: 433 LSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-- 489
           +SD G+A  + +        +    T+GYMAPE  +  + + + D ++ G +L E     
Sbjct: 327 ISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

Query: 490 -------RKKPTDEIFFGDMT 503
                  +K   +E+      
Sbjct: 383 SPFQQRKKKIKREEVERLVKE 403

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 63/254 (24%), Positives = 99/254 (38%), Gaps = 41/254 (16%)

Query: 274 PRISNQRRFTYLEI----FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK----VF 324
            R      F  +EI    F     +     IG G  G V  A        VA+K     F
Sbjct: 3   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF 62

Query: 325 DLQYG--RAFKSFDIECDMIKRIRHRNIIKI----ISSCSSDDFKA--LVLEYMP---HG 373
             Q    RA++    E  ++K + H+NII +        S ++F+   +V+E M      
Sbjct: 63  QNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118

Query: 374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
            ++  L        ++Q L         +++LH   S  IIH DLKPSN+++  +    +
Sbjct: 119 VIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 168

Query: 434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 493
            DFG+A+       S   T  + T  Y APE         N D++S G ++ E       
Sbjct: 169 LDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV- 224

Query: 494 TDEIFFGDMTLKHW 507
              +F G   +  W
Sbjct: 225 ---LFPGTDHIDQW 235

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.0 bits (227), Expect = 2e-20
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKII 354
           IG G +G+V+KA+  +    VA+K   L      +        E  ++K ++H+NI+++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLH 67

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
               SD    LV E+     L+K   S N  LD     + +  +   L + H   S  ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVS 472
           H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+  +G +   S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAK-LYS 180

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
           T+ D++S G +  E     +P   +F G+
Sbjct: 181 TSIDMWSAGCIFAELANAGRP---LFPGN 206

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 42/208 (20%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD------LQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G F  V K R    G E A K          + G + +  + E ++++ IRH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 400
           +     +     L+LE +  G L             F  L              +  +  
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH----LSDFGMAKPLLKEDQSLTQTQTLA 456
            + YLH   S  I H DLKP N++L D  V +    L DFG+A   ++            
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFG 173

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIML 484
           T  ++APE      +    D++S G++ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 52/249 (20%), Positives = 91/249 (36%), Gaps = 67/249 (26%)

Query: 273 MPRISNQRRFTYLEIFQA----TNGFSE-----NNLIGRGGFGSVYKAR-IQDGMEVAVK 322
           M    +        +FQ         ++       ++G G  G V +    + G + A+K
Sbjct: 1   MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60

Query: 323 VFDLQYGRAFKSFDI--ECDMIKRI-RHRNIIKII----SSCSSDDFKALVLEYMPHGSL 375
           +          S     E D   +     +I+ I+    +         +++E M  G L
Sbjct: 61  LLY-------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113

Query: 376 EKCLYSSNYILD-IFQRLN----------IMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
                        I +R +          IM D+ +A+++LH   S  I H D+KP N+L
Sbjct: 114 ----------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLL 160

Query: 425 L---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE------YGREGQVSTNG 475
               + + V  L+DFG AK       +L       T  Y+APE      Y +        
Sbjct: 161 YTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCYTPYYVAPEVLGPEKYDKS------C 210

Query: 476 DVYSFGIML 484
           D++S G+++
Sbjct: 211 DMWSLGVIM 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 56/240 (23%)

Query: 288 FQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVK--VFDLQY-GRAFKSFDIECDMIKR 344
            Q    ++   +IG G FG V++A++ +  EVA+K  + D ++  R       E  +++ 
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRI 88

Query: 345 IRHRNIIK----IISSCSSDDFKA--LVLEYMP--------HGSLEKCLYSSNYI-LDIF 389
           ++H N++       S+    D     LVLEY+P        H +  K       I L ++
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQS 448
           Q L        +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK L+  + +
Sbjct: 149 QLLR-------SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 449 LTQTQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                 + +  Y APE       Y      +TN D++S G ++ E     +P   +F G+
Sbjct: 199 ---VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 90.6 bits (226), Expect = 2e-20
 Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 43/287 (14%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-AFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           IG G +G VYKA+   G   A+K   L+       S  I E  ++K ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            +     LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNG 475
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+   G + + ST  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSK-KYSTTI 182

Query: 476 DVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHWVNDLLPIS 515
           D++S G +  E                          P  + +     L  +  +     
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                         +     G       +L  K     P QRI AK+
Sbjct: 243 ------PLPWESFLKGLDESG------IDLLSKMLKLDPNQRITAKQ 277

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 42/208 (20%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNIIK 352
           +G G F  V K R    G+E A K    +  RA +          E  +++++ H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 400
           +     +     L+LE +  G L             F  L            + +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 456
            + YLH   +  I H DLKP N++L           L DFG+A   +++           
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFG 180

Query: 457 TIGYMAPEYGREGQVSTNGDVYSFGIML 484
           T  ++APE      +    D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 48/291 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFK-SFDI----ECDMIKRIRHRNIIKI 353
           +G G F +VYKAR       VA+K   L +    K   +     E  +++ + H NII +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           + +       +LV ++M    LE  +  ++ +L        M+     LEYLH      I
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQV 471
           +H DLKP+N+LLD+N V  L+DFG+AK     +++   T  + T  Y APE  +G     
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR-MY 190

Query: 472 STNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHWVNDL 511
               D+++ G +L E   R                      PT+E +    +L  +V   
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-- 248

Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                 +      L                  +L     + +P  RI A +
Sbjct: 249 -----FKSFPGIPLHHIFSAAGDDL------LDLIQGLFLFNPCARITATQ 288

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 37/204 (18%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD-LQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
           +G G FG V+       G+E  +K  +  +     +  + E +++K + H NIIKI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---------NIMIDVASALEYLHFG 408
                  +V+E    G L         I+    R           +M  + +AL Y H  
Sbjct: 90  EDYHNMYIVMETCEGGEL------LERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141

Query: 409 YSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE- 464
            S  ++H DLKP N+L      +    + DFG+A+ L K D+    T    T  YMAPE 
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAPEV 197

Query: 465 ----YGREGQVSTNGDVYSFGIML 484
                  +       D++S G+++
Sbjct: 198 FKRDVTFK------CDIWSAGVVM 215

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 32/202 (15%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIRHR-NIIK 352
           +GRG F  V +      G E A K       R            E  +++  +    +I 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 353 IISSCSSDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRL------NIMIDVASALEYL 405
           +     +     L+LEY   G +   C      + ++ + +       ++  +   + YL
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAH---LSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
           H      I+H DLKP N+LL          + DFGM++  +     L   + + T  Y+A
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLA 201

Query: 463 PEYGREGQVSTNGDVYSFGIML 484
           PE      ++T  D+++ GI+ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 38/206 (18%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD--------LQYGRAFKSFDIECDMIKRIRHRNI 350
           +G G FG V+ A   +   EV VK                      +E  ++ R+ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVA 399
           IK++    +  F  LV+E    G L+  L+   +I             IF++L       
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD--LF--AFIDRHPRLDEPLASYIFRQL------V 140

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 459
           SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L  T    TI 
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194

Query: 460 YMAPE-YGREGQVSTNGDVYSFGIML 484
           Y APE            +++S G+ L
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTL 220

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.1 bits (226), Expect = 4e-20
 Identities = 52/261 (19%), Positives = 96/261 (36%), Gaps = 71/261 (27%)

Query: 300 IGRGGFGSVYKARI------QDGMEVAVK-VFDLQYGRAFKSFDIECDMIKRI-RHRNII 351
           +GRG FG V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 352 KIISSCSSDDFKALV-LEYMPHGSLEKCL----------------------YSSNYILDI 388
            ++ +C+      +V +E+   G+L   L                      Y     +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 389 FQRLNIMI------------------------------DVASALEYLHFGYSV------- 411
            +RL+ +                               D  +    + + + V       
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 412 ---PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
                IH DL   N+LL +  V  + DFG+A+ + K+   + +      + +MAPE   +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 469 GQVSTNGDVYSFGIMLMETFT 489
              +   DV+SFG++L E F+
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 39/235 (16%)

Query: 288 FQATNGFSENNLIGRGGFGSVYKARIQD-GMEVAVK-VFDLQYGRAFKSFDI-ECDMIKR 344
            +  + F    + G+G FG+V   + +  GM VA+K V        F++ ++     +  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDLAV 75

Query: 345 IRHRNIIK---IISSCSSDDFK----ALVLEYMP---HGSLEKCLYSSNYILDIFQRLNI 394
           + H NI++      +    D +     +V+EY+P   H               I  ++  
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-F 134

Query: 395 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQ 453
           +  +  ++  LH   SV + H D+KP NVL++  +    L DFG AK L   + +     
Sbjct: 135 LFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VA 190

Query: 454 TLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
            + +  Y APE       Y      +T  D++S G +  E     +P   IF GD
Sbjct: 191 YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.0 bits (224), Expect = 6e-20
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 28/201 (13%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFD------LQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +G G F  V K R    G++ A K          + G + +  + E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
           +     +     L+LE +  G L     EK   +     +       +  + + + YLH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131

Query: 408 GYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
             S+ I H DLKP N++L           + DFG+A   +             T  ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVAP 186

Query: 464 EYGREGQVSTNGDVYSFGIML 484
           E      +    D++S G++ 
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 36/200 (18%), Positives = 67/200 (33%), Gaps = 17/200 (8%)

Query: 15  LQKLQLLSLEDNQLEGSIPDD-LCRLAALFELD-SGGNKLDGFVPACFGNLTNLRNLYLG 72
              L+ + +  N +   I  D    L  L E+     N L    P  F NL NL+ L + 
Sbjct: 53  FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112

Query: 73  SNKLTSIPS-TLWNLKDILYLDLSSNFLL--------IGNLKVLVQVDLSMNNFSDVIPT 123
           +  +  +P     +    + LD+  N  +        +G     V + L+ N   ++  +
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS 172

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDIN 183
              G +  +    + N L+    D          L++S   +       LE L  L+  +
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 232

Query: 184 VSFNKLEGEIPNKGPFRNFS 203
               K   ++P         
Sbjct: 233 TYNLK---KLP---TLEKLV 246

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 7e-17
 Identities = 40/202 (19%), Positives = 74/202 (36%), Gaps = 16/202 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA-C 59
            + +   IP  +   +    L     +L             L +++   N +   + A  
Sbjct: 18  ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74

Query: 60  FGNLTNLRNLYL-GSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVD 111
           F NL  L  + +  +N L  I      NL ++ YL +S+  +         +    V +D
Sbjct: 75  FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134

Query: 112 LSMNNFSDVIPT-TIGGL-KDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI 169
           +  N     I   +  GL  +   L+L  N +Q  I +S  +   L  LNLS+NN    +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 170 PI-SLEKLLDLKDINVSFNKLE 190
           P            +++S  ++ 
Sbjct: 194 PNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 15/160 (9%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDL-CRLAALFELDSGGN-KLDGFVPACFGNLT-NLRNLY 70
            L  LQ L + +  ++  +PD           LD   N  +       F  L+     L+
Sbjct: 102 NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160

Query: 71  LGSNKLTSIPSTLWNLKDILYLDLSSNFLL-------IGNLKVLVQVDLSMNNFSDVIPT 123
           L  N +  I ++ +N   +  L+LS N  L              V +D+S      +   
Sbjct: 161 LNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN 163
            +  LK L+       +    +P ++  L+ L   +L+  
Sbjct: 221 GLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 35/186 (18%), Positives = 62/186 (33%), Gaps = 15/186 (8%)

Query: 21  LSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI- 79
              +++++   IP DL       EL     KL       F    +L  + +  N +  + 
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 80  -PSTLWNLKDILYLDLS-SNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDL 131
                 NL  +  + +  +N L         NL  L  + +S      +           
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130

Query: 132 QYLFLEYNRLQGSIPDSI--GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
             L ++ N    +I  +   G       L L+ N +   I  S      L ++N+S N  
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189

Query: 190 EGEIPN 195
             E+PN
Sbjct: 190 LEELPN 195

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 21/133 (15%), Positives = 45/133 (33%), Gaps = 23/133 (17%)

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTT 124
           + R      +K+T IPS L   ++ + L                           +    
Sbjct: 10  SNRVFLCQESKVTEIPSDL--PRNAIELRFVLT------------------KLRVIQKGA 49

Query: 125 IGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDI 182
             G  DL+ + +  N +   I   +  +L  L  + +   N    I     + L +L+ +
Sbjct: 50  FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109

Query: 183 NVSFNKLEGEIPN 195
            +S   ++  +P+
Sbjct: 110 LISNTGIK-HLPD 121

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 17/84 (20%), Positives = 28/84 (33%), Gaps = 3/84 (3%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
            Q  +L   ++N LE    D     +    LD    ++         NL  LR       
Sbjct: 177 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--Y 234

Query: 75  KLTSIPSTLWNLKDILYLDLSSNF 98
            L  +P+ L  L  ++   L+   
Sbjct: 235 NLKKLPT-LEKLVALMEASLTYPS 257

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 57/213 (26%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRI-RHRNIIKII- 354
           +G G  G V +    +   + A+K+                E ++  R  +  +I++I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 355 ---SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-IFQRLN----------IMIDVAS 400
              +  +      +V+E +  G L             I  R +          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           A++YLH   S+ I H D+KP N+L      N +  L+DFG AK       SL  T    T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSL--TTPCYT 226

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIML 484
             Y+APE      Y +        D++S G+++
Sbjct: 227 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 55/265 (20%)

Query: 268 PNDANMPRISNQRRFTYLEIFQATNG----------FSENNLIGRGGFGSVYKARIQD-G 316
           P+     ++S  +  + +    AT G          +++  +IG G FG VY+A++ D G
Sbjct: 20  PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79

Query: 317 MEVAVK-VF-DLQY-GRAFKSFDIECDMIKRIRHRNIIK----IISSCSSDDFKAL--VL 367
             VA+K V  D ++  R       E  +++++ H NI++      SS    D   L  VL
Sbjct: 80  ELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132

Query: 368 EYMP---HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL 424
           +Y+P   +        +   +  I+ +L  M  +  +L Y+H   S  I H D+KP N+L
Sbjct: 133 DYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH---SFGICHRDIKPQNLL 188

Query: 425 LD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGREGQVSTNGD 476
           LD D  V  L DFG AK L++ + +      + +  Y APE       Y      +++ D
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDY------TSSID 239

Query: 477 VYSFGIMLMETFTRKKPTDEIFFGD 501
           V+S G +L E     +P   IF GD
Sbjct: 240 VWSAGCVLAELLLG-QP---IFPGD 260

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 60/287 (20%), Positives = 112/287 (39%), Gaps = 42/287 (14%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           +G G + +VYK +       VA+K   L++        I E  ++K ++H NI+ +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            ++    LV EY+    L++ L     I+++      +  +   L Y H      ++H D
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQVSTNG 475
           LKP N+L+++     L+DFG+A+      ++      + T+ Y  P+   G     ST  
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDILLGST-DYSTQI 182

Query: 476 DVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHWVNDLLPIS 515
           D++  G +  E  T +                     PT+E + G ++ + +     P  
Sbjct: 183 DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP-- 240

Query: 516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                 A  L        + G       +L  K        RI+A++
Sbjct: 241 ---KYRAEALLSHAPRLDSDG------ADLLTKLLQFEGRNRISAED 278

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 37/240 (15%)

Query: 272 NMPRISNQRRFTYLEI----FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK---- 322
           NM +     +F  +E+    F     +     IG G  G V  A        VA+K    
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 323 VFDLQYG--RAFKSFDIECDMIKRIRHRNIIKII----SSCSSDDFKA--LVLEYMP--- 371
            F  Q    RA++    E  ++K + H+NII ++       + ++F+   LV+E M    
Sbjct: 98  PFQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153

Query: 372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA 431
              ++  L        ++Q L         +++LH   S  IIH DLKPSN+++  +   
Sbjct: 154 CQVIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTL 203

Query: 432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
            + DFG+A+       S   T  + T  Y APE         N D++S G ++ E    K
Sbjct: 204 KILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 42/213 (19%), Positives = 80/213 (37%), Gaps = 15/213 (7%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
           G         +   L+ L +  +  +             + +   +   +        C 
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 61  GNLTNLRNLYLGSNKLTSIPST-LWNLKDILYLDLSSNFL--------LIGNLKVLVQVD 111
             ++   +L   +N LT        +L ++  L L  N L        +   +K L Q+D
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 112 LSMNNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
           +S N+ S           K L  L +  N L  +I   +     +K L+L +N +  +IP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP 437

Query: 171 ISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
             + KL  L+++NV+ N+L+  +P  G F   +
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVP-DGIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 83.0 bits (205), Expect = 6e-17
 Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 18/177 (10%)

Query: 2   NNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLD--GFVPA 58
            +    + +    K+     L   +N L  ++ ++   L  L  L    N+L     +  
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368

Query: 59  CFGNLTNLRNLYLGSNKLTSI--PSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQ 109
               + +L+ L +  N ++           K +L L++SSN L       L   +KVL  
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVL-- 426

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNL 165
            DL  N     IP  +  L+ LQ L +  N+L+ S+PD I   L +L+ + L  N  
Sbjct: 427 -DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 36/180 (20%), Positives = 66/180 (36%), Gaps = 12/180 (6%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
             +L++  N +      D+  L+ L  L    N++     + F     L  L L  NKL 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 78  SIPSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKD 130
            I        ++ +LDLS N           GN+  L  + LS  +        I  L  
Sbjct: 83  KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140

Query: 131 LQ-YLFLEYNRLQGSIPDSIGDL--INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
            +  L L     +   P+ + D    +L  +  +N      + +S++ + +L+  N+   
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 13/127 (10%)

Query: 1   GNNLNGSIPIAVG---KLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFV 56
            N L   +        +++ LQ L +  N +        C    +L  L+   N L   +
Sbjct: 357 MNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415

Query: 57  PACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLI------GNLKVLVQV 110
             C      ++ L L SNK+ SIP  +  L+ +  L+++SN L          L  L ++
Sbjct: 416 FRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473

Query: 111 DLSMNNF 117
            L  N +
Sbjct: 474 WLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 24/129 (18%)

Query: 73  SNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ 132
            N L  +P            DLS          +L   ++S N  S++  + I  L  L+
Sbjct: 9   KNGLIHVPK-----------DLSQK------TTIL---NISQNYISELWTSDILSLSKLR 48

Query: 133 YLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE 192
            L + +NR+Q            L+ L+LS+N L     IS    ++LK +++SFN  +  
Sbjct: 49  ILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD-A 104

Query: 193 IPNKGPFRN 201
           +P    F N
Sbjct: 105 LPICKEFGN 113

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 31/216 (14%), Positives = 60/216 (27%), Gaps = 28/216 (12%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAAL---------FELDSGGNKL 52
                        LQ     SL            +  ++            +     NK 
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206

Query: 53  DGFVPACFGNLTN-------LRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIG--- 102
             F+       TN       L N+    N    I   +W+   + Y  +S+  L      
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH-TTVWYFSISNVKLQGQLDF 265

Query: 103 --------NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN 154
                   +LK L    +  + F            ++       +  +         +  
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325

Query: 155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
              L+ SNN L+ T+  +   L +L+ + +  N+L+
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 30/216 (13%), Positives = 64/216 (29%), Gaps = 27/216 (12%)

Query: 1   GNNLNGSIPIA--VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVP- 57
            N  + ++PI    G + +L+ L L    LE S    +  L     L   G         
Sbjct: 99  FNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157

Query: 58  ------------------ACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL 99
                               F  + ++    + + +L++I   L + K   +L + +   
Sbjct: 158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ 217

Query: 100 LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN----- 154
               L  L   ++     S +    +     + Y  +   +LQG +     D        
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277

Query: 155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
           L    + ++          E   ++   N + +   
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 37/185 (20%), Positives = 75/185 (40%), Gaps = 15/185 (8%)

Query: 324 FDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSN 383
           + L       +  ++   +     +N +  +   S   +  + ++     +L+  +    
Sbjct: 97  WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 384 YI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 441
            +   +    L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 442 LLKEDQSLTQTQTLA----------TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 491
           + ++++  T    +           T  YM+PE       S   D++S G++L E     
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273

Query: 492 KPTDE 496
               E
Sbjct: 274 STQME 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 2/91 (2%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNII 351
           F     +GRGGFG V++A+   D    A+K   L     A +    E   + ++ H  I+
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSS 382
           +  ++      +    E       ++     
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 35/234 (14%), Positives = 69/234 (29%), Gaps = 37/234 (15%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           +       + V    +L  L    N++      D+ +   L  L+   N +         
Sbjct: 156 HLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKLD---LN 209

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL---IGNLKVLVQVDLSMNNFS 118
               L  L   SNKLT I   +  L  + Y D S N L    +  L  L  +     +  
Sbjct: 210 QNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLL 267

Query: 119 DV-------------------IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN 159
           ++                       +     L  L  +   +   +   +     L  L 
Sbjct: 268 EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324

Query: 160 LSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL 213
           L+N  L+  + +S      LK ++     ++ +  + G     +       + +
Sbjct: 325 LNNTELT-ELDVS--HNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 36/207 (17%), Positives = 68/207 (32%), Gaps = 23/207 (11%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            NN+   + +   +  +L  L    N+L   I  D+  L  L   D   N L        
Sbjct: 200 TNNIT-KLDL--NQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLTEL---DV 250

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSN----FLLIGNLKVLVQVDLSMNN 116
             L+ L  L+     L  I   L +   ++Y           L + +   L  +D     
Sbjct: 251 STLSKLTTLHCIQTDLLEID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAG 308

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            +++    +     L YL+L    L   +   +     LKSL+  N ++      S+ K+
Sbjct: 309 ITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKI 360

Query: 177 LDLKDINVSFNKLEGEIPNKGPFRNFS 203
             L +   +  +            + +
Sbjct: 361 PALNNNFEAEGQTITMPKETLTNNSLT 387

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 36/179 (20%), Positives = 60/179 (33%), Gaps = 18/179 (10%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
                  + E    +        +LA L  LD   + +          LT L  L   SN
Sbjct: 20  FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSN 74

Query: 75  KLTSIPSTLWNLKDILYLDLSSNFLL---IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDL 131
            +T++   L    ++ YL   SN L    +  L  L  ++   N  + +    +     L
Sbjct: 75  NITTLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKL---DVSQNPLL 129

Query: 132 QYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
            YL    N L   I   +     L  L+   N     + ++      L  ++ SFNK+ 
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 24/168 (14%), Positives = 52/168 (30%), Gaps = 14/168 (8%)

Query: 10  IAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           I +    +L     E  +    +  D+     L+ LD     +             L  L
Sbjct: 269 IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITELD---LSQNPKLVYL 323

Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTI 125
           YL + +LT +   + +   +  L   +  +     +G +  L     +      +   T+
Sbjct: 324 YLNNTELTELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETL 381

Query: 126 GGLKDLQYLFLEYNRLQG---SIPDSIGDLINLKSLNLSNNNLSGTIP 170
                   +  +     G   +I    G + +  +  ++  NLS   P
Sbjct: 382 TNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 90.3 bits (224), Expect = 4e-19
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 26/224 (11%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDM--------IKR 344
           FS + +IGRGGFG VY  R  D  ++ A+K   L   R          +        +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 345 IRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                I+ +  +  + D  + +L+ M  G L   L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 463
           +H   +  +++ DLKP+N+LLD++    +SD G+A    K+     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

Query: 464 EYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKH 506
           E  ++G    +  D +S G ML +      P    F    T   
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK 399

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 52/241 (21%), Positives = 101/241 (41%), Gaps = 41/241 (17%)

Query: 272 NMPRISNQRRFTYLEI----FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK---- 322
           ++  +  ++ F   ++    ++    +     +G G +GSV  A   + G +VA+K    
Sbjct: 1   SLS-LIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR 59

Query: 323 VFDLQYG--RAFKSFDIECDMIKRIRHRNIIKI----ISSCSSDDFKA--LVLEYMP--- 371
            F  +    RA++    E  ++K ++H N+I +      + S  +F    LV+ +M    
Sbjct: 60  PFQSEIFAKRAYR----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL 115

Query: 372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA 431
              +            ++Q L         L+Y+H   S  ++H DLKP N+ ++++   
Sbjct: 116 QKIMGLKFSEEKIQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCEL 165

Query: 432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTR 490
            + DFG+A+           T  + T  Y APE        +   D++S G ++ E  T 
Sbjct: 166 KILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

Query: 491 K 491
           K
Sbjct: 221 K 221

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 49/181 (27%), Positives = 70/181 (38%), Gaps = 15/181 (8%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
            + L L+ N+L         RL  L  L    NKL       F  L NL  L++  NKL 
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98

Query: 78  SIPS-TLWNLKDILYLDLSSN---------FLLIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
           ++P      L ++  L L  N         F  +  L  L    L  N    +       
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL---SLGYNELQSLPKGVFDK 155

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 186
           L  L+ L L  N+L+  +P+   D L  LK+L L NN L      + + L  LK + +  
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

Query: 187 N 187
           N
Sbjct: 215 N 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 22/160 (13%)

Query: 7   SIPIAV-GKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFELDSGGNKLDGFVPACFGNLT 64
           ++P  +  +L+ L+ L + DN+L+ ++P  +  +L  L EL    N+L    P  F +LT
Sbjct: 75  TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT 133

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTT 124
            L  L LG N+L S+P  +              F  + +LK L    L  N    V    
Sbjct: 134 KLTYLSLGYNELQSLPKGV--------------FDKLTSLKEL---RLYNNQLKRVPEGA 176

Query: 125 IGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNN 163
              L +L+ L L+ N+L+  +P+   D L  LK L L  N
Sbjct: 177 FDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 11/135 (8%)

Query: 64  TNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNN 116
            + + L L SNKL+S+PS  +  L  +  L L+ N L      +   LK L  + ++ N 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIPISL-E 174
              +       L +L  L L+ N+L+ S+P  + D L  L  L+L  N L  ++P  + +
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 175 KLLDLKDINVSFNKL 189
           KL  LK++ +  N+L
Sbjct: 155 KLTSLKELRLYNNQL 169

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 15/147 (10%)

Query: 51  KLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNL 104
           K DG V +C  N  ++      S KLT+IPS +    D   LDL SN L          L
Sbjct: 6   KKDGGVCSCNNNKNSV---DCSSKKLTAIPSNI--PADTKKLDLQSNKLSSLPSKAFHRL 60

Query: 105 KVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNN 163
             L  + L+ N    +       LK+L+ L++  N+LQ ++P  + D L+NL  L L  N
Sbjct: 61  TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119

Query: 164 NLSGTIPISL-EKLLDLKDINVSFNKL 189
            L  ++P  + + L  L  +++ +N+L
Sbjct: 120 QLK-SLPPRVFDSLTKLTYLSLGYNEL 145

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 62/295 (21%), Positives = 118/295 (40%), Gaps = 49/295 (16%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKIISSC 357
           +G G + +VYK      G+ VA+K   L       S  I E  ++K ++H NI+++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYI-----LDIFQRLNIMIDVASALEYLHFGYSVP 412
            +++   LV E+M +  L+K + S         L++         +   L + H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGREGQ 470
           I+H DLKP N+L++      L DFG+A+       +   +  + T+ Y AP+   G    
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSR-T 185

Query: 471 VSTNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHWVND 510
            ST+ D++S G +L E  T K                     P + ++     L  +  +
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN 245

Query: 511 LL---PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
           +    P  + +++  +     D +            +        +P+ R++AK+
Sbjct: 246 IQQRPPRDLRQVLQPHTKEPLDGNL----------MDFLHGLLQLNPDMRLSAKQ 290

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 50/213 (23%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD----LQYGRAFKSFDI--ECDMIKRIRHR--N 349
           L+G GGFGSVY    + D + VA+K  +      +G       +  E  ++K++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALE 403
           +I+++      D   L+LE  P    +  L+  ++I +    L           V  A+ 
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LF--DFITE-RGALQEELARSFFWQVLEAVR 163

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLKEDQSLTQTQTLAT----I 458
           + H   +  ++H D+K  N+L+D N     L DFG          +L +           
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDGTR 212

Query: 459 GYMAPEY-------GREGQVSTNGDVYSFGIML 484
            Y  PE+       GR         V+S GI+L
Sbjct: 213 VYSPPEWIRYHRYHGRS------AAVWSLGILL 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 56/217 (25%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD----LQYGRAFKSFDI--ECDMIKRIR----H 347
           L+G+GGFG+V+    + D ++VA+KV      L +     S     E  ++ ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF------QRL------NIM 395
             +I+++    + +   LVLE                  D+F        L         
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQT 454
             V +A+++ H   S  ++H D+K  N+L+D     A L DFG     L  D+  T    
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD- 199

Query: 455 LATIGYMAPEY-------GREGQVSTNGDVYSFGIML 484
             T  Y  PE+                  V+S GI+L
Sbjct: 200 -GTRVYSPPEWISRHQYHALP------ATVWSLGILL 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.7 bits (213), Expect = 9e-19
 Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 47/209 (22%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNII 351
            +G G +G V  A        VAVK+ D++     ++ D       E  + K + H N++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 400
           K        + + L LEY   G L       + I              F +L       +
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MA 116

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM-AKPLLKEDQSLTQTQTLATIG 459
            + YLH    + I H D+KP N+LLD+     +SDFG+         + L       T+ 
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172

Query: 460 YMAPE--YGRE--GQVSTNGDVYSFGIML 484
           Y+APE    RE   +     DV+S GI+L
Sbjct: 173 YVAPELLKRREFHAEPV---DVWSCGIVL 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 53/300 (17%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIK-- 352
           IG+G FG V+KAR  + G +VA+K   +      + F I    E  +++ ++H N++   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 353 -IISSCSSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
            I  + +S   +      LV ++  H  L   L +      + +   +M  + + L Y+H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGYMAPE 464
                 I+H D+K +NVL+  + V  L+DFG+A+   L K  Q    T  + T+ Y  PE
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198

Query: 465 --YGREGQVSTNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDM 502
              G E       D++  G ++ E +TR                       T E++    
Sbjct: 199 LLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257

Query: 503 TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
             + +    L            +  + + +           +L  K  V  P QRI++ +
Sbjct: 258 NYELYEKLELVKGQ-----KRKVKDRLKAYVRDPYA----LDLIDKLLVLDPAQRIDSDD 308

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 54/211 (25%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKR-------IRHRNI 350
            IG G FG     R       VAVK  +       +   I+ + ++R       +RH NI
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAID-ENVQREIINHRSLRHPNI 78

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVA 399
           ++      +    A+++EY   G L         I +            FQ+L       
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQL------L 126

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLAT 457
           S + Y H   S+ I H DLK  N LLD +    L   DFG +K       S  ++ T+ T
Sbjct: 127 SGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKS-TVGT 180

Query: 458 IGYMAPE--YGRE--GQVSTNGDVYSFGIML 484
             Y+APE    +E  G+++   DV+S G+ L
Sbjct: 181 PAYIAPEVLLRQEYDGKIA---DVWSCGVTL 208

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 15/181 (8%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
              +    +L+   +  ++      L ++ ++ +  + +          L N+  L+L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 74  NKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
           NKLT I   L NLK++ +L L  N +     + +LK L  + L  N  SD+    +  L 
Sbjct: 78  NKLTDI-KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING--LVHLP 134

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
            L+ L+L  N++  +    +  L  L +L+L +N +S  I   L  L  L+++ +S N +
Sbjct: 135 QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190

Query: 190 E 190
            
Sbjct: 191 S 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 11/186 (5%)

Query: 12  VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYL 71
           +  L+ L  L L++N+++  +   L  L  L  L    N +         +L  L +LYL
Sbjct: 86  LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYL 141

Query: 72  GSNKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
           G+NK+T I + L  L  +  L L  N +     +  L  L  + LS N+ SD+    + G
Sbjct: 142 GNNKITDI-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA--LAG 198

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
           LK+L  L L          +   +L+   ++  ++ +L     IS +   +  ++     
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLP 258

Query: 188 KLEGEI 193
           +   E+
Sbjct: 259 EFTNEV 264

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 48/226 (21%), Positives = 93/226 (41%), Gaps = 45/226 (19%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIEC-----DMIKRIRHRNIIK 352
           +IGRG FG V   ++++  +V A+K+  L      K  +  C     D++     + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID----------VASAL 402
           +  +   D+   LV++Y   G L          L +  +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTLATIGY 460
           + +H    +  +H D+KP N+L+D N   H  L+DFG    L+++    +    + T  Y
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242

Query: 461 MAPEYGREGQVSTNG-----DVYSFGIMLMETFTRKKPTDEIFFGD 501
           ++PE  +  +          D +S G+ + E    + P    F+ +
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP----FYAE 284

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 50/227 (22%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIEC-----DMIKRIRHRNIIK 352
           +IGRG FG V   R +   +V A+K+  L      K  D        D++       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA--------SALEY 404
           +  +   D +  +V+EYMP G L          +++    ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           +H   S+  IH D+KP N+LLD +    L+DFG    + KE      T  + T  Y++PE
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPE 239

Query: 465 ----------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
                     YGRE       D +S G+ L E      P    F+ D
Sbjct: 240 VLKSQGGDGYYGRE--C----DWWSVGVFLYEMLVGDTP----FYAD 276

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 34/202 (16%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G G FG V        G +VAVK+ +   ++          E   +K  RH +IIK+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALE 403
              S+     +V+EY+  G L       +YI             +FQ++       SA++
Sbjct: 78  QVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI------LSAVD 125

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           Y H      ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAP 179

Query: 464 E-YGREGQVSTNGDVYSFGIML 484
           E            D++S G++L
Sbjct: 180 EVISGRLYAGPEVDIWSCGVIL 201

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 39/239 (16%)

Query: 274 PRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK-------VFD 325
              +        ++F     ++  + IG G +G V  A    + + VA+K          
Sbjct: 9   AAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY 68

Query: 326 LQYGRAFKSFDIECDMIKRIRHRNIIK---IISSCSSDDFKA--LVLEYMPHGSLEKCLY 380
            Q  R  +    E  ++ R RH NII    II + + +  K   +V + M    L K L 
Sbjct: 69  CQ--RTLR----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK 121

Query: 381 SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 440
           +  ++ +       +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+
Sbjct: 122 T-QHLSNDHICY-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176

Query: 441 PLLKEDQSLTQ-TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK 491
               +       T+ +AT  Y APE       Y      + + D++S G +L E  + +
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 47/209 (22%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIRHRNII 351
            +G G +G V  A        VAVK+ D++     ++ D       E  + K + H N++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 400
           K        + + L LEY   G L       + I              F +L       +
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MA 116

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM-AKPLLKEDQSLTQTQTLATIG 459
            + YLH    + I H D+KP N+LLD+     +SDFG+         + L       T+ 
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLP 172

Query: 460 YMAPE--YGRE--GQVSTNGDVYSFGIML 484
           Y+APE    RE   +     DV+S GI+L
Sbjct: 173 YVAPELLKRREFHAEPV---DVWSCGIVL 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 47/207 (22%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI-----ECDMIKRIRHRNIIKI 353
           IG+G F  V  AR I  G EVA+K+ D           +     E  ++K + H NI+K+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASAL 402
                ++    L++EY   G +       +Y++             F+++       SA+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAV 127

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI---- 458
           +Y H      I+H DLK  N+LLD +M   ++DFG +          T    L       
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAP 177

Query: 459 GYMAPE-YGREGQVSTNGDVYSFGIML 484
            Y APE +  +       DV+S G++L
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVIL 204

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 9e-18
 Identities = 57/326 (17%), Positives = 110/326 (33%), Gaps = 79/326 (24%)

Query: 296 ENNLIGRGGFGSVYKAR---IQDGMEVAVKVFDLQYGRAFKSFDI------ECDMIKRIR 346
           E   +GRG +G VYKA+    +D  + A+K          +   I      E  +++ ++
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALK--------QIEGTGISMSACREIALLRELK 76

Query: 347 HRNIIKIISSCSSDDFKA--LVLEYMPH-------GSLEKCLYSSNYILDIFQRLNIMID 397
           H N+I +     S   +   L+ +Y  H                    L      +++  
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH----LSDFGMAKPLLKEDQSLTQ-T 452
           +   + YLH   +  ++H DLKP+N+L+           ++D G A+      + L    
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 453 QTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK-------------- 491
             + T  Y APE       Y      +   D+++ G +  E  T +              
Sbjct: 194 PVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247

Query: 492 ---------------KPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG 536
                           P D+ +     +      +         + +L+   ++H     
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307

Query: 537 QCVSFIFNLAMKCTVESPEQRINAKE 562
              S  F+L  K     P +RI +++
Sbjct: 308 ---SKAFHLLQKLLTMDPIKRITSEQ 330

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 44/217 (20%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIEC-----DMIKRIRHRNIIK 352
            IG+G FG V   +  D  ++ A+K   +   +  +  ++        +++ + H  ++ 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------------DVAS 400
           +  S   ++   +V++ +  G             D+   L   +            ++  
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEETVKLFICELVM 126

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIG 459
           AL+YL    +  IIH D+KP N+LLD++   H++DF +A  L +E    TQ  T+A T  
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKP 179

Query: 460 YMAPE-YGREGQVSTNGDV--YSFGIMLMETFTRKKP 493
           YMAPE +        +  V  +S G+   E    ++P
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.9 bits (210), Expect = 1e-17
 Identities = 46/228 (20%), Positives = 97/228 (42%), Gaps = 28/228 (12%)

Query: 261 RKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEV 319
           ++  +   + ++ P  S  R  +    +Q  + +   +LIG G +G V +A    +   V
Sbjct: 25  QEGQQRKQHHSSKPTASMPRPHS---DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81

Query: 320 AVK----VF----DLQYGRAFKSFDIECDMIKRIRHRNIIK---IISSCSSDDFKA--LV 366
           A+K    VF    D +  R  +    E  ++ R+ H +++K   I+     + F    +V
Sbjct: 82  AIKKILRVFEDLIDCK--RILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135

Query: 367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD 426
           LE       +K   +  Y+ ++  +  ++ ++   ++Y+H   S  I+H DLKP+N L++
Sbjct: 136 LEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SAGILHRDLKPANCLVN 190

Query: 427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTN 474
            +    + DFG+A+ +   +   +Q         M        +    
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)

Query: 277 SNQRR--FTYLEI----FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK----VFD 325
            +Q R  F   E+    ++    +   + +G G +GSV  A   + G+ VAVK     F 
Sbjct: 8   HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67

Query: 326 LQYG--RAFKSFDIECDMIKRIRHRNIIKI----ISSCSSDDFKA--LVLEYMPHGSLEK 377
                 R ++    E  ++K ++H N+I +      + S ++F    LV   M    L  
Sbjct: 68  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNN 122

Query: 378 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 437
            +       D  Q   ++  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG
Sbjct: 123 IVKCQKLTDDHVQ--FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177

Query: 438 MAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRK 491
           +A+       +   T  +AT  Y APE        +   D++S G ++ E  T +
Sbjct: 178 LARH-----TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 43/233 (18%), Positives = 78/233 (33%), Gaps = 24/233 (10%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFELDSGGNKLDGFVPAC 59
            N++      +  +LQ LQ L +E       I ++  R L++L  L    N+        
Sbjct: 39  LNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGA 98

Query: 60  FGNLTNLRNLYLGSNKLTSI---PSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQ 109
           F  L NL  L L    L       +    L  +  L L  N +          N++    
Sbjct: 99  FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158

Query: 110 VDLSMNNFSDVIPTTIGGL--KDLQYLFLEYNRLQGSIPDSIGD--------LINLKSLN 159
           +DL+ N    +    +     K    L L    LQ      +G           ++ +L+
Sbjct: 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218

Query: 160 LSNNNLSGTIP---ISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEG 209
           LS N    ++            ++ + +S +   G       F++    +F+G
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 32/195 (16%), Positives = 65/195 (33%), Gaps = 23/195 (11%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA-CFGNLTNLRNLYLGSNKL 76
           +  + L  N +         RL  L  L          +    F  L++L  L L  N+ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 77  TSIPS-TLWNLKDILYLDLSSNFL--------LIGNLKVLVQVDLSMNNFSDVIPTTI-G 126
             + +     L ++  L L+   L            L  L  + L  NN   + P +   
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 127 GLKDLQYLFLEYNRLQGSIPDSIGD-----------LINLKSLNLSNNNLSGTIPISLEK 175
            ++    L L +N+++ SI +               L ++   +++   L      +  K
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 176 LLDLKDINVSFNKLE 190
              +  +++S N  +
Sbjct: 211 NTSITTLDLSGNGFK 225

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 39/221 (17%), Positives = 72/221 (32%), Gaps = 36/221 (16%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAA--LFELDSGGNKL--------DGFVPACFGNL 63
            +++  +L L  N+++    +DL          L      L                   
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211

Query: 64  TNLRNLYLGSNKLTSIPS----TLWNLKDILYLDLSSNFLLIGNLKV------------- 106
           T++  L L  N      +           I  L LS+++ +  +                
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

Query: 107 -----LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNL 160
                +   DLS +    ++ +      DL+ L L  N +   I D+    L +L  LNL
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNL 330

Query: 161 SNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRN 201
           S N L        E L  L+ +++S+N +   + +   F  
Sbjct: 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGD-QSFLG 369

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 76.7 bits (189), Expect = 5e-15
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 13/159 (8%)

Query: 18  LQLLSLEDNQLEGSIPDDLCR---LAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
               S      +    +   +    + +   D   +K+   + + F + T+L  L L  N
Sbjct: 251 NMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309

Query: 75  KLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
           ++  I     W L  +L L+LS NFL      +  NL  L  +DLS N+   +   +  G
Sbjct: 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNL 165
           L +L+ L L+ N+L+ S+PD I D L +L+ + L  N  
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 28/120 (23%), Positives = 49/120 (40%), Gaps = 10/120 (8%)

Query: 7   SIPIAV-GKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPACFGNLT 64
           ++  +V      L+ L+L  N++   I D+    L  L +L+   N L       F NL 
Sbjct: 289 ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347

Query: 65  NLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNF 117
            L  L L  N + ++   +   L ++  L L +N L      +   L  L ++ L  N +
Sbjct: 348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 36/175 (20%), Positives = 63/175 (36%), Gaps = 23/175 (13%)

Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKL-TSIPSTLWNLKDILYLDLSSNFLLIG 102
            +D   N +       F  L +L+ L +        I +                F  + 
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT--------------FRGLS 79

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI--PDSIGDLINLKSLNL 160
           +L +L    L  N F  +      GL +L+ L L    L G++   +    L +L+ L L
Sbjct: 80  SLIIL---KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136

Query: 161 SNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC 214
            +NN+    P S    +     ++++FNK++  I       NF  + F    L  
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICE-EDLLNFQGKHFTLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 13/84 (15%), Positives = 25/84 (29%), Gaps = 9/84 (10%)

Query: 110 VDLSMNNFSDV--IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG 167
                     V  +P        + Y+ L  N +      S   L +L+ L +       
Sbjct: 15  AICINRGLHQVPELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68

Query: 168 TIPI-SLEKLLDLKDINVSFNKLE 190
            I   +   L  L  + + +N+  
Sbjct: 69  VIRNNTFRGLSSLIILKLDYNQFL 92

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)

Query: 287 IFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK---VF-DLQYG-RAFKSFDIECD 340
           ++  ++ F   +L+G G +G V  A     G  VA+K    F    +  R  +    E  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIK 61

Query: 341 MIKRIRHRNIIK---IISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 395
           ++K  +H NII    I    S ++F    ++ E M    L + + S+  + D   +   +
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FI 118

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ---- 451
                A++ LH      +IH DLKPSN+L++ N    + DFG+A+ + +     ++    
Sbjct: 119 YQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 452 ----TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK 491
                + +AT  Y APE       Y      S   DV+S G +L E F R+
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 63/295 (21%), Positives = 106/295 (35%), Gaps = 53/295 (17%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI----ECDMIKRIRHRNIIKII 354
           +G G +G VYKA        VA+K   L      +        E  ++K ++HRNII++ 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
           S    +    L+ EY  +  L+K +   N  + +    + +  + + + + H   S   +
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCL 154

Query: 415 HCDLKPSNVLLDDNMVAH-----LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE--YGR 467
           H DLKP N+LL  +  +      + DFG+A+      +    T  + T+ Y  PE   G 
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGS 212

Query: 468 EGQVSTNGDVYSFGIMLMETFTRK--------------------KPTDEIFFGDMTLKHW 507
               ST+ D++S   +  E   +                      P D  + G   L  W
Sbjct: 213 R-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271

Query: 508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                           L          +G       +L        P +RI+AK 
Sbjct: 272 KQSFPKFRGK-----TLKRVLGALLDDEG------LDLLTAMLEMDPVKRISAKN 315

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 49/228 (21%), Positives = 88/228 (38%), Gaps = 47/228 (20%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR-----IRHRNIIK 352
           +IGRG F  V   +++   +V A+K+  +      K  ++ C   +R        R I +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID----------VASAL 402
           +  +   +++  LV+EY   G L          L +  +    I           +  A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTLATIGY 460
           + +H    +  +H D+KP N+LLD     H  L+DFG    L  +    +    + T  Y
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229

Query: 461 MAPEYGREGQVSTNGDVY-------SFGIMLMETFTRKKPTDEIFFGD 501
           ++PE  +          Y       + G+   E F  + P    F+ D
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP----FYAD 273

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 29/210 (13%)

Query: 282 FTYLEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK----VF----DLQYGRAF 332
           F  ++     + +   +LIGRG +G VY A        VA+K    +F    D +  R  
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK--RIL 73

Query: 333 KSFDIECDMIKRIRHRNIIK---IISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILD 387
           +    E  ++ R++   II+   +I       F    +VLE      L+K   +  ++ +
Sbjct: 74  R----EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTE 128

Query: 388 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
              +  I+ ++     ++H      IIH DLKP+N LL+ +    + DFG+A+ +  E  
Sbjct: 129 EHIKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 448 SLTQTQTLATIGYMAPEYGREGQ----VST 473
           +                   + Q    V T
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.5 bits (204), Expect = 7e-17
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 34/202 (16%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G G FG V   +    G +VAVK+ +   ++          E   +K  RH +IIK+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALE 403
              S+     +V+EY+  G L       +YI             +FQ++       S ++
Sbjct: 83  QVISTPSDIFMVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQI------LSGVD 130

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           Y H      ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y AP
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAP 184

Query: 464 E-YGREGQVSTNGDVYSFGIML 484
           E            D++S G++L
Sbjct: 185 EVISGRLYAGPEVDIWSSGVIL 206

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 44/232 (18%)

Query: 288 FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK--VFDLQYG--RAFKSFDIECDMI 342
           F   + + +   +G GG G V+ A        VA+K  V         A +    E  +I
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKII 62

Query: 343 KRIRHRNIIKII------------SSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDI 388
           +R+ H NI+K+                S  +  +  +V EYM    L   L     + + 
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEH 121

Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQ 447
            +    M  +   L+Y+H   S  ++H DLKP+N+ ++ +++V  + DFG+A+ +     
Sbjct: 122 AR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 448 SLTQ-TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK 491
                ++ L T  Y +P        Y      +   D+++ G +  E  T K
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 38/171 (22%), Positives = 65/171 (38%), Gaps = 48/171 (28%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRI-RHRNIIKII- 354
           +G G  G V +    +   + A+K+                E ++  R  +  +I++I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 355 ---SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--------------NIMID 397
              +  +      +V+E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKE 445
           +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK    E
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 3e-16
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 61/216 (28%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIEC-----DMIKRIRHRNIIK 352
            +G G FG V+  R +      A+KV  L+     +   +E       M+  + H  II+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 399
           +  +        ++++Y+  G L                 Y++              +V 
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--------------EVC 116

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL-A 456
            ALEYLH   S  II+ DLKP N+LLD N   H  ++DFG AK           T TL  
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTLCG 165

Query: 457 TIGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
           T  Y+APE      Y +   +    D +SFGI++ E
Sbjct: 166 TPDYIAPEVVSTKPYNKS--I----DWWSFGILIYE 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 43/177 (24%), Positives = 63/177 (35%), Gaps = 27/177 (15%)

Query: 18  LQLLSLEDNQLEGSIP--DDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNK 75
             LL L  N L   +       RL  L  L    N L+      F  + NLR L L SN 
Sbjct: 41  TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99

Query: 76  LTSIPS-TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYL 134
           L ++      +L+ +  L L +N +          V +  N F          +  LQ L
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHI----------VVVDRNAFE--------DMAQLQKL 141

Query: 135 FLEYNRLQGSIP----DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
           +L  N++    P         L  L  L+LS+N L       L+KL       +  +
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 35/156 (22%), Positives = 50/156 (32%), Gaps = 20/156 (12%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
           +L  L  L L  N L   I  +    +  L  LD   N L       F +L  L  L L 
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120

Query: 73  SNKLTSIPS-TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDL 131
           +N +  +      ++  +  L LS N +              +    D        L  L
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQI----------SRFPVELIKDG-----NKLPKL 165

Query: 132 QYLFLEYNRLQGSIPDSIGDLINLK--SLNLSNNNL 165
             L L  N+L+      +  L       L L NN L
Sbjct: 166 MLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.2 bits (177), Expect = 9e-14
 Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 21/143 (14%)

Query: 64  TNLRNLYLGSNKLTSIPS--TLWNLKDILYLDLSSN---------FLLIGNLKVLVQVDL 112
           +    L L  N L+ + +  T   L ++  L LS N         F+ + NL+ L   DL
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL---DL 95

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIP- 170
           S N+   +       L+ L+ L L  N +   +  +   D+  L+ L LS N +S   P 
Sbjct: 96  SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153

Query: 171 ---ISLEKLLDLKDINVSFNKLE 190
                  KL  L  +++S NKL+
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 32/139 (23%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 73  SNKLTSIPSTLWNLKDILYLDLSSNFLLI-------GNLKVLVQVDLSMNNFSDVIPTTI 125
             +L ++P +L        LDLS N L           L  L  + LS N+ + +     
Sbjct: 27  KQQLPNVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF 84

Query: 126 GGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINV 184
             + +L+YL L  N L  ++ + +  DL  L+ L L NN++      + E +  L+ + +
Sbjct: 85  VPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143

Query: 185 SFNKLEGEIPNKGPFRNFS 203
           S N++    P     ++ +
Sbjct: 144 SQNQIS-RFPV-ELIKDGN 160

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.4 bits (194), Expect = 5e-16
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 34/215 (15%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR-AFKSFDI----ECDMIKRIR---HR 348
             IG G +G+VYKAR    G  VA+K   +  G        I    E  +++R+    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 349 NIIKIISSCSSDDFKA-----LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASAL 402
           N+++++  C++          LV E++    L   L  +    L      ++M      L
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
           ++LH   +  I+H DLKP N+L+       L+DFG+A+        +  T  + T+ Y A
Sbjct: 134 DFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRA 187

Query: 463 PE------YGREGQVSTNGDVYSFGIMLMETFTRK 491
           PE      Y      +T  D++S G +  E F RK
Sbjct: 188 PEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 47/239 (19%)

Query: 278 NQRRFTYLEI----FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK----VFDLQY 328
            +  F   E+    ++    + +   +G G +G+V  A   + G +VA+K     F  + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66

Query: 329 G--RAFKSFDIECDMIKRIRHRNIIKII----SSCSSDDFKA--LVLEYMPHGSLEKCLY 380
              RA++    E  ++K +RH N+I ++       + DDF    LV+ +M    L K + 
Sbjct: 67  FAKRAYR----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK 121

Query: 381 SSN-------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 433
                     ++  ++Q L         L Y+H   +  IIH DLKP N+ ++++    +
Sbjct: 122 HEKLGEDRIQFL--VYQMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKI 169

Query: 434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRK 491
            DFG+A+           T  + T  Y APE      + +   D++S G ++ E  T K
Sbjct: 170 LDFGLARQ-----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 55/253 (21%), Positives = 95/253 (37%), Gaps = 73/253 (28%)

Query: 300 IGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDI-ECDMIKRIRHRNIIKII--- 354
           +G G FG V +    + G   A+K            +   E D++K + H NIIK++   
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKVLDHVNIIKLVDYF 69

Query: 355 ---------------------------------SSCSSDDFKA--LVLEYMP---HGSLE 376
                                               +    K   +++EY+P   H  L+
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 377 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSD 435
             + S   I      +  +  +  A+ ++H   S+ I H D+KP N+L++  +    L D
Sbjct: 130 SFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 436 FGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETF 488
           FG AK L+  + S      + +  Y APE       Y      + + D++S G +  E  
Sbjct: 186 FGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELI 236

Query: 489 TRKKPTDEIFFGD 501
              KP   +F G+
Sbjct: 237 LG-KP---LFSGE 245

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 37/203 (18%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKII 354
            +G G FG V  A   +   +VA+K      L+        + E   +K +RH +IIK+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 355 SSCSSDDFKALVLEY---------MPHGSL---EKCLYSSNYILDIFQRLNIMIDVASAL 402
              ++     +V+EY         +    +   E   +        FQ++        A+
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--------FQQI------ICAI 121

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
           EY H      I+H DLKP N+LLDDN+   ++DFG++   +  D +  +T +  +  Y A
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAA 175

Query: 463 PE-YGREGQVSTNGDVYSFGIML 484
           PE    +       DV+S GI+L
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVL 198

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.1 bits (197), Expect = 7e-16
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 60/232 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  +  +   E+ AVK+  L+     +  D+EC M+ KR+     +   + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-------------EKCLYSSNYILDIFQRLNIMIDV 398
           ++ S   + D    V+EY+  G L                 Y++              ++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 451

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-T 457
           A  L +L    S  II+ DLK  NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 505

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             Y+APE      YG+   V    D ++FG++L E    + P      DE+F
Sbjct: 506 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 59/231 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR-----IRHRNIIK 352
           L+G+G FG V   R +      A+K+  L+        ++   + +       RH  +  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 399
           +  +  + D    V+EY   G L           E+    Y +              ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATI 458
           SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +  +    +T   T 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169

Query: 459 GYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
            Y+APE      YGR   V    D +  G+++ E    + P      + +F
Sbjct: 170 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 35/159 (22%), Positives = 46/159 (28%), Gaps = 21/159 (13%)

Query: 2   NNLNGSIPI-AVGKLQKLQLLSLEDNQLEGSI-------PDDLCRLAALFELDSGGNKLD 53
              + +     V     L  L L DN   G         P     L  L   ++G     
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217

Query: 54  GFVPACFGNLTNLRNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFL------LIGNLK 105
           G   A       L+ L L  N L       +      +  L+LS   L      L   L 
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS 277

Query: 106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGS 144
           VL   DLS N        +   L  +  L L+ N    S
Sbjct: 278 VL---DLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 36/184 (19%), Positives = 60/184 (32%), Gaps = 19/184 (10%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDL--CRLAALFELDSGGNKLDG---FVPACFGNL-TNLRN 68
           +  LQ L+LE+ ++ G+ P  L       L  L+           ++      L   L+ 
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 69  LYLGSNKLTSIPSTLW-NLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
           L +      +           +  LDLS N  L                 S + P     
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER-----------GLISALCPLKFPT 202

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSF 186
           L+ L           G         + L+ L+LS+N+L       S +    L  +N+SF
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262

Query: 187 NKLE 190
             L+
Sbjct: 263 TGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 31/222 (13%), Positives = 65/222 (29%), Gaps = 37/222 (16%)

Query: 10  IAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPAC---FGNLTNL 66
           +  G      LL   D + +     D+ +  +L  L     ++   +         ++ L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 67  RNLYLGSNKLT---SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPT 123
           + L L + ++T     P       D+  L+L +      +          +  +      
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNV-----SWATRDAWLAELQQWL----- 147

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS----LEKLLDL 179
                  L+ L +          + +     L +L+LS+N   G   +       K   L
Sbjct: 148 ----KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203

Query: 180 KDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQV 221
           + + +    +E             T S   + L      LQ 
Sbjct: 204 QVLALRNAGME-------------TPSGVCSALAAARVQLQG 232

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 35/216 (16%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIEC-----DMIKRIRHRNIIK 352
            +G G FG V   + ++     A+K+  L   +  K   IE       +++ +    ++K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +  S   +    +V+EY+  G +   L       +   R      +    EYLH   S+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAPE------Y 465
           +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T   +APE      Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGY 215

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
            +   V    D ++ G+++ E      P    FF D
Sbjct: 216 NK--AV----DWWALGVLIYEMAAGYPP----FFAD 241

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 58/231 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR-----IRHRNIIK 352
           L+G+G FG V   + +      A+K+  L+        ++   + +       RH  +  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 353 IISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 399
           +  S  + D    V+EY   G L           E     Y +              ++ 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIV 258

Query: 400 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATI 458
           SAL+YLH   +  +++ DLK  N++LD +    ++DFG+ K  +K+  +    +T   T 
Sbjct: 259 SALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTP 313

Query: 459 GYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
            Y+APE      YGR   V    D +  G+++ E    + P      +++F
Sbjct: 314 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 67/234 (28%), Positives = 100/234 (42%), Gaps = 64/234 (27%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMIKR------IRHRNII 351
           +IG+G FG V  AR +      AVKV  LQ     K  + +  M +R      ++H  ++
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 398
            +  S  + D    VL+Y+  G L           E     Y++              ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL- 455
           ASAL YLH   S+ I++ DLKP N+LLD     H  L+DFG+ K  ++ + +   T T  
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200

Query: 456 ATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
            T  Y+APE      Y R   V    D +  G +L E      P     T E++
Sbjct: 201 GTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 64/309 (20%), Positives = 109/309 (35%), Gaps = 76/309 (24%)

Query: 298 NLIGRGGFGSVYKAR--IQDGMEVAVKVFDLQYGRAFKSFDIECD--------------M 341
             IG G +G V+KAR     G  VA+K   +             +               
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLSTIREVAVLRH 67

Query: 342 IKRIRHRNIIKIISSCSSDDFKA-----LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIM 395
           ++   H N++++   C+           LV E++    L   L       +      ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 455
             +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  T  +
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180

Query: 456 ATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRK--------------------KP 493
            T+ Y APE         +T  D++S G +  E F RK                     P
Sbjct: 181 VTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 494 TDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVES 553
            +E +  D+ L                 A  + +        G       +L +KC   +
Sbjct: 239 GEEDWPRDVALPRQAFHSKS--------AQPIEKFVTDIDELG------KDLLLKCLTFN 284

Query: 554 PEQRINAKE 562
           P +RI+A  
Sbjct: 285 PAKRISAYS 293

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 19/146 (13%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
             + LE N ++   P        L  +D   N++    P  F  L +L +L L  NK+T 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94

Query: 79  IPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEY 138
           +P +L+                   L  L  + L+ N  + +       L +L  L L  
Sbjct: 95  LPKSLFE-----------------GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137

Query: 139 NRLQGSIPDSIGD-LINLKSLNLSNN 163
           N+LQ +I       L  +++++L+ N
Sbjct: 138 NKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 30/135 (22%), Positives = 54/135 (40%), Gaps = 15/135 (11%)

Query: 64  TNLRNLYLGSNKLTSIPST-LWNLKDILYLDLSSN---------FLLIGNLKVLVQVDLS 113
             +  + L  N +  IP       K +  +DLS+N         F  + +L  L    L 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL---VLY 88

Query: 114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIPIS 172
            N  +++  +   GL  LQ L L  N++   +       L NL  L+L +N L      +
Sbjct: 89  GNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147

Query: 173 LEKLLDLKDINVSFN 187
              L  ++ ++++ N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 29/100 (29%), Positives = 42/100 (42%), Gaps = 4/100 (4%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFELDSGGNKLDGFVPA 58
            NN    +       L+ L  L L  N++   +P  L   L +L  L    NK++     
Sbjct: 64  SNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVD 122

Query: 59  CFGNLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSN 97
            F +L NL  L L  NKL +I   T   L+ I  + L+ N
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 55/215 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  AR+++  ++ AVKV  L+     +  D+EC M  KRI      H  + 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 398
           ++     + D    V+E++  G L           E     Y++              ++
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 133

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 457
            SAL +LH      II+ DLK  NVLLD      L+DFGM K  +    +   T T   T
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
             Y+APE      YG    V    D ++ G++L E
Sbjct: 188 PDYIAPEILQEMLYGPA--V----DWWAMGVLLYE 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 60/232 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V  +  +   E+ AVK+  L+     +  D+EC M+ KR+     +   + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 398
           ++ S   + D    V+EY+  G L           E     Y++              ++
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 457
           A  L +L    S  II+ DLK  NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             Y+APE      YG+   V    D ++FG++L E    + P      DE+F
Sbjct: 185 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 31/180 (17%), Positives = 71/180 (39%), Gaps = 14/180 (7%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
           +L  +Q  + +++ ++ S+   +     L EL    N++    P    +LT L  L +  
Sbjct: 39  ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94

Query: 74  NKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
           N+L ++ + + +   +  L L +N L     + +LK L  + +  N    ++   +G L 
Sbjct: 95  NRLKNL-NGIPSAC-LSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLS 150

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
            L+ L L  N +  +    +  L  +  ++L+             +L     +     + 
Sbjct: 151 KLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 37/172 (21%), Positives = 73/172 (42%), Gaps = 16/172 (9%)

Query: 23  LEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPST 82
                +    PD    LA   + + G   +   V      L+ ++N    ++ + S+ + 
Sbjct: 4   QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL-AG 58

Query: 83  LWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEY 138
           +    ++  L LS N +     + +L  L ++ ++ N   ++    I     L  LFL+ 
Sbjct: 59  MQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKNLNG--IPSAC-LSRLFLDN 115

Query: 139 NRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
           N L     DS+  L NL+ L++ NN L  +I   L  L  L+ +++  N++ 
Sbjct: 116 NEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 14/183 (7%)

Query: 12  VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYL 71
           +     L+ L L  NQ+   +   L  L  L EL    N+L             L  L+L
Sbjct: 59  MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFL 113

Query: 72  GSNKLTSIPSTLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
            +N+L     +L +LK++  L + +N L    ++G L  L  +DL  N  ++     +  
Sbjct: 114 DNNELRDT-DSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGG--LTR 170

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
           LK + ++ L   +          +L    ++   +       P  +       D  V + 
Sbjct: 171 LKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWE 228

Query: 188 KLE 190
              
Sbjct: 229 LPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 37/165 (22%), Positives = 59/165 (35%), Gaps = 25/165 (15%)

Query: 10  IAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL 69
           +       L  L L++N+L     D L  L  L  L    NKL   V    G L+ L  L
Sbjct: 100 LNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVL 155

Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
            L  N++T+    L  LK + ++DL+       N  V  Q +L + N           +K
Sbjct: 156 DLHGNEITNT-GGLTRLKKVNWIDLTGQK--CVNEPVKYQPELYITN----------TVK 202

Query: 130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
           D    ++         P  I +  +     +       T  +S +
Sbjct: 203 DPDGRWIS--------PYYISNGGSYVDGCVLWELPVYTDEVSYK 239

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 47/211 (22%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           ++G+G FG V+ A  +   +  A+K   L+        D+EC M+ KR+      H  + 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 398
            +  +  + +    V+EY+  G L                 Y++              ++
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--------------EI 127

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL- 455
              L++LH   S  I++ DLK  N+LLD +   H  ++DFGM K  +  D     T T  
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFC 179

Query: 456 ATIGYMAPEYGREGQVSTNGDVYSFGIMLME 486
            T  Y+APE     + + + D +SFG++L E
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 55/215 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           +IGRG +  V   R++    + A+KV  ++        DI+     K +      H  ++
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 398
            + S   ++     V+EY+  G L           E+    YS+              ++
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 119

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 457
           + AL YLH      II+ DLK  NVLLD      L+D+GM K  L+       T T   T
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 173

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
             Y+APE      YG    V    D ++ G+++ E
Sbjct: 174 PNYIAPEILRGEDYGFS--V----DWWALGVLMFE 202

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 56/242 (23%)

Query: 288 FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVK----VF----DLQYGRAFKSFDIE 338
                 +     +G+G +G V+K+   + G  VAVK     F    D Q  R F+    E
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFR----E 58

Query: 339 CDMIKRIR-HRNIIKIISSCSSDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 395
             ++  +  H NI+ +++   +D+ +   LV +YM    L   + ++  IL+   +  ++
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVV 115

Query: 396 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ---- 451
             +   ++YLH   S  ++H D+KPSN+LL+      ++DFG+++  +   +        
Sbjct: 116 YQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 452 ---------------TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFT 489
                          T  +AT  Y APE       Y      +   D++S G +L E   
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILC 226

Query: 490 RK 491
            K
Sbjct: 227 GK 228

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 65/235 (27%)

Query: 299 LIGRGGFGSVYKARIQDGMEV----AVKVFDLQYGRAFKSFDIECDMIKRI----RHRNI 350
           ++G+G FG V+  +   G +     A+KV  L+         +   M + I     H  I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 351 IKIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMID 397
           +K+  +  ++    L+L+++  G L           E+    Y +              +
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA--------------E 134

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL 455
           +A AL++LH   S+ II+ DLKP N+LLD+    H  L+DFG++K  +  ++      + 
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSF 186

Query: 456 -ATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDEIF 498
             T+ YMAPE      + +        D +SFG+++ E  T   P       E  
Sbjct: 187 CGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQGKDRKETM 235

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 55/215 (25%)

Query: 299 LIGRGGFGSVYKARIQDGMEV-AVKVFDLQYGRAFKSFDIECDMI-KRI-----RHRNII 351
           +IGRG +  V   R++    + A++V  ++        DI+     K +      H  ++
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 352 KIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 398
            + S   ++     V+EY+  G L           E+    YS+              ++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 162

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 457
           + AL YLH      II+ DLK  NVLLD      L+D+GM K  L+       T T   T
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216

Query: 458 IGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
             Y+APE      YG    V    D ++ G+++ E
Sbjct: 217 PNYIAPEILRGEDYGFS--V----DWWALGVLMFE 245

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 27/193 (13%), Positives = 62/193 (32%), Gaps = 25/193 (12%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDL-CRLAALFELD-SGGNKLDGFVPACFGNLTNLRNLYLG 72
           L  +  + +  +     +       L+ +  ++      L    P     L  L+ L + 
Sbjct: 54  LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 73  SNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPT-TIGGL-KD 130
           +  L   P                +   + +  +   ++++ N +   IP     GL  +
Sbjct: 114 NTGLKMFP----------------DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157

Query: 131 LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLL-DLKDINVSFNK 188
              L L  N    S+     +   L ++ L+ N     I   +   +      ++VS   
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216

Query: 189 LEGEIPNKGPFRN 201
           +   +P+KG   +
Sbjct: 217 VT-ALPSKG-LEH 227

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 30/138 (21%), Positives = 52/138 (37%), Gaps = 16/138 (11%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDD--LCRLAALFELDSGGNKLDGFVPA-CFGNLTN-LRNL 69
           +L  L+ L + +  L+   PD   +      F L+   N     +P   F  L N    L
Sbjct: 103 ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161

Query: 70  YLGSNKLTSIPSTLWNLKDILYLDLSSNFLL--------IGNLKVLVQVDLSMNNFSDVI 121
            L +N  TS+    +N   +  + L+ N  L         G       +D+S  + +  +
Sbjct: 162 KLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220

Query: 122 PTTIGGLKDLQYLFLEYN 139
           P+   GL+ L+ L     
Sbjct: 221 PS--KGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 30/164 (18%), Positives = 58/164 (35%), Gaps = 13/164 (7%)

Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSN-KLTSIPS-TLWNLKDILYLDLSSNFLL- 100
            L      L       F NL N+  +Y+  +  L  + S + +NL  + ++++ +   L 
Sbjct: 35  TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94

Query: 101 ------IGNLKVLVQVDLSMNNFSDVIPTT-IGGLKDLQYLFLEYNRLQGSIP-DSIGDL 152
                 +  L +L  + +           T +        L +  N    SIP ++   L
Sbjct: 95  YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154

Query: 153 IN-LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
            N   +L L NN  + ++         L  + ++ NK    I  
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 14/140 (10%), Positives = 40/140 (28%), Gaps = 24/140 (17%)

Query: 64  TNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPT 123
               +  +    +  IPS   + + +                      L   +   +   
Sbjct: 11  HQEEDFRVTCKDIQRIPSLPPSTQTL---------------------KLIETHLRTIPSH 49

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSI-GDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKD 181
               L ++  +++  +     +      +L  +  + + N      I    L++L  LK 
Sbjct: 50  AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109

Query: 182 INVSFNKLEGEIPNKGPFRN 201
           + +    L+   P+     +
Sbjct: 110 LGIFNTGLK-MFPDLTKVYS 128

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 68/223 (30%)

Query: 299 LIGRGGFGSVYKARIQDGMEV----AVKVFD----LQYGRAFKSFDIECDMIKR-----I 345
           ++G+GG+G V++ R   G       A+KV      ++      + D      +R     +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 346 RHRNIIKIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRL 392
           +H  I+ +I +  +     L+LEY+  G L           E   C Y +          
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA---------- 128

Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLT 450
               +++ AL +LH      II+ DLKP N++L+     H  L+DFG+ K  + +     
Sbjct: 129 ----EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV-- 177

Query: 451 QTQTLA-TIGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
            T T   TI YMAPE      + R   V    D +S G ++ +
Sbjct: 178 -THTFCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYD 213

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 73/271 (26%)

Query: 266 PLPNDANMPRISNQRR---FTYLEIFQATNGFSEN----NLIGRGGFGSVYKAR-IQDGM 317
           P+P+ A +    N  R   +   E      G  ++      +GRG +  V++A  I +  
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62

Query: 318 EVAVKVFDLQYGRAFKSFDIECDMIKR-IR-------HRNIIKII----SSCSSDDFKAL 365
           +V VK+             ++   IKR I+         NII +        S     AL
Sbjct: 63  KVVVKILKP----------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP--AL 110

Query: 366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS-------ALEYLHFGYSVPIIHCDL 418
           V E++ +   ++          ++Q L    D+         AL+Y H   S+ I+H D+
Sbjct: 111 VFEHVNNTDFKQ----------LYQTLTDY-DIRFYMYEILKALDYCH---SMGIMHRDV 156

Query: 419 KPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-------YGREGQ 470
           KP NV++D ++    L D+G+A+      +       +A+  +  PE       Y     
Sbjct: 157 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMY----- 208

Query: 471 VSTNGDVYSFGIMLMETFTRKKPTDEIFFGD 501
              + D++S G ML     RK+P    F G 
Sbjct: 209 -DYSLDMWSLGCMLASMIFRKEP---FFHGH 235

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 24/155 (15%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
           + L L+   L          L  L  L+   N+L       F +LT L  L L +N+L S
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 79  IPSTLW-NLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTI-GGLKDLQYLFL 136
           +P  ++ +L  +  L L  N L                     +P+ +   L  L+ L L
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQL-------------------KSLPSGVFDRLTKLKELRL 138

Query: 137 EYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIP 170
             N+LQ SIP    D L NL++L+LS N L  ++P
Sbjct: 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVP 171

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 51/170 (30%), Positives = 69/170 (40%), Gaps = 31/170 (18%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFELDSGGNKLDGFVPAC 59
              L          L KL  L+L+ NQL+ ++   +   L  L  L    N+L       
Sbjct: 44  STGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGV 102

Query: 60  FGNLTNLRNLYLGSNKLTSIPS----TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMN 115
           F +LT L  LYLG N+L S+PS     L  LK    L L++N L                
Sbjct: 103 FDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLK---ELRLNTNQL---------------- 143

Query: 116 NFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNN 163
                IP      L +LQ L L  N+LQ S+P    D L  L+++ L  N
Sbjct: 144 ---QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 40/126 (31%), Positives = 58/126 (46%), Gaps = 10/126 (7%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFELDSGGNKLDGFVPA 58
             N   ++   V   L +L  L L +NQL  S+P  +   L  L +L  GGN+L      
Sbjct: 67  DYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSG 125

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFL------LIGNLKVLVQVD 111
            F  LT L+ L L +N+L SIP+  ++ L ++  L LS+N L          L  L  + 
Sbjct: 126 VFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185

Query: 112 LSMNNF 117
           L  N F
Sbjct: 186 LFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 64  TNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNN 116
            +   L L S  L ++    +  L  + +L+L  N L      +  +L  L  + L+ N 
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIPISL-E 174
            + +       L  L  L+L  N+L+ S+P  + D L  LK L L+ N L  +IP    +
Sbjct: 95  LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 175 KLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
           KL +L+ +++S N+L+  +P  G F    
Sbjct: 153 KLTNLQTLSLSTNQLQS-VP-HGAFDRLG 179

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 64/223 (28%)

Query: 299 LIGRGGFGSVYKARIQDGMEV----AVKVFD----LQYGRAFKSFDIECDMI-KRI---- 345
           ++G G +G V+  R   G +     A+KV      +Q     K+   E     +++    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHI 115

Query: 346 -RHRNIIKIISSCSSDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQR 391
            +   ++ +  +  ++    L+L+Y+  G L           E    +Y           
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG--------- 166

Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSL 449
                ++  ALE+LH    + II+ D+K  N+LLD N   H  L+DFG++K  + ++   
Sbjct: 167 -----EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER 216

Query: 450 TQTQTLATIGYMAPE------YGREGQVSTNGDVYSFGIMLME 486
                  TI YMAP+       G +  V    D +S G+++ E
Sbjct: 217 AYD-FCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 29/166 (17%), Positives = 57/166 (34%), Gaps = 46/166 (27%)

Query: 1   GNNLNGSIPIAV-GKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFELDSGGNKLDGFVPA 58
            N         +  KL +L+ ++  +N++   I +      + + E+    N+L+     
Sbjct: 41  NNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHK 99

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFS 118
            F  L +L+ L L SN++T +                                       
Sbjct: 100 MFKGLESLKTLMLRSNRITCVG-------------------------------------- 121

Query: 119 DVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNN 163
                +  GL  ++ L L  N++  ++     D L +L +LNL  N
Sbjct: 122 ---NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 31/147 (21%), Positives = 56/147 (38%), Gaps = 22/147 (14%)

Query: 44  ELDSGGNKLDGFVP-ACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIG 102
           EL    N+         F  L  LR +   +NK+T I                  F    
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA--------------FEGAS 81

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLS 161
            +  +    L+ N   +V      GL+ L+ L L  NR+   + +     L +++ L+L 
Sbjct: 82  GVNEI---LLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137

Query: 162 NNNLSGTIPI-SLEKLLDLKDINVSFN 187
           +N ++ T+   + + L  L  +N+  N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 30/169 (17%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIP--DDLCRLAALFELDSGGNKLDGFVPAC 59
           N+   S+   +  L  ++ L+L  N+L   I        L  L  L   GN+L       
Sbjct: 50  NSDIKSVQ-GIQYLPNVRYLALGGNKLH-DISALK---ELTNLTYLILTGNQLQSLPNGV 104

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFS 118
           F  LTNL+ L L  N+L S+P  +++ L ++ YL+L+ N      L+ L           
Sbjct: 105 FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN-----QLQSL----------- 148

Query: 119 DVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNL 165
              P  +   L +L  L L YN+LQ S+P+ + D L  LK L L  N L
Sbjct: 149 ---PKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 24/164 (14%)

Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS--TLWNLKDILYLDLSSNFLL- 100
           + +     +          L ++  +   ++ + S+     L N++   YL L  N L  
Sbjct: 23  KANLKKKSVTD-AVT-QNELNSIDQIIANNSDIKSVQGIQYLPNVR---YLALGGNKLHD 77

Query: 101 IG---NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLK 156
           I     L  L  + L+ N    +       L +L+ L L  N+LQ S+PD + D L NL 
Sbjct: 78  ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136

Query: 157 SLNLSNNNLSGTIPISLE-----KLLDLKDINVSFNKLEGEIPN 195
            LNL++N L      SL      KL +L ++++S+N+L+  +P 
Sbjct: 137 YLNLAHNQLQ-----SLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 47/162 (29%), Positives = 64/162 (39%), Gaps = 50/162 (30%)

Query: 7   SIPIAV-GKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLT 64
           S+P  V  KL  L+ L L +NQL+ S+PD +  +L  L  L+   N+L       F  LT
Sbjct: 99  SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLT 157

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTT 124
           NL  L L  N+L S+P                     G    L Q               
Sbjct: 158 NLTELDLSYNQLQSLPE--------------------GVFDKLTQ--------------- 182

Query: 125 IGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN---LSNN 163
                 L+ L L  N+L+ S+PD + D   L SL    L +N
Sbjct: 183 ------LKDLRLYQNQLK-SVPDGVFD--RLTSLQYIWLHDN 215

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.2 bits (171), Expect = 7e-13
 Identities = 26/117 (22%), Positives = 39/117 (33%), Gaps = 8/117 (6%)

Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL--- 100
            L      L   V      L  + +L L  N+L ++P  L  L+ +  L  S N L    
Sbjct: 445 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 502

Query: 101 -IGNLKVLVQVDLSMNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINL 155
            + NL  L ++ L  N          +     L  L L+ N L          L  +
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 1e-12
 Identities = 35/224 (15%), Positives = 75/224 (33%), Gaps = 25/224 (11%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            +            ++L    L   +    +  +L     L EL+         +     
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393

Query: 62  NLTNLRNLYLGSNKLTSI----PSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNF 117
            L  L          +++    P     L D+    L  N +L      +  + L+  + 
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453

Query: 118 SDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL 177
           + +    +  L  + +L L +NRL+ ++P ++  L  L+ L  S+N L   +   +  L 
Sbjct: 454 TVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLP 508

Query: 178 DLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQV 221
            L+++ +  N+L               +     + L   P L +
Sbjct: 509 RLQELLLCNNRL---------------QQSAAIQPLVSCPRLVL 537

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 24/91 (26%), Positives = 37/91 (40%), Gaps = 4/91 (4%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGF-VPAC 59
            N L  ++P A+  L+ L++L   DN LE ++   +  L  L EL    N+L        
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP 528

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDIL 90
             +   L  L L  N L         L ++L
Sbjct: 529 LVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 54/278 (19%), Positives = 104/278 (37%), Gaps = 60/278 (21%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIR--------- 346
            +G G F +V+ A+ + +   VA+K+   D  Y  A +    E  +++R+          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDS 82

Query: 347 --HRNIIKIISSCSSDDFKA---------LVLEYMPHGSLEKCLYSSNYI---LDIFQRL 392
               +I+K++     D F           +V E +   +L   +    +    L   ++ 
Sbjct: 83  MGANHILKLL-----DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ- 135

Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH------LSDFGMAKPLLKED 446
            I   +   L+Y+H      IIH D+KP NVL++            ++D G A    +  
Sbjct: 136 -ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH 506
            +  QT+      Y +PE           D++S   ++ E  T       +F  D    +
Sbjct: 193 TNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSY 243

Query: 507 WVNDLLPISVMEI---VDANLLSQ---KDEHFTTKGQC 538
             +D     ++E+   + + LL         F ++G  
Sbjct: 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 281

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 15/149 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH-RNIIKIISSC 357
           IG G FG +   + +     VA+K+             +E    K++     I ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
               + A+VLE +   SLE      +    +   L I I + S +EY+H   S  +I+ D
Sbjct: 75  PCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRD 130

Query: 418 LKPSNVLL------DDNMVAHLSDFGMAK 440
           +KP N L+         ++ H+ DF +AK
Sbjct: 131 VKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 49/152 (32%), Positives = 63/152 (41%), Gaps = 32/152 (21%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
           Q+L L DNQ+    P     L  L EL  G N+L       F +LT L  L LG+N+LT 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 79  IPS----TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYL 134
           +PS     L +LK    L +  N L                     +P  I  L  L +L
Sbjct: 103 LPSAVFDRLVHLK---ELFMCCNKL-------------------TELPRGIERLTHLTHL 140

Query: 135 FLEYNRLQGSIPDSIGDLINLKSLN---LSNN 163
            L+ N+L+ SIP    D   L SL    L  N
Sbjct: 141 ALDQNQLK-SIPHGAFD--RLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 2/99 (2%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACF 60
           N +    P     L  L+ L L  NQL  ++P  +   L  L  LD G N+L     A F
Sbjct: 50  NQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVF 108

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL 99
             L +L+ L++  NKLT +P  +  L  + +L L  N L
Sbjct: 109 DRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQL 147

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 31/166 (18%)

Query: 300 IGRGGFGSVYKAR---------IQDGMEVAVKV---------FDLQYGRAFKSFDIECDM 341
             R   G +Y+A               + ++K+             + RA K   +    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 342 -IKRIRHRNIIKIISS-CSSDDFKALVLEYMPHG-SLEKCL-YSSNYILDIFQRLNIMID 397
            +       I   +      D ++ LVL  +  G SL+  L  S  ++L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 440
           +  ALE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 15/149 (10%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH-RNIIKIISSC 357
           IG G FG +++   + +  +VA+K    +          E    K +     I  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                  LV++ +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 418 LKPSNVLL------DDNMVAHLSDFGMAK 440
           +KP N L+      + NM+ ++ DFGM K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH-RNIIKIISSC 357
           IG G FG +Y    I  G EVA+K+  ++         IE  + K ++    I  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
           +  D+  +V+E +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 418 LKPSNVLL---DDNMVAHLSDFGMAK 440
           +KP N L+       + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 30/165 (18%)

Query: 299 LIGRGGFGSVYKA-RIQDGMEVAVKVFDLQ-------------YGRAFKSFDIECDM-IK 343
            IG GGFG +Y A       + A  V  ++             Y R  K   I+  +  K
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 344 RIRHRNIIKIISS----CSSDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDV 398
           ++ +  I     S         ++ +V+E +  G  L+K +   N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 440
              LEY+H       +H D+K +N+LL   + + V +L+D+G++ 
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 30/127 (23%), Positives = 58/127 (45%), Gaps = 12/127 (9%)

Query: 44  ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL---- 99
           EL      ++  + A    L   ++L L +N +  I S+L  ++++  L L  N +    
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIE 86

Query: 100 -LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ--GSIPDSIGDLINLK 156
            L      L ++ +S N  + +  + I  L +L+ L++  N++   G I D +  L  L+
Sbjct: 87  NLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLE 143

Query: 157 SLNLSNN 163
            L L+ N
Sbjct: 144 DLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.1 bits (133), Expect = 7e-09
 Identities = 30/130 (23%), Positives = 45/130 (34%), Gaps = 14/130 (10%)

Query: 21  LSLEDNQLEGSIPDDLCRLAALFELDSGGN---KLDGFVPACFGNLTNLRNLYLGSNKLT 77
           L      +E  +   L  L A   L    N   K+          + NLR L LG N + 
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSL-----SGMENLRILSLGRNLIK 83

Query: 78  SIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQ 132
            I +       +  L +S N +     I  L  L  + +S N  ++      +  L  L+
Sbjct: 84  KIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143

Query: 133 YLFLEYNRLQ 142
            L L  N L 
Sbjct: 144 DLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 20/85 (23%), Positives = 44/85 (51%), Gaps = 6/85 (7%)

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
            V++   +      +  T+  LK  ++L L  N ++  I  S+  + NL+ L+L  N + 
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83

Query: 167 GTIPISLEKLLD-LKDINVSFNKLE 190
             I  +L+ + D L+++ +S+N++ 
Sbjct: 84  -KIE-NLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 32/127 (25%), Positives = 49/127 (38%), Gaps = 19/127 (14%)

Query: 13  GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGN---KLDGFVPACFGNLTNLRNL 69
             ++ L++LSL  N ++  I +       L EL    N    L G        L NLR L
Sbjct: 67  SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVL 120

Query: 70  YLGSNKLTSIPS--TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
           Y+ +NK+T+      L  L  +  L L+ N         L       N  S+     +  
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGN--------PLYNDYKENNATSEYRIEVVKR 172

Query: 128 LKDLQYL 134
           L +L+ L
Sbjct: 173 LPNLKKL 179

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.7 bits (154), Expect = 4e-11
 Identities = 44/298 (14%), Positives = 82/298 (27%), Gaps = 73/298 (24%)

Query: 275 RISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKV--------FDL 326
              +Q+          T        IG G FG V++    D   VA+K+         + 
Sbjct: 3   GECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNG 61

Query: 327 QYGRAFKSFDIECDMIKRI---------RHRNIIKIISSC-------------------- 357
            + + F+    E  + K +         R    I + S                      
Sbjct: 62  SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 358 ----------SSDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
                       DD   +VLE+   G  LE+       +  +    +I+  + ++L    
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAE 178

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL---------LKEDQSLTQTQTLAT 457
                   H DL   NVLL    +  L      K              D +L++ +    
Sbjct: 179 ASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI 236

Query: 458 IGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL 512
           + +       +   G      D+Y           ++       +   +   W++ L 
Sbjct: 237 VVFCDVSMDEDLFTGDGDYQFDIYRL-------MKKENNNRWGEYHPYSNVLWLHYLT 287

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 40/211 (18%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSF----DIECDMIKRIRHR----- 348
           +IG+G FG V KA   +    VA+K+      R  K F      E  +++ +R +     
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 349 -NIIKIISSCSSDDFKA---LVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMIDVASA 401
            N+I ++ +     F+    +  E +   +L + +  + +    L + ++      +   
Sbjct: 159 MNVIHMLEN---FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQC 212

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQT-QTLATI 458
           L+ LH      IIHCDLKP N+LL     +   + DFG +     E Q +    Q+    
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQSRF-- 264

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
            Y APE     +     D++S G +L E  T
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 31/167 (18%)

Query: 299 LIGRGGFGSVYKAR------IQDGMEVAVKV--------FDLQ--YGRAFKSFDIECDM- 341
            IG+GGFG +Y A       +       VKV        F     Y RA K   I+  + 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 342 IKRIRHRNIIKIISS----CSSDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMI 396
            +++++  + K   S     +   ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 440
            +   LEY+H       +H D+K SN+LL   + + V +L D+G+A 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 5e-11
 Identities = 30/148 (20%), Positives = 49/148 (33%), Gaps = 48/148 (32%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
             L L+ NQ    +P +L     L  +D   N++       F N+T L  L L  N+L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92

Query: 79  IPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEY 138
           IP   ++                                         GLK L+ L L  
Sbjct: 93  IPPRTFD-----------------------------------------GLKSLRLLSLHG 111

Query: 139 NRLQGSIPDSIGDLINLKSLN---LSNN 163
           N +   +P+   +  +L +L+   +  N
Sbjct: 112 NDIS-VVPEGAFN--DLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 21/108 (19%)

Query: 64  TNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPT 123
            ++  LYL  N+ T +P  L N K +  +DLS+N +            LS  +FS     
Sbjct: 31  RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI----------STLSNQSFS----- 75

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIP 170
               +  L  L L YNRL+  IP    D L +L+ L+L  N++S  +P
Sbjct: 76  ---NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 21/93 (22%), Positives = 42/93 (45%), Gaps = 3/93 (3%)

Query: 7   SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLTN 65
            +P  +   + L L+ L +N++  ++ +     +  L  L    N+L    P  F  L +
Sbjct: 45  LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103

Query: 66  LRNLYLGSNKLTSIP-STLWNLKDILYLDLSSN 97
           LR L L  N ++ +P     +L  + +L + +N
Sbjct: 104 LRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 11/147 (7%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSC 357
           IG G FG +Y    IQ   EVA+K+ +++          E  + + ++    I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
              D+  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 418 LKPSNVLLDDNMVAH---LSDFGMAKP 441
           +KP N L+     A+   + DFG+AK 
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKK 155

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 29/151 (19%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
             L LE N L+         L +L +L  GGNKL       F  LT+L  L L +N+L S
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 79  IPS----TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTI-GGLKDLQY 133
           +P+     L  LK    L L++N L                     +P  +   L  L+ 
Sbjct: 91  LPNGVFDKLTQLK---ELALNTNQL-------------------QSLPDGVFDKLTQLKD 128

Query: 134 LFLEYNRLQGSIPDSIGD-LINLKSLNLSNN 163
           L L  N+L+ S+PD + D L +L+ + L +N
Sbjct: 129 LRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 4/94 (4%)

Query: 7   SIPIAV-GKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLT 64
           S+P  V  KL  L  L+L  NQL+ S+P+ +  +L  L EL    N+L       F  LT
Sbjct: 66  SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT 124

Query: 65  NLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSN 97
            L++L L  N+L S+P  ++  L  + Y+ L  N
Sbjct: 125 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 37/121 (30%), Positives = 51/121 (42%), Gaps = 17/121 (14%)

Query: 56  VPACFGNLTNLRNLYLGSNKLTSIPSTLW-NLKDILYLDLSSN---------FLLIGNLK 105
           VP   G       L L +N L S+P+ ++  L  +  L L  N         F  + +L 
Sbjct: 22  VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNN 164
            L   +LS N    +       L  L+ L L  N+LQ S+PD + D L  LK L L  N 
Sbjct: 80  YL---NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135

Query: 165 L 165
           L
Sbjct: 136 L 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 3/86 (3%)

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTI 169
           DL  N+   +       L  L  L+L  N+LQ S+P+ + + L +L  LNLS N L    
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLP 92

Query: 170 PISLEKLLDLKDINVSFNKLEGEIPN 195
               +KL  LK++ ++ N+L+  +P+
Sbjct: 93  NGVFDKLTQLKELALNTNQLQ-SLPD 117

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 16/84 (19%)

Query: 14  KLQKLQLLSLEDNQLEGSIPD---DLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLY 70
           KL +L+ L+L  NQL+ S+PD   D  +L  L +L    N+L       F  LT+L+ ++
Sbjct: 98  KLTQLKELALNTNQLQ-SLPDGVFD--KLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154

Query: 71  LGSNKLTSIPSTLWN--LKDILYL 92
           L  N     P   W+     I YL
Sbjct: 155 LHDN-----P---WDCTCPGIRYL 170

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 35/148 (23%), Positives = 55/148 (37%), Gaps = 46/148 (31%)

Query: 19  QLLSLEDNQLEGSIPDD--LCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKL 76
             L L DN+L   I  D    RL  L +L+   N+L G  P  F   ++++ L LG NK+
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90

Query: 77  TSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFL 136
             I + ++                                          GL  L+ L L
Sbjct: 91  KEISNKMFL-----------------------------------------GLHQLKTLNL 109

Query: 137 EYNRLQGSIPDSIGD-LINLKSLNLSNN 163
             N++   +     + L +L SLNL++N
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 5e-09
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 3/86 (3%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
           +L  L  L L+ NQL   I  +     + + EL  G NK+       F  L  L+ L L 
Sbjct: 52  RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110

Query: 73  SNKLTSIP-STLWNLKDILYLDLSSN 97
            N+++ +   +  +L  +  L+L+SN
Sbjct: 111 DNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 19/108 (17%)

Query: 64  TNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPT 123
            +   L L  N+L  I S                  L G L  LV+++L  N  + + P 
Sbjct: 29  LHTTELLLNDNELGRISSDG----------------LFGRLPHLVKLELKRNQLTGIEPN 72

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIP 170
              G   +Q L L  N+++  I + +   L  LK+LNL +N +S  + 
Sbjct: 73  AFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 7e-09
 Identities = 23/99 (23%), Positives = 32/99 (32%), Gaps = 1/99 (1%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPD-DLCRLAALFELDSGGNKLDGFVPACF 60
            +        +   + L  L +E+ Q    +   DL  L  L  L    + L    P  F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL 99
                L  L L  N L S+         +  L LS N L
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 9e-09
 Identities = 21/117 (17%), Positives = 43/117 (36%), Gaps = 18/117 (15%)

Query: 73  SNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ 132
            +        L   +++  L + +                   +   +    + GL +L+
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQ-----------------QHLQHLELRDLRGLGELR 59

Query: 133 YLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 189
            L +  + L+   PD+      L  LNLS N L  ++     + L L+++ +S N L
Sbjct: 60  NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 297 NNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSF----DIECDMIKRIRHR--- 348
           ++LIG+G FG V KA    +   VA+K+      +  K+F     IE  +++ +      
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 349 ---NIIKIISSCSSDDFKA---LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASA 401
               I+ +        F+    LV E +   +L   L ++N+  + +         + +A
Sbjct: 114 MKYYIVHLKRHF---MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTLATIG 459
           L +L     + IIHCDLKP N+LL +   +   + DFG +    +  Q +   Q + +  
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRI--YQYIQSRF 223

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFT 489
           Y +PE           D++S G +L+E  T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 1/82 (1%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
             L LE N+L+        +L  L +L    N++       F  LT L  LYL  NKL S
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90

Query: 79  IPSTLW-NLKDILYLDLSSNFL 99
           +P+ ++  L  +  L L +N L
Sbjct: 91  LPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.4 bits (129), Expect = 2e-08
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 3/86 (3%)

Query: 14  KLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
           KL +L  LSL  NQ++ S+PD +  +L  L  L    NKL       F  LT L+ L L 
Sbjct: 50  KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108

Query: 73  SNKLTSIPSTLW-NLKDILYLDLSSN 97
           +N+L S+P  ++  L  +  + L +N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 35/113 (30%), Positives = 50/113 (44%), Gaps = 25/113 (22%)

Query: 56  VPACFGNLTNLRNLYLGSNKLTSIPSTLWN-LKDILYLDLSSNFLLIGNLKVLVQVDLSM 114
           VP   G  ++   L L SNKL S+P  +++ L  +  L LS N      ++ L       
Sbjct: 22  VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN-----QIQSL------- 67

Query: 115 NNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNL 165
                  P  +   L  L  L+L  N+LQ S+P+ + D L  LK L L  N L
Sbjct: 68  -------PDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 7e-05
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 6/95 (6%)

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTI 169
           +L  N    +       L  L  L L  N++Q S+PD + D L  L  L L  N L  ++
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SL 91

Query: 170 PISL-EKLLDLKDINVSFNKLEGEIPNKGPFRNFS 203
           P  + +KL  LK++ +  N+L+  +P+ G F   +
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKS-VPD-GIFDRLT 124

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 57/235 (24%), Positives = 85/235 (36%), Gaps = 66/235 (28%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSF----DIECDMIKRIRHR----- 348
            +G G FG V   + I +    AVKV      R  K +     IE D++K+I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 349 NIIKIISSCSSDDFKA---LVLEYMPHGSLEKCLY----SSNYI-LDIFQRLNIMIDVAS 400
           NI+K         +     L+ E      L   LY     +NY    I       I++  
Sbjct: 97  NIVKYHGKF---MYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT---------- 450
           AL YL     + + H DLKP N+LLDD                K+ Q             
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 451 ------QTQTLATI----GYMAPE------YGREGQVSTNGDVYSFGIMLMETFT 489
                 ++    +I     Y APE      +        + D++SFG +L E +T
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 72/373 (19%), Positives = 115/373 (30%), Gaps = 135/373 (36%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIR--------HR 348
           +G G F +V+ +  IQ    VA+KV      Y         E  ++K +R          
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101

Query: 349 NIIKIISSCSSDDFK---------ALVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMI 396
            +++++     DDFK          +V E + H  L K +  SNY    L   ++  I+ 
Sbjct: 102 MVVQLL-----DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQ 153

Query: 397 DVASALEYLHFGYSVPIIHCDLKPSNVLL------------------------------- 425
            V   L+YLH      IIH D+KP N+LL                               
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 426 ------------------DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
                              + +   ++D G A  + K      QT+      Y + E   
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266

Query: 468 EGQVSTNGDVYSFGIMLMETFT------------------------------------RK 491
               +T  D++S   M  E  T                                      
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326

Query: 492 KPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTV 551
           K + E F     LKH +  L P  + E++       ++E          F+    +    
Sbjct: 327 KYSKEFFTKKGDLKH-ITKLKPWGLFEVLVEKYEWSQEE----AAGFTDFL----LPMLE 377

Query: 552 ESPEQRINAKEIV 564
             PE+R  A E +
Sbjct: 378 LIPEKRATAAECL 390

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 40/231 (17%), Positives = 79/231 (34%), Gaps = 62/231 (26%)

Query: 299 LIGRGGFGSVYKA--RIQDGMEVAVKVFDLQYGRAFKSF----DIECDMIKRIRHR---- 348
            +G G FG V +     +   +VA+K+      R    +     +E +++K+I+ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 349 --NIIKIISSCSSDDFKA---LVLEYMPHGSLEKCLY----SSNYI-LDIFQRLNIMIDV 398
               + +       +F     +  E      L K  +     +N+    +    ++   +
Sbjct: 81  KFLCVLMSDWF---NFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL--------- 449
             AL +LH      + H DLKP N+L  ++    L +   +        +          
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 450 -TQTQTLATI----GYMAPE------YGREGQVSTNGDVYSFGIMLMETFT 489
               +   TI     Y  PE      +      +   DV+S G +L E + 
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 27/127 (21%), Positives = 43/127 (33%), Gaps = 21/127 (16%)

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI 121
           N    R L L   K+  I +    L     +D S N +              ++ F    
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR------------KLDGFP--- 61

Query: 122 PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLK 180
                 L+ L+ L +  NR+          L +L  L L+NN+L     +  L  L  L 
Sbjct: 62  -----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 181 DINVSFN 187
            + +  N
Sbjct: 117 YLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 4/85 (4%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
           L +   +   DN++   + D    L  L  L    N++          L +L  L L +N
Sbjct: 41  LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98

Query: 75  KLTSIP--STLWNLKDILYLDLSSN 97
            L  +     L +LK + YL +  N
Sbjct: 99  SLVELGDLDPLASLKSLTYLCILRN 123

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 37/231 (16%), Positives = 75/231 (32%), Gaps = 62/231 (26%)

Query: 299 LIGRGGFGSVYKA--RIQDGMEVAVKVFDLQYGRAFKSF----DIECDMIKRIRHR---- 348
            +G G FG V +       G  VAVK+      +    +      E  +++ +       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 349 --NIIKIISSCSSDDFKA---LVLEYMPHGSLEKCLY----SSNYI-LDIFQRLNIMIDV 398
               ++++      +      +V E      L    Y     + ++   +     +   +
Sbjct: 76  TFRCVQMLEWF---EHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL--------- 449
             ++ +LH   S  + H DLKP N+L   +      +  + +                  
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 450 -TQTQTLATI----GYMAPE------YGREGQVSTNGDVYSFGIMLMETFT 489
               +  +T+     Y APE      +      S   DV+S G +L+E + 
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 41/235 (17%), Positives = 74/235 (31%), Gaps = 43/235 (18%)

Query: 1   GNNLN--GSIPIAVGKLQ---KLQLLSLEDNQL--EG--SIPDDLCRLAALFELDSGGNK 51
            N L   G   +  G L    +L+ L LE   L       +   L       EL    N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 52  LDG-----FVPACFGNLTNLRNLYLGSNKLT-----SIPSTLWNLKDILYLDLSSNFL-- 99
           ++             +   L  L L S  +T      +   + +   +  L L SN L  
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241

Query: 100 ---------LIGNLKVLVQVDLSMNNFSDV----IPTTIGGLKDLQYLFLEYNRLQGSIP 146
                    L+     L  + +     +      +   +   + L+ L L  N L     
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301

Query: 147 DSIGDLI-----NLKSLNLSNNNLS--GTIPIS--LEKLLDLKDINVSFNKLEGE 192
             + + +      L+SL + + + +       S  L +   L ++ +S N+LE  
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 50.7 bits (122), Expect = 7e-07
 Identities = 39/195 (20%), Positives = 70/195 (35%), Gaps = 34/195 (17%)

Query: 17  KLQLLSLEDNQL--EG--SIPDDLCRLAALFELDSGGNKLD-----GFVPACFGNLTNLR 67
           +L+ L + +  +  +G   +   L    +L EL   GN+L                  L 
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316

Query: 68  NLYLGSNKLTS-----IPSTLWNLKDILYLDLSSNFL-----------LIGNLKVLVQVD 111
           +L++ S   T+       S L   + +L L +S+N L           L     VL  + 
Sbjct: 317 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376

Query: 112 LSMNNFSDV----IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI-----NLKSLNLSN 162
           L+  + SD     +  T+     L+ L L  N L  +    + + +      L+ L L +
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 436

Query: 163 NNLSGTIPISLEKLL 177
              S  +   L+ L 
Sbjct: 437 IYWSEEMEDRLQALE 451

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 47.6 bits (114), Expect = 7e-06
 Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 31/170 (18%)

Query: 15  LQKLQLLSLEDNQL--EG--SIPDDLCRLAALFELDSGGNKL--DGFVPACFG---NLTN 65
           LQ+ Q++ L+D  L       I   L    AL EL+   N+L   G      G       
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 66  LRNLYLGSNKLT-----SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV 120
           ++ L L +  LT      + STL  L  +  L LS N L    L++L +  L        
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ----- 141

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI----NLKSLNLSNNNLS 166
                     L+ L LEY  L  +  + +  ++    + K L +SNN+++
Sbjct: 142 --------CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 36/193 (18%), Positives = 66/193 (34%), Gaps = 40/193 (20%)

Query: 11  AVGKLQKLQLLSLEDNQLEGS-----IPDDLCRLAALFELDSGGNKLD----GFVPACFG 61
            V     L+ L+L  N+L         P  L   + L  L      +     G +     
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 62  NLTNLRNLYLGSNKLT---------SIPSTLWNLKDILYLDLSSNFL----------LIG 102
              +L+ L L  N+L          ++      L+    L + S             ++ 
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLES---LWVKSCSFTAACCSHFSSVLA 338

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIG-GLKD----LQYLFLEYNRLQ----GSIPDSIGDLI 153
             + L+++ +S N   D     +  GL      L+ L+L    +      S+  ++    
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398

Query: 154 NLKSLNLSNNNLS 166
           +L+ L+LSNN L 
Sbjct: 399 SLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 35/199 (17%), Positives = 68/199 (34%), Gaps = 36/199 (18%)

Query: 17  KLQLLSLEDNQL--EG--SIPDDLCRLAALFELDSGGNKLDG-----FVPACFGNLTNLR 67
           +L+ L LE   +  +    +   +   A+L EL  G NKL         P      + LR
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259

Query: 68  NLYLGSNKLTS-----IPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP 122
            L++    +T+     +   L   + +  L L+ N L     ++L +  L          
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET-LLEPGCQ---- 314

Query: 123 TTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI----NLKSLNLSNNNLSGTIPISLEKLLD 178
                   L+ L+++      +       ++     L  L +SNN L       L + L 
Sbjct: 315 --------LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG 366

Query: 179 -----LKDINVSFNKLEGE 192
                L+ + ++   +   
Sbjct: 367 QPGSVLRVLWLADCDVSDS 385

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 4e-07
 Identities = 30/182 (16%), Positives = 54/182 (29%), Gaps = 20/182 (10%)

Query: 5   NGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLT 64
              +   +  +  L  L ++              L +L E+ SGG            +L 
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILGSDLP 219

Query: 65  NLR--NLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP 122
           NL    LY+G               D                  L  + +      +V+ 
Sbjct: 220 NLEKLVLYVGVE---------DYGFDGDMNVFRP-LFSKDRFPNLKWLGIVDAEEQNVVV 269

Query: 123 TTIGG---LKDLQYLFLEYNRLQGS----IPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
                   L  L+ + +    L       + D +  + +LK +N+  N LS  +   L+K
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

Query: 176 LL 177
            L
Sbjct: 330 SL 331

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.2 bits (118), Expect = 4e-07
 Identities = 28/80 (35%), Positives = 36/80 (45%), Gaps = 1/80 (1%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
           Q L L +NQ+    P     L  L +L    NKL       F  LT L  L L  N L S
Sbjct: 36  QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS 95

Query: 79  IPSTLW-NLKDILYLDLSSN 97
           IP   + NLK + ++ L +N
Sbjct: 96  IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.1 bits (110), Expect = 5e-06
 Identities = 36/116 (31%), Positives = 48/116 (41%), Gaps = 35/116 (30%)

Query: 56  VPACFGNLTNLRNLYLGSNKLTSIPS----TLWNLKDILYLDLSSNFLLIGNLKVLVQVD 111
           VPA  G  T+ + L+L +N++T +       L NL+    L  +SN      L  +    
Sbjct: 27  VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQ---QLYFNSN-----KLTAI---- 72

Query: 112 LSMNNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN---LSNN 163
                     PT +   L  L  L L  N L+ SIP    D  NLKSL    L NN
Sbjct: 73  ----------PTGVFDKLTQLTQLDLNDNHLK-SIPRGAFD--NLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 39.5 bits (93), Expect = 8e-04
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 15/98 (15%)

Query: 109 QVDLSMNNFSDV---IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNN 164
            V+      + V   IPT      D Q L+L  N++   +   + D L+NL+ L  ++N 
Sbjct: 16  LVNCQNIRLASVPAGIPT------DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNK 68

Query: 165 LSGTIPISL-EKLLDLKDINVSFNKLEGEIPNKGPFRN 201
           L+  IP  + +KL  L  ++++ N L+  IP +G F N
Sbjct: 69  LT-AIPTGVFDKLTQLTQLDLNDNHLKS-IP-RGAFDN 103

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.2 bits (118), Expect = 4e-07
 Identities = 30/80 (37%), Positives = 39/80 (48%), Gaps = 1/80 (1%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS 78
           Q+L L DNQ+    P    RL  L  LD   N+L       F  LT L  L L  N+L S
Sbjct: 33  QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS 92

Query: 79  IPSTLW-NLKDILYLDLSSN 97
           IP   + NLK + ++ L +N
Sbjct: 93  IPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.1 bits (110), Expect = 4e-06
 Identities = 37/116 (31%), Positives = 45/116 (38%), Gaps = 35/116 (30%)

Query: 56  VPACFGNLTNLRNLYLGSNKLTSIPS----TLWNLKDILYLDLSSNFLLIGNLKVLVQVD 111
           VP   G  T  + LYL  N++T +       L  L     LDL +N      L VL    
Sbjct: 24  VPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLT---RLDLDNN-----QLTVL---- 69

Query: 112 LSMNNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN---LSNN 163
                     P  +   L  L  L L  N+L+ SIP    D  NLKSL    L NN
Sbjct: 70  ----------PAGVFDKLTQLTQLSLNDNQLK-SIPRGAFD--NLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 39.9 bits (94), Expect = 6e-04
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)

Query: 109 QVDLSMNNFSDV---IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD-LINLKSLNLSNNN 164
            VD S  + + V   IPT        Q L+L  N++   +   + D L  L  L+L NN 
Sbjct: 13  TVDCSGKSLASVPTGIPT------TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQ 65

Query: 165 LSGTIPISL-EKLLDLKDINVSFNKLEGEIPNKGPFRN 201
           L+  +P  + +KL  L  ++++ N+L+  IP +G F N
Sbjct: 66  LT-VLPAGVFDKLTQLTQLSLNDNQLKS-IP-RGAFDN 100

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 41/236 (17%), Positives = 78/236 (33%), Gaps = 55/236 (23%)

Query: 11  AVGKLQKLQLLSLEDNQLEGSIPDD-----------LCRLAALFELDSGGNKL--DGFVP 57
            +   + L++    D    G + D+           L +   L  +    N        P
Sbjct: 55  NIASKKDLEIAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP 113

Query: 58  --ACFGNLTNLRNLYLGSNKLT--------------SIPSTLWNLKDILYLDLSSNFL-- 99
                   T L +LYL +N L               ++     N   +  +    N L  
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173

Query: 100 --------LIGNLKVLVQVDLSMNNFSDV-IPTTIG-GLKD---LQYLFLEYNRL--QG- 143
                      + ++L  V +  N      I   +  GL     L+ L L+ N     G 
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233

Query: 144 -SIPDSIGDLINLKSLNLSNNNLS--GTIPIS--LEKL--LDLKDINVSFNKLEGE 192
            ++  ++    NL+ L L++  LS  G   +     KL  + L+ + + +N++E +
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 34/207 (16%), Positives = 68/207 (32%), Gaps = 46/207 (22%)

Query: 18  LQLLSLEDNQL-------------EGSIPDDLCRLAALFELDSGGNKL-DGFVPA---CF 60
           L+ L L +N L             E ++         L  +  G N+L +G +      F
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 61  GNLTNLRNLYLGSNKLTS------IPSTLWNLKDILYLDLSSNFL----------LIGNL 104
            +   L  + +  N +        +   L   +++  LDL  N             + + 
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243

Query: 105 KVLVQVDLSMNNFSDVIPTTIG-GLKD-----LQYLFLEYNRLQGSIPDSIGDLI----- 153
             L ++ L+    S      +           LQ L L+YN ++     ++  +I     
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303

Query: 154 NLKSLNLSNNNLS--GTIPISLEKLLD 178
           +L  L L+ N  S    +   + ++  
Sbjct: 304 DLLFLELNGNRFSEEDDVVDEIREVFS 330

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 27/174 (15%), Positives = 50/174 (28%), Gaps = 43/174 (24%)

Query: 61  GNLTNLRNLYLGSNKLTS-----IPSTLWNLKDILYLDLSSNFL----------LIGNLK 105
              + +    L  + +T+     + + L     +  + LS N +           I + K
Sbjct: 2   ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 106 VLVQVDLSMNNFSDVIPTTIGGLKD----------LQYLFLEYNRLQGSIPDSIGDLI-- 153
            L   + S      V       L+           L  + L  N    +  + + D +  
Sbjct: 61  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 154 --NLKSLNLSNNNLS-------------GTIPISLEKLLDLKDINVSFNKLEGE 192
              L+ L L NN L                +    +    L+ I    N+LE  
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 4e-06
 Identities = 70/486 (14%), Positives = 129/486 (26%), Gaps = 158/486 (32%)

Query: 10  IAVGK-------LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFV-----P 57
           + +         L+ LQ L  + +    S  D    +     + S   +L   +      
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK--LRIHSIQAELRRLLKSKPYE 244

Query: 58  ACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGN-------LKVLVQV 110
            C   L  L N+               N K     +LS   LL          L      
Sbjct: 245 NC---LLVLLNV--------------QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287

Query: 111 DLSMNNFSDVIPTTIGGLKDL--QYLFLEYNRL-----QGSIP---DSIGDLI------- 153
            +S+++ S  +  T   +K L  +YL      L       + P     I + I       
Sbjct: 288 HISLDHHSMTL--TPDEVKSLLLKYLDCRPQDLPREVLTTN-PRRLSIIAESIRDGLATW 344

Query: 154 -NLKSLNLSNNNLSGTIPISLEKL---------LDL----KDINVSFNKLE---GEIPNK 196
            N K +N   + L+  I  SL  L           L       ++    L     ++   
Sbjct: 345 DNWKHVN--CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402

Query: 197 GPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKNDLLIGIVLPLSTIFMMAVILF 256
                          L+      Q       I        + + + + L   + +   + 
Sbjct: 403 DVMV--VVNKLHKYSLV----EKQPKESTISIP------SIYLELKVKLENEYALHRSI- 449

Query: 257 ILRYRKRGKPLPNDANMPRISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVY---KARI 313
           +  Y        +D   P +       Y   +         + IG       +       
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQ-----Y--FY---------SHIG-------HHLKNIEH 486

Query: 314 QDGMEVAVKVF-DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH 372
            + M +   VF D         F +E    ++IRH +     S    +      L++   
Sbjct: 487 PERMTLFRMVFLDF-------RF-LE----QKIRHDSTAWNASGSILNTL--QQLKF--- 529

Query: 373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF--GYSVPII---HCDL------KPS 421
                  Y   YI D   +   +++       L F       +I   + DL         
Sbjct: 530 -------Y-KPYICDNDPKYERLVN-----AILDFLPKIEENLICSKYTDLLRIALMAED 576

Query: 422 NVLLDD 427
             + ++
Sbjct: 577 EAIFEE 582

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 5e-05
 Identities = 89/599 (14%), Positives = 179/599 (29%), Gaps = 165/599 (27%)

Query: 87  KDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP 146
           KDIL       F+           +    +  D +P +I   +++ ++ +  + + G+  
Sbjct: 19  KDIL-SVFEDAFV----------DNFDCKDVQD-MPKSILSKEEIDHIIMSKDAVSGT-- 64

Query: 147 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTES 206
                 +   +L          +   +E++L   +     + ++ E   + P     T  
Sbjct: 65  ----LRL-FWTLLSKQEE---MVQKFVEEVLR-INYKFLMSPIKTE--QRQPSMM--TRM 111

Query: 207 F-EGNELLCGMPNLQVPPCRTRIH-HTSRKNDLLIGIVLPLSTIFMMA------VILFIL 258
           + E  + L     +      +R+  +   +  LL         I  +       V L + 
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171

Query: 259 RYRKRGKPLPNDANMPRISNQRRF-TYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGM 317
              K    +        + N     T LE+ Q      + N   R    S  K RI    
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231

Query: 318 EVAVKVF-------------DLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC------- 357
               ++              ++Q  +A+ +F++ C ++   R + +   +S+        
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291

Query: 358 -------SSDDFKALVLEY--MPHGSL--EKCLYS-----------------SNYILDI- 388
                  + D+ K+L+L+Y       L  E    +                  +    + 
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 389 FQRLNIMIDVASALEYLH-------------FGYSVPIIHCDLKPSNVL----------L 425
             +L  +I+  S+L  L              F  S  I      P+ +L           
Sbjct: 352 CDKLTTIIE--SSLNVLEPAEYRKMFDRLSVFPPSAHI------PTILLSLIWFDVIKSD 403

Query: 426 DDNMVAHLSDFGMAKP------------LLKEDQSLTQTQTL-ATI--GYMAPE-YGREG 469
              +V  L  + + +              L+    L     L  +I   Y  P+ +  + 
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463

Query: 470 QVSTNGDVYSF---GIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
            +    D Y +   G  L       +  + +             L     M  +D   L 
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNI----EHPERM------------TLFR---MVFLDFRFLE 504

Query: 527 QKDEHFTTKGQCVSFIFNLAMKC-------TVESP--EQRINAKEIVTRLLKIRDSLLK 576
           QK  H +T       I N   +            P  E+ +NA  I+  L KI ++L+ 
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENLIC 561

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 5e-06
 Identities = 24/98 (24%), Positives = 46/98 (46%), Gaps = 4/98 (4%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            +  G +     + ++L+ LS  +  L  SI  +L +L  L +L+   N++ G +     
Sbjct: 28  RSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAE 85

Query: 62  NLTNLRNLYLGSNKLTSIPS--TLWNLKDILYLDLSSN 97
              NL +L L  NK+  + +   L  L+++  LDL + 
Sbjct: 86  KCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 25/129 (19%), Positives = 49/129 (37%), Gaps = 23/129 (17%)

Query: 62  NLTNLRNLYLGSNKLT--SIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSD 119
             ++++ L L +++     +       +++ +L   +  L             S+ N   
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------SIANLPK 62

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG-TIPISLEKLLD 178
                   L  L+ L L  NR+ G +        NL  LNLS N +   +    L+KL +
Sbjct: 63  --------LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114

Query: 179 LKDINVSFN 187
           LK +++   
Sbjct: 115 LKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 5/100 (5%)

Query: 121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLK 180
           +       ++L++L      L  SI + +  L  LK L LS+N +SG + +  EK  +L 
Sbjct: 34  LEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91

Query: 181 DINVSFNKLE--GEIPNKGPFRNFSTESFEGNELLCGMPN 218
            +N+S NK++    I       N  +      E +  + +
Sbjct: 92  HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE-VTNLND 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 5e-06
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 4/98 (4%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            + +G I     +   L+ LSL +  L  S+  +L +L  L +L+   N++ G +     
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 62  NLTNLRNLYLGSNKLTSIPS--TLWNLKDILYLDLSSN 97
            L NL +L L  NKL  I +   L  L+ +  LDL + 
Sbjct: 93  KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 28/104 (26%), Positives = 40/104 (38%), Gaps = 8/104 (7%)

Query: 90  LYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGS 144
           L LD   +       L      L  + L       V  + +  L  L+ L L  NR+ G 
Sbjct: 29  LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86

Query: 145 IPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFN 187
           +      L NL  LNLS N L     +  L+KL  LK +++   
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 35/220 (15%), Positives = 70/220 (31%), Gaps = 50/220 (22%)

Query: 17  KLQLLSLEDNQLEGSIPDDLCRL-----AALFELDSGGNKLD-----GFVPACFGNLTNL 66
            + +L L  N        +  +      A++  L+  GN L        +        N+
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANV 169

Query: 67  RNLYLGSNKLT------------SIPSTLWNLKDILYLDLSSNFL-----------LIGN 103
            +L L  N L             SIP+++        LDLS+N L               
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPASV------TSLDLSANLLGLKSYAELAYIFSSI 223

Query: 104 LKVLVQVDLSMNNFSDV----IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI------ 153
              +V ++L +N         +      LK LQ ++L+Y+ ++    +    L       
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283

Query: 154 -NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE 192
             +  ++ +   +  +  I +  L+           L  +
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 43/214 (20%), Positives = 72/214 (33%), Gaps = 41/214 (19%)

Query: 17  KLQLLSLEDNQLEGSIPDDLCRL-----AALFELDSGGNKLD-----GFVPACFGNLTNL 66
            +  L+L  N L     D+L ++     A +  L+  GN L        V         +
Sbjct: 52  SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111

Query: 67  RNLYLGSNKLTS-----IPSTLWNLKDIL-YLDLSSNFL-----------LIGNLKVLVQ 109
             L LG N  +S           NL   +  L+L  N L           L      +  
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNS 171

Query: 110 VDLSMNNFSDVIPTTIG-GLKD----LQYLFLEYNRLQGSIPDSIGDLI-----NLKSLN 159
           ++L  NN +      +   L      +  L L  N L       +  +      ++ SLN
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231

Query: 160 LSNNNLSGTIPISLEKLLD----LKDINVSFNKL 189
           L  N L G    +L+ L D    L+ + + ++ +
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	580
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.97
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.94
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.94
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.94
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.93
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.93
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.93
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.93
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.93
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.92
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.92
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.92
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.92
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.92
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.92
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.92
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.92
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.92
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.92
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.92
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.92
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.91
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.91
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.9
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.9
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.9
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.9
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.9
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.9
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.89
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.89
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.88
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.88
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.88
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.88
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.87
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.87
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.87
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.85
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.85
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.82
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.82
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.82
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.81
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.81
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.81
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.81
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.8
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.8
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.72
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.72
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.69
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.64
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.62
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.57
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.5
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.44
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.42
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.38
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.34
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.3
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.19
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.18
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.03
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.98
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.94
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	98.88
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.78
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.7
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	98.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.62
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.5
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.45
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.3
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.94
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.9
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.82
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.78
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.75
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.67
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.65
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.63
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.53
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.48
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.43
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.38
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.32
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.14
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.13
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.89
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.6
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.04
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.61
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.47
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.25
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.44
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.1

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-57  Score=446.40  Aligned_cols=259  Identities=29%  Similarity=0.457  Sum_probs=217.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999864      477899999976655667889999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEE
Q 038098          366 VLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  433 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl  433 (580)
                      |||||++|+|.++++..+            ..++|.+++.++.|||+||+|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997643            46999999999999999999999   899999999999999999999999


Q ss_pred             ccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhc
Q 038098          434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       434 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      +|||+|+.....+.........||+.|||||.+.++.++.++|||||||++|||+| |+.||.+...  ..+...     
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~-----  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC-----  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH-----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH-----
Confidence            99999987655444434445579999999999999999999999999999999999 8999876311  111111     


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                            +...       .+...+..++.++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus       243 ------i~~~-------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ------ITQG-------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ------HHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHcC-------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                  1110       11233456788999999999999999999999999999887653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6e-57  Score=448.60  Aligned_cols=258  Identities=28%  Similarity=0.455  Sum_probs=209.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|.+.+.||+|+||.||+|+++      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999864      478899999976655566789999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          366 VLEYMPHGSLEKCLYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      |||||++|+|.++++..+              .+++|.+++.++.|||+||+|||   +.+|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999987542              46999999999999999999999   8999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  510 (580)
                      ||+|||+|+.+...+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.....  .....    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~----  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAID----  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHH----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHH----
Confidence            9999999997655444444455679999999999999999999999999999999999 8999875311  11111    


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                             .+..       ..+...+..+++++.+|+.+||+.||++||||+||+++|+.+.+
T Consensus       272 -------~i~~-------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          272 -------CITQ-------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             -------HHHH-------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------HHHc-------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                   1111       01223445678899999999999999999999999999998865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-57  Score=441.31  Aligned_cols=263  Identities=28%  Similarity=0.414  Sum_probs=209.0

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +++.+.+.||+|+||+||+|+++  ..||||+++...  .+..+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            56778899999999999999876  369999986432  3345789999999999999999999999865 568999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      |++|+|.++++..+..+++.+++.++.|||+||+|||   +.+|+||||||+|||+++++.+||+|||+|+.........
T Consensus       113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999887778999999999999999999999   8999999999999999999999999999998764433333


Q ss_pred             cccccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          450 TQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      ......||+.|||||++.+   +.++.++|||||||++|||+||+.||.+.... ......+.            .....
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~~------------~~~~~  256 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVG------------RGYAS  256 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHH------------TTCCC
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHHh------------cCCCC
Confidence            4456689999999999863   46899999999999999999999999753211 01111111            11000


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      .  .....+..++.++.+|+.+||+.||++||||+||+++|+.++..+.
T Consensus       257 p--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          257 P--DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             C--CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             C--CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            0  0112335678889999999999999999999999999998876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.8e-57  Score=443.55  Aligned_cols=255  Identities=25%  Similarity=0.423  Sum_probs=213.2

Q ss_pred             CCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +++..+.||+|+||+||+|.+.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3556788999999999999863      46789999996543 3345789999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc
Q 038098          366 VLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  430 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~  430 (580)
                      |||||++|+|.+++....               ..++|..++.++.|||+||+|||   +.+|+||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996532               45899999999999999999999   899999999999999999999


Q ss_pred             EEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHH
Q 038098          431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVN  509 (580)
Q Consensus       431 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  509 (580)
                      +||+|||+|+.....+.........||+.|||||++.++.++.++|||||||++|||+| |+.||.+...  ..+...  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~--  259 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEM--  259 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHH--
Confidence            99999999987655444444456679999999999999999999999999999999999 8999875311  111111  


Q ss_pred             hhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          510 DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       510 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                                +..      ..+.+.+..++.++.+|+.+||+.||++||||+||+++|+++
T Consensus       260 ----------i~~------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 ----------IRN------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ----------HHT------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----------HHc------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      111      112234567888999999999999999999999999999865

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.8e-55  Score=434.68  Aligned_cols=250  Identities=25%  Similarity=0.319  Sum_probs=212.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999865 79999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +||+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999998764  4899999999999999999999   99999999999999999999999999999987643322  3


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|++||.+..    ....+         ..+.+     ....
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~---------~~i~~-----~~~~  288 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAM---------KMIRD-----NLPP  288 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH---------HHHHH-----SSCC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHH---------HHHHc-----CCCC
Confidence            345689999999999999999999999999999999999999996521    11110         00111     1111


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            223345677889999999999999999999999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.6e-55  Score=433.23  Aligned_cols=250  Identities=21%  Similarity=0.326  Sum_probs=204.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            67999999999999999999865 79999999997542  2345678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+||+|.+++...+ ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.+...  
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            999999999997654 46799999999999999999999   999999999999999999999999999999865321  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......+||+.|||||++.+..++.++||||+||++|||+||+.||.+..     ..+...        .+....    
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~--------~i~~~~----  241 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVL--------KIISGS----  241 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHH--------HHHHTC----
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHH--------HHHcCC----
Confidence            112345679999999999999999999999999999999999999997521     111111        111111    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   ...+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       242 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          242 F---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   01234567889999999999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-54  Score=428.46  Aligned_cols=257  Identities=22%  Similarity=0.257  Sum_probs=211.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +.|...+.||+|+||.||+|+++ +|+.||||+++.+..     ..+|+.++++++|||||++++++.+++..++|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999865 699999999975422     246999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +||+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+| .+||+|||+|+.+.......
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999997654 5999999999999999999999   99999999999999999988 59999999998765433211


Q ss_pred             ---cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          450 ---TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       450 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         .....+||+.|||||++.+..++.++||||+||++|||+||+.||.+...... ......            .    
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~------------~----  271 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIAS------------E----  271 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHH------------S----
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHc------------C----
Confidence               22345799999999999999999999999999999999999999976432211 111111            0    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                       .......+..+++++.+++.+||+.||++|||+.|++++|.+...+..
T Consensus       272 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          272 -PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             -CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence             001112345677889999999999999999999999999998877643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-54  Score=427.75  Aligned_cols=277  Identities=23%  Similarity=0.299  Sum_probs=203.4

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC----ceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD----FKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  367 (580)
                      .+|.+.+.||+|+||+||+|+++ |+.||||+++..... ......|+..+.+++|||||+++++|.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            34677889999999999999985 899999999654221 122344666667889999999999997654    578999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      |||++|+|.++++..  .++|..+++++.|+++||+|||..     ...+|+||||||+|||++.++++||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999764  489999999999999999999932     1239999999999999999999999999999866


Q ss_pred             CCCCCc--ccccccccCCCcCCcccccCC------CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc-
Q 038098          443 LKEDQS--LTQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP-  513 (580)
Q Consensus       443 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-  513 (580)
                      ......  .......||+.|||||++.+.      .++.++|||||||++|||+||++|+............+...... 
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            433322  122345799999999998654      46789999999999999999998876533222211111100000 


Q ss_pred             cchhh-hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          514 ISVME-IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       514 ~~~~~-~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ..+.. +.+...... .+......+++..+.+|+.+||+.||++||||+||++.|+++.++
T Consensus       239 ~~~~~~~~~~~~rp~-~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPN-IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCC-CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCC-CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            00111 111111111 111112235677899999999999999999999999999998765

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-54  Score=424.78  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=211.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999865 7999999999754   2344577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||++||+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999997654 5999999999999999999999   99999999999999999999999999999997755444


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......+||+.|||||++.+..++.++||||+||++|||+||+.||.+..     ......        .+..    . 
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~--------~i~~----~-  249 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFA--------KIIK----L-  249 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH--------HHHH----T-
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHH--------HHHc----C-
Confidence            444556789999999999999999999999999999999999999996521     111111        1111    1 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....+..+++++.+|+.+||+.||++|||++|+..+
T Consensus       250 ---~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          250 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ---CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence               111234567789999999999999999999987543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-54  Score=432.56  Aligned_cols=265  Identities=23%  Similarity=0.379  Sum_probs=218.1

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeCC------CCEEEEEEEecccc-chhhhHHHHHHHHhhcCC-CCcceEEeeee
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQD------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRH-RNIIKIISSCS  358 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~~~  358 (580)
                      .+...++|++.+.||+|+||+||+|.+..      ++.||||++..... ...+.+.+|++++++++| ||||+++|+|.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            33345789999999999999999998642      35799999965433 345678999999999965 89999999986


Q ss_pred             cC-CceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCC
Q 038098          359 SD-DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  422 (580)
Q Consensus       359 ~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N  422 (580)
                      +. +..++|||||++|+|.++++..+               ..+++..++.++.|||+||+|||   +++|+||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccc
Confidence            64 56899999999999999997532               35899999999999999999999   9999999999999


Q ss_pred             EEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCC
Q 038098          423 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGD  501 (580)
Q Consensus       423 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~  501 (580)
                      ||+++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.....
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999997755544444556679999999999999999999999999999999998 999997632111


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                       .+.            ..+...      .+...+..+++++.+++.+||+.||++||||+||+++|+++.+.
T Consensus       296 -~~~------------~~i~~g------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 -EFC------------RRLKEG------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             -HHH------------HHHHHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHH------------HHHHcC------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence             111            111111      12233456788899999999999999999999999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.5e-54  Score=435.82  Aligned_cols=250  Identities=25%  Similarity=0.319  Sum_probs=212.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46889999999999999999865 79999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +||+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            999999998754  4899999999999999999999   99999999999999999999999999999987643322  3


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..    ....+         ..+.+     ....
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~---------~~i~~-----~~~~  365 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAM---------KMIRD-----NLPP  365 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH---------HHHHH-----SCCC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHH---------HHHHc-----CCCC
Confidence            345689999999999999999999999999999999999999996521    11110         00110     0111


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+..++.++.+|+.+||..||++|||++|+++|
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            223334567889999999999999999999999886

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-53  Score=412.23  Aligned_cols=245  Identities=25%  Similarity=0.346  Sum_probs=197.6

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec----CCceeeEe
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFKALVL  367 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  367 (580)
                      ...+.||+|+||+||+|.+. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ++..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45567999999999999865 68999999996542  2345678999999999999999999999864    34679999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeC-CCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  444 (580)
                      |||++|+|.+++... ..+++..+..++.||+.||+|||   +.+  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999764 46999999999999999999999   777  99999999999998 489999999999985422


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                          ......+||+.|||||++.+ .++.++|||||||++|||+||+.||.....    .......         +... 
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~---------i~~~-  245 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRR---------VTSG-  245 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHH---------HTTT-
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHH---------HHcC-
Confidence                12345679999999998864 699999999999999999999999964211    1111111         1000 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ..  ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       246 --~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          246 --VK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --CC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --CC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00  111223456778999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.4e-53  Score=409.98  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=193.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ......+.+|++++++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999864 79999999996542   233567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+ +|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 679999987654 5999999999999999999999   9999999999999999999999999999998653322 


Q ss_pred             cccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....     .......        +...    
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~--------i~~~----  227 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKN--------ISNG----  227 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--------HHHT----
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH--------HHcC----
Confidence              2345679999999999988775 589999999999999999999996521     1111111        1110    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       228 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          228 ----VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                111233467788999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-53  Score=414.78  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999752    47889999996542  2234568889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |||||+||+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 5999999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .  ......+||+.|||||++.+..++.++||||+||++|||+||+.||.+...     .+...        .+...   
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~--------~i~~~---  241 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMT--------MILKA---  241 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHHC---
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHH--------HHHcC---
Confidence            2  223456799999999999999999999999999999999999999975211     11111        11110   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                           ....+..+++++.+|+.+||+.||++|||+     +|+++|
T Consensus       242 -----~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          242 -----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                 112234567889999999999999999984     677764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.4e-51  Score=402.37  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=190.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCC--------
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--------  361 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  361 (580)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999865 799999999975433 33467889999999999999999999986544        


Q ss_pred             ----ceeeEeeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          362 ----FKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       362 ----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                          ..++||||+++|+|.+++....  ...++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                3689999999999999998655  34567788999999999999999   99999999999999999999999999


Q ss_pred             ccCccccCCCCCc----------ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH
Q 038098          436 FGMAKPLLKEDQS----------LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK  505 (580)
Q Consensus       436 fg~a~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~  505 (580)
                      ||+|+.+......          ...+..+||+.|||||++.+..++.++||||+||++|||++   ||....    ...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence            9999876433211          11234579999999999999999999999999999999996   764311    100


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....        .+.+    ..   ........++.+.+|+.+||+.||++|||+.|+++|
T Consensus       235 ~~~~--------~~~~----~~---~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          235 RTLT--------DVRN----LK---FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHH--------HHHT----TC---CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHH--------HHhc----CC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000        0000    00   011223344567889999999999999999999885

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-49  Score=399.96  Aligned_cols=269  Identities=25%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeec------CCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSS------DDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  362 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999865 799999999964422  334678899999999999999999998753      367


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 6899988764 46999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCC--CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc--ccch-
Q 038098          443 LKED--QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL--PISV-  516 (580)
Q Consensus       443 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~-  516 (580)
                      ....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.... ..+........  +... 
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGGT
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHHh
Confidence            4332  12234456899999999998775 5699999999999999999999999753111 01111111100  0000 


Q ss_pred             --------hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 --------MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 --------~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                              ...+..................+.++.+|+.+||..||++|||++|+++|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                    00000000000000111123456788999999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-48  Score=393.00  Aligned_cols=268  Identities=21%  Similarity=0.275  Sum_probs=200.7

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCcee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  364 (580)
                      ..+.|++.+.||+|+||+||+|+.+    +++.||+|++...  .....+.+|+++++.+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999753    4678999998644  2345678899999998 6999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCccccC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLL  443 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a~~~~  443 (580)
                      +||||+++|+|.+++.    .+++.++..++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999999999884    4899999999999999999999   9999999999999999876 899999999998653


Q ss_pred             CCCCc--------------------------ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          444 KEDQS--------------------------LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       444 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                      .....                          ......+||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            32110                          112345799999999998775 589999999999999999999999854


Q ss_pred             cccCCchHHHHHH------------hh----------cccchhhhcchh---------cc---CCcccccchhhhhHHHH
Q 038098          497 IFFGDMTLKHWVN------------DL----------LPISVMEIVDAN---------LL---SQKDEHFTTKGQCVSFI  542 (580)
Q Consensus       497 ~~~~~~~~~~~~~------------~~----------~~~~~~~~~d~~---------~~---~~~~~~~~~~~~~~~~l  542 (580)
                      .......+.....            ..          ............         ..   .............++++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            2111111111110            00          000000000000         00   00000111234566788


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHH
Q 038098          543 FNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       543 ~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+|+.+||+.||++|||++|+++|
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcC
Confidence            999999999999999999999876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.2e-48  Score=413.47  Aligned_cols=253  Identities=17%  Similarity=0.236  Sum_probs=212.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            367999999999999999999865 7999999999765555567788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC--CcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN--MVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+||+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            9999999999877777999999999999999999999   9999999999999999854  899999999999764322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        .....+||+.|||||++.+..++.++||||+||++|||++|+.||.+...    . ....        .+.    ...
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~-~~~~--------~i~----~~~  372 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----D-ETLR--------NVK----SCD  372 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----H-HHHH--------HHH----TTC
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----H-HHHH--------HHH----hCC
Confidence              23456799999999999999999999999999999999999999975211    0 1000        011    011


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........++.++.+|+.+||+.||++|||++|+++|
T Consensus       373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111112234567889999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.1e-48  Score=408.18  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=201.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHH---HHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDI---ECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|++.++||+|+||.||+|+.+ +|+.||||+++...   .........   ++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56999999999999999999865 69999999996532   122223333   456677789999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||++||+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999997654 5999999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ..    ....+||+.|||||++.. ..++.++||||+||++|||++|++||.+....+  ......            ..
T Consensus       345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~------------~i  406 (689)
T 3v5w_A          345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR------------MT  406 (689)
T ss_dssp             CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHH------------HH
T ss_pred             CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH------------hh
Confidence            22    234689999999999975 578999999999999999999999997532211  111111            00


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                      ...    ....+..++.++.+|+.+||+.||++|++     ++||++|
T Consensus       407 ~~~----~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          407 LTM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHC----CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             cCC----CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            000    11223456788999999999999999998     6888765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5e-47  Score=380.29  Aligned_cols=281  Identities=32%  Similarity=0.524  Sum_probs=231.7

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      ++.++...+++|+..+.||+|+||.||+|.+++|+.||||++........+.+.+|++++++++||||+++++++...+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            33445557789999999999999999999988899999999876656667889999999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      .++||||+++|+|.+++....   ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999987654   35899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC-CchHHHHHHhhccc-chh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG-DMTLKHWVNDLLPI-SVM  517 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~  517 (580)
                      +...............||+.|+|||.+.++.++.++|||||||++|||+||+.||...... ......|....... ...
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            8654333333334456899999999998889999999999999999999999999764332 23344444322211 122


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      ..+++...      ......++..+.+++.+||+.||++||+++|++++|+.+.+
T Consensus       267 ~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          267 QIVDPNLA------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSSCT------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcChhhc------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            22222211      12345678889999999999999999999999999998875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.1e-46  Score=375.44  Aligned_cols=287  Identities=36%  Similarity=0.546  Sum_probs=234.6

Q ss_pred             cccCCccCHHHHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEE
Q 038098          276 ISNQRRFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKII  354 (580)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~  354 (580)
                      ....+.+++.++....++|+..+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++||||++++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            345567899999999999999999999999999999988899999999865432 2334788999999999999999999


Q ss_pred             eeeecCCceeeEeeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          355 SSCSSDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       355 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      +++...+..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||..+..+|+||||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999999998654   359999999999999999999993322399999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCcc---ccCCchHHHHH
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEI---FFGDMTLKHWV  508 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~---~~~~~~~~~~~  508 (580)
                      ||+|||+++....... .......||+.|+|||.+.+..++.++||||+||++|||+||+.||+..   .........|.
T Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999986643322 2334456999999999998889999999999999999999999999742   12334456666


Q ss_pred             Hhhcccc-hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 038098          509 NDLLPIS-VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK  569 (580)
Q Consensus       509 ~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~  569 (580)
                      ....... .....+....      .......+..+.+++.+||+.||++|||++||+++|++
T Consensus       253 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQ------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCT------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhhchhhhhhcChhhc------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            5544332 3333333222      12335667889999999999999999999999999974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=370.94  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=218.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56888999999999999999865 68999999986555556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc-
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL-  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-  449 (580)
                      ++|+|.+++......+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......... 
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999999999887778999999999999999999999   8999999999999999999999999999998664332211 


Q ss_pred             -----------cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          450 -----------TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       450 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                                 ......||+.|+|||.+.+..++.++||||||+++|||++|..|+............        ....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------~~~~  238 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRG  238 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------CHHH
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------hhhc
Confidence                       111456999999999999999999999999999999999999998653222111100        0111


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      ..+.          ..+..++..+.+++.+||+.||++||+++|+++.|+++...+..
T Consensus       239 ~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          239 FLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             HHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            1111          01234556788999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-45  Score=364.61  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=211.3

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            36799999999999999999985 47899999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999998765  4899999999999999999999   89999999999999999999999999999986643322  


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.....    .....         .+...     ..
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~---------~~~~~-----~~  233 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALY---------LIATN-----GT  233 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHH---------HHHHH-----CS
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHH---------HHHhC-----CC
Confidence            23455799999999999999999999999999999999999999865211    11100         00000     01


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....+..++..+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1122345567889999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.5e-46  Score=370.94  Aligned_cols=276  Identities=24%  Similarity=0.309  Sum_probs=212.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc----eeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF----KALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv  366 (580)
                      .++|++.+.||+|+||.||+|++. ++.||||++.... ........|+.++++++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467889999999999999999886 7999999996543 233455668889999999999999999987543    6999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEEecCCCCCEEeCCCCcEEEccc
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV----------PIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~----------~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      |||+++|+|.+++....  +++..++.++.||++||+|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997644  899999999999999999999   77          9999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc-hHHHHHHh
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM-TLKHWVND  510 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~  510 (580)
                      |+++.+.............||+.|+|||.+.+     ..++.++|||||||++|||+||+.||........ ........
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987654444333445679999999999876     3566789999999999999999999976432211 11111111


Q ss_pred             hccc-chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          511 LLPI-SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       511 ~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      .... ...+.+.................++.++.+|+.+||+.||++|||++|+++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0000 01111111111111111112234677899999999999999999999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-45  Score=375.58  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=216.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||++.... ......+.+|+++++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367888999999999999999752        35579999996543 23456788999999999 899999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      +..++||||+++|+|.+++...+               ..+++..++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998654               34899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......  ..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence            9999999999999987654443333444567889999999999999999999999999999999 99998653211  11


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ..            .+...      .+...+..++.++.+++.+||+.||++||++.|++++|+++.....
T Consensus       315 ~~------------~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          315 FK------------LLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HH------------HHHTT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HH------------HHhcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11            11110      0112334567889999999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.1e-45  Score=363.44  Aligned_cols=262  Identities=24%  Similarity=0.308  Sum_probs=216.8

Q ss_pred             CccCHHHHHHHhcC----------CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCC
Q 038098          280 RRFTYLEIFQATNG----------FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHR  348 (580)
Q Consensus       280 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  348 (580)
                      ..+++.++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888877764          666778999999999999876 7999999999876666667889999999999999


Q ss_pred             CcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC
Q 038098          349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN  428 (580)
Q Consensus       349 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~  428 (580)
                      ||+++++++...+..++||||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999988653  5899999999999999999999   8999999999999999999


Q ss_pred             CcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHH
Q 038098          429 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWV  508 (580)
Q Consensus       429 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~  508 (580)
                      +.+||+|||++........  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .......
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~  253 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRL  253 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence            9999999999986643222  23445799999999999999999999999999999999999999865211  0111111


Q ss_pred             HhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          509 NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       509 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..                ...........++.++.+++.+||+.||++||+++|+++|
T Consensus       254 ~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          254 RD----------------SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH----------------SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hc----------------CCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10                0111112234566789999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.7e-46  Score=380.65  Aligned_cols=261  Identities=28%  Similarity=0.424  Sum_probs=215.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|...+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            356888899999999999999976 789999999865422 334578899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++|+|.+++...+..+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999877777999999999999999999999   899999999999999999999999999999865332221


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......++..|+|||.+.++.++.++|||||||++|||+| |..||.....  ....            +.+...    
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~------------~~~~~~----  331 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTR------------EFVEKG----  331 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHH------------HHHHTT----
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHH------------HHHHcC----
Confidence            11222345778999999998899999999999999999999 9999865311  1111            111111    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                        .+...+..++.++.+++.+||+.||++|||++++++.|+++.++.
T Consensus       332 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          332 --GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence              112234457788999999999999999999999999999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.3e-44  Score=356.00  Aligned_cols=282  Identities=29%  Similarity=0.478  Sum_probs=228.8

Q ss_pred             cCCccCHHHHHHHhcCCCcC------ceeccccCceEEEEEeCCCCEEEEEEEeccc----cchhhhHHHHHHHHhhcCC
Q 038098          278 NQRRFTYLEIFQATNGFSEN------NLIGRGGFGSVYKARIQDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRIRH  347 (580)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h  347 (580)
                      ....|++.++..+++.|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999887      8999999999999987 48899999986432    2345678899999999999


Q ss_pred             CCcceEEeeeecCCceeeEeeccCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       348 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      |||+++++++...+..++||||+++|+|.+++...  ..++++..++.++.||+.||.|||   +.+++||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998743  346899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK  505 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~  505 (580)
                      +.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||+...... ...
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence            9999999999999986644333333345578999999998764 58999999999999999999999997643222 222


Q ss_pred             HHHHhhc--ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          506 HWVNDLL--PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       506 ~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      .+.....  ...+...++....       ..+..++..+.+++.+||+.||++||++++++++|+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMN-------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCS-------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhcccccc-------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2222211  1112333332221       1234567889999999999999999999999999998864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5e-45  Score=363.20  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=205.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..++|++.+.||+|+||.||+|+.. |+.||||++....  ......+.+|++++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            3467888999999999999999874 8899999986543  233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          368 EYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ||+++|+|.+++....  ..+++..++.++.||+.||+|||   +.+  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999998654  24899999999999999999999   888  9999999999999999999999999997543


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ..  ........||+.|+|||.+.+..++.++|||||||++|||+||+.||......  .......              
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~--------------  252 (309)
T 3p86_A          191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVG--------------  252 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHH--------------
T ss_pred             cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH--------------
Confidence            22  12234457999999999999999999999999999999999999998753111  0000000              


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                       .  .......+..++.++.+++.+||+.||++||+++|+++.|+.+.++.
T Consensus       253 -~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          253 -F--KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -H--SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -h--cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence             0  00112233456778999999999999999999999999999887653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-45  Score=355.97  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=214.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|+..+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5688889999999999999998888999999997543 234678999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++......+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  164 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  164 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence            99999999887778999999999999999999999   9999999999999999999999999999998653321 1223


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+|..|+|||.+.+..++.++||||+|+++|||++ |+.||.....     .....        .+...       .
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----~~~~~--------~~~~~-------~  224 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVE--------DISTG-------F  224 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH--------HHHTT-------C
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH--------HHhcC-------c
Confidence            34456778999999998999999999999999999999 9999865211     11111        00000       0


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ....+..++..+.+++.+||+.||++||+++|++++|+++.++
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1112234567799999999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=365.51  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=212.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|.+.+.||+|+||.||+|.+.    .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999874    34469999997542 23456788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++......+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999877778999999999999999999999   8999999999999999999999999999998764432


Q ss_pred             C-cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          447 Q-SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       447 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      . ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......     ....         .+... 
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~---------~~~~~-  270 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVIS---------SVEEG-  270 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHH---------HHHTT-
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHH---------HHHcC-
Confidence            2 122233446778999999998899999999999999999999 99998653111     1100         01100 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                           .....+..++.++.+++.+||+.||++||+++|+++.|+++.+..
T Consensus       271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                 111233456788999999999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-45  Score=362.62  Aligned_cols=276  Identities=26%  Similarity=0.418  Sum_probs=213.7

Q ss_pred             hcCCCcCceeccccCceEEEEEe-----CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  363 (580)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35688899999999999999984     2688999999976655556788999999999999999999999854  3568


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++|+|.+++...+..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887777999999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCCc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc--hhhhc
Q 038098          444 KEDQS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS--VMEIV  520 (580)
Q Consensus       444 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~  520 (580)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....   ....+........  .....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---HHHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---HHHhhhcCccccchhHHHHH
Confidence            33221 222334577789999999999999999999999999999999999865211   0111111000000  00111


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      +. ..  ...+...+..++.++.+++.+||+.||++|||++|+++.|+++.+++.
T Consensus       243 ~~-~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          243 EL-LK--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HH-HH--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HH-Hh--ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            11 00  111223345678899999999999999999999999999999987653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.5e-45  Score=363.65  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=207.4

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++....  ......+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999986 579999999997543  234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999987654 5899999999999999999999   8999999999999999999999999999998653322 


Q ss_pred             cccccccccCCCcCCcccccCCCCC-CchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVS-TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        ......||+.|+|||.+.+..+. .++||||+||++|||+||+.||+...     .......        +.    ..
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~--------i~----~~  229 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRER--------VL----RG  229 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--------HH----HC
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHH--------HH----hC
Confidence              23456799999999999887764 79999999999999999999997531     1111110        10    01


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       230 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 ----KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                111223456778999999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.5e-45  Score=356.29  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=214.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|+..+.||+|+||.||+|.++++..||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            36788899999999999999999888899999996543 23467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++++|.+++...+..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999887777999999999999999999999   8999999999999999999999999999998664332 222


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....+|..|+|||.+.+..++.++||||+|+++|||+| |+.||+.....     ....        .+...       
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~--------~~~~~-------  221 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVL--------KVSQG-------  221 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHH--------HHHTT-------
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHH--------HHHcC-------
Confidence            334456778999999988889999999999999999999 99998653111     1000        00000       


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      .....+..++..+.+++.+||+.||++|||++|++++|+++.++
T Consensus       222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            01112234567799999999999999999999999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=362.11  Aligned_cols=253  Identities=20%  Similarity=0.292  Sum_probs=210.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367889999999999999999865 6889999998644 23446688999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC--CCcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +++|+|.+++......+++..++.++.||+.||.|||   +.+|+||||||+||+++.  ++.+||+|||+++.+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999877777999999999999999999999   899999999999999987  7899999999998764322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|+|||.+.+..++.++||||+||++|||++|..||.....     .....        .+..    ..
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~--------~i~~----~~  219 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIE--------NIMN----AE  219 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHH----TC
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHH--------HHHc----CC
Confidence              23345689999999999888899999999999999999999999865211     11111        1111    11


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ..........++.++.+++.+||..||++|||+.|+++|-
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            1111122345677899999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.8e-45  Score=370.78  Aligned_cols=270  Identities=22%  Similarity=0.370  Sum_probs=217.8

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEE
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKII  354 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~  354 (580)
                      ...+.....++|.+.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3444455668899999999999999999973      2467899999975432 3346789999999999 789999999


Q ss_pred             eeeecCC-ceeeEeeccCCCChHHHhhcCCC-------------------------------------------------
Q 038098          355 SSCSSDD-FKALVLEYMPHGSLEKCLYSSNY-------------------------------------------------  384 (580)
Q Consensus       355 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------  384 (580)
                      +++...+ ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9987755 48999999999999999976532                                                 


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          385 ----------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       385 ----------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                                      .+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                            2899999999999999999999   899999999999999999999999999999876544444


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... ....            .+....   
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~------------~~~~~~---  313 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR------------RLKEGT---  313 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHH------------HHHHTC---
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHH------------HHHcCC---
Confidence            44455678899999999999999999999999999999999 999987532211 1111            111100   


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                         ....+..++.++.+++.+||+.||++||+++|++++|+++....
T Consensus       314 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          314 ---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence               11122345678999999999999999999999999999998754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.2e-44  Score=363.21  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=207.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .+.|.+.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999865 6899999999754321      346788999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC----cEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~a  439 (580)
                      ++||||+++|+|.+++... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999998754 46999999999999999999999   89999999999999998777    7999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .......   ......||+.|+|||.+.+..++.++||||+||++|||++|..||.....     ......        +
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~~--------i  230 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN--------I  230 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH--------H
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------H
Confidence            8664322   23345699999999999988999999999999999999999999865211     111110        1


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..    .........+...+.++.+|+.+||..||++|||++|+++|
T Consensus       231 ~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          231 TA----VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HT----TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             Hh----cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00    01111112234567789999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-44  Score=361.86  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=207.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            67899999999999999999866 78999999986443 23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++|+|.+++... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.......
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999988654 35999999999999999999999   9999999999999999999999999999998664333333


Q ss_pred             cccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||............|....                 
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------  225 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-----------------  225 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-----------------
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-----------------
Confidence            3445679999999999987765 7889999999999999999999976433222222222210                 


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ........++.++.+|+.+||+.||++|||++|++++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             0111224456778999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-44  Score=369.79  Aligned_cols=260  Identities=25%  Similarity=0.466  Sum_probs=203.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|.+.+.||+|+||.||+|+..    ++..||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57899999999999999999864    57789999986543 23456789999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++...+..+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999887778999999999999999999999   8999999999999999999999999999998664332


Q ss_pred             Cc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          447 QS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       447 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .. .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....     ..         ....+....
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~---------~~~~i~~~~  267 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QD---------VIKAVDEGY  267 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HH---------HHHHHHTTE
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HH---------HHHHHHcCC
Confidence            11 11222345778999999999999999999999999999998 9999865311     11         111111111


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                            +...+..++.++.+++.+||+.||++||++.||++.|+++.+..
T Consensus       268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                  11223456788999999999999999999999999999987653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-44  Score=355.26  Aligned_cols=258  Identities=22%  Similarity=0.388  Sum_probs=212.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|+..+.||+|+||.||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            45788899999999999999999888899999997543 23467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++|+|.+++......+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            999999999876677999999999999999999999   8999999999999999999999999999998653321 112


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      .....+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||......     ...         +.+....     
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~---------~~~~~~~-----  238 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETA---------EHIAQGL-----  238 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHH---------HHHHTTC-----
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHH---------HHHhccc-----
Confidence            233456788999999998899999999999999999998 99998653111     100         0011000     


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                       ....+..++..+.+++.+||+.||++||+++|++++|+++.++
T Consensus       239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence             1112234567799999999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.1e-45  Score=378.88  Aligned_cols=260  Identities=20%  Similarity=0.257  Sum_probs=210.5

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      +....++|+..++||+|+||.||+|+.+ +++.||+|++....   ......+..|+.++..++||||+++++++.+.+.
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3345678999999999999999999976 57899999996531   2334558899999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||+++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            99999999999999999876677999999999999999999999   999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchh
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM  517 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      .... ........||+.|+|||++.     .+.++.++|||||||++|||++|+.||.....     .+..        .
T Consensus       226 ~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----~~~~--------~  291 (437)
T 4aw2_A          226 MEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETY--------G  291 (437)
T ss_dssp             CTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH--------H
T ss_pred             ccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----hHHH--------H
Confidence            4332 22334467999999999986     56789999999999999999999999975211     1111        1


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTR  566 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~  566 (580)
                      .++.........   .....++.++.+|+.+|+..+|++  ||+++|+++|
T Consensus       292 ~i~~~~~~~~~p---~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 KIMNHKERFQFP---TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHTHHHHCCCC---SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhhhccccccCC---cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            111111000000   111235678899999999999988  9999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-43  Score=353.85  Aligned_cols=269  Identities=24%  Similarity=0.305  Sum_probs=208.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|++.+.||+|+||.||+|+..+|+.||+|++....  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46799999999999999999999889999999986442  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++ +|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--  173 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--  173 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence            9975 898888877777999999999999999999999   8999999999999999999999999999998663222  


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---ccchhhhcchh-
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---PISVMEIVDAN-  523 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~-  523 (580)
                      .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+........   +.......+.. 
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccch
Confidence            22344568999999998876 568999999999999999999999997643221 2222211110   00010000000 


Q ss_pred             ----ccC--CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 ----LLS--QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ----~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ...  ...........++.++.+|+.+||+.||++|||++|+++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                000  0001111223456788999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.9e-44  Score=357.96  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=207.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++...   .......+..|+++++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999865 6999999999754   2334567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence            9999999999887543 5899999999999999999999   8999999999999999999999999999998543222 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                       .......||+.|+|||.+.+..++.++||||+||++|||++|+.||....     .......        +...     
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~--------i~~~-----  220 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFEL--------ILME-----  220 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--------HHHC-----
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHH--------HHcC-----
Confidence             22345679999999999999999999999999999999999999986521     1111111        1110     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                         ....+..++.++.+++.+||+.||++||     +++|+++|
T Consensus       221 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               0112234677899999999999999999     89999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=367.76  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=215.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      .++|.+.+.||+|+||.||+|...        ++..||||++..... .....+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888999999999999999852        235799999965432 3456788999999999 999999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      +..++||||+++|+|.+++....               ..+++..++.++.||+.||+|||   +.+|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998654               35899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654433334445567889999999999999999999999999999999 9999865311     


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      .....         .+....      ....+..++.++.+++.+||+.||++||+++|++++|+++....
T Consensus       300 ~~~~~---------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          300 EELFK---------LLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHHH---------HHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHH---------HHHcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            11111         111110      11223456788999999999999999999999999999998653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-44  Score=364.66  Aligned_cols=253  Identities=18%  Similarity=0.279  Sum_probs=209.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            367999999999999999999865 6899999999765444556788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC--CCcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +++|+|.+++......+++..++.++.||+.||+|||   +.+|+||||||+||+++.  ++.+||+|||+++...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999877777999999999999999999999   899999999999999974  5789999999998764322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.....    . .....        +..    ..
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~-~~~~~--------i~~----~~  266 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----L-ETLQN--------VKR----CD  266 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----H-HHHHH--------HHH----CC
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----H-HHHHH--------HHh----CC
Confidence              22344699999999999998999999999999999999999999875211    1 11110        000    00


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........++.++.+++.+||+.||++|||+.|+++|
T Consensus       267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            000111223567789999999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=355.81  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=206.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      +.|...+.||+|+||.||+|... +|+.||+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56888999999999999999865 689999999965432      13567889999999999999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC----cEEEccccCcc
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAK  440 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~a~  440 (580)
                      +||||+++|+|.+++... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            999999999999998754 46999999999999999999999   89999999999999999887    89999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ......   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ......        +.
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~--------~~  230 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN--------VS  230 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH--------HH
T ss_pred             ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHH--------HH
Confidence            663322   22345699999999999988999999999999999999999999865211     011000        00


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .    ............++..+.+++.+||+.||++|||++|+++|
T Consensus       231 ~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          231 A----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             H----TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             h----cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0    00001111224566788999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=362.40  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=212.2

Q ss_pred             hcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  362 (580)
                      .++|...+.||+|+||.||+|..      .+++.||+|++.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46788899999999999999985      245679999996442 33457889999999999 89999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCC
Q 038098          363 KALVLEYMPHGSLEKCLYSSNY----------------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP  420 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~  420 (580)
                      .++||||+++|+|.+++.....                      .+++..++.++.||+.||+|||   +.+|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence            9999999999999999986543                      3799999999999999999999   89999999999


Q ss_pred             CCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCcccc
Q 038098          421 SNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFF  499 (580)
Q Consensus       421 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~  499 (580)
                      +||+++.++.+||+|||++................+|+.|+|||.+.++.++.++|||||||++|||+| |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999986654433333445567889999999988899999999999999999998 9999876321


Q ss_pred             CCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      . ......            +....      ....+..++.++.+++.+||+.||++||++.|++++|+.+.++...
T Consensus       281 ~-~~~~~~------------~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          281 D-ANFYKL------------IQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             S-HHHHHH------------HHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             H-HHHHHH------------HhcCC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            1 111111            11110      1122334577899999999999999999999999999998776544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.4e-44  Score=362.98  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=205.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-----GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +.|++.+.||+|+||.||+|... +|+.||||++....     ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            56889999999999999999865 68999999996432     1235678999999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc---EEEccccCc
Q 038098          366 VLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFGMA  439 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~a  439 (580)
                      ||||+++|+|.+++...   +..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877543   345899999999999999999999   899999999999999987655   999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +......  .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....      ....        .+
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~--------~i  244 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFE--------GI  244 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HHHH--------HH
T ss_pred             eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HHHH--------HH
Confidence            8764322  123345799999999999988999999999999999999999999865210      0000        01


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..    ............++.++.+++.+||+.||++||++.|+++|
T Consensus       245 ~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          245 IK----GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HH----TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Hc----CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11    01111111224567789999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-44  Score=361.69  Aligned_cols=258  Identities=23%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCE----EEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGME----VAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|+..+.||+|+||.||+|.+. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56888999999999999999854 4554    5777764332 344578899999999999999999999998754 789


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+||+.+|+|.+++......+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999987788999999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........+|..|+|||.+.+..++.++|||||||++|||+| |+.||+.....  ...            ..+....
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~------------~~~~~~~  236 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EIS------------SILEKGE  236 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH------------HHHHTTC
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHH------------HHHHcCC
Confidence            44334445567889999999999999999999999999999999 99998763211  111            1111111


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                            ....+..++.++.+++.+||+.||++||+++|++++|+++.+.
T Consensus       237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                  1122345677899999999999999999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=369.91  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=212.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|.+.+.||+|+||.||+|.+.      +++.||||++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999843      46789999986432 334457888999999999999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEEEcc
Q 038098          365 LVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSD  435 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~D  435 (580)
                      +||||+++|+|.+++...+      ..+++..++.++.||++||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999987643      45899999999999999999999   99999999999999999555   599999


Q ss_pred             ccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhccc
Q 038098          436 FGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |..||.....  .....        
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~--------  297 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLE--------  297 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH--------
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH--------
Confidence            999986543333333445568899999999999999999999999999999998 9999865311  11111        


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                          .+...      .....+..++..+.+|+.+||+.||++||+++||+++|+.+.+...
T Consensus       298 ----~i~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          298 ----FVTSG------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             ----HHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ----HHHcC------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                11110      0112234567789999999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7e-44  Score=352.60  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=207.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357899999999999999999865 68999999985432   23346788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++...+ ++++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999987654 5899999999999999999999   8999999999999999999999999999998653322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       ........||+.|+|||.+.+..++.++||||+|+++|||+||+.||......    .....         .+..   .
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~---------~~~~---~  228 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----SIAIK---------HIQD---S  228 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----HHHHH---------HHSS---C
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHH---------Hhhc---c
Confidence             12233456999999999999999999999999999999999999999753111    11000         0000   0


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-NAKEIVTRLLKIRD  572 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ev~~~L~~~~~  572 (580)
                      ...........++..+.+++.+||+.||++|| +++++.+.|+++..
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            00001112244677899999999999999999 99999999887654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=365.35  Aligned_cols=264  Identities=26%  Similarity=0.401  Sum_probs=214.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      ..++|...+.||+|+||.||+|+..      +++.||||++..... .....+.+|++++++++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4578999999999999999999864      347899999975432 345678899999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCC
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  419 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  419 (580)
                      .++||||+++|+|.+++....                       ..+++..++.++.||++||.|||   +.+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999997642                       56899999999999999999999   8999999999


Q ss_pred             CCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccc
Q 038098          420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIF  498 (580)
Q Consensus       420 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~  498 (580)
                      |+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986644333333345568899999999988899999999999999999999 999986521


Q ss_pred             cCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      .     .....        .+.+..       ....+..++.++.+++.+||+.||++||++.|++++|+++.+++..
T Consensus       282 ~-----~~~~~--------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          282 H-----EEVIY--------YVRDGN-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             H-----HHHHH--------HHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             h-----HHHHH--------HHhCCC-------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            1     11111        011110       1122345677899999999999999999999999999998877654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-43  Score=350.83  Aligned_cols=265  Identities=27%  Similarity=0.363  Sum_probs=204.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhh--cCCCCcceEEeeeec----CCcee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKR--IRHRNIIKIISSCSS----DDFKA  364 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~  364 (580)
                      .++|++.+.||+|+||.||+|++ +|+.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 5899999998643   33455667777666  799999999998644    34578


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      +||||+++|+|.+++..  ..+++..++.++.||+.||+|||..     .+.+|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            99999999999999954  3589999999999999999999932     2678999999999999999999999999999


Q ss_pred             cccCCCCCcc--cccccccCCCcCCcccccCC------CCCCchhhHhHHHHHHHHHhC----------CCCCCccccCC
Q 038098          440 KPLLKEDQSL--TQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTR----------KKPTDEIFFGD  501 (580)
Q Consensus       440 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~elltg----------~~p~~~~~~~~  501 (580)
                      +.........  ......||+.|+|||.+.+.      .++.++|||||||++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            7654332211  12334799999999998776      455799999999999999999          77776543333


Q ss_pred             chHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      .............         ......+.......++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVD---------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhcc---------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            3332222211100         00001111112345678899999999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.9e-44  Score=356.18  Aligned_cols=263  Identities=23%  Similarity=0.372  Sum_probs=216.8

Q ss_pred             hcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  362 (580)
                      .++|...+.||+|+||.||+|.+      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            36788899999999999999985      2467899999975432 3456788999999999 99999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          363 KALVLEYMPHGSLEKCLYSSNY-----------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      .++||||+++|+|.+++.....                 .+++..++.++.||++||+|||   +.+++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999986543                 4899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ..
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HH
Confidence            9999999999999987654443333344567889999999988999999999999999999999 999986532211 11


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ..            .+....      ....+..++.++.+++.+||+.||++||+++|++++|+++..+..
T Consensus       258 ~~------------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          258 YK------------MIKEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HH------------HHHHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HH------------HhccCC------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            11            111111      011123456789999999999999999999999999999887644

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.5e-44  Score=357.72  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=204.6

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|.. .+|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6789999999999999999986 578999999996542   233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+ +|+|.+++...+ .+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence            999 679998886544 5999999999999999999999   8999999999999999999999999999998653322 


Q ss_pred             cccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+......                 ....    
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~~~~----  219 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------LFKK----  219 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------CBCC----
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------HHHH----
Confidence              2334569999999999987775 789999999999999999999996531110                 0000    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ........+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       220 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0011122334567789999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=362.28  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999864 6899999999766545667889999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe--CCCCcEEEccccCccccCCCCCcccccc
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL--DDNMVAHLSDFGMAKPLLKEDQSLTQTQ  453 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  453 (580)
                      .+++......+++..++.++.||++||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.+....   ....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~  247 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV  247 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence            9999877777999999999999999999999   8999999999999999  677899999999998764322   2234


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccc
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT  533 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  533 (580)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..            +....    ......
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~------------i~~~~----~~~~~~  310 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNN------------ILACR----WDLEDE  310 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH------------HHHTC----CCSCSG
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH------------HHhcc----CCCChh
Confidence            46999999999999889999999999999999999999998653110 01111            11110    001112


Q ss_pred             hhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       534 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....++.++.+|+.+||+.||++||+++|+++|
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            224567789999999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=368.49  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=206.4

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567999999999999999999864 78999999997543  23346788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~a~~~~  443 (580)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++   .++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999887654 5999999999999999999999   89999999999999998   56789999999998664


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ...  .......||+.|+|||.+.+..++.++||||+||++|||++|++||.....     .....         .+.. 
T Consensus       165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~---------~i~~-  227 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQ---------QIKA-  227 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH---------HHHH-
T ss_pred             CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHH---------HHHh-
Confidence            332  223446799999999999988999999999999999999999999865211     11111         0000 


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ............+++++.+|+.+||+.||++|||++|+++|
T Consensus       228 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          228 --GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             --TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              11111111223567889999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.5e-44  Score=356.51  Aligned_cols=260  Identities=25%  Similarity=0.416  Sum_probs=214.9

Q ss_pred             hcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .++|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46688899999999999999975      245789999986543 23456788999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCC
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP  420 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~  420 (580)
                      ++||||+++|+|.+++....                       ..+++..++.++.||++||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999997643                       24899999999999999999999   89999999999


Q ss_pred             CCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCcccc
Q 038098          421 SNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFF  499 (580)
Q Consensus       421 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~  499 (580)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||+| |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333444567888999999988889999999999999999999 9999865321


Q ss_pred             CCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      .  ....            .+....      ....+..++.++.+++.+||+.||++||+++|++++|+++..+
T Consensus       259 ~--~~~~------------~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 E--RLFN------------LLKTGH------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             G--GHHH------------HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             H--HHHH------------HhhcCC------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            1  1111            111100      1122345677899999999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.4e-43  Score=347.71  Aligned_cols=252  Identities=27%  Similarity=0.467  Sum_probs=205.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc-------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR-------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      ++|...+.||+|+||.||+|+.. +++.||+|++......       ..+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            67888999999999999999864 7899999998543221       1267889999999999999999999997654  


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeCCCCc-----EEEccc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMV-----AHLSDF  436 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~-----~kl~Df  436 (580)
                      ++||||+++|+|.+++......+++..++.++.|++.|++|||   +.+  |+||||||+||+++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6999999999999999887778999999999999999999999   888  999999999999988776     999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccc--cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYG--REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      |+++....     ......||+.|+|||.+  ....++.++||||+||++|||++|+.||................    
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----  244 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE----  244 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH----
T ss_pred             Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc----
Confidence            99974322     23345689999999998  34567899999999999999999999997643222111111110    


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                             .      ......+..++.++.+++.+||+.||++||+++|+++.|+++
T Consensus       245 -------~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 -------E------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -------S------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -------c------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                   0      001122345678899999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.6e-44  Score=363.04  Aligned_cols=271  Identities=17%  Similarity=0.200  Sum_probs=212.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeCC------CCEEEEEEEeccccch-----------hhhHHHHHHHHhhcCCCCcceE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQD------GMEVAVKVFDLQYGRA-----------FKSFDIECDMIKRIRHRNIIKI  353 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~  353 (580)
                      .++|.+.+.||+|+||.||+|.+.+      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4579999999999999999998754      4789999986543211           1123345566777889999999


Q ss_pred             EeeeecC----CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC--C
Q 038098          354 ISSCSSD----DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--D  427 (580)
Q Consensus       354 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~  427 (580)
                      ++++...    ...++||||+ +++|.+++......+++..++.++.||+.||+|||   +.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4579999999 99999999887778999999999999999999999   89999999999999999  8


Q ss_pred             CCcEEEccccCccccCCCCCcc-----cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc
Q 038098          428 NMVAHLSDFGMAKPLLKEDQSL-----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM  502 (580)
Q Consensus       428 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~  502 (580)
                      ++.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-~~  268 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-DP  268 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-CH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-CH
Confidence            9999999999998764332211     12334599999999999999999999999999999999999999975322 22


Q ss_pred             hHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          503 TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ....+........+.+.++..+.         ...++.++.+++.+||+.||++||+++++++.|+++..+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            22222222222233333333221         13456789999999999999999999999999999987653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-43  Score=349.51  Aligned_cols=267  Identities=15%  Similarity=0.129  Sum_probs=216.9

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+|+++++++ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35789999999999999999985 57899999998644  3346788899999999 79999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc-----EEEccccCccccC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-----AHLSDFGMAKPLL  443 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  443 (580)
                      |+ +++|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999887777999999999999999999999   999999999999999987776     9999999998764


Q ss_pred             CCCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          444 KEDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       444 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .....        .
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~--------~  232 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYE--------R  232 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHH--------H
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHH--------H
Confidence            43221     123455699999999999999999999999999999999999999976422111  11000        0


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      +.......   ........++.++.+++.+||+.||++||++++|++.|+++.++...
T Consensus       233 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          233 IGEKKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHHHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHhhccCc---cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            00000000   00111234677899999999999999999999999999999887543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-43  Score=359.82  Aligned_cols=252  Identities=21%  Similarity=0.351  Sum_probs=206.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999865 68999999997543  234467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++   .+||+|||++.....
T Consensus       108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999999988754 45899999999999999999999   89999999999999998654   599999999986643


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ......        +. .  
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~--------i~-~--  244 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQ--------IK-A--  244 (362)
T ss_dssp             CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--------HH-H--
T ss_pred             Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------HH-h--
Confidence            22   22345799999999999988999999999999999999999999865211     111110        00 0  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ............++.++.+++.+||+.||++||++.|+++|
T Consensus       245 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          245 -GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00000112234567789999999999999999999999886

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-43  Score=356.16  Aligned_cols=265  Identities=20%  Similarity=0.207  Sum_probs=214.2

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++....  ....+..|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36788999999999999999985 578999999986542  335788999999999 99999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc-----EEEccccCccccC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-----AHLSDFGMAKPLL  443 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  443 (580)
                      |+ +++|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.     +||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999877678999999999999999999999   899999999999999999887     9999999998764


Q ss_pred             CCCCcc-----cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          444 KEDQSL-----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       444 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ........        
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~--------  231 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQK--------  231 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHH--------
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHH--------
Confidence            332211     124567999999999999999999999999999999999999999764221  11111111        


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      +.+......   .......++ ++.+++.+||+.||.+||++++|.+.|+++.++..
T Consensus       232 i~~~~~~~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          232 IGDTKRATP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHHHHSC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhhhccCC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            000000000   000112244 89999999999999999999999999998887653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.3e-44  Score=357.42  Aligned_cols=258  Identities=23%  Similarity=0.380  Sum_probs=208.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCE----EEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGME----VAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|+..+.||+|+||.||+|.+. +++.    ||+|++.... ......+..|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56888999999999999999864 4554    7777774332 334467788999999999999999999986 456889


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+.+|+|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999877678999999999999999999999   899999999999999999999999999999977554


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........+|..|+|||.+.++.++.++|||||||++|||+| |+.||......  .......            ...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~------------~~~  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLE------------KGE  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHH------------TTC
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHH------------cCC
Confidence            44444455668889999999998999999999999999999999 99998763211  1111111            100


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                            ....+..++.++.+++.+||+.||++||+++|++++|+++...
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  1112233455678999999999999999999999999987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.5e-43  Score=347.41  Aligned_cols=269  Identities=24%  Similarity=0.266  Sum_probs=206.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999875 689999999975432  334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++ ++.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9976 777777666677999999999999999999999   8999999999999999999999999999998663322  


Q ss_pred             ccccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc---hhhhc---c
Q 038098          449 LTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS---VMEIV---D  521 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---d  521 (580)
                      .......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.........+...........   .....   +
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2234457899999999987765 799999999999999999988886432111111222211111000   00000   0


Q ss_pred             hh---ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 AN---LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..   ...............+.++.+|+.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00   0000001111223567789999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-43  Score=353.05  Aligned_cols=270  Identities=27%  Similarity=0.393  Sum_probs=207.0

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhc--CCCCcceEEeeeecC----
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI--RHRNIIKIISSCSSD----  360 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----  360 (580)
                      -....++|++.+.||+|+||.||+|+.. |+.||||++...   ....+..|.+++...  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3345578999999999999999999986 899999998643   224445566666555  899999999998876    


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEEecCCCCCEEeCCCCcEE
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV--------PIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~--------~i~H~dlk~~Nill~~~~~~k  432 (580)
                      ...++||||+++|+|.+++...  .+++..++.++.|++.||+|||   +.        +|+||||||+||+++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6789999999999999999764  4899999999999999999999   77        999999999999999999999


Q ss_pred             EccccCccccCCCCCcc--cccccccCCCcCCcccccCCCCCCc------hhhHhHHHHHHHHHhC----------CCCC
Q 038098          433 LSDFGMAKPLLKEDQSL--TQTQTLATIGYMAPEYGREGQVSTN------GDVYSFGIMLMETFTR----------KKPT  494 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~Dvws~Gvil~elltg----------~~p~  494 (580)
                      |+|||+++.+.......  ......||+.|+|||.+.+...+.+      +|||||||++|||+||          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999997664332211  1234579999999999987766665      9999999999999999          4555


Q ss_pred             CccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          495 DEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      ............+..         .+.................++.++.+++.+||+.||++||+++|++++|+++.++.
T Consensus       263 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          263 HDLVPSDPSYEDMRE---------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTSCSSCCHHHHHH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhcCCCCchhhhHH---------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            443222222222211         11111111111111223467889999999999999999999999999999988753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.6e-44  Score=368.15  Aligned_cols=256  Identities=23%  Similarity=0.273  Sum_probs=208.3

Q ss_pred             HHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          288 FQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       288 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      ....++|...+.||+|+||.||+|+.+ +++.||+|++...   .......+..|+.+++.++||||+++++++.+.+..
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            335678999999999999999999876 6899999999653   123345688999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       145 ~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            9999999999999998764  4899999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCCcccccccccCCCcCCcccccCCC----CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQ----VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ... ........||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....     ....        ..+
T Consensus       220 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~--------~~i  285 (410)
T 3v8s_A          220 KEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY--------SKI  285 (410)
T ss_dssp             TTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH--------HHH
T ss_pred             cCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHH--------HHH
Confidence            332 22234567999999999987654    78999999999999999999999965211     1111        111


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQ--RINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ev~~~  566 (580)
                      ......    ..++....++.++.+|+.+||..+|.+  ||+++||++|
T Consensus       286 ~~~~~~----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          286 MNHKNS----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HTHHHH----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             Hhcccc----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            111100    011222346678999999999999998  9999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-43  Score=349.15  Aligned_cols=268  Identities=23%  Similarity=0.278  Sum_probs=204.5

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|...+.||+|+||.||+|+..+|+.||+|++....  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999998889999999986442  22346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++ +|.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            976 999998877777999999999999999999999   8999999999999999999999999999998653221  1


Q ss_pred             cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc---chhhh-----c
Q 038098          450 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI---SVMEI-----V  520 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~  520 (580)
                      ......+|+.|+|||.+.+ ..++.++||||+||++|||+||+.||......+ .+..........   .....     .
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence            2234568999999999876 458999999999999999999999997632111 111111110000   00000     0


Q ss_pred             chhccC-CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLS-QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ++.... ...........++.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000 0000111123467788999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-43  Score=369.71  Aligned_cols=252  Identities=29%  Similarity=0.435  Sum_probs=209.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-ceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-FKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  369 (580)
                      .++|...+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            356888899999999999999986 7899999997543  4578999999999999999999999987655 78999999


Q ss_pred             cCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++...+. .+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999987653 4799999999999999999999   899999999999999999999999999999854221   


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        .....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+  ...            .+...    
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~------------~i~~~----  402 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP------------RVEKG----  402 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH------------HHHTT----
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------------HHHcC----
Confidence              122357889999999999999999999999999999999 999987532211  111            11110    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                        .+...+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence              12233456788999999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.9e-44  Score=349.66  Aligned_cols=260  Identities=23%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|++.+.||+|+||.||+|....    +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678889999999999999998642    4569999986432 234567889999999999999999999985 466899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++...+..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999887778999999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .. .......+|+.|+|||.+....++.++||||||+++|||++ |..||......  .....           +...  
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~-----------i~~~--  233 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR-----------IENG--  233 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH-----------HHTT--
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHH-----------HHcC--
Confidence            21 12233456788999999988899999999999999999997 99998753211  11111           1000  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                           .....+..++.++.+++.+||+.||++||++.|++++|+++..+..
T Consensus       234 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          234 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence                 0112234567889999999999999999999999999999987653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=350.51  Aligned_cols=273  Identities=19%  Similarity=0.276  Sum_probs=211.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC--ceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--FKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999876 58999999996543 344567789999999999999999999987655  679999


Q ss_pred             eccCCCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe----CCCCcEEEccccCccc
Q 038098          368 EYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKP  441 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~a~~  441 (580)
                      ||+++|+|.+++.....  .+++..++.++.||+.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999986543  3899999999999999999999   8999999999999999    8888999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCccccc--------CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch---HHHHHHh
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGR--------EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT---LKHWVND  510 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~---~~~~~~~  510 (580)
                      .....   ......||..|+|||.+.        +..++.++|||||||++|||+||+.||.........   .......
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            64332   223456999999999876        578899999999999999999999999653222211   1111221


Q ss_pred             hcccchhhhcch---h--ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          511 LLPISVMEIVDA---N--LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       511 ~~~~~~~~~~d~---~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ..+..+......   .  ...............+..+.+++.+||+.||++|||++|+++|..+.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            111111100000   0  00011111223456788899999999999999999999999998753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.6e-44  Score=346.99  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=213.9

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|...+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56888899999999999999988889999999975432 34678899999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +++|.+++......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~  162 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  162 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence            99999999887777999999999999999999999   8999999999999999999999999999998653221 1122


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.....     ......        +.. ..      
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~--------i~~-~~------  222 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED--------IST-GF------  222 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH--------HHT-TC------
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHH--------Hhc-CC------
Confidence            33457788999999988899999999999999999999 8999865211     111110        000 00      


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ....+..++..+.+++.+||+.||++||+++|++++|+++.++
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1112234567789999999999999999999999999998763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8e-44  Score=357.39  Aligned_cols=262  Identities=24%  Similarity=0.442  Sum_probs=197.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeCC-CC---EEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQD-GM---EVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      ..++|.+.+.||+|+||.||+|.... ++   .||||++...  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34679999999999999999998653 32   7999998654  334567889999999999999999999999876655


Q ss_pred             ------eeEeeccCCCChHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEE
Q 038098          364 ------ALVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  432 (580)
Q Consensus       364 ------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k  432 (580)
                            ++||||+++|+|.+++....     ..+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  89999999999999986432     25899999999999999999999   89999999999999999999999


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhh
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......  ....     
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~-----  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYN-----  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH-----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHH-----
Confidence            999999987644443333445567889999999999999999999999999999999 99998753211  1111     


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                            .+...       .....+..++.++.+++.+||+.||++||++.++++.|+++....
T Consensus       251 ------~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          251 ------YLIGG-------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ------HHHTT-------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ------HHhcC-------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  01100       011223456778999999999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=360.15  Aligned_cols=249  Identities=24%  Similarity=0.304  Sum_probs=202.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|+..+.||+|+||.||+|+.+ +|+.||||++...   .......+..|.++++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999865 6899999999754   223456678899999988 69999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            999999999999987654 5999999999999999999999   899999999999999999999999999999854222


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                        ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .....        .+...   
T Consensus       178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~--------~i~~~---  239 (353)
T 3txo_A          178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFE--------AILND---  239 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHHC---
T ss_pred             --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHH--------HHHcC---
Confidence              2233456799999999999988899999999999999999999999975311     11111        11111   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA------KEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~ev~~~  566 (580)
                           ....+...+.++.+++.+||+.||++||++      +|+++|
T Consensus       240 -----~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          240 -----EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                 111223456778999999999999999998      777765

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=358.34  Aligned_cols=281  Identities=26%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHH--HhhcCCCCcceEEeeee-----cCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDM--IKRIRHRNIIKIISSCS-----SDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~~~  363 (580)
                      .++|.+.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++++.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36788999999999999999987 48999999996442   2334444444  44589999999998543     23356


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEEecCCCCCEEeCCCCcEEEc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV---------PIIHCDLKPSNVLLDDNMVAHLS  434 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~---------~i~H~dlk~~Nill~~~~~~kl~  434 (580)
                      ++||||+++|+|.+++....  .++..++.++.||++||+|||   +.         +|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997654  589999999999999999999   77         99999999999999999999999


Q ss_pred             cccCccccCCCCC------cccccccccCCCcCCcccccC-------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCC
Q 038098          435 DFGMAKPLLKEDQ------SLTQTQTLATIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD  501 (580)
Q Consensus       435 Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~  501 (580)
                      |||+++.+.....      ........||+.|+|||.+.+       ..++.++|||||||++|||++|+.||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987643221      112234569999999999876       456788999999999999999977753321111


Q ss_pred             chHHHHHHhhccc----chhhhcch-hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          502 MTLKHWVNDLLPI----SVMEIVDA-NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       502 ~~~~~~~~~~~~~----~~~~~~d~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      .....+.......    .....+.. ...............++.++.+++.+||+.||++|||++|+++.|+++...+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence            1001111000000    01111111 111111111222345677899999999999999999999999999999999988


Q ss_pred             hhcC
Q 038098          577 NVKR  580 (580)
Q Consensus       577 ~~~~  580 (580)
                      +.++
T Consensus       323 ~~~~  326 (336)
T 3g2f_A          323 NKSV  326 (336)
T ss_dssp             ----
T ss_pred             cccC
Confidence            8753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-43  Score=361.73  Aligned_cols=255  Identities=22%  Similarity=0.301  Sum_probs=204.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367899999999999999999866 68899999997542   23345678899999887 89999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|..++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999887644 5999999999999999999999   899999999999999999999999999999853222


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch---HHHHHHhhcccchhhhcch
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT---LKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~d~  522 (580)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..   ...+..       ..+...
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-------~~i~~~  277 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-------QVILEK  277 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH-------HHHHHC
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH-------HHHhcc
Confidence            2  2334567999999999999999999999999999999999999999653211100   000000       001110


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA------KEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~ev~~~  566 (580)
                              ....+..++.++.+|+.+||+.||++||++      +|+++|
T Consensus       278 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          278 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             --------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                    112234467789999999999999999985      677654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-43  Score=348.43  Aligned_cols=245  Identities=25%  Similarity=0.308  Sum_probs=205.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56889999999999999999865 69999999997542   234567788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus        86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            9999999999997654 5899999999999999999999   999999999999999999999999999999865322  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ....        ..+....    
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~--------~~i~~~~----  219 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTY--------EKILNAE----  219 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH--------HHHHHCC----
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH--------HHHHhCC----
Confidence               2345799999999999999999999999999999999999999865211     1111        1111111    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                          ...+...+.++.+++.+|+..||++||     +++|+++|
T Consensus       220 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                112234567889999999999999999     89999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.1e-43  Score=348.42  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=198.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|++.+.||+|+||.||+|+..  ..||+|++....  ....+.+.+|++++++++||||+++++++. .+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            467899999999999999999865  469999986543  234567889999999999999999999664 556899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877778999999999999999999999   899999999999999999999999999999865433333


Q ss_pred             ccccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          449 LTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .......||+.|+|||.+.   ...++.++||||+|+++|||++|+.||......+ ......            .....
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~------------~~~~~  243 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMV------------GRGSL  243 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHH------------HHTSC
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHh------------ccccc
Confidence            3344557999999999886   5678889999999999999999999997532111 111111            11100


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      ...  .......++.++.+++.+||+.||++||+++|+++.|+++.+
T Consensus       244 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPD--LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCC--TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             Ccc--hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            000  011224567889999999999999999999999999998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-43  Score=353.76  Aligned_cols=271  Identities=22%  Similarity=0.364  Sum_probs=218.4

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEE
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKII  354 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~  354 (580)
                      ...+.....++|.+.+.||+|+||.||+|.+      .+++.||||++..... .....+.+|++++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444445567899999999999999999974      2468899999975432 3346788999999999 799999999


Q ss_pred             eeeecCC-ceeeEeeccCCCChHHHhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecC
Q 038098          355 SSCSSDD-FKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL  418 (580)
Q Consensus       355 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl  418 (580)
                      +++...+ ..++||||+++|+|.+++......               +++..++.++.||++||.|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987654 589999999999999999865432               899999999999999999999   899999999


Q ss_pred             CCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCcc
Q 038098          419 KPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEI  497 (580)
Q Consensus       419 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~  497 (580)
                      ||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654443334445568889999999998999999999999999999998 99998653


Q ss_pred             ccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          498 FFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      .... .....            +....      ....+..++.++.+++.+||+.||++||++.|++++|+++.+...
T Consensus       255 ~~~~-~~~~~------------~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          255 KIDE-EFCRR------------LKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCSH-HHHHH------------HHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             chhH-HHHHH------------hccCc------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            2211 11111            10000      111223456779999999999999999999999999999987653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.3e-43  Score=355.69  Aligned_cols=262  Identities=26%  Similarity=0.430  Sum_probs=214.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC--------CCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSD  360 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  360 (580)
                      .++|.+.+.||+|+||.||+|.+.        +++.||+|++..... .....+..|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367888999999999999999863        467899999865432 3456788999999999 899999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      +..++||||+++|+|.+++....               ..+++..++.++.||++||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999998654               24899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchH
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTL  504 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~  504 (580)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....     
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            9999999999999987654433333344557889999999988889999999999999999999 9999865311     


Q ss_pred             HHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       505 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      .....         .+....      ....+..++.++.+++.+||+.||++||+++|++++|+++.....
T Consensus       266 ~~~~~---------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          266 EELFK---------LLKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHH---------HHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHH---------HHhcCC------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            11111         111100      111234567789999999999999999999999999999987653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.9e-44  Score=374.66  Aligned_cols=257  Identities=23%  Similarity=0.402  Sum_probs=212.4

Q ss_pred             HhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ..++|...+.||+|+||.||+|.++++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            346788889999999999999999888999999997543 34678999999999999999999999987 5678999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence            99999999997543 36899999999999999999999   8999999999999999999999999999998653221 1


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......+|..|+|||.+..+.++.++|||||||++|||+| |+.||......  ....            .+...    
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~------------~i~~~----  401 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR------------ALERG----  401 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH------------HHHHT----
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHcC----
Confidence            11233446788999999998999999999999999999999 99998653111  1111            11111    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                        .+...+..++.++.+++.+||+.||++|||+++|++.|+++..
T Consensus       402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence              1122345677889999999999999999999999999988754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=358.99  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=204.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56889999999999999999865 68899999996542   334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+.+|+|.+++... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...  
T Consensus        95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence            999999999998764 45999999999999999999999   999999999999999999999999999999866332  


Q ss_pred             cccccccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          448 SLTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                       .......||+.|+|||++..   ..++.++||||+||++|||++|+.||......  ........         +... 
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~---------~~~~-  235 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHT---------FETT-  235 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHH---------HHHC-
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHH---------Hhhc-
Confidence             22345679999999999864   45899999999999999999999999753211  11111110         0000 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-AKEIVT  565 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~ev~~  565 (580)
                            ....+..++.++.+|+.+||+.||++||+ ++++.+
T Consensus       236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                  11123345678999999999999999998 777665

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-43  Score=345.64  Aligned_cols=250  Identities=28%  Similarity=0.424  Sum_probs=195.7

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEecccc----chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG----RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||.||+|.+. |+.||||++.....    ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888999999999999999986 89999999864422    33467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEEecCCCCCEEeCC--------CCcEEEccc
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP---IIHCDLKPSNVLLDD--------NMVAHLSDF  436 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~---i~H~dlk~~Nill~~--------~~~~kl~Df  436 (580)
                      ||+++++|.+++..  ..+++..++.++.|++.|++|||   +.+   |+||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999998864  45899999999999999999999   666   999999999999986        778999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      |+++......    .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......  ...          
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~----------  224 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--VAY----------  224 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHH----------
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----------
Confidence            9998653322    224468999999999998899999999999999999999999986531110  000          


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                       .....      ......+..++.++.+++.+||+.||++||+++|++++|+++
T Consensus       225 -~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 -GVAMN------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HHHTS------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -hhhcC------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             00000      011122345677899999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=365.16  Aligned_cols=260  Identities=21%  Similarity=0.270  Sum_probs=208.5

Q ss_pred             HHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC
Q 038098          286 EIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD  361 (580)
Q Consensus       286 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  361 (580)
                      +.....++|+..+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            33345678999999999999999999875 79999999996531   234456889999999999999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+++|+|.+++...+..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            999999999999999999876667999999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCccccc-------CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGR-------EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ...... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||.....     .....     
T Consensus       212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~-----  280 (412)
T 2vd5_A          212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----AETYG-----  280 (412)
T ss_dssp             CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH-----
T ss_pred             ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----HHHHH-----
Confidence            643322 2233457999999999887       45789999999999999999999999965211     11111     


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR---INAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~ev~~~  566 (580)
                         .++........   ......++.++.+|+.+||. +|++|   |+++|+++|
T Consensus       281 ---~i~~~~~~~~~---p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 ---KIVHYKEHLSL---PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ---HHHTHHHHCCC---C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ---HHHhcccCcCC---CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence               11110000000   00123467789999999999 99998   589999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.4e-43  Score=349.28  Aligned_cols=271  Identities=23%  Similarity=0.399  Sum_probs=211.6

Q ss_pred             cCCCcCceeccccCceEEEEEe-----CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--Cce
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  363 (580)
                      ..|+..+.||+|+||.||+|++     .+++.||+|++.... ......+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984     368899999996443 33457789999999999999999999999876  668


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999777777999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc-hhhhcc
Q 038098          444 KEDQS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS-VMEIVD  521 (580)
Q Consensus       444 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d  521 (580)
                      ..... .......+|..|+|||.+.+..++.++||||+|+++|||+||+.|+.....   ............. ......
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA---LFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCGGGHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh---HHhhccCCcccccCHHHHHH
Confidence            43321 223345688889999999988999999999999999999999998643210   0000000000000 111111


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      . ...  ......+..++.++.+++.+||+.||++|||++|+++.|+++.
T Consensus       255 ~-~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 T-LKE--GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             H-HHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H-Hhc--cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1 111  1122234567788999999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=347.22  Aligned_cols=250  Identities=25%  Similarity=0.340  Sum_probs=198.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--------------------------chhhhHHHHHHHHh
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--------------------------RAFKSFDIECDMIK  343 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  343 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999864 689999999864421                          12356889999999


Q ss_pred             hcCCCCcceEEeeeec--CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCC
Q 038098          344 RIRHRNIIKIISSCSS--DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPS  421 (580)
Q Consensus       344 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~  421 (580)
                      +++||||+++++++..  .+..++||||+++++|.+++..  ..+++..++.++.||++||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999976  5678999999999999886543  46999999999999999999999   899999999999


Q ss_pred             CEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCC---CCCchhhHhHHHHHHHHHhCCCCCCccc
Q 038098          422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDEIF  498 (580)
Q Consensus       422 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~elltg~~p~~~~~  498 (580)
                      ||+++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999986643322  233457999999999987655   4788999999999999999999986521


Q ss_pred             cCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ...+...        +... ..     .......++.++.+++.+||+.||++||+++|+++|
T Consensus       245 -----~~~~~~~--------~~~~-~~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 -----IMCLHSK--------IKSQ-AL-----EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             -----HHHHHHH--------HHHC-CC-----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             -----HHHHHHH--------Hhcc-cC-----CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence                 1111110        0000 00     111123456789999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.8e-43  Score=355.00  Aligned_cols=266  Identities=23%  Similarity=0.382  Sum_probs=216.9

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CC-----CEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecCC
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DG-----MEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  361 (580)
                      ..++|...+.||+|+||.||+|... ++     ..||+|++..... .....+.+|+++++++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            3467889999999999999999864 23     4799999965432 3456788999999999 8999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC
Q 038098          362 FKALVLEYMPHGSLEKCLYSS-------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN  428 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~  428 (580)
                      ..++||||+++|+|.+++...             ...+++..++.++.||+.||+|||   +.+|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            999999999999999998753             235799999999999999999999   8999999999999999999


Q ss_pred             CcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHH
Q 038098          429 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       429 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~  507 (580)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |..||....... .....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHH
Confidence            9999999999986644433333344567889999999988899999999999999999999 999986532111 11111


Q ss_pred             HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 038098          508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN  577 (580)
Q Consensus       508 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~  577 (580)
                      ..            ...      ....+..++..+.+++.+||+.||++||+++|++++|+++..+..++
T Consensus       280 ~~------------~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  331 (333)
T 2i1m_A          280 VK------------DGY------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE  331 (333)
T ss_dssp             HH------------HTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             Hh------------cCC------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence            11            110      11122345677899999999999999999999999999998887664

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.8e-44  Score=351.19  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CC-------CEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DG-------MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      ++|...+.||+|+||.||+|... ++       ..||+|++........+.+.+|++++++++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            56888999999999999999854 33       46999999766666668899999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc--------EEEcc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--------AHLSD  435 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--------~kl~D  435 (580)
                      ++||||+++|+|.+++...+..+++..++.++.||++||.|||   +.+|+||||||+||+++.++.        +||+|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999999887777999999999999999999999   899999999999999998887        99999


Q ss_pred             ccCccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          436 FGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ||++.....      .....+|..|+|||.+.+ ..++.++|||||||++|||++|..|+....... .......     
T Consensus       165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~-----  232 (289)
T 4fvq_A          165 PGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RKLQFYE-----  232 (289)
T ss_dssp             CCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHH-----
T ss_pred             CcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HHHHHhh-----
Confidence            999975422      123457889999999887 678999999999999999999655543211100 0000000     


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                             .        ....+...+.++.+++.+||+.||++|||++|++++|+++..
T Consensus       233 -------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 -------D--------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -------T--------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -------c--------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                   0        000111224457899999999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-43  Score=355.59  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=205.6

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ...++|...+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999975 68999999997542   23456678899999887 899999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999987644 5899999999999999999999   8999999999999999999999999999998542


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ...  .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ......        +..  
T Consensus       170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~--------i~~--  232 (345)
T 1xjd_A          170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHS--------IRM--  232 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--------HHH--
T ss_pred             cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH--------HHh--
Confidence            222  123456799999999999999999999999999999999999999865211     111110        100  


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAK-EIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ev~~~  566 (580)
                        ..    ...+..++.++.+++.+||..||++||++. |+++|
T Consensus       233 --~~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 --DN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             --CC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --CC----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence              00    111234567889999999999999999997 66643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=354.71  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=191.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ..+.|.+.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467999999999999999999976 58899999997542  34567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCccccCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+++|+|.+++...+ .+++..++.++.||+.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999987654 5899999999999999999999   899999999999999975   889999999999865322


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............            +..... 
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------i~~~~~-  268 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR------------ILNCEY-  268 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH------------HHTTCC-
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH------------HHhCCC-
Confidence            1   223456899999999999989999999999999999999999998652211101111            111100 


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         .........++.++.+|+.+||+.||++||++.|+++|
T Consensus       269 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 ---YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00011223567789999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-43  Score=354.39  Aligned_cols=260  Identities=22%  Similarity=0.303  Sum_probs=204.6

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ-----YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD  360 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  360 (580)
                      +....++|.+.+.||+|+||.||+|... +++.||+|++...     .....+.+..|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4566788999999999999999999864 6889999998654     234557889999999999999999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 038098          361 DFKALVLEYMPHGSLEKCLYSS---------------------------------------NYILDIFQRLNIMIDVASA  401 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  401 (580)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988521                                       1224677888999999999


Q ss_pred             HHHHhcCCCCCeEEecCCCCCEEeCCCC--cEEEccccCccccCCCCC--cccccccccCCCcCCcccccC--CCCCCch
Q 038098          402 LEYLHFGYSVPIIHCDLKPSNVLLDDNM--VAHLSDFGMAKPLLKEDQ--SLTQTQTLATIGYMAPEYGRE--GQVSTNG  475 (580)
Q Consensus       402 l~~Lh~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~  475 (580)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   89999999999999998776  899999999986533221  112345679999999999865  6789999


Q ss_pred             hhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCC
Q 038098          476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPE  555 (580)
Q Consensus       476 Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  555 (580)
                      |||||||++|||++|+.||......     ..        ...+.....    .........++.++.+++.+||+.||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~-----~~--------~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDA-----DT--------ISQVLNKKL----CFENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHH-----HH--------HHHHHHCCC----CTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChH-----HH--------HHHHHhccc----ccCCcccccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999998653211     00        111111111    011122234677899999999999999


Q ss_pred             CCCCHHHHHHH
Q 038098          556 QRINAKEIVTR  566 (580)
Q Consensus       556 ~Rps~~ev~~~  566 (580)
                      +||++.|+++|
T Consensus       321 ~Rps~~~~l~h  331 (345)
T 3hko_A          321 ERFDAMRALQH  331 (345)
T ss_dssp             TSCCHHHHHHS
T ss_pred             HCCCHHHHhcC
Confidence            99999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=353.52  Aligned_cols=259  Identities=23%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEE----EEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEV----AVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|+..+.||+|+||.||+|.+. +++.|    |+|.+... .......+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57889999999999999999864 45554    66666433 2345678899999999999999999999998755 789


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+||+.+|+|.+++......+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            99999999999999887778999999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||+.....  ...            ..+....
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~------------~~~~~~~  236 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EIS------------SILEKGE  236 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH------------HHHHTTC
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHH------------HHHHcCC
Confidence            43333444557889999999999999999999999999999999 99998763221  111            1111111


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                            ....+..++.++.+++.+||+.||++||+++|+++.|+++.+.-
T Consensus       237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                  11223456778999999999999999999999999999987543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.6e-44  Score=359.77  Aligned_cols=269  Identities=21%  Similarity=0.383  Sum_probs=217.2

Q ss_pred             HHHHHHhcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeee
Q 038098          285 LEIFQATNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSC  357 (580)
Q Consensus       285 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~  357 (580)
                      .+.....++|.+.+.||+|+||.||+|.+.      +++.||+|++..... .....+.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344455678999999999999999999754      367899999864432 3345688999999999999999999999


Q ss_pred             ecCCceeeEeeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC
Q 038098          358 SSDDFKALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN  428 (580)
Q Consensus       358 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~  428 (580)
                      ...+..++||||+++|+|.+++...+         ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence            99999999999999999999987532         45799999999999999999999   8999999999999999999


Q ss_pred             CcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHH
Q 038098          429 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHW  507 (580)
Q Consensus       429 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~  507 (580)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||.....     ...
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~  249 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQV  249 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----HHH
Confidence            9999999999986644333333344567889999999988899999999999999999999 8889865211     111


Q ss_pred             HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          508 VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       508 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      ...        +....       ....+..++..+.+++.+||+.||++||++.|++++|+++.....+
T Consensus       250 ~~~--------~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~  303 (322)
T 1p4o_A          250 LRF--------VMEGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  303 (322)
T ss_dssp             HHH--------HHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHH--------HHcCC-------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence            110        11110       1112345677899999999999999999999999999887554433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=346.84  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=201.7

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|++.+.||+|+||.||+|++. ++.||+|++...  ...+.+..|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56888899999999999999986 789999998533  345778999999999999999999999874  4789999999


Q ss_pred             CCChHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc-EEEccccCccccCCCCCc
Q 038098          372 HGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-AHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       372 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~  448 (580)
                      +|+|.+++.....  .+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986553  4789999999999999999999322289999999999999998886 799999999755322   


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                        .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+........ ..|..          ..       
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~----------~~-------  219 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAV----------HN-------  219 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHH----------HT-------
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHH----------hc-------
Confidence              22345899999999999999999999999999999999999999753211110 01100          00       


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      .........++..+.+++.+||+.||++||+++|++++|+.+.+.+
T Consensus       220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            0011122346678999999999999999999999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=343.40  Aligned_cols=263  Identities=22%  Similarity=0.367  Sum_probs=214.6

Q ss_pred             cCCCcCc-eeccccCceEEEEEeC---CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENN-LIGRGGFGSVYKARIQ---DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence            4455555 8999999999999753   57789999997543 234567889999999999999999999994 5668999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++......+++..++.++.||++||.|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999877778999999999999999999999   8999999999999999999999999999998764333


Q ss_pred             Cc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          447 QS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       447 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....  ......+.            .. 
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~------------~~-  229 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIE------------QG-  229 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHH------------TT-
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHh------------cC-
Confidence            21 11233456889999999988889999999999999999999 9999865321  11111111            00 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNV  578 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~~  578 (580)
                           .....+..++.++.+++.+||+.||++||++.|++++|+++..+.....
T Consensus       230 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          230 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             -----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence                 0112234567889999999999999999999999999999988876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=343.26  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=188.2

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++....   ......+.+|++++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35788999999999999999986 479999999996542   22346788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++......+++..++.++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999887778999999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      .  ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......     .        ...+.    . 
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~--------~~~~~----~-  226 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----T--------LNKVV----L-  226 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CC----S-
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----H--------HHHHh----h-
Confidence            1  2234568999999999998889999999999999999999999987532110     0        00000    0 


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         .....+..++.++.+++.+||+.||++||+++|+++|
T Consensus       227 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          227 ---ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ---SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence               0112233456788999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-42  Score=347.73  Aligned_cols=269  Identities=23%  Similarity=0.300  Sum_probs=192.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999865 68999999996543 2344678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          369 YMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      |++ |+|.+++....     ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886532     45899999999999999999999   8999999999999999999999999999998663


Q ss_pred             CCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc--ccc-hhhh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL--PIS-VMEI  519 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~  519 (580)
                      ....  ......+|+.|+|||.+.+ ..++.++||||+||++|||+||+.||...... ..+........  ... ....
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhh
Confidence            3221  2334568999999999876 46899999999999999999999999753211 11111111100  000 0000


Q ss_pred             c-----chhccCCcccc------cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 V-----DANLLSQKDEH------FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~-----d~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .     ...........      .......+.++.+++.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0     00000000000      00112456789999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.1e-43  Score=373.95  Aligned_cols=256  Identities=23%  Similarity=0.398  Sum_probs=213.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|...+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            356888899999999999999976 48899999986543 3457889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999998643 56899999999999999999999   8999999999999999999999999999998664322 2


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......++..|+|||.+....++.++|||||||++|||+| |..||......  ..            .+.+...    
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~------------~~~~~~~----  435 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV------------YELLEKD----  435 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH------------HHHHHTT----
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HH------------HHHHHcC----
Confidence            22234456788999999998899999999999999999999 99998653211  11            1111111    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                        .+...+..++.++.+|+.+||+.||++||+++++++.|+.+.
T Consensus       436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence              112234567788999999999999999999999999998763

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-42  Score=340.07  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=206.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            456899999999999999999865 5789999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +++++|.+++...+ .+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999887644 5899999999999999999999   9999999999999999   788999999999998664322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         ......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+ .....            ..    .
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~------------~~----~  222 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKI------------RE----G  222 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH------------HH----C
T ss_pred             ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHH------------Hh----C
Confidence               2334569999999998865 58999999999999999999999986532110 00000            00    0


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...........++.++.+++.+||+.||++||++.|+++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111123467789999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=348.19  Aligned_cols=245  Identities=21%  Similarity=0.237  Sum_probs=196.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|+..+.||+|+||+||+|... +|+.||||++.....  ........|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56999999999999999999876 799999999854322  2234455566666555 8999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+ +++|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 66999998877778999999999999999999999   8999999999999999999999999999998653322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...    .....+            ....    
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~------------~~~~----  268 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQL------------RQGY----  268 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHH------------TTTC----
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHH------------hccC----
Confidence              2334568999999998875 7899999999999999999997775431    111111            0000    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .....+..++.++.+++.+||+.||++|||++|+++|
T Consensus       269 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          269 --LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence              0112234567889999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=351.22  Aligned_cols=272  Identities=26%  Similarity=0.433  Sum_probs=217.0

Q ss_pred             cCCCcCceeccccCceEEEEEe-----CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC--cee
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--FKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~  364 (580)
                      ++|.+.+.||+|+||.||+|++     .+|+.||||++..........+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688889999999999999984     368899999997665566678999999999999999999999986544  789


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++++|.+++...+..+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999999887777999999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc-----cchhh
Q 038098          445 EDQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP-----ISVME  518 (580)
Q Consensus       445 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~  518 (580)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||+||..|+.....   ...........     ..+.+
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHHHH
Confidence            33211 12334577789999999888899999999999999999999998754210   00000000000     00111


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      .+...      .....+..++.++.+++.+||+.||++||++.|+++.|+++.+++.
T Consensus       275 ~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          275 LLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhhcC------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11111      1122345677889999999999999999999999999999998875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-43  Score=343.88  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=206.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC--CceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD--DFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|+++ ++.||||++....  ....+.+.+|+.++++++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888999999999999999986 8899999997543  23446788999999999999999999999876  7789999


Q ss_pred             eccCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++..... .+++..++.++.||++||+|||   +.+  ++||||||+||+++.++.++|+|||++.... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999987653 5899999999999999999999   888  9999999999999999999999999876432 


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCC---chhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVST---NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                            .....+|+.|+|||.+.+...+.   ++|||||||++|||++|+.||......     ....        ....
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~--------~~~~  225 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGM--------KVAL  225 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHHH--------HHHH
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHHH--------HHHh
Confidence                  12345889999999988765544   799999999999999999998653111     0000        0000


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      .    .  .....+..++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       226 ~----~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 E----G--LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             S----C--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             c----C--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0    0  0112234567789999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.4e-43  Score=359.13  Aligned_cols=272  Identities=18%  Similarity=0.269  Sum_probs=206.0

Q ss_pred             hcCCCcCceeccc--cCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRG--GFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4678999999999  99999999976 79999999997553  2334678889999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          366 VLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999987653 56999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCC-----cccccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc--
Q 038098          445 EDQ-----SLTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS--  515 (580)
Q Consensus       445 ~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  515 (580)
                      ...     ........||+.|+|||.+.+  ..++.++||||+||++|||++|+.||............+ ....+..  
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCcccc
Confidence            211     111223468899999999887  578999999999999999999999997632222111111 0000000  


Q ss_pred             ---------------------hhhhcc---hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 ---------------------VMEIVD---ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ---------------------~~~~~d---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                                           ..+...   .............+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                 000000   000000000112234567789999999999999999999999976

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-43  Score=354.41  Aligned_cols=276  Identities=24%  Similarity=0.303  Sum_probs=214.7

Q ss_pred             cCCCcCceeccccCceEEEEEe-----CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeee--cCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-----QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS--SDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  364 (580)
                      ++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999984     368899999997665555677899999999999999999999876  456689


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++++|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999876667999999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          445 EDQS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       445 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      .... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||.......  ...+.............+..
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC----CCHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccccccccHHHHHHHh
Confidence            3321 12334568888999999988889999999999999999999999975421110  00000000000111111111


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ..   ......+..++.++.+++.+||+.||++||+++|++++|+++.....
T Consensus       258 ~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          258 EE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             hc---ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            11   11222345677889999999999999999999999999999876554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.5e-43  Score=351.19  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC-------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD-------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  361 (580)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356889999999999999999976 79999999997543 334577899999999999999999999985543       


Q ss_pred             --------------------------------------------------ceeeEeeccCCCChHHHhhcCC--CCCCHH
Q 038098          362 --------------------------------------------------FKALVLEYMPHGSLEKCLYSSN--YILDIF  389 (580)
Q Consensus       362 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~  389 (580)
                                                                        ..++||||+++|+|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2789999999999999998654  346777


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc----------ccccccccCCC
Q 038098          390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS----------LTQTQTLATIG  459 (580)
Q Consensus       390 ~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~~~~  459 (580)
                      .++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   899999999999999999999999999999876443211          12234569999


Q ss_pred             cCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhH
Q 038098          460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCV  539 (580)
Q Consensus       460 y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  539 (580)
                      |+|||.+.+..++.++||||+||++|||++|..|+...       .....        ....    .   .........+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~--------~~~~----~---~~~~~~~~~~  299 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIIT--------DVRN----L---KFPLLFTQKY  299 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHH--------HHHT----T---CCCHHHHHHC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHH--------Hhhc----c---CCCcccccCC
Confidence            99999999999999999999999999999988774220       00000        0000    0   0111223445


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          540 SFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       540 ~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +++.+++.+||+.||++||+++|+++|
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            677899999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-42  Score=351.95  Aligned_cols=245  Identities=21%  Similarity=0.254  Sum_probs=206.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999875 68999999996542   234567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999987654 5899999999999999999999   999999999999999999999999999999865332  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         .....||+.|+|||.+.+..++.++||||+||++|||++|+.||....     ......        .+...     
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~--------~i~~~-----  253 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYE--------KIVSG-----  253 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH--------HHHHC-----
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHH--------HHHcC-----
Confidence               234569999999999999999999999999999999999999986521     111111        11111     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                         ....+..++.++.+++.+||+.||++||+     ++|+++|
T Consensus       254 ---~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence               01122346778999999999999999998     8888875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-42  Score=347.89  Aligned_cols=273  Identities=24%  Similarity=0.389  Sum_probs=213.7

Q ss_pred             CCcCceeccccCceEEEEEeC-----CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeec--CCceee
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-----DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKAL  365 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  365 (580)
                      |+..+.||+|+||.||++.+.     +|+.||||++..... .....+.+|++++++++||||+++++++..  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998643     588899999975532 345678899999999999999999999987  457899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++....  +++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  899999999999999999999   899999999999999999999999999999876443


Q ss_pred             CCc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-ccchhhhcchh
Q 038098          446 DQS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-PISVMEIVDAN  523 (580)
Q Consensus       446 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~  523 (580)
                      ... .......+|..|+|||.+.+..++.++||||+|+++|||+||+.||............+..... .....+.++..
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            321 1233455788899999999889999999999999999999999998652111000000000000 00011111111


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN  577 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~  577 (580)
                            .....+..++.++.+++.+||+.||++||+++|+++.|+++.+++...
T Consensus       268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence                  122334567788999999999999999999999999999999988643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.2e-43  Score=354.39  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999876 78999999996543 2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc--EEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~~  447 (580)
                      +++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.  +||+|||+++.....  
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--  171 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  171 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence            99999999887544 5999999999999999999999   999999999999999987765  999999999743221  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCc-hhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                       .......||+.|+|||.+.+..++.+ +||||+||++|||++|+.||....... ........        +....   
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~--------~~~~~---  238 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQR--------ILSVK---  238 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHH--------HHTTC---
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHH--------HhcCC---
Confidence             12334569999999999988777655 899999999999999999997632211 11111111        11110   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ........++.++.+|+.+||+.||++|||++|+++|
T Consensus       239 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 ---YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               0111222456788999999999999999999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-42  Score=346.70  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=206.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc------hhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR------AFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356889999999999999999865 6899999999654321      356789999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC----cEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~a  439 (580)
                      ++||||+++++|.+++... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999998754 46899999999999999999999   89999999999999999888    7999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .......   ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     ......        +
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~--------i  230 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN--------I  230 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH--------H
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------H
Confidence            8664322   22345689999999999988999999999999999999999999865211     111110        0


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..    .............+..+.+++.+||+.||++|||++|+++|
T Consensus       231 ~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TS----VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HT----TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Hh----cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00    00000111223456788999999999999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.8e-43  Score=353.21  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=204.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|...+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999875 68899999997543   22345678899999988 899999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999987644 5899999999999999999999   8999999999999999999999999999998543222


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch---HHHHHHhhcccchhhhcchh
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT---LKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~d~~  523 (580)
                        .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.........   .....       ...+... 
T Consensus       165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------~~~i~~~-  234 (345)
T 3a8x_A          165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-------FQVILEK-  234 (345)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH-------HHHHHHC-
T ss_pred             --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH-------HHHHHcC-
Confidence              2234567999999999999999999999999999999999999999653211100   00000       0011111 


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA------KEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~ev~~~  566 (580)
                             ....+...+.++.+++.+||+.||++||++      +|+++|
T Consensus       235 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          235 -------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                   111234567789999999999999999995      677654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=355.27  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=198.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCC--CCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRH--RNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  366 (580)
                      .+.|++.+.||+|+||.||+|...+++.||||++.....  ...+.+.+|++++.+++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            356889999999999999999988899999999975432  334678899999999986  9999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ||+ .+|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5789999998654 6899999999999999999999   89999999999999997 6789999999998765443


Q ss_pred             CcccccccccCCCcCCcccccC-----------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc
Q 038098          447 QSLTQTQTLATIGYMAPEYGRE-----------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      .........||+.|+|||.+.+           ..++.++|||||||++|||++|+.||......   ...         
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~---------  229 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK---------  229 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHH---------
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHH---------
Confidence            3333445679999999998864           67899999999999999999999999653211   111         


Q ss_pred             hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          516 VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       516 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      ....++...      ....+...+.++.+++.+||+.||++|||++|+++|-
T Consensus       230 ~~~~~~~~~------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          230 LHAIIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HHHHHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHhcCCc------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            111122111      1112233456789999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.7e-43  Score=349.51  Aligned_cols=263  Identities=23%  Similarity=0.414  Sum_probs=201.4

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC--
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  361 (580)
                      ..++|.+.+.||+|+||.||+|...    +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567888899999999999999754    34579999986542  234567889999999999999999999987655  


Q ss_pred             ---ceeeEeeccCCCChHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEE
Q 038098          362 ---FKALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  433 (580)
Q Consensus       362 ---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl  433 (580)
                         ..++||||+++|+|.+++..     ....+++..++.++.||++||.|||   +.+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               34899999999999999853     2356999999999999999999999   999999999999999999999999


Q ss_pred             ccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhc
Q 038098          434 SDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       434 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......  .....     
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~-----  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDY-----  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH-----
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHH-----
Confidence            99999986644433333344567889999999999999999999999999999999 88888653211  11110     


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                            +...       .....+..++.++.+++.+||+.||++||++.+++++|+++.+++.
T Consensus       262 ------~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          262 ------LLHG-------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ------HHTT-------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ------HHcC-------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                  0000       0112234567789999999999999999999999999999988754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-42  Score=340.25  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=209.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356889999999999999999875 78999999997543 3345778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|.+++... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.+.........
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999988654 45899999999999999999999   899999999999999999999999999999865433322


Q ss_pred             ccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      .......|+..|+|||.+.+..+ +.++||||+|+++|||++|+.||............|....                
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  225 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------------  225 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC----------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc----------------
Confidence            23345568999999999987665 7899999999999999999999976433222233322210                


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .........+..+.+++.+||+.||++|||++|+++|
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              0111223456778999999999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.1e-42  Score=340.48  Aligned_cols=252  Identities=21%  Similarity=0.355  Sum_probs=206.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999865 68999999996543  234467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc---EEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~  444 (580)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999998887553 5899999999999999999999   899999999999999986655   99999999986533


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..   ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     ......         +... 
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~---------~~~~-  222 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQ---------IKAG-  222 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH---------HHHT-
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHH---------HHhc-
Confidence            22   22345689999999999999999999999999999999999999865211     111110         0000 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ...........++.++.+++.+||+.||++|||++|+++|
T Consensus       223 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          223 --AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0001111223566789999999999999999999999886

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=361.42  Aligned_cols=260  Identities=25%  Similarity=0.440  Sum_probs=200.5

Q ss_pred             CCcCceeccccCceEEEEEeC--CC--CEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeee-cCCceeeEe
Q 038098          294 FSENNLIGRGGFGSVYKARIQ--DG--MEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCS-SDDFKALVL  367 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~  367 (580)
                      |...+.||+|+||.||+|.+.  ++  ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            556789999999999999853  22  358999886432 344578899999999999999999999864 456789999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++......+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999887778999999999999999999999   89999999999999999999999999999986543321


Q ss_pred             c--ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          448 S--LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       448 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .  .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||......  .......           ..  
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~-----------~~--  312 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL-----------QG--  312 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHH-----------TT--
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHH-----------cC--
Confidence            1  12234457888999999999999999999999999999999 67777553211  1111111           00  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                           .+...+..++..+.+++.+||+.||++||+++|++++|+++...+..
T Consensus       313 -----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          313 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                 01122345677899999999999999999999999999999877653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-42  Score=348.46  Aligned_cols=251  Identities=21%  Similarity=0.242  Sum_probs=183.4

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEeeccCCCC
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      .+.||+|+||.||+|... +|+.||||++...   ....+..|+.++..+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999875 6899999999643   3466788999999997 9999999999999999999999999999


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEEEccccCccccCCCCCcccc
Q 038098          375 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       375 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      |.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++   .+||+|||+++......  ...
T Consensus        93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            99999765 46999999999999999999999   89999999999999997665   89999999998653322  223


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH  531 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  531 (580)
                      ....||+.|+|||.+.+..++.++||||+||++|||++|+.||........          .....+..+..........
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHHHHHTTTCCCCC
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHHHHHHHcCCCCCC
Confidence            345689999999999999999999999999999999999999976322100          0001111111111111112


Q ss_pred             cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       532 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            22334567889999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.3e-43  Score=343.60  Aligned_cols=261  Identities=22%  Similarity=0.351  Sum_probs=209.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|...+.||+|+||.||+|.+.+    +..||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678889999999999999998542    3359999986542 23457788999999999999999999998754 5689


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++++|.+++...+..+++..++.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999877777999999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .. .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......  .......            ...
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~------------~~~  231 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLE------------KGD  231 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHH------------HTC
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHh------------cCC
Confidence            21 22334457888999999988899999999999999999998 99998653211  1111110            000


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                            ....+..++..+.+++.+||+.||++||++.|++++|+++.+....
T Consensus       232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence                  1112234667899999999999999999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-42  Score=349.36  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             hcCCCcCceeccccCceEEEEEe----CCCCEEEEEEEeccc----cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|++....    ......+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36789999999999999999986    478999999996542    2334567889999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||+++|+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987644 5899999999999999999999   899999999999999999999999999999754


Q ss_pred             CCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      .....  ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     .....        .+...
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~--------~i~~~  236 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTID--------KILKC  236 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH--------HHHHT
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHHH--------HHHhC
Confidence            32221  23345699999999999988999999999999999999999999975311     11111        11111


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                              ....+...+.++.+++.+||+.||++||     ++.|+++|
T Consensus       237 --------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 --------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             --------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                    0112234567889999999999999999     78888875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.5e-43  Score=369.44  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=206.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|...+.||+|+||.||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45688889999999999999999878889999987543 234678999999999999999999999876 6789999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++... +..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence            999999999753 345899999999999999999999   8999999999999999999999999999998664322 12


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......+|..|+|||.+..+.++.++|||||||++|||+| |+.||.....     .+..         ..+...     
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~---------~~i~~~-----  397 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVL---------DQVERG-----  397 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHH---------HHHHTT-----
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----HHHH---------HHHHcC-----
Confidence            2234457788999999998999999999999999999999 9999865311     1110         011110     


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                       .+...+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus       398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence             1122345677889999999999999999999999999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.9e-43  Score=352.37  Aligned_cols=250  Identities=20%  Similarity=0.264  Sum_probs=205.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCcee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  364 (580)
                      ..++|...+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467999999999999999999876 58899999997542   23456678899999988 7999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987644 5899999999999999999999   89999999999999999999999999999985422


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..  .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     .....        .+...  
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~--------~i~~~--  236 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ--------SIMEH--  236 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHHC--
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHH--------HHHhC--
Confidence            22  223456799999999999999999999999999999999999999865211     11111        11111  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                            ....+...+.++.+|+.+||+.||++||+     ++|+++|
T Consensus       237 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          237 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                  11122356778999999999999999995     5777765

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-43  Score=352.14  Aligned_cols=255  Identities=22%  Similarity=0.355  Sum_probs=196.0

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCce---
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK---  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  363 (580)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....   .....+.+|++++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999986 5789999999975432   2345788999999999999999999998765543   


Q ss_pred             -eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          364 -ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       364 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                       ++||||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence             99999999999999987654 5899999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          443 LKEDQS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       443 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ......            
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~------------  233 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVR------------  233 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH------------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhc------------
Confidence            443222 223345689999999999999999999999999999999999999865311100 000000            


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ............++.++.+++.+||+.||++||++.+++.+
T Consensus       234 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          234 ----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             ----CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ----CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence                01111111223467789999999999999999977666543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7e-43  Score=344.57  Aligned_cols=261  Identities=23%  Similarity=0.392  Sum_probs=216.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ..++|+..+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3467888999999999999999876 5889999998644 3345778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+++++|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999997643 56899999999999999999999   8999999999999999999999999999998664332 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      ........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||......  ...            +.+....  
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~------------~~~~~~~--  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY------------ELLEKDY--  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH------------HHHHTTC--
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH------------HHHhccC--
Confidence            223344557888999999998899999999999999999999 99998653211  111            1111110  


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                          ....+..++.++.+++.+||+.||++||+++|+++.|+++..+..
T Consensus       230 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          230 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                112234567889999999999999999999999999999887643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.2e-43  Score=342.40  Aligned_cols=260  Identities=22%  Similarity=0.384  Sum_probs=211.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            35688899999999999999998888899999986543 345778999999999999999999999874 5589999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence            9999999987543 36899999999999999999999   8999999999999999999999999999998764322 12


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |+.||.....     .....         .+....    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~---------~~~~~~----  227 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQ---------NLERGY----  227 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHH---------HHHTTC----
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHHH---------HHhccc----
Confidence            2234457788999999988889999999999999999999 8999865211     11111         000000    


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                        ....+..++.++.+++.+||+.||++||++.++++.|+++......
T Consensus       228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence              1112235667899999999999999999999999999998876543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.4e-42  Score=346.38  Aligned_cols=277  Identities=23%  Similarity=0.355  Sum_probs=215.5

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhh--cCCCCcceEEeeeecC
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKR--IRHRNIIKIISSCSSD  360 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~  360 (580)
                      +...-....++|.+.+.||+|+||.||+|+.. |+.||||++...   ....+..|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            33334455678999999999999999999985 899999998643   34567788888887  7899999999999876


Q ss_pred             C----ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEecCCCCCEEeCCCCcE
Q 038098          361 D----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       361 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      .    ..++||||+++|+|.+++...  .+++..++.++.|++.||+|||...     +.+|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    789999999999999999764  4899999999999999999999321     4689999999999999999999


Q ss_pred             EEccccCccccCCCCCcc--cccccccCCCcCCcccccCC------CCCCchhhHhHHHHHHHHHhC----------CCC
Q 038098          432 HLSDFGMAKPLLKEDQSL--TQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTR----------KKP  493 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~elltg----------~~p  493 (580)
                      ||+|||++..........  ......||+.|+|||.+.+.      .++.++|||||||++|||+||          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998664333211  23445699999999998765      234789999999999999999          667


Q ss_pred             CCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          494 TDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      |............+.......        ....... .......++..+.+|+.+||+.||++||+++||+++|+++.++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQ--------KLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTS--------CCCCCCC-GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccCcCcccHHHHHHHHHHH--------HhCCCCc-ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            765433333333333221111        1111110 1112245678899999999999999999999999999999876


Q ss_pred             H
Q 038098          574 L  574 (580)
Q Consensus       574 ~  574 (580)
                      .
T Consensus       338 ~  338 (342)
T 1b6c_B          338 E  338 (342)
T ss_dssp             T
T ss_pred             h
Confidence            4

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=343.75  Aligned_cols=261  Identities=23%  Similarity=0.404  Sum_probs=208.9

Q ss_pred             CCcCceeccccCceEEEEEeC-CC---CEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCce-eeEe
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DG---MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK-ALVL  367 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~  367 (580)
                      |...+.||+|+||.||+|.+. ++   ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            555688999999999999853 23   3699999864332 3456788999999999999999999999766655 8999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+.+|+|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            999999999999887778999999999999999999999   89999999999999999999999999999986543221


Q ss_pred             --cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          448 --SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       448 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                        ........+|..|+|||.+.+..++.++||||+|+++|||++|+.|+..... .........            ... 
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~------------~~~-  245 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLA------------QGR-  245 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHH------------TTC-
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhh------------cCC-
Confidence              1223345678899999999999999999999999999999996665432111 111111111            100 


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                           ....+..++..+.+++.+||+.||++|||++++++.|+++..++..
T Consensus       246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                 1122334567899999999999999999999999999999887643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=349.84  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=206.1

Q ss_pred             cCCCcCceeccccCceEEEEEeCC-----CCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD-----GMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|...+.||+|+||.||+|....     +..||||++..... .....+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999998642     23599999975432 334578899999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++......+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999887778999999999999999999999   899999999999999999999999999999866433


Q ss_pred             CC-cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          446 DQ-SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       446 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      .. ........+|..|+|||.+.+..++.++|||||||++|||++ |+.||.....     ....         ..+...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~---------~~~~~~  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVM---------KAINDG  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH---------HHHHTT
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHH---------HHHHCC
Confidence            21 112223346788999999998899999999999999999999 9999865211     0100         011000


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                            .+...+..++.++.+++.+||+.||++||++.|++++|+++.+...
T Consensus       267 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          267 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                  0112234567789999999999999999999999999999876543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-42  Score=341.64  Aligned_cols=266  Identities=20%  Similarity=0.217  Sum_probs=210.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeee-ecCCceeeEe
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC-SSDDFKALVL  367 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  367 (580)
                      ..++|...+.||+|+||.||+|.. .+++.||||++....  ....+..|++++++++|++++..++.+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999986 578999999875442  335688899999999988877776655 6677889999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+ +++|.+++......+++..++.++.||+.||.|||   +.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999877777999999999999999999999   9999999999999999   7899999999999987644


Q ss_pred             CCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC--chHHHHHHhhcccchh
Q 038098          445 EDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD--MTLKHWVNDLLPISVM  517 (580)
Q Consensus       445 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~  517 (580)
                      ....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ..........      
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  234 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------  234 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc------
Confidence            3221     12235578999999999999999999999999999999999999997642221  1111111110      


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                            ....   .......++.++.+++.+||+.||++||+++++++.|+++..+...
T Consensus       235 ------~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          235 ------MSTP---IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             ------HHSC---HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             ------ccch---hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                  0000   0011134567899999999999999999999999999999887653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-42  Score=344.00  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             cCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeee-ecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSC-SSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l  365 (580)
                      ..|...+.||+|+||.||+|...+    +..||+|.+.... ....+.+.+|+.++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457788999999999999998542    2358999886432 23456788999999999999999999985 45667899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999887778999999999999999999999   899999999999999999999999999999866433


Q ss_pred             CC--cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          446 DQ--SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       446 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ..  ........+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||......  .......           ..
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~-----------~~  248 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL-----------QG  248 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHH-----------TT
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHh-----------cC
Confidence            21  122334567889999999998999999999999999999999 55555442111  1111110           00


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                             .....+..++..+.+++.+||+.||++||+++|+++.|+++.+++.
T Consensus       249 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          249 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                   0111223456789999999999999999999999999999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=343.36  Aligned_cols=269  Identities=25%  Similarity=0.287  Sum_probs=202.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc-----chhhhHHHHHHHHhhcC---CCCcceEEeeeecC
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG-----RAFKSFDIECDMIKRIR---HRNIIKIISSCSSD  360 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  360 (580)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++.....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999986 4789999999864321     12346677888777765   99999999999765


Q ss_pred             C-----ceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEc
Q 038098          361 D-----FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  434 (580)
Q Consensus       361 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  434 (580)
                      .     ..++||||+. |+|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999997 59999987665 34899999999999999999999   8999999999999999999999999


Q ss_pred             cccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          435 DFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       435 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      |||+++......   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .............
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            999998653222   234557899999999999999999999999999999999999999753211 1111111111000


Q ss_pred             c---hhhhc--chhccCC--cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 S---VMEIV--DANLLSQ--KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~---~~~~~--d~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   .....  .......  ..........++.++.+|+.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0   00000  0000000  000011223567889999999999999999999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.1e-42  Score=342.83  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=202.0

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++....   ......+.+|++++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688999999999999999986 478999999986432   23456788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      |||+++|+|.+++..   ....+++..++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999998864   3456899999999999999999999   8999999999999999999999999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|+.||......   ...+...         +...
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~---------~~~~  253 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK---------IEQC  253 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHH---------HHTT
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHH---------hhcc
Confidence            3221  223456899999999999989999999999999999999999998653211   1111111         0000


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      ...     ......++.++.+++.+||+.||++||++++++++|+++....
T Consensus       254 ~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 DYP-----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CSC-----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCC-----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            000     0111345678999999999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=347.37  Aligned_cols=260  Identities=23%  Similarity=0.290  Sum_probs=207.1

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeee----cCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS----SDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~l  365 (580)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..........+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            36789999999999999999986 578999999987655556678899999999999999999999986    3447889


Q ss_pred             EeeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          366 VLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      ||||+++|+|.+++..   .+..+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999876   3567999999999999999999999   899999999999999999999999999998755


Q ss_pred             CCCCCcc-------cccccccCCCcCCcccccCCC---CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc
Q 038098          443 LKEDQSL-------TQTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       443 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      .......       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||+..............   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---  261 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---  261 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH---
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh---
Confidence            3211110       112345799999999987543   689999999999999999999998642221111111111   


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                               ..      ........++.++.+++.+||+.||++||+++|++++|+++.
T Consensus       262 ---------~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          262 ---------NQ------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ---------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ---------cc------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                     00      011122345678999999999999999999999999998864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-42  Score=363.10  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=206.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999875 79999999996542   233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-  170 (476)
T 2y94_A           96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  170 (476)
T ss_dssp             ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence            999999999998754 45999999999999999999999   9999999999999999999999999999998664322 


Q ss_pred             cccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+....     .....        .+.+.    
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~--------~i~~~----  231 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFK--------KICDG----  231 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHH--------HHHTT----
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHH--------HHhcC----
Confidence              2334579999999999987765 6899999999999999999999975211     11111        11111    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       232 ----~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          232 ----IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                111223456778999999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-42  Score=346.50  Aligned_cols=268  Identities=22%  Similarity=0.276  Sum_probs=201.2

Q ss_pred             cCCCcC-ceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSEN-NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +.|.+. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467774 78999999999999854 7899999999766555667889999999985 79999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc---EEEccccCccccCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPLLKE  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~  445 (580)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.   +||+|||++......
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999987654 5899999999999999999999   899999999999999998776   999999999865322


Q ss_pred             CC-----cccccccccCCCcCCcccccC-----CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc
Q 038098          446 DQ-----SLTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS  515 (580)
Q Consensus       446 ~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  515 (580)
                      ..     ........||+.|+|||.+..     ..++.++||||+||++|||++|+.||......+..   |........
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~  244 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---WDRGEACPA  244 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---C----CCHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---ccccccchh
Confidence            21     111234459999999998865     56889999999999999999999999764322110   110000000


Q ss_pred             -hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 -VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 -~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ......................++.++.+|+.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             000111100011100111123467789999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-42  Score=357.31  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=198.9

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcC--CCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIR--HRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..|.+.+.||+|+||.||+|...+++.||||++....  ......+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4488999999999999999998889999999996543  234577889999999996  599999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      | +.+++|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56789999988755 6899999999999999999999   99999999999999995 58999999999987644333


Q ss_pred             cccccccccCCCcCCcccccC-----------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          448 SLTQTQTLATIGYMAPEYGRE-----------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......   . ..        +
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~-~~--------~  277 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---I-SK--------L  277 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H-HH--------H
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---H-HH--------H
Confidence            333445679999999998864           46889999999999999999999999653111   0 10        1


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..+++....      ...+...+.++.+|+.+||+.||++||+++|+++|
T Consensus       278 ~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 HAIIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhCcccc------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            112221111      11122335678999999999999999999999976

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.9e-43  Score=351.82  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|...+.||+|+||.||+|..+ +|+.||||++.....    ....|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999865 689999999975432    345688888888 79999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC----CcEEEccccCccccCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKPLLK  444 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~a~~~~~  444 (580)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||++..+    +.+||+|||+++....
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999887654 5999999999999999999999   8999999999999998533    3599999999986643


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ...  ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....  .........         +.   
T Consensus       173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~---------i~---  236 (342)
T 2qr7_A          173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILAR---------IG---  236 (342)
T ss_dssp             TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHH---------HH---
T ss_pred             CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHH---------Hc---
Confidence            322  23345789999999999887889999999999999999999999975211  111111111         00   


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........+..++.++.+|+.+||..||++||+++|+++|
T Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            011111111234567889999999999999999999999886

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-42  Score=340.90  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999865 57899999986432   22346788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++.... .+++..++.++.||+.|++|||   +.+|+||||||+||+++.++.++|+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            99999999999887654 5899999999999999999999   999999999999999999999999999998644222 


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.....     ......        + ...   
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~--------~-~~~---  222 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKR--------I-SRV---  222 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--------H-HHT---
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHH--------H-HhC---
Confidence               22345689999999999998999999999999999999999999865211     111000        0 000   


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                          ....+..++..+.+++.+||+.||++||+++|+++|-
T Consensus       223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                1112234567789999999999999999999999873

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.5e-43  Score=350.21  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=200.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            56888999999999999999875 789999999864432 2223455799999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++ |+|.+++...+..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5999999887778999999999999999999999   8999999999999999999999999999998553222  2


Q ss_pred             cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---ccchhhhcchhc-
Q 038098          450 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---PISVMEIVDANL-  524 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~~-  524 (580)
                      ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ..........   +........... 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhh
Confidence            2334568999999998876 568999999999999999999999997632111 1111111000   000111111000 


Q ss_pred             ----cC--CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 ----LS--QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ----~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ..  ...........++.++.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                00  0001112233567789999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-41  Score=336.73  Aligned_cols=264  Identities=20%  Similarity=0.223  Sum_probs=212.5

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeee-ecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC-SSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  368 (580)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ....+..|+++++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999986 578999999986543  335688999999999998877666655 56677899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+ +++|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999877778999999999999999999999   8999999999999999   48899999999999876443


Q ss_pred             CCcc-----cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC--chHHHHHHhhcccchhh
Q 038098          446 DQSL-----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD--MTLKHWVNDLLPISVME  518 (580)
Q Consensus       446 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  518 (580)
                      ....     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ..........       
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------  234 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------  234 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-------
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-------
Confidence            2211     1245579999999999999999999999999999999999999997642211  1111111110       


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                           ....   .......++.++.+++.+||+.||++||+++++++.|+++..+..
T Consensus       235 -----~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          235 -----MSTP---IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             -----HHSC---HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             -----cCCc---hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                 0000   001123456789999999999999999999999999999987654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=349.50  Aligned_cols=243  Identities=26%  Similarity=0.335  Sum_probs=204.1

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--------chhhhHHHHHHHHhhcCCCCcceEEeeeecC
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--------RAFKSFDIECDMIKRIRHRNIIKIISSCSSD  360 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  360 (580)
                      ..++|...+.||+|+||.||+|... +++.||||++.....        .....+..|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3467999999999999999999854 689999999975421        1335677899999999999999999999999


Q ss_pred             CceeeEeeccCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          361 DFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       361 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      +..++||||+.+| +|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887654 5999999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      +......   ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....                   +
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------------------~  235 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-------------------E  235 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-------------------G
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-------------------H
Confidence            8664332   2234569999999999988776 789999999999999999999986421                   0


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....        ....+..++.++.+++.+||+.||++||+++|++++
T Consensus       236 ~~~~--------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 TVEA--------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             GTTT--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHhh--------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110        011122356779999999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.1e-42  Score=354.22  Aligned_cols=250  Identities=21%  Similarity=0.272  Sum_probs=193.7

Q ss_pred             cCCCcC-ceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhh-cCCCCcceEEeeeec----CCcee
Q 038098          292 NGFSEN-NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKR-IRHRNIIKIISSCSS----DDFKA  364 (580)
Q Consensus       292 ~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~  364 (580)
                      ++|... +.||+|+||.||+|... +|+.||||++..     ...+.+|++++.+ .+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999865 689999999853     2456788888754 489999999998865    56789


Q ss_pred             eEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCcc
Q 038098          365 LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAK  440 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a~  440 (580)
                      +||||+++|+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998754 46999999999999999999999   899999999999999997   7899999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc--hHHHHHHhhcccchhh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM--TLKHWVNDLLPISVME  518 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  518 (580)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+.         
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---------  280 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---------  280 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---------
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---------
Confidence            653221   23455789999999999999999999999999999999999999975322111  0111000         


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                         ..   ...........++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       281 ---~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          281 ---MG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             ---HT---CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---cC---cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence               00   00001112245678899999999999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-42  Score=340.09  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=198.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56889999999999999999865 68999999997653 33457889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccC
Q 038098          370 MPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       370 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~  443 (580)
                      +++|+|.+++...   ...+++..++.++.||++||+|||   +.+|+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988643   356999999999999999999999   8999999999999999   556889999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ...   ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||......  .......              
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~--------------  238 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKAT--------------  238 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH--------------
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhc--------------
Confidence            322   233456899999999875 57899999999999999999999998753211  0000000              


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ..... ........++++.+++.+||+.||++||+++|+++|
T Consensus       239 -~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          239 -YKEPN-YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -HCCCC-CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -cCCcc-cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00000 001112245678899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=372.92  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             eeccccCceEEEEEeC---CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCCCC
Q 038098          299 LIGRGGFGSVYKARIQ---DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       299 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999764   46679999997543 3356789999999999999999999999976 56899999999999


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc-ccccc
Q 038098          375 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS-LTQTQ  453 (580)
Q Consensus       375 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~  453 (580)
                      |.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877778999999999999999999999   899999999999999999999999999999866433221 11223


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccccc
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF  532 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  532 (580)
                      ..+|+.|+|||++.++.++.++|||||||++|||+| |+.||.....  ......            +...      .+.
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~------------i~~~------~~~  558 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAF------------IEQG------KRM  558 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHH------------HHTT------CCC
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHH------------HHcC------CCC
Confidence            346688999999998999999999999999999998 9999875321  111111            1111      122


Q ss_pred             chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       533 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                      ..+..++.++.+|+.+||+.||++||+++++++.|+.+..+..
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            2345678899999999999999999999999999999877654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-42  Score=342.36  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=201.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999865 688999999865422   224678899999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++++|.+++...+ .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999987643 5899999999999999999999   899999999999999999999999999999865332


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......  .......            .   
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~------------~---  249 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN------------Q---  249 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH------------S---
T ss_pred             cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc------------c---
Confidence            21 2233456899999999999999999999999999999999999998753110  0111000            0   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-NAKEIVTRLLKIRDS  573 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ev~~~L~~~~~~  573 (580)
                       ........+..++.++.+++.+||+.||++|| +++++++.|+++...
T Consensus       250 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          250 -AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             -CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             -CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence             00001122345667899999999999999999 999999999887544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-42  Score=364.73  Aligned_cols=249  Identities=24%  Similarity=0.302  Sum_probs=197.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|+..+.||+|+||.||+|... +|+.||||++...   .......+..|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999865 6899999999754   223445677899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   + .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999887644 5899999999999999999999   7 89999999999999999999999999999854322


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......        +..    
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~--------i~~----  363 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFEL--------ILM----  363 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--------HHH----
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHH--------HHh----
Confidence            2  223456799999999999999999999999999999999999999865211     111110        100    


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      .    ....+..++.++.+|+.+||+.||++||     +++|+++|
T Consensus       364 ~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          364 E----EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             C----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C----CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            0    0112234567899999999999999999     99999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.1e-42  Score=336.92  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999876 689999999865421      13567899999999999999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC----cEEEccccCcc
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAK  440 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~a~  440 (580)
                      +||||+++++|.+++... ..+++..++.++.||+.||.|||   +.+++||||||+||+++.++    .+||+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            999999999999998754 35899999999999999999999   89999999999999998877    89999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ......   ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.....     ......        +.
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~--------~~  224 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----QETLTN--------IS  224 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--------HH
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----HHHHHH--------hH
Confidence            653322   22345689999999999988999999999999999999999999865311     111100        00


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          .............++..+.+++.+||+.||++||+++|+++|
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          225 ----AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             ----TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             ----hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                000111112234556789999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-42  Score=347.27  Aligned_cols=257  Identities=28%  Similarity=0.465  Sum_probs=207.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEE--EEEEEecc-ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEV--AVKVFDLQ-YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|...+.||+|+||.||+|+.. +|..+  |+|++... .......+..|+++++++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999864 56654  99988643 233456788999999999 899999999999999999999


Q ss_pred             eeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          367 LEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      |||+++|+|.+++...+               ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999987654               46899999999999999999999   9999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  510 (580)
                      ||+|||+++....   ........++..|+|||.+.+..++.++||||+||++|||+| |+.||.....     ......
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~  253 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK  253 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHHH
Confidence            9999999974321   112233457889999999988889999999999999999998 9999865311     111111


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                               +...      .....+..++.++.+++.+||+.||++||+++|++++|+++..+.
T Consensus       254 ---------~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          254 ---------LPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             ---------GGGT------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---------hhcC------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence                     1110      011223456778999999999999999999999999999987754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=342.44  Aligned_cols=267  Identities=21%  Similarity=0.253  Sum_probs=200.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999875 589999999854432  234667889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            99999999877644 45899999999999999999999   89999999999999999999999999999986643222 


Q ss_pred             ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc---chhhhcch-h
Q 038098          449 LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI---SVMEIVDA-N  523 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~-~  523 (580)
                       ......||..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+  ...........   ........ .
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhccccccccccccccc
Confidence             2234568999999998876 668999999999999999999999997632211  11111111000   00000000 0


Q ss_pred             cc-----CCc---ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LL-----SQK---DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~-----~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..     ...   .........++.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00     000   00001113467789999999999999999999999976

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=351.98  Aligned_cols=264  Identities=20%  Similarity=0.206  Sum_probs=200.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC----CCCEEEEEEEeccccc-----------hhhhHHHHHHHHhhcCCCCcceEEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQYGR-----------AFKSFDIECDMIKRIRHRNIIKIISS  356 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~  356 (580)
                      ++|.+.+.||+|+||.||+|...    ++..||+|++......           ....+..|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56889999999999999999875    5788999998654321           12345678888999999999999999


Q ss_pred             eec----CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC--c
Q 038098          357 CSS----DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM--V  430 (580)
Q Consensus       357 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~--~  430 (580)
                      +..    ....++||||+ +++|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            877    67889999999 999999987655 7999999999999999999999   89999999999999999887  9


Q ss_pred             EEEccccCccccCCCCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH
Q 038098          431 AHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK  505 (580)
Q Consensus       431 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~  505 (580)
                      +||+|||+++.+......     .......||..|+|||.+.+..++.++|||||||++|||+||+.||...........
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999999876432211     112445799999999999998999999999999999999999999964322211111


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      ........ .....+...         .....++.++.+++.+||+.||++||++++|++.|+++
T Consensus       272 ~~~~~~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          272 TAKTNLLD-ELPQSVLKW---------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHH-TTTHHHHHH---------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHhhcc-cccHHHHhh---------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            11111100 000000000         00124667899999999999999999999999999764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=352.18  Aligned_cols=266  Identities=14%  Similarity=0.145  Sum_probs=209.8

Q ss_pred             cCCCcCceeccccCceEEEEEeCC---------CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcce----------
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD---------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK----------  352 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------  352 (580)
                      ++|.+.+.||+|+||.||+|....         ++.||+|++...     ..+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578899999999999999998653         789999998643     56889999999999999988          


Q ss_pred             -----EEeeeec-CCceeeEeeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          353 -----IISSCSS-DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       353 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                           +++++.. .+..++||||+ +++|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5666655 67889999999 99999999875 357999999999999999999999   8999999999999999


Q ss_pred             CCCC--cEEEccccCccccCCCCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccc
Q 038098          426 DDNM--VAHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIF  498 (580)
Q Consensus       426 ~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~  498 (580)
                      +.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999866433221     11234479999999999999899999999999999999999999997643


Q ss_pred             cCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      ........+...... ......         ........++.++.+++.+||+.||++||+++++++.|+++.++...
T Consensus       273 ~~~~~~~~~~~~~~~-~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          273 PNTEDIMKQKQKFVD-KPGPFV---------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TCHHHHHHHHHHHHH-SCCCEE---------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCHHHHHHHHHhccC-Chhhhh---------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            222222221111000 000000         00011124567899999999999999999999999999999887653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=355.37  Aligned_cols=276  Identities=19%  Similarity=0.275  Sum_probs=213.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC--ceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD--FKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999876 58999999996543 334567789999999999999999999987655  679999


Q ss_pred             eccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe----CCCCcEEEccccCccc
Q 038098          368 EYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKP  441 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~a~~  441 (580)
                      ||+++|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999987654  23899999999999999999999   8999999999999999    7888899999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccC--------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHH---HHHh
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGRE--------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH---WVND  510 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~---~~~~  510 (580)
                      .....   ......||..|+|||.+.+        ..++.++|||||||++|||+||+.||............   ....
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            63322   2234569999999998764        56788999999999999999999999653322222111   1111


Q ss_pred             hcccchhhhc---chh--ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          511 LLPISVMEIV---DAN--LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       511 ~~~~~~~~~~---d~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ..+..+....   +..  ...............+..+.+++.+||+.||++||+++|+++.++++.++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1111110000   000  00011111223356788899999999999999999999999999887653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-42  Score=351.45  Aligned_cols=247  Identities=27%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      +.|...+.||+|+||.||+|+. .+|+.||||++.....   .....+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4488889999999999999986 5789999999965422   23457889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+. |+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 5888888766677999999999999999999999   899999999999999999999999999999865322  


Q ss_pred             cccccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          448 SLTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                          ....||+.|+|||.+.   .+.++.++|||||||++|||++|+.||.....    ... ..        .+.....
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~-~~--------~~~~~~~  270 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSA-LY--------HIAQNES  270 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHH-HH--------HHHHSCC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHH-HH--------HHHhcCC
Confidence                2346899999999874   56789999999999999999999999865211    110 00        0110000


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                            .......++..+.+++.+||+.||++|||+++++++-
T Consensus       271 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          271 ------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                  0011234567789999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.6e-42  Score=351.78  Aligned_cols=274  Identities=24%  Similarity=0.269  Sum_probs=208.3

Q ss_pred             ccCHHHHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-----CCCcceEE
Q 038098          281 RFTYLEIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-----HRNIIKII  354 (580)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~  354 (580)
                      .+++.+.....++|.+.+.||+|+||.||+|+.. +++.||||++... ......+..|+++++.+.     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3444444455688999999999999999999864 6899999998632 233456778999999996     99999999


Q ss_pred             eeeecCCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC------
Q 038098          355 SSCSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD------  427 (580)
Q Consensus       355 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~------  427 (580)
                      +++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 889999988665 45899999999999999999999   999999999999999975      


Q ss_pred             -------------------CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHH
Q 038098          428 -------------------NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF  488 (580)
Q Consensus       428 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ell  488 (580)
                                         ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||+||++|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                               789999999999864322     23456899999999999999999999999999999999


Q ss_pred             hCCCCCCccccCCchHHHHHHhhccc---c-h--------hhhcchhcc-CCccccc--------------chhhhhHHH
Q 038098          489 TRKKPTDEIFFGDMTLKHWVNDLLPI---S-V--------MEIVDANLL-SQKDEHF--------------TTKGQCVSF  541 (580)
Q Consensus       489 tg~~p~~~~~~~~~~~~~~~~~~~~~---~-~--------~~~~d~~~~-~~~~~~~--------------~~~~~~~~~  541 (580)
                      ||+.||......  ............   . .        ...++.... .......              .........
T Consensus       254 ~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          254 TGSLLFRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HSSCSCCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HCCCCCCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            999999753211  111111111100   0 0        000000000 0000000              001112367


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          542 IFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       542 l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      +.+|+.+||+.||++|||++|+++|
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhcC
Confidence            8899999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-42  Score=348.89  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=208.1

Q ss_pred             hcCCCcCceeccccCceEEEEEe------CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            36799999999999999999984      257789999986432 23456788999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLS  434 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~  434 (580)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      45899999999999999999999   899999999999999984   4469999


Q ss_pred             cccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcc
Q 038098          435 DFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       435 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      |||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....  .....++.    
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~----  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVT----  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHH----
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHh----
Confidence            9999986543333333344568899999999988899999999999999999998 9999865211  11111111    


Q ss_pred             cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       514 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                              ...      ....+..++..+.+++.+||+.||++||++.|++++|+.+...-.
T Consensus       260 --------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          260 --------SGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             --------TTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             --------cCC------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence                    000      111234566789999999999999999999999999998876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-42  Score=360.28  Aligned_cols=271  Identities=20%  Similarity=0.268  Sum_probs=187.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec-----CCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS-----DDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  362 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999865 78999999986432  2345678899999999999999999999843     357


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||+ +|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 46999988654 46999999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCc-------------------------ccccccccCCCcCCcccc-cCCCCCCchhhHhHHHHHHHHHh-------
Q 038098          443 LKEDQS-------------------------LTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFT-------  489 (580)
Q Consensus       443 ~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~ellt-------  489 (580)
                      ......                         ......+||+.|+|||++ ....++.++||||+||++|||+|       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            422111                         123455789999999976 55679999999999999999999       


Q ss_pred             ----CCCCCCccccCC------------------chHHHHHHhhccc---c-h--------hhhcchhccCCcccccchh
Q 038098          490 ----RKKPTDEIFFGD------------------MTLKHWVNDLLPI---S-V--------MEIVDANLLSQKDEHFTTK  535 (580)
Q Consensus       490 ----g~~p~~~~~~~~------------------~~~~~~~~~~~~~---~-~--------~~~~d~~~~~~~~~~~~~~  535 (580)
                          |+++|.+.....                  ......+......   . +        ...+...............
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                555554321000                  0000000000000   0 0        0000000000000111122


Q ss_pred             hhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       536 ~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...+.++.+|+.+||..||++|||++|+++|
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            3457889999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.1e-42  Score=364.62  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=208.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+..|++++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999875 79999999996542   23446678899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          367 LEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |||++||+|.+++...+ ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987654 35999999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......         .+..   
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~---------~i~~---  403 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER---------LVKE---  403 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHH---------HHHH---
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHH---------Hhhc---
Confidence            2   2234579999999999999899999999999999999999999997632211 1111111         0000   


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                      .    ....+..++.++.+|+.+||+.||++||     +++|+++|
T Consensus       404 ~----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 V----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             c----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0    0111234567899999999999999999     78999876

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-42  Score=341.05  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457889999999999999999865 7899999999765444456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      +++++|.+++...+ .+++..+..++.|++.||.|||   +.+++||||||+||++   +.++.+||+|||++...... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999886544 5899999999999999999999   8999999999999999   78899999999999754221 


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                         ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     .....        .+... .. 
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~--------~i~~~-~~-  224 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFE--------KIKEG-YY-  224 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHH--------HHHHC-CC-
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH--------HHHcC-CC-
Confidence               22334689999999999999999999999999999999999999865211     11111        00000 00 


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .........++.++.+++.+||+.||++||+++|+++|
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 --EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              00111223466789999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.9e-42  Score=356.59  Aligned_cols=272  Identities=22%  Similarity=0.263  Sum_probs=199.6

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----C
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----D  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  361 (580)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3568999999999999999999865 68899999996432  23456788999999999999999999998765     5


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||++ |+|.+++... ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            6899999996 5999988754 45999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCc--------------------ccccccccCCCcCCcccc-cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC
Q 038098          442 LLKEDQS--------------------LTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG  500 (580)
Q Consensus       442 ~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~  500 (580)
                      .......                    .......||+.|+|||.+ ....++.++||||+||++|||++|..||.....+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            6433211                    123566799999999985 5567999999999999999999976665432111


Q ss_pred             C-------c--------------------hHHHHHHhh--cc---------cchhhhcchhccCCcccccchhhhhHHHH
Q 038098          501 D-------M--------------------TLKHWVNDL--LP---------ISVMEIVDANLLSQKDEHFTTKGQCVSFI  542 (580)
Q Consensus       501 ~-------~--------------------~~~~~~~~~--~~---------~~~~~~~d~~~~~~~~~~~~~~~~~~~~l  542 (580)
                      +       .                    .+.....-.  .+         ......+.................+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence            0       0                    000000000  00         00000000000000000011123467889


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHH
Q 038098          543 FNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       543 ~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .+|+.+||+.||++|||++|+++|
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcC
Confidence            999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=349.16  Aligned_cols=254  Identities=16%  Similarity=0.155  Sum_probs=207.8

Q ss_pred             hcCCCcCceeccccCceEEEEE------eCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC---CCCcceEEeeeecCC
Q 038098          291 TNGFSENNLIGRGGFGSVYKAR------IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR---HRNIIKIISSCSSDD  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  361 (580)
                      .++|.+.+.||+|+||.||+|.      ..+++.||||++...   ....+..|++++.+++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4678889999999999999993      446889999998643   3456777888888886   999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC----------
Q 038098          362 FKALVLEYMPHGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD----------  427 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~----------  427 (580)
                      ..++||||+++|+|.+++..    ....+++..++.++.||++||+|||   +.+|+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999875    3456999999999999999999999   999999999999999998          


Q ss_pred             -CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHH
Q 038098          428 -NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH  506 (580)
Q Consensus       428 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~  506 (580)
                       ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.....+...   
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---  294 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---  294 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence             8999999999998654333344455667999999999999999999999999999999999999998542211100   


Q ss_pred             HHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHHHHHHH
Q 038098          507 WVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR-INAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       507 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-ps~~ev~~~L~~~~~~~~  575 (580)
                                   .+.     ...+.    ...+.+.+++.+|++.+|.+| |+++++.+.|+++..+..
T Consensus       295 -------------~~~-----~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          295 -------------PEG-----LFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             -------------ECS-----CCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             -------------ech-----hcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence                         000     00011    124567789999999999998 588888888888877643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.9e-42  Score=356.08  Aligned_cols=254  Identities=24%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCCcceEEeeeec
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--------GRAFKSFDIECDMIKRIRHRNIIKIISSCSS  359 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  359 (580)
                      ...++|...+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999865 68999999996542        1223468899999999999999999999864


Q ss_pred             CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEEEccc
Q 038098          360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDF  436 (580)
Q Consensus       360 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Df  436 (580)
                       +..++||||+++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++   .+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             4578999999999999988654 45999999999999999999999   89999999999999997544   5999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      |+++.....   .......||+.|+|||++..   ..++.++||||+||++|||+||+.||....... .+......   
T Consensus       287 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~---  359 (419)
T 3i6u_A          287 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITS---  359 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHT---
T ss_pred             ccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhc---
Confidence            999865322   22334579999999999853   567889999999999999999999997532211 11111111   


Q ss_pred             cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                               ..   ..........++.++.+++.+||+.||++||+++|+++|
T Consensus       360 ---------~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          360 ---------GK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ---------TC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---------CC---CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                     00   000111224467789999999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.7e-42  Score=361.28  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=205.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|.+.+.||+|+||+||+|... +|+.||||++....  ......+.+|++++++++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            456999999999999999999865 78999999996432  334577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+||+++   .++.+||+|||+++....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999886544 5899999999999999999999   89999999999999995   556799999999986533


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..   ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||.....     ...            +....
T Consensus       177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~------------~~~i~  235 (486)
T 3mwu_A          177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDI------------LKRVE  235 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH------------HHHHH
T ss_pred             CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH------------HHHHH
Confidence            22   2344579999999999865 689999999999999999999999865211     011            11101


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ........+.+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             hCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111111223345667889999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-42  Score=344.25  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=202.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .+.|++.+.||+|+||.||+|... +|+.||+|++..........+..|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467889999999999999999976 5899999999766556678889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++++|.+++......+++..++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            9999999998876677999999999999999999999   899999999999999999999999999987633111  11


Q ss_pred             cccccccCCCcCCcccc-----cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          450 TQTQTLATIGYMAPEYG-----REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ......||..|+|||.+     ....++.++||||||+++|||++|+.||....... .......               
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---------------  236 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK---------------  236 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH---------------
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhc---------------
Confidence            12334689999999987     46678999999999999999999999987531100 0000000               


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ........+..++.++.+++.+||+.||++|||++|+++|
T Consensus       237 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          237 --SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             --SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             --cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0001112234567789999999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.3e-42  Score=341.25  Aligned_cols=252  Identities=26%  Similarity=0.369  Sum_probs=204.2

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ..+.|...+.||+|+||.||+|... +|+.||+|++...  .....+..|++++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467999999999999999999875 5899999999754  345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++++|.+++......+++..++.++.||+.||.|||   +.+++|+||+|+||+++.++.+||+|||++.......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999999866667999999999999999999999   8999999999999999999999999999998653322  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....    .....         . +.    ...
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~---------~-~~----~~~  241 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAIF---------M-IP----TNP  241 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHH---------H-HH----HSC
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHH---------H-Hh----cCC
Confidence            123345689999999999998999999999999999999999999865211    00000         0 00    001


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ......+..++..+.+++.+||+.||++||++.++++|
T Consensus       242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11122334567789999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-42  Score=342.15  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=210.6

Q ss_pred             hcCCCcCc-eeccccCceEEEEEeC---CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          291 TNGFSENN-LIGRGGFGSVYKARIQ---DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       291 ~~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      .++|.+.+ .||+|+||.||+|.+.   +++.||||++....  ....+.+.+|++++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999642   46889999996542  22356788999999999999999999999 566789


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++++|.+++...+ .+++..++.++.||+.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999997654 5899999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          445 EDQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       445 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....  ......            +..
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~------------~~~  235 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAM------------LEK  235 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH------------HHT
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH------------HHc
Confidence            33221 1223346788999999988889999999999999999999 9999865311  111111            111


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNV  578 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~~  578 (580)
                      .      .....+..++.++.+++.+||+.||++||++.|+++.|+++..+..+..
T Consensus       236 ~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  285 (291)
T 1xbb_A          236 G------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  285 (291)
T ss_dssp             T------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             C------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence            0      0112234567889999999999999999999999999999988876554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-42  Score=353.46  Aligned_cols=271  Identities=24%  Similarity=0.342  Sum_probs=194.3

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCC--c
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDD--F  362 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~  362 (580)
                      ...++|++.+.||+|+||.||+|... +|+.||||++...  .......+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999864 7899999998543  2234566788999999997 999999999987544  6


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||++ |+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 5999988763  5899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCC-------------------CcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc
Q 038098          443 LKED-------------------QSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM  502 (580)
Q Consensus       443 ~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~  502 (580)
                      ....                   .........||+.|+|||.+.+ ..++.++||||+||++|||++|++||.+.... .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            3211                   1112344579999999998876 67899999999999999999999999753211 1


Q ss_pred             hHHHHHHhhcccc---h--------hhhcch---hc---cCCccccc----------chhhhhHHHHHHHHhhccCCCCC
Q 038098          503 TLKHWVNDLLPIS---V--------MEIVDA---NL---LSQKDEHF----------TTKGQCVSFIFNLAMKCTVESPE  555 (580)
Q Consensus       503 ~~~~~~~~~~~~~---~--------~~~~d~---~~---~~~~~~~~----------~~~~~~~~~l~~l~~~cl~~dP~  555 (580)
                      .+.......-...   +        ...++.   ..   .......+          .....++.++.+|+.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            1111111000000   0        000000   00   00000000          01124567899999999999999


Q ss_pred             CCCCHHHHHHH
Q 038098          556 QRINAKEIVTR  566 (580)
Q Consensus       556 ~Rps~~ev~~~  566 (580)
                      +|||++|+++|
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-42  Score=338.83  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=201.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec-CCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  369 (580)
                      .++|...+.||+|+||.||+|... |+.||||++...  ...+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            367888999999999999999886 889999998643  345778899999999999999999998754 4578999999


Q ss_pred             cCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++...+. .+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999876542 4799999999999999999999   899999999999999999999999999999754322   


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......     ....         .+...    
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~---------~~~~~----  230 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP---------RVEKG----  230 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHH---------HHTTT----
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---------HHhcC----
Confidence              123357889999999988899999999999999999998 99998653111     1110         01100    


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                        .....+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence              01122345678899999999999999999999999999998765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.4e-42  Score=358.61  Aligned_cols=265  Identities=23%  Similarity=0.227  Sum_probs=196.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecC------C
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD------D  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  361 (580)
                      .++|+..+.||+|+||.||+|... +|+.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999855 6899999999654  233456788999999999999999999998654      3


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+++ +|.+.+..   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999976 56665543   4899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--------
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--------  513 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  513 (580)
                      ....   .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ..+.......-.        
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ---C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred             cCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence            5322   2334567999999999999999999999999999999999999999753211 011111110000        


Q ss_pred             --cchhhhcchhccCC------------cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 --ISVMEIVDANLLSQ------------KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 --~~~~~~~d~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ......++......            ...........+.++.+|+.+||..||++|||++|+++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00000000000000            000001112236789999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.2e-42  Score=348.80  Aligned_cols=276  Identities=21%  Similarity=0.259  Sum_probs=205.4

Q ss_pred             CHHHHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccc-----------hhhhHHHHHHHHhhcCCCCcc
Q 038098          283 TYLEIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGR-----------AFKSFDIECDMIKRIRHRNII  351 (580)
Q Consensus       283 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv  351 (580)
                      ...++....++|.+.+.||+|+||.||+|...+|+.||||++......           ..+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            345777888999999999999999999999888999999998543221           126788999999999999999


Q ss_pred             eEEeeeec-----CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          352 KIISSCSS-----DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       352 ~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ++++++..     ....++||||++ |+|.+++...+..+++..+..++.||+.||.|||   +.+|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence            99999843     346799999997 5899988877778999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~  505 (580)
                      .++.+||+|||+++.....   .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~  244 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLN  244 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred             CCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence            9999999999999754222   22344568999999998876 678999999999999999999999997632111 111


Q ss_pred             HHHHhhccc-----------chhhhcchhccCCc-ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          506 HWVNDLLPI-----------SVMEIVDANLLSQK-DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       506 ~~~~~~~~~-----------~~~~~~d~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .........           ...+.+........ ..........+..+.+|+.+||+.||++|||++|+++|
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            111100000           01111111111111 11112234456789999999999999999999999976

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.7e-42  Score=361.02  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=207.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|...+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|++++++++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999975 69999999996542   234467888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||++||+|.+++....   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.+|.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999987643   46999999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+...        +...  
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~--------i~~~--  408 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQR--------VLEQ--  408 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHH--------HHHC--
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHH--------Hhhc--
Confidence            322  223457999999999999999999999999999999999999999763211 111111111        1110  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                            ....+..++.++.+++.+||+.||++||++     +++++|
T Consensus       409 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          409 ------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                  111224567789999999999999999965     667654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3e-42  Score=350.96  Aligned_cols=245  Identities=26%  Similarity=0.318  Sum_probs=193.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHH-HhhcCCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDM-IKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|...+.||+|+||.||+|+.+ +++.||+|++.....   .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999876 588999999975432   233455666666 567899999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987644 5889999999999999999999   999999999999999999999999999999854222


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .....        .+....  
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~--------~i~~~~--  255 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYD--------NILNKP--  255 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHH--------HHHHSC--
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHH--------HHHhcc--
Confidence            2  233456799999999999999999999999999999999999999865211     11111        111110  


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE  562 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  562 (580)
                            ...+..++.++.+|+.+||+.||++||++.+
T Consensus       256 ------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                  1112345677899999999999999999853

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-41  Score=346.38  Aligned_cols=256  Identities=26%  Similarity=0.368  Sum_probs=206.5

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--------chhhhHHHHHHHHhhc-CCCCcceEEee
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--------RAFKSFDIECDMIKRI-RHRNIIKIISS  356 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~  356 (580)
                      .....++|.+.+.||+|+||.||+|... +|+.||||++.....        .....+..|+++++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3444567999999999999999999975 799999999865432        1245678899999999 79999999999


Q ss_pred             eecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       357 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      +...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.+||+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence            99999999999999999999998754 35899999999999999999999   899999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccC------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHh
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  510 (580)
                      |++..+....   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....  .......  
T Consensus       245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i--  317 (365)
T 2y7j_A          245 GFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMI--  317 (365)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH--
T ss_pred             CcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHH--
Confidence            9998664322   2334579999999998753      3588999999999999999999999865211  0010000  


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                               ..    .........+..++.++.+++.+||+.||++||+++|+++|
T Consensus       318 ---------~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          318 ---------ME----GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             ---------HH----TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---------Hh----CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                     00    00101111223456779999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-42  Score=346.49  Aligned_cols=272  Identities=24%  Similarity=0.278  Sum_probs=201.9

Q ss_pred             HHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-----chhhhHHHHHHHHhhcCCCCcceEEeeeecCC
Q 038098          288 FQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-----RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD  361 (580)
Q Consensus       288 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  361 (580)
                      ....++|...+.||+|+||.||+|... +|+.||||++.....     .....+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999865 689999999864321     12356788999999999999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999986 899988877777999999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc---hh
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS---VM  517 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  517 (580)
                      +....  .......+|+.|+|||.+.+. .++.++||||+||++|||++|.+||...... ..+...........   ..
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhh
Confidence            64322  223445789999999998654 5789999999999999999999998653211 11111111110000   00


Q ss_pred             h---hcchhccCCc--ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 E---IVDANLLSQK--DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~---~~d~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   ..+.......  .........++.++.+|+.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0   0000000000  00001123456889999999999999999999999876

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-41  Score=361.34  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=200.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.+++.++||||+++++++......++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            346889999999999999999875 68999999996542  334577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC---CcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++..   +.+||+|||+++....
T Consensus       116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            999999999988654 35899999999999999999999   8999999999999999764   4599999999986643


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..   ......||+.|+|||.+. +.++.++||||+||++|||++|+.||.....     .....        .+ .   
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~--------~i-~---  250 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILR--------KV-E---  250 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HH-H---
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH--------HH-H---
Confidence            22   234457999999999876 5799999999999999999999999875311     11111        00 0   


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       251 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             hCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            011111112234567789999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=371.82  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=210.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45688889999999999999999888889999997543 234678999999999999999999999876 6789999999


Q ss_pred             CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++... +..+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  419 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence            999999999753 245899999999999999999999   8999999999999999999999999999998653221 11


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      ......++..|+|||.+..+.++.++|||||||++|||+| |+.||.....     .+..         +.+...     
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~---------~~i~~~-----  480 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVL---------DQVERG-----  480 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHH---------HHHHTT-----
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH---------HHHHcC-----
Confidence            2233456788999999998999999999999999999999 9999865311     1111         111110     


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                       .+...+..++.++.+||.+||+.||++||++++|++.|+++..
T Consensus       481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence             1122334677889999999999999999999999999987643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.1e-42  Score=338.28  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec---------
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS---------  359 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  359 (580)
                      ...+|+..+.||+|+||.||+|... +|+.||+|++....    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3456889999999999999999976 79999999986442    456789999999999999999998854         


Q ss_pred             -------CCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          360 -------DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       360 -------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                             ....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   445799999999999999997543 56999999999999999999999   8999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      ||+|||++.......   ......+|+.|+|||.+.+..++.++||||||+++|||++|..|+...       ..+..  
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~--  229 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT--  229 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH--
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH--
Confidence            999999998664332   223456899999999999889999999999999999999999885321       01111  


Q ss_pred             cccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhhhc
Q 038098          512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVK  579 (580)
Q Consensus       512 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~~~  579 (580)
                            ...+..          .+..++.++.+++.+||+.||++||++.|++++|+.+.+...++.+
T Consensus       230 ------~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~  281 (284)
T 2a19_B          230 ------DLRDGI----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER  281 (284)
T ss_dssp             ------HHHTTC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred             ------Hhhccc----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence                  000000          1123456788999999999999999999999999999877665543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=345.36  Aligned_cols=258  Identities=24%  Similarity=0.283  Sum_probs=191.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeee--------cC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCS--------SD  360 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~  360 (580)
                      ..+|++.+.||+|+||.||+|++. +|+.||||++..........+..|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            356888999999999999999865 78999999986665555677889999999996 999999999983        34


Q ss_pred             CceeeEeeccCCCChHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeCCCCcEEEccc
Q 038098          361 DFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      ...++||||++ |+|.+++..  ....+++..++.++.||+.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45789999996 699998865  3456999999999999999999999   888  999999999999999999999999


Q ss_pred             cCccccCCCCCcc----------cccccccCCCcCCcccc---cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch
Q 038098          437 GMAKPLLKEDQSL----------TQTQTLATIGYMAPEYG---REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT  503 (580)
Q Consensus       437 g~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~  503 (580)
                      |+++.........          ......||+.|+|||.+   .+..++.++|||||||++|||+||+.||......   
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---  259 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---  259 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence            9998664322211          11244589999999988   5667899999999999999999999998642110   


Q ss_pred             HHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 038098          504 LKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLL  575 (580)
Q Consensus       504 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~  575 (580)
                                    .+......      .......+..+.+++.+||+.||++||+++|++++|+++.....
T Consensus       260 --------------~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          260 --------------RIVNGKYS------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------------CC------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             --------------HhhcCccc------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                          01111100      01112233457899999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.4e-42  Score=338.71  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=206.6

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|...+.||+|+||.||+|... +++.||+|++....   ....+.+..|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888999999999999999876 58899999986542   23456788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++... ..+++..++.++.|+++|++|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            9999999999987654 35899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      .  ......||..|+|||.+.+..++.++||||+|+++|||++|+.||.....     .....        .+...    
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~--------~~~~~----  230 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYL--------RIKKN----  230 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHTT----
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH--------HHhhc----
Confidence            2  23345689999999999988899999999999999999999999865311     11100        00000    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+..++..+.+++.+||+.||++||+++|++++
T Consensus       231 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          231 ----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                111223456778999999999999999999999886

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.9e-42  Score=363.04  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=207.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|...+.||+|+||.||+|... +|+.||||++....   ......+.+|++++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356889999999999999999875 79999999996542   33457788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~  443 (580)
                      |||+.+|+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+||++   +.++.+||+|||+++.+.
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999887654 5899999999999999999999   8999999999999999   567899999999998663


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ...   ......||+.|+|||.+.+ .++.++||||+||++|||++|++||.....  ......           +    
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~-----------i----  239 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKK-----------V----  239 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-----------H----
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-----------H----
Confidence            322   2344569999999998865 789999999999999999999999975311  011110           1    


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .........+.+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            0111111223345677889999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.3e-42  Score=335.80  Aligned_cols=246  Identities=24%  Similarity=0.328  Sum_probs=205.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999865 67889999986432   233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..++.++.||++|+.|||   +.+++||||||+||+++.++.+||+|||++......  
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            9999999999987654 5899999999999999999999   999999999999999999999999999999755322  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.....     .....        .+...     
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~--------~~~~~-----  227 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHR--------RIVNV-----  227 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHTT-----
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHH--------HHhcc-----
Confidence              22345689999999999998999999999999999999999999865211     11111        11110     


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....+...+.++.+++.+||+.||++||+++|+++|
T Consensus       228 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 ---DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence               011223456778999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=347.39  Aligned_cols=263  Identities=25%  Similarity=0.302  Sum_probs=197.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999864 79999999985432  223467889999999999999999999987653      


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+ +++|.+++..  ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 7899999876  35899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh--cccch--
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL--LPISV--  516 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~--  516 (580)
                      ....     .....+|..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ..+.......  .+...  
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            5322     234578999999998877 67999999999999999999999999753211 0111111100  00000  


Q ss_pred             -------hhhcchhccCC-cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 -------MEIVDANLLSQ-KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 -------~~~~d~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                             ...+.. +... ..........++.++.+|+.+||..||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          252 RLQSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             TCSCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhHHHHHHHHh-CCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                   000000 0000 111111224567889999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2e-41  Score=360.40  Aligned_cols=252  Identities=22%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-------------chhhhHHHHHHHHhhcCCCCcceEEe
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-------------RAFKSFDIECDMIKRIRHRNIIKIIS  355 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~  355 (580)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3577999999999999999999865 688999999864321             23467889999999999999999999


Q ss_pred             eeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC---cEE
Q 038098          356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAH  432 (580)
Q Consensus       356 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~k  432 (580)
                      ++.+....++||||+++|+|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999887643 5999999999999999999999   89999999999999998776   699


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      |+|||+++......   ......||+.|+|||.+. +.++.++||||+||++|+|++|+.||.....     .....   
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~---  257 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDIIK---  257 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH---
Confidence            99999998664322   234456999999999886 5689999999999999999999999875311     11111   


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                               .............+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       258 ---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          258 ---------KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ---------HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     101111111122334567889999999999999999999999876

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3e-41  Score=339.70  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=202.8

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeec--CCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSS--DDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  366 (580)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...   ..+.+.+|++++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36688999999999999999985 47899999998633   3467889999999997 9999999999987  6678999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLKE  445 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  445 (580)
                      |||+++++|.+++..    +++..+..++.||+.||+|||   +.+|+||||||+||+++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998753    889999999999999999999   99999999999999999776 8999999999865432


Q ss_pred             CCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh-
Q 038098          446 DQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN-  523 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-  523 (580)
                      .   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.........+.............+.++.. 
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            2   2234568999999999877 6789999999999999999999999854222111121111111111111111110 


Q ss_pred             --------------ccCCcc--cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 --------------LLSQKD--EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 --------------~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                                    ......  ........++.++.+|+.+||+.||++|||++|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                          000000  0011123367889999999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-42  Score=354.74  Aligned_cols=252  Identities=15%  Similarity=0.159  Sum_probs=196.3

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecc---ccchhhhHHHHH---HHHhhcCCCCcceEE-------ee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQ---YGRAFKSFDIEC---DMIKRIRHRNIIKII-------SS  356 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  356 (580)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999995 46999999999743   234557788999   555566899999998       55


Q ss_pred             eecCC-----------------ceeeEeeccCCCChHHHhhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 038098          357 CSSDD-----------------FKALVLEYMPHGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYLHFGYSVPI  413 (580)
Q Consensus       357 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i  413 (580)
                      +..++                 ..++||||+ +|+|.+++...+.      .+++..++.++.||+.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 6799999876432      2346888999999999999999   8999


Q ss_pred             EEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC-----------CCCCchhhHhHHH
Q 038098          414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-----------QVSTNGDVYSFGI  482 (580)
Q Consensus       414 ~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dvws~Gv  482 (580)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2334457 999999999877           8999999999999


Q ss_pred             HHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHH
Q 038098          483 MLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE  562 (580)
Q Consensus       483 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  562 (580)
                      ++|||+||+.||.......             ....+.            .....++.++.+++.+||+.||++||++.|
T Consensus       302 il~elltg~~Pf~~~~~~~-------------~~~~~~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG-------------GSEWIF------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------C-------------CSGGGG------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCccccccc-------------chhhhh------------hhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            9999999999986521110             000000            011345677899999999999999999999


Q ss_pred             HHH--HHHHHHHHHHhh
Q 038098          563 IVT--RLLKIRDSLLKN  577 (580)
Q Consensus       563 v~~--~L~~~~~~~~~~  577 (580)
                      +++  .++++.+.....
T Consensus       357 ~l~hp~f~~~~~~~~~~  373 (377)
T 3byv_A          357 AMETPEYEQLRTELSAA  373 (377)
T ss_dssp             HHTSHHHHHHHHHHHHH
T ss_pred             HhhChHHHHHHHHHHHh
Confidence            997  456666555443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-41  Score=343.31  Aligned_cols=270  Identities=23%  Similarity=0.322  Sum_probs=203.5

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec--------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS--------  359 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  359 (580)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....  ......+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36789999999999999999987 478999999985443  2234577889999999999999999999876        


Q ss_pred             CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       360 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      .+..++||||+++ +|.+.+......+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 888888777677999999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCC--CcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc---c
Q 038098          440 KPLLKED--QSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL---P  513 (580)
Q Consensus       440 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~  513 (580)
                      +.+....  .........||+.|+|||.+.+ ..++.++||||+||++|||+||+.||......  ..........   +
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSIT  249 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence            8664322  1222345578999999998876 45799999999999999999999999763211  1111111110   0


Q ss_pred             cc-hhhhcchhccCC----cccccchh-----hhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 IS-VMEIVDANLLSQ----KDEHFTTK-----GQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~-~~~~~d~~~~~~----~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .. .....+......    ........     ...++++.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00 111100000000    00000000     1124668899999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.4e-41  Score=351.54  Aligned_cols=265  Identities=19%  Similarity=0.217  Sum_probs=212.0

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC-CCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH-RNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++....  ....+..|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999986 478999999986543  23568899999999987 556666666777888899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe---CCCCcEEEccccCccccCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |+ +++|.+++......+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 89999999877778999999999999999999999   8999999999999999   68899999999999876443


Q ss_pred             CCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          446 DQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       446 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ...     .......||..|+|||.+.+..++.++|||||||++|||++|+.||........  ...+..        +.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~--------i~  229 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEK--------IS  229 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHH--------HH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHH--------Hh
Confidence            321     112356799999999999999999999999999999999999999976432211  111110        00


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      .......   .......++.++.+++.+||+.||++||++++|++.|+++....
T Consensus       230 ~~~~~~~---~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          230 EKKVATS---IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHSC---HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcccccc---HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            1000000   00112345678999999999999999999999999999987653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.6e-42  Score=338.57  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC--CCC--EEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--DGM--EVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|++.+.||+|+||.||+|.+.  +++  .||+|++...   .....+.+.+|++++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56888999999999999999853  333  6899998644   2344577889999999999999999999998765 78


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +|+||+++|+|.+++......+++..++.++.||++||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999877667999999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          445 EDQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       445 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ......        +...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~--------~~~~  240 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHK--------IDKE  240 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH--------HHTS
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHH--------HHcc
Confidence            33221 2234457788999999988889999999999999999999 9999865311     111110        0000


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                            ......+..++.++.+++.+||+.||++||++.+++++|+++...-
T Consensus       241 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          241 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                  0111223456788999999999999999999999999999886543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=335.90  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      +|.....||+|+||.||+|... +++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3555569999999999999864 688999999976655566788999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEccccCccccCCCCCc
Q 038098          372 HGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       372 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|.+++....  ..+++..+..++.||+.||+|||   +.+++||||||+||+++. ++.+||+|||++.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999988654  35678999999999999999999   899999999999999987 8999999999998653322  


Q ss_pred             ccccccccCCCcCCcccccCCC--CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          449 LTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      .......|+..|+|||.+.+..  ++.++||||||+++|||++|+.||......  ....+..             ....
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~-------------~~~~  242 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKV-------------GMFK  242 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHH-------------HHHC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhh-------------cccc
Confidence            1223456899999999987643  789999999999999999999998642111  1100000             0000


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .   ....+..++.++.+++.+||+.||++||+++|++++
T Consensus       243 ~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 V---HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             C---CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             c---cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0   111234567789999999999999999999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-41  Score=340.54  Aligned_cols=255  Identities=20%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             HHhcCCCcC-ceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCce
Q 038098          289 QATNGFSEN-NLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFK  363 (580)
Q Consensus       289 ~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  363 (580)
                      ...+.|.+. +.||+|+||.||+|... +|+.||+|++....  ......+..|+.++.++. ||||+++++++...+..
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            344567776 88999999999999865 68999999996543  233567889999999995 69999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a  439 (580)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999999999988654 356999999999999999999999   899999999999999987   789999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +......   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......    ..+.         .+
T Consensus       182 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~---------~i  245 (327)
T 3lm5_A          182 RKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETYL---------NI  245 (327)
T ss_dssp             EEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH---------HH
T ss_pred             cccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHH---------HH
Confidence            8663322   223456999999999999999999999999999999999999998653111    0000         00


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...    ...........++..+.+++.+||+.||++|||++|+++|
T Consensus       246 ~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQV----NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHT----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hhc----ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            000    0111112234567789999999999999999999999876

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-41  Score=337.43  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=207.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      +.|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999864 68999999997553 34457889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++++|.+++..  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......  .
T Consensus       102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  174 (303)
T 3a7i_A          102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I  174 (303)
T ss_dssp             CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence            999999999865  45899999999999999999999   8999999999999999999999999999998664322  1


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD  529 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  529 (580)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....  ........            ...     
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~------------~~~-----  235 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLIP------------KNN-----  235 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHH------------HSC-----
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHhh------------cCC-----
Confidence            23345689999999999999999999999999999999999999865311  00111100            000     


Q ss_pred             cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       530 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       .......++..+.+++.+||+.||++||++.|++++.
T Consensus       236 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence             0011234567799999999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.4e-42  Score=344.63  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=206.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|...+.||+|+||.||+|... +++.||+|++....   ....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357888999999999999999875 58899999986542   23456788899999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999987654 45899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                      .  ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....     .....        .+...    
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~--------~~~~~----  256 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYL--------RIKKN----  256 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHHT----
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHH--------HHhcC----
Confidence            2  23345689999999999988899999999999999999999999865211     11100        00000    


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....+..++.++.+++.+||+.||++||+++|++++
T Consensus       257 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                011223456778999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.5e-42  Score=370.50  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=202.7

Q ss_pred             ceeccccCceEEEEEeC---CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||.||+|.+.   +++.||||+++....  ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   467899999975432  335789999999999999999999999975 457899999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC-cccc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ-SLTQ  451 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~  451 (580)
                      |+|.+++... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus       454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999754 45899999999999999999999   89999999999999999999999999999987644332 1223


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......  ..            ...+...      .
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~------------~~~i~~~------~  589 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV------------TAMLEKG------E  589 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH------------HHHHHTT------C
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH------------HHHHHcC------C
Confidence            34457788999999999999999999999999999999 99998653211  11            1111111      1


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      +...+..++.++.+++.+||+.||++||++++|++.|+++..++
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            12234467788999999999999999999999999999988765

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-41  Score=342.98  Aligned_cols=269  Identities=25%  Similarity=0.333  Sum_probs=201.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467888999999999999999875 589999999865432  23456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++++|.++.... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999999888876543 45999999999999999999999   89999999999999999999999999999986533222


Q ss_pred             cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc--ccchhhhcch--
Q 038098          448 SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL--PISVMEIVDA--  522 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~--  522 (580)
                        ......||..|+|||.+.+. .++.++||||+||++|||++|+.||......+ ..........  ..........  
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhcc
Confidence              23345689999999998765 78999999999999999999999987632111 1111111000  0000000000  


Q ss_pred             ----hccC---CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          523 ----NLLS---QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       523 ----~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ....   ...........++.++.+|+.+||+.||++|||++|+++|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0000   0001111223567889999999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.6e-42  Score=348.77  Aligned_cols=266  Identities=23%  Similarity=0.348  Sum_probs=206.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888999999999999999876 78999999997553 23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++...+ .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||++......   
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            99999999987654 5899999999999999999999   75 8999999999999999999999999999754221   


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHH-----------------------
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLK-----------------------  505 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~-----------------------  505 (580)
                       ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......+....                       
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             22345689999999999999999999999999999999999999975321110000                       


Q ss_pred             -HHH-HhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          506 -HWV-NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       506 -~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       .+. .........+..+........  ......++.++.+|+.+||+.||++|||++|+++|-
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             cccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence             000 000000111122211111110  011233567899999999999999999999999873

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.3e-41  Score=331.46  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             CCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec----CCceeeE
Q 038098          294 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFKALV  366 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  366 (580)
                      |...+.||+|+||.||+|... ++..||+|++....  ......+.+|+.++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            667788999999999999865 68899999986543  2345678899999999999999999998864    3568999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeC-CCCcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~  443 (580)
                      |||+++|+|.+++... ..+++..++.++.||+.||.|||   +.+  |+||||||+||+++ .++.+||+|||++....
T Consensus       108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999998764 35899999999999999999999   887  99999999999998 88999999999997543


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ..    ......||+.|+|||.+. +.++.++||||+||++|||++|+.||.....    .........         . 
T Consensus       184 ~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~---------~-  244 (290)
T 1t4h_A          184 AS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVT---------S-  244 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHT---------T-
T ss_pred             cc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHHh---------c-
Confidence            22    223456899999999876 5689999999999999999999999865321    111111100         0 


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ..  .....+...++++.+++.+||+.||++|||++|+++|
T Consensus       245 --~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          245 --GV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --TC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --cC--CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              00  0111223345678999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-41  Score=343.17  Aligned_cols=266  Identities=20%  Similarity=0.258  Sum_probs=205.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccch-----------------hhhHHHHHHHHhhcCCCCcceE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRA-----------------FKSFDIECDMIKRIRHRNIIKI  353 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~  353 (580)
                      .++|.+.+.||+|+||.||+|.. +|+.||||++.......                 ...+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36799999999999999999998 89999999996542211                 1788999999999999999999


Q ss_pred             EeeeecCCceeeEeeccCCCChHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEe
Q 038098          354 ISSCSSDDFKALVLEYMPHGSLEKC------LYSS-NYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLL  425 (580)
Q Consensus       354 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill  425 (580)
                      ++++...+..++||||+++|+|.++      +... ...+++..++.++.||+.||.|||   + .+++||||+|+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5543 467999999999999999999999   7 999999999999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC-CCCC-chhhHhHHHHHHHHHhCCCCCCccccCCch
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVST-NGDVYSFGIMLMETFTRKKPTDEIFFGDMT  503 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dvws~Gvil~elltg~~p~~~~~~~~~~  503 (580)
                      +.++.+||+|||.+......    ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence            99999999999999865332    33445689999999999877 5666 999999999999999999999753221 11


Q ss_pred             HHHHHHhhcccchhhhcchhccC-CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          504 LKHWVNDLLPISVMEIVDANLLS-QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       504 ~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ........... ........... ...........++.++.+++.+||+.||++||+++|+++|
T Consensus       261 ~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 LFNNIRTKNIE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHTSCCCC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhccCcC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111100000 00000000000 0000001114567789999999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.4e-42  Score=342.96  Aligned_cols=270  Identities=21%  Similarity=0.247  Sum_probs=195.8

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ...++|.+.+.||+|+||.||+|... +|+.||||++.....  .....+.+|++++++++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44578999999999999999999854 789999999864422  234567789999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe-----CCCCcEEEccccCcc
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL-----DDNMVAHLSDFGMAK  440 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill-----~~~~~~kl~Dfg~a~  440 (580)
                      ||||+++ +|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+||++     +.++.+||+|||+++
T Consensus       111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9999975 9999987654 4899999999999999999999   8999999999999999     455569999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-cc-c-h
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-PI-S-V  516 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~-~  516 (580)
                      ......  .......+|..|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+........ +. . .
T Consensus       186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred             ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhh
Confidence            653222  123345689999999998774 4899999999999999999999998653211 11111111110 00 0 0


Q ss_pred             hhhc-----chhccCCcc--cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIV-----DANLLSQKD--EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~-----d~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....     .........  ........++.++.+|+.+||+.||++|||++|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000     000000000  0001122356788999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-42  Score=346.37  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=204.2

Q ss_pred             cCCCcCceeccccCceEEEEEe----CCCCEEEEEEEeccc----cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY----GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  362 (580)
                      ++|.+.+.||+|+||.||+|+.    .+|+.||||++....    ......+..|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999986    368999999985432    23345677899999999 69999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999987654 5899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCcccccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .... ........||+.|+|||.+.+  ..++.++|||||||++|||+||+.||....... ....+....         
T Consensus       210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~---------  278 (355)
T 1vzo_A          210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRI---------  278 (355)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHH---------
T ss_pred             ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHH---------
Confidence            3322 222344579999999999875  347899999999999999999999997532211 111111110         


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTRL  567 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~L  567 (580)
                         ...    ....+..++..+.+|+.+||..||++||     +++|+++|.
T Consensus       279 ---~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 ---LKS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---HHC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---hcc----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence               000    0112344567789999999999999999     999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=335.31  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=201.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc----cchhhhHHHHHHHHhhcCCCCcceEEeee--ecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY----GRAFKSFDIECDMIKRIRHRNIIKIISSC--SSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~  363 (580)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....    ......+.+|++++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999864 68999999996542    23457788999999999999999999998  445678


Q ss_pred             eeEeeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          364 ALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      ++||||++++ |.+++... ...+++..++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 76766543 456999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCcccccccccCCCcCCcccccCCC--CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .............||..|+|||.+.+..  .+.++||||+|+++|||++|+.||....     .......         +
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~---------i  225 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFEN---------I  225 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHH---------H
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHH---------H
Confidence            4433333344566999999999987644  3789999999999999999999987521     1111110         0


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...       ....+..++..+.+++.+||+.||++||+++|+++|
T Consensus       226 ~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 GKG-------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHC-------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hcC-------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000       111223466788999999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-41  Score=333.18  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=205.0

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---------chhhhHHHHHHHHhhcC-CCCcceEEeeee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---------RAFKSFDIECDMIKRIR-HRNIIKIISSCS  358 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  358 (580)
                      ..++|...+.||+|+||.||+|... +|+.||||++.....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3477999999999999999999875 689999999965421         22456778999999996 999999999999


Q ss_pred             cCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccC
Q 038098          359 SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  438 (580)
Q Consensus       359 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  438 (580)
                      ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||   +.+++||||+|+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999998764 45899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCCCcCCccccc------CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc
Q 038098          439 AKPLLKEDQSLTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       439 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      +.......   ......++..|+|||.+.      ...++.++||||||+++|||++|+.||.....     .....   
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~---  239 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLR---  239 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHH---
Confidence            98664322   223456899999999874      45688999999999999999999999865211     01100   


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           .+...    ...........++.++.+++.+||+.||++||+++|+++|
T Consensus       240 -----~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          240 -----MIMSG----NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             -----HHHHT----CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -----HHhcC----CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence                 00000    0000111224567789999999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-41  Score=334.35  Aligned_cols=244  Identities=20%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|...+.||+|+||.||+|... +++.||+|++....  ......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999876 79999999997542  33456788899999999 999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC---------------
Q 038098          367 LEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---------------  428 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---------------  428 (580)
                      |||+++|+|.+++....   ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999987642   56899999999999999999999   8999999999999999844               


Q ss_pred             ----CcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCch
Q 038098          429 ----MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT  503 (580)
Q Consensus       429 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~  503 (580)
                          ..+||+|||.+.......      ...||..|+|||.+.+. .++.++|||||||++|||++|.+|+...    ..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence                479999999998664322      23589999999998765 5668999999999999999999875431    11


Q ss_pred             HHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          504 LKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       504 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....            .....       ...+..++.++.+++.+||+.||++||+++|+++|
T Consensus       237 ~~~~------------~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 WHEI------------RQGRL-------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHH------------HTTCC-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHH------------HcCCC-------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1111            11000       11223456789999999999999999999999876

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-41  Score=332.31  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367889999999999999999876 79999999996542   23456788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++...+ .+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999987654 5899999999999999999999   8999999999999999999999999999998653322


Q ss_pred             CcccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                         ......+++.|+|||.+.+..+ +.++||||+|+++|||++|+.||+....     ......         +...  
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~---------~~~~--  226 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKK---------IRGG--  226 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH---------HHHC--
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHH---------hhcC--
Confidence               1234468999999999987665 6899999999999999999999865211     111110         0000  


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ....+..++.++.+++.+||+.||++||+++|+++|
T Consensus       227 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 -----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 011123456778999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.2e-42  Score=336.15  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=202.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeee--cCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCS--SDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  365 (580)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+..|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357889999999999999999875 68999999997543  234567889999999999999999999874  4678899


Q ss_pred             EeeccCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEEecCCCCCEEeCCCCcEEEcccc
Q 038098          366 VLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVP-----IIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-----i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +.+     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532   45899999999999999999999   777     9999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchh
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM  517 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      +++......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....  ......          
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~----------  227 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGK----------  227 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----------
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHH----------
Confidence            998653321  122344689999999999988999999999999999999999999875311  111110          


Q ss_pred             hhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       518 ~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                       +... ..      ...+..++.++.+++.+||+.||++||+++|+++++.
T Consensus       228 -i~~~-~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          228 -IREG-KF------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             -HHHT-CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -Hhhc-cc------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence             0000 00      0122346678999999999999999999999998753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.8e-41  Score=367.46  Aligned_cols=250  Identities=20%  Similarity=0.260  Sum_probs=207.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCcee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  364 (580)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||++...   .......+..|..++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3567999999999999999999865 6889999999754   234456778899999988 7999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999988654 5999999999999999999999   89999999999999999999999999999985432


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....        .+...  
T Consensus       495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~--------~i~~~--  557 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ--------SIMEH--  557 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHSS--
T ss_pred             CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHH--------HHHhC--
Confidence            222  23456799999999999999999999999999999999999999975211     11111        11111  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA-----KEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ev~~~  566 (580)
                            ....+...+.++.+|+.+||+.||++||++     +||++|
T Consensus       558 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          558 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                  112234567889999999999999999997     777654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.8e-42  Score=350.44  Aligned_cols=263  Identities=11%  Similarity=0.125  Sum_probs=189.7

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhc--CCCCcceEE-------eeee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRI--RHRNIIKII-------SSCS  358 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~  358 (580)
                      ..|...+.||+|+||.||+|.+. +|+.||||++.....   .....+..|+++++.+  +||||++++       +.+.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            44888899999999999999965 789999999976432   3345677785555544  699988755       3333


Q ss_pred             cC-----------------CceeeEeeccCCCChHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEE
Q 038098          359 SD-----------------DFKALVLEYMPHGSLEKCLYSSNYILDIFQR------LNIMIDVASALEYLHFGYSVPIIH  415 (580)
Q Consensus       359 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~~~~~i~H  415 (580)
                      ..                 ...++||||++ |+|.+++...+..+++..+      +.++.||++||+|||   +.+|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence            22                 33799999998 8999999876555666667      788899999999999   999999


Q ss_pred             ecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCC
Q 038098          416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKP  493 (580)
Q Consensus       416 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p  493 (580)
                      |||||+|||++.++.+||+|||+|+.....     .....+|+.|+|||.+.+  ..++.++|||||||++|||+||+.|
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999865221     113457799999999987  6799999999999999999999999


Q ss_pred             CCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 038098          494 TDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR--LLKIR  571 (580)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~--L~~~~  571 (580)
                      |.........  .|..          ............+.....++..+.+|+.+||+.||++|||++|+++|  ++++.
T Consensus       293 f~~~~~~~~~--~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          293 FGLVTPGIKG--SWKR----------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             TTBCCTTCTT--CCCB----------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CCCcCccccc--chhh----------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            9764221100  0000          00000001111222234667889999999999999999999999874  44544


Q ss_pred             HHHH
Q 038098          572 DSLL  575 (580)
Q Consensus       572 ~~~~  575 (580)
                      .+..
T Consensus       361 ~~~~  364 (371)
T 3q60_A          361 NEIS  364 (371)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            4443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-41  Score=334.47  Aligned_cols=251  Identities=22%  Similarity=0.255  Sum_probs=188.0

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.....  .....+..+...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999986 4789999999865422  22233444555588889999999999999999999999


Q ss_pred             eccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          368 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       368 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ||+++ +|.+++..   .+..+++..++.++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 88777654   4567999999999999999999999   87 99999999999999999999999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccc----cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYG----REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...   ......||+.|+|||.+    .+..++.++||||+||++|||+||+.||+............            
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------  226 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------------  226 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH------------
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH------------
Confidence            322   22334689999999995    56678999999999999999999999987521111111111            


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ......      ......++.++.+++.+||+.||++|||++|+++|
T Consensus       227 ~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          227 VEEPSP------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHSCCC------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             hccCCC------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            111100      01123456779999999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-41  Score=337.85  Aligned_cols=253  Identities=25%  Similarity=0.287  Sum_probs=199.1

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCCcceEEeeeecC
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--------GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD  360 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  360 (580)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+..|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999865 68899999985432        12234688999999999999999999999765


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc---EEEcccc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFG  437 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg  437 (580)
                      + .++||||+++|+|.+++... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 89999999999999988654 46899999999999999999999   899999999999999987665   9999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      +++.....   .......||+.|+|||.+.   ...++.++|||||||++|||++|+.||....... .+.......   
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~---  235 (322)
T 2ycf_A          163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSG---  235 (322)
T ss_dssp             TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHT---
T ss_pred             cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhC---
Confidence            99865322   1223456899999999863   5678999999999999999999999997532211 111111110   


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                               .   ..........++.++.+++.+||+.||++||+++|+++|
T Consensus       236 ---------~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 ---------K---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             ---------C---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---------c---cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                     0   000011223456789999999999999999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-41  Score=343.16  Aligned_cols=272  Identities=23%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             HHhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec--------
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS--------  359 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  359 (580)
                      ...++|...+.||+|+||.||+|.. .+|+.||||++....    ....+|+++++.++||||+++++++..        
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999986 479999999986432    223479999999999999999999843        


Q ss_pred             ------------------------------CCceeeEeeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038098          360 ------------------------------DDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLH  406 (580)
Q Consensus       360 ------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh  406 (580)
                                                    ....++||||+++ +|.+.+..   .+..+++..+..++.||++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          2347899999984 88777653   4467999999999999999999999


Q ss_pred             cCCCCCeEEecCCCCCEEeC-CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHH
Q 038098          407 FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIML  484 (580)
Q Consensus       407 ~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil  484 (580)
                         +.+|+||||||+||+++ .++.+||+|||+|+.+....   ......+|..|+|||.+.+. .++.++||||+||++
T Consensus       159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence               99999999999999998 68999999999998663332   22345689999999988764 589999999999999


Q ss_pred             HHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc--chhcc----C---CcccccchhhhhHHHHHHHHhhccCCCCC
Q 038098          485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV--DANLL----S---QKDEHFTTKGQCVSFIFNLAMKCTVESPE  555 (580)
Q Consensus       485 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~~~----~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  555 (580)
                      |||++|+.||...... ..+.......-......+.  ++...    .   ........+..++.++.+|+.+||+.||+
T Consensus       233 ~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          233 GELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999763211 1112221111111100000  00000    0   00000112234677899999999999999


Q ss_pred             CCCCHHHHHHH--HHHHHH
Q 038098          556 QRINAKEIVTR--LLKIRD  572 (580)
Q Consensus       556 ~Rps~~ev~~~--L~~~~~  572 (580)
                      +|||+.|+++|  ++++++
T Consensus       312 ~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GSCCHHHHHTSGGGHHHHH
T ss_pred             hCCCHHHHhcCHHHHHHHh
Confidence            99999999975  444444

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.1e-42  Score=339.86  Aligned_cols=263  Identities=23%  Similarity=0.283  Sum_probs=188.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999854 68999999986442 334567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          368 EYMPHGSLEKCLYS-------SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       368 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ||+++++|.+++..       ....+++..++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864       3456899999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCC---cccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          441 PLLKEDQ---SLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       441 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      .......   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........  ............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~  247 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTLQNDPPSL  247 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHTSSCCCT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHhccCCCcc
Confidence            6543221   111234568999999998865 5689999999999999999999999976322111  000000000000


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .         ...........++.++.+++.+||+.||++||+++|+++|
T Consensus       248 ~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          248 E---------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             T---------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c---------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0         0000011123456778999999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.4e-41  Score=341.34  Aligned_cols=270  Identities=24%  Similarity=0.264  Sum_probs=203.9

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----Cc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  362 (580)
                      ..++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3467999999999999999999865 68899999996433 23346788999999999999999999998654     36


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||++ |+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            899999997 4999988764  4899999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCc-ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc---hh
Q 038098          443 LKEDQS-LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS---VM  517 (580)
Q Consensus       443 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  517 (580)
                      ...... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...........   ..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence            433221 12344579999999998654 458999999999999999999999997632211 1111111100000   00


Q ss_pred             hhcc--------hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          518 EIVD--------ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       518 ~~~d--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...+        ................++.++.+|+.+||+.||++|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000        000000000111223456789999999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.5e-41  Score=341.26  Aligned_cols=262  Identities=23%  Similarity=0.250  Sum_probs=193.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999865 68999999997542  233467888999999999999999999987654      


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+++ +|.+++.   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            67999999975 7888775   24899999999999999999999   89999999999999999999999999999985


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh--ccc-----
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL--LPI-----  514 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~-----  514 (580)
                      ....   .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+...    ...|..-.  ...     
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCHHH
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHH
Confidence            5322   123345789999999999998999999999999999999999999975321    11111100  000     


Q ss_pred             ------chhhhcchhcc----------C--CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 ------SVMEIVDANLL----------S--QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ------~~~~~~d~~~~----------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            ...........          .  ............+.++.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                  00000000000          0  0000011123347789999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2e-41  Score=344.98  Aligned_cols=264  Identities=23%  Similarity=0.272  Sum_probs=185.9

Q ss_pred             HhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecC------
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD------  360 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  360 (580)
                      ..++|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+++++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            347899999999999999999985 478999999986432  23456788999999999999999999998654      


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ...++|+|++ +++|.+++..  ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            5679999999 6799998865  45899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--cc--
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--IS--  515 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~--  515 (580)
                      ....     ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ..+.......-.  ..  
T Consensus       181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred             cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            6432     1234578999999999876 67899999999999999999999999753211 111111111000  00  


Q ss_pred             -------hhhhcchhccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 -------VMEIVDANLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 -------~~~~~d~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                             ....+.. +....... ......++.++.+|+.+||..||++|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                   0001000 00000000 11123456789999999999999999999999876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=341.60  Aligned_cols=255  Identities=25%  Similarity=0.318  Sum_probs=199.0

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeec-----
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSS-----  359 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----  359 (580)
                      +....++|++.+.||+|+||.||+|... +|+.||||++.... .....+..|+.+++++ +||||+++++++..     
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3345678999999999999999999864 78999999986543 3457788999999999 79999999999876     


Q ss_pred             -CCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          360 -DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       360 -~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                       .+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence             467899999999999999988653 56899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      ++.......  .......||..|+|||.+.     +..++.++|||||||++|||++|+.||......  .....     
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-----  245 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFL-----  245 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH-----
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHH-----
Confidence            998653221  1223456899999999986     567899999999999999999999998652110  00000     


Q ss_pred             ccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       513 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            +.....      .......++..+.+++.+||..||++||+++|+++|
T Consensus       246 ------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 ------IPRNPA------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ------HHHSCC------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------hhcCcc------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  000000      001123456788999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.7e-41  Score=348.43  Aligned_cols=197  Identities=22%  Similarity=0.289  Sum_probs=171.3

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhc------CCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRI------RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  363 (580)
                      ..+|++.+.||+|+||.||+|... +++.||||++... ......+..|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            456889999999999999999865 6899999999643 23345677788888877      577999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc--EEEccccCcc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAK  440 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~a~  440 (580)
                      ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 59999887655 45899999999999999999999   899999999999999999887  9999999997


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCcc
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEI  497 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~  497 (580)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||+||++||...
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            54322     23457899999999999999999999999999999999999999763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.9e-41  Score=367.08  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=207.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      .++|.+.+.||+|+||.||+|.+..    +..||+|++.... ....+.+..|+.++++++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            3557778899999999999998642    4579999886432 233467889999999999999999999985 456899


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+++|+|.+++...+..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999887777999999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      . ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......  .....           +.+.  
T Consensus       545 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~-----------i~~~--  608 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR-----------IENG--  608 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-----------HHHT--
T ss_pred             c-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH-----------HHcC--
Confidence            2 222233457789999999988899999999999999999997 99998653111  11111           1000  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                           .....+..++..+.+++.+||+.||++||++.|+++.|+++.++.
T Consensus       609 -----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          609 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                 011223456788999999999999999999999999999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8e-41  Score=345.48  Aligned_cols=265  Identities=22%  Similarity=0.226  Sum_probs=200.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC--------CCCcceEEeeee----
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR--------HRNIIKIISSCS----  358 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~----  358 (580)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            67999999999999999999854 6889999998643 234567888999999985        788999999987    


Q ss_pred             cCCceeeEeeccCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCC-------
Q 038098          359 SDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNM-------  429 (580)
Q Consensus       359 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~-------  429 (580)
                      .....++||||+ ++++.+++... ...+++..++.++.||+.||+|||   +. +|+||||||+|||++.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            566889999999 55666655544 367999999999999999999999   87 999999999999999775       


Q ss_pred             ------------------------------------------cEEEccccCccccCCCCCcccccccccCCCcCCccccc
Q 038098          430 ------------------------------------------VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR  467 (580)
Q Consensus       430 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  467 (580)
                                                                .+||+|||+++.....     .....||..|+|||++.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence                                                      7999999999865332     23456899999999999


Q ss_pred             CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch----HHHHHHhhcccchhhhcch-----hccCC-----------
Q 038098          468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT----LKHWVNDLLPISVMEIVDA-----NLLSQ-----------  527 (580)
Q Consensus       468 ~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~d~-----~~~~~-----------  527 (580)
                      +..++.++|||||||++|||+||+.||.........    ................+..     .....           
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            999999999999999999999999999764322111    0000100000000000000     00000           


Q ss_pred             -------cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 -------KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 -------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                             .......+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                   000112235567889999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-40  Score=327.57  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=204.3

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4567999999999999999999875 78999999996543  23457788999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC---CcEEEccccCccccC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLL  443 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~a~~~~  443 (580)
                      |||+++++|.+++.... .+++..++.++.||+.||.|||   +.+++||||||+||+++.+   +.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999886544 5899999999999999999999   8999999999999999754   479999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ....   .....+++.|+|||.+.+ .++.++||||+|+++|||++|+.||.....     ......        +..  
T Consensus       176 ~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~--------~~~--  236 (287)
T 2wei_A          176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKR--------VET--  236 (287)
T ss_dssp             CCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--------HHH--
T ss_pred             CCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHc--
Confidence            3221   223458889999998865 589999999999999999999999865311     111110        000  


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        ............++.++.+++.+||+.||++|||++|++++
T Consensus       237 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          237 --GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             --CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence              01111112234567789999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-40  Score=340.84  Aligned_cols=263  Identities=20%  Similarity=0.254  Sum_probs=198.8

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCce----
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK----  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  363 (580)
                      .++|...+.||+|+||.||+|... +|+.||||++.....  .....+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999865 689999999965422  2356788999999999999999999999877655    


Q ss_pred             --eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          364 --ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       364 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                        ++||||+. ++|.+++.   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 58888763   34899999999999999999999   89999999999999999999999999999985


Q ss_pred             cCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc--cc---
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP--IS---  515 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~---  515 (580)
                      ...     ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.........  ..   
T Consensus       194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred             ccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHHH
Confidence            432     2234568999999999877 68899999999999999999999999763211 111111110000  00   


Q ss_pred             ------hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 ------VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ------~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            ......................++.++.+|+.+||+.||++|||++|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                  000000000000111111223567889999999999999999999999876

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-40  Score=331.20  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=195.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec----------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS----------  359 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  359 (580)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++... ......+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457889999999999999999865 7899999998643 2345678899999999999999999998754          


Q ss_pred             ---CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          360 ---DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       360 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                         .+..++||||+++|+|.+++...+..+++..++.++.||++||+|||   +.+++||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               45678999999999999999877777899999999999999999999   899999999999999999999999999


Q ss_pred             cCccccCCCCC------------cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCch
Q 038098          437 GMAKPLLKEDQ------------SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT  503 (580)
Q Consensus       437 g~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~  503 (580)
                      |++........            ........||..|+|||.+.+. .++.++||||+||++|||++   ||...    ..
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----~~  233 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----ME  233 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----HH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----hh
Confidence            99986532210            1122345689999999998754 78999999999999999998   54321    01


Q ss_pred             HHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          504 LKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       504 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......        +.... ...   ........+..+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~--------~~~~~-~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILKK--------LRSVS-IEF---PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHH--------HHSTT-CCC---CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHh--------ccccc-ccc---CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1111111        00000 000   011223456778999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.3e-41  Score=334.23  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=198.2

Q ss_pred             HhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcC--CCCcceEEeeeecCCceee
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIR--HRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l  365 (580)
                      ..++|.+.+.||+|+||.||+|...+++.||||++....  ......+.+|++++.+++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            346789999999999999999998889999999996543  234577889999999997  5999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||| +.+++|.+++.... .+++..++.++.||++||.|||   +.+|+||||||+||++++ +.+||+|||+++.....
T Consensus       106 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            999 55789999987654 6899999999999999999999   899999999999999965 89999999999876443


Q ss_pred             CCcccccccccCCCcCCcccccC-----------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGRE-----------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ..........||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......   ...        
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~--------  248 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK--------  248 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHH--------
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---HHH--------
Confidence            33333345568999999998865           46888999999999999999999998653211   111        


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                       .....+...      ....+...+.++.+++.+||+.||++||+++|++++-
T Consensus       249 -~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          249 -LHAIIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             -HHHHHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -HHHHHhccc------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence             111111111      1111223456789999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-40  Score=344.92  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=194.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecC------Ccee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSD------DFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  364 (580)
                      .+|...+.||+|+||.||+|++. +|+.||||++....    ....+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            45888899999999999999975 68999999986432    2334699999999999999999987432      2367


Q ss_pred             eEeeccCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-CcEEEccccCcc
Q 038098          365 LVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  440 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~a~  440 (580)
                      +||||+++ ++.+.+.   .....+++..++.++.||++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 6666554   34567999999999999999999999   9999999999999999955 678999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc---h
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS---V  516 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  516 (580)
                      .+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.......-...   +
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence            663322   22345789999999998764 789999999999999999999999976321 112222222111110   1


Q ss_pred             hhhcchhccCCccccc-------chhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHF-------TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ... ++.......+..       ......+.++.+|+.+||..||++||++.|+++|
T Consensus       282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            111 110000000000       0123456789999999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.3e-40  Score=331.46  Aligned_cols=269  Identities=25%  Similarity=0.304  Sum_probs=204.0

Q ss_pred             HhcCCCcCceeccccCceEEEEEe--CCCCEEEEEEEecccc--chhhhHHHHHHHHhhc---CCCCcceEEeeee----
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI--QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRI---RHRNIIKIISSCS----  358 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  358 (580)
                      ..++|.+.+.||+|+||.||+|..  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  3688999999865432  2234667788887776   8999999999986    


Q ss_pred             -cCCceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          359 -SDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       359 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                       .....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5667899999997 59999987654 45899999999999999999999   899999999999999999999999999


Q ss_pred             cCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc--
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI--  514 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  514 (580)
                      |+++.....   .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..........  
T Consensus       165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCG
T ss_pred             cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCc
Confidence            999865322   1234456899999999999989999999999999999999999998753211 1111111110000  


Q ss_pred             -chhhhcc---hhccC-CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 -SVMEIVD---ANLLS-QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 -~~~~~~d---~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .......   ..... ...........++..+.+++.+||+.||++||++.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0000000   00000 0001111224567889999999999999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.3e-41  Score=334.81  Aligned_cols=269  Identities=21%  Similarity=0.262  Sum_probs=197.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeee-----------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS-----------  358 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----------  358 (580)
                      .++|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467889999999999999999876 58999999997665556678899999999999999999998873           


Q ss_pred             ---cCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEc
Q 038098          359 ---SDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLS  434 (580)
Q Consensus       359 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~  434 (580)
                         .....++||||++ |+|.+++..  ..+++..++.++.||+.||+|||   +.+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 599998864  45899999999999999999999   89999999999999997 67799999


Q ss_pred             cccCccccCCCCC-cccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc
Q 038098          435 DFGMAKPLLKEDQ-SLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       435 Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      |||+++....... ........+|..|+|||.+.. ..++.++|||||||++|||+||+.||...... ...........
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC
Confidence            9999986533211 112234457899999998765 67899999999999999999999999763211 11111111110


Q ss_pred             ccc---hhhh-------cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          513 PIS---VMEI-------VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       513 ~~~---~~~~-------~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...   ..+.       +.................++.++.+++.+||+.||++||+++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            000   0000       00000001111111223567889999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=338.58  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=201.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|.+.+.||+|+||.||+|...+  .||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4678899999999999999998763  59999986442  2334667789999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC--
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED--  446 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  446 (580)
                      |+++++|.+++...+..+++..++.++.||+.||+|||   +.+++||||||+||+++ ++.+||+|||+++......  
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            99999999999887777999999999999999999999   89999999999999998 6799999999987543211  


Q ss_pred             -CcccccccccCCCcCCcccccC---------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          447 -QSLTQTQTLATIGYMAPEYGRE---------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       447 -~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                       .........|+..|+|||.+..         ..++.++||||||+++|||++|+.||.....     ......      
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~------  254 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIWQ------  254 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHHHH------
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH------
Confidence             1122234458899999998864         3578899999999999999999999865311     111100      


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                        +.. ....    . .....++.++.+++.+||..||++||+++++++.|+++..+..+
T Consensus       255 --~~~-~~~~----~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          255 --MGT-GMKP----N-LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             --HHT-TCCC----C-CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             --hcc-CCCC----C-CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence              000 0000    0 01123456688999999999999999999999999998876543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-40  Score=338.18  Aligned_cols=269  Identities=25%  Similarity=0.279  Sum_probs=201.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecC-----Cce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----DFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  363 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467899999999999999999865 68999999996432 23345678899999999999999999987654     678


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+. |+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999988763  5899999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCCcc--------cccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-c
Q 038098          444 KEDQSL--------TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-P  513 (580)
Q Consensus       444 ~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~  513 (580)
                      ......        ......||..|+|||.+.. ..++.++|||||||++|||++|+.||....... .+.......- +
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            322111        1223468999999998754 678999999999999999999999997632110 0111100000 0


Q ss_pred             c-----------chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 I-----------SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~-----------~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .           ...+.+.................++.++.+++.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0           0000000000000000111223567889999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.4e-40  Score=340.73  Aligned_cols=264  Identities=24%  Similarity=0.320  Sum_probs=195.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCC------ceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------FKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  365 (580)
                      .+|...+.||+|+||.||+|+...+..||+|++....    ....+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            4688899999999999999998777779999885432    22346999999999999999999985433      3789


Q ss_pred             EeeccCCCChHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEccccCcccc
Q 038098          366 VLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPL  442 (580)
Q Consensus       366 v~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~  442 (580)
                      ||||++++.+....  ......+++..+..++.||++||+|||   +.+|+||||||+|||++ .++.+||+|||+|+..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            99999875443332  223457999999999999999999999   89999999999999999 8999999999999866


Q ss_pred             CCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchh--hh
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM--EI  519 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  519 (580)
                      ....   ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... ..+.......-.....  ..
T Consensus       193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence            3322   22345689999999988764 5899999999999999999999999763211 1122222111100000  00


Q ss_pred             cchhccCC-----ccc--ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQ-----KDE--HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~-----~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .++.....     ...  ....+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            01110000     000  001123466789999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.8e-40  Score=331.41  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=203.3

Q ss_pred             hcCCCcCceeccccCceEEEEEe-C-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCC------cceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-Q-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN------IIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  362 (580)
                      .++|++.+.||+|+||.||+|.. . +|+.||||++... ......+..|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35799999999999999999986 3 6889999998643 234567888999999987654      9999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC--------------
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--------------  427 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--------------  427 (580)
                      .++||||+ +++|.+++...+ .++++..++.++.||++||+|||   +.+|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999987665 46899999999999999999999   899999999999999987              


Q ss_pred             -----CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc
Q 038098          428 -----NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM  502 (580)
Q Consensus       428 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~  502 (580)
                           ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||+||++|||++|+.||......+ 
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                 678999999999864322     234568999999999999899999999999999999999999997532111 


Q ss_pred             hHHHHHHhh--cccch-hhhcchhc---------------------cCCcccccchhhhhHHHHHHHHhhccCCCCCCCC
Q 038098          503 TLKHWVNDL--LPISV-MEIVDANL---------------------LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI  558 (580)
Q Consensus       503 ~~~~~~~~~--~~~~~-~~~~d~~~---------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  558 (580)
                      .........  .+... ........                     .............++.++.+|+.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            111111100  00000 00000000                     0000001112234578899999999999999999


Q ss_pred             CHHHHHHH
Q 038098          559 NAKEIVTR  566 (580)
Q Consensus       559 s~~ev~~~  566 (580)
                      |++|+++|
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999876

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=334.33  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=197.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecCCc-----
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF-----  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  362 (580)
                      .++|...+.||+|+||.||+|... +|+.||||++.....  .....+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999865 689999999965422  234678889999999999999999999977654     


Q ss_pred             -eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          363 -KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       363 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                       .++||||++ ++|.+++..   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887643   4899999999999999999999   89999999999999999999999999999985


Q ss_pred             cCCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh--cccc---
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL--LPIS---  515 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~---  515 (580)
                      ....     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.......  .+..   
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            4221     234568999999998876 67899999999999999999999998753211 0111111100  0000   


Q ss_pred             ------hhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 ------VMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 ------~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            ....+.................++.++.+++.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                  000110000000001111224567889999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-39  Score=331.66  Aligned_cols=275  Identities=21%  Similarity=0.243  Sum_probs=193.2

Q ss_pred             HHHHHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc-
Q 038098          285 LEIFQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF-  362 (580)
Q Consensus       285 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  362 (580)
                      .+.....++|.+.+.||+|+||.||+|... +|+.||||++.... ........+++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345667789999999999999999999875 68999999985432 334566778888999999999999999865433 


Q ss_pred             ------eeeEeeccCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEE
Q 038098          363 ------KALVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAH  432 (580)
Q Consensus       363 ------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~k  432 (580)
                            .++||||+++ +|.+.+.   .....+++..+..++.|++.|+.|||. ++.+|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999986 5554433   244568999999999999999999993 3678999999999999996 89999


Q ss_pred             EccccCccccCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhh
Q 038098          433 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL  511 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  511 (580)
                      |+|||+++......   ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||..... ...+..+....
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHc
Confidence            99999998664332   22345689999999988654 489999999999999999999999976321 11122222111


Q ss_pred             ccc--chhhhcchhcc-----CCccc-----ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          512 LPI--SVMEIVDANLL-----SQKDE-----HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       512 ~~~--~~~~~~d~~~~-----~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...  .....+++...     .....     ........+.++.+|+.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            100  01111111000     00000     001112357889999999999999999999999876

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.7e-40  Score=332.17  Aligned_cols=254  Identities=19%  Similarity=0.226  Sum_probs=176.1

Q ss_pred             HhcCCCcCc-eeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec----CCce
Q 038098          290 ATNGFSENN-LIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFK  363 (580)
Q Consensus       290 ~~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  363 (580)
                      ..++|.+.+ .||+|+||.||+|... +|+.||||++....    .........++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788854 6999999999999876 79999999986431    222223334667799999999999875    4458


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a  439 (580)
                      ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998664 46999999999999999999999   899999999999999986   455999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +.....    ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..         ....
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~---------~~~~  244 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PG---------MKRR  244 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hh---------HHHh
Confidence            865322    223456899999999998888999999999999999999999998653221100 00         0000


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL  567 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L  567 (580)
                      +...   ...........++.++.+|+.+||+.||++|||++|+++|-
T Consensus       245 ~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          245 IRLG---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhcc---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000   00001112245678899999999999999999999999853

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=341.84  Aligned_cols=268  Identities=21%  Similarity=0.240  Sum_probs=183.5

Q ss_pred             CCCc-CceeccccCceEEEEEeC---CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeee--cCCceeeE
Q 038098          293 GFSE-NNLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCS--SDDFKALV  366 (580)
Q Consensus       293 ~~~~-~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  366 (580)
                      .|.+ .++||+|+||.||+|++.   +++.||||++...  .....+.+|++++++++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3554 458999999999999865   5788999998643  23357889999999999999999999994  46788999


Q ss_pred             eeccCCCChHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe----CCCCcEEEc
Q 038098          367 LEYMPHGSLEKCLYSSN--------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLS  434 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~  434 (580)
                      |||+++ +|.+++....        ..+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999965 8888775321        35899999999999999999999   8999999999999999    778999999


Q ss_pred             cccCccccCCCCC-cccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCC--------chH
Q 038098          435 DFGMAKPLLKEDQ-SLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD--------MTL  504 (580)
Q Consensus       435 Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~--------~~~  504 (580)
                      |||+|+.+..... ........||+.|+|||.+.+. .++.++||||+||++|||+||++||.......        ..+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999986643221 1223456789999999998774 58999999999999999999999997532210        111


Q ss_pred             HHHHHhhcccc---hhhh------------cchhccCCccc---ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          505 KHWVNDLLPIS---VMEI------------VDANLLSQKDE---HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       505 ~~~~~~~~~~~---~~~~------------~d~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .......-...   +..+            +..........   ........+.++.+|+.+||+.||++|||++|+++|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111100000   0000            00000000000   000001125678899999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=343.16  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=190.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      .+|...++||+|+||+||.....+|+.||||++....   ...+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            4588889999999999776556679999999986432   23467899999999 7999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-----CCcEEEccccCccccCCC
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~  445 (580)
                      . |+|.+++........+..++.++.||++||+|||   +.+|+||||||+||+++.     ...+||+|||+++.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            6 5999999877766666677899999999999999   899999999999999953     335889999999866433


Q ss_pred             CCc-ccccccccCCCcCCccccc---CCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          446 DQS-LTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       446 ~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      ... .......||+.|+|||.+.   ...++.++||||+||++|||+| |..||......   ....           ..
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~-----------~~  242 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANI-----------LL  242 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHH-----------HT
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHH-----------Hh
Confidence            211 2234567999999999987   4567889999999999999999 89998542110   0000           00


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..    ............+..+.+|+.+||+.||++||+++|+++|
T Consensus       243 ~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          243 GA----CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TC----CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc----CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00    0000111123345668899999999999999999999964

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.6e-40  Score=342.19  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=187.8

Q ss_pred             CCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEeeccC
Q 038098          293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556889999999998776677999999998643   235678899999887 89999999999999999999999996


Q ss_pred             CCChHHHhhcCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC-------------CcEE
Q 038098          372 HGSLEKCLYSSNYI------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-------------MVAH  432 (580)
Q Consensus       372 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-------------~~~k  432 (580)
                       |+|.+++......      .++..++.++.||+.||+|||   +.+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             5999999765421      133345789999999999999   8999999999999999754             4899


Q ss_pred             EccccCccccCCCCCcc--cccccccCCCcCCcccccC-------CCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCc
Q 038098          433 LSDFGMAKPLLKEDQSL--TQTQTLATIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDM  502 (580)
Q Consensus       433 l~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~  502 (580)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||+.....  
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--  246 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--  246 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence            99999998764432211  1234579999999999865       678999999999999999999 99998653211  


Q ss_pred             hHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          503 TLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ...+.....             ............++.++.+++.+||+.||++||++.|+++|
T Consensus       247 -~~~i~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          247 -ESNIIRGIF-------------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -HHHHHHTCC-------------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHhcCCC-------------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             111111100             00000111223567889999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.7e-40  Score=330.46  Aligned_cols=253  Identities=24%  Similarity=0.294  Sum_probs=180.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc-chhhhHHHHHH-HHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-RAFKSFDIECD-MIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|...+.||+|+||.||+|... +|+.||||++..... .....+..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999875 789999999975432 23344555665 6777899999999999999999999999


Q ss_pred             ccCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          369 YMPHGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       369 ~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      |+++ +|.+++..    ....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 88777653    2456899999999999999999999   77 99999999999999999999999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccc----cCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYG----REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ...   ......||..|+|||.+    .+..++.++|||||||++|||++|+.||.......    ..        ...+
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~--------~~~~  242 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQ--------LTQV  242 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CCC
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HH--------HHHH
Confidence            322   22334689999999998    45678999999999999999999999986521100    00        0011


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....   ..........++..+.+++.+||+.||++||++.|++++
T Consensus       243 ~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 VKGDP---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCSCC---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             hcCCC---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            11000   000011123467789999999999999999999999886

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.7e-39  Score=331.91  Aligned_cols=199  Identities=25%  Similarity=0.331  Sum_probs=170.2

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CC-----CcceEEeeeecCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HR-----NIIKIISSCSSDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~  362 (580)
                      ..++|.+.+.||+|+||.||+|... +++.||||++... ......+..|+++++.++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3578999999999999999999865 6889999999643 223456777888888885 44     49999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC--CCCcEEEccccCc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMA  439 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~a  439 (580)
                      .++||||++ |+|.+++.... ..+++..+..++.||+.||.|||. +..+|+||||||+|||++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999988765 568999999999999999999992 146899999999999994  5788999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                      +.....     .....||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            866322     2345689999999999999999999999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.4e-40  Score=328.13  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=183.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc-h-hhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR-A-FKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .++|...+.||+|+||.||+|... +|+.||||++...... . ...+..+..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            367888899999999999999875 7899999999754322 2 233444555678889999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      ||+ ++.+..+.......+++..++.++.||+.||.|||   +. +++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666555567999999999999999999999   75 99999999999999999999999999997653322


Q ss_pred             CcccccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                         ......+|+.|+|||.+.     ...++.++|||||||++|||++|+.||......   ...+ .        .+..
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~-~--------~~~~  244 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVL-T--------KVLQ  244 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHH-H--------HHHH
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHH-H--------HHhc
Confidence               223446899999999984     557889999999999999999999998652111   1111 0        0110


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .     ..........++.++.+++.+||+.||++||+++|+++|
T Consensus       245 ~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          245 E-----EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             S-----CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             c-----CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0     001111123456789999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-40  Score=329.60  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=201.1

Q ss_pred             HHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc------hhhhHHHHHHHHhhcC--CCCcceEEeeeec
Q 038098          289 QATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR------AFKSFDIECDMIKRIR--HRNIIKIISSCSS  359 (580)
Q Consensus       289 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~  359 (580)
                      ...++|.+.+.||+|+||.||+|... +++.||||++......      ....+..|+.++++++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34577999999999999999999854 6899999999755321      2356778999999996  5999999999999


Q ss_pred             CCceeeEeeccCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEcccc
Q 038098          360 DDFKALVLEYMPH-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFG  437 (580)
Q Consensus       360 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg  437 (580)
                      .+..++|+|++.+ ++|.+++... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++ .++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999976 8999998764 35899999999999999999999   89999999999999999 78999999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV  516 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  516 (580)
                      +++.....    ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....       .          
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~----------  254 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----------  254 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----------
T ss_pred             cccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------h----------
Confidence            99866432    2234568999999999877665 688999999999999999999986520       0          


Q ss_pred             hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                        .....        ...+..++.++.+++.+||+.||++||+++|++++
T Consensus       255 --~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 --IIRGQ--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --HHHCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --hhccc--------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00000        01123456778999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-39  Score=329.07  Aligned_cols=264  Identities=20%  Similarity=0.250  Sum_probs=200.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CC-CEEEEEEEeccccchhhhHHHHHHHHhhcCCCC------cceEEeeeecCCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DG-MEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN------IIKIISSCSSDDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  362 (580)
                      .++|.+.+.||+|+||.||+|... ++ +.||+|++... ......+..|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367999999999999999999864 44 68999998643 234567788999999997766      8999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe----------------
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----------------  425 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----------------  425 (580)
                      .++||||+ ++++.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 567777666544 57999999999999999999999   9999999999999999                


Q ss_pred             ---CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCc
Q 038098          426 ---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM  502 (580)
Q Consensus       426 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~  502 (580)
                         +.++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||+||++|||++|+.||......  
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--  245 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR--  245 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--
Confidence               56789999999999854322     23456899999999999999999999999999999999999999753211  


Q ss_pred             hHHHHHHhhcccchhhhcc----hhc---------------------cCCcccccchhhhhHHHHHHHHhhccCCCCCCC
Q 038098          503 TLKHWVNDLLPISVMEIVD----ANL---------------------LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR  557 (580)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~d----~~~---------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  557 (580)
                      ...................    ...                     ..............+.++.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            1111111111000000000    000                     000000011123346789999999999999999


Q ss_pred             CCHHHHHHH
Q 038098          558 INAKEIVTR  566 (580)
Q Consensus       558 ps~~ev~~~  566 (580)
                      ||++|+++|
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999865

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=327.42  Aligned_cols=244  Identities=25%  Similarity=0.339  Sum_probs=193.2

Q ss_pred             HHHhcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc------chhhhHHHHHHHHhhc----CCCCcceEEee
Q 038098          288 FQATNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG------RAFKSFDIECDMIKRI----RHRNIIKIISS  356 (580)
Q Consensus       288 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~~~  356 (580)
                      ....++|.+.+.||+|+||.||+|... +++.||||++.....      .....+..|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            344578999999999999999999864 689999999864422      1234556799999998    89999999999


Q ss_pred             eecCCceeeEeec-cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC-CCCcEEEc
Q 038098          357 CSSDDFKALVLEY-MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLS  434 (580)
Q Consensus       357 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~  434 (580)
                      +...+..++|+|+ +.+++|.+++...+ .+++..++.++.||++||+|||   +.+|+||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEE
Confidence            9999999999999 78999999987644 5899999999999999999999   89999999999999999 89999999


Q ss_pred             cccCccccCCCCCcccccccccCCCcCCcccccCCCCC-CchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc
Q 038098          435 DFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS-TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP  513 (580)
Q Consensus       435 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  513 (580)
                      |||+++......    .....|+..|+|||.+.+..+. .++||||+|+++|||++|+.||....               
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------------  243 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------------  243 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------------
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------------
Confidence            999998664322    2345689999999998776664 58999999999999999999986420               


Q ss_pred             cchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 ISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ++.+.        ....+..++.++.+++.+||+.||++||+++|+++|
T Consensus       244 ----~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 ----EILEA--------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ----HHHHT--------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----HHhhh--------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                01110        011123456778999999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-39  Score=334.38  Aligned_cols=265  Identities=19%  Similarity=0.242  Sum_probs=199.0

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-----------CCCcceEEeeeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-----------HRNIIKIISSCSS  359 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  359 (580)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+..|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5789999999999999999986 478999999986432 23466788999999886           8999999999876


Q ss_pred             CC----ceeeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeC------C
Q 038098          360 DD----FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLD------D  427 (580)
Q Consensus       360 ~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~------~  427 (580)
                      .+    ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||   +. +|+||||||+||+++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence            44    789999999 889999987643 45999999999999999999999   87 999999999999994      4


Q ss_pred             CCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC-----c
Q 038098          428 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD-----M  502 (580)
Q Consensus       428 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~-----~  502 (580)
                      .+.+||+|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||+||+.||.......     .
T Consensus       174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            458999999999865322     233468999999999999999999999999999999999999997532111     0


Q ss_pred             hHHHHHHhhc--ccch-------hhhcchh-ccCC------------cccccchhhhhHHHHHHHHhhccCCCCCCCCCH
Q 038098          503 TLKHWVNDLL--PISV-------MEIVDAN-LLSQ------------KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA  560 (580)
Q Consensus       503 ~~~~~~~~~~--~~~~-------~~~~d~~-~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  560 (580)
                      .+.......-  +...       ...++.. ....            .......+..++.++.+|+.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            1111111000  0000       0000000 0000            000112335678889999999999999999999


Q ss_pred             HHHHHH
Q 038098          561 KEIVTR  566 (580)
Q Consensus       561 ~ev~~~  566 (580)
                      +|+++|
T Consensus       329 ~ell~h  334 (373)
T 1q8y_A          329 GGLVNH  334 (373)
T ss_dssp             HHHHTC
T ss_pred             HHHhhC
Confidence            999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.3e-39  Score=344.64  Aligned_cols=264  Identities=25%  Similarity=0.317  Sum_probs=200.2

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeec------CCc
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSS------DDF  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  362 (580)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999864 68999999986542 3345678899999999999999999998765      677


Q ss_pred             eeeEeeccCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCc---EEEcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFG  437 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg  437 (580)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998654  36899999999999999999999   899999999999999997665   9999999


Q ss_pred             CccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchh
Q 038098          438 MAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM  517 (580)
Q Consensus       438 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  517 (580)
                      ++.......   ......||..|+|||.+.+..++.++||||+||++|||++|+.||...    .....|..........
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~----~~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN----WQPVQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS----CHHHHSSTTCC-----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc----cchhhhhhhhhcccch
Confidence            998664322   223457999999999999999999999999999999999999998652    2223332222111111


Q ss_pred             hh-cchhccC------CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038098          518 EI-VDANLLS------QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV  564 (580)
Q Consensus       518 ~~-~d~~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~  564 (580)
                      .. .......      ............+..+.+++.+||..||++|||++|++
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            00 0000000      00001122345788999999999999999999998844

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.7e-38  Score=308.37  Aligned_cols=233  Identities=15%  Similarity=0.080  Sum_probs=185.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.++++++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999875 589999999975432   23467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++++|.+++...   ....++.+++.||+.||+|||   +.+|+||||||+||+++.++.+||+++|          
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999999998542   355678899999999999999   8999999999999999999999998543          


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                                  |++       .++.++|||||||++|||+||+.||........ +.             .........
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~-------------~~~~~~~~~  221 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LA-------------PAERDTAGQ  221 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SE-------------ECCBCTTSC
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hH-------------HHHHHhccC
Confidence                        333       367899999999999999999999976322110 00             000000000


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      ..........++.++.+++.+||+.||++| |+.|+++.|+++....
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            000111224567789999999999999999 9999999999987554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-38  Score=328.38  Aligned_cols=249  Identities=16%  Similarity=0.152  Sum_probs=186.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCC-CCcceE-------------
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRH-RNIIKI-------------  353 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~-------------  353 (580)
                      ..|...+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.+++.++| +|....             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34667789999999999999854 79999999986332   2336778899999999987 322111             


Q ss_pred             --------Eeeeec-----CCceeeEeeccCCCChHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 038098          354 --------ISSCSS-----DDFKALVLEYMPHGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPII  414 (580)
Q Consensus       354 --------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~  414 (580)
                              ..++..     ....+++|+++ +++|.+++.      ..+..+++..++.++.||++||+|||   +.+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                    111111     12356777766 679999884      23456888999999999999999999   99999


Q ss_pred             EecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccc----------cCCCCCCchhhHhHHHHH
Q 038098          415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYG----------REGQVSTNGDVYSFGIML  484 (580)
Q Consensus       415 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dvws~Gvil  484 (580)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999854322     334467 999999998          556688999999999999


Q ss_pred             HHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038098          485 METFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV  564 (580)
Q Consensus       485 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~  564 (580)
                      |||+||+.||......+                 ..+..        +.....++.++.+|+.+||+.||++||++.|++
T Consensus       308 ~elltg~~Pf~~~~~~~-----------------~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALG-----------------GSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGS-----------------CSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhh-----------------hHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999997532110                 01110        011123457799999999999999999999997


Q ss_pred             HH--HHHHHHHHH
Q 038098          565 TR--LLKIRDSLL  575 (580)
Q Consensus       565 ~~--L~~~~~~~~  575 (580)
                      ++  ++++...+.
T Consensus       363 ~~~~~~~~~~~~~  375 (413)
T 3dzo_A          363 ETPEYEQLRTELS  375 (413)
T ss_dssp             TSHHHHHHHHHHH
T ss_pred             hCHHHHHHHHHHH
Confidence            76  555555543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-38  Score=346.72  Aligned_cols=242  Identities=22%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC--CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCc-----e
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF-----K  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~  363 (580)
                      ++|.+.+.||+|+||.||+|.+.  +|+.||||++.... ......+..|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999875  58999999985432 2344678899999999999999999999987665     6


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccC
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  443 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~  443 (580)
                      ++||||+++++|.+++..   .+++..++.++.||++||.|||   +.+|+||||||+||+++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987654   6899999999999999999999   8999999999999999985 99999999998653


Q ss_pred             CCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          444 KEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       444 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      ..      ....||+.|+|||++.++ ++.++|||||||++|||++|.+||........                     
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------  284 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------  284 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------
T ss_pred             cC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------------
Confidence            32      345699999999988765 48999999999999999999988764211100                     


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-NAKEIVTRLLKIRDSL  574 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ev~~~L~~~~~~~  574 (580)
                       .     ........+..+.+++.+||+.||++|| +++++.+.|..+..+.
T Consensus       285 -~-----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  330 (681)
T 2pzi_A          285 -P-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV  330 (681)
T ss_dssp             -C-----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred             -c-----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence             0     0011122346788999999999999999 5667777777766554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-37  Score=308.36  Aligned_cols=231  Identities=19%  Similarity=0.260  Sum_probs=181.6

Q ss_pred             hcCCCcC-ceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHH-hhcCCCCcceEEeeeec----CCce
Q 038098          291 TNGFSEN-NLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMI-KRIRHRNIIKIISSCSS----DDFK  363 (580)
Q Consensus       291 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~  363 (580)
                      .++|... +.||+|+||.||+|.. .+++.||+|++..     ...+.+|++++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567666 7899999999999986 4789999999853     24567888887 55689999999999876    6778


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a  439 (580)
                      ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 46999999999999999999999   899999999999999998   789999999998


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      ....                        +..++.++||||+||++|||+||+.||........             ....
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------~~~~  210 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------SPGM  210 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCS
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------------hHHH
Confidence            7431                        23467799999999999999999999865311100             0000


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..................++.++.+++.+||+.||++||+++|+++|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000000111111224567889999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.5e-37  Score=309.27  Aligned_cols=245  Identities=18%  Similarity=0.185  Sum_probs=185.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--------cchhhhHHHHHHHHhhcC---------CCCcceE
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--------GRAFKSFDIECDMIKRIR---------HRNIIKI  353 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~~  353 (580)
                      .++|.+.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|++++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 58999999997542        223377889999999886         6666665


Q ss_pred             Eee-----------------eec-------------CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 038098          354 ISS-----------------CSS-------------DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE  403 (580)
Q Consensus       354 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  403 (580)
                      .+.                 +.+             .+..++||||+++|++.+.+..  ..+++..++.++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999977666643  45899999999999999999


Q ss_pred             HHhcCCCCCeEEecCCCCCEEeCCCC--------------------cEEEccccCccccCCCCCcccccccccCCCcCCc
Q 038098          404 YLHFGYSVPIIHCDLKPSNVLLDDNM--------------------VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  463 (580)
Q Consensus       404 ~Lh~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  463 (580)
                      |||+  +.+|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9992  36899999999999999887                    999999999986532       134699999999


Q ss_pred             ccccCCCCCCchhhHhHHHH-HHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHH
Q 038098          464 EYGREGQVSTNGDVYSFGIM-LMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFI  542 (580)
Q Consensus       464 E~~~~~~~~~~~Dvws~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l  542 (580)
                      |.+.+.. +.++||||+|++ .+++++|..||..        ..|....    ...+.+.. ..........+..++.++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYL----TDKMLKQM-TFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHH----HHHHHHTC-CCSSCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHH----HHhhhhhh-ccCcccchhhhhhcCHHH
Confidence            9998655 899999998777 7789999999743        1121111    01111110 111111223345688999


Q ss_pred             HHHHhhccCCCCCCCCCHHHHH-HH
Q 038098          543 FNLAMKCTVESPEQRINAKEIV-TR  566 (580)
Q Consensus       543 ~~l~~~cl~~dP~~Rps~~ev~-~~  566 (580)
                      .+|+.+||+.|     |++|++ +|
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999976     999998 64

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.97  E-value=2e-31  Score=265.39  Aligned_cols=215  Identities=35%  Similarity=0.544  Sum_probs=186.3

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCC-CCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT-SIP   80 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~lp   80 (580)
                      |++++.+|.+|.++++|++|+|++|.+++.+|..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|+ .+|
T Consensus        87 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  166 (313)
T 1ogq_A           87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP  166 (313)
T ss_dssp             TTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred             CcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCC
Confidence            6777788888888888888888888887778888888888888888888888778888888888888888888887 577


Q ss_pred             CCCcCCC-CCceEeCcCCccc------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccc
Q 038098           81 STLWNLK-DILYLDLSSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI  153 (580)
Q Consensus        81 ~~~~~l~-~L~~L~l~~n~l~------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  153 (580)
                      ..+..++ +|++|+|++|++.      +..++ |+.|++++|.+++..+..|..+++|+.|+|++|.+++.+|. +..++
T Consensus       167 ~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~  244 (313)
T 1ogq_A          167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK  244 (313)
T ss_dssp             GGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCT
T ss_pred             HHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccC
Confidence            7788777 8888888888872      45555 88999999999888888899999999999999999866655 88889


Q ss_pred             ccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCCC
Q 038098          154 NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPN  218 (580)
Q Consensus       154 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p~  218 (580)
                      +|++|+|++|++++.+|..+..+++|+.|++++|++++.+|....++.+..+++.+|++.|+.|.
T Consensus       245 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             CCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            99999999999999999999999999999999999999999888899999999999999999774

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.97  E-value=2.5e-30  Score=288.82  Aligned_cols=224  Identities=37%  Similarity=0.598  Sum_probs=193.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCC-CC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT-SI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~l   79 (580)
                      +|++++.+|..|..+++|++|+|++|.+++.+|..+.++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+
T Consensus       451 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  530 (768)
T 3rgz_A          451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI  530 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEEC
T ss_pred             CCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcC
Confidence            46777777777777888888888888887777888888888888888888888778888888888888888888887 47


Q ss_pred             CCCCcCCCCCceEeCcCCccc-----------------------------------------------------------
Q 038098           80 PSTLWNLKDILYLDLSSNFLL-----------------------------------------------------------  100 (580)
Q Consensus        80 p~~~~~l~~L~~L~l~~n~l~-----------------------------------------------------------  100 (580)
                      |..+..+++|++|+|++|++.                                                           
T Consensus       531 p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  610 (768)
T 3rgz_A          531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR  610 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGT
T ss_pred             CHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccc
Confidence            777888888888888888762                                                           


Q ss_pred             -----------------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccc
Q 038098          101 -----------------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN  163 (580)
Q Consensus       101 -----------------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  163 (580)
                                       +..+++|+.|+|++|++++.+|..|+.++.|+.|+|++|.++|.+|..|..+++|+.|||++|
T Consensus       611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N  690 (768)
T 3rgz_A          611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN  690 (768)
T ss_dssp             CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence                             122467899999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCCCCCCCCCCCc
Q 038098          164 NLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTR  227 (580)
Q Consensus       164 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p~~~~~~c~~~  227 (580)
                      ++++.+|..+..+++|+.|++++|+++|.+|....+..+...++.||+..|+.|.   ++|...
T Consensus       691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~  751 (768)
T 3rgz_A          691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPS  751 (768)
T ss_dssp             CCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSC
T ss_pred             cccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCC
Confidence            9999999999999999999999999999999998899999999999999999874   367543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.2e-31  Score=280.43  Aligned_cols=185  Identities=19%  Similarity=0.113  Sum_probs=131.4

Q ss_pred             eccccCceEEEEE-eCCCCEEEEEEEeccc----------cchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeEe
Q 038098          300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY----------GRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       300 lg~G~~g~v~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      .+.|+.|.+..++ ...|+.||+|++....          ....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666665554 3458999999996542          12345688999999999 7999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||++|++|.+++...+ +++..   +|+.||++||+|+|   +.|||||||||+|||++.+|.+||+|||+|+.......
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            9999999999997654 46654   58999999999999   99999999999999999999999999999986643322


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  494 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~  494 (580)
                        .....+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       395 --~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 --WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence              2345679999999999864 5678899999999998887766553

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.5e-28  Score=256.06  Aligned_cols=215  Identities=26%  Similarity=0.297  Sum_probs=197.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.|.+|.++++|++|+|++|.|++..|+.|.++++|++|+|++|.|+.+.+..|.++++|++|+|++|+|+.+|
T Consensus        84 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  163 (452)
T 3zyi_A           84 ENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIP  163 (452)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEEC
T ss_pred             CCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeC
Confidence            58899999999999999999999999999888899999999999999999999888888999999999999999999987


Q ss_pred             C-CCcCCCCCceEeCcCCc-c------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccc
Q 038098           81 S-TLWNLKDILYLDLSSNF-L------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~-l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                      . .+.++++|++|+|++|. +      .+.++++|+.|+|++|.++++  ..+..+++|+.|+|++|.|++..|..|..+
T Consensus       164 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  241 (452)
T 3zyi_A          164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGL  241 (452)
T ss_dssp             TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTC
T ss_pred             HhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc--ccccccccccEEECcCCcCcccCcccccCc
Confidence            6 67789999999999854 4      377899999999999999976  358889999999999999998889999999


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ++|+.|+|++|++++..+..|..+++|+.|++++|++++.++.. ..++++..+++.+|+|.|++.
T Consensus       242 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             cCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence            99999999999999888999999999999999999999888765 568889999999999999865

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=3.2e-28  Score=254.34  Aligned_cols=215  Identities=24%  Similarity=0.293  Sum_probs=197.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.+.+|.++++|++|+|++|.|+.+.++.|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|+|+.+|
T Consensus        73 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  152 (440)
T 3zyj_A           73 ENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIP  152 (440)
T ss_dssp             SCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEEC
T ss_pred             CCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccC
Confidence            58899888899999999999999999999888899999999999999999999888889999999999999999999987


Q ss_pred             C-CCcCCCCCceEeCcCCc-c------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccc
Q 038098           81 S-TLWNLKDILYLDLSSNF-L------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~-l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                      . .+..+++|++|+|++|. +      .+.++++|+.|+|++|.++.++  .+..+++|+.|+|++|.|++..|..|..+
T Consensus       153 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  230 (440)
T 3zyj_A          153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP--NLTPLIKLDELDLSGNHLSAIRPGSFQGL  230 (440)
T ss_dssp             TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC--CCTTCSSCCEEECTTSCCCEECTTTTTTC
T ss_pred             HHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc--ccCCCcccCEEECCCCccCccChhhhccC
Confidence            6 67789999999999954 3      4778999999999999999663  58899999999999999998889999999


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ++|+.|+|++|++++..+..|..+++|+.|++++|+++..++.. ..++++..+++.+|+|.|++.
T Consensus       231 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             TTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             ccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            99999999999999888999999999999999999999888765 668899999999999999854

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.2e-28  Score=242.14  Aligned_cols=212  Identities=24%  Similarity=0.279  Sum_probs=177.6

Q ss_pred             ccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCC-CCCC-C
Q 038098            3 NLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNK-LTSI-P   80 (580)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~l-p   80 (580)
                      .++ .+|..+  .++|++|+|++|.|+...++.|..+++|++|+|++|.++++.+..|.++++|++|+|++|+ ++.+ |
T Consensus        22 ~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~   98 (285)
T 1ozn_A           22 GLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP   98 (285)
T ss_dssp             CCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCT
T ss_pred             Ccc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCH
Confidence            344 455444  4689999999999987777888889999999999999988888889999999999999997 8887 5


Q ss_pred             CCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      ..+..+++|++|+|++|.+      .+.++++|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++
T Consensus        99 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  178 (285)
T 1ozn_A           99 ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS  178 (285)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             HHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccc
Confidence            6777889999999999987      2667888999999999998887778888899999999999998666667888899


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCCCccccCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      |+.|+|++|.+++..|..+..+++|+.|++++|++++.++. ...++.+..+++.+|++.|+.+
T Consensus       179 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~  242 (285)
T 1ozn_A          179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (285)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence            99999999999887788888899999999999999887754 4667888888899999988765

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.2e-27  Score=235.02  Aligned_cols=217  Identities=27%  Similarity=0.300  Sum_probs=195.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCc-CCcCCCccccCCCCCcEEEcCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNK-LDGFVPACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      +|+|+++.+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|. ++.+.+..|..+++|++|+|++|+++.+
T Consensus        41 ~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  120 (285)
T 1ozn_A           41 GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL  120 (285)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCC
T ss_pred             CCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEE
Confidence            588898888899999999999999999998889999999999999999997 8888899999999999999999999998


Q ss_pred             C-CCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccc
Q 038098           80 P-STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        80 p-~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                      + ..+..+++|++|+|++|++      .+..+++|+.|++++|.++++++..|..+++|+.|+|++|.+++..|..|..+
T Consensus       121 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  200 (285)
T 1ozn_A          121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL  200 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCc
Confidence            4 5678899999999999998      26789999999999999998888889999999999999999998889999999


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCC
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ++|+.|+|++|++++..+..+..+++|+.|++++|++++.++....+.++.......+...|..|
T Consensus       201 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             TTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             ccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence            99999999999999877788999999999999999999988765444555555566667777655

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.95  E-value=1.8e-28  Score=243.93  Aligned_cols=215  Identities=23%  Similarity=0.396  Sum_probs=196.8

Q ss_pred             CCcccc--CCCcccCCCCCCCEEeccC-CcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCC
Q 038098            1 GNNLNG--SIPIAVGKLQKLQLLSLED-NQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus         1 ~N~~~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~   77 (580)
                      +|++++  .+|.+|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+|+
T Consensus        59 ~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  138 (313)
T 1ogq_A           59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS  138 (313)
T ss_dssp             CCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred             CCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccC
Confidence            578888  8999999999999999995 9999899999999999999999999999999999999999999999999999


Q ss_pred             -CCCCCCcCCCCCceEeCcCCccc------ccCCC-cccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccc
Q 038098           78 -SIPSTLWNLKDILYLDLSSNFLL------IGNLK-VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        78 -~lp~~~~~l~~L~~L~l~~n~l~------~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~  149 (580)
                       .+|..+..+++|++|+|++|++.      +..++ +|+.|++++|.+++..|..+..++ |+.|+|++|.+++.+|..|
T Consensus       139 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~  217 (313)
T 1ogq_A          139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLF  217 (313)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGC
T ss_pred             CcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHH
Confidence             58888999999999999999983      66777 999999999999988999999887 9999999999999999999


Q ss_pred             ccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCCCccccCCC
Q 038098          150 GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       150 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ..+++|+.|+|++|++++.+|. +..+++|+.|++++|++++.+|. ...++.++.+++++|......|
T Consensus       218 ~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          218 GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             CTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             hcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            9999999999999999976665 88899999999999999977665 4678889999999998765444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.4e-29  Score=267.21  Aligned_cols=194  Identities=23%  Similarity=0.207  Sum_probs=100.6

Q ss_pred             CCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCC--------------
Q 038098           17 KLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPST--------------   82 (580)
Q Consensus        17 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~--------------   82 (580)
                      +|++|+|++|.|++..|+.|..+++|++|+|++|.|++..|  |..+++|++|+|++|+|+.+|..              
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~  112 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS  112 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence            55555555555555455555555555555555555554333  55555555555555555544321              


Q ss_pred             ---CcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccC-CccccceeccccccccccCCcccccc
Q 038098           83 ---LWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIG-GLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        83 ---~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                         ...+++|+.|+|++|.+      .+.++++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++. |. +..+
T Consensus       113 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l  190 (487)
T 3oja_A          113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVF  190 (487)
T ss_dssp             CEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCC
T ss_pred             CCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccC
Confidence               01234455555555554      134455555555555555554444443 455555555555555533 21 2235


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccC
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~  215 (580)
                      ++|+.|+|++|.+++. |..+..+++|+.|++++|.+++.++....++.+..+++.+|++.|+
T Consensus       191 ~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          191 AKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             TTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             CCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence            5555556666655532 2335555566666666666655544444555555555666655553

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.94  E-value=5.2e-27  Score=261.99  Aligned_cols=217  Identities=35%  Similarity=0.528  Sum_probs=173.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCC-CC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT-SI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~l   79 (580)
                      +|++++.+|..|..+++|+.|+|++|.+++.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|+++ .+
T Consensus       427 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  506 (768)
T 3rgz_A          427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI  506 (768)
T ss_dssp             SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred             CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC
Confidence            46777777777777788888888888877777778888888888888888888777888888888888888888887 46


Q ss_pred             CCCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcc-----------------------------
Q 038098           80 PSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTT-----------------------------  124 (580)
Q Consensus        80 p~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~-----------------------------  124 (580)
                      |..+..+++|++|+|++|++      .+.++++|+.|++++|.+++.+|..                             
T Consensus       507 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (768)
T 3rgz_A          507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE  586 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTT
T ss_pred             ChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccc
Confidence            77777888888888888887      3667888888888888887555432                             


Q ss_pred             -----------------------------------------cCCccccceeccccccccccCCccccccccccccccccc
Q 038098          125 -----------------------------------------IGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN  163 (580)
Q Consensus       125 -----------------------------------------~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  163 (580)
                                                               +..++.|+.|+|++|+++|.+|..++.+++|+.|+|++|
T Consensus       587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N  666 (768)
T 3rgz_A          587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN  666 (768)
T ss_dssp             CCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCC
Confidence                                                     334567888888888888888888888899999999999


Q ss_pred             ccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          164 NLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       164 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ++++.+|..+..+++|+.||+++|++++.+|.. ..+..++.+++++|+....-|
T Consensus       667 ~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             CCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             ccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            999888988999999999999999998877754 667778888888888755444

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.94  E-value=4.3e-27  Score=233.61  Aligned_cols=216  Identities=23%  Similarity=0.322  Sum_probs=179.6

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCC--CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGS--IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~   78 (580)
                      +|+|+++.+..|.++++|++|+|++|.++..  .|..+..+++|++|+|++|.++. +|..|..+++|++|+|++|+++.
T Consensus        37 ~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~  115 (306)
T 2z66_A           37 SNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ  115 (306)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEES
T ss_pred             CCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccc
Confidence            4677765556688889999999999988733  36777788899999999998884 56678889999999999999988


Q ss_pred             CCC--CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCC-CCCcccCCccccceeccccccccccCCccc
Q 038098           79 IPS--TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSD-VIPTTIGGLKDLQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        79 lp~--~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~  149 (580)
                      ++.  .+..+++|++|++++|.+      .+..+++|+.|++++|.+++ ..|..+..+++|+.|+|++|.+++..|..|
T Consensus       116 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  195 (306)
T 2z66_A          116 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF  195 (306)
T ss_dssp             STTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             cccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHh
Confidence            764  677889999999999987      26678899999999999986 567888899999999999999997778888


Q ss_pred             ccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCC-ccCccccCCCCccccCCC
Q 038098          150 GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPF-RNFSTESFEGNELLCGMP  217 (580)
Q Consensus       150 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~-~~l~~~~~~~n~~~c~~p  217 (580)
                      ..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..+.. ..+ +.+..+++.+|++.|+++
T Consensus       196 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~  265 (306)
T 2z66_A          196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  265 (306)
T ss_dssp             TTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred             cCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence            89999999999999999777778888999999999999998877654 445 478888999999988743

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=1.2e-26  Score=227.90  Aligned_cols=202  Identities=27%  Similarity=0.265  Sum_probs=182.4

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCc
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDIL   90 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~   90 (580)
                      .+.++++++.+++++|.++ .+|..+.  ++|++|+|++|.|+++.+..|.++++|++|+|++|+|+.++.. ..+++|+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~   80 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG   80 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence            4778999999999999998 5665554  6899999999999988889999999999999999999998765 7899999


Q ss_pred             eEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccccc
Q 038098           91 YLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNL  165 (580)
Q Consensus        91 ~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l  165 (580)
                      +|+|++|++     .+..+++|+.|++++|+++++++..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus        81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G           81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            999999998     367889999999999999998889999999999999999999977777788999999999999999


Q ss_pred             CCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCC
Q 038098          166 SGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGM  216 (580)
Q Consensus       166 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~  216 (580)
                      +...+..+..+++|+.|++++|+++..++.......+..+++.+|+|.|++
T Consensus       161 ~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          161 TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence            977777788999999999999999988887777788899999999999974

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.94  E-value=1.1e-26  Score=244.05  Aligned_cols=217  Identities=26%  Similarity=0.271  Sum_probs=148.8

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchh--hhCCCCCceeeCCCCcCCcCCCcc-ccCCCCCcEEEcCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDD--LCRLAALFELDSGGNKLDGFVPAC-FGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~   77 (580)
                      +|++++..|.+|.++++|++|+|++|.+++..|..  |..+++|++|+|++|.+++..|.. |.++++|++|+|++|+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            45666666667777777777777777776544443  667777777777777777665654 677777777777777776


Q ss_pred             CCCC-CCcC----------------------------------CCCCceEeCcCCcc-----------------------
Q 038098           78 SIPS-TLWN----------------------------------LKDILYLDLSSNFL-----------------------   99 (580)
Q Consensus        78 ~lp~-~~~~----------------------------------l~~L~~L~l~~n~l-----------------------   99 (580)
                      .++. .+..                                  +++|++|++++|++                       
T Consensus       168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~  247 (455)
T 3v47_A          168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS  247 (455)
T ss_dssp             CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred             ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence            5432 2221                                  23455555555432                       


Q ss_pred             ----------------------------------------------cccCCCcccEEeCCCCcCCCCCCcccCCccccce
Q 038098          100 ----------------------------------------------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQY  133 (580)
Q Consensus       100 ----------------------------------------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  133 (580)
                                                                    .+..+++|+.|++++|.+++..+..|..+++|+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  327 (455)
T 3v47_A          248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK  327 (455)
T ss_dssp             TCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCE
Confidence                                                          1345667777777777777776777777777777


Q ss_pred             eccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCcc
Q 038098          134 LFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNEL  212 (580)
Q Consensus       134 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~  212 (580)
                      |+|++|.+++..|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++++.++.. ..++.++.+++.+|++
T Consensus       328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  407 (455)
T 3v47_A          328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  407 (455)
T ss_dssp             EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence            777777777666777777777888888888877666777777888888888888887766644 5667777788888888


Q ss_pred             ccCCC
Q 038098          213 LCGMP  217 (580)
Q Consensus       213 ~c~~p  217 (580)
                      .|+.|
T Consensus       408 ~~~~~  412 (455)
T 3v47_A          408 DCSCP  412 (455)
T ss_dssp             CCCTT
T ss_pred             ccCCC
Confidence            77765

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.94  E-value=1e-27  Score=243.10  Aligned_cols=217  Identities=17%  Similarity=0.209  Sum_probs=184.4

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.+.+|.++++|++|+|++|.+++..|+.|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+++.+|
T Consensus        61 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~  140 (353)
T 2z80_A           61 NNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLG  140 (353)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSC
T ss_pred             CCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccC
Confidence            57788777778999999999999999999888888999999999999999999766666999999999999999999988


Q ss_pred             C--CCcCCCCCceEeCcCCc-c------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccc
Q 038098           81 S--TLWNLKDILYLDLSSNF-L------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD  151 (580)
Q Consensus        81 ~--~~~~l~~L~~L~l~~n~-l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~  151 (580)
                      .  .+..+++|++|++++|. +      .+.++++|+.|++++|.+++..|..|..+++|+.|++++|.++...+..+..
T Consensus       141 ~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~  220 (353)
T 2z80_A          141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV  220 (353)
T ss_dssp             SSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHH
T ss_pred             chhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhh
Confidence            7  67789999999999984 4      3678889999999999999888889999999999999999987433334456


Q ss_pred             ccccccccccccccCCCc-------------------------------cccccccCcccEEEccCCcccCCCCCC-CCC
Q 038098          152 LINLKSLNLSNNNLSGTI-------------------------------PISLEKLLDLKDINVSFNKLEGEIPNK-GPF  199 (580)
Q Consensus       152 l~~L~~L~l~~N~l~~~~-------------------------------~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~  199 (580)
                      +++|+.|++++|.+++..                               |..+..+++|+.|++++|+++..++.. ..+
T Consensus       221 ~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l  300 (353)
T 2z80_A          221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL  300 (353)
T ss_dssp             TTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcC
Confidence            889999999999998643                               345667889999999999999777664 678


Q ss_pred             ccCccccCCCCccccCCC
Q 038098          200 RNFSTESFEGNELLCGMP  217 (580)
Q Consensus       200 ~~l~~~~~~~n~~~c~~p  217 (580)
                      +++..+++.+|++.|+.|
T Consensus       301 ~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          301 TSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             TTCCEEECCSSCBCCCHH
T ss_pred             CCCCEEEeeCCCccCcCC
Confidence            899999999999988754

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=3.5e-26  Score=223.43  Aligned_cols=208  Identities=22%  Similarity=0.267  Sum_probs=184.0

Q ss_pred             CCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC-CCCcC
Q 038098            7 SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP-STLWN   85 (580)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp-~~~~~   85 (580)
                      .+|..+.  ++|++|+|++|.+++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|+|+.++ ..+.+
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            4666554  58999999999999878889999999999999999999888889999999999999999999977 56889


Q ss_pred             CCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCC-CCcccCCccccceeccccccccccCCcccccccccc--
Q 038098           86 LKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK--  156 (580)
Q Consensus        86 l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~--  156 (580)
                      +++|++|++++|.+      .+..+++|+.|++++|.+++. .|..|..+++|+.|+|++|++++..+..+..+.+|+  
T Consensus        99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l  178 (276)
T 2z62_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL  178 (276)
T ss_dssp             CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred             CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence            99999999999998      377889999999999999875 488999999999999999999987778888888888  


Q ss_pred             --cccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          157 --SLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       157 --~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                        .|++++|.+++..+..+. ..+|+.|++++|.+++.++.. ..++++..+++.+|++.|+++
T Consensus       179 ~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          179 NLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             ceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence              899999999965555554 458999999999999888765 668899999999999999866

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.94  E-value=2.5e-26  Score=236.19  Aligned_cols=208  Identities=23%  Similarity=0.229  Sum_probs=125.9

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.|.+|..+++|++|+|++|.+++..|..|.++++|++|+|++|.++.+.+..|.++++|++|+|++|+++.++
T Consensus        78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~  157 (390)
T 3o6n_A           78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE  157 (390)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred             CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence            46677666677777777777777777777666777777777777777777777665556777777777777777777764


Q ss_pred             C-CCcCCCCCceEeCcCCccc---ccCC----------------------------------------CcccEEeCCCCc
Q 038098           81 S-TLWNLKDILYLDLSSNFLL---IGNL----------------------------------------KVLVQVDLSMNN  116 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l~---~~~l----------------------------------------~~L~~L~l~~N~  116 (580)
                      . .+..+++|++|++++|++.   +..+                                        ++|+.|++++|.
T Consensus       158 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~  237 (390)
T 3o6n_A          158 DDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNN  237 (390)
T ss_dssp             TTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSC
T ss_pred             hhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCC
Confidence            3 4666777777777777652   1111                                        123333333333


Q ss_pred             CCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       117 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      +++.  ..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++..
T Consensus       238 l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  314 (390)
T 3o6n_A          238 LTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQ  314 (390)
T ss_dssp             CCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCCCCGGGH
T ss_pred             Cccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcceecCccc
Confidence            3322  23445555666666666665555555555556666666666555 33444445555555555555555444443


Q ss_pred             CCCccCccccCCCCc
Q 038098          197 GPFRNFSTESFEGNE  211 (580)
Q Consensus       197 ~~~~~l~~~~~~~n~  211 (580)
                      ..++.++.+++.+|+
T Consensus       315 ~~l~~L~~L~L~~N~  329 (390)
T 3o6n_A          315 PQFDRLENLYLDHNS  329 (390)
T ss_dssp             HHHTTCSEEECCSSC
T ss_pred             cccCcCCEEECCCCc
Confidence            344444445554444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.7e-25  Score=217.79  Aligned_cols=198  Identities=28%  Similarity=0.398  Sum_probs=148.9

Q ss_pred             CCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCC-cCCCCCceEeCc
Q 038098           17 KLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTL-WNLKDILYLDLS   95 (580)
Q Consensus        17 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~-~~l~~L~~L~l~   95 (580)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+|... ..+++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            4677888888877 4555444  56788888888887776667888888888888888888777654 567788888888


Q ss_pred             CCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCc
Q 038098           96 SNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI  169 (580)
Q Consensus        96 ~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  169 (580)
                      +|++      .+..+++|+.|++++|.++++.+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            8877      2566778888888888888777777788888888888888887555556777888888888888888766


Q ss_pred             cccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCCCccccCCC
Q 038098          170 PISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       170 ~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      +..+..+++|+.|++++|+++..++. ...++.+..+++.+|+|.|+++
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            66777788888888888888876664 3456777777888888877654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=4.3e-26  Score=247.38  Aligned_cols=99  Identities=23%  Similarity=0.196  Sum_probs=75.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.|.+|..+++|++|+|++|.|++..|..|+++++|++|+|++|.|+++.+..|+++++|++|+|++|+|+.++
T Consensus        84 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (597)
T 3oja_B           84 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE  163 (597)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred             CCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCC
Confidence            46777777777888888888888888887777777778888888888888887666666777888888888888877765


Q ss_pred             C-CCcCCCCCceEeCcCCcc
Q 038098           81 S-TLWNLKDILYLDLSSNFL   99 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l   99 (580)
                      . .+..+++|++|+|++|.+
T Consensus       164 ~~~~~~l~~L~~L~L~~N~l  183 (597)
T 3oja_B          164 DDTFQATTSLQNLQLSSNRL  183 (597)
T ss_dssp             TTTTTTCTTCCEEECTTSCC
T ss_pred             hhhhhcCCcCcEEECcCCCC
Confidence            4 566777777777777765

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.93  E-value=2e-26  Score=230.69  Aligned_cols=204  Identities=23%  Similarity=0.276  Sum_probs=139.1

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCC-CCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNK-LTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~l   79 (580)
                      +|+|+ .+|..+.++++|++|+|++|.++ .+|..|+.+++|++|+|++|.++ .+|..|.++++|++|+|++|+ +..+
T Consensus        90 ~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~  166 (328)
T 4fcg_A           90 SVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL  166 (328)
T ss_dssp             SSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCC
T ss_pred             CCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCcccc
Confidence            35555 56666777777777777777777 66777777777777777777777 556677777777777777754 3446


Q ss_pred             CCCCcC---------CCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccC
Q 038098           80 PSTLWN---------LKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI  145 (580)
Q Consensus        80 p~~~~~---------l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (580)
                      |..+..         +++|++|+|++|++     .+..+++|+.|+|++|.++++ |..+..+++|+.|+|++|.+.+.+
T Consensus       167 p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l-~~~l~~l~~L~~L~Ls~n~~~~~~  245 (328)
T 4fcg_A          167 PEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNY  245 (328)
T ss_dssp             CSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCC-CGGGGGCTTCCEEECTTCTTCCBC
T ss_pred             ChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcC-chhhccCCCCCEEECcCCcchhhh
Confidence            655543         67777777777776     255667777777777777754 445677777777777777777677


Q ss_pred             CcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCC
Q 038098          146 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFE  208 (580)
Q Consensus       146 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~  208 (580)
                      |..+..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|++.+.+|.. ..++.+..+.+.
T Consensus       246 p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~  309 (328)
T 4fcg_A          246 PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP  309 (328)
T ss_dssp             CCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred             HHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence            777777777777777777777777777777777777777777776666543 444444444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.93  E-value=2.8e-26  Score=242.37  Aligned_cols=216  Identities=23%  Similarity=0.278  Sum_probs=123.4

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC-
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP-   80 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp-   80 (580)
                      |+|+++.|.+|.++++|++|+|++|.|++..|+.|.++++|++|+|++|.++.+.+..|.++++|++|+|++|+++.++ 
T Consensus        42 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~  121 (477)
T 2id5_A           42 NRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLD  121 (477)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECT
T ss_pred             CccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCCh
Confidence            4555555555555555555555555555444555555555555555555555444444555555555555555544432 


Q ss_pred             C------------------------CCcCCCCCceEeCcCCccc------ccCCCcccEE--------------------
Q 038098           81 S------------------------TLWNLKDILYLDLSSNFLL------IGNLKVLVQV--------------------  110 (580)
Q Consensus        81 ~------------------------~~~~l~~L~~L~l~~n~l~------~~~l~~L~~L--------------------  110 (580)
                      .                        .+.++++|++|+|++|++.      +.++++|+.|                    
T Consensus       122 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~  201 (477)
T 2id5_A          122 YMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR  201 (477)
T ss_dssp             TTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTT
T ss_pred             hHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcc
Confidence            2                        3334444444444444431      2222233333                    


Q ss_pred             ----------------------------eCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccc
Q 038098          111 ----------------------------DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN  162 (580)
Q Consensus       111 ----------------------------~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  162 (580)
                                                  ++++|.++.+++..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++
T Consensus       202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  281 (477)
T 2id5_A          202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG  281 (477)
T ss_dssp             CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred             cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence                                        3333333333333455566666666666666655556667777777777777


Q ss_pred             cccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          163 NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       163 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      |++++..|..+..+++|+.|++++|.+++.++.. ..++++..+++.+|++.|+++
T Consensus       282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred             CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence            7777666777777778888888888887766543 556777778888888887643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=5.7e-27  Score=249.35  Aligned_cols=186  Identities=18%  Similarity=0.165  Sum_probs=145.4

Q ss_pred             CcCceeccccCceEEEEEeCCCCEEEEEEEecccc--------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          295 SENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG--------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ...+.||+|+||.||+|... ++.+++|.......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44678999999999999554 78899998743221        1134578999999999999999666666677778999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++++|.+++..         +..++.|+++||+|||   +.+|+||||||+|||++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999875         5689999999999999   999999999999999999  99999999999764322


Q ss_pred             Ccc-----cccccccCCCcCCcccccC--CCCCCchhhHhHHHHHHHHHhCCCCCC
Q 038098          447 QSL-----TQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTD  495 (580)
Q Consensus       447 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~elltg~~p~~  495 (580)
                      ...     ......||+.|+|||++..  ..|+..+|+||.++-..+-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1235579999999999876  567788899999999999888887763

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=2.8e-25  Score=216.23  Aligned_cols=193  Identities=26%  Similarity=0.330  Sum_probs=174.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+++ .+|..+.  ++|++|+|++|+|+...+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|++|+|+.+|
T Consensus        25 ~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~  101 (270)
T 2o6q_A           25 SKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALP  101 (270)
T ss_dssp             TSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCC
T ss_pred             CCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCC
Confidence            35566 4676554  68999999999999877789999999999999999999888888999999999999999999988


Q ss_pred             C-CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccc
Q 038098           81 S-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI  153 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  153 (580)
                      . .+..+++|++|+|++|++      .+..+++|+.|+|++|.++++++..|..+++|+.|+|++|.+++..+..|..++
T Consensus       102 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  181 (270)
T 2o6q_A          102 IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT  181 (270)
T ss_dssp             TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             HhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCC
Confidence            6 457899999999999998      367899999999999999998888899999999999999999977777899999


Q ss_pred             ccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          154 NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       154 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      +|+.|+|++|++++..+..+..+++|+.|++++|++.+.+...
T Consensus       182 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  224 (270)
T 2o6q_A          182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGI  224 (270)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSSS
T ss_pred             CcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCccH
Confidence            9999999999999877778999999999999999999988644

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.93  E-value=8.7e-26  Score=235.88  Aligned_cols=195  Identities=27%  Similarity=0.305  Sum_probs=181.8

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCC-CCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS-NKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~l   79 (580)
                      +|+|+++.+.+|.++++|++|+|++|+|+...++.|..+++|++|+|++|.|+.+.+..|.++++|++|+|++ |.++.+
T Consensus        97 ~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i  176 (440)
T 3zyj_A           97 RNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI  176 (440)
T ss_dssp             SSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             CCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCccee
Confidence            5889988889999999999999999999977778899999999999999999988888999999999999998 567777


Q ss_pred             CC-CCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           80 PS-TLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        80 p~-~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      +. .+.++++|++|+|++|++    .+..+++|+.|+|++|.++++.+..|.++++|+.|+|++|.|++..+..|..+++
T Consensus       177 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  256 (440)
T 3zyj_A          177 SEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS  256 (440)
T ss_dssp             CTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred             CcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCC
Confidence            76 677899999999999999    3678899999999999999999999999999999999999999888999999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      |+.|+|++|++++..+..+..+++|+.|++++|++.|.+..
T Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l  297 (440)
T 3zyj_A          257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI  297 (440)
T ss_dssp             CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred             CCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence            99999999999988888899999999999999999998753

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=6.7e-26  Score=221.42  Aligned_cols=196  Identities=23%  Similarity=0.276  Sum_probs=177.1

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.+.+|.++++|++|+|++|.++...++.|..+++|++|+|++|.+++..+..|.++++|++|++++|+++.++
T Consensus        37 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  116 (276)
T 2z62_A           37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE  116 (276)
T ss_dssp             TCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCST
T ss_pred             CCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccC
Confidence            58888888889999999999999999999888889999999999999999999988899999999999999999999987


Q ss_pred             C-CCcCCCCCceEeCcCCcc-------cccCCCcccEEeCCCCcCCCCCCcccCCccccc----eeccccccccccCCcc
Q 038098           81 S-TLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ----YLFLEYNRLQGSIPDS  148 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l-------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~p~~  148 (580)
                      . .+..+++|++|+|++|++       .+.++++|+.|++++|.++++.+..|..++.|+    .|++++|.+++..+..
T Consensus       117 ~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~  196 (276)
T 2z62_A          117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA  196 (276)
T ss_dssp             TCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTS
T ss_pred             chhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccc
Confidence            6 688999999999999998       256789999999999999998888888888887    8999999999655554


Q ss_pred             cccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCC
Q 038098          149 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKG  197 (580)
Q Consensus       149 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~  197 (580)
                      +. ..+|+.|+|++|++++..+..+..+++|+.|++++|+++|.++...
T Consensus       197 ~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~  244 (276)
T 2z62_A          197 FK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  244 (276)
T ss_dssp             SC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred             cC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence            54 4689999999999998777778999999999999999999987653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.93  E-value=9e-26  Score=236.64  Aligned_cols=195  Identities=25%  Similarity=0.270  Sum_probs=182.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCC-CCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS-NKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~l   79 (580)
                      +|+|+++.|.+|..+++|++|+|++|.|+...++.|..+++|++|+|++|.|+.+.+..|.++++|++|+|++ |.++.+
T Consensus       108 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i  187 (452)
T 3zyi_A          108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI  187 (452)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             CCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcccc
Confidence            5889999999999999999999999999988888899999999999999999988888999999999999998 677778


Q ss_pred             CC-CCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           80 PS-TLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        80 p~-~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      +. .+.++++|++|+|++|++    .+..+++|+.|+|++|.+++..+..|.++++|+.|+|++|.+++..|..|..+++
T Consensus       188 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  267 (452)
T 3zyi_A          188 SEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS  267 (452)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             ChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence            76 577899999999999999    3678899999999999999999999999999999999999999888999999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      |+.|+|++|++++..+..+..+++|+.|++++|++.|.+..
T Consensus       268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~  308 (452)
T 3zyi_A          268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI  308 (452)
T ss_dssp             CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred             CCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence            99999999999988888899999999999999999998763

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.93  E-value=6.9e-26  Score=255.53  Aligned_cols=212  Identities=25%  Similarity=0.293  Sum_probs=133.5

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |++.+..|..|..+++|+.|+|++|.|++..|+.|..+++|++|+|++|.++++.|..|.++++|++|+|++|+|+.++.
T Consensus       276 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  355 (844)
T 3j0a_A          276 GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD  355 (844)
T ss_dssp             CCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCS
T ss_pred             CcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccCh
Confidence            55555556666666666666666666665566666666666666666666666666666666666666666666666543


Q ss_pred             -CCcCCCCCceEeCcCCccc----------------------------------------------ccCCCcccEEeCCC
Q 038098           82 -TLWNLKDILYLDLSSNFLL----------------------------------------------IGNLKVLVQVDLSM  114 (580)
Q Consensus        82 -~~~~l~~L~~L~l~~n~l~----------------------------------------------~~~l~~L~~L~l~~  114 (580)
                       .+..+++|++|+|++|.+.                                              +.++++|+.|+|++
T Consensus       356 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~  435 (844)
T 3j0a_A          356 QTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ  435 (844)
T ss_dssp             SCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEES
T ss_pred             hhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCC
Confidence             3445666666666655541                                              11445555566666


Q ss_pred             CcCCCCC------------------------------CcccCCccccceeccccccccccCCcccccccccccccccccc
Q 038098          115 NNFSDVI------------------------------PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNN  164 (580)
Q Consensus       115 N~l~~~~------------------------------~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~  164 (580)
                      |++++..                              +..|.++++|+.|+|++|.|++..|..|..+++|+.|+|++|+
T Consensus       436 N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  515 (844)
T 3j0a_A          436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR  515 (844)
T ss_dssp             CCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCC
T ss_pred             CcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCC
Confidence            5555322                              2335556666666666666665556666666666666666666


Q ss_pred             cCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCC
Q 038098          165 LSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       165 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      +++..+..+.  ++|+.|++++|++++.+|..  +..+..+++.+|++.|+++
T Consensus       516 l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          516 LTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             CSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred             CCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence            6655555444  56666667777766666643  5677888899999999765

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.93  E-value=7.7e-26  Score=226.35  Aligned_cols=190  Identities=24%  Similarity=0.264  Sum_probs=177.7

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccC---------CCCCcEEEc
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGN---------LTNLRNLYL   71 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~---------l~~L~~L~l   71 (580)
                      +|+|+ .+|.+|..+++|++|+|++|.++ .+|..|.++++|++|+|++|++.+.+|..+..         +++|++|+|
T Consensus       113 ~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L  190 (328)
T 4fcg_A          113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL  190 (328)
T ss_dssp             SSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEE
T ss_pred             CCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEEC
Confidence            57888 88999999999999999999999 78999999999999999999888888887654         999999999


Q ss_pred             CCCCCCCCCCCCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCC
Q 038098           72 GSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP  146 (580)
Q Consensus        72 ~~N~l~~lp~~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p  146 (580)
                      ++|+|+.+|..+..+++|++|+|++|++     .+..+++|+.|++++|.+.+..|..|..+++|+.|+|++|.+.+.+|
T Consensus       191 ~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p  270 (328)
T 4fcg_A          191 EWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP  270 (328)
T ss_dssp             EEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCC
T ss_pred             cCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcc
Confidence            9999999999999999999999999998     36789999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccccccccCcccEEEccCCcccCC
Q 038098          147 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE  192 (580)
Q Consensus       147 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~  192 (580)
                      ..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+...
T Consensus       271 ~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL  316 (328)
T ss_dssp             TTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred             hhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence            9999999999999999999999999999999999999998876543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=4.3e-25  Score=216.78  Aligned_cols=188  Identities=26%  Similarity=0.217  Sum_probs=169.9

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+++ .+|..+.  ++|++|+|++|.|++..+..|..+++|++|+|++|.|+++.+  ...+++|++|+|++|+|+.+|
T Consensus        19 ~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~   93 (290)
T 1p9a_G           19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQSLP   93 (290)
T ss_dssp             TSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCSSCC
T ss_pred             CCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCCcCc
Confidence            35666 5666554  799999999999998888999999999999999999997644  388999999999999999999


Q ss_pred             CCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      ..+..+++|++|+|++|+|      .+.++++|+.|+|++|+++++++..|..+++|+.|+|++|+|++..+..|..+++
T Consensus        94 ~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~  173 (290)
T 1p9a_G           94 LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN  173 (290)
T ss_dssp             CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTT
T ss_pred             hhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCC
Confidence            9999999999999999998      3778999999999999999998889999999999999999999666667888999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      |+.|+|++|+++ .+|..+..+++|+.|++++|++.|.+.
T Consensus       174 L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            999999999999 778888888999999999999998763

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.93  E-value=5.7e-25  Score=220.86  Aligned_cols=206  Identities=19%  Similarity=0.232  Sum_probs=120.9

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+|+++.|.+|.++++|++|+|++|.|++..|..|.++++|++|+|++|.++.+ |..+.  ++|++|++++|+++.+|.
T Consensus        64 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~  140 (332)
T 2ft3_A           64 NDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPK  140 (332)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCS
T ss_pred             CcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCH
Confidence            555555555566666666666666666555555566666666666666665532 22222  455555555555555554


Q ss_pred             C-CcCCCCCceEeCcCCccc--------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccc
Q 038098           82 T-LWNLKDILYLDLSSNFLL--------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        82 ~-~~~l~~L~~L~l~~n~l~--------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                      . +..+++|++|++++|.+.        +..+ +|+.|++++|.+++++ ..+.  ++|+.|+|++|.+++..+..|..+
T Consensus       141 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~-~~~~--~~L~~L~l~~n~i~~~~~~~l~~l  216 (332)
T 2ft3_A          141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP-KDLP--ETLNELHLDHNKIQAIELEDLLRY  216 (332)
T ss_dssp             GGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCC-SSSC--SSCSCCBCCSSCCCCCCTTSSTTC
T ss_pred             hHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccC-cccc--CCCCEEECCCCcCCccCHHHhcCC
Confidence            2 445566666666666551        2222 4444444444444322 1111  466666777777765555667777


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                      ++|+.|+|++|++++..+..+..+++|+.|++++|+++..+.....++.+..+++.+|....
T Consensus       217 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~  278 (332)
T 2ft3_A          217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK  278 (332)
T ss_dssp             TTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCB
T ss_pred             CCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCc
Confidence            77777777777777666666777777777777777777555555566666777777666543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.93  E-value=7.1e-25  Score=220.01  Aligned_cols=207  Identities=21%  Similarity=0.263  Sum_probs=113.9

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++.+.+|.++++|++|+|++|.+++..|+.|..+++|++|+|++|.++.+ |..+.  ++|++|++++|+++.++
T Consensus        61 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~  137 (330)
T 1xku_A           61 NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVR  137 (330)
T ss_dssp             SSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBC
T ss_pred             CCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCcc-Chhhc--ccccEEECCCCcccccC
Confidence            3555555555566666666666666666655555666666666666666665532 22221  44555555555555443


Q ss_pred             C-CCcCCCCCceEeCcCCcc--------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccc
Q 038098           81 S-TLWNLKDILYLDLSSNFL--------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGD  151 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~  151 (580)
                      . .+.++++|++|++++|.+        .+.++++|+.|++++|.++.++. .+.  ++|+.|+|++|.+++..|..|..
T Consensus       138 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~-~~~--~~L~~L~l~~n~l~~~~~~~~~~  214 (330)
T 1xku_A          138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ-GLP--PSLTELHLDGNKITKVDAASLKG  214 (330)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS-SCC--TTCSEEECTTSCCCEECTGGGTT
T ss_pred             HhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCc-ccc--ccCCEEECCCCcCCccCHHHhcC
Confidence            2 234455555555555554        13345555555555555554322 211  45555666666665555556666


Q ss_pred             ccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          152 LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       152 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      +++|+.|+|++|.+++..+..+..+++|+.|++++|+++..+.....++.+..+++.+|+..
T Consensus       215 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~  276 (330)
T 1xku_A          215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS  276 (330)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC
T ss_pred             CCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCC
Confidence            66666666666666655555566666666666666666655544555556666666666543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.92  E-value=7e-25  Score=220.06  Aligned_cols=211  Identities=24%  Similarity=0.309  Sum_probs=186.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC--
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS--   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--   78 (580)
                      +|+|+++.|.+|..+++|++|+|++|.++ .+|..+.  ++|++|++++|.++++.+..|.++++|++|++++|+++.  
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  161 (330)
T 1xku_A           85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG  161 (330)
T ss_dssp             SSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred             CCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence            58899999999999999999999999998 5665554  799999999999998888899999999999999999974  


Q ss_pred             -CCCCCcCCCCCceEeCcCCccc---ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           79 -IPSTLWNLKDILYLDLSSNFLL---IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        79 -lp~~~~~l~~L~~L~l~~n~l~---~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                       .+..+.++++|++|++++|.+.   ..-.++|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..+..+++
T Consensus       162 ~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  241 (330)
T 1xku_A          162 IENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH  241 (330)
T ss_dssp             BCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred             cChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCC
Confidence             4567788999999999999983   222379999999999999998999999999999999999999877888999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCCCC-------CCccCccccCCCCccccC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKG-------PFRNFSTESFEGNELLCG  215 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~-------~~~~l~~~~~~~n~~~c~  215 (580)
                      |+.|+|++|+++ .+|..+..+++|+.|++++|++++..+...       ....+..+++.+|++.+.
T Consensus       242 L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~  308 (330)
T 1xku_A          242 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  308 (330)
T ss_dssp             CCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             CCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence            999999999999 788889999999999999999998776542       235566788889987653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.92  E-value=3.3e-25  Score=244.83  Aligned_cols=217  Identities=26%  Similarity=0.335  Sum_probs=193.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCc-hhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCC--
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIP-DDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT--   77 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--   77 (580)
                      +|+++++.|.+|..+++|+.|+|++|.+.+.+| ..|..+++|++|+|++|++.+..+..|..+++|+.|++++|.++  
T Consensus       390 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~  469 (680)
T 1ziw_A          390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV  469 (680)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT
T ss_pred             CCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc
Confidence            478888999999999999999999999986555 78999999999999999999899999999999999999999986  


Q ss_pred             -CCCCCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCC--------cccCCccccceecccccccc
Q 038098           78 -SIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIP--------TTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus        78 -~lp~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~l~~L~~L~l~~n~l~  142 (580)
                       .+|..+.++++|++|+|++|++      .+.++++|+.|++++|.++++.+        ..|.++++|+.|+|++|.++
T Consensus       470 ~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  549 (680)
T 1ziw_A          470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD  549 (680)
T ss_dssp             TCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC
T ss_pred             ccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC
Confidence             4688899999999999999998      37789999999999999987532        23788999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-C-CCccCccccCCCCccccCCC
Q 038098          143 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-G-PFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       143 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~-~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ...+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++++.++.. . .++++..+++.+|+|.|+++
T Consensus       550 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            544567999999999999999999877888899999999999999999988764 2 57889999999999999866

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.92  E-value=2.8e-25  Score=220.49  Aligned_cols=212  Identities=23%  Similarity=0.263  Sum_probs=186.9

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCC--CccccCCCCCcEEEcCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFV--PACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      ++++ .+|..+.  ++|++|+|++|.++...++.|.++++|++|+|++|.++...  +..+..+++|++|+|++|+++.+
T Consensus        17 ~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l   93 (306)
T 2z66_A           17 KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM   93 (306)
T ss_dssp             SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEE
T ss_pred             CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccC
Confidence            3444 5665554  79999999999999666667899999999999999998442  56778899999999999999999


Q ss_pred             CCCCcCCCCCceEeCcCCcc-------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccc-cCCccccc
Q 038098           80 PSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQG-SIPDSIGD  151 (580)
Q Consensus        80 p~~~~~l~~L~~L~l~~n~l-------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~  151 (580)
                      |..+..+++|++|++++|++       .+..+++|+.|++++|.+++..+..|..+++|+.|+|++|.+++ .+|..+..
T Consensus        94 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  173 (306)
T 2z66_A           94 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE  173 (306)
T ss_dssp             EEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred             hhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhh
Confidence            98899999999999999998       26678999999999999998889999999999999999999986 57899999


Q ss_pred             ccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCCCccccCC
Q 038098          152 LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEGNELLCGM  216 (580)
Q Consensus       152 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~  216 (580)
                      +++|+.|+|++|++++..|..+..+++|+.|++++|++++.++. ...+++++.+++++|......
T Consensus       174 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  239 (306)
T 2z66_A          174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK  239 (306)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCS
T ss_pred             CcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccC
Confidence            99999999999999988899999999999999999999987763 466788999999999875543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.92  E-value=1.4e-24  Score=218.02  Aligned_cols=209  Identities=25%  Similarity=0.272  Sum_probs=183.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC--
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS--   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--   78 (580)
                      +|+|+++.|.+|.++++|++|+|++|.++ .+|..+.  ++|++|++++|.++.+.+..|.++++|++|++++|+++.  
T Consensus        87 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  163 (332)
T 2ft3_A           87 NNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG  163 (332)
T ss_dssp             SSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGG
T ss_pred             CCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCC
Confidence            58899999999999999999999999999 5665554  799999999999998888889999999999999999974  


Q ss_pred             -CCCCCcCCCCCceEeCcCCccc---ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           79 -IPSTLWNLKDILYLDLSSNFLL---IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        79 -lp~~~~~l~~L~~L~l~~n~l~---~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                       .|..+..+ +|++|++++|++.   ..-.++|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++
T Consensus       164 ~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  242 (332)
T 2ft3_A          164 FEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT  242 (332)
T ss_dssp             SCTTSSCSC-CCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTT
T ss_pred             CCcccccCC-ccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCC
Confidence             45566667 9999999999983   122368999999999999998899999999999999999999877888999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCCCC-------CCccCccccCCCCcccc
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKG-------PFRNFSTESFEGNELLC  214 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~-------~~~~l~~~~~~~n~~~c  214 (580)
                      |+.|+|++|+++ .+|..+..+++|+.|++++|++++..+...       ....+..+++.+|++.+
T Consensus       243 L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~  308 (332)
T 2ft3_A          243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY  308 (332)
T ss_dssp             CCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred             CCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccc
Confidence            999999999999 788889999999999999999998776431       13556778889998764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.92  E-value=7.6e-26  Score=225.03  Aligned_cols=207  Identities=23%  Similarity=0.249  Sum_probs=173.8

Q ss_pred             Ccc-ccCCCcccC-------CCCCCCEEeccCCcCCCCCchhh--hCCCCCceeeCCCCcCCcCCCccccCC-----CCC
Q 038098            2 NNL-NGSIPIAVG-------KLQKLQLLSLEDNQLEGSIPDDL--CRLAALFELDSGGNKLDGFVPACFGNL-----TNL   66 (580)
Q Consensus         2 N~~-~~~~p~~~~-------~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L   66 (580)
                      |++ ...+|..+.       ++++|++|+|++|.+++..|..+  ..+++|++|+|++|++++. |..|..+     ++|
T Consensus        73 n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L  151 (312)
T 1wwl_A           73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGL  151 (312)
T ss_dssp             EEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTC
T ss_pred             ccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCC
Confidence            444 234555555       78999999999999998888876  8899999999999999977 8888777     999


Q ss_pred             cEEEcCCCCCCCCC-CCCcCCCCCceEeCcCCcc----------cccCCCcccEEeCCCCcCCCC---CCcccCCccccc
Q 038098           67 RNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFL----------LIGNLKVLVQVDLSMNNFSDV---IPTTIGGLKDLQ  132 (580)
Q Consensus        67 ~~L~l~~N~l~~lp-~~~~~l~~L~~L~l~~n~l----------~~~~l~~L~~L~l~~N~l~~~---~~~~~~~l~~L~  132 (580)
                      ++|+|++|+|+.++ ..+..+++|++|+|++|++          .+..+++|+.|++++|.+++.   ....+..+++|+
T Consensus       152 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~  231 (312)
T 1wwl_A          152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ  231 (312)
T ss_dssp             CEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCS
T ss_pred             cEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCC
Confidence            99999999999987 6788999999999999985          127889999999999999843   224456789999


Q ss_pred             eeccccccccccCC-cccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCc
Q 038098          133 YLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNE  211 (580)
Q Consensus       133 ~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~  211 (580)
                      .|+|++|.+++..| ..+..+++|+.|+|++|+|+ .+|..+.  ++|+.|++++|++++. |....+++++.+++.+|+
T Consensus       232 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~  307 (312)
T 1wwl_A          232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNP  307 (312)
T ss_dssp             EEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCT
T ss_pred             EEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCC
Confidence            99999999997665 45667899999999999999 7777766  8999999999999988 447788889999999998


Q ss_pred             cc
Q 038098          212 LL  213 (580)
Q Consensus       212 ~~  213 (580)
                      +.
T Consensus       308 l~  309 (312)
T 1wwl_A          308 FL  309 (312)
T ss_dssp             TT
T ss_pred             CC
Confidence            64

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.92  E-value=3.6e-25  Score=233.89  Aligned_cols=217  Identities=21%  Similarity=0.201  Sum_probs=169.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+++++.|..|..+++|++|+|++|.++...+..|..+++|++|+|++|.++++.+..|.++++|+.|+|++|+++.++
T Consensus       113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~  192 (477)
T 2id5_A          113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR  192 (477)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred             CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence            46677777777777777777777777777666777777777777777777777666566777777777777777766654


Q ss_pred             C-CCcCCC------------------------CCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCcc
Q 038098           81 S-TLWNLK------------------------DILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLK  129 (580)
Q Consensus        81 ~-~~~~l~------------------------~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  129 (580)
                      . .+..++                        +|++|+|++|++      .+..+++|+.|+|++|.++++.+..|..++
T Consensus       193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  272 (477)
T 2id5_A          193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL  272 (477)
T ss_dssp             TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCT
T ss_pred             hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccc
Confidence            3 344444                        455555555655      266889999999999999999889999999


Q ss_pred             ccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCC
Q 038098          130 DLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEG  209 (580)
Q Consensus       130 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~  209 (580)
                      +|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++|+++|.++..-.+.......+.+
T Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~  352 (477)
T 2id5_A          273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNR  352 (477)
T ss_dssp             TCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTT
T ss_pred             cCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCc
Confidence            99999999999998889999999999999999999998888889999999999999999999876432223334456667


Q ss_pred             CccccCCC
Q 038098          210 NELLCGMP  217 (580)
Q Consensus       210 n~~~c~~p  217 (580)
                      +...|..|
T Consensus       353 ~~~~C~~p  360 (477)
T 2id5_A          353 QQPTCATP  360 (477)
T ss_dssp             CCCBEEES
T ss_pred             cCceeCCc
Confidence            77777655

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.92  E-value=4e-25  Score=227.24  Aligned_cols=211  Identities=24%  Similarity=0.270  Sum_probs=180.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|.++.+.+..|..+++|++|+|++|.++...+..|..+++|++|+|++|.++++.|..|.++++|++|+|++|+|+.+|
T Consensus        54 ~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~  133 (390)
T 3o6n_A           54 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP  133 (390)
T ss_dssp             SCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCC
Confidence            35566555556889999999999999999888889999999999999999999888889999999999999999999999


Q ss_pred             CCC-cCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCc-------------------------
Q 038098           81 STL-WNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGL-------------------------  128 (580)
Q Consensus        81 ~~~-~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------------------------  128 (580)
                      ..+ .++++|++|+|++|++      .+..+++|+.|++++|.+++.....+..+                         
T Consensus       134 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~  213 (390)
T 3o6n_A          134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDAS  213 (390)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECC
T ss_pred             HHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECC
Confidence            764 6899999999999998      36788999999999999987654444333                         


Q ss_pred             ------------cccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          129 ------------KDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       129 ------------~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                                  ++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|++++.+...
T Consensus       214 ~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  291 (390)
T 3o6n_A          214 HNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG  291 (390)
T ss_dssp             SSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSS
T ss_pred             CCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCccc
Confidence                        2466666666666632  46788999999999999999888999999999999999999999987777


Q ss_pred             CCCccCccccCCCCccc
Q 038098          197 GPFRNFSTESFEGNELL  213 (580)
Q Consensus       197 ~~~~~l~~~~~~~n~~~  213 (580)
                      ..+++++.+++++|...
T Consensus       292 ~~l~~L~~L~L~~n~l~  308 (390)
T 3o6n_A          292 QPIPTLKVLDLSHNHLL  308 (390)
T ss_dssp             SCCTTCCEEECCSSCCC
T ss_pred             CCCCCCCEEECCCCcce
Confidence            77899999999998764

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.92  E-value=1.1e-24  Score=238.62  Aligned_cols=95  Identities=21%  Similarity=0.320  Sum_probs=71.4

Q ss_pred             cccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCC-c
Q 038098          123 TTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPF-R  200 (580)
Q Consensus       123 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~-~  200 (580)
                      ..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|++++|+|++.+|.. ..+ .
T Consensus       488 ~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~  567 (635)
T 4g8a_A          488 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS  567 (635)
T ss_dssp             SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCT
T ss_pred             hhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhC
Confidence            34555666777777777777777777888888888888888888777777888888888888888888877654 334 5


Q ss_pred             cCccccCCCCccccCCC
Q 038098          201 NFSTESFEGNELLCGMP  217 (580)
Q Consensus       201 ~l~~~~~~~n~~~c~~p  217 (580)
                      +++.+++.+|||.|++.
T Consensus       568 ~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          568 SLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             TCCEEECTTCCBCCSGG
T ss_pred             cCCEEEeeCCCCcccCC
Confidence            67778888888888744

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.92  E-value=4.7e-25  Score=240.28  Aligned_cols=205  Identities=23%  Similarity=0.276  Sum_probs=136.0

Q ss_pred             cCCCCCCCEEeccCCcCCCCC--chhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC-C-CCcCCC
Q 038098           12 VGKLQKLQLLSLEDNQLEGSI--PDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP-S-TLWNLK   87 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp-~-~~~~l~   87 (580)
                      |..+++|++|+|++|.+++..  +..+..+++|++|+|++|.+.+..|..|..+++|++|+|++|+++..+ . .+..++
T Consensus       346 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  425 (606)
T 3t6q_A          346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH  425 (606)
T ss_dssp             TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCT
T ss_pred             hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcc
Confidence            555555555555555555433  455566666666666666666555666666666666666666665532 2 355666


Q ss_pred             CCceEeCcCCcc------cccCCCcccEEeCCCCcCCCC---CCcccCCccccceeccccccccccCCcccccccccccc
Q 038098           88 DILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDV---IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSL  158 (580)
Q Consensus        88 ~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  158 (580)
                      +|++|++++|.+      .+..+++|+.|++++|.+++.   .+..+..+++|+.|+|++|.+++..|..|..+++|+.|
T Consensus       426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  505 (606)
T 3t6q_A          426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV  505 (606)
T ss_dssp             TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence            666666666665      245566777777777776652   23456667777777777777776667777777777777


Q ss_pred             cccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          159 NLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       159 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      +|++|++++..|..+..+++| .|++++|++++.+|.. ..++.++.+++.+|++.|+++
T Consensus       506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          506 DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             ECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             ECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            777777777777777777777 7777777777766653 456777888888888888754

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.92  E-value=3.8e-25  Score=219.96  Aligned_cols=186  Identities=20%  Similarity=0.228  Sum_probs=165.9

Q ss_pred             CCccccCCCccc--CCCCCCCEEeccCCcCCCCCchhhhCC-----CCCceeeCCCCcCCcCCCccccCCCCCcEEEcCC
Q 038098            1 GNNLNGSIPIAV--GKLQKLQLLSLEDNQLEGSIPDDLCRL-----AALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS   73 (580)
Q Consensus         1 ~N~~~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~   73 (580)
                      +|+|++.+|..+  ..+++|++|+|++|.+++. |..+..+     ++|++|+|++|+|++..+..|+++++|++|+|++
T Consensus       104 ~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  182 (312)
T 1wwl_A          104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD  182 (312)
T ss_dssp             EEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCS
T ss_pred             CCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCC
Confidence            478999999987  8999999999999999976 8888887     9999999999999998889999999999999999


Q ss_pred             CCCCC---CCCCC--cCCCCCceEeCcCCccc---------ccCCCcccEEeCCCCcCCCCCC-cccCCccccceecccc
Q 038098           74 NKLTS---IPSTL--WNLKDILYLDLSSNFLL---------IGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEY  138 (580)
Q Consensus        74 N~l~~---lp~~~--~~l~~L~~L~l~~n~l~---------~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~  138 (580)
                      |++..   +|..+  ..+++|++|+|++|++.         +.++++|+.|++++|.+++..| ..+..+++|+.|+|++
T Consensus       183 N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~  262 (312)
T 1wwl_A          183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF  262 (312)
T ss_dssp             CTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTT
T ss_pred             CCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCC
Confidence            99865   34333  78999999999999983         3477999999999999998774 5667789999999999


Q ss_pred             ccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCC
Q 038098          139 NRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE  192 (580)
Q Consensus       139 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~  192 (580)
                      |.|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|++++|++++.
T Consensus       263 N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          263 TGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             SCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             CccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence            9999 7888776  8999999999999966 65 89999999999999999863

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.92  E-value=1.2e-24  Score=228.51  Aligned_cols=99  Identities=23%  Similarity=0.220  Sum_probs=57.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCC-CCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC-
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG-SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS-   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-   78 (580)
                      +|+|+++.|.+|.++++|++|+|++|.+.+ ..++.|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++. 
T Consensus        39 ~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  118 (455)
T 3v47_A           39 LNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA  118 (455)
T ss_dssp             SSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTH
T ss_pred             CCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCcc
Confidence            356666666666666666666666666642 234556666666666666666665556666666666666666666554 


Q ss_pred             CCC--CCcCCCCCceEeCcCCcc
Q 038098           79 IPS--TLWNLKDILYLDLSSNFL   99 (580)
Q Consensus        79 lp~--~~~~l~~L~~L~l~~n~l   99 (580)
                      +|.  .+..+++|++|+|++|++
T Consensus       119 ~~~~~~~~~l~~L~~L~L~~n~l  141 (455)
T 3v47_A          119 VLSGNFFKPLTSLEMLVLRDNNI  141 (455)
T ss_dssp             HHHSSTTTTCTTCCEEECCSSBC
T ss_pred             ccCcccccCcccCCEEECCCCcc
Confidence            221  244455555555555554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.92  E-value=7.4e-25  Score=238.71  Aligned_cols=206  Identities=24%  Similarity=0.259  Sum_probs=182.5

Q ss_pred             ccCCCCCCCEEeccCCcCCCC--CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC--CCcCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGS--IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS--TLWNL   86 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~--~~~~l   86 (580)
                      .+..+++|++|+|++|.+++.  .|..+..+++|++|+|++|.+++ .|..|..+++|++|++++|+++.++.  .+..+
T Consensus       345 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  423 (606)
T 3vq2_A          345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL  423 (606)
T ss_dssp             CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC
T ss_pred             hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcc
Confidence            567788888888888888755  37888999999999999999885 55889999999999999999988654  67789


Q ss_pred             CCCceEeCcCCcc------cccCCCcccEEeCCCCcCCC-CCCcccCCccccceeccccccccccCCccccccccccccc
Q 038098           87 KDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSD-VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN  159 (580)
Q Consensus        87 ~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  159 (580)
                      ++|++|++++|.+      .+.++++|+.|++++|.+++ ..|..|..+++|+.|+|++|.+++..|..|..+++|+.|+
T Consensus       424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  503 (606)
T 3vq2_A          424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN  503 (606)
T ss_dssp             TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence            9999999999998      36788999999999999987 4688899999999999999999988899999999999999


Q ss_pred             ccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCc-cCccccCCCCccccCCC
Q 038098          160 LSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFR-NFSTESFEGNELLCGMP  217 (580)
Q Consensus       160 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~l~~~~~~~n~~~c~~p  217 (580)
                      |++|++++..|..+..+++|+.|++++|+++..++....++ ++..+++.+|++.|+++
T Consensus       504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            99999998889999999999999999999998777666665 58899999999999866

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.91  E-value=3e-25  Score=221.31  Aligned_cols=200  Identities=22%  Similarity=0.193  Sum_probs=108.3

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCC--------
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPST--------   82 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~--------   82 (580)
                      .+..+++|++|+|++|.|++..|+.|..+++|++|+|++|.+++..+  |..+++|++|+|++|+|+.++..        
T Consensus        29 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l  106 (317)
T 3o53_A           29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHA  106 (317)
T ss_dssp             HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEEC
T ss_pred             HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEEC
Confidence            34445566666666666665555566666666666666666654433  56666666666666665554321        


Q ss_pred             ---------CcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCccc-CCccccceeccccccccccCC
Q 038098           83 ---------LWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTI-GGLKDLQYLFLEYNRLQGSIP  146 (580)
Q Consensus        83 ---------~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~p  146 (580)
                               ...+++|++|++++|++      .+..+++|+.|++++|.+++..+..+ ..+++|+.|+|++|.+++. +
T Consensus       107 ~~n~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~  185 (317)
T 3o53_A          107 ANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K  185 (317)
T ss_dssp             CSSCCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred             CCCccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c
Confidence                     01134455555555554      23345555555555555555444444 2455555555555555532 2


Q ss_pred             cccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccC
Q 038098          147 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       147 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~  215 (580)
                      . ...+++|+.|+|++|++++ +|..+..+++|+.|++++|+++..++....++++..+++.+|++.|+
T Consensus       186 ~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          186 G-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             C-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             c-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence            2 2235556666666666663 33335556666666666666665544445555566666666665543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.91  E-value=1.4e-24  Score=235.53  Aligned_cols=210  Identities=23%  Similarity=0.263  Sum_probs=164.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|.++++.+..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.|+++.|..|+++++|++|+|++|+|+.+|
T Consensus        60 ~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~  139 (597)
T 3oja_B           60 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP  139 (597)
T ss_dssp             SCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCC
Confidence            35566665667888999999999999999888889999999999999999999988889999999999999999999998


Q ss_pred             CCC-cCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCc-------------------------
Q 038098           81 STL-WNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGL-------------------------  128 (580)
Q Consensus        81 ~~~-~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------------------------  128 (580)
                      ..+ .++++|++|+|++|.+      .+.++++|+.|++++|.+++.....+..+                         
T Consensus       140 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls  219 (597)
T 3oja_B          140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDAS  219 (597)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECC
T ss_pred             HHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeecc
Confidence            764 7899999999999998      37788999999999999987654443332                         


Q ss_pred             ------------cccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          129 ------------KDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       129 ------------~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                                  ++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|.+++.+...
T Consensus       220 ~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~  297 (597)
T 3oja_B          220 HNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG  297 (597)
T ss_dssp             SSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSS
T ss_pred             CCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCccc
Confidence                        124445555555543  245666777777777777777666777777777777777777777765555


Q ss_pred             CCCccCccccCCCCcc
Q 038098          197 GPFRNFSTESFEGNEL  212 (580)
Q Consensus       197 ~~~~~l~~~~~~~n~~  212 (580)
                      ..++.+..+++++|..
T Consensus       298 ~~l~~L~~L~Ls~N~l  313 (597)
T 3oja_B          298 QPIPTLKVLDLSHNHL  313 (597)
T ss_dssp             SCCTTCCEEECCSSCC
T ss_pred             ccCCCCcEEECCCCCC
Confidence            5566777777776654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.91  E-value=3.2e-24  Score=233.64  Aligned_cols=212  Identities=18%  Similarity=0.158  Sum_probs=173.1

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCC-
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI-   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l-   79 (580)
                      +|+|+++.|.+|.++++|++|+|++|.+++..|+.|.++++|++|+|++|.+++..|..|+++++|++|+|++|+|+.+ 
T Consensus        42 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~  121 (606)
T 3t6q_A           42 FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID  121 (606)
T ss_dssp             TCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGG
T ss_pred             CCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCC
Confidence            5888888889999999999999999999988899999999999999999999988888999999999999999999987 


Q ss_pred             CCCCcCCCCCceEeCcCCccc------ccCCCcccEEeCCCCcCCCCCCcccCCccccc--eeccccccccccCCccccc
Q 038098           80 PSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ--YLFLEYNRLQGSIPDSIGD  151 (580)
Q Consensus        80 p~~~~~l~~L~~L~l~~n~l~------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~--~L~l~~n~l~~~~p~~~~~  151 (580)
                      |..+.++++|++|+|++|++.      +..+++|+.|++++|.+++..+..|..+++|+  .|++++|.+++..|..|..
T Consensus       122 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~  201 (606)
T 3t6q_A          122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS  201 (606)
T ss_dssp             GSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT
T ss_pred             cchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh
Confidence            567888999999999999882      34578899999999999888888888888888  7888888888666554432


Q ss_pred             c---------------------------------------------------cccccccccccccCCCccccccccCccc
Q 038098          152 L---------------------------------------------------INLKSLNLSNNNLSGTIPISLEKLLDLK  180 (580)
Q Consensus       152 l---------------------------------------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~  180 (580)
                      .                                                   .+|+.|++++|.+++..+..+..+++|+
T Consensus       202 ~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  281 (606)
T 3t6q_A          202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ  281 (606)
T ss_dssp             CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCS
T ss_pred             ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCC
Confidence            1                                                   1567777777777766676777778888


Q ss_pred             EEEccCCcccCCCCCCCCCccCccccCCCCcc
Q 038098          181 DINVSFNKLEGEIPNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       181 ~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~  212 (580)
                      .|++++|.++..++....+++++.+++.+|..
T Consensus       282 ~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l  313 (606)
T 3t6q_A          282 ELDLTATHLSELPSGLVGLSTLKKLVLSANKF  313 (606)
T ss_dssp             EEECTTSCCSCCCSSCCSCTTCCEEECTTCCC
T ss_pred             EEeccCCccCCCChhhcccccCCEEECccCCc
Confidence            88888888776666666667777777777654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=7.4e-24  Score=206.29  Aligned_cols=182  Identities=26%  Similarity=0.342  Sum_probs=162.2

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCC-CcCCCCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPST-LWNLKDI   89 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~-~~~l~~L   89 (580)
                      .+..+++|+.|++++|.++ .+ +.+..+++|++|+|++|.+++.  ..+..+++|++|+|++|+|+.++.. +..+++|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             ccccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            4667899999999999998 33 4588999999999999999964  4799999999999999999998764 6789999


Q ss_pred             ceEeCcCCccc------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccc
Q 038098           90 LYLDLSSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN  163 (580)
Q Consensus        90 ~~L~l~~n~l~------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  163 (580)
                      ++|+|++|++.      +..+++|+.|++++|.+++.++..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            99999999982      678899999999999999888888899999999999999999777777899999999999999


Q ss_pred             ccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          164 NLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       164 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      ++++..+..+..+++|+.|++++|+++|.+|..
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l  224 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI  224 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCccccCcHH
Confidence            999888888899999999999999999887754

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.7e-23  Score=201.19  Aligned_cols=177  Identities=25%  Similarity=0.303  Sum_probs=150.5

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeC
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDL   94 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l   94 (580)
                      .+.++++++++.++ .+|..+.  ++|++|+|++|.++++.+..|.++++|++|+|++|+|+.++. .+..+++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            35678888888887 5665554  578888888888888888888888888888888888888765 4677888888888


Q ss_pred             cCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCC
Q 038098           95 SSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGT  168 (580)
Q Consensus        95 ~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  168 (580)
                      ++|++      .+..+++|+.|+|++|.++++++..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            88887      356788999999999999988888899999999999999999976677899999999999999999988


Q ss_pred             ccccccccCcccEEEccCCcccCCCCC
Q 038098          169 IPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       169 ~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      .+..+..+++|+.|++++|++++....
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~~~~  197 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCSRCE  197 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCCccc
Confidence            888899999999999999999987443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=2.7e-24  Score=205.30  Aligned_cols=197  Identities=16%  Similarity=0.167  Sum_probs=170.8

Q ss_pred             CCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCc-CCcCCCccccCCCCCcEEEcCC-CCCCCCCC-CC
Q 038098            7 SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNK-LDGFVPACFGNLTNLRNLYLGS-NKLTSIPS-TL   83 (580)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~lp~-~~   83 (580)
                      .+|. +.  ++|++|+|++|+|++..+..|..+++|++|+|++|. ++.+.+..|.++++|++|+|++ |+|+.+|. .+
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            5665 43  489999999999998788899999999999999997 9988888999999999999998 99999885 56


Q ss_pred             cCCCCCceEeCcCCccc----ccCCCccc---EEeCCCC-cCCCCCCcccCCccccc-eeccccccccccCCc-cccccc
Q 038098           84 WNLKDILYLDLSSNFLL----IGNLKVLV---QVDLSMN-NFSDVIPTTIGGLKDLQ-YLFLEYNRLQGSIPD-SIGDLI  153 (580)
Q Consensus        84 ~~l~~L~~L~l~~n~l~----~~~l~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~p~-~~~~l~  153 (580)
                      .++++|++|++++|++.    +..+++|+   .|++++| .++++.+..|.++++|+ .|++++|.++ .+|. .|.. +
T Consensus       102 ~~l~~L~~L~l~~n~l~~lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~  179 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-T  179 (239)
T ss_dssp             ECCTTCCEEEEEEECCCSCCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-C
T ss_pred             CCCCCCCEEeCCCCCCccccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-C
Confidence            78999999999999983    56777787   9999999 99988888899999999 9999999999 5554 4544 8


Q ss_pred             ccccccccccc-cCCCcccccccc-CcccEEEccCCcccCCCCCCCCCccCccccCCCC
Q 038098          154 NLKSLNLSNNN-LSGTIPISLEKL-LDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN  210 (580)
Q Consensus       154 ~L~~L~l~~N~-l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n  210 (580)
                      +|+.|+|++|+ +++..+..|..+ ++|+.|++++|+++..++.  .++.++.+.+.++
T Consensus       180 ~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             EEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred             CCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence            99999999995 997777889999 9999999999999987665  5677777766654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.90  E-value=1.1e-24  Score=220.86  Aligned_cols=196  Identities=20%  Similarity=0.206  Sum_probs=170.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCC-ccccCCCCCcEEEcCCC-CCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVP-ACFGNLTNLRNLYLGSN-KLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~   78 (580)
                      +|+|+++.|.+|.++++|++|+|++|.|+...+..|.++++|++|+|++|+++.+.+ ..|.++++|++|++++| .++.
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~  164 (353)
T 2z80_A           85 SNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK  164 (353)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCE
T ss_pred             CCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccc
Confidence            588999889999999999999999999997677779999999999999999996655 58999999999999999 5887


Q ss_pred             CC-CCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccccccc-------
Q 038098           79 IP-STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGS-------  144 (580)
Q Consensus        79 lp-~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------  144 (580)
                      ++ ..+.++++|++|++++|++      .+..+++|++|++++|.++..++..+..+++|+.|+|++|.+++.       
T Consensus       165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~  244 (353)
T 2z80_A          165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST  244 (353)
T ss_dssp             ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----
T ss_pred             cCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc
Confidence            75 5788999999999999998      367889999999999999866555566789999999999999863       


Q ss_pred             ------------------------CCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          145 ------------------------IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       145 ------------------------~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                                              +|..+..+++|+.|+|++|+++...+..+..+++|+.|++++|+++|.++..
T Consensus       245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l  320 (353)
T 2z80_A          245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  320 (353)
T ss_dssp             --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred             ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCCc
Confidence                                    3445677899999999999999544444689999999999999999988743

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.90  E-value=1.1e-24  Score=237.63  Aligned_cols=204  Identities=20%  Similarity=0.295  Sum_probs=177.5

Q ss_pred             CCcccC--CCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCc-CCc-CCCccccCC------CCCcEEEcCCCCCC
Q 038098            8 IPIAVG--KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNK-LDG-FVPACFGNL------TNLRNLYLGSNKLT   77 (580)
Q Consensus         8 ~p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~l~~N~l~   77 (580)
                      +|++++  ++++|++|+|++|.+.+.+|+.|+++++|++|+|++|+ +++ .+|..++++      ++|++|+|++|+++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            899999  99999999999999998999999999999999999998 887 788888776      89999999999999


Q ss_pred             CCCC--CCcCCCCCceEeCcCCccc-----ccCCCcccEEeCCCCcCCCCCCcccCCccc-cceeccccccccccCCccc
Q 038098           78 SIPS--TLWNLKDILYLDLSSNFLL-----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKD-LQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        78 ~lp~--~~~~l~~L~~L~l~~n~l~-----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~p~~~  149 (580)
                      .+|.  .+.++++|++|+|++|++.     +..+++|+.|++++|.++ .+|..+..+++ |+.|+|++|.++ .+|..+
T Consensus       319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~  396 (636)
T 4eco_A          319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF  396 (636)
T ss_dssp             SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred             ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence            9998  8899999999999999884     567789999999999998 56777888988 999999999998 788877


Q ss_pred             cccc--ccccccccccccCCCcccccc-------ccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccc
Q 038098          150 GDLI--NLKSLNLSNNNLSGTIPISLE-------KLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELL  213 (580)
Q Consensus       150 ~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~  213 (580)
                      ..+.  +|+.|++++|++++.+|..+.       .+++|+.|++++|.++..++.. ..+++++.+++.+|...
T Consensus       397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~  470 (636)
T 4eco_A          397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT  470 (636)
T ss_dssp             CTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred             hhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence            7654  899999999999988888888       7889999999999999665543 34678888888888765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=7.5e-24  Score=210.48  Aligned_cols=195  Identities=21%  Similarity=0.195  Sum_probs=143.1

Q ss_pred             CCCCCEEeccCCcCCCCCchhh--hCCCCCceeeCCCCcCCcCCC----ccccCCCCCcEEEcCCCCCCCCC-CCCcCCC
Q 038098           15 LQKLQLLSLEDNQLEGSIPDDL--CRLAALFELDSGGNKLDGFVP----ACFGNLTNLRNLYLGSNKLTSIP-STLWNLK   87 (580)
Q Consensus        15 l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~lp-~~~~~l~   87 (580)
                      +++|++|+|++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|+|+.++ ..+..++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            4568888888888887777777  778888888888888876544    33456788888888888887765 4666788


Q ss_pred             CCceEeCcCCccc----------ccCCCcccEEeCCCCcCCCCCCc---ccCCccccceeccccccccccCCcccccc--
Q 038098           88 DILYLDLSSNFLL----------IGNLKVLVQVDLSMNNFSDVIPT---TIGGLKDLQYLFLEYNRLQGSIPDSIGDL--  152 (580)
Q Consensus        88 ~L~~L~l~~n~l~----------~~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~~L~l~~n~l~~~~p~~~~~l--  152 (580)
                      +|++|+|++|++.          +..+++|++|+|++|.++...+.   .+..+++|++|+|++|.|++..|..+..+  
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            8888888888751          25677888888888888643221   24567788888888888887667666665  


Q ss_pred             -cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          153 -INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       153 -~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                       ++|+.|+|++|+++ .+|..+.  ++|+.|++++|++++.+ ....++.++.+++++|++.
T Consensus       250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~-~~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAP-QPDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCC-CTTSCCCCSCEECSSTTTS
T ss_pred             cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCc-hhhhCCCccEEECcCCCCC
Confidence             58888888888888 5566554  68888888888888753 2456677778888888753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.90  E-value=2.7e-24  Score=239.12  Aligned_cols=208  Identities=22%  Similarity=0.293  Sum_probs=179.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCC-----------------CCchhhh--CCCCCceeeCCCCcCCcCCCcccc
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG-----------------SIPDDLC--RLAALFELDSGGNKLDGFVPACFG   61 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~   61 (580)
                      +|++++ +|.+|++|++|+.|+|++|.|++                 .+|+.++  ++++|++|+|++|.+.+.+|..|+
T Consensus       434 ~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~  512 (876)
T 4ecn_A          434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY  512 (876)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred             cCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence            378888 89999999999999999999997                 2888877  999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCC-CCC--CCCCCcCC-------CCCceEeCcCCcc-------cccCCCcccEEeCCCCcCCCCCCcc
Q 038098           62 NLTNLRNLYLGSNK-LTS--IPSTLWNL-------KDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTT  124 (580)
Q Consensus        62 ~l~~L~~L~l~~N~-l~~--lp~~~~~l-------~~L~~L~l~~n~l-------~~~~l~~L~~L~l~~N~l~~~~~~~  124 (580)
                      ++++|++|+|++|+ |+.  +|..+..+       ++|++|+|++|++       .+.++++|+.|+|++|.++ .+| .
T Consensus       513 ~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~  590 (876)
T 4ecn_A          513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-A  590 (876)
T ss_dssp             GCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred             CCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence            99999999999998 885  77655544       5999999999998       2668889999999999999 556 8


Q ss_pred             cCCccccceeccccccccccCCcccccccc-cccccccccccCCCccccccccCc--ccEEEccCCcccCCCCCCC----
Q 038098          125 IGGLKDLQYLFLEYNRLQGSIPDSIGDLIN-LKSLNLSNNNLSGTIPISLEKLLD--LKDINVSFNKLEGEIPNKG----  197 (580)
Q Consensus       125 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~--L~~l~l~~N~l~~~~~~~~----  197 (580)
                      |..+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..+..  |+.|++++|++++.+|...    
T Consensus       591 ~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~  668 (876)
T 4ecn_A          591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD  668 (876)
T ss_dssp             CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTT
T ss_pred             hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhc
Confidence            999999999999999999 88988999999 999999999999 78888877654  9999999999998776542    


Q ss_pred             --CCccCccccCCCCccc
Q 038098          198 --PFRNFSTESFEGNELL  213 (580)
Q Consensus       198 --~~~~l~~~~~~~n~~~  213 (580)
                        ...++..+++++|...
T Consensus       669 ~~~~~~L~~L~Ls~N~L~  686 (876)
T 4ecn_A          669 DYKGINASTVTLSYNEIQ  686 (876)
T ss_dssp             TCCCCCEEEEECCSSCCC
T ss_pred             cccCCCcCEEEccCCcCC
Confidence              2346667777777653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=6.8e-24  Score=202.47  Aligned_cols=183  Identities=17%  Similarity=0.213  Sum_probs=163.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCc-CCCCCchhhhCCCCCceeeCCC-CcCCcCCCccccCCCCCcEEEcCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQ-LEGSIPDDLCRLAALFELDSGG-NKLDGFVPACFGNLTNLRNLYLGSNKLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~   78 (580)
                      +|+|+++.+.+|..+++|++|+|++|. ++.+.+..|.++++|++|+|++ |+|+++.+..|.++++|++|+|++|+++.
T Consensus        40 ~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~  119 (239)
T 2xwt_C           40 ETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM  119 (239)
T ss_dssp             SCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS
T ss_pred             CCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc
Confidence            588998888899999999999999997 9877778999999999999999 99998888899999999999999999999


Q ss_pred             CCCCCcCCCCCc---eEeCcCC-cc------cccCCCccc-EEeCCCCcCCCCCCcccCCccccceecccccc-ccccCC
Q 038098           79 IPSTLWNLKDIL---YLDLSSN-FL------LIGNLKVLV-QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNR-LQGSIP  146 (580)
Q Consensus        79 lp~~~~~l~~L~---~L~l~~n-~l------~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~p  146 (580)
                      +|. +..+++|+   +|++++| ++      .+.++++|+ .|++++|.++.+++..|.. ++|+.|+|++|+ +++..+
T Consensus       120 lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~  197 (239)
T 2xwt_C          120 FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDK  197 (239)
T ss_dssp             CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECT
T ss_pred             ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCH
Confidence            997 88888888   9999999 77      377899999 9999999999777777776 899999999995 996667


Q ss_pred             cccccc-cccccccccccccCCCccccccccCcccEEEccCCc
Q 038098          147 DSIGDL-INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK  188 (580)
Q Consensus       147 ~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~  188 (580)
                      ..|..+ ++|+.|++++|++++..+.   .+++|+.|+++++.
T Consensus       198 ~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          198 DAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW  237 (239)
T ss_dssp             TTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred             HHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence            889999 9999999999999954443   67789999998764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.90  E-value=1.8e-23  Score=223.30  Aligned_cols=154  Identities=25%  Similarity=0.271  Sum_probs=127.6

Q ss_pred             cCCCCCcEEEcCCCCCCC-CCCCCcCCCCCceEeCcCCccc--------ccCCCcccEEeCCCCcCCC-CCCcccCCccc
Q 038098           61 GNLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL--------IGNLKVLVQVDLSMNNFSD-VIPTTIGGLKD  130 (580)
Q Consensus        61 ~~l~~L~~L~l~~N~l~~-lp~~~~~l~~L~~L~l~~n~l~--------~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~  130 (580)
                      ..+++|++|+|++|+++. +|..+..+++|++|+|++|++.        +..+++|+.|++++|.+++ +++..+..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            567788888888888887 6777888888999999888873        5678889999999999887 44455788889


Q ss_pred             cceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCC
Q 038098          131 LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEG  209 (580)
Q Consensus       131 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~  209 (580)
                      |+.|+|++|.+++.+|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. ...++++..+++.+
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  477 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT  477 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcC
Confidence            99999999998877776654  68999999999999 7777777999999999999999977765 56778888899999


Q ss_pred             CccccCCC
Q 038098          210 NELLCGMP  217 (580)
Q Consensus       210 n~~~c~~p  217 (580)
                      |++.|+++
T Consensus       478 N~~~c~c~  485 (520)
T 2z7x_B          478 NPWDCSCP  485 (520)
T ss_dssp             SCBCCCHH
T ss_pred             CCCcccCC
Confidence            99988743

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.90  E-value=1.9e-24  Score=215.51  Aligned_cols=195  Identities=23%  Similarity=0.212  Sum_probs=143.7

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLS   95 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~   95 (580)
                      ..++.++++.+.+...++..+..+++|++|+|++|+|+++.|..|.++++|++|+|++|+++.++. +..+++|++|+|+
T Consensus        10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls   88 (317)
T 3o53_A           10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLN   88 (317)
T ss_dssp             TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECC
T ss_pred             CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECc
Confidence            346677888888875666677778899999999999998888899999999999999999998765 7889999999999


Q ss_pred             CCccc-c---------------------cCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccc-cc
Q 038098           96 SNFLL-I---------------------GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIG-DL  152 (580)
Q Consensus        96 ~n~l~-~---------------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~l  152 (580)
                      +|++. +                     ..+++|+.|++++|.+++..+..+..+++|+.|+|++|.+++..+..+. .+
T Consensus        89 ~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  168 (317)
T 3o53_A           89 NNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS  168 (317)
T ss_dssp             SSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGT
T ss_pred             CCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhcc
Confidence            99882 2                     2344566666666666666566666667777777777777655555543 56


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      ++|+.|+|++|.+++. +. ...+++|+.|++++|++++.++....++++..+++++|...
T Consensus       169 ~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~  227 (317)
T 3o53_A          169 DTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV  227 (317)
T ss_dssp             TTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred             CcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence            6777777777777643 22 22466777777777777776666666677777777777654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.1e-23  Score=208.69  Aligned_cols=191  Identities=24%  Similarity=0.390  Sum_probs=154.0

Q ss_pred             cCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCce
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILY   91 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~   91 (580)
                      +..+++|++|++++|.++. +| .+..+++|++|+|++|.++++.+  +..+++|++|+|++|+|+.++ .+..+++|++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~  111 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS-AIAGLQSIKT  111 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG-GGTTCTTCCE
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCch-hhcCCCCCCE
Confidence            4567888888998888874 44 57888888899999888886544  888888999999988888876 5778888889


Q ss_pred             EeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCC
Q 038098           92 LDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG  167 (580)
Q Consensus        92 L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  167 (580)
                      |+|++|++    .+..+++|+.|++++|.+++..+  +..+++|+.|+|++|.+++ ++. +..+++|+.|+|++|++++
T Consensus       112 L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          112 LDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             EECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC
T ss_pred             EECCCCCCCCchhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCc
Confidence            99988888    36778888888999888887644  7788888889998888884 443 7888888889999888886


Q ss_pred             CccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          168 TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       168 ~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                      ..+  +..+++|+.|++++|++++.++ ...++++..+++.+|++.+
T Consensus       188 ~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEEC
T ss_pred             Chh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeec
Confidence            544  7788888889999888887765 5667788888888888754

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.90  E-value=7.4e-24  Score=235.60  Aligned_cols=210  Identities=20%  Similarity=0.289  Sum_probs=180.7

Q ss_pred             CCccccCCCcccCCCCCCCEEec-cCCcCCCC------------------------------------------------
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSL-EDNQLEGS------------------------------------------------   31 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L-~~n~l~~~------------------------------------------------   31 (580)
                      +|+++|.+|++|++|++|++|+| ++|.+.+.                                                
T Consensus       332 ~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~  411 (876)
T 4ecn_A          332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN  411 (876)
T ss_dssp             TTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTC
T ss_pred             cCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhC
Confidence            58899999999999999999999 77754322                                                


Q ss_pred             ----------------------------CchhhhCCCCCceeeCCCCcCCc-----------------CCCcccc--CCC
Q 038098           32 ----------------------------IPDDLCRLAALFELDSGGNKLDG-----------------FVPACFG--NLT   64 (580)
Q Consensus        32 ----------------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~   64 (580)
                                                  +|..|+++++|++|+|++|.|++                 .+|..++  +++
T Consensus       412 ~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~  491 (876)
T 4ecn_A          412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLK  491 (876)
T ss_dssp             TTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCT
T ss_pred             ccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCC
Confidence                                        78889999999999999999998                 3788877  999


Q ss_pred             CCcEEEcCCCCCC-CCCCCCcCCCCCceEeCcCCc-cc-------c-------cCCCcccEEeCCCCcCCCCCCc--ccC
Q 038098           65 NLRNLYLGSNKLT-SIPSTLWNLKDILYLDLSSNF-LL-------I-------GNLKVLVQVDLSMNNFSDVIPT--TIG  126 (580)
Q Consensus        65 ~L~~L~l~~N~l~-~lp~~~~~l~~L~~L~l~~n~-l~-------~-------~~l~~L~~L~l~~N~l~~~~~~--~~~  126 (580)
                      +|++|+|++|++. .+|..+.++++|++|+|++|+ +.       +       ..+++|+.|+|++|.++ .+|.  .|.
T Consensus       492 ~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~  570 (876)
T 4ecn_A          492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ  570 (876)
T ss_dssp             TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHT
T ss_pred             CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhh
Confidence            9999999999865 488889999999999999998 42       2       34459999999999999 5666  899


Q ss_pred             CccccceeccccccccccCCcccccccccccccccccccCCCccccccccCc-ccEEEccCCcccCCCCCCCCCc--cCc
Q 038098          127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD-LKDINVSFNKLEGEIPNKGPFR--NFS  203 (580)
Q Consensus       127 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~l~l~~N~l~~~~~~~~~~~--~l~  203 (580)
                      .+++|+.|+|++|.++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|++++|+++..+.......  .+.
T Consensus       571 ~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~  647 (876)
T 4ecn_A          571 KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG  647 (876)
T ss_dssp             TCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEE
T ss_pred             cCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCC
Confidence            9999999999999999 888 8999999999999999999 88888999999 9999999999996554433333  377


Q ss_pred             cccCCCCcccc
Q 038098          204 TESFEGNELLC  214 (580)
Q Consensus       204 ~~~~~~n~~~c  214 (580)
                      .+++++|....
T Consensus       648 ~L~Ls~N~l~g  658 (876)
T 4ecn_A          648 SVDFSYNKIGS  658 (876)
T ss_dssp             EEECCSSCTTT
T ss_pred             EEECcCCcCCC
Confidence            88888887644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.90  E-value=2.3e-23  Score=230.00  Aligned_cols=195  Identities=22%  Similarity=0.270  Sum_probs=178.7

Q ss_pred             CCccccCCC-cccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCC--cCCCccccCCCCCcEEEcCCCCCC
Q 038098            1 GNNLNGSIP-IAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLD--GFVPACFGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus         1 ~N~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~   77 (580)
                      +|++++.+| ..|..+++|++|+|++|++....+..|..+++|++|++++|.++  +..|..|.++++|++|+|++|+|+
T Consensus       414 ~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~  493 (680)
T 1ziw_A          414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA  493 (680)
T ss_dssp             SSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCC
T ss_pred             CCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCC
Confidence            578887666 79999999999999999999889999999999999999999987  567889999999999999999999


Q ss_pred             CCCC-CCcCCCCCceEeCcCCccc--------------ccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccccc
Q 038098           78 SIPS-TLWNLKDILYLDLSSNFLL--------------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus        78 ~lp~-~~~~l~~L~~L~l~~n~l~--------------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  142 (580)
                      .+|. .+.++++|++|+|++|++.              +.++++|+.|+|++|.++.+++..|.++++|+.|+|++|+++
T Consensus       494 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~  573 (680)
T 1ziw_A          494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN  573 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCC
Confidence            9876 4778999999999999983              578899999999999999887788999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCcccccc-ccCcccEEEccCCcccCCCCC
Q 038098          143 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLE-KLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       143 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      +..+..|..+++|+.|+|++|++++..+..+. .+++|+.|++++|++.|.++.
T Consensus       574 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            76677789999999999999999988887787 789999999999999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.90  E-value=2e-23  Score=225.03  Aligned_cols=154  Identities=24%  Similarity=0.278  Sum_probs=124.3

Q ss_pred             cCCCCCcEEEcCCCCCCC-CCCCCcCCCCCceEeCcCCccc--------ccCCCcccEEeCCCCcCCC-CCCcccCCccc
Q 038098           61 GNLTNLRNLYLGSNKLTS-IPSTLWNLKDILYLDLSSNFLL--------IGNLKVLVQVDLSMNNFSD-VIPTTIGGLKD  130 (580)
Q Consensus        61 ~~l~~L~~L~l~~N~l~~-lp~~~~~l~~L~~L~l~~n~l~--------~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~  130 (580)
                      ..+++|++|+|++|+++. +|..+..+++|++|+|++|++.        +.++++|+.|++++|.+++ +++..+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            566788888888888877 5677778888888888888873        5677888888888888887 55556778888


Q ss_pred             cceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCC
Q 038098          131 LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEG  209 (580)
Q Consensus       131 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~  209 (580)
                      |+.|+|++|.+++.+|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. ...++.+..+++.+
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence            88888888888776666554  68999999999998 6676666899999999999999987776 57788888999999


Q ss_pred             CccccCCC
Q 038098          210 NELLCGMP  217 (580)
Q Consensus       210 n~~~c~~p  217 (580)
                      |++.|+++
T Consensus       507 N~~~c~c~  514 (562)
T 3a79_B          507 NPWDCTCP  514 (562)
T ss_dssp             CCBCCCHH
T ss_pred             CCcCCCcc
Confidence            99988744

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.90  E-value=2.8e-24  Score=226.71  Aligned_cols=179  Identities=25%  Similarity=0.239  Sum_probs=134.1

Q ss_pred             CchhhhCCC----CCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCccc-c-----
Q 038098           32 IPDDLCRLA----ALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-I-----  101 (580)
Q Consensus        32 ~p~~~~~l~----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~-~-----  101 (580)
                      +|..+..+.    +|++|+|++|.|+++.|..|..+++|++|+|++|+|+.+++ +..+++|++|+|++|.|. +     
T Consensus        22 l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~~~  100 (487)
T 3oja_A           22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVGPS  100 (487)
T ss_dssp             HHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEECTT
T ss_pred             hHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCCCC
Confidence            455665554    89999999999999888999999999999999999998765 888999999999999872 1     


Q ss_pred             ----------------cCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccc-cccccccccccccc
Q 038098          102 ----------------GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIG-DLINLKSLNLSNNN  164 (580)
Q Consensus       102 ----------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~  164 (580)
                                      ..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.
T Consensus       101 L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          101 IETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             CCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             cCEEECcCCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence                            2345666667777777666666666777777777777777766666654 56777777777777


Q ss_pred             cCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          165 LSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       165 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      +++..+  +..+++|+.|++++|.+++.++....++.+..+++++|...
T Consensus       181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  227 (487)
T 3oja_A          181 IYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV  227 (487)
T ss_dssp             CCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred             cccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCc
Confidence            774422  33467777777777777777766666677777777777654

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.90  E-value=6.8e-24  Score=231.48  Aligned_cols=210  Identities=20%  Similarity=0.211  Sum_probs=180.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCc-CCC-CCchhhhCC------CCCceeeCCCCcCCcCCCc--cccCCCCCcEEE
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQ-LEG-SIPDDLCRL------AALFELDSGGNKLDGFVPA--CFGNLTNLRNLY   70 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~   70 (580)
                      +|++.+.+|.+|+++++|++|+|++|+ +++ .+|..++.+      ++|++|+|++|+++ .+|.  .|+++++|++|+
T Consensus       258 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~  336 (636)
T 4eco_A          258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE  336 (636)
T ss_dssp             CCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred             CCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence            588999999999999999999999998 987 789988887      99999999999999 7787  899999999999


Q ss_pred             cCCCCCC-CCCCCCcCCCCCceEeCcCCcc-----cccCCCc-ccEEeCCCCcCCCCCCcccCCcc--ccceeccccccc
Q 038098           71 LGSNKLT-SIPSTLWNLKDILYLDLSSNFL-----LIGNLKV-LVQVDLSMNNFSDVIPTTIGGLK--DLQYLFLEYNRL  141 (580)
Q Consensus        71 l~~N~l~-~lp~~~~~l~~L~~L~l~~n~l-----~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~l~~n~l  141 (580)
                      |++|+++ .+| .+..+++|++|+|++|++     .+.++++ |+.|++++|.++ .+|..+..++  +|+.|+|++|.+
T Consensus       337 L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l  414 (636)
T 4eco_A          337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEI  414 (636)
T ss_dssp             CCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCT
T ss_pred             CcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcC
Confidence            9999999 899 888999999999999998     3667888 999999999998 5566776654  899999999999


Q ss_pred             cccCCcccc-------cccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCC--------ccCcccc
Q 038098          142 QGSIPDSIG-------DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPF--------RNFSTES  206 (580)
Q Consensus       142 ~~~~p~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~--------~~l~~~~  206 (580)
                      ++.+|..+.       .+.+|+.|+|++|+++...+..+..+++|+.|++++|.++..++.....        +.+..++
T Consensus       415 ~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~  494 (636)
T 4eco_A          415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID  494 (636)
T ss_dssp             TTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEE
T ss_pred             CCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEE
Confidence            988888888       7789999999999999544455667899999999999999555544221        1777788


Q ss_pred             CCCCccc
Q 038098          207 FEGNELL  213 (580)
Q Consensus       207 ~~~n~~~  213 (580)
                      +++|...
T Consensus       495 Ls~N~l~  501 (636)
T 4eco_A          495 LRFNKLT  501 (636)
T ss_dssp             CCSSCCC
T ss_pred             CcCCcCC
Confidence            8888654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=3.1e-23  Score=201.94  Aligned_cols=184  Identities=28%  Similarity=0.381  Sum_probs=165.0

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |.++. + .++..+++|++|+|++|.+++ + +.+..+++|++|+|++|.++++.+..|.++++|++|+|++|+++.++.
T Consensus        51 ~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  126 (272)
T 3rfs_A           51 SDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPD  126 (272)
T ss_dssp             SCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             CCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCH
Confidence            45543 2 468899999999999999985 3 489999999999999999998888889999999999999999999876


Q ss_pred             C-CcCCCCCceEeCcCCccc------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           82 T-LWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        82 ~-~~~l~~L~~L~l~~n~l~------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      . +..+++|++|+|++|++.      +..+++|+.|++++|.+++.++..|..+++|+.|+|++|.+++..|..+..+++
T Consensus       127 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  206 (272)
T 3rfs_A          127 GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS  206 (272)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             HHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcC
Confidence            5 678999999999999982      678999999999999999988888999999999999999999888888999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      |+.|+|++|.+.+.       +++|+.+++..|.+++.+|..
T Consensus       207 L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          207 LQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             CCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            99999999998854       457899999999999988764

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.89  E-value=2.3e-23  Score=224.52  Aligned_cols=121  Identities=21%  Similarity=0.270  Sum_probs=61.9

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC-
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP-   80 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp-   80 (580)
                      |+|+++.|.+|..+++|++|+|++|.|++..|+.|.++++|++|+|++|.|+.+ |..  .+++|++|+|++|+|+.+| 
T Consensus        62 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~--~l~~L~~L~Ls~N~l~~l~~  138 (562)
T 3a79_B           62 NSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI-SCC--PMASLRHLDLSFNDFDVLPV  138 (562)
T ss_dssp             SCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEE-CSC--CCTTCSEEECCSSCCSBCCC
T ss_pred             CCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCcc-Ccc--ccccCCEEECCCCCccccCc
Confidence            455555555555555555555555555544555555555555555555555532 222  4555555555555555543 


Q ss_pred             -CCCcCCCCCceEeCcCCccc---ccCCCcc--cEEeCCCCcC--CCCCCccc
Q 038098           81 -STLWNLKDILYLDLSSNFLL---IGNLKVL--VQVDLSMNNF--SDVIPTTI  125 (580)
Q Consensus        81 -~~~~~l~~L~~L~l~~n~l~---~~~l~~L--~~L~l~~N~l--~~~~~~~~  125 (580)
                       ..+.++++|++|+|++|++.   +..+++|  +.|++++|.+  ++..|..+
T Consensus       139 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l  191 (562)
T 3a79_B          139 CKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL  191 (562)
T ss_dssp             CGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEE
T ss_pred             hHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccc
Confidence             34555555555555555552   3333333  5555555555  44444433

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.89  E-value=1.8e-23  Score=227.83  Aligned_cols=194  Identities=21%  Similarity=0.160  Sum_probs=177.3

Q ss_pred             CCccccC--CCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCC-ccccCCCCCcEEEcCCCCCC
Q 038098            1 GNNLNGS--IPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVP-ACFGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus         1 ~N~~~~~--~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~   77 (580)
                      +|++++.  +|..+..+++|++|+|++|.++ .+|..|..+++|++|++++|.+.+..+ ..|.++++|++|++++|+++
T Consensus       359 ~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~  437 (606)
T 3vq2_A          359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK  437 (606)
T ss_dssp             SSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCE
T ss_pred             CCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCC
Confidence            4677766  4889999999999999999998 466899999999999999999998877 68999999999999999998


Q ss_pred             C-CCCCCcCCCCCceEeCcCCccc-------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccc
Q 038098           78 S-IPSTLWNLKDILYLDLSSNFLL-------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        78 ~-lp~~~~~l~~L~~L~l~~n~l~-------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~  149 (580)
                      . .|..+..+++|++|+|++|++.       +..+++|+.|++++|.+++..|..|..+++|+.|+|++|++++..|..|
T Consensus       438 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  517 (606)
T 3vq2_A          438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY  517 (606)
T ss_dssp             ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGT
T ss_pred             ccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHc
Confidence            8 5667889999999999999883       6788999999999999999999999999999999999999998889999


Q ss_pred             ccccccccccccccccCCCccccccccC-cccEEEccCCcccCCCCCC
Q 038098          150 GDLINLKSLNLSNNNLSGTIPISLEKLL-DLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       150 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~~  196 (580)
                      ..+++|+.|+|++|+++ .+|..+..++ +|+.|++++|++.|.++..
T Consensus       518 ~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          518 NQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             TTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             cCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            99999999999999999 6777788887 5999999999999988754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.89  E-value=1.5e-23  Score=226.73  Aligned_cols=214  Identities=22%  Similarity=0.230  Sum_probs=178.6

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhh-------------------hCCCCCceeeCCCCcCCcCC--Cccc
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDL-------------------CRLAALFELDSGGNKLDGFV--PACF   60 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~-------------------~~l~~L~~L~L~~N~l~~~~--~~~~   60 (580)
                      |+++ .+|..+..+ +|++|++++|.+.......+                   ..+++|++|++++|.+++..  +..+
T Consensus       292 ~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~  369 (570)
T 2z63_A          292 VTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD  369 (570)
T ss_dssp             CEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHH
T ss_pred             ccch-hhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccc
Confidence            3444 455555555 56666665555552221111                   56788999999999988654  6778


Q ss_pred             cCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcc-------cccCCCcccEEeCCCCcCCCCCCcccCCccccce
Q 038098           61 GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQY  133 (580)
Q Consensus        61 ~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l-------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  133 (580)
                      .++++|++|++++|+++.+|..+..+++|++|++++|.+       .+.++++|+.|++++|.+++..+..|..+++|+.
T Consensus       370 ~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  449 (570)
T 2z63_A          370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  449 (570)
T ss_dssp             HTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             cccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcE
Confidence            899999999999999999887788899999999999987       2567899999999999999888999999999999


Q ss_pred             ecccccccc-ccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCc
Q 038098          134 LFLEYNRLQ-GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNE  211 (580)
Q Consensus       134 L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~  211 (580)
                      |+|++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++.++.. ..+++++.+++.+|+
T Consensus       450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  529 (570)
T 2z63_A          450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP  529 (570)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence            999999997 578999999999999999999999888999999999999999999999988764 678889999999999


Q ss_pred             cccCCC
Q 038098          212 LLCGMP  217 (580)
Q Consensus       212 ~~c~~p  217 (580)
                      +.|+.|
T Consensus       530 ~~~~~~  535 (570)
T 2z63_A          530 WDCSCP  535 (570)
T ss_dssp             BCCCTT
T ss_pred             ccCCCc
Confidence            999866

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=4.6e-24  Score=208.11  Aligned_cols=150  Identities=15%  Similarity=0.126  Sum_probs=119.7

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEecccc------------------chhhhHHHHHHHHhhcCCC
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG------------------RAFKSFDIECDMIKRIRHR  348 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  348 (580)
                      +......|...+.||+|+||.||+|...+|+.||+|++.....                  .....+.+|++++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344455667799999999999999987799999999854321                  12456889999999999  


Q ss_pred             CcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCC
Q 038098          349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN  428 (580)
Q Consensus       349 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~  428 (580)
                      | +++.+++.. +..++||||++||+|.+ +..       .....++.|++.|+.|||   +.+|+||||||+|||++ +
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-T
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-C
Confidence            4 566665543 55699999999999998 421       224479999999999999   99999999999999999 9


Q ss_pred             CcEEEccccCccccCCCCCcccccccccCCCcCCccccc
Q 038098          429 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR  467 (580)
Q Consensus       429 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  467 (580)
                      +.+||+|||+|+.               +..|+|||++.
T Consensus       229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             CcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9999999999973               23478899774

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.89  E-value=3.8e-23  Score=233.12  Aligned_cols=98  Identities=29%  Similarity=0.282  Sum_probs=47.4

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCC-CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC-C
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGS-IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS-I   79 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-l   79 (580)
                      |+|+++.|.+|.++++|++|+|++|.+.+. .|+.|.++++|++|+|++|.|+++.|..|.++++|++|+|++|+++. +
T Consensus        34 N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  113 (844)
T 3j0a_A           34 NYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV  113 (844)
T ss_dssp             CCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCC
T ss_pred             CcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccc
Confidence            555555555555555555555555533222 24445555555555555555554445555555555555555555443 2


Q ss_pred             CCC--CcCCCCCceEeCcCCcc
Q 038098           80 PST--LWNLKDILYLDLSSNFL   99 (580)
Q Consensus        80 p~~--~~~l~~L~~L~l~~n~l   99 (580)
                      |..  +.++++|++|+|++|.+
T Consensus       114 ~~~~~~~~L~~L~~L~Ls~N~l  135 (844)
T 3j0a_A          114 LKDGYFRNLKALTRLDLSKNQI  135 (844)
T ss_dssp             STTCCCSSCSSCCEEEEESCCC
T ss_pred             ccCccccccCCCCEEECCCCcc
Confidence            222  34444444444444443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.9e-23  Score=207.53  Aligned_cols=186  Identities=18%  Similarity=0.176  Sum_probs=159.5

Q ss_pred             CCccccCCCccc--CCCCCCCEEeccCCcCCCCCc----hhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCC
Q 038098            1 GNNLNGSIPIAV--GKLQKLQLLSLEDNQLEGSIP----DDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN   74 (580)
Q Consensus         1 ~N~~~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N   74 (580)
                      +|++++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|.+++..+..|+.+++|++|+|++|
T Consensus       100 ~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N  179 (310)
T 4glp_A          100 DLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDN  179 (310)
T ss_dssp             SCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSC
T ss_pred             CCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCC
Confidence            588999999988  899999999999999986555    45567899999999999999888899999999999999999


Q ss_pred             CCCC---CCC--CCcCCCCCceEeCcCCccc---------ccCCCcccEEeCCCCcCCCCCCcccCCc---cccceeccc
Q 038098           75 KLTS---IPS--TLWNLKDILYLDLSSNFLL---------IGNLKVLVQVDLSMNNFSDVIPTTIGGL---KDLQYLFLE  137 (580)
Q Consensus        75 ~l~~---lp~--~~~~l~~L~~L~l~~n~l~---------~~~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~  137 (580)
                      ++..   ++.  .+..+++|++|+|++|++.         +.++++|++|+|++|.+++..|..+..+   ++|+.|+|+
T Consensus       180 ~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls  259 (310)
T 4glp_A          180 PGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLS  259 (310)
T ss_dssp             TTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECC
T ss_pred             CCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECC
Confidence            9865   433  3467899999999999983         3577999999999999998877777766   699999999


Q ss_pred             cccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccC
Q 038098          138 YNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       138 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~  191 (580)
                      +|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|++++|+++.
T Consensus       260 ~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          260 FAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             SSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             CCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            99999 7787764  7999999999999954 43 6788999999999999874

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=1.1e-22  Score=201.72  Aligned_cols=181  Identities=25%  Similarity=0.367  Sum_probs=159.9

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+++. +| ++..+++|++|+|++|.++.. +. +..+++|++|+|++|.+++.  ..+..+++|++|+|++|+|+.++
T Consensus        50 ~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~  123 (308)
T 1h6u_A           50 GTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT  123 (308)
T ss_dssp             TSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG
T ss_pred             CCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCch
Confidence            466664 44 689999999999999999954 44 99999999999999999964  47999999999999999999987


Q ss_pred             CCCcCCCCCceEeCcCCccc----ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                      . +..+++|++|+|++|++.    +..+++|+.|++++|.+++..+  +..+++|+.|+|++|.+++. +. +..+++|+
T Consensus       124 ~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~  198 (308)
T 1h6u_A          124 P-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI-SP-LASLPNLI  198 (308)
T ss_dssp             G-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCC
T ss_pred             h-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC-hh-hcCCCCCC
Confidence            5 889999999999999983    6789999999999999997654  89999999999999999954 43 88999999


Q ss_pred             cccccccccCCCccccccccCcccEEEccCCcccCCCC
Q 038098          157 SLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       157 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      .|+|++|++++..+  +..+++|+.|++++|++++.+.
T Consensus       199 ~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~  234 (308)
T 1h6u_A          199 EVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV  234 (308)
T ss_dssp             EEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred             EEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence            99999999996553  8899999999999999988554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.89  E-value=1.6e-23  Score=223.82  Aligned_cols=123  Identities=22%  Similarity=0.206  Sum_probs=68.6

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC--C
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS--I   79 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--l   79 (580)
                      |+|+++.|.+|.++++|++|+|++|+|++..|+.|+++++|++|+|++|+|+. +|..  .+++|++|+|++|+|+.  +
T Consensus        31 n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~  107 (520)
T 2z7x_B           31 NYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPI  107 (520)
T ss_dssp             SCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCCC
T ss_pred             CcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCCccccccc
Confidence            55555555556666666666666666655555556666666666666666553 2322  55566666666666654  3


Q ss_pred             CCCCcCCCCCceEeCcCCcc---cccCCCcc--cEEeCCCCcC--CCCCCcccCC
Q 038098           80 PSTLWNLKDILYLDLSSNFL---LIGNLKVL--VQVDLSMNNF--SDVIPTTIGG  127 (580)
Q Consensus        80 p~~~~~l~~L~~L~l~~n~l---~~~~l~~L--~~L~l~~N~l--~~~~~~~~~~  127 (580)
                      |..+.++++|++|+|++|++   .+..+++|  +.|++++|.+  .+..|..+..
T Consensus       108 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~  162 (520)
T 2z7x_B          108 CKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD  162 (520)
T ss_dssp             CGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred             hhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccc
Confidence            44555666666666666655   24445555  6666666665  4444444433

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=2.3e-22  Score=193.30  Aligned_cols=164  Identities=26%  Similarity=0.323  Sum_probs=149.9

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+++ .+|..+.  ++|++|+|++|.+++..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|+|+.+|.
T Consensus        24 ~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  100 (251)
T 3m19_A           24 KSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPL  100 (251)
T ss_dssp             CCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             CCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccCh
Confidence            4555 5666665  689999999999998888999999999999999999999989999999999999999999999885


Q ss_pred             -CCcCCCCCceEeCcCCccc------ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           82 -TLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        82 -~~~~l~~L~~L~l~~n~l~------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                       .+..+++|++|+|++|+|.      +..+++|+.|+|++|.++++++..|..+++|+.|+|++|.+++..+..|..+++
T Consensus       101 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  180 (251)
T 3m19_A          101 GVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK  180 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             hHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCC
Confidence             5678999999999999992      678999999999999999988889999999999999999999777778999999


Q ss_pred             cccccccccccCCC
Q 038098          155 LKSLNLSNNNLSGT  168 (580)
Q Consensus       155 L~~L~l~~N~l~~~  168 (580)
                      |+.|+|++|++++.
T Consensus       181 L~~L~l~~N~~~c~  194 (251)
T 3m19_A          181 LQTITLFGNQFDCS  194 (251)
T ss_dssp             CCEEECCSCCBCTT
T ss_pred             CCEEEeeCCceeCC
Confidence            99999999999965

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.88  E-value=4.5e-23  Score=221.81  Aligned_cols=126  Identities=20%  Similarity=0.234  Sum_probs=101.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCC-
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI-   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l-   79 (580)
                      +|+|+++.|.+|.++++|++|+|++|++++..|+.|..+++|++|+|++|.+++..+..|+++++|++|+|++|+++.+ 
T Consensus        35 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  114 (549)
T 2z81_A           35 FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG  114 (549)
T ss_dssp             SSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSC
T ss_pred             CCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccc
Confidence            5788888888899999999999999999888888899999999999999999887777789999999999999998854 


Q ss_pred             -CCCCcCCCCCceEeCcCCcc-------cccCCCcccEEeCCCCcCCCCCCcccC
Q 038098           80 -PSTLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTTIG  126 (580)
Q Consensus        80 -p~~~~~l~~L~~L~l~~n~l-------~~~~l~~L~~L~l~~N~l~~~~~~~~~  126 (580)
                       |..+.++++|++|++++|.+       .+.++++|++|++++|.+++..|..+.
T Consensus       115 ~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~  169 (549)
T 2z81_A          115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK  169 (549)
T ss_dssp             SSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred             hhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhh
Confidence             56777888888888888873       355666777777777776665554443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.88  E-value=2.9e-22  Score=202.48  Aligned_cols=202  Identities=24%  Similarity=0.363  Sum_probs=104.8

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|++++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|++|++++|+++.++
T Consensus       119 ~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~  193 (347)
T 4fmz_A          119 EDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS  193 (347)
T ss_dssp             TSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCG
T ss_pred             CCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccccc
Confidence            355554433  6677777777777775443333 36666666666666666664332  666666666666666666654


Q ss_pred             CCCcCCCCCceEeCcCCccc----ccCCCcccEEeCCCCcCCCCCC--------------------cccCCccccceecc
Q 038098           81 STLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIP--------------------TTIGGLKDLQYLFL  136 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~----~~~l~~L~~L~l~~N~l~~~~~--------------------~~~~~l~~L~~L~l  136 (580)
                      . +..+++|+.|++++|.+.    +..+++|+.|++++|.+++..+                    ..+..+++|+.|++
T Consensus       194 ~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l  272 (347)
T 4fmz_A          194 P-LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNV  272 (347)
T ss_dssp             G-GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEEC
T ss_pred             c-ccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCChhHhcCCCcCEEEc
Confidence            4 444555555555555441    3344444555555554443322                    23444445555555


Q ss_pred             ccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCc
Q 038098          137 EYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNE  211 (580)
Q Consensus       137 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~  211 (580)
                      ++|.+++ + ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.+| ...++.+..+++.+|+
T Consensus       273 ~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          273 GSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV  344 (347)
T ss_dssp             CSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred             cCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence            5554442 2 224444555555555555554444445555555555555555554444 3344444444444443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.88  E-value=1.2e-22  Score=219.59  Aligned_cols=160  Identities=24%  Similarity=0.303  Sum_probs=76.0

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+|+++.+.+|.++++|++|+|++|.+++..|+.|.++++|++|+|++|.++++.|..|.++++|++|+|++|+++.++.
T Consensus        38 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~  117 (570)
T 2z63_A           38 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN  117 (570)
T ss_dssp             CCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTT
T ss_pred             CccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCC
Confidence            44444444455555555555555555544444445555555555555555554444455555555555555555554443


Q ss_pred             -CCcCCCCCceEeCcCCccc-------ccCCCcccEEeCCCCcCCCCCCcccCCcccc----ceeccccccccccCCccc
Q 038098           82 -TLWNLKDILYLDLSSNFLL-------IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDL----QYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        82 -~~~~l~~L~~L~l~~n~l~-------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L----~~L~l~~n~l~~~~p~~~  149 (580)
                       .+.++++|++|+|++|.+.       +.++++|++|++++|.+++..+..+..+++|    ..|++++|.+++..|..|
T Consensus       118 ~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~  197 (570)
T 2z63_A          118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF  197 (570)
T ss_dssp             CSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT
T ss_pred             ccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHh
Confidence             3444555555555555431       3334455555555555544444444444444    444555554443333333


Q ss_pred             ccccccccccccc
Q 038098          150 GDLINLKSLNLSN  162 (580)
Q Consensus       150 ~~l~~L~~L~l~~  162 (580)
                      ..+ +|+.|++++
T Consensus       198 ~~~-~L~~L~l~~  209 (570)
T 2z63_A          198 KEI-RLHKLTLRN  209 (570)
T ss_dssp             TTC-EEEEEEEES
T ss_pred             ccC-cceeEeccc
Confidence            322 344444433

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.88  E-value=9e-23  Score=219.48  Aligned_cols=208  Identities=22%  Similarity=0.248  Sum_probs=177.3

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|+++++.|..|.++++|++|+|++|+++.++.
T Consensus        15 ~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   91 (549)
T 2z81_A           15 RSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS   91 (549)
T ss_dssp             SCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred             Cccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence            5565 5676654  799999999999998889999999999999999999999999999999999999999999999886


Q ss_pred             C-CcCCCCCceEeCcCCccc-------ccCCCcccEEeCCCCc-CCCCCCcccCCccccceeccccccccccCCcccccc
Q 038098           82 T-LWNLKDILYLDLSSNFLL-------IGNLKVLVQVDLSMNN-FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        82 ~-~~~l~~L~~L~l~~n~l~-------~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                      . +.++++|++|+|++|++.       +.++++|+.|++++|. +..+++..|..+++|+.|++++|.+++..|..+..+
T Consensus        92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l  171 (549)
T 2z81_A           92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI  171 (549)
T ss_dssp             HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred             HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence            5 889999999999999883       6678999999999998 555556789999999999999999998899999999


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCC----CCCCCCccCccccCCCCcc
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEI----PNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~----~~~~~~~~l~~~~~~~n~~  212 (580)
                      ++|+.|++++|.+....+..+..+++|+.|++++|++++..    +.....+.++.+++.+|..
T Consensus       172 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l  235 (549)
T 2z81_A          172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL  235 (549)
T ss_dssp             SEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEE
T ss_pred             ccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceecccccc
Confidence            99999999999998444334467899999999999999853    2223345566666665543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.87  E-value=3.7e-22  Score=196.03  Aligned_cols=171  Identities=27%  Similarity=0.383  Sum_probs=151.4

Q ss_pred             cCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCce
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILY   91 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~   91 (580)
                      +..+++|+.|++++|.++.. + .+..+++|++|+|++|+++++.+  +.++++|++|+|++|+++.+|. +..+++|++
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~  116 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS-LKDLKKLKS  116 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCE
T ss_pred             hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChh-hccCCCCCE
Confidence            55789999999999999844 4 48999999999999999997654  9999999999999999999875 888999999


Q ss_pred             EeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCC
Q 038098           92 LDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG  167 (580)
Q Consensus        92 L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  167 (580)
                      |+|++|++    .+..+++|+.|++++|.++++  ..+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|.+++
T Consensus       117 L~L~~n~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             EECTTSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             EECCCCcCCCChhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence            99999998    367889999999999999976  678899999999999999996544  8899999999999999995


Q ss_pred             CccccccccCcccEEEccCCcccCCC
Q 038098          168 TIPISLEKLLDLKDINVSFNKLEGEI  193 (580)
Q Consensus       168 ~~~~~~~~l~~L~~l~l~~N~l~~~~  193 (580)
                       ++ .+..+++|+.|++++|+++..+
T Consensus       193 -l~-~l~~l~~L~~L~l~~n~i~~~~  216 (291)
T 1h6t_A          193 -LR-ALAGLKNLDVLELFSQECLNKP  216 (291)
T ss_dssp             -CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred             -Ch-hhccCCCCCEEECcCCcccCCc
Confidence             44 4889999999999999998754

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.87  E-value=2.5e-21  Score=202.33  Aligned_cols=192  Identities=22%  Similarity=0.250  Sum_probs=114.6

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+|+++ | +|..+++|++|+|++|.|++. |  ++.+++|++|+|++|.|+++ +  ++++++|++|+|++|+|+.+| 
T Consensus        52 n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l~-  122 (457)
T 3bz5_A           52 SSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKLD-  122 (457)
T ss_dssp             SCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCCC-
T ss_pred             CCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCeec-
Confidence            455543 3 455666666666666666542 2  55566666666666666643 2  556666666666666666654 


Q ss_pred             CCcCCCCCceEeCcCCcc---cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccc
Q 038098           82 TLWNLKDILYLDLSSNFL---LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSL  158 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  158 (580)
                       +..+++|++|++++|++   .+..+++|+.|++++|...+..  .+..+++|+.|++++|.+++ +|  +..+++|+.|
T Consensus       123 -~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L  196 (457)
T 3bz5_A          123 -VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRL  196 (457)
T ss_dssp             -CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEE
T ss_pred             -CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEE
Confidence             55566666666666655   2445556666666666433322  35566667777777777664 34  5666677777


Q ss_pred             cccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          159 NLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       159 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      ++++|++++.   .+..+++|+.|++++|++++.+  ...++.+..+++.+|...
T Consensus       197 ~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~  246 (457)
T 3bz5_A          197 NCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLT  246 (457)
T ss_dssp             ECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCS
T ss_pred             ECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCC
Confidence            7777777643   2666677777777777777643  445666666666666543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.87  E-value=1.4e-21  Score=205.58  Aligned_cols=193  Identities=27%  Similarity=0.436  Sum_probs=99.3

Q ss_pred             cCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCce
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILY   91 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~   91 (580)
                      +.++++|++|++++|.++..  +.+..+++|++|++++|.+++..+  ++.+++|++|++++|+++.++ .+..+++|++
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~  247 (466)
T 1o6v_A          173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-TLASLTNLTD  247 (466)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSE
T ss_pred             hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch-hhhcCCCCCE
Confidence            66666666666666666532  235666666666666666664433  455555555555555555543 3444555555


Q ss_pred             EeCcCCcc----cccCCCcccEEeCCCCcCCCCCC--------------------cccCCccccceeccccccccccCCc
Q 038098           92 LDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIP--------------------TTIGGLKDLQYLFLEYNRLQGSIPD  147 (580)
Q Consensus        92 L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~--------------------~~~~~l~~L~~L~l~~n~l~~~~p~  147 (580)
                      |++++|.+    .+..+++|+.|++++|.+++..+                    ..+..+++|+.|+|++|.+++..| 
T Consensus       248 L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~-  326 (466)
T 1o6v_A          248 LDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-  326 (466)
T ss_dssp             EECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-
T ss_pred             EECCCCccccchhhhcCCCCCEEECCCCccCccccccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh-
Confidence            55555554    13444455555555555544322                    013444444555555554443322 


Q ss_pred             ccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          148 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       148 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                       +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.+| ...++.+..+++.+|++..
T Consensus       327 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred             -hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence             34445555555555555432  234455555555555555555544 3444555555555555443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=8.7e-22  Score=185.00  Aligned_cols=155  Identities=22%  Similarity=0.353  Sum_probs=126.8

Q ss_pred             CEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCC-CCCCcCCCCCceEeCcCC
Q 038098           19 QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSN   97 (580)
Q Consensus        19 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l-p~~~~~l~~L~~L~l~~n   97 (580)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+++.+..|..+++|++|+|++|+|+.+ |..+.++++|        
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L--------   82 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL--------   82 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC--------
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC--------
Confidence            67899999998 5666554  6899999999999988888899999999999999999887 4566555555        


Q ss_pred             cccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccC
Q 038098           98 FLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL  177 (580)
Q Consensus        98 ~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  177 (580)
                                +.|+|++|.|+.+++..|..+++|+.|+|++|.|++..|..|..+++|+.|+|++|+|++..+..+..++
T Consensus        83 ----------~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  152 (220)
T 2v9t_B           83 ----------NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR  152 (220)
T ss_dssp             ----------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             ----------CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCC
Confidence                      5555666666666677788888899999999998877788888888999999999999877777788888


Q ss_pred             cccEEEccCCcccCCCC
Q 038098          178 DLKDINVSFNKLEGEIP  194 (580)
Q Consensus       178 ~L~~l~l~~N~l~~~~~  194 (580)
                      +|+.|++++|++.|.+.
T Consensus       153 ~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          153 AIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             TCCEEECCSSCEECSGG
T ss_pred             CCCEEEeCCCCcCCCCc
Confidence            99999999999988764

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.86  E-value=5.6e-21  Score=193.00  Aligned_cols=198  Identities=27%  Similarity=0.449  Sum_probs=140.9

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|++..+ | +|..+++|++|+|++|.++. ++. +..+++|++|+|++|.++.+  +.|.++++|++|+|++|+++.++
T Consensus        53 ~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~  126 (347)
T 4fmz_A           53 GEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDIS  126 (347)
T ss_dssp             SSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCG
T ss_pred             CCccccc-h-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCch
Confidence            3555543 3 48888899999999998884 343 88888999999999988854  36888899999999999888887


Q ss_pred             CCCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINL  155 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  155 (580)
                      . +..+++|++|++++|..     .+..+++|+.|++++|.+.+..+  +..+++|+.|++++|.+++ ++. +..+++|
T Consensus       127 ~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L  201 (347)
T 4fmz_A          127 P-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSL  201 (347)
T ss_dssp             G-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTC
T ss_pred             h-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCcc
Confidence            6 77788888888888854     35667777777777777775543  6677777777777777763 333 6666667


Q ss_pred             ccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcc
Q 038098          156 KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       156 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~  212 (580)
                      +.|++++|.+++..+  +..+++|+.|++++|.++...+ ...+++++.+++.+|..
T Consensus       202 ~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l  255 (347)
T 4fmz_A          202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQI  255 (347)
T ss_dssp             CEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred             ceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCcc
Confidence            777777776664433  5666666677777666666554 44555666666665543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=8.4e-22  Score=185.10  Aligned_cols=157  Identities=22%  Similarity=0.302  Sum_probs=131.6

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCC-ccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeCc
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVP-ACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLS   95 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l~   95 (580)
                      -+++++++|.++ .+|..+.  +.+++|+|++|+|+++.+ ..|..+++|++|+|++|+|+.++. .+.++         
T Consensus        13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l---------   80 (220)
T 2v70_A           13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA---------   80 (220)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC---------
T ss_pred             CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC---------
Confidence            368999999998 4666554  357899999999997754 468899999999999999998765 45444         


Q ss_pred             CCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccc
Q 038098           96 SNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK  175 (580)
Q Consensus        96 ~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  175 (580)
                               ++|+.|+|++|.++++++..|..+++|+.|+|++|.|++..|..|..+++|+.|+|++|++++..|..|..
T Consensus        81 ---------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  151 (220)
T 2v70_A           81 ---------SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT  151 (220)
T ss_dssp             ---------TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTT
T ss_pred             ---------CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcC
Confidence                     45577777777777888888999999999999999999888889999999999999999999888999999


Q ss_pred             cCcccEEEccCCcccCCCCC
Q 038098          176 LLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       176 l~~L~~l~l~~N~l~~~~~~  195 (580)
                      +++|+.|++++|+++|.++.
T Consensus       152 l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A          152 LHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             CTTCCEEECCSCCEECSGGG
T ss_pred             CCCCCEEEecCcCCcCCCch
Confidence            99999999999999988763

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=5.9e-21  Score=177.92  Aligned_cols=156  Identities=26%  Similarity=0.340  Sum_probs=92.0

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLS   95 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~   95 (580)
                      ++|++|+|++|.+++..+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|+|+.+|...            
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~------------   95 (208)
T 2o6s_A           28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGV------------   95 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT------------
T ss_pred             CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhH------------
Confidence            34555555555555444444445555555555555555444444455555555555555555444321            


Q ss_pred             CCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccc
Q 038098           96 SNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK  175 (580)
Q Consensus        96 ~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  175 (580)
                           +.++++|+.|++++|.++++++..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.+.+       .
T Consensus        96 -----~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~  163 (208)
T 2o6s_A           96 -----FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------T  163 (208)
T ss_dssp             -----TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------C
T ss_pred             -----hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------C
Confidence                 3455566666666666666666666777777777777777775555556677777777777776653       2


Q ss_pred             cCcccEEEccCCcccCCCCC
Q 038098          176 LLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       176 l~~L~~l~l~~N~l~~~~~~  195 (580)
                      +++|+.|+++.|.+++.+|.
T Consensus       164 ~~~l~~L~~~~n~~~g~ip~  183 (208)
T 2o6s_A          164 CPGIRYLSEWINKHSGVVRN  183 (208)
T ss_dssp             TTTTHHHHHHHHHCTTTBBC
T ss_pred             CCCHHHHHHHHHhCCceeec
Confidence            34667777777777776664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.85  E-value=1.3e-20  Score=196.86  Aligned_cols=186  Identities=23%  Similarity=0.223  Sum_probs=161.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+++ |  |+.+++|++|+|++|.|++. |  ++.+++|++|+|++|+++++ +  ++.+++|++|++++|+|+.++
T Consensus        73 ~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~  143 (457)
T 3bz5_A           73 SNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEID  143 (457)
T ss_dssp             SSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCCC
T ss_pred             CCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccceec
Confidence            5788875 4  99999999999999999964 4  89999999999999999975 3  999999999999999999985


Q ss_pred             CCCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                        +..+++|++|++++|..    .+..+++|+.|++++|+++++ |  +..+++|+.|++++|.+++.   .+..+++|+
T Consensus       144 --l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~  215 (457)
T 3bz5_A          144 --VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLT  215 (457)
T ss_dssp             --CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCS
T ss_pred             --cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCC
Confidence              78899999999999953    477899999999999999985 3  88899999999999999954   388899999


Q ss_pred             cccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCC
Q 038098          157 SLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFE  208 (580)
Q Consensus       157 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~  208 (580)
                      .|++++|++++ +|  +..+++|+.|++++|++++.++.  .++.+..+.+.
T Consensus       216 ~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~--~l~~L~~L~l~  262 (457)
T 3bz5_A          216 FLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS--TLSKLTTLHCI  262 (457)
T ss_dssp             EEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT--TCTTCCEEECT
T ss_pred             EEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH--HCCCCCEEecc
Confidence            99999999997 55  88999999999999999997643  34555444333

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.85  E-value=5.4e-21  Score=201.09  Aligned_cols=198  Identities=29%  Similarity=0.422  Sum_probs=168.6

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |++++. | .+..+++|+.|+++ |.+... + .+.++++|++|++++|.++..  ..+..+++|++|++++|+++.++.
T Consensus       144 n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~  216 (466)
T 1o6v_A          144 NTISDI-S-ALSGLTSLQQLSFG-NQVTDL-K-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP  216 (466)
T ss_dssp             EEECCC-G-GGTTCTTCSEEEEE-ESCCCC-G-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred             CccCCC-h-hhccCCcccEeecC-CcccCc-h-hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc
Confidence            566653 3 59999999999997 566533 3 399999999999999999865  458999999999999999999865


Q ss_pred             CCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccc
Q 038098           82 TLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKS  157 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  157 (580)
                       +..+++|+.|++++|++    .+..+++|+.|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.
T Consensus       217 -~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  291 (466)
T 1o6v_A          217 -LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN  291 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             -ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCe
Confidence             77899999999999998    46789999999999999998755  8899999999999999995443  888999999


Q ss_pred             ccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          158 LNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       158 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                      |+|++|++++..+  +..+++|+.|++++|++++..+ ...++++..+++.+|....
T Consensus       292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~  345 (466)
T 1o6v_A          292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSD  345 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred             EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCC
Confidence            9999999997655  7889999999999999998876 5567888888888886543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=2.1e-21  Score=197.03  Aligned_cols=174  Identities=30%  Similarity=0.340  Sum_probs=141.2

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCcccc-CCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeCc
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG-NLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLS   95 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l~   95 (580)
                      -+++++++|.++ .+|..+.  +.+++|+|++|+|+++.+..|. ++++|++|+|++|+|+.++. .|.++++|++|+|+
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            368999999998 5666554  4689999999999988888887 89999999999999999875 57788899999988


Q ss_pred             CCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccc---ccccccccccccccccC
Q 038098           96 SNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI---GDLINLKSLNLSNNNLS  166 (580)
Q Consensus        96 ~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~---~~l~~L~~L~l~~N~l~  166 (580)
                      +|+|      .+.++++|+.|+|++|.|+.+.+..|..+++|+.|+|++|.|++..+..|   ..+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            8888      36778888888888888888888888888889999999998884434444   56888888899999888


Q ss_pred             CCccccccccCc--ccEEEccCCcccCCCC
Q 038098          167 GTIPISLEKLLD--LKDINVSFNKLEGEIP  194 (580)
Q Consensus       167 ~~~~~~~~~l~~--L~~l~l~~N~l~~~~~  194 (580)
                      ...+..+..++.  ++.|++++|++.|.+.
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            666677777776  4778888888887664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.85  E-value=2.3e-21  Score=208.44  Aligned_cols=172  Identities=26%  Similarity=0.373  Sum_probs=155.2

Q ss_pred             cCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCce
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILY   91 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~   91 (580)
                      +..|++|+.|+|++|.|.. +| .|..+++|++|+|++|.|+++.+  |..+++|+.|+|++|+|+.+| .+..+++|+.
T Consensus        39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~  113 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKS  113 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT-TSTTCTTCCE
T ss_pred             hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh-hhccCCCCCE
Confidence            5678999999999999984 44 58999999999999999997655  999999999999999999987 6889999999


Q ss_pred             EeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCC
Q 038098           92 LDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG  167 (580)
Q Consensus        92 L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  167 (580)
                      |+|++|++    .+..+++|+.|+|++|.++++  ..+..+++|+.|+|++|.|++..|  +..+++|+.|+|++|+|++
T Consensus       114 L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          114 LSLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             EECTTSCCCCCGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             EEecCCCCCCCccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence            99999999    377899999999999999976  678999999999999999996655  8999999999999999996


Q ss_pred             CccccccccCcccEEEccCCcccCCCC
Q 038098          168 TIPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       168 ~~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      . | .+..+++|+.|+|++|++++.+.
T Consensus       190 l-~-~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          190 L-R-ALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             C-G-GGTTCTTCSEEECCSEEEECCCC
T ss_pred             C-h-HHccCCCCCEEEccCCcCcCCcc
Confidence            4 3 68899999999999999988654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.85  E-value=1.1e-20  Score=178.82  Aligned_cols=157  Identities=25%  Similarity=0.359  Sum_probs=135.2

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCC-cCCCCCceEeCcC
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTL-WNLKDILYLDLSS   96 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~-~~l~~L~~L~l~~   96 (580)
                      .+.++++++.++ .+|..+.  ++|++|+|++|.|+++.|..|.++++|++|+|++|+|+.+|... ..+          
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l----------   87 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL----------   87 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC----------
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccC----------
Confidence            578999999998 5665554  78999999999999988999999999999999999999988643 344          


Q ss_pred             CcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccccccc
Q 038098           97 NFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL  176 (580)
Q Consensus        97 n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  176 (580)
                              ++|+.|+|++|.|+++++..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+
T Consensus        88 --------~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  158 (229)
T 3e6j_A           88 --------TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL  158 (229)
T ss_dssp             --------TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred             --------CCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence                    45567777777777777788899999999999999999 788889999999999999999997777889999


Q ss_pred             CcccEEEccCCcccCCCCCC
Q 038098          177 LDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       177 ~~L~~l~l~~N~l~~~~~~~  196 (580)
                      ++|+.|++++|+++|.++..
T Consensus       159 ~~L~~L~l~~N~~~c~c~~~  178 (229)
T 3e6j_A          159 SSLTHAYLFGNPWDCECRDI  178 (229)
T ss_dssp             TTCCEEECTTSCBCTTBGGG
T ss_pred             CCCCEEEeeCCCccCCcchh
Confidence            99999999999999988643

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.2e-20  Score=200.60  Aligned_cols=171  Identities=24%  Similarity=0.296  Sum_probs=106.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|++|+|++|+|+.+|
T Consensus        68 ~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp  136 (571)
T 3cvr_A           68 RLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLP  136 (571)
T ss_dssp             SSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCC
T ss_pred             CCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCC
Confidence            355654 555442  66777777777776 445   345667777777777765 444 444  6777777777777766


Q ss_pred             CCCcCCCCCceEeCcCCccc--ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccc---
Q 038098           81 STLWNLKDILYLDLSSNFLL--IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINL---  155 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~--~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L---  155 (580)
                      .   .+++|++|+|++|+|.  -..+++|+.|+|++|.|+++ |. |.  ++|+.|+|++|.|+ .+|. |..  +|   
T Consensus       137 ~---~l~~L~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~L~~l-p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~  205 (571)
T 3cvr_A          137 E---LPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLTFL-PE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHS  205 (571)
T ss_dssp             C---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCC-CC-CC--TTCCEEECCSSCCS-SCCC-CC--------
T ss_pred             C---cCccccEEeCCCCccCcCCCcCCCcCEEECCCCCCCCc-ch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcc
Confidence            5   4566777777777662  12345677777777777663 33 44  66777777777776 5555 443  55   


Q ss_pred             ----ccccccccccCCCccccccccCcccEEEccCCcccCCCC
Q 038098          156 ----KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       156 ----~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                          +.|+|++|+|+ .+|..+..+++|+.|++++|++++.+|
T Consensus       206 ~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             --CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             cccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence                77777777777 456666667777777777777766544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.83  E-value=1.3e-20  Score=190.40  Aligned_cols=204  Identities=19%  Similarity=0.177  Sum_probs=162.1

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCc-CCCccccCCCCCcE-EEcCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDG-FVPACFGNLTNLRN-LYLGSNKLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~-L~l~~N~l~~   78 (580)
                      +|+++ .+|..+  .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+ +.++.|.++++|++ +.+++|+|+.
T Consensus        18 ~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~   94 (350)
T 4ay9_X           18 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY   94 (350)
T ss_dssp             STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCE
T ss_pred             CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccc
Confidence            35666 677766  3789999999999997777889999999999999999865 44568999999875 6777899999


Q ss_pred             CC-CCCcCCCCCceEeCcCCccc------ccCCCcccEEeCCC-CcCCCCCCcccCCcc-ccceeccccccccccCCccc
Q 038098           79 IP-STLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM-NNFSDVIPTTIGGLK-DLQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        79 lp-~~~~~l~~L~~L~l~~n~l~------~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~p~~~  149 (580)
                      ++ ..+..+++|++|++++|++.      +....++..|++++ |.+..+.+..|..+. .++.|+|++|+|+ .+|...
T Consensus        95 l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~  173 (350)
T 4ay9_X           95 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA  173 (350)
T ss_dssp             ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTS
T ss_pred             cCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhh
Confidence            86 46778999999999999983      34556777888855 678877778888775 6889999999999 555555


Q ss_pred             ccccccccccccc-cccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCC
Q 038098          150 GDLINLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN  210 (580)
Q Consensus       150 ~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n  210 (580)
                      ....+|+.|++++ |.++...+..|..+++|+.|++++|+|+..++..  +..+..+...++
T Consensus       174 f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~  233 (350)
T 4ay9_X          174 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARST  233 (350)
T ss_dssp             STTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTC
T ss_pred             ccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccC
Confidence            5668899999975 7788555677899999999999999999887654  445554444333

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=1e-20  Score=177.73  Aligned_cols=146  Identities=25%  Similarity=0.362  Sum_probs=123.6

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+++ .+|..+.  ++|+.|+|++|+|+.+.+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+|
T Consensus        20 ~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~   96 (220)
T 2v9t_B           20 GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP   96 (220)
T ss_dssp             TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCC
T ss_pred             CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccC
Confidence            35555 5666554  78999999999999888889999999999999999999999999999999999999999999998


Q ss_pred             CCC-cCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccc
Q 038098           81 STL-WNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLN  159 (580)
Q Consensus        81 ~~~-~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  159 (580)
                      ... ..++                  +|+.|+|++|.++++.+..|..+++|+.|+|++|.|++..+..|..+++|+.|+
T Consensus        97 ~~~f~~l~------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  158 (220)
T 2v9t_B           97 KSLFEGLF------------------SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMH  158 (220)
T ss_dssp             TTTTTTCT------------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred             HhHccCCC------------------CCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEE
Confidence            764 3444                  456666677777777788888888999999999999877777788888999999


Q ss_pred             ccccccCC
Q 038098          160 LSNNNLSG  167 (580)
Q Consensus       160 l~~N~l~~  167 (580)
                      |++|.+..
T Consensus       159 L~~N~~~c  166 (220)
T 2v9t_B          159 LAQNPFIC  166 (220)
T ss_dssp             CCSSCEEC
T ss_pred             eCCCCcCC
Confidence            99998874

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=1.7e-20  Score=174.76  Aligned_cols=159  Identities=28%  Similarity=0.343  Sum_probs=133.9

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCC
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSN   97 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n   97 (580)
                      -+.++++++.++ .+|..+  .++|++|+|++|+++++.+..|.++++|++|+|++|+|+.+|...+             
T Consensus         9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------   72 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF-------------   72 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT-------------
T ss_pred             CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc-------------
Confidence            367889999998 455544  3589999999999998888889999999999999999998876432             


Q ss_pred             cccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccC
Q 038098           98 FLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL  177 (580)
Q Consensus        98 ~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  177 (580)
                          ..+++|+.|++++|.++++++..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..+..+..++
T Consensus        73 ----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  148 (208)
T 2o6s_A           73 ----NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT  148 (208)
T ss_dssp             ----TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             ----CCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCC
Confidence                2344556667777777777777889999999999999999977777789999999999999999987777799999


Q ss_pred             cccEEEccCCcccCCCCCC
Q 038098          178 DLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       178 ~L~~l~l~~N~l~~~~~~~  196 (580)
                      +|+.|++++|++.+.++..
T Consensus       149 ~L~~L~l~~N~~~~~~~~l  167 (208)
T 2o6s_A          149 SLQYIWLHDNPWDCTCPGI  167 (208)
T ss_dssp             TCCEEECCSCCBCCCTTTT
T ss_pred             CccEEEecCCCeecCCCCH
Confidence            9999999999999887653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.82  E-value=3.9e-21  Score=185.74  Aligned_cols=169  Identities=22%  Similarity=0.306  Sum_probs=137.9

Q ss_pred             CCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEe
Q 038098           14 KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLD   93 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~   93 (580)
                      .+.++..+++++|.++. ++ .+..+++|++|++++|.|+.+ + .+..+++|++|+|++|+|+.++. +..+++|++|+
T Consensus        17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~   91 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEE
T ss_pred             HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEE
Confidence            46667778888888873 33 577888888888888888854 3 67888888888888888888876 77888888888


Q ss_pred             CcCCccc----ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCc
Q 038098           94 LSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI  169 (580)
Q Consensus        94 l~~n~l~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  169 (580)
                      |++|++.    +.. ++|+.|++++|.+++.  ..+..+++|+.|+|++|+|++ ++ .+..+++|+.|+|++|++++. 
T Consensus        92 L~~N~l~~l~~~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-  165 (263)
T 1xeu_A           92 VNRNRLKNLNGIPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-  165 (263)
T ss_dssp             CCSSCCSCCTTCCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-
T ss_pred             CCCCccCCcCcccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-
Confidence            8888872    233 7889999999999875  358899999999999999985 44 688899999999999999966 


Q ss_pred             cccccccCcccEEEccCCcccCCCC
Q 038098          170 PISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       170 ~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                       ..+..+++|+.|++++|++++.+.
T Consensus       166 -~~l~~l~~L~~L~l~~N~~~~~~~  189 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKCVNEPV  189 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEEECCCE
T ss_pred             -HHhccCCCCCEEeCCCCcccCCcc
Confidence             678899999999999999987753

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.82  E-value=1.6e-22  Score=207.35  Aligned_cols=155  Identities=19%  Similarity=0.256  Sum_probs=68.8

Q ss_pred             hCCCCCceeeCCCCcCCc----CCCccccCCCCCcEEEcCCCCCCC-----CCCCCcCC---------CCCceEeCcCCc
Q 038098           37 CRLAALFELDSGGNKLDG----FVPACFGNLTNLRNLYLGSNKLTS-----IPSTLWNL---------KDILYLDLSSNF   98 (580)
Q Consensus        37 ~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~-----lp~~~~~l---------~~L~~L~l~~n~   98 (580)
                      ..+++|++|+|++|.++.    .++..+..+++|++|+|++|+|+.     ++..+..+         ++|++|+|++|+
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            344445555555554443    233344444455555555554432     11112222         445555555554


Q ss_pred             cc----------ccCCCcccEEeCCCCcCCC-----CCCcccCCccccceecccccccc----ccCCccccccccccccc
Q 038098           99 LL----------IGNLKVLVQVDLSMNNFSD-----VIPTTIGGLKDLQYLFLEYNRLQ----GSIPDSIGDLINLKSLN  159 (580)
Q Consensus        99 l~----------~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~l~~n~l~----~~~p~~~~~l~~L~~L~  159 (580)
                      +.          +..+++|+.|+|++|.++.     ..+..+..+++|+.|+|++|.++    ..+|..+..+++|+.|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            41          2234445555555554441     11224444455555555555553    23444444455555555


Q ss_pred             ccccccCCC----cccccc--ccCcccEEEccCCcccC
Q 038098          160 LSNNNLSGT----IPISLE--KLLDLKDINVSFNKLEG  191 (580)
Q Consensus       160 l~~N~l~~~----~~~~~~--~l~~L~~l~l~~N~l~~  191 (580)
                      |++|.+++.    ++..+.  .+++|+.|++++|+++.
T Consensus       251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence            555555433    233332  24455555555555544

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.82  E-value=2.1e-21  Score=197.13  Aligned_cols=211  Identities=18%  Similarity=0.167  Sum_probs=164.4

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCc----hhhhCCC-CCceeeCCCCcCCcCCCccccCC-----CCCcEEE
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIP----DDLCRLA-ALFELDSGGNKLDGFVPACFGNL-----TNLRNLY   70 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~   70 (580)
                      +|++++.+|..+...++|++|+|++|.|+...+    +.|..++ +|++|+|++|.|++..+..|..+     ++|++|+
T Consensus         7 ~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~   86 (362)
T 3goz_A            7 LHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLN   86 (362)
T ss_dssp             CCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred             cccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEE
Confidence            478888888888888889999999999997777    7888898 89999999999998877777665     9999999


Q ss_pred             cCCCCCCCCCCC-----CcCC-CCCceEeCcCCccc----------ccC-CCcccEEeCCCCcCCCCCCc----ccCCcc
Q 038098           71 LGSNKLTSIPST-----LWNL-KDILYLDLSSNFLL----------IGN-LKVLVQVDLSMNNFSDVIPT----TIGGLK  129 (580)
Q Consensus        71 l~~N~l~~lp~~-----~~~l-~~L~~L~l~~n~l~----------~~~-l~~L~~L~l~~N~l~~~~~~----~~~~l~  129 (580)
                      |++|+|+..+..     +..+ ++|++|+|++|++.          +.. .++|++|+|++|.++.....    .+..++
T Consensus        87 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~  166 (362)
T 3goz_A           87 LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP  166 (362)
T ss_dssp             CCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSC
T ss_pred             CcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCC
Confidence            999999875432     4444 79999999999983          233 36999999999999864433    334555


Q ss_pred             -ccceeccccccccccCCccccc----c-cccccccccccccCCC----ccccccc-cCcccEEEccCCcccCCCC----
Q 038098          130 -DLQYLFLEYNRLQGSIPDSIGD----L-INLKSLNLSNNNLSGT----IPISLEK-LLDLKDINVSFNKLEGEIP----  194 (580)
Q Consensus       130 -~L~~L~l~~n~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~----~~~~~~~-l~~L~~l~l~~N~l~~~~~----  194 (580)
                       +|+.|+|++|.+++..+..+..    + ++|+.|+|++|.+++.    ++..+.. .++|+.|++++|+++...+    
T Consensus       167 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~  246 (362)
T 3goz_A          167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLK  246 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHH
T ss_pred             ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHH
Confidence             8999999999998766654443    4 5999999999999863    4455555 3589999999999987654    


Q ss_pred             -CCCCCccCccccCCCCc
Q 038098          195 -NKGPFRNFSTESFEGNE  211 (580)
Q Consensus       195 -~~~~~~~l~~~~~~~n~  211 (580)
                       ....++.+..+++.+|.
T Consensus       247 ~~~~~l~~L~~L~L~~n~  264 (362)
T 3goz_A          247 LLKDSLKHLQTVYLDYDI  264 (362)
T ss_dssp             HTTTTTTTCSEEEEEHHH
T ss_pred             HHHhcCCCccEEEeccCC
Confidence             12445667777777665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.81  E-value=1.9e-19  Score=193.87  Aligned_cols=54  Identities=30%  Similarity=0.247  Sum_probs=31.6

Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      ++|+.|+|++|+|++ +|   ..+++|+.|++++|+|+..++   .++++..+++++|...
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC
Confidence            456666666666663 33   334566666666666665444   3455666666666543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=1.4e-19  Score=192.34  Aligned_cols=183  Identities=23%  Similarity=0.242  Sum_probs=153.7

Q ss_pred             ccCCCC-----CCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcC
Q 038098           11 AVGKLQ-----KLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWN   85 (580)
Q Consensus        11 ~~~~l~-----~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~   85 (580)
                      ++..++     +|+.|+|++|+|++ +|..+.  ++|++|+|++|+|+. +|   ..+++|++|+|++|+|+.+|. +.+
T Consensus        49 ~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~ip~-l~~  120 (571)
T 3cvr_A           49 AVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLSTLPE-LPA  120 (571)
T ss_dssp             HHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC-CCT
T ss_pred             hhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCCcch-hhc
Confidence            455555     89999999999996 666553  799999999999994 55   557999999999999999998 665


Q ss_pred             CCCCceEeCcCCccc--ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccc
Q 038098           86 LKDILYLDLSSNFLL--IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN  163 (580)
Q Consensus        86 l~~L~~L~l~~n~l~--~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  163 (580)
                        +|++|+|++|+|.  -..+++|+.|+|++|.|+++++    .+++|+.|+|++|.|++ +|. |.  ++|+.|+|++|
T Consensus       121 --~L~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N  190 (571)
T 3cvr_A          121 --SLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTN  190 (571)
T ss_dssp             --TCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSS
T ss_pred             --CCCEEECCCCcCCCCCCcCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCC
Confidence              9999999999983  1267799999999999997543    57899999999999995 777 65  89999999999


Q ss_pred             ccCCCccccccccCcc-------cEEEccCCcccCCCCCCCCCccCccccCCCCccccC
Q 038098          164 NLSGTIPISLEKLLDL-------KDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       164 ~l~~~~~~~~~~l~~L-------~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~  215 (580)
                      +|+ .+|. +..  +|       +.|++++|+|+.+++....++++..+++.+|++.+.
T Consensus       191 ~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~  245 (571)
T 3cvr_A          191 LLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSR  245 (571)
T ss_dssp             CCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCHH
T ss_pred             CCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCCc
Confidence            999 6666 554  77       999999999998877777789999999999987653

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=5.4e-20  Score=186.54  Aligned_cols=164  Identities=27%  Similarity=0.270  Sum_probs=143.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhh-CCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      +|+++ .+|..+.  +.++.|+|++|+|+...++.|. .+++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+
T Consensus        27 ~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~  103 (361)
T 2xot_A           27 KQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTL  103 (361)
T ss_dssp             SSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcC
Confidence            35565 4676554  4689999999999988888887 999999999999999999889999999999999999999998


Q ss_pred             CC-CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCccc---CCccccceeccccccccccCCccc
Q 038098           80 PS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTI---GGLKDLQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        80 p~-~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~p~~~  149 (580)
                      +. .+..+++|++|+|++|+|      .+.++++|+.|+|++|.|+++++..|   ..+++|+.|+|++|+|++..+..+
T Consensus       104 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~  183 (361)
T 2xot_A          104 DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL  183 (361)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHH
T ss_pred             CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHh
Confidence            76 577899999999999998      37789999999999999998877777   569999999999999996656778


Q ss_pred             ccccc--cccccccccccCC
Q 038098          150 GDLIN--LKSLNLSNNNLSG  167 (580)
Q Consensus       150 ~~l~~--L~~L~l~~N~l~~  167 (580)
                      ..++.  ++.|+|++|.+..
T Consensus       184 ~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          184 QKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             HHSCHHHHTTEECCSSCEEC
T ss_pred             hhccHhhcceEEecCCCccC
Confidence            88877  4899999999984

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=5.4e-20  Score=180.56  Aligned_cols=187  Identities=24%  Similarity=0.355  Sum_probs=162.1

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLS   95 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~   95 (580)
                      .++..+.+..+.++...  .+..+++|++|++++|.++.+ + .+..+++|++|+|++|+|+.++. +..+++|++|+|+
T Consensus        24 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~   98 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLD   98 (291)
T ss_dssp             HHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECC
T ss_pred             HHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECC
Confidence            34555677888887433  356789999999999999965 3 48999999999999999999987 8899999999999


Q ss_pred             CCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccc
Q 038098           96 SNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI  171 (580)
Q Consensus        96 ~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~  171 (580)
                      +|++    .+..+++|+.|++++|.+++.  ..+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++++..+ 
T Consensus        99 ~n~l~~~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-  173 (291)
T 1h6t_A           99 ENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  173 (291)
T ss_dssp             SSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             CCcCCCChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence            9998    478899999999999999975  5688999999999999999954  578999999999999999997655 


Q ss_pred             cccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          172 SLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       172 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                       +..+++|+.|++++|+++... ....++++..+++.+|+..+
T Consensus       174 -l~~l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          174 -LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             -GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             -hcCCCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCcccC
Confidence             899999999999999999864 46778889999999998755

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.81  E-value=7.8e-22  Score=202.29  Aligned_cols=193  Identities=24%  Similarity=0.287  Sum_probs=160.8

Q ss_pred             CccccCCCccc-------CCCCCCCEEeccCCcCCC----CCchhhhCCCCCceeeCCCCcCCcCCCcccc----CC---
Q 038098            2 NNLNGSIPIAV-------GKLQKLQLLSLEDNQLEG----SIPDDLCRLAALFELDSGGNKLDGFVPACFG----NL---   63 (580)
Q Consensus         2 N~~~~~~p~~~-------~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l---   63 (580)
                      |++++.+|..+       ..+++|++|+|++|.++.    .+|..+..+++|++|+|++|.|+...+..+.    .+   
T Consensus        73 ~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~  152 (386)
T 2ca6_A           73 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN  152 (386)
T ss_dssp             TSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             CccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhh
Confidence            45666677665       789999999999999996    3778899999999999999999754444443    33   


Q ss_pred             ------CCCcEEEcCCCCCC--CCC---CCCcCCCCCceEeCcCCccc-----------ccCCCcccEEeCCCCcCC---
Q 038098           64 ------TNLRNLYLGSNKLT--SIP---STLWNLKDILYLDLSSNFLL-----------IGNLKVLVQVDLSMNNFS---  118 (580)
Q Consensus        64 ------~~L~~L~l~~N~l~--~lp---~~~~~l~~L~~L~l~~n~l~-----------~~~l~~L~~L~l~~N~l~---  118 (580)
                            ++|++|+|++|+|+  .+|   ..+..+++|++|+|++|++.           +..+++|+.|+|++|.++   
T Consensus       153 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g  232 (386)
T 2ca6_A          153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG  232 (386)
T ss_dssp             HHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH
T ss_pred             hhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH
Confidence                  99999999999997  344   45667899999999999983           457889999999999996   


Q ss_pred             -CCCCcccCCccccceecccccccccc----CCcccc--cccccccccccccccCC----Cccccc-cccCcccEEEccC
Q 038098          119 -DVIPTTIGGLKDLQYLFLEYNRLQGS----IPDSIG--DLINLKSLNLSNNNLSG----TIPISL-EKLLDLKDINVSF  186 (580)
Q Consensus       119 -~~~~~~~~~l~~L~~L~l~~n~l~~~----~p~~~~--~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~l~l~~  186 (580)
                       ..++..+..+++|+.|+|++|.|++.    ++..+.  .+++|+.|+|++|.+++    .+|..+ .++++|+.|++++
T Consensus       233 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~  312 (386)
T 2ca6_A          233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG  312 (386)
T ss_dssp             HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred             HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccC
Confidence             45677889999999999999999865    566664  38999999999999997    377777 6689999999999


Q ss_pred             CcccCCCC
Q 038098          187 NKLEGEIP  194 (580)
Q Consensus       187 N~l~~~~~  194 (580)
                      |++++..+
T Consensus       313 N~l~~~~~  320 (386)
T 2ca6_A          313 NRFSEEDD  320 (386)
T ss_dssp             SBSCTTSH
T ss_pred             CcCCcchh
Confidence            99986653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.81  E-value=2.5e-20  Score=194.53  Aligned_cols=194  Identities=21%  Similarity=0.248  Sum_probs=143.6

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCC-------------ceeeCCCCcCCcCCCccccCCCCCc
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAAL-------------FELDSGGNKLDGFVPACFGNLTNLR   67 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~~~~~~~~~~l~~L~   67 (580)
                      +|++ +.+|.+|+++++|++|+|++|.+.+.+|..++++++|             ++|++++|.++++ |..   .++|+
T Consensus        20 ~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~~---~~~L~   94 (454)
T 1jl5_A           20 SSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PEL---PPHLE   94 (454)
T ss_dssp             ---------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CSC---CTTCS
T ss_pred             cCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CCC---cCCCC
Confidence            4677 7899999999999999999999988899988888764             8999999999864 332   37899


Q ss_pred             EEEcCCCCCCCCCCCCcCCCCCceEeCcCCccc-ccCC-CcccEEeCCCCcCCCCCCcccCCccccceeccccccccccC
Q 038098           68 NLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-IGNL-KVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI  145 (580)
Q Consensus        68 ~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~-~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (580)
                      +|++++|+++.+|..   +++|++|++++|++. +..+ ++|+.|++++|.++++ | .|..+++|+.|++++|.+++ +
T Consensus        95 ~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~-l  168 (454)
T 1jl5_A           95 SLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKK-L  168 (454)
T ss_dssp             EEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSC-C
T ss_pred             EEEccCCcCCccccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCC-c-ccCCCCCCCEEECCCCcCcc-c
Confidence            999999999998864   378999999999884 3333 5899999999999874 4 58899999999999999984 6


Q ss_pred             CcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          146 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       146 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      |..+   .+|++|++++|++++ +| .+..+++|+.|++++|.+++.+..   ..+++.+++.+|...
T Consensus       169 p~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~n~l~  228 (454)
T 1jl5_A          169 PDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL---PLSLESIVAGNNILE  228 (454)
T ss_dssp             CCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCS
T ss_pred             CCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC---cCcccEEECcCCcCC
Confidence            6543   489999999999985 55 588889999999999988875432   246667777777543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=5.8e-20  Score=177.50  Aligned_cols=155  Identities=19%  Similarity=0.280  Sum_probs=137.4

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+++++.  .+..+++|++|++++|.|+ .+| .+..+++|++|+|++|+|+++.+  |.++++|++|+|++|+|+.+|.
T Consensus        29 ~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~  102 (263)
T 1xeu_A           29 QSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG  102 (263)
T ss_dssp             SCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT
T ss_pred             CCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc
Confidence            5555443  6889999999999999998 455 78999999999999999997655  9999999999999999999986


Q ss_pred             CCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccc
Q 038098           82 TLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKS  157 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  157 (580)
                      ...  ++|++|+|++|++    .+..+++|+.|++++|+++++  ..+..+++|+.|+|++|++++.  ..+..+++|+.
T Consensus       103 ~~~--~~L~~L~L~~N~l~~~~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~  176 (263)
T 1xeu_A          103 IPS--ACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNW  176 (263)
T ss_dssp             CCC--SSCCEEECCSSCCSBSGGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCE
T ss_pred             ccc--CcccEEEccCCccCCChhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCE
Confidence            444  9999999999999    477899999999999999986  3688999999999999999965  67899999999


Q ss_pred             ccccccccCCC
Q 038098          158 LNLSNNNLSGT  168 (580)
Q Consensus       158 L~l~~N~l~~~  168 (580)
                      |++++|++++.
T Consensus       177 L~l~~N~~~~~  187 (263)
T 1xeu_A          177 IDLTGQKCVNE  187 (263)
T ss_dssp             EEEEEEEEECC
T ss_pred             EeCCCCcccCC
Confidence            99999999965

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.81  E-value=2.3e-21  Score=196.83  Aligned_cols=213  Identities=21%  Similarity=0.195  Sum_probs=169.7

Q ss_pred             CCccccCCC----cccCCCC-CCCEEeccCCcCCCCCchhhhCC-----CCCceeeCCCCcCCcCCCcc----ccCC-CC
Q 038098            1 GNNLNGSIP----IAVGKLQ-KLQLLSLEDNQLEGSIPDDLCRL-----AALFELDSGGNKLDGFVPAC----FGNL-TN   65 (580)
Q Consensus         1 ~N~~~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~----~~~l-~~   65 (580)
                      +|+|++..+    .+|..++ +|++|+|++|.|+...+..|..+     ++|++|+|++|.+++..+..    +..+ ++
T Consensus        31 ~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~  110 (362)
T 3goz_A           31 LNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT  110 (362)
T ss_dssp             TSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             CCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCC
Confidence            578887777    7888999 99999999999998888888776     99999999999999777664    4445 89


Q ss_pred             CcEEEcCCCCCCCCCC-C----CcC-CCCCceEeCcCCccc----------ccCCC-cccEEeCCCCcCCCCCCcccC--
Q 038098           66 LRNLYLGSNKLTSIPS-T----LWN-LKDILYLDLSSNFLL----------IGNLK-VLVQVDLSMNNFSDVIPTTIG--  126 (580)
Q Consensus        66 L~~L~l~~N~l~~lp~-~----~~~-l~~L~~L~l~~n~l~----------~~~l~-~L~~L~l~~N~l~~~~~~~~~--  126 (580)
                      |++|+|++|+|+..+. .    +.. .++|++|+|++|.+.          +..++ +|+.|+|++|.+++..+..+.  
T Consensus       111 L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~  190 (362)
T 3goz_A          111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF  190 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHH
Confidence            9999999999988653 2    333 369999999999994          23454 999999999999887765444  


Q ss_pred             --Cc-cccceecccccccccc----CCccccc-ccccccccccccccCCCcc----ccccccCcccEEEccCCcccCCCC
Q 038098          127 --GL-KDLQYLFLEYNRLQGS----IPDSIGD-LINLKSLNLSNNNLSGTIP----ISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       127 --~l-~~L~~L~l~~n~l~~~----~p~~~~~-l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                        .+ ++|+.|+|++|.|++.    ++..+.. .++|+.|+|++|.+++..+    ..+..+++|+.|++++|.++...+
T Consensus       191 l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~  270 (362)
T 3goz_A          191 LASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSK  270 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCH
T ss_pred             HHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCH
Confidence              44 5999999999999863    4555655 3599999999999997654    345677999999999999665443


Q ss_pred             --------CCCCCccCccccCCCCccc
Q 038098          195 --------NKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       195 --------~~~~~~~l~~~~~~~n~~~  213 (580)
                              ....++.+..+++++|+..
T Consensus       271 ~~~~~l~~~~~~l~~L~~LdL~~N~l~  297 (362)
T 3goz_A          271 EQCKALGAAFPNIQKIILVDKNGKEIH  297 (362)
T ss_dssp             HHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred             HHHHHHHHHhccCCceEEEecCCCcCC
Confidence                    2345666777888888753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.81  E-value=5.4e-21  Score=192.19  Aligned_cols=209  Identities=17%  Similarity=0.141  Sum_probs=155.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCC-CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCC-CCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGS-IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN-KLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~   78 (580)
                      +|.+++..+. +..+++|++|+|++|.++.. +|..+..+++|++|+|++|.+++..+..+..+++|++|+|++| .++.
T Consensus        79 ~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~  157 (336)
T 2ast_B           79 RSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE  157 (336)
T ss_dssp             TCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH
T ss_pred             Cccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCH
Confidence            4666666554 56788999999999988755 7778888899999999999888777778888999999999998 6774


Q ss_pred             --CCCCCcCCCCCceEeCcCC-ccc-------ccCCC-cccEEeCCCC--cCC-CCCCcccCCccccceecccccc-ccc
Q 038098           79 --IPSTLWNLKDILYLDLSSN-FLL-------IGNLK-VLVQVDLSMN--NFS-DVIPTTIGGLKDLQYLFLEYNR-LQG  143 (580)
Q Consensus        79 --lp~~~~~l~~L~~L~l~~n-~l~-------~~~l~-~L~~L~l~~N--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~  143 (580)
                        ++..+..+++|++|++++| .+.       +..++ +|+.|++++|  .++ +..+..+..+++|+.|+|++|. +++
T Consensus       158 ~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~  237 (336)
T 2ast_B          158 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN  237 (336)
T ss_dssp             HHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG
T ss_pred             HHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCH
Confidence              6666677888999999998 763       56788 8999999998  454 3345666778899999999998 776


Q ss_pred             cCCcccccccccccccccccc-cCCCccccccccCcccEEEccCCcccCCCCCCCCC-ccCccccCCCCccc
Q 038098          144 SIPDSIGDLINLKSLNLSNNN-LSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPF-RNFSTESFEGNELL  213 (580)
Q Consensus       144 ~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~-~~l~~~~~~~n~~~  213 (580)
                      ..+..+..+++|+.|++++|. +.......+..+++|+.|++++| ++...  ...+ ..+..+.+..|...
T Consensus       238 ~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~~--~~~l~~~l~~L~l~~n~l~  306 (336)
T 2ast_B          238 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGT--LQLLKEALPHLQINCSHFT  306 (336)
T ss_dssp             GGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTC--HHHHHHHSTTSEESCCCSC
T ss_pred             HHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHHH--HHHHHhhCcceEEecccCc
Confidence            777788888999999999985 33222235778889999999988 33211  1112 23455556555543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.80  E-value=1.3e-19  Score=182.95  Aligned_cols=209  Identities=19%  Similarity=0.192  Sum_probs=163.3

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCC-chhhhCCCCCce-eeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSI-PDDLCRLAALFE-LDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~   78 (580)
                      +|+|+++.+.+|.++++|++|+|++|++.+.+ ++.|.++++|++ +.++.|+|+.+.|+.|.++++|++|++++|+|+.
T Consensus        39 ~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~  118 (350)
T 4ay9_X           39 LTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH  118 (350)
T ss_dssp             SCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSS
T ss_pred             CCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccccccc
Confidence            58899777789999999999999999986544 467899999876 6778899999999999999999999999999999


Q ss_pred             CCC-CCcCCCCCceEeCcC-Ccc------cccCCC-cccEEeCCCCcCCCCCCcccCCccccceecccc-ccccccCCcc
Q 038098           79 IPS-TLWNLKDILYLDLSS-NFL------LIGNLK-VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEY-NRLQGSIPDS  148 (580)
Q Consensus        79 lp~-~~~~l~~L~~L~l~~-n~l------~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~p~~  148 (580)
                      +|. .+....++..|++.+ |++      .+..+. .++.|+|++|.|+.+.+..|. .++|+.|++++ |.++...+..
T Consensus       119 ~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~  197 (350)
T 4ay9_X          119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDV  197 (350)
T ss_dssp             CCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTT
T ss_pred             CCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhcc-ccchhHHhhccCCcccCCCHHH
Confidence            876 455778889999965 455      244554 688999999999987776664 56899999985 6677444467


Q ss_pred             cccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          149 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       149 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                      |..+++|+.|||++|+|+...+..+.   +|+.|.+.++.--...|....++++..+++. +++.|
T Consensus       198 f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c  259 (350)
T 4ay9_X          198 FHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLPTLEKLVALMEASLT-YPSHC  259 (350)
T ss_dssp             TTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCCCTTTCCSCCEEECS-CHHHH
T ss_pred             hccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcCcCCCchhCcChhhCcCC-CCccc
Confidence            89999999999999999966555555   4555555444433445556667777777664 55555

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.80  E-value=1.2e-19  Score=198.45  Aligned_cols=185  Identities=22%  Similarity=0.228  Sum_probs=152.1

Q ss_pred             ccCCCCCCCEEeccCCcCCCC--Cc-----------------------hhhhCCCCCceeeCCCCcCCcCCC-ccccCCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGS--IP-----------------------DDLCRLAALFELDSGGNKLDGFVP-ACFGNLT   64 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~--~p-----------------------~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~   64 (580)
                      .+..+++|+.|++++|.+...  .+                       ..+..+++|+.++++.|.+....+ ..|..++
T Consensus       366 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~  445 (635)
T 4g8a_A          366 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR  445 (635)
T ss_dssp             CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCT
T ss_pred             ccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccc
Confidence            344567777777777766421  22                       334556666666666666543333 4678888


Q ss_pred             CCcEEEcCCCCCCCCC-CCCcCCCCCceEeCcCCcc-------cccCCCcccEEeCCCCcCCCCCCcccCCccccceecc
Q 038098           65 NLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFL  136 (580)
Q Consensus        65 ~L~~L~l~~N~l~~lp-~~~~~l~~L~~L~l~~n~l-------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  136 (580)
                      +++.+++++|+++.++ ..+..+++|+.|+|++|.+       .+..+++|+.|+|++|++++++|..|.++++|+.|+|
T Consensus       446 ~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~L  525 (635)
T 4g8a_A          446 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  525 (635)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEEC
Confidence            9999999999988765 4566789999999999975       3678999999999999999999999999999999999


Q ss_pred             ccccccccCCcccccccccccccccccccCCCcccccccc-CcccEEEccCCcccCCCCC
Q 038098          137 EYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL-LDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       137 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~  195 (580)
                      ++|+|++..|..|..+++|+.|+|++|+|++..|..+..+ ++|+.|++++|+++|.+..
T Consensus       526 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          526 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             TTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            9999998888899999999999999999999999999988 6899999999999999864

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=2.1e-19  Score=168.65  Aligned_cols=155  Identities=21%  Similarity=0.287  Sum_probs=127.0

Q ss_pred             ceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCC
Q 038098           43 FELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI  121 (580)
Q Consensus        43 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~  121 (580)
                      +++++++|.++. +|..+.  +.+++|+|++|+|+.++. ..                 +..+++|+.|+|++|.|+++.
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~-----------------~~~l~~L~~L~L~~N~i~~i~   73 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGI-----------------FKKLPQLRKINFSNNKITDIE   73 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCC-----------------GGGCTTCCEEECCSSCCCEEC
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhh-----------------hccCCCCCEEECCCCcCCEEC
Confidence            467777777774 344432  345777777777777632 21                 234556677777888888888


Q ss_pred             CcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCc
Q 038098          122 PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFR  200 (580)
Q Consensus       122 ~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~  200 (580)
                      +..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|++++|++++..|. ...++
T Consensus        74 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  153 (220)
T 2v70_A           74 EGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH  153 (220)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCT
T ss_pred             HHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCC
Confidence            88999999999999999999988788899999999999999999988899999999999999999999998664 46788


Q ss_pred             cCccccCCCCccccCCC
Q 038098          201 NFSTESFEGNELLCGMP  217 (580)
Q Consensus       201 ~l~~~~~~~n~~~c~~p  217 (580)
                      ++..+++.+|++.|+++
T Consensus       154 ~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          154 SLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TCCEEECCSCCEECSGG
T ss_pred             CCCEEEecCcCCcCCCc
Confidence            99999999999999754

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.80  E-value=7.4e-19  Score=189.18  Aligned_cols=187  Identities=26%  Similarity=0.244  Sum_probs=103.4

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+|+++ |.   .+++|++|+|++|+|+.+|
T Consensus        49 ~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~l~~l~  117 (622)
T 3g06_A           49 ESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PV---LPPGLLELSIFSNPLTHLP  117 (622)
T ss_dssp             SSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCC-CC---CCTTCCEEEECSCCCCCCC
T ss_pred             CCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcC-CC---CCCCCCEEECcCCcCCCCC
Confidence            35555 5565554  67777777777777 3443   456777777777777743 33   5566777777777666665


Q ss_pred             CCCcCCCCCceEeCcCCccc--ccCCCcccEEeCCCCcCCCCCCccc-----------------CCccccceeccccccc
Q 038098           81 STLWNLKDILYLDLSSNFLL--IGNLKVLVQVDLSMNNFSDVIPTTI-----------------GGLKDLQYLFLEYNRL  141 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~--~~~l~~L~~L~l~~N~l~~~~~~~~-----------------~~l~~L~~L~l~~n~l  141 (580)
                      .   .+++|+.|++++|++.  ...+++|++|+|++|.+++++ ..+                 ..+++|+.|+|++|.|
T Consensus       118 ~---~l~~L~~L~L~~N~l~~lp~~l~~L~~L~Ls~N~l~~l~-~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l  193 (622)
T 3g06_A          118 A---LPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLASLP-ALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQL  193 (622)
T ss_dssp             C---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCC-CCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCC
T ss_pred             C---CCCCcCEEECCCCCCCcCCCCCCCCCEEECcCCcCCCcC-CccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCC
Confidence            5   3345555555555542  112344555555555554321 111                 1124555555555555


Q ss_pred             cccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccc
Q 038098          142 QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELL  213 (580)
Q Consensus       142 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~  213 (580)
                      + .+|..   +++|+.|++++|.++ .+|..   +++|+.|++++|.+++.+   ..++++..+++++|...
T Consensus       194 ~-~l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~  254 (622)
T 3g06_A          194 A-SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT  254 (622)
T ss_dssp             S-CCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS
T ss_pred             C-CCCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC
Confidence            5 23322   245555555555555 23322   356777777777777644   23456666667666543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.80  E-value=1.1e-18  Score=182.05  Aligned_cols=159  Identities=27%  Similarity=0.344  Sum_probs=101.7

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLS   95 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~   95 (580)
                      ++|++|+|++|.+++ +| .|+++++|++|++++|++++ +|..+   ++|++|++++|+++.+| .+.++++|++|+++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~  203 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYAD  203 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECC
Confidence            577777777777774 55 47777777777777777774 34332   47777777777777776 56777777777777


Q ss_pred             CCcccc--cCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccc
Q 038098           96 SNFLLI--GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL  173 (580)
Q Consensus        96 ~n~l~~--~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~  173 (580)
                      +|++.-  ...++|+.|++++|.++.+ | .+..+++|+.|++++|++++ +|..   +++|+.|++++|++++ +|.. 
T Consensus       204 ~N~l~~l~~~~~~L~~L~l~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~-  275 (454)
T 1jl5_A          204 NNSLKKLPDLPLSLESIVAGNNILEEL-P-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL-  275 (454)
T ss_dssp             SSCCSSCCCCCTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC-
T ss_pred             CCcCCcCCCCcCcccEEECcCCcCCcc-c-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc-
Confidence            777631  2234677777777777643 3 36677777777777777763 4432   2556666666666664 3322 


Q ss_pred             cccCcccEEEccCCcccC
Q 038098          174 EKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       174 ~~l~~L~~l~l~~N~l~~  191 (580)
                        +++|+.|++++|++++
T Consensus       276 --~~~L~~L~ls~N~l~~  291 (454)
T 1jl5_A          276 --PQSLTFLDVSENIFSG  291 (454)
T ss_dssp             --CTTCCEEECCSSCCSE
T ss_pred             --cCcCCEEECcCCccCc
Confidence              2455555555555554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=7.7e-19  Score=165.99  Aligned_cols=146  Identities=29%  Similarity=0.362  Sum_probs=119.3

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+++ .+|..+.  ++|++|+|++|.|++..|..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++|+|+.+|.
T Consensus        29 ~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~  105 (229)
T 3e6j_A           29 KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPS  105 (229)
T ss_dssp             SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccCh
Confidence            3444 6666554  899999999999998889999999999999999999998888889999999999999999999886


Q ss_pred             C-CcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccc
Q 038098           82 T-LWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNL  160 (580)
Q Consensus        82 ~-~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  160 (580)
                      . +..+++|                  +.|+|++|.|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus       106 ~~~~~l~~L------------------~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  166 (229)
T 3e6j_A          106 AVFDRLVHL------------------KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL  166 (229)
T ss_dssp             TTTTTCTTC------------------CEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             hHhCcchhh------------------CeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEe
Confidence            5 4455555                  55555555555 34667788888899999999888666677888888999999


Q ss_pred             cccccCCCc
Q 038098          161 SNNNLSGTI  169 (580)
Q Consensus       161 ~~N~l~~~~  169 (580)
                      ++|.+.+..
T Consensus       167 ~~N~~~c~c  175 (229)
T 3e6j_A          167 FGNPWDCEC  175 (229)
T ss_dssp             TTSCBCTTB
T ss_pred             eCCCccCCc
Confidence            999888543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=3.4e-19  Score=191.55  Aligned_cols=165  Identities=26%  Similarity=0.366  Sum_probs=143.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|..+ | .|..|++|+.|+|++|.|++..|  +..+++|++|+|++|.|+++  ..+..+++|+.|+|++|+|+.++
T Consensus        52 ~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l~  125 (605)
T 1m9s_A           52 NSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDIN  125 (605)
T ss_dssp             TCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCCG
T ss_pred             CCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCCc
Confidence            3566543 3 69999999999999999996554  99999999999999999964  37999999999999999999985


Q ss_pred             CCCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                       .+..+++|+.|+|++|++    .+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|.|++ +| .+..+++|+
T Consensus       126 -~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~  200 (605)
T 1m9s_A          126 -GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLD  200 (605)
T ss_dssp             -GGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCS
T ss_pred             -cccCCCccCEEECCCCccCCchhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCC
Confidence             588899999999999999    47789999999999999998766  8999999999999999995 44 589999999


Q ss_pred             cccccccccCCCcccccccc
Q 038098          157 SLNLSNNNLSGTIPISLEKL  176 (580)
Q Consensus       157 ~L~l~~N~l~~~~~~~~~~l  176 (580)
                      .|+|++|++++.....+..+
T Consensus       201 ~L~L~~N~l~~~p~~~~~~l  220 (605)
T 1m9s_A          201 VLELFSQECLNKPINHQSNL  220 (605)
T ss_dssp             EEECCSEEEECCCCCCCSSC
T ss_pred             EEEccCCcCcCCcccccccE
Confidence            99999999996544444433

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=3e-19  Score=164.73  Aligned_cols=153  Identities=21%  Similarity=0.286  Sum_probs=103.0

Q ss_pred             CCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC-CCCCCcCCCCCce
Q 038098           13 GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS-IPSTLWNLKDILY   91 (580)
Q Consensus        13 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-lp~~~~~l~~L~~   91 (580)
                      ..+++|++|++++|.|+ .+| .+..+++|++|++++|.++.  +..+..+++|++|+|++|+++. .+..+..      
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~------  110 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSG------  110 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTT------
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcC------
Confidence            45566666666666666 344 46666666666666665542  2356666666666666666664 3444444      


Q ss_pred             EeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccc-ccccCCcccccccccccccccccccCCCcc
Q 038098           92 LDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNR-LQGSIPDSIGDLINLKSLNLSNNNLSGTIP  170 (580)
Q Consensus        92 L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~  170 (580)
                                  +++|+.|++++|.+++..+..+..+++|+.|+|++|. ++ .+| .+..+++|+.|++++|++++ ++
T Consensus       111 ------------l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~  175 (197)
T 4ezg_A          111 ------------LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR  175 (197)
T ss_dssp             ------------CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT
T ss_pred             ------------CCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH
Confidence                        4555666666677766667778888888888888887 65 555 58888888999999998885 33


Q ss_pred             ccccccCcccEEEccCCcccC
Q 038098          171 ISLEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       171 ~~~~~l~~L~~l~l~~N~l~~  191 (580)
                       .+..+++|+.|++++|++..
T Consensus       176 -~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          176 -GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             -TGGGCSSCCEEEECBC----
T ss_pred             -HhccCCCCCEEEeeCcccCC
Confidence             67888889999999988764

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.78  E-value=1.5e-20  Score=188.89  Aligned_cols=201  Identities=18%  Similarity=0.219  Sum_probs=149.4

Q ss_pred             CcccCCC--CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcC-CCccccCCCCCcEEEcCCCCCCC-CCCCCc
Q 038098            9 PIAVGKL--QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGF-VPACFGNLTNLRNLYLGSNKLTS-IPSTLW   84 (580)
Q Consensus         9 p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~-lp~~~~   84 (580)
                      |..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|+|++|+++. .+..+.
T Consensus        61 ~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~  139 (336)
T 2ast_B           61 PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA  139 (336)
T ss_dssp             HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHT
T ss_pred             HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHh
Confidence            3445555  7888888888888865554 55788888888888888755 66778888888888888888874 555667


Q ss_pred             CCCCCceEeCcCC-ccc-------ccCCCcccEEeCCCC-cCCCC-CCcccCCcc-ccceeccccc--ccc-ccCCcccc
Q 038098           85 NLKDILYLDLSSN-FLL-------IGNLKVLVQVDLSMN-NFSDV-IPTTIGGLK-DLQYLFLEYN--RLQ-GSIPDSIG  150 (580)
Q Consensus        85 ~l~~L~~L~l~~n-~l~-------~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~L~l~~n--~l~-~~~p~~~~  150 (580)
                      .+++|++|+|++| .+.       +.++++|+.|++++| .+++. .+..+..++ +|+.|+|++|  .++ +.+|..+.
T Consensus       140 ~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~  219 (336)
T 2ast_B          140 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR  219 (336)
T ss_dssp             TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH
T ss_pred             cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHh
Confidence            7888888888888 452       556888888888888 88754 355677788 8888888888  454 35566777


Q ss_pred             cccccccccccccc-cCCCccccccccCcccEEEccCCc-ccCC-CCCCCCCccCccccCCCC
Q 038098          151 DLINLKSLNLSNNN-LSGTIPISLEKLLDLKDINVSFNK-LEGE-IPNKGPFRNFSTESFEGN  210 (580)
Q Consensus       151 ~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~l~l~~N~-l~~~-~~~~~~~~~l~~~~~~~n  210 (580)
                      .+++|+.|+|++|. +++..+..+..+++|+.|++++|. ++.. ......+++++.+++.++
T Consensus       220 ~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             hCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence            88888888888888 776777788888888888888885 2211 012344666777777665

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=2.3e-19  Score=164.68  Aligned_cols=154  Identities=27%  Similarity=0.359  Sum_probs=110.4

Q ss_pred             ceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCC--CcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCC
Q 038098           43 FELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPST--LWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDV  120 (580)
Q Consensus        43 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~--~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~  120 (580)
                      ++|++++|+++. +|..+..  +|++|+|++|+|+.++..  +..+                  ++|+.|+|++|.|+++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l------------------~~L~~L~Ls~N~l~~~   69 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRL------------------PHLVKLELKRNQLTGI   69 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGC------------------TTCCEEECCSSCCCCB
T ss_pred             CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccC------------------CCCCEEECCCCCCCCc
Confidence            678888888874 4544432  788888888888887653  4444                  4556666777777777


Q ss_pred             CCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCc
Q 038098          121 IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFR  200 (580)
Q Consensus       121 ~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~  200 (580)
                      .|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..+..+++|+.|++++|+++|.++......
T Consensus        70 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~  149 (192)
T 1w8a_A           70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE  149 (192)
T ss_dssp             CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH
T ss_pred             CHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHH
Confidence            77888888888888888888887777778888888888888888887778888888888888888888888765332222


Q ss_pred             cCccccCCCCccccCCC
Q 038098          201 NFSTESFEGNELLCGMP  217 (580)
Q Consensus       201 ~l~~~~~~~n~~~c~~p  217 (580)
                      .+....+.++...|..|
T Consensus       150 ~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A          150 WLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             HHHHHCCSGGGCBBCSS
T ss_pred             HHHHcCCCCCCCCCCCC
Confidence            23333444555566554

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=1.6e-19  Score=173.83  Aligned_cols=137  Identities=21%  Similarity=0.275  Sum_probs=106.0

Q ss_pred             CCcCceeccccCceEEEEEe-CCCCE--EEEEEEeccccc------------------------hhhhHHHHHHHHhhcC
Q 038098          294 FSENNLIGRGGFGSVYKARI-QDGME--VAVKVFDLQYGR------------------------AFKSFDIECDMIKRIR  346 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  346 (580)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+..|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999987 67989  999987432110                        1135788999999998


Q ss_pred             CCCc--ceEEeeeecCCceeeEeeccCC-C----ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCC
Q 038098          347 HRNI--IKIISSCSSDDFKALVLEYMPH-G----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  419 (580)
Q Consensus       347 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  419 (580)
                      |+++  ..++++    +..++||||+.+ |    +|.++...    .++..+..++.|++.|+.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8764  444443    356899999942 3    67765432    2344677899999999999994  4689999999


Q ss_pred             CCCEEeCCCCcEEEccccCcccc
Q 038098          420 PSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       420 ~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=1.6e-18  Score=159.08  Aligned_cols=175  Identities=25%  Similarity=0.313  Sum_probs=127.4

Q ss_pred             CEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCc-cccCCCCCcEEEcCCCCCCCC-CCCCcCCCCCceEeCcC
Q 038098           19 QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA-CFGNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSS   96 (580)
Q Consensus        19 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~l-p~~~~~l~~L~~L~l~~   96 (580)
                      ++|++++|.++ .+|..+..  +|++|+|++|+|+++.+. .|..+++|++|+|++|+|+.+ |..+.++++|       
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------   80 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI-------   80 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC-------
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccC-------
Confidence            78999999997 67766653  899999999999977765 599999999999999999997 4566665555       


Q ss_pred             CcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccccccc
Q 038098           97 NFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL  176 (580)
Q Consensus        97 n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  176 (580)
                                 +.|+|++|+|+++.+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+.. .-.
T Consensus        81 -----------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~~~  148 (192)
T 1w8a_A           81 -----------QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFA  148 (192)
T ss_dssp             -----------CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHH
T ss_pred             -----------CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch-HHH
Confidence                       55555666666677777888888888888888888777888888888888888888888654321 011


Q ss_pred             CcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCC
Q 038098          177 LDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       177 ~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ..++...+.++...|..|..  +......++..+.+.|..+
T Consensus       149 ~~l~~~~~~~~~~~C~~P~~--l~~~~l~~l~~~~~~C~~~  187 (192)
T 1w8a_A          149 EWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             HHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC
T ss_pred             HHHHHcCCCCCCCCCCCChH--HcCCChhhCcHhhcCcCCC
Confidence            12333345556666555533  4444555666677777644

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.8e-21  Score=208.01  Aligned_cols=181  Identities=20%  Similarity=0.228  Sum_probs=143.7

Q ss_pred             cCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCc-------------CCcCCCccccCCCCCcEEE-cCCCCCC
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNK-------------LDGFVPACFGNLTNLRNLY-LGSNKLT   77 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-l~~N~l~   77 (580)
                      +..+++|+.|+|++|.|+ .+|+.++++++|++|++++|.             +.+..|..++++++|+.|+ ++.|.+.
T Consensus       345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~  423 (567)
T 1dce_A          345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD  423 (567)
T ss_dssp             CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence            367899999999999998 789999999999999998875             5566777888888888888 6666544


Q ss_pred             CCCC------CCcC--CCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccC
Q 038098           78 SIPS------TLWN--LKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI  145 (580)
Q Consensus        78 ~lp~------~~~~--l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (580)
                      .++.      .+..  ...|+.|+|++|+|    .+..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++ +
T Consensus       424 ~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-l  501 (567)
T 1dce_A          424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-V  501 (567)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-C
T ss_pred             hhhhhhhhcccccccCccCceEEEecCCCCCCCcCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-C
Confidence            3321      0111  12578888888887    3667778888888888888 457788888888888888888884 6


Q ss_pred             CcccccccccccccccccccCCCc-cccccccCcccEEEccCCcccCCCCCC
Q 038098          146 PDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       146 p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      | .+..+++|+.|+|++|+|++.. |..+..+++|+.|++++|++++.++..
T Consensus       502 p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            6 7888888888888888888766 888888888888888888888877654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=7.8e-19  Score=193.53  Aligned_cols=154  Identities=24%  Similarity=0.243  Sum_probs=100.6

Q ss_pred             CCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcc-----
Q 038098           25 DNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----   99 (580)
Q Consensus        25 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l-----   99 (580)
                      +|.+. ..|+.|..+++|+.|+|++|.|. .+|..+.++++|++|+|++|+|+.+|..+.++++|++|+|++|+|     
T Consensus       210 ~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~lp~  287 (727)
T 4b8c_D          210 ENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPA  287 (727)
T ss_dssp             -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCSSCCS
T ss_pred             cccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCCccCh
Confidence            34443 45667777777777777777777 445555577777777777777777777777777777777777776     


Q ss_pred             cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc-cccccccccccCCCccccccccCc
Q 038098          100 LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN-LKSLNLSNNNLSGTIPISLEKLLD  178 (580)
Q Consensus       100 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~  178 (580)
                      .+.++++|+.|+|++|.|+. +|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..      
T Consensus       288 ~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------  360 (727)
T 4b8c_D          288 ELGSCFQLKYFYFFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------  360 (727)
T ss_dssp             SGGGGTTCSEEECCSSCCCC-CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------
T ss_pred             hhcCCCCCCEEECCCCCCCc-cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------
Confidence            35667778888888888874 4666999999999999999999888887765433 345789999999887754      


Q ss_pred             ccEEEccCC
Q 038098          179 LKDINVSFN  187 (580)
Q Consensus       179 L~~l~l~~N  187 (580)
                      |+.|+++.|
T Consensus       361 l~~l~l~~n  369 (727)
T 4b8c_D          361 RRFIEINTD  369 (727)
T ss_dssp             ---------
T ss_pred             cceeEeecc
Confidence            455666666

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=2.8e-18  Score=157.39  Aligned_cols=130  Identities=27%  Similarity=0.385  Sum_probs=79.3

Q ss_pred             eeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCc
Q 038098           44 ELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPT  123 (580)
Q Consensus        44 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~  123 (580)
                      ++++++|+|+. +|..+.  ++|++|+|++|+|+.+|..+.+++                  +|+.|+|++|.|+++.+.
T Consensus        14 ~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~------------------~L~~L~Ls~N~i~~i~~~   72 (193)
T 2wfh_A           14 VVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFTLVPKELSNYK------------------HLTLIDLSNNRISTLSNQ   72 (193)
T ss_dssp             EEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCSCCGGGGGCT------------------TCCEEECCSSCCCCCCTT
T ss_pred             EEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCchhHHHhhccc------------------CCCEEECCCCcCCEeCHh
Confidence            45555555552 232221  355555555555555554333333                  334444455555555556


Q ss_pred             ccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCC
Q 038098          124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       124 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      .|.++++|+.|+|++|.|++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|++.|.+.
T Consensus        73 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           73 SFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             HccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            66666777777777777776656667777777777777777775555567777788888888888877664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=2.3e-18  Score=158.70  Aligned_cols=152  Identities=18%  Similarity=0.245  Sum_probs=114.5

Q ss_pred             hCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCc
Q 038098           37 CRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNN  116 (580)
Q Consensus        37 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~  116 (580)
                      ..+++|++|++++|.|+. +| .+..+++|++|++++|.++.++                   .+..+++|+.|++++|.
T Consensus        41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~~-------------------~l~~l~~L~~L~l~~n~   99 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNYN-------------------PISGLSNLERLRIMGKD   99 (197)
T ss_dssp             HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCCG-------------------GGTTCTTCCEEEEECTT
T ss_pred             hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcch-------------------hhhcCCCCCEEEeECCc
Confidence            344555555555555552 22 3555555555555555544432                   24456677888888888


Q ss_pred             CCCCCCcccCCccccceeccccccccccCCcccccccccccccccccc-cCCCccccccccCcccEEEccCCcccCCCCC
Q 038098          117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNN-LSGTIPISLEKLLDLKDINVSFNKLEGEIPN  195 (580)
Q Consensus       117 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  195 (580)
                      +++..+..|..+++|+.|+|++|.+++..|..+..+++|+.|+|++|. ++ .+| .+..+++|+.|++++|+++... .
T Consensus       100 l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~  176 (197)
T 4ezg_A          100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-G  176 (197)
T ss_dssp             CBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-T
T ss_pred             cCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-H
Confidence            887778889999999999999999998888999999999999999998 76 555 6899999999999999999855 5


Q ss_pred             CCCCccCccccCCCCcc
Q 038098          196 KGPFRNFSTESFEGNEL  212 (580)
Q Consensus       196 ~~~~~~l~~~~~~~n~~  212 (580)
                      ...+++++.+++.+|+.
T Consensus       177 l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          177 IEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             GGGCSSCCEEEECBC--
T ss_pred             hccCCCCCEEEeeCccc
Confidence            66788888899988874

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.72  E-value=1.9e-19  Score=189.10  Aligned_cols=212  Identities=16%  Similarity=0.116  Sum_probs=138.1

Q ss_pred             CCccccC----CCcccCCCCCCCEEeccCCcCCCCCchhhh-----CCCCCceeeCCCCcCCcC----CCccccCCCCCc
Q 038098            1 GNNLNGS----IPIAVGKLQKLQLLSLEDNQLEGSIPDDLC-----RLAALFELDSGGNKLDGF----VPACFGNLTNLR   67 (580)
Q Consensus         1 ~N~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~   67 (580)
                      +|++++.    ++..|..+++|++|+|++|.++...+..+.     .+++|++|+|++|.++..    ++..+..+++|+
T Consensus       151 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~  230 (461)
T 1z7x_W          151 YCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLR  230 (461)
T ss_dssp             TSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCC
T ss_pred             CCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCcc
Confidence            3556653    355666778888888888887654444443     256888888888887753    355667778888


Q ss_pred             EEEcCCCCCCCC-----CC-CCcCCCCCceEeCcCCccc----------ccCCCcccEEeCCCCcCCCCCCcccCC----
Q 038098           68 NLYLGSNKLTSI-----PS-TLWNLKDILYLDLSSNFLL----------IGNLKVLVQVDLSMNNFSDVIPTTIGG----  127 (580)
Q Consensus        68 ~L~l~~N~l~~l-----p~-~~~~l~~L~~L~l~~n~l~----------~~~l~~L~~L~l~~N~l~~~~~~~~~~----  127 (580)
                      +|+|++|+++..     +. .+..+++|++|+|++|.+.          +..+++|+.|++++|.++...+..+..    
T Consensus       231 ~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~  310 (461)
T 1z7x_W          231 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE  310 (461)
T ss_dssp             EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTS
T ss_pred             EEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhcc
Confidence            888888877652     12 2234677888888888762          334677888888888776543333332    


Q ss_pred             -ccccceecccccccccc----CCcccccccccccccccccccCCCccccccc-----cCcccEEEccCCcccC----C-
Q 038098          128 -LKDLQYLFLEYNRLQGS----IPDSIGDLINLKSLNLSNNNLSGTIPISLEK-----LLDLKDINVSFNKLEG----E-  192 (580)
Q Consensus       128 -l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~----~-  192 (580)
                       .++|+.|+|++|.+++.    ++..+..+++|+.|+|++|.+++..+..+..     .++|+.|++++|+++.    . 
T Consensus       311 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l  390 (461)
T 1z7x_W          311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL  390 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred             CCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHH
Confidence             25777888888877754    3555666677888888888777554444432     5677788888887773    2 


Q ss_pred             CCCCCCCccCccccCCCCcc
Q 038098          193 IPNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       193 ~~~~~~~~~l~~~~~~~n~~  212 (580)
                      +.....++++..+++.+|+.
T Consensus       391 ~~~l~~~~~L~~L~l~~N~i  410 (461)
T 1z7x_W          391 AATLLANHSLRELDLSNNCL  410 (461)
T ss_dssp             HHHHHHCCCCCEEECCSSSC
T ss_pred             HHHHHhCCCccEEECCCCCC
Confidence            22223456667777777754

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.72  E-value=4.5e-20  Score=193.90  Aligned_cols=200  Identities=18%  Similarity=0.111  Sum_probs=159.2

Q ss_pred             CCCCCCEEeccCCcCCCC----CchhhhCCCCCceeeCCCCcCCcCCCcccc-----CCCCCcEEEcCCCCCCC-----C
Q 038098           14 KLQKLQLLSLEDNQLEGS----IPDDLCRLAALFELDSGGNKLDGFVPACFG-----NLTNLRNLYLGSNKLTS-----I   79 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~-----l   79 (580)
                      ..++|++|+|++|.++..    ++..+..+++|++|+|++|.++...+..+.     ..++|++|+|++|+++.     +
T Consensus       140 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  219 (461)
T 1z7x_W          140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL  219 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred             CCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHH
Confidence            367899999999999864    366778889999999999999865444443     36799999999999987     5


Q ss_pred             CCCCcCCCCCceEeCcCCccc-----------ccCCCcccEEeCCCCcCCCC----CCcccCCccccceecccccccccc
Q 038098           80 PSTLWNLKDILYLDLSSNFLL-----------IGNLKVLVQVDLSMNNFSDV----IPTTIGGLKDLQYLFLEYNRLQGS  144 (580)
Q Consensus        80 p~~~~~l~~L~~L~l~~n~l~-----------~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~  144 (580)
                      +..+..+++|++|+|++|.+.           +..+++|+.|++++|.++..    .+..+..+++|+.|+|++|.+++.
T Consensus       220 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  299 (461)
T 1z7x_W          220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE  299 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence            666778899999999999982           23588999999999999864    456677789999999999999865


Q ss_pred             CCcccccc-----cccccccccccccCCC----ccccccccCcccEEEccCCcccCCCCCC------CCCccCccccCCC
Q 038098          145 IPDSIGDL-----INLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEGEIPNK------GPFRNFSTESFEG  209 (580)
Q Consensus       145 ~p~~~~~l-----~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~~~------~~~~~l~~~~~~~  209 (580)
                      .+..+...     ++|+.|+|++|.+++.    ++..+..+++|+.|++++|+++...+..      ...+.++.+++.+
T Consensus       300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~  379 (461)
T 1z7x_W          300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD  379 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             HHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence            55444432     6999999999999965    4666778899999999999998653221      1145788888888


Q ss_pred             Cccc
Q 038098          210 NELL  213 (580)
Q Consensus       210 n~~~  213 (580)
                      |...
T Consensus       380 n~i~  383 (461)
T 1z7x_W          380 CDVS  383 (461)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            8653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.72  E-value=5.1e-20  Score=196.84  Aligned_cols=179  Identities=26%  Similarity=0.228  Sum_probs=145.6

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCc-------------CCCCCchhhhCCCCCceee-CCCCcCCcCCCc-----cccC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQ-------------LEGSIPDDLCRLAALFELD-SGGNKLDGFVPA-----CFGN   62 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~~~-----~~~~   62 (580)
                      |+|+ .+|+++++|++|+.|++++|.             +.+..|+.++.+++|+.|+ ++.|.+..+..-     .+..
T Consensus       359 n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~  437 (567)
T 1dce_A          359 EKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLK  437 (567)
T ss_dssp             HHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhhcccccc
Confidence            4444 679999999999999998775             5567888889999999998 666654321110     0111


Q ss_pred             --CCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceec
Q 038098           63 --LTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLF  135 (580)
Q Consensus        63 --l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  135 (580)
                        ...|+.|+|++|+|+.+|. +..+++|+.|+|++|+|     .+.++++|+.|+|++|.|+++ | .|..+++|+.|+
T Consensus       438 l~~~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~  514 (567)
T 1dce_A          438 MEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELL  514 (567)
T ss_dssp             HHHTTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEE
T ss_pred             cCccCceEEEecCCCCCCCcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCCC-c-ccCCCCCCcEEE
Confidence              1358999999999999987 88999999999999998     377899999999999999985 5 899999999999


Q ss_pred             cccccccccC-CcccccccccccccccccccCCCcccc---ccccCcccEEEc
Q 038098          136 LEYNRLQGSI-PDSIGDLINLKSLNLSNNNLSGTIPIS---LEKLLDLKDINV  184 (580)
Q Consensus       136 l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~~l~l  184 (580)
                      |++|+|++.. |..+..+++|+.|+|++|++++.+|..   +..+++|+.|++
T Consensus       515 Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            9999999776 999999999999999999999665532   334788998864

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=1.9e-17  Score=148.49  Aligned_cols=137  Identities=18%  Similarity=0.147  Sum_probs=103.1

Q ss_pred             CCCCCCEEeccCCcCC-CCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC-CCCCCcCCCCCce
Q 038098           14 KLQKLQLLSLEDNQLE-GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS-IPSTLWNLKDILY   91 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-lp~~~~~l~~L~~   91 (580)
                      ..++|++|+|++|.++ +.+|..+..+++|++|+|++|.|+++  ..|..+++|++|+|++|+++. +|..+..+++|  
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--   97 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL--   97 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC--
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC--
Confidence            4478888888888887 56777788888888888888888865  678888888888888888887 44433334444  


Q ss_pred             EeCcCCcccccCCCcccEEeCCCCcCCCCCC-cccCCccccceeccccccccccCC---cccccccccccccccccccCC
Q 038098           92 LDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIP---DSIGDLINLKSLNLSNNNLSG  167 (580)
Q Consensus        92 L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~l~~N~l~~  167 (580)
                                      +.|++++|.++++.. ..+..+++|+.|++++|.+++..+   ..+..+++|+.|++++|.+. 
T Consensus        98 ----------------~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-  160 (168)
T 2ell_A           98 ----------------THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-  160 (168)
T ss_dssp             ----------------CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-
T ss_pred             ----------------CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-
Confidence                            566666666665432 678888889999999999885444   37888889999999999887 


Q ss_pred             Cccc
Q 038098          168 TIPI  171 (580)
Q Consensus       168 ~~~~  171 (580)
                      ..|.
T Consensus       161 ~~~~  164 (168)
T 2ell_A          161 EAPD  164 (168)
T ss_dssp             BCCS
T ss_pred             hccc
Confidence            4443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.69  E-value=5.2e-18  Score=186.95  Aligned_cols=177  Identities=22%  Similarity=0.214  Sum_probs=120.3

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCC-----ceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAAL-----FELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDIL   90 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L-----~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~   90 (580)
                      +.+++|+|.+|.+.. .+..+.....|     ..++++.|.+. ..+..|..+++|+.|+|++|+|..+|..++.+++|+
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~  250 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLT  250 (727)
T ss_dssp             ---------------------------------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCS
T ss_pred             CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCC
Confidence            568899999999984 44433222222     23445555555 668889999999999999999999999999999999


Q ss_pred             eEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccccc
Q 038098           91 YLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNL  165 (580)
Q Consensus        91 ~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l  165 (580)
                      +|+|++|.|     .+.++++|+.|+|++|.|+ .+|..|..+++|+.|+|++|.|+ .+|..|..+++|+.|+|++|.|
T Consensus       251 ~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l  328 (727)
T 4b8c_D          251 RLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL  328 (727)
T ss_dssp             CCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred             EEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence            999999998     3778999999999999999 55888999999999999999998 8888899999999999999999


Q ss_pred             CCCccccccccCc-ccEEEccCCcccCCCCCC
Q 038098          166 SGTIPISLEKLLD-LKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       166 ~~~~~~~~~~l~~-L~~l~l~~N~l~~~~~~~  196 (580)
                      ++.+|..+..+.. +..+++++|.+++.+|..
T Consensus       329 ~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          329 EKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE  360 (727)
T ss_dssp             CSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred             CCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence            9988888866533 234789999999988764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1.9e-17  Score=165.32  Aligned_cols=134  Identities=16%  Similarity=0.180  Sum_probs=97.7

Q ss_pred             CCcCceeccccCceEEEEEeCCCCEEEEEEEecccc--------------chhhh--------HHHHHHHHhhcCCCCcc
Q 038098          294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG--------------RAFKS--------FDIECDMIKRIRHRNII  351 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~niv  351 (580)
                      |++.+.||+|++|.||+|...+|+.||||+++....              .....        ...|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            888999999999999999988999999999753210              00111        12355555555433322


Q ss_pred             --eEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC
Q 038098          352 --KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  429 (580)
Q Consensus       352 --~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~  429 (580)
                        ..+++    ...++||||++|++|.++...       .....++.||+.++.|||   ..|||||||||.|||+++++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence              22222    123799999999888764321       224568899999999999   89999999999999998776


Q ss_pred             ----------cEEEccccCccc
Q 038098          430 ----------VAHLSDFGMAKP  441 (580)
Q Consensus       430 ----------~~kl~Dfg~a~~  441 (580)
                                .+.|+||+-+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      389999997764

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=4.6e-17  Score=145.87  Aligned_cols=137  Identities=25%  Similarity=0.169  Sum_probs=109.7

Q ss_pred             CCCCceeeCCCCcCC-cCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcC
Q 038098           39 LAALFELDSGGNKLD-GFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNF  117 (580)
Q Consensus        39 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l  117 (580)
                      .++|++|+|++|.++ +.+|..+..+++|++|+|++|+|+.+ ..+..+                  ++|+.|++++|.+
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l------------------~~L~~L~Ls~N~l   83 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKL------------------PKLKKLELSENRI   83 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCC------------------SSCCEEEEESCCC
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccC------------------CCCCEEECcCCcC
Confidence            367888888888887 56677778888888888888888877 444444                  4556666666777


Q ss_pred             CCCCCcccCCccccceeccccccccccC-CcccccccccccccccccccCCCcc---ccccccCcccEEEccCCcccCCC
Q 038098          118 SDVIPTTIGGLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLNLSNNNLSGTIP---ISLEKLLDLKDINVSFNKLEGEI  193 (580)
Q Consensus       118 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~~~~  193 (580)
                      ++.+|..+..+++|+.|+|++|.+++.. +..+..+++|+.|++++|.+++..+   ..+..+++|+.|++++|.+...+
T Consensus        84 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A           84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             CSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             chHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence            7667777878999999999999999532 2789999999999999999996655   48899999999999999987665


Q ss_pred             C
Q 038098          194 P  194 (580)
Q Consensus       194 ~  194 (580)
                      .
T Consensus       164 ~  164 (168)
T 2ell_A          164 D  164 (168)
T ss_dssp             S
T ss_pred             c
Confidence            4

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=1.9e-16  Score=143.16  Aligned_cols=135  Identities=26%  Similarity=0.333  Sum_probs=105.5

Q ss_pred             CceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCC
Q 038098           42 LFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI  121 (580)
Q Consensus        42 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~  121 (580)
                      .+.+++++|+++.+ |..+  .++|++|++++|+++.+|...                 +..+++|+.|++++|.+++++
T Consensus         9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~-----------------~~~l~~L~~L~l~~n~l~~~~   68 (177)
T 2o6r_A            9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGV-----------------FDKLTQLTKLSLSQNQIQSLP   68 (177)
T ss_dssp             TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTT-----------------TTTCTTCSEEECCSSCCCCCC
T ss_pred             CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHH-----------------hcCcccccEEECCCCcceEeC
Confidence            56788888888844 4333  267888888888888776543                 123455567777777777777


Q ss_pred             CcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          122 PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       122 ~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      +..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++++.++..
T Consensus        69 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l  143 (177)
T 2o6r_A           69 DGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  143 (177)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred             hhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCccH
Confidence            777889999999999999999766777888999999999999999776767788999999999999999887643

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=2.9e-16  Score=143.91  Aligned_cols=127  Identities=25%  Similarity=0.392  Sum_probs=104.0

Q ss_pred             CEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeCcCC
Q 038098           19 QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSN   97 (580)
Q Consensus        19 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l~~n   97 (580)
                      +++++++|.++ .+|..+.  ++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+.++. .|.++++         
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~---------   79 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ---------   79 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTT---------
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCC---------
Confidence            68999999998 5666554  58999999999999 567899999999999999999999875 4545544         


Q ss_pred             cccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCC
Q 038098           98 FLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG  167 (580)
Q Consensus        98 ~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  167 (580)
                               |+.|+|++|.|+++.+..|..+++|+.|+|++|.|+...+..|..+++|+.|+|++|.+..
T Consensus        80 ---------L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           80 ---------LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             ---------CCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ---------CCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence                     4666666677777777888888999999999999986556678888999999999998874

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=3.8e-16  Score=141.15  Aligned_cols=133  Identities=23%  Similarity=0.316  Sum_probs=106.1

Q ss_pred             CCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCC-CcCCCCCceEeCc
Q 038098           17 KLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPST-LWNLKDILYLDLS   95 (580)
Q Consensus        17 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~-~~~l~~L~~L~l~   95 (580)
                      +.+.+++++|+++ .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|+|+.+|.. +..+++       
T Consensus         8 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-------   77 (177)
T 2o6r_A            8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK-------   77 (177)
T ss_dssp             ETTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT-------
T ss_pred             CCCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCc-------
Confidence            3578999999998 4555443  6899999999999988888899999999999999999998764 344444       


Q ss_pred             CCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcc
Q 038098           96 SNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP  170 (580)
Q Consensus        96 ~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~  170 (580)
                                 |+.|++++|.+++.++..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.+.+..|
T Consensus        78 -----------L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           78 -----------LTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             -----------CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             -----------cCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence                       4666666666777777778888889999999998886555567788889999999998886544

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=5.5e-17  Score=142.23  Aligned_cols=129  Identities=19%  Similarity=0.171  Sum_probs=97.0

Q ss_pred             CCCCCCEEeccCCcCC-CCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCC-CCCCCcCCCCCce
Q 038098           14 KLQKLQLLSLEDNQLE-GSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTS-IPSTLWNLKDILY   91 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-lp~~~~~l~~L~~   91 (580)
                      ..++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..|..+++|++|+|++|+|+. +|..+..++    
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~----   88 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCP----   88 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCT----
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCC----
Confidence            3477888888888887 56777778888888888888888865  678888888888888888887 554443344    


Q ss_pred             EeCcCCcccccCCCcccEEeCCCCcCCCCC-CcccCCccccceeccccccccccCC---cccccccccccccccc
Q 038098           92 LDLSSNFLLIGNLKVLVQVDLSMNNFSDVI-PTTIGGLKDLQYLFLEYNRLQGSIP---DSIGDLINLKSLNLSN  162 (580)
Q Consensus        92 L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~l~~  162 (580)
                                    +|+.|++++|.+++.. +..+..+++|+.|++++|.+++..+   ..+..+++|+.|++++
T Consensus        89 --------------~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           89 --------------NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             --------------TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             --------------CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence                          4566666666666542 4678888899999999999885554   4688888999988864

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.66  E-value=1.9e-16  Score=158.26  Aligned_cols=179  Identities=15%  Similarity=0.117  Sum_probs=150.9

Q ss_pred             CCCCCEEeccCCcCC--------------------CCCchhhhC--------CCCCceeeCCCCcCCcCCCccccCCCCC
Q 038098           15 LQKLQLLSLEDNQLE--------------------GSIPDDLCR--------LAALFELDSGGNKLDGFVPACFGNLTNL   66 (580)
Q Consensus        15 l~~L~~L~L~~n~l~--------------------~~~p~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L   66 (580)
                      +++|++|||++|+|.                    .+.+.+|.+        +++|++|+|.+ .++.+.+.+|.++++|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L  126 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL  126 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence            788999999999998                    334567788        99999999999 8888888999999999


Q ss_pred             cEEEcCCCCCCCCCC-CCcCCCCCceEeCcCCcc----------cc----------------------------------
Q 038098           67 RNLYLGSNKLTSIPS-TLWNLKDILYLDLSSNFL----------LI----------------------------------  101 (580)
Q Consensus        67 ~~L~l~~N~l~~lp~-~~~~l~~L~~L~l~~n~l----------~~----------------------------------  101 (580)
                      +.|++++|.++.++. .|.++.++..+.++.+..          .+                                  
T Consensus       127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~  206 (329)
T 3sb4_A          127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF  206 (329)
T ss_dssp             CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred             ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence            999999999988775 455677777777665221          00                                  


Q ss_pred             ----------------cCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc-cccccccc
Q 038098          102 ----------------GNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK-SLNLSNNN  164 (580)
Q Consensus       102 ----------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~-~L~l~~N~  164 (580)
                                      ..+++|+.|+|++|.++.+.+.+|.++++|+.|+|++| ++...+.+|.++.+|+ .|++.+ .
T Consensus       207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~  284 (329)
T 3sb4_A          207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S  284 (329)
T ss_dssp             EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred             EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence                            12789999999999999999999999999999999998 7767778899999999 999999 7


Q ss_pred             cCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          165 LSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       165 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      ++.+.+..|..+++|+.+++++|.++.+.+..
T Consensus       285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~a  316 (329)
T 3sb4_A          285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDEL  316 (329)
T ss_dssp             CCEECTTTTTTCTTEEEEEECSSCCCEECTTT
T ss_pred             ceEEchhhhhCCccCCEEEeCCCccCccchhh
Confidence            77677899999999999999999998776643

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.4e-16  Score=139.55  Aligned_cols=129  Identities=23%  Similarity=0.179  Sum_probs=105.3

Q ss_pred             CCCCceeeCCCCcCC-cCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcC
Q 038098           39 LAALFELDSGGNKLD-GFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNF  117 (580)
Q Consensus        39 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l  117 (580)
                      .++|++|++++|.++ +.+|..+..+++|++|+|++|+|+.+ ..+..                  +++|+.|++++|.+
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~------------------l~~L~~L~Ls~n~i   76 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPK------------------LNKLKKLELSDNRV   76 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCC------------------CTTCCEEECCSSCC
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhc------------------CCCCCEEECCCCcc
Confidence            467899999999988 67778888899999999999998887 44444                  44556777777777


Q ss_pred             CCCCCcccCCccccceecccccccccc-CCcccccccccccccccccccCCCcc---ccccccCcccEEEccC
Q 038098          118 SDVIPTTIGGLKDLQYLFLEYNRLQGS-IPDSIGDLINLKSLNLSNNNLSGTIP---ISLEKLLDLKDINVSF  186 (580)
Q Consensus       118 ~~~~~~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~  186 (580)
                      ++..|..+..+++|+.|++++|.+++. .+..+..+++|+.|++++|.+++..+   ..+..+++|+.|++++
T Consensus        77 ~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             cchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            776777888899999999999999853 34789999999999999999996655   5788999999998864

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.64  E-value=2.5e-16  Score=142.21  Aligned_cols=133  Identities=20%  Similarity=0.270  Sum_probs=82.6

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCC-CCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCC-cCCCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLA-ALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTL-WNLKD   88 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~-~~l~~   88 (580)
                      .+.++.+|+.|+|++|.++. +|. +..+. +|++|+|++|.|+++  ..|..+++|++|+|++|+|+.+|..+ ..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            45667777777777777773 444 33333 777777777777755  56777777777777777777766544 34444


Q ss_pred             CceEeCcCCcccccCCCcccEEeCCCCcCCCCCC-cccCCccccceeccccccccccCCcc----ccccccccccccccc
Q 038098           89 ILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIPDS----IGDLINLKSLNLSNN  163 (580)
Q Consensus        89 L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~----~~~l~~L~~L~l~~N  163 (580)
                      |                  +.|++++|.++.+++ ..+..+++|+.|++++|.++ .+|..    +..+++|+.||+++|
T Consensus        90 L------------------~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n  150 (176)
T 1a9n_A           90 L------------------TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKV  150 (176)
T ss_dssp             C------------------CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEEC
T ss_pred             C------------------CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcC
Confidence            4                  444444444443221 25566666777777777766 44443    566666666666666


Q ss_pred             ccC
Q 038098          164 NLS  166 (580)
Q Consensus       164 ~l~  166 (580)
                      .+.
T Consensus       151 ~~~  153 (176)
T 1a9n_A          151 KLK  153 (176)
T ss_dssp             CHH
T ss_pred             CHH
Confidence            654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.63  E-value=1.5e-18  Score=160.20  Aligned_cols=156  Identities=23%  Similarity=0.292  Sum_probs=110.3

Q ss_pred             cCCCCCCCEEeccCCcCCCCCch------hhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcC
Q 038098           12 VGKLQKLQLLSLEDNQLEGSIPD------DLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWN   85 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~   85 (580)
                      +.....++.++++.+.+.+..|.      .|..+++|++|+|++|.|++ +| .+..+++|++|+|++|+|+.+|..+..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~   91 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAV   91 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhc
Confidence            34456677777777777766665      88888888888888888886 45 788888888888888888888765555


Q ss_pred             CCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCC-cccccccccccccccccc
Q 038098           86 LKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNN  164 (580)
Q Consensus        86 l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~  164 (580)
                      +++|++|+|+                  +|.++++ | .+..+++|+.|+|++|.+++..+ ..+..+++|++|++++|.
T Consensus        92 ~~~L~~L~L~------------------~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~  151 (198)
T 1ds9_A           92 ADTLEELWIS------------------YNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             HHHCSEEEEE------------------EEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred             CCcCCEEECc------------------CCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence            5555555554                  4555543 2 46677778888888888774222 367777888888888888


Q ss_pred             cCCCcccc----------ccccCcccEEEccCCcccC
Q 038098          165 LSGTIPIS----------LEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       165 l~~~~~~~----------~~~l~~L~~l~l~~N~l~~  191 (580)
                      +++..|..          +..+++|+.||  +|+++.
T Consensus       152 l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          152 LYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             cccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            77655442          67788888776  677654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.62  E-value=2.7e-16  Score=141.95  Aligned_cols=135  Identities=19%  Similarity=0.178  Sum_probs=101.8

Q ss_pred             hhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCC
Q 038098           35 DLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSM  114 (580)
Q Consensus        35 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~  114 (580)
                      .+.++.+|++|+|++|+++.+ +......++|++|+|++|+|+.+ ..+.                  .+++|+.|++++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~-~~l~------------------~l~~L~~L~Ls~   73 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-DGFP------------------LLRRLKTLLVNN   73 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-CCCC------------------CCSSCCEEECCS
T ss_pred             hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc-cccc------------------cCCCCCEEECCC
Confidence            345566777777777777743 44333334777777777777766 3343                  455567777777


Q ss_pred             CcCCCCCCcccCCccccceeccccccccccCCc--ccccccccccccccccccCCCcccc----ccccCcccEEEccCCc
Q 038098          115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPD--SIGDLINLKSLNLSNNNLSGTIPIS----LEKLLDLKDINVSFNK  188 (580)
Q Consensus       115 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~l~l~~N~  188 (580)
                      |.++++++..|..+++|+.|+|++|.|+ .+|.  .+..+++|+.|++++|.++ ..|..    +..+++|+.||+++|.
T Consensus        74 N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~  151 (176)
T 1a9n_A           74 NRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVK  151 (176)
T ss_dssp             SCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECC
T ss_pred             CcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCC
Confidence            7777776666788999999999999997 5665  7889999999999999998 55654    8899999999999998


Q ss_pred             ccC
Q 038098          189 LEG  191 (580)
Q Consensus       189 l~~  191 (580)
                      +..
T Consensus       152 ~~~  154 (176)
T 1a9n_A          152 LKE  154 (176)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=4.9e-18  Score=156.71  Aligned_cols=139  Identities=22%  Similarity=0.357  Sum_probs=115.3

Q ss_pred             hhhCCCCCceeeCCCCcCCcCCCc------cccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCccc
Q 038098           35 DLCRLAALFELDSGGNKLDGFVPA------CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLV  108 (580)
Q Consensus        35 ~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~  108 (580)
                      .+.....++.++++.|.+++..|.      .|..+++|++|+|++|+|+.+| .+..+++|++|+|++|.          
T Consensus        13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~----------   81 (198)
T 1ds9_A           13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNL----------   81 (198)
T ss_dssp             HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEE----------
T ss_pred             HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCC----------
Confidence            356678899999999999988777      8999999999999999999988 66666666655555554          


Q ss_pred             EEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcc-ccccccCcccEEEccCC
Q 038098          109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFN  187 (580)
Q Consensus       109 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N  187 (580)
                              ++. .|..+..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|
T Consensus        82 --------l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N  150 (198)
T 1ds9_A           82 --------IKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN  150 (198)
T ss_dssp             --------ECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred             --------ccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence                    443 35566778999999999999995 55 68899999999999999995433 57889999999999999


Q ss_pred             cccCCCCC
Q 038098          188 KLEGEIPN  195 (580)
Q Consensus       188 ~l~~~~~~  195 (580)
                      ++++.+|.
T Consensus       151 ~l~~~~~~  158 (198)
T 1ds9_A          151 PLYNDYKE  158 (198)
T ss_dssp             HHHHHHHT
T ss_pred             cccccccc
Confidence            99988765

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=7.1e-15  Score=131.66  Aligned_cols=111  Identities=20%  Similarity=0.200  Sum_probs=82.2

Q ss_pred             CcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccC
Q 038098           66 LRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI  145 (580)
Q Consensus        66 L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (580)
                      .+.|++++|+|+.+|..+.  +                  +|+.|+|++|.|+++.+..|..+++|+.|+|++|+|++..
T Consensus        11 ~~~l~~s~n~l~~ip~~~~--~------------------~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~   70 (170)
T 3g39_A           11 GTTVDCSGKSLASVPTGIP--T------------------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLP   70 (170)
T ss_dssp             TTEEECTTSCCSSCCSCCC--T------------------TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCEEEeCCCCcCccCccCC--C------------------CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccC
Confidence            4677777777777776542  2                  3456666666666777777778888888888888888666


Q ss_pred             CcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          146 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       146 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      +..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++++.++..
T Consensus        71 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l  121 (170)
T 3g39_A           71 AGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI  121 (170)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred             hhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence            666778888888888888888666667888888888888888888877643

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.57  E-value=3.3e-15  Score=149.26  Aligned_cols=175  Identities=13%  Similarity=0.079  Sum_probs=148.2

Q ss_pred             CCCcccCC--------CCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCC--
Q 038098            7 SIPIAVGK--------LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKL--   76 (580)
Q Consensus         7 ~~p~~~~~--------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l--   76 (580)
                      +-+.+|.+        +++|+.|+|.+ +++.+.+.+|.++++|++|+|++|.+..+.+.+|.++.++..|.++.+..  
T Consensus        84 I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~  162 (329)
T 3sb4_A           84 VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR  162 (329)
T ss_dssp             ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH
T ss_pred             cCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh
Confidence            33457778        99999999999 89878888999999999999999999989999999988888887766321  


Q ss_pred             --CCCCC-CC--------------------------------------------------cCCCCCceEeCcCCcc----
Q 038098           77 --TSIPS-TL--------------------------------------------------WNLKDILYLDLSSNFL----   99 (580)
Q Consensus        77 --~~lp~-~~--------------------------------------------------~~l~~L~~L~l~~n~l----   99 (580)
                        ..+.. .+                                                  ..+++|+.|+|++|++    
T Consensus       163 ~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~  242 (329)
T 3sb4_A          163 FKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIP  242 (329)
T ss_dssp             TSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEEC
T ss_pred             ccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceec
Confidence              11110 00                                                  0267999999999988    


Q ss_pred             --cccCCCcccEEeCCCCcCCCCCCcccCCccccc-eeccccccccccCCcccccccccccccccccccCCCcccccccc
Q 038098          100 --LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQ-YLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL  176 (580)
Q Consensus       100 --~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  176 (580)
                        .|.++++|+.|+|++| ++.+.+.+|.++++|+ .|++++ .++...+..|.++++|+.|++++|.++...+..|.++
T Consensus       243 ~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~  320 (329)
T 3sb4_A          243 DFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNG  320 (329)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTT
T ss_pred             HhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCC
Confidence              5889999999999998 8888899999999999 999999 7776778999999999999999999997888899999


Q ss_pred             CcccEEEc
Q 038098          177 LDLKDINV  184 (580)
Q Consensus       177 ~~L~~l~l  184 (580)
                      ++|+.++.
T Consensus       321 ~~L~~ly~  328 (329)
T 3sb4_A          321 VPSKLIYK  328 (329)
T ss_dssp             CCCCEEEC
T ss_pred             cchhhhcc
Confidence            99999874

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1.9e-14  Score=129.27  Aligned_cols=110  Identities=21%  Similarity=0.260  Sum_probs=75.5

Q ss_pred             cEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCC
Q 038098           67 RNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP  146 (580)
Q Consensus        67 ~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p  146 (580)
                      +.+++++|+|+.+|..+.  +                  +|+.|+|++|+|+++.|..|..+++|+.|+|++|+|++..+
T Consensus        15 ~~l~~~~n~l~~iP~~~~--~------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~   74 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--T------------------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPT   74 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--T------------------TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             cEEEeCCCCCCccCCCcC--C------------------CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccCh
Confidence            567777777777766442  2                  33555566666666666777777777777777777775545


Q ss_pred             cccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          147 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       147 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      ..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+.++..
T Consensus        75 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~  124 (174)
T 2r9u_A           75 GVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI  124 (174)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred             hHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence            55677777777777777777655556777777888888888777776543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=5.1e-14  Score=126.03  Aligned_cols=104  Identities=25%  Similarity=0.330  Sum_probs=67.9

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCC-cCCCCCceEeCcC
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTL-WNLKDILYLDLSS   96 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~-~~l~~L~~L~l~~   96 (580)
                      .+.|++++|.++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+|... ..++         
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~---------   78 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT---------   78 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT---------
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC---------
Confidence            467778888777 4555443  67777777777777777777777777777777777777776543 2333         


Q ss_pred             CcccccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccccc
Q 038098           97 NFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus        97 n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  142 (580)
                               +|+.|+|++|+|+++++..|..+++|+.|+|++|.++
T Consensus        79 ---------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           79 ---------QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             ---------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ---------CCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence                     3355555555555555555666666666666666665

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=4.7e-14  Score=126.71  Aligned_cols=104  Identities=30%  Similarity=0.458  Sum_probs=73.3

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCC-cCCCCCceEeCcC
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTL-WNLKDILYLDLSS   96 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~-~~l~~L~~L~l~~   96 (580)
                      -+.+++++|.++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+|... ..+++        
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~--------   82 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQ--------   82 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT--------
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcch--------
Confidence            367888888886 5665554  67888888888888777778888888888888888888877643 33443        


Q ss_pred             CcccccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccccc
Q 038098           97 NFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus        97 n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  142 (580)
                                |+.|+|++|+|+++++..|..+++|+.|+|++|.+.
T Consensus        83 ----------L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           83 ----------LTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             ----------CCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ----------hhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence                      355555555555555556777777777777777766

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.50  E-value=1.1e-13  Score=141.46  Aligned_cols=200  Identities=13%  Similarity=0.087  Sum_probs=120.8

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      ++++.+-..+|.+. +|+.+.|.. .++.+.+.+|.++++|+.++|++|+++.+...+|. .++|+.+.|.+ .++.++.
T Consensus       144 ~~i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~-~l~~I~~  219 (401)
T 4fdw_A          144 EGLKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPV-TLKEIGS  219 (401)
T ss_dssp             TTCCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCT-TCCEECT
T ss_pred             CCccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCC-chheehh
Confidence            34555556667663 577777765 56556666777777777777777777766666666 46777777763 3666654


Q ss_pred             -CCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccccc-----ccCCcccc
Q 038098           82 -TLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ-----GSIPDSIG  150 (580)
Q Consensus        82 -~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~-----~~~p~~~~  150 (580)
                       +|.++++|+.+++..|--     +|.+ .+|+.+.+ .|.++.+...+|.++++|+.+++.+|.+.     ...+..|.
T Consensus       220 ~aF~~~~~L~~l~l~~~l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~  297 (401)
T 4fdw_A          220 QAFLKTSQLKTIEIPENVSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLE  297 (401)
T ss_dssp             TTTTTCTTCCCEECCTTCCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTT
T ss_pred             hHhhCCCCCCEEecCCCccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhh
Confidence             455677777777765522     2444 56666666 34455556666666666776666666553     24445666


Q ss_pred             cccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCC
Q 038098          151 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGN  210 (580)
Q Consensus       151 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n  210 (580)
                      ++++|+.++|.+ .++......|..+.+|+.+++..| ++.+.... ... +++.+.+.+|
T Consensus       298 ~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n  355 (401)
T 4fdw_A          298 GCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGT  355 (401)
T ss_dssp             TCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCS
T ss_pred             CCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCC
Confidence            666666666663 355455566666666666666443 44333322 222 4555555544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.44  E-value=8e-13  Score=135.00  Aligned_cols=199  Identities=14%  Similarity=0.102  Sum_probs=163.5

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      |+++.+-+.+|.+. +|+.+.|..| ++.+...+|.+ .+|+.+.|.. .++.+.+.+|.++++|+.++|++|+++.++.
T Consensus       122 ~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~  197 (401)
T 4fdw_A          122 NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPA  197 (401)
T ss_dssp             TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECT
T ss_pred             CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEech
Confidence            56777777899985 7999999887 77677788888 5799999996 7888888999999999999999999999998


Q ss_pred             CCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           82 TLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                      ..+...+|+.+.|..+--     +|.++++|+.+++..| ++.+...+|.+ .+|+.+.| .|.++...+..|.++.+|+
T Consensus       198 ~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~  274 (401)
T 4fdw_A          198 STFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELA  274 (401)
T ss_dssp             TTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCC
T ss_pred             hhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCC
Confidence            777789999999986622     5889999999999975 77788889988 78999999 4556656688999999999


Q ss_pred             cccccccccC-----CCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCC
Q 038098          157 SLNLSNNNLS-----GTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFE  208 (580)
Q Consensus       157 ~L~l~~N~l~-----~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~  208 (580)
                      .+++.+|.+.     ...+..|..+++|+.+++.+ .++.+.... ..+.+++.+.+.
T Consensus       275 ~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          275 EVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             EEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEEC
T ss_pred             EEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEEC
Confidence            9999998876     46678899999999999984 466554433 334555555553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.42  E-value=1.8e-13  Score=137.76  Aligned_cols=59  Identities=25%  Similarity=0.265  Sum_probs=28.9

Q ss_pred             ccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccC
Q 038098          107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS  166 (580)
Q Consensus       107 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~  166 (580)
                      |+.|+|++|+|++++|..|.++++|+.|+|++|+|++..+..|..+. |+.|+|++|.+.
T Consensus        58 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           58 LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            34444444444555555555555555555555555533333333332 555555555554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.42  E-value=2.4e-15  Score=152.26  Aligned_cols=88  Identities=18%  Similarity=0.201  Sum_probs=45.5

Q ss_pred             CCcccEEeCCCCcCCCCC----CcccCCccccceecccccccccc----CCcccccccccccccccccccCCC----ccc
Q 038098          104 LKVLVQVDLSMNNFSDVI----PTTIGGLKDLQYLFLEYNRLQGS----IPDSIGDLINLKSLNLSNNNLSGT----IPI  171 (580)
Q Consensus       104 l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~~~  171 (580)
                      .++|+.|+|++|.|+...    +..+..+++|++|+|++|.|++.    ++..+...++|+.|+|++|.|++.    ++.
T Consensus       154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~  233 (372)
T 3un9_A          154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR  233 (372)
T ss_dssp             TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence            445555555555554321    22234455566666666665532    233444455666666666666542    222


Q ss_pred             cccccCcccEEEccCCcccC
Q 038098          172 SLEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       172 ~~~~l~~L~~l~l~~N~l~~  191 (580)
                      .+...++|+.|++++|+|+.
T Consensus       234 ~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          234 AAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHCSSCCEEECTTSSCCH
T ss_pred             HHHhCCCCCEEeccCCCCCH
Confidence            33344566666666666553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.38  E-value=9.2e-13  Score=132.54  Aligned_cols=95  Identities=26%  Similarity=0.194  Sum_probs=71.2

Q ss_pred             ccccCCCcccCCCCCCCEEeccC-CcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            3 NLNGSIPIAVGKLQKLQLLSLED-NQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      +|+ .+|. |..+++|++|+|++ |.|+++.++.|..|++|++|+|++|+|+++.|..|.++++|+.|+|++|+|+.+|.
T Consensus        20 ~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~   97 (347)
T 2ifg_A           20 ALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW   97 (347)
T ss_dssp             CCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCS
T ss_pred             CCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCH
Confidence            566 4666 88888888888885 88887777788888888888888888888878888888888888888888888876


Q ss_pred             CCcCCCCCceEeCcCCcc
Q 038098           82 TLWNLKDILYLDLSSNFL   99 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l   99 (580)
                      .++...+|+.|+|++|.+
T Consensus        98 ~~~~~~~L~~l~l~~N~~  115 (347)
T 2ifg_A           98 KTVQGLSLQELVLSGNPL  115 (347)
T ss_dssp             TTTCSCCCCEEECCSSCC
T ss_pred             HHcccCCceEEEeeCCCc
Confidence            655433365555555554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=3.8e-12  Score=122.66  Aligned_cols=147  Identities=17%  Similarity=0.139  Sum_probs=116.0

Q ss_pred             HHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceee
Q 038098          287 IFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       287 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  365 (580)
                      +.....+|......+.|+.+.||++... ++.+++|+...........+..|+++++.+. +..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445577888888888999999999865 6899999986543233457889999999985 6778899999988888999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-------------------------------------  408 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------  408 (580)
                      ||||++|.+|.+.+.      +......++.+++++++.||.-                                     
T Consensus        88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            999999999987532      1122346889999999999950                                     


Q ss_pred             -------------------CCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          409 -------------------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       409 -------------------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                                         ....++|||++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               01458999999999999876666799999875

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.34  E-value=1.9e-14  Score=145.57  Aligned_cols=161  Identities=22%  Similarity=0.177  Sum_probs=119.1

Q ss_pred             CCCCCEEeccCCcCCCCCchhhhCC-----CCCceeeCCCCcCCcCCCcc-ccCCCCCcEEEcCCCCCCCC-----CCCC
Q 038098           15 LQKLQLLSLEDNQLEGSIPDDLCRL-----AALFELDSGGNKLDGFVPAC-FGNLTNLRNLYLGSNKLTSI-----PSTL   83 (580)
Q Consensus        15 l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~l-----p~~~   83 (580)
                      +++|+.|+|++|.|+......+..+     ++|++|+|++|.|+...... ...+++|++|+|++|+|+..     ...+
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            4678999999999985544444433     68999999999987433333 33467899999999999752     2222


Q ss_pred             -cCCCCCceEeCcCCccc----------ccCCCcccEEeCCCCcCCCCC----CcccCCccccceecccccccccc----
Q 038098           84 -WNLKDILYLDLSSNFLL----------IGNLKVLVQVDLSMNNFSDVI----PTTIGGLKDLQYLFLEYNRLQGS----  144 (580)
Q Consensus        84 -~~l~~L~~L~l~~n~l~----------~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~----  144 (580)
                       ...++|++|+|++|.|.          +..+++|++|+|++|.|+...    +..+...++|+.|+|++|.|++.    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             24678999999999982          367888999999999987533    45566778999999999999853    


Q ss_pred             CCcccccccccccccccccccCCCccccccc
Q 038098          145 IPDSIGDLINLKSLNLSNNNLSGTIPISLEK  175 (580)
Q Consensus       145 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  175 (580)
                      +...+...++|++|+|++|.|++.....+..
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~  261 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSEGRQVLRD  261 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence            3344556688999999999998655544443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.30  E-value=2e-13  Score=147.85  Aligned_cols=182  Identities=12%  Similarity=0.013  Sum_probs=114.1

Q ss_pred             ccccCCCcccCC-C-CCCCEEeccCCc-CCC-CCchhhhCCCCCceeeCCCCcCCcCC----CccccCCCCCcEEEcCCC
Q 038098            3 NLNGSIPIAVGK-L-QKLQLLSLEDNQ-LEG-SIPDDLCRLAALFELDSGGNKLDGFV----PACFGNLTNLRNLYLGSN   74 (580)
Q Consensus         3 ~~~~~~p~~~~~-l-~~L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N   74 (580)
                      .+++..+..+.. + .+|++|+|++|. ++. .++.....+++|++|+|++|.+++..    +..+..+++|++|+|++|
T Consensus       123 ~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n  202 (592)
T 3ogk_B          123 IVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT  202 (592)
T ss_dssp             BCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTC
T ss_pred             EecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeecc
Confidence            344444444444 2 348888888776 211 12223346788888888888776542    234566788888888888


Q ss_pred             CCCC-----CCCCCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCC---CCCCcccCCccccceeccccccc
Q 038098           75 KLTS-----IPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFS---DVIPTTIGGLKDLQYLFLEYNRL  141 (580)
Q Consensus        75 ~l~~-----lp~~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~---~~~~~~~~~l~~L~~L~l~~n~l  141 (580)
                      .++.     ++..+.++++|++|+|++|.+     .+.++++|+.|+++.+...   ...+..+..+++|+.|+++++..
T Consensus       203 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~  282 (592)
T 3ogk_B          203 EFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP  282 (592)
T ss_dssp             CCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT
T ss_pred             CCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch
Confidence            8763     333344677888888888876     2556777788877753322   12234556667777777777544


Q ss_pred             cccCCcccccccccccccccccccCCCcc-ccccccCcccEEEcc
Q 038098          142 QGSIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVS  185 (580)
Q Consensus       142 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~  185 (580)
                      . .+|..+..+++|+.|+|++|.+++... ..+..+++|+.|+++
T Consensus       283 ~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~  326 (592)
T 3ogk_B          283 N-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR  326 (592)
T ss_dssp             T-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred             h-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence            3 566667777777777777777654332 335667777777777

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.28  E-value=2e-13  Score=147.78  Aligned_cols=205  Identities=14%  Similarity=0.061  Sum_probs=142.5

Q ss_pred             CccccC----CCcccCCCCCCCEEeccCCcCCCC----CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCC
Q 038098            2 NNLNGS----IPIAVGKLQKLQLLSLEDNQLEGS----IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS   73 (580)
Q Consensus         2 N~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~   73 (580)
                      |.+++.    ++..+..+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+.+ ++..+.++++|+.|++++
T Consensus       174 ~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          174 SSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             CEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             ccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            455444    334556789999999999999733    44556788999999999999985 567889999999999985


Q ss_pred             CCCC----CCCCCCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCC-cccCCccccceeccccccccc
Q 038098           74 NKLT----SIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQG  143 (580)
Q Consensus        74 N~l~----~lp~~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~  143 (580)
                      +...    ..+..+..+++|+.|+++++..     .+..+++|++|+|++|.++.... ..+..+++|+.|+++ |.+.+
T Consensus       253 ~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~  331 (592)
T 3ogk_B          253 LNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD  331 (592)
T ss_dssp             CCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH
T ss_pred             cccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH
Confidence            4322    2345666778888888887643     35677888999999888765433 335778888998888 44432


Q ss_pred             -cCCccccccccccccccc-----------ccccCCCc-cccccccCcccEEEccCCcccCCCCCC--CCCccCccccCC
Q 038098          144 -SIPDSIGDLINLKSLNLS-----------NNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIPNK--GPFRNFSTESFE  208 (580)
Q Consensus       144 -~~p~~~~~l~~L~~L~l~-----------~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~--~~~~~l~~~~~~  208 (580)
                       .++..+..+++|+.|+|+           .|.+++.. +.....+++|+.|+++.|.+++.....  ..+++++.+++.
T Consensus       332 ~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~  411 (592)
T 3ogk_B          332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV  411 (592)
T ss_dssp             HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred             HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence             344445667888888888           36666432 223445788888888888877543211  124455555554

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=4.9e-11  Score=114.58  Aligned_cols=136  Identities=15%  Similarity=0.122  Sum_probs=100.9

Q ss_pred             CCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCC--cceEEeeeecCCceeeEeecc
Q 038098          293 GFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN--IIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++....+.+.|..+.||++...+|+.+++|+....   ....+..|+++++.+.+.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34433333455569999998777889999997533   3356788999999986544  556888888878889999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------------  409 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------------  409 (580)
                      +|.++.  ...    .+   ...++.++++.+..||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    12   2357788888888888321                                         


Q ss_pred             --------------CCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          410 --------------SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       410 --------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                                    ...++|||++|.||++++++.+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          1129999999999999887667799999876

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.19  E-value=1.5e-13  Score=148.95  Aligned_cols=203  Identities=14%  Similarity=0.086  Sum_probs=136.0

Q ss_pred             CCcccCCCCCCCEEeccCCcCCCCC-chhhhCCCCCceeeCCCCcCCcC-CCccccCCCCCcEEEcC---------CCCC
Q 038098            8 IPIAVGKLQKLQLLSLEDNQLEGSI-PDDLCRLAALFELDSGGNKLDGF-VPACFGNLTNLRNLYLG---------SNKL   76 (580)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~---------~N~l   76 (580)
                      +|..+..+++|++|+|++|.++... +..+..+++|++|++++| +... .+.....+++|++|+|+         .|.+
T Consensus       281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l  359 (594)
T 2p1m_B          281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL  359 (594)
T ss_dssp             GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCC
T ss_pred             HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCC
Confidence            3334446899999999999976432 233568899999999988 4422 22233458999999983         3455


Q ss_pred             CCCC-CCC-cCCCCCceEeCcCCccc------c-cCCCcccEEeCC--C----CcCCCCCC-----cccCCccccceecc
Q 038098           77 TSIP-STL-WNLKDILYLDLSSNFLL------I-GNLKVLVQVDLS--M----NNFSDVIP-----TTIGGLKDLQYLFL  136 (580)
Q Consensus        77 ~~lp-~~~-~~l~~L~~L~l~~n~l~------~-~~l~~L~~L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~l  136 (580)
                      +... ..+ ..+++|++|.++.|.+.      + ..+++|+.|+++  +    |.++..+.     ..+..+++|+.|+|
T Consensus       360 ~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L  439 (594)
T 2p1m_B          360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL  439 (594)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEEC
T ss_pred             CHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEee
Confidence            4311 112 24688899988888872      2 357889999998  4    56653321     12556788889998


Q ss_pred             ccccccccCCccccc-ccccccccccccccCCCccccc-cccCcccEEEccCCcccCCCC--CCCCCccCccccCCCCcc
Q 038098          137 EYNRLQGSIPDSIGD-LINLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEIP--NKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       137 ~~n~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~~~~l~~~~~~~n~~  212 (580)
                      ++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|+++....  ....+++++.+++.+++.
T Consensus       440 ~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          440 SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            77 666554445544 7888999999888876554444 567888999999988854322  223466777777776654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.18  E-value=4.8e-13  Score=144.89  Aligned_cols=122  Identities=13%  Similarity=0.103  Sum_probs=64.2

Q ss_pred             CCCCCCEEeccCCcCCCCCchhhh-CCCCCceeeCCCC-cCCcC-CCccccCCCCCcEEEcCCCCCCC-----CCCCCcC
Q 038098           14 KLQKLQLLSLEDNQLEGSIPDDLC-RLAALFELDSGGN-KLDGF-VPACFGNLTNLRNLYLGSNKLTS-----IPSTLWN   85 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~l~~N~l~~-----lp~~~~~   85 (580)
                      .+++|++|+|++|.++...+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.++.     ++.....
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            455666666666666544444443 4566666666666 33321 22233456666666666666543     2222234


Q ss_pred             CCCCceEeCcCCc--c-------cccCCCcccEEeCCCC-cCCCCCCcccCCccccceecc
Q 038098           86 LKDILYLDLSSNF--L-------LIGNLKVLVQVDLSMN-NFSDVIPTTIGGLKDLQYLFL  136 (580)
Q Consensus        86 l~~L~~L~l~~n~--l-------~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l  136 (580)
                      +++|++|++++|.  +       ....+++|+.|++++| .+.+ .+..+..+++|+.|++
T Consensus       183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l  242 (594)
T 2p1m_B          183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGT  242 (594)
T ss_dssp             CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEEC
T ss_pred             CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccc
Confidence            5566666666664  2       1233566666666666 2222 3444445555555553

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.03  E-value=1.3e-10  Score=116.48  Aligned_cols=174  Identities=18%  Similarity=0.186  Sum_probs=117.3

Q ss_pred             CCCCEEeccCCcCCC-CC-------chhhhCCCCCceeeCCCCcCC---------cCCCccccCCCCCcEEEcCCCCCCC
Q 038098           16 QKLQLLSLEDNQLEG-SI-------PDDLCRLAALFELDSGGNKLD---------GFVPACFGNLTNLRNLYLGSNKLTS   78 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~-~~-------p~~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~l~~N~l~~   78 (580)
                      ..++.|.+......+ ..       ..++..+++|+.|.+.++...         +.+...+..+++|+.|+|++|.-..
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~  186 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS  186 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence            456778777665431 11       234566788999988766432         1233456778899999998874223


Q ss_pred             CCCCCcCCCCCceEeCcCCccc--------ccCCCcccEEeCCC--CcCCCC-----CCccc--CCccccceeccccccc
Q 038098           79 IPSTLWNLKDILYLDLSSNFLL--------IGNLKVLVQVDLSM--NNFSDV-----IPTTI--GGLKDLQYLFLEYNRL  141 (580)
Q Consensus        79 lp~~~~~l~~L~~L~l~~n~l~--------~~~l~~L~~L~l~~--N~l~~~-----~~~~~--~~l~~L~~L~l~~n~l  141 (580)
                      ++. + .+++|+.|+|..|.+.        ...+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+
T Consensus       187 l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i  264 (362)
T 2ra8_A          187 IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE  264 (362)
T ss_dssp             CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT
T ss_pred             ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC
Confidence            444 3 3789999999988872        23789999998853  222111     11122  2478999999999998


Q ss_pred             cccCCcccc---cccccccccccccccCCC----ccccccccCcccEEEccCCcccC
Q 038098          142 QGSIPDSIG---DLINLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEG  191 (580)
Q Consensus       142 ~~~~p~~~~---~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~  191 (580)
                      .+..+..+.   .+++|+.|+|+.|.+.+.    ++..+..+++|+.|++++|.++.
T Consensus       265 ~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          265 QNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             HHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             chHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            754433332   478999999999999864    34445567899999999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=7.4e-10  Score=111.75  Aligned_cols=142  Identities=11%  Similarity=0.140  Sum_probs=106.7

Q ss_pred             cCceeccccCceEEEEEeCCCCEEEEEEEe--ccc-cchhhhHHHHHHHHhhcC--CCCcceEEeeeecC---CceeeEe
Q 038098          296 ENNLIGRGGFGSVYKARIQDGMEVAVKVFD--LQY-GRAFKSFDIECDMIKRIR--HRNIIKIISSCSSD---DFKALVL  367 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  367 (580)
                      ..+.++.|.++.||+.... +..+++|+..  ... ......+..|+.+++.+.  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999999876 4678888765  221 123457888999999997  45678899988776   4578999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY--------------------------------------  409 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------  409 (580)
                      ||++|..+.+..   -..++...+..++.+++++|+.||.-.                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998775421   123678888899999999999999410                                      


Q ss_pred             -----------------CCCeEEecCCCCCEEeCCCCc--EEEccccCccc
Q 038098          410 -----------------SVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKP  441 (580)
Q Consensus       410 -----------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~a~~  441 (580)
                                       ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             256999999999999997753  68999999873

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.98  E-value=3.1e-11  Score=120.97  Aligned_cols=174  Identities=21%  Similarity=0.190  Sum_probs=123.2

Q ss_pred             cccCCCCCCCEEeccCCcCC---------CCCchhhhCCCCCceeeCCCCc-CCcCCCccccCCCCCcEEEcCCCCCCCC
Q 038098           10 IAVGKLQKLQLLSLEDNQLE---------GSIPDDLCRLAALFELDSGGNK-LDGFVPACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      .++..+++|+.|.+..+...         +.++..+..+|+|+.|+|++|. +. . +. +. +++|+.|+|..|.++.-
T Consensus       133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l-~~-~~-~~~L~~L~L~~~~l~~~  208 (362)
T 2ra8_A          133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-I-GK-KP-RPNLKSLEIISGGLPDS  208 (362)
T ss_dssp             TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-C-CS-CB-CTTCSEEEEECSBCCHH
T ss_pred             HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-e-cc-cc-CCCCcEEEEecCCCChH
Confidence            34567889999999776432         1355677889999999999984 33 2 22 44 89999999999987641


Q ss_pred             C-CCC--cCCCCCceEeCcC--Cc------c-----cc--cCCCcccEEeCCCCcCCCCCCccc---CCccccceecccc
Q 038098           80 P-STL--WNLKDILYLDLSS--NF------L-----LI--GNLKVLVQVDLSMNNFSDVIPTTI---GGLKDLQYLFLEY  138 (580)
Q Consensus        80 p-~~~--~~l~~L~~L~l~~--n~------l-----~~--~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~l~~  138 (580)
                      . ..+  ..+++|++|+|+.  |.      +     .+  ..+++|+.|+|++|.+....+..+   ..+++|+.|+|+.
T Consensus       209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~  288 (362)
T 2ra8_A          209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA  288 (362)
T ss_dssp             HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCS
T ss_pred             HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCC
Confidence            1 122  2688999999853  22      1     11  357899999999999875333222   3578999999999


Q ss_pred             cccccc----CCcccccccccccccccccccCCCccccccccCcccEEEccCCc
Q 038098          139 NRLQGS----IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK  188 (580)
Q Consensus       139 n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~  188 (580)
                      |.|++.    ++..+..+++|+.|+|++|.|++..-..+...- ...+++++|+
T Consensus       289 n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             SCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             CCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            999864    344456689999999999998865444444311 3568888887

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.94  E-value=1e-09  Score=107.96  Aligned_cols=186  Identities=18%  Similarity=0.161  Sum_probs=122.3

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCC--cceEEeeeecCC---ceeeEeecc
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRN--IIKIISSCSSDD---FKALVLEYM  370 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  370 (580)
                      .+.++.|....||+..    +.+++|+....  .....+..|.++++.+. +..  +.+++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56999986432  34567888999998884 332  445555544333   347899999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------------------------------------------  408 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------------  408 (580)
                      +|.++.+...   ..++..++..++.++++.++.||.-                                          
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988875332   2367777888899999999888841                                          


Q ss_pred             -------------CCCCeEEecCCCCCEEeCC--CCcEEEccccCccccCCCCCcccccc-------------cccCCCc
Q 038098          409 -------------YSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLKEDQSLTQTQ-------------TLATIGY  460 (580)
Q Consensus       409 -------------~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~-------------~~~~~~y  460 (580)
                                   ....++|||++|.||++++  +..+.|+||+.+..-... .......             .....++
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                         1135899999999999998  566889999998643110 0000000             0000011


Q ss_pred             CC-cccccCCCCCCchhhHhHHHHHHHHHhCCCCC
Q 038098          461 MA-PEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  494 (580)
Q Consensus       461 ~a-PE~~~~~~~~~~~Dvws~Gvil~elltg~~p~  494 (580)
                      .. |+....  .....+.|++|.++|++.+|..+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 221110  112258999999999999999875

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=98.88  E-value=9.1e-09  Score=105.09  Aligned_cols=177  Identities=16%  Similarity=0.136  Sum_probs=109.7

Q ss_pred             ccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCC---------
Q 038098            5 NGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNK---------   75 (580)
Q Consensus         5 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~---------   75 (580)
                      ..+...+|.++++|+.+.+.++.. .+....|.++.+|+.+++..| ++.+...+|.+++.|+.+.+.++.         
T Consensus       151 ~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~  228 (394)
T 4fs7_A          151 TVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALS  228 (394)
T ss_dssp             CEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTT
T ss_pred             cccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcc
Confidence            334456888899999999976543 366778888888888888776 555666677777777666655432         


Q ss_pred             ---C---------CCCC-CCCcCCCCCceEeCcCCcc--------------------------cccCCCcccEEeCCCCc
Q 038098           76 ---L---------TSIP-STLWNLKDILYLDLSSNFL--------------------------LIGNLKVLVQVDLSMNN  116 (580)
Q Consensus        76 ---l---------~~lp-~~~~~l~~L~~L~l~~n~l--------------------------~~~~l~~L~~L~l~~N~  116 (580)
                         |         +.+. ..+..+.+|+.+.+..+..                          .+..+.+|+.+.+..+ 
T Consensus       229 ~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-  307 (394)
T 4fs7_A          229 KTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-  307 (394)
T ss_dssp             TCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-
T ss_pred             cCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeeccccccccccccccccccc-
Confidence               1         1122 2344566777777765543                          2445556666666543 


Q ss_pred             CCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccC
Q 038098          117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF  186 (580)
Q Consensus       117 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~  186 (580)
                      ++.+...+|.++++|+.++|.++ ++.....+|.++.+|+.+++..| ++.....+|..+.+|+.+++..
T Consensus       308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~  375 (394)
T 4fs7_A          308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK  375 (394)
T ss_dssp             CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred             cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence            54455566666666666666543 44344556666666666666655 4444455666666666666643

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.78  E-value=3.5e-08  Score=100.72  Aligned_cols=107  Identities=11%  Similarity=0.153  Sum_probs=65.1

Q ss_pred             ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCccc
Q 038098          101 IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLK  180 (580)
Q Consensus       101 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  180 (580)
                      |.++..|+.+.+.++.. .+...+|.+++.|+.+.+. +.++......|.++.+|+.++|.++ ++.....+|..+.+|+
T Consensus       261 F~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~  337 (394)
T 4gt6_A          261 FDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE  337 (394)
T ss_dssp             TTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             eeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence            45566777777765433 3556677777777777775 3444345566777777777777654 5445566677777777


Q ss_pred             EEEccCCcccCCCCCC-CCCccCccccCCCCc
Q 038098          181 DINVSFNKLEGEIPNK-GPFRNFSTESFEGNE  211 (580)
Q Consensus       181 ~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~  211 (580)
                      .+.+..+ ++.+.... ....+|+.+.+.++.
T Consensus       338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             EEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred             EEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence            7777543 44333222 334555666665554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.70  E-value=3e-09  Score=96.20  Aligned_cols=107  Identities=9%  Similarity=0.116  Sum_probs=53.5

Q ss_pred             hhCCCCCceeeCCCC-cCCcC----CCccccCCCCCcEEEcCCCCCCC-----CCCCCcCCCCCceEeCcCCcc------
Q 038098           36 LCRLAALFELDSGGN-KLDGF----VPACFGNLTNLRNLYLGSNKLTS-----IPSTLWNLKDILYLDLSSNFL------   99 (580)
Q Consensus        36 ~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~-----lp~~~~~l~~L~~L~l~~n~l------   99 (580)
                      +...++|++|+|++| .|...    +...+...++|++|+|++|+|..     +...+...++|++|+|++|.|      
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~  111 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL  111 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence            334444555555554 44321    11223344455555555555442     222233334455555555555      


Q ss_pred             ----cccCCCcccEEeC--CCCcCCCCC----CcccCCccccceecccccccc
Q 038098          100 ----LIGNLKVLVQVDL--SMNNFSDVI----PTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus       100 ----~~~~l~~L~~L~l--~~N~l~~~~----~~~~~~l~~L~~L~l~~n~l~  142 (580)
                          .+...++|++|+|  ++|.|....    ...+...++|+.|+|++|.+.
T Consensus       112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence                1344556666666  666665432    233444567778888777775

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=98.67  E-value=8e-08  Score=98.06  Aligned_cols=92  Identities=11%  Similarity=0.031  Sum_probs=64.0

Q ss_pred             ccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-
Q 038098            3 NLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-   81 (580)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-   81 (580)
                      ++..+...+|..+..+.......  +......+|.++++|+.+.+.++- ..+....|.++++|+.+.+..| ++.++. 
T Consensus       127 ~l~~i~~~aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~  202 (394)
T 4fs7_A          127 MLKSIGVEAFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY  202 (394)
T ss_dssp             TCCEECTTTTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT
T ss_pred             ceeeecceeeecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch
Confidence            44445556777765544443333  232456789999999999998765 4478889999999999999876 666654 


Q ss_pred             CCcCCCCCceEeCcCCc
Q 038098           82 TLWNLKDILYLDLSSNF   98 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~   98 (580)
                      .+.++..|+.+.+..+.
T Consensus       203 ~F~~~~~L~~i~~~~~~  219 (394)
T 4fs7_A          203 CFAECILLENMEFPNSL  219 (394)
T ss_dssp             TTTTCTTCCBCCCCTTC
T ss_pred             hhccccccceeecCCCc
Confidence            45566777776665543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.62  E-value=4.8e-09  Score=94.83  Aligned_cols=108  Identities=11%  Similarity=0.088  Sum_probs=53.7

Q ss_pred             cccCCCCCcEEEcCCC-CCCC-----CCCCCcCCCCCceEeCcCCcc----------cccCCCcccEEeCCCCcCCCC--
Q 038098           59 CFGNLTNLRNLYLGSN-KLTS-----IPSTLWNLKDILYLDLSSNFL----------LIGNLKVLVQVDLSMNNFSDV--  120 (580)
Q Consensus        59 ~~~~l~~L~~L~l~~N-~l~~-----lp~~~~~l~~L~~L~l~~n~l----------~~~~l~~L~~L~l~~N~l~~~--  120 (580)
                      .+...++|++|+|++| .|..     +...+...++|++|+|++|.|          .+...++|++|+|++|.|...  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            3445555666666655 5543     223334445555666666655          123344555666666655532  


Q ss_pred             --CCcccCCccccceecc--cccccccc----CCcccccccccccccccccccC
Q 038098          121 --IPTTIGGLKDLQYLFL--EYNRLQGS----IPDSIGDLINLKSLNLSNNNLS  166 (580)
Q Consensus       121 --~~~~~~~l~~L~~L~l--~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~  166 (580)
                        +...+...++|+.|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              1233444455566666  55555432    1223333455566666555554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.57  E-value=2.5e-07  Score=94.31  Aligned_cols=106  Identities=9%  Similarity=0.173  Sum_probs=88.7

Q ss_pred             CCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           82 TLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                      +|.++.+|+.+.+..+..     .+.+++.|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.....+|.++.+|+
T Consensus       260 aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~  337 (394)
T 4gt6_A          260 AFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE  337 (394)
T ss_dssp             TTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             eeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence            455678899999987754     57889999999996 5677788899999999999999875 6646678899999999


Q ss_pred             cccccccccCCCccccccccCcccEEEccCCccc
Q 038098          157 SLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE  190 (580)
Q Consensus       157 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~  190 (580)
                      .+.|..+ ++.....+|.++.+|+.+++.+|...
T Consensus       338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             EEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence            9999765 66567789999999999999988643

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.50  E-value=8.7e-09  Score=97.85  Aligned_cols=81  Identities=23%  Similarity=0.255  Sum_probs=45.4

Q ss_pred             CCCCCceeeCCCCcCCcC--CCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCC
Q 038098           38 RLAALFELDSGGNKLDGF--VPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMN  115 (580)
Q Consensus        38 ~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N  115 (580)
                      ++++|++|+|++|+|+++  +|..+..+++|+.|+|++|+|+.+. .+..+               ..+ +|+.|+|++|
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~-~l~~l---------------~~l-~L~~L~L~~N  230 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER-ELDKI---------------KGL-KLEELWLDGN  230 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGG-GGGGG---------------TTS-CCSEEECTTS
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCch-hhhhc---------------ccC-CcceEEccCC
Confidence            455566666666666542  2244455566666666666655541 12211               122 6677777777


Q ss_pred             cCCCCCC-------cccCCccccceec
Q 038098          116 NFSDVIP-------TTIGGLKDLQYLF  135 (580)
Q Consensus       116 ~l~~~~~-------~~~~~l~~L~~L~  135 (580)
                      .+.+..|       ..+..+|+|+.||
T Consensus       231 pl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          231 SLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             TTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             cCccccCcchhHHHHHHHHCcccCeEC
Confidence            7765433       2356778888887

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.45  E-value=2.7e-08  Score=94.44  Aligned_cols=66  Identities=24%  Similarity=0.335  Sum_probs=34.8

Q ss_pred             cCCCcccEEeCCCCcCCCCC--CcccCCccccceeccccccccccCCccccccc--ccccccccccccCCCc
Q 038098          102 GNLKVLVQVDLSMNNFSDVI--PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI--NLKSLNLSNNNLSGTI  169 (580)
Q Consensus       102 ~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~  169 (580)
                      .++++|+.|+|++|.|+++.  +..+..+++|+.|+|++|.|++.  ..+..+.  +|+.|+|++|.+.+..
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~  236 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF  236 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence            34556666666666666532  23444556666666666666532  1222222  5555666666655433

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.42  E-value=1.4e-06  Score=85.36  Aligned_cols=135  Identities=16%  Similarity=0.127  Sum_probs=95.4

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCC---CcceEEeeee-cCCceeeEeeccCC
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHR---NIIKIISSCS-SDDFKALVLEYMPH  372 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  372 (580)
                      .+.++.|....||+.    |+.+++|+...  ......+..|.++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899988    57789998532  23346788999999999752   3566777764 45567899999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG--------------------------------------------  408 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------------------------------------------  408 (580)
                      .++.+....   .++......++.++++.++.||.-                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888763211   234555555666666666666521                                            


Q ss_pred             -------------CCCCeEEecCCCCCEEeCC---CCc-EEEccccCcc
Q 038098          409 -------------YSVPIIHCDLKPSNVLLDD---NMV-AHLSDFGMAK  440 (580)
Q Consensus       409 -------------~~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~a~  440 (580)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+.
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                         2345799999999999987   455 4899999876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=2.1e-06  Score=82.50  Aligned_cols=140  Identities=17%  Similarity=0.098  Sum_probs=101.3

Q ss_pred             cCCCcCceeccccCc-eEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFG-SVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .+|+. +.+..|..+ .||+.... ++..+++|+-...   ....+..|...++.+. +--+.++++++.+.+..++|||
T Consensus        25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            34433 345556665 68988754 4678999986532   3456788999998884 3347788999988899999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG----------------------------------------  408 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------  408 (580)
                      +++|.++.+.....     ......++.+++..+..||.-                                        
T Consensus       101 ~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             CCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             eeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            99998887754321     123345677777888888831                                        


Q ss_pred             ---------------CCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          409 ---------------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       409 ---------------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                                     ....++|||+.+.||+++.++.+-|+||+.+.
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           01237899999999999988777899999876

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.34  E-value=2.9e-06  Score=85.89  Aligned_cols=180  Identities=14%  Similarity=0.157  Sum_probs=96.5

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCC------------CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEE
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGS------------IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNL   69 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~------------~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L   69 (580)
                      ++++.+...+|..+.+++.+.+..+.....            ....+.....+..+.+..+.- .+....|..+.+|+.+
T Consensus       144 ~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i  222 (379)
T 4h09_A          144 KSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKI  222 (379)
T ss_dssp             TTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEE
T ss_pred             ceeeccccchhcccccccccccccccceeecccceecccccceecccccccccccccccccee-EEeeccccccccccee
Confidence            345666677888888888888776543211            112233333444444443322 2344455555666666


Q ss_pred             EcCCCCCCCCC-CCCcCCCCCceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccc
Q 038098           70 YLGSNKLTSIP-STLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQG  143 (580)
Q Consensus        70 ~l~~N~l~~lp-~~~~~l~~L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~  143 (580)
                      .+..+ ++.+. ..+.++.+|+.+.+..+--     .+.++.+|+.+.+..+ ++.+...+|.++++|+.+.+.++.++.
T Consensus       223 ~~~~~-~~~i~~~~f~~~~~L~~i~lp~~v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~  300 (379)
T 4h09_A          223 TITSG-VTTLGDGAFYGMKALDEIAIPKNVTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIET  300 (379)
T ss_dssp             ECCTT-CCEECTTTTTTCSSCCEEEECTTCCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCE
T ss_pred             eeccc-eeEEccccccCCccceEEEcCCCccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccce
Confidence            55433 33333 2344555566665554421     3455556666665433 444455566666666666666665554


Q ss_pred             cCCcccccccccccccccccccCCCccccccccCcccEEEcc
Q 038098          144 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS  185 (580)
Q Consensus       144 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~  185 (580)
                      .....|.++.+|+.+.|.++ ++.+...+|.++.+|+.+.+.
T Consensus       301 I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          301 LEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             ehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            44555666666666666543 443444556666666666553

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.30  E-value=3.5e-06  Score=85.28  Aligned_cols=163  Identities=12%  Similarity=0.072  Sum_probs=116.2

Q ss_pred             cccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCC
Q 038098           10 IAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKD   88 (580)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~   88 (580)
                      .++.....+..+.+..+.-. .....+....+|+.+.+..+ +..+....|.++.+|+.+.+..+ ++.+.. .+.++.+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~  264 (379)
T 4h09_A          188 ESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTA  264 (379)
T ss_dssp             EECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTT
T ss_pred             ccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeeh
Confidence            45555666666666554333 45566777778888877655 45466677888888888888765 666654 4556778


Q ss_pred             CceEeCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccccccccccccccccc
Q 038098           89 ILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNN  163 (580)
Q Consensus        89 L~~L~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  163 (580)
                      |+.+.+..+--     .|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+..+
T Consensus       265 l~~i~l~~~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          265 LKTLNFYAKVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             CCEEEECCCCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             hccccccccceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            88887765422     4778888899999888888888889999999999999765 65455678888999999988765


Q ss_pred             ccCCCccccccccC
Q 038098          164 NLSGTIPISLEKLL  177 (580)
Q Consensus       164 ~l~~~~~~~~~~l~  177 (580)
                       ++..-..+|.++.
T Consensus       344 -v~~I~~~aF~~c~  356 (379)
T 4h09_A          344 -ITLIESGAFEGSS  356 (379)
T ss_dssp             -CCEECTTTTTTSS
T ss_pred             -cCEEchhHhhCCC
Confidence             5545556666553

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=1.8e-06  Score=86.58  Aligned_cols=80  Identities=6%  Similarity=0.006  Sum_probs=56.4

Q ss_pred             cee-ccccCceEEEEEeC-------CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCC---CCcceEEeeeecC---
Q 038098          298 NLI-GRGGFGSVYKARIQ-------DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRH---RNIIKIISSCSSD---  360 (580)
Q Consensus       298 ~~l-g~G~~g~v~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---  360 (580)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.+..   -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            556 78888999998754       26788999864332   1113567889999888843   3577888887655   


Q ss_pred             CceeeEeeccCCCChHH
Q 038098          361 DFKALVLEYMPHGSLEK  377 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~  377 (580)
                      +..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999876653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=2.7e-05  Score=79.24  Aligned_cols=75  Identities=17%  Similarity=0.153  Sum_probs=50.0

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEecccc-------chhhhHHHHHHHHhhcCC--C-CcceEEeeeecCCceee
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-------RAFKSFDIECDMIKRIRH--R-NIIKIISSCSSDDFKAL  365 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l  365 (580)
                      .+.+|.|..+.||++... +++.++||.......       .....+..|.++++.+..  + .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            467899999999999754 468899998643211       123556789999888742  3 344566543  445689


Q ss_pred             EeeccCCC
Q 038098          366 VLEYMPHG  373 (580)
Q Consensus       366 v~e~~~~g  373 (580)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.94  E-value=4.5e-05  Score=75.76  Aligned_cols=138  Identities=17%  Similarity=0.180  Sum_probs=79.8

Q ss_pred             ceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC--CCcceEEee------eecCCceeeEeec
Q 038098          298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH--RNIIKIISS------CSSDDFKALVLEY  369 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~------~~~~~~~~lv~e~  369 (580)
                      +.++.|..+.||+....+| .+++|+....    ......|.++++.+..  -.+.+++..      ....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999987654 5999988642    2334445566555531  123444431      1235667899999


Q ss_pred             cCCCChH-----H---------HhhcC--CC-----------CCCHHHHH------------------------------
Q 038098          370 MPHGSLE-----K---------CLYSS--NY-----------ILDIFQRL------------------------------  392 (580)
Q Consensus       370 ~~~g~L~-----~---------~l~~~--~~-----------~~~~~~~~------------------------------  392 (580)
                      ++|.++.     .         .++..  ..           ...|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         11211  00           01222110                              


Q ss_pred             -HHHHHHHHHHHHHhc----------CCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          393 -NIMIDVASALEYLHF----------GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       393 -~i~~~i~~~l~~Lh~----------~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                       .+..++..++.+|+.          .....++|||+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111223345666652          125789999999999999888899999999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.90  E-value=5.4e-05  Score=73.26  Aligned_cols=78  Identities=13%  Similarity=0.107  Sum_probs=58.0

Q ss_pred             CCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC---CCcceEEeeeecCCceeeEeecc
Q 038098          294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH---RNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       294 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ....+.+|.|..+.||+.+..+|+.|++|+...........+..|++.|+.+.-   --+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            444577899999999999999999999998754444444568889999998842   2345566543    247899999


Q ss_pred             CCCCh
Q 038098          371 PHGSL  375 (580)
Q Consensus       371 ~~g~L  375 (580)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87643

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.82  E-value=2.7e-06  Score=74.79  Aligned_cols=83  Identities=12%  Similarity=0.133  Sum_probs=49.2

Q ss_pred             cccEEeCCCCcCCCCCCcccCCccccceecccccc-ccccCCcccccc----cccccccccccc-cCCCccccccccCcc
Q 038098          106 VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNR-LQGSIPDSIGDL----INLKSLNLSNNN-LSGTIPISLEKLLDL  179 (580)
Q Consensus       106 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~L  179 (580)
                      .|+.||++++.++...-..+.++++|+.|+|++|. |++..-..+..+    ++|+.|+|++|. |++.--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34555555555554444455666777777777774 554333334432    357777777763 665444456667777


Q ss_pred             cEEEccCCc
Q 038098          180 KDINVSFNK  188 (580)
Q Consensus       180 ~~l~l~~N~  188 (580)
                      +.|++++++
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            777777664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.78  E-value=0.00019  Score=69.86  Aligned_cols=136  Identities=15%  Similarity=0.100  Sum_probs=92.3

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC---CCCcceEEeeeecCCceeeEeeccCCC
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR---HRNIIKIISSCSSDDFKALVLEYMPHG  373 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  373 (580)
                      .+.++.|....+|+.... ++.+++|+....   ....+..|.+.++.+.   ...+.++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            457899999999999864 678999987533   3466888999988884   366888999888888899999999987


Q ss_pred             ChHH-----------HhhcCCC---------------------CCCHHHHH---HHHH----------------HHHHH-
Q 038098          374 SLEK-----------CLYSSNY---------------------ILDIFQRL---NIMI----------------DVASA-  401 (580)
Q Consensus       374 ~L~~-----------~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~~-  401 (580)
                      .+..           .++....                     .-+|....   ++..                .+++. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222110                     12454332   1111                11111 


Q ss_pred             HHHHh-cCCCCCeEEecCCCCCEEeCCCCcEEEcccc
Q 038098          402 LEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  437 (580)
Q Consensus       402 l~~Lh-~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  437 (580)
                      ...|. ......++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            12332 12356799999999999999887 8899973

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.75  E-value=1e-05  Score=72.57  Aligned_cols=107  Identities=11%  Similarity=0.125  Sum_probs=65.7

Q ss_pred             hhCCCCCceeeCCCC-cCCcC----CCccccCCCCCcEEEcCCCCCCC-----CCCCCcCCCCCceEeCcCCcc------
Q 038098           36 LCRLAALFELDSGGN-KLDGF----VPACFGNLTNLRNLYLGSNKLTS-----IPSTLWNLKDILYLDLSSNFL------   99 (580)
Q Consensus        36 ~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~-----lp~~~~~l~~L~~L~l~~n~l------   99 (580)
                      +.+-+.|++|+|++| .|...    +...+..-+.|+.|+|++|+|..     +...+..-+.|++|+|+.|.|      
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344566777777764 55421    22345556677777777777763     333444456777777777777      


Q ss_pred             ----cccCCCcccEEeCCCCc---CCCC----CCcccCCccccceecccccccc
Q 038098          100 ----LIGNLKVLVQVDLSMNN---FSDV----IPTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus       100 ----~~~~l~~L~~L~l~~N~---l~~~----~~~~~~~l~~L~~L~l~~n~l~  142 (580)
                          .+...+.|+.|+|++|.   +...    +...+..-+.|+.|+++.|.+.
T Consensus       117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence                24455668888887653   3321    2234555678888888877654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.67  E-value=7.9e-06  Score=73.26  Aligned_cols=107  Identities=14%  Similarity=0.151  Sum_probs=64.5

Q ss_pred             ccCCCCCcEEEcCCC-CCCC-----CCCCCcCCCCCceEeCcCCcc----------cccCCCcccEEeCCCCcCCCCC--
Q 038098           60 FGNLTNLRNLYLGSN-KLTS-----IPSTLWNLKDILYLDLSSNFL----------LIGNLKVLVQVDLSMNNFSDVI--  121 (580)
Q Consensus        60 ~~~l~~L~~L~l~~N-~l~~-----lp~~~~~l~~L~~L~l~~n~l----------~~~~l~~L~~L~l~~N~l~~~~--  121 (580)
                      +.+-+.|++|+|++| +|..     +...+..-+.|+.|+|++|.|          .+...+.|++|+|++|.|....  
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            455567777777774 6653     334455556777777777777          2345567777777777776432  


Q ss_pred             --CcccCCccccceecccccc---ccc----cCCcccccccccccccccccccC
Q 038098          122 --PTTIGGLKDLQYLFLEYNR---LQG----SIPDSIGDLINLKSLNLSNNNLS  166 (580)
Q Consensus       122 --~~~~~~l~~L~~L~l~~n~---l~~----~~p~~~~~l~~L~~L~l~~N~l~  166 (580)
                        ..++..-+.|+.|+|++|.   +..    .+...+..-+.|+.|+++.|.+.
T Consensus       117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence              2334455667777777543   222    12233445567777777766543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.65  E-value=7.4e-06  Score=71.99  Aligned_cols=86  Identities=15%  Similarity=0.084  Sum_probs=44.2

Q ss_pred             CCCcEEEcCCCCCCCCC-CCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCc----cccceecccc
Q 038098           64 TNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGL----KDLQYLFLEY  138 (580)
Q Consensus        64 ~~L~~L~l~~N~l~~lp-~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l----~~L~~L~l~~  138 (580)
                      -+|+.|+|+++.|+..- ..+.++++|++|+|++|.                 .++...-..++.+    ++|+.|+|++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~-----------------~ItD~gL~~L~~~~~~~~~L~~L~Ls~  123 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCH-----------------YIEDGCLERLSQLENLQKSMLEMEIIS  123 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCT-----------------TCCHHHHHHHHTCHHHHHHCCEEEEES
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCC-----------------ccCHHHHHHHHhcccccCCCCEEEcCC
Confidence            45777777777665421 123344455444444443                 2333222233332    3566666666


Q ss_pred             cc-ccccCCcccccccccccccccccc-cC
Q 038098          139 NR-LQGSIPDSIGDLINLKSLNLSNNN-LS  166 (580)
Q Consensus       139 n~-l~~~~p~~~~~l~~L~~L~l~~N~-l~  166 (580)
                      |. ||+..-..+..+++|+.|+|+++. ++
T Consensus       124 C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It  153 (176)
T 3e4g_A          124 CGNVTDKGIIALHHFRNLKYLFLSDLPGVK  153 (176)
T ss_dssp             CTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred             CCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence            63 654333445566677777777664 44

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.63  E-value=0.00037  Score=62.67  Aligned_cols=102  Identities=15%  Similarity=0.066  Sum_probs=69.4

Q ss_pred             ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccc
Q 038098          374 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  453 (580)
Q Consensus       374 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  453 (580)
                      +|.++|...+.+++++++|.++.|.+++|.-.-.  ...-..+=+.|..|++..+|.|.+.+ ..+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            8999999999999999999999999999887721  11101222456899999999988764 1110             


Q ss_pred             cccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCC
Q 038098          454 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP  493 (580)
Q Consensus       454 ~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p  493 (580)
                       .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             0122467888763 3557788999999999998875555

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.53  E-value=0.00039  Score=71.13  Aligned_cols=80  Identities=10%  Similarity=0.063  Sum_probs=48.7

Q ss_pred             CCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCC---CCCCchhhHhHHHHHHH
Q 038098          410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLME  486 (580)
Q Consensus       410 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~e  486 (580)
                      ...++|||+++.||+++.++ +.++||+.+..-.. ..........-...|++|+.....   ......++.+.+..+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999998876 99999998873211 000000000011235666554311   11223556688888888


Q ss_pred             HHhCC
Q 038098          487 TFTRK  491 (580)
Q Consensus       487 lltg~  491 (580)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.48  E-value=0.00061  Score=66.23  Aligned_cols=127  Identities=13%  Similarity=0.132  Sum_probs=76.3

Q ss_pred             CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCc-ceEEeeeecCCceeeEeecc-CCCC
Q 038098          297 NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI-IKIISSCSSDDFKALVLEYM-PHGS  374 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~  374 (580)
                      .+.|+.|....+|+.     +.+++|+...... .......|+.+++.+....+ .+++++.  .+.-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678889999999998     5689998754321 12234568888877743333 4566554  33457899999 6544


Q ss_pred             hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 038098          375 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF-----------------------------------------------  407 (580)
Q Consensus       375 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----------------------------------------------  407 (580)
                      +.......        +..++.++++.|+-||.                                               
T Consensus        95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l  166 (301)
T 3dxq_A           95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL  166 (301)
T ss_dssp             CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred             CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence            43200000        00112222222222221                                               


Q ss_pred             ---CCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          408 ---GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       408 ---~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                         .....++|+|+.+.||+ ..++.+.++||..+.
T Consensus       167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HhcCCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence               12345899999999999 566788999999886

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.43  E-value=0.00042  Score=68.07  Aligned_cols=157  Identities=14%  Similarity=0.176  Sum_probs=89.5

Q ss_pred             ccCHHHHHHHhcCCCcC-----ceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCC--cceE
Q 038098          281 RFTYLEIFQATNGFSEN-----NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN--IIKI  353 (580)
Q Consensus       281 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  353 (580)
                      .++..++......|...     +.++.|....+|+....+| .+++|+....  .....+..|+.++..+....  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            34566676666667652     3456688889999987655 6889988642  12345566777777774222  3334


Q ss_pred             Eeee------ecCCceeeEeeccCCCChHH-----H---------hhcC--C--CC----C---CHHHHHH---------
Q 038098          354 ISSC------SSDDFKALVLEYMPHGSLEK-----C---------LYSS--N--YI----L---DIFQRLN---------  393 (580)
Q Consensus       354 ~~~~------~~~~~~~lv~e~~~~g~L~~-----~---------l~~~--~--~~----~---~~~~~~~---------  393 (580)
                      +...      ...+..+++++|++|..+..     +         ++..  .  .+    .   .|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            3221      22355689999998865321     0         1211  0  00    1   1222110         


Q ss_pred             ---HHHHHHHHHHHHhc----CCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          394 ---IMIDVASALEYLHF----GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       394 ---i~~~i~~~l~~Lh~----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                         +...+.+.+++++.    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               00113344555542    224579999999999999987666899999875

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.38  E-value=0.00025  Score=59.29  Aligned_cols=35  Identities=29%  Similarity=0.325  Sum_probs=16.8

Q ss_pred             CCcEEEcCCCCCCCCCCC-CcCCCCCceEeCcCCcc
Q 038098           65 NLRNLYLGSNKLTSIPST-LWNLKDILYLDLSSNFL   99 (580)
Q Consensus        65 ~L~~L~l~~N~l~~lp~~-~~~l~~L~~L~l~~n~l   99 (580)
                      +|++|+|++|+|+.+|.. |..+++|++|+|++|.+
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            345555555555555432 22445555555555544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.32  E-value=0.0003  Score=58.80  Aligned_cols=34  Identities=24%  Similarity=0.294  Sum_probs=17.6

Q ss_pred             cEEeCCCCcCCCCCCcccCCccccceeccccccc
Q 038098          108 VQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRL  141 (580)
Q Consensus       108 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l  141 (580)
                      +.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus        34 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           34 TELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             SEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4445555555555455555555555555555544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.25  E-value=0.00056  Score=70.05  Aligned_cols=72  Identities=18%  Similarity=0.222  Sum_probs=49.3

Q ss_pred             ceeccccCceEEEEEeCC--------CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCC-cceEEeeeecCCceeeEee
Q 038098          298 NLIGRGGFGSVYKARIQD--------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN-IIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  368 (580)
                      +.|+.|....+|+....+        ++.+++|+....  .....+..|..+++.+...+ ..++++.+..    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            567888889999998653        578999987431  11145557888888885333 3567776643    38999


Q ss_pred             ccCCCCh
Q 038098          369 YMPHGSL  375 (580)
Q Consensus       369 ~~~~g~L  375 (580)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0023  Score=63.07  Aligned_cols=138  Identities=12%  Similarity=0.090  Sum_probs=73.8

Q ss_pred             ceeccccCce-EEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC--CCcceEEeeeecCCceeeEeeccCCCC
Q 038098          298 NLIGRGGFGS-VYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH--RNIIKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       298 ~~lg~G~~g~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      +.++.|.... +|+....+|+.+++|......   ...+..|+.+++.+..  -.+.+++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455554444 667765446778887643321   1344567777777642  23556776644333  78999997766


Q ss_pred             hHHHhhcCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 038098          375 LEKCLYSSN-------------------------YILDIFQRL-------N-I------------MIDVASALEYLH---  406 (580)
Q Consensus       375 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~Lh---  406 (580)
                      +.+++....                         ..++.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         012221110       0 0            001112222221   


Q ss_pred             cCCCCCeEEecCCCCCEEeCCC----CcEEEccccCcc
Q 038098          407 FGYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAK  440 (580)
Q Consensus       407 ~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~a~  440 (580)
                      ......++|||+.+.||+++.+    +.+.|+||+.+.
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            1125679999999999999874    689999999886

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.14  E-value=0.0065  Score=59.57  Aligned_cols=156  Identities=13%  Similarity=0.109  Sum_probs=88.9

Q ss_pred             ccCHHHHHHHhcCCCc-----CceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCC--cceE
Q 038098          281 RFTYLEIFQATNGFSE-----NNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN--IIKI  353 (580)
Q Consensus       281 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  353 (580)
                      .++.+++......|..     ...++ |....||+....+|+.+++|+..... .....+..|..+++.+....  +.++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3455555554444432     23566 88889999887778889999986331 12356667888887774222  3444


Q ss_pred             Eee-----eecCCceeeEeeccCCCChH-----HH---------hhc----C----CCCCCHHHH---------------
Q 038098          354 ISS-----CSSDDFKALVLEYMPHGSLE-----KC---------LYS----S----NYILDIFQR---------------  391 (580)
Q Consensus       354 ~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~----~~~~~~~~~---------------  391 (580)
                      +..     ....+..++||||++|..+.     .+         ++.    .    ....++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     11234557899999875432     11         111    0    011222211               


Q ss_pred             -------HHHHHHHHHHHHHHhc-CCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          392 -------LNIMIDVASALEYLHF-GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       392 -------~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                             ...+..++..+..+-. .....++|||+++.||+++ + .+.|+||+.+.
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                   0111122222222211 1245688999999999999 4 89999998876

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.13  E-value=0.0019  Score=66.52  Aligned_cols=74  Identities=15%  Similarity=0.145  Sum_probs=48.5

Q ss_pred             CceeccccCceEEEEEeCC-CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCc-ceEEeeeecCCceeeEeeccCCCC
Q 038098          297 NNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI-IKIISSCSSDDFKALVLEYMPHGS  374 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  374 (580)
                      .+.|+.|-...+|+....+ +..+++|+...... ..-.-..|..+++.+...++ .++++++..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            3568888889999998764 47889998743321 11222578899998865444 567777632    35999998754


Q ss_pred             h
Q 038098          375 L  375 (580)
Q Consensus       375 L  375 (580)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.13  E-value=0.002  Score=64.39  Aligned_cols=138  Identities=14%  Similarity=0.163  Sum_probs=82.7

Q ss_pred             ceeccccCceEEEEEeC--------CCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEee
Q 038098          298 NLIGRGGFGSVYKARIQ--------DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +.+..|-...+|+....        +++.+++|+.... ........+|.++++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888899998864        2478999985322 223455668999988884 3334567777654    38999


Q ss_pred             ccCCCChHHH-----------------hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 038098          369 YMPHGSLEKC-----------------LYSSN----YILD--IFQRLNIMIDVAS-------------------ALEYLH  406 (580)
Q Consensus       369 ~~~~g~L~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~Lh  406 (580)
                      |++|.++..-                 ++...    ....  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9988655311                 11111    1122  3444445444322                   122322


Q ss_pred             -----cCCCCCeEEecCCCCCEEeCCC----CcEEEccccCcc
Q 038098          407 -----FGYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAK  440 (580)
Q Consensus       407 -----~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~a~  440 (580)
                           ......++|+|+.+.||+++.+    +.+.++||.++.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                 1224568899999999999876    789999999886

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.89  E-value=0.0019  Score=64.80  Aligned_cols=73  Identities=10%  Similarity=0.192  Sum_probs=44.7

Q ss_pred             ceeccccCceEEEEEeCC---------CCEEEEEEEeccccchhhhHHHHHHHHhhcCCCC-cceEEeeeecCCceeeEe
Q 038098          298 NLIGRGGFGSVYKARIQD---------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRN-IIKIISSCSSDDFKALVL  367 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  367 (580)
                      +.++.|....+|+....+         ++.+++|+..... ........|.++++.+...+ +.++++...    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            467788888999998653         2688888864332 11223467888888875333 446665542    36899


Q ss_pred             eccCCCCh
Q 038098          368 EYMPHGSL  375 (580)
Q Consensus       368 e~~~~g~L  375 (580)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.60  E-value=0.018  Score=56.82  Aligned_cols=67  Identities=15%  Similarity=0.147  Sum_probs=43.4

Q ss_pred             cccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC---CCCcceEEee------eecCCceeeEeeccCC
Q 038098          302 RGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR---HRNIIKIISS------CSSDDFKALVLEYMPH  372 (580)
Q Consensus       302 ~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~  372 (580)
                      .|....||+....+| .+++|+......      ..|+..++.+.   -|.+.+++..      ....+..++||||++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333679999987767 999998754321      34666666553   2335555543      2334667899999998


Q ss_pred             CCh
Q 038098          373 GSL  375 (580)
Q Consensus       373 g~L  375 (580)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.04  E-value=0.018  Score=58.47  Aligned_cols=137  Identities=14%  Similarity=0.185  Sum_probs=83.2

Q ss_pred             ceeccccCceEEEEEeCC--------CCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEee
Q 038098          298 NLIGRGGFGSVYKARIQD--------GMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      +.+..|-...+|+....+        ++.+++|+..... ...-.-.+|..+++.+. +.-..++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            567778888999998753        5789999864322 22233467888888874 333456665442    378999


Q ss_pred             ccCCCChHH-------H----------hhc------------CCCCCCHHHHHHHHHHH-------------------HH
Q 038098          369 YMPHGSLEK-------C----------LYS------------SNYILDIFQRLNIMIDV-------------------AS  400 (580)
Q Consensus       369 ~~~~g~L~~-------~----------l~~------------~~~~~~~~~~~~i~~~i-------------------~~  400 (580)
                      |++|.+|..       .          ++.            .+.+.-+.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999865421       0          010            01111233333333222                   12


Q ss_pred             HHHHHh---------------------cCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          401 ALEYLH---------------------FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       401 ~l~~Lh---------------------~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      .+.+|.                     ......++|+|+.+.||+ +.++.+.++||.+|.
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            233332                     112356889999999999 888899999999886

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.61  E-value=0.31  Score=49.01  Aligned_cols=29  Identities=28%  Similarity=0.400  Sum_probs=24.8

Q ss_pred             CeEEecCCCCCEEe------CCCCcEEEccccCcc
Q 038098          412 PIIHCDLKPSNVLL------DDNMVAHLSDFGMAK  440 (580)
Q Consensus       412 ~i~H~dlk~~Nill------~~~~~~kl~Dfg~a~  440 (580)
                      .++|+|+.+.||++      +++..+.++||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            35699999999999      456779999999886

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.47  E-value=0.46  Score=30.37  Aligned_cols=23  Identities=22%  Similarity=0.335  Sum_probs=8.9

Q ss_pred             hhhhhHHHHHHHHHHHHHhhhhc
Q 038098          240 GIVLPLSTIFMMAVILFILRYRK  262 (580)
Q Consensus       240 ~~~~~~~~~~~~~vi~~i~~~~~  262 (580)
                      +++.+++.+++++..++++++||
T Consensus        16 gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           16 GMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ehhHHHHHHHHHHHHHHHHhhhh
Confidence            34433443333333334433333

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.25  E-value=1.3  Score=39.74  Aligned_cols=121  Identities=12%  Similarity=0.127  Sum_probs=80.4

Q ss_pred             CCCCcceEEeeeecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEe
Q 038098          346 RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  425 (580)
Q Consensus       346 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill  425 (580)
                      .||+.+.. ..-.+++...+.|+.-+  +...|-.-  ...+...+++++.+|+....+++   .+  +|--+.|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~~---~r--~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI--KSFTKNEKLRYLLNIKNLEEVNR---TR--YTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG--GGSCHHHHHHHHHHGGGGGGGGG---SS--EECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH--HhcCHHHHHHHHHHHHHHHHHhc---Cc--eEEEEecceEEE
Confidence            57887765 45555666555555433  23332221  23788999999999999886666   33  577899999999


Q ss_pred             CCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccC
Q 038098          426 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFG  500 (580)
Q Consensus       426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~  500 (580)
                      +.++.+++.=.|+-..+                   +|.     ..++..=.-.+=+++..+++++..|+....|
T Consensus       113 ~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G  163 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEG  163 (215)
T ss_dssp             CTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred             cCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence            99999999877764422                   121     1122223446778889999999998764333

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.44  E-value=1  Score=28.69  Aligned_cols=27  Identities=22%  Similarity=0.367  Sum_probs=10.7

Q ss_pred             cceehhhhhHHHHHHHHHHHHHhhhhc
Q 038098          236 DLLIGIVLPLSTIFMMAVILFILRYRK  262 (580)
Q Consensus       236 ~~ii~~~~~~~~~~~~~vi~~i~~~~~  262 (580)
                      ..+++.+++++++++++.+++++.+||
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehh
Confidence            334444444333333333333333333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.10  E-value=6  Score=35.48  Aligned_cols=115  Identities=12%  Similarity=0.134  Sum_probs=76.5

Q ss_pred             CCCCcceEEeeeecCCceeeEeeccCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEEecCCCCCE
Q 038098          346 RHRNIIKIISSCSSDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALE-YLHFGYSVPIIHCDLKPSNV  423 (580)
Q Consensus       346 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-~Lh~~~~~~i~H~dlk~~Ni  423 (580)
                      .||++  -...-.+++...+.++.-+++ ++.. +    ...+...+++++.+|+.... +++     .-+|--+.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            57887  333446667776666664332 3332 3    23788999999999988776 555     335677899999


Q ss_pred             EeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCc
Q 038098          424 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  496 (580)
Q Consensus       424 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~  496 (580)
                      ++|.++.+++.-.|+-..+                   +|.-     .++..=.-.+=+++..++.++..|+.
T Consensus       116 ~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999877764322                   2221     11122234667888889999888754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	580
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-65
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 26/282 (9%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIIS 355
             IG G FG+VYK +     +VAVK+ ++     +  ++F  E  ++++ RH NI+  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
             ++    A+V ++    SL   L+      ++ + ++I    A  ++YLH      IIH
Sbjct: 72  YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY---GREGQVS 472
            DLK +N+ L +++   + DFG+A    +   S    Q   +I +MAPE      +   S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
              DVY+FGI+L E  T + P   I   D  +       L   + ++             
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------- 236

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                C   +  L  +C  +  ++R    +I+  +  +  SL
Sbjct: 237 ----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 3e-61
 Identities = 68/306 (22%), Positives = 134/306 (43%), Gaps = 39/306 (12%)

Query: 282 FTYLEIFQATNGFSEN---------NLIGRGGFGSVYKARI----QDGMEVAVKVFDLQY 328
           FT+ +  +A   F++           +IG G FG V    +    +  + VA+K     Y
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 329 G-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILD 387
             +  + F  E  ++ +  H N+I +    +      ++ E+M +GSL+  L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 388 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ 447
           + Q + ++  +A+ ++YL     +  +H DL   N+L++ N+V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 448 SLTQTQTL---ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTL 504
             T T  L     I + APE  +  + ++  DV+S+GI++ E  +  +      + DMT 
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER----PYWDMTN 239

Query: 505 KHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
           +  +N +               ++D        C S +  L + C  +    R    +IV
Sbjct: 240 QDVINAI---------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 565 TRLLKI 570
             L K+
Sbjct: 285 NTLDKM 290

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 9e-59
 Identities = 64/275 (23%), Positives = 122/275 (44%), Gaps = 26/275 (9%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
                 +G G FG V+        +VAVK        +  +F  E +++K+++H+ ++++
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVP 412
            +  + +    ++ EYM +GSL   L + + I L I + L++   +A  + ++       
Sbjct: 74  YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
            IH DL+ +N+L+ D +   ++DFG+A+ L+++++   +      I + APE    G  +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
              DV+SFGI+L E  T  +      +  MT    + +L     M   D           
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI----PYPGMTNPEVIQNLERGYRMVRPD----------- 233

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                C   ++ L   C  E PE R     + + L
Sbjct: 234 ----NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-58
 Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 24/280 (8%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
            +    IG G FG V+     +  +VA+K        + + F  E +++ ++ H  ++++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
              C       LV E+M HG L   L +   +      L + +DV   + YL       +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +PE     + S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             DV+SFG+++ E F+  K      + + +    V D+   +   +    L S       
Sbjct: 182 KSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVEDIS--TGFRLYKPRLASTH----- 230

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
                   ++ +   C  E PE R     ++ +L +I +S
Sbjct: 231 --------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-57
 Identities = 55/277 (19%), Positives = 115/277 (41%), Gaps = 24/277 (8%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
            +    +G G FG V   + +   +VA+K+       +   F  E  ++  + H  ++++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
              C+      ++ EYM +G L   L    +     Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 121

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           +H DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  PE     + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             D+++FG+++ E ++  K      +   T              E +   L   +    +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKM----PYERFT---------NSETAEHIAQGLRLYRPHLAS 227

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
            K      ++ +   C  E  ++R   K +++ +L +
Sbjct: 228 EK------VYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 8e-57
 Identities = 62/299 (20%), Positives = 119/299 (39%), Gaps = 29/299 (9%)

Query: 286 EIFQATNGFS-ENNLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQYGRAF-KSFDIECD 340
           ++F   +     +  +G G FGSV +   +     ++VA+KV      +A  +    E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 341 MIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 400
           ++ ++ +  I+++I  C ++    LV+E    G L K L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 401 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIG 459
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 460 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
           + APE     + S+  DV+S+G+ + E  +  +      +  M             VM  
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMK---------GPEVMAF 224

Query: 520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNV 578
           ++     +       +      ++ L   C +   E R +   +  R+     SL   V
Sbjct: 225 IEQGKRMECPPECPPE------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-56
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 32/276 (11%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
             IG+G FG V       G +VAVK          ++F  E  ++ ++RH N+++++   
Sbjct: 13  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 358 SSDDFK-ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
             +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           DV+SFGI+L E ++  +      +  + LK  V  +     M+  D              
Sbjct: 182 DVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPD-------------- 223

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
             C   ++ +   C       R +  ++  +L  I+
Sbjct: 224 -GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-56
 Identities = 66/292 (22%), Positives = 117/292 (40%), Gaps = 22/292 (7%)

Query: 300 IGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS 359
           IG+G FG V++ +   G EVAVK+F  +  R++   + E      +RH NI+  I++ + 
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 360 DDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FGYS 410
           D+       LV +Y  HGSL   L  + Y + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT--QTQTLATIGYMAPEY--- 465
             I H DLK  N+L+  N    ++D G+A        ++       + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 466 ---GREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM-EIVD 521
               +  +     D+Y+ G++  E   R           +     V     +  M ++V 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
              L     +     + +  +  +  +C   +   R+ A  I   L ++   
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-56
 Identities = 62/275 (22%), Positives = 122/275 (44%), Gaps = 26/275 (9%)

Query: 294 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKI 353
                 +G+G FG V+         VA+K        + ++F  E  ++K++RH  ++++
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIF-QRLNIMIDVASALEYLHFGYSVP 412
            +  S +    +V EYM  GSL   L           Q +++   +AS + Y+     + 
Sbjct: 78  YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVS 472
            +H DL+ +N+L+ +N+V  ++DFG+A+ L+++++   +      I + APE    G+ +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 473 TNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHF 532
              DV+SFGI+L E  T+ +      +  M             V++ V+           
Sbjct: 193 IKSDVWSFGILLTELTTKGRV----PYPGMV---------NREVLDQVERGYRMPCPPE- 238

Query: 533 TTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                C   + +L  +C  + PE+R   + +   L
Sbjct: 239 -----CPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-55
 Identities = 69/287 (24%), Positives = 130/287 (45%), Gaps = 29/287 (10%)

Query: 294 FSENNLIGRGGFGSVYKARIQDG-----MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRH 347
            +   +IG G FG VYK  ++       + VA+K     Y  +    F  E  ++ +  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
            NII++    S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQTLATIGYMAPEYG 466
             ++  +H DL   N+L++ N+V  +SDFG+++ L  + + + T +     I + APE  
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
              + ++  DV+SFGI++ E  T  +                 +L    VM+ ++     
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAINDGFRL 232

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS 573
                      C S I+ L M+C  +   +R    +IV+ L K+  +
Sbjct: 233 PTPMD------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  185 bits (471), Expect = 6e-55
 Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 26/279 (9%)

Query: 294 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
            +  + +G G +G VY+   +   + VAVK          + F  E  ++K I+H N+++
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSV 411
           ++  C+ +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL      
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 134

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
             IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     + 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
           S   DV++FG++L E  T         +  + L           V E+++ +   ++ E 
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQ---------VYELLEKDYRMERPEG 240

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                 C   ++ L   C   +P  R +  EI      +
Sbjct: 241 ------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-54
 Identities = 62/306 (20%), Positives = 123/306 (40%), Gaps = 38/306 (12%)

Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKS-FDIECDMI 342
           +E+    + F + + +G G  G V+K      G+ +A K+  L+   A ++    E  ++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 343 KRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 402
                  I+    +  SD   ++ +E+M  GSL++ L  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 462
            YL   +   I+H D+KPSN+L++      L DFG++  L+           + T  YM+
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171

Query: 463 PEYGREGQVSTNGDVYSFGIMLMETFTRKKP-------------------------TDEI 497
           PE  +    S   D++S G+ L+E    + P                             
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 498 FFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQR 557
             G     + ++   P+++ E++D   +  +       G       +   KC +++P +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDY--IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289

Query: 558 INAKEI 563
            + K++
Sbjct: 290 ADLKQL 295

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-54
 Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 30/288 (10%)

Query: 297 NNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRHRNII 351
           N +IGRG FG VY   + D     +  AVK  +          F  E  ++K   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 352 KIISSCSSDDFKA-LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
            ++  C   +    +VL YM HG L   + +  +   +   +   + VA  +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 149

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIGYMAPEYGRE 468
              +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA E  + 
Sbjct: 150 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + +T  DV+SFG++L E  TR  P     + D+        LL               +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL---------------Q 249

Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK 576
                    C   ++ + +KC     E R +  E+V+R+  I  + + 
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-53
 Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 30/278 (10%)

Query: 296 ENNLIGRGGFGSVYKARIQD---GMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNI 350
           E+  +G G FG+V K   Q       VAVK+   +            E ++++++ +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
           +++I  C ++ +  LV+E    G L K L  + + +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREG 469
              +H DL   NVLL     A +SDFG++K L  ++            + + APE     
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
           + S+  DV+SFG+++ E F+  +      +  M             V  +++        
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK----PYRGMK---------GSEVTAMLEKGERMGCP 232

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
                   C   +++L   C     E R     +  RL
Sbjct: 233 AG------CPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-52
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 29/277 (10%)

Query: 294 FSEN----NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRH 347
           F E+      +G G +G V  A        VAVK+ D++      ++   E  + K + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
            N++K        + + L LEY   G L   +   +  +           + + + YLH 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
              + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+APE  +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 468 EGQVSTNG-DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
             +      DV+S GI+L      + P D+          W      ++  + +D+  L 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL- 237

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                             L  K  VE+P  RI   +I
Sbjct: 238 -----------------ALLHKILVENPSARITIPDI 257

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-52
 Identities = 60/272 (22%), Positives = 110/272 (40%), Gaps = 29/272 (10%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISS 356
             +G G FG VYKA+  +  +  A KV D +     + + +E D++    H NI+K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
              ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY-----GREGQV 471
           DLK  N+L   +    L+DFG++    +  Q         T  +MAPE       ++   
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 192

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
               DV+S GI L+E    + P  E+    + LK   ++   ++      +N        
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK------ 246

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                       +   KC  ++ + R    ++
Sbjct: 247 ------------DFLKKCLEKNVDARWTTSQL 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 2e-52
 Identities = 71/320 (22%), Positives = 123/320 (38%), Gaps = 54/320 (16%)

Query: 281 RFTYLEIFQATNGFSENNLIGRGGFGSVYKAR------IQDGMEVAVKVFDLQYGRAF-K 333
           +   LE     N       IG G FG V++AR       +    VAVK+   +       
Sbjct: 4   KLLSLEY--PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 334 SFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNY--------- 384
            F  E  ++    + NI+K++  C+      L+ EYM +G L + L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 385 --------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 430
                          L   ++L I   VA+ + YL        +H DL   N L+ +NMV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178

Query: 431 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR 490
             ++DFG+++ +   D           I +M PE     + +T  DV+++G++L E F+ 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 491 KKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCT 550
                   +  M  +          +  + D N+L+  +        C   ++NL   C 
Sbjct: 239 GLQ----PYYGMAHEEV--------IYYVRDGNILACPEN-------CPLELYNLMRLCW 279

Query: 551 VESPEQRINAKEIVTRLLKI 570
            + P  R +   I   L ++
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-52
 Identities = 60/330 (18%), Positives = 119/330 (36%), Gaps = 60/330 (18%)

Query: 277 SNQRRFTYLEIFQAT---------NGFSENNLIGRGGFGSVYKA------RIQDGMEVAV 321
           S+   + Y++  +                  ++G G FG V  A      +    ++VAV
Sbjct: 13  SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72

Query: 322 KVFDLQYGRAF-KSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCL 379
           K+   +   +  ++   E  M+ ++  H NI+ ++ +C+      L+ EY  +G L   L
Sbjct: 73  KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132

Query: 380 YSSN----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            S                         +L     L     VA  +E+L        +H D
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 189

Query: 418 LKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDV 477
           L   NVL+    V  + DFG+A+ ++ +   + +      + +MAPE   EG  +   DV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249

Query: 478 YSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQ 537
           +S+GI+L E F+         +  + +             +++       +  +      
Sbjct: 250 WSYGILLWEIFSLGVN----PYPGIPVDAN--------FYKLIQNGFKMDQPFY------ 291

Query: 538 CVSFIFNLAMKCTVESPEQRINAKEIVTRL 567
               I+ +   C      +R +   + + L
Sbjct: 292 ATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-52
 Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 30/292 (10%)

Query: 285 LEIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-----FDLQYGRAFKSFDIE 338
           L I + T  F +  ++G G FG+VYK   I +G +V + V      +    +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 339 CDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
             ++  + + ++ +++  C +   + L+ + MP G L   +      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 459 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME 518
            +MA E       +   DV+S+G+ + E  T         +  +             +  
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASE---------ISS 224

Query: 519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
           I++      +         C   ++ + +KC +   + R   +E++    K+
Sbjct: 225 ILEKGERLPQPPI------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (452), Expect = 7e-52
 Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 36/278 (12%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL---QYGRAFKSFDIECDMIKRIRHRN 349
           FS+   IG G FG+VY AR +++   VA+K       Q    ++    E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            I+       +    LV+EY    + +         L   +   +       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY---G 466
           S  +IH D+K  N+LL +  +  L DFG A  +            + T  +MAPE     
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAM 186

Query: 467 REGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
            EGQ     DV+S GI  +E   RK P     F    +    +               ++
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYH---------------IA 227

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
           Q +      G    +  N    C  + P+ R  ++ ++
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 1e-51
 Identities = 63/276 (22%), Positives = 113/276 (40%), Gaps = 33/276 (11%)

Query: 297 NNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKI 353
           +  IGRG F +VYK    +  +EVA      +       + F  E +M+K ++H NI++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 354 ISSCSS----DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
             S  S         LV E M  G+L+  L     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 410 SVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
           + PIIH DLK  N+ +        + D G+A        S  +   + T  +MAPE   E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAPEM-YE 186

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            +   + DVY+FG+ ++E  T + P  E        +   + + P S  ++    +    
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243

Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                           +   C  ++ ++R + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-50
 Identities = 60/277 (21%), Positives = 100/277 (36%), Gaps = 32/277 (11%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKII 354
             IG G +G   K R   DG  +  K  D         +    E ++++ ++H NI++  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 355 SSC--SSDDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLH--F 407
                 ++    +V+EY   G L   +         LD    L +M  +  AL+  H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
                ++H DLKP+NV LD      L DFG+A+ +L  D S  +     T  YM+PE   
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFV-GTPYYMSPEQMN 187

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
               +   D++S G +L E      P     F   + K     +       I        
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKELAGKIREGKFRRIPY------ 236

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                    +    +  +  +        R + +EI+
Sbjct: 237 ---------RYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-50
 Identities = 62/302 (20%), Positives = 106/302 (35%), Gaps = 46/302 (15%)

Query: 294 FSENNLIGRGGFGSVYKARI------QDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRI- 345
            S    +G G FG V +A           M VAVK+          ++   E  ++  + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 346 RHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSS-----------------NYILDI 388
            H NI+ ++ +C+      ++ EY  +G L   L                       LD+
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
              L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWV 508
           + +      + +MAPE       +   DV+S+GI L E F+           D      +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 509 NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL 568
            +   +   E   A +                   ++   C    P +R   K+IV  + 
Sbjct: 262 KEGFRMLSPEHAPAEMY------------------DIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 569 KI 570
           K 
Sbjct: 304 KQ 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-50
 Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 45/307 (14%)

Query: 292 NGFSENNLIGRGGFGSVYKARIQDG---MEVAVKVFDLQYGR-AFKSFDIECDMIKRI-R 346
           N     ++IG G FG V KARI+     M+ A+K       +   + F  E +++ ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 347 HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQR 391
           H NII ++ +C    +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 392 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 451
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDL 511
           T     + +MA E       +TN DV+S+G++L E  +         +  MT       L
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEKL 239

Query: 512 LPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
                +E                   C   +++L  +C  E P +R +  +I+  L ++ 
Sbjct: 240 PQGYRLEKPL---------------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 572 DSLLKNV 578
           +     V
Sbjct: 285 EERKTYV 291

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-50
 Identities = 65/267 (24%), Positives = 106/267 (39%), Gaps = 26/267 (9%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISS 356
             IG+G  G+VY A  +  G EVA++  +LQ     +    E  +++  ++ NI+  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 416
               D   +V+EY+  GSL   +  +    D  Q   +  +   ALE+LH   S  +IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 417 DLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGD 476
           D+K  N+LL  +    L+DFG    +  E    +      T  +MAPE           D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVD 198

Query: 477 VYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKG 536
           ++S GIM +E    + P               N    +   E + A              
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR----------- 247

Query: 537 QCVSFIFNLAMKCTVESPEQRINAKEI 563
                  +   +C     E+R +AKE+
Sbjct: 248 -------DFLNRCLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 8e-50
 Identities = 63/280 (22%), Positives = 104/280 (37%), Gaps = 30/280 (10%)

Query: 300 IGRGGFGSVYKARI----QDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIK 352
           +G G FG V +          + VAVK           A   F  E + +  + HRN+I+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 353 IISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 412
           +     +   K +V E  P GSL   L        +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 413 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAPEYGREGQV 471
            IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 472 STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEH 531
           S   D + FG+ L E FT  +      +  +     ++ +               ++ E 
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQE----PWIGLNGSQILHKID--------------KEGER 233

Query: 532 FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR 571
                 C   I+N+ ++C    PE R     +   LL+ +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (428), Expect = 5e-49
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 33/271 (12%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFD---LQYGRAFKSFDIECDMIKRIRHRNIIKI 353
             +G+G FG+VY AR  Q    +A+KV     L+          E ++   +RH NI+++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
                      L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE         
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             D++S G++  E    K P    F  +   + +      IS +E    + +++      
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTEG----- 230

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                     +L  +    +P QR   +E++
Sbjct: 231 --------ARDLISRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 6e-49
 Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 29/279 (10%)

Query: 299 LIGRGGFGSVYKARI----QDGMEVAVKVFDLQYGRAFKS-FDIECDMIKRIRHRNIIKI 353
            IG G FG V++          + VA+K        + +  F  E   +++  H +I+K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
           I   + ++   +++E    G L   L    Y LD+   +     +++AL YL    S   
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           +H D+   NVL+  N    L DFG+++  +++      ++    I +MAPE     + ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
             DV+ FG+ + E                          P   ++  D     +  E   
Sbjct: 189 ASDVWMFGVCMWEILMHGVK-------------------PFQGVKNNDVIGRIENGERLP 229

Query: 534 TKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD 572
               C   +++L  KC    P +R    E+  +L  I +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 7e-49
 Identities = 56/301 (18%), Positives = 126/301 (41%), Gaps = 38/301 (12%)

Query: 294 FSENNLIGRGGFGSVYKA------RIQDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIR 346
            + +  +G+G FG VY+       + +    VA+K  +     R    F  E  ++K   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 347 HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYI---------LDIFQRLNIMID 397
             ++++++   S      +++E M  G L+  L S               + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 398 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 457
           +A  + YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 458 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVM 517
           + +M+PE  ++G  +T  DV+SFG++L E  T  +      +  ++ +  +  ++   ++
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLRFVMEGGLL 254

Query: 518 EIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN 577
           +  D                C   +F L   C   +P+ R +  EI++ + +  +   + 
Sbjct: 255 DKPD---------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

Query: 578 V 578
           V
Sbjct: 300 V 300

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  169 bits (428), Expect = 4e-48
 Identities = 47/268 (17%), Positives = 92/268 (34%), Gaps = 26/268 (9%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            +G G FG V++      G   A K     +    ++   E   +  +RH  ++ +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
             D+   ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 418 LKPSNVLL--DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
           LKP N++     +    L DFG+   L  +      T T     + APE      V    
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           D++S G++     +   P    F G+             +  E +        +   +  
Sbjct: 207 DMWSVGVLSYILLSGLSP----FGGE-------------NDDETLRNVKSCDWNMDDSAF 249

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEI 563
                   +   K  +  P  R+   + 
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (425), Expect = 1e-47
 Identities = 51/268 (19%), Positives = 101/268 (37%), Gaps = 26/268 (9%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            +G G FG V++      G     K  +  Y     +   E  ++ ++ H  +I +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
                  L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 418 LKPSNVLLD--DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
           +KP N++ +        + DFG+A  L   +       T AT  + APE      V    
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           D+++ G++     +   P    F G+  L+   N         +   +    +D   +  
Sbjct: 210 DMWAIGVLGYVLLSGLSP----FAGEDDLETLQN---------VKRCDWEFDEDAFSSVS 256

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEI 563
            +   FI         + P +R+   + 
Sbjct: 257 PEAKDFI----KNLLQKEPRKRLTVHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-47
 Identities = 62/274 (22%), Positives = 108/274 (39%), Gaps = 29/274 (10%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRN 349
           F    ++G G F +V  AR +    E A+K+ + ++            E D++ R+ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
            +K+  +   D+     L Y  +G L K +       D         ++ SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH--- 125

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
               + D+++ G ++ +      P    F                +   I    +  + D
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP----FRAG-------------NEYLIFQKIIKLEYD 228

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                  +    +     K  V    +R+  +E+
Sbjct: 229 FPEKFFPKARDLV----EKLLVLDATKRLGCEEM 258

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 2e-46
 Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 47/298 (15%)

Query: 298 NLIGRGGFGSVYKAR--------IQDGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RH 347
             +G G FG V  A              +VAVK+       +       E +M+K I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCL---------------YSSNYILDIFQRL 392
           +NII ++ +C+ D    +++EY   G+L + L               ++    L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 393 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 452
           +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 453 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL 512
                + +MAPE   +   +   DV+SFG++L E FT         +  + ++       
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEE------ 245

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
              + +++       K  + T +      ++ +   C    P QR   K++V  L +I
Sbjct: 246 ---LFKLLKEGHRMDKPSNCTNE------LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (410), Expect = 2e-46
 Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 31/284 (10%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGR---AFKSFDIECDMIKRIRHRNIIKII 354
           ++G GG   V+ AR ++   +VAVKV      R    +  F  E      + H  I+ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 355 SSCSSDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
            +  ++        +V+EY+   +L   +++    +   + + ++ D   AL + H    
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAPEYGREG 469
             IIH D+KP+N+++       + DFG+A+ +     S+TQT  +  T  Y++PE  R  
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
            V    DVYS G +L E  T + P    F GD             S + +   ++     
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVSVAYQHVREDPI 232

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRI-NAKEIVTRLLKIRD 572
                     + +  + +K   ++PE R   A E+   L+++ +
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-42
 Identities = 55/291 (18%), Positives = 117/291 (40%), Gaps = 33/291 (11%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            +GRG FG V++            K   ++ G        E  ++   RHRNI+ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            S +   ++ E++    + + + +S + L+  + ++ +  V  AL++LH   S  I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 418 LKPSNVLLD--DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
           ++P N++     +    + +FG A+ L                 Y APE  +   VST  
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           D++S G ++    +   P    F  +   +   N         I++A     ++      
Sbjct: 185 DMWSLGTLVYVLLSGINP----FLAETNQQIIEN---------IMNAEYTFDEEAFKEIS 231

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEIVT------RLLKIRDSLLKNVKR 580
            + + F+     +  V+  + R+ A E +       ++ ++   +++ +K 
Sbjct: 232 IEAMDFV----DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKH 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 61/304 (20%), Positives = 108/304 (35%), Gaps = 45/304 (14%)

Query: 294 FSENNLIGRGGFGSVYKAR------IQDGMEVAVKVFDLQYGRA-FKSFDIECDMIKRIR 346
                 +GRG FG V +A             VAVK+       +  ++   E  ++  I 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 347 HRNIIKII--SSCSSDDFKALVLEYMPHGSLEKCLYSSNY---------------ILDIF 389
           H   +  +  +         +++E+   G+L   L S                   L + 
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 390 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL 449
             +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   +
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN 509
            +      + +MAPE   +   +   DV+SFG++L E F+        + G    + +  
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCR 248

Query: 510 DLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLK 569
            L   + M   D                    ++   + C    P QR    E+V  L  
Sbjct: 249 RLKEGTRMRAPD---------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

Query: 570 IRDS 573
           +  +
Sbjct: 294 LLQA 297

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (381), Expect = 7e-42
 Identities = 49/268 (18%), Positives = 97/268 (36%), Gaps = 23/268 (8%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAF-KSFDIECDMIKRIRHRNIIKIIS 355
           +++G G F  V  A   +    VA+K    +       S + E  ++ +I+H NI+ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
              S     L+++ +  G L   +    +         ++  V  A++YLH    V    
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
                    LD++    +SDFG++K    ED     +    T GY+APE   +   S   
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTK 535
           D +S G++         P    F+ +             +  ++ +  L ++ +      
Sbjct: 191 DCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEYEFDSPYW 233

Query: 536 GQCVSFIFNLAMKCTVESPEQRINAKEI 563
                   +       + PE+R   ++ 
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (373), Expect = 4e-41
 Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 45/291 (15%)

Query: 294 FSEN----NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDI---------EC 339
           F EN     ++GRG    V +        E AVK+ D+  G +F + ++         E 
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 340 DMIKRIR-HRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 398
           D+++++  H NII++  +  ++ F  LV + M  G L   L +    L   +   IM  +
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119

Query: 399 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 458
              +  LH    + I+H DLKP N+LLDD+M   L+DFG +  L   D      +   T 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173

Query: 459 GYMAPEYGREGQVSTNG------DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL 512
            Y+APE         +       D++S G+++        P    F+             
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR----------- 218

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
               M ++   +                 + +L  +  V  P++R  A+E 
Sbjct: 219 --KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 8e-41
 Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 28/284 (9%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY-----GRAFKSFDIECDMIKRIRHRNII 351
           + +G G F +VYKAR       VA+K   L +         ++   E  +++ + H NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            ++ +       +LV ++M        +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 412 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQV 471
            I+H DLKP+N+LLD+N V  L+DFG+AK       +   T  + T  Y APE     ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 472 -STNGDVYSFGIMLMETFTRKKPTDEIFFGD---MTLKHWVNDLLPISVMEIVDANLLSQ 527
                D+++ G +L E   R         GD     L      L   +  +  D   L  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 528 KDEHFTTKGQCVSFIF--------NLAMKCTVESPEQRINAKEI 563
                +  G  +  IF        +L     + +P  RI A + 
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 63/294 (21%), Positives = 111/294 (37%), Gaps = 19/294 (6%)

Query: 286 EIFQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAF-KSFDIECDMIK 343
           ++F     ++  + IG G +G V  A    + + VA+K       + + +    E  ++ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 344 RIRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASA 401
           R RH NII I     +   + +   Y+    +   LY       L        +  +   
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 402 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGY 460
           L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+      D +   T+ +AT  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 461 MAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI 519
            APE     +  T   D++S G +L E  + +       + D           P      
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 520 VDANLLSQKDEHFTTKGQCVSF----------IFNLAMKCTVESPEQRINAKEI 563
              NL ++           V +            +L  K    +P +RI  ++ 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 60/276 (21%), Positives = 108/276 (39%), Gaps = 35/276 (12%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY------GRAFKSFDIECDMIKRIRHRNII 351
            +G G F  V K R    G++ A K    +       G + +  + E  ++K I+H N+I
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 352 KIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 411
            +     +     L+LE +  G L     +    L   +    +  + + + YLH   S+
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SL 132

Query: 412 PIIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
            I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVN 189

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
              +    D++S G++     +   P    F GD               +  V A     
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP----FLGDT----------KQETLANVSAVNYEF 235

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
           +DE+F+      +   +   +  V+ P++R+  ++ 
Sbjct: 236 EDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 39/285 (13%)

Query: 292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDL------QYGRAFKSFDIECDMIKR 344
           N FS + +IGRGGFG VY  R    G   A+K  D       Q      +  I   ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 345 IRHRNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 404
                I+ +  +  + D  + +L+ M  G L   L S + +           ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 405 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE 464
           +H   +  +++ DLKP+N+LLD++    +SD G+A    K+        ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPE 175

Query: 465 YGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN 523
             ++G    ++ D +S G ML +      P  +    D      +   + + + +     
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEI 563
           L                   +L          +R+      A+E+
Sbjct: 236 LR------------------SLLEGLLQRDVNRRLGCLGRGAQEV 262

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  143 bits (362), Expect = 4e-39
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 13/200 (6%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKI 353
             +G G FG V+  R   +G   A+KV   +     +  +  + E  M+  + H  II++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 354 ISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 413
             +        ++++Y+  G L   L  S              +V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 414 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVST 473
           I+ DLKP N+LLD N    ++DFG AK +     +L       T  Y+APE       + 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 474 NGDVYSFGIMLMETFTRKKP 493
           + D +SFGI++ E      P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (360), Expect = 5e-39
 Identities = 52/281 (18%), Positives = 91/281 (32%), Gaps = 27/281 (9%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            IG G FG +Y    I  G EVA+K+  ++         IE  + K ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
            ++    +++  +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 418 LKPSNVL---LDDNMVAHLSDFGMAKPL-----LKEDQSLTQTQTLATIGYMAPEYGREG 469
           +KP N L        + ++ DFG+AK        +            T  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
           + S   D+ S G +LM       P   +       K+       +S    V       + 
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE- 247

Query: 530 EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI 570
                              C     + + +   +      +
Sbjct: 248 ------------FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 6e-39
 Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 17/282 (6%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVF--DLQYGRAFKSFDIECDMIKRIRHRNI 350
           F +   IG G +G VYKAR    G  VA+K    D +      +   E  ++K + H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 351 IKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 410
           +K++    +++   LV E++     +    S+   + +    + +  +   L + H   S
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120

Query: 411 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREG 469
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178

Query: 470 QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKD 529
             ST  D++S G +  E  TR+         D   + +     P  V+     ++   K 
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 530 EHFTTKGQCVSFIF--------NLAMKCTVESPEQRINAKEI 563
                  Q  S +         +L  +     P +RI+AK  
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 7e-39
 Identities = 61/277 (22%), Positives = 114/277 (41%), Gaps = 17/277 (6%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDL--QYGRAFKSFDIECDMIKRIRHRNIIKIIS 355
             IG G +G VYKA+   G   A+K   L  +      +   E  ++K ++H NI+K+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
              +     LV E++    L+K L      L+     + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVSTN 474
            DLKP N+L++      ++DFG+A+      +    T  + T+ Y AP+      + ST 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 475 GDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP-------ISVMEIVDANLLSQ 527
            D++S G +  E          +   D  ++ +     P       ++ +   D N    
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 528 KDEHFTTKGQCVSFIF-NLAMKCTVESPEQRINAKEI 563
           +   + +  + +     +L  K     P QRI AK+ 
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 35/292 (11%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK 352
           +++  +IG G FG VY+A+    G  VA+K       +  +  + E  +++++ H NI++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 353 IISSCSSDD------FKALVLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEY 404
           +     S        +  LVL+Y+P        +   +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 405 LHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 463
           +H   S  I H D+KP N+LLD D  V  L DFG AK L         +   +       
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192

Query: 464 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDM---TLKHWVNDLLPISVMEIV 520
                   +++ DV+S G +L E    +      F GD     L   +  L   +  +I 
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 521 DANLLSQKDEHFTTKGQCVSFIF---------NLAMKCTVESPEQRINAKEI 563
           + N    + +    K    + +F          L  +    +P  R+   E 
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 54/276 (19%), Positives = 103/276 (37%), Gaps = 36/276 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISS 356
           ++G G  G V +    +   + A+K+      +       E ++  R  +  +I++I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 357 C----SSDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSV 411
                +      +V+E +  G L   +    +      +   IM  +  A++YLH   S+
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 412 PIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
            I H D+KP N+L      N +  L+DFG AK     +   T      T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            +   + D++S G+++        P    F+ +            +++   +   +   +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP----FYSNH----------GLAISPGMKTRIRMGQ 233

Query: 529 DEHFTTKGQCVSFIF-NLAMKCTVESPEQRINAKEI 563
            E    +   VS     L        P QR+   E 
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-38
 Identities = 56/276 (20%), Positives = 108/276 (39%), Gaps = 32/276 (11%)

Query: 294 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYG---RAFKSFDIECDMIKR-IRHR 348
           F  + ++G+G FG V+ A   +     A+K             +   +E  ++     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
            +  +  +  + +    V+EY+  G L   + S +   D+ +      ++   L++LH  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH-- 120

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
            S  I++ DLK  N+LLD +    ++DFGM K  +  D          T  Y+APE    
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG 177

Query: 469 GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK 528
            + + + D +SFG++L E    + P    F G                 E+  +  +   
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ-------------DEEELFHSIRMDNP 220

Query: 529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIV 564
                 + +    +    +K  V  PE+R+  +  +
Sbjct: 221 FYPRWLEKEAKDLL----VKLFVREPEKRLGVRGDI 252

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 30/301 (9%)

Query: 298 NLIGRGGFGSVYKAR--IQDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRI---RHRNI 350
             IG G +G V+KAR     G  VA+K   +Q G      S   E  +++ +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 351 IKIISSCSSDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 405
           +++   C+           LV E++               +      ++M  +   L++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 406 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEY 465
           H   S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T+ Y APE 
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEV 186

Query: 466 GREGQVSTNGDVYSFGIMLMETFTRKKPTD-----EIFFGDMTLKHWVNDLLPISVMEIV 520
             +   +T  D++S G +  E F RK         +     + +     +      + + 
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 521 DANLLSQKDEHFTTKGQCVSFIF-NLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKNVK 579
                S+  +        +  +  +L +KC   +P +RI+A         +     ++++
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQDLE 300

Query: 580 R 580
           R
Sbjct: 301 R 301

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 5e-37
 Identities = 58/279 (20%), Positives = 97/279 (34%), Gaps = 51/279 (18%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAF------KSFDIECDMIKRIR--HRN 349
           L+G GGFGSVY    + D + VA+K  +      +          +E  ++K++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 350 IIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
           +I+++      D   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 410 SVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
           +  ++H D+K  N+L+D +     L DFG    L    +    T    T  Y  PE+ R 
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183

Query: 469 GQVSTNG-DVYSFGIMLMETFTRKKP---TDEIFFGDMTLKHWVNDLLPISVMEIVDANL 524
            +       V+S GI+L +      P    +EI  G +  +  V+               
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS-------------- 229

Query: 525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                       +C   I      C    P  R   +EI
Sbjct: 230 ------------ECQHLI----RWCLALRPSDRPTFEEI 252

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  133 bits (334), Expect = 2e-35
 Identities = 42/287 (14%), Positives = 92/287 (32%), Gaps = 29/287 (10%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            IG G FG +++   + +  +VA+K    +          E    K +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 358 SSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 417
             +    +++  +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 418 LKPSNVLLDDNMVAH-----LSDFGMAK----PLLKEDQSLTQTQTLA-TIGYMAPEYGR 467
           +KP N L+      +     + DFGM K    P+ K+     + + L+ T  YM+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
             + S   D+ + G + M       P   +       K+         + E   +  L +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-------RIGEKKQSTPLRE 239

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL 574
                          +         + +   +   +     K+ + L
Sbjct: 240 LCAG------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 19/279 (6%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKII 354
             IG G +G+V+KA+  +    VA+K   L         S   E  ++K ++H+NI+++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 355 SSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 414
               SD    LV E+      +     +  + D     + +  +   L + H      ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123

Query: 415 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPE-YGREGQVST 473
           H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+        ST
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 474 NGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFT 533
           + D++S G +  E     +P       D  LK     L   +  +      L     +  
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 534 TKGQCVSFIF---------NLAMKCTVESPEQRINAKEI 563
                              +L       +P QRI+A+E 
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-35
 Identities = 62/291 (21%), Positives = 114/291 (39%), Gaps = 29/291 (9%)

Query: 298 NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKII 354
             IG+G FG V+KAR  + G +VA+K   ++        +   E  +++ ++H N++ +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 355 SSCSSDDFKA--------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 406
             C +             LV ++  H               + +   +M  + + L Y+H
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134

Query: 407 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--LKEDQSLTQTQTLATIGYMAPE 464
                 I+H D+K +NVL+  + V  L+DFG+A+     K  Q    T  + T+ Y  PE
Sbjct: 135 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 465 YGREGQ-VSTNGDVYSFGIMLMETFTRKKPTD-----------EIFFGDMTLKHWVNDLL 512
                +      D++  G ++ E +TR                    G +T + W N   
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 513 PISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
                ++       +K +          +  +L  K  V  P QRI++ + 
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 33/305 (10%)

Query: 282 FTYLEIFQATNGFSEN----NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKS 334
           F   E+ +              +G G +G+V  A   + G +VA+K     +      K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 335 FDIECDMIKRIRHRNIIKIISSCSSDDFKA------LVLEYMPHGSLEKCLYSSNYILDI 388
              E  ++K +RH N+I ++   + D+         LV+ +M     +      +  L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120

Query: 389 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS 448
            +   ++  +   L Y+H   +  IIH DLKP N+ ++++    + DFG+A    ++  S
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADS 173

Query: 449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP---------TDEIFF 499
                 +              + +   D++S G ++ E  T K             EI  
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233

Query: 500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF-NLAMKCTVESPEQRI 558
              T        L     +     L   + + F +     S +  NL  K  V   EQR+
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

Query: 559 NAKEI 563
            A E 
Sbjct: 294 TAGEA 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 3e-33
 Identities = 57/275 (20%), Positives = 105/275 (38%), Gaps = 31/275 (11%)

Query: 292 NGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRA---FKSFDIECDMIKRIRH 347
           N F    L+G+G FG V   R    G   A+K+   +   A         E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 348 RNIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 407
             +  +  +  + D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 408 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGR 467
             S  +++ D+K  N++LD +    ++DFG+ K  + +  ++       T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 468 EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ 527
           +       D +  G+++ E    + P    F+                   + +  L+ +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQ-------------DHERLFELILMEE 221

Query: 528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE 562
                T   +  S +         + P+QR+    
Sbjct: 222 IRFPRTLSPEAKSLL----AGLLKKDPKQRLGGGP 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (314), Expect = 3e-32
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 17/206 (8%)

Query: 300 IGRGGFGSVYKAR-IQDGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIIS 355
           +G G FG V   +  + G   A+K+ D Q     +  +    E  +++ +    ++K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 356 SCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 415
           S   +    +V+EY+  G +   L                  +    EYLH   S+ +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIY 164

Query: 416 CDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNG 475
            DLKP N+L+D      ++DFG AK +     +L       T   +APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAV 219

Query: 476 DVYSFGIMLMETFTRKKPTDEIFFGD 501
           D ++ G+++ E      P    FF D
Sbjct: 220 DWWALGVLIYEMAAGYPP----FFAD 241

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 61/321 (19%), Positives = 119/321 (37%), Gaps = 37/321 (11%)

Query: 267 LPNDANMPRISNQRRFTYLEI-FQATNGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVF 324
           +  D N  R      +    + +   + +     +GRG +  V++A  I +  +V VK+ 
Sbjct: 9   VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68

Query: 325 DLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFK--ALVLEYMPHGSLEKCLYS 381
                +  K    E  +++ +R   NII +         +  ALV E++ +   ++   +
Sbjct: 69  KPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 125

Query: 382 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAK 440
               L  +     M ++  AL+Y H   S+ I+H D+KP NV++D ++    L D+G+A+
Sbjct: 126 ----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178

Query: 441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFF 499
                         +A+  +  PE   + Q    + D++S G ML     RK+P      
Sbjct: 179 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235

Query: 500 GDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF---------------- 543
               L      L    + + +D   +          G+     +                
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295

Query: 544 -NLAMKCTVESPEQRINAKEI 563
            +   K      + R+ A+E 
Sbjct: 296 LDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-30
 Identities = 58/303 (19%), Positives = 107/303 (35%), Gaps = 29/303 (9%)

Query: 282 FTYLEIFQATNGFSEN----NLIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKS 334
           F   E+ +      E     + +G G +GSV  A   + G+ VAVK     +      K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 335 FDIECDMIKRIRHRNIIKIISSCSSD----DFKALVLEYMPHGSLEKCLYSSNYILDIFQ 390
              E  ++K ++H N+I ++   +      +F  + L     G+    +      L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 391 RLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 450
              ++  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+    E     
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179

Query: 451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP---------TDEIFFGD 501
            T                   +   D++S G ++ E  T +              I    
Sbjct: 180 AT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 502 MTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIF-NLAMKCTVESPEQRINA 560
            T    +   +          +L      +F       + +  +L  K  V   ++RI A
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

Query: 561 KEI 563
            + 
Sbjct: 296 AQA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 6e-30
 Identities = 56/274 (20%), Positives = 104/274 (37%), Gaps = 33/274 (12%)

Query: 298 NLIGRGGFGSVYKAR----IQDGMEVAVKVFD----LQYGRAFKSFDIECDMIKRIRHR- 348
            ++G G +G V+  R       G   A+KV      +Q  +  +    E  +++ IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 349 NIIKIISSCSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 408
            ++ +  +  ++    L+L+Y+  G L   L         F    + I V   +  L   
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 409 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGRE 468
           + + II+ D+K  N+LLD N    L+DFG++K  + ++          TI YMAP+  R 
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRG 204

Query: 469 GQVSTNG--DVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS 526
           G    +   D +S G+++ E  T   P    F  D                         
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASP----FTVD-------------GEKNSQAEISRR 247

Query: 527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINA 560
                     +  +   +L  +  ++ P++R+  
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (287), Expect = 1e-28
 Identities = 60/295 (20%), Positives = 104/295 (35%), Gaps = 40/295 (13%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIIS 355
            IG G  G V  A        VA+K     +      K    E  ++K + H+NII +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 356 SCSSDDFK------ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 409
             +            LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 410 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREG 469
           S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE     
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 470 QVSTNGDVYSFGIMLMETFTRKKP---------------------TDEIFFGDMTLKHWV 508
               N D++S G ++ E    K                        + +     T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 509 NDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEI 563
            +    + +        S             S   +L  K  V  P +RI+  + 
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 1e-27
 Identities = 49/309 (15%), Positives = 101/309 (32%), Gaps = 47/309 (15%)

Query: 299 LIGRGGFGSVYKAR-IQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSC 357
            +G G F +V+ A+ + +   VA+K+         ++ + E  +++R+   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 358 SSDDFK---------------ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 402
           ++   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 403 EYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 461
           +Y+H      IIH D+KP NVL++  +   +L    +A            T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 462 APEYGREGQVSTNGDVYSFGIMLMETFTRKKP---------------------------T 494
           +PE           D++S   ++ E  T                               +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 495 DEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESP 554
             +  G  T   + +  L  ++ ++    L     E +         I +         P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 555 EQRINAKEI 563
            +R +A  +
Sbjct: 317 RKRADAGGL 325

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.1 bits (235), Expect = 1e-21
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 17/191 (8%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
            N ++   P+ +     L  LSL  NQL+      L  L  L +LD   N++    P   
Sbjct: 206 NNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSN----FLLIGNLKVLVQVDLSMNN 116
             LT L  L LG+N++++I   L  L  +  L+L+ N       I NLK L  + L  NN
Sbjct: 260 SGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL 176
            SD+ P  +  L  LQ LF   N++      S+ +L N+  L+  +N +S   P++   L
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NL 372

Query: 177 LDLKDINVSFN 187
             +  + ++  
Sbjct: 373 TRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 80.8 bits (198), Expect = 5e-17
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 11/184 (5%)

Query: 13  GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG 72
            KL  L+ L   +NQ+    P  +     L EL   GN+L         +LTNL +L L 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 73  SNKLTSIPSTLWNLKDILYLDLSSNFL--LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKD 130
           +N+++++   L  L  +  L L +N +  +     +    +L +N       + I  LK+
Sbjct: 250 NNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308

Query: 131 LQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 190
           L YL L +N +    P  +  L  L+ L  +NN +S     SL  L ++  ++   N++ 
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364

Query: 191 GEIP 194
              P
Sbjct: 365 DLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 9e-07
 Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 5/78 (6%)

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
            L   ++  L   N +D +  +   L  +  L  +   ++ SI D +  L NL  +N SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75

Query: 163 NNLSGTIPIS-LEKLLDL 179
           N L+   P+  L KL+D+
Sbjct: 76  NQLTDITPLKNLTKLVDI 93

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 7e-05
 Identities = 40/230 (17%), Positives = 72/230 (31%), Gaps = 52/230 (22%)

Query: 12  VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSG----------------------- 48
           V  L  L  ++  +NQL    P  L  L  L ++                          
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 49  ---------------------GNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLK 87
                                 N +               +       L  + +     +
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 88  DILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPD 147
             +  +  S+  ++  L  L  +  + N  SD+ P  I    +L  L L  N+L+     
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235

Query: 148 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKG 197
           ++  L NL  L+L+NN +S   P+S   L  L ++ +  N++    P  G
Sbjct: 236 TLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAG 283

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 15/78 (19%), Positives = 27/78 (34%), Gaps = 7/78 (8%)

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNF 117
            L       LG   +T    +  +L  +  L      +     +  L  L Q++ S N  
Sbjct: 20  ALAEKMKTVLGKTNVTDTV-SQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQL 78

Query: 118 SDVIPTTIGGLKDLQYLF 135
           +D+ P  +  L  L  + 
Sbjct: 79  TDITP--LKNLTKLVDIL 94

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 18/82 (21%), Positives = 33/82 (40%), Gaps = 7/82 (8%)

Query: 15 LQKLQLLSLEDNQLEGSIP-DDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGS 73
          L +     L    +  ++   DL ++  L     G   +DG        L NL  +   +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFSN 75

Query: 74 NKLTSIPSTLWNLKDILYLDLS 95
          N+LT I   L NL  ++ + ++
Sbjct: 76 NQLTDITP-LKNLTKLVDILMN 96

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 2e-20
 Identities = 23/159 (14%), Positives = 51/159 (32%), Gaps = 26/159 (16%)

Query: 298 NLIGRGGFGSVYKARIQDGMEVAVKVFDL----------QYGRAFKSFDIECDMIKRIRH 347
            L+G G   +V+    +   E  VK   +          +       F +      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 348 RNIIKIISSCSSDDF----KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE 403
           R + K+        +     A+++E +    L +          +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 404 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 442
             +      I+H DL   NVL+ +  +  + DF  +  +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.8 bits (216), Expect = 1e-19
 Identities = 45/207 (21%), Positives = 77/207 (37%), Gaps = 9/207 (4%)

Query: 18  LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT 77
             LL L++N++      D   L  L  L    NK+    P  F  L  L  LYL  N+L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 78  SIPSTLWNLKDILY------LDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDL 131
            +P  +      L         +  +     N  ++V++  +    S +      G+K L
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152

Query: 132 QYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG 191
            Y+ +    +  +IP  +    +L  L+L  N ++     SL+ L +L  + +SFN +  
Sbjct: 153 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209

Query: 192 EIPNKGPFRNFSTESFEGNELLCGMPN 218
                        E    N  L  +P 
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 68.1 bits (165), Expect = 4e-13
 Identities = 45/224 (20%), Positives = 83/224 (37%), Gaps = 38/224 (16%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           N ++   P A   L KL+ L L  NQL+  +P+ + +     EL    N++     + F 
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTL--QELRVHENEITKVRKSVFN 121

Query: 62  NLTNLRNLYLGSNKLTS---IPSTLWNLKDILYLDLSSNFLLI---GNLKVLVQVDLSMN 115
            L  +  + LG+N L S          +K + Y+ ++   +     G    L ++ L  N
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGN 181

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSI-----------------------PDSIGDL 152
             + V   ++ GL +L  L L +N +                           P  + D 
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241

Query: 153 INLKSLNLSNNNLSG------TIPISLEKLLDLKDINVSFNKLE 190
             ++ + L NNN+S         P    K      +++  N ++
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.1 bits (139), Expect = 7e-10
 Identities = 30/180 (16%), Positives = 52/180 (28%), Gaps = 21/180 (11%)

Query: 57  PACFGNLT-NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMN 115
           P C      +LR +      L  +P  L                   +  +L   DL  N
Sbjct: 2   PVCPFRCQCHLRVVQCSDLGLEKVPKDLPP-----------------DTALL---DLQNN 41

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK 175
             +++       LK+L  L L  N++    P +   L+ L+ L LS N L        + 
Sbjct: 42  KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 101

Query: 176 LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCRTRIHHTSRKN 235
           L +L+       K+   + N               +             +      +  N
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.2 bits (134), Expect = 3e-09
 Identities = 33/158 (20%), Positives = 54/158 (34%), Gaps = 14/158 (8%)

Query: 5   NGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLT 64
                I  G    L  L L+ N++       L  L  L +L    N +         N  
Sbjct: 160 TNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219

Query: 65  NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTT 124
           +LR L+L +NKL  +P  L + K I  + L +N +            +  N+F    P  
Sbjct: 220 HLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI----------SAIGSNDFCP--PGY 267

Query: 125 IGGLKDLQYLFLEYNRLQGS--IPDSIGDLINLKSLNL 160
                    + L  N +Q     P +   +    ++ L
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.2 bits (183), Expect = 2e-15
 Identities = 60/257 (23%), Positives = 92/257 (35%), Gaps = 36/257 (14%)

Query: 1   GNNLNGSIPI--AVGKLQKLQLLSLEDN-QLEGSIPDDLCRLAALFELDSGGNKLDGFVP 57
           G NL    PI  ++  L  L  L +     L G IP  + +L  L  L      + G +P
Sbjct: 59  GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118

Query: 58  ACFGNLTNLRNLYLGSNKLTSI-PSTLWNLKDILYLDLSSNFLL------IGNLKVLVQV 110
                +  L  L    N L+   P ++ +L +++ +    N +        G+   L   
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178

Query: 111 DLSMNN-----------------------FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPD 147
                N                         +   + + G                    
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 148 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESF 207
            +G   NL  L+L NN + GT+P  L +L  L  +NVSFN L GEIP  G  + F   ++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298

Query: 208 EGNELLCGMPNLQVPPC 224
             N+ LCG P   +P C
Sbjct: 299 ANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 41.3 bits (95), Expect = 2e-04
 Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 44  ELDSGGNKLDGF--VPACFGNLTNLRNLYLGS--NKLTSIPSTLWNLKDILYLDLSSNFL 99
            LD  G  L     +P+   NL  L  LY+G   N +  IP  +  L  + YL ++   +
Sbjct: 54  NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113

Query: 100 LIGN------LKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI 153
                     +K LV +D S N  S  +P +I  L +L  +  + NR+ G+IPDS G   
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173

Query: 154 NLKSLNLSNNN 164
            L +    + N
Sbjct: 174 KLFTSMTISRN 184

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 40.5 bits (93), Expect = 4e-04
 Identities = 37/122 (30%), Positives = 53/122 (43%), Gaps = 10/122 (8%)

Query: 61  GNLTNLRNLYLGSNKLT---SIPSTLWNLKDILYLDLSSNFLLIGNL-------KVLVQV 110
                + NL L    L     IPS+L NL  + +L +     L+G +         L  +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIP 170
            ++  N S  IP  +  +K L  L   YN L G++P SI  L NL  +    N +SG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 171 IS 172
            S
Sbjct: 167 DS 168

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 1e-13
 Identities = 51/197 (25%), Positives = 79/197 (40%), Gaps = 11/197 (5%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
             L    P     L +L  L L+   L+   P     LAAL  L    N L       F 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 62  NLTNLRNLYLGSNKLTSIP-STLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
           +L NL +L+L  N+++S+P      L  +  L L  N +         +L  L+ + L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
           NN S +    +  L+ LQYL L  N        +      L+    S++ +  ++P  L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRL- 268

Query: 175 KLLDLKDINVSFNKLEG 191
              DLK +  + N L+G
Sbjct: 269 AGRDLKRL--AANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.1 bits (136), Expect = 1e-09
 Identities = 47/217 (21%), Positives = 69/217 (31%), Gaps = 11/217 (5%)

Query: 7   SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNL 66
           ++P+ +      Q + L  N++             L  L    N L     A F  L  L
Sbjct: 25  AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 67  RNLYLGSNKLTS--IPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFS 118
             L L  N       P+T   L  +  L L    L      L   L  L  + L  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 119 DVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD 178
            +   T   L +L +LFL  NR+      +   L +L  L L  N ++   P +   L  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 179 LKDINVSFN-KLEGEIPNKGPFRNFSTESFEGNELLC 214
           L  + +  N           P R         N  +C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 2e-09
 Identities = 57/225 (25%), Positives = 82/225 (36%), Gaps = 8/225 (3%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFV-PAC 59
           GN ++     +    + L +L L  N L          LA L +LD   N     V PA 
Sbjct: 41  GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPAT 100

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYL-DLSSNFL------LIGNLKVLVQVDL 112
           F  L  L  L+L    L  +   L+     L    L  N L         +L  L  + L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
             N  S V      GL  L  L L  NR+    P +  DL  L +L L  NNLS     +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220

Query: 173 LEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP 217
           L  L  L+ + ++ N    +   +  +          +E+ C +P
Sbjct: 221 LAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 27/146 (18%), Positives = 46/146 (31%), Gaps = 9/146 (6%)

Query: 57  PACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVLVQV 110
            AC                L ++P  +        + L  N +           + L  +
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 111 DLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLNLSNNNLSGTI 169
            L  N  + +      GL  L+ L L  N    S+ P +   L  L +L+L    L    
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 170 PISLEKLLDLKDINVSFNKLEGEIPN 195
           P     L  L+ + +  N L+    +
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDD 147

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 58.3 bits (139), Expect = 9e-10
 Identities = 21/88 (23%), Positives = 34/88 (38%), Gaps = 12/88 (13%)

Query: 50  NKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNL 104
           N     + +      +L  L + +NKL  +P+    L+    L  S N L     L  NL
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAEVPELPQNL 326

Query: 105 KVLVQVDLSMNNFSDVIPTTIGGLKDLQ 132
           K L    +  N   +  P     ++DL+
Sbjct: 327 KQL---HVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.5 bits (124), Expect = 6e-08
 Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 12/97 (12%)

Query: 84  WNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQG 143
               +    ++ S   L  +L+ L   ++S N   + +P     L   + L   +N L  
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEEL---NVSNNKLIE-LPALPPRL---ERLIASFNHLA- 317

Query: 144 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLK 180
            +P+      NLK L++  N L    P   E + DL+
Sbjct: 318 EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 8e-08
 Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 9/92 (9%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           N  +  I         L+ L++ +N+L   +P    RL     L +  N L   VP    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL-AEVPEL-- 322

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLD 93
              NL+ L++  N L   P    +++D L ++
Sbjct: 323 -PQNLKQLHVEYNPLREFPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 13/93 (13%)

Query: 135 FLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 194
               N     I        +L+ LN+SNN L   +P    +   L+ +  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 195 NKGPFRNFSTESFEGN------ELLCGMPNLQV 221
                +N      E N      ++   + +L++
Sbjct: 321 EL--PQNLKQLHVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 8/63 (12%)

Query: 129 KDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK 188
           +    L L    L  S+P+      +L+SL  S N+L+  +P   E    LK + V  N 
Sbjct: 38  RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP---ELPQSLKSLLVDNNN 89

Query: 189 LEG 191
           L+ 
Sbjct: 90  LKA 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 14/63 (22%), Positives = 22/63 (34%), Gaps = 4/63 (6%)

Query: 37 CRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSS 96
          C      EL+     L            +L +L    N LT +P    +LK +L  + + 
Sbjct: 35 CLDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSLTELPELPQSLKSLLVDNNNL 90

Query: 97 NFL 99
            L
Sbjct: 91 KAL 93

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.0 bits (129), Expect = 1e-09
 Identities = 32/107 (29%), Positives = 43/107 (40%), Gaps = 9/107 (8%)

Query: 67  RNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL-----LIGNLKVLVQVDLSMNNFSDVI 121
           R L+L    LT +   L  L  + +LDLS N L      +  L+ L  +  S N   +V 
Sbjct: 1   RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 122 PTTIGGLKDLQYLFLEYNRLQG-SIPDSIGDLINLKSLNLSNNNLSG 167
                    LQ L L  NRLQ  +    +     L  LNL  N+L  
Sbjct: 60  GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.2 bits (114), Expect = 2e-07
 Identities = 26/116 (22%), Positives = 39/116 (33%), Gaps = 8/116 (6%)

Query: 45  LDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL---- 100
           L      L   V      L  + +L L  N+L ++P  L  L+ +  L  S N L     
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 101 IGNLKVLVQVDLSMNNFSDV-IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINL 155
           + NL  L ++ L  N          +     L  L L+ N L          L  +
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 1e-04
 Identities = 21/105 (20%), Positives = 35/105 (33%), Gaps = 27/105 (25%)

Query: 19  QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNL------------ 66
           ++L L    L  ++   L +L  +  LD   N+L    P     L  L            
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 67  ----------RNLYLGSNKLTSIP--STLWNLKDILYLDLSSNFL 99
                     + L L +N+L        L +   ++ L+L  N L
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 1e-04
 Identities = 21/112 (18%), Positives = 33/112 (29%), Gaps = 24/112 (21%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIP---------------------DDLCRL 39
             +L  ++   + +L  +  L L  N+L    P                     D +  L
Sbjct: 7   HKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL 64

Query: 40  AALFELDSGGNKLDGF-VPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDIL 90
             L EL    N+L          +   L  L L  N L         L ++L
Sbjct: 65  PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 1e-08
 Identities = 48/195 (24%), Positives = 70/195 (35%), Gaps = 12/195 (6%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACF 60
             NL  ++P  + K     +L L +N L       L     L +L+    +         
Sbjct: 19  KRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVD 73

Query: 61  GNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL------IGNLKVLVQVDLSM 114
           G L  L  L L  N+L S+P     L  +  LD+S N L       +  L  L ++ L  
Sbjct: 74  GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133

Query: 115 NNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE 174
           N    + P  +     L+ L L  N L       +  L NL +L L  N+L  TIP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 175 KLLDLKDINVSFNKL 189
               L    +  N  
Sbjct: 193 GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 1e-06
 Identities = 13/64 (20%), Positives = 23/64 (35%), Gaps = 3/64 (4%)

Query: 101 IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNL 160
           +  +   ++V+    N +  +P  +   KD   L L  N L      ++     L  LNL
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 161 SNNN 164
               
Sbjct: 63  DRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 1e-06
 Identities = 52/207 (25%), Positives = 80/207 (38%), Gaps = 7/207 (3%)

Query: 12  VGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYL 71
           V K+     ++ +   L  ++P DL +      L    N L  F  A     T L  L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 72  GSNKLTSIPSTLW----NLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGG 127
              +LT +            D+ +  L S  LL   L  L  +D+S N  + +    + G
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 128 LKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 187
           L +LQ L+L+ N L+   P  +     L+ L+L+NNNL+      L  L +L  + +  N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 188 KLEGEIPNKGPFRNFSTESFEGNELLC 214
            L                   GN  LC
Sbjct: 183 SLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 7e-04
 Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 3/62 (4%)

Query: 124 TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDIN 183
            +  +     +  +   L  ++P  +    +   L+LS N L      +L     L  +N
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 184 VS 185
           + 
Sbjct: 62  LD 63

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 50.2 bits (118), Expect = 1e-07
 Identities = 39/158 (24%), Positives = 59/158 (37%), Gaps = 9/158 (5%)

Query: 67  RNLYLGSNKLTSIPSTLWNLKDILYLDLSSN-------FLLIGNLKVLVQVDLSMNNFSD 119
             +      L  IP  +        L L+ N         L G L  LV+++L  N  + 
Sbjct: 11  TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 120 VIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL 179
           + P    G   +Q L L  N+++         L  LK+LNL +N +S  +P S E L  L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 180 KDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP 217
             +N++ N                 +S  G    CG P
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (116), Expect = 2e-07
 Identities = 30/153 (19%), Positives = 55/153 (35%), Gaps = 7/153 (4%)

Query: 71  LGSNKLTSIPSTLWNLKD--ILYLDLSSNFLL--IGNLKVLVQVDLSMNNFSDVIPTTIG 126
           L   ++  +   +    D     LDL        +    + V ++   ++ +  +     
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEE 62

Query: 127 GLKDLQYLFLEYNRLQG--SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINV 184
            + +L  L L  NRL     +   +    NLK LNLS N L     +   K L L+++ +
Sbjct: 63  NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122

Query: 185 SFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP 217
             N L     ++  + +   E F     L G  
Sbjct: 123 DGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 2e-07
 Identities = 16/80 (20%), Positives = 29/80 (36%), Gaps = 8/80 (10%)

Query: 103 NLKVLVQVDLSMNNFSDV-IPTTIGGLKDLQYLFLEYNRLQG----SIPDSIGDLINLKS 157
           +++ L   D+     SD      +  L+  Q + L+   L       I  ++     L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 158 LNLSNNNLSGTIPISLEKLL 177
           LNL +N L       + + L
Sbjct: 60  LNLRSNELGDVGVHCVLQGL 79

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 12/87 (13%)

Query: 103 NLKVLVQVDLSMNNFSDV----IPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLI----- 153
            L+VL    L+  + SD     +  T+     L+ L L  N L  +    + + +     
Sbjct: 370 VLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 154 NLKSLNLSNNNLSGTIPISLEKLLDLK 180
            L+ L L +   S  +   L+ L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 2e-06
 Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 11/91 (12%)

Query: 88  DILYLDLSSNFL-------LIGNLKVLVQVDLSMNNFSDV----IPTTIGGLKDLQYLFL 136
           DI  LD+    L       L+  L+    V L     ++     I + +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 137 EYNRLQGSIPDSIGDLINLKSLNLSNNNLSG 167
             N L       +   +   S  +   +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 3e-05
 Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 16/89 (17%)

Query: 57  PACFGNLTNLRNLYLGSNKLT-----SIPSTLWNLKDILYLDLSSNFL-----------L 100
                  + LR L+L    ++     S+ +TL     +  LDLS+N L           +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 101 IGNLKVLVQVDLSMNNFSDVIPTTIGGLK 129
                +L Q+ L    +S+ +   +  L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 4e-05
 Identities = 14/74 (18%), Positives = 31/74 (41%), Gaps = 9/74 (12%)

Query: 131 LQYLFLEYNRLQG----SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD-----LKD 181
           L+ L+L    +      S+  ++    +L+ L+LSNN L     + L + +      L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 182 INVSFNKLEGEIPN 195
           + +       E+ +
Sbjct: 431 LVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 16/64 (25%), Positives = 22/64 (34%), Gaps = 6/64 (9%)

Query: 42 LFELDSGGNKL-DGFVPACFGNLTNLRNLYLGSNKLT-----SIPSTLWNLKDILYLDLS 95
          +  LD    +L D         L   + + L    LT      I S L     +  L+L 
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 96 SNFL 99
          SN L
Sbjct: 64 SNEL 67

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (108), Expect = 2e-06
 Identities = 26/132 (19%), Positives = 45/132 (34%), Gaps = 8/132 (6%)

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMN 115
           + N    R L L   K+  I +    L     +D S N +        L+ L  + ++ N
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNN 73

Query: 116 NFSDVIPTTIGGLKDLQYLFLEYNRLQG-SIPDSIGDLINLKSLNLSNNN---LSGTIPI 171
               +       L DL  L L  N L      D +  L +L  L +  N           
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 172 SLEKLLDLKDIN 183
            + K+  ++ ++
Sbjct: 134 VIYKVPQVRVLD 145

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 5e-06
 Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)

Query: 101 IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNL 160
           + NL  L  +    N  SD+ P  +  L +L  + L+ N++    P  + +  NL  + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 161 SN 162
           +N
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 6e-05
 Identities = 16/65 (24%), Positives = 31/65 (47%), Gaps = 3/65 (4%)

Query: 31  SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDIL 90
           S    L  L+ L  L +  NK+    P    +L NL  ++L +N+++ +   L N  ++ 
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLF 220

Query: 91  YLDLS 95
            + L+
Sbjct: 221 IVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 18/73 (24%), Positives = 31/73 (42%), Gaps = 4/73 (5%)

Query: 113 SMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS 172
           S+ N      T +  L  L  L  + N++    P  +  L NL  ++L NN +S   P  
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212

Query: 173 LEKLLDLKDINVS 185
           L    +L  + ++
Sbjct: 213 LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 31/201 (15%), Positives = 65/201 (32%), Gaps = 27/201 (13%)

Query: 15  LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN 74
           L     ++   + +  ++      L  +  L + G  +          L NL  L L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 75  KLTSIPST---------------------LWNLKDILYLDLSSNFLLIGNLKVLVQVDLS 113
           ++T +                        +  L+ I  LDL+S  +        +     
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 114 MNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISL 173
           +    + I             +L     Q S    + +L  L +L   +N +S   P++ 
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA- 192

Query: 174 EKLLDLKDINVSFNKLEGEIP 194
             L +L ++++  N++    P
Sbjct: 193 -SLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 14/68 (20%), Positives = 29/68 (42%), Gaps = 5/68 (7%)

Query: 32 IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILY 91
           PD    LA   ++ +G + +   V     +L  +  L      +T+I   +  L +++ 
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG-VQYLNNLIG 67

Query: 92 LDLSSNFL 99
          L+L  N +
Sbjct: 68 LELKDNQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 21/79 (26%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFS 118
              NL+ L  L    NK++ I                     + +L  L++V L  N  S
Sbjct: 168 PLANLSKLTTLKADDNKISDISP-------------------LASLPNLIEVHLKNNQIS 208

Query: 119 DVIPTTIGGLKDLQYLFLE 137
           DV P  +    +L  + L 
Sbjct: 209 DVSP--LANTSNLFIVTLT 225

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 1e-05
 Identities = 28/165 (16%), Positives = 50/165 (30%), Gaps = 25/165 (15%)

Query: 64  TNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLL-------IGNLKVLVQVDLSMNN 116
                L    +        L   +++  L + +   L       +  L  L  + +  + 
Sbjct: 8   HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 117 FSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEK 175
              V P        L  L L +N L+ S+       ++L+ L LS N L  +  +  L++
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 176 LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQ 220
             +     V   KL+                      L  MPN  
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGP----------------LAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.5 bits (98), Expect = 3e-05
 Identities = 22/132 (16%), Positives = 43/132 (32%), Gaps = 2/132 (1%)

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNL 165
              +  + +   D     + G ++L  L++E  +    +    +  L  L++L +  + L
Sbjct: 10  SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 166 SGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMPNLQVPPCR 225
               P +      L  +N+SFN LE          +       GN L C      +    
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 226 TRIHHTSRKNDL 237
                   +  L
Sbjct: 129 EEGLGGVPEQKL 140

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 7e-05
 Identities = 14/37 (37%), Positives = 22/37 (59%), Gaps = 1/37 (2%)

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSS 96
              LT L+NLYL  N ++ + + L  LK++  L+L S
Sbjct: 174 LAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 12/70 (17%), Positives = 28/70 (40%), Gaps = 4/70 (5%)

Query: 103 NLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
                ++ +L   + +D +  T   L  +  +    + ++      I  L N+  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 163 NNLSGTIPIS 172
           N L+   P++
Sbjct: 78  NKLTDIKPLA 87

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 9/184 (4%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
            ++  ++     +L  +  +   ++ ++      +  L  + +L   GNKL         
Sbjct: 34  KSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK--PLA 87

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI 121
           NL NL  L+L  NK+  + S     K        +    I  L  L Q++      + + 
Sbjct: 88  NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT 147

Query: 122 PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKD 181
             T+             +     I   +  L  L++L LS N++S  +  +L  L +L  
Sbjct: 148 DITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDV 204

Query: 182 INVS 185
           + + 
Sbjct: 205 LELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 30/163 (18%), Positives = 53/163 (32%), Gaps = 9/163 (5%)

Query: 2   NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFG 61
           NN +      +  L  +  L L  N+L          LA L  L       +        
Sbjct: 54  NNSDIKSVQGIQYLPNVTKLFLNGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSL 108

Query: 62  NLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVI 121
                       +   S  + L +L  +  L L +N +    +   +    +++   + I
Sbjct: 109 KDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168

Query: 122 PT--TIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN 162
                + GL  LQ L+L  N +      ++  L NL  L L +
Sbjct: 169 SDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 22/126 (17%), Positives = 43/126 (34%), Gaps = 14/126 (11%)

Query: 45  LDSGGNKLDGFVPACFGNLT--NLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL--- 99
           LD  G  L    P   G L    +       + +    +  ++   + ++DLS++ +   
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 100 ----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLE--YNRLQGSIPDSIGDLI 153
               ++     L  + L     SD I  T+    +L  L L       + ++   +    
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 154 NLKSLN 159
            L  LN
Sbjct: 122 RLDELN 127

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 3e-04
 Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 5/88 (5%)

Query: 110 VDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNLSG- 167
           +DL+  N     P   G L     +     R     P         ++ ++LSN+ +   
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 168 TIPISLEKLLDLKDINVSFNKLEGEIPN 195
           T+   L +   L+++++   +L   I N
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVN 89

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 6e-04
 Identities = 33/222 (14%), Positives = 63/222 (28%), Gaps = 42/222 (18%)

Query: 1   GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG-SIPDDLCRLAALFELDSGGNKLDGFVPAC 59
             +             ++Q + L ++ +E  ++   L + + L  L   G +L   +   
Sbjct: 31  PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90

Query: 60  FGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSM----- 114
               +NL  L L      S  +    L     LD  +        +  VQV ++      
Sbjct: 91  LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150

Query: 115 -----------------------------------NNFSDVIPTTIGGLKDLQYLFLEY- 138
                                                  +        L  LQ+L L   
Sbjct: 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210

Query: 139 NRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLK 180
             +       +G++  LK+L +      GT+ +  E L  L+
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 2e-04
 Identities = 9/40 (22%), Positives = 16/40 (40%), Gaps = 1/40 (2%)

Query: 59  CFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLSSN 97
            F   +    L +   ++ S+PS  L NLK +      + 
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 2e-04
 Identities = 11/68 (16%), Positives = 22/68 (32%), Gaps = 4/68 (5%)

Query: 107 LVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS 166
                   NN  ++      G      L +   R+       + +L  L++ +  N    
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL--- 235

Query: 167 GTIPISLE 174
             +P +LE
Sbjct: 236 KKLP-TLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 9/50 (18%), Positives = 14/50 (28%), Gaps = 2/50 (4%)

Query: 32  IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS 81
             D     +    LD    ++         NL  LR        L  +P+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (84), Expect = 0.003
 Identities = 9/51 (17%), Positives = 16/51 (31%), Gaps = 3/51 (5%)

Query: 145 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN 195
             D          L++S   +       LE L  L+  +    K   ++P 
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 14/82 (17%), Positives = 29/82 (35%), Gaps = 13/82 (15%)

Query: 112 LSMNNFSDVIPTTIG------GLKDLQYLFLEYNRLQGSIPDSIGDLI-----NLKSLNL 160
           L+    S      +           LQ L L+YN ++     ++  +I     +L  L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 161 SNNNLS--GTIPISLEKLLDLK 180
           + N  S    +   + ++   +
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 10/79 (12%), Positives = 23/79 (29%), Gaps = 11/79 (13%)

Query: 23  LEDNQLEGSIPDDL------CRLAALFELDSGGNKLDG-----FVPACFGNLTNLRNLYL 71
           L D  L       +           L  L    N+++              + +L  L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 72  GSNKLTSIPSTLWNLKDIL 90
             N+ +     +  ++++ 
Sbjct: 310 NGNRFSEEDDVVDEIREVF 328

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 18/90 (20%), Positives = 31/90 (34%), Gaps = 11/90 (12%)

Query: 132 QYLFLEYNRLQGSIPDSIGD------LINLKSLNLSNNNLSGTIPISL-----EKLLDLK 180
           + L L    L      ++ D       I L++L L  N +      +L     EK+ DL 
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305

Query: 181 DINVSFNKLEGEIPNKGPFRNFSTESFEGN 210
            + ++ N+   E       R   +    G 
Sbjct: 306 FLELNGNRFSEEDDVVDEIREVFSTRGRGE 335

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	580
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.91
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.89
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.86
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.81
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.77
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.72
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.65
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.62
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.62
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.6
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.57
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.53
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.48
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.46
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.45
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.44
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.36
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.35
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.26
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.19
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.77
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.65
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.6
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.6
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.17
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.03
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.01
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.42
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.77

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-55  Score=421.80  Aligned_cols=263  Identities=27%  Similarity=0.429  Sum_probs=209.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeCCCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|.+.+.||+|+||+||+|+++  ..||||+++..  .....+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            367899999999999999999875  46999998644  23456788999999999999999999998764 56899999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++|+|.+++...+..+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999887778999999999999999999999   899999999999999999999999999999876544343


Q ss_pred             ccccccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          449 LTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .......||+.|||||++.+   +.++.++|||||||++|||+||+.||.+..... ....            .+.....
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~------------~~~~~~~  227 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIF------------MVGRGYL  227 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHH------------HHHHTSC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHH------------HHhcCCC
Confidence            34456679999999999864   357899999999999999999999997532111 1111            1111100


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      .  ......+..+++++.+|+.+||+.||++||||+||+++|+.+.+.+
T Consensus       228 ~--p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         228 S--PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             C--CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             C--CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            0  0011223457788999999999999999999999999999887643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=417.69  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=205.2

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|+..+.||+|+||+||+|.+.+++.||||+++... ...+.+.+|++++++++||||++++|+|..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5688889999999999999999888999999986543 345779999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++......+++..++.++.|||+||+|||   +.+|+||||||+|||+++++.+||+|||+|+....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999888788999999999999999999999   89999999999999999999999999999986643322 223


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCC-CCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....||+.|+|||.+.+..++.++|||||||++|||+|++ +|+...     ...+...         .+...      .
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~---------~i~~~------~  219 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVE---------DISTG------F  219 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHH---------HHHHT------C
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHH---------HHHhc------C
Confidence            3456899999999999999999999999999999999954 444331     1111111         11110      1


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      +...+..++.++.+|+.+||+.||++||||+||+++|+++.+
T Consensus       220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            112234567889999999999999999999999999999865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=415.44  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=208.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56889999999999999999875 79999999996543 23456789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +++|+|.+++... ..+++..+..++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.......
T Consensus        85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999998654 46999999999999999999999   9999999999999999999999999999999765444333


Q ss_pred             cccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||............+...                  
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~------------------  222 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------------  222 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT------------------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------------
Confidence            4456789999999999988776 678999999999999999999997643222212111110                  


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .........++.++.+|+.+||+.||++|||++|+++|
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00112234566788999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=413.52  Aligned_cols=250  Identities=26%  Similarity=0.342  Sum_probs=211.4

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999986 479999999998765556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999987654  4899999999999999999999   8999999999999999999999999999998764332  23


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....||+.|+|||.+.+..++.++||||+||++|||+||+.||......+ .+..            +...     ...
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~------------~~~~-----~~~  234 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYL------------IATN-----GTP  234 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH------------HHHH-----CSC
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHH------------HHhC-----CCC
Confidence            345679999999999999999999999999999999999999996521100 0000            1100     011


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223345677889999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-53  Score=418.17  Aligned_cols=259  Identities=23%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC---EEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM---EVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      +.|++.++||+|+||+||+|.++ +|+   .||||.+.... ....+.+.+|++++++++|||||+++|++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34556689999999999999875 333   58889876443 33456799999999999999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++......+++.+++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887778999999999999999999999   8999999999999999999999999999998764432


Q ss_pred             Ccc---cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          447 QSL---TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       447 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ...   ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....  .....            .+..
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~------------~i~~  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVIN------------AIEQ  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH------------HHHT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHH------------HHHc
Confidence            221   1223457899999999999999999999999999999998 8999865311  11111            1111


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                            ..+.+.+..++.++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus       249 ------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 ------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                  112233456788899999999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=406.81  Aligned_cols=254  Identities=21%  Similarity=0.377  Sum_probs=216.6

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|+..+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6789999999999999999999988899999997543 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcccc
Q 038098          372 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  451 (580)
Q Consensus       372 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  451 (580)
                      +|+|.+++......+++..+++++.||++||+|||   +.+|+||||||+||++++++.+||+|||+|+....... ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence            99999998888788999999999999999999999   89999999999999999999999999999987644332 234


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....+|..|+|||.+.+..++.++|||||||++|||+| |+.||.....     .+...         .+..      ..
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~~~~---------~i~~------~~  218 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAE---------HIAQ------GL  218 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHH---------HHHT------TC
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HHHHH---------HHHh------CC
Confidence            45679999999999999999999999999999999998 8999875321     11111         0111      01


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                      +...+..++.++.+|+.+||+.||++|||++|++++|.++
T Consensus       219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1223445678899999999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=415.09  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=211.6

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45888999999999999999865 68999999998766667788999999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      ++|+|.+++...+..+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998776677999999999999999999999   999999999999999999999999999999754221  112


Q ss_pred             ccccccCCCcCCccccc-----CCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          451 QTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .....||+.|+|||++.     ...++.++||||+||++|||+||+.||.+....+ .+..            +..    
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~------------i~~----  229 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLK------------IAK----  229 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHH------------HHH----
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHH------------HHc----
Confidence            34567999999999874     4567899999999999999999999997532111 1111            111    


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      . .......+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       230 ~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         230 S-EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             S-CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C-CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0 111223345677889999999999999999999999885

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=409.56  Aligned_cols=256  Identities=22%  Similarity=0.374  Sum_probs=210.1

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            5688889999999999999999888999999996543 345679999999999999999999998865 56789999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +|+|.+++.... ..+++..++.++.||++||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+... ....
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~  166 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTA  166 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEEC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-cccc
Confidence            999999776543 46899999999999999999999   899999999999999999999999999999976433 2223


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....||+.|+|||.+.++.++.++|||||||++|||+||+.|+.....    ..+...         .+..      ..
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~---------~i~~------~~  227 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQ---------NLER------GY  227 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHH---------HHHT------TC
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHH---------HHHh------cC
Confidence            3456789999999999999999999999999999999997665433111    111110         1110      01


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                      +...+..++.++.+|+.+||+.||++||||+||++.|+.+..
T Consensus       228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            122334577889999999999999999999999999998754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=406.76  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=207.8

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++...   .......+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999875 6899999999643   2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999987644 5999999999999999999999   899999999999999999999999999999865322  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.+...     .+....        +..    . 
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~--------i~~----~-  219 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKR--------ISR----V-  219 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--------HHT----T-
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHH--------HHc----C-
Confidence              23345799999999999999999999999999999999999999965211     111110        100    0 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       220 ---~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence               112234567789999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=406.30  Aligned_cols=262  Identities=22%  Similarity=0.375  Sum_probs=215.1

Q ss_pred             cCCCcCce-eccccCceEEEEEeC---CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNL-IGRGGFGSVYKARIQ---DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~-lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|...+. ||+|+||+||+|.++   ++..||||+++.... ...+.+.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            44556664 999999999999764   355799999965433 345789999999999999999999999975 467999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++...+..+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877778999999999999999999999   8999999999999999999999999999999775433


Q ss_pred             Cc-ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          447 QS-LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       447 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .. .......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+...  ......            +..  
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~------------i~~--  227 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAF------------IEQ--  227 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHH------------HHT--
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH------------HHc--
Confidence            22 22334568999999999999999999999999999999998 8999875321  111111            111  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN  577 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~  577 (580)
                          ..+...+..+++++.+|+.+||+.||++||||.+|++.|+.+..++...
T Consensus       228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence                1122334567889999999999999999999999999999887766543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-53  Score=413.03  Aligned_cols=257  Identities=23%  Similarity=0.388  Sum_probs=213.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|+..+.||+|+||+||+|.++ +|+.||||+++... ...+++.+|++++++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            456888899999999999999876 58899999986543 3457799999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          370 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       370 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      +++|+|.+++... ...+++..++.++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+|+...... .
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence            9999999998754 467999999999999999999999   8999999999999999999999999999998664332 2


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .......|++.|+|||.+.++.++.++|||||||++|||++|+.|+...    .....         +.+.+...     
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~~~~~---------~~~~i~~~-----  232 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQ---------VYELLEKD-----  232 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHH---------HHHHHHTT-----
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc----chHHH---------HHHHHhcC-----
Confidence            2334456889999999999999999999999999999999977775331    11111         11111111     


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                       .+...+..++.++.+|+.+||+.||++|||++||++.|+.+.
T Consensus       233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             112234557788999999999999999999999999998764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=405.55  Aligned_cols=260  Identities=26%  Similarity=0.435  Sum_probs=206.1

Q ss_pred             cCCCcCceeccccCceEEEEEeCCC-----CEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDG-----MEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      +.|+..++||+|+||.||+|.+++.     ..||||++..... .....+.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999986532     3699999965433 334578899999999999999999999999999999


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ||||+.+|++.+++......+++.+++.++.||+.|++|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998888788999999999999999999999   899999999999999999999999999999876443


Q ss_pred             CC-cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQ-SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .. ........||+.|+|||.+.++.++.++|||||||++|||+||+.|+.....    ..+.         ...+... 
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~---------~~~i~~~-  229 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEV---------MKAINDG-  229 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH---------HHHHHTT-
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHH---------HHHHhcc-
Confidence            22 2223445689999999999999999999999999999999997666533111    1111         1111111 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                           .+.+.+..++.++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus       230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                 12233455778899999999999999999999999999988753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=404.87  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=194.0

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec--CCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS--DDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  366 (580)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++....  ....+.+.+|++++++++||||+++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999865 78999999996543  2334668899999999999999999999854  4568999


Q ss_pred             eeccCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          367 LEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGY--SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      |||+++|+|.+++..   .+..+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   2357999999999999999999999321  13499999999999999999999999999987


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      +.....  ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.+...     .+...        .+..
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~--------~i~~  228 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAG--------KIRE  228 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH--------HHHH
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHH--------HHHc
Confidence            643222  23456799999999999999999999999999999999999999975311     11111        1111


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...       ...+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~-------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 GKF-------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             TCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            100       11234567789999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=406.39  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=205.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999864 79999999997532   334567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 5999999999999999999999   99999999999999999999999999999997754444


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||.+...     .....        .+..    . 
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~--------~i~~----~-  225 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQ--------KIIK----L-  225 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHT----T-
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHH--------HHHc----C-
Confidence            4444556799999999999999999999999999999999999999975211     11111        1111    0 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                         ....+..+++++.+|+.+||+.||++|||++|++++
T Consensus       226 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence               111234567789999999999999999999997654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=412.09  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             cCCCcCceeccccCceEEEEEeCC-C-----CEEEEEEEecc-ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD-G-----MEVAVKVFDLQ-YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ++|++.+.||+|+||+||+|++.. +     ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            568889999999999999998642 2     26999998543 234456788999999998 899999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCC
Q 038098          364 ALVLEYMPHGSLEKCLYSSN----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPS  421 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~  421 (580)
                      ++||||+++|+|.+++...+                      ..+++..++.++.||++||+|||   +.+|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            99999999999999997653                      34899999999999999999999   899999999999


Q ss_pred             CEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccC
Q 038098          422 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFG  500 (580)
Q Consensus       422 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~  500 (580)
                      ||+++.++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||+| |+.||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987655444444455678999999999999999999999999999999998 89998753211


Q ss_pred             CchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 038098          501 DMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLL  568 (580)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~  568 (580)
                       ..+..            ++...      .+.+.+..++.++.+|+.+||+.||++|||++||+++|.
T Consensus       274 -~~~~~------------~~~~~------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 -ANFYK------------LIQNG------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -HHHHH------------HHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHH------------HHhcC------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence             11111            11111      122334567788999999999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-51  Score=412.55  Aligned_cols=253  Identities=17%  Similarity=0.242  Sum_probs=211.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      -++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999865 7999999999765555567788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC--CCCcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      +++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999777777999999999999999999999   99999999999999996  46789999999998764322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                        ......||+.|||||++.+..++.++||||+||++|||+||+.||.+...     .+...        .+.    ...
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~--------~i~----~~~  241 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLR--------NVK----SCD  241 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHH----HTC
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHH--------HHH----hCC
Confidence              23456799999999999999999999999999999999999999865211     11111        111    111


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........++.++.+|+.+||+.||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111112234567789999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=398.62  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             ceeccccCceEEEEEeC---CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccCC
Q 038098          298 NLIGRGGFGSVYKARIQ---DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMPH  372 (580)
Q Consensus       298 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  372 (580)
                      +.||+|+||+||+|.++   +++.||||+++...  ....+.+.+|++++++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999864   35679999996432  2345679999999999999999999999965 457899999999


Q ss_pred             CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc-cc
Q 038098          373 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQ  451 (580)
Q Consensus       373 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~  451 (580)
                      |+|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....... ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999987654 5999999999999999999999   8999999999999999999999999999998765433322 23


Q ss_pred             cccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          452 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       452 ~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      ....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+...  ....            ..+..      ..
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~------------~~i~~------~~  227 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVT------------AMLEK------GE  227 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH------------HHHHT------TC
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHH------------HHHHc------CC
Confidence            34568999999999999999999999999999999998 8999875311  1111            11111      11


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                      +...+..++.++.+|+.+||+.||++|||+++|++.|+....+...
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  273 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  273 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence            2233456788999999999999999999999999999887665543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-51  Score=405.75  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=193.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .+.|++.+.||+|+||+||+|+.+ +|+.||||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466899999999999999999865 68999999996543 2334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEccccCccccCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~  445 (580)
                      |++||+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            99999999999764 46999999999999999999999   99999999999999994   5789999999999865322


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                      .   ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.+....  ....           .+..    
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~-----------~i~~----  223 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFE-----------QILK----  223 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH-----------HHHT----
T ss_pred             C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHH-----------HHhc----
Confidence            2   233467999999999999999999999999999999999999999652111  1111           0111    


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ............+++++.+|+.+||+.||++|||++|+++|
T Consensus       224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11111112334567889999999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-51  Score=410.63  Aligned_cols=252  Identities=17%  Similarity=0.271  Sum_probs=211.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  370 (580)
                      +.|++.+.||+|+||.||+|... +|+.||||+++.........+.+|++++++++|||||++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999864 79999999997665455567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC--CCCcEEEccccCccccCCCCCc
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      ++|+|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            999999988877778999999999999999999999   99999999999999998  67899999999998764332  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+...     .....        .+.    ....
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~--------~i~----~~~~  245 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQ--------NVK----RCDW  245 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHH--------HHH----HCCC
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHH--------HHH----hCCC
Confidence             23445799999999999999999999999999999999999999965211     01000        010    1111


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .........++.++.+|+.+||+.||++|||++|+++|
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11112234567889999999999999999999999886

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=393.13  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             CcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec----CCceeeEe
Q 038098          295 SENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS----DDFKALVL  367 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  367 (580)
                      +..+.||+|+||+||+|... +++.||+|++....  ....+.+.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999865 68899999986543  2345678899999999999999999999864    34578999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEecCCCCCEEeC-CCCcEEEccccCccccCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  444 (580)
                      ||+++|+|.+++.... .+++..++.++.||++||+|||   +.+  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999987644 5899999999999999999999   777  99999999999996 588999999999985422


Q ss_pred             CCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      .    ......||+.|+|||++.+ .++.++||||+||++|||+||+.||.....    .......         +..  
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~---------i~~--  227 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRR---------VTS--  227 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHH---------HTT--
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHH---------HHc--
Confidence            1    2335679999999998865 699999999999999999999999964211    1111110         000  


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ...  ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       228 -~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         228 -GVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -TCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -CCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence             000  111223456778999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-52  Score=410.15  Aligned_cols=266  Identities=23%  Similarity=0.350  Sum_probs=207.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.++++++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999865 78999999997553 3335678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      |+++|+|.+++...+ .+++..+..++.||+.||.|||   +. +|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999987654 5999999999999999999999   64 8999999999999999999999999999865322  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHH--------------------
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHW--------------------  507 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~--------------------  507 (580)
                        .....+||+.|+|||++.+..++.++||||+||++|||+||+.||.............                    
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              2234689999999999999999999999999999999999999996532111000000                    


Q ss_pred             -----HHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          508 -----VNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       508 -----~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ..........+..+........ . ......+.++.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPP-K-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCC-C-CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCCc-c-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                 0000000011111111111000 0 0112346789999999999999999999999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=397.06  Aligned_cols=252  Identities=20%  Similarity=0.299  Sum_probs=208.4

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc------chhhhHHHHHHHHhhcCCCCcceEEeeeecCCce
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  363 (580)
                      .+.|++.+.||+|+||+||+|+.+ +|+.||||+++....      ...+.+.+|++++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999974 799999999965421      2356789999999999999999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC----cEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~a  439 (580)
                      ++||||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999987654 5999999999999999999999   99999999999999998776    4999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +......   ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.+...    ... ..        .+
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~-~~--------~i  228 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QET-LA--------NV  228 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH-HH--------HH
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH----HHH-HH--------HH
Confidence            8763322   23445789999999999999999999999999999999999999875211    111 00        00


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                          ...........+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       229 ----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         229 ----SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ----HTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----HhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0111111112334567789999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=401.85  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=208.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC----EEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM----EVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  365 (580)
                      ++|+..++||+|+||+||+|.+. +|+    .||+|.+... ..+..+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999864 454    5888887543 334567899999999999999999999999865 5678


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCC
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKE  445 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  445 (580)
                      ++||+.+|+|.+++......+++..++.++.|||+||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999888888999999999999999999999   899999999999999999999999999999977555


Q ss_pred             CCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhc
Q 038098          446 DQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANL  524 (580)
Q Consensus       446 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  524 (580)
                      ..........||+.|+|||.+.++.++.++|||||||++|||+| |.+||++....  .            +...+... 
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~------------~~~~i~~~-  229 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E------------ISSILEKG-  229 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--G------------HHHHHHHT-
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--H------------HHHHHHcC-
Confidence            44444455678999999999999999999999999999999999 78888653211  1            11111111 


Q ss_pred             cCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          525 LSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       525 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                           .+...+..++.++.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus       230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                 12233456778899999999999999999999999999988654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=397.42  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=204.1

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeeccC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEYMP  371 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  371 (580)
                      ++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5688999999999999999999888899999996543 345789999999999999999999999865 56789999999


Q ss_pred             CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCccc
Q 038098          372 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  450 (580)
Q Consensus       372 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  450 (580)
                      +|+|.+++.... ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+|+...... ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence            999999877543 56999999999999999999999   8999999999999999999999999999998664332 223


Q ss_pred             ccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCccc
Q 038098          451 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQKDE  530 (580)
Q Consensus       451 ~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  530 (580)
                      .....||+.|+|||++..+.++.++|||||||++|||+||+.|+..... ......++.            ..      .
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~------------~~------~  231 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE------------RG------Y  231 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH------------TT------C
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHH------------hc------C
Confidence            3445689999999999999999999999999999999997766543111 111111111            10      1


Q ss_pred             ccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          531 HFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       531 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      +.+.+..++.++.+++.+||+.||++||+|++|++.|+++.
T Consensus       232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            12234567788999999999999999999999999888754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=392.28  Aligned_cols=251  Identities=28%  Similarity=0.422  Sum_probs=201.8

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec-CCceeeEeecc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDFKALVLEYM  370 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  370 (580)
                      ++|+..+.||+|+||.||+|+++ |+.||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45778899999999999999986 789999998643  445789999999999999999999998854 46689999999


Q ss_pred             CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          371 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       371 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      ++|+|.+++...+ ..+++..+++++.||++||.|||   +.+|+||||||+||+++.++.+|++|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999987654 45899999999999999999999   899999999999999999999999999999865322    


Q ss_pred             cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          450 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                       .....+|..|+|||.+.++.++.++|||||||++|||+| |++||.....  .+...++.            .      
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~------------~------  215 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE------------K------  215 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHT------------T------
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH------------c------
Confidence             233457889999999999999999999999999999998 6777765311  11111111            0      


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      ..+.+.+..+++++.+|+.+||+.||++||||+|++++|++++..
T Consensus       216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            112233445678899999999999999999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-51  Score=399.52  Aligned_cols=245  Identities=26%  Similarity=0.349  Sum_probs=201.3

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .|+..+.||+|+||+||+|+.. +|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999864 789999999975432   334568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+++|+|..++... ..+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+....    
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            99999997766544 46999999999999999999999   89999999999999999999999999999985532    


Q ss_pred             ccccccccCCCcCCcccccC---CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          449 LTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                        .....||+.|+|||++.+   +.++.++|||||||++|||++|+.||.+..    ....+         ..+..... 
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~---------~~i~~~~~-  231 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSAL---------YHIAQNES-  231 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH---------HHHHHSCC-
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----HHHHH---------HHHHhCCC-
Confidence              233569999999998853   468999999999999999999999986521    11111         11111100 


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           .......+++++.+|+.+||+.||++|||++|+++|
T Consensus       232 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -----CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                 001123456789999999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=393.04  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=202.4

Q ss_pred             cCCCcCceeccccCceEEEEEeCC----CCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD----GMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|++.+.||+|+||.||+|.+..    +..||||.++... ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            568889999999999999998642    3468888875433 234567899999999999999999999996 4678999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++......+++..++.++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999998887788999999999999999999999   9999999999999999999999999999998664322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcchhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLL  525 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  525 (580)
                       ........||+.|+|||.+.++.++.++|||||||++|||+| |.+||......  .....           +..    
T Consensus       163 -~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~-----------i~~----  224 (273)
T d1mp8a_         163 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR-----------IEN----  224 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH-----------HHT----
T ss_pred             -ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH-----------HHc----
Confidence             223344568999999999999999999999999999999998 88898653211  11111           111    


Q ss_pred             CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          526 SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       526 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                         ..+.+.+..++.++.+|+.+||+.||++|||++||+++|+++.++
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 ---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               011233456788899999999999999999999999999998776

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=398.69  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=212.8

Q ss_pred             HhcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhcCCCCcceEEeeeecCCc
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDF  362 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  362 (580)
                      -.++|++.+.||+|+||+||+|+++      +++.||||+++.... +..+++.+|++++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3567999999999999999999864      357899999875433 345679999999999999999999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCC
Q 038098          363 KALVLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  419 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk  419 (580)
                      .++||||+++|+|.+++....                       ..+++..++.++.||+.||+|||   +.+++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999986432                       34899999999999999999999   9999999999


Q ss_pred             CCCEEeCCCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCC-CCCCccc
Q 038098          420 PSNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDEIF  498 (580)
Q Consensus       420 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~-~p~~~~~  498 (580)
                      |+|||++.++.+||+|||+|+.+.............+|+.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998765544444445667899999999999999999999999999999999986 5665421


Q ss_pred             cCCchHHHHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 038098          499 FGDMTLKHWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIR  571 (580)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~  571 (580)
                      .  ......           +.+.       .....+..++.++.+|+.+||+.||++||||.||++.|+++.
T Consensus       248 ~--~e~~~~-----------v~~~-------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 H--EEVIYY-----------VRDG-------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             H--HHHHHH-----------HHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             H--HHHHHH-----------HHcC-------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1  111111           1111       112234567788999999999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=396.63  Aligned_cols=259  Identities=25%  Similarity=0.440  Sum_probs=210.8

Q ss_pred             CceeccccCceEEEEEeCCC----CEEEEEEEecc-ccchhhhHHHHHHHHhhcCCCCcceEEeeeec-CCceeeEeecc
Q 038098          297 NNLIGRGGFGSVYKARIQDG----MEVAVKVFDLQ-YGRAFKSFDIECDMIKRIRHRNIIKIISSCSS-DDFKALVLEYM  370 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  370 (580)
                      .++||+|+||+||+|.+.++    ..||||+++.. .....+++.+|++++++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999986532    25899998643 33455789999999999999999999999865 56789999999


Q ss_pred             CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc--
Q 038098          371 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS--  448 (580)
Q Consensus       371 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  448 (580)
                      ++|+|.+++.......++..+++++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999888888899999999999999999999   999999999999999999999999999999876443322  


Q ss_pred             ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCCc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQK  528 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  528 (580)
                      .......||..|+|||.+..+.++.++||||||+++|||+||+.||..... ......++.           .       
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~-----------~-------  249 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL-----------Q-------  249 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH-----------T-------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHH-----------c-------
Confidence            223345689999999999999999999999999999999998888754211 111111111           0       


Q ss_pred             ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 038098          529 DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLKN  577 (580)
Q Consensus       529 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~~  577 (580)
                      +.+...+..+++++.+|+.+||+.||++||+|.||+++|+++..++.++
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence            0112233456788999999999999999999999999999998876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=393.29  Aligned_cols=276  Identities=23%  Similarity=0.302  Sum_probs=203.7

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHH--HHHHHhhcCCCCcceEEeeeecCC----ceee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDI--ECDMIKRIRHRNIIKIISSCSSDD----FKAL  365 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~----~~~l  365 (580)
                      .+|...+.||+|+||.||+|+++ |+.||||+++...   ...+..  |+..+.+++||||+++++++.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            35667789999999999999975 8999999986442   233334  455556789999999999997654    5789


Q ss_pred             EeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          366 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       366 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ||||+++|+|.+++++.  .++|..+++++.|+|.||+|||..     ..++|+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999999865  489999999999999999999932     13699999999999999999999999999998


Q ss_pred             ccCCCCCc--ccccccccCCCcCCcccccCC------CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc
Q 038098          441 PLLKEDQS--LTQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL  512 (580)
Q Consensus       441 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  512 (580)
                      ........  .......||+.|+|||++.+.      .++.++|||||||++|||+||..|+..................
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            76443322  223456799999999988654      3677899999999999999999887553222211111100000


Q ss_pred             c-cchhh-hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          513 P-ISVME-IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       513 ~-~~~~~-~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      . ..... ..+...... .+.......+..++.+|+.+||+.||++|||+.||+++|+++.++-
T Consensus       237 ~~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPN-IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CHHHHHHHHTTSCCCCC-CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCC-CCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            0 00111 111111111 1111223456678999999999999999999999999999998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=395.03  Aligned_cols=261  Identities=23%  Similarity=0.390  Sum_probs=202.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhc-CCCCcceEEeeeec-CC
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRI-RHRNIIKIISSCSS-DD  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~  361 (580)
                      .++|++.+.||+|+||.||+|.+.      +++.||||+++... ....+.+..|..++.++ +|+||+.+++++.. ..
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            367889999999999999999853      34689999986443 23456677888888877 68999999998765 45


Q ss_pred             ceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ..++||||+++|+|.+++...+               ..+++..++.++.||++||+|||   +.+|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999987543               35899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCC-CCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~-~p~~~~~~~~~~~~  505 (580)
                      .++.+||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||+||. +||...... ..+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence            99999999999998765544444455667999999999999999999999999999999999975 566542111 1111


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      .            .+...      .+...+..+++++.+++.+||+.||++|||++||++||+++.+.
T Consensus       248 ~------------~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         248 R------------RLKEG------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             H------------HHHHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H------------HHhcC------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1            11111      11223345678899999999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=395.62  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=208.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|+.+ +|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999864 7999999999754   2334577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+|||++++|.+||+|||+|+...... 
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-  159 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence            9999999999887655 5899999999999999999999   9999999999999999999999999999998653322 


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                       ......+||+.|+|||++.+..++.++||||+||++|||++|++||.+...     .....            ..... 
T Consensus       160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~------------~i~~~-  220 (337)
T d1o6la_         160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE------------LILME-  220 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH------------HHHHC-
T ss_pred             -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHH------------HHhcC-
Confidence             233456799999999999999999999999999999999999999875311     11111            00000 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                         ....+..+++++.+|+.+||++||++||+     ++|+++|
T Consensus       221 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence               11223456788999999999999999995     8888875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=389.54  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=201.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC--CC--CEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ--DG--MEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++...   ..+..+.+.+|++++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999853  23  36899998643   23445789999999999999999999999976 4678


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++|++.+++......+++..++.++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988877778999999999999999999999   89999999999999999999999999999997644


Q ss_pred             CCCcc-cccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHHHHHHhhcccchhhhcch
Q 038098          445 EDQSL-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDA  522 (580)
Q Consensus       445 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  522 (580)
                      ..... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||.+...  .....++           .. 
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~~~i-----------~~-  229 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKI-----------DK-  229 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH-----------HT-
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHHHHHH-----------Hh-
Confidence            43322 2334457889999999999999999999999999999998 8999865211  1111111           11 


Q ss_pred             hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 038098          523 NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKI  570 (580)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~  570 (580)
                           ...+.+.+..++.++.+|+.+||+.||++||||+||.+.|++.
T Consensus       230 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 1112233456778899999999999999999999999988875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=392.97  Aligned_cols=252  Identities=19%  Similarity=0.271  Sum_probs=208.9

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .++|.+.+.||+|+||+||+|... +|+.||||+++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367899999999999999999865 68899999997543 2345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC--CCcEEEccccCccccCCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ++||+|.+++...+..+++.++..++.||+.||+|||   +.+|+||||||+|||++.  .+.+||+|||+++.....  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999999887777999999999999999999999   999999999999999985  458999999999865332  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                       .......+|+.|+|||...+..++.++||||+||++|||++|+.||.....     .....        .+..    ..
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~--------~i~~----~~  219 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIE--------NIMN----AE  219 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHH----TC
T ss_pred             -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHHH--------HHHh----CC
Confidence             223445689999999999999999999999999999999999999965311     11111        1111    11


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..........++.++.+|+.+||..||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111112233567789999999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-49  Score=389.81  Aligned_cols=245  Identities=25%  Similarity=0.308  Sum_probs=206.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46889999999999999999964 6999999999754   2344577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||++||+|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999877655 5888999999999999999999   999999999999999999999999999999876432  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+...     .....        .+..    . 
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~--------~i~~----~-  216 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYE--------KILN----A-  216 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHH----C-
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHH--------HHHc----C-
Confidence               2345799999999999999999999999999999999999999975211     11111        1111    1 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                         ....+..++.++.+++.+||+.||++||     |++|+++|
T Consensus       217 ---~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 ---ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence               1122344667899999999999999996     89999876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-49  Score=383.54  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=206.5

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccc---------hhhhHHHHHHHHhhcC-CCCcceEEeeeecC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGR---------AFKSFDIECDMIKRIR-HRNIIKIISSCSSD  360 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  360 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++......         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57889999999999999999864 7899999999654321         2346788999999997 99999999999999


Q ss_pred             CceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          361 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       361 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      +..++||||+++|+|.+++...+ .+++.+++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997644 6999999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccC------CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGRE------GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      .+....   ......||..|+|||.+.+      ..++.++||||+||++|||+||+.||.+...    ...        
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~--------  223 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLM--------  223 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH--------
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHH--------
Confidence            764322   2345679999999998753      3568899999999999999999999976311    000        


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       ...+..    ............+++++.+|+.+||+.||++|||++|+++|
T Consensus       224 -~~~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         224 -LRMIMS----GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -HHHHHH----TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -HHHHHh----CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             001111    11111122334677889999999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-49  Score=386.49  Aligned_cols=260  Identities=22%  Similarity=0.357  Sum_probs=203.9

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc---chhhhHHHHHHHHhhcCCCCcceEEeeeecCC----c
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG---RAFKSFDIECDMIKRIRHRNIIKIISSCSSDD----F  362 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  362 (580)
                      .++|++.+.||+|+||.||+|.. .+|+.||||+++....   .....+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999986 4799999999965432   23457889999999999999999999987654    3


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||++||+|.+++...+ .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999886654 5999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCC-CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcc
Q 038098          443 LKED-QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVD  521 (580)
Q Consensus       443 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  521 (580)
                      .... .........||+.|+|||.+.+..++.++||||+||++|||+||+.||......     +...            
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~------------  224 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAY------------  224 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHH------------
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHH------------
Confidence            3322 222344567999999999999999999999999999999999999999752111     1110            


Q ss_pred             hhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 038098          522 ANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-NAKEIVTRLLKIR  571 (580)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ev~~~L~~~~  571 (580)
                      ..+.............++.++.+++.+||+.||++|| |++++.+.|.+++
T Consensus       225 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            0011111111122345678899999999999999999 8999999988875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=390.54  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=214.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecCCce
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFK  363 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  363 (580)
                      ++|++.++||+|+||.||+|++.      +++.||||+++.... .....+.+|+.+++++ +|||||++++++.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57888999999999999999752      456899999975432 3455788999999999 699999999999999999


Q ss_pred             eeEeeccCCCChHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-----------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ++||||+++|+|.+++....                 ..+++..+..++.||++|++|||   +.+++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999987543                 35899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKH  506 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~  506 (580)
                      .++.+|++|||.++...............||+.|+|||.+.++.++.++|||||||++|||+|++.|+.........+..
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999999775554444555678999999999999999999999999999999999955554322222222222


Q ss_pred             HHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          507 WVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       507 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                      .+            +...      +...+..++.++.+|+.+||+.||++||||+||++.|+++.++
T Consensus       260 ~i------------~~~~------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         260 MI------------KEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HH------------HHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH------------hcCC------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            22            1111      1122344677899999999999999999999999999987654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=388.47  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=209.7

Q ss_pred             cCCCcCceeccccCceEEEEEeCC--------CCEEEEEEEecccc-chhhhHHHHHHHHhhc-CCCCcceEEeeeecCC
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQD--------GMEVAVKVFDLQYG-RAFKSFDIECDMIKRI-RHRNIIKIISSCSSDD  361 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  361 (580)
                      ++|.+.+.||+|+||.||+|+..+        +..||||+++.... .....+.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            568888999999999999997532        24799999976543 3457788899999888 8999999999999999


Q ss_pred             ceeeEeeccCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC
Q 038098          362 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  426 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~  426 (580)
                      ..++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999997553               35899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHh-CCCCCCccccCCchHH
Q 038098          427 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEIFFGDMTLK  505 (580)
Q Consensus       427 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~ellt-g~~p~~~~~~~~~~~~  505 (580)
                      .++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||+| |.+||......  ...
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~~  247 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF  247 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HHH
Confidence            999999999999997755554444556678999999999999999999999999999999998 67887542111  111


Q ss_pred             HHHHhhcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          506 HWVNDLLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       506 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                                  ..+...      .+...+..++.++.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       248 ------------~~i~~~------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 ------------KLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ------------HHHHTT------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------HHHHcC------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                        111111      1222344567889999999999999999999999999999865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=389.75  Aligned_cols=256  Identities=29%  Similarity=0.461  Sum_probs=206.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCC--EEEEEEEecc-ccchhhhHHHHHHHHhhc-CCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGM--EVAVKVFDLQ-YGRAFKSFDIECDMIKRI-RHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|++.++||+|+||+||+|.++ +|.  .||||++... ..+..+.+.+|+++++++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56888899999999999999865 454  4778877543 334556799999999998 799999999999999999999


Q ss_pred             eeccCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcE
Q 038098          367 LEYMPHGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  431 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~  431 (580)
                      |||+++|+|.++++..               ...+++..++.++.|||+||.|||   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999998754               356999999999999999999999   9999999999999999999999


Q ss_pred             EEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCC-CCCccccCCchHHHHHHh
Q 038098          432 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK-PTDEIFFGDMTLKHWVND  510 (580)
Q Consensus       432 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~  510 (580)
                      ||+|||+|+......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...     +..+... 
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~~-  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYE-  237 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHH-
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHHHHHH-
Confidence            999999998543222   2234468999999999999999999999999999999999765 55432     1111111 


Q ss_pred             hcccchhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 038098          511 LLPISVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDS  573 (580)
Q Consensus       511 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~  573 (580)
                              .+..      ..+...+..+++++.+|+.+||+.||++||||+||+++|+++.++
T Consensus       238 --------~i~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 --------KLPQ------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             --------HGGG------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --------HHHh------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                    1111      112233456778899999999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.6e-49  Score=395.52  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHH---HHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDI---ECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|++.++||+|+||.||+|+.. +|+.||||++....   ......+..   |+++++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999865 69999999996432   112223333   466777788999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      +||||+++|+|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999987654 5899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh
Q 038098          445 EDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN  523 (580)
Q Consensus       445 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  523 (580)
                      .    ......||+.|+|||++.. ..++.++||||+||++|||+||+.||......+  ......            ..
T Consensus       160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~------------~~  221 (364)
T d1omwa3         160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR------------MT  221 (364)
T ss_dssp             S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHH------------HS
T ss_pred             C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH------------hc
Confidence            3    2234579999999999875 468999999999999999999999997632211  111111            00


Q ss_pred             ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038098          524 LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRIN-----AKEIVTR  566 (580)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ev~~~  566 (580)
                      .    ......+..+++++.+|+.+||+.||++|||     ++|+++|
T Consensus       222 ~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         222 L----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             S----SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             c----cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            0    0111223456788999999999999999999     6888875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=391.00  Aligned_cols=262  Identities=21%  Similarity=0.396  Sum_probs=216.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC------CCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCcee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ------DGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  364 (580)
                      ++|...+.||+|+||+||+|.+.      +++.||||+++... .+....+.+|++++++++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            67888899999999999999763      25789999996543 234456889999999999999999999999999999


Q ss_pred             eEeeccCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEcc
Q 038098          365 LVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  435 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  435 (580)
                      +||||+++|+|.+++...+         ..+++..+.+++.|+|+||.|||   +.+|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            9999999999999886432         35799999999999999999999   89999999999999999999999999


Q ss_pred             ccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCC-CCCCccccCCchHHHHHHhhccc
Q 038098          436 FGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDEIFFGDMTLKHWVNDLLPI  514 (580)
Q Consensus       436 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  514 (580)
                      ||+|+.+.............+|+.|+|||.+.++.++.++|||||||++|||+||+ +||...     ...++..     
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~-----  246 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLR-----  246 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHH-----
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHH-----
Confidence            99998775555544555667999999999999999999999999999999999985 665432     1112111     


Q ss_pred             chhhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 038098          515 SVMEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSLLK  576 (580)
Q Consensus       515 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~~~  576 (580)
                         .+.+.       .+...+..++..+.+++.+||+.+|++||||+||+++|++..+...+
T Consensus       247 ---~i~~~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         247 ---FVMEG-------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             ---HHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             ---HHHhC-------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence               11111       12233456778899999999999999999999999999887654443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-48  Score=390.27  Aligned_cols=245  Identities=21%  Similarity=0.254  Sum_probs=206.9

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc---ccchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ---YGRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++|++.+.||+|+||.||+|+.+ +|+.||||+++..   .....+.+.+|++++++++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999865 7999999999643   2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQ  447 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  447 (580)
                      ||+.+|+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987654 5999999999999999999999   999999999999999999999999999999876432  


Q ss_pred             cccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccCC
Q 038098          448 SLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLSQ  527 (580)
Q Consensus       448 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  527 (580)
                         .....||+.|||||++.+..++.++||||+||++|||+||+.||.+..     ......        .+..    . 
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~--------~i~~----~-  253 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYE--------KIVS----G-  253 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH--------HHHH----C-
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHH--------HHhc----C-
Confidence               234579999999999999999999999999999999999999996521     111111        0111    0 


Q ss_pred             cccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          528 KDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       528 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                         ....+..+++++.+++.+||+.||++|+     |++|+++|
T Consensus       254 ---~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence               1112345677899999999999999994     89999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=387.71  Aligned_cols=252  Identities=20%  Similarity=0.249  Sum_probs=200.6

Q ss_pred             hcCCCcCc-eeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhc-CCCCcceEEeeeec----CCce
Q 038098          291 TNGFSENN-LIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRI-RHRNIIKIISSCSS----DDFK  363 (580)
Q Consensus       291 ~~~~~~~~-~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~  363 (580)
                      .++|.+.. .||+|+||.||+|+. .+|+.||||+++.     ...+.+|++++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35787764 699999999999986 4799999999853     25677899987655 89999999999865    4568


Q ss_pred             eeEeeccCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC---CCcEEEccccCc
Q 038098          364 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  439 (580)
Q Consensus       364 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~a  439 (580)
                      ++|||||+||+|.+++...+ ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998654 56999999999999999999999   999999999999999985   567999999999


Q ss_pred             cccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          440 KPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... .....            
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~------------  225 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGM------------  225 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHH------------
Confidence            8664332   2345679999999999999999999999999999999999999996531110 00000            


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..................+++++.+|+.+||+.||++|||+.|+++|
T Consensus       226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000011111112234577889999999999999999999999886

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=387.08  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=204.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc---cchhhhHHHHHHHHh-hcCCCCcceEEeeeecCCceeeE
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY---GRAFKSFDIECDMIK-RIRHRNIIKIISSCSSDDFKALV  366 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  366 (580)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||+++...   ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999865 79999999997532   334456667777765 68999999999999999999999


Q ss_pred             eeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCC
Q 038098          367 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       367 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999987654 5899999999999999999999   8999999999999999999999999999998653322


Q ss_pred             CcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchhccC
Q 038098          447 QSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDANLLS  526 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  526 (580)
                        .......||+.|+|||.+.+..++.++||||+||++|||+||+.||.+...     .+...        .+    ...
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~--------~i----~~~  218 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFH--------SI----RMD  218 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HH----HHC
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHH--------HH----HcC
Confidence              233456799999999999999999999999999999999999999975211     11000        00    001


Q ss_pred             CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 038098          527 QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAK-EIVTR  566 (580)
Q Consensus       527 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ev~~~  566 (580)
                          ....+..++.++.+|+.+||+.||++||++. |+++|
T Consensus       219 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 ----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                1122345678899999999999999999995 77653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=379.02  Aligned_cols=264  Identities=25%  Similarity=0.276  Sum_probs=196.9

Q ss_pred             cCceeccccCceEEEEEeC-CCCEEEEEEEecccc-----chhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          296 ENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG-----RAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       296 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      .+++||+|+||+||+|+.+ +|+.||||+++....     .....+.+|++++++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999864 699999999854321     1235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +.++++..+. ..+..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            9887666554 44556899999999999999999999   99999999999999999999999999999986543322  


Q ss_pred             cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhcchh-----
Q 038098          450 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIVDAN-----  523 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-----  523 (580)
                      ......||+.|+|||.+..+ .++.++||||+||++|||+||++||.+....+ .+................+..     
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence            23345799999999988654 57999999999999999999999986532111 111111110000000000000     


Q ss_pred             -ccCC-c-ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 -LLSQ-K-DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 -~~~~-~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .... . ..........+.++.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence             0000 0 00001123456789999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=377.90  Aligned_cols=269  Identities=24%  Similarity=0.264  Sum_probs=203.2

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999986 479999999996442  2345788899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      |+.++.+..........+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99765444444445567999999999999999999999   9999999999999999999999999999998664322  


Q ss_pred             ccccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc-c-cc-hhhhcch-h
Q 038098          449 LTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL-P-IS-VMEIVDA-N  523 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~~~~~d~-~  523 (580)
                      .......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+.... ..+........ + +. ....... .
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccccc
Confidence            2334557999999999876655 588999999999999999999999753211 11111111110 0 00 0000000 0


Q ss_pred             ccC-----CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          524 LLS-----QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       524 ~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...     ............+.++.+|+.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000     0000011123456788999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-47  Score=373.80  Aligned_cols=268  Identities=21%  Similarity=0.245  Sum_probs=203.3

Q ss_pred             cCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  369 (580)
                      ++|+..+.||+|+||+||+|++++|+.||||++....  ....+.+.+|+.++++++||||+++++++..++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788999999999999999999999999999996542  23357889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCcc
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQSL  449 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  449 (580)
                      +.++.+..+. .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.|.......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            9876665554 44567999999999999999999999   8999999999999999999999999999998663322  2


Q ss_pred             cccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccc---hhhhcc----
Q 038098          450 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPIS---VMEIVD----  521 (580)
Q Consensus       450 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~d----  521 (580)
                      ......+++.|+|||.+... .++.++||||+||++|||++|+.||......+ .+...........   ......    
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhhc
Confidence            23445689999999988654 56899999999999999999999997532111 1111111110000   000000    


Q ss_pred             -h-hccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 -A-NLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 -~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       . ................+.++.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0 00001111112234456789999999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-48  Score=372.72  Aligned_cols=240  Identities=24%  Similarity=0.294  Sum_probs=198.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecccc------chhhhHHHHHHHHhhcC--CCCcceEEeeeecCCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYG------RAFKSFDIECDMIKRIR--HRNIIKIISSCSSDDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~  362 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.....      .....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999864 799999999965421      12345678999999996  8999999999999999


Q ss_pred             eeeEeeccCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-CCcEEEccccCcc
Q 038098          363 KALVLEYMPH-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAK  440 (580)
Q Consensus       363 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~a~  440 (580)
                      .++||||+.+ +++.+++... ..+++..++.++.||++||+|||   +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 5777777654 45999999999999999999999   999999999999999985 5799999999998


Q ss_pred             ccCCCCCcccccccccCCCcCCcccccCCCC-CCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhh
Q 038098          441 PLLKEDQSLTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEI  519 (580)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  519 (580)
                      .....    ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....                   ++
T Consensus       160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------------~i  216 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------------EI  216 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------------HH
T ss_pred             ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------------HH
Confidence            65322    2334679999999999987665 577899999999999999999986520                   01


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....        ...+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       217 ~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         217 IRGQ--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HHCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhcc--------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1100        01123456789999999999999999999999886

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-47  Score=373.03  Aligned_cols=268  Identities=23%  Similarity=0.279  Sum_probs=203.5

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CC-CCEEEEEEEecccc--chhhhHHHHHHHHhhc---CCCCcceEEeeeec----
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QD-GMEVAVKVFDLQYG--RAFKSFDIECDMIKRI---RHRNIIKIISSCSS----  359 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  359 (580)
                      .++|++.+.||+|+||+||+|+. ++ ++.||||++.....  .....+.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999986 34 56799999865432  2344567788887766   79999999998853    


Q ss_pred             -CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccC
Q 038098          360 -DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  438 (580)
Q Consensus       360 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  438 (580)
                       ....+++|||++++++..........+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             34679999999998877666666677999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          439 AKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       439 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      ++....   ........||+.|+|||++.+..++.++||||+||++|||+||++||...... ..+........... ..
T Consensus       163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~-~~  237 (305)
T d1blxa_         163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG-EE  237 (305)
T ss_dssp             CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC-GG
T ss_pred             hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCc-hh
Confidence            985422   22345667999999999999999999999999999999999999999753211 11111111110000 00


Q ss_pred             hcch------hc-c-CCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          519 IVDA------NL-L-SQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       519 ~~d~------~~-~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ....      .. . .............+..+.+|+.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000      00 0 00011111233456788999999999999999999999886

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-45  Score=360.41  Aligned_cols=260  Identities=20%  Similarity=0.212  Sum_probs=204.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcce-EEeeeecCCceeeEeec
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIK-IISSCSSDDFKALVLEY  369 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~  369 (580)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....  ....+..|++++++++|+|++. +.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999864 68999999987543  3356888999999998776554 55566778888999999


Q ss_pred             cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeC---CCCcEEEccccCccccCCCC
Q 038098          370 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLKED  446 (580)
Q Consensus       370 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~  446 (580)
                      + ++++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++   .+..+||+|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 55787777777778999999999999999999999   99999999999999986   45579999999999775433


Q ss_pred             Cc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCch--HHHHHHhhcccchhhh
Q 038098          447 QS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMT--LKHWVNDLLPISVMEI  519 (580)
Q Consensus       447 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  519 (580)
                      ..     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.........  ...+....        
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--------  232 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--------  232 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--------
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--------
Confidence            21     1234557999999999999999999999999999999999999999764322111  11111100        


Q ss_pred             cchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 038098          520 VDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRD  572 (580)
Q Consensus       520 ~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~  572 (580)
                          ...   ........+++++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus       233 ----~~~---~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         233 ----MST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ----HHS---CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----CCC---ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                000   0011223567889999999999999999999999998887754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.4e-45  Score=356.70  Aligned_cols=265  Identities=15%  Similarity=0.128  Sum_probs=213.0

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCC-CCcceEEeeeecCCceeeEee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH-RNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  368 (580)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+..|++.++.+.| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            357999999999999999999865 68999999986542  33567889999999975 899999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCC-----CCcEEEccccCccccC
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLL  443 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~  443 (580)
                      |+ +++|.+++...+..+++.++..++.|++.||+|||   +.+|+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 68999999888778999999999999999999999   999999999999999974     5789999999998764


Q ss_pred             CCCCc-----ccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhh
Q 038098          444 KEDQS-----LTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVME  518 (580)
Q Consensus       444 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  518 (580)
                      .....     .......||+.|||||.+.+..++.++|||||||++|||+||+.||.+........  ...        .
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~--------~  227 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYE--------R  227 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHH--------H
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHH--------H
Confidence            33221     12334579999999999999999999999999999999999999997643221111  000        0


Q ss_pred             hcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 038098          519 IVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTRLLKIRDSL  574 (580)
Q Consensus       519 ~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~L~~~~~~~  574 (580)
                      +.+.....   ........+++++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus       228 i~~~~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         228 IGEKKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhccCCC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            00000000   001122346678999999999999999999999999988887654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-45  Score=365.61  Aligned_cols=270  Identities=23%  Similarity=0.241  Sum_probs=199.1

Q ss_pred             hcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccc-cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC----cee
Q 038098          291 TNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQY-GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD----FKA  364 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  364 (580)
                      +++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999985 489999999996443 234567889999999999999999999986543    234


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCC
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLK  444 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  444 (580)
                      ++++|+.+|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            556667799999999764  4899999999999999999999   99999999999999999999999999999986644


Q ss_pred             CCCc-ccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccch------
Q 038098          445 EDQS-LTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISV------  516 (580)
Q Consensus       445 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  516 (580)
                      .... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+. .............      
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhhh
Confidence            3222 22345679999999998855 4568999999999999999999999976322111 1111110000000      


Q ss_pred             -----hhhcchhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 -----MEIVDANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 -----~~~~d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ......................+.++.+|+.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00000000000000011123455678999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-45  Score=364.99  Aligned_cols=263  Identities=24%  Similarity=0.307  Sum_probs=194.2

Q ss_pred             CCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCcceEEeeeec------CCceee
Q 038098          293 GFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNIIKIISSCSS------DDFKAL  365 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~l  365 (580)
                      +|+..++||+|+||+||+|+.. +|+.||||++....    ....+|++++++++||||+++++++..      ....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5778899999999999999975 69999999996542    223479999999999999999999843      234789


Q ss_pred             EeeccCCCChHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCcccc
Q 038098          366 VLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPL  442 (580)
Q Consensus       366 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~  442 (580)
                      ||||++++.+.....  .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764443322  34457999999999999999999999   99999999999999999775 8999999999866


Q ss_pred             CCCCCcccccccccCCCcCCcccccC-CCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc---chhh
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI---SVME  518 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  518 (580)
                      ....   ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.......-..   .+..
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence            4332   2234579999999998765 57899999999999999999999999653211 1111111110000   0111


Q ss_pred             hcchh----ccCCcc--cccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          519 IVDAN----LLSQKD--EHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       519 ~~d~~----~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      .....    ......  .........++++.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            10000    000000  0001123456789999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=365.97  Aligned_cols=264  Identities=24%  Similarity=0.286  Sum_probs=196.1

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCC------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDD------  361 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  361 (580)
                      .++|++++.||+|+||+||+|... +|+.||||+++...  ....+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999864 69999999996432  233567889999999999999999999997654      


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..++||||+ +++|..+....  .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            469999999 56888876543  4999999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhc--ccc---
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLL--PIS---  515 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~---  515 (580)
                      ....     .+...||+.|+|||.+.+. .++.++||||+||++|||++|++||...... ..+........  +..   
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence            5332     2346799999999988764 5689999999999999999999999763211 11111111100  000   


Q ss_pred             -----hhhhcchhccCCc-ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          516 -----VMEIVDANLLSQK-DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       516 -----~~~~~d~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                           ............. ..........++++.+|+.+||..||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 0000000011100 11111223456788999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=360.08  Aligned_cols=271  Identities=23%  Similarity=0.301  Sum_probs=197.7

Q ss_pred             hcCCCcCceeccccCceEEEEEeC-CCCEEEEEEEecc--ccchhhhHHHHHHHHhhcCCCCcceEEeeeec--------
Q 038098          291 TNGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ--YGRAFKSFDIECDMIKRIRHRNIIKIISSCSS--------  359 (580)
Q Consensus       291 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  359 (580)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++...  ......++.+|++++++++|||++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            467999999999999999999864 7999999998544  23345678899999999999999999998754        


Q ss_pred             CCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCc
Q 038098          360 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  439 (580)
Q Consensus       360 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a  439 (580)
                      .+..++||||+.++.+.. .......+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            346789999998766654 4444556899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCc--ccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHH---hhcc
Q 038098          440 KPLLKEDQS--LTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVN---DLLP  513 (580)
Q Consensus       440 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~  513 (580)
                      +.+......  .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ........   ...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~  243 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP  243 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCCCh
Confidence            866433221  223345799999999988765 6899999999999999999999999753211 01111111   0000


Q ss_pred             cchhhhcchhc----cCCcccccch-----hhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 ISVMEIVDANL----LSQKDEHFTT-----KGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~~~~~~d~~~----~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ...........    ..........     ....+.++.+|+.+||+.||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000000000    0000000001     11234567899999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=354.75  Aligned_cols=269  Identities=23%  Similarity=0.248  Sum_probs=206.1

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeecCCceeeEee
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSSDDFKALVLE  368 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  368 (580)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  .....++.+|+.+++.++||||+++++++...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999864 78999999996543  2345788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccccCCCCCc
Q 038098          369 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLKEDQS  448 (580)
Q Consensus       369 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  448 (580)
                      ++.++++..++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            9999888877654 456899999999999999999999   89999999999999999999999999999987643332 


Q ss_pred             ccccccccCCCcCCcccccCCC-CCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc---c---hhhhcc
Q 038098          449 LTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI---S---VMEIVD  521 (580)
Q Consensus       449 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~---~~~~~d  521 (580)
                       ......++..|+|||.+.... ++.++||||+||++|||++|+.||....................   .   .....+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             233446788899999887655 68999999999999999999999743211111111111110000   0   000000


Q ss_pred             hh---ccCCcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          522 AN---LLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       522 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..   ...............+.++.+|+.+||+.||.+|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   0001111112234556788999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-45  Score=360.58  Aligned_cols=253  Identities=24%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             cCCCcCceeccccCceEEEEEeC----CCCEEEEEEEecc----ccchhhhHHHHHHHHhhcCC-CCcceEEeeeecCCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ----DGMEVAVKVFDLQ----YGRAFKSFDIECDMIKRIRH-RNIIKIISSCSSDDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  362 (580)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999742    5889999998543    22345678889999999976 899999999999999


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .++||||+.+|+|.+++...+ .+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999987665 4678899999999999999999   999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccCCCcCCcccccCC--CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcccchhhhc
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPISVMEIV  520 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  520 (580)
                      .... ........|++.|+|||.+.+.  .++.++||||+||++|||+||+.||......+. ......           
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~-----------  246 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISR-----------  246 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHH-----------
T ss_pred             cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-----------
Confidence            4332 2233456799999999988654  468899999999999999999999976432221 111111           


Q ss_pred             chhccCCcccccchhhhhHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038098          521 DANLLSQKDEHFTTKGQCVSFIFNLAMKCTVESPEQRI-----NAKEIVTR  566 (580)
Q Consensus       521 d~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ev~~~  566 (580)
                       .....    ....+..++.++.+|+.+||++||++||     |++|+++|
T Consensus       247 -~~~~~----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         247 -RILKS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -HHHHC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -hcccC----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence             00000    1122345778899999999999999999     48899875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.5e-44  Score=356.86  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=198.2

Q ss_pred             cCCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeec--CCceeeEe
Q 038098          292 NGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSS--DDFKALVL  367 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  367 (580)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..   ..+.+.+|++++++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999986 47899999998643   3467889999999995 9999999999874  45689999


Q ss_pred             eccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCC-cEEEccccCccccCCCC
Q 038098          368 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLKED  446 (580)
Q Consensus       368 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  446 (580)
                      ||+++++|..+.    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997754    35899999999999999999999   99999999999999998654 69999999998664332


Q ss_pred             CcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchH------------HHHHHhhcc
Q 038098          447 QSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTL------------KHWVNDLLP  513 (580)
Q Consensus       447 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~------------~~~~~~~~~  513 (580)
                         ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..........            ..|......
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence               23455789999999987765 47999999999999999999999986532111000            011110000


Q ss_pred             cc---hhhhcchhccCCc--ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 IS---VMEIVDANLLSQK--DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 ~~---~~~~~d~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                      ..   .............  .........+++++.+|+.+||+.||++|||++|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   0000000000000  00111223467789999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-44  Score=359.91  Aligned_cols=264  Identities=23%  Similarity=0.237  Sum_probs=191.2

Q ss_pred             cCCCcCceeccccCceEEEEEeC-CCCEEEEEEEeccc--cchhhhHHHHHHHHhhcCCCCcceEEeeeec------CCc
Q 038098          292 NGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQY--GRAFKSFDIECDMIKRIRHRNIIKIISSCSS------DDF  362 (580)
Q Consensus       292 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  362 (580)
                      ++|++.++||+|+||+||+|.+. +|+.||||++....  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999865 69999999997543  2334568899999999999999999999853      367


Q ss_pred             eeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCcccc
Q 038098          363 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  442 (580)
Q Consensus       363 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~~  442 (580)
                      .|+||||+.++.+. .+.   ..+++..++.++.||+.||+|||   +.||+||||||+|||++.++.++++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999775544 343   34899999999999999999999   999999999999999999999999999998854


Q ss_pred             CCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhcc---------
Q 038098          443 LKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLP---------  513 (580)
Q Consensus       443 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  513 (580)
                      ..   ........+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+..... ...........         
T Consensus       170 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         170 GT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTS
T ss_pred             cc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHh
Confidence            32   223455679999999999999999999999999999999999999986531110 00110000000         


Q ss_pred             -cchhhhcchhccC------------CcccccchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          514 -ISVMEIVDANLLS------------QKDEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       514 -~~~~~~~d~~~~~------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                       .......+.....            ............+.++.+|+.+||..||++|||++|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000011100000            0000111234467889999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=357.51  Aligned_cols=266  Identities=22%  Similarity=0.256  Sum_probs=197.0

Q ss_pred             HhcCCCcCceeccccCceEEEEEe-CCCCEEEEEEEecccc--chhhhHHHHHHHHhhcCCCCcceEEeeeecC-----C
Q 038098          290 ATNGFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYG--RAFKSFDIECDMIKRIRHRNIIKIISSCSSD-----D  361 (580)
Q Consensus       290 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  361 (580)
                      .+++|++.+.||+|+||+||+|+. .+|+.||||+++....  ...+.+.+|++++++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            357899999999999999999985 4799999999965432  3345788999999999999999999998533     3


Q ss_pred             ceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccccCccc
Q 038098          362 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  441 (580)
Q Consensus       362 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~~  441 (580)
                      ..+++++|+.+|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++..
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             ceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            456777888899999998654  5999999999999999999999   99999999999999999999999999999975


Q ss_pred             cCCCCCcccccccccCCCcCCcccccCC-CCCCchhhHhHHHHHHHHHhCCCCCCccccCCchHHHHHHhhccc--ch--
Q 038098          442 LLKEDQSLTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDEIFFGDMTLKHWVNDLLPI--SV--  516 (580)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~--  516 (580)
                      ...     ......|++.|+|||...+. .++.++||||+||++|||++|+.||.+..... ............  ..  
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhh
Confidence            422     23445688999999986665 46899999999999999999999997531110 011111100000  00  


Q ss_pred             ------hhhcchhccCCcccc-cchhhhhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038098          517 ------MEIVDANLLSQKDEH-FTTKGQCVSFIFNLAMKCTVESPEQRINAKEIVTR  566 (580)
Q Consensus       517 ------~~~~d~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev~~~  566 (580)
                            ............... .......+.++.+|+.+||..||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                  000000000000000 01123456788999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-39  Score=325.01  Aligned_cols=265  Identities=19%  Similarity=0.211  Sum_probs=188.9

Q ss_pred             CCCcCceeccccCceEEEEEe-CCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-----------CCCcceEEeeeec-
Q 038098          293 GFSENNLIGRGGFGSVYKARI-QDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-----------HRNIIKIISSCSS-  359 (580)
Q Consensus       293 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~-  359 (580)
                      +|++++.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            489999999999999999986 479999999997542 22356778888888775           5789999988754 


Q ss_pred             -CCceeeEeeccCCCChHH--HhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEecCCCCCEEeCCCC------
Q 038098          360 -DDFKALVLEYMPHGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNM------  429 (580)
Q Consensus       360 -~~~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~i~H~dlk~~Nill~~~~------  429 (580)
                       ....+++++++..+....  ........+++..+..++.||+.|++|||   + .+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccc
Confidence             345566666655443322  23334467899999999999999999999   6 8899999999999998665      


Q ss_pred             cEEEccccCccccCCCCCcccccccccCCCcCCcccccCCCCCCchhhHhHHHHHHHHHhCCCCCCccccCC-----chH
Q 038098          430 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEIFFGD-----MTL  504 (580)
Q Consensus       430 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gvil~elltg~~p~~~~~~~~-----~~~  504 (580)
                      .++++|||.|......     .....||+.|+|||.+....++.++||||+||+++||++|+.||.......     ..+
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            3999999999855322     234569999999999999999999999999999999999999997532211     011


Q ss_pred             HHHHHhh--cccc-------hhhhcchhcc-----CCc--------ccccchhhhhHHHHHHHHhhccCCCCCCCCCHHH
Q 038098          505 KHWVNDL--LPIS-------VMEIVDANLL-----SQK--------DEHFTTKGQCVSFIFNLAMKCTVESPEQRINAKE  562 (580)
Q Consensus       505 ~~~~~~~--~~~~-------~~~~~d~~~~-----~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  562 (580)
                      .......  .+..       .....+....     ...        ..........+.++.+|+.+|+..||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1111100  0000       0001110000     000        0011223456788999999999999999999999


Q ss_pred             HHHH
Q 038098          563 IVTR  566 (580)
Q Consensus       563 v~~~  566 (580)
                      +++|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9876

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.94  E-value=3.2e-27  Score=232.93  Aligned_cols=220  Identities=32%  Similarity=0.533  Sum_probs=179.7

Q ss_pred             CCcccc--CCCcccCCCCCCCEEeccC-CcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCC
Q 038098            1 GNNLNG--SIPIAVGKLQKLQLLSLED-NQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus         1 ~N~~~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~   77 (580)
                      +|++++  .+|.+|++|++|++|+|++ |++++.+|..|++|++|++|+|++|++.+..+..+..+++|+.+++++|++.
T Consensus        59 ~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~  138 (313)
T d1ogqa_          59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS  138 (313)
T ss_dssp             CCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred             CCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccc
Confidence            467776  4788889999999999986 7888888888888999999999999888888888888888888888888765


Q ss_pred             C-CCCCCcCCCCCceEeCcCCccc------ccCCCcc-cE-----------------------EeCCCCcCCCCCCcccC
Q 038098           78 S-IPSTLWNLKDILYLDLSSNFLL------IGNLKVL-VQ-----------------------VDLSMNNFSDVIPTTIG  126 (580)
Q Consensus        78 ~-lp~~~~~l~~L~~L~l~~n~l~------~~~l~~L-~~-----------------------L~l~~N~l~~~~~~~~~  126 (580)
                      . +|..+.++++|+.+++++|.+.      +..+..+ +.                       +++++|.+.+.+|..+.
T Consensus       139 ~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~  218 (313)
T d1ogqa_         139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG  218 (313)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCC
T ss_pred             ccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4 6677778888888888888761      2222222 34                       45555555555566667


Q ss_pred             CccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCcccc
Q 038098          127 GLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTES  206 (580)
Q Consensus       127 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~  206 (580)
                      .++.|+.|++++|.+++.+| .+..+++|+.|+|++|++++.+|..+.++++|+.|++++|+|+|.+|....+..+..++
T Consensus       219 ~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~  297 (313)
T d1ogqa_         219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA  297 (313)
T ss_dssp             TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGG
T ss_pred             cccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHH
Confidence            77889999999999986554 68888999999999999999999999999999999999999999999888889999999


Q ss_pred             CCCCccccCCCCCCCCCC
Q 038098          207 FEGNELLCGMPNLQVPPC  224 (580)
Q Consensus       207 ~~~n~~~c~~p~~~~~~c  224 (580)
                      +.+|+..|+.|   .|+|
T Consensus       298 l~~N~~l~g~p---lp~c  312 (313)
T d1ogqa_         298 YANNKCLCGSP---LPAC  312 (313)
T ss_dssp             TCSSSEEESTT---SSCC
T ss_pred             hCCCccccCCC---CCCC
Confidence            99999999987   3456

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.3e-26  Score=218.97  Aligned_cols=199  Identities=27%  Similarity=0.258  Sum_probs=138.9

Q ss_pred             CCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceE
Q 038098           13 GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYL   92 (580)
Q Consensus        13 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L   92 (580)
                      .+...+..++.++++|+ .+|+.+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+|. +..+++|++|
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L   82 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTL   82 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccccc
Confidence            34455666677777776 4555443  467777777777776666667777777777777777776653 3556777777


Q ss_pred             eCcCCcc-----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCC
Q 038098           93 DLSSNFL-----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSG  167 (580)
Q Consensus        93 ~l~~n~l-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  167 (580)
                      +|++|++     .+.++++|+.|++++|.+.++.+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++++
T Consensus        83 ~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             ECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             ccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            7777776     25566777777777777777666777777777777777777775555666677777777777777776


Q ss_pred             CccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccC
Q 038098          168 TIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       168 ~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~  215 (580)
                      ..+..+..+++|+.|+|++|+|+..++....++.++.+++.+|||.|+
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence            666667777777777777777776665566666777777777777776

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-25  Score=215.34  Aligned_cols=188  Identities=26%  Similarity=0.220  Sum_probs=171.0

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+ .+|..+.  ++|++|+|++|+|+++.++.|.++++|++|+|++|+|+.+.  .++.+++|++|+|++|+|+.++
T Consensus        19 ~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~~~~   93 (266)
T d1p9ag_          19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQSLP   93 (266)
T ss_dssp             TSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCSSCCSSCC
T ss_pred             CCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccccccccccccccc
Confidence            46677 5687664  68999999999999777789999999999999999999653  4688999999999999999999


Q ss_pred             CCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      ..+.++++|++|++++|.+      .+..+.++..|++++|.++.+.+..+..++.|+.|++++|+|++..+..|..+++
T Consensus        94 ~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~  173 (266)
T d1p9ag_          94 LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN  173 (266)
T ss_dssp             CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTT
T ss_pred             cccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccc
Confidence            9999999999999999998      3678899999999999999998999999999999999999999877888999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP  194 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  194 (580)
                      |++|+|++|+|+ .+|..+..+++|+.|+|++|++.|.+.
T Consensus       174 L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            999999999999 788888899999999999999999764

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.6e-25  Score=214.02  Aligned_cols=212  Identities=23%  Similarity=0.267  Sum_probs=189.3

Q ss_pred             ccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcC-CCCCCCCC-
Q 038098            3 NLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLG-SNKLTSIP-   80 (580)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-~N~l~~lp-   80 (580)
                      +++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|+|..+.+..+.+++.++.+... .|.++.++ 
T Consensus        22 ~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~   98 (284)
T d1ozna_          22 GLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP   98 (284)
T ss_dssp             CCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCT
T ss_pred             CCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccc
Confidence            344 5676554  678999999999997777899999999999999999999999999999999998775 67788885 


Q ss_pred             CCCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLIN  154 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  154 (580)
                      ..+.++++|++|++++|.+      .+...++|+.+++++|+++++++..|..+++|+.|+|++|.+++..+..|.++++
T Consensus        99 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~  178 (284)
T d1ozna_          99 ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS  178 (284)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             hhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccc
Confidence            4678899999999999997      3567889999999999999988899999999999999999999888889999999


Q ss_pred             cccccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccccCCCCccccCCC
Q 038098          155 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       155 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      |+.+++++|++++..|..|..+++|+.|++++|.+++.++.. ..++.++.+++++|++.|+++
T Consensus       179 L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             cchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            999999999999888999999999999999999999988754 577889999999999999744

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.7e-25  Score=213.96  Aligned_cols=215  Identities=26%  Similarity=0.283  Sum_probs=188.9

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeC-CCCcCCcCCCccccCCCCCcEEEcCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDS-GGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      +|+|+++.+.+|.++++|++|++++|+|..+.+..+..+..+..++. ..|.++.+.+..|.++++|++|++++|.+..+
T Consensus        41 ~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~  120 (284)
T d1ozna_          41 GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL  120 (284)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCC
T ss_pred             CCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccc
Confidence            68999888889999999999999999999888899999999999876 46778888899999999999999999999987


Q ss_pred             CC-CCcCCCCCceEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccc
Q 038098           80 PS-TLWNLKDILYLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDL  152 (580)
Q Consensus        80 p~-~~~~l~~L~~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  152 (580)
                      +. .+...++|+.+++++|.+      .+..+++|+.|++++|+++++.+.+|.++++|+.+++++|++++..|..|..+
T Consensus       121 ~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l  200 (284)
T d1ozna_         121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL  200 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             cccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhh
Confidence            65 455789999999999998      36788999999999999999999999999999999999999998889999999


Q ss_pred             cccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccC
Q 038098          153 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       153 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~  215 (580)
                      ++|+.|++++|++++..+..|..+++|+.|++++|++.|.++......++.......+...|.
T Consensus       201 ~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~  263 (284)
T d1ozna_         201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS  263 (284)
T ss_dssp             TTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred             hhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence            999999999999998888999999999999999999999886433233344444444555554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.89  E-value=8.5e-23  Score=200.08  Aligned_cols=208  Identities=24%  Similarity=0.319  Sum_probs=156.5

Q ss_pred             CccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCC
Q 038098            2 NNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS   81 (580)
Q Consensus         2 N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~   81 (580)
                      ++++ .+|..+.  ++|++|+|++|+|+.+.+..|.++++|++|++++|.+..+.|..|.++++|++|++++|+|+.+|.
T Consensus        20 ~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~   96 (305)
T d1xkua_          20 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE   96 (305)
T ss_dssp             SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCS
T ss_pred             CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCcc
Confidence            3455 5676664  689999999999986666789999999999999999998888889999999999999999887765


Q ss_pred             CCcCCCCCceEeCcCCcc--------------------------------------------------c---ccCCCccc
Q 038098           82 TLWNLKDILYLDLSSNFL--------------------------------------------------L---IGNLKVLV  108 (580)
Q Consensus        82 ~~~~l~~L~~L~l~~n~l--------------------------------------------------~---~~~l~~L~  108 (580)
                      .+.  ..|..|++++|.+                                                  .   ...+++|+
T Consensus        97 ~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~  174 (305)
T d1xkua_          97 KMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT  174 (305)
T ss_dssp             SCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCS
T ss_pred             chh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccC
Confidence            432  2344444444433                                                  1   12345677


Q ss_pred             EEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccccCcccEEEccCCc
Q 038098          109 QVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK  188 (580)
Q Consensus       109 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~  188 (580)
                      .|++++|.++...+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+
T Consensus       175 ~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~  253 (305)
T d1xkua_         175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN  253 (305)
T ss_dssp             EEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSC
T ss_pred             EEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCc
Confidence            7777777777777777888888888888888888777788888888888888888888 567788888888888888888


Q ss_pred             ccCCCCCC-------CCCccCccccCCCCccccC
Q 038098          189 LEGEIPNK-------GPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       189 l~~~~~~~-------~~~~~l~~~~~~~n~~~c~  215 (580)
                      |+.+....       .....+..+++.+|++.+.
T Consensus       254 i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             CCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             cCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            88754322       2345566777888887653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=5e-24  Score=193.45  Aligned_cols=164  Identities=17%  Similarity=0.186  Sum_probs=120.7

Q ss_pred             CcCceeccccCceEEEEEeCCCCEEEEEEEecccc------------------chhhhHHHHHHHHhhcCCCCcceEEee
Q 038098          295 SENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYG------------------RAFKSFDIECDMIKRIRHRNIIKIISS  356 (580)
Q Consensus       295 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  356 (580)
                      .+.++||+|+||+||+|...+|+.||||++.....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999988899999998743210                  011334568888999999999998866


Q ss_pred             eecCCceeeEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEecCCCCCEEeCCCCcEEEccc
Q 038098          357 CSSDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  436 (580)
Q Consensus       357 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  436 (580)
                      ..    .+++|||++++.+.+        ++...+..++.|+++|++|||   +.+|+||||||+|||++++ .++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            42    379999998866543        344456689999999999999   8999999999999999965 4899999


Q ss_pred             cCccccCCCCCcccccccccCCCcCC------cccccCCCCCCchhhHhHHHHHH
Q 038098          437 GMAKPLLKEDQSLTQTQTLATIGYMA------PEYGREGQVSTNGDVYSFGIMLM  485 (580)
Q Consensus       437 g~a~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~Dvws~Gvil~  485 (580)
                      |.|.....+...          .|..      .|. ....++.++|+||..--+.
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            999755322110          0111      011 1356788999999765443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.89  E-value=1.6e-23  Score=206.15  Aligned_cols=200  Identities=27%  Similarity=0.389  Sum_probs=166.7

Q ss_pred             CCCCCEEeccCCcCCC--CCchhhhCCCCCceeeCCC-CcCCcCCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCc
Q 038098           15 LQKLQLLSLEDNQLEG--SIPDDLCRLAALFELDSGG-NKLDGFVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDIL   90 (580)
Q Consensus        15 l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~   90 (580)
                      -..++.|+|++|.+++  .+|+.+++|++|++|+|++ |++++.+|..|+++++|++|+|++|+|..++. .+..+.+|+
T Consensus        49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence            3468999999999987  4789999999999999997 89998999999999999999999999998654 577899999


Q ss_pred             eEeCcCCcc------cccCCCcccEEeCCCCcCCCCCCcccCCcccc-ceeccccccccccCC-----------------
Q 038098           91 YLDLSSNFL------LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDL-QYLFLEYNRLQGSIP-----------------  146 (580)
Q Consensus        91 ~L~l~~n~l------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~p-----------------  146 (580)
                      ++++++|.+      .+.+++.|+.+++++|.+++..|..+..+..+ +.+++++|++++..|                 
T Consensus       129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~  208 (313)
T d1ogqa_         129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM  208 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSE
T ss_pred             ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999987      47789999999999999998888888877765 777888777765544                 


Q ss_pred             ------cccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCC-CCCCccCccccCCCCccccC
Q 038098          147 ------DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPN-KGPFRNFSTESFEGNELLCG  215 (580)
Q Consensus       147 ------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~  215 (580)
                            ..+..+++++.|++++|.+++.+| .+..+++|+.|++++|++++.+|. ...+++++.+++++|.....
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~  283 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE  283 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccccc
Confidence                  344455778888888888886554 577788899999999999876654 56778888888888876543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.86  E-value=4.1e-21  Score=187.92  Aligned_cols=188  Identities=22%  Similarity=0.293  Sum_probs=161.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCc----------------------
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPA----------------------   58 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~----------------------   58 (580)
                      +|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|++|++++|+|+.+...                      
T Consensus        40 ~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~  119 (305)
T d1xkua_          40 NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV  119 (305)
T ss_dssp             SSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHH
T ss_pred             CCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccchhhhhhhh
Confidence            5888877777899999999999999999988899999999999999999987633211                      


Q ss_pred             -------------------------cccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcc------cccCCCcc
Q 038098           59 -------------------------CFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFL------LIGNLKVL  107 (580)
Q Consensus        59 -------------------------~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l------~~~~l~~L  107 (580)
                                               .|..+++|+.+++++|+++.+|..+  .++|+.|++++|.+      .+.+++.+
T Consensus       120 ~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l  197 (305)
T d1xkua_         120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL  197 (305)
T ss_dssp             HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTC
T ss_pred             hhccccccccccccccccccCCCccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccc
Confidence                                     1244678888999999988887655  57899999999987      47788999


Q ss_pred             cEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccc------ccccCcccE
Q 038098          108 VQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPIS------LEKLLDLKD  181 (580)
Q Consensus       108 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~------~~~l~~L~~  181 (580)
                      +.|++++|.+++..+..|.++++|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+......      ...+++|+.
T Consensus       198 ~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~  276 (305)
T d1xkua_         198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG  276 (305)
T ss_dssp             CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSE
T ss_pred             cccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCE
Confidence            99999999999999999999999999999999999 77889999999999999999999654333      346788999


Q ss_pred             EEccCCcccC
Q 038098          182 INVSFNKLEG  191 (580)
Q Consensus       182 l~l~~N~l~~  191 (580)
                      |++++|+++.
T Consensus       277 L~L~~N~~~~  286 (305)
T d1xkua_         277 VSLFSNPVQY  286 (305)
T ss_dssp             EECCSSSSCG
T ss_pred             EECCCCcCcc
Confidence            9999999874

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=2.6e-20  Score=171.22  Aligned_cols=162  Identities=27%  Similarity=0.383  Sum_probs=132.8

Q ss_pred             CCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEe
Q 038098           14 KLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLD   93 (580)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~   93 (580)
                      .+.+|+.|++++|.++. ++ .+..+++|++|+|++|+|+++.  .++++++|++|++++|+|+.+| .+..+++|+.|+
T Consensus        44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEE
T ss_pred             HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-cccccccccccc
Confidence            47789999999999984 33 4788999999999999998653  4788999999999999999887 477889999999


Q ss_pred             CcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCc
Q 038098           94 LSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTI  169 (580)
Q Consensus        94 l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  169 (580)
                      +++|.+    .+..++.++.++++.|.++..  ..+..+++|+.+++++|.+++ ++. +.++++|+.|+|++|+|++ +
T Consensus       119 l~~~~~~~~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~~-l  193 (210)
T d1h6ta2         119 LEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISD-L  193 (210)
T ss_dssp             CTTSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCB-C
T ss_pred             ccccccccccccccccccccccccccccccc--ccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCCC-C
Confidence            999887    366788889999999988754  456678889999999999884 443 7888899999999999884 4


Q ss_pred             cccccccCcccEEEccC
Q 038098          170 PISLEKLLDLKDINVSF  186 (580)
Q Consensus       170 ~~~~~~l~~L~~l~l~~  186 (580)
                      | .+..+++|+.|++++
T Consensus       194 ~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         194 R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             G-GGTTCTTCSEEEEEE
T ss_pred             h-hhcCCCCCCEEEccC
Confidence            4 588889999998864

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.81  E-value=3.4e-20  Score=167.96  Aligned_cols=176  Identities=23%  Similarity=0.260  Sum_probs=116.5

Q ss_pred             CCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCc-CCCccccCCCCCcEEEcCCCCCCCCCC-CCcCCCCCceEeCc
Q 038098           18 LQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDG-FVPACFGNLTNLRNLYLGSNKLTSIPS-TLWNLKDILYLDLS   95 (580)
Q Consensus        18 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~lp~-~~~~l~~L~~L~l~   95 (580)
                      .++++.++|+++ .+|..+.  +++++|+|++|+|++ +.+..|.++++|++|+|++|+++.++. .+..+++|      
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L------   80 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI------   80 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC------
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccc------
Confidence            467899999998 5666554  588999999999975 446678889999999999999988765 44445555      


Q ss_pred             CCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCccccccc
Q 038098           96 SNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEK  175 (580)
Q Consensus        96 ~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  175 (580)
                                  +.|+|++|+|+.+++.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+ ...-
T Consensus        81 ------------~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~  147 (192)
T d1w8aa_          81 ------------QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWF  147 (192)
T ss_dssp             ------------CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHH
T ss_pred             ------------ceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHH
Confidence                        555555555556666667777777777777777775556666677777777777777663321 1111


Q ss_pred             cCcccEEEccCCcccCCCCCCCCCccCccccCCCCccccCCC
Q 038098          176 LLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLCGMP  217 (580)
Q Consensus       176 l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~p  217 (580)
                      ...++.+.+..|.+++..|.  .+..+...++..|.+.|..+
T Consensus       148 ~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         148 AEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             HHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC
T ss_pred             hhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCCC
Confidence            23455556666666665543  24445555666666666544

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=1.1e-19  Score=165.69  Aligned_cols=148  Identities=26%  Similarity=0.443  Sum_probs=70.9

Q ss_pred             CCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeC
Q 038098           15 LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDL   94 (580)
Q Consensus        15 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l   94 (580)
                      +++|++|++++|.|+. + +.+..+++|++|+|++|+|++..+  ++++++|++|++++|.+..++. +.++++|+    
T Consensus        39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~----  109 (199)
T d2omxa2          39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLT----  109 (199)
T ss_dssp             HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCS----
T ss_pred             hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccccc-cccccccc----
Confidence            4455555555555542 2 234455555555555555553321  5555555555555555555432 44444454    


Q ss_pred             cCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccccc
Q 038098           95 SSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE  174 (580)
Q Consensus        95 ~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~  174 (580)
                                    .|++++|.+...  ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++..  .+.
T Consensus       110 --------------~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~  169 (199)
T d2omxa2         110 --------------GLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK--PLA  169 (199)
T ss_dssp             --------------EEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred             --------------cccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCc--ccc
Confidence                          444444444432  22444455555555555554 222 2444455555555555555321  244


Q ss_pred             ccCcccEEEccCCcccC
Q 038098          175 KLLDLKDINVSFNKLEG  191 (580)
Q Consensus       175 ~l~~L~~l~l~~N~l~~  191 (580)
                      .+++|+.|++++|+++.
T Consensus       170 ~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         170 NLTTLERLDISSNKVSD  186 (199)
T ss_dssp             TCTTCCEEECCSSCCCC
T ss_pred             CCCCCCEEECCCCCCCC
Confidence            55555555555555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=7.3e-20  Score=165.73  Aligned_cols=171  Identities=25%  Similarity=0.304  Sum_probs=133.7

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCC-CCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEG-SIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      +|+++ .+|..+.  +++++|+|++|+|+. ..+..|.++++|++|+|++|.+..+.++.|..+++|++|+|++|+|+.+
T Consensus        17 ~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l   93 (192)
T d1w8aa_          17 GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI   93 (192)
T ss_dssp             TSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEE
T ss_pred             CCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccccc
Confidence            46677 6676664  789999999999975 4567889999999999999999999999999999999999999999999


Q ss_pred             CCC-CcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccc
Q 038098           80 PST-LWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSL  158 (580)
Q Consensus        80 p~~-~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  158 (580)
                      |.. |.+++                  +|++|+|++|+|+++.+.+|..+++|++|+|++|.+....+. ..-...++.+
T Consensus        94 ~~~~F~~l~------------------~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~  154 (192)
T d1w8aa_          94 SNKMFLGLH------------------QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKK  154 (192)
T ss_dssp             CSSSSTTCT------------------TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHH
T ss_pred             CHHHHhCCC------------------cccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhh
Confidence            764 44454                  456777777777778888898999999999999988743221 1112457778


Q ss_pred             cccccccCCCccccccccCcccEEEccCCcccCCCCCC
Q 038098          159 NLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK  196 (580)
Q Consensus       159 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  196 (580)
                      .+..|.++...|..+   ..++.++++.|.++|..+..
T Consensus       155 ~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~~~~~  189 (192)
T d1w8aa_         155 SLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSENS  189 (192)
T ss_dssp             CCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCCCC--
T ss_pred             cccCCCeEeCCChhh---cCCEeeecCHhhCcCCCCCC
Confidence            888888887666554   45667788899998876643

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=1.5e-19  Score=168.40  Aligned_cols=185  Identities=23%  Similarity=0.379  Sum_probs=155.4

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCc
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDIL   90 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~   90 (580)
                      .+..|.+|+.|++++|+|+. ++ .+..+++|++|+|++|.+++..+  |..+++|++|++++|.++.++ .+..+++|+
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i~-~l~~l~~L~  110 (227)
T d1h6ua2          36 TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS-AIAGLQSIK  110 (227)
T ss_dssp             CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG-GGTTCTTCC
T ss_pred             CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccccc-ccccccccc
Confidence            45678999999999999984 44 58999999999999999996543  999999999999999999886 577899999


Q ss_pred             eEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccC
Q 038098           91 YLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLS  166 (580)
Q Consensus        91 ~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~  166 (580)
                      ++++++|..    .+...+.+..+.++++.+...  ..+..+++|+.|++++|.+++. + .+..+++|+.|+|++|+++
T Consensus       111 ~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~  186 (227)
T d1h6ua2         111 TLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKIS  186 (227)
T ss_dssp             EEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             ccccccccccccchhccccchhhhhchhhhhchh--hhhccccccccccccccccccc-h-hhcccccceecccCCCccC
Confidence            999999987    356788999999999998754  3467789999999999999843 3 3888999999999999999


Q ss_pred             CCccccccccCcccEEEccCCcccCCCCCCCCCccCccccC
Q 038098          167 GTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESF  207 (580)
Q Consensus       167 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~  207 (580)
                      +. + .+..+++|+.|++++|+++...+ ...++++..+++
T Consensus       187 ~l-~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~l  224 (227)
T d1h6ua2         187 DI-S-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTL  224 (227)
T ss_dssp             CC-G-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEE
T ss_pred             CC-h-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEe
Confidence            64 3 38899999999999999997654 445666665554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=9e-20  Score=166.14  Aligned_cols=168  Identities=25%  Similarity=0.370  Sum_probs=127.6

Q ss_pred             CCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeC
Q 038098           15 LQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDL   94 (580)
Q Consensus        15 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l   94 (580)
                      +.++..+.++.+.+++.++  ...+.++++|++++|.|+.+  ..+..+++|++|+|++|+|+.++. +.++++|     
T Consensus        17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L-----   86 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP-LKNLTKL-----   86 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTC-----
T ss_pred             HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc-ccCCccc-----
Confidence            3444556777777774433  34567888888888888854  347778888888888888887754 5455544     


Q ss_pred             cCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccccccCCCcccccc
Q 038098           95 SSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE  174 (580)
Q Consensus        95 ~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~  174 (580)
                                   +.|++++|.+..+  ..+.+++.|+.|++++|.+.. + ..+..+++|+.|++++|++.. ++ .+.
T Consensus        87 -------------~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~l~  147 (199)
T d2omxa2          87 -------------VDILMNNNQIADI--TPLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTISD-IS-ALS  147 (199)
T ss_dssp             -------------CEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-GGT
T ss_pred             -------------ccccccccccccc--ccccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhcc-cc-ccc
Confidence                         5666666666544  247889999999999999884 3 347889999999999999984 43 588


Q ss_pred             ccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcc
Q 038098          175 KLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       175 ~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~  212 (580)
                      .+++|+.|++++|+++...+ ...+++++.+++++|+.
T Consensus       148 ~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         148 GLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKV  184 (199)
T ss_dssp             TCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred             ccccccccccccccccCCcc-ccCCCCCCEEECCCCCC
Confidence            99999999999999987654 56788999999998864

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=1.8e-18  Score=161.01  Aligned_cols=173  Identities=27%  Similarity=0.380  Sum_probs=148.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|+.+  +.|..+++|++|+|++|.|++..|  +..+++|++|++++|.++.+  ..+.++++|+.+++++|....++
T Consensus        50 ~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~  123 (227)
T d1h6ua2          50 GTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT  123 (227)
T ss_dssp             TSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG
T ss_pred             CCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            5777754  369999999999999999985433  89999999999999999854  46889999999999999988764


Q ss_pred             CCCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                       .+...+.+..+.++.+.+    .+.++++|+.|++++|.++..  ..+.++++|+.|+|++|++++ ++. +..+++|+
T Consensus       124 -~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~  198 (227)
T d1h6ua2         124 -PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-ISP-LASLPNLI  198 (227)
T ss_dssp             -GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCC
T ss_pred             -hhccccchhhhhchhhhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCC-Chh-hcCCCCCC
Confidence             356678999999999988    367888999999999999865  348899999999999999984 443 88999999


Q ss_pred             cccccccccCCCccccccccCcccEEEccC
Q 038098          157 SLNLSNNNLSGTIPISLEKLLDLKDINVSF  186 (580)
Q Consensus       157 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~  186 (580)
                      +|+|++|++++..|  +..+++|+.|++++
T Consensus       199 ~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         199 EVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             EEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             EEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            99999999995443  88999999999973

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=1.3e-18  Score=175.66  Aligned_cols=192  Identities=27%  Similarity=0.435  Sum_probs=162.4

Q ss_pred             CCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCC
Q 038098            7 SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNL   86 (580)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l   86 (580)
                      .....+..+++++.|++++|.+++..|  +..+++|++|++++|.++..  +.+..+++|+.|++++|+++.++. +..+
T Consensus       188 ~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~~  262 (384)
T d2omza2         188 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGL  262 (384)
T ss_dssp             CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTC
T ss_pred             ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc-cccc
Confidence            345677889999999999999986544  46678999999999999853  468899999999999999999864 7788


Q ss_pred             CCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccccccccc
Q 038098           87 KDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSN  162 (580)
Q Consensus        87 ~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  162 (580)
                      ++|++|++++|++    .+..++.++.++++.|.+++.  ..+..+++++.|++++|++++. + .+..+++|+.|++++
T Consensus       263 ~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~  338 (384)
T d2omza2         263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFAN  338 (384)
T ss_dssp             TTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCS
T ss_pred             ccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCC
Confidence            9999999999998    367788999999999999864  4578889999999999999954 3 388899999999999


Q ss_pred             cccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCC
Q 038098          163 NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGN  210 (580)
Q Consensus       163 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n  210 (580)
                      |+|++ ++ .+..+++|+.|++++|++++.+| ...+++++.+++++|
T Consensus       339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            99985 44 58899999999999999998776 556778888888776

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=4.4e-18  Score=171.57  Aligned_cols=174  Identities=33%  Similarity=0.518  Sum_probs=144.4

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|.++++.|  +...++|++|++++|.++. + +.+..+++|++|++++|.+++..  .+..+++|++|++++|+++.++
T Consensus       206 ~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~  279 (384)
T d2omza2         206 NNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS  279 (384)
T ss_dssp             SSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG
T ss_pred             CCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC
Confidence            356666654  5667899999999999983 3 46888899999999999998653  3888899999999999998876


Q ss_pred             CCCcCCCCCceEeCcCCcc----cccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFL----LIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                      . +..++.++.++++.|.+    .+..+++++.|++++|+++++.  .+..+++|+.|++++|+|+ .++ .+.++++|+
T Consensus       280 ~-~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~  354 (384)
T d2omza2         280 P-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNIN  354 (384)
T ss_dssp             G-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCC
T ss_pred             c-cccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCC
Confidence            4 66788899999999987    3677889999999999998764  3788899999999999998 444 588899999


Q ss_pred             cccccccccCCCccccccccCcccEEEccCC
Q 038098          157 SLNLSNNNLSGTIPISLEKLLDLKDINVSFN  187 (580)
Q Consensus       157 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N  187 (580)
                      +|++++|++++..|  +.++++|+.|++++|
T Consensus       355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             EEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            99999999996654  788999999999987

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=2.1e-18  Score=162.38  Aligned_cols=199  Identities=17%  Similarity=0.158  Sum_probs=156.7

Q ss_pred             ccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCc-CCCccccCCCCCcEEEcC-CCCCCCCC
Q 038098            3 NLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDG-FVPACFGNLTNLRNLYLG-SNKLTSIP   80 (580)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~-~N~l~~lp   80 (580)
                      +++ .+|..+.  +++++|+|++|+|+.+.++.|.++++|++|+|++|.+.. +.+..|.+++++++|.+. .|++..++
T Consensus        19 ~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~   95 (242)
T d1xwdc1          19 KVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYIN   95 (242)
T ss_dssp             SCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEEC
T ss_pred             CCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccc
Confidence            455 6776654  689999999999997777789999999999999999875 456689999999999986 46788766


Q ss_pred             C-CCcCCCCCceEeCcCCccc-------ccCCCcccEEeCCCCcCCCCCCcccCCcc-ccceeccccccccccCCccccc
Q 038098           81 S-TLWNLKDILYLDLSSNFLL-------IGNLKVLVQVDLSMNNFSDVIPTTIGGLK-DLQYLFLEYNRLQGSIPDSIGD  151 (580)
Q Consensus        81 ~-~~~~l~~L~~L~l~~n~l~-------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~  151 (580)
                      . .+.++++|++|++++|++.       ...+..+..+..+++.+..+.+..|.+++ .++.|++++|+++...+..| .
T Consensus        96 ~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~  174 (242)
T d1xwdc1          96 PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-N  174 (242)
T ss_dssp             TTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-T
T ss_pred             cccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-c
Confidence            4 5678999999999999882       33456667778888899888888888775 79999999999995444444 4


Q ss_pred             ccccc-cccccccccCCCccccccccCcccEEEccCCcccCCCCCC-CCCccCccc
Q 038098          152 LINLK-SLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNK-GPFRNFSTE  205 (580)
Q Consensus       152 l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~  205 (580)
                      ..++. .+++++|+++...+..|..+++|+.|++++|+++..++.. ..++.++.+
T Consensus       175 ~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l  230 (242)
T d1xwdc1         175 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR  230 (242)
T ss_dssp             TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred             chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence            45554 4568889999666777999999999999999999776543 334444433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=7.3e-18  Score=154.64  Aligned_cols=151  Identities=27%  Similarity=0.384  Sum_probs=130.5

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+|++..  .+..+++|++|+|++|.|++ ++ .++.+++|++|++++|+|+++ + .+.++++|+.|++++|.+..++
T Consensus        55 ~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~~  128 (210)
T d1h6ta2          55 NSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISDIN  128 (210)
T ss_dssp             TSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCCG
T ss_pred             CCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccccc-c-cccccccccccccccccccccc
Confidence            35666543  48889999999999999985 44 478999999999999999964 3 5899999999999999998875


Q ss_pred             CCCcCCCCCceEeCcCCccc----ccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCcccccccccc
Q 038098           81 STLWNLKDILYLDLSSNFLL----IGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLK  156 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  156 (580)
                       .+..+++|+.+++++|.+.    +..+++|+.+++++|+++++.  .+.++++|+.|+|++|+|+ .+| .+.++++|+
T Consensus       129 -~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~  203 (210)
T d1h6ta2         129 -GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLD  203 (210)
T ss_dssp             -GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCS
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCC
Confidence             5778999999999999983    667899999999999998763  4889999999999999998 555 589999999


Q ss_pred             cccccc
Q 038098          157 SLNLSN  162 (580)
Q Consensus       157 ~L~l~~  162 (580)
                      .|+|++
T Consensus       204 ~L~Ls~  209 (210)
T d1h6ta2         204 VLELFS  209 (210)
T ss_dssp             EEEEEE
T ss_pred             EEEccC
Confidence            999975

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=8.2e-18  Score=158.21  Aligned_cols=186  Identities=18%  Similarity=0.182  Sum_probs=150.7

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCC-CchhhhCCCCCceeeCC-CCcCCcCCCccccCCCCCcEEEcCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGS-IPDDLCRLAALFELDSG-GNKLDGFVPACFGNLTNLRNLYLGSNKLTS   78 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~   78 (580)
                      +|+|+++.+.+|.++++|++|+|++|.+... .++.|.+++++++|.+. .|.+....+..|.++++|++|++++|++..
T Consensus        38 ~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          38 LTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             CCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhcc
Confidence            5888877777899999999999999998754 45678999999999876 478888888999999999999999999998


Q ss_pred             CCC--CCcCCCCCceEeCcCCcc------cccCCC-cccEEeCCCCcCCCCCCcccCCccccceeccccccccccCCccc
Q 038098           79 IPS--TLWNLKDILYLDLSSNFL------LIGNLK-VLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIPDSI  149 (580)
Q Consensus        79 lp~--~~~~l~~L~~L~l~~n~l------~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~  149 (580)
                      .+.  .+..+..+..+..+++.+      .+.+++ .++.|++++|+++.+.+..|.....++.+++++|.++...+..|
T Consensus       118 ~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f  197 (242)
T d1xwdc1         118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF  197 (242)
T ss_dssp             CCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHh
Confidence            764  334567777777777776      244444 78899999999998777776654445556788899995545678


Q ss_pred             ccccccccccccccccCCCccccccccCcccEEEccC
Q 038098          150 GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF  186 (580)
Q Consensus       150 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~  186 (580)
                      .++++|+.|+|++|+|+...+..|.++++|+.+++.+
T Consensus       198 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             TTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             cCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            9999999999999999976677788888888877644

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=9.3e-17  Score=140.11  Aligned_cols=127  Identities=20%  Similarity=0.261  Sum_probs=74.5

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCc-CCCCC
Q 038098           11 AVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLW-NLKDI   89 (580)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~-~l~~L   89 (580)
                      .|.++.+|+.|+|++|+|+ .+++.+..+++|++|+|++|.|+.+  +.|..+++|++|+|++|+|+.+|..++ .+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            4556667777777777776 3455566677777777777777754  346677777777777777777665433 34444


Q ss_pred             ceEeCcCCcccccCCCcccEEeCCCCcCCCCCC-cccCCccccceeccccccccccCCc----cccccccccccc
Q 038098           90 LYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIPD----SIGDLINLKSLN  159 (580)
Q Consensus        90 ~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~----~~~~l~~L~~L~  159 (580)
                                        ++|++++|+++.+.. ..+..+++|+.|++++|+++ ..|.    .+..+++|+.||
T Consensus        90 ------------------~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 ------------------TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             ------------------CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             ------------------ccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence                              444444444443321 34555566666666666665 3332    244455555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=1.6e-16  Score=138.50  Aligned_cols=126  Identities=18%  Similarity=0.182  Sum_probs=89.9

Q ss_pred             hhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCC
Q 038098           36 LCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMN  115 (580)
Q Consensus        36 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N  115 (580)
                      |.+..+|++|+|++|+|+.+ ++.+..+++|+.|+|++|+|++++ .+.                  .+++|+.|++++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~-~~~------------------~l~~L~~L~ls~N   73 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLD-GFP------------------LLRRLKTLLVNNN   73 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEEC-CCC------------------CCSSCCEEECCSS
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccC-Ccc------------------cCcchhhhhcccc
Confidence            45566677777777777744 555666777777777777777663 343                  3445566677777


Q ss_pred             cCCCCCCcccCCccccceeccccccccccCC--cccccccccccccccccccCCCcc----ccccccCcccEEE
Q 038098          116 NFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP--DSIGDLINLKSLNLSNNNLSGTIP----ISLEKLLDLKDIN  183 (580)
Q Consensus       116 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~l~  183 (580)
                      +++.+.+..+..+++|+.|++++|+|+. ++  ..+..+++|+.|++++|.++. .|    ..+..+|+|+.||
T Consensus        74 ~i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          74 RICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             cccCCCccccccccccccceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            7776666667778899999999999884 33  467788899999999998873 33    2477788888876

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.62  E-value=6.2e-16  Score=128.18  Aligned_cols=118  Identities=22%  Similarity=0.236  Sum_probs=84.0

Q ss_pred             CEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCc
Q 038098           19 QLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNF   98 (580)
Q Consensus        19 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~   98 (580)
                      ++|+|++|+|+ .++ .+..+++|++|++++|+|+. +|..|+.+++|++|++++|+|+.+|. +..+++|         
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L---------   67 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDG-VANLPRL---------   67 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSC---------
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccccCc-ccccccc---------
Confidence            57899999998 444 48888999999999999984 56678889999999999999988863 5555555         


Q ss_pred             ccccCCCcccEEeCCCCcCCCCC-CcccCCccccceeccccccccccC---Ccccccccccccc
Q 038098           99 LLIGNLKVLVQVDLSMNNFSDVI-PTTIGGLKDLQYLFLEYNRLQGSI---PDSIGDLINLKSL  158 (580)
Q Consensus        99 l~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~---p~~~~~l~~L~~L  158 (580)
                               ++|++++|+++... ...+..+++|+.|++++|++++..   ...+..+++|+.|
T Consensus        68 ---------~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          68 ---------QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             ---------CEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ---------CeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence                     55555555555543 245777788888888888887321   1223345666554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=1e-15  Score=126.78  Aligned_cols=118  Identities=27%  Similarity=0.261  Sum_probs=91.3

Q ss_pred             ceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCC
Q 038098           43 FELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP  122 (580)
Q Consensus        43 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~  122 (580)
                      ++|+|++|+|+.+ + .+..+++|++|++++|+|+++|..+..+++|                  +.|++++|.|+++  
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L------------------~~L~l~~N~i~~l--   58 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRALPPALAALRCL------------------EVLQASDNALENV--   58 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTC------------------CEEECCSSCCCCC--
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCcchhhhhhhhcc------------------ccccccccccccc--
Confidence            5799999999944 4 4899999999999999999998777666666                  5555555556554  


Q ss_pred             cccCCccccceeccccccccccC-CcccccccccccccccccccCCCc---cccccccCcccEE
Q 038098          123 TTIGGLKDLQYLFLEYNRLQGSI-PDSIGDLINLKSLNLSNNNLSGTI---PISLEKLLDLKDI  182 (580)
Q Consensus       123 ~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~l  182 (580)
                      +.+..+++|+.|++++|+|++.. ...+..+++|+.|++++|++++..   ......+|+|+.|
T Consensus        59 ~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            35889999999999999998433 256889999999999999998432   2334456777765

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.57  E-value=3.3e-14  Score=140.73  Aligned_cols=194  Identities=24%  Similarity=0.239  Sum_probs=124.2

Q ss_pred             CCccccCCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCC
Q 038098            1 GNNLNGSIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIP   80 (580)
Q Consensus         1 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp   80 (580)
                      +|+++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|++|++++|+++.+ +..   .++|++|++++|+|+.+|
T Consensus        47 ~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~~n~l~~lp  114 (353)
T d1jl5a_          47 NLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEKLP  114 (353)
T ss_dssp             TSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSSCC
T ss_pred             CCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhh---cccccccccccccccccc
Confidence            35565 56743   568899999999998 567554   4678888888887743 221   145888888888888887


Q ss_pred             CCCcCCCCCceEeCcCCcc------------------------cccCCCcccEEeCCCCcCCCCC---------------
Q 038098           81 STLWNLKDILYLDLSSNFL------------------------LIGNLKVLVQVDLSMNNFSDVI---------------  121 (580)
Q Consensus        81 ~~~~~l~~L~~L~l~~n~l------------------------~~~~l~~L~~L~l~~N~l~~~~---------------  121 (580)
                      . +..+++|+.|++++|.+                        .+..++.++.|++++|.+....               
T Consensus       115 ~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~  193 (353)
T d1jl5a_         115 E-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNI  193 (353)
T ss_dssp             C-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSC
T ss_pred             c-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccc
Confidence            4 46678888888877765                        1223445555555555443211               


Q ss_pred             ---CcccCCccccceecccccccccc------------------------------------------C-----------
Q 038098          122 ---PTTIGGLKDLQYLFLEYNRLQGS------------------------------------------I-----------  145 (580)
Q Consensus       122 ---~~~~~~l~~L~~L~l~~n~l~~~------------------------------------------~-----------  145 (580)
                         ...+..++.|+.+++++|.....                                          .           
T Consensus       194 ~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~  273 (353)
T d1jl5a_         194 LEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS  273 (353)
T ss_dssp             CSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhccccccc
Confidence               01123344555555554433210                                          0           


Q ss_pred             ---CcccccccccccccccccccCCCccccccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcccc
Q 038098          146 ---PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNELLC  214 (580)
Q Consensus       146 ---p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c  214 (580)
                         +.....+++|++|+|++|+|+ .+|..   +++|+.|++++|+|+..+..   ..+++.+++++|+...
T Consensus       274 ~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         274 NEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAEVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             SCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSS
T ss_pred             CccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCccccc---cCCCCEEECcCCcCCC
Confidence               000111368999999999999 56643   57899999999999965432   4578888899998643

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.53  E-value=8.4e-17  Score=145.48  Aligned_cols=151  Identities=22%  Similarity=0.273  Sum_probs=99.4

Q ss_pred             CCCCCEEeccCC--cCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceE
Q 038098           15 LQKLQLLSLEDN--QLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYL   92 (580)
Q Consensus        15 l~~L~~L~L~~n--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L   92 (580)
                      ...++.+++.++  .++ .+|..+..|++|++|+|++|+|+.+ + .|..+++|++|+|++|+|+.+|.....+++|++|
T Consensus        22 ~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L   98 (198)
T d1m9la_          22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEEL   98 (198)
T ss_dssp             CTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEE
T ss_pred             ccccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccc
Confidence            345667777765  354 5778899999999999999999965 3 5888999999999999999887544344455555


Q ss_pred             eCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceeccccccccccCC-cccccccccccccccccccCCCccc
Q 038098           93 DLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQGSIP-DSIGDLINLKSLNLSNNNLSGTIPI  171 (580)
Q Consensus        93 ~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~  171 (580)
                      ++++|+                  ++.+  ..+..+++|+.|+|++|+|++... ..+..+++|+.|+|++|++....+.
T Consensus        99 ~l~~N~------------------i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_          99 WISYNQ------------------IASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             ECSEEE------------------CCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             cccccc------------------cccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence            555554                  4432  235556666666666666663211 3456666666666666666533222


Q ss_pred             c----------ccccCcccEEEccCCccc
Q 038098          172 S----------LEKLLDLKDINVSFNKLE  190 (580)
Q Consensus       172 ~----------~~~l~~L~~l~l~~N~l~  190 (580)
                      .          +..+|+|+.||  +.+++
T Consensus       159 ~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         159 NNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             TTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             ccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            1          45677888765  44444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=3.3e-14  Score=122.82  Aligned_cols=93  Identities=25%  Similarity=0.148  Sum_probs=70.3

Q ss_pred             CCCcccCCCCCCCEEeccCC-cCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcC
Q 038098            7 SIPIAVGKLQKLQLLSLEDN-QLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWN   85 (580)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~   85 (580)
                      ..|..+..+++|+.|+|++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+|+++|...+.
T Consensus        22 ~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  101 (156)
T d2ifga3          22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ  101 (156)
T ss_dssp             TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC
T ss_pred             cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhc
Confidence            45677777788888888655 47766667788888888888888888877777788888888888888888888776665


Q ss_pred             CCCCceEeCcCCcc
Q 038098           86 LKDILYLDLSSNFL   99 (580)
Q Consensus        86 l~~L~~L~l~~n~l   99 (580)
                      ..+|+.|+|++|.+
T Consensus       102 ~~~l~~L~L~~Np~  115 (156)
T d2ifga3         102 GLSLQELVLSGNPL  115 (156)
T ss_dssp             SCCCCEEECCSSCC
T ss_pred             cccccccccCCCcc
Confidence            55677777777765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=7.7e-15  Score=140.77  Aligned_cols=176  Identities=20%  Similarity=0.172  Sum_probs=138.6

Q ss_pred             cCCCCCCCEEeccCCcCCCC-CchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCC-CCCC--CCCCCcCCC
Q 038098           12 VGKLQKLQLLSLEDNQLEGS-IPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSN-KLTS--IPSTLWNLK   87 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~--lp~~~~~l~   87 (580)
                      .....+|++|||++|.++.. ++..+..+++|++|+|++|.++...+..+..+++|++|+|+++ .++.  +..-+.+++
T Consensus        42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~  121 (284)
T d2astb2          42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  121 (284)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence            34567899999999998743 4556788999999999999998777788999999999999995 6664  222234689


Q ss_pred             CCceEeCcCCc-cc-------c-cCCCcccEEeCCCC--cCCCCC-CcccCCccccceeccccc-cccccCCcccccccc
Q 038098           88 DILYLDLSSNF-LL-------I-GNLKVLVQVDLSMN--NFSDVI-PTTIGGLKDLQYLFLEYN-RLQGSIPDSIGDLIN  154 (580)
Q Consensus        88 ~L~~L~l~~n~-l~-------~-~~l~~L~~L~l~~N--~l~~~~-~~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~  154 (580)
                      +|++|+++++. ++       + ...++|+.|+++++  .++... ...+..+++|++|+|++| .+++.....+..+++
T Consensus       122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~  201 (284)
T d2astb2         122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY  201 (284)
T ss_dssp             TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence            99999999864 31       2 23578999999975  344322 223456899999999997 477777788889999


Q ss_pred             ccccccccc-ccCCCccccccccCcccEEEccCC
Q 038098          155 LKSLNLSNN-NLSGTIPISLEKLLDLKDINVSFN  187 (580)
Q Consensus       155 L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N  187 (580)
                      |++|+|+++ .+++.....+.++++|+.|+++++
T Consensus       202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            999999994 688777777889999999999987

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.45  E-value=1.1e-12  Score=129.51  Aligned_cols=183  Identities=22%  Similarity=0.207  Sum_probs=133.0

Q ss_pred             CCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCCCCCceEeCc
Q 038098           16 QKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNLKDILYLDLS   95 (580)
Q Consensus        16 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l~~L~~L~l~   95 (580)
                      .++++|||++|.++ .+|+.   .++|++|+|++|+|+ .+|..   +.+|+.|++++|+++.++.-.   +.|++|+++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~lp---~~L~~L~L~  106 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSDLP---PLLEYLGVS  106 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCSCC---TTCCEEECC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhhhc---ccccccccc
Confidence            46899999999998 57754   478999999999999 45655   468999999999999886422   469999999


Q ss_pred             CCcc----cccCCCcccEEeCCCCcCCCCCC------------------cccCCccccceeccccccccccC--------
Q 038098           96 SNFL----LIGNLKVLVQVDLSMNNFSDVIP------------------TTIGGLKDLQYLFLEYNRLQGSI--------  145 (580)
Q Consensus        96 ~n~l----~~~~l~~L~~L~l~~N~l~~~~~------------------~~~~~l~~L~~L~l~~n~l~~~~--------  145 (580)
                      +|.+    .+..+++|+.|++++|.+.....                  ..+..++.++.|++++|.+....        
T Consensus       107 ~n~l~~lp~~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~  186 (353)
T d1jl5a_         107 NNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLES  186 (353)
T ss_dssp             SSCCSSCCCCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCE
T ss_pred             ccccccccchhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccc
Confidence            9998    35678999999999998864322                  23455677788888888765311        


Q ss_pred             ----------CcccccccccccccccccccCCCcc----------------------c----------------------
Q 038098          146 ----------PDSIGDLINLKSLNLSNNNLSGTIP----------------------I----------------------  171 (580)
Q Consensus       146 ----------p~~~~~l~~L~~L~l~~N~l~~~~~----------------------~----------------------  171 (580)
                                ...+..++.|+.+++++|.......                      .                      
T Consensus       187 l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~  266 (353)
T d1jl5a_         187 IVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL  266 (353)
T ss_dssp             EECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence                      1123446777777777766542110                      0                      


Q ss_pred             ------------cccccCcccEEEccCCcccCCCCCCCCCccCccccCCCCcc
Q 038098          172 ------------SLEKLLDLKDINVSFNKLEGEIPNKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       172 ------------~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~  212 (580)
                                  ....+++|++|++++|+++..+..   +++++.+++++|..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~L  316 (353)
T d1jl5a_         267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHL  316 (353)
T ss_dssp             CEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCC
T ss_pred             cccccccCccccccccCCCCCEEECCCCccCccccc---cCCCCEEECCCCcC
Confidence                        001135799999999999976533   57788888887764

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=2.5e-13  Score=117.18  Aligned_cols=110  Identities=22%  Similarity=0.163  Sum_probs=75.4

Q ss_pred             CCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCC-cCCcCCCccccCCCCCcEEEcCCCCCCCCCCC-CcCCCCCc
Q 038098           13 GKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGN-KLDGFVPACFGNLTNLRNLYLGSNKLTSIPST-LWNLKDIL   90 (580)
Q Consensus        13 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~-~~~l~~L~   90 (580)
                      ......+.++.+++++. ..|..+..+++|++|++++| .|+.+.++.|.++++|+.|+|++|+|+.++.. |..+++| 
T Consensus         5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L-   82 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL-   82 (156)
T ss_dssp             SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC-
T ss_pred             CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc-
Confidence            34455677888888887 56777778888888888665 48877777888888888888888888887543 4344444 


Q ss_pred             eEeCcCCcccccCCCcccEEeCCCCcCCCCCCcccCCccccceecccccccc
Q 038098           91 YLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIPTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus        91 ~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  142 (580)
                                       +.|+|++|+|+.+.+..|..+ .|+.|+|++|.+.
T Consensus        83 -----------------~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          83 -----------------SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             -----------------CEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             -----------------cceeccCCCCcccChhhhccc-cccccccCCCccc
Confidence                             555555555555555555443 5777777777764

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.44  E-value=3.2e-16  Score=141.63  Aligned_cols=136  Identities=22%  Similarity=0.306  Sum_probs=96.3

Q ss_pred             CCCcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCCcCCcCCCccccCCCCCcEEEcCCCCCCCCCCCCcCC
Q 038098            7 SIPIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGNKLDGFVPACFGNLTNLRNLYLGSNKLTSIPSTLWNL   86 (580)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~lp~~~~~l   86 (580)
                      .+|.+|..|++|++|+|++|+|+. ++ .|..+++|++|+|++|.|+. ++..+..+++|++|++++|+|+.++ .+..+
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l  114 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLS-GIEKL  114 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCHH-HHHHH
T ss_pred             hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-ccccccccccccccccccccccccc-ccccc
Confidence            345688999999999999999994 44 58999999999999999994 5666666788999999999999875 35555


Q ss_pred             CCCceEeCcCCcccccCCCcccEEeCCCCcCCCCCC-cccCCccccceeccccccccccCCcc----------ccccccc
Q 038098           87 KDILYLDLSSNFLLIGNLKVLVQVDLSMNNFSDVIP-TTIGGLKDLQYLFLEYNRLQGSIPDS----------IGDLINL  155 (580)
Q Consensus        87 ~~L~~L~l~~n~l~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~----------~~~l~~L  155 (580)
                      ++|+.|+|++|+|                  +.+.. ..+..+++|+.|+|++|+++...+..          +..+++|
T Consensus       115 ~~L~~L~L~~N~i------------------~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L  176 (198)
T d1m9la_         115 VNLRVLYMSNNKI------------------TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL  176 (198)
T ss_dssp             HHSSEEEESEEEC------------------CCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred             ccccccccccchh------------------ccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence            6665555555554                  43321 34566666677777766665332221          4456777


Q ss_pred             ccccccccccC
Q 038098          156 KSLNLSNNNLS  166 (580)
Q Consensus       156 ~~L~l~~N~l~  166 (580)
                      +.||  +..++
T Consensus       177 ~~LD--~~~I~  185 (198)
T d1m9la_         177 KKLD--GMPVD  185 (198)
T ss_dssp             CEES--SGGGT
T ss_pred             CEeC--CccCC
Confidence            7765  44444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.36  E-value=3.7e-14  Score=140.23  Aligned_cols=206  Identities=18%  Similarity=0.212  Sum_probs=146.9

Q ss_pred             CcccCCCCCCCEEeccCCcCCCC---Cc-------hhhhCCCCCceeeCCCCcCCcCCC----ccccCCCCCcEEEcCCC
Q 038098            9 PIAVGKLQKLQLLSLEDNQLEGS---IP-------DDLCRLAALFELDSGGNKLDGFVP----ACFGNLTNLRNLYLGSN   74 (580)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~~~---~p-------~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N   74 (580)
                      ...+...++|+.|+++++.+...   .+       ..+...++|++|+|++|.++....    ..+...++|+.|++++|
T Consensus        52 ~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n  131 (344)
T d2ca6a1          52 SENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN  131 (344)
T ss_dssp             HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSS
T ss_pred             HHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccc
Confidence            35677889999999998866522   12       345667899999999999875422    23556789999999999


Q ss_pred             CCCC-----CCCC---------CcCCCCCceEeCcCCccc----------ccCCCcccEEeCCCCcCCCC-----CCccc
Q 038098           75 KLTS-----IPST---------LWNLKDILYLDLSSNFLL----------IGNLKVLVQVDLSMNNFSDV-----IPTTI  125 (580)
Q Consensus        75 ~l~~-----lp~~---------~~~l~~L~~L~l~~n~l~----------~~~l~~L~~L~l~~N~l~~~-----~~~~~  125 (580)
                      .+..     +...         ....+.|+.|++++|.+.          +..++.|+.|+|++|.+...     ....+
T Consensus       132 ~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l  211 (344)
T d2ca6a1         132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL  211 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG
T ss_pred             cccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhh
Confidence            8753     1111         124568999999999872          45677899999999998742     23456


Q ss_pred             CCccccceecccccccccc----CCcccccccccccccccccccCCCcccc----ccc--cCcccEEEccCCcccCCC--
Q 038098          126 GGLKDLQYLFLEYNRLQGS----IPDSIGDLINLKSLNLSNNNLSGTIPIS----LEK--LLDLKDINVSFNKLEGEI--  193 (580)
Q Consensus       126 ~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~--l~~L~~l~l~~N~l~~~~--  193 (580)
                      ..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.....    +..  .+.|+.|++++|+++..-  
T Consensus       212 ~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~  291 (344)
T d2ca6a1         212 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR  291 (344)
T ss_dssp             GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH
T ss_pred             cchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHH
Confidence            6788999999999998643    3455677889999999999998643333    222  357999999999986421  


Q ss_pred             ---CCC-CCCccCccccCCCCcccc
Q 038098          194 ---PNK-GPFRNFSTESFEGNELLC  214 (580)
Q Consensus       194 ---~~~-~~~~~l~~~~~~~n~~~c  214 (580)
                         ... ...+.+..+++++|.+..
T Consensus       292 ~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         292 TLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHHHHHccCCCCCEEECCCCcCCC
Confidence               111 134567788888888744

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1.9e-13  Score=130.92  Aligned_cols=181  Identities=23%  Similarity=0.240  Sum_probs=135.6

Q ss_pred             CcccCCCCCCCEEeccCCcCCCCCchhhhCCCCCceeeCCCC-cCCcC-CCccccCCCCCcEEEcCCC-CCCC--CCCCC
Q 038098            9 PIAVGKLQKLQLLSLEDNQLEGSIPDDLCRLAALFELDSGGN-KLDGF-VPACFGNLTNLRNLYLGSN-KLTS--IPSTL   83 (580)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~--lp~~~   83 (580)
                      +..+..+++|++|+|++|.++...+..++.+++|++|+|+++ .++.. +...+.++++|++|+++++ +++.  ++..+
T Consensus        64 ~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~  143 (284)
T d2astb2          64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  143 (284)
T ss_dssp             HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             HHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhh
Confidence            345778999999999999998777888999999999999995 56532 2223567899999999996 4543  22223


Q ss_pred             c-CCCCCceEeCcCCc--c-------cccCCCcccEEeCCCC-cCCCCCCcccCCccccceeccccc-cccccCCccccc
Q 038098           84 W-NLKDILYLDLSSNF--L-------LIGNLKVLVQVDLSMN-NFSDVIPTTIGGLKDLQYLFLEYN-RLQGSIPDSIGD  151 (580)
Q Consensus        84 ~-~l~~L~~L~l~~n~--l-------~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~  151 (580)
                      . ..++|+.|+++++.  +       ...++++|++|++++| .++......+..+++|++|+|++| .+++.....+..
T Consensus       144 ~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~  223 (284)
T d2astb2         144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE  223 (284)
T ss_dssp             HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG
T ss_pred             cccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhc
Confidence            3 24789999999763  3       2456899999999986 477666778889999999999995 687766677888


Q ss_pred             ccccccccccccccCC-CccccccccCcccEEEccCCcccCCC
Q 038098          152 LINLKSLNLSNNNLSG-TIPISLEKLLDLKDINVSFNKLEGEI  193 (580)
Q Consensus       152 l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~~  193 (580)
                      +++|+.|+++++ +++ ..+.....+|+|   .+..++++...
T Consensus       224 ~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~  262 (284)
T d2astb2         224 IPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTIA  262 (284)
T ss_dssp             CTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCTT
T ss_pred             CCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCCC
Confidence            999999999998 443 223223345554   45677776543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.26  E-value=2.2e-13  Score=134.53  Aligned_cols=203  Identities=14%  Similarity=0.099  Sum_probs=149.2

Q ss_pred             CcccCCCCCCCEEeccCCcCCCC----CchhhhCCCCCceeeCCCCcCCcCC----------CccccCCCCCcEEEcCCC
Q 038098            9 PIAVGKLQKLQLLSLEDNQLEGS----IPDDLCRLAALFELDSGGNKLDGFV----------PACFGNLTNLRNLYLGSN   74 (580)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----------~~~~~~l~~L~~L~l~~N   74 (580)
                      ..++.+.+.|+.|+|++|.|...    +...+..+++|+.|+++++.+....          ...+..+++|+.|+|++|
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            34566788999999999998643    3345677899999999988765221          123567899999999999


Q ss_pred             CCCC-----CCCCCcCCCCCceEeCcCCccc-------------------ccCCCcccEEeCCCCcCCCCC----CcccC
Q 038098           75 KLTS-----IPSTLWNLKDILYLDLSSNFLL-------------------IGNLKVLVQVDLSMNNFSDVI----PTTIG  126 (580)
Q Consensus        75 ~l~~-----lp~~~~~l~~L~~L~l~~n~l~-------------------~~~l~~L~~L~l~~N~l~~~~----~~~~~  126 (580)
                      .++.     +...+...++|+.|++++|.+.                   ....+.|+.+++++|.++...    ...+.
T Consensus       104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~  183 (344)
T d2ca6a1         104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ  183 (344)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred             ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence            9876     3334456789999999999871                   235778999999999987433    23345


Q ss_pred             Cccccceecccccccccc-----CCcccccccccccccccccccCCC----ccccccccCcccEEEccCCcccCCCCCC-
Q 038098          127 GLKDLQYLFLEYNRLQGS-----IPDSIGDLINLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEGEIPNK-  196 (580)
Q Consensus       127 ~l~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~~~-  196 (580)
                      ..+.|+.|+|++|.|+..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|++++|+++..-... 
T Consensus       184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l  263 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV  263 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred             hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHH
Confidence            678999999999998742     334567789999999999998743    4456778899999999999987531100 


Q ss_pred             ------CCCccCccccCCCCc
Q 038098          197 ------GPFRNFSTESFEGNE  211 (580)
Q Consensus       197 ------~~~~~l~~~~~~~n~  211 (580)
                            .....+..+++++|.
T Consensus       264 ~~~l~~~~~~~L~~L~ls~N~  284 (344)
T d2ca6a1         264 VDAFSKLENIGLQTLRLQYNE  284 (344)
T ss_dssp             HHHHHTCSSCCCCEEECCSSC
T ss_pred             HHHhhhccCCCCCEEECCCCc
Confidence                  112345566666664

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=3.5e-13  Score=138.17  Aligned_cols=84  Identities=14%  Similarity=0.080  Sum_probs=55.4

Q ss_pred             cccceeccccccccccCCc----ccccccccccccccccccCCC----cccccc-ccCcccEEEccCCcccCCC-----C
Q 038098          129 KDLQYLFLEYNRLQGSIPD----SIGDLINLKSLNLSNNNLSGT----IPISLE-KLLDLKDINVSFNKLEGEI-----P  194 (580)
Q Consensus       129 ~~L~~L~l~~n~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~----~~~~~~-~l~~L~~l~l~~N~l~~~~-----~  194 (580)
                      ..|+.+++++|.++.....    .+....+|++|+|++|++++.    ++..+. ..+.|+.|++++|+|+...     .
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            4688888888888754322    234456899999999988753    223332 3567899999999987521     1


Q ss_pred             CCCCCccCccccCCCCcc
Q 038098          195 NKGPFRNFSTESFEGNEL  212 (580)
Q Consensus       195 ~~~~~~~l~~~~~~~n~~  212 (580)
                      .....+++..+++++|+.
T Consensus       392 ~l~~~~~L~~L~Ls~N~i  409 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCL  409 (460)
T ss_dssp             HHHHCCCCCEEECCSSSC
T ss_pred             HHhcCCCCCEEECCCCcC
Confidence            112346777888888865

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.77  E-value=2.7e-10  Score=116.15  Aligned_cols=181  Identities=21%  Similarity=0.138  Sum_probs=128.7

Q ss_pred             cCCCCCCCEEeccCCcCCCC-----CchhhhCCCCCceeeCCCCcCCcCCC----ccccCCCCCcEEEcCCCCCCC----
Q 038098           12 VGKLQKLQLLSLEDNQLEGS-----IPDDLCRLAALFELDSGGNKLDGFVP----ACFGNLTNLRNLYLGSNKLTS----   78 (580)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~----   78 (580)
                      +...+.++.+++++|.+...     .+..+.....++.|++++|.+.....    ..+...+.++.+++++|.++.    
T Consensus       222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~  301 (460)
T d1z7xw1         222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  301 (460)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            44678899999999987521     23344556789999999998864322    235667899999999999863    


Q ss_pred             -CCCCC-cCCCCCceEeCcCCccc----------ccCCCcccEEeCCCCcCCCCC----CcccC-Cccccceeccccccc
Q 038098           79 -IPSTL-WNLKDILYLDLSSNFLL----------IGNLKVLVQVDLSMNNFSDVI----PTTIG-GLKDLQYLFLEYNRL  141 (580)
Q Consensus        79 -lp~~~-~~l~~L~~L~l~~n~l~----------~~~l~~L~~L~l~~N~l~~~~----~~~~~-~l~~L~~L~l~~n~l  141 (580)
                       +...+ .....|+.+++++|.+.          +...++|++|+|++|+++...    +..+. ..+.|+.|+|++|.|
T Consensus       302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i  381 (460)
T d1z7xw1         302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  381 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence             21212 23467999999999872          345668999999999986432    22332 456799999999999


Q ss_pred             ccc----CCcccccccccccccccccccCCCccccc----c-ccCcccEEEccCCcccCC
Q 038098          142 QGS----IPDSIGDLINLKSLNLSNNNLSGTIPISL----E-KLLDLKDINVSFNKLEGE  192 (580)
Q Consensus       142 ~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~-~l~~L~~l~l~~N~l~~~  192 (580)
                      ++.    +...+..+++|++|+|++|+|++.....+    . ....|+.|++.+|.+...
T Consensus       382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence            752    44556677999999999999986433333    2 234799999999998753

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=6e-10  Score=96.19  Aligned_cols=21  Identities=29%  Similarity=0.376  Sum_probs=10.5

Q ss_pred             cccCCCCCcEEEcCCCCCCCC
Q 038098           59 CFGNLTNLRNLYLGSNKLTSI   79 (580)
Q Consensus        59 ~~~~l~~L~~L~l~~N~l~~l   79 (580)
                      .+..+++|++|+|++|+|+.+
T Consensus        60 ~~~~~~~L~~L~Ls~N~i~~l   80 (162)
T d1koha1          60 IEENIPELLSLNLSNNRLYRL   80 (162)
T ss_dssp             HHHHCTTCCCCCCCSSCCCCC
T ss_pred             HHHhCCCCCEeeCCCccccCC
Confidence            334445555555555555544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.60  E-value=3e-09  Score=91.65  Aligned_cols=82  Identities=23%  Similarity=0.223  Sum_probs=54.0

Q ss_pred             cCCCcccEEeCCCCcCCCCC--CcccCCccccceeccccccccccCCcccccccccccccccccccCCCccc-------c
Q 038098          102 GNLKVLVQVDLSMNNFSDVI--PTTIGGLKDLQYLFLEYNRLQGSIPDSIGDLINLKSLNLSNNNLSGTIPI-------S  172 (580)
Q Consensus       102 ~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-------~  172 (580)
                      ..+++|+.|+|++|+|+.+.  +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|.++.....       .
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence            45677777777777777653  34456678888888888888743332344445678888888888754432       2


Q ss_pred             ccccCcccEEE
Q 038098          173 LEKLLDLKDIN  183 (580)
Q Consensus       173 ~~~l~~L~~l~  183 (580)
                      +..+|+|+.||
T Consensus       142 ~~~~P~L~~LD  152 (162)
T d1koha1         142 RERFPKLLRLD  152 (162)
T ss_dssp             HTTSTTCCEET
T ss_pred             HHHCCCCCEEC
Confidence            45567777664

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.60  E-value=1.5e-07  Score=87.90  Aligned_cols=148  Identities=17%  Similarity=0.143  Sum_probs=105.9

Q ss_pred             HHHHHhcCCCcCceeccccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCcee
Q 038098          286 EIFQATNGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKA  364 (580)
Q Consensus       286 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  364 (580)
                      |+......|+..+..+-++.+.||+.... ++.+++|+...........+.+|...++.+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            56666677776655444445789988654 6778899886665555567888999888774 334677888888888899


Q ss_pred             eEeeccCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 038098          365 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------  409 (580)
Q Consensus       365 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------  409 (580)
                      +||++++|.++.+.....      .....++.++++.++.||+..                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998886543221      112345666777777777310                                   


Q ss_pred             ---------------------CCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          410 ---------------------SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       410 ---------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                                           ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 1237899999999999987767799999876

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.17  E-value=2.7e-06  Score=78.58  Aligned_cols=130  Identities=16%  Similarity=0.122  Sum_probs=89.3

Q ss_pred             eeccccC-ceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCC--CCcceEEeeeecCCceeeEeeccCCCCh
Q 038098          299 LIGRGGF-GSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRH--RNIIKIISSCSSDDFKALVLEYMPHGSL  375 (580)
Q Consensus       299 ~lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L  375 (580)
                      .+..|.. +.||+....++..+++|.....   ....+..|...++.+..  -.+.+++++..+++..++|||+++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 6789999888888999986433   33457778888887743  3356788888888888999999988665


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 038098          376 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----------------------------------------------  408 (580)
Q Consensus       376 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----------------------------------------------  408 (580)
                      .+..      ...   ...+.++++.++-||.-                                               
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4311      111   12233444455555520                                               


Q ss_pred             --------CCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          409 --------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       409 --------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                              ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    02347999999999999987777899999875

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.03  E-value=5.6e-07  Score=77.40  Aligned_cols=39  Identities=5%  Similarity=0.198  Sum_probs=17.6

Q ss_pred             CCCCCEEeccCC-cCCCC----CchhhhCCCCCceeeCCCCcCC
Q 038098           15 LQKLQLLSLEDN-QLEGS----IPDDLCRLAALFELDSGGNKLD   53 (580)
Q Consensus        15 l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~N~l~   53 (580)
                      .++|+.|+|+++ .++..    +-..+...++|++|+|++|.+.
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence            355556666542 34311    1123334445555555555544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.01  E-value=1.1e-06  Score=75.53  Aligned_cols=106  Identities=12%  Similarity=0.097  Sum_probs=79.6

Q ss_pred             hCCCCCceeeCCCC-cCCcC----CCccccCCCCCcEEEcCCCCCCC-----CCCCCcCCCCCceEeCcCCcc-------
Q 038098           37 CRLAALFELDSGGN-KLDGF----VPACFGNLTNLRNLYLGSNKLTS-----IPSTLWNLKDILYLDLSSNFL-------   99 (580)
Q Consensus        37 ~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~-----lp~~~~~l~~L~~L~l~~n~l-------   99 (580)
                      .+.++|++|+|+++ .++..    +-..+...++|++|+|++|.+..     +...+...+.|++|+|++|.|       
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            35689999999974 56532    22347778999999999999974     333445568899999999998       


Q ss_pred             ---cccCCCcccEEeCCCCcCCCCC-------CcccCCccccceecccccccc
Q 038098          100 ---LIGNLKVLVQVDLSMNNFSDVI-------PTTIGGLKDLQYLFLEYNRLQ  142 (580)
Q Consensus       100 ---~~~~l~~L~~L~l~~N~l~~~~-------~~~~~~l~~L~~L~l~~n~l~  142 (580)
                         .+...++|++|++++|.+..+.       ...+...++|+.|+++.+...
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~  144 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  144 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence               3667889999999999876442       334455688999999877543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.57  E-value=4e-06  Score=71.80  Aligned_cols=66  Identities=14%  Similarity=0.131  Sum_probs=37.3

Q ss_pred             cCCCCCCCEEeccC-CcCCCC----CchhhhCCCCCceeeCCCCcCCcCCC----ccccCCCCCcEEEcCCCCCC
Q 038098           12 VGKLQKLQLLSLED-NQLEGS----IPDDLCRLAALFELDSGGNKLDGFVP----ACFGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus        12 ~~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~   77 (580)
                      ..+.++|++|+|++ +.|+..    +-..+...++|++|+|++|.++....    ..+...++++.|++++|.++
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            34556777777776 345421    22344456677777777776653211    13444566666666666664

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00021  Score=69.88  Aligned_cols=77  Identities=18%  Similarity=0.217  Sum_probs=50.2

Q ss_pred             CceeccccCceEEEEEeC-CCCEEEEEEEecc-------ccchhhhHHHHHHHHhhcC-C--CCcceEEeeeecCCceee
Q 038098          297 NNLIGRGGFGSVYKARIQ-DGMEVAVKVFDLQ-------YGRAFKSFDIECDMIKRIR-H--RNIIKIISSCSSDDFKAL  365 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  365 (580)
                      .+.||.|....||+.... +++.|+||.-...       ......+...|.+.++.+. +  ..+.+++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            356899999999999865 4678999976421       1123345667888887763 2  3456666553  445678


Q ss_pred             EeeccCCCCh
Q 038098          366 VLEYMPHGSL  375 (580)
Q Consensus       366 v~e~~~~g~L  375 (580)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.42  E-value=1.2e-05  Score=68.70  Aligned_cols=41  Identities=7%  Similarity=0.016  Sum_probs=20.6

Q ss_pred             hCCCCCceeeCCC-CcCCcC----CCccccCCCCCcEEEcCCCCCC
Q 038098           37 CRLAALFELDSGG-NKLDGF----VPACFGNLTNLRNLYLGSNKLT   77 (580)
Q Consensus        37 ~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~l~~N~l~   77 (580)
                      .+.++|++|+|++ |.|+..    +-..+...++|++|+|++|.++
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence            3445666666665 334311    1112345556666666666554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.97  E-value=0.00095  Score=63.26  Aligned_cols=133  Identities=14%  Similarity=0.162  Sum_probs=77.8

Q ss_pred             CceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCc--ceEEe-----eeecCCceeeEeeccCCCCh--
Q 038098          305 FGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI--IKIIS-----SCSSDDFKALVLEYMPHGSL--  375 (580)
Q Consensus       305 ~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~g~L--  375 (580)
                      --.||++...+|+.|++|+.... ....+++..|...+..+....+  +..+.     .....+..+.++++++|..+  
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            35899999999999999997644 2244667888888888753222  11111     12345567889999876422  


Q ss_pred             ---HHH---------hhc----C----CCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCC
Q 038098          376 ---EKC---------LYS----S----NYILDIF----------------------QRLNIMIDVASALEYL-HFGYSVP  412 (580)
Q Consensus       376 ---~~~---------l~~----~----~~~~~~~----------------------~~~~i~~~i~~~l~~L-h~~~~~~  412 (580)
                         ..+         ++.    .    +...++.                      .....+.++...+.-. ......+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               111         010    0    0111111                      1122233333333222 1233567


Q ss_pred             eEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          413 IIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       413 i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      ++|+|+.+.|||++++  ..++||+-++
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcc
Confidence            8999999999999743  4589999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.87  E-value=0.0024  Score=59.97  Aligned_cols=157  Identities=13%  Similarity=0.090  Sum_probs=85.8

Q ss_pred             ccCHHHHHHHhcCCCcCceec-----cccCceEEEEEeCCCCEEEEEEEeccccchhhhHHHHHHHHhhcCCCCc--ceE
Q 038098          281 RFTYLEIFQATNGFSENNLIG-----RGGFGSVYKARIQDGMEVAVKVFDLQYGRAFKSFDIECDMIKRIRHRNI--IKI  353 (580)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~lg-----~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~  353 (580)
                      ..+..|+.....+|.+.+...     .|---+.|+....+| .+++|+....  ...+.+..|++++..+...++  ...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence            356788888888998865543     455567899987755 5899998543  223455567777777642222  111


Q ss_pred             Eee------eecCCceeeEeeccCCCChHH-----H---------hhc----CC----C------------------CCC
Q 038098          354 ISS------CSSDDFKALVLEYMPHGSLEK-----C---------LYS----SN----Y------------------ILD  387 (580)
Q Consensus       354 ~~~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~----~~----~------------------~~~  387 (580)
                      +..      .........++.++.+.....     .         ++.    ..    .                  ...
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            111      112334455566655432210     0         000    00    0                  000


Q ss_pred             HHHHHHHHHHHHHHHHHHh-cCCCCCeEEecCCCCCEEeCCCCcEEEccccCcc
Q 038098          388 IFQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  440 (580)
Q Consensus       388 ~~~~~~i~~~i~~~l~~Lh-~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~a~  440 (580)
                      .......+..+...+...+ .....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111122222333333333 2346789999999999999998877899999886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.77  E-value=0.0026  Score=61.91  Aligned_cols=73  Identities=16%  Similarity=0.165  Sum_probs=49.1

Q ss_pred             CceeccccCceEEEEEeCCC--------CEEEEEEEeccccchhhhHHHHHHHHhhcC-CCCcceEEeeeecCCceeeEe
Q 038098          297 NNLIGRGGFGSVYKARIQDG--------MEVAVKVFDLQYGRAFKSFDIECDMIKRIR-HRNIIKIISSCSSDDFKALVL  367 (580)
Q Consensus       297 ~~~lg~G~~g~v~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  367 (580)
                      ++.|+-|-.-.+|++..+++        +.|.+++.. .. .......+|..+++.+. +.-..++++++..    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            35688888889999986542        457777654 22 22334567888888874 4334577887753    6899


Q ss_pred             eccCCCCh
Q 038098          368 EYMPHGSL  375 (580)
Q Consensus       368 e~~~~g~L  375 (580)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544